<SEC-DOCUMENT>0000950170-23-008437.txt : 20230316
<SEC-HEADER>0000950170-23-008437.hdr.sgml : 20230316
<ACCEPTANCE-DATETIME>20230316160252
ACCESSION NUMBER:		0000950170-23-008437
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		91
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230316
DATE AS OF CHANGE:		20230316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GERON CORP
		CENTRAL INDEX KEY:			0000886744
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				752287752
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20859
		FILM NUMBER:		23738718

	BUSINESS ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6504737700

	MAIL ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GERON CORPORATION
		DATE OF NAME CHANGE:	19960521
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>gern-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-03-16T10:10:11.2003+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:gern="http://www.geron.com/20221231" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_484f1f7c-80da-4a5f-a649-6ee82880af52" name="dei:AmendmentFlag" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d">false</ix:nonNumeric><ix:nonNumeric id="F_52f00f46-0bfb-40c9-82a1-760c37619fda" name="dei:CurrentFiscalYearEndDate" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d">--12-31</ix:nonNumeric><ix:nonNumeric id="F_2979800c-ed6f-41d1-96e0-3d396f1f479c" name="dei:DocumentFiscalPeriodFocus" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d">FY</ix:nonNumeric><ix:nonNumeric id="F_9bf61295-c017-4436-ab49-b8f01772ba7d" name="dei:EntityCentralIndexKey" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d">0000886744</ix:nonNumeric><ix:nonFraction id="F_bfd71529-05f4-48f8-877b-c43d276239bd" name="us-gaap:DebtCurrent" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_6f65910a-85b0-43bb-9607-4708c982ad15" name="us-gaap:CommitmentsAndContingencies" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_a1a45976-6577-45f6-bd62-311e76651aed" name="gern:LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" contextRef="C_8af4ea7a-14b9-439a-947c-122628bbe8e3" format="ixt-sec:durwordsen">three month</ix:nonNumeric><ix:nonFraction id="F_3aabcce5-1c7c-451e-b4c2-7b744fe20a51" name="us-gaap:CommitmentsAndContingencies" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_92ef33b6-8618-4974-b348-ee7b47f16ded" name="us-gaap:PreferredStockValue" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_fac1e377-c483-4a1a-9d83-c9d6e9abca35" name="us-gaap:PreferredStockValue" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" unitRef="U_USD" xsi:nil="true"></ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="gern-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_7067ae1e-fdcb-4353-ba94-faa3c668d9a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4cae8e78-c215-4912-8bd0-8a601c68ba56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gern:AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-04</xbrli:startDate><xbrli:endDate>2020-09-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0bcef938-7207-4be9-86d3-25661bdb92a4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4c2322a1-867d-4db1-bcb9-a772d5cbd539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eb51ffc8-633d-41e3-86c8-d3c430b99a37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c435dd46-e5e9-46ae-a67c-f00cecd6b5ca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d8e95986-943a-430c-9308-147c97f446ca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CorporateNoteSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5a8fb967-a98b-480a-b077-c269bd33b318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8af4ea7a-14b9-439a-947c-122628bbe8e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USTreasurySecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2300d06c-433b-4ed1-92b5-9487bbe32374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_00475ab1-e9e1-429c-8b5f-a7102a011121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5972d6c9-9d7e-481d-990f-61c5b5a57683"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:ClassActionStipulationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-02</xbrli:startDate><xbrli:endDate>2022-09-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_65c0c19d-b9d5-425b-8f80-5c1480a5777f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_17094203-716a-4cd1-bfc5-d68528adcc58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2007-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_81527741-3307-4f06-998a-99b34c4ab029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a854c1d-782a-4c0f-9f77-518042e397b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyTwoStockPurchaseWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoUnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_baba9cae-f153-4485-a773-5ab5408054ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9ec15f2a-f73b-4dc2-aa8c-a5bb91e19d44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:IncentiveAwardPlan2011Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_40862263-7a78-4142-96a9-9c68851d893e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b658edd-fed5-40c3-886d-f2742643a130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyPreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1282d3f-c653-4ad5-895b-9c6f061f0d82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7ec69a5c-401a-4250-9b22-6bf9e011ced3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bb1cd79-e4c2-4cca-9bd9-1694bdbca8bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4ee2c259-7a89-4422-9ee1-25f729319635"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5fc3a521-0418-415b-ac73-ad0099a49a25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_39a6cda9-f091-4e32-8ec9-20bf358a8724"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:PublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b2e14894-763e-4f1a-963f-b97397735098"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_77f8406a-f6d2-4060-81b8-e54a35afa90b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d1078eed-3e6a-4e01-b62d-1ba7e0711b75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a981f541-3690-49c7-8693-645d2e5d3905"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_07596f55-6ae2-4a67-8b3a-4ad996e8ecda"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:OptionThreeMinCashDebtCovenantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4128807c-b8ab-4df3-874f-d7528b109faf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_119d0654-c503-470b-bd38-81fafe81f4a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50d35c3d-da63-429d-b83a-be9fed64780e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a5a96aa2-9ab9-4312-a1d6-6a03ed292708"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:FosterCityOfficeSpaceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-10</xbrli:startDate><xbrli:endDate>2020-03-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3b7b4b9-7629-4b56-93a5-2b3ac17f8fa9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:PublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e324494e-e119-4b64-9797-465da2721c25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyThreeUnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-10</xbrli:startDate><xbrli:endDate>2023-01-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6a7a9685-7310-4141-b7de-f1f3a5fe3099"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">gern:ConsultantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2a620b62-e7da-4c15-931d-242b957c2e33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsMarketValueStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4dd4d649-9e3f-43f2-a911-a45ce22da643"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f4b65990-18fd-492e-bb4e-3100622411aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">gern:ConsultantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_45b58f62-d075-497a-b48c-39eed3349c1e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_df267c14-3ea1-4c00-bdd8-a254e98ace01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b3526ab0-c75e-405c-863a-c481f65b0e53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_510d1c51-dbe3-4e7b-b27f-0d63cbea1e18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:DerivativeStipulationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USTreasurySecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e1ca1ecd-84e7-44b0-9101-90008f265fe7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:DerivativeStipulationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-21</xbrli:startDate><xbrli:endDate>2022-12-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46064b1d-9be0-4b4a-b281-d673cc14f9ce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0c264877-8e22-46f9-81fb-86523d23e816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-08-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b2a2ed0b-eacb-4d70-8bd1-ea1bfa4295ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7499ed6b-e67c-4f6e-a715-1f45f02f42a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7173b90d-0319-4205-a8c0-5d652abfb4d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_de7e0e4c-33d2-4fbd-abef-d98a0ee733d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_08938cfb-9117-4cc5-bf8f-c64669b9d0c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_67437463-073a-4955-8276-418e60d06173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c2932c3c-e846-4bca-b1d9-5fb417e16d20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a1d6bb34-0ef3-4d19-8ba5-2d252c631a2d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:FirstDirectorOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsPlan2006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_97fcaa43-bed8-4b86-a62c-6f9d8b9c790c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7721473b-e44a-495b-a88c-6dcad8f4774e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d86d7526-9741-423f-bbce-ccac767d714b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c72685f3-ef5b-4333-a58d-7abf3242e43e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dbfbf1d8-b44a-4e72-892f-10af9a860032"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:DerivativeStipulationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a277aece-144d-41bf-ac57-a96d6580356c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cdf85569-9ffa-4bd1-9243-691e0be460f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8dde9c08-9af2-47ef-968f-e8dd40116f7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b32a587f-ad3d-4276-b2dd-b2191eb465c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_763fcb27-2540-444d-aa95-1260c6a8a319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8a321658-2588-4571-b73d-e0f5a7ae11d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48f80dba-88b9-464b-b378-7d4f9dec15e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_53f68612-65e0-46e6-9f29-f76b1403dad8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_edd74574-ef0b-4838-bc41-a10ed60b1539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsPlan2006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2df5fcf2-ae81-4411-9005-55dc5786810b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a42e573b-f7ea-45fe-a906-765e787d71d7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:OptionOneMinCashDebtCovenantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2160f3d4-592d-437d-adaa-f0dadac52a38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a9d34b21-3b42-469c-8d2b-2b3121f04885"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6f3c409b-23a5-42d9-b49c-56b851f33720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2df0f37c-c30d-41b8-bfdd-adc5d10dafdf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:FosterCityOfficeSpaceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a27088b6-011b-4c88-b5b1-4d7e58876f27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4eef0fe5-3ea8-493b-b90b-931244691f4b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6c35c921-9678-4686-aae9-1f7c867e1bf1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1dbff205-2f6f-4aba-8edf-3911a28267ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8cfe8a11-2aaf-4633-afe2-e2611965102d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cc50e10a-98c8-4c05-bd82-9e1ea746a195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eb5e283e-aa95-4522-b670-5622af075da2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CorporateNoteSecuritiesDueInOneToTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_de96a085-6c20-4cd2-b653-9124bc246e53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e0cb6378-4392-4819-891f-21cef9a108eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_49598f56-03d9-4dbd-bdcf-22537e7a9cdc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cb27a432-0c32-4ac0-85da-f75446291e71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:OptionTwoMinCashDebtCovenantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_51f08322-078d-49e5-a68a-9be92cd9298d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2007-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_648decac-61a1-4e4b-9ed3-d82a76be83ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b0bbca5f-033b-4845-9d80-bbded572734a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CorporateNoteSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4179612c-6be5-467d-9224-83de62d460cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d81bd636-0218-4286-b8c2-3cccfc33f5fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_61a9529a-15e0-492a-891c-e7c1701d7744"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3ddd7b62-3be3-4f53-81bf-05b1841c6fb1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cd9ae385-7003-4516-b937-03283c53b8c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bef8e8ac-62e3-46f1-91db-450c61420e02"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5c61e68e-3e69-41cb-8620-6254f8ecadab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6c5c907c-4ae9-4b51-a14d-03a3b5e1c929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsMarketValueStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9d9caad1-b187-4705-af84-3d4912060cb5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:MunicipalSecuritiesDueInOneToTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_133df937-8209-4564-b4d5-073c7409a5c5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsMarketValueStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9c4a1e4a-ddee-40c4-b8df-5752dec9177f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ccde2552-23ce-42cd-8f03-8868e1c3afee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USTreasurySecuritiesDueInOneToTwoYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e7b46167-4167-4419-ac2b-387a17bd683b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenInducementAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_15ca08dc-811e-4853-9a21-7cadf99c377c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cdb043ed-5bb6-48a5-9edc-3b464d5cb5cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7763dbfa-0c47-4691-b0c0-db932124a4fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a9eac63f-ff18-4e30-bd6c-4d89efb022b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_368cb29f-d2a8-456f-a097-df828e4c375b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a6f63570-90af-4655-9959-2d2b2d53203e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_20457731-c8fd-4ab5-9a21-4c427a763c88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:FosterCityOfficeSpaceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0d35dd6e-fea6-436e-9ee7-9ee08382b573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fb131e02-2952-4669-a8d3-c6f166ff823e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoPurchaseWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_964ca538-6017-4a3b-b8a2-c9d92e9678f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_54fac2af-1b06-465c-8688-a1f93e1c62db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoPurchaseWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c5ddc099-a29b-4862-ab9f-bc6cd0c2eeb4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_20b70013-d0fe-4f60-92b2-60c28f12e1f9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyStockPurchaseWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_904fa704-ef5e-41de-bcb5-2bf7706d0288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1bd32fc3-5385-4fc1-8876-a5ae5a63137b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_626b835f-8e2e-4400-9c68-0c1fa598c173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_09482968-6804-42ef-b55a-7e47a1585b7a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:SubsequentDirectorOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_36ec7de2-c549-426b-84af-98fe5ccaae70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e9362c9-abee-4e6e-9b1f-44d66edd6913"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2007-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aecbaf53-81e4-4762-8e18-b6fdfe03ee7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7edff532-41dd-4915-82d0-0b9e814e4cc5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c9710e3f-58c2-40a2-971c-f2229ca8bfa7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e89875f1-6be5-42d0-a126-eaeafb581f48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:PublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c1b00895-a644-46d2-a56f-b109682d7aff"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9a7438fe-fa93-48c8-875b-77ecf443a7b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47db9b05-7d9e-4426-bef0-d9bcedf945c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_73738e9e-def3-4ee6-be15-64304b5e3b63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9097bf2a-3ae2-4f30-af86-bb131d89eb94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:SiliconValleyBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_638535ad-bd14-404f-b802-160cfe13fd2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_55d50b28-7933-42d2-89ca-ec42b87d67cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1d4e0718-b0bc-4bde-abe3-dd33013adfd1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bb6bcd2c-ccc9-458c-9e1a-1799ed2c561e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6dfbe752-26a8-4b61-804f-713c8b76e3b2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_04fded04-be5d-4eb8-81d5-fec058c4ac52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gern:AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_603a7d01-dfd6-49d7-a945-469443432a26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">gern:ConsultantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_82638e68-0f41-4c08-bac3-823ad702cd9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_acfe2948-7468-4c15-a637-904a59f62dc4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:ClassActionStipulationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_edb3e230-dfab-42f5-babc-05523982f83c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8e72c6e8-4130-431a-9367-bbc923943f0f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_944921c7-37fd-48a6-87d7-c57fd7ba68ce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cedb5760-788e-4697-a91b-595a15fe918f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a85bc201-e73d-4e53-910e-2be441096a11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-30</xbrli:startDate><xbrli:endDate>2019-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_00c2bd33-0379-417c-a384-344e1e28579a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:PerformanceBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_57eb8407-20bb-4fe8-b65e-a963754a7c2b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoUnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a5f6ada7-da6a-4619-8ac7-5fa8e6c89e2d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b8581e38-a6e8-4457-9acf-b0368e005111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyStockPurchaseWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8265167c-6a10-47c2-8235-d350b2140d50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_60c0161f-8996-404d-9368-ce41e9ce095e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a42ef773-e97a-473e-b41a-016b95e3980a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CommercialPaperDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50b6ef82-13c8-416b-8944-219722e7b07e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fd3dace5-dba8-440f-ae0b-9ef36f749a0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:FirstDirectorOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_51e2839a-be67-48c5-84d2-a44bd56bb75e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_193c3b80-125b-49fe-affd-e5219ad32f26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1bf14810-4b41-4fda-8ccf-f5f7c92e07e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9985ac27-b487-43dc-84e4-99f5eb3e2ee4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50af7db3-82da-48d8-bf5d-ca3bb07f1a6d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyPurchaseWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1acf8b0f-f8d1-4664-927d-c462800c5922"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyPurchaseWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1671901-1570-4d9b-ac8b-2fea04dc608d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7912cfc0-c229-4fc9-8043-9b98680b2a7e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:IncentiveAwardPlan2011Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a3cf8441-940c-4769-a1c9-ba37e4bc2812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:PublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e1b24643-c361-410f-bc44-b8aaa587644d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_80155c28-6ebb-4859-b15c-960beb5fc480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8188c97d-d82a-44e3-b0a5-e6f672e559c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2a6d46ff-973f-470e-82a2-82e94b643f46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_efcc9f37-8c8e-44d9-845b-1357eb47cb94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_876ba767-8660-41ef-8db0-cd6ad696ef32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyLeaseAndFosterCityLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dbeb080e-402b-4949-8760-3551ff83fae6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4ee8d9b9-dc68-4df6-9be2-6f4529782e09"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gern:AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_54a3bd1a-57e5-404b-8439-d921de6bd8fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1254ade3-fe72-434a-a6db-19a268f35273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_51546caa-efa4-41ff-89e0-38e80356cf4c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ae8e381a-0b3e-4435-957f-00dcf58c3b45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ceb4ddb1-f869-4bd6-84c2-9da20049ed84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4ff1bc89-e218-42c3-bcc6-62cce404dde7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:ClassActionStipulationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dd0bdc01-735d-4224-95b4-e75ddebf918f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoUnderwrittenPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyTwoPreFundedWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a7e69a6d-c732-438a-9a6d-1aab2a5533f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7cb51813-f174-40c0-8540-44661459217d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoUnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d47e697-4d40-47ed-be0f-6e5c7c2ad573"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:OptionTwoMinCashDebtCovenantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7b1c8d57-8ddb-43ec-96da-0180f39ff551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_80164d16-83fd-44b2-b84d-550276c31ca8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CommercialPaperDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c25e7348-7048-4607-8352-1048d40e8f79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:MunicipalSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2fbdf3b1-b70e-4491-98dc-8a732e4ad69a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_549c9ca4-a070-4d8b-8dea-097cccf0168e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4f5a5bab-8021-4724-80ff-5ed5222dffe6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ad743706-922f-45c0-83cd-2d0300569661"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:DerivativeStipulationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f076ddd2-9af8-4327-95c6-3a61cf5015db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ff678df4-6021-4567-a09d-3093fe7f6409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:FirstDirectorOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b205ee9d-75ed-48cf-b5e9-efc423b1fd1d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsPlan2006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:SubsequentDirectorOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7d2260f7-9b52-4e12-9966-22d0182d746c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsMarketValueStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c12dd335-911a-4fd2-9a2d-0514622f97e4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_76e00114-46f1-4f21-825f-b517b415c860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-30</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0dfd4851-82fe-4cb9-8ea1-8e34b2a9c816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f1b3c92-0ecb-4923-9ca5-2be4cf72dc09"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenInducementAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0ec8418b-4210-4aed-a7a0-402e2cb1fc9b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyThreeUnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1ac565cd-3589-476a-8008-a137d294bc33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_88b14be1-08cb-441b-9cd9-8b8e631765f9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_affcd469-d055-47cc-bca1-8f79424c3ea3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ee96da23-ae41-4e87-8c4d-c559a324f7a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0b8de677-089a-4241-b514-5dc0cbded8a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3fa5ac2d-7b0a-4dc7-b48d-d537f56e2330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4183e218-4909-4bf2-b115-abdea99d97df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d2345eb5-3285-459c-8d09-b6264509d71b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_537e337a-f742-4d0a-a5b6-5cf335eb225f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:FosterCityOfficeSpaceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_771ba2f2-3a2e-49fa-95cf-19050fec9326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886744</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_Item"><xbrli:measure>gern:Item</xbrli:measure></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_Institution"><xbrli:measure>gern:Institution</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="margin-left:35.187%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:35.185%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f2aa927c-4f78-4c01-a1e1-d87e8f202cae" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:35.187%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:35.185%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Mark One)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;"><ix:nonNumeric id="F_69bf5653-4a82-4354-9371-214de132bbef" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9746; </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the Fiscal Year Ended </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_734a0184-8b33-4634-ba09-f50c5138d347" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_64b5deea-ce57-479e-8f34-137d998c326a" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;"><ix:nonNumeric id="F_2fe185cd-c261-4251-b86a-61a3a71e9397" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the transition period from </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">          </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">         </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> .</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commission File Number: </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_690e2fd5-6bb6-4098-8348-6c8702a25138" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></ix:nonNumeric></span></p>
  <p style="margin-left:35.187%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:35.185%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:15.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_93c1fae8-f8b9-403e-a801-d224f2ab5808" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:15.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORP</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:15.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ORATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p>
  <p style="margin-left:35.187%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:35.185%;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_130335de-1e36-42f7-bbdc-a03246363f82" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or other jurisdiction of incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6ca44e7d-60f6-4e57-9c49-99eed9b1b540" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75-2287752</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />(I.R.S. Employer Identification No.)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6853e19d-df88-40ee-bb60-46e418a91243" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">919 East Hillsdale Blvd.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_30319888-c475-4d37-ba6a-dec7ab02cd54" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Suite 250</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9adea57a-741f-4ce2-bcce-b47c3e6217b2" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foster City</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_37e451d2-16f9-416e-908b-dd8f548a9b9d" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityAddressStateOrProvince"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CA</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5ec00ccb-2b3b-4e0e-8dab-8b088fd572ac" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94404</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s telephone number, including area code: (</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4d4409bc-b038-43df-882d-08708b936449" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">650</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7f1e49d5-46c5-4806-ba4e-83b2023017a4" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">473-7700</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:85.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.268%;"></td>
    <td style="width:23.115%;"></td>
    <td style="width:43.617%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of each class:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading symbol(s):</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of each exchange on which registered:</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eede46c0-e876-4dd0-afac-cd858c2f51d7" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock, $0.001 par value</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8b4643d3-a520-40a8-83cd-82036c390abf" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERN</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_837d9c06-bc18-404a-89de-06fb7367149e" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the registrant is a well&#x2011;known seasoned issuer, as defined in Rule 405 of the Securities Act.    </span><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d6163a24-427d-40dd-a3f6-8e7d58914f21" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityWellKnownSeasonedIssuer"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#9746;    No  &#9744;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  &#9744;    </span><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_254d8a3e-2b1a-4724-b44b-61af554c3ca3" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityVoluntaryFilers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#9746;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    </span><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c19a3a4b-3412-47fe-ba07-6699eaf0cb39" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#9746;    No  &#9744;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S&#x2011;T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5c0f82af-9dc1-432a-bd11-4d0d6b526168" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#9746;   No &#9744;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non&#x2011;accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b&#x2011;2 of the Exchange Act.</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:28.598%;"></td>
    <td style="width:2.857%;"></td>
    <td style="width:21.415%;"></td>
    <td style="width:4.286%;"></td>
    <td style="width:25.714%;"></td>
    <td style="width:1.415%;"></td>
    <td style="width:15.714%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_596210b6-f042-4005-90b1-f78a2a307282" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3bfb09b6-dc37-46cb-91a2-ce18ffbe2b8a" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fe80016e-d66b-4b77-8418-1c7b67fd05d8" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  &#9744;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#x2019;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eb667325-5ce5-477a-81e5-48bb6b3a243b" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:IcfrAuditorAttestationFlag" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#x2019;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b&#x2011;2 of the Act).  Yes    </span><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e7776162-35b3-4bc4-a76a-8241abc57b60" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  No  &#9746;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate market value of voting and non&#x2011;voting common equity held by non&#x2011;affiliates of the registrant was approximately $</span><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_82c7d575-0adc-4c81-b97f-e0c5a96a65b5" contextRef="C_36ec7de2-c549-426b-84af-98fe5ccaae70" name="dei:EntityPublicFloat" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">503,187,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> based upon the closing price of the registrant&#x2019;s common stock on June 30, 2022 on the Nasdaq Global Select Market. The calculation of the aggregate market value of voting and non&#x2011;voting common equity held by non&#x2011;affiliates of the registrant excludes shares of common stock held by each officer, director and stockholder that the registrant concluded were affiliates on that date. This determination of affiliate status is not necessarily a conclusive determination for other purposes.</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 9, 2023, there were </span><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_152675b8-fe8e-4025-81b9-5a18be3024ef" contextRef="C_7721473b-e44a-495b-a88c-6dcad8f4774e" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">508,722,486</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> sh</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ares of common stock outstanding.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f4274a34-0498-49ec-9027-7b190793664a" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:90.0%;"></td>
      <td style="width:1.0%;"></td>
      <td style="width:9.0%;"></td>
     </tr>
     <tr style="height:7.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Document</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form 10&#x2011;K<br />Parts</span></p></td>
     </tr>
     <tr style="height:8.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portions of the Registrant&#x2019;s definitive proxy statement for the 2023 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days of the Registrant&#x2019;s fiscal year ended December 31, 2022.</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">III</span></p></td>
     </tr>
    </table></ix:nonNumeric></div>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TABLE OF CONTENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.342%;"></td>
    <td style="width:83.483%;"></td>
    <td style="width:6.175%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><a href="#part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Business</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Properties</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><a href="#part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART II</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:right;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><a href="#item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market for the Registrant&#x2019;s Common Equity, Related Stockholder Matters and Issuer Purchases <br />of Equity Securities</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_6_reserved"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[Reserved]</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#mda"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">137</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">137</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9C.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9c_disclosure_regarding_foreign"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><a href="#part_iii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART III</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 10.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 11.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 12.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder <br />Matters</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 13.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 14.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal Accountant Fees and Services</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><a href="#part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART IV</span></a></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 15.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits and Financial Statement Schedules</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 16.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_16"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form 10&#x2011;K Summary</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">142</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">143</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In this report, unless otherwise indicated or the context otherwise requires, &#x201c;Geron,&#x201d; &#x201c;the registrant,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; and &#x201c;our&#x201d; refer to Geron Corporation, a Delaware corporation, and its wholly owned subsidiaries, Geron UK Limited, a United Kingdom company, and Geron Netherlands, B.V., a Dutch company.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Forward&#x2011;Looking Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This annual report on Form 10&#x2011;K, including &#x201c;Business&#x201d; in Part I, Item 1 of this annual report on Form 10-K and &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; in Part II, Item 7 of this annual report on Form 10-K, contains forward&#x2011;looking statements that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause the results of Geron Corporation, or Geron or the Company, to differ materially from those expressed or implied by such forward&#x2011;looking statements. All statements other than statements of historical fact are statements that could be deemed forward&#x2011;looking statements. In some cases, forward&#x2011;looking statements can be identified by the use of terminology such as &#x201c;may,&#x201d; &#x201c;expects,&#x201d; &#x201c;plans,&#x201d; &#x201c;intends,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;projects,&#x201d; &#x201c;believes,&#x201d; &#x201c;predicts,&#x201d; &#x201c;anticipates,&#x201d; &#x201c;estimates,&#x201d; &#x201c;potential,&#x201d; or &#x201c;continue&#x201d; or the negative thereof or other comparable terminology. The risks and uncertainties referred to above include, without limitation, risks related to uncertainty of non-clinical and clinical trial results or regulatory approvals or clearances, the future development of imetelstat, including any future efficacy or safety results that may cause the benefit&#x2011;risk profile of imetelstat to become unacceptable, our need for additional capital to support the development and commercialization of imetelstat and to otherwise grow our business, establishing and maintaining imetelstat manufacture and supply, enforcement of our patent and proprietary rights, managing our business growth, litigation risks, the effects of the COVID-19 pandemic or geopolitical events, potential competition and other risks that are described herein and that are otherwise described from time to time in our Securities and Exchange Commission reports including, but not limited to, the factors described in &#x201c;Risk Factors,&#x201d; in Part I, Item 1A of this annual report on Form 10&#x2011;K. Geron assumes no obligation for and except as required by law, disclaims any obligation to update these forward&#x2011;looking statements to reflect future information, events or circumstances.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factor Summary</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Below is a summary of material factors that make an investment in our common stock speculative or risky. Importantly, this summary does not address all of the risks and uncertainties that we face. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider this summary to be a complete discussion of all potential risks or uncertainties that may substantially impact our business. Additional discussion of the risks and uncertainties summarized in this risk factor summary, as well as other risks and uncertainties that we face, can be found under &#x201c;Risk Factors&#x201d; in Part I, Item 1A of this annual report on Form 10-K. The summary below is qualified in its entirety by that more complete discussion of such risks and uncertainties. Moreover, we operate in a competitive and rapidly changing environment. New factors emerge from time to time and it is not possible to predict the impact of all of these factors on our business, financial condition or results of operations. You should consider carefully the risks and uncertainties described under &#x201c;Risk Factors&#x201d; in Part I, Item 1A of this annual report on Form 10-K as part of your evaluation of an investment in our common stock.</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are wholly dependent on the success of our sole product candidate, imetelstat.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we fail to demonstrate sufficient safety and efficacy data from IMerge Phase 3 to the satisfaction of the U.S. Food and Drug Administration, or FDA, or similar international regulatory authorities, additional clinical testing may be required before we can seek regulatory approval for imetelstat in Low or Intermediate-1 risk myelodysplastic syndromes, or lower risk MDS, and begin commercialization, if at all, any of which could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our business and commercial prospects.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any suspension of or delays in IMpactMF, including due to the effects of macroeconomic conditions such the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our commercial prospects. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any termination of IMpactMF would have a material adverse effect on our business, business prospects and the future of imetelstat.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat may continue to cause, or have attributed to it, undesirable or unintended side effects or other adverse events that could further delay or prevent the commencement and/or completion of clinical trials for imetelstat, further delay or prevent its regulatory approval, or limit its commercial potential.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If IMpactMF fails to demonstrate safety and effectiveness to the satisfaction of the FDA or similar regulatory authorities in other countries or does not otherwise produce positive results, we would incur additional costs, experience delays in completing or ultimately fail in completing the development and commercialization of imetelstat in patients with Intermediate-2 or High-Risk myelofibrosis who have relapsed after or are refractory to treatment with a janus associate kinase inhibitor, or JAK inhibitor, or relapsed/refractory MF, which would have a material adverse effect on our business, business prospects and the future of imetelstat.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes, and results of earlier stage clinical trials and non-clinical studies may not be predictive of future results.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on third parties to conduct our clinical trials and their failure to perform could have a material adverse effect on our business that might cause us to cease operations.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our failure to obtain regulatory approval for imetelstat in the United States, or U.S., would have a material adverse effect on our business that would likely cause us to cease operations.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If imetelstat is approved for marketing and commercialization and we are unable to establish sales, marketing and distribution capabilities, or obtain coverage and adequate third-party payor reimbursement, we will be unable to successfully commercialize imetelstat.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are not successful in commercializing imetelstat, we will not be able to achieve our projections for future revenue, if any. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on third parties to manufacture and supply imetelstat, and may be unable to ensure that we have adequate quantities of imetelstat that meet specifications that may be approved or required by regulatory authorities, and timelines necessary for current and potential future clinical trials and potential commercial uses.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory inspections of third-party manufacturers may identify deficiencies in manufacturing processes or facilities which could impact the ability of third-party manufacturers to produce and deliver products, including imetelstat.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The COVID-19 pandemic has affected and continues to affect our ability to conduct clinical trial activities, causing delays in IMpactMF, IMproveMF, and our investigator-led clinical trial, IMpress, in acute myeloid leukemia, or AML, and Intermediate-2 or High-Risk myelodysplastic syndromes, or higher risk MDS. Additionally, the COVID-19 pandemic may delay and disrupt regulatory activities and our manufacturing and supply chain and have other adverse effects on our business and operations.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are unable to obtain and maintain sufficient intellectual property protection for imetelstat for an adequate amount of time, or if the scope of the intellectual property protection is not sufficiently broad, our competitors could develop and commercialize products similar or identical to imetelstat, and our ability to successfully commercialize imetelstat may be adversely affected.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If competitors develop products, product candidates or technologies that are superior to or more cost-effective than imetelstat, this would significantly impact the development and commercial viability of imetelstat; severely and adversely affect our financial results, business and business prospects and the future of imetelstat; and might cause us to cease operations.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the absence of potential proceeds from exercises of currently outstanding warrants and potential drawdowns under our term loan facility, or Loan Agreement, with Hercules Capital Inc., or Hercules, and Silicon Valley Bank, or SVB, we will require substantial additional funding to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as conducting the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned. We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or availability of additional funds under the Loan Agreement, if at all, particularly given the recent closure of SVB by banking regulators. The global economic slowdown, inflation, rising interest </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">rates and the prospects for recession, as well as recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure, could materially and adversely affect our ability to raise additional capital, which could negatively affect our liquidity, our business and business prospects and the future of imetelstat. If we are unable to raise this capital when needed, we would be forced to delay, reduce or eliminate our research and development activities and other operations or commercialization efforts which would have a material adverse effect on our business that might cause us to cease operations. Raising additional capital may subject us to unfavorable terms, cause dilution to our existing stockholders, restrict our operations, or require us to relinquish certain rights to imetelstat.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred significant losses and negative cash flows from operations since our inception and anticipate that we will continue to incur significant expenses and losses for the foreseeable future.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our level of indebtedness and debt service obligations could adversely affect our financial condition, and may make it more difficult for us to fund our operations.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We and certain of our officers have been named as defendants in pending securities class action lawsuits and shareholder derivative lawsuits. These lawsuits, and potential similar or related lawsuits, could result in substantial damages, divert management&#x2019;s time and attention from our business, and have a material adverse effect on our results of operations. These lawsuits, and any other lawsuits to which we are subject, will be costly to defend or pursue and are uncertain in their outcome.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to legal and contractual obligations related to privacy and information security. Our actual or perceived failure, or that of third parties upon which we rely, to comply with such obligations could harm our business. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additionally, if our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience adverse consequences.</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in and failures to comply with privacy and data protection obligations may adversely affect our business, operations and financial performance.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Calculation of Aggregate Market Value of Non&#x2011;Affiliate Shares</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of calculating the aggregate market value of shares of our common stock held by non&#x2011;affiliates as set forth on the cover page of this annual report on Form 10&#x2011;K, we have assumed that all outstanding shares are held by non&#x2011;affiliates, except for shares held by each of our executive officers, directors and certain 5% or greater stockholders. In the case of 5% or greater stockholders, we have not deemed such stockholders to be affiliates unless there are facts and circumstances which would indicate that such stockholders exercise any control over Geron. These assumptions should not be deemed to constitute an admission that all executive officers, directors and certain 5% or greater stockholders are, in fact, affiliates of Geron, or that there are no other persons who may be deemed to be affiliates of Geron. Further information concerning shareholdings of our executive officers, directors and principal stockholders is incorporated by reference in Part III, Item 12 of this annual report on Form 10&#x2011;K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PAR</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">T I</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 1.     BUSINESS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company Overview</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Our investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes, or lower risk MDS. In January 2023, we reported positive top-line results from our IMerge Phase 3 clinical trial. The trial met its primary endpoint of 8-week transfusion independence rate and a key secondary endpoint of 24-week transfusion independence rate, demonstrating highly statistically significant (i.e., P&lt;0.001 for both) and clinically meaningful benefits in imetelstat versus placebo. Furthermore, statistically significant and clinically meaningful efficacy results were observed in the trial across key subtypes, including patients who were ringed sideroblast positive, or RS positive, and ringed sideroblast negative, or RS negative; patients with high and very high baseline transfusion burden; and patients classified as Low or Intermediate-1 risk according to the International Prognostic Scoring System, or IPSS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on the positive top-line data from IMerge Phase 3 and the prior IMerge Phase 2, we plan to submit a New Drug Application, or NDA, to the FDA in the U.S. in mid-2023 and a marketing authorization application, or MAA, in Europe in the second half of 2023 for the use of imetelstat in adult patients with lower risk MDS. If the NDA is accepted for filing and imetelstat is approved for commercialization by the FDA within the timelines we expect, we anticipate commercial launch of imetelstat in lower risk MDS in the U.S. could occur in the first half of 2024. In Europe, we anticipate review of the planned MAA, if validated by the European Medicines Agency, or EMA, could take approximately 14 months and, if approved, we anticipate that the commercial launch of imetelstat in lower risk MDS in Europe could occur by the end of 2024.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that the positive top-line data from IMerge Phase 3 and IMerge Phase 2, as well as our prior Phase 2 clinical trial of imetelstat in patients with Intermediate-2 or High-Risk myelofibrosis who have relapsed after or are refractory to treatment with a janus associate kinase inhibitor, or JAK inhibitor, or relapsed/refractory MF, provide strong evidence that imetelstat targets telomerase to inhibit the uncontrolled proliferation of malignant stem and progenitor cells enabling recovery of bone marrow and normal blood cell production, which suggest potential disease-modifying activity. We believe this potential for disease modification could differentiate imetelstat from currently approved treatments in myeloid hematologic malignancies. Accordingly, in addition to lower risk MDS, we are developing imetelstat for the treatment of several myeloid hematologic malignancies with the following ongoing clinical trials:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF, a Phase 3 clinical trial in relapsed/refractory MF with overall survival, or OS, as the primary endpoint, that currently is enrolling patients. Based on our planning assumptions for enrollment and event (death) rates in the trial, we expect the interim analysis for OS in IMpactMF may occur in 2024, and the final analysis may occur in 2025. Because these analyses are event-driven and it is uncertain whether actual rates for enrollment and events will reflect current planning assumptions, the results may be available at different times than currently expected. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMproveMF, a Phase 1 combination clinical trial in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that currently is enrolling patients and the first patient was dosed in April 2021; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpress, an investigator-led Phase 2 clinical trial in Intermediate-2 or High-Risk myelodysplastic syndromes, or higher risk MDS, and acute myeloid leukemia, or AML, with the initial clinical site planned to open in 2023.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Imetelstat Regulatory Designations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat has been granted Fast Track designations by the FDA for development in two indications:  (1) for the treatment of adult patients with transfusion-dependent anemia due to lower risk MDS, who do not have a deletion 5q chromosomal abnormality, also known as non-del(5q), and who are refractory or resistant to treatment with an erythropoiesis stimulating agent, or ESA (i.e., the treatment population in IMerge Phase 3); and (2) for the treatment of adult patients with Intermediate-2 or High-Risk MF whose disease has relapsed after or is refractory to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JAK inhibitor treatment (i.e., the treatment population in IMpactMF). The FDA granted orphan drug designation to imetelstat in June 2015 for the treatment of MF and for the treatment of MDS in December 2015, and the EMA granted orphan drug designation in December 2015 to imetelstat for the treatment of MF and in July 2020 for the treatment of MDS. In October 2021, we gained access to the Innovative Licensing and Access Pathway, or ILAP, in the United Kingdom, or U.K., through the receipt of an Innovation Passport for imetelstat to treat lower risk MDS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stage-Gated Milestone-Driven Global Commercial Plans for Imetelstat</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If imetelstat is approved in lower risk MDS for marketing by regulatory authorities, we plan to commercialize imetelstat ourselves in the U.S. and may seek commercialization partners for territories outside of the U.S. We have therefore developed a commercial pre-launch and potential launch plan that is driven by the achievement of certain regulatory milestones, such as FDA acceptance for filing of our planned NDA, as well as EMA validation of our planned EU MAA submission. We are conducting pre-commercial preparations for the U.S., such as: enhancing and/or establishing company processes and systems to support a potential commercial launch, refining our market research in lower risk MDS, engaging in marketing and commercial access/reimbursement preparatory efforts, as well as executing on long-lead time activities, such as selecting a third-party logistics provider, completing state licensing requirements and hiring personnel to support potential sales, marketing and commercial operations. In light of the positive top-line IMerge Phase 3 results, we continue to evaluate our strategy for the potential launch and commercialization of imetelstat in Europe. Based on our internal estimates of pricing and addressable patient populations in 2030 and if regulatory authorities approve imetelstat for marketing in lower risk MDS and relapsed/refractory MF, we believe the combined potential peak market opportunity in the U.S. and key European markets for imetelstat is approximately $3.0 billion, of which lower risk MDS represents approximately $1.2 billion and relapsed/refractory MF represents approximately $1.8 billion.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Resources</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had approximately $173.1 million in cash, cash equivalents, restricted cash and current and noncurrent marketable securities. On January 10, 2023, we completed an underwritten public offering of 68,007,741 shares of our common stock and a pre-funded warrant to purchase 25,000,000 shares of our common stock, or the 2023 pre-funded warrant. The net cash proceeds from this offering are approximately $213.3 million, after deducting the underwriting discount and other offering expenses paid by us, and excludes any future proceeds from the exercise of the 2023 pre-funded warrant. In addition, from January 1, 2023 through March 9, 2023, we have received $59.8 million in cash proceeds from the exercise of outstanding warrants.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our current operating plan and our expectations regarding the timing of the submission and potential acceptance and approval of our planned NDA by the FDA for imetelstat in lower risk MDS and the potential commercialization in the U.S. for the use of imetelstat in adult patients with lower risk MDS, we believe that our existing cash, cash equivalents, restricted cash and current and noncurrent marketable securities, including the net cash proceeds from our recently closed underwritten public offering in January 2023 and the proceeds from the exercise of warrants that we received in the January and February 2023, will be sufficient to fund our projected operating requirements through the end of the third quarter of 2025, which includes potential U.S. commercial launch of imetelstat in lower risk MDS in the first half of 2024. In the absence of potential proceeds from exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as conducting the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned. We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or availability of additional funds under the Loan Agreement, if at all, particularly given the recent closure of SVB by banking regulators.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Orphan Drug Designations and Market Exclusivity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat has been granted orphan drug designations for both the treatment of myelodysplastic syndromes, or MDS, and MF in the U.S. and in Europe. In the U.S., under the Orphan Drug Act of 1983, orphan drug designation would convey market exclusivity in the designated indication for seven years after drug product approval. Thus, if we were to receive drug product approval in the U.S. for imetelstat in lower risk MDS in the first half of 2024, we anticipate that imetelstat will have orphan drug market exclusivity in the U.S. for such indication until the first half of 2031.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Europe, under the European Union Orphan drug regulation (EC) No. 141/2000, orphan drug designation would convey 12 years of market exclusivity, assuming we maintain orphan drug designation and fulfill the agreed</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">upon pediatric investigation plan under the European Union Orphan drug regulation (EC) No. 141/2000. Thus, if we were to receive drug product approval in Europe for imetelstat in lower risk MDS in the second half of 2024, we anticipate that imetelstat will have orphan drug market exclusivity in Europe for such indication until the second half of 2036.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patents and Patent Term Extensions</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have issued U.S. and European patents that provide patent coverage into 2033 pertaining to the treatment of MF and MDS with imetelstat. We also hold issued patents covering imetelstat composition of matter.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., our composition of matter patent coverage extends until December 2025, and our method of treatment patent rights for MDS and MF expire in March 2033. Under the provisions of the Drug Price Competition and Patent Term Restoration Act of 1984 (as amended), or the Hatch-Waxman Act, upon receipt of drug product approval, potential patent term extensions, if any, may be available to extend the patent term of either our composition of matter patent, or our method of treatment patent for MDS, in the U.S.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Europe, our composition of matter patent coverage expires in September 2024, and our method of treatment patent rights for MDS and MF expire in November 2033 in member countries of the European Patent Convention. One of our patents in each member country of the European Patent Convention may be eligible for patent term extension under a Supplementary Protection Certificate, or SPC, permitted under European Council (EC) Regulation No. 469/2009, or the European SPC Regulation, upon receipt of drug product approval, such as, for example, our method of treatment patent for MDS.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information provided in this section should be reviewed in the context of the section entitled &#x201c;Risks Related to Protecting Our Intellectual Property&#x201d; described in &#x201c;Risk Factors&#x201d; in Part I, Item 1A of this annual report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Telomerase: Scientific Rationale</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Telomeres and Telomerase in Normal Development</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the human body, normal growth and maintenance of tissues occurs by cell division. However, most cells are only able to divide a limited number of times, and this number of divisions is regulated by telomere length. Telomeres are repetitions of a deoxyribonucleic acid, or DNA, sequence located at the ends of chromosomes. They act as protective caps to maintain stability and integrity of the chromosomes, which contain the cell&#x2019;s genetic material. Normally, every time a cell divides, the telomeres shorten. Eventually, they shrink to a critically short length, and as a result, the cell either dies by apoptosis or stops dividing and senesces.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Telomerase is a naturally occurring enzyme that maintains telomeres and prevents them from shortening during cell division, such as stem cells that must remain immortalized to support normal health. Telomerase consists of at least two essential components: a ribonucleic acid, or RNA, template, which binds to the telomere, and a catalytic subunit with reverse transcriptase activity, which adds a specific DNA sequence to the chromosome ends. The 2009 Nobel Prize for Physiology or Medicine was awarded to Drs. Elizabeth H. Blackburn, Carol W. Greider and Jack Szostak, former Geron collaborators, for the discovery of how chromosomes are protected by both telomeres and telomerase.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Telomerase is active during embryonic development, enabling the rapid cell division that supports normal growth. During the latter stages of human fetal development and in adulthood, telomerase is repressed in most cells, and telomere length gradually decreases during a lifetime. In tissues that have a high turnover throughout life, such as blood and gut, telomerase can be transiently upregulated in progenitor cells to enable controlled, self&#x2011;limited proliferation to replace cells lost through natural cell aging processes. As the progeny of progenitor cells mature, telomerase is downregulated and telomeres shorten with cell division, preventing uncontrolled proliferation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Telomeres and Telomerase in Cancer</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Telomerase is upregulated in many tumor progenitor cells, enabling the continued and uncontrolled proliferation of the malignant cells that drive tumor growth and progression. Telomerase expression has been found to be present in approximately 90% of biopsies taken from a broad range of human cancers. Our non-clinical studies, in which the telomerase gene was artificially introduced and expressed in normal cells grown in culture, have suggested that telomerase does not itself cause a normal cell to become malignant. Instead, the sustained upregulation of telomerase enables tumor cells to maintain telomere length, providing them with the capacity for</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limitless proliferation. We believe that the sustained upregulation of telomerase is critical for tumor progression as it enables malignant progenitor cells to acquire cellular immortality and avoid apoptosis, or cell death.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Telomerase Inhibition and Hematologic Malignancies: Inducing Cancer Cell Death</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that inhibiting telomerase may be an attractive approach to treating cancer because it may limit the proliferative capacity of malignant stem and progenitor cells, which are believed to be important drivers of tumor growth and progression. We and others have observed in various in vitro and rodent tumor models that inhibiting telomerase: (a) results in telomere shortening and (b) arrests uncontrolled malignant cell proliferation and tumor growth.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hematologic malignancies, or blood cancers, are classified according to the precursor cell type. A myeloid hematologic malignancy is a cancer that occurs in the myeloid hematopoietic progenitor cells, such as the precursor cells of red blood cells, platelets and certain myeloid white blood cells, such as granulocytes. Myeloid neoplasms include myeloproliferative neoplasms, MDS and AML. Examples of myeloproliferative neoplasms include chronic myeloid leukemia, essential thrombocythemia, or ET, polycythemia vera and MF. These myeloid neoplasms are different from lymphocytic malignancies which typically occur in the lymphoid cell progenitor lineage, such as precursor cells of T lymphocytes and B lymphocytes. Examples of lymphoid malignancies include acute lymphoblastic leukemia, chronic lymphocytic leukemia, lymphomas and multiple myeloma.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many myeloid hematologic malignancies, such as ET, MF and MDS, have been shown to arise from malignant stem and progenitor cells that express higher telomerase activity and have shorter telomeres when compared to normal healthy cells. In vitro studies have suggested that tumor cells with short telomeres may be especially sensitive to the anti&#x2011;proliferative effects of inhibiting telomerase.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Imetelstat: The First Telomerase Inhibitor to Advance to Clinical Development</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat, our proprietary telomerase inhibitor which was discovered and developed at Geron, was designed to inhibit telomerase in malignant cells with continuously upregulated telomerase.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat is a lipid conjugated 13&#x2011;mer oligonucleotide that we designed to be complementary to and bind with high affinity to the RNA template of telomerase, thereby directly inhibiting telomerase activity. Imetelstat does not act as an antisense inhibitor of protein translation. The compound has a proprietary thio&#x2011;phosphoramidate backbone, which is designed to provide resistance to the effect of cellular nucleases, thus conferring improved stability in plasma and tissues, as well as improved binding affinity to its target. To improve the ability of imetelstat to penetrate cellular membranes, we conjugated the oligonucleotide to a lipid group. Imetelstat&#x2019;s IC50, or half maximal inhibitory concentration, is 3 &#x2013; 9 nM in cell free assays. Single&#x2011;dose kinetics in patients has shown dose&#x2011;dependent increases in exposure to imetelstat, with a plasma half&#x2011;life, which is the time it takes for the concentration or amount of imetelstat to be reduced by half, ranging from 4 &#x2013; 5 hours. Data from animal studies and clinical trials have suggested that the residence time of imetelstat in bone marrow is long, with 0.19 &#x2013; 0.51 &#xb5;M observed at 41 &#x2013; 45 hours after a 7.5 mg/kg dose in patients. Imetelstat also has been shown in non-clinical studies to exhibit relatively preferential inhibition of the clonal proliferation of malignant progenitor cells compared to normal progenitor cells. For these reasons, imetelstat has been studied as a potential treatment for malignant diseases.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe imetelstat is the first telomerase inhibitor to advance to clinical development. The Phase 1 trials that we completed evaluated the safety, tolerability, pharmacokinetics and pharmacodynamic effects of imetelstat. We established doses and dosing schedules that were tolerable and achieved target exposures in patients that were consistent with those required for efficacy in animal models. Following intravenous administration of imetelstat using tolerable dosing regimens, clinically relevant and significant inhibition of telomerase activity was observed in various types of tissue in which telomerase activity is measurable, including normal bone marrow hematopoietic cells, malignant plasma cells, hair follicle cells and peripheral blood mononuclear cells. Dose&#x2011;limiting toxicities included thrombocytopenia, or reduced platelet count, and neutropenia, or reduced neutrophil count.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Proof&#x2011;of&#x2011;Concept of Imetelstat&#x2019;s Disease&#x2011;Modifying Potential</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that imetelstat may have the potential to suppress the proliferation of malignant stem and progenitor cells while transiently affecting normal cells. Early clinical data from a Phase 2 trial of imetelstat in patients with ET, or the ET Trial, and a pilot study of imetelstat in patients with MF conducted at Mayo Clinic, or the Pilot Study, suggest imetelstat inhibits the progenitor cells of the malignant clones believed to be responsible for the underlying diseases in a relatively select manner, indicating potential disease-modifying activity. These data were published in two separate articles in a September 2015 issue of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The New England Journal of Medicine</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reported adverse events, or AEs, and laboratory investigations associated with imetelstat in the ET Trial and the Pilot Study included cytopenias, gastrointestinal symptoms, constitutional symptoms, and hepatic biochemistry abnormalities. Dose&#x2011;limiting toxicities, such as profound and prolonged thrombocytopenia and neutropenia, and other safety issues, including death, were observed in the ET Trial and the Pilot Study. In those trials, such myelosuppression was managed by dose holds and modification rules.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lead Indication in Phase 3 Clinical Development: Lower Risk Myelodysplastic Syndromes (MDS)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Unmet Medical Need in Lower Risk MDS for Broad and Durable Transfusion Independence</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MDS is a group of blood disorders in which the proliferation of malignant progenitor cells produces multiple malignant cell clones in the bone marrow resulting in disordered and ineffective production of the myeloid lineage, which includes red blood cells, white blood cells and platelets. In MDS, bone marrow and peripheral blood cells may have abnormal, or dysplastic, cell morphology. MDS is frequently characterized clinically by severe anemia, or low red blood cell counts, and low hemoglobin. In addition, other peripheral cytopenias, or low numbers of white blood cells and platelets, may cause life&#x2011;threatening infections and bleeding. Transformation to AML occurs in up to 30% of MDS cases and results in poorer overall survival.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MDS is the most common of the myeloid malignancies. There are approximately 60,000 people in the U.S. living with the disease and approximately 16,000 reported new cases of MDS in the U.S. every year. MDS is primarily a disease of the elderly, with median age at diagnosis around 70 years. The majority of patients, approximately 70%, fall into what are considered to be the lower risk groups at diagnosis, according to the International Prognostic Scoring System that assigns relative risk of progression to AML and overall survival by taking into account the presence of a number of disease factors, such as cytopenias and cytogenetics.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chronic anemia is the predominant clinical problem in patients who have lower risk MDS. Typically, these patients are treated with ESAs, such as erythropoietin, or EPO. Although ESAs provide an improvement in anemia in approximately 50% of patients, the effect is transient with a median duration of response of approximately two years. Once ESAs fail for patients, HMAs and lenalidomide have been used to improve anemia, but with limited success, such as reported 8-week red blood cell transfusion independence, or RBC-TI, rates of 17% for azacitidine, an HMA, and 27% for lenalidomide. In April 2020, a new drug, Reblozyl (luspatercept) was approved for use in a subgroup of lower risk MDS patients &#x2013; those with ringed sideroblasts. Such patients comprise approximately 15% to 30% of all lower risk MDS patients. The majority of patients who do not have ringed sideroblasts or who no longer respond to ESAs or other available drug therapies become dependent on red blood cell transfusions due to low hemoglobin. Serial red blood cell transfusions can lead to elevated levels of iron in the blood and other tissues, which the body has no normal way to eliminate. Iron overload is a potentially dangerous condition. Published studies in patients with MDS have shown that iron overload resulting from regular red blood cell transfusions is associated with a poorer overall survival and a higher risk of developing AML. We believe that, to date, no drug therapy has been shown prospectively to alter or delay the course of the disease in any human clinical trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">IMerge: Ongoing Phase 2/3 Clinical Trial in Lower Risk MDS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trial Design</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMerge is a two-part Phase 2/3 clinical trial evaluating imetelstat (7.5 mg/kg dose administered as a two-hour intravenous infusion every four weeks) in transfusion dependent lower risk MDS patients who are relapsed after, refractory to, or ineligible for prior treatment with an ESA. To be eligible for IMerge, patients were required to be transfusion dependent, defined as requiring at least four units of packed red blood cells, or RBCs, over an eight-week period during the 16 weeks prior to entry into the trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMerge Phase 3 is a double-blind, 2:1 randomized, placebo-controlled clinical trial that, based on discussions with U.S. and European regulatory authorities, was designed to support, if successful, the registration of imetelstat in lower risk MDS. The trial enrolled patients with lower risk transfusion dependent MDS who were relapsed, or refractory to, or ineligible for ESA, had not received prior treatment with either a hypomethylating agent, or HMA, or lenalidomide and were non-del(5q). IMerge Phase 3 is being conducted at 118 medical centers globally in 17 countries in North America, Europe, Middle East and Asia.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The primary efficacy endpoint of IMerge Phase 3 is the rate of red blood cell transfusion independence, or RBC-TI, lasting at least eight weeks, defined as the proportion of patients without any RBC transfusions during any consecutive eight weeks since entry to the trial, or 8-week TI. Key secondary endpoints for IMerge Phase 3 include the rate of RBC-TI lasting at least 24 weeks, or 24-week TI, and the rate of hematologic improvement erythroid, or HI-E, which is a rise in hemoglobin of at least 1.5 g/dL above the pretreatment level for at least eight weeks or a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reduction of at least four units of RBC transfusions over eight weeks compared with the prior RBC transfusion burden. Other secondary endpoints include the time to and duration of RBC-TI; the proportion of patients achieving Complete Response, or CR, or Partial Response, or PR, according to the 2006 International Working Group, or IWG, criteria for MDS; the proportion of patients requiring RBC transfusions and the transfusion burden; the proportion of patients requiring the use of myeloid growth factors and the dose; assessments of the change in the patients&#x2019; quality of life using several validated instruments; as well as an assessment of OS, and time to progression to AML.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Positive Top-Line Results from IMerge Phase 3</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, we reported positive top-line results from IMerge Phase 3. A total of 178 patients were enrolled in IMerge Phase 3, with patients randomized on a 2:1 basis to imetelstat (n=118) or placebo (n=60), and represents the intent-to-treat population in the trial. The population for the analysis of safety data is based on 177 patients (imetelstat, n=118, placebo, n=59) because one patient in the placebo arm was enrolled, but did not receive any treatment. The trial met its primary endpoint of 8-week TI rate and key secondary endpoint of 24-week TI rate, among others, demonstrating statistically significant and clinically meaningful results with imetelstat versus placebo with no new safety signals and safety results consistent with prior imetelstat clinical trials. Key patient participation information is as follows:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:67.358%;"></td>
    <td style="width:16.321%;"></td>
    <td style="width:16.321%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=60)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Median time on study, months (range)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.5 (1.4-36.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17.5 (0.7-34.3)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Median time on treatment, months (range)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.8 (0.03-32.5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.5 (0.03-26.7)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;Median time on treatment for 8-week TI responders, months (range)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17.2 (1.8-32.5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15.0 (4.1-25.8)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Median treatment, cycles (range)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (1-34)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (1-30)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.04in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;padding-bottom:0.04in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;Median treatment cycles for 8-week TI responders, months (range)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 (3-34)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 (3-29)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Key baseline demographics and disease characteristics of patients in IMerge Phase 3, summarized below, demonstrate the broad range of lower risk MDS subtypes, and patients with high disease burden, enrolled in the trial:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:67.005%;"></td>
    <td style="width:15.658%;"></td>
    <td style="width:17.337%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=60)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Age, years, median (range)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71.5 (44-87)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73.0 (39-85)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHO 2001 category, n (%)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;RS+</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73 (61.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37 (61.7)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;RS-</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44 (37.3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23 (38.3)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RBC transfusion burden, units/8 weeks, median (range)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (4-33)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (4-13)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;4 - 6 units / 8 weeks, n (%)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62 (52.5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33 (55.0)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&gt;6 units / 8 weeks, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56 (47.5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27 (45.0)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IPSS risk category, n (%)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Low</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80 (67.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39 (65.0)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Intermediate-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38 (32.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21 (35.0)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior luspatercept use, n (%)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">*</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (5.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.7)</span></p></td>
   </tr>
   <tr style="height:1.55pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-treatment hemoglobin</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">**</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, median (range), g/dL</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.9 (5.3-10.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.02in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.02in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.8 (6.1-9.2)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      There were an insufficient number of patients (imetelstat: 7/118; placebo: 4/60) who were previously treated with luspatercept enrolled in IMerge Phase 3 to draw conclusions about the effect of imetelstat treatment in such patients. Of these patients, no imetelstat-treated patients and one placebo patient achieved 8-week TI.</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">**    Pretreatment hemoglobin is defined as the average of all hemoglobin values in the eight weeks prior to the first dose date, excluding values that were within 14 days after transfusion (thus considered to be influenced by transfusion).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After a median follow-up time of 18 months for all patients in the trial, the following chart is the status of patients as of October 13, 2022, the clinical cut-off date for top-line results.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:66.663%;"></td>
    <td style="width:16.0%;"></td>
    <td style="width:17.337%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treatment ongoing, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27 (22.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14 (23.7)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treatment discontinued, n (%)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91 (77.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45 (76.3)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;Lack of efficacy</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28 (23.7)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25 (42.4)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;Adverse event</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19 (16.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;Cytopenias</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11 (9.3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;Unrelated</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (6.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;Disease relapse after initial response on study</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17 (14.4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;Patient decision</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16 (13.6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10 (16.9)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;Progressive disease</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (5.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 (8.5)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;AML progression</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (1.7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;Investigator decision</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (1.7)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.4)</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;Death</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;position:relative;min-width:fit-content;">*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.4)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;Lost to follow up</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      On imetelstat treatment arm, patient death: neutropenic sepsis not related to drug after ~two-year treatment duration</span></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On placebo treatment arm, patient deaths: (1) COVID-19 and (1) heart valve issue</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Efficacy results for the primary 8-week TI endpoint and 24-week TI secondary endpoint summarized below illustrate the depth and durability of transfusion independence demonstrated with high statistical significance for imetelstat versus placebo in IMerge Phase 3.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:42.866%;"></td>
    <td style="width:22.449%;"></td>
    <td style="width:19.38%;"></td>
    <td style="width:15.305%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=60)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value *</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Primary endpoint: 8-week TI, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47 (39.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (15.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;95% confidence interval</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(30.9, 49.3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(7.1, 26.6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Secondary endpoint: 24-week TI, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33 (28.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;95% confidence interval</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(20.1, 37.0)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(0.4, 11.5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      Cochran Mantel Haenszel test stratified for prior RBC transfusion burden (&#x2264;6 units or &gt;6 units of RBCs/8 weeks) and baseline IPSS risk score (Low or Intermediate-1)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Highly statistically significant (p&lt;0.001; hazard ratio 0.23) durable transfusion independence was achieved with median TI duration approaching one year (95% CI (weeks): 26.9, 83.9) for imetelstat and approximately 13 weeks for placebo (95% CI (weeks): 8.0, 24.9), using Kaplan Meier estimates, as shown in the following graph. Approximately 83% of patients achieving 8-week TI had a single continuous TI period. For imetelstat patients achieving 24-week TI, the median TI duration was 80.0 weeks (95% CI (weeks): 51.6, not estimable (NE)). In addition, approximately 70% of imetelstat patients who achieved 8-week TI continued to achieve 24-week TI.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img42689296_0.jpg" alt="img42689296_0.jpg" style="width:624px;height:316px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, there was an increasing magnitude of benefit for imetelstat versus placebo with longer time intervals, as shown in the graph below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img42689296_1.jpg" alt="img42689296_1.jpg" style="width:574px;height:338px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Highly statistically significant (p&lt;0.001) increase in hemoglobin levels over time for imetelstat patients as shown in the graph below. For patients achieving 8-week TI, median increases in hemoglobin were 3.6 g/dL for imetelstat and 0.8 g/dL for placebo. The peak hemoglobin reached for these patients was 11.3 g/dL for imetelstat and 8.9 g/dL for placebo.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img42689296_2.jpg" alt="img42689296_2.jpg" style="width:517px;height:378px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corresponding to the increases in hemoglobin, a statistically significant decrease in the number of RBC units transfused was achieved for imetelstat treated patients versus placebo, as shown in the graph below.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img42689296_3.jpg" alt="img42689296_3.jpg" style="width:573px;height:334px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, as shown in the table below, statistically significant 8-week RBC-TI was observed with imetelstat versus placebo across lower risk MDS subtypes (p&lt;0.05) and similar 8-week RBC-TI was observed for imetelstat within each subtype category in comparison to the overall population.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:23.474%;"></td>
    <td style="width:21.432%;"></td>
    <td style="width:18.375%;"></td>
    <td style="width:23.463%;"></td>
    <td style="width:13.255%;"></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat, n (%)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo, n (%)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Difference (95% CI)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value*</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overall</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47/118 (39.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9/60 (15.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.8 (9.9, 36.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">WHO category</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;RS+</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33/73 (45.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7/37 (18.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.3 (5.9, 42.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.016</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;RS-</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14/44 (31.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2/23 (8.7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.1 (-1.3, 40.6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.038</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfusion burden</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;4-6 units</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28/62 (45.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7/33 (21.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.9 (1.9, 41.4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.027</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&gt;6 units</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19/56 (33.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2/27 (7.4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26.5 (4.7, 41.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.023</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IPSS risk category</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Low</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32/80 (40.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8/39 (20.5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.5 (-0.1, 35.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.034</span></p></td>
   </tr>
   <tr style="height:14.25pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Intermediate-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15/38 (39.5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1/21 (4.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.7 (8.8, 52.4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.004</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      Cochran Mantel Haenszel test stratified for prior RBC transfusion burden (&#x2264;6 units or &gt;6 units of RBCs/8 weeks) and baseline IPSS risk score (Low or Intermediate-1)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specifically for the RS+ and RS- subtypes, statistically significant improvement in both 8-week and 24-week TI was achieved with imetelstat versus placebo, as shown in the table below.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.257%;"></td>
    <td style="width:15.155%;"></td>
    <td style="width:13.144%;"></td>
    <td style="width:11.123%;"></td>
    <td style="width:12.118%;"></td>
    <td style="width:13.144%;"></td>
    <td style="width:9.059%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td colspan="3" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RS+</span></p></td>
    <td colspan="3" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RS-</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=73)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=37)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=44)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=23)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value*</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-week TI responders, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33 (45.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (18.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.016</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14 (31.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (8.7)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.038</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Median duration of TI*, weeks</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;(95% CI)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46.9</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(25.9, 83.9)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.9</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(8.0, 24.9)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.035</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51.6</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(11.9, NE)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11.2</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(10.1, NE)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.062</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24-week TI responders, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24 (32.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (5.4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.003</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (20.5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0 (0.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.019</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;Median duration of TI*, weeks</span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;(95% CI)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80.0</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(41.6, NE)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NE</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(24.9, NE)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.808</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">122.9</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(25.0, NE)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NE</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(NE, NE)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NE</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      Kaplan-Meier estimates of duration of RBC TI; 8-week/24-week TI Responder Analysis Set; P-value for TI rate is based on Cochran Mantel Haenszel test stratified for prior RBC transfusion burden (&#x2264;6 units or &gt;6 units of RBCs/8 weeks) and baseline IPSS risk score (Low or Intermediate-1); P-value for duration of TI is based on stratified log-rank test.</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NE   Not estimable</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The IMerge Phase 3 protocol specified use of the International Working Group, or IWG, 2006 criteria to measure HI-E and was not statistically significant (p=0.112) for imetelstat versus placebo. The current IWG 2018 HI-E criteria places greater emphasis on durability by measuring response for &#x2265;16 weeks, rather than &#x2265;8 weeks. Under these new 2018 IWG criteria, a highly statistically significant (p&lt;0.001) HI-E rate was achieved for imetelstat versus placebo. See the table below for HI-E response under both 2018 and 2006 IWG criteria.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:56.128%;"></td>
    <td style="width:15.305%;"></td>
    <td style="width:15.305%;"></td>
    <td style="width:13.262%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=60)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">P-value *</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HI-E per IWG 2018, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50 (42.4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (13.3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;95% CI, %</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(33.3, 51.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(5.9, 24.6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">     </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;16-week TI, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37 (31.4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.7)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;95% CI, %</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(23.1, 40.5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1.9, 16.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">      </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Transfusion reduction by &#x2265;50%/16 weeks</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51 (43.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (15.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;95% CI, %</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(34.1, 52.7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(7.1, 26.6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HI-E per IWG 2006, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75 (63.6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31 (51.7)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.112</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;95% CI, %</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(54.2, 72.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(38.4, 64.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#x2265;1.5 g/dL increase in Hgb &#x2265;8 weeks, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40 (33.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (10.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&lt;0.001</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;95% CI, %</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(25.4, 43.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(3.8, 20.5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;Transfusion reduction by &#x2265;4U/8 weeks, n (%)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71 (60.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30 (50.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.175</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;95% CI, %</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(50.8, 69.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(36.8, 63.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*      Cochran Mantel Haenszel test stratified for prior RBC transfusion burden (&#x2264;6 units or &gt;6 units of RBCs/8 weeks) and baseline IPSS risk score (Low or Intermediate-1)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical and molecular evidence supporting the potential for disease modification with imetelstat includes a one-year median TI duration for imetelstat 8-week TI responders, a median rise of 3.6 g/dL in hemoglobin levels in those same patients and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50% variant allele frequency decreases in SF3B1, TET2, DNMT3A and ASXL1 mutations, as shown in the graph below.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img42689296_4.jpg" alt="img42689296_4.jpg" style="width:624px;height:301px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The safety results in IMerge Phase 3 were consistent with prior clinical trials of imetelstat in hematologic malignancies, and no new safety signals were identified. The most frequent non-hematologic toxicities occurring in &#x2265;10% of patients on either imetelstat or placebo arms are listed in the table below. Grade 3 elevations in liver function tests, or LFTs, on imetelstat were short in duration (median &lt; 2 weeks) and more than 80% resolved to Grade 2 or lower within 4 weeks, with no cases of liver test elevations consistent with Hy&#x2019;s Law or Drug Induced Liver Injury.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:41.433%;"></td>
    <td style="width:15.155%;"></td>
    <td style="width:14.139%;"></td>
    <td style="width:15.155%;"></td>
    <td style="width:14.118%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AE, n (%)</span></p></td>
    <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</span></p></td>
    <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3/4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3/4</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Asthenia</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22 (18.6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (13.6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">COVID-19*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21 (17.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (1.7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (15.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (5.1)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Peripheral edema</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13 (11.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (13.6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Headache</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15 (12.7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (5.1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diarrhea</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.01in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;14 (11.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (11.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alanine aminotransferase increased</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14 (11.9)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (2.5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.4)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hyperbilirubinemia</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11 (9.3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (10.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Constipation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (7.6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (11.9)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pyrexia</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (7.6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (1.7)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (11.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> _________________</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*    Includes COVID-19, asymptomatic COVID-19, COVID-19 pneumonia</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:40.995%;"></td>
    <td style="width:14.995%;"></td>
    <td style="width:14.0%;"></td>
    <td style="width:15.005%;"></td>
    <td style="width:15.005%;"></td>
   </tr>
   <tr style="height:3.1pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LFT Lab Abnormality, n (%)</span></p></td>
    <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</span></p></td>
    <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alanine Aminotransferase (ALT*)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46 (39.3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (3.4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22 (37.3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (5.1)</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Alkaline Phosphatase (ALP)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53 (44.9)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7 (11.9)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aspartate Aminotransferase (AST)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57 (48.3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13 (22.0)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Bilirubin</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46 (39.0)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23 (39.0)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*     n=117 for ALT imetelstat patients</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The most frequent hematologic toxicities are listed in the table below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:41.422%;"></td>
    <td style="width:15.155%;"></td>
    <td style="width:14.0%;"></td>
    <td style="width:15.305%;"></td>
    <td style="width:14.118%;"></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AE, n (%)</span></p></td>
    <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</span></p></td>
    <td colspan="2" style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3/4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All Grades</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade 3/4</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thrombocytopenia</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89 (75.4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73 (61.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (10.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 (8.5)</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neutropenia</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87 (73.7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80 (67.8)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 (3.4)</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Anemia</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24 (20.3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23 (19.5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 (10.2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 (6.8)</span></p></td>
   </tr>
   <tr style="height:1.3pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leukopenia</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12 (10.2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9 (7.6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical consequences from cytopenias were similar between imetelstat and placebo groups as shown in the table below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:84.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.803%;"></td>
    <td style="width:27.718%;"></td>
    <td style="width:23.478%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Event, n (%)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=118)</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(n=59)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 bleeding events*</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 (2.5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (1.7)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 infections+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13 (11.0)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8 (13.6)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Grade febrile neutropenia**</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 (0.8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*     No &#x2265;Grade 3 bleeding events in the setting of Grade 3/4 thrombocytopenia; on imetelstat: two patients with Grade 4 gastrointestinal bleeding, unrelated and resolved and one Grade 3 hematuria, unrelated and resolved</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">+     On imetelstat: three patients with Grade 3/4 infections in setting of Grade 3/4 neutropenia; all three were sepsis and resolved with only one considered related</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">**   Occurred at day 33, lasted 8 days; assessed by investigator as possibly related to imetelstat; patient subsequently achieved TI &gt;40 weeks and remains on treatment at data cut-off</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, as shown in the table below, the median duration of cytopenias was shorter for imetelstat versus placebo and the resolution to Grade 2 or lower was higher for imetelstat versus placebo.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:84.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.803%;"></td>
    <td style="width:27.718%;"></td>
    <td style="width:23.478%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">+</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thrombocytopenia events*</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Median duration, weeks, (range)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4 (0.1-12.6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.0 (0.3-11.6)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Resolved within &lt;4 weeks, %</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86.3</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44.4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Neutropenia events*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Median duration, weeks, (range)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.9 (0-15.9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2 (1.0-4.6)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;Resolved within &lt;4 weeks, %</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81.0</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.05in;border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:top;padding-bottom:0.05in;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.1in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50.0</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">_________________</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">+     18% of imetelstat treated patients received a median of 1 platelet transfusions; 35% of imetelstat treated patients received growth factor support</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*     Analysis performed for patients who experienced Grade 3/4 cytopenias. Resolution determined by return to Grade 2 or lower</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Planned Next Steps to Advance Imetelstat in Lower Risk MDS Toward Potential Commercialization</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We plan to present additional data from IMerge Phase 3 at medical meetings later this year, including data relating to potential correlation of decreases in mutation burden and abnormal cytogenetic clones with clinical responses, patient reported outcomes, human telomerase reverse transcriptase, or hTERT, and telomerase activity biomarker data and continued follow-up of durability of transfusion independence.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe the depth, breadth and durability of transfusion independence reported from IMerge Phase 3 to date, as well as from IMerge Phase 2, provide strong support for our planned regulatory submissions in the U.S. and in the EU for the use of imetelstat in patients with lower risk MDS. We therefore plan to submit an NDA in the U.S. in mid-2023 and an MAA in Europe in the second half of 2023 for the use of imetelstat in adult patients with lower risk MDS. With Fast Track designation for imetelstat from the FDA for the treatment of adult patients with transfusion-dependent anemia due to lower risk MDS, non-del(5q), and who are refractory or resistant to treatment with an ESA (i.e., the treatment population in IMerge Phase 3), the FDA granted our request for rolling submission of the NDA. If the NDA is accepted for filing and approved within the timelines we expect, we anticipate that the commercial launch of imetelstat in lower risk MDS could occur in the U.S. in the first half of 2024. In Europe, we anticipate review of the planned MAA, if validated by the EMA could take approximately 14 months and, if approved, we anticipate that the commercial launch of imetelstat in lower risk MDS in Europe could occur by the end of 2024.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Indication in Phase 3 Clinical Development: Myelofibrosis (MF)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Unmet Medical Need in Relapsed/Refractory MF for Improvement in Overall Survival</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MF, a type of myeloproliferative neoplasm, is a chronic blood cancer in which abnormal or malignant precursor cells in the bone marrow proliferate rapidly, causing scar tissue, or fibrosis, to form. As a result, normal blood production in the bone marrow is impaired and may shift to other organs, such as the spleen and liver, which can cause them to enlarge substantially. People with MF may have abnormally low or high numbers of circulating RBCs, white blood cells or platelets, and abnormally high numbers of immature cells in the blood or bone marrow. MF patients can also suffer from debilitating constitutional symptoms, such as drenching night sweats, fatigue, severe itching, or pruritus, abdominal pain, fever and bone pain. There are approximately 13,000 patients living with MF in the U.S. and approximately 3,000 reported new cases each year. Up to 20% of patients with MF develop AML.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Approximately 70% of MF patients are classified as having Intermediate&#x2011;2 or High-risk disease, as defined by the Dynamic International Prognostic Scoring System Plus described in a 2011 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Journal of Clinical Oncology</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> article. Drug therapies currently approved by the FDA and other regulatory authorities for treating these MF patients include JAK inhibitors, ruxolitinib and fedratinib, as well as pacritinib, a kinase inhibitor. Currently, no drug therapy is approved for those patients who fail or no longer respond to JAK inhibitor treatment, and median survival for MF patients after discontinuation from ruxolitinib is only approximately 14 &#x2013; 16 months, representing a significant unmet medical need.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">IMpactMF: Ongoing Phase 3 Clinical Trial in Relapsed/Refractory MF</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trial Design</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF, our Phase 3 clinical trial in relapsed/refractory MF, is an open label, 2:1 randomized, controlled clinical trial designed to evaluate imetelstat (9.4 mg/kg administered by intravenous infusion over two hours every three weeks) in approximately 320 patients. Patients relapsed after or refractory to a JAK inhibitor are defined as having an inadequate spleen response or symptom response after treatment with a JAK inhibitor for at least six months, including an optimal dose of a JAK inhibitor for at least two months. The best available therapy, or BAT, control arm of IMpactMF excludes the use of JAK inhibitors. With respect to the trial design for IMpactMF, the FDA urged us to consider adding a third dosing arm to assess a lower dose and/or a more frequent dosing schedule that might improve the planned trial&#x2019;s chance of success by identifying a less toxic regimen and/or more effective spleen response, one of the trial&#x2019;s secondary endpoints. Based on data from IMbark, we believe that testing a lower dose regimen would likely result in a lower median OS, which is the trial&#x2019;s primary endpoint, in the imetelstat treatment arm. We believe existing data also suggest that lowering the dose would not result in a clinically meaningful reduction in toxicity. For these reasons, we therefore determined not to add a third dosing arm to the trial design, and the FDA did not object to our proposed imetelstat dose and schedule of 9.4 mg/kg every three weeks.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The primary efficacy endpoint for IMpactMF is OS. Key secondary endpoints include symptom response; spleen response; progression free survival; complete remission, partial remission or clinical improvement, as defined by the International Working Group for Myeloproliferative Neoplasms Research and Treatment criteria; duration of response; safety; pharmacokinetics; and patient reported outcomes. Currently, we have selected 165 of the planned 180 sites to participate in IMpactMF across North America, South America, Europe, Australia and Asia.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF is designed with &gt;85% power to detect a 40% reduction in the risk of death (hazard ratio=0.60; one-sided alpha=0.025). The final analysis for OS is planned to be conducted after more than 50% of the patients planned to be enrolled in the trial have died (referred to as an event). An interim analysis of OS, in which the alpha spend is expected to be approximately 0.01, is planned to be conducted after approximately 70% of the total projected number of events (deaths) for the final analysis have occurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current Status of IMpactMF</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF opened for patient screening and enrollment in December 2020. As of December 31, 2022, we had 140 of the 165 selected sites open for patient enrollment, and we are continuing to select additional sites. The first patient was dosed in April 2021. Given the uncertain and unpredictable impact of the COVID-19 pandemic on our clinical trial activities, including the constraints on clinical site personnel resources due to other competing trials in MF at the sites where IMpactMF is planned to be conducted, under current planning assumptions, we expect IMpactMF to be fully enrolled in 2024. Based on our planning assumptions for enrollment and event (death) rates in the trial, we expect the interim analysis for OS in IMpactMF may occur in 2024 and the final analysis may occur in 2025. Because these analyses are event-driven and it is uncertain whether actual rates for enrollment and events will reflect current planning assumptions, the results may be available at different times than currently expected. At the interim analysis, if the pre-specified statistical OS criterion is met, then we expect such data may potentially support the registration of imetelstat in relapsed/refractory MF. Subject to protocol-specified stopping rules for futility, if the pre-specified OS criterion is not met at the interim analysis, the trial will continue to the final analysis, which is expected to occur approximately one year later.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The timing and achievement of either or both of the planned analyses depend on numerous factors, including delays or interruptions related to the effects of the COVID-19 pandemic or geopolitical events. In addition, our ability to enroll, conduct and complete IMpactMF depends on whether we can obtain and maintain the relevant clearances from regulatory authorities and other institutions to enroll, conduct and complete the trial, and our ability to raise additional capital if and when needed in order to complete the trial.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Improvement in Overall Survival and Potential Disease-Modifying Activity Observed in IMbark Phase 2</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The IMbark Phase 2 clinical trial was designed to evaluate two dosing regimens of imetelstat (either 4.7 mg/kg or 9.4 mg/kg administered by intravenous infusion every three weeks) in patients with relapsed/refractory MF. The co-primary efficacy endpoints for IMbark were spleen response rate, defined as the proportion of patients who achieve a reduction of at least 35% in spleen volume as assessed by imaging, and symptom response rate, defined as the proportion of patients who achieve a reduction of at least 50% in Total Symptom Score, at 24 weeks. Key secondary endpoints were OS and safety.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We previously reported efficacy and safety results from the IMbark Phase 2 clinical trial, including median OS of 28.1 months for patients on the high dose arm of the study, which is almost twice the reported median OS of 14 &#x2013; 16 months in medical literature. To evaluate this potential benefit, we conducted a post-hoc analysis of OS for patients treated with imetelstat 9.4 mg/kg in IMbark compared to OS calculated from real world data, or RWD, collected at the Moffitt Cancer Center for patients who had discontinued treatment with ruxolitinib, a JAK inhibitor, and who were subsequently treated with BAT. To make a comparison between the IMbark data and RWD, a cohort from the real-world dataset was identified that closely matched the IMbark patients, using guidelines for inclusion and exclusion criteria as defined in the IMbark clinical protocol, such as platelet count and spleen size. Calculations from two propensity score analysis approaches resulted in a median OS of 30.7 months for the imetelstat-treated patients from IMbark, which is more than double the median OS of 12.0 months using RWD for patients treated with BAT. These analyses also showed a 65% &#x2013; 67% lower risk of death for the imetelstat-treated patients vs. BAT-treated patients. We believe these analyses suggest potentially longer OS for imetelstat-treated relapsed/refractory MF patients in IMbark, compared to BAT in closely-matched patients from RWD. However, comparative analyses between RWD and our clinical trial data have several limitations. For instance, the analyses create a balance between treatment groups with respect to commonly available covariates, but do not take into account the unmeasured and unknown covariates that may affect the outcomes of the analyses. Potential biases are introduced by factors which include, for example, the selection of the patients included in the analyses, misclassification in the matching process, the small sample size, and estimates that may not represent the outcomes for the true treated patient population. For these and other reasons, such comparative analyses and any conclusions from such analyses should be considered carefully and with caution, and should not be relied upon as demonstrative or otherwise predictive or indicative of any current or potential future clinical trial results of imetelstat in relapsed/refractory MF, including IMpactMF.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In IMbark, patients also experienced other positive clinical outcomes, including symptom improvement, spleen reduction and bone marrow fibrosis improvement. In June 2020, we reported correlation analyses from IMbark that showed a trend of longer OS in patients who achieved symptom response, spleen volume reductions and improved bone marrow fibrosis, in a dose-dependent manner. Furthermore, the reductions in the variant allele frequency of key driver mutations in MF and the improvement in bone marrow fibrosis observed in IMbark have also been correlated to the improvement in OS. We believe the improvement in bone marrow fibrosis, potential survival benefit, molecular data and correlations from IMbark provide strong evidence of the potential for disease modification with imetelstat, which we believe differentiates imetelstat from currently approved treatments for MF.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The safety results observed in IMbark were consistent with prior clinical trials of imetelstat in hematologic malignancies, and no new safety signals were identified. In the 9.4 mg/kg arm, reversible and manageable Grade 3/4 thrombocytopenia and neutropenia were reported in 24/59 patients (41%) and 19/59 patients (32%), respectively, without significant clinical consequences. 1/59 patients (2%) had Grade 3 febrile neutropenia. 3/59 patients (5%) had Grade 3/4 bleeding. 6/59 patients (10%) had Grade 3/4 infections. Furthermore, more than 70% of the observed Grade 3/4 cytopenias resolved to Grade 2 or lower by laboratory assessment within four weeks.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exploratory Clinical Trials of Imetelstat in Additional Indications</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">IMproveMF: Phase 1 Combination Clinical Trial in Frontline Myelofibrosis (Frontline MF)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMproveMF is a two-part Phase 1 clinical trial evaluating imetelstat in combination with ruxolitinib in patients with frontline MF. The trial is designed to use a Bayesian Optimal Interval design to test various doses of imetelstat in an escalating dose sequence with a defined number of patients per dosing arm. Escalation to the next higher dosing arm will only occur if the prior dose is tolerable to the patients. The primary objective of the first part of IMproveMF is to identify a recommended dosing regimen for further evaluation. Up to 20 patients are expected to be enrolled into the first part of IMproveMF, or IMproveMF Part 1. The first patient was dosed in IMproveMF in August 2022.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon identification of a tolerable dosing regimen for the combination treatment of imetelstat and ruxolitinib, the second part of IMproveMF, or IMproveMF Part 2, is planned to evaluate the efficacy and further evaluate the safety of that dosing regimen. Under IMproveMF Part 2, the primary endpoints are safety and symptom response rate, defined as the proportion of patients who achieve a </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50% reduction in Total Symptom Score at 24 weeks. Secondary endpoints include change in fibrosis; spleen response rate, defined as the proportion of patients who achieve a </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&gt;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35% reduction in spleen volume from baseline as assessed by imaging; and the number of patients achieving complete remission, partial remission or clinical improvement, as defined by the International Working Group for Myeloproliferative Neoplasms Research and Treatment criteria. Up to 20 patients are expected to be enrolled into the IMproveMF Part 2.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, two clinical sites in the U.S. were open for enrollment. We plan to open the remaining U.S. clinical site for enrollment in 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">IMpress: Investigator-Led Phase 2 Clinical Trial in Higher Risk Myelodysplastic Syndromes (Higher Risk MDS) and Acute Myeloid Leukemia (AML)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In collaboration with investigators in Germany, France and Australia, we are supporting IMpress, an investigator-led study of imetelstat in patients with higher risk MDS and relapsed/refractory AML, post-treatment with a hypomethylating agent, or HMA. The first site is planned to open in 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpress is an open-label, single arm, Phase 2 clinical trial being conducted at three clinical sites. The primary endpoint is overall response rate per criteria from the 2018 International Working Group for MDS and the European LeukemiaNet for AML. Secondary endpoints include safety, duration of response, progression-free survival and overall survival. In addition, pending the results of IMpress, we plan to support a Phase 1/2 investigator-led study in relapsed/refractory AML using a combination approach of imetelstat and venetoclax or azacitidine.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research Programs</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical Lymphoid Hematologic Malignancy Program</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Academic research data suggests that certain lymphoid hematologic malignancies have higher telomerase activity and shorter telomeres when compared to normal healthy cells. Thus, we believe a telomerase inhibition approach may find utility in this disease setting.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on this scientific hypothesis, we initiated a preclinical research project with MD Anderson Cancer Center to determine the potential application of imetelstat in lymphoid hematologic malignancies. Preliminary results from this research were published in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Blood</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in November 2022. Based on early results, we plan to collaborate further with MD Anderson Cancer Center to conduct preclinical research to assess the potential therapeutic effect of imetelstat in lymphoid malignancies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Next Generation Telomerase Inhibitor Discovery Program</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have initiated a discovery program to identify a lead compound as a potential next generation oral telomerase inhibitor. If such a compound is identified, we plan to conduct preclinical experiments that may serve as a basis for potential future clinical testing. Discovery research is an uncertain and unpredictable process. As such, the timing and nature of any results from this discovery effort are difficult to forecast. If we select a lead compound from this discovery program, we expect to provide an update on our efforts at that time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Impact of COVID-19 on Our Business</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ongoing COVID-19 pandemic is having widespread, continually evolving, and unpredictable impacts on global societies, economies, financial markets, and business practices. We are closely monitoring the impact of the pandemic, the identification of new variants of the COVID-19 virus and related developments, and our focus remains on promoting employee health and safety while continuing to advance the development of imetelstat. All plans and timing expectations will be delayed or interrupted if COVID-19 pandemic conditions worsen, creating further limitations on our clinical trial and other development activities. For discussion regarding the impact of the COVID-19 pandemic on our business and financial results, see the sub-section entitled &#x201c;Risks Related to COVID-19&#x201d; under &#x201c;Risk Factors&#x201d; in Part I, Item 1A and Note 6 on Commitments and Contingencies &#x2013; Risks Related to Global Economic Conditions, COVID-19 and the Military Conflict Between Ukraine and Russia in Notes to Consolidated Financial Statements of this annual report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual Property and Exclusivity</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intellectual property, including patent protection, is very important to our business. We file patent applications in the U.S. and other jurisdictions, and we also rely on trade secret protection and contractual arrangements to protect aspects of our business. An enforceable patent with appropriate claim coverage can provide an advantage over competitors who may seek to employ similar approaches to develop therapeutics, and so the future commercial success of imetelstat, and therefore our future success, will be in part dependent on our intellectual property strategy. The information provided in this section should be reviewed in the context of the section entitled &#x201c;Risks Related to Protecting Our Intellectual Property&#x201d; described in &#x201c;Risk Factors&#x201d; in Part I, Item 1A of this annual report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our intellectual property strategy includes the early development of a technology, such as imetelstat, followed by rounds of increasingly focused innovation around a product opportunity, including identification and definition of a specific product candidate and uses thereof, manufacturing processes, product formulation and methods of treatment and administration. The result of this process is that products in development are often protected by several families of patent filings that are filed at different times during the development process and cover different aspects of the product. Consequently, earlier filed, broad technology patents will usually expire ahead of patents covering later developments, such as product formulations and methods of treatment and administration, so that patent expirations on a product may span several years. Patent coverage may also vary from country to country based on the scope of available patent protection. There are also opportunities to obtain an extension of patent coverage for a product in certain countries, which adds further complexity to the determination of patent life.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, we may endeavor to monitor worldwide patent filings by third parties that are relevant to our business. Based on this monitoring, we may determine that an action is appropriate to protect our business interests. Such actions may include negotiating patent licenses where appropriate, filing oppositions against a patent, filing a request for post grant review against a patent or filing a request for the declaration of an interference with a patent application or issued patent.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Imetelstat</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have global rights to imetelstat. We own issued patents related to imetelstat in the U.S., Europe and other countries. Composition of matter patents generally provide the most material coverage, and therefore may convey competitive advantages. Because imetelstat is still under development, subsequent innovation and associated patent filings may provide additional patent coverage with later expiration dates. Examination of overseas patent applications typically lags behind U.S. examination, particularly where cases are filed first in the U.S. It may be possible to obtain patent term extensions of some patents in some countries for claims covering imetelstat, which could further extend the patent term.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have issued U.S. and European patents that provide patent coverage into 2033 pertaining to the treatment of MF and MDS with imetelstat. We also hold issued U.S. and European patents covering imetelstat composition of matter.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., our composition of matter patent coverage extends until December 2025, and our method of treatment patent rights for MDS and MF expire in March 2033. Under the Hatch-Waxman Act, upon receipt of drug product approval, potential patent term extensions, if any, may be available to extend the patent term of either our composition of matter patent, or our method of treatment patent for MDS, in the U.S.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Europe, our composition of matter patent coverage expires in September 2024, and our method of treatment patent rights for MDS and MF expire in November 2033 in member countries of the European Patent Convention. One of our patents in each member country of the European Patent Convention may be eligible for patent term extension under the European SPC Regulation, upon receipt of drug product approval, such as, for example, our method of treatment patent for MDS. Our patent rights relating to imetelstat also include reagents useful in manufacturing processes for the drug, and method of treatment and kit claims, certain of which are co&#x2011;owned with other entities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If regulatory approval of imetelstat occurs after a patent has expired, we may be unable to obtain any patent term extension of that expired patent, and the scope of our patent rights will be limited. In addition, should we seek such a patent term extension, we may not be granted any such patent term extension and/or the applicable time period of such patent term extension could be less than five years. Moreover, in some countries, including the U.S., the scope of protection for claims under such patent term extensions, if any, does not extend to the full scope of the claims but is limited to the product composition as approved. Thus, if we were to receive drug product approval in the U.S. for imetelstat in lower risk MDS in the first half of 2024, we may potentially extend the term of our product composition claims in the U.S. for a maximum of five years until December 2030, subject to U.S. Patent and Trademark Office, or USPTO, approval. If we do not receive a patent term extension for our U.S. composition of matter patent for imetelstat, our U.S. composition of matter patent will expire in December 2025. If we do not receive marketing approval and submit a request for an SPC before our composition of matter patents expire in countries of the European Economic Area, or EEA, our imetelstat composition of matter patents will expire in September 2024. If we receive drug product approval in Europe for imetelstat in lower risk MDS in the second half of 2024, we may potentially extend the term of our patents in the EEA for the method of treatment of MDS for a maximum of five years, from November 2033 until November 2038, subject to European Patent Office approval. If we do not have sufficient patent life to protect imetelstat, our financial results, business and business prospects, and the future of imetelstat would be materially and adversely affected, which might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the effective date of termination of the license and collaboration agreement, or the Collaboration Agreement, with Janssen Biotech, Inc., or Janssen, on September 28, 2018, we regained global rights to imetelstat and are continuing development of imetelstat on our own. In accordance with the termination provisions of the Collaboration Agreement, we have an exclusive worldwide license for intellectual property developed under the Collaboration Agreement for the further development of imetelstat, without any economic obligations to Janssen with respect to such license. Janssen has assigned to us certain intellectual property developed by it under the Collaboration Agreement. We now are responsible for the costs of maintaining, prosecuting and litigating all imetelstat intellectual property that we own.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Market Exclusivity and Orphan Drug Designation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For a drug to qualify for orphan drug designation by the FDA, both the drug and the disease or condition must meet certain criteria specified in the Orphan Drug Act, or ODA, and FDA&#x2019;s implementing regulations. Orphan drug designation is granted by the FDA&#x2019;s Office of Orphan Drug Products in order to support development of medicines for underserved or rare diseases and patient populations that affect fewer than 200,000 people in the U.S. or, if the disease or condition affects more than 200,000 individuals annually in the U.S., if there is no reasonable expectation that the cost of developing and making the drug would be recovered from sales in the U.S. Orphan drug designation qualifies the sponsor of the drug for various development incentives of the ODA, including, if regulatory approval is received, the potential for seven years of market exclusivity with certain limited exceptions and certain tax credits for qualified clinical testing. A marketing application for a prescription drug product that has received orphan drug designation is not subject to a prescription drug user fee unless the application includes an indication for a disease or condition other than the rare disease or condition for which the drug was granted orphan drug designation. The granting of orphan drug designation does not alter the standard regulatory requirements and process for obtaining marketing approval. The safety and effectiveness of a drug must be established through adequate and well&#x2011;controlled studies. Orphan drug exclusivity does not prevent the FDA from approving a different drug for the same disease or condition, or the same drug for a different disease or condition.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2015 and December 2015, the FDA granted orphan drug designation to imetelstat for the treatment of MF and MDS, respectively.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., under the Hatch-Waxman Act, upon drug product approval a new chemical entity is entitled to four years of data exclusivity and one year of market exclusivity, conferring a total of five years exclusivity, or NCE exclusivity, for the first-approved indication. Thus, if we receive drug product approval for imetelstat in lower risk MDS in the first half of 2024, we expect that we may receive exclusivity in lower risk MDS under the Hatch-Waxman Act until the first half of 2029. In addition, under the Orphan Drug Act of 1983, orphan drug designation confers market exclusivity in the designated indication for seven years after drug product approval. Thus, if we receive drug product approval for imetelstat in the U.S. for imetelstat in lower risk MDS in the first half of 2024, we anticipate that we may receive market exclusivity under the Orphan Drug Act of 1982 in the U.S. until the first half of 2031.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, a six-month pediatric extension may be available in the U.S. pursuant to the Food and Drug Administration Safety and Innovation Act of 2012, or FDASIA, to the longest extension or exclusivity period available under any of a patent term extension, the NCE exclusivity period or the orphan drug exclusivity period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Europe, orphan drug designation by the European Commission provides regulatory and financial incentives for companies to develop and market therapies that treat a life&#x2011;threatening or chronically debilitating condition affecting no more than five in 10,000 persons in the European Union, or EU, and where no satisfactory treatment is available. In the EU, orphan drug designation also entitles a party to financial incentives such as reduction of fees or fee waivers, as well as protocol assistance from the EMA during the product development phase, and direct access to the centralized authorization procedure. In addition, ten years of market exclusivity is granted following drug product approval, meaning that another application for marketing authorization of a later similar medicinal product for the same therapeutic indication will generally not be approved in the EU. This period may be reduced to six years if the orphan drug designation criteria are no longer met, including where it is shown that the product is sufficiently profitable to not justify maintenance of market exclusivity.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2015 and July 2020, the EMA granted orphan drug designation to imetelstat for the treatment of MF and MDS, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Europe, under the European Union Data Exclusivity Directive 2004/27/EC, upon drug product approval a new medicinal product is entitled to eight years of data exclusivity and two years of market exclusivity, conferring a total of ten years of exclusivity for the first-approved indication. Thus, if we receive drug product approval in Europe for imetelstat in lower risk MDS in the second half of 2024, we anticipate receiving a total of ten years of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exclusivity for lower risk MDS, until the second half of 2034. Separately, orphan drug designation under the European Union Orphan drug regulation (EC) No. 141/2000 confers market exclusivity for ten years following drug product approval for each of the orphan disease indications. Thus, if we receive drug product approval in Europe for imetelstat in lower risk MDS in the second half of 2024 and we maintain orphan drug designation, we anticipate that we may receive market exclusivity in Europe for imetelstat in lower risk MDS until the second half of 2034. In addition, if we fulfill the pediatric investigation plan agreed upon with the European Medicines Agency, such market exclusivity may be extended for an additional two years under the European Pediatric Regulation, which may enable us to receive market exclusivity in Europe for imetelstat in lower risk MDS for an additional two years, until the second half of 2036. Further, if we receive drug product approval in Europe for imetelstat for refractory MF, and we maintain orphan drug designation, we anticipate that we may receive ten years exclusivity in Europe for refractory MF following drug product approval, if any.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fast Track Designation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fast Track designation provides opportunities for frequent interactions with FDA review staff, as well as eligibility for priority review, if relevant criteria are met, and rolling review. Fast Track designation is intended to facilitate and expedite development and review of an NDA to address unmet medical needs in the treatment of serious or life-threatening conditions. However, Fast Track designation does not accelerate conduct of clinical trials or mean that the regulatory requirements are less stringent, nor does it ensure that imetelstat will receive marketing approval or that approval will be granted within any particular timeframe. In addition, the FDA may withdraw Fast Track designation if it believes that the designation is no longer supported by data emerging from the imetelstat clinical development program.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2017, the FDA granted Fast Track designation to imetelstat for the treatment of adult patients with transfusion-dependent anemia due to Low or Intermediate-1 risk MDS who are non-del(5q) and who are refractory or resistant to treatment with an ESA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2019, the FDA granted Fast Track designation to imetelstat for the treatment of adult patients with relapsed/refractory MF.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Licensing</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2016, we granted a license to Janssen Pharmaceuticals, Inc., or Janssen Pharmaceuticals, an affiliate of Janssen, for the research, development and commercialization of products based on specialized oligonucleotide backbone chemistry and novel amidates for disorders, excluding cancers originating from the blood or bone marrow. In connection with this license, we also granted to Janssen Pharmaceuticals a non-exclusive worldwide license under our patent rights covering the synthesis of monomers, which are the building blocks of oligonucleotides. Janssen Pharmaceuticals has terminated the license, and termination was effective as of April 12, 2021. Upon the effective date of termination, all patent rights originally conveyed under the license reverted to Geron.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We previously granted patent licenses to a number of other organizations to utilize aspects of our technologies to develop and commercialize products outside of the imetelstat program; however, all of our patent license agreements related to our telomerase technology have now expired or been terminated, and we expect no further revenue under such agreements in the future.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x2014;Revenues&#x201d; included in Part II, Item 7, of this annual report on Form 10-K for a further discussion of revenues from our license agreements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A typical sequence of steps in the manufacture of imetelstat drug product includes the following key components:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">starting materials, which are well&#x2011;defined raw materials that are used to make bulk drug substance;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">bulk drug substance, which is the active pharmaceutical ingredient in a drug product that provides pharmacological activity or other direct effect in the treatment of disease; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">final drug product, which is the finished dosage form that contains the drug substance that is shipped to the clinic for patient treatment.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since September 2018, we have engaged third&#x2011;party contract manufacturers and have re-established our own manufacturing supply chain to manufacture and supply additional quantities of imetelstat that meet applicable regulatory standards for current and potential future clinical trials and potential commercial uses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not have direct control over third&#x2011;party personnel or operations. These third&#x2011;party contract manufacturers, and/or any other third parties that we may rely upon for the manufacture and/or supply of imetelstat, typically complete their services on a proposal by proposal basis under master supply agreements and may need to make substantial investments to enable sufficient capacity increases and cost reductions, and to implement those regulatory and compliance standards necessary for successful Phase 3 clinical trials and commercial production. These third&#x2011;party contract manufacturers, and/or any other third parties that we may rely upon for the manufacture and/or supply of imetelstat, may not be able to achieve such capacity increases, cost reductions, or regulatory and compliance standards, and even if they do, such achievements may not be at a commercially reasonable cost. We are responsible for establishing any long&#x2011;term commitments or commercial supply agreements with any of the third&#x2011;party contract manufacturers for imetelstat. The information provided in this section should be reviewed in the context of the section entitled &#x201c;Risks Related to Manufacturing Imetelstat&#x201d; under Part I, Item 1A, &#x201c;Risk Factors&#x201d; of this annual report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Competition</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The pharmaceutical and biotechnology industries are characterized by intense and dynamic competition with rapidly advancing technologies and a strong emphasis on proprietary products. While we believe our proprietary oligonucleotide chemistry; experience with the biological mechanisms related to imetelstat, telomeres and telomerase; clinical data to date indicating potential disease-modifying activity with imetelstat treatment; and knowledge and expertise around the development of potential treatments for myeloid hematologic malignancies provide us with competitive advantages, we face competition from many different sources, including major pharmaceutical, specialty pharmaceutical and biotechnology companies, academic institutions, governmental agencies, and public and private research institutions. Imetelstat will compete, if approved, with other products and therapies that currently exist, are being developed or will in the future be developed, some of which we may not currently be aware of.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Competition in Lower Risk MDS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The current standard of care for the treatment of lower risk MDS is the use of ESAs to address the patient&#x2019;s chronic anemia. Once ESAs are no longer effective, serial blood transfusions are often administered that can cause damaging effects to other organs due to iron overload, resulting in shorter survival. In addition, other best available therapies are used without durable effect for the patient.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In lower risk MDS, positive top-line results from IMerge Phase 3 describe potentially meaningful and durable transfusion independence, activity across MDS patient subtypes, and potential disease-modifying activity achievable with imetelstat treatment. We believe that these key features are differentiators compared to currently approved products as well as investigational drugs currently in clinical development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If approved for commercial sale for the treatment of lower risk MDS, imetelstat would compete against a number of currently existing therapies, including ESAs and other hematopoietic growth factors that are indicated for anemia; immunomodulators, such as Revlimid (lenalidomide) by Celgene Corporation, a Bristol-Myers Squibb Corporation, or Celgene; hypomethylating agents, such as Vidaza (azacitidine) by Celgene and manufacturers of generic azacitidine; Dacogen (decitabine) by Otsuka America Pharmaceutical, Inc. and other manufacturers in the U.S. and Janssen in the EU; Inqovi (oral combination of decitabine and cedazuridine) by Astex Pharmaceuticals, Inc., or Astex; and Reblozyl (luspatercept), a TGF-beta inhibitor, by Acceleron Pharma, Inc., or Acceleron (acquired by Merck &amp; Co., Inc., or Merck, in November 2021), in collaboration with Celgene. In November 2022, Bristol-Myers Squibb Company, or BMS, announced that the Phase 3 front-line COMMANDS trial that compared Reblozyl (luspatercept) to ESAs was positive and that data would be presented in 2023 at a major medical meeting.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other therapies currently in Phase 3 development in lower risk MDS, some of which may obtain regulatory approval earlier than imetelstat include roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, by FibroGen, Inc; Onureg (oral azacytidine) by Bristol-Myers Squibb Corporation, or BMS; and Hengqu (hetrombopag), an oral nonpeptide thrombopoietin receptor agonist, by Jiangsu Hengrui Pharmaceuticals Co., Ltd.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, there are multiple Phase 1 and Phase 2 clinical trials of other agents being developed for lower risk MDS, including but not limited to: LB&#x2010;100, a PP2A inhibitor, by Lixte Biotechnology Holdings, Inc.; bemcentinib, an AXL inhibitor, by BerGenBio ASA; H3B&#x2010;8800, a spliceosome inhibitor, by H3 Biomedicine, Inc.; KER-050, a TGF-beta inhibitor, by Keros Therapeutics, Inc., or Keros Therapeutics; TP-0184, an inhibitor of ALK2</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or ACVR1 kinase, by Sumitomo Dainippon Pharma Oncology, Inc; ilginatinib (NS-018), a JAK2 inhibitor, by NS Pharma, Inc., a U.S. subsidiary of Nippon Shinyaku Co., Ltd., or NS Pharma; RVT-2001, a SF3B1 modulator, by Roivant Sciences, Ltd.; sabatolimab (MBG453), a TIM-3 inhibitor, by Novartis AG; a lower dose of ASTX727, an oral formulation of decitabine and cedazuridine, referred to as ASTX727 LD, by Astex; ASTX030, an oral formulation of azacitidine and cedazuridine, by Astex; R289, an oral inhibitor of interleukin receptor-associated kinases 1 and 4, or IRAK1/4, by Rigel Pharmaceuticals, Inc.; a combination treatment regimen of luspatercept and lenalidomide by BMS; and HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, by BMS and etavopivat, an oral, small molecule activator of erythrocyte pyruvate kinase (PKR) by Forma Therapeutics, Inc., a Novo Nordisk Company; canakinumab, an interleukin antagonist, by Novartis AG; and AG946, a next-generation pyruvate kinase-R (PKR) activator, by Agios Pharmaceuticals, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Competition in Relapsed/Refractory MF</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The current standard of care for the treatment of Intermediate-2 or High-risk MF is the use of JAK inhibitors, to address the patient&#x2019;s symptoms. Once JAK inhibitors fail or are no longer effective, a variety of best available therapies are used since there are no approved treatments for this patient population and median OS is 14 &#x2013; 16 months after discontinuation from the predominant JAK inhibitor being used today.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Intermediate-2 or High-risk relapsed/refractory MF, data from IMbark suggest potential disease-modifying activity with imetelstat treatment and a potential meaningful improvement in OS, which is supported in a comparison to real-world data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If approved for commercial sale for the treatment of MF, imetelstat would compete against currently approved JAK inhibitors: Jakafi (ruxolitinib) by Incyte Corporation, or Incyte, and Inrebic (fedratinib) by Celgene, as well as a kinase inhibitor, Vonjo (pacritinib), by CTI Biopharma Corp., which was approved in February 2022 for the treatment of adults with Intermediate or High-Risk primary or secondary myelofibrosis with a platelet count below 50 &#xd7; 109/L. Other treatment modalities for MF include hydroxyurea for the management of splenomegaly, leukocytosis, thrombocytosis and constitutional symptoms; splenectomy and splenic irradiation for the management of splenomegaly and co-existing cytopenias; chemotherapy; and pegylated interferon. Drugs for the treatment of MF-associated anemia include ESAs, androgens, danazol, corticosteroids, thalidomide and lenalidomide.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other therapies currently in Phase 3 development in MF, some of which may obtain regulatory approval earlier than imetelstat, include momelotinib, a JAK inhibitor, by GlaxoSmithKline plc; or momelotinib plus AZD5153, a BET inhibitor by GlaxoSmithKline plc; pelabresib (CPI-0610), a BET inhibitor, by MorphoSys AG; navitoclax, a BCLXL, BCL-2 and BCLW inhibitor, by AbbVie, Inc.; and parsaclisib, a PI3K delta inhibitor, by Incyte. Other approaches for MF currently under investigation that could compete with imetelstat in the future include luspatercept; zinpentraxin alfa (RG6354, formerly PRM-151), an anti-fibrosis antibody, by F. Hoffmann-La Roche, Ltd.; LCL-161, an inhibitor of apoptosis protein (IAP), by Novartis; KRT-232, an inhibitor of MDM2, by Kartos Therapeutics, Inc.; GB2064, a LOXL2 inhibitor, by Galecto Biotech; elraglusib (9-ING-41), a glycogen synthase kinase-3 beta inhibitor, by Actuate Therapeutics, Inc.; XPOVIO (selinexor), a nuclear export inhibitor, by Karyopharm Therapeutics, Inc.; TL-895, an oral tyrosine kinase inhibitor, by Telios Pharma, Inc.; IMG-7289, a LSD1 inhibitor, by Imago Biosciences, Inc.; APG-1252, a dual BCL-2/BCL-XL inhibitor, by Ascentage Pharma; ilginatinib (NS-018), a JAK2 inhibitor by NS Pharma; DISC-0974, a monoclonal antibody against hemojuvelin (HJV) by DISC Management Inc.; KER-050 in combination with ruxolitinib, by Keros Therapeutics; CK0804, an allogeneic T-regulatory cell agent, by Cellenkos, Inc. in collaboration with Incyte; TP-3654, PIM kinase inhibitor by Sumitomo Pharma Co., Ltd.; and a mutated-CALR vaccine, a peptide-based vaccine, from the Icahn School of Medicine at Mount Sinai.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our competitors, either alone or with their strategic partners, could have substantially greater financial, technical and human resources than we do and significantly greater experience in obtaining FDA and other regulatory approvals of treatments and commercializing those treatments. We believe that the commercial success of imetelstat is subject to a number of factors, including: product efficacy and safety; method of product administration; cost of manufacturing; the timing and scope of regulatory consents; status of coverage and reimbursement; price; the level of generic competition; and our patent position.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Smaller companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. We anticipate increased competition in the future as new companies explore treatments for myeloid hematologic malignancies, which may significantly impact the commercial viability of imetelstat. Academic institutions, government agencies and other public and private research organizations may also conduct research, seek patent protection and establish collaborative arrangements for research, clinical development and marketing of products similar to imetelstat. These companies and institutions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compete with us in recruiting and retaining qualified development and management personnel as well as in acquiring technologies complementary to the imetelstat program.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of the foregoing, competitors may develop more commercially desirable or affordable products than imetelstat, or achieve earlier patent protection or product commercialization than we may be able to achieve with imetelstat. Competitors have developed, or are in the process of developing, technologies that are, or in the future may be, competitive to imetelstat. Some of these products may have an entirely different approach or means of accomplishing therapeutic effects similar or superior to those that may be demonstrated by imetelstat. Competitors may develop products that are safer, more effective, or less costly than imetelstat, or more convenient to administer to patients and, therefore, present a serious competitive threat to imetelstat. In addition, competitors may price their products below what we may determine to be an acceptable price for imetelstat, may receive better third-party payor coverage and/or reimbursement, or may be more cost-effective than imetelstat. Such competitive products or activities by competitors may render imetelstat obsolete, which may cause us to cease any further development or future commercialization of imetelstat, which would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government Regulation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulation by governmental authorities in the U.S. and other countries is a significant factor in the development, manufacture and potential future marketing of imetelstat. Imetelstat will require regulatory approval by governmental agencies prior to commercialization. In particular, potential human therapeutic products, such as imetelstat, are subject to rigorous preclinical and clinical testing and other approval procedures of the FDA and similar regulatory authorities in European and other countries. Various governmental statutes and regulations also govern or influence testing, manufacturing, safety, labeling, storage, import, export, distribution and recordkeeping related to such products and their marketing. The process of obtaining these approvals and the subsequent compliance with appropriate statutes and regulations require the expenditure of substantial time and money, and there can be no guarantee that approvals will be granted. Moreover, compliance with government regulations governing personal information and information security requires the expenditure of substantial time and financial resources. The information provided in this section should be reviewed in the context of the sections entitled &#x201c;Risks Related to the Development of Imetelstat&#x201d; and &#x201c;Risks Related to Regulatory Compliance Matters and Commercialization of Imetelstat&#x201d; under Part I, Item 1A, &#x201c;Risk Factors&#x201d; of this annual report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">United States Food and Drug Administration Regulatory Approval Process</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to commencement of clinical trials involving humans, preclinical testing of new pharmaceutical products is generally conducted on animals in the laboratory to evaluate the potential efficacy and safety of a product candidate. The results of these trials are submitted to the FDA as part of an Investigational New Drug, or IND, application, which must become effective before clinical testing in humans can begin. The FDA can place an IND on clinical hold at any time, which prevents the conduct of clinical trials under the IND until safety concerns or questions are addressed by the IND sponsor to the FDA&#x2019;s satisfaction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Typically, clinical evaluation involves a time consuming and costly three phase trial process. In Phase 1, clinical trials are conducted with a small number of healthy volunteers or patients afflicted with a specific disease to assess safety and to evaluate the pattern of drug distribution and metabolism within the body. In Phase 2, clinical trials are conducted with groups of patients afflicted with a specific disease in order to determine preliminary efficacy, optimal dosages and expanded evidence of safety. The Phase 2 trials can be conducted comparing the investigational treatment to a comparator arm, or not. If used, a comparator usually includes standard of care therapy. Safety and efficacy data from Phase 2 clinical trials, even if favorable, may not provide sufficient rationale for proceeding to a Phase 3 clinical trial. In Phase 3, large scale, multi&#x2011;center, comparative trials are conducted with patients afflicted with a target disease to provide sufficient data to demonstrate the efficacy and safety required by the FDA. The FDA closely monitors the progress of each of the three phases of clinical testing and may, at its discretion, re&#x2011;evaluate, alter, suspend, or terminate the trials. Human clinical trials must be conducted in compliance with Good Clinical Practice, or GCP, regulations and applicable laws, with the oversight of Institutional Review Boards for the protection of human subjects. The manufacture of drug product candidates is subject to requirements that drugs be manufactured, packaged and labeled in conformity with current Good Manufacturing Practices, or cGMP, and applicable laws.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The results of the preclinical and clinical testing of drugs and complete manufacturing information are submitted to the FDA in the form of an NDA for review and approval prior to commencement of commercial sales. Submission of an NDA requires the payment of a substantial user fee to the FDA, which may be waived in certain cases. In responding to an NDA submission, the FDA may approve the drug for commercialization, impose limitations on its indications for use and labeling, including in the form of Risk Evaluation and Mitigation Strategies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or may issue a complete response letter. Even if an NDA is approved, its sponsor is subject to ongoing and pervasive regulatory compliance requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">European and Other Regulatory Approval Process</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to initiating clinical trials in a region outside of the U.S., a clinical trial application must be submitted and reviewed by the appropriate regulatory authority regulating the country in which the trial will be conducted. Whether or not FDA clearance or approval has been obtained, approval of a product by comparable regulatory authorities in Europe and other countries is necessary prior to commencement of marketing the product in such countries. The regulatory authorities in each country may impose their own requirements and may refuse to grant an approval, or may require additional data before granting it, even though the relevant product has been cleared or approved by the FDA or another authority. As with the FDA, the regulatory authorities in the EU and other developed countries have lengthy approval processes for pharmaceutical products. The process for gaining approval in particular countries varies, but generally follows a similar sequence to that described for FDA approval. In Europe, the European Medicine Agency, or EMA, and the European Committee for Proprietary Medicinal Products for Human Use, or CHMP, provide a mechanism for EU member states to exchange information on all aspects of product licensing. The EU has established the EMA for the evaluation of medical products, with a centralized procedure which is mandatory for orphan and oncology products and which grants a single marketing authorization valid in all EU member states.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2021, we gained access to the Innovative Licensing and Access Pathway, or ILAP, through the receipt of an Innovation Passport for imetelstat to treat lower risk MDS. The ILAP is a new program sponsored by the Medicines and Healthcare products Regulatory Agency, or MHRA, in the U.K. post-Brexit. The objective of this new licensing and access pathway is to reduce the time to market and enable earlier patient access for innovative medicines. The Innovation Passport is the first prescribed entry point in the ILAP process. Key benefits of being within ILAP include a 150-day accelerated assessment and rolling review of an MAA, as well as opportunities for frequent interactions with the review staff at the MHRA and its partner agencies to discuss imetelstat&#x2019;s development, regulatory and reimbursement plans.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fraud and Abuse, Data Privacy and Security, and Transparency Laws and Regulations</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may also be subject to additional regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which we conduct our business. These additional regulations could affect our current and future arrangements with healthcare professionals, principal investigators, consultants, customers and third&#x2011;party payors. Such laws include, without limitation, state and federal anti&#x2011;kickback, fraud and abuse, false claims, privacy and security, and healthcare professionals payment sunshine laws.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The federal Anti&#x2011;Kickback Statute makes it illegal for any person or entity, including a prescription drug manufacturer (or a party acting on its behalf) to knowingly and willfully, directly or indirectly, solicit, receive, offer, or pay any remuneration that is intended to induce the referral of business, including the purchase, order, or lease of any good, facility, item or service for which payment may be made under a federal healthcare program, such as Medicare or Medicaid. The term &#x201c;remuneration&#x201d; has been broadly interpreted to include anything of value. Several courts have interpreted the statute&#x2019;s intent requirement to mean that if any one purpose of an arrangement involving remuneration is to induce referrals of federal healthcare covered business, the Anti&#x2011;Kickback Statute has been violated. The Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act, collectively the Affordable Care Act or ACA, among other things, amended the intent requirement of the federal Anti&#x2011;Kickback Statute such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to violate, in order to commit a violation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal civil and criminal false claims and false statement laws, including the federal civil False Claims Act and its whistleblower or </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">qui tam</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> provisions that permit private individuals to bring an action on behalf of the government to enforce the civil False Claims Act, prohibit, among other things, any person or entity from knowingly presenting, or causing to be presented, for payment to, or approval by, federal programs, including Medicare and Medicaid, claims for items or services, including drugs, that are false or fraudulent or not provided as claimed. Entities can be held liable under these laws if they are deemed to &#x201c;cause&#x201d; the submission of false or fraudulent claims by, for example, providing inaccurate billing or coding information to customers, promoting a product off&#x2011;label, or for providing medically unnecessary services or items. In addition, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. Criminal prosecution is also possible for making or presenting a false, fictitious or fraudulent claim to the federal government.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, created criminal and civil liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third&#x2011;party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations, imposes obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security, transmission and breach reporting of individually identifiable health information, upon entities subject to the law, such as health plans, healthcare clearinghouses and certain healthcare providers and their respective business associates and their subcontractors that perform services for them that involve individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in U.S. federal courts to enforce the federal HIPAA laws and seek attorneys&#x2019; fees and costs associated with pursuing federal civil actions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The federal Physician Payments Sunshine Act requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#x2019;s Health Insurance Program, with specific exceptions, to report annually to the Centers for Medicare &amp; Medicaid Services, or CMS, information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists, and chiropractors), other healthcare professionals (such as physicians assistants and nurse practitioners), and teaching hospitals, and applicable manufacturers and applicable group purchasing organizations to report annually to CMS ownership and investment interests held by physicians and their immediate family members.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Analogous state and foreign laws and regulations, such as state anti&#x2011;kickback and false claims laws, may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non&#x2011;governmental third-party payors, including private insurers. Additionally, we may be subject to state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government. Further, we may be subject to state laws that require drug manufacturers to report information related to payments and other transfers of value to physicians, other healthcare providers and healthcare entities, or marketing expenditures, as well as state and local laws that require the registration of pharmaceutical sales representatives; state laws that require the reporting of information related to drug pricing; and state, federal and foreign laws governing the privacy and security of personal information (including key-coded data and health information), including the European Union&#x2019;s General Data Protection Regulation, or EU GDPR, many of which differ from each other in significant ways, thus complicating compliance efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Efforts to ensure that our current and future business arrangements will comply with applicable privacy and data security laws and regulations will involve substantial costs. For example, foreign data privacy and security laws (including but not limited to the EU GDPR and UK GDPR) impose significant and complex compliance obligations on entities that are subject to those laws. As one example, the EU GDPR imposes heightened and codified standards for data subject consent, requiring the implementation and maintenance of technical and organizational safeguards for personal data, mandating data breach notifications to relevant supervisory authority(ies), and mandating the appointment of representatives in the UK and/or the EU in certain circumstances. Foreign privacy laws, such as the EU GDPR, also impose strict rules on the transfer of personal data out of the applicable jurisdiction. Further, the EU GDPR provides for significant penalties (such as restrictions or prohibitions on personal data processing) and large fines for noncompliance, including the potential for fines of up to &#x20ac;20 million or 4% of the annual global revenues of the noncompliant company, whichever is greater. Moreover, we expect that there will continue to be new proposed privacy laws, regulations and industry standards in the U.S. As one example, the California Consumer Privacy Act of 2018, or CCPA, imposes numerous obligations on covered business. Although the CCPA exempts certain data processed in the context of clinical trials, the CCPA, to the extent applicable to our business and operations, may increase our compliance costs and potential liability with respect to the personal information we maintain about California residents. See the section titled &#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to stringent and changing obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could lead to regulatory investigations and actions; litigation; fines and penalties; disruptions to our business operations; reputational harm; loss of revenue and profits; and other adverse business impacts,&#x201d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> under &#x201c;Risk Factors&#x201d; in Part I, Item 1A of this annual report on Form 10-K for additional information about the laws and regulations to which we may become subject and about the risks to our business associated with such laws and regulations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If our operations are found to be in violation of any of these or any other healthcare, information security and privacy-related regulatory laws that may apply to us, we may be subject to significant penalties, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgement, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, reputational harm, diminished profits and future earnings, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations. Defending against any such actions can be costly, time-consuming and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reimbursement and Healthcare Reform</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant uncertainty exists as to the coverage and reimbursement status of any product candidate that receives regulatory approval. In the U.S. and markets in other countries, sales of imetelstat, if approved for commercial sale, will depend, in part, on the extent to which third&#x2011;party payors provide coverage and establish adequate reimbursement levels for imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., third&#x2011;party payors include federal and state healthcare programs, government authorities, private managed care providers, private health insurers and other organizations. There has been increasing legislative and enforcement interest in the U.S. with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries, Presidential executive orders, and federal and state legislative activity designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, reduce the cost of drugs under Medicare, and reform government program reimbursement methodologies for drugs. At the federal level, in July 2021, the Biden administration released an executive order, &#x201c;Promoting Competition in the American Economy,&#x201d; with multiple provisions aimed at prescription drugs. In response to Biden&#x2019;s executive order, on September 9, 2021, HHS released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue to advance these principles. On August 16, 2022, President Biden signed the Inflation Reduction Act of 2022, or IRA, into law, which, among other things, (i) directs HHS to negotiate the price of certain high-expenditure, single-source drugs and biologics covered under Medicare, and subject drug manufacturers to civil monetary penalties and a potential excise tax by offering a price that is not equal to or less than the negotiated &#x201c;maximum fair price&#x201d; for such drugs and biologics under the law, and (ii) imposes rebates with respect to certain drugs and biologics covered under Medicare Part B or Medicare Part D to penalize price increases that outpace inflation. The IRA permits HHS to implement many of these provisions through guidance, as opposed to regulation, for the initial years. These provisions will take effect progressively starting in fiscal year 2023, although they may be subject to legal challenges. It is currently unclear how the IRA will be implemented but is likely to have a significant impact on the pharmaceutical industry. Further, the Biden administration released an additional executive order on October 14, 2022, directing HHS to submit a report on how the Center for Medicare and Medicaid Innovation can be further leveraged to test new models for lowering drug costs for Medicare and Medicaid beneficiaries. It is unclear whether this executive order or similar policy initiatives will be implemented in the future. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, to encourage importation from other countries and bulk purchasing. Further, third&#x2011;party payors are increasingly challenging the price, examining the medical necessity and reviewing the cost&#x2011;effectiveness of medical drug products and medical services, in addition to questioning their safety and efficacy. Such payors may limit coverage to specific drug products on an approved list, also known as a formulary, which might not include all of the FDA&#x2011;approved drugs for a particular indication. We may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost&#x2011;effectiveness of imetelstat, in addition to the costs required to obtain the FDA approvals. Nonetheless, imetelstat may not be considered medically necessary or cost&#x2011;effective.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, the process for determining whether a third&#x2011;party payor will provide coverage for a drug product may be separate from the process for setting the price of a drug product or for establishing the reimbursement rate that such a payor will pay for the drug product. A payor&#x2019;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#x2019;s determination to provide coverage for a drug product does not assure that other payors will also provide coverage for the drug product, as there is no uniform coverage and reimbursement policy among third-party payors in the U.S. Adequate third&#x2011;party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The U.S. and some foreign jurisdictions are considering or have enacted legislative and regulatory proposals to contain healthcare costs, as well as to improve quality and expand access. For example, in March 2010, the ACA was signed into law, which included a number of provisions of importance to the biopharmaceutical industry. There have been judicial and Congressional challenges to certain aspects of the ACA. For example, on June 17, 2021, the U.S. Supreme Court dismissed a challenge on procedural grounds that argued the ACA is unconstitutional in its entirety because the &#x201c;individual mandate&#x201d; was repealed by Congress. Further, prior to the U.S. Supreme Court ruling, on January 28, 2021, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. In addition, the IRA, among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in PPACA marketplaces through plan year 2025. The IRA also eliminates the &#x201c;donut hole&#x201d; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and creating a new manufacturer discount program. It is possible that the ACA will be subject to judicial or Congressional challenges in the future. It is unclear how such challenges and the healthcare reform measures of the Biden administration will impact the ACA. We expect that other healthcare reform measures that may be adopted in the future may result in more rigorous coverage criteria and lower reimbursement, and additional downward pressure on the price that may be charged for imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, other legislative changes have been proposed and adopted since the ACA was enacted. For example, in August 2011, the Budget Control Act of 2011 was enacted, which, among other things, created the Joint Select Committee on Deficit Reduction to recommend to Congress proposals in spending reductions. The Joint Select Committee on Deficit Reduction did not achieve a targeted deficit reduction of at least $1.2 trillion for fiscal years 2012 through 2021, triggering the legislation&#x2019;s automatic reduction to several government programs. This includes aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, which went into effect beginning on April 1, 2013 and, due to subsequent legislative amendments to the statute will stay in effect through 2031 unless additional Congressional action is taken. Under current legislation, the actual reduction in Medicare payments will vary from 1% in 2022 to up to 4% in the final fiscal year of this sequester. Additionally, in January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, reduced Medicare payments to several providers, including hospitals and imaging centers. More recently, there has been heightened governmental scrutiny in the U.S. to control the rising cost of healthcare.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Information About Our Officers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table sets forth certain information with respect to our executive officers and other members of management as of January 31, 2023:</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:24.264%;"></td>
    <td style="width:1.127%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:5.351%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.575%;"></td>
    <td style="width:65.682%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Age</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Position</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Officers</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">John A. Scarlett, M.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President, Chief Executive Officer and Chairman of the Board</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Olivia K. Bloom</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Vice President, Finance, Chief Financial Officer<br />&#160;&#160;&#160;and Treasurer</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Faye Feller, M.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Vice President, Chief Medical Officer</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Andrew J. Grethlein, Ph.D.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Vice President, Chief Operating Officer</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Anil Kapur</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Vice President, Corporate Strategy and Chief Commercial Officer</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td colspan="7" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Members of Management</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Melissa A. Kelly Behrs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Vice President, Business Operations and Chief Alliance Officer</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Edward E. Koval</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Vice President, Chief Business Officer</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stephen N. Rosenfield, J.D.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Vice President, Chief Legal Officer and Corporate Secretary</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.587%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">John A. Scarlett, M.D.,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has served as our Chief Executive Officer and a director since September 2011 and President since January 2012 and was appointed to Chairman of the Board in December 2018. Dr. Scarlett served as a director of CytomX Therapeutics, Inc., a biopharmaceutical company focused on developing antibody therapeutics for the treatment of cancer, from June 2016 to June 2022. He was also a director for Chiasma, Inc., a biopharmaceutical company focused on transforming injectable drugs into oral medications, from February 2015 until its acquisition by Amyrt Pharma plc, a biopharmaceutical company, in August 2021. Prior to joining Geron, Dr. Scarlett served as President, Chief Executive Officer and a member of the board of directors of Proteolix, Inc., a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">privately held, oncology oriented biopharmaceutical company, from February 2009 until its acquisition by Onyx Pharmaceuticals, Inc., an oncology oriented biopharmaceutical company, in November 2009. From February 2002 until its acquisition by Ipsen, S.A. in October 2008, Dr. Scarlett served as the Chief Executive Officer and a member of the board of directors of Tercica, Inc., an endocrinology oriented biopharmaceutical company, and also as its President from February 2002 through February 2007. From March 1993 to May 2001, Dr. Scarlett served as President and Chief Executive Officer of Sensus Drug Development Corporation. In 1995, he co-founded Covance Biotechnology Services, Inc., a contract biopharmaceutical manufacturing operation, and served as a member of its board of directors from inception to 2000. From 1991 to 1993, Dr. Scarlett headed the North American Clinical Development Center and served as Senior Vice President of Medical and Scientific Affairs at Novo Nordisk Pharmaceuticals, Inc., a wholly owned subsidiary of Novo Nordisk A/S. Dr. Scarlett received his B.A. degree in chemistry from Earlham College and his M.D. from the University of Chicago, Pritzker School of Medicine.</span></p>
  <p style="text-indent:4.587%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Olivia K. Bloom</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has served as our Executive Vice President, Finance since February 2014, Chief Financial Officer since December 2012 and Treasurer since February 2011. Ms. Bloom previously served as our Senior Vice President, Finance from December 2012 to February 2014, Chief Accounting Officer from September 2010 to December 2012 and Vice President, Finance from January 2007 to December 2012. Ms. Bloom joined the Company in 1994 as a Senior Financial Analyst and from 1996 to 2011 served as our Controller. Prior to joining Geron, Ms. Bloom started her career in public accounting at KPMG Peat Marwick and became a Certified Public Accountant in 1994. Ms. Bloom has served as a member of the board of directors for Personalis, Inc., a genomic sequencing and analytics company supporting the development of personalized therapeutics, since March 2022. Ms. Bloom graduated Phi Beta Kappa with a B.S. in Business Administration from the University of California at Berkeley.</span></p>
  <p style="text-indent:4.587%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Faye Feller, M.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, has served as our Executive Vice President, Chief Medical Officer since July 2022. Previously, she served as our Vice President of Clinical Development since she joined Geron in April 2019. In this role, Dr. Feller played a strategic role in designing and driving execution of Geron&#x2019;s Phase 3 clinical trials, served as the primary medical point of contact between Geron and our clinical investigators and led the preparation of data for assessment by the data monitoring committees. Dr. Feller's career in the pharmaceutical industry started at Janssen Research and Development, LLC (Janssen) in February 2015. At Janssen, she held several clinical research roles with increasing responsibility, including both Compound Lead and Study Responsible Physician for multiple clinical trials of early and late-stage development assets, including the IMbark Phase 2 clinical trial of imetelstat. Prior to Janssen, Dr. Feller was an instructor in the leukemia department of Memorial Sloan Kettering Cancer Center in New York. She received a B.A. from New York University and an M.D. from Mount Sinai School of Medicine. She completed her residency in internal medicine at Mount Sinai Hospital and her fellowship in medical oncology at Memorial Sloan Kettering Cancer Center.</span></p>
  <p style="text-indent:4.587%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Andrew J. Grethlein, Ph.D.,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has served as our Executive Vice President, Chief Operating Officer since January 2019. Previously, he served as our Executive Vice President, Development and Technical Operations, from July 2014 to January 2019. He joined Geron in September 2012 as our Executive Vice President, Technical Operations. Prior to joining Geron, Dr. Grethlein was Executive Vice President and Chief Operating Officer for Inspiration Biopharmaceuticals, a biopharmaceutical company, from January 2010 to September 2012. From October 2008 until January 2010, Dr. Grethlein was Senior Vice President of Biotechnology and Portfolio Management Team Leader for Hematology at Ipsen S.A., a global specialty pharmaceutical company. His responsibilities at Ipsen included planning and execution of worldwide strategy for product and portfolio development in the hematologic therapeutic area. From 2003 to 2008, Dr. Grethlein served as Senior Vice President of Pharmaceutical Operations at Tercica, Inc., an endocrinology&#x2011;oriented biopharmaceutical company, where he was a member of the senior executive team that governed corporate strategy, business planning and company operations, and had responsibility for all manufacturing and quality functions. Before joining Tercica, Dr. Grethlein served in various positions at Elan Corporation, a biotechnology company, from 1997 to 2003, including as Senior Director, South San Francisco Pharmaceutical Operations. From 1995 to 1997, Dr. Grethlein served as Manager, Biologics Development and Manufacturing, for Athena Neurosciences, Inc., a pharmaceutical company. Prior to this, he served in various engineering positions for the Michigan Biotechnology Institute, a nonprofit technology research and business development corporation. Dr. Grethlein received his A.A. degree in liberal arts from Simon&#x2019;s Rock Early College, his B.S. in biology from Bates College, and his M.S. and Ph.D. in chemical engineering from Michigan State University.</span></p>
  <p style="text-indent:4.587%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Anil Kapur </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">has served as our Executive Vice President, Corporate Strategy and Chief Commercial Officer since December 2019. Prior to joining Geron, Mr. Kapur was Chief Commercial Officer at Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, from February 2018 to November 2019. From October 2016 until February 2018, Mr. Kapur was Vice President, Head of Early Assets, Biomarkers and External Innovation for Worldwide Oncology Commercialization at Bristol-Myers Squibb Company, a global biopharmaceutical company. Mr. Kapur served as Vice President, Global Head of Commercial and Portfolio Strategy at Baxalta, Incorporated, a biopharmaceutical company, in a newly created Oncology Division, from</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 2015 until after its acquisition by Shire plc in July 2016. Before joining Baxalta, Mr. Kapur held marketing and sales leadership roles of increasing responsibility during his 15-year tenure at the Janssen Pharmaceutical Companies of Johnson &amp; Johnson (Janssen). As Vice President, Commercial Leader, Hematology Franchise in Janssen&#x2019;s Global Commercial Strategy Organization, he led the development and execution of commercial strategy and launch plans for in-market development, late development, and early pipeline assets, including imetelstat. Among Mr. Kapur&#x2019;s most recognized achievements while at Janssen were the successful global launches of two transformational blockbuster hematology-oncology drugs, Imbruvica and Darzalex. Mr. Kapur has served as a member of the board of directors of Verastem, Inc., a development-stage biopharmaceutical company, since October 2022. Mr. Kapur holds a Bachelor of Engineering from Birla Institute of Technology in India; an M.S. in Industrial Engineering from Louisiana Tech University; and an M.B.A. from the Fuqua School of Business at Duke University.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Melissa A. Kelly Behrs</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has served as our Executive Vice President, Business Operations and Chief Alliance Officer since December 2021. Previously, she was our Executive Vice President, Chief Business Officer from January 2019 to December 2021, Executive Vice President, Business Development and Portfolio &amp; Alliance Management, from February 2014 to January 2019, and our Senior Vice President, Portfolio and Alliance Management from September 2012 to February 2014. Ms. Behrs joined Geron in November 1998 as Director of Corporate Development. Since then, she has also served in various managerial positions, including General Manager, R&amp;D Technologies; Vice President, Corporate Development; Senior Vice President, Therapeutic Development, Oncology; and Senior Vice President, Strategic Portfolio Management. From 1990 to 1998, Ms. Behrs worked at Genetics Institute, Inc., a biotechnology research and development company, serving initially as Assistant Treasurer and then as Associate Director of Preclinical Operations where she was responsible for all business development, regulatory, and project management activities for the Preclinical Development function. Ms. Behrs received a B.S. from Boston College and an M.B.A. from Babson College.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Edward E. Koval </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">has served as our Executive Vice President, Chief Business Officer since December 2021. From 2020 to 2021, he was Chief Business Officer at ZebiAI Therapeutics, a company spun out of X-Chem, Inc. in order to discover and develop advanced drug discovery programs based on novel machine learning technologies, until its acquisition by Relay Therapeutics, Inc., a clinical-stage precision medicine company, in April 2021. Prior to the spin-out of ZebiAI, from 2013 to 2020, he was Senior Vice President, Corporate Development, at X-Chem, Inc., a drug discovery company, where he closed multiple transactions with multinational pharmaceutical companies for programs in oncology, hematology/oncology, inflammation, infectious disease and rare diseases. From 2012 to 2015, Mr. Koval served as an independent corporate and business development consultant, advising multiple private and public biotech companies on partnering and fundraising. Mr. Koval&#x2019;s prior pharmaceutical experience from 1992 to 2012 includes serving roles in business and corporate development, strategic planning, alliance management and financial evaluation and analysis at Novartis Pharmaceuticals Corporation, a pharmaceutical company, Merck &amp; Co., Inc., a pharmaceutical company, and Chiron Corporation, a pharmaceutical company, where he finalized negotiations and executed and managed multiple strategic corporate partnerships and alliances. Mr. Koval holds an M.Sc. in Engineering from Rensselaer Polytechnic Institute and an M.B.A. from the Sloan School of Management at the Massachusetts Institute of Technology.</span></p>
  <p style="text-indent:4.587%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stephen N. Rosenfield, J.D.,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has served as our Executive Vice President, Chief Legal Officer and Corporate Secretary since January 2019. Previously, he served as our Executive Vice President, General Counsel and Corporate Secretary from February 2012 to January 2019, General Counsel and Secretary since January 2012 and Secretary since October 2011. Mr. Rosenfield received a B.S. from Hofstra University and a J.D. from Northeastern University School of Law.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employees</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had 107 full&#x2011;time employees. Seventeen of our employees hold Ph.D. degrees and 41 hold other advanced degrees. Of this current total workforce, 58 employees were engaged in, or directly supported, our research and development activities, and 49 employees were engaged in commercial, medical affairs, business development, legal, finance, human resources, information technology and administration. None of our employees are covered by a collective bargaining agreement; nor have we experienced work stoppages. We consider relations with our employees to be good.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consultants</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have established, and expect to continue to establish, consulting agreements with drug development professionals, clinicians, attorneys and regulatory experts with experience in numerous fields, including clinical science, biostatistics, clinical operations, pharmacovigilance, quality, manufacturing and regulatory affairs. We currently have approximately 90 active consulting agreements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate Information</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Geron Corporation was incorporated in the State of Delaware on November 28, 1990. Geron UK Limited was incorporated in the United Kingdom on September 29, 2021. Geron Netherlands B.V. was incorporated in the Netherlands on February 17, 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 1A.           R</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ISK FACTORS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">operate in a dynamic and rapidly changing environment involving numerous risks and uncertainties that may have a material adverse effect on our business, financial condition or results of operations. You should carefully consider the risks and uncertainties described below, together with all of the other information included in this annual report on Form 10&#x2011;K. Our business faces significant risks and uncertainties, and those described below may not be the only risks and uncertainties we face. Additional risks and uncertainties not presently known to us or that we currently believe are immaterial may also significantly impair our business, financial condition or results of operations. If any of these risks or uncertainties occur, our business, financial condition or results of operations could suffer, the market price of our common stock could decline and you could lose all or part of your investment in our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RISKS RELATED TO THE DEVELOPMENT OF IMETELSTAT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our future success depends solely on imetelstat, our only product candidate, and we cannot be certain that we will be able to continue to develop imetelstat or advance imetelstat to subsequent clinical trials, or that we will be able to receive regulatory approval for or to commercialize imetelstat, on a timely basis or at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat is our sole product candidate, upon whose success we are wholly dependent. We do not currently have any other products or product candidates. Our ability to develop imetelstat and launch it commercially is subject to significant risks and uncertainties, including, obtaining regulatory approval from the FDA and EMA for commercializing imetelstat in lower risk MDS, as well as, among other things, our ability to:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">submit an NDA, to the FDA in the U.S., and a MAA to the EMA in the EU, in lower risk MDS that is accepted and/or validated for filing by the respective regulatory agency; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain from the FDA and EMA their respective determinations that the regulatory submissions are sufficient to support regulatory approval to commercialize imetelstat in lower risk MDS, without the requirement for additional pre-approval clinical trials or further testing or development commitments, if at all, any of which could result in increased costs to us, delay or limit our ability to generate revenue; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain sufficient safety and efficacy data from IMpactMF to support any application for regulatory approval in relapsed/refractory MF, without clinically meaningful safety issues, side effects or dose-limiting toxicities related to imetelstat that may negatively impact its benefit-risk profile, whether or not in the same indications or therapeutic areas;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ascertain that the use of imetelstat does not result in significant systemic or organ toxicities, including hepatotoxicity, or other safety issues resulting in an unacceptable benefit-risk profile;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain additional capital in order to enable us to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and IMpress, as well as to conduct the regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">develop clinical plans for, and successfully commence, conduct and complete potential future clinical trials of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">generate sufficient safety and efficacy data from ongoing and potential future clinical trials of imetelstat that provide a positive benefit-risk profile to support the continued and future development of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain and maintain required regulatory clearances and approvals to enable continued clinical development, as well as potential commercialization, of imetelstat; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">enter into and maintain arrangements with third parties to provide services needed to further research and develop imetelstat, including maintaining the agreements with our contract research organizations, or CROs, or to manufacture imetelstat, in each case at commercially reasonable costs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">recruit and retain sufficient qualified and experienced personnel to support the development and potential commercialization of imetelstat in the U.S., including to enroll, conduct and complete current </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and potential future clinical trials of imetelstat, and to provide internal capabilities for sales, marketing, distribution and other functions to support the potential commercialization of imetelstat in the U.S.;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">enter into and maintain arrangements with third parties to provide services needed to support the potential commercialization of imetelstat for territories outside of the U.S. in compliance with applicable laws;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">achieve acceptance of imetelstat, if approved, by patients and the relevant medical communities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compete effectively with other approved treatments in lower risk MDS;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain appropriate coverage and reimbursement levels for the cost of imetelstat from governmental authorities, private health insurers and other third-party payors; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtain, maintain and enforce adequate intellectual property and regulatory exclusivity for imetelstat both in the U.S. and globally.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we are not able to successfully achieve the above-stated goals and overcome other challenges that we may encounter in the research, development, manufacturing and potential commercialization of imetelstat, we may be forced to abandon our development and/or commercialization of imetelstat, which would severely harm our business, prospects and our ability to raise additional capital, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our current and potential future clinical trials of imetelstat could be interrupted, delayed, terminated or abandoned for a variety of reasons, including due to the effects of macroeconomic conditions such as the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, which could severely and adversely affect our financial results, business and business prospects, and the future of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Currently, the active clinical trials of imetelstat are IMpactMF and IMproveMF, and the investigator-led clinical trial, IMpress, and we are also retaining remaining patients in the treatment or follow-up phase of IMerge Phase 3. The conduct and completion of IMpactMF, IMproveMF and IMpress could be interrupted, delayed or abandoned for a variety of reasons, including due to the effects of macroeconomic conditions such as the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession. In particular, the fluidity and dynamic nature of the COVID-19 pandemic precludes any firm estimates as to the ultimate effect COVID-19 will have on our current and potential future clinical trials, our operations and our business, all of which depend on the continued worldwide progress toward managing this health crisis. Although vaccine distribution, including booster shots, is being conducted in many countries, the emergence of COVID-19 variants and subvariants, and the resurgence of COVID-19 cases in many parts of the world cause further uncertainty and unpredictability on clinical trial activities, including clinical site initiations, patient screening and enrollment, as well as constraints on available sites and site personnel. For instance, the pace of enrollment for IMerge Phase 3 was slower than planned due to the COVID-19 pandemic, and we have experienced a similar effect on our other clinical trials, and we may face difficulties in retaining patients in the treatment or follow-up phases of our clinical trials. Site personnel resources for IMpactMF and IMproveMF remain constrained in the countries where we plan to conduct the trials, due to the negative impact of COVID-19, as well as a number of competing trials in MF and other oncology indications. Based on assumptions for enrollment and event (death) rates in the trial, we expect the interim analysis for OS for IMpactMF may occur in 2024 and the final analysis may occur in 2025. Because these analyses are event-driven and it is uncertain whether actual rates for enrollment and events will reflect current planning assumptions, the results may be available at different times than currently expected. Such macroeconomic conditions have and may continue to cause delays and suspensions in clinical trial activities at clinical sites. In addition, we may also experience clinical trial failures or delays related to:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">overcoming patient recruitment and enrollment challenges and operational delays related to opening new clinical sites, and conducting and completing IMpactMF, IMproveMF and IMpress due to the effects of the COVID-19 pandemic, while also competing with clinical trials for other investigational drugs in the same patient population; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">clinical sites electing to terminate their participation in any of our clinical trials, which would likely have a detrimental effect on patient enrollment;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any inability to successfully retain patients in IMpactMF, including completing the planned interim analysis for IMpactMF;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">difficulties in patient recruitment and enrollment in IMproveMF;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patient recruitment, enrollment, or retention, clinical site initiation, or retention problems associated with civil or political unrest or military conflicts around the world, including specifically the current military conflict between Ukraine and Russia;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a higher number of patients being required for clinical trials, or higher than expected patient drop out rates;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining and/or maintaining regulatory clearances in the U.S. or other countries to conduct clinical trials, such as obtaining or maintaining regulatory clearances to commence, conduct or modify current or potential future clinical trials of imetelstat, in a timely manner, or at all, which could, for example, prevent us from, or result in substantial delays in, conducting or completing IMpactMF, IMproveMF and IMpress, or commencing potential future clinical trials of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">maintaining the investigational new drug applications, or INDs, and equivalent submissions in other countries for imetelstat without such INDs and/or equivalent submissions in other countries being placed on full or partial clinical hold, suspended or subject to other requirements by the FDA or other similar international regulatory authorities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">contracting with a sufficient number of clinical trial sites to conduct current and potential future clinical trials, and ensuring that such contracts contain all necessary terms and conditions required by applicable laws, including providing for valid mechanisms to engage in cross-border data transfers, as well as identifying, recruiting and training suitable clinical investigators, especially given the constraints caused by the COVID-19 pandemic, and other competing clinical trials in MF and other oncology indications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining or accessing necessary clinical data in accordance with appropriate clinical or quality practices and regulatory requirements, in a timely and accurate manner to ensure complete data sets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">responding to safety findings, recommendations or conclusions by the internal data safety review committees, independent data monitoring committees and/or hepatic expert committees of current and potential future clinical trials of imetelstat based on emerging data occurring during such clinical trials, such as significant systemic or organ toxicities, including severe cytopenias, hepatotoxicity, fatal bleeding with or without any associated thrombocytopenia, or reduced platelet count, patient injury or death, or other safety issues, resulting in an unacceptable benefit-risk profile;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">use of trial endpoints that inherently require prolonged periods of clinical observation or analysis of the resulting data to determine trial outcomes;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing sufficient quantities that meet our specifications and timelines of imetelstat, or other clinical trial materials, in a manner that meets the quality standards of the FDA and other similar international regulatory authorities, and responding to any disruptions to drug supply, clinical trial materials or quality issues that may arise, including as a result of (a) limitations in available manufacturing capacity due to obligations to manufacture and distribute vaccines to address the COVID-19 pandemic; (b) temporary or permanent shut down of contract manufacturing facilities due to violations of good manufacturing practices, or GMP, regulations or other applicable requirements; (c) infections or cross-contaminations of product candidates in the manufacturing process; (d) or capacity limitations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ensuring the ability to manufacture and supply imetelstat at acceptable costs for potential future clinical trials of imetelstat and potential commercial uses;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining sufficient quantities of any study-related treatments, materials (including best available therapy, or BAT, comparator products, placebo or combination therapies) or ancillary supplies, including in light of challenges and delays that may arise from the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining acceptance by regulatory authorities of any manufacturing changes for imetelstat, as well as successfully implementing any such manufacturing changes;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">complying with current and future regulatory requirements, policies or guidelines, including domestic and international laws and regulations pertaining to fraud and abuse, transparency, and the privacy and security of health information;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reaching agreement on acceptable terms and on a timely basis, if at all, with collaborators, physician investigators, vendors and other third parties located in the U.S. or jurisdictions in other countries, including our CROs, laboratory service providers and clinical trial sites, on all aspects of clinical </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">development and collaborating with them successfully, including with respect to challenges and delays that have arisen and may continue to arise from the effects of the COVID-19 pandemic;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">third-party clinical investigators or our CROs losing the licenses or permits necessary to perform our clinical trials, not performing our clinical trials according to our anticipated schedule or consistent with the clinical trial protocol, good clinical practices, or GCP, or regulatory requirements, or not performing data collection or analyses in a timely or accurate manner;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">third-party contractors becoming debarred, disqualified or suspended or otherwise penalized by the FDA or other similar international regulatory authorities for violations of applicable regulatory requirements, in which case we may need to find a substitute contractor, and we may not be able to use some or all of the data produced by such contractors in support of any applications for regulatory approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining timely review and clearances by regulatory authorities for any clinical protocol amendments, modifications to our manufacturing process which may be sought for current and potential future clinical trials of imetelstat, including responding to questions or comments from these authorities in a timely and adequate manner, which could, for example, prevent us from conducting or completing IMpactMF, IMproveMF or IMpress, or commencing potential future clinical trials of imetelstat; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining institutional review board or ethics committee approvals for clinical trial protocols or protocol amendments, including any future refinements to the trial designs we may seek for IMpactMF, IMproveMF or IMpress, or as a result of changes in regulatory requirements and policies, which could, for example, prevent us from conducting or completing IMpactMF, IMproveMF or IMpress, and commencing potential future clinical trials of imetelstat.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We could also encounter delays if a clinical trial is suspended or terminated. Clinical trials may be suspended or terminated due to a number of factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">inspection of the clinical trial operations or trial site by the FDA or similar international regulatory authorities resulting in the imposition of a clinical hold;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">safety issues or adverse side effects;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to demonstrate a benefit from using a drug; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in governmental regulations or administrative actions. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failures or delays with respect to any of the aforementioned events could adversely affect our ability to conduct or complete IMpactMF, IMproveMF or IMpress, or to commence, conduct and complete potential future clinical trials of imetelstat, which could increase development costs, or interrupt, further delay or halt our development or potential commercialization of imetelstat, any of which could severely and adversely affect our financial results, business and business prospects, and the future of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Further difficulties retaining patients in IMerge Phase 3 and enrolling or retaining patients in IMpactMF, IMproveMF and the investigator-led clinical trial IMpress, whether as a result of the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, or for any other reasons, could further delay or otherwise adversely affect our clinical development and commercialization activities, which would cause our business and business prospects to be severely harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The timely completion of a clinical trial in accordance with its protocol depends, among other things, on the ability to enroll a sufficient number of patients who remain in the trial until its conclusion. Further challenges in retaining patients in IMerge Phase 3 and screening, enrolling and retaining patients in IMpactMF, IMproveMF and IMpress, whether as a result of the effects macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, or for any other reasons, may further delay our conduct of such trials, or cause them to be discontinued. For example, we have clinical trial sites in Ukraine, Russia and nearby European countries, and have experienced, and may continue to experience, delays and suspensions in clinical trial activities at clinical sites in Ukraine and Russia due to the current civil or political unrest conditions, including delays in clinical site initiations, patient screening and enrollment, as well as constraints on available sites and site personnel.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we reported positive top-line results from IMerge Phase 3 in January 2023, retaining remaining patients in the treatment or follow-up phase would allow us to continue to assess the longer-term durability of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RBC-TI responses. Therefore, if we experience difficulties in retaining such patients, whether due to the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, or for any other reasons, our ability to assess the longer-term durability of RBC-TI responses would be adversely affected. The retention of patients in IMerge Phase 3 and the enrollment and retention of patients in IMpactMF, IMproveMF and IMpress, depend on many factors, such as:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to identify and screen patients who meet the patient eligibility criteria specified in the protocol;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size of the patient population required for analysis of the trial&#x2019;s primary endpoint;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the proximity of patients to trial sites, and patients&#x2019; willingness and ability to travel to trial sites for treatment or monitoring during the COVID-19 pandemic or civil or political unrest, such as the military conflict between Ukraine and Russia;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the design of the trial;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to recruit and retain clinical trial investigators with the appropriate competencies and experience;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">clinicians&#x2019; and patients&#x2019; perceptions of the potential advantages of imetelstat, both in relation to other available therapies, including new drugs that have been approved or may be approved for the indications being investigated, and as a result of data reported from previous or current clinical trials of imetelstat, and their willingness to participate in clinical trials of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">monitoring patients adequately during and after treatment;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to obtain and maintain patient consents; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the risk that disease progression will result in death or clinical deterioration before the patient can enroll in a clinical trial of imetelstat, or before sufficient data has been collected from such patient, such that any data collected from the patient does not contribute in a meaningful way to the interpretation of the results of the clinical trial in which the patient is enrolled; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the risk that patients enrolled in any imetelstat clinical trial will drop out of the trial before completion, due to lack of efficacy, adverse side effects, investigator decision, progressive disease, site restrictions due to the effects of macroeconomic conditions like the COVID-19 pandemic, or civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, alternate treatments being approved for the indication, or personal issues.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, IMpactMF has competed and will continue to compete with, and earlier stage clinical trials of imetelstat, such as IMproveMF and IMpress, will compete with, other clinical trials for product candidates that are in the same therapeutic areas with imetelstat, and such trials may also be conducted at the same clinical sites. This competition is reducing the number of clinical sites and hospital staff available to participate in IMpactMF, IMproveMF and IMpress, as well as the number and type of patients available to enroll or remain in current and potential future imetelstat clinical trials. Moreover, because imetelstat represents a departure from more commonly used methods for cancer treatment, potential patients and their doctors may be inclined to use conventional therapies, rather than enroll patients into imetelstat clinical trials, or may decide not to enroll, or may not recommend enrollment, in IMpactMF, IMproveMF or IMpress, based on efficacy and safety results reported to date and that may be reported in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, if imetelstat is approved for commercialization, we will need to complete substantial preparations to be ready for any potential future commercialization of imetelstat. The development of an in-house marketing and sales force or entering into an arrangement with a third party for the commercialization of imetelstat outside of the U.S. will require significant capital expenditures, management resources and time, and may have an adverse effect on the timely completion of IMpactMF, IMproveMF and IMpress.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delays caused by the effects of macroeconomic effects, like the COVID-19 pandemic or civil or political unrest or military conflicts around the world, such as the current military conflict between Ukraine and Russia, or other factors in patient enrollment, or the inability to retain or treat patients, have resulted in and may in the future result in further increased costs due to extended timelines and other factors, and may lead to incomplete data sets, or adversely affect the timing or outcome of current and potential future clinical trials of imetelstat which could delay or prevent the commencement, conduct or completion of these trials and adversely affect the clinical development, as well as the timing or outcome of the potential commercialization of imetelstat. Such occurrences would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Imetelstat may continue to cause, or have attributed to it, undesirable or unintended side effects or other adverse events that could further delay or prevent the commencement and/or completion of clinical trials for imetelstat, further delay or prevent its regulatory approval, or limit its commercial potential.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat may continue to cause, or have attributed to it, undesirable or unintended side effects or other adverse events affecting its safety or efficacy that could interrupt, further delay or halt current or potential future clinical trials of imetelstat, such as IMerge Phase 3, IMpactMF, IMproveMF and IMpress. In this regard, adverse events and dose-limiting toxicities observed in previous and ongoing clinical trials of imetelstat include:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hematologic toxicities, such as profound and/or prolonged thrombocytopenia or neutropenia, including one case of febrile neutropenia after prolonged myelosuppression with intracranial hemorrhage resulting in patient death, which the investigator assessed as possibly related to imetelstat, as well as reversible Grade 4 febrile neutropenia;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">bleeding events, with or without thrombocytopenia, including reversible Grade 3/4 bleeding events;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">hepatotoxicity and liver function test abnormalities, as well as hepatic failure;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">gastrointestinal events;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">infections;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">muscular and joint pain;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fatigue;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">headache; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">infusion-related reactions.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If patients in any clinical trials of imetelstat, including IMerge Phase 3, IMpactMF, IMproveMF, IMpress or any potential future clinical trials of imetelstat, experience similar or more severe adverse events, or new or unusual adverse events, or if the FDA or other similar international regulatory authorities determine that efficacy and safety data in current or potential future clinical trials of imetelstat do not support an adequate benefit-risk profile to justify continued treatment of patients, then the FDA or other similar international regulatory authorities may again place one or more of the INDs for imetelstat on clinical hold, as occurred in March 2014. If this were to occur, there would be a significant delay in, or possible termination of, such clinical trial or all the imetelstat clinical trials and any potential commercialization efforts, which might cause us to cease operations. For example, we recently became aware of a case in our IMpactMF clinical trial of a patient with myelofibrosis associated with underlying progressive bone marrow failure, who died from febrile neutropenia, pulmonary hemorrhage and bilateral pneumonia, which, at the time of reporting, the investigator related to imetelstat. If such toxicities or other safety issues in any clinical trial of imetelstat are determined by us, the FDA or similar international regulatory authorities to result in an unacceptable benefit-risk profile, then:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additional information supporting the benefit-risk profile of imetelstat may be requested by the FDA or similar international regulatory authorities and if any such information supplied by us, or by our former collaboration partner, is not deemed acceptable, current clinical trials of imetelstat could be suspended, terminated, or placed on clinical hold by the FDA or similar international regulatory authorities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to retain enrolled patients in current clinical trials may be negatively affected, resulting in incomplete data sets and the inability to adequately assess the benefit-risk profile of imetelstat in a specific patient population; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">additional, unexpected clinical trials or non-clinical studies may be required to be conducted.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, clinical trials by their nature examine the effect of a potential therapy in a sample of the potential future patient population. As such, clinical trials conducted with imetelstat, to date and in the future, may not uncover all possible adverse events that patients treated with imetelstat may experience. Because remaining patients in IMerge Phase 3, IMpactMF and IMproveMF continue to receive imetelstat treatment, additional or more severe toxicities or safety issues, including additional non-serious or serious adverse events and dose-limiting toxicities, may be observed as patient treatment continues and more data become available. In addition, because additional data are being generated from these trials, the benefit-risk profile of imetelstat will continue to be assessed, including the risk of hepatotoxicity, severe cytopenias, fatal bleeding with or without any associated thrombocytopenia, patient injury or death, and any other severe adverse effects that may be associated with life-threatening clinical outcomes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The occurrence of any of the aforementioned events could interrupt, further delay, or halt, any development, and as a result, impact or preclude the potential commercialization of imetelstat, as well as increase costs to develop imetelstat, which would have a severe adverse effect on our results of operations, financial condition and ability to raise additional capital, business prospects and the future of imetelstat, any of which might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The design of a clinical trial can determine whether its results will support regulatory approval of a product, and flaws in the trial design may not become apparent until the clinical trial is well advanced or during the approval process after the trial is completed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A trial design that is considered appropriate for regulatory approval includes a sufficiently large sample size with appropriate statistical power, as well as proper control of bias, to allow a meaningful interpretation of the results. The preliminary results of imetelstat clinical trials with smaller sample sizes can be disproportionately influenced by the impact the treatment had on a few individuals, which limits the ability to generalize the results across a broader community, making the trial results of clinical trials with smaller sample sizes less reliable than trials with a larger number of patients. As a result, there may be less certainty that imetelstat will achieve a statistically significant effect in any future clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For example, we shortened the follow-up period after the last patient has been enrolled from 15 months to 12 months to enable an earlier clinical cut-off date for the primary analysis in IMerge Phase 3. Although we reported positive top-line results from IMerge Phase 3 in January 2023, our decision to shorten the follow-up period after the last patient has been enrolled may result in further clinical responses that could occur after the 12-month clinical cut-off date being excluded from the primary analysis. The exclusion of this future data from the primary analysis could reduce the overall efficacy results of the trial, including durability of transfusion independence, which could limit or prevent marketing approval of imetelstat in lower risk MDS by the FDA or similar international regulatory authorities, cause them not to approve imetelstat at all or require additional clinical trials or further testing prior to granting any regulatory approval to market imetelstat in lower risk MDS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, with respect to the trial design for IMpactMF, the FDA urged us to consider adding a third dosing arm to the trial to assess a lower dose and/or a more frequent dosing schedule that might improve the trial&#x2019;s chance of success by identifying a less toxic regimen and/or more effective spleen response, one of the trial&#x2019;s secondary endpoints. Based on data from IMbark, we believe that testing a lower dose regimen would likely result in a lower median OS, which is the trial&#x2019;s primary endpoint, in the imetelstat treatment arm. Existing data also suggest that lowering the dose would not result in a clinically meaningful reduction in toxicity, and for these reasons we therefore determined not to add a third dosing arm to the trial design, and the FDA did not object to our proposed imetelstat dose and schedule of 9.4 mg/kg every three weeks. Our belief may ultimately be incorrect. Therefore, our failure to add a third dosing arm could result in a failure to maintain regulatory clearance from the FDA and similar international regulatory authorities, could result in the trial&#x2019;s failure, or could otherwise delay, limit or prevent marketing approval of imetelstat in relapsed/refractory MF by the FDA or similar international regulatory authorities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Results and data we disclosed from prior non-clinical studies and clinical trials may not predict success in later clinical trials, and we cannot assure you that any ongoing or future clinical trials of imetelstat will lead to similar results and data that could potentially enable us to obtain any regulatory approvals.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Success in non-clinical testing and early clinical trials, including Phase 2 clinical trials, such as IMbark, does not ensure that later clinical trials will be successful, nor does it predict final clinical trial results. In addition, even though we reported positive top-line results from IMerge Phase 3 in January 2023, this does not ensure that any other clinical trials of imetelstat, including IMpactMF, IMproveMF and IMpress, will be successful. We cannot be certain that any of the prior, current or potential future clinical trials of imetelstat will generate sufficient, consistent or adequate efficacy and safety data demonstrating a positive benefit-risk profile, which would be necessary to obtain regulatory approval to market imetelstat in any indication. Imetelstat in later stages of clinical trials may fail to show the desired benefit-risk profile despite having progressed through non-clinical studies and initial clinical trials. Many companies in the biopharmaceutical industry have frequently suffered significant setbacks in later clinical trials, even after achieving promising results in earlier non-clinical studies or clinical trials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In IMbark, we reported a median overall survival of 19.9 months and 28.1 months for the 4.7 mg/kg and 9.4 mg/kg dosing arms, respectively, in relapsed/refractory MF patients. In general, Phase 3 clinical trials with larger numbers of patients or longer durations of therapy may fail to replicate efficacy and safety results observed in earlier clinical trials, such as IMbark, and if this were to occur with IMpactMF, this would adversely affect future development prospects of imetelstat, and as a result, impact the potential commercialization of imetelstat, which would substantially impair our ability to raise additional capital.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, non-clinical and clinical data are often susceptible to varying interpretations and analyses. In some instances, there can be significant variability between different clinical trials of imetelstat due to numerous factors, including changes in trial procedures set forth in trial protocols, differences in the size and type of patient populations, and changes in and adherence to the dosing regimens. For example, complete and partial remissions were observed in an investigator-sponsored pilot study of imetelstat conducted at Mayo Clinic in MF patients, or the Pilot Study. However, similar activity was not observed in the MF patients enrolled in IMbark, as shown by the one partial remission observed in the IMbark primary analysis. We believe that differences in the IMbark study design when compared to the Pilot Study design, such as more restrictive patient enrollment criteria requiring either documented objective lack of response to a JAK inhibitor or evidence of progressive disease while on treatment with a JAK inhibitor, may have contributed to the data observed in IMbark differing significantly from data reported from the Pilot Study, but we cannot assure you that any future clinical trials of imetelstat in relapsed/refractory MF will yield results comparable to IMbark or the Pilot Study. In addition, the potential improvement in survival observed in the 9.4 mg/kg dosing arm in IMbark will need to be further assessed in IMpactMF, and similar results, including potential improvement in survival, if any, with respect to any patient population or patient population subgroup, may not be observed in IMpactMF. Likewise, although the statistical analyses comparing IMbark data to closely matched real world data, or RWD, published in the September 2021 issue of the Annals of Hematology, suggest potentially favorable OS in relapsed/refractory MF patients treated with imetelstat, compared to BAT using closely matched patients&#x2019; RWD, such comparative analyses between RWD and our clinical trial data have several limitations. For instance, the analyses create a balance between treatment groups with respect to commonly available covariates, but do not take into account the unmeasured and unknown covariates that may affect the outcomes of the analyses. Potential biases are introduced by factors which include, for example, the selection of the patients included in the analyses, misclassification in the matching process, the small sample size, and estimates that may not represent the outcomes for the true treated patient population. For these and other reasons, such comparative analyses and any conclusions from such analyses should be considered carefully and with caution, and should not be relied upon as demonstrative or otherwise predictive or indicative of any current or potential future clinical trial results of imetelstat in relapsed/refractory MF, including IMpactMF.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failure to achieve results supporting a positive benefit-risk profile in current or potential future imetelstat clinical trials would interrupt, further delay, or halt, any development, and as a result, potential commercialization of imetelstat, which would have a severe adverse effect on our results of operations, financial condition and ability to raise additional capital, business prospects and the future of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interim, &#x201c;snapshot,&#x201d; &#x201c;top-line,&#x201d; and preliminary data or statistical analyses from clinical trials that we announce or publish from time-to-time may change as more patient data become available, may be more positive than the final data, and are subject to audit and verification procedures that could result in material changes in the final data. Thus, such preliminary data should be considered carefully and with caution and not relied upon as indicative of future clinical results.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time-to-time, preliminary or interim safety and efficacy data from previous and current imetelstat clinical trials have been reported or announced by us, clinical investigators or our former collaboration partner. Preliminary data is based on a preliminary analysis of then available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As such, preliminary or interim results may not be reproduced in any current or potential future clinical trials of imetelstat, and thus should be considered carefully and with caution, and not relied upon as indicative of future clinical results. Additional or updated safety and efficacy data from current or potential future clinical trials of imetelstat may result in a benefit-risk profile that does not justify the continued development of imetelstat in a particular patient population, or at all. Any data reported from IMpactMF may materially differ from and be less positive than data previously reported from IMbark. Thus, reported data should be considered carefully and with caution, and not relied upon as indicative of future clinical results. Such additional data could result in a lower benefit-risk profile than initially expected, which could hinder the potential success of IMpactMF, IMproveMF or IMpress, or cause us to abandon further development of imetelstat entirely.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, we announced positive top-line results from IMerge Phase 3. Such top-line results may differ from future results of the same study, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Top-line data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, top-line data, including from IMerge Phase 3, should be viewed with caution until the final data are available. Material adverse differences in final data, compared to preliminary or interim data, could severely</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and adversely affect our financial results, business and business prospects, and the future of imetelstat, including the potential commercialization of imetelstat, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The research and development of imetelstat is subject to numerous risks and uncertainties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The science and technology of telomere biology, telomerase and our proprietary oligonucleotide chemistry are relatively new. There is no precedent for the successful commercialization of a therapeutic product candidate based on these technologies. Significant research and development activities will be necessary to further develop imetelstat, our sole product candidate, and may take years to accomplish, if at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because of the significant scientific, regulatory and commercial challenges that must be overcome to successfully research, develop and commercialize imetelstat, the development of imetelstat in myeloid hematologic malignancies, including MDS and MF, may be further delayed or abandoned, even after significant resources have been expended on it. Examples of such situations include:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in September 2012, the discontinuation of our Phase 2 clinical trial of imetelstat in metastatic breast cancer;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in April 2013, the discontinuation of our development of imetelstat in solid tumors with short telomeres;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in March 2014, the full clinical hold placed by the FDA on imetelstat clinical trials; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the third quarter of 2016, closure of the 4.7 mg/kg dosing arm in IMbark to new patient enrollment and suspension of enrollment in the 9.4 mg/kg dosing arm in IMbark because an insufficient number of patients in the 9.4 mg/kg dosing arm met the protocol defined interim efficacy criteria at 12 weeks;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in the third quarter of 2017, expansion of IMerge Phase 2 to enroll additional lower risk MDS patients in a target patient population; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in September 2018, our former collaboration partner&#x2019;s decision to terminate its imetelstat collaboration agreement with us.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further delay, suspension or abandonment of our development of imetelstat in myeloid hematologic malignancies, including with respect to our IMpactMF, IMproveMF and IMpress clinical trials, could have a material adverse effect on the future of imetelstat and our business prospects, including the potential commercialization of imetelstat in indications other than lower risk MDS.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We rely on third parties to conduct our current and potential future clinical trials of imetelstat. If these third parties do not successfully carry out their contractual duties or meet expected deadlines, we may be unable to continue the development of, obtain regulatory approval for, or commercialize imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not have the ability to independently conduct clinical trials. Therefore, we rely on medical institutions, clinical investigators, contract laboratories and other third parties, such as CROs, service providers, vendors, suppliers and consultants, to conduct clinical trials of imetelstat. The third parties we contract with for execution of our current and potential future clinical trials of imetelstat play a critical role in the conduct of these trials and the subsequent collection and analysis of data. However, these third parties are not our employees, and except for contractual duties and obligations, we have limited ability to control their performance, or the amount or timing of resources that they devote to imetelstat. For example, we have retained CROs to support our imetelstat clinical development activities, and any failure by our CROs to perform their contractual obligations, whether due to the effects of the COVID-19 pandemic or otherwise, or disputes with our CROs about the quality of their performance or other matters, could further delay or halt our imetelstat clinical development activities including current or future imetelstat clinical trials. These third parties may also have relationships with other commercial entities, some of which may compete with us. Under certain circumstances, these third parties may terminate their agreements with us without cause and upon immediate written notice.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we rely on third parties to conduct our imetelstat clinical trials, including IMerge Phase 3, IMpactMF and IMproveMF, we remain responsible for ensuring that each clinical trial is conducted in accordance with its investigational plan and protocol, and applicable laws. Moreover, the FDA and similar international regulatory authorities require us to comply with GCP regulations and standards for conducting, monitoring, recording and reporting the results of clinical trials to ensure that the data and results are scientifically credible and accurate, and that the rights, integrity and confidentiality of patients participating in clinical trials are protected, including being adequately informed of the potential risks. Regulatory authorities enforce these GCP requirements through periodic inspections of trial sponsors, principal investigators and trial sites. If we or any of our CROs fail to comply with applicable GCP requirements, the clinical data generated in our clinical trials may be deemed</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unreliable and the FDA, or similar international regulatory authorities, may require us to perform additional clinical trials before approving any application for approval. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials comply with GCP or other applicable regulations. In addition, our clinical trials must be conducted with imetelstat produced under applicable GMP regulations. Our failure to comply with these regulations may require us to repeat clinical trials, which would further delay the process for any regulatory approval. Our ability to comply with these regulations and standards may be contingent upon activities conducted by third parties, and if they fail to perform in accordance with contractual obligations and legal requirements, our development of imetelstat may be interrupted, further delayed or halted. Any failures by us or third parties noted above would have a severe adverse effect on our results of operations, financial condition and ability to raise additional capital, business prospects and the future of imetelstat, including the potential commercialization of imetelstat, any of which might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also are required to register imetelstat clinical trials that we sponsor and post the results of certain completed clinical trials on certain government-sponsored databases, such as ClinicalTrials.gov, within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, the execution of clinical trials and the subsequent compilation and analysis of the data produced, including the interim and final analyses for IMpactMF, requires coordination among various parties. In order for these functions to be carried out effectively and efficiently, it is imperative that these parties communicate and coordinate with one another. If the quality or accuracy of the clinical data obtained, compiled or analyzed by third parties is compromised due to their failure to adhere to our clinical trial protocols, GCP or GMP requirements, or for any other reason, we may need to enter into new arrangements with alternative third parties, which would cause delay, and could be difficult, costly or impossible. If third parties conducting our clinical trials do not perform their contractual duties or obligations, experience work stoppages, do not meet expected deadlines, terminate their agreements with us or need to be replaced, our clinical trials may be extended, delayed or terminated, or may be unsuccessful or need to be repeated, which could have a material adverse effect on our business, including the potential commercialization of imetelstat, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If any of our relationships with these third parties terminate, we may not be able to enter into arrangements with alternative third parties or do so on commercially reasonable terms. Switching or adding CROs, investigators and other third parties involves additional costs and delays because of the time it takes to finalize a contract with a new CRO and for their commencement of work. As a result, delays can occur, which could materially impact our ability to meet our desired clinical development timelines. The COVID-19 pandemic and public health safety measures taken in response have also had a significant impact on our CROs and other third parties. Although we carefully manage our relationships with our CROs, investigators and other third parties, we and any of these third parties may nonetheless encounter challenges or delays in the future, which could have a material and adverse impact on our business, business prospects and the future of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, certain principal investigators for our clinical trials serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA. The FDA may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected conduct of the trial. The FDA may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of any applications for approval by the FDA and may ultimately lead to the denial of approval of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We will not control the conduct of current or any potential future investigator-led clinical trials, and data from such trials could show marginal efficacy and/or clinically relevant safety concerns related to imetelstat resulting in an unfavorable benefit-to-risk assessment that could impact our ongoing clinical trials or development program for imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will not control the design or administration of the investigator-led clinical trial, IMpress, or any potential future investigator-led trials, nor the submission, approval or maintenance of any IND or foreign equivalent required to conduct these clinical trials. In addition, we will not have control over the timing and reporting of the data from any such investigator-led clinical trials. A delay in the timely completion of or reporting of data from any potential future investigator-led clinical trial could have a material adverse effect on our ability to further develop imetelstat or to advance imetelstat to subsequent clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investigator-led clinical trials may be conducted under less rigorous clinical standards than those used in company-sponsored clinical trials. Accordingly, regulatory authorities may closely scrutinize the data collected from these investigator-led clinical trials. In addition, any potential future investigator-led clinical trials could show marginal efficacy and/or clinically relevant safety concerns that could delay the further clinical development or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">marketing approval of imetelstat for any indication. To the extent that the results of any potential future investigator-led clinical trials raise safety or other concerns regarding imetelstat, regulatory authorities may question the results of such investigator-led clinical trials, or question the results of IMerge Phase 3, IMpactMF, and IMproveMF. Safety concerns arising from any potential future investigator-led clinical trials could result in partial or full clinical holds being placed on the imetelstat INDs by the FDA or other similar international regulatory authorities, as occurred in March 2014, which would further delay or prevent us from advancing imetelstat into further clinical development and cause us to discontinue our development of imetelstat, which would severely harm our business and prospects, including the potential commercialization of imetelstat, and could potentially cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Regulatory APPROVAL and Commercialization of Imetelstat</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our inability to obtain and maintain regulatory clearances and approvals to continue the clinical development of, and to potentially commercialize, imetelstat, would severely and adversely affect imetelstat&#x2019;s future value, and our business and business prospects, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal, state and local governments in the U.S. and governments in other countries have significant regulations in place that govern drug research and development and may prevent us from successfully conducting development efforts or potentially commercializing imetelstat. Delays in obtaining or failure to maintain regulatory clearances and approvals, or limitations in the scope of such clearances or approvals, could:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">impede or halt our activities and plans for clinical development and commercialization;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significantly harm the commercial potential of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">impose additional development costs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">diminish any competitive advantages that may have been available to us; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">further delay or preclude any revenue we may receive from the future commercialization of imetelstat, if any.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, with respect to the trial design for IMpactMF, the FDA urged us to consider adding a third dosing arm to the trial to assess a lower dose and/or a more frequent dosing schedule that might improve the trial&#x2019;s chance of success by identifying a less toxic regimen and/or more effective spleen response, one of the trial&#x2019;s secondary endpoints. Based on data from IMbark, we believe that testing a lower dose regimen would likely result in a lower median OS, which is the trial&#x2019;s primary endpoint, in the imetelstat treatment arm. Existing data also suggest that lowering the dose would not result in a clinically meaningful reduction in toxicity, and for these reasons we therefore determined not to add a third dosing arm to the trial design and the FDA did not object to our proposed imetelstat dose and schedule of 9.4 mg/kg every three weeks. Our belief may ultimately be incorrect. Therefore, our failure to add a third dosing arm could result in a failure to maintain regulatory clearance from the FDA and similar international regulatory authorities, could result in the trial&#x2019;s failure, or could otherwise delay, limit or prevent marketing approval of imetelstat for relapsed/refractory MF by the FDA or similar international regulatory authorities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, in IMerge Phase 3 we shortened the follow-up period after the last patient has been enrolled from 15 months to 12 months to enable an earlier clinical cut-off date for the primary analysis. Although we reported positive top-line results from IMerge Phase 3 in January 2023, our decision to shorten the follow-up period after the last patient has been enrolled may result in further clinical responses that could occur after the 12-month clinical cut-off date being excluded from the primary analysis. The exclusion of this future data from the primary analysis could reduce the overall efficacy results, including durability of transfusion independence, which could otherwise delay, limit or prevent marketing approval of imetelstat in lower risk MDS by the FDA or similar international regulatory authorities or require additional clinical trials and further testing prior to granting any regulatory approval to market imetelstat in lower risk MDS.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even though we reported positive top-line results from IMerge Phase 3 in January 2023, those results are not necessarily predictive of imetelstat activity in other indications and for other pivotal trials that may be needed to support any application to the FDA or similar international regulatory authorities for such other indications, such as from IMpactMF. We may therefore fail to further develop or commercialize imetelstat, which would severely and adversely affect our business and business prospects, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to prepare and timely submit the planned NDA for imetelstat in lower risk MDS, and to successfully obtain regulatory approval for and commercialize imetelstat, or experience significant delays in doing so, our business will be materially harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process of obtaining marketing approvals, both in the U.S. and in other countries, is lengthy, expensive and uncertain. It may take many years to obtain approval, if approval is obtained at all, and can vary substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Of the large number of drugs in development, only a small percentage complete the regulatory approval process and are successfully commercialized. In addition, the lengthy review process as well as the unpredictability of future clinical trial results may result in a delay in obtaining, or our failure to obtain, regulatory approval for imetelstat in lower risk MDS, relapsed/refractory MF, or any other indication, which would significantly harm our business, business prospects, including the potential commercialization of imetelstat, and the future value of imetelstat and might cause us to cease operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securing marketing approval requires the submission of extensive non-clinical and clinical data and supporting information to regulatory authorities for each therapeutic indication to establish the product candidate&#x2019;s safety and efficacy, as well as information about the product manufacturing process and any inspections of manufacturing facilities conducted by regulatory authorities through the filing of an NDA in the U.S. and an MAA in Europe. As a company, we have not previously submitted an NDA to the FDA or similar applications to comparable international regulatory authorities for imetelstat. The preparation of an NDA requires a great deal of effort and expertise, and if we do not secure the necessary resources and retain personnel having the requisite expertise to prepare and submit an NDA, the filing of any NDA would be delayed. Further, if we submit an NDA, there can be no assurance that it will be accepted by the FDA. If the FDA determines after an initial review of the NDA that the data included in the application is insufficient and not ready for formal consideration, we could receive a &#x201c;refuse to file&#x201d; notice. The FDA also has substantial discretion in the approval process.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While we reported positive top-line results from IMerge Phase 3 in lower risk MDS, and while we believe that these results and our assessment of the positive benefit-risk profile of imetelstat, combined with data from our Phase 2 clinical trials, are supportive of planned regulatory submissions in the U.S. and in the EU for imetelstat in lower risk MDS, regulatory authorities in those jurisdictions may disagree with our interpretation of the data and may require additional clinical testing before we can seek regulatory approval and begin commercialization of imetelstat, if at all, any of which could result in increased costs to us, delay or limit our ability to generate revenue and adversely affect our commercial prospects. There is no guarantee that we will obtain regulatory approval or be able to commence commercialization on the timeline we are planning or at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Imetelstat must receive all relevant regulatory approvals before it may be marketed in the U.S. or other countries. Regulatory authorities have substantial discretion in the approval process and can delay, limit or deny approval of imetelstat or require us to conduct additional non-clinical or clinical testing or abandon a program for many reasons, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disagreement with the design or implementation of our clinical trials, including our statistical analysis of trial results;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to demonstrate to the FDA or similar international regulatory authorities that imetelstat&#x2019;s efficacy results, including duration of response, is acceptable;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unfavorable benefit-to-risk assessment, in the case of marginal efficacy and/or clinically relevant safety concerns, for any proposed indication;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">serious and unexpected drug-related side effects experienced by participants in our clinical trials or by individuals using drugs similar to imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disagreement with our interpretation of data from non-clinical studies or clinical trials, including disagreement from any advisory committee convened in connection with the NDA review;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to collect data from clinical trials of imetelstat meeting the level of integrity or statistical or clinical significance required by the FDA or similar international regulatory authorities, or a determination such data is not sufficient to support the submission of an NDA, MAA, or other submission, or to obtain regulatory approval in the U.S., the EU or elsewhere;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">deficiencies in our clinical trial operations or the clinical trial operations of trial sites, including as a result of FDA or EMA bioresearch monitoring inspections in conjunction with NDA or MAA review;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">identification of critical issues as a result of a pre-approval health authority inspection that could negatively impact the integrity of data in an NDA or MAA and lead to a rejection by the FDA and similar international health authorities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">errors or deficiencies in the conduct of the imetelstat program prior to its transition to us by our former collaborator, and/or in the transition of the imetelstat program to us by our former collaborator;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unwillingness or inability by our former collaborator to provide information requested by the FDA or similar international regulatory authorities regarding the time period when our former collaborator was responsible for the imetelstat program;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a determination by the FDA or similar international regulatory authorities that the appropriate indication for commercial use of imetelstat is narrower or more restrictive than anticipated;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to satisfy the requirement to develop a risk evaluation and mitigation strategy, or REMS, for the U.S. and a risk management plan for the EU including post-marketing studies, as a potential condition to approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disagreement regarding the formulation, labeling and/or the specifications for imetelstat; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">a determination by the FDA or similar international regulatory authorities that the manufacturing processes, test procedures and specifications applicable to the manufacture of imetelstat, or the facilities of the third-party manufacturers with which we contract for clinical and commercial supplies of imetelstat are inadequate, or failure by such third-party manufacturers to maintain compliance with the regulatory and other requirements established by the FDA or similar international regulatory authorities, including as a result of preapproval inspections conducted in conjunction with NDA or MAA review;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the failure of the quality or stability of imetelstat to meet acceptable regulatory standards;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or similar international regulatory authorities may lack resources or be delayed in conducting pre-approval inspections due to reasons related to COVID-19 or otherwise;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we or any third-party service providers may be unable to demonstrate compliance with current good manufacturing practices, or cGMPs, and/or good clinical practices, or GCPs, to the satisfaction of the FDA or similar international regulatory authorities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in regulatory policies or approval processes, or potential reduction of unmet medical need with the entry of competitive therapies to the market, could render our clinical efficacy or safety data insufficient for approval; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">political factors surrounding the approval process, such as government shutdowns, political instability or global pandemics, such as COVID-19.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, in recent years, there has been increased public and political scrutiny on the FDA and similar international regulatory authorities with respect to the approval process for new drugs, and as a result regulatory authorities may apply more stringent regulatory standards, especially regarding drug safety, when reviewing regulatory submissions for new drugs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we believe we have complied with all of the regulatory requirements to receive marketing approval for imetelstat, we may not obtain marketing approval for reasons that we do not currently predict. If we fail to obtain regulatory approval for imetelstat, we will have no commercialized products and correspondingly no revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any marketing approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments that render imetelstat not commercially viable, which would harm imetelstat&#x2019;s future value and our business and business prospects. In addition, obtaining regulatory approval is a lengthy, expensive and uncertain process. For example, following the result of a referendum in 2016, the U.K. left the EU on January 31, 2020, commonly referred to as Brexit, and its withdrawal from the EU was completed on December 31, 2020. The withdrawal of the U.K. from the EU has resulted in uncertainty in relation to the regulatory process in the U.K., and for Europe could potentially result in a delay in the review of regulatory submissions which could also lead to less efficient, more expensive, and potentially lengthier regulatory review processes for companies like us, who may seek to obtain regulatory approval for drug products in the EU or the U.K. Such regulatory changes in the U.K. or elsewhere could adversely affect and/or delay our ability to obtain approval of, and market and sell, imetelstat in the U.S. or other countries.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Regulatory authorities may also not approve the labeling claims that are necessary or desirable for the successful commercialization of a drug, such as imetelstat. For example, future regulatory clearances, if any, that we</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">might obtain for imetelstat may be limited to fewer or narrower indications than we might request, or may be granted subject to the performance of post-marketing studies, which may impose further requirements or restrictions on the distribution or use of imetelstat, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet certain safe-use criteria, and requiring treated patients to enroll in a registry. These limitations and restrictions may limit the size of the market for imetelstat and affect reimbursement by third-party payors. Future regulatory clearances, if any, may be limited to a smaller patient population, or may require a different drug formulation or a different manufacturing process, than we might in the future decide to seek.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, failure by our former collaborator to comply with applicable regulatory guidelines prior to our assumption of sponsorship of the imetelstat program could result in administrative or judicially imposed sanctions on us, including warning letters, civil and criminal penalties, injunctions, product seizures or detention, product recalls, total or partial suspension of manufacturing activities, and the potential refusal to approve any NDAs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any delay in obtaining or failure to obtain required approvals of imetelstat, or limitations on any regulatory approval that we might receive in the future, if any, could reduce the potential commercial use of imetelstat, and potential market demand for imetelstat and therefore result in decreased revenue for us from any commercialization of imetelstat, any of which would severely and adversely affect our financial results and ability to raise additional capital, the price of our common stock, our business and business prospects, including the potential commercialization of imetelstat, and the future of imetelstat, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If imetelstat is approved for commercialization and we are unable to establish sales, marketing and distribution capabilities or enter into agreements with third parties to commercialize imetelstat, we will be unable to successfully commercialize imetelstat if and when it is approved.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will need to complete substantial preparations to be ready for any potential future commercialization of imetelstat, and currently we have no sales, marketing or distribution capabilities and no experience in marketing products. To advance imetelstat to potential marketing approval, we will be required to complete our commercialization preparatory activities, and continue to incur related expenses, before we obtain any marketing approval. These activities will include, among other things, the development of an in-house marketing and sales force, which will require significant capital expenditures, management resources and time. We will have to compete with other companies to recruit, hire, train and retain qualified marketing and sales personnel. If we are unable to adequately prepare for the potential future commercialization of imetelstat, we may not be able to generate product revenue if marketing authorization is obtained.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are risks involved with both establishing our own sales, marketing and distribution capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force is expensive and time consuming and could delay any product launch. If the commercial launch of imetelstat for which we recruit a sales and marketing force and establish distribution capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses, which would be costly. Even if imetelstat is approved in lower risk MDS and we are able to establish our own sales and marketing capabilities, imetelstat will be a newly-marketed drug. As a result, we will be required to expend significant time and resources to train sales personnel in commercializing imetelstat. If we are unable to effectively train sales personnel and equip them with compliant and effective materials, our efforts to successfully commercialize imetelstat could be adversely affected, which would negatively impact our business, business prospects and the future value of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Factors that may inhibit our efforts to commercialize imetelstat on our own include:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to recruit, train and retain adequate numbers of effective sales, marketing, distribution, coverage or reimbursement, customer service, medical affairs and other support personnel;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to equip sales personnel with compliant and effective materials, including medical and sales literature to help them educate physicians regarding the indications we are targeting and imetelstat, if approved;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability of sales personnel to obtain access to physicians or persuade adequate numbers of physicians to prescribe imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement and other acceptance by payors;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the lack of complementary medicines to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to price imetelstat at a sufficient price point to ensure an adequate and attractive level of profitability; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">unforeseen costs and expenses associated with creating an independent sales and marketing organization;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to maintain existing supply arrangements, or to establish new supply arrangements with third-party suppliers and contract manufacturers to ensure sufficient commercial supplies; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to obtain and maintain patent protection, trade secret protection and regulatory exclusivity, both in the U.S. and in other countries;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">lack of an acceptable safety profile following any regulatory approval; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our inability to compete effectively with other therapies.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we enter into arrangements with third parties to perform commercialization services like sales, marketing and distribution, we will be reliant on the efforts of such third parties, and our sales revenue from sales of imetelstat or the profitability from such sales to us are likely to be lower than if we were to market and sell imetelstat ourselves. In addition, we may not be successful in entering into arrangements with third parties to commercialize imetelstat or may be unable to do so on terms that are favorable to us. In entering into third-party commercialization arrangements, any revenue we receive will depend upon the efforts of the third parties, and we cannot assure you that such third parties will establish adequate commercialization capabilities or devote the necessary resources and attention to commercialize imetelstat effectively. We also face competition in our search for third parties to assist us with the commercialization efforts of imetelstat.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our inability to successfully establish commercialization capabilities for imetelstat, if we receive regulatory approval to do so, would severely and adversely affect our financial results, business and business prospects, including the potential commercialization of imetelstat, and the future of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If acceptable prices or adequate reimbursement for imetelstat is not obtained, the use of imetelstat could be severely limited.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ability to successfully commercialize imetelstat, if approved, will depend significantly on obtaining acceptable prices and the availability of coverage and adequate reimbursement to the patient from third-party payors. Government payors, such as the Medicare and Medicaid programs, and other third-party payors, such as private health insurers and health maintenance organizations, determine which medications they will cover and the reimbursement levels. Assuming we obtain coverage for imetelstat by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments that patients find unacceptably high. If imetelstat is approved for commercial sale, patients are unlikely to use it unless coverage is provided, and reimbursement is adequate to cover all or a significant portion of its cost. Therefore, coverage and adequate reimbursement will be critical to new product acceptance.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government authorities and other third-party payors are developing increasingly sophisticated methods of controlling healthcare costs, such as by limiting coverage and the amount of reimbursement for particular medications. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices as a condition of coverage, are using restrictive formularies and preferred drug lists to leverage greater discounts in competitive classes, and are challenging the prices charged for medical products. Further, no uniform policy requirement for coverage and reimbursement for drug products exists among third-party payors in the U.S. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of imetelstat to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot be sure that coverage and reimbursement will be available for imetelstat, if approved for commercial sale, and, if reimbursement is available, what the level of reimbursement will be. There may also be significant delays in obtaining coverage and reimbursement for newly approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA or similar international regulatory authorities. Coverage and reimbursement may impact the demand for, or the price of imetelstat, if marketing approval is obtained. If coverage and reimbursement are not available or reimbursement is available only to limited levels, we may not successfully commercialize imetelstat, even if marketing approval is obtained, which would negatively impact our business and business prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Although orphan drug designation has been granted to imetelstat for the treatment of MF and MDS in the U.S. and in the EU, these designations may not be maintained, which would eliminate the benefits associated with orphan drug designation, including the potential for market exclusivity, which would likely result in decreased sales revenue from commercialization of imetelstat, if any, and would likely harm our business and business prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA granted orphan drug designation to imetelstat in June 2015 for the treatment of MF and for the treatment of MDS in December 2015, and the EMA granted orphan drug designation in December 2015 to imetelstat for the treatment of MF and in July 2020 for the treatment of MDS. The designation of imetelstat as an orphan drug does not guarantee that any regulatory authority will accelerate regulatory review of, or ultimately approve, imetelstat, nor does it limit the ability of any regulatory authority to grant orphan drug designation to product candidates of other companies that treat the same indications as imetelstat prior to imetelstat receiving any exclusive marketing approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may lose orphan drug exclusivity for certain reasons, including if the FDA or EMA determines that the request for orphan drug designation was materially defective or if we cannot ensure sufficient quantities of imetelstat to meet the needs of patients with MF or MDS. Failure to maintain orphan designation status in the EU at the time of submitting the MAA, or failure to complete the agreed pediatric plan, would lead to the loss of the additional two-year exclusivity period.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we maintain orphan drug exclusivity for imetelstat, the exclusivity may not effectively protect imetelstat from all competition because different drugs with different active moieties can be approved for the same condition. Even after an orphan drug product is approved, the FDA or EMA can subsequently approve a different drug with the same active moiety for the same condition, if the FDA or EMA concludes that the later drug is safer, more effective, or makes a major contribution to patient care. The occurrence of any of these events could result in decreased sales of imetelstat, should it ever receive marketing approval, and may harm our business and business prospects. In addition, orphan drug designation will neither shorten the development time nor regulatory review time for imetelstat, and it does not give imetelstat any advantage in the regulatory review or approval process.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">A Fast Track designation by the FDA, such as the Fast Track designations received for imetelstat for MDS and MF, does not guarantee marketing approval and may not lead to a faster development, regulatory review or approval process.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2017, the FDA granted Fast Track designation to imetelstat for the treatment of adult patients with transfusion-dependent low red blood cell counts, or anemia, due to non-del(5q) lower risk MDS and who are refractory or resistant to treatment with an ESA. In September 2019, the FDA granted Fast Track designation to imetelstat for the treatment of adult patients with relapsed/refractory MF.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fast Track designation provides opportunities for frequent interactions with FDA review staff, as well as eligibility for priority review, if relevant criteria are met, and rolling review of the sponsor&#x2019;s NDA. Fast Track designation is intended to facilitate and expedite development and review of an NDA to address unmet medical needs in the treatment of serious or life-threatening conditions. However, Fast Track designation does not accelerate conduct of clinical trials or mean that the regulatory requirements are less stringent, nor does it ensure that any imetelstat NDA will be approved or that any approval will be granted within any particular timeframe. In addition, the FDA may withdraw Fast Track designation for any indication if it believes that the designation is no longer supported by data emerging from the imetelstat clinical development program.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The Innovation Passport designation from the United Kingdom regulatory authorities does not guarantee marketing approval and may not lead to a faster development, regulatory review or approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2021, we gained access to the ILAP through the receipt of an Innovation Passport for imetelstat to treat lower risk MDS. The ILAP is a new program sponsored by the Medicines and Healthcare products Regulatory Agency, or MHRA, in the U.K., post-Brexit. The objective of this new licensing and access pathway is to reduce the time to market and enable earlier patient access for innovative medicines. The Innovation Passport is the first prescribed entry point in the ILAP process. Key benefits of being within ILAP include a potential 150-day accelerated assessment and rolling review of an MAA, as well as opportunities for frequent interactions with the review staff at the MHRA and its partner agencies to discuss imetelstat&#x2019;s development, regulatory and reimbursement plans.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although the goal of ILAP and the Innovation Passport is to reduce the time to market and enable earlier patient access, it does not accelerate conduct of clinical trials or mean that the regulatory requirements are less stringent, nor does it ensure that any imetelstat MAA will be approved or that any approval will be granted within</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any particular timeframe. Despite receiving Innovation Passport designation, we may decide to delay or forego the commercialization of imetelstat in the U.K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Failure to achieve continued compliance with government regulations could delay or halt potential commercialization of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Approved products and their manufacturers are subject to continual review, and discovery of previously unknown problems with a product or its manufacturer may result in restrictions on the product or manufacturer, including import restrictions, seizure and withdrawal of the product from the market. If approved for commercial sale, future sales of imetelstat will be subject to government regulation related to numerous matters, including the processes of:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacturing;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">advertising and promoting;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">selling and marketing;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">medical information;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">labeling; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">distribution.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If, and to the extent that, we are unable to comply with these regulations, our ability to earn potential revenue from the commercialization of imetelstat, if any, would be materially and adversely impacted.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if imetelstat causes serious or unexpected side effects or is associated with other safety risks after receiving marketing approval, a number of potential significant negative consequences could result, including, but not limited to:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities may withdraw their approval of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be required to recall imetelstat, seek to change the way it is administered, conduct additional clinical trials or change the labeling of the product;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities may require revisions to the labeling of imetelstat, including limitations on approved uses or the addition of further warnings, contraindications or other safety information, or may impose restrictions on distribution in the form of REMS in connection with approval, if any;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may experience manufacturing delays and supply disruptions if regulatory inspectors identify regulatory noncompliance by third party manufacturers requiring remediation;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">imetelstat may be rendered less competitive and sales may decrease;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our reputation may suffer generally both among clinicians and patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be exposed to potential lawsuits and associated legal expenses, including costs of resolving claims;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the FDA or similar international regulatory authorities may refuse to approve pending applications or supplements to approved applications filed by us, or may suspend or revoke license approvals; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may be required to change or stop ongoing clinical trials of imetelstat, which would negatively impact the development of imetelstat for other potential indications.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any of these events could prevent us from achieving or maintaining market acceptance for imetelstat or could substantially increase the costs and expenses of commercializing imetelstat, which in turn could delay or prevent us from generating any revenues from the sale of the imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, the FDA strictly regulates the promotional claims that may be made about drug products. In particular, a product may not be promoted for uses that are not approved by the FDA as reflected in the product&#x2019;s approved labeling. The FDA and other agencies actively enforce regulations prohibiting the promotion of any drug product for off-label uses. If we were found to have improperly promoted off-label use of imetelstat, we would be subject to significant civil, criminal and administrative penalties, which would inhibit our ability to commercialize imetelstat and generate revenue, require us to expend significant time and resources in response, and generate negative publicity. Enforcement actions include, among others:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adverse regulatory inspection findings;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fines, warning letters, or untitled letters;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">voluntary or mandatory product recalls or public notification or medical product safety alerts to healthcare professionals;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on, or prohibitions against, marketing imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on, or prohibitions against, importation or exportation of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">suspension of review or refusal to approve pending applications or supplements to approved applications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exclusion from participation in government-funded healthcare programs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">exclusion from eligibility for the award of government contracts for imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">suspension or withdrawal of product approvals;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product seizures;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">injunctions; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">civil and criminal penalties and fines.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The imposition of any of these penalties or other commercial limitations would severely and adversely affect our financial results, business and business prospects, including the potential commercialization of imetelstat, and the future of imetelstat, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If, in the future, we seek regulatory approval to market imetelstat internationally, we may experience a variety of risks that would materially adversely affect our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If, in the future, we seek regulatory approval of imetelstat outside of the U.S., and if the necessary approvals are obtained, we will be subject to additional risks related to operating in countries outside of the U.S., including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">foreign regulatory approvals, if any, may take longer and be more costly to obtain than approvals in the U.S., due to differing regulatory requirements in foreign countries, such as the lack of pathways for accelerated drug approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory authorities outside of the U.S. may disagree with the design, implementation or results of our clinical trials or our interpretation of data from nonclinical studies or clinical trials;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">approval policies or regulations of regulatory authorities outside of the U.S. may significantly change in a manner rendering our clinical data insufficient for potential approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the COVID-19 pandemic may negatively impact our ability to produce imetelstat and conduct clinical trials in countries outside of the U.S.;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we may experience unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">general economic weakness, including inflation, rising interest rates, the prospect of a recession or civil or political instability in particular economies and markets outside of the U.S., including as a result of the conflict between Russia and Ukraine;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">risks of potential noncompliance with legal requirements applicable to privacy, data protection, information security and other matters;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">risks of potential noncompliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increased taxes outside of the U.S., including withholding of payroll taxes;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">significant foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">difficulties staffing and managing operations outside of the U.S.;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">complexities associated with managing multiple payor reimbursement regimes and government payors in foreign countries;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">workforce uncertainty in countries where labor unrest is more common than in the U.S.;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential liability under the Foreign Corrupt Practices Act of 1977 or comparable regulations outside of the U.S.;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">challenges enforcing our contractual and intellectual property rights, especially in those countries outside of the U.S. that do not respect and protect intellectual property rights to the same extent as the U.S.;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">business interruptions resulting from geopolitical actions, including war and terrorism including the conflict between Russia and Ukraine.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These and other risks associated with international operations may materially adversely affect our ability to attain or maintain profitable operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also subject to numerous regulatory requirements outside of the U.S. governing, among other things, the conduct of clinical trials, manufacturing and marketing authorization, pricing and third-party reimbursement. The regulatory approval process varies among countries and may include all of the risks associated with FDA approval described above as well as risks attributable to the satisfaction of local regulations in jurisdictions outside of the U.S. Moreover, the time required to obtain approval may differ from that required to obtain FDA approval. Approval by the FDA does not ensure approval by regulatory authorities outside the U.S. and vice versa.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In Europe, the Clinical Trials Regulation, which came into effect in January 2022, introduced substantial changes in how clinical trials are authorized in the European Economic Area, or EEA, enabling sponsors to submit a single application to run a clinical trial in several European countries. The objectives of the new regulation include consistent rules for conducting trials throughout the European Union, consistent data standards and adverse events listing, and consistent information on the authorization status. Information on the conduct and results of each clinical trial carried out in the EU will be made publicly available. Commencing in January 2023, clinical trial sponsors will need to use the Clinical Trials Information System, or CTIS, to apply to start a new clinical trial in the EEA; and from January 2025, clinical trials in the EEA will need to comply with the Clinical Trials Regulation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, a new pan-European clinical trial data information database has been created that will be complementary to the database established for pharmacovigilance (Regulation (EC) No 726/2004 with respect to centrally authorized medicinal products). In addition, Commission Implementing Regulation (EU) No 520/2012 outlines the practical implications for marketing authorization holders, national competent authorities, and the EMA. Also, Commission Delegated Regulation (EU) No 357/2014 on post-authorization efficacy studies specifies the situations in which such studies may be required. Post-authorization efficacy studies may be required where concerns relating to some aspects of efficacy of the medicinal product are identified and can be resolved only after the medicinal product has been marketed, or where the understanding of the disease, the clinical methodology or the use of the medicinal product under real-life conditions indicate that previous efficacy evaluations might have to be revised significantly.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Brexit is also expected to disrupt the operation of pre- and post-authorization clinical trial infrastructure. The rules around GMP and pharmacovigilance in the U.K. currently remain similar to the EU requirements. However, the Falsified Medicines Directive will not apply in Great Britain though it is likely that the U.K. will implement a procedure to minimize the risk of falsified medicines.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Uncertainty in the regulatory framework and future legislation could lead to disruption in the execution of international multi-center clinical trials, the monitoring of adverse events through pharmacovigilance programs, the evaluation of the benefit-risk profiles of new medicinal products, and determination of marketing authorization across different jurisdictions. Changes to existing regulations may add considerably to the development lead time to marketing authorization and commercialization of products in the EU and increase our costs. We cannot predict the impact of such changes and future regulation on our business or the results of our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to requests for access to imetelstat. Demand for compassionate use of imetelstat could strain our resources, delay our drug development activities, negatively impact our regulatory approval or commercial activities, and result in losses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing imetelstat to treat life-threatening hematologic malignancies for which there are currently limited therapeutic options. Other companies in our field have been the target of campaigns requesting access to unapproved drugs. If we experience similar request for access campaigns, we may experience significant disruption to our business which could result in losses. We are a small company with limited resources, and any unanticipated trials or access programs resulting from requests for access could deplete our drug supply, increase our capital expenditures, reduce the availability of potentially eligible clinical trial participants, and otherwise divert our resources from our primary goals.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, legislation referred to as &#x201c;Right to Try&#x201d; laws have been introduced at the local and national levels, which are intended to give patients access to unapproved therapies. New and emerging legislation regarding expanded access to unapproved drugs for life-threatening illnesses could negatively impact our business in the future. Either activism or legislation related to requests for access may require us to initiate an unanticipated expanded access program or to make imetelstat more widely available sooner than anticipated.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patients who receive access to unapproved drugs through compassionate use or expanded access programs have life-threatening illnesses and generally have exhausted all other available therapies. The risk for serious adverse events, including those which may be unrelated to imetelstat, in this patient population is high and could have a negative impact on the safety profile of imetelstat, which could cause significant delays or an inability to successfully commercialize imetelstat and could materially harm our business. In addition, if, in order to perform the controlled clinical trials required for potential regulatory approval and successful commercialization of imetelstat, we do not provide compassionate use access or expanded access programs in response to requests for access from patients in the U.S. or elsewhere in the world, we may receive adverse publicity or experience other disruptions. Should we agree to provide compassionate use access or decide to initiate an expanded access program, we could experience adverse publicity or other disruptions related to potential participants in such programs. Similarly, we could experience adverse publicity or other disruptions if we were to restructure or pause any compassionate use and/or expanded access program after initiating such a program or after the provision of our product through compassionate access to an individual patient or patients.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to comply with federal, state and international healthcare laws, including fraud and abuse, transparency, and health information privacy and security laws, we could face substantial penalties and our business, results of operations, financial condition and prospects could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business operations and current and future arrangements with investigators, healthcare professionals, consultants, third-party payors and customers, may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations, including federal and state fraud and abuse laws, including anti-kickback and false claims laws; data privacy and security laws, including the Health Insurance Portability and Accountability Act, or HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH; and transparency laws related to payments and/or other transfers of value made to physicians, other healthcare professionals and teaching hospitals. These laws may constrain the business or financial arrangements and relationships through which we conduct our operations, including how we research, market, sell and distribute imetelstat, if marketing approval is obtained. For details regarding the restrictions under applicable federal and state healthcare laws and regulations that may affect our ability to operate see Item 1 &#x201c;Business&#x2014;Government Regulation&#x2014; Fraud and Abuse, Data Privacy and Security, and Transparency Laws and Regulations&#x201d; in our Annual Report on Form 10-K for the year ended December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal and state enforcement bodies have increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. If our operations are found to be in violation of any of these or any other healthcare and privacy-related regulatory laws that may apply to us, we may be subject to significant penalties, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgement, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, reputational harm, diminished profits and future earnings, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations. Defending against any such actions can be costly, time-consuming and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Manufacturing Imetelstat</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Failure by us to establish and/or maintain a manufacturing supply chain to appropriately and adequately supply imetelstat for future clinical and commercial uses would result in a further delay in or cessation of clinical trials and a delay in our ability to obtain regulatory approvals of imetelstat, and affect our ability to commercialize imetelstat, and our business and business prospects could be severely harmed, and we could cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The manufacture of imetelstat must comply with applicable regulatory standards for current and potential future clinical trials and potential commercial uses. The process of manufacturing imetelstat is complex and remains subject to several risks, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to scale-up and attain sufficient production yields with appropriate quality control and quality assurance to meet the needs of our clinical trials and potential future market demand, and to establish commercial supply agreements;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reliance on third-party manufacturers and suppliers, whose efforts we do not control;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">supply chain issues, including the timely availability and shelf life requirements of raw materials and other supplies, any of which may be impacted by a number of factors, including the effects of macroeconomic conditions such as the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">shortage of qualified personnel; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory acceptance and compliance with regulatory requirements, which are less well-defined for oligonucleotide products than for small molecule drugs and vary in each country where imetelstat might be sold or used.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of these and other risks, we may be unable to establish and/or maintain a manufacturing infrastructure and supply chain capable of providing imetelstat for IMerge Phase 3, IMpactMF, IMproveMF and IMpress, and potential future commercial uses, which would delay or result in a cessation of such current or potential future clinical trials of imetelstat. Occurrence of any such events would further delay or preclude any applications for regulatory approval and therefore further delay or preclude our ability to earn revenue from the commercialization, if any, of imetelstat, which would severely and adversely affect our financial results, business and business prospects, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If third parties that manufacture imetelstat fail to perform as needed, then the clinical and commercial supply of imetelstat will be limited, and we may be unable to conduct or complete current or potential future clinical trials of imetelstat or to commercialize imetelstat in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our imetelstat manufacturing supply chain relies, and will continue to rely, solely upon third-party manufacturers to perform certain process development or other technical and scientific work with respect to imetelstat, as well as to supply starting materials and manufacture drug substance and drug product. While we have established arrangements with third parties for the manufacture of imetelstat, our manufacturing supply chain is highly specialized, and as such we are reliant upon a small group of third-party manufacturers to supply starting materials, drug substance and drug product. Failure by such third-party manufacturers to perform in a timely manner and in compliance with all regulatory requirements, or at all, could further delay, perhaps substantially, or preclude our ability to pursue imetelstat development on our own, increase our costs and otherwise negatively affect our financial results, business and business prospects. In this regard, a recent FDA inspection of one of our third-party manufacturers identified certain deficiencies in the manufacturer&#x2019;s processes and facilities which, while not directly related to the production of imetelstat, could impact the manufacturer&#x2019;s ability to produce and deliver products, including imetelstat, if not remediated by the manufacturer, and could lead to delays or shortages in drug supply, or the inability to manufacture or ship drug supply necessary for non-clinical and clinical activities, and commercialization. In addition, we may not be able to obtain imetelstat from third-party manufacturers on acceptable terms, or at all. We expect to rely on third-party manufacturers to produce and deliver sufficient quantities of imetelstat and other materials to support clinical trials on a timely basis and to comply with applicable regulatory requirements. We do not have direct control over these third-party personnel or operations. Reliance on these third-party manufacturers is subject to numerous risks, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">being unable to contract with suitable third-party manufacturers, including for potential commercial supply of imetelstat, because the number of potential manufacturers is limited;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delays and disruptions experienced by third-party manufacturers due to the effects of the COVID-19 pandemic, which have adversely impacted and could continue to adversely impact the ability of such parties to fulfill their contractual obligations to us;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">capacity limitations and scheduling constraints experienced by third-party manufacturers due to scheduling and other commitments, and queued manufacturing activities in contracted facilities; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential shortages of available manufacturing capacity or consumable manufacturing supplies at third-party manufacturers, due to obligations to manufacture and distribute vaccines to address the spread of COVID-19; and we anticipate that other delays, or potential shortages of consumable manufacturing supplies, may continue throughout 2023;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requirements by regulatory authorities to validate and qualify significant activities for any current or replacement manufacturer, which could involve new testing and compliance inspections;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability to execute timely contracts with third-party manufacturers and suppliers on acceptable terms, or at all;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the inability of third-party manufacturers to timely formulate and manufacture imetelstat or to produce or ship imetelstat in the quantities or of the quality required to meet clinical and commercial needs, whether due to the effects of the COVID-19 pandemic or any other reasons;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the possible mislabeling by third-party manufacturers of clinical supplies, potentially resulting in the wrong dose amounts being supplied or active drug or comparator not being properly identified;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">decisions by third-party manufacturers to exit the contract manufacturing business during the time required to supply clinical trials or to successfully produce, store and distribute imetelstat to meet commercial needs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compliance by third-party manufacturers with GMP standards mandated by the FDA and state agencies and other government regulations corresponding to similar international regulatory authorities, including any deficiencies identified during regulatory inspections, such as those identified in a recent FDA inspection of one of our third-party manufacturers;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">breach or termination of manufacturing or supply contracts;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">inadequate storage or maintenance at contracted facilities resulting in theft or spoilage; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">natural disasters that affect contracted facilities.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Each of these risks could lead to delays or shortages in drug supply, or the inability to manufacture or ship drug supply necessary for non-clinical and clinical activities, and commercialization. For example, manufacturing delays could adversely impact the conduct or completion of imetelstat clinical trials, such as IMerge Phase 3, IMpactMF, IMproveMF and IMpress, or commencement of potential future clinical trials of imetelstat, or preclude or delay potential future commercial sales, which could severely and adversely affect our financial results, business and business prospects, and the future of imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, third-party manufacturers and/or any other manufacturers may need to make substantial investments to enable sufficient capacity increases and cost reductions, and to implement those regulatory and compliance standards necessary for successful Phase 3 clinical trials and commercial production of imetelstat. These third-party manufacturers may not be willing or able to achieve such capacity increases, cost reductions, or regulatory and compliance standards, and even if they do, such achievements may not be at commercially reasonable costs. Changing manufacturers may be prolonged and difficult due to inherent technical complexities and because the number of potential manufacturers is limited. It may be difficult or impossible for us to find a replacement manufacturer on acceptable terms, or at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">It may not be possible to manufacture imetelstat at costs or scales necessary to conduct clinical trials or potential future commercialization activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Oligonucleotides are relatively large molecules produced using complex chemistry, and the cost of manufacturing an oligonucleotide like imetelstat is greater than the cost of making typical small molecule drugs. Therefore, imetelstat for clinical use is more expensive to manufacture than most other treatments currently available today or that may be available in the future. Similarly, the cost of manufacturing imetelstat for commercial use will need to be significantly lower than current costs in order for imetelstat to become a commercially successful product. We may not be able to enter into suitable commercial supply agreements, or to achieve sufficient scale increases or cost reductions necessary for successful commercial production of imetelstat. Failure to achieve necessary cost reductions could result in decreased sales or reduced gross margins, if any, for us, which would materially and adversely affect our financial results, business and business prospects, and the future of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RISKS RELATED TO COVID-19</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The effects of the ongoing COVID-19 global pandemic have negatively impacted, and will likely continue to negatively impact, our business and healthcare resources around the world, including a significant number of current and planned clinical sites involved with IMpactMF, IMproveMF and IMpress.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business and business prospects, our financial condition and ability to raise additional capital, and the future of imetelstat generally could be materially and adversely affected by the effects of the ongoing global COVID-19 pandemic. The ongoing COVID-19 pandemic and public health safety measures taken in response to COVID-19 have had a significant impact, both direct and indirect, on businesses, as significant reductions in business-related activities have occurred, clinical development and regulatory activities have been curtailed, delayed or suspended and supply chains have been disrupted. We have allowed voluntary access to our offices in California and New Jersey to employees who have been vaccinated. While almost all of our employees continue to work remotely without any significant disruption to our business, the effects of our policies regarding remote working may negatively impact productivity, disrupt our business and continue to delay our imetelstat development program and clinical trial timelines, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations on our ability to conduct our business in the ordinary course. In addition, our increased reliance on personnel working remotely could increase our cybersecurity risk, create data accessibility concerns and make us more susceptible to communication disruptions, any of which could adversely impact our business operations. These and similar, and perhaps more severe, disruptions in our operations could continue to negatively impact our business and business prospects, our financial condition and the future of imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the effects of the COVID-19 pandemic, we have had, and expect to continue to have, or we may potentially have in the future, disruptions and/or delays in our imetelstat development program, including with respect to our ability to:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">open trial sites for screening and enrollment;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">screen, enroll and assess patients;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">retain enrolled patients in our clinical trials;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ensure patient visits to clinical sites and laboratories;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">conduct monitoring visits;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">manufacture and/or supply study drug or other supplies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">report trial results; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">interact with regulators or other important agencies due to limitations in employee resources or otherwise. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restrictions on travel, availability of site personnel, and diversion of hospital staff and resources to COVID-19 patients, have disrupted our clinical trial operations, as well as patient recruitment in many areas, resulting in a slowdown in patient enrollment and/or deviations from or disruptions in key clinical trial activities, such as opening, initiating and monitoring clinical trial sites. Although vaccine distribution, including booster shots, is being conducted in many countries, the emergence of COVID-19 variants and subvariants, and the resurgence of COVID-19 cases in parts of the world, causes further uncertainty and unpredictability in clinical trial activities, including clinical site initiations, patient screening and enrollment. Like many other biopharmaceutical companies, we have experienced and continue to experience delays in clinical site initiations and patient screening and enrollment in our clinical trials, IMerge Phase 3, IMpactMF and IMproveMF, due to the COVID-19 pandemic, which have impacted our trial operations. Even though we completed patient enrollment in IMerge Phase 3, the pace of enrollment was slower than planned.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For IMpactMF, in addition to the negative impact of COVID-19, site personnel resources remain constrained in the countries where we planned to conduct the trial due to the number of competing trials in MF and other oncology indications. As such, we have experienced and expect to continue to experience disruption in clinical trial activities and delays in enrollment, as well as constraints on available sites and site personnel. Based on assumptions for enrollment and event (death) rates in the trial, we expect the interim analysis for OS for IMpactMF may occur in 2024 and the final analysis may occur in 2025. Because these analyses are event-driven and it is uncertain whether actual rates for enrollment and events will reflect current planning assumptions, the results may be available at different times than currently expected.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The continuing effects of the COVID-19 pandemic could cause further disruptions to our clinical development timelines, including continued delays in enrollment and clinical trial site initiation in IMpactMF, IMproveMF and IMpress, and other disruptions that could severely impact our business and the imetelstat development program, including those resulting from:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">new, continued or heightened difficulties in opening clinical trial sites for patient screening and enrollment and recruiting clinical site investigators and clinical site staff;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continued or heightened delays or difficulties caused by missed patient visits to clinical sites and laboratories, and uncertainty how the FDA will view deviations from clinical protocols caused by the effects of the COVID-19 pandemic;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potential refusal by the FDA to accept data, including from clinical trials in affected geographies or failure to comply with updated FDA guidance and expectations related to the conduct of clinical trials during the COVID-19 pandemic;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">continued or heightened delays or disruptions in clinical trial activities, including executing clinical site contracts, due to reduced availability of personnel at CROs, clinical site legal groups and vendors, or for any other reasons;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">substantial reduction of healthcare resources available for the conduct of clinical trials, including the temporary postponement of clinical trial activities at certain hospitals serving as our clinical trial sites and diversion of hospital staff away from the conduct of our clinical trials, such as those experienced by us to date;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">interruption of, or delays in receiving, supplies of imetelstat from our third-party manufacturers due to among other things, staffing shortages, production slowdowns or stoppages, shipping delays, shortages in raw materials or laboratory supplies because of ongoing efforts to address the pandemic, limitations in available capacity at contract manufacturing vendors or drug distribution service providers due to obligations to manufacture and distribute vaccines to address the spread of COVID-19, disruptions in supply chain and production systems and import/export complications; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">interruption of key clinical trial activities, such as clinical trial site data monitoring, due to limitations on travel imposed or recommended by federal or state governments, employers and others or interruption of clinical trial subject visits and study procedures (particularly any procedures that may be deemed non-essential), which may impact the integrity of subject data and clinical study endpoints;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">loss of potential and recruited patients in clinical trials due to clinical site COVID-19 activities, desire of patients to avoid frequent visits to hospitals because of potential increased exposure to COVID-19, or loss of life of patients due to COVID-19;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increased costs for clinical trial activities due to delays or disruptions in opening sites, screening and enrolling patients or treating and following patients,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">whether as a result of the effects of the COVID-19 pandemic or for any other reasons, which would require further additional capital that may not be available; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limitations on employee resources that would otherwise be focused on the conduct of our clinical trials, product development, manufacturing, potential commercialization activities and general company operations, including because of sickness of employees or their families, the desire of employees to avoid contact with large groups of people, an increased reliance on working from home, or mass transit disruptions.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These and other factors arising from the effects of the COVID-19 pandemic could further adversely impact our ability to enroll, conduct and complete IMpactMF, IMproveMF and IMpress and any potential future clinical trials of imetelstat, and could otherwise materially and adversely affect our business and business prospects, our financial condition and the future of imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we rely on third-party CROs and other third parties to assist us with clinical trial activities. The COVID-19 pandemic has also had a significant impact on our CROs and other vendors, and we cannot guarantee that they will continue to perform their contractual duties in a timely and satisfactory manner as a result of the COVID-19 pandemic. Also, absenteeism by governmental employees or the focus of regulatory authorities&#x2019; efforts and attention on the approval of other therapeutics or other activities related to COVID-19 could likewise impact the timeliness of regulatory authority responses and the processing of regulatory submissions for imetelstat. In any event, if the effects of the COVID-19 pandemic become more severe, we may experience more significant disruptions to our clinical development timelines, which would materially and adversely affect our business and business prospects, our financial condition and ability to raise additional capital, and the future of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While at this time we believe that we have sufficient drug supply for potential commercialization activities necessary to potentially bring imetelstat to market in lower risk MDS in the U.S., as well as for clinical use in IMerge Phase 3, IMpactMF, IMproveMF and IMpress, we could experience disruptions to our supply chain, as well as delays or limitations in our ability to obtain sufficient materials for the manufacture of imetelstat for our current and potential future clinical trials. Such disruptions could adversely affect our ability to conduct ongoing and potential future clinical trials of imetelstat. For example, some of our suppliers of certain materials used in the production of imetelstat are located in countries that were or are heavily affected by the COVID-19 pandemic. In these countries, shipping delays, closures and other restrictions resulting from the COVID-19 pandemic in the region could disrupt our supply chain or limit our ability to obtain sufficient materials for the manufacture of imetelstat. In addition, we may experience limitations in available capacity at contract manufacturers or drug suppliers, or potential shortages of consumable manufacturing supplies, due to obligations to manufacture and distribute vaccines to address the spread of COVID-19. We anticipate other delays, or potential shortages of consumable manufacturing supplies due to the COVID-19 pandemic may continue throughout 2023.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The effects of the COVID-19 pandemic, as well as broader economic conditions, including inflation, rising interest rates and the prospects for recession, have increased market volatility and could result in a significant long-term disruption of global financial markets, reducing or eliminating our ability to raise additional capital. In the absence of future proceeds from potential cash exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as conducting the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned. We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing of availability of additional funds under the Loan Agreement, if at all. In addition, the global economic slowdown caused by, among other things, the COVID-19 pandemic and the military conflict between Ukraine and Russia, inflation, rising interest rates and the prospects for recession, as well as recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure, could materially and adversely affect our business and the value of our common stock. As a result of these factors, our ability to raise additional capital may be impaired which could negatively affect our liquidity, our business and business prospects, and the future of imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The extent to which the COVID-19 pandemic impacts our business, our regulatory and clinical development activities, clinical supply chain and other business operations, as well as the value of and market for our common stock, will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time. Such developments include continued spread of COVID-19 variants and subvariants in the U.S. and other countries and the potential emergence of new variants or additional sub-variants that may prove especially contagious or virulent, the ultimate duration and severity of the pandemic, travel restrictions, quarantines, social distancing, shipping delays and business closure requirements in the U.S. and in other countries, and the effectiveness of vaccination programs and other actions taken globally to treat and manage this health crisis. Accordingly, we do not yet know the full extent of potential delays or impacts on our business, our regulatory and clinical development activities, clinical supply chain and other business operations or the global economy as a whole. However, these effects could materially and adversely affect our business and business prospects, our financial condition and ability to raise additional capital, and the future of imetelstat. In addition, to the extent the effects of the COVID-19 pandemic adversely affect our business and financial condition, they may also have the effect of heightening many of the other risks and uncertainties described elsewhere under the heading &#x201c;Risk Factors&#x201d;.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Financial Position and Need For Additional Financing</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our failure to obtain additional capital would force us to further delay, reduce or eliminate development of imetelstat in current and any potential future clinical trials of imetelstat, and our potential future imetelstat commercialization efforts, any of which would severely and adversely affect our financial results, business and business prospects, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Successful drug development and commercialization requires significant amounts of capital. As of December 31, 2022, we had approximately $173.1 million in cash, cash equivalents, restricted cash and current and noncurrent marketable securities. On January 10, 2023, we completed an underwritten public offering of 68,007,741 shares of our common stock and a pre-funded warrant to purchase 25,000,000 shares of our common stock, or the 2023 pre-funded warrant. The net cash proceeds from this offering are approximately $213.3 million, after deducting the underwriting discount and other offering expenses paid by us, and excludes any future proceeds from the exercise of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the 2023 pre-funded warrant. In addition, from January 1, 2023 through March 9, 2023, we have received $59.8 million in cash proceeds from the exercise of outstanding warrants.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our current operating plan and our expectations regarding the timing of the submission and potential  acceptance and approval of our planned NDA by the FDA for imetelstat in lower risk MDS and the potential commercialization in the U.S. for the use of imetelstat in adult patients with lower risk MDS, we believe that our existing cash, cash equivalents, restricted cash and current and noncurrent marketable securities, including the net cash proceeds from our recently closed underwritten public offering in January 2023 and the cash proceeds from the exercise of warrants that we received in the January and February 2023, will be sufficient to fund our projected operating requirements through the end of the third quarter of 2025, which includes potential U.S. commercial launch of imetelstat in lower risk MDS in the first half of 2024. In the absence of potential proceeds from exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as conducting the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned. We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or availability of additional funds under the Loan Agreement, if at all, particularly given the recent closure of SVB by banking regulators.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our ability to commercialize imetelstat in the U.S., if regulatory approval is granted, depends on us being able to establish sales and marketing capabilities which we may be unable to do in a timely manner or at all.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because the outcome of any clinical activities and/or regulatory approval process is highly uncertain, we cannot reasonably estimate whether any development activities we may undertake will succeed, whether we will be able to commercialize imetelstat, and we may never recoup our investment in any imetelstat development, which would adversely affect our financial condition and our business and business prospects, and might cause us to cease operations. In addition, our plans and timing expectations could be further delayed or interrupted by macroeconomic conditions, such as if COVID-19 or pandemic conditions worsen, creating further limitations on our clinical trial or commercial preparatory activities, or if U.S. and/or international banking system fails to stabilize in light of recent and potential future bank failures, or could be disrupted by civil or political unrest or military conflicts around the world, such as the current military conflict between Ukraine and Russia. Further, our future capital requirements are difficult to forecast and will depend on many factors, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accuracy of the assumptions underlying our estimates for our capital needs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, timing, magnitude and costs of clinical development, manufacturing and potential commercialization of imetelstat, including the number of indications being pursued, subject to clearances and approvals by the FDA and similar international regulatory authorities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, duration, results and costs of current clinical trials, including IMerge Phase 3, IMpactMF, IMproveMF and IMpress, and any potential future clinical trials of imetelstat, as well as non-clinical studies and assessments of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delays or disruptions in opening sites, screening and enrolling patients or treating and following patients,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in IMpactMF, IMproveMF, IMpress, or any potential future clinical trials of imetelstat, whether as a result of the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs, timing and outcomes of regulatory reviews or other regulatory actions related to imetelstat, such as obtaining and maintaining regulatory clearances and approvals to continue clinical development of imetelstat in current and potential future clinical trials, as well as to commence potential commercialization of imetelstat in the U.S. and in other countries;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications and maintaining, enforcing and defending intellectual property-related claims;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of manufacturing imetelstat, including our ability to achieve any meaningful reduction in manufacturing costs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of multiple third-party vendors and service providers, including our CROs and third-party manufacturers, to pursue the development, manufacturing and potential commercialization of imetelstat;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish, enforce and maintain collaborative or other strategic arrangements for research, development, clinical testing and manufacturing of imetelstat and potential future commercialization and marketing;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our efforts to enhance operational, financial and management processes and systems that will be required for future development and commercialization of imetelstat, and our ability to successfully recruit and retain additional key personnel to support the development and potential future commercialization of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to successfully market and sell imetelstat, if imetelstat receives future regulatory approval or clearance, in the U.S. and other countries, and the associated costs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs and timing necessary to build a sales force in the U.S. and potentially other countries to market and sell imetelstat, should it receive regulatory approval, to the extent that such sales, marketing, manufacturing and distribution are not the responsibility of any collaborator; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the sales price for imetelstat, if any;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of coverage and adequate third-party reimbursement for imetelstat, if any;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire or in-license other drugs and technologies, or to which we out-license imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire or invest in businesses, products or technologies, although we currently have no commitments or agreements relating to any of these types of transactions;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we are able to enter into strategic partnerships, collaborations and alliances or licensing arrangements with third parties including for the commercialization of imetelstat in certain global regions; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish and maintain collaborations on favorable terms, if at all;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the success of any collaborations that we may enter into with third parties;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expenses associated with settlement of the pending securities class action lawsuits, and the ongoing derivative lawsuits, as well as any other potential litigation;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent and scope of our general and administrative expenses, including expenses associated with potential future litigation; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our level of indebtedness and associated debt service obligations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of maintaining and operating facilities in California and New Jersey, telecommunications and administrative oversight, as well as higher expenses for travel; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">broader economic conditions, including inflation, rising interest rates, the prospects for recession, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure, that may reduce our ability to access debt capital or financing on preferable terms, which may adversely affect future capital requirements and forecasts; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of enabling our personnel to work remotely, including providing supplies, equipment and technology necessary for them to perform their responsibilities; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the amount of proceeds, if any, of cash exercises of our currently outstanding warrants.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until we can generate a sufficient amount of revenue from imetelstat to finance our cash requirements, which we may never achieve, we expect to finance future cash needs through a combination of public or private equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements, which may not be possible. Availability of such financing sources may be negatively impacted by any further delays in reporting results from IMpactMF or investors&#x2019; perception of top-line results from IMerge Phase 3, despite our interpretation of such data being positive, as well as factors such as the global economic slowdown, inflation, rising interest rates and the prospects for recession, as well as recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional financing through public or private debt or equity financings, including pursuant to the 2020 Sales Agreement with B. Riley Securities, Inc., or B. Riley, the remaining tranches of up to $55.0 million available under the Loan Agreement, which are subject to the achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, as well as approval by an investment committee</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">comprised of Hercules and SVB (or its successor, if any) for the final $25.0 million tranche; capital lease transactions or other financing sources, may not be available on acceptable terms, or at all. We may be unable to raise equity capital, or may be forced to do so at a stock price or on other terms that could result in substantial dilution of ownership for our stockholders. The receptivity of the public and private debt and equity markets to proposed financings has been substantially affected by uncertainty in the general economic, market and political climate due to the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates, prospects of a recession, or recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure, and may in the future be affected by other factors which are unpredictable and over which we have no control. In this regard, the effects of the COVID-19 pandemic have increased market volatility and could result in a significant long-term disruption of global financial markets, which could reduce or eliminate our ability to raise additional funds through financings, and could negatively impact the terms upon which we may raise those funds. Similarly, these macroeconomic conditions have created extreme volatility and disruption in the capital markets and is expected to have further global economic consequences. If the equity and credit markets deteriorate, including as a result of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates, prospects of a recessions or recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure, it may make any necessary debt or equity financing more difficult to obtain in a timely manner or on favorable terms, more costly or more dilutive. If we are unable to raise additional capital or establish alternative collaborative arrangements with third-party collaborative partners for imetelstat, the development and potential commercialization of imetelstat may be further delayed, altered or abandoned, which might cause us to cease operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we may seek additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. Due to uncertainty in the general economic, market and political climate, we may determine that it is necessary or appropriate to raise additional funds proactively to meet longer-term anticipated operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt securities, including pursuant to the 2020 Sales Agreement, your ownership interest as a stockholder may be diluted, and the terms may include liquidation or other preferences that materially and adversely affect your rights as a stockholder. In addition, we have borrowed, and in the future may borrow, additional capital from institutional and commercial banking sources to fund imetelstat development and our future growth, including pursuant to our Loan Agreement or potentially pursuant to new arrangements with different lenders. We may borrow funds on terms under agreements, such as the Loan Agreement, that include restrictive covenants, including covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. Moreover, if we raise additional funds through alliance, collaborative or licensing arrangements with third parties, we may have to relinquish valuable rights to imetelstat or our technologies or grant licenses on terms that are not favorable to us.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot assure you that our existing capital resources, including net cash proceeds from our recent underwritten public offering in January 2023, future interest income, future proceeds from potential cash exercises of currently outstanding warrants and potential future sales of our common stock, including under the 2020 Sales Agreement with B. Riley or potential future drawdowns, if available, of the remaining up to $55.0 million under the Loan Agreement (which are subject to the achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, as well as approval by an investment committee comprised of Hercules and SVB (or its successor, if any) for the final $25.0 million tranche), will be sufficient to fund our operating plans. In this regard, on March 10, 2023, the Federal Deposit Insurance Corporation, or FDIC, issued a press release stating that SVB was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. Of the remaining term commitments under the Loan Agreement, Hercules and its affiliates hold 65% and 35% were held by SVB. As a result of the closure of SVB, we do not know whether Hercules and SVB&#x2019;s successor, if any, will fund their respective portions of the remaining term commitments or whether and to what extent we will otherwise be able to draw down the remaining $55.0 million under the Loan Agreement, even if we meet the conditions set forth in the Loan Agreement necessary for additional draw downs, and it is possible that we will not be able to access any additional funding under the Loan Agreement, which would require us to obtain additional or alternative financing to advance our development of imetelstat. Moreover, while we did not hold cash deposits or securities at SVB, if other banks and financial institutions enter receivership, become insolvent or otherwise fail in the future in response to financial conditions affecting the banking system and financial markets or otherwise, our ability to access our existing cash, cash equivalents and marketable securities may be delayed or precluded, which could have a material adverse effect on our business, business prospects and financial position.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We currently have no source of product revenue and may never become profitable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although in the past we have received license and other payments under former license and collaboration agreements, we do not currently have any material revenue-generating license or collaboration agreements, have no products approved for commercialization and have never generated any revenue from product sales. In addition, we are incurring and have incurred operating losses every year since our operations began in 1990, except for one. As of December 31, 2022, our accumulated deficit was approximately $1.4 billion. Losses have resulted principally from costs incurred in connection with our research and development activities and from general and administrative costs associated with our operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Substantially all of our revenues to date have been payments under collaboration agreements and milestones, royalties and other revenues from our licensing arrangements. Our license agreements related to our hTERT technology have expired or been terminated due to expiration of the underlying hTERT patents, and will not generate any further revenues. We have no ongoing collaborations related to imetelstat and have no current plans to enter into any corporate collaboration, partnership or license agreements that result in revenues, although we may seek a collaborative partner or partners, at an appropriate time, to assist us in the potential development and commercialization of imetelstat, especially outside the U.S., and to provide funding for such activities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We also expect to experience increased negative cash flow for the foreseeable future as we fund our operations and imetelstat clinical development activities and research programs continue, and we prepare for potential commercialization of imetelstat. This will result in decreases in our working capital, total assets and stockholders&#x2019; equity. Further, we may be unable to replenish our working capital by future financings. We will need to generate significant revenues to achieve consistent future profitability. We may never achieve consistent future profitability. Even if we do become profitable in the future, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to achieve consistent future profitability could negatively impact the market price of our common stock and our ability to sustain operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our net operating loss carryforwards attributable to tax years beginning before January 1, 2018 could expire unused and be unavailable to offset future income tax liabilities. Under the Tax Cuts and Jobs Act of 2017, or the Tax Act, as modified by the Coronavirus Aid, Relief and Economic Security Act, or CARES Act, federal net operating losses incurred in taxable years beginning after December 31, 2017, can be carried forward indefinitely, but the deductibility of such federal net operating losses in taxable years beginning after December 31, 2020, is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to the Tax Act or the CARES Act.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, or the Code, and corresponding provisions of state law, if a corporation undergoes an &#x201c;ownership change,&#x201d; generally defined as a greater than 50&#x2011;percentage&#x2011;point cumulative change (by value) in its equity ownership over a three-year period, the corporation&#x2019;s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes (such as research and development tax credits) to offset its post-change taxable income or taxes may be limited. Changes in our stock ownership, some of which are outside of our control, may have resulted in, or other future changes could result in, an ownership change. If a limitation were to apply, utilization of a portion of our domestic net operating loss and tax credit carryforwards could be limited in future periods. In addition, a portion of the carryforwards may expire before being available to reduce future income tax liabilities which could adversely impact our financial position. At the state level, there may be periods during which the use of net operating loss carryforwards is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to our Indebtedness</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our level of indebtedness and debt service obligations could adversely affect our financial condition, and may make it more difficult for us to fund our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the total outstanding principal amount under the Loan Agreement was $50.0 million. The tranches for the remaining $55.0 million available to us under the Loan Agreement are as follows: (a) the first remaining tranche of $10.0 million is available from January 1, 2023 until December 15, 2023, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain other requirements; (b) the second remaining tranche of $20.0 million is available from September 15, 2023 until September 15, 2024, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain capitalization requirements; and (c) the final remaining tranche of $25.0 million is available through December 31, 2024, subject to approval by an investment committee comprised of Hercules and SVB (or its successor, if any). Without the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">achievement of the required clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, we will not be eligible to draw funds under the first three remaining tranches. If we do not receive investment committee approval, we will not be eligible to draw funds under the final remaining tranche under the Loan Agreement. In addition, on March 10, 2023, the FDIC issued a press release stating that SVB was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. Of the remaining term commitments under the Loan Agreement, Hercules and its affiliates hold 65% and 35% were held by SVB. As a result of the closure of SVB, we do not know whether Hercules and SVB&#x2019;s successor, if any, will fund their respective portions of the remaining term commitments or whether and to what extent we will otherwise be able to draw down the remaining $55.0 million under the Loan Agreement, even if we meet the conditions set forth in the Loan Agreement necessary for additional draw downs, and it is possible that we will not be able to access any additional funding under the Loan Agreement, which would require us obtain additional or alternative financing to advance our development of imetelstat. Such additional or alternative financing may not be available on attractive terms, if at all, and could be more costly for us to obtain. In addition, before we would consider drawing down any of the remaining tranches under the Loan Agreement, if available, we must first satisfy ourselves that we will have access to future alternate sources of capital, such as from the equity capital markets or debt capital markets, in order to repay any additional principal borrowed, which we may be unable to do, in which case, our liquidity and ability to fund our operations may be substantially impaired. As a result, our development and potential commercialization of imetelstat and other research and development programs could be significantly delayed, which would materially adversely affect our business, business prospects, financial condition and operating results.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All obligations under the Loan Agreement are secured by substantially all of our existing property and assets, excluding intellectual property, which is subject to a negative pledge. This indebtedness may create additional financing risk for us, particularly if our business or prevailing financial market conditions are not conducive to paying off or refinancing the outstanding debt obligations at maturity. If we are able to draw down any of the remaining tranches under the Loan Agreement, our indebtedness will increase, which would further increase our risk of being unable to pay off or refinance our outstanding debt obligations at maturity. Our indebtedness could also have important negative consequences, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we will need to repay the indebtedness by making payments of interest and principal, which will reduce the amount of cash available to finance our operations, our research and development efforts and other general corporate activities; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure to comply with the obligations of our affirmative and restrictive covenants in the Loan Agreement could result in an event of default that, if not cured or waived, would accelerate our obligation to repay this indebtedness, and Hercules and SVB (or its successor, if any) could seek to enforce its security interest in the assets securing such indebtedness.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent additional debt is added to our current debt levels, the risks described above could increase.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The terms of the Loan Agreement place restrictions on our operating and financial flexibility.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Loan Agreement imposes operating and other restrictions on us. Such restrictions will affect, and in many respects limit or prohibit, our ability and the ability of any future subsidiaries to, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">dispose of certain assets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">change our line of business;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">engage in mergers, acquisitions or consolidations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incur additional indebtedness;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">create liens on assets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pay dividends and make contributions or repurchase our capital stock; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">engage in certain transactions with affiliates.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Loan Agreement, as recently amended in June 2022, also contains financial covenants. Beginning June 1, 2022 and prior to receiving potential regulatory approval for imetelstat, if any, we are required to maintain a minimum cash balance in an amount equal to the greater of: 50% of the outstanding principal amount under the Loan Agreement or $30.0 million. Under the Loan Agreement, if we enter into certain licensing transactions, this cash covenant requirement would increase to $35.0 million. After the potential regulatory approval for imetelstat, if any, the minimum cash requirement may be satisfied through one of the following three options, as elected by us: (a) maintaining a cash balance in an amount not less than 40% of the outstanding principal amount under the Loan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agreement; (b) maintaining a cash balance in an amount not less than 25% of the outstanding principal amount under the Loan Agreement, if our market cap is or exceeds $750.0 million; or (c) maintaining six month net product revenues of at least 70% of net product revenues forecasted by us, should any potential regulatory approval for imetelstat be obtained. The breach of any of these restrictive covenants or any other terms of the Loan Agreement would accelerate our obligation to repay our indebtedness under the Loan Agreement, which could have a material adverse effect on our business, business prospects and financial position.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not have cash available in an amount sufficient to enable us to make interest or principal payments on our indebtedness when due.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to make scheduled payments on or to refinance our indebtedness depends on our future performance and ability to raise additional sources of cash, which is subject to economic, financial, competitive and other factors beyond our control. If we are unable to generate sufficient cash to service our debt, we may be required to adopt one or more alternatives, such as selling assets, restructuring our debt or obtaining additional equity capital on terms that may be onerous or highly dilutive. If we desire to refinance our indebtedness, our ability to do so will depend on the state of the capital and lending markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failure to satisfy our current and future debt obligations under the Loan Agreement could result in an event of default. In addition, the Loan Agreement includes customary affirmative and negative covenants and other events of default, the occurrence and continuance of which provide Hercules and SVB (or its successor, if any) with the right to demand immediate repayment of all principal and unpaid interest under the Loan Agreement, and to exercise remedies against us and the collateral securing the Loan Agreement. These events of default include, among other things:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">insolvency, liquidation, bankruptcy or similar events; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to observe any covenant or secured obligation under the Loan Agreement, which failure, in most cases, is not cured within 15 days; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">occurrence of an event that could reasonably be expected to have a material adverse effect on our business, operations, properties, assets or financial condition; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">material misrepresentations; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">occurrence of any default under any other agreement involving indebtedness in excess of specified amounts, or the occurrence of a default under any agreement that could reasonably be expected to have a material adverse effect on us; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">certain money judgments being entered against us or any portion of our assets are attached or seized.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of default, Hercules and SVB (or its successor, if any) could accelerate all of the amounts due under the Loan Agreement. Under such circumstances, we may not have enough available cash or be able to raise additional funds through equity or debt financings to repay such indebtedness at the time of such acceleration. In that case, we may be required to delay, limit, reduce or terminate imetelstat development or potential commercialization efforts or grant to others rights to develop and market imetelstat. Hercules and SVB (or its successor, if any) could also exercise their rights to take possession and dispose of the collateral securing the Loan Agreement, which collateral includes substantially all of our property other than intellectual property. Our business, financial condition and results of operations could be materially adversely affected as a result of any of these events.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Protecting Our Intellectual Property</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we are unable to obtain and maintain sufficient intellectual property protection for imetelstat for an adequate amount of time, or if the scope of the intellectual property protection is not sufficiently broad, our competitors could develop and commercialize products similar or identical to imetelstat, and our ability to successfully commercialize imetelstat may be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Protection of our proprietary technology is critically important to our business. Our success and the success of our planned future development and commercialization of imetelstat will depend on our ability to protect our technologies and imetelstat through patents and other intellectual property rights. Our success will depend in part on our ability to obtain, maintain, enforce, and extend our patents and maintain trade secrets, both in the U.S. and in other countries.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the U.S. and in other countries. Such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated, or held unenforceable, which could limit our ability to stop others from using or commercializing imetelstat or our technology and/or limit the duration of the patent protection for imetelstat and our technology. In the event that we are unsuccessful in obtaining, maintaining, enforcing and extending our patents and other intellectual property rights or having our licensors maintain the intellectual property rights we have licensed, the value of imetelstat and/or our technologies will be adversely affected, and we may not be able to further develop or potentially commercialize imetelstat.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While we have method-of-use patents that protect the use of imetelstat for the treatment of certain diseases, this type of patent does not prevent a generic competitor from making and marketing a product that is identical to imetelstat for an indication that is outside the scope of our approved use after our composition of matter patents or their patent term extensions have expired. Moreover, even if competitors do not actively promote their product for our approved indications, physicians may prescribe or use these generic products &#x201c;off-label,&#x201d; which would result in decreased sales for us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss or impairment of our intellectual property rights related to imetelstat might further delay or halt ongoing or potential future clinical trials of imetelstat and any applications for regulatory approval, and therefore might further delay or preclude any future development or commercialization of imetelstat by us. Furthermore, if imetelstat is approved for commercial sale, such loss of intellectual property rights could impair our ability to exclude others from commercializing products similar or identical to imetelstat and therefore result in decreased sales for us. Occurrence of any of these events would materially and adversely affect our financial results, business and business prospects, and the future of imetelstat, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Obtaining and maintaining our patent rights depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The U.S. Patent and Trademark Office, or the Patent Office, and various governmental patent agencies in other countries require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In addition, periodic maintenance fees, renewal fees, annuity fees and various other government fees on patents and/or patent applications will have to be paid to the Patent Office and various governmental patent agencies in other countries over the lifetime of our owned and licensed patents and/or patent applications and any patent rights we may own or license in the future. Maintaining such compliance may be impacted by the COVID-19 pandemic and the military conflict between Ukraine and Russia. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, nonpayment of fees and failure to properly legalize and submit formal documents. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. There are situations, however, in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. For example, we have issued patents and pending patent applications in Ukraine and Russia, and if we are unable to submit responses to governmental patent agencies or make payments related to such patents and patent applications in a timely manner due to the military conflict in the region, these patents or patent applications may be irrevocably lost. In such an event, potential competitors might be able to enter the market with imetelstat or similar products, and this circumstance could harm our financial condition, business and business prospects and the future of imetelstat. In addition, if we are responsible for patent prosecution and maintenance of patent rights in-licensed to us or jointly owned with us, any of the foregoing could expose us to liability to the applicable patent owner or patent co-owner.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Patent terms may be inadequate to protect our competitive position on imetelstat for an adequate amount of time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patents have a limited lifespan. In the U.S., the natural expiration of a patent is generally 20 years after its first effective nonprovisional filing date. Given the amount of time required for the development, testing and regulatory review of imetelstat, patents protecting imetelstat (e.g., patents claiming imetelstat and/or components thereof, methods of use, or methods of making) might expire before imetelstat is commercialized. As a result, our intellectual property may not provide us with sufficient rights to exclude others from commercializing products similar or identical to imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S., the Hatch-Waxman Act permits one patent per approved product to receive a patent term extension of up to five years beyond its normal expiration. The length of the patent term extension is typically calculated as one half of the clinical trial period plus the entire period of time during the review of the NDA by the FDA, minus any time of delay by us during these periods. There is also a limit on the patent term extension to a term</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">that is no greater than fourteen years from drug approval. One of our owned or licensed U.S. patents may be eligible for patent term extension under the Hatch-Waxman Act.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similar extensions are also available in certain countries and territories outside the U.S., such as in Japan, and in Europe as Supplementary Protection Certificates, or SPCs. If we select and are granted a patent term extension on a recently filed and issued patent, we may not receive the full benefit of a possible patent term extension, if at all. We might also not be granted a patent term extension at all, because of, for example, failure to apply within the applicable period, failure to apply prior to the expiration of relevant patents or otherwise failure to satisfy any of the numerous applicable requirements. Moreover, the applicable authorities, including the FDA and the Patent Office in the U.S., and any equivalent regulatory authorities in other countries, may not agree with our assessment of whether such extensions are available, may refuse to grant extensions to our patents, or may grant more limited extensions than we request. If we fail to apply for applicable patent term extensions or adjustments, we will have a more limited time during which we can enforce our granted patent rights. Should we seek a patent term extension, we may not be granted any such patent term extension and/or the applicable time period of such patent term extension could be less than five years. Moreover, in some countries, including the U.S., the scope of protection for claims under such patent term extensions, if any, does not extend to the full scope of the claims but is limited to the product composition as approved and, for a method of treatment patent, is limited to the approved indication. Thus, for example, if we do not receive a patent term extension for our U.S. composition of matter patent for imetelstat, as approved by the regulatory authorities, our U.S. composition of matter patent will expire in December 2025. If we do not have sufficient patent life to protect imetelstat, our financial results, business and business prospects, and the future of imetelstat would be materially and adversely affected, which might cause us to cease operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If regulatory approval of imetelstat occurs after a patent has expired in a country that does not allow interim patent term extensions, as is the case in many countries and territories including Europe, we will be unable to obtain any patent term extension of that expired patent, and the duration of our patent rights may be limited. If we do not receive marketing approval and submit a request for an SPC before our patents expire in the European Economic Area, or EEA, where we have imetelstat composition of matter patents, our imetelstat composition of matter patents will expire in September 2024. In all other countries outside the U.S. and the EEA where we have imetelstat composition of matter patents, either: (a) extension of patent term is not available, and the patents will expire in September 2024, or (b) we may not have marketing authorization in those countries in sufficient time to file an extension of patent term before our composition of matter patents expire in September 2024. If we do not have sufficient patent life to protect imetelstat, our financial results, business and business prospects, and the future of imetelstat would be materially and adversely affected, which might cause us to cease operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Also, there are regulations for the listing of patents in the Approved Drug Products with Therapeutic Equivalence Evaluations, or the Orange Book. If we submit a patent for listing in the Orange Book, the FDA may decline to list the patent, or a manufacturer of generic drugs may challenge the listing. If imetelstat is approved and an appropriate patent covering imetelstat is not listed in the Orange Book or is subsequently removed from the Orange Book, a manufacturer of generic drugs would not be required to provide advance notice to us of any abbreviated NDA filed with the FDA to obtain permission to sell a generic version of imetelstat. Any of the foregoing could harm our competitive position, business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in U.S. or international patent law or interpretations of such patent laws could diminish the value of our patents in general, thereby impairing our ability to protect our technologies and imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patent positions of pharmaceutical and biopharmaceutical companies, including ours, are highly uncertain and involve complex legal and technical questions. In particular, legal principles for biotechnology and pharmaceutical patents in the U.S. and in other countries are evolving, and the extent to which we will be able to obtain patent coverage to protect our technologies and imetelstat, or enforce or defend issued patents, is uncertain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The U.S. has enacted and implemented wide-ranging patent reform legislation, including the Leahy-Smith America Invents Act, or the AIA, signed into law on September 16, 2011. The U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. Depending on actions by Congress, the federal courts, and the Patent Office, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents or patents that we might obtain in the future. Similarly, changes in patent law and regulations in other countries or jurisdictions or changes in the governmental bodies that enforce them or changes in how the relevant governmental authority enforces patent laws or regulations may weaken our ability to obtain new patents or to enforce our existing patents or patents that we may obtain in the future. Occurrence of these events and/or significant impairment of our imetelstat patent rights would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, which might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of the AIA, in March 2013, the U.S. transitioned to a first-inventor-to-file system under which, assuming the other requirements for patentability are met, the first inventor to file a patent application is entitled to the patent. However, since the publication of discoveries in scientific or patent literature tends to lag behind actual discoveries by at least several months and sometimes several years, we are not able to be certain upon filing that the persons or entities that we name as inventors or applicants in our patent applications were the first to invent the inventions disclosed therein, or the first to file patent applications for these inventions. Thus, our ability to protect our patentable intellectual property depends, in part, on our ability to be the first to file patent applications with respect to our inventions, or inventions that were developed by our former collaboration partner and assigned to us, for the future development, commercialization and manufacture of imetelstat. As a result, if we are not the first-inventor-to-file, we may not be able to obtain patents for discoveries that we otherwise would consider patentable and that we consider to be significant to the future success of imetelstat. Delay in the filing of a patent application for any purpose, including further development or refinement of an invention, may result in the risk of loss of patent rights.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following the result of a referendum in 2016, the U.K. left the EU on January 31, 2020, commonly referred to as Brexit. The impact of the withdrawal of the U.K. from the EU will not be known for some time, which could lead to a period of uncertainty relating to our ability to obtain and maintain SPCs of imetelstat based on our U.K. patents and our ability to establish and maintain European trademarks in the U.K. In 2012, the European Patent Package, or EU Patent Package, regulations were passed with the goal of providing for a single pan-European Unitary Patent, and a new European Unified Patent Court, or UPC, for litigation of European patents. The EU Patent Package was ratified in February 2023 and currently covers 17 EU states. On June 1, 2023, all European patents, including those issued prior to ratification, will by default automatically fall under the jurisdiction of the UPC and allow for the possibility of obtaining pan-European injunctions and also be at risk of central revocation at the UPC in participating UPC states. Under the EU Patent Package, patent holders are permitted to &#x201c;opt out&#x201d; of the UPC on a patent-by-patent basis during an initial seven year period after the EU Patent Package is ratified. Owners of European patent applications who receive notice of grant after the EU Patent Package is ratified could, for the UPC contracting states, either obtain a Unitary Patent or validate the patent nationally and file an opt-out demand. The EU Patent Package may increase the uncertainties and costs surrounding the enforcement or defense of our issued European patents and pending applications. The full impact on future European patent filing strategy and the enforcement or defense of our issued European patents in member states and/or the UPC is not known.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Challenges to our owned or licensed patent rights would result in costly and time-consuming legal proceedings that could prevent or limit development of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our patents or those patent rights we have licensed, including patent rights that we may seek with respect to inventions made by past or future collaborators, may be challenged through administrative or judicial proceedings, which could result in the loss of important patent rights. For example, where more than one party seeks U.S. patent protection for the same technology in patent applications that are subject to the law before the implementation of the AIA, the Patent Office may declare an interference proceeding in order to ascertain the party to which the patent should be issued. Patent interferences are typically complex, highly contested legal proceedings, subject to appeal. They are usually expensive and prolonged and can cause significant delay in the issuance of patents. Our pending patent applications or our issued patents, or those we have licensed and may license from others, may be drawn into interference proceedings or be challenged through post-grant review procedures or litigation, any of which could delay or prevent the issuance of patents, or result in the loss of issued patent rights. We may not be able to obtain from our past or future collaborators the information needed to support our patent rights which could result in the loss of important patent rights.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the AIA, interference proceedings between patent applications filed on or after March 16, 2013, have been replaced with other types of proceedings, including derivation proceedings. The AIA also includes post-grant review procedures subjecting U.S. patents to post-grant review procedures similar to European oppositions, such as </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">inter partes </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">review, or IPR, covered business method post-grant reviews and other post-grant reviews. This applies to all of our U.S. patents and those we have licensed and may license from others, even those issued before March 16, 2013. Because of a lower evidentiary standard necessary to invalidate a patent claim in Patent Office proceedings compared to the evidentiary standard in U.S. federal court, a third-party could potentially provide evidence in a Patent Office proceeding sufficient for the Patent Office to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. Accordingly, a third-party could attempt to use the Patent Office procedures to invalidate patent claims that would not have been invalidated if first challenged by the third-party as a defendant in a district court action. U.S. patents owned or licensed by us may therefore be subject to post-grant review procedures, as well as other forms of review and re-examination. In addition, the IPR process under the AIA permits any person, whether they are accused of infringing the patent at issue or not, to challenge the validity of certain patents. As a result, entities associated with hedge funds</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">have challenged valuable pharmaceutical patents through the IPR process. Significant impairment of our imetelstat patent rights would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, which might cause us to cease operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain jurisdictions, such as Europe, New Zealand and Australia, permit oppositions to be filed against granted patents or patents proposed to be granted. Because we seek to enable potential global commercialization of imetelstat, securing both proprietary protection and freedom to operate outside of the U.S. is important to our business. Opposition proceedings require significant time and costs, and if we are unsuccessful or are unable to commit these types of resources to protect our imetelstat patent rights, we could lose our patent rights and we could be prevented or limited in the development and commercialization of imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As more groups become engaged in scientific research and product development in the areas of telomerase biology and hematologic malignancies, the risk of our patents, or patents that we have in-licensed, being challenged through patent interferences, derivation proceedings, IPRs, post-grant proceedings, oppositions, re-examinations, litigation or other means will likely increase. For example, litigation may arise as a result of our decision to enforce our patent rights against third parties. Challenges to our patents through these procedures would be extremely expensive and time-consuming, even if the outcome was favorable to us. An adverse outcome in a patent dispute could severely harm our ability to further develop or commercialize imetelstat, or could otherwise have a material adverse effect on our business, and might cause us to cease operations, by:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">causing us to lose patent rights in the relevant jurisdiction(s);</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">subjecting us to litigation, or otherwise preventing us from commercializing imetelstat in the relevant jurisdiction(s);</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requiring us to obtain licenses to the disputed patents;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">forcing us to cease using the disputed technology; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">requiring us to develop or obtain alternative technologies.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filing, prosecuting, maintaining, defending and enforcing patents for imetelstat and our technologies in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the U.S. are less extensive than those in the U.S. The requirements for patentability may differ in certain countries, particularly in developing countries; thus, even in countries where we do pursue patent protection, there can be no assurance that any patents will issue with claims that cover imetelstat and our technologies. There can be no assurance that we will obtain or maintain patent rights inside or outside the U.S. under any future license agreements. In addition, the laws of some countries outside the U.S. do not protect intellectual property rights to the same extent as federal and state laws in the U.S. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the U.S., even in jurisdictions where we pursue patent protection, or from selling or importing products made using our inventions in and into the U.S. or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not pursued and obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the U.S. These products may compete with imetelstat and our technologies and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many companies have encountered significant problems in protecting and defending intellectual property rights in jurisdictions outside the U.S. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology and pharmaceutical products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. For example, many countries outside the U.S. have compulsory licensing laws under which a patent owner must grant licenses to third parties. Proceedings to enforce our patent rights, even if obtained, in jurisdictions outside the U.S. could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. While we intend to protect our intellectual property rights in major markets for imetelstat, we cannot ensure that we will be able to initiate or maintain similar efforts in all jurisdictions in which we may wish to market imetelstat. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we own and potentially develop in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to infringement claims that are costly to defend, and such claims may limit our ability to use disputed technologies and prevent us from pursuing research, development, manufacturing or commercialization of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The commercial success of imetelstat will depend upon our ability to research, develop, manufacture, market and sell imetelstat without infringing or otherwise violating the intellectual property and other proprietary rights of third parties. There is considerable intellectual property litigation in the biotechnology and pharmaceutical industries, and many pharmaceutical companies, including potential competitors, have substantial patent portfolios. Since we cannot be aware of all intellectual property rights potentially relating to imetelstat and its uses, we do not know with certainty that imetelstat, or the intended commercialization thereof, does not and will not infringe or otherwise violate any third-party&#x2019;s intellectual property. For example, we are aware that certain third parties have or may be prosecuting patents and patent estates that may relate to imetelstat, and while we believe these patents will expire before imetelstat is able to be commercialized and/or that these patents are invalid and/or would not be infringed by the manufacture, use or sale of imetelstat, it is possible that the owner(s) of these patents will assert claims against us in the future.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event our technologies infringe the rights of others or require the use of discoveries and technologies controlled by third parties, we may be prevented from pursuing research, development, manufacturing or commercialization of imetelstat, or may be required to obtain unblocking licenses from such third parties, develop alternative non-infringing technologies, which we may not be able to do at an acceptable cost or on acceptable terms, or at all, or cease the development of imetelstat. If we are unable to resolve an infringement claim successfully, we could be subject to an injunction that would prevent us from potentially commercializing imetelstat and could also require us to pay substantial damages. In addition, while our past collaboration agreements have terminated, we are still subject to indemnification obligations to certain collaborators, including with respect to claims of third-party patent infringement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to infringement claims, in the future we may also be subject to other claims relating to intellectual property, such as claims that we have misappropriated the trade secrets of third parties. Provided that we are successful in continuing the development of imetelstat, we expect to see more efforts by others to obtain patents that are positioned to cover imetelstat. Our success therefore depends significantly on our ability to operate without infringing patents and the proprietary rights of others.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may become aware of discoveries and technologies controlled by third parties that are advantageous or necessary to further develop or manufacture imetelstat. Under such circumstances, we may initiate negotiations for licenses to other technologies as the need or opportunity arises. We may not be able to obtain a license to a technology required to pursue the research, development, manufacture or commercialization of imetelstat on commercially favorable terms, or at all, or such licenses may be terminated on certain grounds, including as a result of our failure to comply with any material obligations under such licenses. If we do not obtain a necessary license or if such a license is terminated, we may need to redesign such technologies or obtain rights to alternative technologies, which may not be possible, and even if possible, could cause further delays in the development efforts for imetelstat and could increase the development and/or production costs of imetelstat. In cases where we are unable to license necessary technologies, we could be subject to litigation and prevented from pursuing research, development, manufacturing or commercialization of imetelstat, which would materially and adversely impact our business. Failure by us to obtain rights to alternative technologies or a license to any technology that may be required to pursue research, development, manufacturing or commercialization of imetelstat would further delay current and potential future clinical trials of imetelstat and any applications for regulatory approval, impair our ability to sell imetelstat, if approved, and therefore result in decreased sales of imetelstat for us. Occurrence of any of these events would materially and adversely affect our business, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are seeking registered trademarks for a commercial trade name for imetelstat in the U.S. and jurisdictions outside of the U.S. and failure to secure such registrations could adversely affect our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are seeking registration of trademarks for a potential commercial trade name for imetelstat in the U.S. and other jurisdictions outside of the U.S. During trademark registration proceedings, we may receive rejections. Although we are given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the U.S. Patent and Trademark Office and in comparable agencies in many jurisdictions outside of the U.S., third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. Moreover, any name we propose to use for imetelstat in the U.S. and Europe must be approved by the FDA and the EMA respectively, regardless of whether we have registered it, or applied to register it, as a trademark. Both the FDA and the EMA typically conduct a review of proposed product</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">names, including an evaluation of potential for confusion with other product names. If the FDA or the EMA rejects all of our proposed proprietary product names, we may be required to expend additional time and resources in an effort to identify a suitable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA and the EMA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may become involved in disputes with past or future collaborator(s) over intellectual property inventorship, ownership or use, and publications by us, or by investigators, scientific consultants, research collaborators or others. Such disputes could impair our ability to obtain patent protection or protect our proprietary information, which, in either case, could have a significant impact on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inventions discovered under research, material transfer or other collaboration agreements may become jointly owned by us and the other party to such agreements in some cases, and may be the exclusive property of either party in other cases. Under some circumstances, it may be difficult to determine who invents and owns a particular invention, or whether it is jointly owned, and disputes can arise regarding inventorship, ownership and use of those inventions. These disputes could be costly and time-consuming, and an unfavorable outcome could have a significant adverse effect on our business if we are not able to protect or license rights to these inventions. In addition, clinical trial investigators, scientific consultants and research collaborators generally have contractual rights to publish data and other proprietary information, subject to review by the trial sponsor. Publications by us, or by investigators, scientific consultants, previous employees, research collaborators or others, either with permission or in contravention of the terms of their agreements with us or with our past or future collaborators, may impair our ability to obtain patent protection or protect proprietary information which would have a material adverse effect on our business, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Much of the information and know-how that is critical to our business is not patentable, and we may not be able to prevent others from obtaining this information and establishing competitive enterprises.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on trade secrets to protect our proprietary technology, especially in circumstances in which we believe patent protection is not appropriate or available. We attempt to protect our proprietary technology in part by confidentiality agreements with our employees, consultants, collaborators and contractors. However, we cannot provide assurance that these agreements will not be breached, that we would have adequate remedies for any breach, or that our trade secrets will not otherwise become known or be independently discovered by competitors, any of which would harm our business significantly.</span></p>
  <p style="text-indent:4.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2016, the Defend Trade Secrets Act of 2016, or the DTSA, was enacted, providing a federal cause of action for misappropriation of trade secrets. Under the DTSA, an employer may not collect enhanced damages or attorney fees from an employee or contractor in a trade secret dispute brought under the DTSA, unless certain advanced provisions are observed. We cannot provide assurance that our existing agreements with employees and contractors contain notice provisions that would enable us to seek enhanced damages or attorneys&#x2019; fees in the event of any dispute for misappropriation of trade secrets brought under the DTSA.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Managing Our Growth and Other Business Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be unable to successfully retain or recruit key personnel to support the development and potential future commercialization of imetelstat or to otherwise successfully manage our growth.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to successfully develop imetelstat in the future and to potentially commercialize imetelstat depends to a significant extent on the skills, experience and efforts of our executive officers and key members of our staff. In addition, we need to recruit, maintain, motivate and integrate additional personnel with expertise and experience in clinical science, biostatistics, clinical operations, pharmacovigilance, quality, manufacturing, regulatory affairs, medical affairs, legal affairs, market access, pricing, commercial operations, sales, and marketing, to enable us to further develop and potentially commercialize imetelstat.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We face intense competition for qualified individuals from numerous pharmaceutical, biopharmaceutical and biotechnology companies, as well as academic and other research institutions, and competition in our geographic regions is particularly intense. The substantial risks and uncertainties related to our development and potential commercialization of imetelstat and the risks and uncertainties regarding our future business viability could have an adverse impact on our ability to retain and recruit qualified personnel. We may also face higher than expected personnel costs in order to attract new personnel due to shortages in qualified applicants, or to maintain our current management and personnel due to the increased number of opportunities in the biotechnology sector. If we are unable to successfully retain, motivate and incentivize our existing personnel, or to attract, assimilate and retain other highly qualified personnel in the future on acceptable terms, our ability to further develop and potentially</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">commercialize imetelstat will be impaired, and our business and the price of our common stock would be adversely impacted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our personnel are currently performing their duties in multiple jurisdictions, and if we are unable or fail to comply with employment, tax, benefits and other laws in such jurisdictions, we may face penalties, fines or litigation. Further, if members of our management and other key personnel in critical functions across our organization are unable to perform their duties or have limited availability due to the effects of the COVID-19 pandemic, we may not be able to execute on our business strategy and/or our operations may be negatively impacted.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future financial performance and our ability to develop, manufacture and commercialize imetelstat will depend, in part, on our ability to effectively manage any future growth. Our management may have to divert financial and other resources, as well as devote a substantial amount of time, to managing growth activities, such as enhancing operational, financial and management processes and systems. If we do not effectively manage the expansion of our operations, we could experience weaknesses in our infrastructure and ability to comply with applicable legal and regulatory requirements and regulations, operational mistakes or shortcomings, loss of business opportunities, loss of employees and reduced productivity among remaining employees. The expansion of our operations also could lead to significant costs and could delay the execution of our business plans or disrupt our current operations. Our ineffective performance in managing any such future growth would negatively impact our business prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As our operations continue to expand, we expect that we will need to manage new and additional relationships with various service providers, vendors, suppliers and other third parties, as well as a workforce in multiple countries, jurisdictions and locations. For example, in September 2021, we established a subsidiary in the U.K. to accommodate our growing workforce in that location. Our business needs and the expansion of our workforce may require us to establish additional business offices or entities in additional jurisdictions outside of the U.S., including additional subsidiaries, or to retain third parties to manage employment-related matters in new countries, jurisdictions and locations. Because the legal and regulatory requirements related to the operation and maintenance of such entities, and the employment of personnel in such countries, jurisdictions and regions is multi-national and complex, we may be unable to effectively operate and maintain such entities, or be unable to attract and retain ex-U.S. personnel, which could lead to significant costs and could delay the execution of our business plans or disrupt our current and future operations. If we fail to achieve key development goals, our abilities to grow as a company, and to further develop and potentially commercialize imetelstat, could be prevented or hindered, and our business and business prospects would be severely harmed, which might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Notwithstanding our research and discovery efforts, we expect imetelstat to remain our sole product candidate for the foreseeable future. If we are unable to successfully develop and commercialize imetelstat, our business and business prospects would be severely harmed, which might cause us to cease operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other than imetelstat, we do not currently have any other product candidates. While we recently initiated a discovery program to identify a lead compound as a potential next generation oral telomerase inhibitor, our discovery efforts are at an early stage and may not be successful. In this regard, internal discovery efforts to identify new product candidates require substantial technical, financial and human resources, and the outcome of those efforts are uncertain and unpredictable. In addition, these discovery efforts may initially show promise in identifying a potential product candidate, yet fail to yield a product candidate for clinical development for a number of reasons, including where the research methodology used may not be successful in identifying a potential product candidate, or where a potential product candidate may, on further study, be shown to have inadequate efficacy, harmful side effects, suboptimal pharmaceutical profile or other characteristics suggesting that it is unlikely to be an effective product. Furthermore, in addition to research and development risks, any potential lead compounds identified during discovery may not be patentable, and therefore unsuitable for further development. Likewise, our research efforts to evaluate imetelstat in lymphoid hematologic malignancies may not be successful. In any event, notwithstanding our research and discovery efforts, we remain and expect to continue remain wholly reliant upon the development of imetelstat, our sole product candidate, for the foreseeable future. If we are unable to successfully develop and commercialize imetelstat, our business and business prospects would be severely harmed, which might cause us to cease operations. Similarly, if we are unable to discover and develop new product candidates or to develop imetelstat in lymphoid hematologic malignancies through our research and discovery efforts, our business and business prospects would be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we seek to establish potential future collaborative arrangements for imetelstat, we may be unable to establish such collaborative arrangements on acceptable terms, or at all, and may have to delay, alter or abandon our imetelstat development and commercialization plans.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We intend to develop imetelstat broadly for hematologic malignancies, and to potentially commercialize, market and sell imetelstat in the U.S. We may seek a collaborative partner or partners, at an appropriate time, to assist us in the potential development and commercialization of imetelstat, especially outside the U.S., and to provide funding for such activities. We face significant competition in seeking appropriate collaborative partners, and these potential collaborative arrangements are complex and time consuming to negotiate, document and implement. Our ability to seek and establish potential collaborative arrangements may be impacted by the effects of the COVID-19 pandemic on our clinical trial activities and the resulting delays in reporting any results from IMpactMF, as well as the period of the patent term for our intellectual property portfolio and market exclusivity for imetelstat. We may not be able to establish collaborative arrangements on acceptable terms, or at all. In this regard, collaborative arrangements with third parties may require us to relinquish material rights, including revenue from potential commercialization, or assume material ongoing development obligations that we would have to fund or otherwise support.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In any event, we are unable to predict when, if ever, we will enter into any collaborative arrangements because of the numerous risks and uncertainties associated with establishing collaborative arrangements. Moreover, given the significant risks and uncertainties regarding the future imetelstat development program, potential collaborative partners may be reluctant to enter into new collaborative arrangements with us, or may only be willing to do so on terms that are not favorable to us. As a result, we may not be successful in finding a collaborative partner or partners on favorable terms, if at all. If we are unable to negotiate collaborative arrangements, we may have to:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delay or curtail the additional development of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">further delay or abandon the potential commercialization of imetelstat outside of the U.S.;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reduce the scope of potential future sales or marketing activities; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increase our expenditures and undertake development or commercialization activities at our own expense, which will require additional capital than our current resources.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the absence of future proceeds from potential cash exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as conducting the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned. However, we cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or availability of additional funds under the Loan Agreement, if at all. In addition, if we elect to increase our expenditures to fund imetelstat development or commercialization activities outside the U.S., we will be required to substantially increase our personnel resources and we will need to obtain substantial further capital, which may not be available to us on acceptable terms, or at all. If we are unable to raise additional capital if and when needed, we will not be able to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as to conduct the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications to generate product revenues. Establishing the infrastructure necessary to further develop, commercialize, market and sell imetelstat worldwide will require substantial resources and may divert the attention of our management and key personnel and negatively impact our imetelstat development or commercialization efforts in the U.S.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We currently have no products approved for commercial sale, and we have not yet demonstrated an ability to obtain marketing approvals for any product candidates, which makes it difficult to assess our future viability.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never derived any revenue from the sales of any products. Our operations to date have been limited to organizing and staffing our company, acquiring, developing and securing our technology, undertaking non-clinical studies and clinical trials of imetelstat and past product candidates that we have subsequently discontinued, and engaging in research and development under collaboration agreements. We have not yet demonstrated an ability to obtain regulatory approvals for commercialization activities, formulate and manufacture commercial-scale products, or conduct sales and marketing activities necessary for successful product commercialization. Consequently, for these and other reasons discussed elsewhere in these risk factors, it is difficult to predict our future success and the viability of our business and the imetelstat program.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have business operations in the United Kingdom which exposes us to additional costs and risks.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business operations in the U.K. subject us to certain additional costs and risks associated with doing business outside the U.S., including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the increased complexity and costs inherent in managing international operations in geographically disparate locations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">challenges of complying with diverse regulatory, financial and legal requirements, which are subject to change at any time;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potentially adverse tax consequences, including changes in applicable tax laws and regulations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">potentially costly trade laws, tariffs, export quotas, custom duties or other trade restrictions, and any changes to them;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">liabilities for activities of, or related to, our international operations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">challenges inherent in efficiently managing employees in diverse geographies, including the need to adapt systems, policies, benefits and compliance programs to differing labor and other regulations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">natural disasters, political and economic instability, including terrorism and civil and political unrest, outbreak of health epidemics, including the evolving COVID-19 pandemic, and the resulting global economic and social impacts;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">workforce uncertainty in countries where labor unrest is more common than in the U.S.; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">compliance with the United Kingdom Bribery Act 2010, or UK Bribery Act, and similar antibribery and anticorruption laws in other jurisdictions, and the Foreign Corrupt Practices Act, including its books and records provisions and its anti-bribery provisions, including by failing to maintain accurate information and control over sales and distributors&#x2019; activities.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our international operations in the U.K. expose us to fluctuations in currency exchange rates between the British pound and the U.S. dollar. Given the volatility of currency exchange rates, there is no assurance that we will be able to effectively manage currency transaction and/or conversion risks. To date, we have not entered into derivative instruments to offset the impact of foreign exchange fluctuations, which fluctuations could have an adverse effect on our financial condition and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be able to obtain or maintain sufficient insurance on commercially reasonable terms or with adequate coverage against potential liabilities in order to protect ourselves against product liability claims or claims related to clinical trial conduct, or claims related to data protection.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business exposes us to potential product liability and other risks that are inherent in the testing, manufacturing and marketing of human therapeutic and diagnostic products. We may become subject to product liability claims or claims related to clinical trial conduct, including if the use of imetelstat is alleged to have injured patients, such as injuries alleged to arise from any hepatotoxicity or hemorrhagic event associated with the use of imetelstat. We currently have limited clinical trial liability insurance, and we may not be able to maintain this type of insurance for any of our current or potential future clinical trials of imetelstat. In addition, this type of insurance may become too expensive for us to afford because of the highly risky and uncertain nature of clinical trials generally and the high cost of insurance for our business activities. We may be unable to obtain or maintain clinical trial insurance in all of the jurisdictions where we conduct current or potential future clinical trials. In addition, business liability, product liability and cybersecurity insurance are becoming increasingly expensive, particularly for biotechnology and pharmaceutical companies, and the pool of insurers offering insurance coverage to biotechnology and pharmaceutical companies generally is becoming smaller, making it more difficult to obtain insurance for our business activities at a reasonable price, or at all. Being unable to obtain or maintain product liability, clinical trial liability, cybersecurity or other insurance for our business activities in the future on acceptable terms or with adequate coverage against potential liabilities would have a material adverse effect on our business, and could cause us to cease our development of imetelstat.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We and certain of our officers have been named as defendants in pending securities class action lawsuits and shareholder derivative lawsuits. These lawsuits, and potential similar or related lawsuits, could result in substantial damages, divert management&#x2019;s time and attention from our business, and have a material adverse effect on our results of operations. These lawsuits, and any other lawsuits to which we are subject, will be costly to defend or pursue and are uncertain in their outcome.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities-related class action lawsuits and/or derivative lawsuits have often been brought against companies, including biotechnology and biopharmaceutical companies, that experience volatility in the market price of their securities. This risk is especially relevant for us because we often experience significant stock price volatility in connection with our product development activities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between January 23, 2020 and March 5, 2020, three securities class action lawsuits were filed against us and certain of our officers. One of the lawsuits was voluntarily dismissed on March 19, 2020. The other two lawsuits, filed in the U.S. District Court, or the Court, for the Northern District of California, or the Northern District, were consolidated by the Court on May 14, 2020, and on August 20, 2020, the lead plaintiffs filed a consolidated class action complaint. The consolidated class action complaint alleges violations of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in connection with allegedly false and misleading statements made by us related to IMbark during the period from March 19, 2018, to September 26, 2018. The consolidated class action complaint alleges, among other things, that we violated Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5 by failing to disclose facts related to the alleged failure of IMbark to meet the two primary endpoints of the trial, spleen response rate and Total Symptom Score, and that our stock price dropped when such information was disclosed. The plaintiffs in the consolidated class action complaint seek damages and interest, and an award of reasonable costs, including attorneys&#x2019; fees. On October 22, 2020, lead plaintiffs filed an amended consolidated class action complaint. We filed a motion to dismiss the amended consolidated class action complaint on November 23, 2020. On April 12, 2021, the Court granted in part and denied in part our motion to dismiss. Our answer to the amended consolidated class action complaint was filed on May 13, 2021. On September 30, 2021, lead plaintiffs filed their motion for class certification, and on April 2, 2022, the Court granted the lead plaintiffs&#x2019; motion for class certification. On September 2, 2022, the parties agreed to a settlement and entered into a Stipulation and Agreement of Settlement, or the Stipulation, which is subject to court approval. On October 13, 2022, the Court preliminarily approved the parties&#x2019; settlement, permitted notice to be distributed to the class members, and scheduled a final approval hearing for March 30, 2023. Final approval of the settlement is subject to a number of conditions and contingencies out of our control. There can be no guarantee that all of these conditions and contingencies will occur. Should a material condition or contingency to the settlement fail to occur, one or both of the parties to the settlement may exercise their right to terminate the settlement agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between April 23, 2020 and June 8, 2021, seven shareholder derivative actions were filed, naming as defendants certain of our current officers and certain current and former members of our board. Of these actions, or the Derivative Lawsuits, two were filed in the Northern District, two were filed in the Court of Chancery of the State of Delaware, two were filed in the U.S. District Court for the District of Delaware, and one was filed in the Superior Court of California for the County of San Mateo, respectively. The plaintiffs in the Derivative Lawsuits allege breach of fiduciary duty and/or violations of Section 14 of the Exchange Act, based on the same underlying facts as the consolidated class action lawsuit described above. The plaintiffs seek damages, corporate governance reforms, equitable relief, restitution, and an award of reasonable costs, including attorneys&#x2019; fees. The status of the seven Derivative Lawsuits is currently as follows:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 2, 2021, we filed a motion to dismiss the consolidated shareholder derivative actions filed in the Court of Chancery of the State of Delaware, or the Chancery Court Derivative Lawsuits. On September 1, 2021, the plaintiffs filed a consolidated amended complaint in the Chancery Court Derivative Lawsuits. On October 12, 2021, we filed our motion to dismiss the consolidated amended complaint. The Court of Chancery of the State of Delaware heard oral argument on the motion on February 15, 2022, and, on June 22, 2022, issued an order staying its decision on our motion to dismiss until after final resolution of the consolidated class action lawsuit described above. On December 21, 2022, the parties in the Chancery Court Derivative Lawsuits entered into a Stipulation of Settlement, or the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the Chancery Court Derivative Lawsuits. A final approval hearing regarding the Derivative Stipulation has been scheduled for May 17, 2023. Final approval of the settlement is subject to a number of conditions and contingencies out of our control. There can be no guarantee that all of these conditions and contingencies will occur. Should a material condition or contingency to the settlement fail to occur, one or more of the parties to the settlement may exercise their right to terminate the settlement agreement;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated shareholder derivative actions filed in the U.S. District Court for the District of Delaware have been stayed pending the ruling on our motion to dismiss the Chancery Court Derivative </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lawsuits. On December 21, 2022, the parties in the consolidated District of Delaware derivative actions entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated District of Delaware derivative actions;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated shareholder derivative actions filed in the Northern District were initially stayed through the ruling on our motion to dismiss in the consolidated class action lawsuit described above and then subsequently were stayed through the ruling on the lead plaintiffs&#x2019; motion for class certification in the consolidated class action lawsuit. Subsequent to the grant of class certification in the consolidated class action lawsuit, on May 3, 2022, the Northern District entered an order providing plaintiffs until June 7, 2022, to file an amended complaint. On June 7, 2022, plaintiffs filed an amended shareholder derivative complaint. On July 6, 2022, the Northern District entered an order staying the consolidated shareholder derivative actions filed in the Northern District until the earlier of either a public announcement of a settlement in the consolidated class action lawsuit or a final, non-appealable judgment in the consolidated class action lawsuit. The stay has subsequently been extended on a number of occasions and the case is currently stayed through March 31, 2023. On December 21, 2022, the parties in the consolidated derivative actions in the Northern District entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated derivative actions in the Northern District; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our motion to dismiss the shareholder derivative action pursuant to the forum selection clause in our amended and restated bylaws was filed in the Superior Court of California for the County of San Mateo on August 5, 2021. At the hearing on the motion to dismiss on November 2, 2021, the court granted our motion to dismiss and stayed the case until April 19, 2022. At the case management conference on April 19, 2022, the court continued the stay until June 14, 2022. At the case management conference on June 14, 2022, the court continued the stay until December 13, 2022. On December 13, 2022, the court dismissed the action without prejudice.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It is possible that additional lawsuits will be filed, or allegations received from stockholders, with respect to these same or other matters and also naming us and/or our officers and directors as defendants. Such lawsuits and any other related lawsuits are subject to inherent uncertainties, and the actual defense and disposition costs will depend upon many unknown factors. The outcome of such lawsuits is necessarily uncertain. We could be forced to expend significant resources in the defense of the pending lawsuits and any additional lawsuits, and we may not prevail. In addition, we have and may continue to incur substantial legal fees and costs in connection with such lawsuits. As discussed in Note 6 on Commitments and Contingencies in Notes to Consolidated Financial Statements of this annual report on Form 10-K for the year ended December 31, 2022, we recorded our portion of the settlement amounts for the Stipulation and the Derivative Stipulation on our consolidated statements of operations for the year ended December 31, 2022, as well as corresponding liabilities on our consolidated balance sheet as of December 31, 2022. We currently are not able to estimate the possible additional costs to us, if any, from these matters, and we cannot be certain how long it may take to resolve the pending lawsuits or the possible amount of any damages or legal costs that we may be required to pay. Monitoring, initiating and defending against legal actions is time-consuming for our management, is likely to be expensive and may detract from our ability to fully focus our internal resources on our business activities. We could be forced to expend significant resources in the settlement or defense of the pending lawsuits and any potential future lawsuits, and we may not prevail in such lawsuits. Additionally, we may not be successful in having any such lawsuits dismissed or settled within the limits of our insurance coverage.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have not established any reserve for any potential liability relating to the pending lawsuits or any potential future lawsuits, other than for the total settlement amount under the Stipulation. It is possible that we could, in the future, incur judgments or enter into settlements of claims for monetary damages. A decision adverse to our interests in the pending lawsuits, or in similar or related litigation, could result in the payment of substantial damages, or possibly fines, and could have a material adverse effect on our business, our stock price, cash flow, results of operations and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be subject to third-party litigation, and such litigation would be costly to defend or pursue and uncertain in its outcome.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business may bring us into conflict with our licensees, licensors, or others with whom we have contractual or other business relationships, or with our competitors or others whose interests differ from ours. We may experience employment-related disputes as we seek to expand our personnel resources. We may become involved in performance or other disputes with the CROs we have retained to support our imetelstat clinical development activities, or with other third parties such as service providers, vendors, manufacturers, suppliers or consultants, which could result in a further delay or cessation of current and potential future clinical trials and otherwise significantly further delay our ability to develop imetelstat. If we are unable to resolve those conflicts on terms that are satisfactory to all parties, we may become involved in litigation brought by or against us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lawsuits are subject to inherent uncertainties, and defense and disposition costs depend upon many unknown factors. Despite the availability of insurance, we may incur substantial legal fees and costs in connection with litigation. Lawsuits could result in judgments against us that require us to pay damages, enjoin us from certain activities, or otherwise negatively affect our legal or contractual rights, which could have a significant adverse effect on our business. In addition, the inherent uncertainty of such litigation could lead to increased volatility in our stock price and a decrease in the value of our stockholders&#x2019; investment in our securities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws, and anti-money laundering laws and regulations. Compliance with these legal standards could impair our ability to compete in domestic and international markets. We can face criminal liability and other serious consequences for violations, which can harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations, U.S. Customs regulations, various economic and trade sanctions regulations administered by the U.S. Treasury Department&#x2019;s Office of Foreign Assets Controls, the U.S. Foreign Corrupt Practices Act of 1977, as amended, or FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, the USA PATRIOT Act, and other state and national anti-bribery and anti-money laundering laws in the countries in which we conduct activities. Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, contractors, and other collaborators from authorizing, promising, offering, or providing, directly or indirectly, improper payments or anything else of value to recipients in the public or private sector. We may engage third parties to sell our products outside the United States, to conduct clinical trials, and/or to obtain necessary permits, licenses, patent registrations, and other regulatory approvals. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We can be held liable for the corrupt or other illegal activities of our employees, agents, contractors, and other collaborators, even if we do not explicitly authorize or have actual knowledge of such activities. Any violations of the laws and regulations described above may result in substantial civil and criminal fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Competitive Factors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If competitors develop products, product candidates or technologies that are superior to or more cost-effective than imetelstat, this would significantly impact the development and commercial viability of imetelstat, which would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, and might cause us to cease operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The pharmaceutical and biotechnology industries are characterized by intense and dynamic competition with rapidly advancing technologies and a strong emphasis on proprietary products. While we believe our proprietary oligonucleotide chemistry; experience with the biological mechanisms related to imetelstat, telomeres and telomerase; clinical data to date indicating potential disease-modifying activity with imetelstat treatment; and knowledge and expertise around the development of potential treatments for myeloid hematologic malignancies provide us with competitive advantages, we face competition from many different sources, including major pharmaceutical, specialty pharmaceutical and biotechnology companies, academic institutions, governmental agencies, and public and private research institutions. Imetelstat will compete, if approved, with other products and therapies that currently exist, are being developed or will in the future be developed, some of which we may not currently be aware of.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If approved for commercial sale for the treatment of lower risk MDS, imetelstat would compete against a number of currently existing therapies, including ESAs and other hematopoietic growth factors that are indicated for anemia; immunomodulators, such as Revlimid (lenalidomide) by Celgene Corporation, a Bristol-Myers Squibb Corporation, or Celgene; hypomethylating agents, such as Vidaza (azacitidine) by Celgene and manufacturers of generic azacitidine; Dacogen (decitabine) by Otsuka America Pharmaceutical, Inc. and other manufacturers in the U.S. and Janssen in the EU; Inqovi (oral combination of decitabine and cedazuridine) by Astex Pharmaceuticals, Inc., or Astex; and Reblozyl (luspatercept), a TGF-beta inhibitor, by Acceleron Pharma, Inc., or Acceleron (acquired by Merck &amp; Co., Inc., or Merck, in November 2021), in collaboration with Celgene. In November 2022, Bristol-Myers Squibb Company, or BMS, announced that the Phase 3 front-line COMMANDS trial that compared Reblozyl (luspatercept) to ESAs was positive and that data would be presented in 2023 at a major medical meeting.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other therapies currently in Phase 3 development in lower risk MDS, some of which may obtain regulatory approval earlier than imetelstat include roxadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, by</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FibroGen, Inc; Onureg (oral azacytidine) by BMS; and Hengqu (hetrombopag), an oral nonpeptide thrombopoietin receptor agonist, by Jiangsu Hengrui Pharmaceuticals Co., Ltd.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, there are multiple Phase 1 and Phase 2 clinical trials of other agents being developed for lower risk MDS, including but not limited to: LB&#x2010;100, a PP2A inhibitor, by Lixte Biotechnology Holdings, Inc.; bemcentinib, an AXL inhibitor, by BerGenBio ASA; H3B&#x2010;8800, a spliceosome inhibitor, by H3 Biomedicine, Inc.; KER-050, a TGF-beta inhibitor, by Keros Therapeutics, Inc., or Keros Therapeutics; TP-0184, an inhibitor of ALK2 or ACVR1 kinase, by Sumitomo Dainippon Pharma Oncology, Inc; ilginatinib (NS-018), a JAK2 inhibitor, by NS Pharma, Inc., a U.S. subsidiary of Nippon Shinyaku Co., Ltd., or NS Pharma; RVT-2001, a SF3B1 modulator, by Roivant Sciences, Ltd.; sabatolimab (MBG453), a TIM-3 inhibitor, by Novartis AG; a lower dose of ASTX727, an oral formulation of decitabine and cedazuridine, referred to as ASTX727 LD, by Astex; ASTX030, an oral formulation of azacitidine and cedazuridine, by Astex; R289, an oral inhibitor of interleukin receptor-associated kinases 1 and 4, or IRAK1/4, by Rigel Pharmaceuticals, Inc.; a combination treatment regimen of luspatercept and lenalidomide by BMS; HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, by BMS and etavopivat, an oral, small molecule activator of erythrocyte pyruvate kinase (PKR) by Forma Therapeutics, Inc., a Novo Nordisk Company; canakinumab, an interleukin antagonist, by Novartis AG; and AG946, a next-generation pyruvate kinase-R (PKR) activator, by Agios Pharmaceuticals, Inc.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If approved for commercial sale for the treatment of MF, imetelstat would compete against currently approved JAK inhibitors: Jakafi (ruxolitinib) by Incyte Corporation, or Incyte, and Inrebic (fedratinib) by Celgene, as well as a kinase inhibitor, Vonjo (pacritinib), by CTI Biopharma Corp., which was approved in February 2022 for the treatment of adults with Intermediate or High-Risk primary or secondary myelofibrosis with a platelet count below 50 &#xd7; 10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/L. Other treatment modalities for MF include hydroxyurea for the management of splenomegaly, leukocytosis, thrombocytosis and constitutional symptoms; splenectomy and splenic irradiation for the management of splenomegaly and co-existing cytopenias; chemotherapy and pegylated interferon. Drugs for the treatment of MF-associated anemia include ESAs, androgens, danazol, corticosteroids, thalidomide and lenalidomide.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other therapies currently in Phase 3 development in MF, some of which may obtain regulatory approval earlier than imetelstat, include momelotinib, a JAK inhibitor, by GlaxoSmithKline plc; or momelotinib plus AZD5153, a BET inhibitor by GlaxoSmithKline plc; pelabresib (CPI-0610), a BET inhibitor, by MorphoSys AG; navitoclax, a BCLXL, BCL-2 and BCLW inhibitor, by AbbVie, Inc.; and parsaclisib, a PI3K delta inhibitor, by Incyte. Other approaches for MF currently under investigation that could compete with imetelstat in the future include luspatercept; zinpentraxin alfa (RG6354, formerly PRM-151), an anti-fibrosis antibody, by F. Hoffmann-La Roche, Ltd.; LCL-161, an inhibitor of apoptosis protein (IAP), by Novartis; KRT-232, an inhibitor of MDM2, by Kartos Therapeutics, Inc.; GB2064, a LOXL2 inhibitor, by Galecto Biotech; elraglusib (9-ING-41), a glycogen synthase kinase-3 beta inhibitor, by Actuate Therapeutics, Inc.; XPOVIO (selinexor), a nuclear export inhibitor, by Karyopharm Therapeutics, Inc.; TL-895, an oral tyrosine kinase inhibitor, by Telios Pharma, Inc.; IMG-7289, a LSD1 inhibitor, by Imago Biosciences, Inc.; APG-1252, a dual BCL-2/BCL-XL inhibitor, by Ascentage Pharma; ilginatinib (NS-018), a JAK2 inhibitor by NS Pharma; DISC-0974, a monoclonal antibody against hemojuvelin (HJV) by DISC Management Inc.; KER-050 in combination with ruxolitinib, by Keros Therapeutics; CK0804, an allogeneic T-regulatory cell agent, by Cellenkos, Inc. in collaboration with Incyte; TP-3654, PIM kinase inhibitor by Sumitomo Pharma Co., Ltd.; and a mutated-CALR vaccine, a peptide-based vaccine, from the Icahn School of Medicine at Mount Sinai.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Smaller companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. We anticipate increased competition in the future as new companies explore treatments for myeloid hematologic malignancies, which may significantly impact the commercial viability of imetelstat. Academic institutions, government agencies and other public and private research organizations may also conduct research, seek patent protection and establish collaborative arrangements for research, clinical development and marketing of products similar to imetelstat. These companies and institutions compete with us in recruiting and retaining qualified development and management personnel as well as in acquiring technologies complementary to the imetelstat program.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our competitors, either alone or with their strategic partners, could have substantially greater financial, technical and human resources than we do and significantly greater experience in obtaining FDA and other regulatory approvals of treatments and commercializing those treatments. We believe that the commercial success of imetelstat is subject to a number of factors, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">product efficacy and safety;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">method of product administration;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">cost of manufacturing;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing and scope of regulatory consents;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">status of coverage and level of reimbursement;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">level of generic competition;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">price; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">patent position, including potentially dominant patent positions of others.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a result of the foregoing, competitors may develop more commercially desirable or affordable products than imetelstat, or achieve earlier patent protection or product commercialization than we may be able to achieve with imetelstat. Competitors have developed, or are in the process of developing, technologies that are, or in the future may be, competitive to imetelstat. Some of these products may have an entirely different approach or means of accomplishing therapeutic effects similar or superior to those that may be demonstrated by imetelstat. Competitors may develop products that are safer, more effective, or less costly than imetelstat, or more convenient to administer to patients and, therefore, present a serious competitive threat to imetelstat. In addition, competitors may price their products below what we may determine to be an acceptable price for imetelstat, may receive better third-party payor coverage and/or reimbursement, or may be more cost-effective than imetelstat. Such competitive products or activities by competitors may render imetelstat obsolete, which may cause us to cease any further development or future commercialization of imetelstat, which would severely and adversely affect our financial results, business and business prospects, and the future of imetelstat, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">To be commercially successful, imetelstat must be accepted by the healthcare community, which can be very slow to adopt or unreceptive to new technologies and products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if approved for marketing, imetelstat may not achieve market acceptance, or the potential worldwide or U.S. revenue we believe may be possible, since hospitals, physicians, patients or the medical community in general may decide not to accept and utilize imetelstat. If approved for commercial sale, imetelstat will compete with a number of conventional and widely accepted drugs and therapies manufactured and marketed by major pharmaceutical companies. The degree of market acceptance of imetelstat will depend on a number of factors, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the clinical indications for which imetelstat is approved, if any;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the country and/or regions within which imetelstat is approved, if any;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the establishment and demonstration to the medical community of the clinical efficacy and safety of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to demonstrate that imetelstat is superior to alternatives on the market at the time;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the ability to establish in the medical community the potential advantages of imetelstat over alternative treatment methods, including with respect to efficacy, safety, cost or route of administration;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of medical professionals to prescribe, and patients to use, imetelstat, or to continue to use imetelstat; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the publication of unfavorable safety or efficacy data concerning imetelstat by third parties or us;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restrictions on use of imetelstat in combination with other products;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the label and promotional claims allowed by the FDA or similar international regulatory authorities for imetelstat, if any, including usage for only certain indications and any limitations or warnings about the prevalence or severity of any side effects;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing of market introduction of imetelstat as well as competitive products, including sequencing of available products;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effectiveness of sales, marketing and distribution support for imetelstat, particularly during the remote COVID-19 environment;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which imetelstat is approved for inclusion on formularies in hospitals and managed care organizations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the pricing of imetelstat, both in absolute terms and relative to alternative treatments;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of coverage and adequate reimbursement by government and third-party payors; and</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the willingness of patients to pay out-of-pocket in the absence of coverage by third-party payors, including governmental authorities.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The established use of conventional products competitive with imetelstat may limit or preclude the potential for imetelstat to receive market acceptance upon any commercialization. We may be unable to demonstrate any therapeutic or economic advantage for imetelstat compared to established or standard-of-care therapies, or newly developed therapies, for myeloid hematologic malignancies. Third-party payors may decide that any potential benefit that imetelstat may provide to clinical outcomes in myeloid hematologic malignancies is not adequate to justify the costs of treatment with imetelstat. If the healthcare community does not accept imetelstat for any of the foregoing reasons, or for any other reasons, our ability to further develop or potentially commercialize imetelstat may be negatively impacted or precluded altogether, which would seriously and adversely affect our business and business prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If the market opportunities for imetelstat are smaller than we believe, our potential revenue may be adversely affected, and our business may suffer.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our initial focus for imetelstat development has been on the lead indications, lower risk MDS and relapsed/refractory MF. The addressable patient populations, if imetelstat is approved in those indications, are based on our estimates. These estimates, which have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations and market research, may prove to be incorrect. Further, new information from us or others may change the estimated incidence or prevalence of those indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any regulatory approval of imetelstat would be limited to the therapeutic indications examined in our clinical trials and as determined by the FDA and similar international regulatory authorities, which would not permit us to market imetelstat for any other indications not expressly approved by those regulatory authorities. Additionally, the potentially addressable patient population for imetelstat may not ultimately be amenable to treatment with imetelstat. Even if we receive regulatory approval for imetelstat, such approval could be conditioned upon label restrictions that materially limit the addressable patient population.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our market opportunity may also be limited by the pricing we are able to achieve for imetelstat, if approved, the quality and expiration of our intellectual property rights and licenses, and future competitor treatments that enter the market. If any of our estimates prove to be inaccurate, the market opportunities for imetelstat that we or any potential future collaborative partners develop could be significantly diminished which would have a material adverse impact on our business and business prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The adoption of health policy changes and healthcare reform in the U.S. may adversely affect our business and financial results.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the U.S. and some jurisdictions outside the U.S., there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could impact our business. Generally, there has been increasing legislative and enforcement interest in the U.S. with respect to drug pricing, including specialty drug pricing practices, in light of the rising cost of prescription drugs and biologics. Specifically, there have been U.S. Congressional inquiries and federal and state legislative activity designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer patient programs, reduce the price of drugs under Medicare, and reform government program reimbursement methodologies for drugs and biologics. In July 2021, the Biden administration released an executive order, &#x201c;Promoting Competition in the American Economy,&#x201d; with multiple provisions aimed at prescription drugs. In response to Biden&#x2019;s executive order, on September 9, 2021, the Department of Health and Human Services, or HHS, released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. Furthermore, the Inflation Reduction Act of 2022, or the IRA, signed into law by President Biden on August 16, 2022, includes several provisions to lower prescription drug costs for people with Medicare and reduce drug spending by the federal government. Some of the specific provisions under the IRA that could impact us include:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Requirement that the federal government negotiate prices for certain single-source drugs covered under Medicare Part B and D with the highest total spending, beginning in 2026; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Requirement that drug companies pay rebates to Medicare if prices rise faster than inflation for drugs used by Medicare beneficiaries, beginning in 2023.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, the Biden administration released an additional executive order on October 14, 2022, directing HHS to submit a report on how the Center for Medicare and Medicaid Innovation can be further leveraged to test</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">new models for lowering drug costs for Medicare and Medicaid beneficiaries. We expect that additional state and federal healthcare reform measures may be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could affect pricing for imetelstat if it is approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Moreover, the U.S. and some jurisdictions in other countries are considering or have enacted legislative and regulatory proposals to contain healthcare costs, as well as to improve quality and expand access. For example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the ACA was signed into law, which included a number of provisions of importance to the biopharmaceutical industry. There have been judicial and Congressional challenges to certain aspects of the ACA, and it is possible that the ACA will be subject to judicial or Congressional challenges in the future. In addition, the IRA, among other things, extends enhanced subsidies for individuals purchasing health insurance coverage in PPACA marketplaces through plan year 2025. The IRA also eliminates the &#x201c;donut hole&#x201d; under the Medicare Part D program beginning in 2025 by significantly lowering the beneficiary maximum out-of-pocket cost and creating a new manufacturer discount program. We expect that other healthcare reform measures that may be adopted in the future may result in more rigorous coverage criteria and lower reimbursement, and additional downward pressure on the price that may be charged for imetelstat. For additional details regarding healthcare reform measures that may affect our ability to operate see Item 1 &#x201c;Business&#x2014;Government Regulation&#x2014; Reimbursement and Healthcare Reform&#x201d; in our Annual Report on Form 10-K for the year ended December 31, 2022.</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If future legislation were to impose direct governmental price controls and access restrictions, it could have a significant adverse impact on our business and financial results. Managed care organizations, as well as Medicaid and other government agencies, continue to seek price discounts. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biologic product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, to encourage importation from other countries and bulk purchasing. Due to the volatility in the current economic and market dynamics, we are unable to predict the impact of any unforeseen or unknown legislative, regulatory, payor or policy actions, which may include cost containment and healthcare reform measures. Such policy actions could have a material adverse impact on future worldwide sales of imetelstat, if approved.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost control initiatives also could decrease the price that we may receive for imetelstat in the future. If imetelstat is not considered cost-effective or adequate third-party reimbursement for the users of imetelstat cannot be obtained, then we may be unable to maintain price levels sufficient to realize an appropriate return on our investment in imetelstat. Any of these events would severely and adversely affect our financial results, business and business prospects, and might cause us to cease operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to comply with federal, state and international healthcare laws, including fraud and abuse, transparency, and health information privacy and security laws, we could face substantial penalties and our business, results of operations, financial condition and prospects could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business operations and current and future arrangements with investigators, healthcare professionals, consultants, third-party payors and customers, may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations, including federal and state fraud and abuse laws, including anti-kickback and false claims laws; data privacy and security laws, including the Health Insurance Portability and Accountability Act, or HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH; and transparency laws related to payments and/or other transfers of value made to physicians, other healthcare professionals and teaching hospitals. These laws may constrain the business or financial arrangements and relationships through which we conduct our operations, including how we research, market, sell and distribute imetelstat, if marketing approval is obtained. For details regarding the restrictions under applicable federal and state healthcare laws and regulations that may affect our ability to operate see Item 1 &#x201c;Business&#x2014;Government Regulation&#x2014; Fraud and Abuse, Data Privacy and Security, and Transparency Laws and Regulations&#x201d; in our Annual Report on Form 10-K for the year ended December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal and state enforcement bodies have increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. If our operations are found to be in violation of any of these or any other healthcare and privacy-related regulatory laws that may apply to us, we may be subject to significant penalties, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgement, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, reputational harm, diminished profits and future earnings, additional reporting requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations. Defending against any such actions can be costly, time-consuming and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our employees, independent contractors, principal investigators, clinical trial sites, contract research organizations, consultants or vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to the risk that our employees, independent contractors, principal investigators, clinical trial sites, CROs, consultants or vendors may engage in fraudulent or other illegal activity. Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violate the FDA&#x2019;s or similar international regulatory authorities&#x2019; regulations, including those laws requiring the reporting of true, complete and accurate information; manufacturing standards; healthcare fraud and abuse laws and regulations; or laws that require the true, complete and accurate reporting of financial information or data. Specifically, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Activities subject to these laws also involve the improper use or misrepresentation of information obtained in the course of clinical trials or creating fraudulent data in our non-clinical studies or clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct by our employees and third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. Additionally, we are subject to the risk that a person could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished potential profits and future earnings, and curtailment of our operations, any of which could adversely affect our business, financial condition, results of operations or prospects.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Our Common Stock and Financial Reporting</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Historically, our stock price has been extremely volatile and your investment may suffer a decline in value.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Historically, our stock price has been extremely volatile. Between January 1, 2013 and December 31, 2022, our stock has traded as high as $7.79 per share and as low as $0.75 per share. Between January 1, 2022 and December 31, 2022, the price has ranged between a high of $3.06 per share and a low of $0.99 per share. The significant market price fluctuations of our common stock have been due to and may in the future be influenced by a variety of factors, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements regarding our ability to timely submit applications for regulatory approvals of imetelstat in lower risk MDS;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">regulatory approval or non-approval of imetelstat, specific label indications for or restrictions, warnings or limitations in its use, or delays in the regulatory review process;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements regarding the research and development of imetelstat, or adverse efficacy or safety results of, further delays in the commencement, enrollment or conduct of, discontinuation of, or further modifications or refinements to any current clinical trials of imetelstat, including IMerge Phase 3 or IMpactMF, IMproveMF and IMpress, or for potential future clinical trials of imetelstat, for any reason, or our inability, for any reason, to successfully continue the development of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">obtaining additional capital on commercially reasonable terms to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, and to conduct the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and other future indications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">timeliness of preliminary, interim or final clinical trial data expected to be reported with respect to current or potential future clinical trials of imetelstat, and investor perceptions thereof;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">not receiving timely regulatory clearances or approvals in any jurisdiction, whether within or outside of the U.S. to continue clinical development of imetelstat in relapsed/refractory MF, lower risk MDS or any additional myeloid hematologic malignancies in a timely manner or at all;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in laws or regulations applicable to imetelstat, including but not limited to clinical trial requirements for approval;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements regarding the safety of imetelstat and partial or full clinical holds placed on the imetelstat INDs by the FDA or similar international regulatory authorities, or other regulatory developments related to imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the successful completion of any clinical trials, regulatory approval and commercialization of imetelstat for one or more label expansion indications;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements of technological innovations, new commercial products, or clinical progress or lack thereof by us, potential future collaborative partners or our competitors;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adverse developments concerning our manufacturers, including our inability to obtain adequate product supply for imetelstat or inability to do so at acceptable prices;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure to launch and commercialize imetelstat on the timelines anticipated, or at all;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the size and growth of our lead indications, lower risk MDS and relapsed/refractory MF;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements concerning imetelstat proprietary rights;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the terms and timing of any future collaboration agreements for the development and potential commercialization of imetelstat that we may establish;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements of significant acquisitions, strategic partnerships, collaborations, joint ventures or capital commitments by us or our competitors;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to acquire or in-license new product candidates to grow our pipeline; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the demand in the market for our common stock;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fluctuations in our operating results;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">increased or continuing operating losses;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">general domestic and international market conditions or market conditions relating to the biopharmaceutical and pharmaceutical industries, especially given the volatility caused by macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">perceptions of the biotechnology and pharmaceutical industry by the public, legislature, regulators and the investment community;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">comments by securities analysts or other third parties, including blogs, articles and other media;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure to meet the estimates and projections of the investment community or that we may otherwise provide to the public;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">publication of research reports about us or our industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">large stockholders increasing or exiting their position in our common stock or an increase in the short interest in our common stock;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">changes in the market valuations of similar companies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcements of or developments concerning pending and potential future litigation;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">disputes or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">actions instituted by activist shareholders or others;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the issuance of common stock to partners, vendors or investors to raise additional capital; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">other events or factors that are beyond our control; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the occurrence of any other risks and uncertainties discussed under the heading &#x201c;Risk Factors.&#x201d;</span></div></div>
  <p style="text-indent:4.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock prices and trading volumes for many biopharmaceutical companies fluctuate widely for a number of reasons, including factors which may be unrelated to their businesses or results of operations, such as media coverage, statements made on message boards and social media forums, legislative and regulatory measures and the activities of various interest groups or organizations. In addition to the risk factors described in this section, overall market volatility, as well as general domestic or international economic, market and political conditions, including those resulting from the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates or prospects of a recession, could materially and adversely affect the market price of our common stock and the return on your investment in our securities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, as further discussed in the Risk Factor above entitled </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">&#x201c;We and certain of our officers have been named as defendants in pending securities class action lawsuits and shareholder derivative lawsuits. These lawsuits, and potential similar or related lawsuits, could result in substantial damages, divert management&#x2019;s time and attention from our business, and have a material adverse effect on our results of operations. These lawsuits, and any other lawsuits to which we are subject, will be costly to defend or pursue and are uncertain in their outcome&#x201d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we and one of our officers have been named as defendants in pending securities class action lawsuits. In addition, certain of our current officers and current and former board members have been named as defendants in the pending Derivative Lawsuits filed in the Northern District, the Court of Chancery of the State of Delaware, and the District Court for the District of Delaware, respectively. Such lawsuits have often been instituted against companies, including us, whose securities have experienced periods of volatility in market price. The pending lawsuits and any lawsuits brought against us in the future could result in substantial costs, which would hurt our financial condition and results of operations and divert management&#x2019;s attention and resources, which could result in delays of IMpactMF, IMproveMF and IMpress, and/or could preclude or delay potential future clinical trials, or could preclude or delay commercialization efforts.</span></p>
  <p style="text-indent:4.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The sale of a substantial number of shares may adversely affect the market price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 9, 2023, 508,722,486 shares of common stock are issued and outstanding, and we had reserved 166,207,514 shares of our common stock for future issuance pursuant to our stock option and equity incentive plans and outstanding warrants.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future sales of our common stock or the perception that such sales could occur, or the issuance of common stock to fund our operations and imetelstat development, including pursuant to the 2020 Sales Agreement with B. Riley or upon the potential exercise of currently outstanding warrants, could cause immediate dilution and adversely affect the market price of our common stock. The sale or issuance of our securities, as well as the existence of outstanding stock options and shares of common stock reserved for issuance under our stock option and equity incentive plans and outstanding warrants, also may adversely affect the terms upon which we are able to obtain additional capital through the sale of equity securities, which could negatively affect the market price of our common stock and the return on stockholders&#x2019; investment.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our undesignated preferred stock may inhibit potential acquisition bids; this may adversely affect the market price of our common stock and the voting rights of holders of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our certificate of incorporation provides our board of directors with the authority to issue up to 3,000,000 shares of undesignated preferred stock and to determine or alter the rights, preferences, privileges and restrictions granted to or imported upon these shares without further vote or action by our stockholders. The issuance of shares of preferred stock may delay or prevent a change in control transaction without further action by our stockholders. As a result, the market price of our common stock may be adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if in the future, we issue preferred stock that has preference over our common stock with respect to the payment of dividends or upon our liquidation, dissolution or winding up, or if we issue preferred stock with voting rights that dilute the voting power of our common stock, the rights of holders of our common stock or the market price of our common stock could be adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Provisions in our charter, bylaws and Delaware law may inhibit potential acquisition bids for us, which may prevent holders of our common stock from benefiting from what they believe may be the positive aspects of acquisitions and takeovers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provisions of our charter documents and bylaws may make it substantially more difficult for a third-party to acquire control of us and may prevent changes in our management, including provisions that:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">prevent stockholders from taking actions by written consent;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">divide the board of directors into separate classes with terms of office that are structured to prevent all of the directors from being elected in any one year; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">set forth procedures for nominating directors and submitting proposals for consideration at stockholders&#x2019; meetings.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provisions of Delaware law may also inhibit potential acquisition bids for us or prevent us from engaging in business combinations. In addition, we have individual severance agreements with our executive officers and a company-wide severance plan, either of which could require a potential acquirer to pay a higher price. Either collectively or individually, these provisions may prevent holders of our common stock from benefiting from what they may believe are the positive aspects of acquisitions and takeovers, including the potential realization of a higher rate of return on their investment from these types of transactions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our amended and restated bylaws provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#x2019; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our amended and restated bylaws provide that, unless we consent to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any derivative action or proceeding brought on our behalf;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or to our stockholders;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a claim arising pursuant to any provision of the General Corporation Law of the State of Delaware, our certificate of incorporation, or our bylaws; or</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">any action asserting a claim governed by the internal affairs doctrine.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While the exclusive forum provisions in our bylaws do not apply to lawsuits brought to enforce a duty or liability created by the Exchange Act or the Securities Act of 1933, as amended, or any claim for which the federal courts have exclusive jurisdiction, these provisions may nonetheless limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our current or former directors, officers, or other employees, which may discourage such lawsuits against us and our current or former directors, officers, and other employees. Alternatively, if a court were to find the exclusive forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could have a material and adverse impact on our business and our financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We do not intend to pay cash dividends on our common stock in the foreseeable future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not anticipate paying cash dividends on our common stock in the foreseeable future. Any payment of cash dividends will depend upon our financial condition, results of operations, capital requirements and other factors, and will be at the discretion of our board of directors. In addition, the terms of our Loan Agreement prevent us from paying dividends and any future debt agreements may continue to preclude us from paying dividends. As a result, capital appreciation, if any, of our common stock will be the sole source of gain for our stockholders for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RISKS RELATED TO INFORMATION TECHNOLOGY SYSTEMS, DATA SECURITY AND DATA PRIVACY</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If our information technology systems or data, or those of third parties upon which we rely, are or were compromised, we could experience adverse consequences resulting from such compromise, including, but not limited to, regulatory investigations and actions; litigation; fines and penalties; a disruption of our business operations such as our clinical trials; reputational harm; loss of revenue and profits; and other adverse consequences.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of our business, we (and third parties upon which we rely) may collect, receive, store, process, use, transfer, make accessible, protect, secure, dispose of, transmit, disclose, or otherwise process (commonly known as processing) proprietary, confidential, and sensitive data, including personal data (such as health-related data and participant study related data), intellectual property, and trade secrets (collectively, sensitive information). In addition, we rely on third-party service providers to establish and maintain appropriate information technology and data security protections over the information technology systems they provide us to operate our critical business systems, including cloud-based infrastructure and systems, employee email, and data storage and management systems. However, except for contractual duties and obligations, we have limited ability to control their safeguards and actions related to such matters, and these third parties may not have adequate information security measures in place. Furthermore, while we may be entitled to damages if our third-party service providers fail to satisfy their privacy or security-related obligations to us, any award may be insufficient to cover our damages, or we may be unable to recover such award. We may share or receive sensitive information with or from third parties. In particular, the COVID-19 pandemic has caused us to modify our business and information technology practices, including that most of our employees continue to work remotely, which has increased risks to our information technology systems and data, as employees utilize network connections, computers, and devices outside our premises and networks, including working at home, while in transit and in public locations. Additionally, the prevalent use of mobile devices that access our sensitive information increases the risk of breaches.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our information technology systems, including in our remote work environment as a result of the COVID-19 pandemic, and those of the third parties upon which we rely, are potentially vulnerable to evolving threats. These threats are prevalent, continue to increase, and come from a variety of sources such as &#x201c;hackers,&#x201d; threat or internal bad actors, personnel (such as through theft, error or misuse), sophisticated nation states and nation-state-supported actors. These threats include, but are not limited to, social-engineering attacks, malicious code or malware, unauthorized intrusions, denial-of-service attacks, personnel misconduct or errors, ransomware attacks, supply-chain attacks, software bugs, computer viruses, server malfunctions, software, hardware or data center failures, loss of data or other information technology assets, natural disasters, terrorism, war, and telecommunication and electrical failures. In particular, ransomware attacks are becoming increasingly prevalent and severe and can lead to significant interruptions in operations, loss of data and income, reputational harm, and diversion of funds. If we were to experience such an attack, extortion payments might alleviate the negative impact of a ransomware attack, but we might be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. Similarly, supply-chain attacks and attacks on clinical trial sites as well as regulatory and health authorities have increased in frequency and severity, and we cannot guarantee that third parties and infrastructure in our supply chain or our third-party partners&#x2019; supply chains, or of clinical trial sites and regulatory and health authorities, have not been compromised or that they do not contain exploitable defects or bugs that could result in a breach of or disruption to our information technology systems (including those related to imetelstat) or the third-party information technology systems that support us and the services provided to us. Any of the aforementioned threats may result in unauthorized, unlawful or accidental loss, corruption, access, modification, destruction, alteration, acquisition or disclosure of sensitive information, such as clinical trial data or information, intellectual property, proprietary business data and personal data. The costs to us to attempt to protect against such breaches could be significant, including potentially requiring us to modify our business (including non-clinical and clinical trial activities), and while we have implemented security measures designed to protect our information technology systems and to identify and remediate vulnerabilities, such measures may not be successful. We may be unable in the future to detect vulnerabilities in our information technology systems because such threats and techniques change frequently, are sophisticated in nature, and may not be detected until after a security incident has occurred.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we or third parties upon which we rely experience or are perceived to have experienced a breach, we may experience adverse consequences. These consequences may include: government enforcement actions (for example, investigations, fines, penalties, audits, and inspections), interruptions in our operations, including disruption of our imetelstat development program, interruptions or restrictions on processing sensitive data (which could result in delays in obtaining, or our inability to obtain, regulatory approvals and significantly increase our costs to recover or reproduce the data), reputational harm, litigation (including class action claims), indemnification obligations, negative publicity, monetary fund diversions, financial loss, and other harms. In addition, such a breach may require</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">notification of the breach to relevant stakeholders. Such disclosures are costly, and the disclosure or the failure to comply with such requirements could lead to adverse consequences.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our contracts with relevant stakeholders include obligations relating to the safeguard of sensitive information, and a breach could lead to claims against us by such stakeholders. There can be no assurance that the limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us from liabilities, damages, or claims relating to our data privacy and security obligations. In addition, failure to maintain effective internal accounting controls related to data security breaches and cybersecurity in general could impact our ability to produce timely and accurate financial statements and could subject us to regulatory scrutiny.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are subject to stringent and changing U.S. and foreign laws, regulations, rules, contractual obligations, policies and other obligations related to data privacy and security. Our actual or perceived failure to comply with such obligations could lead to regulatory investigations and actions; litigation; fines and penalties; disruptions to our business operations; reputational harm; loss of revenue and profits; and other adverse business impacts.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of business, we process personal data and other sensitive data, including proprietary and confidential business data, trade secrets, intellectual property, data we collect about trial participants in connection with clinical trials, and sensitive third-party data. We are therefore subject to or affected by numerous data privacy and security obligations, such as various federal, state, local and foreign laws, regulations, guidances, industry standards, external and internal privacy and security policies, contracts, and other obligations governing the processing of personal data by us and on our behalf. These obligations may change, are subject to differing interpretations and may be inconsistent among jurisdictions or conflict. The global data protection landscape is rapidly evolving, and implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. This evolution may create uncertainty in our business; affect us or our collaborators&#x2019;, service providers&#x2019; and contractors&#x2019; ability to operate in certain jurisdictions or to collect, store, transfer, use and share personal data; necessitate the acceptance of more onerous obligations in our contracts; result in liability; or impose additional costs on us. The cost of compliance with these laws, regulations and guidances is high and is likely to increase in the future. These obligations may necessitate changes to our information technologies, systems, and practices and to those of any third parties that process personal data on our behalf. In addition, these obligations may require us to change our business model.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outside the U.S., an increasing number of laws, regulations, and industry standards apply to data privacy and security. For example, the European Union&#x2019;s General Data Protection Regulation (GDPR) (EU) 2016/679, or the EU GDPR, imposes strict requirements on the processing of personal data. Under the EU GDPR, government regulators may impose temporary or definitive bans on data processing, as well as fines of up to &#x20ac;20 million or 4% of the annual global revenues of the noncompliant company, whichever is greater.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we may be unable to transfer personal data from Europe and other jurisdictions to the U.S. or other countries due to data localization requirements or limitations on cross-border data flows. Europe and other jurisdictions have enacted laws requiring data to be localized or limiting the transfer of personal data to other countries. In particular, the European Economic Area, or the EEA, and the United Kingdom, or UK, have significantly restricted the transfer of personal data to the United States and other countries whose privacy laws it believes are inadequate. Other jurisdictions may adopt similarly stringent interpretations of their data localization and cross-border data transfer laws. Although there are currently various mechanisms that may be used to transfer personal data from the EEA and UK to the U.S. in compliance with law, such as the EEA and UK&#x2019;s standard contractual clauses, these mechanisms are subject to legal challenges, and there is no assurance that we can satisfy or rely on these measures to lawfully transfer personal data to the U.S. If there is no lawful manner for us to transfer personal data from the EEA, the UK, or other jurisdictions to the U.S., or if the requirements for a legally-compliant transfer are too onerous, we could face significant adverse consequences, including the interruption or degradation of our operations, the need to relocate part of or all of our business or data processing activities to other jurisdictions at significant expense, increased exposure to regulatory actions, substantial fines and penalties, the inability to transfer data and work with partners, vendors and other third parties, and injunctions against our processing or transferring of personal data necessary to operate our business.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Some European regulators have prevented companies from transferring personal data out of Europe for allegedly violating the GDPR&#x2019;s cross-border data transfer limitations.</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Likewise, we expect that there will continue to be new proposed laws, regulations and industry standards relating to privacy and data protection in the U.S. For example, HIPAA, as amended by HITECH, imposes specific requirements relating to the privacy, security, and transmission of individually identifiable health data. Additionally, the California Consumer Privacy Act of 2018, or CCPA, imposes obligations on businesses to which it applies. These obligations include, but are not limited to, providing specific disclosures in privacy notices and affording California residents certain rights related to their personal data. The CCPA allows for statutory fines for</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">noncompliance (up to $7,500 per violation). While the CCPA contains limited exceptions for clinical trial data, the CCPA&#x2019;s implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. It is anticipated that the California Privacy Rights Act of 2020, or CPRA, will expand the CCPA. For example, the CPRA establishes a new California Privacy Protection Agency to implement and enforce the CPRA, which could increase the risk of an enforcement action, and applies to personal information of business representatives and employees. Other states have also enacted data privacy laws. For example, Virginia passed the Consumer Data Protection Act, and Colorado passed the Colorado Privacy Act, both of which differ from the CPRA and become effective in 2023. If we become subject to new data privacy laws, at the state level or otherwise, the risk of enforcement action against us could increase because we may become subject to additional obligations, and the number of individuals or entities that can initiate actions against us may increase (including individuals, via a private right of action, and state actors).</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to data privacy and security laws, we may be contractually subject to industry standards adopted by industry groups and may become subject to such obligations in the future. We may also be bound by other contractual obligations related to data privacy and security, and our efforts to comply with such obligations may not be successful. We may publish privacy policies, marketing materials, and other statements, such as compliance with certain certifications or self-regulatory principles, regarding data privacy and security. If these policies, materials or statements are found to be deficient, lacking in transparency, deceptive, unfair, or misrepresentative of our practices, we may be subject to investigation, enforcement actions by regulators, or other adverse consequences.</span></p>
  <p style="text-indent:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we endeavor to comply with all applicable data privacy and security obligations, we may at times fail to do so or may be perceived to have failed to do so. Moreover, despite our efforts, we may not be successful in achieving compliance if our personnel or third parties upon whom we rely fail to comply with such obligations, which could negatively impact our business operations and compliance posture. For example, any failure by a third-party processor, including our clinical trial sites, to comply with applicable law, regulations, or contractual obligations could result in adverse effects, including inability to operate our business and proceedings against us by governmental entities or others. If we fail, or are perceived to have failed, to address or comply with data privacy and security obligations, we could face significant consequences. These consequences may include, but are not limited to, government enforcement actions (e.g., investigations, fines, penalties, audits, inspections, and similar activities); litigation (including class-related claims); additional reporting requirements and/or oversight; bans on processing personal data; orders to destroy or not use personal data; and imprisonment of company officials. Any of these events could have a material adverse effect on our reputation, business, or financial condition, including but not limited to: interruptions or stoppages in our business operations (including, as relevant, our clinical trials if any); inability to process personal data or to operate in certain jurisdictions; limited ability to develop or commercialize imetelstat; expenditure of time and resources to defend any claim or inquiry; adverse publicity; or revision or restructuring of our operations. Moreover, clinical trial participants or research subjects about whom we or our vendors obtain information, as well as the providers who share this information with us, may contractually limit our ability to use and disclose the information.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General Risk FACTORs</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our operations, and those of our CROs, suppliers, and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, public health pandemics or epidemics (including, for example, the ongoing COVID-19 pandemic), civil or political unrest or military conflicts around the world (such as the current military conflict between Ukraine and Russia), terrorism, insurrection or war, and other natural or man-made disasters or business interruptions. Furthermore, other events, such as the armed conflict between Russia and Ukraine, could lead to sanctions, embargoes, supply shortages, regional instability, geopolitical shifts, cyberattacks, other retaliatory actions, and adverse effects on macroeconomic conditions, currency exchange rates, and financial markets, which could adversely impact our operations and financial results, as well as those of third parties with whom we conduct business. There is a risk that one or more of our CROs, suppliers, and other contractors and consultants might not survive an economic downturn. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our ability to develop and potentially commercialize imetelstat could be disrupted if our operations or those of our CROs and other contractors or consultants are affected by geopolitical events, man-made or natural disasters or other business interruptions. Our corporate headquarters are located in California near major earthquake faults and fire zones. The ultimate impact on us, our CROs, contractors and consultants, and our general infrastructure of being located near major earthquake faults and fire zones and being consolidated in certain geographical areas is unknown,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">but our operations and financial condition could suffer in the event of a major earthquake, fire or other natural disaster.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, financial condition or results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">New income, sales, use, excise or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could affect the tax treatment of our domestic and foreign sales and earnings. Any new taxes could adversely affect our domestic and international business operations and our business and financial condition. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the Tax Act, as modified by the CARES Act, significantly revised the Code, and recently enacted federal tax legislation made additional changes. Future guidance from the U.S. Internal Revenue Service and other tax authorities with respect to such legislation may adversely affect us, and certain aspects of such legislation could be repealed or modified in the future, which could have an adverse effect on us. For example, the recently enacted Inflation Reduction Act of 2022, or the Inflation Reduction Act, includes provisions that will impact the U.S. federal income taxation of corporations, including imposing a minimum tax on the book income of certain large corporations and an excise tax on certain corporate stock repurchases that would be imposed on the corporation repurchasing such stock. It is uncertain if and to what extent various states will conform to the Tax Act, the CARES Act, the Inflation Reduction Act or any newly enacted federal tax legislation. Changes in corporate tax rates, the realization of net deferred tax assets relating to our U.S. operations, the taxation of earnings from other countries, and the deductibility of expenses under the Tax Act or future tax reform legislation could have a material impact on the value of our deferred tax assets, could result in significant one-time charges in the current or future taxable years, and could increase our future U.S. tax expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Failure to achieve and maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 could have a material adverse effect on our business and stock price.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 404 of the Sarbanes-Oxley Act of 2002, or Section 404, requires that we establish and maintain an adequate internal control structure and procedures for financial reporting. Our Annual Reports on Form 10-K must contain an annual assessment by management of the effectiveness of our internal control over financial reporting and must include disclosure of any material weaknesses in internal control over financial reporting that we have identified. In the past, our independent registered public accounting firm provided an opinion annually on the effectiveness of our internal control over financial reporting. As a smaller reporting company, we are no longer subject to this requirement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The requirements of Section 404 are ongoing and also apply to future years. We expect that our internal control over financial reporting will continue to evolve as our business develops. Although we are committed to continue to improve our internal control processes and we will continue to diligently and vigorously review our internal control over financial reporting in order to ensure compliance with Section 404 requirements, any control system, regardless of how well designed, operated and evaluated, can provide only reasonable, not absolute, assurance that its objectives will be met. Therefore, we cannot assure you that material weaknesses or significant deficiencies will not exist or otherwise be discovered in the future, particularly in light of our increased reliance on personnel working remotely as a result of the COVID-19 pandemic. If material weaknesses or other significant deficiencies occur, such weaknesses or deficiencies could result in misstatements of our results of operations, restatements of our financial statements, a decline in our stock price, or other material adverse effects on our business, reputation, results of operations, financial condition or liquidity.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 1B. UNRESOLVE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">D STAFF COMMENTS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 2. P</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ROPERTIES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2019, we entered into an operating lease agreement for office space located at 3 Sylvan Way, Parsippany, New Jersey, or the New Jersey Lease. The initial term of the New Jersey Lease is 11 years with an option to extend for an additional five years and a one-time option to terminate the New Jersey Lease without cause as of the 103</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">rd</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> month anniversary of the commencement date of the lease. The New Jersey Lease commenced on October 1, 2019, upon our control of the office space on that date.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2019, we entered into an operating lease agreement for office space located at 919 East Hillsdale Boulevard, Foster City, California, or the Foster City Lease. The initial term of the Foster City Lease is 87 months</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">with an option to extend for an additional five years. The Foster City Lease commenced on March 10, 2020, upon our control of the office space on that date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 3. LEGAL</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> PROCEEDINGS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See Note 6 on Commitments and Contingencies in Notes to Consolidated Financial Statements of this annual report on Form 10&#x2011;K for information on legal proceedings.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 4. MINE SAF</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ETY DISCLOSURES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> II</span></p>
  <p style="text-indent:-9.091%;padding-left:8.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:-9.091%;padding-left:8.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 5. MARKET FOR THE REGISTRANT&#x2019;S COMMON EQUITY, RELATED S</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is quoted on the Nasdaq Global Select Market under the symbol GERN. As of March 9, 2023, there were approximately 469 stockholders of record of our common stock. This number does not include &#x201c;street name&#x201d; or beneficial holders, whose shares are held of record by banks, brokers and other financial institutions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend Policy</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never paid cash dividends on our capital stock and do not anticipate paying cash dividends in the foreseeable future, but intend to retain our capital resources for reinvestment in our business. Any future determination to pay cash dividends will be at the discretion of the board of directors and will be dependent upon our financial condition, results of operations, capital requirements and other factors our board of directors deems relevant.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent Sales of Unregistered Securities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, there were no unregistered sales of equity securities by us.</span></p>
  <p style="text-indent:-9.091%;padding-left:8.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:-9.091%;padding-left:8.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_6_reserved"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 6. [RESERVED]</span></p>
  <p style="text-indent:-9.091%;padding-left:8.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:-9.091%;padding-left:8.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="mda"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 7. MANAGEMENT&#x2019;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following discussion should be read in conjunction with the section entitled &#x201c;Business&#x201d; in Part I, Item 1 and the audited financial statements and notes thereto included in Part II, Item 8 of this annual report on Form 10&#x2011;K. The information provided should be reviewed in the context of the sections entitled &#x201c;Risks Related to the Development of Imetelstat&#x201d;, &#x201c;Risks Related to COVID-19&#x201d; and &#x201c;Risks Related to Regulatory Compliance Matters and Commercialization of Imetelstat&#x201d; under &#x201c;Risk Factors&#x201d; in Part I, Item 1A and elsewhere in this annual report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Company Overview</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Summary</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Our investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes, or lower risk MDS. In January 2023, we reported positive top-line results from our IMerge Phase 3 clinical trial. The trial met its primary endpoint of 8-week transfusion independence rate and a key secondary endpoint of 24-week transfusion</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">independence rate, demonstrating highly statistically significant (i.e., P&lt;0.001 for both) and clinically meaningful benefits in imetelstat versus placebo. Furthermore, statistically significant and clinically meaningful efficacy results were observed in the trial across key subtypes, including patients who were ringed sideroblast positive, or RS positive, and ringed sideroblast negative, or RS negative; patients with high and very high baseline transfusion burden; and patients classified as Low or Intermediate-1 risk according to the International Prognostic Scoring System, or IPSS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on the positive top-line data from IMerge Phase 3 and the prior IMerge Phase 2, we plan to submit a New Drug Application, or NDA, to the FDA in the U.S. in mid-2023 and a marketing authorization application, or MAA, in Europe in the second half of 2023 for the use of imetelstat in adult patients with lower risk MDS. If the NDA is accepted for filing and imetelstat is approved for commercialization by the FDA within the timelines we expect, we anticipate commercial launch of imetelstat in lower risk MDS in the U.S. could occur in the first half of 2024. In Europe, we anticipate review of the planned MAA, if validated by the European Medicines Agency, or EMA, could take approximately 14 months and, if approved, we anticipate that the commercial launch of imetelstat in lower risk MDS in Europe could occur by the end of 2024.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe that the positive top-line data from IMerge Phase 3 and IMerge Phase 2, as well as our prior Phase 2 clinical trial of imetelstat in patients with Intermediate-2 or High-Risk myelofibrosis who have relapsed after or are refractory to treatment with a janus associate kinase inhibitor, or JAK inhibitor, or relapsed/refractory MF, provide strong evidence that imetelstat targets telomerase to inhibit the uncontrolled proliferation of malignant stem and progenitor cells enabling recovery of bone marrow and normal blood cell production, which suggest potential disease-modifying activity. We believe this potential for disease modification could differentiate imetelstat from currently approved treatments in myeloid hematologic malignancies. Accordingly, in addition to lower risk MDS, we are developing imetelstat for the treatment of several myeloid hematologic malignancies with the following ongoing clinical trials:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpactMF, a Phase 3 clinical trial in relapsed/refractory MF with overall survival, or OS, as the primary endpoint, that currently is enrolling patients. Based on our planning assumptions for enrollment and event (death) rates in the trial, we expect the interim analysis for OS in IMpactMF may occur in 2024, and the final analysis may occur in 2025. Because these analyses are event-driven and it is uncertain whether actual rates for enrollment and events will reflect current planning assumptions, the results may be available at different times than currently expected. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMproveMF, a Phase 1 combination clinical trial in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that currently is enrolling patients and the first patient was dosed in April 2021; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IMpress, an investigator-led Phase 2 clinical trial in Intermediate-2 or High-Risk myelodysplastic syndromes, or higher risk MDS, and acute myeloid leukemia, or AML, with the initial clinical site planned to open in 2023.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note on the COVID-19 Pandemic</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ongoing COVID-19 pandemic is having widespread, continually evolving, and unpredictable impacts on global societies, economies, financial markets, and business practices. We are closely monitoring the impact of the pandemic, the identification of new variants of the COVID-19 virus and related developments, and our focus remains on promoting employee health and safety while continuing to advance the development of imetelstat. For discussion regarding the impact of the COVID-19 pandemic on our business and financial results, see the sub-section entitled &#x201c;Risks Related to COVID-19&#x201d; under &#x201c;Risk Factors&#x201d; in Part I, Item 1A and Note 6 on Commitments and Contingencies &#x2013; Risks Related to Global Economic Conditions, COVID-19 and the Military Conflict Between Ukraine and Russia in Notes to Consolidated Financial Statements of this annual report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Overview</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Since our inception, we have primarily financed our operations through the sale of equity securities, interest income on our marketable securities and payments we received under our collaborative and licensing arrangements. As of December 31, 2022, we had approximately $173.1 million in cash, cash equivalents, restricted cash and current and noncurrent marketable securities, and a long-term debt principal balance of $50.0 million.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On January 10, 2023, we completed an underwritten public offering of 68,007,741 shares of our common stock and a pre-funded warrant to purchase 25,000,000 shares of our common stock, or the 2023 pre-funded warrant. The net cash proceeds from this offering are approximately $213.3 million, after deducting the underwriting discount and other offering expenses paid by us, and excludes any future proceeds from the exercise of the 2023</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pre-funded warrant. In addition, from January 1, 2023 through March 9, 2023, we have received $59.8 million in cash proceeds from the exercise of outstanding warrants.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2021, we drew down the remaining $10.0 million available under Tranche A of the Loan Agreement with Hercules and SVB. In August 2021, we amended the Loan Agreement to adjust the timing threshold for certain clinical milestones associated with Tranche B under the Loan Agreement. In addition, under the amended Loan Agreement, the minimum cash covenant requirement beginning as of June 1, 2022, was increased from $25.0 million to $30.0 million, and the minimum cash covenant required upon the execution of certain licensing transactions being executed was increased from $30.0 million to $35.0 million. All other terms of the Loan Agreement were unchanged, including the maturity date, interest rate, payment terms, events of default and other covenants.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2021, we drew down $15.0 million available under Tranche B of the Loan Agreement with Hercules and SVB.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On June 30, 2022, we entered into a second amendment to the Loan Agreement. Under the second amendment, the aggregate principal amount available to us increased from $75.0 million to $125.0 million with such principal being available in a series of tranches, subject to certain terms and conditions. As of March 9, 2023, remaining tranches of up to $55.0 million are available under the Loan Agreement, subject to certain conditions. However, on March 10, 2023, the Federal Deposit Insurance Corporation, or FDIC, issued a press release stating that SVB was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. Of the remaining term commitments under the Loan Agreement, Hercules and its affiliates hold 65% and 35% were held by SVB. As a result of the closure of SVB, we do not know whether Hercules and SVB&#x2019;s successor, if any, will fund their respective portions of the remaining term commitments or whether and to what extent we will otherwise be able to draw down the remaining $55.0 million under the Loan Agreement, even if we meet the conditions set forth in the Loan Agreement necessary for additional draw downs, and it is possible that we will not be able to access any additional funding under the Loan Agreement. See Note 8 on Debt in Notes to Consolidated Financial Statements of this annual report on Form 10&#x2011;K for additional information on the Loan Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Substantially all of our revenues to date have been payments under collaboration agreements, and milestones, royalties and other revenues from our licensing arrangements. We currently have no source of product revenue. While we reported a small profit for the year ended December 31, 2015 due to our recognition of revenue in connection with the upfront payment under a former imetelstat collaboration agreement, until 2015 we had never been profitable, and have not reported any profit since. We have incurred significant net losses since our inception in 1990, resulting principally from costs incurred in connection with our research and development activities and from general and administrative costs associated with our operations. As of December 31, 2022, we had an accumulated deficit of approximately $1.4 billion.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The significance of future losses, future revenues and any potential future profitability will depend primarily on the clinical and commercial success of imetelstat, our sole product candidate. In any event, imetelstat may require significant additional clinical testing prior to possible regulatory approval in the U.S. and other countries. We expect research and development expenses, general and administrative expenses, and losses to substantially increase in future periods as we continue to support the imetelstat development program, including the conduct and completion of IMpactMF, IMproveMF and IMpress, as well as the potential U.S. commercialization of imetelstat lower risk MDS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our current operating plan and our expectations regarding the timing of the submission and potential acceptance and approval of our planned NDA by the FDA for imetelstat in lower risk MDS and the potential commercialization in the U.S. for the use of imetelstat in adult patients with lower risk MDS, we believe that our existing cash, cash equivalents, restricted cash and current and noncurrent marketable securities, including the net cash proceeds from our recently closed underwritten public offering in January 2023 and the cash proceeds from the exercise of warrants that we received in the January and February 2023, will be sufficient to fund our projected operating requirements through the end of the third quarter of 2025, which includes the potential U.S. commercial launch of imetelstat in lower risk MDS in the first half of 2024. In the absence of potential proceeds from exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as conducting the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned. We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">availability of additional funds under the Loan Agreement, if at all, particularly given the recent closure of SVB by banking regulators.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If approved for marketing by regulatory authorities outside of the U.S., we may seek potential commercialization partners for such territories. Until the FDA or similar international regulatory authorities approve imetelstat for marketing in lower risk MDS, if at all, we cannot begin commercialization.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Critical Accounting Policies and Estimates</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Note 1 of Notes to Consolidated Financial Statements of this annual report on Form 10-K describes the significant accounting policies used in the preparation of our consolidated financial statements. Certain of these significant accounting estimates are considered to be critical, as defined below.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A critical accounting estimate is defined as one that is both material to the presentation of our consolidated financial statements and requires management to make difficult, subjective or complex judgments that could have a material effect on our financial condition and results of operations. Specifically, critical accounting estimates have the following attributes: (i) we are required to make assumptions about matters that are highly uncertain at the time of the estimate; and (ii) different estimates we could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on our financial condition or results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimates and assumptions about future events and their effects cannot be determined with certainty. We base our estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as our operating environment changes. These changes historically have been minor and have been included in the consolidated financial statements as soon as they became known. Based on a critical assessment of our accounting policies and the underlying judgments and uncertainties affecting the application of those policies, management believes that our financial statements are stated fairly in accordance with accounting principles generally accepted in the U.S., and meaningfully present our financial condition and results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe the following accounting estimates reflect our critical estimates and assumptions used in the preparation of our consolidated financial statements:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value of Financial Instruments</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We categorize financial instruments recorded at fair value on our consolidated balance sheets based upon the level of judgment associated with inputs used to measure their fair value. The categories are as follows:</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1&#x2014;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2&#x2014;Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#x2019;s anticipated life.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3&#x2014;Inputs reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A financial instrument&#x2019;s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Following is a description of the valuation methodologies used for financial instruments measured at fair value on our consolidated balance sheets, including the category for such financial instruments.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments classified as Level 1 include money market funds and certificates of deposit, representing approximately 26% of our total financial instruments classified as assets measured at fair value as of December 31, 2022. Financial instruments classified as Level 2 include commercial paper, government-sponsored enterprise securities, U.S. Treasury securities, municipal securities, and corporate notes, representing approximately 74% of our total financial instruments classified as assets measured at fair value as of December 31, 2022. The price</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for each security at the measurement date is derived from various sources. Periodically, we assess the reasonableness of these sourced prices by comparing them to the prices provided by our portfolio managers from broker quotes as well as reviewing the pricing methodologies used by our portfolio managers. Historically, we have not experienced significant deviation between the sourced prices and our portfolio managers&#x2019; prices.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For a further discussion regarding fair value measurements, see Note 2 on Fair Value Measurements in Notes to Consolidated Financial Statements of this annual report on Form 10&#x2011;K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating leases are included in operating leases, right-of-use assets and lease liabilities on our consolidated balance sheets. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of remaining lease payments over the expected lease term. The present value of remaining lease payments within the 12 months following the balance sheet date are classified as current lease liabilities. The present value of lease payments not within the 12 months following the balance sheet date are classified as noncurrent lease liabilities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The interest rate implicit in lease contracts to calculate the present value is typically not readily determinable. As such, significant management judgment is required to estimate the incremental borrowing rate, which is the rate incurred to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment as of the lease commencement date. We evaluate the assumptions used in estimating the incremental borrowing rate by reviewing industry and regional data for operating leases and loans with similar terms. We have not made any revisions to borrowing rate estimates. If the basis for the incremental borrowing rate estimate were to change, then the present value of remaining lease payments could differ significantly which would affect the value recognized for the right-of-use assets and corresponding lease liabilities on our consolidated balance sheets. See Note 7 on Operating Leases in Notes to Consolidated Financial Statements of this annual report on Form 10-K for further discussion of our operating lease obligations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical Trial Accruals</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current imetelstat clinical trials are being supported by CROs and other vendors. Invoicing from CROs for services rendered can be delayed several months, or longer. We accrue the cost of services rendered in connection with CRO activities based on our estimate of site management, monitoring costs, project management costs, and investigator fees. We accrue expenses for clinical trial activities performed by CROs based upon the estimated amount of work completed on each trial. We maintain regular communications with our CROs to assess the reasonableness of our estimates. To date, differences between actual clinical trial expenses and estimated clinical trial expenses recorded have not been material and are adjusted for in the period in which they become known. However, if we incorrectly estimate activity levels associated with the CRO services at a given point in time, we could be required to record material adjustments in future periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For clinical trial expenses and related expenses associated with the conduct of clinical trials, the significant factors used in estimating accruals include the number of patients enrolled, the number of active clinical sites, and the duration for which the patients have been enrolled in the trial. We monitor patient enrollment levels and related activities to the extent possible through internal reviews, review of contractual terms and correspondence with CROs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Valuation of Stock&#x2011;Based Compensation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure and recognize compensation expense for all share&#x2011;based payment awards to our employees and directors, including service-based and performance-based stock options, restricted stock awards and employee stock purchases related to our Employee Stock Purchase Plan, or ESPP, based on estimated grant&#x2011;date fair values for these instruments. The grant&#x2011;date fair value of share&#x2011;based payment awards is amortized over the vesting period of the awards using a straight&#x2011;line method and reduced for estimated forfeitures. For performance-based stock options with vesting conditioned on the achievement of certain strategic milestones, stock-based compensation expense is recognized over the period from the date the performance condition is determined to be probable of occurring through the date the applicable condition is expected to be met and is reduced for estimated forfeitures, as applicable. If the performance condition is not considered probable of being achieved, no stock-based compensation expense is recognized until such time as the performance condition is considered probable of being met, if at all. If that assessment of the probability of the performance condition being met changes, the impact of the change in estimate would be recognized in the period of the change. We use the Black Scholes option&#x2011;pricing model to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">estimate the grant&#x2011;date fair value of our service-based and performance-based stock options and employee stock purchases.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Option&#x2011;pricing model assumptions, such as expected volatility, expected term and risk&#x2011;free interest rate, impact the fair value estimate. Expected volatilities are based on historical volatilities of our stock since traded options on our common stock do not correspond to option terms and trading volume of options is limited. The expected term of stock options represents the period of time that stock options granted are expected to be outstanding. In deriving this assumption, we review actual historical exercise and post&#x2011;vesting cancellation data and the remaining outstanding stock options not yet exercised or cancelled. For performance-based stock options, we also assess the projected timing of potential achievement of the milestones. The expected term of employees&#x2019; purchase rights under our ESPP is equal to the purchase period. The risk&#x2011;free interest rate is based on the U.S. Zero Coupon Treasury Strip Yields for the expected term in effect on the date of grant. Forfeiture rates are estimated based on historical data and are adjusted, if necessary, over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from their estimate.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We evaluate the assumptions used in estimating grant&#x2011;date fair values of our share&#x2011;based payment awards by reviewing current trends in comparison to historical data on an annual basis. We evaluate whether an adjustment to the assumptions of fair value of our common stock and historical volatility are required if observed prices of our common stock materially differ from historical information. We have not revised the methods by which we derive assumptions in order to estimate grant&#x2011;date fair values of our share&#x2011;based payment awards. If factors change and we employ different assumptions in future periods, the stock&#x2011;based compensation expense that we record for share&#x2011;based payment awards to employees and directors may differ significantly from what we have recorded in the current period.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Results of Operations</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our results of operations have fluctuated from period to period and may continue to fluctuate in the future. Results of operations for any period may be unrelated to results of operations for any other period. Thus, historical results should not be viewed as indicative of future operating results.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenue based on sales of imetelstat is dependent on obtaining regulatory approval to commercialize imetelstat in the U.S. and other countries. We are subject to risks common to companies in our industry and at our stage of development, including, but not limited to, risks inherent in research and development efforts, including the development, manufacture, regulatory approval for and commercialization of, imetelstat; uncertainty of non-clinical and clinical trial results or regulatory approvals or clearances; the future development of imetelstat by us, including any future efficacy or safety results that may cause the benefit-risk profile of imetelstat to become unacceptable; the uncertain and unpredictable drug research and discovery process; overcoming disruptions and/or delays due to the COVID-19 pandemic or geopolitical events; our need for substantial additional capital; enforcement of our patent and proprietary rights; reliance upon our CROs, contract manufacturing organizations, or CMOs, consultants, licensees, investigators and other third parties; and potential competition. In order for imetelstat to be commercialized, we must conduct non-clinical tests and clinical trials to demonstrate the safety and efficacy of imetelstat, obtain regulatory approvals or clearances and enter into manufacturing, distribution and marketing arrangements, as well as obtain market acceptance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Revenues</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We previously entered into license or collaboration agreements with companies involved with oncology, diagnostics, research tools and biologics production, whereby we granted certain rights to our non-imetelstat related technologies. As of December 31, 2020, our license agreements related to our hTERT technology have been terminated or expired due to patent expirations on such technology. The remaining active license agreement was a license related to our specialized oligonucleotide backbone chemistry, as well as patent rights covering the synthesis of monomers, the building blocks of oligonucleotides. This license was terminated effective April 2021. In connection with these agreements, we were eligible to receive license fees, option fees, milestone payments and royalties on future sales of products, or any combination thereof. Also, in connection with the divestiture of Geron&#x2019;s human embryonic stem cell assets, including intellectual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on sales from certain research or commercial products utilizing Geron&#x2019;s divested intellectual property.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We did not recognize any license fee revenues during the year ended December 31, 2022 and recognized license fee revenues of $28,000 and $55,000 in for the years ended December 31, 2021 and 2020, respectively, related to our various agreements. The decrease in license fee revenues in 2022 and 2021 primarily reflects a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">reduction in the number of active license agreements in 2020 for research licenses related to our hTERT technology, due to the patent expirations on such technology.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognized royalty revenues of $596,000, $1.4 million and $198,000 during the years ended December 31, 2022, 2021 and 2020, respectively. Royalty revenues in 2022, 2021 and 2020 primarily reflect estimated royalties from sales of cell-based research products from our divested stem cell assets. The decrease in royalty revenues in 2022 and the increase in royalty revenues in 2021 primarily reflects retroactive royalties of approximately $911,000 on product sales of cell-based research products received in 2021.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future license fee and royalty revenues are dependent on additional agreements being signed, if any, our current license agreement being maintained and the underlying patent rights for the license remaining active. Historical revenues may not be predictive of future revenues. We expect revenues in 2023 to be lower than 2022 as a result of reduced royalties from sales of cell-based research products from our divested stem cell assets.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the years ended December 31, 2022 and 2021, we supported the imetelstat development programs and a research discovery program related to potential next generation telomerase inhibitors. For the year ended December 31, 2020, imetelstat was the sole development program we supported. For the imetelstat program, we incur direct external, personnel related and other research and development costs. For the years ended December 31, 2022, 2021 and 2020, direct external expenses included costs for our CROs, consultants and other clinical-related vendors, as well as expenses for contract manufacturing and quality activities. Personnel-related expenses primarily consist of salaries and wages, stock-based compensation, payroll taxes and benefits for our employees involved with ongoing research and development efforts. Other research and development expenses primarily consist of research-related overhead associated with allocated expenses for rent and maintenance of facilities and other supplies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses for the years ended December 31, 2022, 2021 and 2020 were as follows:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:46.78%;"></td>
    <td style="width:1.735%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.903%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.735%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.903%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.735%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:14.212%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Direct external research and development expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical program: Imetelstat</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65,699</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61,516</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,838</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Personnel related expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,042</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,716</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,566</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All other research and development expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,777</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,495</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,084</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95,518</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85,727</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51,488</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The increase in research and development expenses in 2022 primarily reflects the net result of increased personnel-related expenses for additional headcount and higher consulting costs related to compilation and analysis of data for top-line results and preparations for regulatory submissions in lower risk MDS, partially offset by decreased manufacturing costs due to the timing of imetelstat manufacturing batches and reduced clinical trial expenses due to declining number of patients in IMerge Phase 3. The increase in research and development expenses in 2021 primarily reflects higher direct external costs to support the conduct of the ongoing Phase 3 clinical trials, IMerge and IMpactMF, as well as increased costs for producing validation batches at contract manufacturers to enable future production of imetelstat for clinical and potential commercial purposes. In addition, personnel-related expenses have increased in 2021 as a result of additional development and manufacturing hires.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect research and development expenses to remain consistent in the future as we support IMpactMF, IMproveMF and IMpress, as well as the long-term treatment and follow-up of remaining patients in IMerge Phase 3. At this time, we cannot provide reliable estimates of how much time or investment will be necessary to advance imetelstat toward commercialization. For a more complete discussion of the risks and uncertainties associated with the development of imetelstat, see the sub-sections entitled &#x201c;Risks Related to the Development of Imetelstat&#x201d; and &#x201c;Risks Related to Regulatory Compliance Matters and Commercialization of Imetelstat&#x201d; under &#x201c;Risk Factors&#x201d; in Part I, Item 1A and elsewhere in this annual report on Form 10&#x2011;K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and Administrative Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative expenses were $43.6 million, $29.7 million and $25.7 million for the years ended December 31, 2022, 2021 and 2020, respectively. The increase in general and administrative expenses in 2022 primarily reflects the net result of increased costs for commercial preparatory activities of approximately $3.1 million; higher personnel-related expenses of approximately $5.4 million for additional headcount; and approximately $6.2 million related to our portion of settlement costs related to the class action and derivative</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">lawsuits, net of lower legal fees in 2022 compared to 2021; partially offset by lower consulting expenses of $1.6 million. The increase in general and administrative expenses in 2021 primarily reflects new costs in connection with pre-commercial activities, including costs of $2.8 million for modernizing our internal infrastructure to support a potential commercial launch, and higher legal costs of $1.3 million. We expect general and administrative expenses to increase in the future as the imetelstat program matures and potential commercial launch execution activities begin.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income was $2.5 million, $527,000 and $1.8 million for the years ended December 31, 2022, 2021 and 2020, respectively. The increase in interest income in 2022 compared to 2021 primarily reflects a larger marketable securities portfolio with the receipt of net cash proceeds from the underwritten public offering completed in April 2022 and higher yields due to increasing interest rates. The decrease in interest income in 2021 compared to 2020 primarily reflects lower yields on our marketable securities portfolio due to lower interest rates. Interest earned in future periods will depend on the size of our marketable securities portfolio and prevailing interest rates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Expense</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense was $6.9 million, $3.7 million and $760,000 for the years ended December 31, 2022, 2021 and 2020, respectively. The increase in interest expense primarily reflects rising interest rates and an increased principal debt balance under the Loan Agreement. Currently, we have $50.0 million in principal debt outstanding. Interest expense reflects interest owed under the Loan Agreement, as well as amortization of associated debt issuance costs and debt discounts using the effective interest method and accrual for an end of term charge.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Change in Fair Value of Equity Investment</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We remeasured the fair value of our equity investment at each reporting date and any resulting change in fair value based on observable price changes was included on our consolidated statements of operations. In the first quarter of 2021, we sold our entire equity investment, resulting in a net realized gain which has been recognized in other income and expense (see below). For the year ended December 31, 2020, there was an increase in the fair value of our equity investment of $60,000, resulting from observable price changes in the equity investment. As a result of the sale of our equity investment in the first quarter of 2021, no comparable change in fair value was included on our consolidated statements of operations for the years ended December 31, 2022 or 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Income, Net</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net other income was $1.0 million, $1.1 million and $168,000 for the years ended December 31, 2022, 2021 and 2020, respectively. In the second quarter of 2022, we recognized other income of approximately $1.3 million related to the reimbursement of certain legal expenses under our insurance policies. During the first quarter of 2021, we sold our entire equity investment resulting in a net realized gain of $1.2 million, including foreign currency translation adjustments. During the third quarter of 2020, we recognized other income of $182,000 for the share exchange of our equity investment upon its acquisition. Also included in other income were realized losses of $34,000 for the sales of our equity investment during the third quarter of 2020. See Note 2 on Fair Value Measurements &#x2013; Equity Investment in Notes to Consolidated Financial Statements of this annual report on Form 10&#x2011;K for additional information about the sales of our equity investment. Net other income also includes bank charges related to our cash operating accounts and marketable securities portfolio.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liquidity and Capital Resources</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had cash, restricted cash, cash equivalents and marketable securities of $173.1 million, compared to $212.7 million at December 31, 2021. The decrease in cash, restricted cash, cash equivalents, and current and noncurrent marketable securities from December 31, 2021 was the net result of cash being used for operations, partially offset by the receipt of net cash proceeds of $69.9 million from our underwritten public offering completed in April 2022 and $15.2 million of cash proceeds received from the exercise of outstanding warrants in 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In 2022, warrants to purchase 11,663,387 shares of our common stock were exercised for net cash proceeds of approximately $15.2 million. The warrants were issued in connection with an underwritten public offering of common stock and a pre-funded warrant, together with accompanying stock purchase warrants in May 2020.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had a long-term principal debt balance of $50.0 million under the Loan Agreement with Hercules and SVB. In June 2022, we entered into a second amendment to the Loan Agreement with</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hercules and SVB (or its successor, if any). Under the second amendment, the aggregate principal amount available to us increased from $75.0 million to $125.0 million. See Note 8 on Debt in Notes to Consolidated Financial Statements of this annual report on Form 10-K for additional information on the second amendment.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, a total of $75.0 million was available to be drawn in a series of tranches under the Loan Agreement, subject to certain terms and conditions. Of this amount, $50.0 million was available subject to our achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, and the remaining $25.0 million is available subject to approval by an investment committee comprised of Hercules and SVB. In January 2023, upon reporting of positive top-line results from IMerge Phase 3, a tranche of $20.0 million became available to be drawn for 30 days after our reporting of these clinical results. We declined to draw down this tranche due to the completion of the underwritten public offering in January 2023 noted below. As of March 9, 2023, $55.0 million remains available to be drawn under the Loan Agreement, subject to our achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements to our existing capital resources, as well as approval by an investment committee comprised of Hercules and SVB (or its successor, if any) for the final $25.0 million tranche. However, on March 10, 2023, the FDIC issued a press release stating that SVB was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. Of the remaining term commitments under the Loan Agreement, Hercules and its affiliates hold 65% and 35% were held by SVB. As a result of the closure of SVB, we do not know whether and to what extent we would be able to draw down the remaining $55.0 million under the Loan Agreement, even if we meet the conditions set forth in the Loan Agreement necessary for additional draw downs, and it is possible that we will not be able to access any additional funding under the Loan Agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On January 10, 2023, we completed an underwritten public offering of 68,007,741 shares of our common stock and a pre-funded warrant to purchase 25,000,000 shares of our common stock, or the 2023 pre-funded warrant. The net cash proceeds from this offering are approximately $213.3 million, after deducting the underwriting discount and other offering expenses paid by us, and excludes any future proceeds from the exercise of the 2023 pre-funded warrant. In addition, from January 1, 2023 through March 9, 2023, we have received $59.8 million in cash proceeds from the exercise of outstanding warrants.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have an investment policy to invest our cash in liquid, investment grade securities, such as interest-bearing money market funds, certificates of deposit, U.S. Treasury securities, municipal securities, government and agency securities, corporate notes and commercial paper. Our investment portfolio does not contain securities with exposure to sub-prime mortgages, collateralized debt obligations, asset-backed securities or auction rate securities and, to date, we have not recognized any other-than-temporary impairment charges on our marketable securities or any significant changes in aggregate fair value that would impact our cash resources or liquidity. To date, we have not experienced lack of access to our invested cash and cash equivalents; however, access to our invested cash and cash equivalents may be impacted by adverse conditions in the financial and credit markets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On September 4, 2020, we entered into the 2020 Sales Agreement pursuant to which we may elect to issue and sell shares of our common stock having an aggregate offering price of up to $100 million in such quantities and on such minimum price terms as we set from time to time through B. Riley as our sales agent. We pay B. Riley an aggregate commission rate equal to up to 3.0% of the gross proceeds of the sales price per share for common stock sold through B. Riley under the 2020 Sales Agreement. For the year ended December 31, 2021, we sold an aggregate of 10,571,556 shares of our common stock pursuant to the 2020 Sales Agreement, resulting in net cash proceeds to us of approximately $20.4 million, after deducting sales commissions and other offering expenses payable by us. No shares of common stock were sold under the 2020 Sales Agreement for the year ended December 31, 2022. Approximately $79.1 million of our common stock remained available for issuance under the 2020 Sales Agreement as of December 31, 2022. The 2020 Sales Agreement will expire upon the earlier of: (a) the sale of all common stock subject to the 2020 Sales Agreement, or (b) September 4, 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Strategy</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may, from time to time, consider additional funding through a combination of new collaborative arrangements, strategic alliances, and additional equity and debt financings or from other sources. We will continue to manage our capital structure and consider all financing opportunities, whenever they may occur, that could strengthen our long-term liquidity profile. Any such capital transactions may or may not be similar to transactions in which we have engaged in the past. There can be no assurance that any such financing opportunities will be available on acceptable terms, if at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Future Funding Requirements</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our current operating plan and our expectations regarding the timing of the submission and potential acceptance and approval of our planned NDA by the FDA for imetelstat in lower risk MDS and the potential commercialization in the U.S. for the use of imetelstat in adult patients with lower risk MDS, we believe that our existing cash, cash equivalents, restricted cash and current and noncurrent marketable securities, including the net cash proceeds from our recently closed underwritten public offering in January 2023 and the cash proceeds from the exercise of warrants that we received in the January and February 2023, will be sufficient to fund our projected operating requirements through the end of the third quarter of 2025, which includes the potential U.S. commercial launch of imetelstat in lower risk MDS in the first half of 2024. In the absence of potential proceeds from exercises of currently outstanding warrants and potential drawdowns under the Loan Agreement, we will require substantial additional funding to further advance the imetelstat program, including through the completion of IMpactMF, IMproveMF and the investigator-led trial IMpress, as well as conducting the clinical, regulatory and potential commercialization activities necessary to potentially bring imetelstat to market in relapsed/refractory MF and any other future indications, and our need for additional funds may arise sooner than planned. We cannot predict with any certainty whether and to what extent the outstanding warrants will be exercised for cash, or the timing or availability of additional funds under the Loan Agreement, if at all, particularly given the recent closure of SVB by banking regulators.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our ability to commercialize imetelstat in the U.S., if regulatory approval is granted, depends on us being able to establish sales and marketing capabilities which we may be unable to do in a timely manner or at all.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because the outcome of any clinical activities and/or regulatory approval process is highly uncertain, we cannot reasonably estimate whether any development activities we may undertake will succeed, whether we will be able to commercialize imetelstat, and we may never recoup our investment in any imetelstat development, which would adversely affect our financial condition and our business and business prospects, and might cause us to cease operations. In addition, our plans and timing expectations could be further delayed or interrupted by macroeconomic conditions, such as if COVID-19 or pandemic conditions worsen, creating further limitations on our clinical trial or commercial preparatory activities, or if U.S. and/or international banking system fails to stabilize in light of recent and potential future bank failures, or could be disrupted by civil or political unrest or military conflicts around the world, such as the current military conflict between Ukraine and Russia. Further, our future capital requirements are difficult to forecast and will depend on many factors, including:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accuracy of the assumptions underlying our estimates for our capital needs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, timing, magnitude and costs of clinical development, manufacturing and potential commercialization of imetelstat, including the number of indications being pursued, subject to clearances and approvals by the FDA and similar international regulatory authorities;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the scope, progress, duration, results and costs of current clinical trials, including IMerge Phase 3, IMpactMF, IMproveMF and IMpress, and any potential future clinical trials of imetelstat, as well as non-clinical studies and assessments of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">delays or disruptions in opening sites, screening and enrolling patients or treating and following patients,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in IMpactMF, IMproveMF, IMpress, or any potential future clinical trials of imetelstat, whether as a result of the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs, timing and outcomes of regulatory reviews or other regulatory actions related to imetelstat, such as obtaining and maintaining regulatory clearances and approvals to continue clinical development of imetelstat in current and potential future clinical trials, as well as to commence potential commercialization of imetelstat in the U.S. and in other countries;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of preparing, filing and prosecuting patent applications and maintaining, enforcing and defending intellectual property-related claims;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of manufacturing imetelstat, including our ability to achieve any meaningful reduction in manufacturing costs; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of multiple third-party vendors and service providers, including our CROs and third-party manufacturers, to pursue the development, manufacturing and potential commercialization of imetelstat;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish, enforce and maintain collaborative or other strategic arrangements for research, development, clinical testing and manufacturing of imetelstat and potential future commercialization and marketing;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our efforts to enhance operational, financial and management processes and systems that will be required for future development and commercialization of imetelstat, and our ability to successfully recruit and retain additional key personnel to support the development and potential future commercialization of imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to successfully market and sell imetelstat, if imetelstat receives future regulatory approval or clearance, in the U.S. and other countries, and the associated costs;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs and timing necessary to build a sales force in the U.S. and potentially other countries to market and sell imetelstat, should it receive regulatory approval, to the extent that such sales, marketing, manufacturing and distribution are not the responsibility of any collaborator; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the sales price for imetelstat, if any;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the availability of coverage and adequate third-party reimbursement for imetelstat, if any;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire or in-license other drugs and technologies, or to which we out-license imetelstat;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we acquire or invest in businesses, products or technologies, although we currently have no commitments or agreements relating to any of these types of transactions;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent to which we are able to enter into strategic partnerships, collaborations and alliances or licensing arrangements with third parties including for the commercialization of imetelstat in certain global regions; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to establish and maintain collaborations on favorable terms, if at all;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the success of any collaborations that we may enter into with third parties;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">expenses associated with settlement of the pending securities class action lawsuits, and the ongoing derivative lawsuits, as well as any other potential litigation;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the extent and scope of our general and administrative expenses, including expenses associated with potential future litigation; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our level of indebtedness and associated debt service obligations;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of maintaining and operating facilities in California and New Jersey, telecommunications and administrative oversight, as well as higher expenses for travel; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">broader economic conditions, including inflation, rising interest rates, the prospects for recession, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure, that may reduce our ability to access debt capital or financing on preferable terms, which may adversely affect future capital requirements and forecasts; </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs of enabling our personnel to work remotely, including providing supplies, equipment and technology necessary for them to perform their responsibilities; and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the amount of proceeds, if any, of cash exercises of our currently outstanding warrants.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Until we can generate a sufficient amount of revenue from imetelstat to finance our cash requirements, which we may never achieve, we expect to finance future cash needs through a combination of public or private equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements, which may not be possible. Availability of such financing sources may be negatively impacted by any further delays in reporting results from IMpactMF or investors&#x2019; perception of top-line results from IMerge Phase 3, despite our interpretation of such data being positive, as well as factors such as the global economic slowdown, inflation, rising interest rates and the prospects for recession, as well as recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional financing through public or private debt or equity financings, including pursuant to the 2020 Sales Agreement with B. Riley; the remaining tranches of up to $55.0 million available under the Loan Agreement, which are subject to the achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, as well as approval by an investment committee comprised of Hercules and SVB (or its successor, if any) for the final $25.0 million tranche; capital lease transactions or other financing sources, may not</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">be available on acceptable terms, or at all. We may be unable to raise equity capital, or may be forced to do so at a stock price or on other terms that could result in substantial dilution of ownership for our stockholders. The receptivity of the public and private debt and equity markets to proposed financings has been substantially affected by uncertainty in the general economic, market and political climate due to the effects of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates, prospects of a recession or recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure, and may in the future be affected by other factors which are unpredictable and over which we have no control. In this regard, the effects of the COVID-19 pandemic have increased market volatility and could result in a significant long-term disruption of global financial markets, which could reduce or eliminate our ability to raise additional funds through financings, and could negatively impact the terms upon which we may raise those funds. Similarly, these macroeconomic conditions have created extreme volatility and disruption in the capital markets and is expected to have further global economic consequences. If the equity and credit markets deteriorate, including as a result of macroeconomic conditions like the COVID-19 pandemic, civil or political unrest or military conflicts around the world, such as the military conflict between Ukraine and Russia, inflation, rising interest rates, prospects of a recession or recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure, it may make any necessary debt or equity financing more difficult to obtain in a timely manner or on favorable terms, more costly or more dilutive. If we are unable to raise additional capital or establish alternative collaborative arrangements with third-party collaborative partners for imetelstat, the development and potential commercialization of imetelstat may be further delayed, altered or abandoned, which might cause us to cease operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we may seek additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. Due to uncertainty in the general economic, market and political climate, we may determine that it is necessary or appropriate to raise additional funds proactively to meet longer-term anticipated operating plans. To the extent that we raise additional capital through the sale of equity or convertible debt securities, including pursuant to the 2020 Sales Agreement, your ownership interest as a stockholder may be diluted, and the terms may include liquidation or other preferences that materially and adversely affect your rights as a stockholder. In addition, we have borrowed, and in the future may borrow, additional capital from institutional and commercial banking sources to fund imetelstat development and our future growth, including pursuant to our Loan Agreement or potentially pursuant to new arrangements with different lenders. We may borrow funds on terms under agreements, such as the Loan Agreement, that include restrictive covenants, including covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. Moreover, if we raise additional funds through alliance, collaborative or licensing arrangements with third parties, we may have to relinquish valuable rights to imetelstat or our technologies or grant licenses on terms that are not favorable to us.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot assure you that our existing capital resources, including net cash proceeds from our recent underwritten public offering in January 2023, future interest income, future proceeds from potential cash exercises of currently outstanding warrants and potential future sales of our common stock, including under the 2020 Sales Agreement with B. Riley or potential future drawdowns, if available, of the remaining up to $55.0 million under the Loan Agreement (which are subject to the achievement of certain clinical and regulatory milestones and satisfaction of certain capitalization and other requirements, as well as approval by an investment committee comprised of Hercules and SVB (or its successor, if any) for the final $25.0 million tranche), will be sufficient to fund our operating plans. In this regard, on March 10, 2023, the FDIC issued a press release stating that SVB was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. Of the remaining term commitments under the Loan Agreement, Hercules and its affiliates hold 65% and 35% were held by SVB. As a result of the closure of SVB, we do not know whether Hercules and SVB&#x2019;s successor, if any, will fund their respective portions of the remaining term commitments or whether and to what extent we will otherwise be able to draw down the remaining $55.0 million under the Loan Agreement, even if we meet the conditions set forth in the Loan Agreement necessary for additional draw downs, and it is possible that we will not be able to access any additional funding under the Loan Agreement, which would require us obtain additional or alternative financing to advance our development of imetelstat. Moreover, while we did not hold cash deposits or securities at SVB, if other banks and financial institutions enter receivership, become insolvent or otherwise fail in the future in response to financial conditions affecting the banking system and financial markets or otherwise, our ability to access our existing cash, cash equivalents and marketable securities may be delayed or precluded, which could have a material adverse effect on our business, business prospects and financial position.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows from Operating Activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in operating activities was $127.4 million, $95.6 million and $66.7 million in 2022, 2021 and 2020, respectively. The increase in net cash used in operating activities in 2022 and 2021 primarily reflects higher</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">payments for research and development expenses in connection with supporting the clinical trials, IMerge Phase 3, IMpactMF, IMproveMF and IMpress, and increases in headcount.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows from Investing Activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by investing activities in 2022 and 2021 was $62.1 million and $71.9 million, respectively. Net cash used in investing activities in 2020 was $105.3 million. Net cash provided by investing activities in 2022 and 2021 primarily reflects a higher rate of maturities than purchases of marketable securities. Net cash used in investing activities in 2020 primarily reflects a higher rate of purchases than maturities of marketable securities resulting from the investment of net cash proceeds from the underwritten public offering completed in 2020.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three years ended December 31, 2022, we purchased approximately $1.0 million in property and equipment, none of which was financed through equipment financing arrangements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows from Financing Activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by financing activities in 2022, 2021 and 2020 was $87.3 million, $48.6 million and $168.3 million, respectively. Financing activities in 2022, 2021 and 2020 primarily reflect the receipt of net cash proceeds of $69.9 million from the underwritten public offering of common stock, pre-funded warrant and stock purchase warrants completed in April 2022, cash proceeds from the exercise of warrants, receipt of net cash proceeds from the sales of our common stock under the 2020 Sales Agreement in 2021, the receipt of $140.2 million in net cash proceeds from the underwritten public offering of common stock, pre-funded warrant and stock purchase warrants in May 2020, receipt of net cash proceeds from the sales of our common stock under the 2018 Sales Agreement with B. Riley in 2020 and aggregate drawdowns of $25.0 million in each of 2021 and 2020 under the Loan Agreement with Hercules and SVB.</span></p>
  <p style="text-indent:-9.17%;padding-left:8.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:-9.17%;padding-left:8.4%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contractual Obligations</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have entered into arrangements that contractually obligate us to make payments that will affect our liquidity and cash flows in future periods. Our contractual obligations primarily consist of our obligations under non-cancellable operating leases. The aggregate amount of future operating lease payments over the term of our leases is $4.6 million as of December 31, 2022. For additional information on our leases and timing of future payments, see Note 7 on Operating Leases in Notes to Consolidated Financial Statements of this annual report on Form 10&#x2011;K.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the normal course of business, we enter into agreements with CROs for clinical trials and CMOs for clinical supply manufacturing and with other vendors for preclinical research studies, investigator-led trials and other services and products for operating purposes. We have not considered these payments to be contractual obligations since the contracts are generally cancelable at any time by us upon less than 180 days&#x2019; prior written notice. We also have certain in-license agreements that require us to pay milestones to such third parties upon achievement of certain development, regulatory or commercial milestones. Amounts related to contingent milestone payments are not considered contractual obligations as they are contingent on the successful achievement of certain development, regulatory approval and commercial milestones, which may not be achieved.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:-9.17%;padding-left:8.4%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 7A. Q</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and are not required to provide the information specified under this item.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 8. FINANCIAL STATEME</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NTS AND SUPPLEMENTARY DATA</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following financial statements and the related notes thereto, of Geron Corporation and the Report of Independent Registered Public Accounting Firm, Ernst &amp; Young LLP, are filed as a part of this annual report on Form 10&#x2011;K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:93.259%;"></td>
    <td style="width:6.741%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#report_independent_registered_public_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Report of Independent Registered Public Accounting Firm</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;(PCAOB ID: </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_73160013-6f74-4557-ba53-d4f4cdacb8a5" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:AuditorFirmId"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Balance Sheets</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Operations</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_comprehensive_loss"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Comprehensive Loss</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_stockholders_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Stockholders&#x2019; Equity</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Cash Flows</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#note_1_"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="report_independent_registered_public_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Report of Independent Registered Public Accounting Firm</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the Stockholders and the Board of Directors of Geron Corporation</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Opinion on the Financial Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of Geron Corporation (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive loss, stockholders' equity and cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively referred to as the &#x201c;consolidated financial statements&#x201d;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#x2019;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. <br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. <br /><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Critical Audit Matter</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:16.282%;"></td>
    <td style="width:83.718%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:80.5pt;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="margin-left:80.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for accrued clinical trial expenses</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Description of the Matter</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded research and development expenses of $95.5 million for the year ended December 31, 2022. As described in Note 1, research and development expenses are expensed as incurred. Research and development expenses include fees paid to contract research organizations (&#x201c;CROs&#x201d;), and other vendors, that conduct certain research and development activities on behalf of the Company. Accrued expenses for clinical trial activities performed by CROs are based upon the estimated amount of work completed on each trial. For clinical trial expenses and related expenses associated with the conduct of clinical trials, the significant factors used in estimating accruals include the number of patients enrolled, the number of active clinical sites, the activities conducted by each clinical site, and the duration and level of activities for each patient in the trial. The Company monitors patient enrollment levels and related activities to the extent possible through internal reviews, review of contractual terms and correspondence with CROs. The accrued expense estimates are based on the best information available.<br /><br /><br /><br />Auditing the accounting for accrued clinical trial expenses is complex because of the high volume of data used in management&#x2019;s estimates, the assumptions used by management to develop their estimates and the extensive verification to determine the costs incurred and extent of the services performed by CROs and other vendors during the reporting period and as of the balance sheet date.<br /><br /><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">How We Addressed the Matter in Our Audit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To test the Company&#x2019;s accounting for accrued clinical trial expenses, our audit procedures included, among others, obtaining supporting evidence from third parties of the research and development activities performed for significant clinical trials and testing the accuracy and completeness of the inputs used in management&#x2019;s analyses to determine the costs incurred. We inspected key terms, timelines of completion, activities and costs for a sample of vendor contracts, including amendments, and compared these to management&#x2019;s analyses used in tracking the progress of service agreements. We met with internal clinical personnel to understand the status of significant clinical trial activities. We also tested a sample of subsequent payments by agreeing the invoice to the original accrual and the invoice payments to bank statements.</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0f45602c-287f-4002-99f4-42a3218cddd7" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:AuditorName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ernst &amp; Young LLP</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have served as the Company&#x2019;s auditor since 1992.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1c746ef1-da76-4f9e-b585-37771e94678c" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="dei:AuditorLocation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Jose, California</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSOLIDATED BALANCE </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SHEETS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:64.862%;"></td>
    <td style="width:1.023%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:14.347%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.419%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:14.347%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASSETS</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current assets:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a4e7752-58f9-4213-81a4-1fcd1cb3d748" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">56,845</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3089e38-cd3d-479f-996e-d4c6ab468b43" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,871</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_672f70c7-7ed6-4ab0-958f-a6eb016efd81" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3">364</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0bf7f884-3690-4052-bd35-a686e51670a1" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3">364</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_43be23eb-ae0d-4971-8d7c-f8b8b7139a41" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">115,901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ce4fa24e-fabf-4224-b18b-a2db3346a7f3" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">148,851</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest and other receivables</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ec8210f-ac0b-4a89-804a-bada57f9e6c6" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:NontradeReceivablesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,144</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c22585f1-327c-4c12-ba41-4b13157a7039" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:NontradeReceivablesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,763</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid and other current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_81f301c3-c402-45da-ab3a-e8e909aed91b" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,992</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bc69a405-c759-4f80-9123-8279bb6399e3" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,357</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb7dd2e4-e243-4c31-871c-f1278fa06322" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">180,246</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c78b130e-2633-426d-95ca-0631dc3fce17" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">187,206</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noncurrent marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7d244d34-ef87-499a-a51e-9ccda04876a0" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,651</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_69d161ec-39de-48c5-a883-0ce837b5c8b5" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3">793</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9384700-f7bd-4aba-a76b-b4b4da3f2a1f" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3">650</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating leases, right-of-use assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b2ded67e-0435-42ba-8faa-c811ca2581b0" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,147</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_97b09004-4302-450b-9545-1a7f8b25478f" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,727</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deposits and other assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3f89c538-8934-4caf-8fb7-f43d2ad15925" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:DepositsAndOtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,389</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_66bc76bb-f5a2-4d39-bbf2-f08e2685fd85" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="gern:DepositsAndOtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,800</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77151c3b-4c66-41bd-a867-3a5b436041fa" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">190,575</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6cb685b4-89c5-43ec-986c-0916e51ff3bf" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">226,034</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LIABILITIES AND STOCKHOLDERS' EQUITY</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8cc71ad3-a398-422b-bde3-3cb6ac70ac7c" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,190</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0e7c9bdd-1119-4e65-859b-885fe28cbeab" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,687</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued compensation and benefits</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5dca84e-3e36-4a95-b266-6c9ca97a0aeb" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,534</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_437efe52-1ce9-4872-98ab-67c4ac0c2e3c" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,099</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_afe7cf7b-62a8-4a73-9a68-97896ee4beaf" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3">925</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2f4be026-89c6-4e7e-8e4c-cb8d8d3e5200" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3">901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Debt</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0e4035de-7bb5-479f-b341-dbb2f2849c54" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,945</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_bfd71529-05f4-48f8-877b-c43d276239bd;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3232b013-5673-4fbd-99ed-2b53641fc358" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,100</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_74e5c0ed-edb9-4705-a1ae-c4941865f587" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,834</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d0c08085-3cf6-4473-9f02-f47c4fdb6f1f" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">76,694</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19aa9f41-2e2e-4e4f-a1c4-af652a678f8f" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,521</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noncurrent operating lease liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5eee7547-9d39-4393-8e59-468a71ae06ab" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,671</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0ef17723-c369-43a4-a1df-0224ad45c257" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,267</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noncurrent debt</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94148843-3bd4-45b3-8166-320885b5149e" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,212</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7e370b91-f490-4701-9b05-f0ca699b355e" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49,830</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a46a1d75-a9fa-47ac-9a20-22b2912f2c5b" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">110,577</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d0943329-6c1e-4d51-ac4b-b02eb6f6bc18" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">99,618</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_6f65910a-85b0-43bb-9607-4708c982ad15;"><span style="-sec-ix-hidden:F_3aabcce5-1c7c-451e-b4c2-7b744fe20a51;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commitments and contingencies</span></span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stockholders' equity:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred stock, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9900e465-02ed-4ff1-81f8-7f0549b9e145" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_b7e9b7b5-670d-4c66-9ba4-531e9f8e3de6" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f730a31e-f976-4181-9534-7c0627c79fce" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_86e428b3-872c-4d4c-beb3-39830969033b" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares authorized; </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_869426ba-6dcd-4c9a-8134-2dcce4aff2c1" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_a91e2273-52c2-4795-8c99-17440e52a01e" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_c25f62ad-4d28-4ed3-91db-3a6ae7ff1029" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f4f8cce6-490f-40ac-bd5b-9c69457ddde7" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />&#160;&#160;&#160;shares issued and outstanding at December 31, 2022 and 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_fac1e377-c483-4a1a-9d83-c9d6e9abca35;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_92ef33b6-8618-4974-b348-ee7b47f16ded;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b59fe16d-6ca2-4407-be81-9fd475269724" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_d7bb2b29-4be6-405b-a379-2ce41f92f5c5" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value; </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7d8cfa84-5935-4fac-8cf7-c26d1356a5e4" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_5875c55e-37c2-4d9e-9f45-49a40167e046" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">675,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares authorized; <br />&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a907270a-3c79-4750-ba69-ba287ca923ba" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_844715c6-c644-477b-af5d-45080b6cbab1" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">390,262,524</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ed973b4-ac0d-40d1-bdb5-54203baaf0a3" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_01d09bd7-a91e-40e2-b7e6-437accd81e96" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">323,731,591</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares issued and outstanding<br />&#160;&#160;&#160;at December 31, 2022 and 2021, respectively</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be6f50b7-32d7-438e-96d0-ae25292a9e94" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3">390</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0fd7ed36-4c0a-4a31-8589-e80e6f8d1ccb" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3">324</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c32b25fe-388d-40c1-ad66-efd49182869f" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,493,469</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1942698-5fd3-48b1-a65e-d5ab68085e6c" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,398,006</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6405a894-1434-4473-bdac-3bf40420bd2a" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,413,642</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c773b24a-cb70-439f-a851-0cfdf9166bf9" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,271,741</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f3f8fd81-f81e-42de-9a64-897ecd8fd8ba" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">219</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad839b1c-506f-4cf9-930c-c46a80c8f58d" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">173</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stockholders' equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_315a8036-6d2b-47ee-a969-955ba735d782" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">79,998</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a62186c3-ecd9-48ba-9822-43ca12e7b41d" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">126,416</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f0366b66-aae4-4a30-92a1-26d645a85e44" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">190,575</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2fc2d719-e5c3-4137-937c-3100411b195b" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">226,034</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSOLIDATED STATEMENTS O</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F OPERATIONS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.319%;"></td>
    <td style="width:1.632%;"></td>
    <td style="width:1.632%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.353%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.642%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.353%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.642%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.427%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenues:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">License fees and royalties</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af030d1f-fcee-4113-b041-d252a3081e26" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3">596</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ae7db40-db22-491d-a6f3-cb0a6912e781" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,393</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_35676ee6-9f06-4d92-adf7-62909acc23ef" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3">253</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_554ab0e2-c028-4e40-803b-c7f091428859" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">95,518</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_26cb0ea0-13e5-40cf-96f4-5672fcd09c92" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">85,727</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c57dc5c3-6cef-4416-91ed-24d863c7a30f" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">51,488</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6273a42d-bc2e-4595-b41a-cbdcc3c991db" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">43,628</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aeaae356-c4c4-4add-b018-e11ab23ccc75" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,665</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5a245dd-25ca-43ba-94de-15759605721b" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,678</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf34ca36-7dbc-4d14-b87a-cf8dbadfceaf" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">139,146</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc956681-347a-4f71-9d7d-548b0e18e8cf" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">115,392</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_777f1447-0a08-4b85-844e-8a83dd9c589d" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">77,166</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19c876f8-9af7-4d5c-b3ea-dd3d503caecc" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">138,550</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3ccf320-aeb5-4234-b7a9-49c3870d3ce8" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">113,999</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d28a6a4-e25b-4c48-8c2a-e4fcfa706e21" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">76,913</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a131b6b-fa8f-4fb6-b55a-6f7613a20632" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,529</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3c582a40-03c8-4406-9608-45b63333b0b4" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3">527</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fc2c065b-f484-486c-8a8b-27cfe39a38f1" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,828</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f99228b-d54d-4c11-9008-6fb6ffa0f49e" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,882</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_43bfccde-999f-496c-8391-216f57cd8f13" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,740</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ee990f6c-17f9-4145-b570-16cc4f0ee05f" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3">760</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value of equity investment</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bd69d3cc-36af-46bf-bdab-56155c7694c5" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" unitRef="U_USD" scale="3" decimals="-3">60</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other income, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8399c80b-8ff7-48e7-a130-802008327592" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,002</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48837b9c-0ebd-45f2-b94f-ad99ce7e5d1f" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,100</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a9e7a449-78fc-4a2e-bf88-32405d5cbd85" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">168</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9ab3479-b48c-4885-bc6c-281dde70ca03" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">141,901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d65d64f8-ce7e-416a-91aa-67e3d8610661" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">116,112</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d131cb29-9ded-4884-bc6b-30f5aaff57e0" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">75,617</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic and diluted net loss per share</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7cbea338-1d8c-4549-a5b7-40302163af60" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_b3ac7dc4-846a-4676-afce-908d81be232d" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">0.37</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7229ce44-c80d-46a7-a7b6-9a1d2cf4e249" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_90d641fc-bb1e-45a4-8971-8139f0c23d85" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">0.35</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f9574b19-3a8c-4850-9d7a-9500cbffdd5e" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_b69b658f-5620-4c79-9b61-4ee16e8323c6" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">0.28</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares used in computing basic and <br />&#160;&#160;&#160;diluted net loss per share</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de147963-b9a8-4186-b51c-15a8888da1c0" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_0c2cd245-eb3f-48d3-8822-ba8d1ba21e04" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">380,784,846</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_285c23d9-4c88-4316-8c9f-34c588ea23d7" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_e195a5c2-2973-48bc-8217-a4b68f71f735" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">327,631,814</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_76c220cd-0a6d-4a6e-be48-78ea39422e2d" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_dddce6d6-6ac8-4e2e-9e03-ab1acb7d7519" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">271,460,265</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_comprehensive_loss"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">STATEMENTS OF CO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MPREHENSIVE LOSS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:48.84%;"></td>
    <td style="width:1.621%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:14.029%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.632%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.086%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.632%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.16%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6056d41a-bded-42f2-83bb-9a814e8f5558" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">141,901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d48641ab-97d5-41bb-bd9b-813055ec5edd" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">116,112</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_02f05444-d7ba-422a-b309-5ba9ab53631d" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">75,617</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net unrealized loss on marketable securities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d3c5339-9a61-4afa-9b3e-c024d2f40325" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">68</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d348fff8-0da2-4b69-b9cc-f7a8e392c76c" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">251</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d8b4e255-431b-408a-b33d-2a65bb490f2e" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">54</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign currency translation adjustments</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_35a08788-3273-4a30-9766-a1d18a1601b2" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a29be249-70ea-4a7a-a87d-4524f0e63d74" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">141,947</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfaa974c-fc9d-4ea5-8368-b22841cf6a1c" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">116,363</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_10f1a73e-f149-46da-9b86-76f3ba48f20c" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">75,671</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_stockholders_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSOLIDATED STATEMENTS OF STOC</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KHOLDERS&#x2019; EQUITY</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.428%;"></td>
    <td style="width:0.761%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:8.909%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.761%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.579%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.772%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.499%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.772%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.59%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.772%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.794%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.772%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.59%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Paid-In</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stockholders'</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain (Loss)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="22" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands, except share data)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances at December 31, 2019</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_05838b4b-3737-47bc-80d9-d7ded659261b" contextRef="C_193c3b80-125b-49fe-affd-e5219ad32f26" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">199,814,581</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06f436ad-4f0c-4b1d-9de3-4884a7204ad0" contextRef="C_193c3b80-125b-49fe-affd-e5219ad32f26" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">200</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_92231a29-dcfa-45d2-8fee-459c6c02ab34" contextRef="C_9bb1cd79-e4c2-4cca-9bd9-1694bdbca8bd" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,214,835</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aab6ef5c-30b1-45ad-84ce-5988e0035ef6" contextRef="C_4128807c-b8ab-4df3-874f-d7528b109faf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,080,012</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_830378ba-4958-44af-9680-af2db0a09862" contextRef="C_ae8e381a-0b3e-4435-957f-00dcf58c3b45" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">132</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7ebe6ce-04d2-4e16-ab28-ceac51285e63" contextRef="C_51546caa-efa4-41ff-89e0-38e80356cf4c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">135,155</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90cf9aa0-9732-4fea-b457-a5257df835a4" contextRef="C_763fcb27-2540-444d-aa95-1260c6a8a319" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">75,617</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d9b3ed2d-9499-4d3a-83b4-14f5f8b82c8d" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">75,617</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7aabbad5-65a5-41ca-8621-b1775d31e737" contextRef="C_df267c14-3ea1-4c00-bdd8-a254e98ace01" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">54</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_59c137da-304f-4728-a214-2aea92cc33aa" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">54</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock, pre-funded<br />&#160;&#160;&#160;warrant and warrants to purchase  <br />&#160;&#160;&#160;common stock in public offering, net<br />&#160;&#160;&#160;of issuance costs of $</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39994dd6-056c-4dcc-87c9-824a2568b3b0" contextRef="C_39a6cda9-f091-4e32-8ec9-20bf358a8724" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,808</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8811c34a-8110-48f0-9885-8b61fbff3c34" contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480" name="gern:PublicOfferingStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">107,049,375</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4111d7b-e0d7-4dcd-b224-a325976e8e72" contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480" name="gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3">107</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_66c93545-68f0-460b-979c-a84cac887b5a" contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b" name="gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">140,077</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57264c80-e940-4949-be71-98c29d3bbfcf" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">140,184</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock in<br />&#160;&#160;&#160;connection with at market offering,<br />&#160;&#160;&#160;net of issuance costs of $</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a974305a-7a4b-43b6-9069-a0f9137befb5" contextRef="C_e0cb6378-4392-4819-891f-21cef9a108eb" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">144</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be3b20d7-88aa-49f9-917e-ff2d410d4030" contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,496,616</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_02b40011-1708-48c7-968a-884db4656d03" contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3">3</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c10f8e56-e9cf-4ba7-916c-aac2649674dd" contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,072</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e3a0ad2-bd2f-453c-a8da-f0e5ad5b0bfe" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,075</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock in<br />&#160;&#160;&#160;connection with exercise of warrants</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_32aebbcf-32ae-495c-af41-ee47c7f45732" contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">12,500</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06001011-3eee-4a12-9799-95d97a8a277d" contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" unitRef="U_USD" scale="3" decimals="-3">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c2202dea-a193-43fb-942e-cbbfa6b6c652" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" unitRef="U_USD" scale="3" decimals="-3">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation related to<br />&#160;&#160;&#160;issuance of common stock and <br />&#160;&#160;&#160;options in exchange for services</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_978f4579-c376-494e-9200-3ff00fb58475" contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">17,986</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_722b9700-4a31-45de-8c21-a9a2172e6eba" contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="U_USD" scale="3" decimals="-3">85</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c54edd4a-e6fa-477b-a037-a6c79c827a9a" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="U_USD" scale="3" decimals="-3">85</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuances of common stock <br />&#160;&#160;&#160;under equity plans</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8a3030b8-a0c7-4fd8-bbd9-46fef82a65eb" contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">175,795</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_20eb2ed7-fdb3-4034-8aed-a1e3ddfe72fe" contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3">208</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_adf48940-9ad5-4ced-a42b-10c10e3a4a73" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3">208</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation for equity-<br />&#160;&#160;&#160;based awards to employees<br />&#160;&#160;&#160;and directors</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5a9c321c-ae10-4a7e-8a1a-20891f43dcb0" contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,895</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cd66b4b6-b3a4-4424-a444-f7eca2b3ada9" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,895</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances at December 31, 2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cdf2b3c6-bd79-471d-8265-47562b7d4f35" contextRef="C_c12dd335-911a-4fd2-9a2d-0514622f97e4" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">310,566,853</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e213e19c-a3da-418e-af2c-f3e0406d8066" contextRef="C_c12dd335-911a-4fd2-9a2d-0514622f97e4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">310</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4853d264-b478-4bdd-957e-3b14c8fadc3f" contextRef="C_40862263-7a78-4142-96a9-9c68851d893e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,366,188</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e59eda13-1588-42d0-b31e-c18adf387222" contextRef="C_a9d34b21-3b42-469c-8d2b-2b3121f04885" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,155,629</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d2c00759-b7b1-4283-a941-b8333db6e742" contextRef="C_8a321658-2588-4571-b73d-e0f5a7ae11d0" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">78</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae2fc0fb-464d-4239-a9d3-2da09c942430" contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">210,947</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_00c883f3-8988-48b4-9080-74b2a8be1f8b" contextRef="C_b3526ab0-c75e-405c-863a-c481f65b0e53" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">116,112</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_862ed909-0807-428c-a383-bcfc68f828bd" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">116,112</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eeb7f005-5b72-436d-962f-e0de82951d24" contextRef="C_4179612c-6be5-467d-9224-83de62d460cc" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">251</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d402b0a9-f5e7-430d-9e2b-57422a5748cf" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">251</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock in<br />&#160;&#160;&#160;connection with at market offering,<br />&#160;&#160;&#160;net of issuance costs of $</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ed617b0-f8bd-4893-8f04-123a93ff7e2f" contextRef="C_edb3e230-dfab-42f5-babc-05523982f83c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">470</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e8965c2-790f-4864-8348-d540154171c2" contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,571,556</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2205c81d-d5b1-4ba5-ad43-f8a696de7a4f" contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3">11</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_51d63600-b968-4798-b9e3-9dea06ef403a" contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,374</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f95e69c-3f83-4167-99ee-29dee3531077" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,385</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock in<br />&#160;&#160;&#160;connection with exercise of warrants</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7a3013c9-483b-44f8-bfec-413b86b44347" contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,906,341</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_87bfc9cb-20e9-4bf3-be5e-966ce043bc53" contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" unitRef="U_USD" scale="3" decimals="-3">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3921435b-629f-4cf3-b6ba-594c560d7269" contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,477</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9726fb4e-f586-4c3d-92c4-5214c2bb5229" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,479</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation related to<br />&#160;&#160;&#160;issuance of common stock and <br />&#160;&#160;&#160;options in exchange for services</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b6c68d1-d258-4940-9b8d-ca3c85a30d27" contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,783</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ad9a52c-0826-48b7-933e-c54eb811bc30" contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="U_USD" scale="3" decimals="-3">91</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8505175-3be4-46b5-a7cc-281fe169c063" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="U_USD" scale="3" decimals="-3">91</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuances of common stock <br />&#160;&#160;&#160;under equity plans</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_20c106e3-467a-4291-b0b1-119632a61797" contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">666,058</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_56f2dbd3-68b7-4c2a-a2af-8e70d16c0357" contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b1f0f895-ccfa-4720-b0c0-4afacbd28edf" contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3">796</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f22ebcd-718d-46e3-b2a2-f881bbf00171" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3">797</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation for equity-<br />&#160;&#160;&#160;based awards to employees<br />&#160;&#160;&#160;and directors</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_418c1558-5683-4d66-810d-5ca310a1ed45" contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,080</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e79027a6-30d9-484a-aaee-02f831965460" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,080</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances at December 31, 2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb88d58d-ef14-49f5-a284-31b25d65d28e" contextRef="C_904fa704-ef5e-41de-bcb5-2bf7706d0288" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">323,731,591</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d6d81bb2-baf6-4554-831d-a606ee1c3a89" contextRef="C_904fa704-ef5e-41de-bcb5-2bf7706d0288" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">324</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0de39e4d-8552-4551-abbc-8343443edad4" contextRef="C_50b6ef82-13c8-416b-8944-219722e7b07e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,398,006</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_671ebb1f-afa9-4e98-b9fd-4b25f672d05e" contextRef="C_626b835f-8e2e-4400-9c68-0c1fa598c173" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,271,741</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4d33ebc-616f-4fd5-9c00-4e62959f256e" contextRef="C_54a3bd1a-57e5-404b-8439-d921de6bd8fd" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-">173</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4e80fede-c30a-4a54-a42d-acb8af978484" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">126,416</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d44ef83c-b1f0-4160-957b-ad8cf05c3644" contextRef="C_77f8406a-f6d2-4060-81b8-e54a35afa90b" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">141,901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c14b2ae3-5c86-4c64-9919-e29f989ed3ba" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">141,901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b670c059-604c-43bc-9913-1e1d40bb021b" contextRef="C_5a8fb967-a98b-480a-b077-c269bd33b318" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_10d6e57a-1c30-4e05-a869-b9e90ac7a8df" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">68</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign currency translation adjustment</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d4db1b9a-d5cc-4f04-94c9-f55d2dddc3c4" contextRef="C_5a8fb967-a98b-480a-b077-c269bd33b318" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_54e17294-5a3c-4760-9af8-46e0ca3e604d" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock, pre-funded<br />&#160;&#160;&#160;warrant and warrants to purchase  <br />&#160;&#160;&#160;common stock in public offering,<br />&#160;&#160;&#160;net of issuance costs of $</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e5c0732-1a6b-40bc-a9df-e7d065560057" contextRef="C_e89875f1-6be5-42d0-a126-eaeafb581f48" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,066</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c3bac345-b690-4541-b43e-4bb10213bd1f" contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7" name="gern:PublicOfferingStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">53,333,334</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fc6d694e-780d-446c-b1e7-c33649cbdad2" contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7" name="gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3">53</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4f8a1d2a-a435-44c3-aa49-d661fab21677" contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27" name="gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">69,863</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ee4c047-4a64-49fa-9300-0f2187a9ebbd" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">69,916</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock in<br />&#160;&#160;&#160;connection with exercise of warrants</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_17c1860e-f82a-4a8b-ba94-b2168a80330b" contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">11,663,387</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b434e291-76e0-42b3-86ac-96b93bc0f382" contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d84c025-ae82-484a-a3d6-cab7aee8b94f" contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,151</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5bef8967-34c3-4e2f-90db-53623fd4980d" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,163</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation related to<br />&#160;&#160;&#160;issuance of common stock and <br />&#160;&#160;&#160;options in exchange for services</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0ecaeb0b-30bd-4db3-a460-a8c1ab1269f7" contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,962</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_479fc55c-b3c5-4fe3-915f-4bedb314d805" contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="U_USD" scale="3" decimals="-3">264</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f63de7dd-f5ab-4b3e-a866-dc430675a1e5" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="U_USD" scale="3" decimals="-3">264</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuances of common stock <br />&#160;&#160;&#160;under equity plans</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_02bf9773-1d1e-4c1c-a8d1-0d28c40a2886" contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,518,250</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ecc0b88-0b1c-48c1-bae7-622b2c91a22b" contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f34f365c-eedb-4d22-b1ed-20c4741f8aa8" contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,184</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_654d8820-41da-435b-8ab7-605d02dd6c35" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,185</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation for equity-<br />&#160;&#160;&#160;based awards to employees<br />&#160;&#160;&#160;and directors</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6021cc13-a069-447d-8b31-b9b8489b51d6" contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,001</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_099c797a-acc7-40db-8e6d-242140f2b9fb" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,001</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balances at December 31, 2022</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_92b76267-282d-45e7-aabe-505782f6fbdc" contextRef="C_8188c97d-d82a-44e3-b0a5-e6f672e559c8" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">390,262,524</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6c26d05-2076-47c2-8ed1-4cad6526869d" contextRef="C_8188c97d-d82a-44e3-b0a5-e6f672e559c8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">390</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9fc6e48b-e5dd-416d-b68e-e55a0aca4ab6" contextRef="C_bef8e8ac-62e3-46f1-91db-450c61420e02" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,493,469</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2fc1a4cd-9381-4bd4-9fa8-142d7e7d1c81" contextRef="C_119d0654-c503-470b-bd38-81fafe81f4a6" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,413,642</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e5e41a5-15f5-447b-bc07-e47c950625cf" contextRef="C_46064b1d-9be0-4b4a-b281-d673cc14f9ce" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-">219</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_395fbd7e-6540-44c8-be1a-0ae97905427b" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">79,998</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSOLIDATED STATEMENTS O</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">F CASH FLOWS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:47.866%;"></td>
    <td style="width:1.607%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:14.359%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.618%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.379999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.618%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.551%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows from operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f082eb0a-7b30-4ade-9d35-5755917a1d53" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">141,901</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e167e31d-b299-40ac-aaf3-351ac7ccca4a" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">116,112</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e6f3698-6d69-4d7e-b69d-a3d86fc4086d" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">75,617</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in<br />&#160;operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation and amortization</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f3dc8b8-6be4-4fbf-b12e-7c22ea27b45d" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">288</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d69c767-7d98-40e4-ad10-e6c6910d2b70" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">215</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_650f448f-4527-461b-b21d-2169af9cf99a" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:DepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">158</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accretion and amortization on investments, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c55ede8-a47f-41fd-990a-135bd7e13e08" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">965</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c4197f4-1894-4a51-93cf-b960854bad5c" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,424</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_297739f5-5d02-45f4-b6b7-5d03cf11e2f7" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">818</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of debt issuance costs/debt discount</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2cb2a94a-146b-4071-b568-171b28cfb464" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,327</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_92c97860-da80-4f9d-bf0d-6ba5441c65b2" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">893</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46d017d3-418f-435c-b126-ae4a5b5db4c0" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">179</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gain on sales of available for sale securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_162929d7-911f-40f1-8025-d55b55459ba7" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:GainOnSaleOfInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net gain on exchange and sales of equity investment</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0f7ba09e-6d45-4c76-8382-1732f4e2ba9e" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,233</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_31fe77c2-1b11-4959-82a0-ada2a67f0aca" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:GainLossOnSaleOfOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">148</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in fair value of equity investment, <br />&#160;&#160;including foreign currency translation</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a3b23995-09ad-4b5c-9f7b-7cf6d9f2619f" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:AssetsFairValueAdjustment" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">163</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation for services by non-employees</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ecb039af-b1ce-47b7-abbf-801b723682b7" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">264</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aa4b4b8b-747b-4004-b95c-67863d26f6db" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">91</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6308f842-b043-4ea8-b014-8d30f0534f56" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">85</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation for employees and directors</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7b561054-88be-4f46-a4fc-8f71391f2cb6" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,001</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc2d529c-43e5-453e-a5b8-928de7588a82" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,080</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3c7f2b98-490b-4e02-b3e1-2fff0bf2964f" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,895</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of right-of-use assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2966367-bc33-45ab-bca6-febeae6db84a" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">580</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d3c0355-fb15-4833-a1f4-9bd7e02e759e" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">568</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0307698-ea22-41bb-b298-f7bc73b5e1ff" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">777</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in assets and liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest and other receivables</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3ec171eb-d811-4f98-982e-a22b931addd3" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,381</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_759dd907-2344-4670-a5eb-668ec875e7e7" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="gern:IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,041</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4e85e49c-24ee-4783-9b5e-7293dff0699a" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="gern:IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">80</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid and other current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_009f3ba0-52b7-4556-8ec7-b8f0069c715b" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,630</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a369f44-53e2-4aaa-9582-671d11218525" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,317</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_15e5c0a0-e94a-4cb2-84ce-99d2b5aaafdb" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:IncreaseDecreaseInPrepaidExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deposit and other assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_773e2a05-e783-4ba6-b5ca-05bbd76974a4" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:IncreaseDecreaseInDepositOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">594</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08f75a3f-9a6a-45e0-a3d7-22d4a1a115ec" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:IncreaseDecreaseInDepositOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,807</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08090a4d-643b-4f8e-a850-eca05ad09c89" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:IncreaseDecreaseInDepositOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">206</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11df9547-ca5a-4c34-9017-5bf7de2d1a56" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,503</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0db9131-92d2-4a07-bb0c-6964509d3a84" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">232</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_10a5bf87-9ff1-4d9e-a525-fec3f0fbd2b6" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,731</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued compensation and benefits</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e0d081bf-ccc5-42a0-9899-7b80b2432f00" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,435</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1680281-f48f-4f0e-8f8e-3c86ef376803" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">119</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b88df068-c059-4f30-81a4-9d519386d546" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,388</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amount due to Janssen Biotech, Inc.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b88ad73-a6bb-4f20-9cff-ef816d6a27ab" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="gern:IncreaseDecreaseDueToCounterparty" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">14,269</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48c93487-93ba-494e-94c1-6d19315d5952" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,266</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7b6cf10-9941-4aac-a0c7-7a9486ab27ce" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,909</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a6ee52bc-dfb8-401d-af16-1c5e56a9eb86" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,397</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_35130f1d-5ae0-4adf-b79a-707278b4e9af" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:IncreaseDecreaseInOperatingLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">572</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_186838b8-b398-4b79-b292-e3631a51c4f3" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="gern:IncreaseDecreaseInOperatingLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">509</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f1f7b348-8b0c-417a-81fe-c90c38d3257b" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="gern:IncreaseDecreaseInOperatingLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">452</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dfdf563e-816c-44c9-ba55-7e4bd305d0bd" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">127,379</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7fe88aef-5228-4fa4-b99a-984bf0d8f4b9" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">95,556</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7b5c5cf2-199a-400a-a560-91460561a4d3" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">66,652</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_da3b823a-c4da-437f-839a-10086c2e741f" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">431</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_490676cc-ae65-4a3b-bc37-0e6001490be3" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">207</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a6385c5-0584-46e1-8fb6-0277c604fcdd" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">401</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bef3112b-60da-4e2f-80f3-4b3300aba6f1" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">258,007</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_31972792-4d98-4949-9400-c4da08975143" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">177,434</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_243f3805-8476-4ada-a737-2156afb610a5" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">313,201</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from sales of securities available for sale</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_acc73bf3-a0f1-49c6-9581-0079227ad2dc" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,681</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from maturities of marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d85be2a2-bc13-48a8-9b9a-85fb39781e7a" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">320,505</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d0278309-8d26-44b7-97b4-21fd3def9f28" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">247,994</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_26de0290-c7cc-4c4d-8a56-f58d4b4296c6" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">200,262</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from sales of equity investment</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4893a616-5a1e-4bcb-86cf-92b2bfc1f548" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,594</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3148e7b9-f258-4180-8ec7-d0dc855fa705" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">339</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by (used in) investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e12d844-b91d-4893-951f-ed68f5a29a3c" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62,067</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_409de623-5fbd-4432-8f34-2885238090c5" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">71,947</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_67f0c97d-f43f-4c78-9a4f-64084af155a9" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">105,320</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuances of common stock from equity plans</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_45cb6da8-5f38-46e2-aa95-dda13fd42bb9" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,185</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0e28fe2d-132a-440a-8cc5-2c5055d91e44" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">797</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_17f819c5-f6c8-46e0-8880-25b132a2c970" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">208</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of common stock and warrants <br />&#160;&#160;&#160;in public offering, net of paid issuance costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a94db49-3bb6-456f-9696-514884132502" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">69,916</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e4c34a6-1be5-4ea4-8880-369c8e2a2146" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="gern:ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">140,184</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuances of common stock from <br />&#160;&#160;&#160;at market offerings, net of paid issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0cd61be1-3f71-4854-94c8-637e94282fd9" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,385</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dbc8e168-3c12-45a9-9e0e-afbfdacfe13f" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,075</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from exercise of warrants</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d503dcb-2763-4b21-8ad8-e706d4e9ebc7" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ProceedsFromWarrantExercises" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,163</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_71ebaba7-1159-404e-acf5-90cfc4fa99c5" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ProceedsFromWarrantExercises" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,479</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8d3750b5-8886-4e58-aa99-07d4ce2786ce" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ProceedsFromWarrantExercises" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from debt financing, net of paid debt issuance costs<br />&#160;&#160;&#160;and debt discounts</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_397a92a9-4056-4868-b5fa-3b2181bd64a6" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,895</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c8becf7-e6a6-4af9-8c68-45e9a3a924ef" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,863</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:30.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_071b0cd1-05de-4ae9-9f5b-cd2d81bc12e8" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87,264</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0360477a-1633-4b56-ba39-605a6739e077" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,556</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fe0c7ab3-6b28-4db6-bdd0-2c7d6d6c2e95" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">168,346</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net effect of exchange rates on cash, cash<br />&#160;&#160;&#160;equivalents and restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3108787-95e8-4481-b1df-3624bf9ea7f3" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net increase (decrease) in cash, cash equivalents <br />&#160;&#160;&#160;and restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a1b3a5ee-1535-40b5-906c-329f69d53cac" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,974</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed550659-1bdd-4fcc-a910-87c68d54aa08" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,947</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8a4a8e9-24e4-401d-bb4b-d7e40b123bdd" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">3,626</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash, cash equivalents and restricted cash <br />&#160;&#160;&#160;at the beginning of the period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c5beedc-8053-4d2a-8248-7d13b2a10470" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,235</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_278349d7-ad27-44c5-b7b0-e2ae1557eafe" contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,288</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_578486fd-044c-46d7-8364-6043208874d9" contextRef="C_51546caa-efa4-41ff-89e0-38e80356cf4c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,914</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash, cash equivalents and restricted cash <br />&#160;&#160;&#160;at the end of the period</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b43adf78-2b8a-430d-b6dc-a79cdea8f185" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">57,209</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9439bd5-c6ec-4879-a1ed-1b23fccb550b" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35,235</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_670e1ffe-5194-4bff-af2d-f669757c19e7" contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,288</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO FINANCIAL STATEMENTS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3975b0bc-5d3b-4385-acbf-c476632218a0" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="note_1_"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Organization</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The terms &#x201c;Geron&#x201d;, the &#x201c;Company&#x201d;, &#x201c;we&#x201d; and &#x201c;us&#x201d; as used in this report refer to Geron Corporation. Geron was incorporated in the State of Delaware on November 28, 1990. We are a late-stage clinical biopharmaceutical company that is focused on the development and potential commercialization of imetelstat, an innovative therapeutic for hematologic malignancies. We have global rights to imetelstat, a first in class telomerase inhibitor, which was discovered and developed at Geron. Principal activities to date have included obtaining financing, securing operating facilities and conducting research and development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2528a059-393c-4007-8c46-6708a5075428" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ConsolidationPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated financial statements include the accounts of Geron and our wholly-owned subsidiary, Geron UK Limited, or Geron UK, a United Kingdom company. Geron UK was incorporated in September 2021, and its operations commenced in January 2022. We have eliminated intercompany accounts and transactions. We prepare the financial statements of Geron UK using the local currency as the functional currency. We translate the assets and liabilities of Geron UK at rates of exchange at the balance sheet date and translate income and expense items at average monthly rates of exchange. The resultant translation adjustments are included in accumulated other comprehensive income (loss), a separate component of stockholders&#x2019; equity, on our consolidated balance sheets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0c6ad84f-f882-4e95-80f2-509aa8482316" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true" continuedAt="F_0c6ad84f-f882-4e95-80f2-509aa8482316_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Loss Per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of shares of common stock outstanding for the periods presented without consideration of potential common shares. In April 2022, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_58b3229b-3040-4c8d-9e83-b836fcdfc565" contextRef="C_a3cf8441-940c-4769-a1c9-ba37e4bc2812" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,095,238</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, also known as the 2022 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. In May 2020, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3fa850a2-817f-4c90-86e8-6f99744f4f6e" contextRef="C_c3b7b4b9-7629-4b56-93a5-2b3ac17f8fa9" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,335,239</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, or the 2020 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. The 2022 pre-funded warrant and 2020 pre-funded warrant each are exercisable immediately at an exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_15a02dbb-3748-4cca-b938-1b2f808d3f8d" contextRef="C_a3cf8441-940c-4769-a1c9-ba37e4bc2812" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:numdotdecimal"><ix:nonFraction id="F_caab1f25-eeff-4d45-9364-e447dfee1dc2" contextRef="C_c3b7b4b9-7629-4b56-93a5-2b3ac17f8fa9" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. We included the 2022 pre-funded warrant and 2020 pre-funded warrant in the computation of basic net loss per share, as applicable, since their exercise price is negligible, and they may be exercised at any time. See Note 9 on Stockholders' Equity for further discussion of the April 2022 public offering.</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_0c6ad84f-f882-4e95-80f2-509aa8482316_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diluted net income per share would be calculated by adjusting the weighted-average number of shares of common stock outstanding for the dilutive effect of additional shares of common stock that would have been outstanding if potentially dilutive securities had been issued, as determined using the treasury-stock method. Potential dilutive securities consist of outstanding stock options and warrants to purchase our common stock. Diluted net loss per share excludes potential dilutive securities for all periods presented as their effect would be anti-dilutive. Accordingly, basic and diluted net loss per share is the same for all periods presented in the accompanying consolidated statements of operations. Since we incurred a net loss for 2022, 2021, and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the diluted net loss per share calculation excludes potential dilutive securities of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d3a419a9-30b6-470a-8c38-f28c9ac298b6" contextRef="C_4183e218-4909-4bf2-b115-abdea99d97df" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">145,726,765</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_665b3b68-97a8-439d-8c31-83b36526b068" contextRef="C_bb6bcd2c-ccc9-458c-9e1a-1799ed2c561e" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">105,725,875</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e3d2c35e-d5f4-415b-b904-342713b72ca0" contextRef="C_a9eac63f-ff18-4e30-bd6c-4d89efb022b6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">101,881,391</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares, respectively, related to outstanding stock options and warrants as their effect would have been anti-dilutive.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fcbbe5dd-93df-44ea-8a01-d0b6cf84b8b1" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to accrued liabilities, revenue recognition, fair value of marketable securities and equity investments, operating leases, right-of-use assets, lease liabilities, income taxes, and stock-based compensation. We base our estimates on historical experience and on various other market specific and relevant assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7098855d-a8be-44f2-92e3-8b51c4490ea4" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Equivalents and Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. We are subject to credit risk related to our cash equivalents and marketable securities. Our marketable debt securities include U.S. Treasury securities, municipal securities, government-sponsored enterprise securities, commercial paper and corporate notes.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We classify our marketable debt securities as available for sale. We record available for sale debt securities at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) in stockholders&#x2019; equity. Realized gains and losses are included in interest income and are derived using the specific identification method for determining the cost of securities sold and have been insignificant to date. Dividend and interest income are recognized when earned and included in interest income on our consolidated statements of operations. We recognize a charge when the declines in the fair values below the amortized cost bases of our available for sale securities are judged to be other than temporary. We consider various factors in determining whether to recognize an other than temporary charge, including whether we intend to sell the security or whether it is more likely than not that we would be required to sell the security before recovery of the amortized cost basis. Declines in market value judged as other than temporary result in a charge to interest income. We have not recorded any other&#x2011;than&#x2011;temporary impairment charges on our available&#x2011;for&#x2011;sale securities for the years ended December 31, 2022, 2021 and 2020. See Note 2 on Fair Value Measurements.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity Investments</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure our investment in equity securities at fair value at each reporting date. Changes in fair value resulting from observable price changes are included in change in fair value of equity investment and changes in fair value resulting from foreign currency translation are included in other expense on our consolidated statements of operations.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a9af653a-f921-4f45-89af-07c3cad0e193" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating leases are included in operating leases, right-of-use assets and lease liabilities on our consolidated balance sheets. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of remaining lease payments over the expected lease term. The present value of remaining lease payments within the 12 months following the balance sheet date are classified as current lease liabilities. The present value of lease payments not within the 12 months following the balance sheet date are classified as noncurrent lease liabilities. The interest rate implicit in lease contracts is typically not readily determinable. As such, to calculate the net present value of lease payments, we apply our incremental borrowing rate, which is the estimated rate to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment as of the lease commencement date. We may adjust the right-of-use assets for certain adjustments, such as initial direct costs paid or incentives received. In addition, we include any options to extend or terminate the lease in the expected lease term when it is reasonably certain that we will exercise any such option. Lease expense is recognized on a straight-line basis over the expected lease term.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For lease agreements entered into after January 1, 2019 that include lease and non-lease components, such components are generally accounted for separately. We have also elected not to recognize on our consolidated balance sheets leases with terms of one year or less.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f0261caa-66ec-42f3-bd4d-7d21c60d907c" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:DebtPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Debt Issuance Costs and Debt Discounts</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Debt issuance costs include legal fees, accounting fees, and other direct costs incurred in connection with the execution of our debt financing. Debt discounts represent costs paid to the lenders. Debt issuance costs and debt discounts are deducted from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt using the effective interest method.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">111</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_402db6cb-e1eb-42ba-8d6a-9454a1f8eaf0" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers, or Topic 606. In determining the appropriate amount and timing of revenue to be recognized under this guidance, we perform the following five steps: (i) identify the contract(s) with our customer; (ii) identify the promised goods or services in the agreement and determine whether they are performance obligations, including whether they are distinct in the context of the agreement; (iii) measure the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations based on stand-alone selling prices; and (v) recognize revenue when (or as) we satisfy each performance obligation. <br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A performance obligation is a promise in an agreement to transfer a distinct good or service to the customer and is the unit of account in Topic 606. Significant management judgment is required to determine the level of effort required and the period over which completion of the performance obligations is expected under an agreement. If reasonable estimates regarding when performance obligations are either complete or substantially complete cannot be made, then revenue recognition is deferred until a reasonable estimate can be made. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We allocate the total transaction price to each performance obligation based on the estimated relative stand-alone selling prices of the promised goods or services underlying each performance obligation. Estimated selling prices for license rights are calculated using an income approach model and include the following key assumptions, judgments and estimates: the development timeline, revenue forecast, commercialization expenses, discount rate and probabilities of technical and regulatory success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following is a description of the principal activities from which we generate revenue. License fees and royalty revenue primarily represent amounts earned under agreements that out-license our technology to various companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">License Agreements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br />We previously entered into several license agreements with various oncology, diagnostics, research tools and biologics production companies, whereby we granted certain rights to our non-imetelstat related technologies. Under these agreements, non-refundable upfront fees and annual license maintenance fees were considered fixed consideration, while milestone payments and royalties were identified as variable consideration. Since June 30, 2021, no active license agreements remain. The license related to our specialized oligonucleotide backbone chemistry, as well as patent rights covering the synthesis of monomers, the building blocks of oligonucleotides, terminated effective April 2021.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the divestiture of Geron&#x2019;s human embryonic stem cell assets, including intellectual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on sales of certain research or commercial products utilizing Geron&#x2019;s divested intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Licenses of Intellectual Property</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If we determine the license to intellectual property is distinct from the other performance obligations identified in the agreement and the licensee can use and benefit from the license, we recognize revenue from non-refundable upfront fees allocated to the license upon the completion of the transfer of the license to the licensee. For such licenses, we recognize revenue from annual license maintenance fees upon the start of the new license period. For licenses that are bundled with other performance obligations, we assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable upfront fees or annual license maintenance fees. At each reporting date, we reassess the progress and, if necessary, adjust the measure of performance and related revenue recognition.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Milestone Payments.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> At the inception of each agreement that includes milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. For milestones that we do not deem</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">112</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to be probable of being achieved, the associated milestone payments are fully constrained and the value of the milestone is excluded from the transaction price with no revenue being recognized. For example, milestone payments that are not within our control, such as regulatory-related accomplishments, are not considered probable of being achieved until those accomplishments have been communicated by the relevant regulatory authority. Once the assessment of probability of achievement becomes probable, we recognize revenue for the milestone payment. At each reporting date, we assess the probability of achievement of each milestone under any current agreements.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Royalties</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For agreements with sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (a) when the related sales occur, or (b) when the performance obligation, to which some or all of the royalty has been allocated, has been satisfied (or partially satisfied). At each reporting date, we estimate the sales incurred by each licensee during the reporting period based on historical experience and accrue the associated royalty amount.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2bdce74c-dee9-41c1-8507-a92a336b03ab" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash consists of funds maintained in separate money market or certificate of deposit accounts for credit card purchases.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fd38318d-5d37-4629-ac37-b896911393f6" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses currently consist of expenses incurred in developing and testing imetelstat and research related to potential next generation telomerase inhibitors. These expenses include, but are not limited to, payroll and personnel expense, lab supplies, non-clinical studies, clinical trials, including support for investigator-led clinical trials, raw materials to manufacture clinical trial drugs, manufacturing costs for research and clinical trial materials, sponsored research at other labs, consulting, costs to maintain technology licenses and research-related overhead.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current imetelstat clinical trials are being supported by contract research organizations, or CROs, and other vendors. We accrue expenses for clinical trial activities performed by CROs based upon the estimated amount of work completed on each trial. For clinical trial expenses and related expenses associated with the conduct of clinical trials, the significant factors used in estimating accruals include the number of patients enrolled, the number of active clinical sites, and the duration for which the patients have been enrolled in the trial. We monitor patient enrollment levels and related activities to the extent possible through internal reviews, review of contractual terms and correspondence with CROs. We base our estimates on the best information available at the time. However, additional information may become available to us which will allow us to make a more accurate estimate in future periods. In that event, we may be required to record adjustments to research and development expenses in future periods when the actual level of activity becomes more certain.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_704ee8fb-46a9-485b-9037-e39c28a978d3" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation and Amortization</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We record property and equipment at cost and calculate depreciation using the straight&#x2011;line method over the estimated useful lives of the assets, generally </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3ce01217-2353-40ef-ab52-41ec5c82dfde" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Leasehold improvements are amortized over the shorter of the estimated useful life or remaining term of the lease.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5e283e79-d3f3-42c6-bb45-08a278c7b799" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock&#x2011;Based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain various stock incentive plans under which stock options and restricted stock awards can be granted to employees, non-employee directors and consultants. We also have an employee stock purchase plan for all eligible employees. We recognize stock-based compensation expense based on grant-date fair values of service-based stock options on a straight-line basis over the requisite service period, which is generally the vesting period. For performance-based stock options with vesting based on the achievement of certain strategic milestones, stock-based compensation expense is recognized over the period from the date the performance condition is determined to be probable of occurring through the date the applicable condition is expected to be met and is reduced for estimated forfeitures, as applicable. If the performance condition is not considered probable of being achieved, no stock-based compensation expense is recognized until such time as the performance condition is considered probable of being met, if at all. If the assessment of probability of the performance condition changes, the impact of the change in estimate would be recognized in the period of the change. The determination of grant-date fair values for our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">113</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">service-based and performance-based stock options and employee stock purchases using the Black Scholes option pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables. The grant-date fair value for service-based restricted stock awards is determined using the fair value of our common stock on the date of grant. We evaluate whether an adjustment to the assumptions of fair value of our common stock and historical volatility are required if observed prices of our common stock materially differ from historical information.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure share-based payments to non-employees based on the grant-date fair value of the equity awards to be issued. We recognize stock-based compensation expense for the fair value of the vested portion of non-employee stock-based awards on our consolidated statements of operations. For additional information, see Note 9 on Stockholders&#x2019; Equity.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_871908f0-a3e1-43cd-b1b8-46c7d1daa42c" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:StockholdersEquityPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated Other Comprehensive Gain (Loss)</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other comprehensive gain (loss) includes certain changes in stockholders&#x2019; equity which are excluded from net income (loss). Accumulated other comprehensive loss on our consolidated balance sheets as of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, is comprised of net unrealized losses on marketable securities and cumulative translation adjustments.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_59585682-51c4-47a1-a83f-d031edd0e576" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are subject to tests of recoverability. Our deferred tax assets include net operating loss carryforwards, federal and state tax credits and capitalized research and development. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Our net deferred tax asset has been fully offset by a valuation allowance because of our history of losses. Any potential accrued interest and penalties related to unrecognized tax benefits would be recorded as income tax expense.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fc018ea6-34e4-4bc7-b7af-8fabe7ddf0d5" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our executive management team represents our chief decision maker. We view our operations as a single segment, the development of therapeutic products for oncology. As a result, the financial information disclosed herein materially represents all of the financial information related to our principal operating segment.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fde7a27b-7e9f-4c3d-a33a-7966bce24dd1" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New Accounting Pronouncements &#x2013; Issued But Not Yet Adopted</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU 2016-13,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2016-13. The main objective of ASU 2016-13 is to provide financial statement users with more decision-useful information about an entity's expected credit losses on financial instruments and other commitments to extend credit at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology currently used today with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to develop credit loss estimates. Subsequent to issuing ASU 2016-13, the FASB issued ASU 2018-19, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Codification Improvements to Topic 326, Financial Instruments &#x2013; Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2018-19, for the purpose of clarifying certain aspects of ASU 2016-13. In May 2019, the FASB issued ASU 2019-05, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments &#x2013; Credit Losses (Topic 326): Targeted Transition Relief</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2019-05, to provide entities with more flexibility in applying the fair value option on adoption of the credit impairment standard. In November 2019, the FASB issued ASU 2019-11, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Codification Improvements to Topic 326, Financial Instruments &#x2013; Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which expands the scope of the practical expedient that allows entities to exclude the accrued interest component of amortized cost from various disclosure. Entities that elect to apply the practical expedient must disclose the total amount of accrued interest that they exclude from their disclosures of amortized cost. ASU 2018-19, ASU 2019-05 and ASU 2019-11 have the same effective date and transition requirements as ASU 2016-13. ASU 2016-13 will be effective for fiscal years beginning after December 15, 2022, using a modified retrospective approach, for smaller reporting companies. Early adoption is permitted. We plan to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">114</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adopt ASU 2016-13 and related updates as of January 1, 2023. We do not expect the adoption of this standard to have a material impact on our financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the FASB issued ASU 2020-06, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2020-06. The key elements of ASU 2020-06 aim to reduce unnecessary complexity in GAAP for certain financial instruments with characteristics of liabilities and equity. In addressing the complexity, the FASB focused on amending the guidance on convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#x2019;s own equity. For convertible instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock. For contracts in an entity&#x2019;s own equity, the FASB observed that the application of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically similar contracts as equity. The FASB also decided to improve and amend the related earnings per share guidance. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years for public business entities that are not smaller reporting companies. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. We plan to adopt ASU 2020-06 as of January 1, 2024. We do not expect the adoption of this standard to have a material impact on our financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on our financial statements.</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6832f1bb-0954-4120-98fe-bbb4476d65d4" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. FAIR VALUE MEASUREMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash Equivalents and Marketable Securities</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0f88f58a-5811-401f-bc4c-4f211e3e5181" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents, restricted cash and marketable securities by security type at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.972%;"></td>
        <td style="width:1.354%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.145%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.366%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.145%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.366%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.145%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.366%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.145%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in cash and cash equivalents:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9dc22b00-2af5-43e2-af09-102567944b4b" contextRef="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a" name="us-gaap:CashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,771</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b9c8e91d-d12d-40e0-af33-2bbfb268223c" contextRef="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,771</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94e28d5c-398d-479f-887e-12344c345851" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,771</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b1c945f-bc2b-4f78-9603-26a11abf0260" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,771</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_614a1881-2064-4618-a066-f6df9e12b20a" contextRef="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">93</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cacadd3b-f44f-45d6-b68b-40c4aa116f2c" contextRef="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a" name="us-gaap:RestrictedInvestmentsAtFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">93</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_40304cb9-fc07-4c85-bce1-44adc45e33b2" contextRef="C_a7e69a6d-c732-438a-9a6d-1aab2a5533f7" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">271</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_818b1258-e21c-475c-9b4a-e3dee30b540d" contextRef="C_a7e69a6d-c732-438a-9a6d-1aab2a5533f7" name="us-gaap:RestrictedInvestmentsAtFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">271</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8f4f439-adc0-4543-a676-85dbc9bbb4b4" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3">364</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_66eb6fca-d36f-4266-a243-5edf7f1cce5f" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:RestrictedInvestmentsAtFairValue" unitRef="U_USD" scale="3" decimals="-3">364</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities (due in <br />&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f18bb94f-c046-4555-9e3a-85becb8103ce" contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,983</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_320966ac-a879-4972-956d-0523c9caa679" contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8dc489d-f768-4f2b-9812-64281a32a44e" contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,921</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities (due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d0869d39-ad70-474c-b4e3-d3e2dc79763d" contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1632bb7-0112-4d54-9856-646ecf180109" contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_111548c9-67ec-4b80-8ae3-be06255d98af" contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,976</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities <br />&#160;&#160;&#160;(due in less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ace861dc-9ab0-440c-97a8-1bef01aaa8b6" contextRef="C_9c4a1e4a-ddee-40c4-b8df-5752dec9177f" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,860</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c814777e-9e11-4ca5-a4a8-681ebf963158" contextRef="C_9c4a1e4a-ddee-40c4-b8df-5752dec9177f" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1473d82a-b21c-4e59-9494-809235f0e25a" contextRef="C_9c4a1e4a-ddee-40c4-b8df-5752dec9177f" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,846</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper (due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75e483b8-1e0a-4f23-adf9-2a6a08d2c2ea" contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,285</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c0f2e2c4-be3d-458d-b457-bd77ce7e2ffd" contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c047bc0f-8242-417b-8956-86caf9147468" contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">92</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f0f0432f-a980-43f9-a3f8-ba6841452741" contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,199</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73e26987-d4a9-4c92-833d-1cab4235bbd6" contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,014</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f8e99436-4e05-41fc-b223-f33c7be42ec0" contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3">55</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4d69e3ad-d1d7-4872-97ed-1dd987fc83fd" contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,959</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c2ac75e9-6156-4f2b-bbcf-eb8e0ecc6452" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">116,142</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f038aea0-00b9-4ffa-b367-c16d9ef87b83" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e74dbd8a-69cb-49e9-be46-2ab5da7a97e2" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">247</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0a056b3-de05-4d20-9e21-43c5c36f6c63" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">115,901</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents, restricted cash and marketable securities by security type at December 31, 2021 were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.972%;"></td>
        <td style="width:1.354%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.145%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.366%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.145%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.366%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.145%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.366%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.145%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in cash and cash equivalents:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aaab3370-ddf8-4357-b656-706e508ab8c0" contextRef="C_9d9caad1-b187-4705-af84-3d4912060cb5" name="us-gaap:CashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,207</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e06f5d91-7d20-4f7d-ab7e-d1a168b264fb" contextRef="C_9d9caad1-b187-4705-af84-3d4912060cb5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,207</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fbe3e244-e788-4e72-87f8-4a16f9850e28" contextRef="C_9985ac27-b487-43dc-84e4-99f5eb3e2ee4" name="us-gaap:CashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,499</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9af715ca-0c22-4583-920c-77456e1469c8" contextRef="C_9985ac27-b487-43dc-84e4-99f5eb3e2ee4" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,499</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6641fd1-8d4a-4957-9168-1424884beabd" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,706</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9b8e351e-de79-4a6a-a5d2-c09fda66f175" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,706</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba329412-440d-4b0c-adcc-c2725b0c7951" contextRef="C_9d9caad1-b187-4705-af84-3d4912060cb5" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3">93</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3350b496-5399-4962-978f-3cb0e6d55c27" contextRef="C_9d9caad1-b187-4705-af84-3d4912060cb5" name="us-gaap:RestrictedInvestmentsAtFairValue" unitRef="U_USD" scale="3" decimals="-3">93</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7673bdd8-8247-431b-8990-695a1fe22869" contextRef="C_d81bd636-0218-4286-b8c2-3cccfc33f5fe" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3">271</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fbf993e9-1df6-4957-b935-708f1fe69c25" contextRef="C_d81bd636-0218-4286-b8c2-3cccfc33f5fe" name="us-gaap:RestrictedInvestmentsAtFairValue" unitRef="U_USD" scale="3" decimals="-3">271</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_86364816-8ed9-4013-889e-14a5921458df" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3">364</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2dbf901e-c9a7-4a08-aca1-d43cc0620339" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:RestrictedInvestmentsAtFairValue" unitRef="U_USD" scale="3" decimals="-3">364</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities (due in <br />&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8790f419-0a54-441e-abc3-237789540475" contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,585</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_354f6a08-51f8-4317-98b1-23e406e6046e" contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_20578b79-2285-4b2f-bf38-b22663a5436a" contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,567</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities (due in <br />&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eb580a13-05f2-4f01-bf56-75d8c7386e36" contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,524</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ac902949-fb01-4141-a800-8c9fba785016" contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16db4d2b-5e31-4779-a6b5-0b81ca431ca6" contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,521</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities (due in <br />&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_74c6c496-a7ea-40ac-9ce8-0c56c393d3f2" contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1859e99f-3aad-4dfb-a841-74ba5a80fb57" contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e262b3b0-017b-4827-ae91-31681b17077a" contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,985</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities <br />&#160;&#160;&#160;(due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c5892c2-4509-4ed1-a8ea-b26bee1c9a6a" contextRef="C_1dbff205-2f6f-4aba-8edf-3911a28267ba" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e86b4054-0146-47c6-8a9a-8e8b9b770969" contextRef="C_1dbff205-2f6f-4aba-8edf-3911a28267ba" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9b8cc09b-2283-4e60-85d3-2bdf5b1a8411" contextRef="C_1dbff205-2f6f-4aba-8edf-3911a28267ba" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,493</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper (due in less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48aff92e-4c74-46a5-b610-ae1e93a801d5" contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">84,398</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ff112f6e-2892-431a-b3f5-798c4a5baa3d" contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf8e645c-7d24-4900-9eab-7e20faffbe31" contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3">38</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_64e07ced-a1a5-44d6-82a3-1313fe160a5c" contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">84,362</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_69bb0795-24ba-414c-83bd-733a1bbefaed" contextRef="C_d8e95986-943a-430c-9308-147c97f446ca" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,444</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_030bbd83-23ba-4cc6-b2f5-62d30a868e66" contextRef="C_d8e95986-943a-430c-9308-147c97f446ca" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_33fc6f72-7d80-4dc8-8a58-89f99fc78046" contextRef="C_d8e95986-943a-430c-9308-147c97f446ca" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3">17</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_633085cb-9be6-42ee-84f6-b6e6ef60d697" contextRef="C_d8e95986-943a-430c-9308-147c97f446ca" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,429</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in one to two years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88f84b9d-f939-4472-be28-c5eedf34289b" contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,224</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9fdadcd2-2ffe-48bb-8ae2-de4c09c4352a" contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">79</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1f350e84-b01d-4413-8408-6326f9d6415a" contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,145</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6cca21d-47db-465c-8d85-50b6c8ea7834" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">177,675</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0d19f4e9-bdf3-4c67-b446-a5ef914ed400" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ce146d44-ed83-4fd5-949e-a885828c42b4" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">177</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_59454cc2-4e28-4b86-b62a-dca24bb30964" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">177,502</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">116</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_adfe7e92-ba3d-4c09-a6db-3ec87a30377d" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents and marketable securities with unrealized losses that have been in a continuous unrealized loss position for less than 12 months and 12 months or longer at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.719%;"></td>
        <td style="width:0.08%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.868%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.08%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.162%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.08%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.613%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.08%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.404%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.08%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.627%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.08%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.122%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less Than 12 Months</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12 Months or Greater</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="4" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury <br />&#160;&#160;&#160;securities (due in <br />&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_acacc255-0a77-4719-8988-d44f03265df2" contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,424</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2222e890-fb61-4fd8-b90f-8da56c47dd89" contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">57</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_252cfda5-bf97-4fe4-b7b5-864207a2ca5e" contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,497</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95b9b147-7da6-4318-b623-63b48fd2d2d9" contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba52538e-b488-49c5-8405-a8f4aab91e37" contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,921</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_12be089b-d98b-4dc1-9970-12173be8e73b" contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities <br />&#160;&#160;&#160;(due in less than a<br />&#160;&#160;&#160;year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e69b2ea8-3285-4cfb-bcef-002c5dc8b75a" contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,976</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_290b6c49-f90e-46e6-9fb0-4150a0327d50" contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0544c403-ca06-4ea4-86a7-6d2d2a22a4b8" contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,976</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b5fc6dd9-f9b2-404f-933e-d7db2ae1e3d5" contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored <br />&#160;&#160;&#160;enterprise securities <br />&#160;&#160;&#160;(due in less than <br />&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5680c1ba-477c-4cbc-af08-da95eae440c8" contextRef="C_53f68612-65e0-46e6-9f29-f76b1403dad8" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,845</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_955287d7-e941-4437-a513-e21c0c736141" contextRef="C_53f68612-65e0-46e6-9f29-f76b1403dad8" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3">14</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_98a5970f-ace7-49b1-a3c6-de5e87fa4e59" contextRef="C_53f68612-65e0-46e6-9f29-f76b1403dad8" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,845</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c805caf-60a3-4415-89b7-e3832ffc5aba" contextRef="C_53f68612-65e0-46e6-9f29-f76b1403dad8" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3">14</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper<br />&#160;&#160;&#160;(due in less than<br />&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5a8628e3-f143-44a6-86ce-bf6eff095852" contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52,454</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_91058098-2f70-4d38-985c-4f6fb9da9588" contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3">92</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93eb7484-1c1f-444b-b042-f0634e7ad131" contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52,454</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b7eab686-f265-46de-8a6c-746a705fd486" contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3">92</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in <br />&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7a459aad-3f3d-4333-a80c-3b39a390de15" contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,998</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c855abaf-0fef-4fca-91a7-33ff542b485b" contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d002185a-f326-4bba-a002-9b1894b98af8" contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,962</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_faebfb0b-d828-46d8-b3aa-52322b33cb2e" contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">53</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c0ed0d3-b529-4861-a00b-0a072102ace1" contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,960</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cfcf8239-a10f-4b45-b3f9-ff06ddfac053" contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">55</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_81c674a0-805e-4b55-9ddd-f1273e6bc532" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75,721</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aa412174-5f53-4d37-9964-5360f95a07fb" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">165</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a071ece-145a-4d9c-bbf2-1e63fa997414" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,435</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_803ff372-d584-4864-b569-4d667a8a053f" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">82</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db8129c5-4882-4395-9cd5-32c18c4340a1" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">104,156</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b892f14b-de82-4239-901c-2630ca350f2f" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">247</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury <br />&#160;&#160;&#160;securities (due in <br />&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b7aeb44a-2018-481d-8f4e-a51cb8f7811a" contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,567</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_42b1167e-b89e-48f9-9db5-954a96df04b8" contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5c5af7dd-589a-4fb0-92d0-867e9f1436f2" contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,567</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ceaade37-73c8-4b04-9dab-82d7d5f5467a" contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury <br />&#160;&#160;&#160;securities (due in <br />&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_097a3468-bdda-4869-91b0-0ad37cff817b" contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,521</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_70e31606-454a-4775-875c-156fd195e980" contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1c82064-ffa5-4d74-a7e6-a150b1236cd9" contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,521</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ad40101-9a82-4816-a14d-df208c974d0c" contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities <br />&#160;&#160;&#160;(due in one to two <br />&#160;&#160;&#160;years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88dadd29-1d36-49c7-888b-9d1f48b9f81a" contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,985</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_038c2053-3d26-4e0d-bfb1-e58e4a60caa8" contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6533b4a3-7483-42c9-aed9-9103a566b1b4" contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,985</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19ce5250-30f9-4e3f-b45e-fc7e4d378a4a" contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored <br />&#160;&#160;&#160;enterprise securities <br />&#160;&#160;&#160;(due in less than <br />&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_600ec2f3-db17-4e45-8118-d708f1243941" contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a57de996-546d-4518-bcfb-b5774fdf74e1" contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,993</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cd5bc296-d84a-4412-ae11-e6b5690945df" contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88fed3b2-6114-40ad-90f5-f936a60e2f79" contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,493</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_deab422e-6816-440b-8fd9-2e93b3f3d467" contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper<br />&#160;&#160;&#160;(due in less than<br />&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1286eaa-f548-462b-a3fa-3a05ca49b1d8" contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">66,872</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_27d37435-fd85-448c-a5d4-393a1fbf43b9" contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3">38</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_888482e2-fc4b-455f-8aea-bbae6142229e" contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">66,872</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a52aeb7f-8dbc-4232-ac26-780f4aca0ae9" contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3">38</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in <br />&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f6730ad-8164-4646-8133-caaf46ae1a91" contextRef="C_d8e95986-943a-430c-9308-147c97f446ca" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,001</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2b5adaf1-a22d-4680-beec-bec76b407b88" contextRef="C_d8e95986-943a-430c-9308-147c97f446ca" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8910c82c-6d78-4d4a-a012-33121b8214f5" contextRef="C_d8e95986-943a-430c-9308-147c97f446ca" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,001</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fff5f4ef-0195-42ed-ab2b-e00b81a11a14" contextRef="C_d8e95986-943a-430c-9308-147c97f446ca" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in <br />&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_579ebedc-8d65-47c7-abf6-fe1eeefb9f5a" contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,145</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a51236a1-37cd-49c5-9bf8-b97756febc47" contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">79</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_13387a18-0b8b-409e-9289-4b29753ac6bf" contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,145</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93865a5e-544c-4921-a4bd-6c400a6b25fe" contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">79</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c50dd786-391d-43a4-a313-9bbb0d14627e" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">128,591</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be45d567-f6ff-4dbb-85fa-72a2158d5588" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">170</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c3925d7-5d64-4f8a-af26-93e411d6944d" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,993</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_662de451-395a-438c-be5e-ad51d75b7eb2" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d8960360-9c11-4144-b401-16371d0f143f" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">133,584</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c2323fa-cf21-454f-8ee2-bf1f7095c02c" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">177</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">117</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The gross unrealized losses related to U.S. Treasury securities, municipal securities, government-sponsored enterprise securities, commercial paper and corporate notes as of December 31, 2022 and 2021 were due to changes in interest rates and not credit risk. We determined that the gross unrealized losses on our cash equivalents and marketable securities as of December 31, 2022 and 2021 were temporary in nature. Our exposure to unrealized losses may increase in the future due to the economic pressures or uncertainties associated with local or global economic recessions as a result of the ongoing COVID-19 pandemic and ongoing geopolitical events, such as the current military conflict between Ukraine and Russia, as well as recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure. We review our investments quarterly to identify and evaluate whether any investments have indications of possible other-than-temporary impairment. Factors considered in determining whether a loss is temporary include the length of time and extent to which the fair value has been less than the amortized cost basis and whether we intend to sell the security or whether it is more likely than not that we would be required to sell the security before recovery of the amortized cost basis. We currently do not intend to sell these securities before recovery of their amortized cost bases.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value on a Recurring Basis</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We categorize financial instruments recorded at fair value on our consolidated balance sheets based upon the level of judgment associated with inputs used to measure their fair value. The categories are as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:1.453%;"></td>
      <td style="width:6.624%;"></td>
      <td style="width:2.137%;"></td>
      <td style="width:89.786%;"></td>
     </tr>
     <tr style="height:10.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></p></td>
     </tr>
     <tr style="height:10.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#x2019;s anticipated life.</span></p></td>
     </tr>
     <tr style="height:10.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</span></p></td>
     </tr>
    </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A financial instrument&#x2019;s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Below is a description of the valuation methodologies used for financial instruments measured at fair value on our consolidated balance sheets, including the category for such financial instruments.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds and certificates of deposit are categorized as Level 1 within the fair value hierarchy as their fair values are based on quoted prices available in active markets. Commercial paper, U.S. Treasury securities, municipal securities, government-sponsored enterprise securities and corporate notes are categorized as Level 2 within the fair value hierarchy as their fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">118</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9fa638eb-a216-4331-91a8-65e8b7cebb0d" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true" continuedAt="F_9fa638eb-a216-4331-91a8-65e8b7cebb0d_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents information about our financial instruments that are measured at fair value on a recurring basis as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 and indicates the fair value category assigned.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:44.762%;"></td>
        <td style="width:1.196%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.81%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.978%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:12.006%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.978%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.935%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.978%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.359%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements at Reporting Date Using</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted Prices in</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Active Markets for</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identical Assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)(2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6af94f60-d14c-46f9-8d81-f6e285dee2b4" contextRef="C_1bd32fc3-5385-4fc1-8876-a5ae5a63137b" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,864</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f777006-9859-4b19-aa7b-a77d7850a6f3" contextRef="C_b2a2ed0b-eacb-4d70-8bd1-ea1bfa4295ef" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,864</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of deposit</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(2)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11dbd71a-8e2c-4046-b773-4ac04c59485a" contextRef="C_a277aece-144d-41bf-ac57-a96d6580356c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">271</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_33fa973f-91c2-419e-8db5-584f2cb4a498" contextRef="C_15ca08dc-811e-4853-9a21-7cadf99c377c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">271</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73f06beb-fc41-46e1-9985-2de7cb4820bf" contextRef="C_c1282d3f-c653-4ad5-895b-9c6f061f0d82" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,921</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f1df1cd0-58a9-4ae5-ad23-e514cba34ea3" contextRef="C_8cfe8a11-2aaf-4633-afe2-e2611965102d" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,921</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24d3ff94-4ced-4072-a2fd-b2c0f1dda975" contextRef="C_771ba2f2-3a2e-49fa-95cf-19050fec9326" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,976</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83be3b42-c0ad-4e9c-8273-d1664ed0ffe1" contextRef="C_5c61e68e-3e69-41cb-8620-6254f8ecadab" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,976</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93485a8c-38d0-4436-97fd-44c4857433db" contextRef="C_3ddd7b62-3be3-4f53-81bf-05b1841c6fb1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,846</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d3f4aa34-1298-4b1f-aea7-d9ccf55026fa" contextRef="C_2fbdf3b1-b70e-4491-98dc-8a732e4ad69a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,846</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34d0f506-694b-4e3f-9062-a6cc4b00dcda" contextRef="C_65c0c19d-b9d5-425b-8f80-5c1480a5777f" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,199</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c7230486-97cb-4c58-a514-5f3ac50a9a09" contextRef="C_549c9ca4-a070-4d8b-8dea-097cccf0168e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,199</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_15c6376b-e2ec-443e-9f0e-49283bc71b60" contextRef="C_97fcaa43-bed8-4b86-a62c-6f9d8b9c790c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,959</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_af2b65ce-2ec5-448c-bbd7-9f4ee16cf3e8" contextRef="C_876ba767-8660-41ef-8db0-cd6ad696ef32" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,959</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c7c4330-c6e2-47cd-81f2-02315263588a" contextRef="C_dbeb080e-402b-4949-8760-3551ff83fae6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,135</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_179ec6aa-97bb-40f1-9028-5cef2f13b020" contextRef="C_5fc3a521-0418-415b-ac73-ad0099a49a25" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">115,901</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c48372ea-f181-451f-bdfd-79f0dae05c45" contextRef="C_6dfbe752-26a8-4b61-804f-713c8b76e3b2" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">156,036</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_505d5fdb-b051-4e32-bd6c-4e11c6e68cb8" contextRef="C_1d4e0718-b0bc-4bde-abe3-dd33013adfd1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,207</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06275670-892a-4005-89bc-60b7343dfce0" contextRef="C_6c35c921-9678-4686-aae9-1f7c867e1bf1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,207</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)(4)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4f5e7a78-5677-450b-a9fa-48628fe677d5" contextRef="C_cedb5760-788e-4697-a91b-595a15fe918f" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,088</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3582f90f-3775-4e1f-ae86-a776d587bed6" contextRef="C_2df5fcf2-ae81-4411-9005-55dc5786810b" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,088</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(4)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_887d520a-f9ba-4ee6-a8cc-908bd6f8c62b" contextRef="C_0dfd4851-82fe-4cb9-8ea1-8e34b2a9c816" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,985</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93274db8-4a19-4b24-8ab3-f2058ace4c3a" contextRef="C_82638e68-0f41-4c08-bac3-823ad702cd9a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,985</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c6b974f-bc70-477c-b36f-9d7101cf1bc2" contextRef="C_2df0f37c-c30d-41b8-bfdd-adc5d10dafdf" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,493</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9144d2f2-c38a-4590-8d25-7c4ccae27ce5" contextRef="C_648decac-61a1-4e4b-9ed3-d82a76be83ef" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,493</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)(3)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_557acbea-1636-4a35-ba40-6a892a0128fd" contextRef="C_67437463-073a-4955-8276-418e60d06173" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">91,861</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6fdf8edc-7923-4996-aca2-f95942d6f1f1" contextRef="C_4f5a5bab-8021-4724-80ff-5ed5222dffe6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">91,861</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)(4)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6cc28668-a96c-4fc1-a9df-13699b24add0" contextRef="C_00475ab1-e9e1-429c-8b5f-a7102a011121" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60,574</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9383275d-10e9-425c-8ad5-675667c6a6bf" contextRef="C_73738e9e-def3-4ee6-be15-64304b5e3b63" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60,574</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_58a9cf0f-a89d-4c04-869c-f52b8e86c4d4" contextRef="C_49598f56-03d9-4dbd-bdcf-22537e7a9cdc" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,207</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8f3d3a80-45cb-4f08-98c5-01bfe9e94915" contextRef="C_d2345eb5-3285-459c-8d09-b6264509d71b" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">185,001</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e8deb56-e867-4ed0-9cf1-1ecff95a437e" contextRef="C_638535ad-bd14-404f-b802-160cfe13fd2e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">209,208</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:74.074%;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_9fa638eb-a216-4331-91a8-65e8b7cebb0d_1"><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in cash and cash equivalents on our consolidated balance sheets.</span></div></div><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in restricted cash on our consolidated balance sheets.</span></div></div><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in current portion of marketable securities on our consolidated balance sheets.</span></div></div><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in noncurrent portion of marketable securities on our consolidated balance sheets.</span></div></div></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Investment</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2007, we received </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae3c75c7-3228-49cc-911b-544e56289a04" contextRef="C_51f08322-078d-49e5-a68a-9be92cd9298d" name="us-gaap:InvestmentOwnedBalanceShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,842,625</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> ordinary shares in Sienna Cancer Diagnostics Limited, or Sienna, in connection with a license we granted to them for our hTERT technology for use in human diagnostics. The shares, which represented less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c96825ad-dd63-4670-91a0-c4d07da81615" contextRef="C_17094203-716a-4cd1-bfc5-d68528adcc58" name="gern:CostMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="INF">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% ownership, were recorded at a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b08b7af9-73cd-43c6-921c-689e296b6a68" contextRef="C_1e9362c9-abee-4e6e-9b1f-44d66edd6913" name="gern:CostMethodInvestmentsCostBasis" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cost basis under the cost method of accounting, upon receipt. Since the adoption of ASU 2016-01 on January 1, 2018, we reassessed the fair value of our equity investment in Sienna at each reporting date and any resulting change in fair value was recognized on our consolidated statements of operations. In April 2020, Sienna announced its merger with BARD1 Life Sciences Limited, or BARD1, subject to approval by Sienna&#x2019;s shareholders. Effective August 3, 2020, the merger was complete, and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_240d987c-0fbd-4137-92bd-904baf57be45" contextRef="C_d86d7526-9741-423f-bbce-ccac767d714b" name="us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we received 13 BARD1 shares for every five shares of Sienna ordinary shares, resulting in our ownership of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3ed7d8e4-5cab-46de-9c3b-c515d50d7d4f" contextRef="C_0c264877-8e22-46f9-81fb-86523d23e816" name="us-gaap:InvestmentOwnedBalanceShares" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">35,990,825</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of BARD1.</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the first quarter of 2021, we sold all of our holdings in BARD1 and recognized a net gain of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8cc4a44-dad6-4969-abd5-c34772fc8c84" contextRef="C_7ec69a5c-401a-4250-9b22-6bf9e011ced3" name="us-gaap:RealizedInvestmentGainsLosses" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">1,233,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the sales, including gains from foreign currency translation adjustments, which has been included in other income and expense on our consolidated statements of operations. As of March 31, 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e0bbdae5-bd56-49aa-88f1-3661d4804891" contextRef="C_ceb4ddb1-f869-4bd6-84c2-9da20049ed84" name="us-gaap:InvestmentOwnedBalanceShares" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> value remained for our equity investment in BARD1.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently place our cash, restricted cash, cash equivalents and marketable securities with </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a62c9782-7a2f-4a0a-943a-c1c36a91dbeb" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:NumberOfFinancialInstitutions" unitRef="U_Institution" decimals="INF" format="ixt-sec:numwordsen">five</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> financial </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">institutions in the United States. Generally, these deposits may be redeemed upon demand and therefore, bear minimal risk. Deposits with banks may exceed the amount of insurance provided on such deposits. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents and marketable securities. Cash equivalents and marketable securities currently consist of money market funds,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">119</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">government-sponsored </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">enterprise securities, U.S. Treasury securities, municipal securities, commercial paper and corporate notes. Our investment policy, approved by the audit committee of our board of directors, limits the amount we may invest in any one type of investment issuer, thereby reducing credit risk concentrations. However, we are exposed to credit risk in the event of default by the financial institutions holding our cash and cash equivalents to the extent recorded in our consolidated balance sheets. We have not experienced any losses in such accounts and we believe that we are not exposed to significant credit risk of our financial position at the depository institutions in which those deposits are held.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1e444280-68c2-4619-8fd4-ceff34c38238" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. PROPERTY AND EQUIPMENT</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_bb82eae4-9dd5-4509-8dc8-f9d93517ae07" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, stated at cost, is comprised of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.186%;"></td>
        <td style="width:1.214%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.701%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.214%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.686%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and computer equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ee07adf-2cb7-4a2d-9b2a-54fef239fd83" contextRef="C_7763dbfa-0c47-4691-b0c0-db932124a4fd" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,554</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a787a4f-a0f3-4a69-a0a5-0d85c9a13acf" contextRef="C_c5ddc099-a29b-4862-ab9f-bc6cd0c2eeb4" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,171</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_54cb97ee-8818-416d-83c8-b1d55c24e2c3" contextRef="C_7edff532-41dd-4915-82d0-0b9e814e4cc5" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">135</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0e957d55-68ad-4dce-b706-98badae66e1c" contextRef="C_7499ed6b-e67c-4f6e-a715-1f45f02f42a6" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">129</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be23151a-21ee-4858-a612-513d152cd6c7" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,689</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e3dbe35-b2c9-43c6-b10c-43c244ced846" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less accumulated depreciation and amortization</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c04e4b9f-698a-42f6-9d6f-d314c384ded9" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">896</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba1f9e7c-84ac-4ac7-8fdb-0d59c8d89f00" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">650</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d2298e9f-305e-4326-9f1e-f6abb67a748c" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3">793</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e01d2a13-d419-487c-ad9a-c4667a468d33" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3">650</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f3a24461-5e06-427a-805e-26811dfde2ce" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. LICENSE AGREEMENT</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Janssen Pharmaceuticals, Inc. License Agreement</span></p><p style="text-indent:4.587%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On September 15, 2016, we entered into the License Agreement with Janssen Pharmaceuticals whereby we granted to Janssen Pharmaceuticals an exclusive worldwide license, or the Exclusive License, under our proprietary patents for the research, development and commercialization of products based on specialized oligonucleotide backbone chemistry and novel amidates for ribonucleic acid interference. In addition to the Exclusive License, we granted to Janssen Pharmaceuticals a non&#x2011;exclusive worldwide license, or the Non&#x2011;Exclusive License, under our patents covering the synthesis of monomers. This agreement was terminated effective April 2021.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5. ACCRUED LIABILITIES</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_830f0a46-343a-4026-89c3-ccc4263dd07f" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued liabilities consisted of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;">&#160;</p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_800086c0-1420-4494-9098-962e4ad2693f" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:58.192%;"></td>
        <td style="width:1.964%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.933%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.964%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.948%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CRO and clinical trial costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3833a5b2-4063-4313-b885-7f4dc4551d21" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,040</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5d1d4e7-7353-422d-ba11-9abcaa779033" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="gern:AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,804</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing activities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_76079f50-66f8-4597-811c-715cdc7815c7" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:AccruedManufacturingActivitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,321</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0cdd597-3b9d-4203-93a8-363c74e5afb2" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="gern:AccruedManufacturingActivitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,123</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Professional legal and accounting fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a38c90e-e8eb-453a-8dbb-4adf9d0b6902" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f81e58e2-2568-46a0-8c13-1841dfb5b8bb" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,030</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest payable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d5e19f6-9879-4871-8e6d-9f55f2be135e" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">561</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a44238b8-a01b-42f6-a5c1-57d70f5dca07" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:InterestPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">336</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_047209bf-b12d-46a5-a705-3a6a3386368a" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">510</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ece60b8c-f941-46d0-9dbe-e59f5f1c3d6d" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">541</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93c72b3c-7b8c-4097-b701-a9e21311ea4d" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">33,100</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b883de7-ca2d-4277-a20b-185e2e33e9c5" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,834</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b06fe4c6-8182-4870-8f9a-82854693a01a" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. COMMITMENTS AND CONTINGENCIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purported Securities Lawsuits</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 23, 2020 and March 5, 2020, three securities class action lawsuits were filed against us and certain of our officers. One of the lawsuits was voluntarily dismissed on March 19, 2020. The other two lawsuits, filed in the U.S. District Court, or the Court, for the Northern District of California, or the Northern District, were consolidated by the Court on May 14, 2020, and on August 20, 2020, the lead plaintiffs filed a consolidated class action complaint. The consolidated class action complaint alleges violations of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in connection with allegedly false and misleading statements made by us related to IMbark during the period from March 19, 2018, to September 26, 2018. The consolidated class action complaint alleges, among other things, that we violated Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5 by failing to disclose facts related to the alleged failure of IMbark to meet the two primary endpoints of the trial, spleen response rate and Total Symptom Score, and that our stock price dropped when such information was disclosed. The plaintiffs in the consolidated class action complaint seek damages and interest, and an award of reasonable costs, including attorneys&#x2019; fees. On October 22, 2020, lead plaintiffs filed an amended consolidated class action complaint.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">filed a motion to dismiss the amended consolidated class action complaint on November 23, 2020. On April 12, 2021, the Court granted in part and denied in part our motion to dismiss. Our answer to the amended consolidated class action complaint was filed on May 13, 2021. On September 30, 2021, lead plaintiffs filed their motion for class certification, and on April 2, 2022, the Court granted the lead plaintiffs&#x2019; motion for class certification. On </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1a254a5e-8af0-4782-8ee4-6475a505731a" contextRef="C_5972d6c9-9d7e-481d-990f-61c5b5a57683" name="us-gaap:LossContingencySettlementAgreementDate"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 2, 2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the parties agreed to a settlement and entered into a Stipulation and Agreement of Settlement, or the Stipulation, which is subject to court approval. On October 13, 2022, the Court preliminarily approved the parties&#x2019; settlement, permitted notice to be distributed to the class members, and scheduled a final approval hearing for March 30, 2023. Final approval of the settlement is subject to a number of conditions and contingencies out of our control. There can be no guarantee that all of these conditions and contingencies will occur. Should a material condition or contingency to the settlement fail to occur, one or both of the parties to the settlement may exercise their right to terminate the settlement agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the Stipulation, in exchange for the release and dismissal with prejudice of all claims against the defendants in the consolidated class action complaint, we agreed to pay and/or to cause our insurance carriers to pay a total of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_38155b31-d7da-43f5-8742-81fef595ed2f" contextRef="C_5972d6c9-9d7e-481d-990f-61c5b5a57683" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">24,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, comprised of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0ee9ba9a-e302-4601-9a48-cd9c5bd17434" contextRef="C_5972d6c9-9d7e-481d-990f-61c5b5a57683" name="us-gaap:PaymentsForLegalSettlements" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">17,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash, which was paid into an escrow account under our available D&amp;O insurance coverage and, at our election, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ddc0d484-a4a1-4485-ae16-2b587d3714b3" contextRef="C_5972d6c9-9d7e-481d-990f-61c5b5a57683" name="gern:LitigationSettlementAmountPaidInCashOrKind" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">7,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in either shares of our common stock and/or cash which is payable after final approval of the settlement by the Court. The proposed settlement does not constitute an admission of fault or wrongdoing by Geron or our Chief Executive Officer. The proposed settlement remains subject to final approval by the Court and certain other conditions. As of December 31, 2022, our portion of the settlement amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7aeba221-ab95-40e1-85b9-3d08c8deeef6" contextRef="C_acfe2948-7468-4c15-a637-904a59f62dc4" name="gern:LitigationSettlementAmountAccruedLiabilitiesRecognized" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_fcfe520e-a486-41b3-a967-fa62cabe74a5" contextRef="C_4ff1bc89-e218-42c3-bcc6-62cce404dde7" name="gern:LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">7,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has been included in accrued liabilities on our consolidated balance sheets and recognized as general and administrative expense on our consolidated statements of operations for the year ended December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between April 23, 2020 and June 8, 2021, seven shareholder derivative actions were filed, naming as defendants certain of our current officers and certain current and former members of our board. Of these actions, or the Derivative Lawsuits, two were filed in the Northern District, two were filed in the Court of Chancery of the State of Delaware, two were filed in the U.S. District Court for the District of Delaware, and one was filed in the Superior Court of California for the County of San Mateo, respectively. The plaintiffs in the Derivative Lawsuits allege breach of fiduciary duty and/or violations of Section 14 of the Exchange Act, based on the same underlying facts as the consolidated class action lawsuit described above. The plaintiffs seek damages, corporate governance reforms, equitable relief, restitution, and an award of reasonable costs, including attorneys&#x2019; fees. The status of the seven Derivative Lawsuits is currently as follows:</span></p><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 2, 2021, we filed a motion to dismiss the consolidated shareholder derivative actions filed in the Court of Chancery of the State of Delaware, or the Chancery Court Derivative Lawsuits. On September 1, 2021, the plaintiffs filed a consolidated amended complaint in the Chancery Court Derivative Lawsuits. On October 12, 2021, we filed our motion to dismiss the consolidated amended complaint. The Court of Chancery of the State of Delaware heard oral argument on the motion on February 15, 2022, and, on June 22, 2022, issued an order staying its decision on our motion to dismiss until after final resolution of the consolidated class action lawsuit described above. On December 21, 2022, the parties in the Chancery Court Derivative Lawsuits entered into a Stipulation of Settlement, or the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the Chancery Court Derivative Lawsuits. A final approval hearing regarding the Derivative Stipulation has been scheduled for May 17, 2023. Final approval of the settlement is subject to a number of conditions and contingencies out of our control. There can be no guarantee that all of these conditions and contingencies will occur. Should a material condition or contingency to the settlement fail to occur, one or more of the parties to the settlement may exercise their right to terminate the settlement agreement;</span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated shareholder derivative actions filed in the U.S. District Court for the District of Delaware have been stayed pending the ruling on our motion to dismiss the Chancery Court Derivative Lawsuits. On </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_765c81e5-7098-40b7-a283-6b0f09043b20" contextRef="C_e1ca1ecd-84e7-44b0-9101-90008f265fe7" name="us-gaap:LossContingencySettlementAgreementDate"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 21, 2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the parties in the consolidated District of Delaware derivative actions entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated District of Delaware derivative actions;</span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated shareholder derivative actions filed in the Northern District were initially stayed through the ruling on our motion to dismiss in the consolidated class action lawsuit described above and then subsequently were stayed through the ruling on the lead plaintiffs&#x2019; motion for class certification in the consolidated class action lawsuit. Subsequent to the grant of class certification in the consolidated class action lawsuit, on May 3, 2022, the Northern District entered an order providing plaintiffs until June 7, 2022, to file an amended complaint. On June 7, 2022, plaintiffs filed an amended shareholder derivative complaint. On July 6, 2022, the Northern District entered an order staying the consolidated shareholder derivative actions filed in the Northern District until the earlier of either a public </span></div></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">121</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcement of a settlement in the consolidated class action lawsuit or a final, non-appealable judgment in the consolidated class action lawsuit. The stay has subsequently been extended on a number of occasions and the case is currently stayed through March 31, 2023. On December 21, 2022, the parties in the consolidated derivative actions in the Northern District entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated derivative actions in the Northern District; and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our motion to dismiss the shareholder derivative action pursuant to the forum selection clause in our amended and restated bylaws was filed in the Superior Court of California for the County of San Mateo on August 5, 2021. At the hearing on the motion to dismiss on November 2, 2021, the court granted our motion to dismiss and stayed the case until April 19, 2022. At the case management conference on April 19, 2022, the court continued the stay until June 14, 2022. At the case management conference on June 14, 2022, the court continued the stay until December 13, 2022. On December 13, 2022, the court dismissed the action without prejudice.</span></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the Derivative Stipulation, in exchange for the release and dismissal with prejudice of all claims against the defendants in the consolidated shareholder derivative actions filed in the Northern District, we agreed to pay and/or to cause our insurance carriers to pay a total of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90011956-ec57-4ca8-8b75-0eb5bea7bcad" contextRef="C_e1ca1ecd-84e7-44b0-9101-90008f265fe7" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">1,350,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, comprised of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa3e44d8-8331-40ba-ba26-ab832ba9d8e3" contextRef="C_e1ca1ecd-84e7-44b0-9101-90008f265fe7" name="us-gaap:PaymentsForLegalSettlements" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">525,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash, which is payable under our available D&amp;O insurance coverage and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_26dc1a00-c96d-42f2-9058-441bc53c7d15" contextRef="C_ad743706-922f-45c0-83cd-2d0300569661" name="gern:LitigationSettlementAmountToBePaid" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">825,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash payable by us. The proposed settlement remains subject to final approval by the Court and certain other conditions, upon which the settlement amounts are payable. The proposed settlement does not constitute an admission of fault or wrongdoing by our current officers or current and former members of our board. As of December 31, 2022, we have recorded the total settlement amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_817eaa41-0241-432c-a5fc-de09227715b0" contextRef="C_dbfbf1d8-b44a-4e72-892f-10af9a860032" name="gern:LitigationSettlementAmountAccruedLiabilitiesRecognized" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">1,350,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as accrued liabilities and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dd7f432e-a448-4150-93dd-196bdd8eb9a2" contextRef="C_dbfbf1d8-b44a-4e72-892f-10af9a860032" name="gern:LitigationSettlementAmountInterestAndOtherReceivableRecognized" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">525,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as interest and other receivables on our consolidated balance sheets. For the year ended December 31, 2022, we have recognized our portion of the settlement of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ff19dec7-2015-47ff-bc5b-356dfcabb6bc" contextRef="C_510d1c51-dbe3-4e7b-b27f-0d63cbea1e18" name="gern:LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">825,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as general and administrative expense on our consolidated statements of operations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The pending lawsuits and any other related lawsuits are subject to inherent uncertainties, and the actual defense and disposition costs will depend upon many unknown factors. The outcome of the pending lawsuits and any other related lawsuits is necessarily uncertain. We could be forced to expend significant resources in the defense against the pending lawsuits and any other related lawsuits, and we may not prevail. In addition, we have and may continue to incur substantial legal fees and costs in connection with such lawsuits. As discussed above, we have recorded the total settlement amount for the Derivative Stipulation on our consolidated balance sheets as of December 31, 2022 and our portion of the settlement amount under the Stipulation remains accrued on our consolidated balance sheets as of December 31, 2022. We currently are not able to estimate the possible additional costs to us, if any, from these matters, and we cannot be certain how long it may take to resolve the pending lawsuits or the possible amount of any damages or legal costs that we may be required to pay. Such amounts could be material to our consolidated financial statements if we do not prevail in the defense against the pending lawsuits and any other related lawsuits, or even if we do prevail. We have not established any reserve for any potential liability relating to the pending lawsuits and any other related lawsuits, other than settlement amounts under the Stipulation and the Derivative Stipulation. It is possible that we could, in the future, incur judgments or enter into settlements of claims for monetary damages.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnifications to Officers and Directors</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our corporate bylaws require that we indemnify our directors, as well as those who act as directors and officers of other entities at our request, against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceedings arising out of their services to Geron. In addition, we have entered into separate indemnification agreements with each of our directors and officers which provide for indemnification of these directors and officers under similar circumstances and under additional circumstances. The indemnification obligations are more fully described in our bylaws and the indemnification agreements. We purchase standard insurance to cover claims or a portion of the claims made against our directors and officers. Since a maximum obligation is not explicitly stated in our bylaws or in our indemnification agreements and will depend on the facts and circumstances that arise out of any future claims, the overall maximum amount of the obligations cannot be reasonably estimated.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">have an Amended and Restated Severance Plan, or Severance Plan, that applies to all employees that are (i) above the Vice President level, (ii) hired by the Company before January 1, 2022, or (iii) not subject to performance improvement plans, and provides for, among other benefits: (i) a severance payment upon a Change of Control Triggering Event and Separation from Service and (ii) a severance payment for each non&#x2011;executive employee upon a Non&#x2011;Change of Control Triggering Event and Separation from Service. As defined in the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">122</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Plan, a Change of Control Triggering Event and Separation from Service requires a &#x201c;double trigger&#x201d; where: (i) an employee is terminated by us without cause in connection with a change of control or within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_09e760f4-d1ea-46db-8d04-b97c51b8556b" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months following a change of control provided, however, that if an employee is terminated by us in connection with a change of control but immediately accepts employment with our successor or acquirer, the employee will not be eligible for the benefits outlined in the Severance Plan, (ii) an employee resigns because in connection with a change of control, the offered terms of employment (new or continuing) by us or our successor or acquirer within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_88ca92b5-fb2a-4bbf-9677-8f395c1fe46a" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> days after the change of control results in a material change in the terms of employment, or (iii) after accepting (or continuing) employment with us after a change of control, an employee resigns within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eee41229-4689-4d9f-a92b-9e1c66b475f1" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months following a change of control due to a material change in the terms of employment. Under the Severance Plan, a Non&#x2011;Change of Control Triggering Event and Separation from Service is defined as an event where a non&#x2011;executive employee is terminated by us without cause. Severance payments range from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_a1a45976-6577-45f6-bd62-311e76651aed;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1087b65f-5751-4d71-bfb8-11827646016b" contextRef="C_baba9cae-f153-4485-a773-5ab5408054ab" name="gern:LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months of base salary, depending on the employee&#x2019;s position with us, payable in a lump sum payment. The Severance Plan also provides that the provisions of employment agreements entered into between us and executive or non&#x2011;executive employees supersede the provisions of the Severance Plan. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, all our executive officers have employment agreements with provisions that may provide greater severance benefits than those in the Severance Plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Global Economic Conditions, COVID-19 and the Military Conflict Between Ukraine and Russia</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of the date of this filing, significant uncertainty exists concerning the ultimate duration and severity of the COVID-19 pandemic and the military conflict between Ukraine and Russia. Both of these events have caused widespread, continually evolving and unpredictable impacts on global societies, economies, financial markets and business practices. With respect to the COVID-19 pandemic, we are closely monitoring the impact of the pandemic, the identification of new variants of the COVID-19 virus and related developments, and our focus remains on promoting employee health and safety while continuing to advance the development of imetelstat. For both our Phase 3 clinical trials, IMerge and IMpactMF, we have limited ongoing clinical trial activity in Ukraine and Russia, but we have experienced, and may continue to experience, delays and suspensions in clinical trial activities at clinical sites in Ukraine and Russia due to the current political and civil unrest conditions. With support from our CRO, we are monitoring the impact of the conflict on our clinical trial activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the dynamic and unpredictable effects of the COVID-19 pandemic, we have had and expect to continue to have disruptions and/or delays in our imetelstat development program, including with respect to our ability to initiate trial sites, enroll and assess patients, maintain patient enrollment, ensure patient clinical and lab collection visits, conduct monitoring visits, supply study drug, report trial results, and interact with regulators or other important agencies due to limitations in employee resources or otherwise. Restrictions on travel, availability of site personnel, and diversion of hospital staff and resources to COVID-19 patients, have disrupted our trial operations, as well as patient recruitment in many areas, resulting in a slowdown in patient enrollment and/or deviations from or disruptions in key clinical trial activities, such as clinical trial site initiation and monitoring. If the effects of the COVID-19 pandemic continue and/or become more severe, we could experience significant disruptions to our clinical development timelines, delays in clinical site initiation and patient enrollment in IMpactMF, IMproveMF and the investigator-led trial IMpress, and other disruptions that could severely impact our business and the imetelstat development program.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have taken and intend to take those actions with regard to COVID-19 that may be required by federal, state or local authorities or that we determine are in the best interests of our patients, investigators, employees and stockholders. In response to the COVID-19 pandemic and previous &#x201c;shelter in place&#x201d; and similar orders issued by state and local governments, we have allowed voluntary access to our offices in California and New Jersey to employees who have been vaccinated, and almost all of our employees continue to work remotely without any significant disruption to our business. Our increased reliance on personnel working remotely could increase our cybersecurity risk, create data accessibility concerns and make us more susceptible to communication disruptions, any of which could adversely impact our business operations. These and similar, and perhaps more severe, disruptions in our operations could occur which would negatively impact our business and business prospects, our financial condition and the future of imetelstat.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The effects of the COVID-19 pandemic and the military conflict between Ukraine and Russia, including the significant sanctions imposed against Russia, as well as broader economic conditions, including inflation, rising interest rates, the prospects for recession, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure have increased market volatility and could result in a significant long-term disruption of global financial markets, reducing or eliminating our ability to raise additional capital, which could negatively affect our liquidity, our ability to complete IMpactMF, IMproveMF and the investigator-led trial IMpress and to commence, conduct and complete any other potential future clinical trials of imetelstat. In addition, the global</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">123</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">economic slowdown caused by, among other things, the COVID-19 pandemic and the military conflict between Ukraine and Russia, as well as inflation, rising interest rates, the prospects for recession, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures could materially and adversely affect our business and the value of our common stock.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The extent to which global economic conditions, including those resulting from the COVID-19 pandemic, the military conflict between Ukraine and Russia and recent and potential future bank failures, ultimately impact our business, our regulatory and clinical development activities, clinical supply chain and other business operations, as well as the value of and market for our common stock, will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time, such as the ultimate duration and severity of the pandemic, travel restrictions, quarantines, social distancing and business closure requirements in the United States, or U.S., and in other countries, the effectiveness of actions taken globally to contain and treat COVID-19, whether the military conflict between Ukraine and Russia resolves in a timely manner, or at all, and whether the U.S. and/or international banking system stabilizes in light of recent and potential future bank failures. Accordingly, we do not yet know the full extent of potential delays or impacts on our business, our regulatory and clinical development activities, clinical supply chain and other business operations or the global economy as a whole. However, these effects could materially and adversely affect our business and business prospects, our financial condition and the future of imetelstat.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5009d16e-1fdf-4017-858d-f67ef64ecea8" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7. OPERATING LEASES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">New Jersey Office Space Lease</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2019, we entered into an operating lease agreement for office space located at 3 Sylvan Way, Parsippany, New Jersey, or the New Jersey Lease. The initial term of the New Jersey Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2840dc8f-02ec-4055-8df9-3ed3d4cf8418" contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear"><ix:nonNumeric id="F_2a1d9d1e-6f06-405a-bde9-6b9fef282624" contextRef="C_2160f3d4-592d-437d-adaa-f0dadac52a38" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></ix:nonNumeric></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years with an option to extend for an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_521584fa-c8ce-4f1d-815b-94c747ea92f2" contextRef="C_2160f3d4-592d-437d-adaa-f0dadac52a38" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b7a52ad0-dee9-4ade-b242-3ac2e928f051" contextRef="C_a85bc201-e73d-4e53-910e-2be441096a11" name="us-gaap:LesseeOperatingLeaseOptionToTerminate"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one-time option to terminate the New Jersey Lease without cause as of the 103</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">rd</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> month anniversary of the commencement date of the lease</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The New Jersey Lease commenced on October 1, 2019, upon our control of the office space on that date. Based on the initial term of the New Jersey Lease of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4d0c8433-8df2-4748-afe6-8a5f184c6bf2" contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years, the right-of-use asset and corresponding operating lease liability was approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46595661-86eb-46de-96f8-a9d9eb8103cf" contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_d0ab8ed7-63af-41ff-91c1-531d50ac743f" contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">2,356,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which represented the present value of lease payments over the initial lease term, net of a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_48f2f8e2-230b-4509-a631-eee3967935c1" contextRef="C_c9710e3f-58c2-40a2-971c-f2229ca8bfa7" name="gern:OperatingLeaseRentAbatementPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seven-month</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> rent abatement period, using an incremental borrowing rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_06d931b5-3e09-46e0-8c5b-e669f5bb6902" contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6" name="us-gaap:LesseeOperatingLeaseDiscountRate" unitRef="U_pure" scale="-2" decimals="INF">8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% based on information available as of October 1, 2019. Under the New Jersey Lease, we are also obligated to pay certain variable expenses separately from the base rent, including electricity and common area maintenance. Such costs are being expensed in the period they are incurred. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the remaining lease term for the New Jersey Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fe208b5a-aee1-429f-b4a5-a1264e1c9fc8" contextRef="C_eb51ffc8-633d-41e3-86c8-d3c430b99a37" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.8</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foster City Office Space Lease</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2019, we entered into an operating lease agreement for office space located at 919 East Hillsdale Boulevard, Foster City, California, or the Foster City Lease. The initial term of the Foster City Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b867f02d-7f6c-4999-9464-7f269f1a10ff" contextRef="C_537e337a-f742-4d0a-a5b6-5cf335eb225f" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months with an option to extend for an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b00c550f-4bf7-49f4-b2b9-9f05235489d2" contextRef="C_537e337a-f742-4d0a-a5b6-5cf335eb225f" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Foster City Lease commenced on March 10, 2020, upon the substantial completion of all tenant improvements. As of the lease commencement date, the right-of-use asset and corresponding operating lease liability was approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9aeca14e-54d9-4781-8bc6-b984c62188d6" contextRef="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_d40d40c7-ac47-4a55-9802-a804bf6c53ab" contextRef="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">3,426,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which represented the present value of remaining lease payments using an incremental borrowing rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f954f64c-a70b-440e-8a0e-7e66976b3870" contextRef="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b" name="us-gaap:LesseeOperatingLeaseDiscountRate" unitRef="U_pure" scale="-2" decimals="INF">7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% over the initial lease term of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b9e7c974-0aab-4faa-9ed9-6c312a047b76" contextRef="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months, net of a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_719ec7f7-ec1f-4aa0-af60-f1ba0cc6912f" contextRef="C_a5a96aa2-9ab9-4312-a1d6-6a03ed292708" name="gern:OperatingLeaseRentAbatementPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three-month</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> rent abatement period. Under the Foster City Lease, we are also obligated to pay certain variable expenses separately from the base rent, including taxes and common area maintenance. Such costs are considered non-lease components and have been excluded from the calculation of the right-of-use asset and corresponding operating lease liability and are being expensed in the period they are incurred. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the remaining lease term for the Foster City Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a1ecad3a-59ea-488b-9ae3-2e47a341a3d6" contextRef="C_20457731-c8fd-4ab5-9a21-4c427a763c88" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.5</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_161fdccc-61a6-431c-901c-55e6af7ed0f3" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:LeaseCostTableTextBlock" escape="true" continuedAt="F_161fdccc-61a6-431c-901c-55e6af7ed0f3_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of lease costs included in operating expenses on our consolidated statements of operations for the New Jersey Lease, the Foster City Lease and a lease from a former location in Menlo Park, California, were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:18.733%;"></td>
        <td style="width:21.617%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.904%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:2.524%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:15.754000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:3.125%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:15.342%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cebdfb35-3d03-4bf5-8e20-dfde0b67795c" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">944</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cde9534d-d8e0-4c7f-ad0a-b0567f5858be" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">946</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2f6ef6ae-d1c1-456e-ac9a-919bab91bf40" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,143</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable lease costs</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">&#160;(1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_79b62e59-a9fe-461c-9fdb-14dc7e5831b1" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">310</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7a541b0b-a77e-4ad5-9615-88b9c78ff17c" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">252</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_59042701-01b4-4c33-b5a5-c859e7351f67" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">293</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e6f9e96-e608-4d3d-b3b9-cdce265fa5fe" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,254</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5f86042-5d67-4f94-91d9-0bf3c0af14ef" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,198</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_648b2a89-daa1-4e80-becf-3a1e003ebd47" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,436</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:10.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:60.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">124</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><div><ix:continuation id="F_161fdccc-61a6-431c-901c-55e6af7ed0f3_1"><div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.588888888888889%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable lease costs represent non-lease components, such as common area maintenance charges.</span></div></div></ix:continuation></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1756aa3a-f44a-4bcb-8d4f-e5e55c9f4586" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undiscounted future non-cancellable lease payments under the New Jersey Lease and the Foster City Lease as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 were as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:35.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.834%;"></td>
        <td style="width:2.869%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:26.296%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_02530a9a-004a-4774-85d8-138e8144a63a" contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">962</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c7eb1234-ddbe-4028-a953-8d72ea3fdbdd" contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">987</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_99188610-3f7f-44ee-9343-4131eca5bb62" contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,014</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_874e1a72-9b18-4d79-858d-67bcdbb61c59" contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,040</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_36e59dd8-24be-4b90-b783-e36ce0137b68" contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">717</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f253b66-a9b2-47d9-8ca1-1c32a7895f72" contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,050</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0003e8cd-2eb0-4e24-9e67-96feff35a604" contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,770</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a6478d92-486a-43ea-9613-d289b5a9d4b6" contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,174</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_41d33d20-b5fc-4dce-ae59-c31224d4bf71" contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,596</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_39aff3ee-409d-4b0b-bbaa-eb95f51d36b7" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:DebtDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8. DEBT</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On September 30, 2020, or the Closing Date, we, Hercules Capital, Inc., or Hercules, and Silicon Valley Bank, or SVB, entered into a term loan facility, or the Term Loan, up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_64b7d170-5434-4bac-a1e5-328c5c110321" contextRef="C_0d35dd6e-fea6-436e-9ee7-9ee08382b573" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">75,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which was amended in August 2021, or the Original Loan Agreement. On June 30, 2022, or the Effective Date, we entered into a second amendment to the Original Loan Agreement, or as amended, the Loan Agreement. Under the second amendment, the aggregate principal amount available to us increased from $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0a2a6464-c6aa-40fc-8638-4f501c95ac6b" contextRef="C_0d35dd6e-fea6-436e-9ee7-9ee08382b573" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">75,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0d6b901c-7bdf-46f8-8eb9-274a9f0776c6" contextRef="C_d1078eed-3e6a-4e01-b62d-1ba7e0711b75" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">125,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, with such principal being available in a series of tranches, subject to certain terms and conditions. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, a total of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90ad4614-12df-4936-983d-c3004c93a1dd" contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">50,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has been drawn under the Loan Agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the second amendment, the $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b57691bf-dfcc-4627-b4a6-35389672524f" contextRef="C_7b1c8d57-8ddb-43ec-96da-0180f39ff551" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">75,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in remaining loan principal as of December 31, 2022 can be drawn as follows: (a) the first tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2a6ca239-620a-4f56-8bdd-b042d528cac2" contextRef="C_964ca538-6017-4a3b-b8a2-c9d92e9678f0" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is available within the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7f967be2-35c8-49e7-b3cb-5bf98a9e85e5" contextRef="C_4c2322a1-867d-4db1-bcb9-a772d5cbd539" name="us-gaap:LineOfCreditFacilityBorrowingCapacityDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">earlier of 30 days of the achievement of certain clinical and financial milestones or September 15, 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, subject to the achievement of such milestones; (b) the second tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52a067da-1224-4f7c-b82c-53b0e1660e09" contextRef="C_c435dd46-e5e9-46ae-a67c-f00cecd6b5ca" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is available from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5cb18157-d17c-487c-817e-6f4d885250a5" contextRef="C_b32a587f-ad3d-4276-b2dd-b2191eb465c3" name="gern:BorrowingAvailableStartDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 1, 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> until </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fd25b100-9ea6-4ae2-a94c-24ede5b94d66" contextRef="C_b32a587f-ad3d-4276-b2dd-b2191eb465c3" name="gern:ExpiryDateOfTranche" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 15, 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain other requirements; (c) the third tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7184006f-9d3d-434d-95e6-827f2e5751a9" contextRef="C_47db9b05-7d9e-4426-bef0-d9bcedf945c6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is available from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3c5dbc2f-cd1c-46ae-bf10-38775ca1b8dd" contextRef="C_76e00114-46f1-4f21-825f-b517b415c860" name="gern:BorrowingAvailableStartDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 15, 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> until </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_44b5e0fc-7829-4d7d-a021-19a0487e1120" contextRef="C_76e00114-46f1-4f21-825f-b517b415c860" name="gern:ExpiryDateOfTranche" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 15, 2024</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain capitalization requirements; and (d) the final tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_67fdb34f-1599-4075-897c-1ca10d2fccf6" contextRef="C_de7e0e4c-33d2-4fbd-abef-d98a0ee733d6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">25,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is available through </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7739ded1-9b99-4ab8-807b-751d63402504" contextRef="C_f076ddd2-9af8-4327-95c6-3a61cf5015db" name="gern:ExpiryDateOfTranche" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2024</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, subject to approval by an investment committee comprised of Hercules and SVB (or its successor, if any). However, on March 10, 2023, the Federal Deposit Insurance Corporation, or FDIC, issued a press release stating that SVB was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. Of the remaining term commitments under the Loan Agreement, Hercules and its affiliates hold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8f9b066-8fce-400d-924f-0cc26e442841" contextRef="C_4dd4d649-9e3f-43f2-a911-a45ce22da643" name="gern:PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">65</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_852f6543-7425-4e0b-becf-66e316e95f3a" contextRef="C_9097bf2a-3ae2-4f30-af86-bb131d89eb94" name="gern:PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">35</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% were held by SVB. As a result of the closure of SVB, we do not know whether and to what extent we would be able to draw down the remaining $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_233881b9-5e4f-44dd-888f-0845d2551299" contextRef="C_88b14be1-08cb-441b-9cd9-8b8e631765f9" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">55.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million under the Loan Agreement, even if we meet the conditions set forth in the Loan Agreement necessary for additional draw downs, and it is possible that we will not be able to access any additional funding under the Loan Agreement. With the exception of the final tranche, and subject to achievement of the applicable milestones and other requirements with respect to each tranche, draw downs are at our election.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the second amendment, the maturity date, interest only payment dates, end of term charges, collateral, events of default, representations, warranties and covenants remain consistent with the terms of the Original Loan Agreement, except as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </span></p><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beginning June 1, 2022 and prior to the regulatory approval for imetelstat, or the potential Regulatory Approval, if any, we are required to maintain a minimum cash balance in an amount equal to the greater of: </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_480ff979-4b5b-4f2f-ab0a-5ef5c6eedc77" contextRef="C_aecbaf53-81e4-4762-8e18-b6fdfe03ee7f" name="gern:DebtCovenantMinimumCashBalancePercentageOfLoanAmount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the outstanding principal amount under the Loan Agreement or $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c67c2947-e217-418c-9c62-4bad3c262d84" contextRef="C_aecbaf53-81e4-4762-8e18-b6fdfe03ee7f" name="gern:DebtCovenantMinimumCashBalance" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">30,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After the potential Regulatory Approval, if any, the minimum cash requirement may be satisfied through one of the following three options, as elected by us: (a) maintaining a cash balance in an amount not less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fe602f76-2bea-4413-988e-d6f616665552" contextRef="C_a42e573b-f7ea-45fe-a906-765e787d71d7" name="gern:DebtCovenantMinimumCashBalancePercentageOfLoanAmount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">40</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the outstanding principal amount under the Loan Agreement; (b) maintaining a cash balance in an amount not less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52a4fde6-48c0-40ef-8de8-1d334a848334" contextRef="C_cb27a432-0c32-4ac0-85da-f75446291e71" name="gern:DebtCovenantMinimumCashBalancePercentageOfLoanAmount" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the outstanding principal amount under the Loan Agreement, if our market cap is or exceeds $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5cb9078e-3ab0-4a11-82ff-3dab1f811079" contextRef="C_3d47e697-4d40-47ed-be0f-6e5c7c2ad573" name="gern:MarketCapMinimumToUseOptionTwo" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">750,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; or (c) maintaining </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2ea1abc6-4610-4e3d-9fbe-9698df34dd85" contextRef="C_07596f55-6ae2-4a67-8b3a-4ad996e8ecda" name="gern:MinimumPercentageOfNetProductRevenuesMaintenancePeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">six month</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> net product revenues of at least </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_19094e9b-3601-41b2-a8be-efddd153a491" contextRef="C_07596f55-6ae2-4a67-8b3a-4ad996e8ecda" name="gern:DebtCovenantPercentageOfProductRevenueAgainstForecast" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">70</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of net product revenues forecasted by us, should any potential Regulatory Approval for imetelstat be obtained.</span></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On the Effective Date of the second amendment, we paid $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a383182e-7ccd-40ad-b2d6-ecafcf19fd97" contextRef="C_9a7438fe-fa93-48c8-875b-77ecf443a7b2" name="us-gaap:DebtInstrumentUnamortizedDiscount" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">100,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as a facility charge that we recognized as a debt discount and are amortizing such cost to interest expense over the life of the loan using the effective interest rate method. Additional facility charges applied to future draw downs will be treated similarly. We incurred approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_42600a5c-a1ec-40d1-87f2-9008d5f82d8f" contextRef="C_9a7438fe-fa93-48c8-875b-77ecf443a7b2" name="us-gaap:DeferredFinanceCostsGross" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">75,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">legal fees in connection with the second amendment, which we recognized as debt</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">issuance </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">costs and are amortizing such cost to interest expense over the life of the loan using the effective interest rate method. Future debt issuance costs will be treated similarly. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a6cc656c-25ff-4a0b-a130-e3c163718704" contextRef="C_55d50b28-7933-42d2-89ca-ec42b87d67cf" name="us-gaap:DebtInstrumentPaymentTerms"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the second amendment, if we choose to prepay the principal with respect to any future draw down after the Effective Date, any such prepayment within the first 36 months after the Effective Date will be subject to a prepayment charge equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4d59ba5-aa91-4e5a-bd76-ae5288cab8d3" contextRef="C_55d50b28-7933-42d2-89ca-ec42b87d67cf" name="gern:PercentageOfPrepaymentCharge" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount prepaid. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c2e07432-6efc-4f45-9232-60c7cc6ea5ef" contextRef="C_55d50b28-7933-42d2-89ca-ec42b87d67cf" name="gern:DollarPrepaymentCharge36MonthsAfterEffectiveDate" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> prepayment charge will be assessed for any prepayment occurring more than 36 months after the Effective Date.</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unchanged from the Original Loan Agreement, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_733a473f-72e4-4415-986e-16cf990c576a" contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8" name="us-gaap:LongTermDebtDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Term Loan matures on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_95a97b8a-176a-401c-9854-4a33d4414671" contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">October 1, 2024</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or the Loan Maturity Date, and may be extended up to an additional 12 months upon the achievement of certain clinical, regulatory and financial milestones.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1f2b60bd-80da-46db-a513-d23baa5a3c7d" contextRef="C_cd9ae385-7003-4516-b937-03283c53b8c7" name="us-gaap:DebtInstrumentInterestRateBasisForEffectiveRate"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Term Loan bears interest at a floating rate per annum equal to the greater of either (i) 9.0% or (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ddca00d5-9a18-4eb1-86cb-1c9ff741646a" contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="INF">9.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% plus the prime rate as reported in The Wall Street Journal (7.5% as of December 31, 2022) less 3.25%.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The Term Loan provided for an initial interest-only payment period from the Closing Date until November 1, 2022. As of December 31, 2022, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3890a213-531e-405a-968b-41ccd882df58" contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8" name="gern:InterestOnlyPeriodPaymentTermDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the interest-only period expires May 1, 2023. Upon the achievement of certain regulatory and financial milestones, the interest-only period may be extended for another six months until November 1, 2023.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Following the expiration of the interest-only period, we will repay the Term Loan in equal monthly amortization payments of principal and interest until the Loan Maturity Date. Upon full repayment of the Term Loan, we are also obligated to pay an end of term charge in an amount equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d44ae4b0-b034-400a-9fec-955f2cfe2e58" contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8" name="gern:DebtInstrumentEndOfTermChargePercentage" unitRef="U_pure" scale="-2" decimals="INF">6.55</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the amount of the Term Loan actually borrowed. Such end of term charge is being accrued to interest expense over the term of the Term Loan using the effective interest rate method. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_bc4ea700-0b1a-43d8-a4f6-7b015809bb8f" contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8" name="us-gaap:DebtInstrumentPaymentTerms"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At our option, upon at least five business days&#x2019; prior written notice to Hercules, we may prepay all or any portion greater than or equal to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_497475d6-5e7d-491f-a299-874386748518" contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8" name="gern:DebtInstrumentMinimumPrepaymentAmount" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">5,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the outstanding loan by paying the entire principal balance (or portion thereof) and all accrued and unpaid interest. Such prepayment is subject to a prepayment charge of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_49615cbf-55d7-406f-acc3-2ebbfb425653" contextRef="C_55d50b28-7933-42d2-89ca-ec42b87d67cf" name="gern:PercentageOfPrepaymentCharge" unitRef="U_pure" scale="-2" decimals="3">1.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the prepayment amount, if the prepayment is made in any of the first 36 months following the Closing Date for any draw downs prior to the second amendment. Thereafter, any prepayment is not subject to a prepayment charge.</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Term Loan is secured by substantially all of Geron&#x2019;s assets, except our intellectual property, which is the subject of a negative pledge. The Term Loan contains certain representations and warranties, affirmative covenants, negative covenants and conditions that are customarily required for similar financings. We are in compliance with the covenants under the Term Loan as of December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of default (subject, in certain instances, to specified grace periods), the principal, interest and any other monetary obligations on all the then outstanding amounts under the Term Loan may become due and payable immediately. Upon the occurrence of an event of default, a default interest rate of an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_689a0d66-835c-4944-b4b8-3f79457431a9" contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8" name="gern:PercentageOfInterestOnPastDueOutstanding" unitRef="U_pure" scale="-2" decimals="INF">5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% may be applied to the outstanding principal balance, and Hercules, as the administrative agent, may declare all outstanding obligations immediately due and payable (subject, in certain instances, to specified grace periods) and take such other actions as set forth in the Term Loan. Upon the occurrence of certain bankruptcy and insolvency events, the obligations under the Term Loan would automatically become due and payable.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Embedded Derivatives and Debt Discounts</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The conditional exercisable call option related to the event of default is considered to be an embedded derivative which is required to be bifurcated and accounted for as a separate financial instrument. In the periods presented, the value of the embedded derivative is not material and therefore, no amount has been recognized. If an event of default becomes more probable than is currently estimated, then the embedded derivative could become material in future periods and would be recognized as a separate financial instrument at that time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the net carrying value of the Term Loan was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ea7898d9-275e-470a-af8e-0b9ba1a545e8" contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff" name="us-gaap:LongTermDebt" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">51,157,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which includes the principal amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e959572a-d135-495c-b8fa-2940799a3c3a" contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">50,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> less the net unamortized discounts and debt issuance costs of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fd958ceb-4ae7-485d-8583-445e781eb43f" contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff" name="us-gaap:UnamortizedDebtIssuanceExpense" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">628,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> plus accrued end of term charge of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_156bb9c2-288c-466a-b483-809019fb9f43" contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff" name="gern:AccruedEndOfTermCharges" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">1,785,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The carrying value of the debt approximates the fair value as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022. The debt discounts and debt issuance costs are being amortized to interest expense over the life of loan amounts under Term Loan using the effective interest rate method.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">127</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future Minimum Payments</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a63e070f-1fb1-4bf0-b0e8-b104fb71af41" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents future minimum payments, including interest and the end of term charge, under the Term Loan as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:61.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.622%;"></td>
        <td style="width:12.76%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:19.618%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_748e85e9-e064-42a9-bbed-32c6a0d3efd0" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,843</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b0e620e-d3cb-4e6e-84a0-5bf840b5a88e" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34,160</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1f67d879-19c1-4092-b9c6-fc68f6e3d34d" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:LongTermDebtGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">61,003</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  amount representing interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b5cd3aac-cae6-41ed-8b33-2bf31a19616c" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:InterestPayableCurrentAndNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,728</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  unamortized debt discount and issuance costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fac356a1-fb7b-4059-a0b8-954123bb825b" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">628</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  unamortized end of term charge</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_35557bac-db95-45c7-83fc-b6d4e567fe68" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:DebtInstrumentUnamortizedEndOfTermCharge" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,490</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  current portion of debt</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4f6c4b44-398a-432c-a79c-75c64097ba0e" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20,945</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noncurrent portion of debt</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bc127c92-0e7d-48ef-9a50-e991de49a8ef" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,212</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d82dd132-687f-4ab6-94f7-0a6424fc4820" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9. STOCKHOLDERS&#x2019; EQUITY</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Authorized Common Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2021, our stockholders approved an amendment to our Restated Certificate of Incorporation to increase the total number of authorized shares of common stock from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57f0894e-7d07-453a-aa24-e0dd449cf363" contextRef="C_ee96da23-ae41-4e87-8c4d-c559a324f7a6" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">450,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e8f48a10-47de-48b4-aa47-2e44bbd7d78f" contextRef="C_de96a085-6c20-4cd2-b653-9124bc246e53" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">675,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public Offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 1, 2022, we completed an underwritten public offering of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77a57e34-fada-4f9f-aefc-f0cbc8f06226" contextRef="C_7cb51813-f174-40c0-8540-44661459217d" name="gern:ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">53,333,334</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock and a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ba8796f-4fb6-4b3e-995c-eb8fab5ead22" contextRef="C_dd0bdc01-735d-4224-95b4-e75ddebf918f" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,095,238</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, or the 2022 pre-funded warrant, together with accompanying warrants to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_407d6526-be33-45bc-9b00-ccada9e4f419" contextRef="C_9a854c1d-782a-4c0f-9f77-518042e397b3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">35,714,286</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, also known as the 2022 stock purchase warrants. The shares of common stock and the 2022 pre-funded warrant were immediately separable from the 2022 stock purchase warrants. All of the securities were issued separately. The combined public offering price of the common stock and accompanying 2022 stock purchase warrants was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2a371f13-5921-4e37-9181-66ab969f8f18" contextRef="C_57eb8407-20bb-4fe8-b65e-a963754a7c2b" name="us-gaap:SharesIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.05</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. The 2022 stock purchase warrants have an exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c6e0e946-f12b-4614-9f75-56ef2b814b5f" contextRef="C_9a854c1d-782a-4c0f-9f77-518042e397b3" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.45</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share and are exercisable immediately. The term of the 2022 stock purchase warrants expires on the earlier to occur of (a) the date that is 30 business days following the date on which we first issue a press release disclosing, if applicable, that the United States Food and Drug Administration, or FDA, has accepted for filing a New Drug Application submitted to the FDA for imetelstat in Low or Intermediate-1 risk myelodysplastic syndromes and (b) April 1, 2027. The combined public offering price of the 2022 pre-funded warrant and accompanying 2022 stock purchase warrant was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_61c61bda-6b38-4263-8e99-56d427418217" contextRef="C_dd0bdc01-735d-4224-95b4-e75ddebf918f" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:numdotdecimal">1.049</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. The 2022 pre-funded warrant has an exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1fd68fac-588a-4bfd-9e3b-b9ab8ae334f8" contextRef="C_dd0bdc01-735d-4224-95b4-e75ddebf918f" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:numdotdecimal">0.001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share and may be exercised at any time until the 2022 pre-funded warrant is exercised in full. As of December 31, 2022, none of the 2022 pre-funded warrant and 2022 stock purchase warrants have been exercised. The net cash proceeds from this offering were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d5de05ff-fe76-48da-8e88-fa8193ff26e9" contextRef="C_7cb51813-f174-40c0-8540-44661459217d" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">69,916,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, after deducting the underwriting discount and other offering expenses paid by us, and exclude any future proceeds from the exercise of the 2022 pre-funded warrant and 2022 stock purchase warrants.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the issuance of the 2022 pre-funded warrant and 2022 stock purchase warrants, we evaluated the terms of each warrant to determine the appropriate accounting and classification pursuant to FASB Accounting Standards Codification Topic 480, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and FASB Accounting Standards Codification Topic 815,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Derivatives and Hedging</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Warrants are classified as liabilities when the warrant terms allow settlement of the warrant exercise in cash and classified as equity when the warrant terms only allow settlement in shares of common stock. The terms of the 2022 pre-funded warrant and the 2022 stock purchase warrants include certain provisions related to fundamental transactions and a cashless exercise provision in the event registered shares are not available, and do not include any mandatory redemption provisions. Based on our evaluation, we concluded the 2022 pre-funded warrant and the 2022 stock purchase warrants should be classified as equity with no subsequent remeasurement as long as such warrants continue to be classified as equity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Exercises</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the year ended December 31, 2022, warrants to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e398bc6-c699-411c-b4d9-4afb7208edd8" contextRef="C_b8581e38-a6e8-4457-9acf-b0368e005111" name="gern:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">11,663,387</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock were exercised for net cash proceeds of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52b238e9-2f06-493b-829b-d6cdd489e418" contextRef="C_20b70013-d0fe-4f60-92b2-60c28f12e1f9" name="us-gaap:ProceedsFromWarrantExercises" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,163,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The warrants were issued in connection with an underwritten public offering of common stock and a pre-funded warrant, together with accompanying stock purchase warrants in May 2020. As of December 31, 2022, the pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a0693b6-003d-4b4e-882c-3a5793ad5686" contextRef="C_4b658edd-fed5-40c3-886d-f2742643a130" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,335,239</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">128</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">common stock was outstanding and stock purchase warrants to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6f723d24-f914-4024-89af-0009ac0d7d96" contextRef="C_b8581e38-a6e8-4457-9acf-b0368e005111" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">44,110,079</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock associated with the May 2020 public offering remained outstanding.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On September 4, 2020, we entered into an At Market Issuance Sales Agreement, or the 2020 Sales Agreement, with B. Riley Securities, Inc., or B. Riley, pursuant to which we may elect to issue and sell shares of our common stock having an aggregate offering price of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0805f1de-babe-49c3-9b08-f7cd24fc29e4" contextRef="C_4cae8e78-c215-4912-8bd0-8a601c68ba56" name="gern:CommonStockAggregateOfferingPrice" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">100,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in such quantities and on such minimum price terms as we set from time to time through B. Riley as our sales agent. We agreed to pay B. Riley an aggregate commission rate equal to up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d95bccae-bec1-4f18-8fcd-4268c58ebad0" contextRef="C_4cae8e78-c215-4912-8bd0-8a601c68ba56" name="gern:MaximumCommissionRate" unitRef="U_pure" scale="-2" decimals="INF">3.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the gross proceeds of the sales price per share for common stock sold through B. Riley under the 2020 Sales Agreement. In connection with the 2020 Sales Agreement, we terminated the 2018 Sales Agreement. For the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we sold an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c4109632-d7ae-4f85-bf2e-874109b0bb7e" contextRef="C_04fded04-be5d-4eb8-81d5-fec058c4ac52" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,571,556</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock pursuant to the 2020 Sales Agreement, resulting in net cash proceeds to us of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_01018e86-6815-471f-b8d6-eadd63b22e70" contextRef="C_04fded04-be5d-4eb8-81d5-fec058c4ac52" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">20,385,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, after deducting sales commissions and other offering expenses paid by us. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e7adb5d-b0d2-4d63-bc5e-aac5f76e7cae" contextRef="C_4ee8d9b9-dc68-4df6-9be2-6f4529782e09" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock were sold pursuant to the 2020 Sales Agreement for the year ended December 31, 2022. The 2020 Sales Agreement will expire upon the earlier of: (a) the sale of all common stock subject to the 2020 Sales Agreement, or (b) September 4, 2023.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Plans</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2011 Incentive Award Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2011, our stockholders approved the adoption of the 2011 Incentive Award Plan, or 2011 Plan. The 2011 Plan provided for grants of either incentive stock options or nonstatutory stock options and stock purchase rights to employees (including officers and employee directors) and consultants (including non&#x2011;employee directors). Upon the adoption of the 2018 Equity Incentive Plan in May 2018 (see below), no further grants of stock options or stock purchase rights were made from the 2011 Plan. Stock options granted under the 2011 Plan expire no later than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5044c048-b181-42ae-ba50-8a690e9934f3" contextRef="C_9ec15f2a-f73b-4dc2-aa8c-a5bb91e19d44" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of grant. Stock option exercise prices were equal to the fair market value of the underlying common stock on the date of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Service&#x2011;based stock options under the 2011 Plan generally vested over a period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_40243fb9-db42-478b-bdc0-0a6f1dc267bc" contextRef="C_7912cfc0-c229-4fc9-8043-9b98680b2a7e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of the stock option grant. Other stock awards (restricted stock awards and restricted stock units) had variable vesting schedules which were determined by our board of directors on the date of grant. All outstanding awards granted under the 2011 Plan remain subject to the terms of the 2011 Plan and the individual award agreements thereunder.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Equity Incentive Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 15, 2018, our stockholders approved the adoption of the 2018 Equity Incentive Plan, or 2018 Plan, as the successor to the 2011 Plan. The 2018 Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, other stock awards, and performance awards that may be settled in cash, stock, or other property. Eligible participants under the 2018 Plan include our employees, consultants and non-employee directors. The number of shares reserved for issuance under the 2018 Plan (subject to adjustment for certain changes in capitalization) is equal to the sum of (i) the unallocated shares of common stock remaining available for grant under the 2011 Plan as of May 15, 2018, (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3293bddf-61bf-4770-b221-37c2ec5d3dc3" contextRef="C_cc50e10a-98c8-4c05-bd82-9e1ea746a195" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> newly reserved shares of common stock and (iii) the number of shares subject to awards granted under the 2002 Equity Incentive Plan, and the 2011 Plan as such shares become available from time to time, referred to as the Prior Plans&#x2019; Returning Shares. Such Prior Plans&#x2019; Returning Shares become available for issuance under the 2018 Plan if outstanding stock awards granted under the 2002 Equity Incentive Plan and the 2011 Plan, after May 15, 2018, expire or terminate for any reason prior to exercise or settlement or are forfeited, cancelled or otherwise returned to us because of the failure to meet a contingency or condition required for the vesting of such shares, or, subject to certain exceptions, are reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection with a stock award. In May 2022, May 2021 and June 2020, our stockholders approved amendments to our 2018 Equity Incentive Plan to increase the total number of shares issuable under such plan by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4c89f37-81b2-4377-81c2-0d0e3d21fe84" contextRef="C_2a6d46ff-973f-470e-82a2-82e94b643f46" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">11,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_63146c85-f4b6-4eb8-bc24-29aa22611be6" contextRef="C_b2e14894-763e-4f1a-963f-b97397735098" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">12,500,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80b5ceaa-b89e-4db5-88f2-82139d2351cb" contextRef="C_efcc9f37-8c8e-44d9-845b-1357eb47cb94" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,700,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options granted under the 2018 Plan expire no later than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fcbcf33d-1ad1-42d7-85b8-74d41b528f65" contextRef="C_81527741-3307-4f06-998a-99b34c4ab029" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of grant. Stock option exercise prices shall be equal to the fair market value of the underlying common stock on the date of grant. If, at the time we grant a stock option, the optionee directly or by attribution owns stock possessing more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_41bc07bc-1ac9-4cfe-9618-8399d011d3ff" contextRef="C_c2932c3c-e846-4bca-b1d9-5fb417e16d20" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue" unitRef="U_pure" scale="-2" decimals="INF">10</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the total combined voting power of all classes of our stock, the stock option exercise price shall be at least </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf7a47fb-780e-43c7-aac5-68d4e2e40600" contextRef="C_c2932c3c-e846-4bca-b1d9-5fb417e16d20" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock" unitRef="U_pure" scale="-2" decimals="INF">110</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">129</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fair </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">market value of the underlying common stock and shall not be exercisable more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f69636d6-7ce4-470b-8043-2d30f64cc2e1" contextRef="C_2300d06c-433b-4ed1-92b5-9487bbe32374" name="gern:ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> after the date of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We grant service-based and performance-based stock options to employees under the 2018 Plan. Service-based stock options generally vest over a period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_54ac5b91-ae14-4bbe-864a-07f26bf14f3c" contextRef="C_2300d06c-433b-4ed1-92b5-9487bbe32374" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of the stock option grant. Performance-based stock options vest upon the achievement of specified milestones. Other stock awards (restricted stock awards and restricted stock units) have variable vesting schedules as determined by our board of directors on the date of grant.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under certain circumstances, stock options may be exercised prior to vesting, subject to our right to repurchase the shares underlying such stock option at the exercise price paid per share. Our repurchase rights would generally terminate on a vesting schedule identical to the vesting schedule of the exercised stock option. During 2022 and 2021, we did not repurchase any shares under the 2018 Plan. As of December 31, 2022, we have no shares outstanding subject to repurchase under the 2018 Plan.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, our Non&#x2011;Employee Director Compensation Policy adopted by our board of directors in March 2014 and amended and restated in February and March 2022 provides for the automatic grant to non&#x2011;employee directors of the following types of equity awards under the 2018 Plan:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">First Director Option.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Each person who becomes a non&#x2011;employee director, whether by election by our stockholders or by appointment by our board of directors to fill a vacancy, will automatically be granted a stock option to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ef950d16-2bdc-4631-84b9-42c01bbacc60" contextRef="C_ff678df4-6021-4567-a09d-3093fe7f6409" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">200,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, or First Director Option, on the date such person first becomes a non&#x2011;employee director. The First Director Option vests annually over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eca4dd0b-c89e-4b54-9077-269df70d7325" contextRef="C_fd3dace5-dba8-440f-ae0b-9ef36f749a0b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon each anniversary date of appointment to our board of directors.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Subsequent Director Option.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Each non&#x2011;employee director (other than any director receiving a First Director Option on the date of the annual meeting) will automatically be granted a subsequent stock option to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d123ad63-376a-42bc-9615-5bfaf109cc97" contextRef="C_09482968-6804-42ef-b55a-7e47a1585b7a" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">125,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, a Subsequent Director Option, on the date of the annual meeting of stockholders in each year during such director&#x2019;s service on our board of directors. The Subsequent Director Option vests in full on the earlier of: (i) the date of the next annual meeting of our stockholders or (ii) the first anniversary of the date of grant.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2006 Directors&#x2019; Stock Option Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2006 Directors&#x2019; Stock Option Plan, or 2006 Directors Plan, was terminated by our board of directors and replaced by the 2011 Plan in March 2014. No further grants of stock options were made from the 2006 Directors Plan upon the 2006 Directors Plan&#x2019;s termination. All outstanding awards granted under the 2006 Directors Plan remain subject to the terms of the 2006 Directors Plan and the individual award agreements thereunder.<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The stock options granted to non-employee directors under the 2006 Directors Plan were nonstatutory stock options, and they expire no later than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0aeccd82-7dfb-4a83-a9f5-cd839cf130d3" contextRef="C_edd74574-ef0b-4838-bc41-a10ed60b1539" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of grant. The option exercise price was equal to the fair market value of the underlying common stock on the date of grant. The first director option granted to non-employee directors under the 2006 Directors Plan vested annually over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_aa59f26b-9ad7-476d-b474-7cd6c7e3bb59" contextRef="C_a1d6bb34-0ef3-4d19-8ba5-2d252c631a2d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon each anniversary date of appointment to the board of directors. The subsequent director option granted to non-employee directors on the date of the annual meeting of stockholders in each year during such director&#x2019;s service on our board of directors under the 2006 Directors Plan vested </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_523911fb-e01d-437d-a5cc-7ddf336bdb50" contextRef="C_b205ee9d-75ed-48cf-b5e9-efc423b1fd1d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of grant.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Inducement Award Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2018, our board of directors approved the adoption of the 2018 Inducement Award Plan, or the Inducement Plan, pursuant to which we reserved </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6ef2fb4a-0f2e-4040-8c83-1361fcf808f3" contextRef="C_8f1b3c92-0ecb-4923-9ca5-2be4cf72dc09" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock to be used exclusively for grants of inducement awards to individuals who were not previously Geron employees or non-employee directors, other than following a bona fide period of non-employment. As of December 31, 2022, an aggregate total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2949ceb-6e69-4a47-87a3-ad128dbb54bc" contextRef="C_e7b46167-4167-4419-ac2b-387a17bd683b" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">21,100,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock have been reserved under the Inducement Plan.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Inducement Plan provides for the grant of nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and other stock awards, and all awards under the Inducement Plan are intended</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">130</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to meet the standards under Rule 5635(c)(4) of the Nasdaq Listing Rules. The terms and conditions of the Inducement Plan and the inducement awards to be granted thereunder are substantially similar to our stockholder-approved 2018 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Directors&#x2019; Market Value Stock Purchase Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2018, our board of directors adopted a Directors&#x2019; Market Value Stock Purchase Plan, or the Directors Market Plan. A total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3b8510b4-b7a0-4524-995c-3146d8e6384a" contextRef="C_133df937-8209-4564-b4d5-073c7409a5c5" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock has been reserved for the Directors Market Plan. Under the Directors Market Plan, non-employee directors may purchase shares of our common stock at the prevailing market price on the purchase date with cash compensation payable to them for their services as a board member. As stated in Geron&#x2019;s Non-Employee Director Compensation Policy, each non-employee director receives annual cash compensation, payable quarterly in arrears, for their services on the board and various committees of the board. As provided in the Non-Employee Director Compensation Policy, a non-employee director may elect to receive fully vested shares of common stock in lieu of cash and such shares shall be issuable from the Directors Market Plan.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the years ended December 31, 2022, 2021 and 2020, we issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7d6146f9-b512-4380-9eaa-f98b81ae8a7f" contextRef="C_6c5c907c-4ae9-4b51-a14d-03a3b5e1c929" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,962</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4eece075-5aa4-45a3-8a12-4ff7558ebf29" contextRef="C_7d2260f7-9b52-4e12-9966-22d0182d746c" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,783</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eb73cf49-96f9-4bad-8e32-d3bd6f9b9a1e" contextRef="C_2a620b62-e7da-4c15-931d-242b957c2e33" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">17,986</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, respectively, from the Directors Market Plan. The weighted average grant date fair value of stock granted during the years ended December 31, 2022, 2021 and 2020 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_33b66040-dea7-4ee4-acab-81ffa5018099" contextRef="C_6c5c907c-4ae9-4b51-a14d-03a3b5e1c929" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.92</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a8cd68d1-3fa1-412b-8465-61e9aa215ecd" contextRef="C_7d2260f7-9b52-4e12-9966-22d0182d746c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.38</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3fa92f4-52d5-4acd-8928-8cab305dc4ca" contextRef="C_2a620b62-e7da-4c15-931d-242b957c2e33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.60</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively. The total fair value of vested stock grants during 2022, 2021 and 2020 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_280b10c4-27fb-4671-984c-440187db7a39" contextRef="C_6c5c907c-4ae9-4b51-a14d-03a3b5e1c929" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">29,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_491d3759-3aa9-4cdb-a39f-d6cab71f31cf" contextRef="C_7d2260f7-9b52-4e12-9966-22d0182d746c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">29,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3974ee1d-ab23-4a66-8d1b-0ff77a059f79" contextRef="C_2a620b62-e7da-4c15-931d-242b957c2e33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">29,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4003598e-554e-4006-9156-455dfd9de929" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate stock option and award activity for the 2011 Plan, 2018 Plan, 2006 Directors Plan, Inducement Plan and Directors Market Plan is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:34.976%;"></td>
        <td style="width:0.086%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.64%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.086%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.08%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.681%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.712%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.086%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.904%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.086%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.663%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding Stock Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intrinsic</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Available</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contractual Life</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For Grant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78975e5b-bb8b-44c4-99dd-5f610fe10464" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,763,393</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_43e1ea6a-af0b-448d-9370-cd7f4c87356a" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">49,952,409</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e26b17db-95d2-4b83-97c3-1cd337c15ae2" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">2.06</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional shares authorized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae77cab6-4a01-4d5b-b622-dfdcbc6f48ce" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">16,755,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options granted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1fdd3b76-7b58-4bf2-84d3-48b4918b5d88" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">19,747,760</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_69ded81d-3629-4329-ba13-442e034addcc" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">19,747,760</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_20ddb810-a42c-41ea-8a7c-1ae2f2b662de" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.37</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Awards granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7412d7c6-516c-499c-af27-cfc26681e0d4" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">15,962</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_40d0f99a-fbb0-4dfb-8ff9-e93262897a46" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,181,711</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfc43d39-39db-4a4c-b9ad-a088c618d573" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.52</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options cancelled/forfeited/expired</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2a878ebb-a078-4a38-b0ff-4a6ff5791972" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:ShareBasedCompensationForfeituresAndExpirationsInPeriodNet" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,616,058</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4f177dd-90cf-4b32-b9ac-625ed68635eb" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,616,058</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11f83080-d707-49a3-b941-f30ac39addf2" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.70</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8fa9b5f8-f191-41c8-bf19-567d6b416b95" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,370,729</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_70e6805c-5c34-4388-8411-ad1221efb6a0" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">65,902,400</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5be2351-45c1-4785-a1bf-146d6ff21aff" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.87</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6a97a782-88ea-433f-be0c-c880adb326b3" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.56</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a010dc66-8dba-4b6a-87be-3672fc37a9a9" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,205</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options exercisable at <br />&#160;&#160;December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db5373d0-3fd3-4240-9709-00ac1a69118e" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">36,085,389</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_61b7ae74-bab5-4d5b-a659-7f45763973ae" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">2.17</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d68afe90-84f6-43cd-a1a5-5e320809f8c1" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.09</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4f92ed98-0783-4fb1-bd6c-4289e69902de" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,878</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options fully vested and expected<br />&#160;&#160;&#160;&#160;to vest at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9afdc9d7-0d70-4bf0-a3e5-6c491c1ad227" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">64,539,649</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7e9c0a5d-f017-433e-8f54-bd78e46625b8" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.88</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c663ff87-b555-47f1-bacb-64fa9f9600f9" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.52</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5a995545-ff4b-4fc9-88ce-56c78337d012" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,951</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:76.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.13%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Includes </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5c7508a6-c43d-411a-9566-168b3966cd51" contextRef="C_6f3c409b-23a5-42d9-b49c-56b851f33720" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,791,750</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> performance-based stock options granted that have not achieved certain strategic milestones.</span></div></div></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on Geron&#x2019;s closing stock price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c375c8f3-0750-41fd-8b6b-f7e98e9e5522" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">2.42</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, which would have been received by the option holders had all the option holders exercised their stock options as of that date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have not granted any stock options with an exercise price below or greater than the fair market value of our common stock on the date of grant in 2022, 2021, and 2020. As of December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d4d94ea1-c802-4102-9ab1-e4fa377af158" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">36,085,389</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5389326c-f841-4104-ade2-e5dc940e4fa8" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">30,459,136</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_670b339a-2ab9-4606-a883-5fa0811c082c" contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">25,721,508</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> exercisable stock options outstanding at weighted average exercise prices per share of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6388fbd7-6eb0-4da5-bc61-dbca10a2a813" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">2.17</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_577ccbeb-6f67-408e-9fd6-4ff8db17dba8" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">2.35</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_527833c3-1f74-4a7c-b2e0-5fc81f1f4753" contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">2.54</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The total pretax intrinsic value of stock options exercised during 2022, 2021, and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8667204c-1b75-4bd1-9722-49758de99956" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">787,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db80b270-2928-46d0-966a-65b0bfd7465b" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">93,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f3f80ba8-e3fa-42ad-8b33-4ebd406264f1" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">17,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. Cash received from the exercise of stock options in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> totaled approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_93671365-8478-4a48-8097-5c1b658fe714" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">1,799,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e76dd25-141d-4727-bbc5-0cd59b53575b" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">556,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_afeeac90-b249-495e-b49f-0e165e49cfa6" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">25,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2014, our board of directors adopted the 2014 Employee Stock Purchase Plan, or 2014 Purchase Plan. The 2014 Purchase Plan was approved by our stockholders in May 2014. The 2014 Purchase Plan replaced the 1996 Employee Stock Purchase Plan, or 1996 Purchase Plan, which was terminated effective as of the date the 2014 Purchase Plan was approved by our stockholders. In May 2022, our stockholders approved an amendment to our 2014 Purchase Plan to increase the total number of shares issuable under such plan by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f6f3fb59-fd50-4db4-af0c-56fcedf3c2f0" contextRef="C_cdb043ed-5bb6-48a5-9edc-3b464d5cb5cb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, for an aggregate total reserve of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c508dff-6c01-484e-bddf-4e24bba62fbc" contextRef="C_1bf14810-4b41-4fda-8ccf-f5f7c92e07e4" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7d7e2849-c504-4599-81c4-af26b498ada0" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">868,236</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock have been issued under the 2014 Purchase Plan since its adoption.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2014 Purchase Plan is comprised of a series of offering periods, each with a maximum duration (not to exceed </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_cbe68772-3d59-4f3a-b684-9fb6feebab68" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months) with new offering periods commencing on January 1st and July 1st of each year. The date an employee enters the offering period will be designated as the entry date for purposes of that offering period. An employee may participate only in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9af148f0-300a-4bb4-a061-c56a68348f43" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime" unitRef="U_Item" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> offering period at a time. Each offering period consists of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c281951-79ee-4323-a96f-dc615a1a2128" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod" unitRef="U_Item" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> consecutive purchase periods of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c24b8de3-304d-4bdf-bae4-65876e98ea4c" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">six months</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2019; duration, with the last day of such period designated a purchase date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the 2014 Purchase Plan, employees can choose to have up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ef52b3c9-798e-4b37-ba78-b3a1886fa1fe" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld" unitRef="U_pure" scale="-2" decimals="INF">10</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of their annual salary withheld to purchase our common stock. An employee may not make additional payments into such account or increase the withholding percentage during the offering period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The purchase price per share at which common stock is purchased by the employee on each purchase date within the offering period is equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb3769b2-a22f-4c42-bbb0-53c344faf637" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" unitRef="U_pure" scale="-2" decimals="INF">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the lower of (i) the fair market value per share of our common stock on the employee&#x2019;s entry date into that offering period or (ii) the fair market value per share of our common stock on the purchase date. If the fair market value per share of our common stock on the purchase date is less than the fair market value at the beginning of the offering period, a new </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2a5101e7-0999-4ff4-81b6-64307d3141f3" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> month offering period will automatically begin on the first business day following the purchase date with a new fair market value.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock&#x2011;Based Compensation for Employees and Directors</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure and recognize compensation expense for all share&#x2011;based payment awards made to employees and directors, including employee stock options, restricted stock awards and employee stock purchases, based on grant&#x2011;date fair values for these instruments. We use the Black Scholes option&#x2011;pricing model to estimate the grant&#x2011;date fair value of our service-based and performance-based stock options and employee stock purchases. The fair value for service&#x2011;based restricted stock awards is determined using the fair value of our common stock on the date of grant.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As stock&#x2011;based compensation expense recognized on the consolidated statements of operations for the years ended December 31, 2022, 2021 and 2020 is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures, but at a minimum, reflects the grant&#x2011;date fair value of those awards that actually vested in the period. Forfeitures have been estimated at the time of grant based on historical data and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In 2022 and 2021, our board of directors awarded </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f9a0436e-5d8a-41d9-aac3-5526ad258cb0" contextRef="C_61a9529a-15e0-492a-891c-e7c1701d7744" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,741,750</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73788897-4dc4-4a41-ac4a-b0a88c1ff7e0" contextRef="C_00c2bd33-0379-417c-a384-344e1e28579a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">550,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> performance-based stock options, respectively, to certain employees. These performance-based stock options are included in the outstanding stock options table above. Performance-based stock options vest only upon achievement of discrete strategic milestones. Stock-based compensation expense for performance-based stock options is recognized over the period from the date the performance condition is determined to be probable of occurring through the date the applicable condition is expected to be met and is reduced for estimated forfeitures, as applicable. If the performance condition is not considered probable of being achieved, no stock-based compensation expense is recognized until such time as the performance condition is considered probable of being achieved, if ever. None of the performance-based stock options have vested.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_692b9105-0ff6-4de5-a951-63d71904a617" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize stock&#x2011;based compensation expense for service-based stock options on a straight&#x2011;line basis over the requisite service period, which is generally the vesting period. We have not recognized any stock-based compensation expense for performance-based stock options on our consolidated statements of operations for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020, as the achievement of the specified strategic milestones was not considered probable during that time. The following table summarizes the stock&#x2011;based compensation expense related to service-based stock options and employee stock purchases for the years ended December 31, 2022, 2021 and 2020 which was allocated as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.977%;"></td>
        <td style="width:1.268%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.517999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.268%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.517999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.268%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.183%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a6cb26e9-922b-4662-89ef-7aac836a0bfd" contextRef="C_944921c7-37fd-48a6-87d7-c57fd7ba68ce" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,720</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3c150b93-4fc0-4785-ad77-c6fb1c540009" contextRef="C_08938cfb-9117-4cc5-bf8f-c64669b9d0c1" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,597</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be6dc5cf-fece-4566-b85d-297266670a46" contextRef="C_50d35c3d-da63-429d-b83a-be9fed64780e" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,337</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8083e590-7173-4c88-bd99-bcfd0c474e2d" contextRef="C_c1671901-1570-4d9b-ac8b-2fea04dc608d" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,281</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eb62d023-bf08-4273-90af-d419cdae3d66" contextRef="C_a5f6ada7-da6a-4619-8ac7-5fa8e6c89e2d" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,483</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_13f8cc92-ffcd-476d-a566-6449b5b87b69" contextRef="C_affcd469-d055-47cc-bca1-8f79424c3ea3" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,558</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation expense<br />&#160;&#160;&#160;included in operating expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_107ddf3f-49c9-48a6-8e6a-04304f15d038" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,001</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_669f3af8-2fdd-4611-99f1-18621516f17d" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,080</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6adfe4e5-e613-484c-a380-be83f9edc1aa" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,895</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f29b4a3e-8816-4680-b247-57c20d832212" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of stock options granted in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020 has been estimated at the date of grant using the Black Scholes option&#x2011;pricing model with the following assumptions:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.489%;"></td>
        <td style="width:1.242%;"></td>
        <td style="width:16.253%;"></td>
        <td style="width:1.242%;"></td>
        <td style="width:16.253%;"></td>
        <td style="width:1.255%;"></td>
        <td style="width:16.266%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94b5212e-04ac-43a3-95cb-10cb875f1f27" contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8c09e4b-04e5-4182-80d2-a280cd0844f4" contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_00885e1e-50bd-45a9-b077-2e4fef99b8b7" contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_99417dd2-ee29-4197-8af9-f48331977e7a" contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.772</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_26e88c1a-e91e-4641-ae71-8647f3c862c8" contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.817</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c73d077-9ba3-4899-a291-2f74879d227d" contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.775</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6222972e-0df7-4256-aadc-44aa219435a8" contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.783</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8abe3a11-e1e7-4da7-8952-608f20be61e3" contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.781</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8acbcb8d-3ad8-414c-bf7f-920d4d4d4463" contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.793</ix:nonFraction></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate range</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e0c654db-8431-4e67-90c1-6d700fff1549" contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.69</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_521c297e-6941-43b7-87c7-4727e819017c" contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">4.57</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c314aae-9e5e-4dc7-8479-25b653d4665c" contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.51</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4205fafc-d4aa-4328-a999-9e9a982ab7cb" contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.30</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94defa0d-b9f9-4fea-8e2a-760c870431ff" contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.31</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_83518215-7d74-4038-9d19-35210167e622" contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.62</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4add4c93-5ca3-48cf-981a-3e52a6965910" contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;yrs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_87bd930e-6a76-4b9f-9b3e-646c43b9c4a2" contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;yrs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_914bd34b-6c90-40dd-acb3-bc04015c8c1b" contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.25</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;yrs</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8441ac1b-0b11-4056-a5bc-dfd5f3201c46" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of employee stock purchases in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020 has been estimated using the Black Scholes option&#x2011;pricing model with the following assumptions:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:39.984%;"></td>
        <td style="width:1.242%;"></td>
        <td style="width:22.503%;"></td>
        <td style="width:1.255%;"></td>
        <td style="width:16.8%;"></td>
        <td style="width:1.255%;"></td>
        <td style="width:16.96%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e120d1c-d920-49b0-b746-2a374305dc35" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bd3f921e-5078-412f-bd6b-0ffa60382fa0" contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c830b3c-5ac3-447d-a605-6f92f15705d0" contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bac49b16-5680-4113-959c-015999089997" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.614</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_92861eae-f85d-48c3-8fba-d76243f31ac1" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.865</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7425c6fc-d05b-4b88-816c-969a43f8a22d" contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.507</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9d4a01b9-e3fb-45e3-87e9-3200c79c580e" contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.707</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1a7c0f08-b6fd-4717-a507-57fe83eb2aa5" contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.478</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e7b38077-f7d8-4661-be15-09796b9a284c" contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="0" decimals="3" format="ixt:numdotdecimal">0.818</ix:nonFraction></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate range</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_420abcc6-6ede-4efe-99e6-c6fd0db16c7d" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.40</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3dbf9dce-21da-4147-81ad-e5f3d0c4101f" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">2.79</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3857abea-3b22-4c48-918d-8c03ef0567be" contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.09</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_26a365fb-4db9-41ea-a060-de8741c2d63c" contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.16</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a8d99c73-22dc-4251-89a3-4f83054dc1c5" contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">0.16</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34c59e6a-a6b1-4bf1-bbd3-fc2a3a5fcfe1" contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.57</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_74938194-0f3a-4ebe-96ba-fb5223eade33" contextRef="C_c72685f3-ef5b-4333-a58d-7abf3242e43e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;- </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b2ca85c4-7c02-4ff4-83bb-585417657de2" contextRef="C_3fa5ac2d-7b0a-4dc7-b48d-d537f56e2330" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;mos</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_09ca2a70-89d2-4737-8fb0-73f7f18791be" contextRef="C_7067ae1e-fdcb-4353-ba94-faa3c668d9a8" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;- </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_925ce1c2-b27f-48d7-ba9b-932d503a64ff" contextRef="C_4eef0fe5-3ea8-493b-b90b-931244691f4b" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;mos</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_180d1f71-92d8-4d7c-ba64-727fa389c35f" contextRef="C_8dde9c08-9af2-47ef-968f-e8dd40116f7c" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;- </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ceff665a-4ea1-44a7-b4e7-e080dbfd21e5" contextRef="C_60c0161f-8996-404d-9368-ce41e9ce095e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;mos</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield is based on historical cash dividend payments and we have paid no cash dividends to date. The expected volatility range is based on historical volatilities of our stock, since traded options on our common stock do not correspond to option terms and the trading volume of options is limited. The risk&#x2011;free interest rate range is based on the U.S. Zero Coupon Treasury Strip Yields for the expected term in effect on the date of grant for an award. The expected term of stock options is derived from actual historical exercise and post&#x2011;vesting cancellation data and represents the period of time that stock options granted are expected to be outstanding. The expected term of employees&#x2019; purchase rights is equal to the purchase period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on the Black Scholes option&#x2011;pricing model, the weighted average estimated fair value of stock options granted during the years ended December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a646c813-0323-49ea-92bc-da49892d2895" contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">0.92</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ca990e4a-d1d3-4069-a435-957bd9be665c" contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">1.17</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e99de40-f854-4e29-bbfc-fa031eada372" contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">0.88</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively. The weighted average estimated fair value of employees&#x2019; purchase rights for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e933395d-2e24-4d27-9177-3ed7b5419a76" contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">0.48</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c9c56c84-2d26-42e8-9d34-bf8504575571" contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">0.56</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d746ea8-1664-49e7-99d9-80eb696b88d8" contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">0.62</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, total compensation cost related to unvested share&#x2011;based payment awards not yet recognized, net of estimated forfeitures and assuming no probability of achievement for outstanding performance-based stock options, was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a13a28ea-c255-43f7-86b4-c680f9846574" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">17,791,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which is expected to be recognized over the next </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9177bb69-8dbe-4250-8b8d-797400b86900" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months on a weighted&#x2011;average basis.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock&#x2011;Based Compensation to Service Providers</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We grant stock options to consultants from time to time in exchange for services performed for us. In general, the stock options vest over the contractual period of the consulting arrangement. The fair value of stock options held by consultants is recorded as operating expenses over the vesting term of the respective equity awards. With the adoption of Accounting Standards Update 2018-07, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Improvements to Nonemployee Share-Based Payment Accounting</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2018-07, in the first quarter of 2019, the measurement date of stock options granted to consultants was fixed at the grant date.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recorded stock&#x2011;based compensation expense of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4b54841a-d454-4b45-b63f-2533a5924e19" contextRef="C_6a7a9685-7310-4141-b7de-f1f3a5fe3099" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">235,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3bc7ca2c-8daa-4f73-939e-ce306aead7dc" contextRef="C_603a7d01-dfd6-49d7-a945-469443432a26" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">62,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57ff2c8e-7e57-4bba-a61e-a116dcebe278" contextRef="C_f4b65990-18fd-492e-bb4e-3100622411aa" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">56,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the vested portion of the fair value of stock options held by consultants in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020, respectively.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock Reserved for Future Issuance</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_75b7465a-44ed-4757-b91d-166ff5c00b7e" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for future issuance as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:73.896%;"></td>
        <td style="width:1.674%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:22.43%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4317b650-712f-47bf-a3ca-56afb6a76673" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">65,902,400</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options and awards available for grant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dd681b18-d799-40e5-90f8-7a921c72cbef" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,370,729</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_47cf329a-f086-4e1f-b7b7-cca02adb21b4" contextRef="C_8e72c6e8-4130-431a-9367-bbc923943f0f" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,131,764</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_430e7b38-80ef-45db-bc8b-1876345cda71" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">106,254,842</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0d72299-89dd-48db-aa53-a55f0205e38e" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">191,659,735</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_f0b9250e-8eee-445b-9a1e-7973b16a4b68" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. INCOME TAXES</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_263edaef-b8d1-47d8-b7e7-c19c6d417f3d" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table reconciles the federal statutory tax rate to the effective income tax rate from continuing operations:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.158%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.196000000000002%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:3.305%;"></td>
        <td style="width:5.199%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.808%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:3.122%;"></td>
        <td style="width:4.295%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:7.612%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:3.305%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax at statutory rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_663b0887-8c46-48b6-be2c-bf3f24be2e5c" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8125d794-557e-4ea6-8c47-1932b98aa85a" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8a0ea1c5-d1a2-40c8-a5c3-09e5b87a306e" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income tax, net of federal benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_52e8f4bd-d59d-4ca2-9d12-1f07b88f09c2" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">6.8</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b905c28d-8a54-4787-bfe1-930c87715bc4" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">9.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2cafafa5-3037-4110-9022-efaa121d3065" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">6.9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal and state tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7e41f91b-cee3-4ba7-ada2-0f0f3ecd493a" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">4.9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e2d6d1a2-405e-4fbb-9306-21cc2e8541c0" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">5.7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3dabcfaf-66d5-4293-b1c1-373323c89ade" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">5.3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5b5a3ffc-2881-4bfb-a9e0-65734c429d35" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.8</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3319b949-eda0-46de-921a-b34846190b69" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">1.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_420b24a2-7a77-444d-bd70-1b405fba49d1" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net operating loss not benefitted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ffe1583a-96b7-4a02-abcf-67602c4da093" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">4.3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ac3bba0-fae9-45dd-9dcd-aef636d1ec17" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="gern:EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">5.4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_74ba33ea-8bab-42f5-8f99-0518ca078a8f" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="gern:EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">6.9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_53c450d3-fd94-40e5-bc8f-1c6c2c5fbd9c" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf5a659b-01e5-499b-a3d0-1c1412f09fdf" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db60b346-06f9-456a-9671-3b0d0e8beae1" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e84938c-ec39-46f0-88f1-ef8b90af8467" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">27.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e52c015a-5db4-4b43-889c-d52907b31993" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">28.9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5606259a-ce75-4137-ac11-6dd070d7cd85" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">25.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective tax rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a3c68ff-e709-42a3-b056-647d5bc6ef47" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4c783bf8-4ff0-47f4-b9d8-c250cd1e74e5" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_96f3a6c2-5e8c-4711-a6a1-821f2410337c" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_80d31dd6-508e-40da-b423-4f1b23a496d9" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_80d31dd6-508e-40da-b423-4f1b23a496d9_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of our deferred tax assets are as follows:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_80d31dd6-508e-40da-b423-4f1b23a496d9_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.802%;"></td>
        <td style="width:1.432%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.742%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.448%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.576%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_50c004f5-168e-4850-995e-e071522fe564" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">254,500</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed4d3eba-766f-4251-9395-15497c05ad4e" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">241,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal and state tax credits</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1569532b-aac8-4c64-8dc7-f3de84f5d604" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:DeferredTaxAssetsFederalAndStateCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">56,700</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_34a57cff-4c6c-4883-80d6-f0459cedaa75" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="gern:DeferredTaxAssetsFederalAndStateCredits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49,600</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e87225f-9e14-48fb-9411-5f31bd8a7259" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:DeferredTaxAssetsCapitalizedResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,800</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7238106c-db4b-4863-9887-d4e01a75257d" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="gern:DeferredTaxAssetsCapitalizedResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,900</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ca8817c5-2515-4d34-930f-1bc5acbb15ba" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,800</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_41f62b2b-232d-449f-93d0-232a7958de40" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,200</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_66f5b7ec-6c07-4edb-b65a-aea04ceaebcc" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:DeferredTaxAssetsOperatingLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29aed149-5329-407c-a4c2-60ac099b1d0a" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="gern:DeferredTaxAssetsOperatingLeaseLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,400</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ff92e230-529e-47a1-808e-b74c6ccdff4d" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,600</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_118b7347-7db9-4de9-b6d1-513d7ca1a256" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,600</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_eda03375-e7b4-4afb-aa55-54d04abc60ae" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">350,700</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfaf21bb-9c97-4ea9-8b8f-1e0ddd64304c" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">312,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fcdf3b29-519d-4bd8-8c2c-75dca6544e8e" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">349,600</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_868bcf2c-9027-4eff-83af-19860740f9fd" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">310,700</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3c88b19-3bd4-4711-a3b2-246f2e919625" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,100</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b30bf350-2d4c-41dd-be70-843cec22216d" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating leases, right-of-use assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3efa7186-e792-4a30-aa5b-06a3e0327ec3" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="gern:DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,100</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1cf58660-11f4-4dec-a246-82df8cbac171" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="gern:DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_46a831cc-df1f-4ae3-8ac6-025b7129a298" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,100</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3152c719-efc0-46f3-9db3-a91a373a9718" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total net deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We record net deferred tax assets to the extent we believe these assets will more likely than not be realized. In making such determination, we consider all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. Because of our history of losses, the net deferred tax assets have been fully offset by a valuation allowance. The valuation allowance increased by $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ce8db30f-5635-4b01-b870-d1a8337e38d6" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">38,900,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6156854b-66f2-4f13-a093-28feccac61b4" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">33,500,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we had domestic federal net operating loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4538ca73-251b-4780-8836-33e3d98a47c7" contextRef="C_a981f541-3690-49c7-8693-645d2e5d3905" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">993,100,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Of this, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_84b5ac81-d266-4ee6-84d8-8c4122cf95f7" contextRef="C_a981f541-3690-49c7-8693-645d2e5d3905" name="gern:OperatingLossCarryforwardsSubjectToExpiration" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">685,300,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will expire at various dates beginning in 2023 through 2037 and the remaining will carryforward indefinitely under the new tax laws, but is subject to an 80% taxable income limitation for tax years beginning after 2020. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we had state net operating loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b6fcbbb0-1a8d-45fd-ad79-52d36c2a595b" contextRef="C_0b8de677-089a-4241-b514-5dc0cbded8a3" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">658,400,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> expiring </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at various dates beginning in 2028 through 2041, if not utilized. We also had</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">134</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">federal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">tax credit carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f5021f36-8181-4bff-8c71-b7f3744ebadd" contextRef="C_a981f541-3690-49c7-8693-645d2e5d3905" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">62,700,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> expiring at various dates beginning in 2023 through 2042, if not utilized. Our state tax credit carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e88c8327-3f41-450f-b31b-d8f90a24b237" contextRef="C_0b8de677-089a-4241-b514-5dc0cbded8a3" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">20,900,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> carry forward indefinitely.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Utilization of net operating loss and tax credit carryforwards may be subject to an annual limitation due to ownership change limitations provided by the Internal Revenue Code and similar state provisions. Annual limitations may result in expiration of net operating loss and tax credit carryforwards before some or all of such amounts have been utilized. The impact of any limitations that may be imposed due to such ownership changes has not yet been determined.</span></p><p style="text-indent:4.587%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March and December 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act, or the CARES Act, and the Consolidated Appropriations Act, 2021 were passed into law and provide additional economic stimulus to address the impact of the COVID-19 pandemic, including among other items, several U.S. income tax provisions related to, among other things, net operating loss carrybacks, alternative minimum tax credits, modifications to interest expense limitations, and an option to defer payroll tax payments for a limited period. In 2021, we assessed our eligibility to claim a refund of employer taxes available under the Employee Retention Credit provisions of the CARES Act. For the years ended December 31, 2022 and 2021, we calculated eligible credits of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c81c25ed-a957-4a9e-9a32-aa93a4524256" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:EmployerTaxReceivable" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">483,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_287deafe-57d7-4fa2-8b34-eabcf641d4e4" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="gern:EmployerTaxReceivable" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">1,152,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, provided by the CARES Act, which have been recognized as offsets to salaries costs in operating expenses in 2022 and 2021, respectively. As of December 31, 2022, the aggregate eligible credit amount has been accrued as a receivable on our consolidated balance sheets.</span></p><p style="text-indent:4.587%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We adopted the provision of the standard for accounting for uncertainties in income taxes on January 1, 2007. Upon adoption, we recognized no material adjustment in the liability for unrecognized tax benefits. At December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we had approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a1d3424-c816-483c-968e-7fbbdf2a2761" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">23,700,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of unrecognized tax benefits, none of which would currently affect our effective tax rate if recognized due to our net deferred tax assets being fully offset by a valuation allowance.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_bcb53bbf-2b6e-44e4-8405-bcfd1fb16afa" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.199%;"></td>
        <td style="width:1.923%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:15.878%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1b6bf3da-b733-47e9-b3fd-d8f8770fc4a2" contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decrease related to prior year tax positions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increase related to current year tax positions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_79df34f5-6212-4c3b-b0c5-e3355f5e27ae" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,400</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e0f8e13-c33c-4f4b-8955-3f7c49bb7f64" contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,700</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If applicable, we would classify interest and penalties related to uncertain tax positions in income tax expense. Through December 31, 2022, there has been no interest expense or penalties related to unrecognized tax benefits.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not currently expect any significant changes to unrecognized tax benefits during the fiscal year ended December 31, 2023. In certain cases, our uncertain tax positions are related to tax years that remain subject to examination by the relevant tax authorities. Tax years for which we have carryforward net operating loss and credit attributes remain subject to examination by federal and most state tax authorities.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_157eb80c-2dad-42d4-9bb6-37fb88b8e028" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. CONSOLIDATED STATEMENTS OF CASH FLOWS DATA</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;">&#160;</p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0c57187c-7e21-44f8-be5f-f15f24c6f9d6" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" escape="true">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:44.689%;"></td>
        <td style="width:1.747%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.706000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.747%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.706000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.747%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.659%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental operating and investing activities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net unrealized loss on <br />&#160;&#160;&#160;marketable securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fded01e9-1d1a-407e-ac5f-95e55067edb3" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_85f4ea7d-2400-43e4-80ef-52eb48e547a9" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">251</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2dbad9ff-d362-4f2b-a38d-c94f452ac3d9" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">54</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Reclassification between prepaid and other<br />&#160;&#160;&#160;current assets and deposits and other assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_babb2620-3e4b-4250-80f2-3a4df8c41885" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="gern:ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease assets obtained in<br />&#160;&#160;&#160;exchange for operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0bb55348-6db6-4e4d-a862-bc63c312b200" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,575</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest paid</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e0f2654-9ffb-433c-bcfb-923a89b33cb5" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,154</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d9d8d28-22a4-446a-962d-4dd72b5df8f1" contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,704</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e88b74ee-cab4-4486-b46c-6d156f3425ea" contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">388</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2613244d-1124-4d10-8baa-3dbbb28c0c58" contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12. SUBSEQUENT EVENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public Offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On January 10, 2023, we completed an underwritten public offering of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9adf0ee4-16bc-46db-8dc2-907162ce24fa" contextRef="C_e324494e-e119-4b64-9797-465da2721c25" name="gern:ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">68,007,741</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock and a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_88da9e23-7713-4693-bbd6-9068b9d66e4b" contextRef="C_0ec8418b-4210-4aed-a7a0-402e2cb1fc9b" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">25,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, or the 2023 pre-funded warrant. The net cash proceeds from this offering are approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a452d4c7-3022-4054-b7fa-0a7e1e485760" contextRef="C_e324494e-e119-4b64-9797-465da2721c25" name="us-gaap:ProceedsFromIssuanceOrSaleOfEquity" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">213,300,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, after deducting the underwriting discount and other offering expenses paid by us, and excludes any future proceeds from the exercise of the 2023 pre-funded warrant, which has not been exercised.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Exercises</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From January 1, 2023 through March 9, 2023, we have received $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_310502ed-aad8-40d5-ba91-6e8724eba8c7" contextRef="C_50af7db3-82da-48d8-bf5d-ca3bb07f1a6d" name="us-gaap:ProceedsFromWarrantExercises" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">46,716,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash proceeds from the exercise of the 2020 purchase warrants, representing </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cf30b420-05b8-4bbb-9a9a-99a10452de8c" contextRef="C_1acf8b0f-f8d1-4664-927d-c462800c5922" name="gern:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">35,935,577</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From January 1, 2023 through March 9, 2023, we have received $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_56ef7f71-5921-40e9-a2fe-697b554c382d" contextRef="C_fb131e02-2952-4669-a8d3-c6f166ff823e" name="us-gaap:ProceedsFromWarrantExercises" unitRef="U_USD" decimals="0" format="ixt:numdotdecimal">13,119,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash proceeds from the exercise of the 2022 purchase warrants, representing </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8690c25b-6e79-455e-a909-305f6232480b" contextRef="C_54fac2af-1b06-465c-8688-a1f93e1c62db" name="gern:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">9,047,617</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">136</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 9A. CONTROLS</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> AND PROCEDURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(I)  Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have carried out an evaluation under the supervision and with the participation of management, including our Chief Executive Officer and our Chief Financial Officer, of our disclosure controls and procedures (as defined in Rule 13a&#x2011;15(e) of the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this annual report on Form 10&#x2011;K. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of December 31, 2022.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In designing and evaluating disclosure controls and procedures, our management recognizes that any system of controls, however well designed and operated, can provide only reasonable assurance, and not absolute assurance, that the desired control objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals in all future circumstances. Accordingly, our disclosure controls and procedures are designed to provide reasonable, not absolute, assurance that the objectives of our disclosure control system are met and, as set forth above, our Chief Executive Officer and our Chief Financial Officer have concluded, based on their evaluation as of the end of the period covered by this annual report on Form 10&#x2011;K, that our disclosure controls and procedures were effective to provide reasonable assurance that the objectives of our disclosure control system were met.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(II)  Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were no changes in our internal control over financial reporting during the quarter ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(III)  Management&#x2019;s Report on Internal Control over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Internal control over financial reporting refers to the process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and</span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Management is responsible for establishing and maintaining an adequate internal control over financial reporting for us. Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">137</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework set forth in &#x201c;Internal Control&#x2014;Integrated Framework&#x201d; issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). Based on our evaluation under the framework set forth in &#x201c;Internal Control&#x2014;Integrated Framework,&#x201d; our management concluded that our internal control over financial reporting was effective as of December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(IV)  Report of Independent Registered Public Accounting Firm</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This annual report on Form 10-K does not include an attestation report of our independent registered public accounting firm. Our independent registered public accounting firm will not be required to formally attest to the effectiveness of our internal control over financial reporting as long as we are a smaller reporting company pursuant to the provisions of Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 9B. OTHE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">R INFORMATION</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9c_disclosure_regarding_foreign"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 9C.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_iii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> III</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain information required by Part III is omitted from this annual report on Form 10&#x2011;K because we will file with the U.S. Securities and Exchange Commission a definitive proxy statement pursuant to Regulation 14A in connection with the solicitation of proxies for Geron&#x2019;s Annual Meeting of Stockholders expected to be held in May 2023, or the Proxy Statement, not later than 120 days after the end of the fiscal year covered by this annual report on Form 10&#x2011;K, and certain information included therein is incorporated herein by reference, or an amendment to this annual report on Form 10-K under cover of Form 10-K/A containing the information required by this Part III.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 10. DIRECTORS, EXECUTIVE OF</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FICERS AND CORPORATE GOVERNANCE</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identification of Directors and Nominees for Director</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item concerning our directors and nominees for director is incorporated by reference from the section captioned &#x201c;Proposal 1: Election of Directors&#x201d; contained in our Proxy Statement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identification of Executive Officers</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item concerning our executive officers is set forth in Part I, Item 1 of this annual report on Form 10&#x2011;K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Code of Ethics</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have adopted a Code of Conduct with which every person who works for Geron, including our board of directors, is expected to comply. The Code of Conduct is publicly available on our website under the Investors &amp; Media section at www.geron.com. This website address is intended to be an inactive, textual reference only; none of the material on this website is part of this annual report on Form 10&#x2011;K. If any substantive amendments are made to the Code of Conduct or any waiver granted, including any implicit waiver, from a provision of the Code of Conduct to our Chief Executive Officer, Chief Financial Officer or Corporate Controller, we will disclose the nature of such amendment or waiver on that website or in a report on Form 8&#x2011;K.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Copies of the Code of Conduct will be furnished without charge to any person who submits a written request directed to the attention of our Corporate Secretary, at our offices located at 919 East Hillsdale Boulevard, Suite 250, Foster City, California, 94404.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Corporate Governance Matters</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item concerning our audit committee, audit committee financial expert and procedures by which stockholders may recommend nominees to our board of directors, may be found under the sections captioned &#x201c;Board Leadership and Governance&#x201d; and &#x201c;Other Matters&#x201d; contained in the Proxy Statement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 11. EXECUTI</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">VE COMPENSATION</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item is incorporated by reference from the sections captioned &#x201c;Summary Compensation Table and Narrative Disclosure to Summary Compensation Table,&#x201d; and &#x201c;Compensation of Directors&#x201d;  contained in the Proxy Statement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OW</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item is incorporated by reference from the sections captioned &#x201c;Equity Compensation Plan Information&#x201d; and &#x201c;Security Ownership of Certain Beneficial Owners and Management&#x201d; contained in the Proxy Statement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 13. CERTAIN RELATIONSHIPS AND RELATE</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">D TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item is incorporated by reference from the sections captioned &#x201c;Proposal 1: Election of Directors&#x201d; and &#x201c;Certain Transactions&#x201d; contained in the Proxy Statement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 14. PRINCIPAL ACCOU</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NTANT FEES AND SERVICES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this item is incorporated by reference from the section captioned &#x201c;Principal Accountant Fees and Services&#x201d; contained in the Proxy Statement.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> IV</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 15. EXHIBITS AND FINAN</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CIAL STATEMENT SCHEDULES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(a) (1) Financial Statements</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in Part II, Item 8 of this Report:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:93.803%;"></td>
    <td style="width:6.197%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#report_independent_registered_public_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Report of Independent Registered Public Accounting Firm</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Balance Sheets&#x2014;December 31, 2022 and 2021</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a><a href="#statements_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Statements of Operations&#x2014;Years Ended December 31, 2022, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a><a href="#statements_comprehensive_loss"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Statements of Comprehensive Loss&#x2014;Years Ended December 31, 2022, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">107</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a><a href="#statements_stockholders_equity"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Statements of Stockholders&#x2019; Equity&#x2014;Years Ended December 31, 2022, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">108</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a><a href="#statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Statements of Cash Flows&#x2014;Years Ended December 31, 2022, 2021 and 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#note_1_"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statement Schedules</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial statement schedules are omitted because they are not required or the information is disclosed in the financial statements listed in Item 15(a)(1) above.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">139</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:18.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.011%;"></td>
    <td style="width:45.829%;"></td>
    <td style="width:9.604%;"></td>
    <td style="width:6.717%;"></td>
    <td style="width:18.235%;"></td>
    <td style="width:11.604%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="4" style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Incorporation by Reference</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit<br />Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit<br />Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filing</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Filing Date</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">File No.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677413000108/exhibit2-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Asset Contribution Agreement by and among Geron Corporation, BioTime, Inc. and Asterias Biotherapeutics, Inc. (formerly known as BioTime Acquisition Corporation)</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 8, 2013</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677412002137/exhibit3-3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restated Certificate of Incorporation</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 18, 2012</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677412002137/exhibit3-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of Amendment of the Restated Certificate of Incorporation</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 18, 2012</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677419001851/geron3600721-ex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of Amendment of the Restated Certificate of Incorporation</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 7, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0000886744/000120677421001453/geron3909221-ex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of Amendment of the Restated Certificate of Incorporation</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 13, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677410000646/exhibit3-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Bylaws of Registrant</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 19, 2010</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677417003236/geron3313905-ex34.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendment to Amended and Restated Bylaws of Registrant</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 22, 2017</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Capital Stock</span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 10, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000104746913002849/a2213377zex-4_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Common Stock Certificate</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 15, 2013</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677420001694/geron3763911-ex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 26, 2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677420001694/geron3763911-ex42.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Warrant to Purchase Common Stock</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 26, 2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.07013888888888889in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459022012684/gern-ex41_8.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 30, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.07013888888888889in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459022012684/gern-ex42_7.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Warrant to Purchase Common Stock</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 30, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.7</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.07013888888888889in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000095017023000349/gern-ex4_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Pre-Funded Warrant to Purchase Common Stock</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 6, 2023</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677412000967/exhibit10-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Indemnification Agreement</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2012</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000110465913082263/a13-19477_1ex10d5.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated 2006 Directors&#x2019; Stock Option Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10&#x2011;Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 7, 2013</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677411001222/exhibit10-1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2011 Incentive Award Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 16, 2011</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000104746913002849/a2213377zex-10_11.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Stock Option Agreement under 2011 Incentive Award Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.11</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 15, 2013</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.06875in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000104746913002849/a2213377zex-10_12.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Restricted Stock Award Agreement under 2011 Incentive Award Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.12</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 15, 2013</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000110465915035645/a15-6935_1ex10d2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Non&#x2011;Employee Director Stock Option Agreement under 2011 Incentive Award Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10&#x2011;Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 7, 2015</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677422001399/geron4061651-ex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2018 Equity Incentive Plan, as amended*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 13, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000095017022022712/gern-ex10_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UK Sub-Plan to 2018 Equity Incentive Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 7, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.9</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.07013888888888889in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000095017022022712/gern-ex10_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of 2018 Equity Incentive Plan Option Agreement (Time Based)*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 7, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.10</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.07013888888888889in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000095017022022712/gern-ex10_3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of 2018 Equity Incentive Plan Option Agreement (Performance Based)*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 7, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.11</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677418001662/geron33139012-ex104.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Non-Employee Director Stock Option Agreement under 2018 Equity Incentive Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 18, 2018</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.12</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459019006759/gern-ex1013_107.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Non-Employee Director Stock Option Agreement under 2018 Equity Incentive Plan, as amended*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.13</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.13</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459019006759/gern-ex1014_106.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Performance-Vesting Stock Option Agreement under 2018 Equity Incentive Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.14</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.14</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.07013888888888889in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459019006759/gern-ex1015_105.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Performance-Vesting Stock Option Agreement under 2018 Equity Incentive Plan, as amended*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.15</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.15</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000095017022016839/gern-ex10_3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2018 Inducement Award Plan, as amended July 15, 2022*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">August 11, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.16</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000095017022022712/gern-ex10_5.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UK Sub-Plan to 2018 Inducement Award Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 7, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.17</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677418003435/geron33139022-ex102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Stock Option Agreement under 2018 Inducement Award Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 14, 2018</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">140</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.011%;"></td>
    <td style="width:45.829%;"></td>
    <td style="width:9.604%;"></td>
    <td style="width:6.717%;"></td>
    <td style="width:18.235%;"></td>
    <td style="width:11.604%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.18</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459019006759/gern-ex1019_103.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Stock Option Agreement under 2018 Inducement Award Plan, as amended*</span></a></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.19</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2019</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459019006759/gern-ex1020_102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Performance-Vesting Stock Option Agreement under 2018 Inducement Award Plan*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677422001399/geron4061651-ex102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2014 Employee Stock Purchase Plan, as amended*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8&#x2011;K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 13, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.21</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000095017022022712/gern-ex10_6.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of 2018 Inducement Award Plan Option Agreement (Time Based)*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 7, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.22</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000095017022022712/gern-ex10_7.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of 2018 Inducement Award Plan Option Agreement (Performance Based)*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.7</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 7, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.23</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459022009627/gern-ex1020_124.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Employee Director Compensation Policy, as amended February 16, 2022 and March 7, 2022*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 10, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.24</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459018026208/gern-ex101_99.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Directors&#x2019; Market Value Stock Purchase Plan, effective October 1, 2018*</span></a><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 1, 2018</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.25</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459022009627/gern-ex1022_125.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Severance Plan, effective as of January 1, 2022*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.22</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 10, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.26</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459019006759/gern-ex1029_99.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Employment Agreement between the Registrant and John A. Scarlett, M.D., effective as of January 31, 2019*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.29</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.27</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459019006759/gern-ex1031_97.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Employment Agreement between the Registrant and Andrew J. Grethlein, effective as of January 31, 2019*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.31</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.28</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459019006759/gern-ex1032_96.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated Employment Agreement between the Registrant and Olivia K. Bloom, effective as of January 31, 2019*</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.32</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 7, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.29</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459020010449/gern-ex1033_153.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employment Agreement between the Registrant and Anil Kapur, effective as of December 2, 2019</span></a><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.33</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 12, 2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.30</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459019015326/gern-ex1018_162.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office Lease Agreement by and between Registrant and 3 Sylvan Realty LLC, effective as of April 30, 2019</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.18</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 2, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.31</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677419003542/geron3657421-ex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office Lease Agreement by and between Registrant and Hudson Metro Center LLC, effective as of October 9, 2019</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">October 15, 2019</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000&#x2011;20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.32</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677420002736/geron3801931-ex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At Market Issuance Sales Agreement, dated September 4, 2020, by and between Registrant and B. Riley Securities, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 4, 2020</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.33&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.07013888888888889in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000156459020051288/gern-ex101_29.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loan and Security Agreement, dated September 30, 2020, amongst Registrant, Hercules Capital, Inc., and Silicon Valley Bank</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">November 5, 2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.34&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0000886744/000156459021044618/gern-ex101_128.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendment to Loan and Security Agreement, dated August 12, 2021, amongst Registrant, Hercules Capital, Inc., and Silicon Valley Bank</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">August 16, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:8.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.35&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.07013888888888889in;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/886744/000095017022016839/gern-ex10_4.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amendment to Loan and Security Agreement, dated June 30, 2022 amongst Registrant, Hercules Capital, Inc., and Silicon Valley Bank</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">August 11, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">000-20859</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="gern-ex21_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">List of Subsidiaries</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="gern-ex23_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#power_attorney"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Power of Attorney (see signature page)</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="gern-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Chief Executive Officer pursuant to Form of Rule 13a&#x2011;14(a), as Adopted Pursuant to Section 302(a) of the Sarbanes&#x2011;Oxley Act of 2002, dated March 16, 2023</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="gern-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Chief Financial Officer pursuant to Form of Rule 13a&#x2011;14(a), as Adopted Pursuant to Section 302(a) of the Sarbanes&#x2011;Oxley Act of 2002, dated March 16, 2023</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="gern-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">141</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.011%;"></td>
    <td style="width:45.829%;"></td>
    <td style="width:9.604%;"></td>
    <td style="width:6.717%;"></td>
    <td style="width:18.235%;"></td>
    <td style="width:11.604%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Section 906 of the Sarbanes&#x2011;Oxley Act of 2002, dated March 16, 2023**</span></span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;margin-top:0.0pt;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="gern-ex32_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes&#x2011;Oxley Act of 2002, dated March 16, 2023**</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following materials from the Registrant&#x2019;s annual report on Form 10&#x2011;K for the year ended December 31, 2022, formatted in Inline Extensible Business Reporting Language (iXBRL) include: (i) Consolidated Balance Sheets as of December 31, 2022 and 2021, (ii) Consolidated Statements of Operations, Consolidated Comprehensive Loss, Stockholders&#x2019; Equity and Cash Flows for each of the three years in the period ended December 31, 2022, and (iii) Notes to Consolidated Financial Statements</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#134;     Confidential treatment has been granted for certain portions of this exhibit. Omitted information has been filed separately with the Securities and Exchange Commission.</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*     Management contract or compensation plan or arrangement.</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">**   The certifications attached as Exhibits 32.1 and 32.2 that accompany this annual report on Form 10&#x2011;K, are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this annual report on Form 10&#x2011;K), irrespective of any general incorporation language contained in such filing.</span></p>
  <p style="text-indent:-3.448%;padding-left:3.333%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_16"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ITEM 16. FORM</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> 10&#x2011;K SUMMARY</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">142</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNAT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">URES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:3.996%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GERON CORPORATION</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 16, 2023</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Olivia Bloom</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OLIVIA K. BLOOM</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Executive Vice President, Finance,</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Chief Financial Officer and Treasurer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="power_attorney"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">POWER OF </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ATTORNEY</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KNOW BY ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints, jointly and severally, John A. Scarlett, M.D., and Olivia K. Bloom, and each one of them, attorneys&#x2011;in&#x2011;fact for the undersigned, each with the power of substitution, for the undersigned in any and all capacities, to sign any and all amendments to this annual report on Form 10&#x2011;K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys&#x2011;in&#x2011;fact, or his or her substitutes, may do or cause to be done by virtue hereof.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">IN WITNESS WHEREOF, each of the undersigned has executed this Power of Attorney as of the date indicated opposite his/her name.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:17.821%;"></td>
    <td style="width:8.878%;"></td>
    <td style="width:15.021%;"></td>
    <td style="width:17.981%;"></td>
    <td style="width:5.321%;"></td>
    <td style="width:18.355%;"></td>
    <td style="width:6.335%;"></td>
    <td style="width:4.904%;"></td>
    <td style="width:5.385%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Signature</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">John A. Scarlett</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">President, Chief Executive Officer and</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chairman of the Board (Principal Executive Officer)</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JOHN A. SCARLETT</span></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Olivia Bloom</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Vice President, Finance, Chief</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Officer and Treasurer (Principal</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial and Accounting Officer)</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OLIVIA K. BLOOM</span></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dawn C. Bir</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DAWN C. BIR</span></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Karin Eastham</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KARIN EASTHAM</span></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">V. Bryan Lawlis</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">V. BRYAN LAWLIS</span></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">John McDonald</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JOHN F. McDONALD</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Susan Molineaux</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td colspan="3" rowspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SUSAN M. MOLINEAUX</span></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Elizabeth G. O&#x2019;Farrell</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ELIZABETH G. O&#x2019;FARRELL</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </span><span style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Robert J. Spiegel</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ROBERT J. SPIEGEL</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">143</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>2
<FILENAME>gern-ex21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html>
 <head>
  <title>EX-21</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT 21.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">List of Subsidiaries</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Geron UK Limited, incorporated September 29, 2021</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Geron Netherlands B.V., incorporated February 17, 2023</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>3
<FILENAME>gern-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT 23.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We consent to the incorporation by reference in the following Registration Statements:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-3, No. 333-248637) and in the related prospectuses and prospectus supplements,</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statements (Form S-3, Nos. 333-225184 and 333-238595) and in the related prospectuses and prospectus supplements,</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">3)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-3ASR, No. 333-269111) and in the related prospectuses and prospectus supplements, </font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">4)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statements (Form S-8, Nos. 333-239324 and 333-258864) pertaining to the 2018 Inducement Award Plan and the 2018 Equity Incentive Plan,</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">5)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8, No. </font><a href="https://www.sec.gov/Archives/edgar/data/886744/000120677419000764/geron33139027-s8.htm"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">333-230171</font></a><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) pertaining to the 2018 Inducement Award Plan,</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">6)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8, No. 333-228147) pertaining to the Directors&#x2019; Market Value Stock Purchase Plan,</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">7)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8, No. 333-225190) pertaining to the 2018 Equity Incentive Plan,</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">8)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8, No. 333-196677) pertaining to the 2014 Employee Stock Purchase Plan,</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">9)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8, No. 333-174350) pertaining to the 2011 Incentive Award Plan, the 2002 Equity Incentive Plan, the 1996 Directors&#x2019; Stock Option Plan and the 1992 Stock Option Plan, </font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">10)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8, No. 333-136330) pertaining to the 2002 Equity Incentive Plan and the 2006 Directors&#x2019; Stock Option Plan; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">11)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registration Statement (Form S-8, No. 333-266795) pertaining to the 2018 Equity Incentive Plan, the 2018 Inducement Award Plan and the 2014 Employee Stock Purchase Plan.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of our report dated March 16, 2023, with respect to the consolidated financial statements of Geron Corporation included in this Annual Report (Form 10-K) of Geron Corporation for the year ended December 31, 2022.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Ernst &amp; Young LLP</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Jose, California</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 16, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>4
<FILENAME>gern-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM OF RULE 13A&#x2011;14(A)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 302(A) OF THE SARBANES&#x2011;OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, John A. Scarlett, M.D., certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this annual report on Form 10&#x2011;K of Geron Corporation;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#x2011;15(e) and 15d&#x2011;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#x2011;15(f) and 15d&#x2011;15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 16, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">John A. Scarlett</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JOHN A. SCARLETT, M.D.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">President, Chief Executive Officer and Chairman of the Board</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>5
<FILENAME>gern-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM OF RULE 13A&#x2011;14(A)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 302(A) OF THE SARBANES&#x2011;OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Olivia K. Bloom, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this annual report on Form 10&#x2011;K of Geron Corporation;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a&#x2011;15(e) and 15d&#x2011;15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#x2011;15(f) and 15d&#x2011;15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant&#x2019;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 16, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:50.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Olivia Bloom</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OLIVIA K. BLOOM</font></p><p style="text-indent:-10.0pt;padding-left:10.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Executive Vice President, Finance,</font></p><p style="text-indent:-10.0pt;padding-left:10.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Chief Financial Officer and Treasurer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>6
<FILENAME>gern-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES&#x2011;OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes&#x2011;Oxley Act of 2002, the undersigned officer of Geron Corporation (the &#x201c;Company&#x201d;) hereby certifies, to such officer&#x2019;s knowledge, that:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accompanying annual report on Form 10&#x2011;K of the Company for the year ended December 31, 2022 (the &#x201c;Report&#x201d;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:55.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dated: March 16, 2023</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">John A. Scarlett</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JOHN A. SCARLETT, M.D.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">President, Chief Executive Officer and Chairman of the Board</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This certification accompanies the Form 10&#x2011;K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10&#x2011;K), irrespective of any general incorporation language contained in such filing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>7
<FILENAME>gern-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">EXHIBIT 32.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES&#x2011;OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes&#x2011;Oxley Act of 2002, the undersigned officer of Geron Corporation (the &#x201c;Company&#x201d;) hereby certifies, to such officer&#x2019;s knowledge, that:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(i)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the accompanying annual report on Form 10&#x2011;K of the Company for the year ended December 31, 2022 (the &#x201c;Report&#x201d;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(ii)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:55.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dated: March 16, 2023</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ </font><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Olivia Bloom</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);font-variant:small-caps;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Olivia K. Bloom</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Executive Vice President, Finance,</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Chief Financial Officer and Treasurer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This certification accompanies the Form 10&#x2011;K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10&#x2011;K), irrespective of any general incorporation language contained in such filing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img42689296_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img42689296_0.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" =&#ET# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKA/C)\9/#WP/\&S>(/$$S;,
M^7;6<.#-=2XR$0'\R3P!R:^'->_X*7>/+C5)7T;PWX?L=/S^[AO4GN)<9_B=
M9$!X]%'>O=R_),;F474H0]U=6[(\7'9Q@\ODH5Y>]V6K/T>HKYC_ &:?VVM'
M^-FJQ^&]=L(_#OBB12;=4E+6UX1DE8R>5?'.TYS@X/:OIRO/QF"KX"JZ.(CR
MR_K8[L+BZ.-IJK0E=!1117$=@4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!YK_ ,-'?#O_ *&'_P DKG_X
MW39/VD/AXJ,PU\N0,A5LKC)]AF.O3*YKXF_\DW\6?]@F[_\ 1+U:Y6]B=3E_
M^&@_"_\ SSU#_ORO_P 51_PT'X7_ .>>H?\ ?E?_ (JO+/"GP9UOQAX=L=9L
M[JPBM;R/S(TGD<.!DCD!".WK6K_PSIXD_P"?W2O^_LO_ ,;K\+_UAXX_Z%\?
M_ 9?_+#]'_LOAW_H*?WK_P"1.^_X:#\+_P#//4/^_*__ !5'_#0?A?\ YYZA
M_P!^5_\ BJX'_AG3Q)_S^Z5_W]E_^-T?\,Z>)/\ G]TK_O[+_P#&Z/\ 6'CC
M_H7Q_P# 9?\ RP/[+X=_Z"G]Z_\ D3OO^&@_"_\ SSU#_ORO_P 51_PT'X7_
M .>>H?\ ?E?_ (JN!_X9T\2?\_NE?]_9?_C='_#.GB3_ )_=*_[^R_\ QNC_
M %AXX_Z%\?\ P&7_ ,L#^R^'?^@I_>O_ )$[[_AH/PO_ ,\]0_[\K_\ %4?\
M-!^%_P#GGJ'_ 'Y7_P"*K@?^&=/$G_/[I7_?V7_XW1_PSIXD_P"?W2O^_LO_
M ,;H_P!8>./^A?'_ ,!E_P#+ _LOAW_H*?WK_P"1.^_X:#\+_P#//4/^_*__
M !5'_#0?A?\ YYZA_P!^5_\ BJX'_AG3Q)_S^Z5_W]E_^-T?\,Z>)/\ G]TK
M_O[+_P#&Z/\ 6'CC_H7Q_P# 9?\ RP/[+X=_Z"G]Z_\ D3OO^&@_"_\ SSU#
M_ORO_P 51_PT'X7_ .>>H?\ ?E?_ (JN!_X9T\2?\_NE?]_9?_C='_#.GB3_
M )_=*_[^R_\ QNC_ %AXX_Z%\?\ P&7_ ,L#^R^'?^@I_>O_ )$[[_AH/PO_
M ,\]0_[\K_\ %4?\-!^%_P#GGJ'_ 'Y7_P"*K@?^&=/$G_/[I7_?V7_XW1_P
MSIXD_P"?W2O^_LO_ ,;H_P!8>./^A?'_ ,!E_P#+ _LOAW_H*?WK_P"1.^_X
M:#\+_P#//4/^_*__ !5'_#0?A?\ YYZA_P!^5_\ BJX'_AG3Q)_S^Z5_W]E_
M^-T?\,Z>)/\ G]TK_O[+_P#&Z/\ 6'CC_H7Q_P# 9?\ RP/[+X=_Z"G]Z_\
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M3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]%
M' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?
M_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:
M?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^
M?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/
M^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <
M!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\
M71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_
M\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]
M=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y
M]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'
M_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q=
M'_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q
M==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU
M#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GU
MU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\
M+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?
M\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%U
MW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/
M^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74
M/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PN
MK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_P
MNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?
MT4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[
M]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_
M[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM
M$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"Z
MM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_1
M0!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OV
MG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_O
MVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3
M_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT
M3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]%
M' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?
M_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:
M?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^
M?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/
M^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <
M!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\
M71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_
M\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]
M=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y
M]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'
M_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q=
M'_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q
M==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU
M#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GU
MU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\
M+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?
M\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%U
MW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/
M^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74
M/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PN
MK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_P
MNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?
MT4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[
M]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_
M[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM
M$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"Z
MM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_1
M0!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OV
MG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_O
MVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3
M_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT
M3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]%
M' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?
M_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:
M?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^
M?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/
M^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <
M!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\
M71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_
M\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]
M=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y
M]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'
M_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q=
M'_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q
M==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU
M#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GU
MU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\
M+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?
M\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%U
MW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/
M^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74
M/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PN
MK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_P
MNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?
MT4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[
M]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"ZM$_Y]=0_
M[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_10!P'_"ZM
M$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OVG_Q='_"Z
MM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_OVG_Q==_1
M0!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3_GUU#_OV
MG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT3_GUU#_O
MVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]% ' ?\+JT3
M_GUU#_OVG_Q='_"ZM$_Y]=0_[]I_\77?T4 <!_PNK1/^?74/^_:?_%T?\+JT
M3_GUU#_OVG_Q==_10!P'_"ZM$_Y]=0_[]I_\71_PNK1/^?74/^_:?_%UW]%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#@/B-_R-/@S_K]_P#9XJ[^N ^(
MW_(T^#/^OW_V>*N_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KFOB;_R3?Q9_P!@F[_]$O72US7Q-_Y)OXL_[!-W_P"B7IQW0GL9
M7P-_Y)+X9_Z]?_9FKNJX7X&_\DE\,_\ 7K_[,U=U0]P6P4444AA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %?$3?>/UK[=KXB;[Q^M?S]XL?\
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M^&Q/"/\ T/=M_P!^F_\ B*_,NBC_ %+P7_/R?X?Y!_K=C/\ GW'\?\S]-/\
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MZ;_XBOS+HH_U+P7_ #\G^'^0?ZW8S_GW'\?\S]-/^&Q/"/\ T/=M_P!^F_\
MB*/^&Q/"/_0]VW_?IO\ XBOS+HH_U+P7_/R?X?Y!_K=C/^?<?Q_S/TT_X;$\
M(_\ 0]VW_?IO_B*/^&Q/"/\ T/=M_P!^F_\ B*_,NBC_ %+P7_/R?X?Y!_K=
MC/\ GW'\?\S]-/\ AL3PC_T/=M_WZ;_XBC_AL3PC_P!#W;?]^F_^(K\RZ*/]
M2\%_S\G^'^0?ZW8S_GW'\?\ ,_33_AL3PC_T/=M_WZ;_ .(H_P"&Q/"/_0]V
MW_?IO_B*_,NBC_4O!?\ /R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_P#0]VW_ 'Z;
M_P"(H_X;$\(_]#W;?]^F_P#B*_,NBC_4O!?\_)_A_D'^MV,_Y]Q_'_,_33_A
ML3PC_P!#W;?]^F_^(H_X;$\(_P#0]VW_ 'Z;_P"(K\RZ*/\ 4O!?\_)_A_D'
M^MV,_P"?<?Q_S/TT_P"&Q/"/_0]VW_?IO_B*/^&Q/"/_ $/=M_WZ;_XBOS+H
MH_U+P7_/R?X?Y!_K=C/^?<?Q_P S]-/^&Q/"/_0]VW_?IO\ XBC_ (;$\(_]
M#W;?]^F_^(K\RZ*/]2\%_P _)_A_D'^MV,_Y]Q_'_,_33_AL3PC_ -#W;?\
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M&Q/"/_0]VW_?IO\ XBOS+HH_U+P7_/R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_\
M0]VW_?IO_B*/^&Q/"/\ T/=M_P!^F_\ B*_,NBC_ %+P7_/R?X?Y!_K=C/\
MGW'\?\S]-/\ AL3PC_T/=M_WZ;_XBC_AL3PC_P!#W;?]^F_^(K\RZ*/]2\%_
MS\G^'^0?ZW8S_GW'\?\ ,_33_AL3PC_T/=M_WZ;_ .(H_P"&Q/"/_0]VW_?I
MO_B*_,NBC_4O!?\ /R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_P#0]VW_ 'Z;_P"(
MH_X;$\(_]#W;?]^F_P#B*_,NBC_4O!?\_)_A_D'^MV,_Y]Q_'_,_33_AL3PC
M_P!#W;?]^F_^(H_X;$\(_P#0]VW_ 'Z;_P"(K\RZ*/\ 4O!?\_)_A_D'^MV,
M_P"?<?Q_S/TT_P"&Q/"/_0]VW_?IO_B*/^&Q/"/_ $/=M_WZ;_XBOS+HH_U+
MP7_/R?X?Y!_K=C/^?<?Q_P S]-/^&Q/"/_0]VW_?IO\ XBC_ (;$\(_]#W;?
M]^F_^(K\RZ*/]2\%_P _)_A_D'^MV,_Y]Q_'_,_33_AL3PC_ -#W;?\ ?IO_
M (BC_AL3PC_T/=M_WZ;_ .(K\RZ*/]2\%_S\G^'^0?ZW8S_GW'\?\S]-/^&Q
M/"/_ $/=M_WZ;_XBC_AL3PC_ -#W;?\ ?IO_ (BOS+HH_P!2\%_S\G^'^0?Z
MW8S_ )]Q_'_,_33_ (;$\(_]#W;?]^F_^(H_X;$\(_\ 0]VW_?IO_B*_,NBC
M_4O!?\_)_A_D'^MV,_Y]Q_'_ #/TT_X;$\(_]#W;?]^F_P#B*/\ AL3PC_T/
M=M_WZ;_XBOS+HH_U+P7_ #\G^'^0?ZW8S_GW'\?\S]-/^&Q/"/\ T/=M_P!^
MF_\ B*/^&Q/"/_0]VW_?IO\ XBOS+HH_U+P7_/R?X?Y!_K=C/^?<?Q_S/TT_
MX;$\(_\ 0]VW_?IO_B*/^&Q/"/\ T/=M_P!^F_\ B*_,NBC_ %+P7_/R?X?Y
M!_K=C/\ GW'\?\S]-/\ AL3PC_T/=M_WZ;_XBC_AL3PC_P!#W;?]^F_^(K\R
MZ*/]2\%_S\G^'^0?ZW8S_GW'\?\ ,_33_AL3PC_T/=M_WZ;_ .(H_P"&Q/"/
M_0]VW_?IO_B*_,NBC_4O!?\ /R?X?Y!_K=C/^?<?Q_S/TT_X;$\(_P#0]VW_
M 'Z;_P"(H_X;$\(_]#W;?]^F_P#B*_,NBC_4O!?\_)_A_D'^MV,_Y]Q_'_,_
M4;PW^T_HGC#7;+1M&\80W^J7DGE6]M'$0TC8S@90#M6GX^^/5O\ "[5H-,\5
M>)$T:_F@%S'!/'DM&690WRJ>,JP_"O@']DW_ )..\ _]A%?_ $%J]<_X*7?\
MEM\/_P#8O0_^E-S7AU.&<-#,Z>"4Y<LHN5]+Z?(]FGQ#B)Y=/&.$>:,DK:V_
M,]]_X;$\(_\ 0]VW_?IO_B*/^&Q/"/\ T/=M_P!^F_\ B*_,NBO<_P!2\%_S
M\G^'^1XW^MV,_P"?<?Q_S/TT_P"&Q/"/_0]VW_?IO_B*/^&Q/"/_ $/=M_WZ
M;_XBOS+HH_U+P7_/R?X?Y!_K=C/^?<?Q_P S]-/^&Q/"/_0]VW_?IO\ XBC_
M (;$\(_]#W;?]^F_^(K\RZ*/]2\%_P _)_A_D'^MV,_Y]Q_'_,_33_AL3PC_
M -#W;?\ ?IO_ (BC_AL3PC_T/=M_WZ;_ .(K\RZ*/]2\%_S\G^'^0?ZW8S_G
MW'\?\S]-/^&Q/"/_ $/=M_WZ;_XBC_AL3PC_ -#W;?\ ?IO_ (BOS+HH_P!2
M\%_S\G^'^0?ZW8S_ )]Q_'_,_33_ (;$\(_]#W;?]^F_^(H_X;$\(_\ 0]VW
M_?IO_B*_,NBC_4O!?\_)_A_D'^MV,_Y]Q_'_ #/TT_X;$\(_]#W;?]^F_P#B
M*/\ AL3PC_T/=M_WZ;_XBOS+HH_U+P7_ #\G^'^0?ZW8S_GW'\?\S]-/^&Q/
M"/\ T/=M_P!^F_\ B*/^&Q/"/_0]VW_?IO\ XBOS+HH_U+P7_/R?X?Y!_K=C
M/^?<?Q_S/TT_X;$\(_\ 0]VW_?IO_B*/^&Q/"/\ T/=M_P!^F_\ B*_,NBC_
M %+P7_/R?X?Y!_K=C/\ GW'\?\S]-/\ AL3PC_T/=M_WZ;_XBC_AL3PC_P!#
MW;?]^F_^(K\RZ*/]2\%_S\G^'^0?ZW8S_GW'\?\ ,_33_AL3PC_T/=M_WZ;_
M .(H_P"&Q/"/_0]VW_?IO_B*_,NBC_4O!?\ /R?X?Y!_K=C/^?<?Q_S/TT_X
M;$\(_P#0]VW_ 'Z;_P"(H_X;$\(_]#W;?]^F_P#B*_,NBC_4O!?\_)_A_D'^
MMV,_Y]Q_'_,_33_AL3PC_P!#W;?]^F_^(H_X;$\(_P#0]VW_ 'Z;_P"(K\RZ
M*/\ 4O!?\_)_A_D'^MV,_P"?<?Q_S/TT_P"&Q/"/_0]VW_?IO_B*/^&Q/"/_
M $/=M_WZ;_XBOS+HH_U+P7_/R?X?Y!_K=C/^?<?Q_P S]-/^&Q/"/_0]VW_?
MIO\ XBC_ (;$\(_]#W;?]^F_^(K\RZ*/]2\%_P _)_A_D'^MV,_Y]Q_'_,_3
M3_AL3PC_ -#W;?\ ?IO_ (BGP?M>>%;J>.&+QS;O+(P15$3<DG 'W*_,BM'P
M[_R,&E_]?47_ *&*4N"\$DW[2?X?Y%1XMQ;:7LX_C_F?JO\ $'XN3_"J"RF\
M6:W_ &+%>,R6[3H#YA4 L!M4],C\ZXO_ (;$\(_]#W;?]^F_^(KC/^"GO_(M
M^ ?^ON[_ /0(J_/ZO&R;AG"YE@H8FI.2;OM:VC:['K9MQ%B<!C)X>G"+2MO?
MJD^Y^FG_  V)X1_Z'NV_[]-_\11_PV)X1_Z'NV_[]-_\17YET5[7^I>"_P"?
MD_P_R/'_ -;L9_S[C^/^9^FG_#8GA'_H>[;_ +]-_P#$4?\ #8GA'_H>[;_O
MTW_Q%?F711_J7@O^?D_P_P @_P!;L9_S[C^/^9^FG_#8GA'_ *'NV_[]-_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *YKXF_P#)-_%G_8)N_P#T2]=+7-?$W_DF
M_BS_ +!-W_Z)>G'=">QE? W_ ))+X9_Z]?\ V9J[JN%^!O\ R27PS_UZ_P#L
MS5W5#W!;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\1
M-]X_6OMVOB)OO'ZU_/WBQ_S _P#<3_VP_3N"?^8C_MW_ -N/4?V=?^1WO/\
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MC(Z]9^*_PB\,_&CPNV@^*+)KJT$@FAEB<I+!( 0'1AT."1SD'/(->3?LZ_\
M([WG_8/D_P#1D=?1E?:>&=2='(X5*;M)3E9H^>XPIPJYA*%173BM&?);?\$T
M_AD6)&N^+ /3[7;?_(])_P .T_AG_P!![Q9_X%VO_P CU]:T5^V?V]F?_/\
M9^;_ -B9=_SY1\E?\.T_AG_T'O%G_@7:_P#R/1_P[3^&?_0>\6?^!=K_ /(]
M?6M%']O9G_S_ &']B9=_SY1\E?\ #M/X9_\ 0>\6?^!=K_\ (]'_  [3^&?_
M $'O%G_@7:__ "/7UK11_;V9_P#/]A_8F7?\^4?)7_#M/X9_]![Q9_X%VO\
M\CU\C_M=_ W0O@#\1M,\/^'[O4+VSNM)COWDU*2-Y!(TTR$ HB#;B->V<D\U
M^MM?FM_P4L_Y+CH'_8N0_P#I3<U]3PWFN-Q>8*E7JN4;/1GS?$&6X/"X%U*-
M-1E=:D?_  35_P"2[:U_V+EQ_P"E-M7Z6U^:7_!-7_DNVM?]BY<?^E-M7Z6U
MY7%O_(S?^%'I<+_\BY>K"BBBOC#ZT**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *_/C]NC_D0='_["X_\ 14M?H/7Y
M\?MT?\B#H_\ V%Q_Z*EKZ#A__D:4/7]&>%GG_(MK>GZH^*****_H,_# HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^ Z_5#_@H!_R;9J__7[:?^C17Y?:'H.H^)M7M=*TFRGU'4KIQ'!:VR%Y)&]
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MU]CLA9<_0FO,?C%^RQ\0?@A:_;]?TR*YT?<J?VKILOG6ZL>@;(#)SQEE ).
M37'1S? 5ZBI4ZT7)]+[^AUU,KQU&FZLZ,E%>1Y%7K'@/]E?XH_$SPO:>(O#?
MA?\ M'1[HN(;G[?:Q;]CE&^6256&&4CD=JY#X=?#'Q-\6=>?1?"FF'5M32!K
MEH!-'%B-2H+9D91U9>^>:_6S]G'P+??#7X(^$_#FJ6PL]3L[4FZ@#J^R5W9V
M&Y25."W4$BO*S_.GE5&/L'%U&UH^UGK9-/>QWY)E/]I5FJJDJ:3U7>ZTNTUU
MN?C[XD\.:CX0\0:AHFKV_P!DU33YWMKF#>K^7(IPR[E)4X/<$BLROJOX[?LA
M_%KQ-\6/&OB'3?"?VG1[S4KF[@N?[2M$WQ%RP;:TH8<=B,U\J5[6 QU+'48S
MA.+E9.23O9M>KMUW/.S'!3P.(G3<6H\TE%M;I/>]DGI;8****](\P**** /6
M_P!DW_DX[P#_ -A%?_06KUS_ (*7?\EM\/\ _8O0_P#I3<UY'^R;_P G'> ?
M^PBO_H+5ZY_P4N_Y+;X?_P"Q>A_]*;FOD*__ "/Z/_7M_FSZFC_R(ZW^-?DC
MY(HHHKZ\^6"BBB@#ZD\/_P#!.WXC^)-!TW5K;6_"R6U_;1W42RW=R'"N@8!@
M+<C.#S@FK_\ P[3^)W_0=\)_^!EU_P#(U?H%\*_^27^#_P#L#V?_ *(2OESQ
MU_P48B\#?$#7?#<W@![J+2K^:R:\CU@*T@C<KO$9@XSC.-WXU^3T<ZSO&XBI
M1PB4N6_1+2]NK1^E?V3E&'P=+$XMM<R7?=J_1,^8_B3^Q7\5/AII\VH7&C0Z
MYIL*[Y;K1)OM'ECN3&0LF!U)"X ZD5X37[0_!;XT>'_CKX-7Q%X?^T10K,UO
M/:W:A98)5 )5@"1T*D$$Y!'?('YY_M[?"NP^'/QF6^TFW6TT_P 06OV\PQ@!
M$G#%90H'0$A6^KFO<R7/L1B<6\!CX<M17MTVZ->FMT>9FN28>CA%CL#.\-+]
M='I=/UT:9]9_#_\ 8M^#6M^ _#>HWO@[SKR\TVVN)Y/[4O5WR/$K,<"8 9)/
M &*_.?XQ:#8>%?BMXOT;2X/LNFV&JW-M;0[V?9&DC*J[F))P .22:_87X5_\
MDO\ !_\ V![/_P!$)7Y%?M!?\ET\?_\ 8=O/_1S5P\-8O$5\PQ$*U24DKV3;
M:7O>9TYSA:%+*</4ITTI/ENTDF_=>[//Z*]<^&/[*OQ,^+-O#>:-X<EM]*EP
M5U+4F%M 5(R&7=\SK[HK5ZG)_P $V/B@D)<:OX5D8#/EK>7&X^W-OC]:^SK9
MM@,//V=6M%/M<^2HY9C<1'GI4FUWL?*%%=7\2/A9XI^$FO?V/XKTB;2;TKOC
MWD/'*O\ >1U)5A]#QT.#7*5Z=.I"M!5*<DT]FM4<%2G.C-TZD6FNC"BO8_A-
M^R9\2?C%9QZAH^C+8Z/)]S5-5D^SP/[H,%W'^TJD<'FO0=:_X)R_%;2M.EN;
M:Y\.ZQ*@R+2ROI%E?V!EB1<_5A7FULVP%"I[*K6BI=K_ )]OF=]'+,;B(>TI
M4FX][?EW/ENBM/Q)X:U7P?K=WH^MZ?<:7JEJ^R:UNHRCH<9'![$$$'H001Q7
M9_"/]GWQS\;;EU\+Z,T]G$X2?4;AA%:Q'T+GJ>1\J@MR.*[IXBE3I^VG-*/>
M^GWG%&C5G4]E&+<NUM?N/.:*^J-2_P""</Q4L;"6XAOO#>HRHI9;6VO91(Y_
MN@R0JN?JP'O7S=XL\(ZSX%UZZT77]-N-*U2U;;+;7*;6'H1V(/4,,@CD$US8
M7,<)C&XX>HI-=GJ=6(R_%82*E7IN*?6Q]1_L(? CP-\9K'QC)XQT/^V'T^2U
M6V/VN>#RPXDW?ZIUSG:.N>E/_;O^ W@7X,Z9X.E\':'_ &/)J$UTMRWVN>?S
M BQE?]:[8QN/3'6N[_X)@_\ (-^(/_7:R_\ 09JZ_P#;T^%OBGXO77P^T3PI
MI$VJ7BR7DLK*0D4*8A&Z1V(51]3SCC)KX/$8ZM2XE]E.JU25KKF:C_#OM>V^
MI]K@<'1JY ZGLDZGO6=DY7YFEKOY(_-BBOJ?4/\ @G'\5;+39+F&\\.7\RIN
M%G;WTHE<_P!T%XE3/U8#WKYK\2^&=5\':Y>:-K=A/IFJ6;^7/:W";70_U!&"
M".""".#7WF%S#"8QN.'J*379GQ.(P&*PD5*O3<4^YF45+:VL]]=0VUM#)<7$
MSB..&)2SNQ. J@<DD]A7T=X-_P""?OQ8\7:5'?7%OI7AM9 &2#6;ITF*D9!*
M1HY7Z-@CN*TQ.,P^#BI8BHHI]V98?"U\7+EH0<GY'S917NWQ0_8L^*'PKTR7
M4[K3+?7-+A3?/=Z),9Q".Y9&59,#J2%( ZD5X358?%T,9#GP\U)>3#$86OA)
M<E>#B_,****ZSE"M'P[_ ,C!I?\ U]1?^ABLZM'P[_R,&E_]?47_ *&*B?PL
MN'Q(^\/^"GO_ "+?@'_K[N__ $"*OS^K] ?^"GO_ "+?@'_K[N__ $"*OS^K
MY;A;_D54O^WO_2F?2<2?\C.I\O\ TE!1117UA\P%%%% !1110 5Z%\$?@CKO
MQ[\67/A[P_=Z?9WL%F]ZTFI22)&45T0@%$<YS(.V.#S7GM?6'_!-G_DNVK_]
MB_/_ .E%O7FYE7GA<'5KT_BBFT=^7T88C%TJ-3:329Q/QD_8S\:_ _P6_B?7
M=4T&[L$GCMS'IUQ.\NY\X.'A48X]:\%K]1O^"AG_ ";K<_\ 83M?YM7Y<UY'
M#N85\RPDJV(M=2:TTTLO\SV.(,OH9=B84J%[.*>NNMVOT/I/X?\ [!7Q ^)'
M@O2/$^F:QX;@L-4@%Q#'=W5PLJJ<\,%@8 \=B:\6^*/PYU+X2^/-5\):Q/:W
M.HZ:T:RRV+L\+;XUD&TLJD\..H'.:_5W]E/_ )-T\ ?]@Q/YFOSH_;8_Y.@\
M<?\ 72U_])(:\W*,XQ6,S6OA*K7)'FMIVDDOP9UYAE>&PV4T,933YY\E]>\6
MW^*-#X0_L4^./C3X'M/%6B:KX?M=/N9)(DCU"XG24%'*G(2%AC(XYKL_^':?
MQ._Z#OA+_P #+K_Y&KZA_8%_Y-HT+_K[O/\ T>U9O[1W[:G_  S_ /$"+PQ_
MPAO]O;[&.\^U?VI]FQO9UV[?)?ILZY[]*\BMG6;U<QJX+!I/E;LK+9>;:/5P
M^4Y7#+Z>,Q;:NE=W>[\DF?*_B;_@GG\6?#]B]S:IHOB!EY-OIEZPD(]0)DC!
M^F<U\XZQHU_X>U2YTW5+*XT[4+9]DUK=1F.2-O1E(R#7ZM_LY_M<>'?VA;R[
MTJWTVZT+7K6#[2]E<.LL;Q[@I:.08W8++G*K]X8SSCR'_@I-\,M/N/".B>.K
M>W6/5;:[73KJ9%YEA=69-Q[[67 _WS[5VY?GV.IXZ. S.FDY;/S>W5II[:'-
MC,DP5;!2QN73;4=6O3?HFFEKJ?GM1117Z*? A1110 4444 %%%% 'VA_P3'_
M .1]\:?]@R+_ -&U\X_M$?\ )>OB)_V,%]_Z/>OH[_@F/_R/OC3_ +!D7_HV
MOG']HC_DO7Q$_P"Q@OO_ $>]?(83_D?8G_#']#ZG%?\ (EP_^*7ZGGM%%%?7
MGRP5ZQ\!_P!FOQ-^T,VMKX<OM)LCI(A,_P#:DTL>[S=^W;LC?/\ JVSG'4=:
M\GK[K_X)>_Z_XC_[NG_SN:\;.<54P67U<31^*-K?.27Y,];*L-3QF-IT*OPR
MO?[F</\ \.T_B=_T'?"7_@9=?_(U4=8_X)R_%;2[*2>VN?#NKR*,BVL[Z19'
M]@98D7\V%?9_[3G[2'_#..BZ)J'_  CO_"0_VE</!Y?VW[+Y>U0V<^6^<YZ8
M%<9\!_V[/#?QD\66GAF^T*Z\,ZS>EA:[KA;FWE8#.SS-J$,0#C*XXQG) /Y_
M1SCB"MAWC*<%*FKZV73?2]S[FME.1T*ZPM6;C-^;Z[:VL?FUXR\$:]\/==FT
M;Q)I-UH^IQ<M;W2;25R0&4]&4X.&4D''!K#K]6_VWOA7I_Q!^!NLZG)!'_;'
MAZ%M1M+K;\ZHN#*F>NUD!XZ953VK\I*^WR/-EF^&=1QM*+LUT]5Y,^0SK*_[
M+KJ$97C)77?T8445WWPO^!/CCXS1Z@_@[15U@:>4%R/MMO T>_=MXED4D':W
M(STKW:M6G1@ZE62C%=6[+[SPZ=.=6:ITXMR?1:LX&BN^^*'P'\=?!F/3Y/&.
M@MH\>H%UMG^U03ARF-PS$[8(W#KC/;H:Y'P_H.H>*M<T_1M*MFO-2OYTMK:W
M4@&21V"J,D@#D]20!WJ:=>E6A[6E-2CW3NOO*J4:M&?LZL7&79JS,^BO9_$7
M['?Q>\)Z#J&M:MX36STRP@>YN;AM4LV$<:C+' F)/ Z $GM7G_@/X8^*OBAJ
MG]G^%=!O-;N00'^S1_NXLYP9)#A4!P>6(%94\9AJL)5*=6+BMVFFEZOH:U,)
MB*4E"I3DF]DTU?T.8HKZGTG_ ()Q?%74;..>XO/#>ERL,FVN[Z5I$]B8XG7/
MT8UY_P#%_P#9&^(WP7TUM4UC3K?4=&3 EU+293-%$3TW@JKJ/]HKMY SDUQT
M\WR^M45*G6BY/S.J>58ZG#VDJ,DO0\97[PK]7=._8?\ @G<:?:RR>"]SO$K,
M?[5O>20"?^6U?E$OWA]:_=+2/^039?\ 7!/_ $$5\IQABL1A84'0J.-W*]FU
M?X>Q]+PKAZ.(J5E6@I62W2??N?B1XZTVVT;QOXAT^SC\FTM=1N((8]Q;:BRL
MJC)))P .O-8===X]T^XU;XL^(K&UC\VZN=;N88H\@;G:=@HR>!DD=:]&N/V(
M?C7:P232>"]L<:EV;^U;(X &2?\ 75]?#&4,/0I/$U5%M+XFE?17W/F*F$K5
M\15CAZ;E9OX4W;5VV/"Z*?#"]Q,D48W2.P51TR2<"O<S^P[\;0F\^"OEQG/]
MJV/_ ,>KJKXK#X6WMZBA?:[2O]YR4<-7Q+:H0<K;V3?Y'A-%.DC:&1D<8925
M(]Q7HGPC_9]\<_&VY=?"^C-/9Q.$GU&X816L1]"YZGD?*H+<CBM*M:G1@ZE6
M2C%=7L1"E4J3]G"+<NW4\YHKZHU+_@G#\5+&PEN(;[PWJ,J*66UMKV42.?[H
M,D*KGZL![U\W>+/".L^!=>NM%U_3;C2M4M6VRVURFUAZ$=B#U##((Y!-<F%S
M'"8QN.'J*379ZG7B,OQ6$BI5Z;BGUL16/AK5]3TRZU&STJ]N]/M2!<7<%N[Q
M0DC(#N!A>/4U]K?LO_LK^!/B5^SC/XDU[0FOO$-T;W[+>"[N(S&$RD>$20(V
M&4GD<YP:XK]C?]K+1_@SIA\':KX:NKJ'4K_SAJ6F'S9VE<(BHT)QN VC[ISZ
M*2:_2>..,1X6,(K<E=N.O7(KX3B;-\;AKX:,'33=XS4MTM]O-]_D?8\.99A,
M0XXB<E-Q^*#6BO>V^^GEN?AM8^&]6U33[N_L]+O;NPLUW7-U!;N\4 ]78#"C
MZUG5^E7[7G[5VA_#BSUOX;Q^%[G5=1OM/,$S7.+>S2*:,@,A&6DQZ  9!&[(
M(K\U:^ORG'U\QI.O5I<D7;EUO==^GY'S.:8&CE]14:=7GEKS:6MV_JX4445[
MIX@5^P/P0^[:_P#8-3_V2OQ^K]@?@A]VU_[!J?\ LE?F'&_PX?UE_P"VGZ+P
M?\=?_MW]3UVBBBORL_2PHHHH **** . ^(W_ "-/@S_K]_\ 9XJ[^N ^(W_(
MT^#/^OW_ -GBKOZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R?]K#_ )-G^)W_ &+]
MY_Z*-?F+_P $W?\ D[3PS_UZ7W_I-)7Z=?M8?\FS_$[_ +%^\_\ 11K\--'U
MS4?#M^E]I5_=:9>H"%N;.9HI%!&" RD$9'%>_E4>:-:/=6^]21\QG3Y9T)]I
M7^YQ?Z']$=%?S^_\+A\>_P#0[^(__!M<?_%T?\+A\>_]#OXC_P#!M<?_ !='
M]D3_ )T5_;E/^1G] 5%?S^_\+A\>_P#0[^(__!M<?_%U^J7_  30\0ZKXF_9
MTN;S6-3O-5N_[=NH_M%].\TFT1PX7<Q)QR>/>N>OETJ%-U'*]CHPV:PQ-6-)
M1:O_ )7/K"BBBO(/="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %?GQ^W1_R(.C_P#87'_HJ6OT
M'K\^/VZ/^1!T?_L+C_T5+7T'#_\ R-*'K^C/"SS_ )%M;T_5'Q11117]!GX8
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?2\5T:<L-A\6U^\E9-^5K[;;GSO#=:I'&5\(G^[7,TO.Z7KL?,'Q8_X*%?\
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M7_U]1?\ H8K.K1\._P#(P:7_ -?47_H8J)_"RX?$C[P_X*>_\BWX!_Z^[O\
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M*5.SY=MMK>2>_7[S',W2R7*_885-JI=<V^ZUOZK:W:_KQ5%%%?KQ^5!1110
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MJ2K8# U)[M-OYQ@>+D%.-',<;3@K)2LO12D?CE=?\G$3?]C4W_I77[%:[_R
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MXF^$J^,8X%76/#\T8,ZCYI+:1PC(?4!F5AGIAL=37;_\-S?!'_H=O_*3??\
MQBO,_P!I3]KGX4>.O@?XKT#0/$HU75[^W2*WM3IUU'N;S$).Z2(*, %N3VK@
MIT\1]?P]?"8*=%1:3^)IJ^M[I6TNF=ZJ4/JE:ABL9&KS)V^%6T]7ULUYH^+_
M -G7Q]X=^&/Q<T/Q)XHTN;5=-L7+A+<C=#(1A)MIX?83G;D<X.>,'Z)^*?\
MP4-U<_%;3;GP5&LG@O2Y"LMO<QE&U4'AV;/S1@#[G<'E@<[1\645^H8G*L)C
M*ZQ&(CS-)JSVU\N_G^MC\UP^98G"494*$N52:=^NGGV_KJ[_ $]^VG^T!X$^
M.EQX:E\+Z==OJ5E"3<:I<+Y7[MP#]GV8RQ5L_-G .[;N#9KYAHHKHP.#I9?0
MCAZ-^5=W??4QQF,JXZLZ]:W,[;*VRL%%%%=YPA7[ _!#[MK_ -@U/_9*_'ZO
MV!^"'W;7_L&I_P"R5^8<;_#A_67_ +:?HO!_QU_^W?U/7:***_*S]+"BBB@
MHHHH X#XC?\ (T^#/^OW_P!GBKOZX#XC?\C3X,_Z_?\ V>*N_H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /)_VL/\ DV?XG?\ 8OWG_HHU^6G_  3\\-Z3XL_:@\.Z
M;K>EV6LZ=):WC/::A;I/"Q%NY!*."#@@$<5^PWCKP;IWQ#\':SX9U82G3-6M
M9+.Y$+['\MQAMK8X.#UKQKX0_L-_#+X(^.K/Q;X:BU9=7M$DCC-U>^;'B1"C
M97:.S&O3P>)AAX58RWDK+[G_ )GCYA@ZF*G1E"UHR3?I>+_1GHO_  H'X8?]
M$X\)?^".U_\ C='_  H'X8?]$X\)?^".U_\ C==[17![2?=GJ>SA_*C@O^%
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MP(/Q&\6$?]ARZ_\ CE<,)7642!V$F=V_/.>N<^M5P_DE3)Y5)5)J7-;;RO\
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M+B_TN4J9+6.WAMTDP01N$2+N (!P>XKEOA_\3O%7PMU<ZGX4URZT6[8;7,#
MI*!G =&!5P,G 8'%<^(R7'9AE[P^-JIU5*Z:VM:UGHO/6QT4LVP6!Q\<1@J3
M5-QM)/?5WNM7Y:'Z)>-OV"?#?CSXR7GC75/$5\^F7UQ]KN]%\D9D?C*B?=E8
MSC[NW(&0&'&/I/P_>Z7?Z1;OHL]M<:9&#!"UFRM$!&2A52O&%*E>/2OR*\:?
MM6?%CX@:/)I6M>,[R6PE!66&UBAM!(I&"KF%$+*0>5)(/I7*:%\7/'7A?2X=
M-T;QIXATC3H=WE6=CJL\$*9)8[45P!DDDX'4FO)J\,9CBZ$*>*Q"?)I%6T2^
MY:[=/F>I#B+ 8:O.KAZ#]_63>[?WO3?_ "+'QM_Y+-X^_P"P_?\ _I3)7Z@?
ML@?$2Q^(7P$\+M;3B2]TFUCTN]A+9>.2)0@+?[RA6'^]7Y(WU]<ZG>W%Y>7$
MMW=W$C2S7$[EY)'8Y9F8\DDDDD\DFM[P'\2/$_PQUC^U/"VMW>BWI&':V?Y9
M!_==#E7'LP(KZ;-<F_M' PPRE:4+6?316^YGSF7YM]1QTL5RWC*]UY-W^]'Z
M _&K]@'2OB1XZUSQ=I_B:XTJ34!)<RZ;]D64/<%3RLF\;59@"058Y)P1QC\V
MY(VBD9'4JZG!4]01VKVZ^_;8^-6H6KV\OCB98W&TF"PM(G_!TB# ^X->)W%Q
M+=W$L\\C2S2L7>1SEF8G))/<DU>2X/,<%!TL;44XI)1MTM?R7EWV'G&,P&,D
MJN$IN,FVY-];_-_IN1T445]*?.!1110!ZW^R;_R<=X!_["*_^@M7KG_!2[_D
MMOA__L7H?_2FYKR/]DW_ )..\ _]A%?_ $%J]<_X*7?\EM\/_P#8O0_^E-S7
MR%?_ )']'_KV_P V?4T?^1'6_P :_)'R11117UY\L%%%% '[:_"O_DE_@_\
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ME0<=.!7!C\.\9A:F'B[.2:^\[<%76%Q-.NU=1:?W'Z8?\%#/^3=;G_L)VO\
M-J_+FNI\1?%3QKXNTTZ?KOC#7M:L"P<VNHZG/<1%AT.UV(R/7%<M7F9'ED\I
MPSH3DI-R;T]$OT/3SK,H9IB(UH1<;1MKZM_J?L/^RG_R;IX _P"P8G\S7YT?
MML?\G0>./^NEK_Z20UP&D_&;X@:#IMOI^F>.?$FG6%NNR&UM-7N(HHE]%57
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MR(^/1E?KZJWI7Y95T'@?X@>(_AMKB:QX8UBZT;45&WSK9\!UZ[74_*ZYQ\K
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M44 %%%% 'K?[)O\ R<=X!_["*_\ H+5ZY_P4N_Y+;X?_ .Q>A_\ 2FYKR/\
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M8"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MNJX7X&_\DE\,_P#7K_[,U=U0]P6P4444AA1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P!
MZW_[XH_ULS3^=?\ @*#_ %8RW^5_>S\Q?^&'O%G_ $'=%_.;_P"(H_X8>\6?
M]!W1?SF_^(K].O\ A%='_P"@=;_]\4?\(KH__0.M_P#OBC_6S-/YU_X"@_U8
MRW^5_>S\Q?\ AA[Q9_T'=%_.;_XBC_AA[Q9_T'=%_.;_ .(K].O^$5T?_H'6
M_P#WQ1_PBNC_ /0.M_\ OBC_ %LS3^=?^ H/]6,M_E?WL_,7_AA[Q9_T'=%_
M.;_XBC_AA[Q9_P!!W1?SF_\ B*_3K_A%='_Z!UO_ -\4?\(KH_\ T#K?_OBC
M_6S-/YU_X"@_U8RW^5_>S\Q?^&'O%G_0=T7\YO\ XBC_ (8>\6?]!W1?SF_^
M(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P! ZW_[XH_ULS3^=?\ @*#_ %8RW^5_
M>S\Q?^&'O%G_ $'=%_.;_P"(H_X8>\6?]!W1?SF_^(K].O\ A%='_P"@=;_]
M\4?\(KH__0.M_P#OBC_6S-/YU_X"@_U8RW^5_>S\Q?\ AA[Q9_T'=%_.;_XB
MC_AA[Q9_T'=%_.;_ .(K].O^$5T?_H'6_P#WQ1_PBNC_ /0.M_\ OBC_ %LS
M3^=?^ H/]6,M_E?WL_,7_AA[Q9_T'=%_.;_XBC_AA[Q9_P!!W1?SF_\ B*_3
MK_A%='_Z!UO_ -\4?\(KH_\ T#K?_OBC_6S-/YU_X"@_U8RW^5_>S\Q?^&'O
M%G_0=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/
M_P! ZW_[XH_ULS3^=?\ @*#_ %8RW^5_>S\Q?^&'O%G_ $'=%_.;_P"(H_X8
M>\6?]!W1?SF_^(K].O\ A%='_P"@=;_]\4?\(KH__0.M_P#OBC_6S-/YU_X"
M@_U8RW^5_>S\Q?\ AA[Q9_T'=%_.;_XBC_AA[Q9_T'=%_.;_ .(K].O^$5T?
M_H'6_P#WQ1_PBNC_ /0.M_\ OBC_ %LS3^=?^ H/]6,M_E?WL_,7_AA[Q9_T
M'=%_.;_XBC_AA[Q9_P!!W1?SF_\ B*_3K_A%='_Z!UO_ -\4?\(KH_\ T#K?
M_OBC_6S-/YU_X"@_U8RW^5_>S\Q?^&'O%G_0=T7\YO\ XBC_ (8>\6?]!W1?
MSF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P! ZW_[XH_ULS3^=?\ @*#_ %8R
MW^5_>S\Q?^&'O%G_ $'=%_.;_P"(H_X8>\6?]!W1?SF_^(K].O\ A%='_P"@
M=;_]\4?\(KH__0.M_P#OBC_6S-/YU_X"@_U8RW^5_>S\Q?\ AA[Q9_T'=%_.
M;_XBC_AA[Q9_T'=%_.;_ .(K].O^$5T?_H'6_P#WQ1_PBNC_ /0.M_\ OBC_
M %LS3^=?^ H/]6,M_E?WL_,7_AA[Q9_T'=%_.;_XBC_AA[Q9_P!!W1?SF_\
MB*_3K_A%='_Z!UO_ -\4?\(KH_\ T#K?_OBC_6S-/YU_X"@_U8RW^5_>S\Q?
M^&'O%G_0=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\
M"*Z/_P! ZW_[XH_ULS3^=?\ @*#_ %8RW^5_>S\Q?^&'O%G_ $'=%_.;_P"(
MH_X8>\6?]!W1?SF_^(K].O\ A%='_P"@=;_]\4?\(KH__0.M_P#OBC_6S-/Y
MU_X"@_U8RW^5_>S\Q?\ AA[Q9_T'=%_.;_XBC_AA[Q9_T'=%_.;_ .(K].O^
M$5T?_H'6_P#WQ1_PBNC_ /0.M_\ OBC_ %LS3^=?^ H/]6,M_E?WL_,7_AA[
MQ9_T'=%_.;_XBC_AA[Q9_P!!W1?SF_\ B*_3K_A%='_Z!UO_ -\4?\(KH_\
MT#K?_OBC_6S-/YU_X"@_U8RW^5_>S\Q?^&'O%G_0=T7\YO\ XBC_ (8>\6?]
M!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P! ZW_[XH_ULS3^=?\ @*#_
M %8RW^5_>S\Q?^&'O%G_ $'=%_.;_P"(H_X8>\6?]!W1?SF_^(K].O\ A%='
M_P"@=;_]\4?\(KH__0.M_P#OBC_6S-/YU_X"@_U8RW^5_>S\Q?\ AA[Q9_T'
M=%_.;_XBC_AA[Q9_T'=%_.;_ .(K].O^$5T?_H'6_P#WQ1_PBNC_ /0.M_\
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M\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P! ZW_[XH_ULS3^=?\
M@*#_ %8RW^5_>S\Q?^&'O%G_ $'=%_.;_P"(H_X8>\6?]!W1?SF_^(K].O\
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M.O\ A%='_P"@=;_]\4?\(KH__0.M_P#OBC_6S-/YU_X"@_U8RW^5_>S\Q?\
MAA[Q9_T'=%_.;_XBC_AA[Q9_T'=%_.;_ .(K].O^$5T?_H'6_P#WQ1_PBNC_
M /0.M_\ OBC_ %LS3^=?^ H/]6,M_E?WL_,7_AA[Q9_T'=%_.;_XBC_AA[Q9
M_P!!W1?SF_\ B*_3K_A%='_Z!UO_ -\4?\(KH_\ T#K?_OBC_6S-/YU_X"@_
MU8RW^5_>S\Q?^&'O%G_0=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\
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MLS3^=?\ @*./_5C+?Y7][/S%_P"&'O%G_0=T7\YO_B*/^&'O%G_0=T7\YO\
MXBOTZ_X171_^@=;_ /?%'_"*Z/\ ] ZW_P"^*/\ 6S-/YU_X"@_U8RW^5_>S
M\Q?^&'O%G_0=T7\YO_B*/^&'O%G_ $'=%_.;_P"(K].O^$5T?_H'6_\ WQ1_
MPBNC_P#0.M_^^*/];,T_G7_@*#_5C+?Y7][/S%_X8>\6?]!W1?SF_P#B*/\
MAA[Q9_T'=%_.;_XBOTZ_X171_P#H'6__ 'Q1_P (KH__ $#K?_OBC_6S-/YU
M_P" H/\ 5C+?Y7][/S%_X8>\6?\ 0=T7\YO_ (BC_AA[Q9_T'=%_.;_XBOTZ
M_P"$5T?_ *!UO_WQ1_PBNC_] ZW_ .^*/];,T_G7_@*#_5C+?Y7][/S%_P"&
M'O%G_0=T7\YO_B*/^&'O%G_0=T7\YO\ XBOTZ_X171_^@=;_ /?%'_"*Z/\
M] ZW_P"^*/\ 6S-/YU_X"@_U8RW^5_>S\Q?^&'O%G_0=T7\YO_B*/^&'O%G_
M $'=%_.;_P"(K].O^$5T?_H'6_\ WQ1_PBNC_P#0.M_^^*/];,T_G7_@*#_5
MC+?Y7][/S%_X8>\6?]!W1?SF_P#B*/\ AA[Q9_T'=%_.;_XBOTZ_X171_P#H
M'6__ 'Q1_P (KH__ $#K?_OBC_6S-/YU_P" H/\ 5C+?Y7][/S%_X8>\6?\
M0=T7\YO_ (BC_AA[Q9_T'=%_.;_XBOTZ_P"$5T?_ *!UO_WQ1_PBNC_] ZW_
M .^*/];,T_G7_@*#_5C+?Y7][/S%_P"&'O%G_0=T7\YO_B*/^&'O%G_0=T7\
MYO\ XBOTZ_X171_^@=;_ /?%'_"*Z/\ ] ZW_P"^*/\ 6S-/YU_X"@_U8RW^
M5_>S\Q?^&'O%G_0=T7\YO_B*/^&'O%G_ $'=%_.;_P"(K].O^$5T?_H'6_\
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M=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P!
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M_P#T#K?_ +XH_P"$5T?_ *!UO_WQ7=_K9FG\Z_\  4<?^K&6_P K^]GYB_\
M##WBS_H.Z+^<W_Q%'_##WBS_ *#NB_G-_P#$5^G7_"*Z/_T#K?\ [XH_X171
M_P#H'6__ 'Q1_K9FG\Z_\!0?ZL9;_*_O9^8O_##WBS_H.Z+^<W_Q%'_##WBS
M_H.Z+^<W_P 17Z=?\(KH_P#T#K?_ +XH_P"$5T?_ *!UO_WQ1_K9FG\Z_P#
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M8MM:]S\T_P#AA[Q9_P!!W1?SF_\ B*/^&'O%G_0=T7\YO_B*_3K_ (171_\
MH'6__?%'_"*Z/_T#K?\ [XKN_P!;,T_G7_@*./\ U8RW^5_>S\Q?^&'O%G_0
M=T7\YO\ XBC_ (8>\6?]!W1?SF_^(K].O^$5T?\ Z!UO_P!\4?\ "*Z/_P!
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M5_V>?A[\<+C3I_&_AR/79=.5TM6>YGB\M7*EA^[=<YVKUSTK@O\ A@/X!_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7F_P -O^1@OO\ KBW_ *&*](KS
M?X;?\C!??]<6_P#0Q2 ](HHHI@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7F]]_P E07_KK'_Z+6O2*\WOO^2H
M+_UUC_\ 1:T@/2****8!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 8_B[_D6M0_ZY?U%8_PP_Y =Q_U\M_Z"M;'B[_D6M0_ZY?U%8_PP_Y
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<U\3?^2;^+/\
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M]FWL5QL^NQCBHEAZT%S2@TO1E1KTIOEC--^J-VBBBL#<**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P""17_(P?$O_KUL?_0YJ_2FKQ>'^JU/9WOL1@\3];I>UM8****XSN"BBB@
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MO[C[1JKJFIVNBZ;=ZA?3I:V5I"\\\\APL<:J69C[  FOB/\ X)<_$3Q7\0-
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M5\.&(1:@;9;S43C#-=2@/(#Z[<A![(*]<IXF-.-:4:7PIBPDJDZ$)UOB:O\
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ML9) [VLZ'YHV( SP58' R&!P.E9/[6'PEA^-'P%\5>'S"LNH);->Z>QZK<Q
MNF/K@J?9C7P+_P $N/B]+X3^+NH^!+R8KIOB6W:2"-SPMY"I88]-T?F ^I5:
M]'#4(8BA5M\<=?E_2?W+N>5BL3/#8BE?X):?/^FOQ/U8KDOBO\3-*^#OP]UG
MQCK<5U/I>E1++-%9(K3,"ZH H9E!.6'5A7472S/:S+;NL<Y1A&[C*JV."1W&
M:_+C]L3Q5^T/\+/ EWX*^)/B'0?%7A;Q&XCMM2MHHH[C$3K)M"*(W'W5R65Q
MSC=DBN2C2=::@FD]-^O>WG8[:]98>'M&FUY=/4_2WP#XTL/B-X)T+Q3I:3Q:
M=K%G%?01W2A95210P5P"0&&<'!(ST)K?K\T/V0?%'[1WQE\'Z'I'@SQ-H'A;
MP-X7>*PGN98(I)YE3#>6R8>0G:1S^[4@G#9!K]+AGOUKHQ>'6'J.*?5V75+I
M?U1SX+%?6J2DT]EKT;ZV]&+1117">@%>;WW_ "5!?^NL?_HM:](KS>^_Y*@O
M_76/_P!%K2 ](HHHI@%%%% !1110 4444 %%%% !1110 4444 %%?/W[>'C#
M5O O[,/BK5-#U2]T;5%DM(H;W3YWAGCW7$8.UU(9<C(X/0FORP\*?%SX^^/-
M1?3_  SXT^)'B*_CB,SVNDZKJ%U*L8(!<K&Y(4%E&>G(]:]#"X.6*C*2=DG;
M\$_U/,QF.C@Y1@XW<E?\;'[H45^+?_&6_P#U6G_RKU^H'[('_"5_\,[>$?\
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M44 %%%% !1110 4444 8_B[_ )%K4/\ KE_45C_##_D!W'_7RW_H*UL>+O\
MD6M0_P"N7]16/\,/^0'<?]?+?^@K0!V%%%% !1110 4444 %%%% !117!?';
MXH-\&/A+XD\:)IPU9])@686;3>2)275,;]K8^]GH>E '>T5^.?Q<_P""C7Q<
M^)D,MEIM_#X'TQC_ *O0-T=RP[;K@DN"/6/9GTKV#_@F7\6O''CWXT>(;'Q-
MXR\0>(K*+09)H[;5M4GNHTD$\(#A9'(#8)&>O)KU_P"S:L:<JDVE9-V]#P_[
M7H2JQI4TW=I7]3]+***_,;]O+XT?'BR^+9\"6KWN@:#>D?V-!X9,GFZK&> 6
ME4!W?)P8UP!D##<,?/H498BHJ4=V>IB*\<-2=62NEV/TYHK\/_%'[(OQQ\%>
M&Y_&FL>#=3L["W3[5->K=PR7$2]2[QI(95QU)*C'4XKU;]C7]N/QCX'\?Z+X
M6\8ZW=>(O!^J7"69?4I3-/8.Y"I(DK'=L!(W*20%R0 >OJ?V9SI^QJ*373^F
M>.LVY))5Z3@GU_79'ZU4445XA] %%9_B";4X-#U"31K>WNM76!VM(+N0QPR2
M[3L5V )"DXR0*_''X@>+?VBOVEOB=JOA&^CUV\UBUF:*Y\-:;NM[.RVG'SH&
M"!0>DDC'.1\QR*ZL-AWB9N*:5M=3CQ>*6%@IM-W=E;N?L]17X5^./@S\8?V7
M[JPU76]-U;P7+<N4MM2T^_4@N!G;YUO(P5L<[20>#Z5]Y_\ !/3]L37OC%=7
MW@+QO=#4=?L;7[78:JRA9+J%2%=)<8!==RD-C+#=GD9/;4R]JFZM*:DE_7GL
M>?1S12JJC6IN#>U_PZ+<^X:***\@]P**** "BBB@ HHHH *BN?\ CWE_W#_*
MI:BN?^/>7_</\J . ^%G_'SJ'^XG\S7HE>=_"S_CYU#_ '$_F:]$I( HHHI@
M%%%% !117AW[7W[1\/[-GPKEUF"**[\1:A)]CTFUFR4:4C)D<#DH@Y/J=HXS
MFFDY-16[$Y**<I.R1[C17X;:7H?QJ_;)\4ZC-:_VMXZU&V7SYS/=)%;6H8\!
M?,9(H\X.$7&<' X-;7PJ_:$^*O[(/Q&.CZA+J4=II\XBU/PIJDK&%D."VQ22
M(V((*R)UX/S*<'VUE;^!U%S[V_K_ "/G_P"V(_&J;Y-K_P!:?B?M?16'X(\9
M:9\0O"&C^)=%G^T:7JMJEW;R8P=K#.".Q'0CL016Y7BRBX2<9+5'OQDIQ4HN
MZ844AX!.,^U?D[^UA^TY\;?B%\6K_P"'>GV&M>#HHKDVMMX=TDO]LO?[KO)'
M\TH<<A4.S!_BQN.V'H2Q%3V<-SGQ.(AA:3JSV\C]8Z*_#CQQ^R[\;/@[HX\8
MZ]X6U31[2)E=M4MKR*:2 G&&<PR,\?..6QSBOJC_ ()__ML>(]<\967PT\?:
MG-K<>H!DTC5KQ]]Q', 6\F5SS(K ':S$L&P,D$;?1EEUX.=&:E;?^M3RX9K^
M\4*]-POLW_PR/T?HKD/BUJGBW1?ASKU]X&TRTUCQ5;VS26-E?.RQR..W'WCC
M.%R,G R.M?CTZ?M _M@>*-2MP/$'BRXMY"+FT:3[-8V;<C858I#$W4;3@G!Z
M\UQ8;#O$N7O));W._%XM851]UR<MDC]M**_";Q+X3^+W[)_B>T34!K7@/59U
M\Z"6SO<).H/.)(7*.!QE<GJ,CFOTR_8+_:KU#]HKP9J>F^)C&WB[03&+BYB0
M1K>0N"$EVC@/E6#!0!]TC&<#JK9>X4O;4YJ45V_IG)A\R52K["K!PD^_](^I
MZ***\D]H**** "BBB@#B/BE_R#['_KJW\JZ7PW_R+^F_]>\?_H(KFOBE_P @
M^Q_ZZM_*NE\-_P#(OZ;_ ->\?_H(I=0-*BBBF 4444 %%%% !1110 45R7Q"
M^+7@WX3Z;]O\7^)=.\/V[ E!>3A9)<=1'']YS[*":J?!_P",?ASXY>$Y/$GA
M66XN-'6[EM$GN(3$963&653R%YXW 'VJU"4HN26B(<XQDH-ZOH=Q17Y;?MT?
MMP>)-<\<ZKX"\!:S<:)X=TJ5K2]O]/D,<]].IQ(!(IRL:G*X4C=@YR"!7SWJ
M_P"S[\:?AOX5MOB5=^'M:T73&"7"ZQ#=*MQ$'QMD=4?S8@<CYG ZCUKTJ&!=
M2FJM2:BGMY]NVYY.(S)4ZKI4H.;CO;IW[[=3]S:*^$O^">O[96L?%"]D^'/C
MJ^.H:]# 9]*U68_O;N-!\\4I_BD5?F#=6 ;/(R?NVN3$8>>&GR3.W"XJ&+I^
MTA\_)A116)XU\8:9\/\ PCJ_B369_L^EZ7;27=Q)U(11D@#N3T [DBN1NRNS
MM6KL;=%?BE\6/VC/BI^US\0DT73YM1-EJ%P8-,\*Z7(RQ;?X0X! D8 99WX'
MS'Y5X&%K'AOXU_L<^)=/N;M=8\"W]S^]@DM[I)+>YVD95C&S128R,HV>HR.:
M]N&6NR]I-1D]E_7Z7/GZF;14I>RIN48[O^OUL?N517AG['_[2,/[2GPKCUBX
MBBM/$>G2"SU:UA^X)<965 >0CCD#L0PYQFN>_;@_:F?]F[X?VT6B^3+XQUMG
MBT]9E#K;HH'F3LO?;D!0>"QYR 17F5*%2G5]@U[U[?U^?H>M3Q%*I1]NG[MK
M_P!?EZGTI17X:^'/AS\:_P!K;4=5UNPM=8\<SV;9N;R\O45(F;)"(TSJN<=$
M3H,< 8KL/V??VLOB'^R_\0(]$\17.J7GARVN/LFJ^'-4=V:U .&,(?F)UY.!
M@-C![$>K_9;^!5%S]OZ_R/'_ +8C\;IM0VO_ %_F?LU15/1]6M->TFRU/3YT
MNK"\A2XMYXSE9(W4,K#V((-?!'[5_P#P44\7_"GXF>)/ 7A7PYI=M/I4B0G5
M[]WN&?=$C[EB&Q5(WX^8N..G->33HU*U3V4%[W^7_#GLU<13HTO;3?N_?OJO
MR/T#HK\(]<_:J^,?B#5+C4+GXG>*H9YVW,ECJLUI"/\ =BB944>RJ*_<3P;/
M+=>$-#FFD:::2Q@=Y)&+,S&-222>I)KLQ&!GAH*<FM3BPF80QDY0A%JW<V**
M**\T]4**** "BBB@ KS?X=_\C/?_ /7%_P#T-:](KS?X=_\ (SW_ /UQ?_T-
M:0'I%%%%, HHHH **** . ^(W_(T^#/^OW_V>*N_K@/B-_R-/@S_ *_?_9XJ
M[^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ***Y+XM^-#\.OA=XL\4*N^32-+N+U%(
MR"Z1LR@^V0*3=E<<5S-(\S^/G[:?PV_9[O#I>M7MQJWB':&.CZ1&LLT8(R#(
M694C['!;=@Y -?/-C_P5JTG4-<MK*/X;7BVL\ZQ"=M73> Q R4\G'?IN_&OD
MG]F3X%ZE^V!\:=1M-9UV:UC\N35]7U+:))Y 9%!" \;V9QR> ,G!P <+XW?#
M+3/@W^TEJG@W1KB[NM-TG4;6.&:^96F8,D3DL551U<] .,5]3ALOP\:L*%;6
M;5_*UTCXS&9IBG0GB</[L(NR[WLW^GZ:G[2_$OXL>$O@_P"'GUOQAKMKHE@,
MA&G;,DS 9VQH,L[>R@FI_AM\1-$^+'@?2?%GAVY:ZT?4XO-A=UVN,$JRL.S*
MP*D>HKYK_P""GOA33]:_9KDU>Y11?Z-J5O+:2?Q?O&\IT'L0V<?[ ]*Y#_@D
MWXLNM4^%/B_P_,[/!I.J1SP;CD(L\9RH]!NB)^K&O%I8>-3"U*]]8M+\O\U]
MQ]!6Q4J6,I8=K2:;^>O_ ,BS[IHHHKA/2"BBB@ HHHH **** "BBB@ HHHH
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M>]EY/_+796/FG]@G]MW4OC!J!\ >/)HYO%$<+2Z=JJJ$-^B#+QR*,#S5&6#
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MMJ.T,UI;J0I* \;V8X![!2>N"/K?2].L]'TVTL=/MX;2PMHEAM[>W4+''&H
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M:T@/2****8!1110 4444 <!\1O\ D:?!G_7[_P"SQ5W]<!\1O^1I\&?]?O\
M[/%7?T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !7-_$KP;%\0_A[XD\,3L$CUC3I[$
MN>B^9&5#?@2#^%=)2,P4$DX Y)-*2NFAQ=FFC\0/@K\6/%/[%_QSO[B\T?SK
MRR\S2]7TBX<Q>='N!(5\'!RJLK8((QU!K"^.WQ:TWXK?'_6O'NGV=U9Z=?WE
MO<K:W(7SD"1QJP."1U0XYZ8Z5^L_[1/['?@']I...^U>*;2O$,<82'7-,*B5
ME_A60$%9%'OR.S"OD'4O^"1_B2.^VV'Q#TJXL\_ZVYT^6*3_ +X#,/\ QZOJ
M,/CZ$IQK5=*B5O+>_P":Z_B?&XO+,1&G+#T?>IR=[=5HUU\GT]=#R;]L#]N#
M4/VEK6ST#2])?P_X2LY_M/DS2B2XNY0"%>3'RJ%!.$&>3DD\8^U_^":?PDO_
M (<? 636-5MWM;_Q1=_VA'#(,,MJ$"0DCMN^=Q[.M8'P3_X)?^"OA_K%OK'C
M+6)?'-W;N)(K%K86UB&'/[Q-S-+@]BP4]"IK[355C5550JJ,!0, #TKBQ&(H
M4Z#P^&6CW?\ 7]::>7HX7"XFIB%BL6]5LO\ ANFK^_[W4445XI] %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<U\
M3?\ DF_BS_L$W?\ Z)>E_P"%E^$/^AJT3_P8P_\ Q5<]\1/B%X6O?A_XFM[?
MQ+H\]Q-IEU''%%?Q,[L8F 4 -DDGC JDG<3:L6_@;_R27PS_ ->O_LS5W5>4
M?!OQYX9TSX8^'K6\\1:3:7,5OMDAGOHD=#N/!4MD5V?_  LOPA_T-6B?^#&'
M_P"*H:=Q)JQTE%16MU#>VT5Q;RI/;S()(Y8F#(ZD9# C@@CG(J6I*"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OG7]HS_D=+'_L'I_Z,
MDKZ*KYU_:,_Y'2Q_[!Z?^C)*_+_$C_D02_Q1_,^QX3_Y&:]&>5U]NK]T?2OB
M*OMU?NCZ5\;X3[X[_N'_ .WGO<;?\P__ &]_[:+1117]!'Y@%%%% !1110 4
M444 %%%% !1110 4444 %%%% 'R=_P %*?\ DA&B_P#8Q6__ *37-? OP5OK
M;2_C)X#O;VXBM+.WUZPFFN)W"1Q(MQ&6=F/ 4 $DG@ 5^AO_  41\.W^O?L_
MQSV5N\Z:7J\%]<[%)*1>7-&6^@:5<^@K\OZ_:N%8QK92Z=]W)?>?D7$LG2S-
M5+=(O[C]I/\ A?/PS_Z*)X3_ /!W;?\ Q='_  OGX9_]%$\)_P#@[MO_ (NO
MQ;HK@_U*P_\ S^?W([/];Z__ #Z7WL_:3_A?/PS_ .BB>$__  =VW_Q='_"^
M?AG_ -%$\)_^#NV_^+K\6Z*/]2L/_P _G]R#_6^O_P ^E][/VD_X7S\,_P#H
MHGA/_P '=M_\71_POGX9_P#11/"?_@[MO_BZ_%NBC_4K#_\ /Y_<@_UOK_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI_D[+\3X:_X)/_\ )>/$W_8NR?\ I1!7TU_P5%_Y-F3_ +#=K_Z#)6C^R?\
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M:UO;O*=0CB)QN\TMY;,!SM\M0>F1UK]"O&7A_3_BM\,]7T?S5DTWQ!I<D"3
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MJ-*5*,W:5^CZJW8^2KT<PQ%:%:5-7C:VJZ._<^W/A+\<O!'QTTJ^U+P/K?\
M;=E8S"WN)?LD]OLD*A@,2HA/!'(!%>&:W_P4:^&_AGXW:EX(U(S1Z'9XMV\3
M6^9H%N@3YB,B@ML'"[US\P/&/FKM_P!DS]EL?LO>$]=T1O$@\4+JEX+LRG3_
M +*(P(PFW;YLF[IG.1]*\8^.?_!+WPKXZUBYUGP+K)\&W=PS22Z;+!Y]DS'D
M[,$-$">PW =@*\E1PD<0TVW3MH_.R_+7H>W*6-EAE*,4JE]5Y7Z:]=.O?J?0
M.O?M<_!KP_H,VK3?$GPY=01Q^9Y%AJ$=S<O[+#&2Y/MBOQ0\;:NGCCXB:]JF
MF63Q1ZOJD]S;6:+EU$LK,B #.3\P&!WKZUC_ ."3OQ3-T%?Q/X/6VSS(MS=%
M\>NW[.!GVW5]0?LU_P#!.SPC\$-<M?$VOZDWC+Q-:L)+1I(!#:6C]G2/+%G!
MZ,QP."%! ->E0EA,&W44^9]CR<1''8^*I2IJ*3O?^OT/?O! /PO^"&@CQ!(8
MCX?\/0?V@_WBOD6Z^9]<;37P+_P]J\2_\)UY@\%:5_PAOG8^R^9+_:'E9QN\
MW?Y>['./+QVSWK])/$&AVGB?0=2T?4(_-L=0MI+2XCSC=&ZE6'Y$U^;?_#I7
MQ+_PG7ECQKI7_"&^=G[3Y<O]H>5G.WRMGE[L<9\S'?':N#"3H5*\YXKKJNV[
MO^ECT<93Q-+#TZ>$Z:/:^B5OUN?H9>?$KP]IOPY_X3F\U!+7PS_9ZZF;R7@"
M!D#J<>I!&!U).*^>/@I_P4<^&/Q/GNK+Q!=+X#U%)W%N-7E MKB'<=C>=@*C
M;<;E?')X+5[_ *U\)?"OB3X:IX"U728M0\+I9QV*V<Q/$<:A4(88(9=H(88(
M(S7PE\2O^"2]PU]/<> ?&L"VKMF.P\00L#&/3SX@=W_?L?C65!864YJJVD_A
M_P"#_5C;$2QD:=.5))M?$N_IY?B>O?MH_M6?"S_A0OBKPYIGBO2/%6M:W9M9
MVMGH]TEX%9B/WCO&2J!?O<G)(& :^ /V)/#.I>*/VHO $>FQR,;+4%O[B1 <
M1PQ NY8]@0-OU8#O7N?A_P#X)+_$*YU!$USQCX9TZQ_BFT_[1=RCZ(\<0/\
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MS9 _V#Z5W/A#_@DKXSNM04>*?&VA:;8@@EM'CFNY&'<8D2(#ZY/T-?>_P+^
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MR#]X@]V\PU[3^R+\!=<^%'[/NH> /&<-N+F>\O4D-I,)8I8)5"AE. <$9X8
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M7S!]>%%%% !1110 5YO\._\ D9[_ /ZXO_Z&M>D5YO\ #O\ Y&>__P"N+_\
MH:T@/2****8!1110 4444 <!\1O^1I\&?]?O_L\5=_7 ?$;_ )&GP9_U^_\
ML\5=_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %9_B"-YM!U)$5G=K:1551DDE#@ 5
MH45,H\T7'N7"7))2['X(:%\1?B?\$;_[%INO>)O!L\;;VT_SYK92?]N%L*W_
M  )37NW@;_@IW\9/"^R/6)-'\70!AN.HV0AEV^BO 4 /NRM^-?I%\4_CQ\'/
M"=G<V/CCQ7X:=$XFTRYDCO)?QMU#N?\ OFOA/XS?'K]D'5I9AI7PBN-?NU_U
M<^E1MHELY^L;JWYQ5]-#%+%?'0OYK7^OO/D*F#>#_AXGE\GI_G^1ZGX'_P""
MLW@[4ML?BWP9J^A2$A?-TR>.^B_WFW>4P'L Q^M?7OPF^,'A7XW>$QXD\'ZB
MVIZ5YS6S2/;R0LDJA2R%74'(#+R,CG@U^%/C[7/"^O:L+CPKX7G\*V.#FSFU
M1K_Z8=HT-?J7_P $MXWC_9FG+(RAM>NF7<,9'EPC(_(_E4XO!T84'6C%Q?:_
MG\_S*P685ZF(C0G)23OK;R;\OR/KZBBBOG3ZH**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YG_ (5AX._Z%31/_!=#
M_P#$USWQ#^'7A2Q\ >)KFW\,Z/!<0Z9=21RQ6$2NC")B&!"Y!!YS7H]<U\3?
M^2;^+/\ L$W?_HEZI-W$TK'%_!OX?^&-4^&/AZ[O?#FDW=U+;[I)I[*)W<[C
MR6*Y-=G_ ,*P\'?]"IHG_@NA_P#B:R_@;_R27PS_ ->O_LS5W5#;N))6(K6U
MAL;6&VMXD@MX4$<<42A410,!0!P !QBI:**DH**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *^=?VC/^1TL?^P>G_HR2OHJOG7]HS_D=+'_
M +!Z?^C)*_+_ !(_Y$$O\4?S/L>$_P#D9KT9Y77VZOW1]*^(J^W5^Z/I7QOA
M/OCO^X?_ +>>]QM_S#_]O?\ MHM%%%?T$?F 4444 %%%% !1110 4444 %%%
M% !1110 4444 -DC2:-XY$62-P596&00>H(KAIO@-\-+B5I9?AYX5DD8Y9FT
M6V))]3\E=W16M.M4I?PY->CL93I4ZGQQ3]4<#_PH#X8?]$Y\)_\ @DMO_B*/
M^% ?##_HG/A/_P $EM_\17?45M];Q'_/R7WLS^JT/^?:^Y' _P#"@/AA_P!$
MY\)_^"2V_P#B*/\ A0'PP_Z)SX3_ /!);?\ Q%=]11];Q'_/R7WL/JM#_GVO
MN1P/_"@/AA_T3GPG_P""2V_^(H_X4!\,/^B<^$__  26W_Q%=]11];Q'_/R7
MWL/JM#_GVON1P/\ PH#X8?\ 1.?"?_@DMO\ XBC_ (4!\,/^B<^$_P#P26W_
M ,17?44?6\1_S\E][#ZK0_Y]K[D<#_PH#X8?]$Y\)_\ @DMO_B*^,?\ @HU\
M/_"_@6/X?'PWX<TG0/M1U#S_ .R[&*V\W;]FV[MBC=C<V,],GUK]#*^$O^"H
MG^K^&OUU+_VUKZ7AO$5JF:T8SFVO>ZO^5GSO$%"E#+*LHP2>G1?S(\%_8;C>
M3]J+P655F"_;&8@9P/L<XR?Q(_.OUF9@JDDX Y)-?%_['/A'0_@7^SSK'Q=U
MZ#=J%[;37 <CYTM48K'"GH9'7.>^Y,]*^.OC)\?O&'QNUVXO=>U.9=/:0M;Z
M1#(PM;9<\!4Z$\#+'DXKZ/'Y?/B3,IND^6%)<CEO=IMNR^??\SP<#CH\/Y?!
M55S3J/F2VLFDE=_(_956#KE2&'J#2U^)_P .?BOXK^$^M1:GX7UFYTR97#20
MHY,,X!'RR1_=<''<5^LGP8^-^F_%;X.VOCF1/L*1PR'4K>-6D^S2Q F4  %F
M&!N  )(8=Z^7SCAZOE*C44N>#=KVL[^FI]'E6>T<S<H./)):VO?3UT/3**\)
M_P"&XO@E_P!#L/\ P5WO_P 9H_X;B^"7_0[#_P %=[_\9KR/[*S#_H'G_P"
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M]_UQ;_T,5Z17F_PV_P"1@OO^N+?^ABD!Z11113 **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!C^+O\ D6M0_P"N7]16/\,/^0'<?]?+?^@K6QXN
M_P"1:U#_ *Y?U%8_PP_Y =Q_U\M_Z"M '84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_\
M'O+_ +A_E4M17/\ Q[R_[A_E0!P'PL_X^=0_W$_F:]$KSOX6?\?.H?[B?S->
MB4D 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH XCXI?\@^Q_ZZM_*NE\-_\B_IO_7O'_Z"*YKXI?\ (/L?^NK?RKI?
M#?\ R+^F_P#7O'_Z"*74#2HHHI@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>;_#O_D9[_\
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M-_%G_8)N_P#T2]=+7-?$W_DF_BS_ +!-W_Z)>G'=">QE? W_ ))+X9_Z]?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7FOPY=4UZ^+,%'E-U./
MXQ7I5>->'_#C^(+^>V2=83&I?<RYSR!_6D![#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"O.;Z1?^%FJVX;?-CYSQ_JUJ7_ (59
M/_S_ ,?_ '[/^-<_-X;>'Q(-(,ZERRKYNWCE0>GXT >P_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
MA5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV
M?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_
MX_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\
M*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[
MZ%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O^>B?]]"C[1%_
MST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z#]HB_P">B?\
M?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\ ?L_XT >@_:(O
M^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/_'_W[/\ C0!Z
M#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\ A5D__/\ Q_\
M?L_XT >@_:(O^>B?]]"C[1%_ST3_ +Z%>??\*LG_ .?^/_OV?\:/^%63_P#/
M_'_W[/\ C0!Z#]HB_P">B?\ ?0H^T1?\]$_[Z%>??\*LG_Y_X_\ OV?\:/\
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M2^([*2X2Z6 )(8]K*3V!S^M 'JWVB+_GHG_?0H^T1?\ /1/^^A7GW_"K)_\
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MB_YZ)_WT*/M$7_/1/^^A7GW_  JR?_G_ (_^_9_QH_X59/\ \_\ '_W[/^-
M'H/VB+_GHG_?0H^T1?\ /1/^^A7GW_"K)_\ G_C_ ._9_P :/^%63_\ /_'_
M -^S_C0!Z#]HB_YZ)_WT*/M$7_/1/^^A7GW_  JR?_G_ (_^_9_QH_X59/\
M\_\ '_W[/^- 'H/VB+_GHG_?0H^T1?\ /1/^^A7GW_"K)_\ G_C_ ._9_P :
M/^%63_\ /_'_ -^S_C0!Z#]HB_YZ)_WT*/M$7_/1/^^A7GW_  JR?_G_ (_^
M_9_QH_X59/\ \_\ '_W[/^- 'H/VB+_GHG_?0H^T1?\ /1/^^A7GW_"K)_\
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MH^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\
MGHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/^- '
MH/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_
M (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_
M ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5
MD_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G
M_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G
M_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"
MK)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^
MA7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T 7/BA(DEA9;65OWIZ'/:N
MD\.S1KH&G R*#]GC[C^Z*XYOA;<X^6^B)]T(I1\+;C S?Q@_]<S_ (T >@_:
M(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/
M^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_
M]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59
M/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&
MC_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_
M +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)
M_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7
MGW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$
M_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*
M/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GH
MG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:
M(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59/_S_ ,?_ '[/
M^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&C_A5D_\ S_Q_
M]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_ +]G_&C_ (59
M/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)_P#G_C_[]G_&
MC_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*/M$7_/1/^^A7GW_"K)_^?^/_
M +]G_&C_ (59/_S_ ,?_ '[/^- 'H/VB+_GHG_?0H^T1?\]$_P"^A7GW_"K)
M_P#G_C_[]G_&C_A5D_\ S_Q_]^S_ (T >@_:(O\ GHG_ 'T*\[^'?_(SWW_7
M%_\ T-:?_P *LG_Y_P"/_OV?\:@^&L?E^(KM<YVV[+_X^M 'IE%%%, HHHH
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M/\."04445@=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5S7Q-_Y)OXL_[!-W_P"B7KI:YKXF_P#)-_%G_8)N_P#T
M2]..Z$]C*^!O_))?#/\ UZ_^S-7=5POP-_Y)+X9_Z]?_ &9J[JA[@M@HHHI#
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q
M/''_ ")>O_\ 8/N/_1;5\>5]A^./^1+U_P#[!]Q_Z+:OCROYN\5?]\PO^%_F
M?K'!?^[UO5?D>W?LT_>\1?2W_P#:M>X5X?\ LT_>\1?2W_\ :M>X5^H< _\
M)-X;_M__ -.2/C^)O^1M6_[=_P#24%%%%?H)\N%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^:_P#P
M4L_Y+AH'_8NP_P#I3<U^E%?G3_P4R\.W\/Q,\+Z\UN_]F7&D"Q2?:=OFQS2N
MRD^NV53^?I7V/"<E'-(W>Z?Y'RG$Z;RZ5NC7YG)_\$^O%FA^#?C1J][K^LZ?
MH=D^@SPK<:E=1V\;.;BW(4,Y +$*QQUP#Z5^A'_"^/AI_P!%$\*?^#NV_P#B
MZ_%NBOT'-.&Z6:8AXB=1Q=DK)+H?"Y;Q!5RVA["%--7;^\_<+PWXZ\->,_-/
MA_Q#I6N^5S)_9M[%<;/KL8XK<K\;OV9_$E_X7^/G@.YT^X>"2XUBULI=C8#P
MS2K'(A]058_IZ5^R-?F6>9.LGK1IQGS*2N?HN39J\UHRG*/*XNP4445\T?0!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %>;_#;_D8+[_KBW_H8KTBO
M-_AM_P C!??]<6_]#%(#TBBBBF 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %>;WW_)4%_ZZQ_\ HM:](KS>^_Y*
M@O\ UUC_ /1:T@/2****8!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 8_B[_D6M0_ZY?U%8_P ,/^0'<?\ 7RW_ *"M;'B[_D6M0_ZY?U%8
M_P ,/^0'<?\ 7RW_ *"M '84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%<_\>\O^X?Y5+45S
M_P >\O\ N'^5 ' ?"S_CYU#_ '$_F:]$KSOX6?\ 'SJ'^XG\S7HE) %%%%,
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *\W^'?_ ",]_P#]<7_]#6O2*\W^'?\
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M !7-?$W_ ))OXL_[!-W_ .B7KI:YKXF_\DW\6?\ 8)N__1+TX[H3V,KX&_\
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M'#HZ^H8<$?2K%<SNM&=&^J"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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M22J3/;\@,[,?F)7<I='+?*05;@@^C]3ES>RYES_R_I?:_D>7]>CR^U4'[/\
MF_6V]O.Q]]44U'61592&5AD,#D$>M.KSSTPHHHH *BN?^/>7_</\JEJ*Y_X]
MY?\ </\ *@#@/A9_Q\ZA_N)_,UZ)7G?PL_X^=0_W$_F:]$I( HHHI@%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7F_P[_Y&>_\ ^N+_ /H:UZ17F_P[_P"1GO\
M_KB__H:T@/2****8!1110 4444 <!\1O^1I\&?\ 7[_[/%7?UP'Q&_Y&GP9_
MU^_^SQ5W] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!A>.O%EMX$\%:]XCO!NMM)L9K
MV1<XW"-"V/QQC\:_$O3])^(_[:'QJNOL^[6O$NI%[B1IY=EO9VZGU/"1)N
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *\W^&W_ ",%]_UQ;_T,5Z17F_PV_P"1@OO^N+?^ABD!Z11113 ****
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M)=I8_LX_$J:3[HT"\'7N8F _4UZ69-_69OJK?@E8\K*HQ^J0CT=_Q;N>5?\
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M/Q(C+*'9-.8+GD@&YR<?B/S%?>E?C=^S/XDO_"_Q\\!W.GW#P27&L6ME+L;
M>&:58Y$/J"K']/2OV1K/B["NCF'MKW51)^EDE^A?"V)5; ^QMK!M>MW?]0HH
MHKX@^Q"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O-_AM_P C!??]<6_]#%>D5YO\
M-O\ D8+[_KBW_H8I >D4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU3O)OOI;_-BI_6YS3J6C%=M6_P#)'YX?&S_E*3X&_P"NFG?^BVK]'J\WUO\
M9U^'OB/XI6/Q&U'P_P#:/&=B8S;ZE]MN%V>6"$_=K((S@$]5/O7I%9U*L94:
M=-;QO^+-*5&5.O5JO:5K?)6"BBBN4[ KS>^_Y*@O_76/_P!%K7I%>;WW_)4%
M_P"NL?\ Z+6D!Z11113 **** "BBB@ HHHH *^'?V[?VTSX'\_X9?#^^5O%M
MYB#4=3CD55TY6X\M7)P)3GDG[@.>O3[BKP/Q%^PC\#?%>O:CK6J^!_M6IZA<
M275S/_:U\GF2NQ9FVK. ,DG@ "MZ/LE43K*\5T77_@'/B%6=)K#M*3ZOI_P3
MR7]C;PK\%_V;/"K7VL_$[P->>/\ 5(P=1O&U^S)M5.#]FC)D^Z#RS?QD ] N
M/J7PS\9OA_XUU5-+\/>.?#>O:DZLZV>F:O;W,Q4#)(1')P!U.*\D_P"'>7[/
MW_0@?^5G4/\ Y(KJOAG^R)\)?@[XJB\2>$/"?]D:U%$\*77]I7<^$<88;9)6
M7D>U==>K1KR<Y2E?T5O);['#AZ.(P\8TXQCR]=7?S>VY\[_\%&?!.J^$?%7P
M\^.&@VK7,OAB\AAU *.B+,)(6;T4L70G_;6OKCX;_%SPI\5O!-KXI\/:Q:W>
MERPB65O-4-:G&6289^1E[@^GI74:II=GKFFW6GZC:0WUA=1M#/;7$8>.5&&&
M5E/!!'8U\H^*/^"8/P9\1:U)J%L?$'A^*1MQL-+OX_L^<Y.!+%(P'L&P.V*Q
MIU(3I*A5=K-M/??=->NQO4IU(5GB**OS))IZ7MLT]>FGXGCFNZU!^U3_ ,%%
M/"UQX2E&I>&_!B0/<:I!\T++;R-*S*PZJTKK&#WZCCFOM3X[_'SPK^SMX,3Q
M)XK>Z:UEN%M;>UL(A)//*06VH&95X56)+,!QUZ5<^$/P/\%_ OP\VC^#-%BT
MJWE8/<3%FDGN' QNDD8EF[X&<#)P!5/X\? /PK^T5X-3PWXK2Z6VBN%NK>ZL
M)1'/!* 5W(65EY5F!#*1STZ4ZE6G+V=*-^2/WN[NV%&C5C[6M*W//[E96BO\
MS3^#_P 7/#OQP\!V'BWPO/-+I=V639<1^7+#(IPT;KD@,#Z$CH02#5?PS\=O
M /B_QQK/@_2?%&GW?B329/*N=/64"3=CY@F?]9M/#;<[2,'%6/@_\(O#OP.\
M!V/A+PO!-%I=J6??<2>9+-(QRTCM@ L3Z  8   &*\J^,/[!7PD^,VLSZQ?:
M5=Z!K%PV^XOM G6W:=N[.C*\98]VV9/<FH?L/:M*_)T[_P##?B:+ZPJ*;2<^
MO;_A_P "#]M']IS0?@K\+]:TRTU6WG\;ZI;/9Z?IL,@>>(R J9W4<JJ@DC.,
MD #OA/V!_@=>?!/X#V::Q;&U\0:],=4O89%P\(90L43>A" $CLSL.U3?![]@
M?X2?!K7+?6K'3+SQ!K-LXDMKW7YUG,##HR(B)'N!Y#%20>017T75RJ4Z5*5*
MD[N5KO;1;)+UU,HTZM:K&M622C>R3OJ]VWIZ'RO^TQ^WMHO[./Q*T[PA/X6O
M-?E>".ZOKJ&[6 6\;L0-BE6\QL*3@E!TYYX^FM"UJS\2:'I^KZ?+Y]A?V\=U
M;R@8WQNH93^((KXB_P""D.E^ ?%D>B>';#18->^-.JSPV6EI8NWVJ" R;F,J
MJP!4C*KY@.-S$8 )K[(^''A=_!'P]\,^'9)1/)I.F6UB\HZ.T<2H2/J5H<*?
MU6-2UI7:]5Y>FB];A&=7ZY*FVG#E3]'Y^NK]+;'1,-RD=,C%?G!^QCXUT[]F
M']H3XF_#CXA7*Z!=:M=1M8ZCJ#^7#,T;RE,R'@"1)0RL< D$9R0*_2"O+_C3
M^S5\/?C]:PIXPT%+N\MUV6^I6[F&ZA'H)%ZKDD[6RN3G%9X>JJ4I*:O&2L^^
M]TUZ,UQ-&5:,7!VE%W5]NJL_DSKO&GQ#\-_#SPS<>(?$6M6>E:1#&9#=7$H"
MN,9 3^^Q[*N2>U?"W_!.'1[[QI\<?BS\4;:REL?#.HRSV]MN7:LDDUR)]H[$
MHBKG'0N/6O2]#_X):_!K2=32ZNKCQ-K4"G)LK[48UB;V)ABC?\FKZI\)^$=%
M\"^'[/0_#^F6VCZ19KL@L[2,)&@SD\#J2222>222>:WC4HT(S]FW*4E;:R2>
M_75G-*G7Q,H>UBHQB[[W;:VZ*R/(/#/[9_PUU[XL>(OA]=:HV@:SI-T;2*75
MP+>"^<8#B)V/#!LJ%;!;@KG/'K/BWQUX>\!^'Y]<\0ZS9:/I,*;VNKN943Z
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M2G0QD:LJT^5R?F]%V6G_  Y[+I^L^#/C!X9O$L;[0O&WAZ9C;7*V\T-_:2$
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MT2O._A9_Q\ZA_N)_,UZ)20!1113 **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /:M>X5^H< _\DWAO^W_ /TY(^/XF_Y&U;_MW_TE!1117Z"?+A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %?*W_!1^PN+SX V,L,321VNNV\TS <(AAG0$^VYU
M'XBOJFJ.MZ'I_B32;K2]5LH-1TZZ0QSVMS&'CD4]B#UKT,OQ7U+%4\0U?E=[
M'#CL-]<PU2@G;F5C\,*7S'_O-^=?K+-^P[\$YY6D;P6%+')":G>*/P FP*Y+
MXL?L9_!_PS\*_&6L:;X2-OJ.GZ->7=M-_:=V^R6.!W1MK2D'# '!!%?K-/C#
M 5)Q@H3N]-E_\D?F%3A7&TXN;G&RUW?_ ,B?FUX=\5:QX2U:#4]%U.ZTO4(&
M#QW%K*R,"#ZCJ/8\&OVC^&'B6?QG\-?"FOW2JMUJFDVM[,JC #R0J[8]LL:_
M$>OV?_9^_P"2$?#K_L7=/_\ 2:.O.XUIP]C1J6UNU?Y'?PA.7M:L+Z63M\SO
MZ***_)S]."BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7F__  FWB3_GQ7_P'?\ QH_X3;Q)_P ^*_\ @._^- 'I%>;WW_)4%_ZZQ_\
MHM:/^$V\2?\ /BO_ (#O_C6)+?ZI-KPU-K1OM@96VB)L9"@#CZ"@#V.BO-_^
M$V\2?\^*_P#@._\ C1_PFWB3_GQ7_P !W_QH ](HKS?_ (3;Q)_SXK_X#O\
MXT?\)MXD_P"?%?\ P'?_ !H ](HKS?\ X3;Q)_SXK_X#O_C1_P )MXD_Y\5_
M\!W_ ,: /2**\W_X3;Q)_P ^*_\ @._^-'_";>)/^?%?_ =_\: /2**\W_X3
M;Q)_SXK_ . [_P"-'_";>)/^?%?_  '?_&@#TBBO-_\ A-O$G_/BO_@._P#C
M1_PFWB3_ )\5_P# =_\ &@#TBBO-_P#A-O$G_/BO_@._^-'_  FWB3_GQ7_P
M'?\ QH ](HKS?_A-O$G_ #XK_P" [_XT?\)MXD_Y\5_\!W_QH ](HKS?_A-O
M$G_/BO\ X#O_ (T?\)MXD_Y\5_\  =_\: /2**\W_P"$V\2?\^*_^ [_ .-'
M_";>)/\ GQ7_ ,!W_P : /2**\W_ .$V\2?\^*_^ [_XT?\ ";>)/^?%?_ =
M_P#&@#TBBO-_^$V\2?\ /BO_ (#O_C1_PFWB3_GQ7_P'?_&@#TBBO-_^$V\2
M?\^*_P#@._\ C1_PFWB3_GQ7_P !W_QH ](HKS?_ (3;Q)_SXK_X#O\ XT?\
M)MXD_P"?%?\ P'?_ !H ](HKS?\ X3;Q)_SXK_X#O_C1_P )MXD_Y\5_\!W_
M ,: /2**\W_X3;Q)_P ^*_\ @._^-'_";>)/^?%?_ =_\: /2**\W_X3;Q)_
MSXK_ . [_P"-'_";>)/^?%?_  '?_&@#TBBO-_\ A-O$G_/BO_@._P#C1_PF
MWB3_ )\5_P# =_\ &@#TBBO-_P#A-O$G_/BO_@._^-'_  FWB3_GQ7_P'?\
MQH ](HKS?_A-O$G_ #XK_P" [_XT?\)MXD_Y\5_\!W_QH ](HKS?_A-O$G_/
MBO\ X#O_ (T?\)MXD_Y\5_\  =_\: .P\7?\BUJ'_7+^HK'^&'_(#N/^OEO_
M $%:Y[4?%&OZC8S6TUEB*1<,5@8''YU6T'7-9T.T>"TLR\;.7)>%F.< =OH*
M /6J*\W_ .$V\2?\^*_^ [_XT?\ ";>)/^?%?_ =_P#&@#TBBO-_^$V\2?\
M/BO_ (#O_C1_PFWB3_GQ7_P'?_&@#TBBO-_^$V\2?\^*_P#@._\ C1_PFWB3
M_GQ7_P !W_QH ](HKS?_ (3;Q)_SXK_X#O\ XT?\)MXD_P"?%?\ P'?_ !H
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MS?\ X3;Q)_SXK_X#O_C1_P )MXD_Y\5_\!W_ ,: /2**\W_X3;Q)_P ^*_\
M@._^-'_";>)/^?%?_ =_\: /2**\W_X3;Q)_SXK_ . [_P"-'_";>)/^?%?_
M  '?_&@#TBBO-_\ A-O$G_/BO_@._P#C1_PFWB3_ )\5_P# =_\ &@#TBBO-
M_P#A-O$G_/BO_@._^-'_  FWB3_GQ7_P'?\ QH ](HKS?_A-O$G_ #XK_P"
M[_XT?\)MXD_Y\5_\!W_QH ](HKS?_A-O$G_/BO\ X#O_ (T?\)MXD_Y\5_\
M =_\: /2**\W_P"$V\2?\^*_^ [_ .-'_";>)/\ GQ7_ ,!W_P : /2**\W_
M .$V\2?\^*_^ [_XT?\ ";>)/^?%?_ =_P#&@#TBBO-_^$V\2?\ /BO_ (#O
M_C1_PFWB3_GQ7_P'?_&@#TBBO-_^$V\2?\^*_P#@._\ C1_PFWB3_GQ7_P !
MW_QH ](HKS?_ (3;Q)_SXK_X#O\ XT?\)MXD_P"?%?\ P'?_ !H ](HKS?\
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M%%, HHHH **** . ^(W_ "-/@S_K]_\ 9XJ[^N ^(W_(T^#/^OW_ -GBKOZ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5S7Q-_Y)OXL_[!-W_P"B7KI:YKXF_P#)-_%G_8)N_P#T2]..Z$]C*^!O_))?
M#/\ UZ_^S-7=5POP-_Y)+X9_Z]?_ &9J[JA[@M@HHHI#"BBB@ HHHH ****
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M!_QU96L;375SH5]#%&HR7=K=PH'N2173A7:O3;[K\SGQ&M&:79_D?BE7[/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO_LS5W5<+\#?^22^&?\ KU_]F:NZH>X+8****0PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .(^-'_)
M,]9^D/\ Z.2OEBOJ?XT?\DSUGZ0_^CDKY8K^7O%'_D<TO^O2_P#2YG[%P;_N
M$_\ &_\ TF)]%?LY_P#(EWW_ &$'_P#1<=>J5Y7^SG_R)=]_V$'_ /1<=>J5
M^X<'_P#(@PG^']6?G>??\C.OZA1117V)X(4444 %%%% !1110 4444 %%%%
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M7+^-_P#(?1117YB?HH4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!P'Q&_Y&GP9_P!?O_L\5=_7 ?$;_D:?!G_7[_[/%7?T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !115#Q!&\V@ZE'&C22/;2*JJ,DDH< #UJ92Y8N78N$
M>:2CW/-_BG\>/@YX3L[FQ\<>*_#3HG$VF7,D=Y+^-NH=S_WS7PG\9OCU^R#J
MTLPTKX17&OW:_P"KGTJ-M$MG/UC=6_.*OB7Q!X8UGPEJ#6&N:3?:-?+RUKJ%
ML\$H_P" N :]>^%.O?L\6+0R^//"OCN]E7 >.QU6VFMW]]HC@=?IO-?54\OA
M17.I-^FG]?>?&5<TJ5Y>S<(Q_P 6O]?<>:^/M<\+Z]JPN/"OA>?PK8X.;.;5
M&O\ Z8=HT-?J7_P2WC>/]F:<LC*&UZZ9=PQD>7",C\C^58_P1^*7[&EC]E3P
MY:>'?#NHK\Z/XDT]UGB/_7U<!@#])*^Q/#_B#2/$^EQ7^AZE9:MIS\1W6GSI
M-"V.P9"0:Y\9BG[)T53:7=^OS_,Z<#@U[=8AU(MKI&W:W2UON-*BBBOGSZ<*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *YKXF_P#)-_%G_8)N_P#T2]=+7-?$W_DF_BS_ +!-W_Z)>G'=">QE? W_
M ))+X9_Z]?\ V9J[JN%^!O\ R27PS_UZ_P#LS5W5#W!;!1112&%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!Q'QH_Y)GK/TA_\ 1R5\L5]3_&C_ ))GK/TA_P#1R5\L5_+WBC_R.:7_
M %Z7_I<S]BX-_P!PG_C?_I,3Z*_9S_Y$N^_["#_^BXZ]4KRO]G/_ )$N^_["
M#_\ HN.O5*_<.#_^1!A/\/ZL_.\^_P"1G7]0HHHK[$\$**** "BBB@ HHHH
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M/:^)S?*YY3B/82ES75T]M-5M\C[#*\RCFF']O&/+9V:W_K<****\0]@****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHK[$\$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CN+>*\MY8)XDG@E4
MI)%(H974C!!!X(([5)10!X=J'[$WP6U.\EN9?!,4<DAW,MO?W4* ^R)*%4>P
M %5O^&%_@E_T)C?^#6]_^/5[U17J+-<P2LL1/_P)_P"9YKRW O5T(?\ @*_R
M/!?^&%_@E_T)C?\ @UO?_CU'_#"_P2_Z$QO_  :WO_QZO>J*?]K9A_T$3_\
M I?YA_9F!_Y\0_\  5_D>"_\,+_!+_H3&_\ !K>__'J/^&%_@E_T)C?^#6]_
M^/5[U11_:V8?]!$__ I?YA_9F!_Y\0_\!7^1X+_PPO\ !+_H3&_\&M[_ /'J
M^4/V\?@3X(^"\?@@^#M%.D'4C>BZS=SS^9Y?D;/]8[8QO;IC.>>U?I37PG_P
M5#_U/PU_WM2_E:U]'P[F&,KYG2IU:TI1=]')M?"_,\#/L#A*.75:E*E&+5M5
M%)_$O(\"_8?_ .3H_!'^]>?^D4]?K37Y+?L/_P#)T?@C_>O/_2*>OUIK;C/_
M '^'^!?^E2,N$O\ <9_XW^40HHHKX$^V"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=11161L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1Z/^':?PT_Z#_BO_ ,"K;_Y'K]2GQ-DU5WJ*[\XW/S>'#N;4U:#LO*1\*?\
M#0'Q/_Z*-XK_ /!U<_\ Q='_  T!\3_^BC>*_P#P=7/_ ,77W7_P[3^&G_0?
M\5_^!5M_\CT?\.T_AI_T'_%?_@5;?_(]9_ZQ9'_)_P"2%_V#G'\W_DQ\*?\
M#0'Q/_Z*-XK_ /!U<_\ Q='_  T!\3_^BC>*_P#P=7/_ ,77W7_P[3^&G_0?
M\5_^!5M_\CT?\.T_AI_T'_%?_@5;?_(]'^L61_R?^2!_8.<?S?\ DQ\*?\-
M?$__ **-XK_\'5S_ /%T?\- ?$__ **-XK_\'5S_ /%U]U_\.T_AI_T'_%?_
M (%6W_R/1_P[3^&G_0?\5_\ @5;?_(]'^L61_P G_D@?V#G'\W_DQ\*?\- ?
M$_\ Z*-XK_\ !U<__%T?\- ?$_\ Z*-XK_\ !U<__%U]U_\ #M/X:?\ 0?\
M%?\ X%6W_P CT?\ #M/X:?\ 0?\ %?\ X%6W_P CT?ZQ9'_)_P"2!_8.<?S?
M^3'PI_PT!\3_ /HHWBO_ ,'5S_\ %T?\- ?$_P#Z*-XK_P#!U<__ !=?=?\
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M^&G_ $'_ !7_ .!5M_\ (]'_  [3^&G_ $'_ !7_ .!5M_\ (]'^L61_R?\
MD@?V#G'\W_DQ\*?\- ?$_P#Z*-XK_P#!U<__ !='_#0'Q/\ ^BC>*_\ P=7/
M_P 77W7_ ,.T_AI_T'_%?_@5;?\ R/1_P[3^&G_0?\5_^!5M_P#(]'^L61_R
M?^2!_8.<?S?^3'PI_P - ?$__HHWBO\ \'5S_P#%T?\ #0'Q/_Z*-XK_ /!U
M<_\ Q=?=?_#M/X:?]!_Q7_X%6W_R/1_P[3^&G_0?\5_^!5M_\CT?ZQ9'_)_Y
M(']@YQ_-_P"3'PI_PT!\3_\ HHWBO_P=7/\ \71_PT!\3_\ HHWBO_P=7/\
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M]<5V5<U\2O!T?Q"^'GB7PQ*PC36-.N+'>1D*9(RH;\"0?PJ)_"RX?$C\I?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#B/C1_P DSUGZ0_\
MHY*^6*^I_C1_R3/6?I#_ .CDKY8K^7O%'_D<TO\ KTO_ $N9^Q<&_P"X3_QO
M_P!)B?17[.?_ ")=]_V$'_\ 1<=>J5Y7^SG_ ,B7??\ 80?_ -%QUZI7[AP?
M_P B#"?X?U9^=Y]_R,Z_J%%%%?8G@A1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 <!\1O^1I\&?]?O\ [/%7?UP'Q&_Y&GP9_P!?O_L\
M5=_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %1W%Q':6\L\K;(HE+NV,X4#)-,OKM=
M/L;BZ<,R0QM(P7J0 2<?E7Q#JW_!5CX8ZAI=Y:IX8\6J\T+QJS06N 2I'/[_
M -ZN-.K54O91NU_2_(SG6HT7%UY<J;_RO^9Z%=>+/V7?VO/&-EH<W]E>,/$T
MD;& _8;NUN6CC4N1YX2,[0 3M+8]J]V^''PG\'_"+16TKP=X>LM LF(:1;5/
MGE8=#(YRSGW8DU^+G[)WQDTCX"_&[2/&>N6=[?:=9P7$3PZ>J-,3)"R# =E'
M5AGFOO7_ (>Q_"__ *%;Q=_X#VO_ ,?KVL5@:E*U.A=Q:N_6[_X!\_@\QI5N
M:IB>6,D[+O:R_6Z/=_VIO!_PI\4?#*YE^+)M['0[=ML6K,"MQ:2-T,+JI8,<
M?=P0V,$'I5K]F7QU\-_%WPSM]/\ A;=M=>&/#SC2D+P20MN5%<L1(JL2V_<6
M(&26KX'_ &P?^"@.@_'SX8/X*\+^&]2L;>\N(I[N]U8QJZB-@ZK&D;-U8#+$
MC@$8YR/6?^"1]G=Q^ OB!=N&%A+J5M'">QD6)C)^CQUE'"5(82I.K=6::73H
MK^NK-Y8ZG4QM*G12E=--]5N[7[:+[S[YHHHKQSW0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KFOB;_R3?Q9_V";O
M_P!$O72US7Q-_P"2;^+/^P3=_P#HEZ<=T)[&5\#?^22^&?\ KU_]F:NZKA?@
M;_R27PS_ ->O_LS5W5#W!;!1112&%%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZH>X+8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MHKX\^J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH X#XC?\ (T^#/^OW_P!GBKOZX#XC?\C3X,_Z_?\ V>*N
M_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "N!^/OB34/!WP1\=ZWI19=2L-%NY[=ES
ME9%B8JP]P>?PKOJI:UI]EJVCWUEJ4<<NG7,$D-S'*<(T3*0X;VP343UBRXZ2
M1^#GP;^"OB_]H3QLWA_PK;)>ZD8VN[FXNYO+CAC# -)(YR?O,!P"23TKZ)_X
M=4_&#_H+>$?_  /N/_D>N;\)_$FQ_8?_ &F-1O\ PAK.E_$'P9=1- SZ;>I*
M9+-W#!"ZDA9HR@]FQV#<?<5K_P %+O@;<6L,LFL:K:R.@9H9-+E+1DCE25!&
M1TX)'O7U^(Q&(M">&C>+7;6_H?#X7"X7FG3Q<K23[Z6[WZGR#_PZI^,'_06\
M(_\ @?<?_(]?=G[%?P*\0_L\_!Z;PMXFN-/N=1?5)[T/ILKR1;'2-0,LBG.4
M/;TKEO\ AY1\"O\ H/ZE_P""J?\ ^)KVSX/_ !F\+_'3PF_B3PC=37FE+<O:
M&2>!H6\Q0I8;6&<88<UY5>OBYTW&K&T?0]G#X; TZL949IRZ:WZ'<4445Y![
M@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5S7Q-_Y)OXL_P"P3=_^B7KI:YKXF_\ )-_%G_8)N_\ T2]..Z$]C*^!
MO_))?#/_ %Z_^S-7=5POP-_Y)+X9_P"O7_V9J[JA[@M@HHHI#"BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O!OVE?
MVM- _9]BAT];7^W?%-S'YD6FQR[%A0YQ)*V#M!(X4#)P>@YKWFOQJ_:2UZ]\
M1_'SQ_=7\K2S1ZU=6J[B?ECAD:*->?1$4?A7UO#>5TLSQ35?X(J]N_EZ'R_$
M&95,NPR='XI.U^Q[C;?\%+?B(FHB2X\/>&I;'<2;>.&X1]OH',IP??:>_%?9
MG[/O[1GAS]H3P[->:6K:=JUH0+[29W#209^ZP8 ;T.#A@!TP0*_'FOH/]@_Q
M!?:-^TMX=M;1V$&IPW5I=1J?OQB!Y1GZ/&C?\!K[G.N'<%]3J5</#DE!-Z=;
M:M,^,RC/L9];A2KSYHS:6O2^ET?JW17PA^V9^TS\2?A)\9/[#\*^)ET_2VTZ
M"Y^S?8+:;8[%PWS21LW.T'KWKPK_ (;H^-O_ $.2_P#@JLO_ (S7QF%X5QN+
MH0Q%.<;25U=N_P#Z2?78GB;!X6M*A.,KQ=M$O\S]9**_)O\ X;H^-O\ T.2_
M^"JR_P#C-6+#]O+XTV=W'-+XHM[Z-#DV]QI=J$?V)2-6Q]"*Z7P;F%OCA][_
M /D3G_ULP/\ +/[E_P#)'ZN45PWP0^)B?&#X5^'O%RVPM'U&!C-;J<K'*CM'
M( ?3>C8SVQ7<U\15ISHU)4IJSBVGZH^QIU(UH1J0=TU=>C"BBBLC0**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#@/B-_P C3X,_
MZ_?_ &>*N_K@/B-_R-/@S_K]_P#9XJ[^@ HHHH **** "BBB@ HHHH ****
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M]WH^K_(W:***_I(_)@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;<PSVK\WQ^'JXG,Z].C%RDYRT7JS]!P5>EA\NHU*TE%<D=7Z(]9HKYH\#?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOAWZW'_M*O;J\1_:6^[X=^MQ_P"TJ_/^/O\ DF\5_P!N?^G(GT_#/_(VH_\
M;W_I+/#Z^P? ?_(D>'_^P?;_ /HM:^/J^P? ?_(D>'_^P?;_ /HM:_+?"O\
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M>F_'T\O\5_\ !1+XF>&?%&L:.VA>%7;3[R:T+-:7()\MRF?^/CVKVK_@G_\
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M+^+?C/P9J'@OP_H&LZAH6D7MO/=W$NGSO UQ(KJH1G4@D*#G;G&6!/05U?\
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M.O X[#RJ*A1I\M_\KGU+1117AGT84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!YM_PT9\._P#H8A_X!W'_ ,;K#\=?
M'KP)K'@GQ#86>NB:[NM.N((8_LDZ[G:)E49*8&21UKV/:O\ ='Y5S?Q,4?\
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M4JU7>3B[OYQ/>Z***_'S]5"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** .'^.G_)$?B%_V+NH?^DTE?BS
M7[3?'3_DB/Q"_P"Q=U#_ -)I*_%FOUO@K_=ZWJOR/R_B_P#CTO1_F?L]^S[_
M ,D'^'7_ &+NG_\ I.E>@5Y_^S[_ ,D'^'7_ &+NG_\ I.E>@5^7XO\ WBI_
MB?YGZ-A?]WI^B_(****Y#J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK-,%E>+Q$\;54%**2OUU/ON*L'B,91I1P\')IO;T/9**\M_X:*\-?\^>J?\
M?F/_ ..4?\-%>&O^?/5/^_,?_P <K]W_ -;\A_Z"X_>?F_\ 869_\^)'J5%>
M6_\ #17AK_GSU3_OS'_\<H_X:*\-?\^>J?\ ?F/_ ..4?ZWY#_T%Q^\/["S/
M_GQ(]2HKRW_AHKPU_P ^>J?]^8__ (Y1_P -%>&O^?/5/^_,?_QRC_6_(?\
MH+C]X?V%F?\ SXD>I45Y;_PT5X:_Y\]4_P"_,?\ \<H_X:*\-?\ /GJG_?F/
M_P".4?ZWY#_T%Q^\/["S/_GQ(]2HKGO"/CS1_&T,KZ9.S21?ZR"5=LB^^.X]
MQ70U]-AL50QE*-?#34X/9IW1Y%:C4P\W3JQ<9+HPHHHKJ,0HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#B?C="]Q\%_'\4
M:EY'\/Z@JJO4DVT@ K\5Z_=R2-)HVCD571@596&00>H(KY?\2?\ !.OX6:]J
M]Q?6UQKVAI,Y?['I]U%Y"$]E$D3L![9P.U?=\-9UALKC4IXF_O---*Y\7Q!D
M^(S*5.IA[:733T/SYT[XW_$71]/MK&Q\>>);*RMHUA@MK?5[A(XHU&%55#X
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M"K;_ .1Z/^':?PT_Z#_BO_P*MO\ Y'H_UBR/^3_R0/[!SC^;_P F/A7_ (:
M^)__ $4;Q7_X.KG_ .+H_P"&@/B?_P!%&\5_^#JY_P#BZ^ZO^':?PT_Z#_BO
M_P "K;_Y'H_X=I_#3_H/^*__  *MO_D>C_6+(_Y/_) _L'./YO\ R8^%?^&@
M/B?_ -%&\5_^#JY_^+H_X: ^)_\ T4;Q7_X.KG_XNONK_AVG\-/^@_XK_P#
MJV_^1Z/^':?PT_Z#_BO_ ,"K;_Y'H_UBR/\ D_\ ) _L'./YO_)CX5_X: ^)
M_P#T4;Q7_P"#JY_^+H_X: ^)_P#T4;Q7_P"#JY_^+K[J_P"':?PT_P"@_P"*
M_P#P*MO_ )'H_P"':?PT_P"@_P"*_P#P*MO_ )'H_P!8LC_D_P#) _L'./YO
M_)CX5_X: ^)__11O%?\ X.KG_P"+H_X: ^)__11O%?\ X.KG_P"+K[J_X=I_
M#3_H/^*__ JV_P#D>C_AVG\-/^@_XK_\"K;_ .1Z/]8LC_D_\D#^P<X_F_\
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M-/\ H/\ BO\ \"K;_P"1Z/\ AVG\-/\ H/\ BO\ \"K;_P"1Z/\ 6+(_Y/\
MR0/[!SC^;_R8^%?^&@/B?_T4;Q7_ .#JY_\ BZ];_9B_:F^(.E_%[PSI.L>)
MM2\1:+K%_#IUQ;:K<-<E?-<(KHSDLI5F!X." 0:Z/]K?]D'PA\ _AK8>(M U
M36[V]N-5BL6CU*:%XPC12N2 D2G.8U[XY/%?/?P+_P"2V_#[_L8=/_\ 2F.O
M6C_9^:8"I5HTTXV:^%+9'F/Z]EN-A2JS?-==6]V?M-1117X&?MH4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !7-?$W_ ))OXL_[!-W_ .B7KI:YKXF_\DW\6?\ 8)N__1+TX[H3V,KX&_\
M))?#/_7K_P"S-7=5POP-_P"22^&?^O7_ -F:NZH>X+8****0PHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KQO]I#3IIM,T6]1&:"WDECD8#[I<+C/_?!KV2H;RS@U"UEMKJ%+
MBWE7:\<BAE8>A!KP,^RM9UEM; <W+SI6?9IIK\5J>GEN,_L_%T\3:_+T]59_
MF?$]%?4\GP7\&RR%SHX!/9;B4#\@]-_X4GX-_P"@0?\ P*F_^+K^?'X79STJ
MTOOE_P#('Z?_ *XX#^2?W+_Y(^6J*^I?^%)^#?\ H$'_ ,"IO_BZ/^%)^#?^
M@0?_  *F_P#BZ/\ B%V=?\_:7_@4O_D!_P"N.7_R3^Y?_)'RU17U+_PI/P;_
M - @_P#@5-_\71_PI/P;_P! @_\ @5-_\71_Q"[.O^?M+_P*7_R ?ZXY?_)/
M[E_\D?+5%?4O_"D_!O\ T"#_ .!4W_Q='_"D_!O_ $"#_P"!4W_Q='_$+LZ_
MY^TO_ I?_(!_KCE_\D_N7_R1\M45]2_\*3\&_P#0(/\ X%3?_%U\X>++&'2_
M%.L6=LGEV]O>311IDG:JN0!D\G@5\KQ!PCCN'*4*N+G!J;LN5M^?6*/9RS/,
M-FLY0H1DG%7U2_1LZ;X(W,EO\2-,1&PLRS1N/5?+9L?FH_*OJ*OECX+_ /)3
M-&^LW_HEZ^IZ_;/"^3>354^E67_I,#\]XQ26/A_@7YR"BBBOV ^%"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.H"]E,)+@'TRJ5Q'[)_[$7B >+=-\7_$"P.D:=ITJW-II,^TSW,JG*F1>=B
M@':W)P!C%;?_  5"R+?X<'<V"VH97<=O MN<=,\GFN7%8[#X[/,)1H2OR<UV
MMM5M^'XG5A\'7P>3XFK6C;GY;)^3W_'\#RS]@7XG:_HOQRTGPNFHW$NA:U%<
M136,DA:)62%Y5D52<*V8\9'9C7Z?5^2O[$/_ "=%X(_WKO\ ](YZ_6JOE>,:
M<(9A%Q5KQ3?K=H^EX4G*>!DI.]I-+[D%%%%?"GV84444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% ' ?$;_ )&GP9_U^_\ L\5=_7 ?$;_D:?!G_7[_ .SQ5W] !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7_V9J[JN%^!O_))?#/\ UZ_^S-7=4/<%L%%%%(84444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KX4_X*A?\ 'O\ #;_?U'^5M7W77PI_P5"_
MX]_AM_OZC_*VKZCAG_D;4?\ M[_TEGSG$7_(KJ_+_P!*1X!^Q#_R=%X(_P!Z
M[_\ 2.>OUJK\E?V(?^3HO!'^]=_^D<]?K57K<9_[_#_ O_2I'E\)?[C/_&_R
MB%%%%? GVX45X/\ M*_M::!^S[##IZVW]N^*;F/S(M-CEV+"AR!),V#@$]%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCZ'J/B*_2QTK3[K4[UP2MM9PM+(P R2%4$G YKH?^%/>/?\ H2/$?_@IN/\
MXBO2Q.7T:DDTU#3]7K_78\K!YG7IQDI1<[O?MHM-OG\S]V?^%J>"O^APT'_P
M9P?_ !5;>CZ]IOB*T-UI6H6NIVH8H9K.=94W#&1N4D9Y''O7X%_\*>\>_P#0
MD>(__!3<?_$5^J7_  30\/:KX9_9TN;/6-,O-*N_[=NI/L]];O#)M,<.&VL
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MAL7.-9:MMI][O='O7[!_B"^T;]I;P[:VCL(-3ANK2ZC4_?C$#RC/T>-&_P"
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MC,-";3Y)7EULM-/GV.S(<#BI87$3BK<\;1Z7??Y=S\J?^&@/B?\ ]%%\5_\
M@ZN?_BZ/^&@/B?\ ]%%\5_\ @ZN?_BZ^Z?\ AVG\-?\ H/\ BO\ \"K;_P"1
MZ/\ AVG\-?\ H/\ BO\ \"K;_P"1ZZ?]8LC_ )/_ "0P_L'./YO_ "8^%O\
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M**C>*;MWNU^A]KPO7J5L%+VLF[2:5^UD_P!0HHHKXD^P"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#@/B-_R-/@S_K]_]GBKOZX#XC?\C3X,_P"OW_V>*N_H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8P]K3ES1.[!YE]8J>QJQY9?F>PT445Y![84444 %%%% !1110 4444 %%%%
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MEZ^IZ[_"[_D35?\ KZ__ $B!S<9?[_#_  +_ -*D%%%%?L1\(%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !31&@<N%4,>K8Y_P \"G44 %%%% !3
M7C208=58>C#-.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OA7_@J%_QZ_#?_ ']1
M_E;5]U5\*_\ !4+_ (]?AO\ [^H_RMJ^HX9_Y&U'_M[_ -)9\YQ%_P BNK\O
M_2D?/W[$?_)T7@C_ '[O_P!(YZ_6NOR4_8C_ .3HO!'^_=_^D<]?K77K<9_[
M_3_P+_TJ1Y?"7^XS_P ;_*(4445\"?;A1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!P'Q&_Y&GP9_U^_^SQ5W]<!\1O\ D:?!G_7[_P"SQ5W] !1110 4444
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M_P#2('-QE_O\/\"_]*D%%%%?L1\(%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6#4]'U&ZTK4K?)BO+*9H9H\J5.UU((R"1P>A-=A_PT!\3_\ HHOBO_P=7/\
M\77Z'GO#U7-L3&O3J**4;:W[M_J?"9+GM+*\/*C.#;;OIZ)?H?L_17XP?\-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKFOB;_R3?Q9_V";O_P!$O72US7Q-_P"2;^+/^P3=_P#HEZ<=T)[&5\#?^22^
M&?\ KU_]F:NZKA?@;_R27PS_ ->O_LS5W5#W!;!1112&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5\?>//^1W\0?]A"X_]&-7V#7R1\2]
M.FTWQYKD<Z,ADNI)TR,95V+ C\#7XCXJ0D\!AII:*;_%'Z'P9)?6:L>O+^I'
M\/?$5MX3\8:?JMXDLEO;^9O6$ N=T;*, D#JP[U[3_PT5X:_Y\]4_P"_,?\
M\<KYSHK\=R7BW,\AP\L-@G%1;YM5?5I+]$?>9ADF#S*JJV(3NE;1VTU?ZGT9
M_P -%>&O^?/5/^_,?_QRC_AHKPU_SYZI_P!^8_\ XY7SG17O_P#$2,^_FA_X
M">9_JGEG:7WGT9_PT5X:_P"?/5/^_,?_ ,<H_P"&BO#7_/GJG_?F/_XY7SG1
M1_Q$C/OYH?\ @(?ZIY9VE]Y]&?\ #17AK_GSU3_OS'_\<H_X:*\-?\^>J?\
M?F/_ ..5\YT4?\1(S[^:'_@(?ZIY9VE]Y]&?\-%>&O\ GSU3_OS'_P#'*/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ($_\SAO^%)^#?\ H$'_ ,"IO_BZ/^%)^#?^@0?_  *F_P#BZ[FBC_5W)?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_(]'_#T./\ Z)JW_@\'_P CUX%_PP_\;?\ H2&_\&=E_P#'J/\ AA_XV_\
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M_HFK?^#P?_(]'_#T./\ Z)JW_@\'_P CUX%_PP_\;?\ H2&_\&=E_P#'J/\
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M  ]#C_Z)JW_@\'_R/1_P]#C_ .B:M_X/!_\ (]>!?\,/_&W_ *$AO_!G9?\
MQZC_ (8?^-O_ $)#?^#.R_\ CU']F<,_S0_\&/\ ^2#^T.(OY9_^"U_\B>^_
M\/0X_P#HFK?^#P?_ "/1_P /0X_^B:M_X/!_\CUX%_PP_P#&W_H2&_\ !G9?
M_'J/^&'_ (V_]"0W_@SLO_CU']F<,_S0_P#!C_\ D@_M#B+^6?\ X+7_ ,B>
M^_\ #T./_HFK?^#P?_(]?0G[,_[1C?M%:#K>K'P[_P ([;Z;<);#=??:?-8I
MN8_ZM-H *^N<]L<_G]_PP_\ &W_H2&_\&=E_\>K['_85^%/C?X1^%_%6B>,]
M DT9+F[CN[63[7!,)<H4D'[IV*D;$ZXSNXZ5X6=8')*."E/!.+FK;3N]]=.9
MGLY1C,XK8N,,8I<FN\++;37E1\%_'[XR:G\;OB1J>O7MQ(VGB5XM-M6)VVUL
M&.Q0.Q(P6..237F]==\5_ASJ7PG^(&L^%]3B=)K&=DBD=2!/#G]W*O'(9<']
M.U<C7ZAA8T84(1P_P65K=C\YQ,JLJTW7^.[OZGWU_P $X?C-J6L?VQ\/-4N9
M+N"QM?[0TQI6R88PZI+$#_=S(C =OF_#I/BO_P % V^%?Q&U_P )S^ #?/I=
MR8!=+K'EB5<!E;;Y!VY!!QDX]37G_P#P33^&E^WB+Q#X[N(7BTV.T.E6CNI
MFD=T>1EXYVB-03_M^QQRW[0'[*_QA^)/QG\7>)-.\&22Z=?7S&VD;4;-2\2
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MAQ%_+/\ \%K_ .1/??\ AZ''_P!$U;_P>#_Y'H_X>AQ_]$U;_P '@_\ D>O
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M ,>H_LSAG^:'_@Q__)!_:'$7\L__  6O_D3WW_AZ''_T35O_  >#_P"1Z/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MR.#GM@^[?MK?MX>"?C9\)Y/!'@_3M2N'O+F&>YO]0@6%(DC;> @W%BQ( .0
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MNXTIS7O-:_UZMGJ93:,JT(?"I:?UZ)!1117AGT(4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\V_\
M@I=_R6CP[_V+\?\ Z4W%4O\ @FW_ ,EZU3_L7[C_ -'V]7?^"EW_ "6CP[_V
M+\?_ *4W%4O^";?_ "7K5/\ L7[C_P!'V]?LT?\ DF?^W/U/R67_ "47_;_Z
M'Z8T445^,GZT%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 <!\1O^1I\&?]?O\ [/%7?UP'
MQ&_Y&GP9_P!?O_L\5=_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'PS^TI_P3
M.T_XE>*+[Q1X UFV\-:C?2--=Z7?1L;.25CEG1T!:/)R2NUAD\;>E</\(/\
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MF?/4/;PV&IX6')304445S'4%%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /S;_ ."EW_):/#O_ &+\?_I3<52_X)M_\EZU
M3_L7[C_T?;U=_P""EW_):/#O_8OQ_P#I3<52_P"";?\ R7K5/^Q?N/\ T?;U
M^S1_Y)G_ +<_4_)9?\E%_P!O_H?IC1117XR?K04444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!P'Q&_Y&GP9_P!?O_L\5=_7 ?$;_D:?!G_7[_[/%7?T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1U!X^S_^"?/BCP;XF_9YL?\ A$=&C\/RVMT\6KZ=%/+,JWNU-T@:1F;:ZA&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5\M?&S_DIFL?2'_P!$I7U+7RU\;/\ DIFL?2'_ -$I7X_XH_\ (EI?
M]?8_^DS/N^#O^1A/_ __ $J)@^!_^1TT#_L(6_\ Z,6OL.OCSP/_ ,CIH'_8
M0M__ $8M?8=>;X5?[GBO\2_(ZN-/X]'T?YA1117[D?G04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** . ^(W_(T^#/^OW_ -GBKOZX#XC?\C3X,_Z_?_9X
MJ[^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *9-,EO#)+*P2.-2S,>@ &2:CO;I+"S
MGN9 QCAC:1@O7 &3C\J^,M7_ ."I7PAOM)O;:/2_%@DF@>-2UA!C)4@9_?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?FW_ ,%+O^2T>'?^Q?C_ /2FXJE_P3;_ .2]
M:I_V+]Q_Z/MZN_\ !2[_ )+1X=_[%^/_ -*;BJ7_  3;_P"2]:I_V+]Q_P"C
M[>OV:/\ R3/_ &Y^I^2R_P"2B_[?_0_3&BBBOQD_6@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#@/B-_R-/@S_K]_]GBKOZX#XC?\C3X,_P"OW_V>*N_H **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\M?&S
M_DIFL?2'_P!$I7U+7RU\;/\ DIFL?2'_ -$I7X_XH_\ (EI?]?8_^DS/N^#O
M^1A/_ __ $J)@^!_^1TT#_L(6_\ Z,6OL.OCSP/_ ,CIH'_80M__ $8M?8=>
M;X5?[GBO\2_(ZN-/X]'T?YA1117[D?G04444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!^;?_  4N_P"2T>'?^Q?C_P#2FXJE
M_P $V_\ DO6J?]B_<?\ H^WJ[_P4N_Y+1X=_[%^/_P!*;BJ7_!-O_DO6J?\
M8OW'_H^WK]FC_P DS_VY^I^2R_Y*+_M_]#],:***_&3]:"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YKXF_\DW\6?\
M8)N__1+UTM<U\3?^2;^+/^P3=_\ HEZ<=T)[&5\#?^22^&?^O7_V9J[JN%^!
MO_))?#/_ %Z_^S-7=4/<%L%%%%(84444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'YM_\ !2[_ )+1X=_[%^/_ -*;BJ7_  3;_P"2]:I_V+]Q
M_P"C[>KO_!2[_DM'AW_L7X__ $IN*I?\$V_^2]:I_P!B_<?^C[>OV:/_ "3/
M_;GZGY++_DHO^W_T/TQHHHK\9/UH**** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
ME[XXV\D/Q(U%W7"S)"Z'U'EJN?S4_E7U#7.^+_ 6C^-X8DU*!C)%_JYX6VR+
MGJ,]Q[&OAN,<AK<0Y9]5P\DIQDI*^SLFK>6C^\^CR',J>5XOVU57BTT[?)_H
M?(=%?1/_  SGX=_Y_P#5/^_D?_QNC_AG/P[_ ,_^J?\ ?R/_ .-U^"_\0XS_
M /DC_P"!(_2O]:\L_F?W'SM17T3_ ,,Y^'?^?_5/^_D?_P ;H_X9S\._\_\
MJG_?R/\ ^-T?\0XS_P#DC_X$@_UKRS^9_<?.U%?1/_#.?AW_ )_]4_[^1_\
MQNC_ (9S\._\_P#JG_?R/_XW1_Q#C/\ ^2/_ ($@_P!:\L_F?W'SM17T3_PS
MGX=_Y_\ 5/\ OY'_ /&Z^=V&&(KYC.^&\PX?]G]>27/>UG?:U_S1[&7YMALT
MY_JS?NVO=6WO_D>M_LY:E/'XDU&P#M]FDM3,4SQN5U ./HQKZ"KYS_9U_P"1
MXO/^P?)_Z,CKZ,K^B_#F<I9!!2=[2DE]Y^5<5Q4<SDTMT@HHHK]//CPHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK$?\_H_<P_UOH?\ /I_>C]GZJZIJ5KHNFW>H7TZ6UE:0O//-(<+'&JEF8^P
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M;Z'_ #Z?WH_9^BOQ@_X:"^*'_11?%7_@ZN?_ (NC_AH+XH?]%%\5?^#JY_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YKXF_\DW\6?]@F[_\
M1+UTM<U\3?\ DF_BS_L$W?\ Z)>G'=">QE? W_DDOAG_ *]?_9FKNJX7X&_\
MDE\,_P#7K_[,U=U0]P6P4444AA1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5\1O]YOK7VY7Q&_WF^M?S]XL;8'_N)_[8?IW!/_,1_P!N_P#M
MQZA^SK_R/%Y_V#Y/_1D=?1E?.?[.O_(\7G_8/D_]&1U]&5]?X;_\B&/^.7Z'
MA\6?\C)_X4%%%%?J1\:%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIC%"=E&25FNGWGQ.#QU+ RG3NY0;NGU^YG[9T5^+?_#PW]H'_H?_ /RC:?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7Q&_WF^M?;E?$;_>;ZU_/WBQM@?\ N)_[8?IW!/\ S$?]
MN_\ MQZA^SK_ ,CQ>?\ 8/D_]&1U]&5\Y_LZ_P#(\7G_ &#Y/_1D=?1E?7^&
M_P#R(8_XY?H>'Q9_R,G_ (4%%%%?J1\:%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?)G_  4L
M_P"2%:%_V,D'_I+=5\(? /\ Y+K\.?\ L9--_P#2J.ON_P#X*6?\D*T+_L9(
M/_26ZKX0^ ?_ "77X<_]C)IO_I5'7[-PY_R))_\ ;Y^2Y]_R.(_]NG[14445
M^,GZT%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!P'Q&_P"1I\&?
M]?O_ +/%7?UP'Q&_Y&GP9_U^_P#L\5=_0 4444 %%%% !1110 4444 %%%%
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M5W_7;[SV_P#9J&)A15-*33:=EY_Y,^DZ***X#T@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KFOB;_P DW\6?]@F[
M_P#1+UTM<U\3?^2;^+/^P3=_^B7IQW0GL97P-_Y)+X9_Z]?_ &9J[JN%^!O_
M "27PS_UZ_\ LS5W5#W!;!1112&%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7Q&_P!YOK7VY7Q&_P!YOK7\_>+&V!_[B?\ MA^G<$_\Q'_;
MO_MQZA^SK_R/%Y_V#Y/_ $9'7T97SG^SK_R/%Y_V#Y/_ $9'7T97U_AO_P B
M&/\ CE^AX?%G_(R?^%!1117ZD?&A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R9_P4L_Y(5H7
M_8R0?^DMU7PA\ _^2Z_#G_L9--_]*HZ^[_\ @I9_R0K0O^QD@_\ 26ZKX0^
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M_8R0?^DMU7PA\ _^2Z_#G_L9--_]*HZ^[_\ @I9_R0K0O^QD@_\ 26ZKX0^
M?_)=?AS_ -C)IO\ Z51U^S<.?\B2?_;Y^2Y]_P CB/\ VZ?M%1117XR?K044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% ' ?$;_D:?!G_ %^_^SQ5
MW]<!\1O^1I\&?]?O_L\5=_0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?/G[0O[;WP
M[_9XU#^Q]2DNM>\2;0S:3I*JS0 C(,KL0J9].6Y!VX.:]D^('BF/P/X%\0^(
MI0"FE:?<7I5NA\N-GQ^.*_"3P_H?BC]H+XM0:?;N=2\4^)K]F::X<A3(Y+.[
M'G"J-S'T"\"O0P.%6*J-2=HQW^?_  SN>7F.,>#I1<%>4G9?+?\ -6/T!T'_
M (*W^%[K4A'K/P_U;3K#./M%E?1W4@'J8V6,>G\5?7GPY\<> _CIX;MO%7AJ
M73]>LY#L,[0*9H7')CD5AN1AD<'U!'!!K\^O%O\ P2=\6:-X3N+_ $;QKI^N
M:S#%YG]EM8O;K*0,E$E+MD]AN50>Y%<%_P $X_BEJ/PW_:,M/#$\DD.E^)5?
M3KNUDR MPBLT3D?W@RE/I(:]&6%PF(A+ZL_>CKU_7OTMU/+AC,;AIP^MQ]V6
MG3]/U/U^50J@ 8 X %+117SQ]0%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7-?$W_DF_BS_ +!-W_Z)>NEK
MFOB;_P DW\6?]@F[_P#1+TX[H3V,KX&_\DE\,_\ 7K_[,U<Y^T!^TSX6_9[T
M^U.KK-J.L7JE[72[3'F.H(!=F/"+[GDD' .#CH_@;_R27PS_ ->O_LS5^=__
M  4$T_4[7]HS4;F]1Q975C:M8NR$*8UC"L >^)!)T]:^DR#+Z.98[V-=^ZDW
MZVZ'S^=XZKE^#]K17O-I>GF>N/\ \%1%#L$^&A9<\%M=P2/I]FI/^'HG_5,_
M_*]_]S5\(45^J_ZL91_SY_\ )I?_ "1^:?ZQ9I_S]_\ )8_Y'W?_ ,/1/^J9
M_P#E>_\ N:C_ (>B?]4S_P#*]_\ <U?"%%'^K&4?\^?_ ":7_P D'^L6:?\
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M5_X&Q?\ Q5'_  G7AO\ Z&#2O_ V+_XJOCVBOI/^(J8W_H&C][/*_P!2\/\
M\_G]R/L+_A.O#?\ T,&E?^!L7_Q5'_"=>&_^A@TK_P #8O\ XJOCVBC_ (BI
MC?\ H&C][#_4O#_\_G]R/L+_ (3KPW_T,&E?^!L7_P 51_PG7AO_ *&#2O\
MP-B_^*KX]HH_XBIC?^@:/WL/]2\/_P _G]R/L+_A.O#?_0P:5_X&Q?\ Q5'_
M  G7AO\ Z&#2O_ V+_XJOCVBC_B*F-_Z!H_>P_U+P_\ S^?W(^PO^$Z\-_\
M0P:5_P"!L7_Q5'_"=>&_^A@TK_P-B_\ BJ^/:*/^(J8W_H&C][#_ %+P_P#S
M^?W(^PO^$Z\-_P#0P:5_X&Q?_%4?\)UX;_Z&#2O_  -B_P#BJ^/:*/\ B*F-
M_P"@:/WL/]2\/_S^?W(^PO\ A.O#?_0P:5_X&Q?_ !5'_"=>&_\ H8-*_P#
MV+_XJOCVBC_B*F-_Z!H_>P_U+P__ #^?W(^PO^$Z\-_]#!I7_@;%_P#%4?\
M"=>&_P#H8-*_\#8O_BJ^/:*/^(J8W_H&C][#_4O#_P#/Y_<C["_X3KPW_P!#
M!I7_ (&Q?_%4?\)UX;_Z&#2O_ V+_P"*KX]HH_XBIC?^@:/WL/\ 4O#_ //Y
M_<C["_X3KPW_ -#!I7_@;%_\51_PG7AO_H8-*_\  V+_ .*KX]HH_P"(J8W_
M *!H_>P_U+P__/Y_<C["_P"$Z\-_]#!I7_@;%_\ %4?\)UX;_P"A@TK_ ,#8
MO_BJ^/:*/^(J8W_H&C][#_4O#_\ /Y_<C["_X3KPW_T,&E?^!L7_ ,51_P )
MUX;_ .A@TK_P-B_^*KX]HH_XBIC?^@:/WL/]2\/_ ,_G]R/L+_A.O#?_ $,&
ME?\ @;%_\51_PG7AO_H8-*_\#8O_ (JOCVBC_B*F-_Z!H_>P_P!2\/\ \_G]
MR/L+_A.O#?\ T,&E?^!L7_Q5'_"=>&_^A@TK_P #8O\ XJOCVBC_ (BIC?\
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M .A@TK_P-B_^*KX]HH_XBIC?^@:/WL/]2\/_ ,_G]R/L+_A.O#?_ $,&E?\
M@;%_\51_PG7AO_H8-*_\#8O_ (JOCVBC_B*F-_Z!H_>P_P!2\/\ \_G]R/L+
M_A.O#?\ T,&E?^!L7_Q5'_"=>&_^A@TK_P #8O\ XJOCVBC_ (BIC?\ H&C]
M[#_4O#_\_G]R/L+_ (3KPW_T,&E?^!L7_P 51_PG7AO_ *&#2O\ P-B_^*KX
M]HH_XBIC?^@:/WL/]2\/_P _G]R/L+_A.O#?_0P:5_X&Q?\ Q5'_  G7AO\
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MPG7AO_H8-*_\#8O_ (JOCVBC_B*F-_Z!H_>P_P!2\/\ \_G]R/L+_A.O#?\
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M_%4?\)UX;_Z&#2O_  -B_P#BJ^/:*/\ B*F-_P"@:/WL/]2\/_S^?W(^PO\
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M]#!I7_@;%_\ %4?\)UX;_P"A@TK_ ,#8O_BJ^/:*/^(J8W_H&C][#_4O#_\
M/Y_<C["_X3KPW_T,&E?^!L7_ ,51_P )UX;_ .A@TK_P-B_^*KX]HH_XBIC?
M^@:/WL/]2\/_ ,_G]R/L+_A.O#?_ $,&E?\ @;%_\51_PG7AO_H8-*_\#8O_
M (JOCVBC_B*F-_Z!H_>P_P!2\/\ \_G]R/L+_A.O#?\ T,&E?^!L7_Q5'_"=
M>&_^A@TK_P #8O\ XJOCVBC_ (BIC?\ H&C][#_4O#_\_G]R/L+_ (3KPW_T
M,&E?^!L7_P 51_PG7AO_ *&#2O\ P-B_^*KX]HH_XBIC?^@:/WL/]2\/_P _
MG]R/L+_A.O#?_0P:5_X&Q?\ Q5'_  G7AO\ Z&#2O_ V+_XJOCVBC_B*F-_Z
M!H_>P_U+P_\ S^?W(^PO^$Z\-_\ 0P:5_P"!L7_Q5'_"=>&_^A@TK_P-B_\
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MFW?SYHQT/QK.\=EN*IPC@7.Z>O.HI6\K29_0YI__ !XVW_7-?Y"K%?BMIO\
MP4"^/.DV$%G;^.<00((XQ)I5DY"CH-S0DG\37U__ ,$[_P!IKXC_ !W\9>+K
M#QOX@76;6PL(I[=!8V]OL<R;2<Q1J3QZYJJF7UZ-+VE2VF]FW^B_0[J.:4*]
M54J:>O=+_-GW51117FGL!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^7X'B?ZL9?[7VEG;M?3_ #_$XW7?A3HVK_"VX\ 6CW.@Z!-8C3A_9;(DL<&
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M,B@@@R0M%"LI! /SN>><U]M?LL_LG^"OV3? \F@^%8Y;N^O&674]:O,&YO9
M,#.!A47)VH.!D]22QBFK2<Y/2VB\^[]/Z\KGK%1BM;ZOR[?/^O/X]_X+>_\
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M7DG[8_\ P3O\%?M97$>OK?R^$/',,2PKK5K )H[E%^ZMQ%E=^!D!@RL.,E@
MM?.*?L%_MEV>G'PW:_M%6X\, ^6KMKVI+<"+H !Y)*C&!L$NWM1"3]E&$E[T
M5:_1^?E_7J[J).K*I%Z2=_1]O3^NMEU7C;XY_L\>#OVL-*^#7AC]G'P7XMU2
M2\MK*36-*TC3T^R7CO\ .FS[.<^4,,S!QM(88!4UUW_!8S_DT6+_ +&*R_\
M0)JZS]C3_@G3X1_93U"3Q/>ZG)XR\>31M$-6N(!##:(WWA!%EB&8<-(S$D9
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M5)XR;F-"BLKIC8>JGIQ7/:4\+.BG:2<VO^WK6_S-Y2BL1&K:\;13^6Y\4_\
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M_0+_ .3U/_D@_P!9LV_Y_?\ DL?\CQ#_ (9I_P"IC_\ )'_[91_PS3_U,?\
MY(__ &RO;Z*/]0>&_P#H%_\ )ZG_ ,D'^LV;?\_O_)8_Y'B'_#-/_4Q_^2/_
M -LH_P"&:?\ J8__ "1_^V5[?11_J#PW_P! O_D]3_Y(/]9LV_Y_?^2Q_P C
MQ#_AFG_J8_\ R1_^V4?\,T_]3'_Y(_\ VRO;Z*/]0>&_^@7_ ,GJ?_)!_K-F
MW_/[_P EC_D>(?\ #-/_ %,?_DC_ /;*/^&:?^IC_P#)'_[97M]%'^H/#?\
MT"_^3U/_ )(/]9LV_P"?W_DL?\CQ#_AFG_J8_P#R1_\ ME'_  S3_P!3'_Y(
M_P#VRO;Z*/\ 4'AO_H%_\GJ?_)!_K-FW_/[_ ,EC_D>(?\,T_P#4Q_\ DC_]
MLH_X9I_ZF/\ \D?_ +97M]%'^H/#?_0+_P"3U/\ Y(/]9LV_Y_?^2Q_R/$/^
M&:?^IC_\D?\ [91_PS3_ -3'_P"2/_VRO;Z*/]0>&_\ H%_\GJ?_ "0?ZS9M
M_P _O_)8_P"1XA_PS3_U,?\ Y(__ &RC_AFG_J8__)'_ .V5[?11_J#PW_T"
M_P#D]3_Y(/\ 6;-O^?W_ )+'_(\0_P"&:?\ J8__ "1_^V4?\,T_]3'_ .2/
M_P!LKV^BC_4'AO\ Z!?_ ">I_P#)!_K-FW_/[_R6/^1XA_PS3_U,?_DC_P#;
M*/\ AFG_ *F/_P D?_ME>WT4?Z@\-_\ 0+_Y/4_^2#_6;-O^?W_DL?\ (\0_
MX9I_ZF/_ ,D?_ME'_#-/_4Q_^2/_ -LKV^BC_4'AO_H%_P#)ZG_R0?ZS9M_S
M^_\ )8_Y'B'_  S3_P!3'_Y(_P#VRC_AFG_J8_\ R1_^V5[?11_J#PW_ - O
M_D]3_P"2#_6;-O\ G]_Y+'_(\0_X9I_ZF/\ \D?_ +91_P ,T_\ 4Q_^2/\
M]LKV^BC_ %!X;_Z!?_)ZG_R0?ZS9M_S^_P#)8_Y'B'_#-/\ U,?_ )(__;*/
M^&:?^IC_ /)'_P"V5[?11_J#PW_T"_\ D]3_ .2#_6;-O^?W_DL?\CQ#_AFG
M_J8__)'_ .V4?\,T_P#4Q_\ DC_]LKV^BC_4'AO_ *!?_)ZG_P D'^LV;?\
M/[_R6/\ D>(?\,T_]3'_ .2/_P!LH_X9I_ZF/_R1_P#ME>WT4?Z@\-_] O\
MY/4_^2#_ %FS;_G]_P"2Q_R/$/\ AFG_ *F/_P D?_ME'_#-/_4Q_P#DC_\
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M .V4?\,T_P#4Q_\ DC_]LKV^BC_4'AO_ *!?_)ZG_P D'^LV;?\ /[_R6/\
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MV4?\,T_]3'_Y(_\ VRO;Z*/]0>&_^@7_ ,GJ?_)!_K-FW_/[_P EC_D>(?\
M#-/_ %,?_DC_ /;*/^&:?^IC_P#)'_[97M]%'^H/#?\ T"_^3U/_ )(/]9LV
M_P"?W_DL?\CQ#_AFG_J8_P#R1_\ ME'_  S3_P!3'_Y(_P#VRO;Z*/\ 4'AO
M_H%_\GJ?_)!_K-FW_/[_ ,EC_D>(?\,T_P#4Q_\ DC_]LH_X9I_ZF/\ \D?_
M +97M]%'^H/#?_0+_P"3U/\ Y(/]9LV_Y_?^2Q_R/$/^&:?^IC_\D?\ [91_
MPS3_ -3'_P"2/_VRO;Z*/]0>&_\ H%_\GJ?_ "0?ZS9M_P _O_)8_P"1XA_P
MS3_U,?\ Y(__ &RC_AFG_J8__)'_ .V5[?11_J#PW_T"_P#D]3_Y(/\ 6;-O
M^?W_ )+'_(\0_P"&:?\ J8__ "1_^V4?\,T_]3'_ .2/_P!LKV^BC_4'AO\
MZ!?_ ">I_P#)!_K-FW_/[_R6/^1XA_PS3_U,?_DC_P#;*/\ AFG_ *F/_P D
M?_ME>WT4?Z@\-_\ 0+_Y/4_^2#_6;-O^?W_DL?\ (\0_X9I_ZF/_ ,D?_ME'
M_#-/_4Q_^2/_ -LKV^BC_4'AO_H%_P#)ZG_R0?ZS9M_S^_\ )8_Y'B'_  S3
M_P!3'_Y(_P#VRC_AFG_J8_\ R1_^V5[?11_J#PW_ - O_D]3_P"2#_6;-O\
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M3_U,?_DC_P#;*]OHH_U!X;_Z!?\ R>I_\D'^LV;?\_O_ "6/^1XA_P ,T_\
M4Q_^2/\ ]LH_X9I_ZF/_ ,D?_ME>WT4?Z@\-_P#0+_Y/4_\ D@_UFS;_ )_?
M^2Q_R/$/^&:?^IC_ /)'_P"V4?\ #-/_ %,?_DC_ /;*]OHH_P!0>&_^@7_R
M>I_\D'^LV;?\_O\ R6/^1XA_PS3_ -3'_P"2/_VRC_AFG_J8_P#R1_\ ME>W
MT4?Z@\-_] O_ )/4_P#D@_UFS;_G]_Y+'_(\0_X9I_ZF/_R1_P#ME'_#-/\
MU,?_ )(__;*]OHH_U!X;_P"@7_R>I_\ )!_K-FW_ #^_\EC_ )'B'_#-/_4Q
M_P#DC_\ ;*/^&:?^IC_\D?\ [97M]%'^H/#?_0+_ .3U/_D@_P!9LV_Y_?\
MDL?\CQ#_ (9I_P"IC_\ )'_[91_PS3_U,?\ Y(__ &RO;Z*/]0>&_P#H%_\
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M_P"2/_VRO;Z*/]0>&_\ H%_\GJ?_ "0?ZS9M_P _O_)8_P"1XA_PS3_U,?\
MY(__ &RC_AFG_J8__)'_ .V5[?11_J#PW_T"_P#D]3_Y(/\ 6;-O^?W_ )+'
M_(\0_P"&:?\ J8__ "1_^V4?\,T_]3'_ .2/_P!LKV^BC_4'AO\ Z!?_ ">I
M_P#)!_K-FW_/[_R6/^1XA_PS3_U,?_DC_P#;*/\ AFG_ *F/_P D?_ME>WT4
M?Z@\-_\ 0+_Y/4_^2#_6;-O^?W_DL?\ (\0_X9I_ZF/_ ,D?_ME'_#-/_4Q_
M^2/_ -LKV^BC_4'AO_H%_P#)ZG_R0?ZS9M_S^_\ )8_Y'B'_  S3_P!3'_Y(
M_P#VRC_AFG_J8_\ R1_^V5[?11_J#PW_ - O_D]3_P"2#_6;-O\ G]_Y+'_(
M\0_X9I_ZF/\ \D?_ +91_P ,T_\ 4Q_^2/\ ]LKV^BC_ %!X;_Z!?_)ZG_R0
M?ZS9M_S^_P#)8_Y'B'_#-/\ U,?_ )(__;*/^&:?^IC_ /)'_P"V5[?11_J#
MPW_T"_\ D]3_ .2#_6;-O^?W_DL?\CQ#_AFG_J8__)'_ .V4?\,T_P#4Q_\
MDC_]LKV^BC_4'AO_ *!?_)ZG_P D'^LV;?\ /[_R6/\ D>(?\,T_]3'_ .2/
M_P!LH_X9I_ZF/_R1_P#ME>WT4?Z@\-_] O\ Y/4_^2#_ %FS;_G]_P"2Q_R/
M$/\ AFG_ *F/_P D?_ME'_#-/_4Q_P#DC_\ ;*]OHH_U!X;_ .@7_P GJ?\
MR0?ZS9M_S^_\EC_D>(?\,T_]3'_Y(_\ VRC_ (9I_P"IC_\ )'_[97M]%'^H
M/#?_ $"_^3U/_D@_UFS;_G]_Y+'_ "/$/^&:?^IC_P#)'_[91_PS3_U,?_DC
M_P#;*]OHH_U!X;_Z!?\ R>I_\D'^LV;?\_O_ "6/^1XA_P ,T_\ 4Q_^2/\
M]LH_X9I_ZF/_ ,D?_ME>WT4?Z@\-_P#0+_Y/4_\ D@_UFS;_ )_?^2Q_R/$/
M^&:?^IC_ /)'_P"V4?\ #-/_ %,?_DC_ /;*]OHH_P!0>&_^@7_R>I_\D'^L
MV;?\_O\ R6/^1XA_PS3_ -3'_P"2/_VRC_AFG_J8_P#R1_\ ME>WT4?Z@\-_
M] O_ )/4_P#D@_UFS;_G]_Y+'_(\0_X9I_ZF/_R1_P#ME'_#-/\ U,?_ )(_
M_;*]OHH_U!X;_P"@7_R>I_\ )!_K-FW_ #^_\EC_ )'B'_#-/_4Q_P#DC_\
M;*/^&:?^IC_\D?\ [97M]%'^H/#?_0+_ .3U/_D@_P!9LV_Y_?\ DL?\CQ#_
M (9I_P"IC_\ )'_[91_PS3_U,?\ Y(__ &RO;Z*/]0>&_P#H%_\ )ZG_ ,D'
M^LV;?\_O_)8_Y'B'_#-/_4Q_^2/_ -LH_P"&:?\ J8__ "1_^V5[?11_J#PW
M_P! O_D]3_Y(/]9LV_Y_?^2Q_P CQ#_AFG_J8_\ R1_^V4?\,T_]3'_Y(_\
MVRO;Z*/]0>&_^@7_ ,GJ?_)!_K-FW_/[_P EC_D>(?\ #-/_ %,?_DC_ /;*
M/^&:?^IC_P#)'_[97M]%'^H/#?\ T"_^3U/_ )(/]9LV_P"?W_DL?\CQ#_AF
MG_J8_P#R1_\ ME'_  S3_P!3'_Y(_P#VRO;Z*/\ 4'AO_H%_\GJ?_)!_K-FW
M_/[_ ,EC_D>(?\,T_P#4Q_\ DC_]LH_X9I_ZF/\ \D?_ +97M]%'^H/#?_0+
M_P"3U/\ Y(/]9LV_Y_?^2Q_R/$/^&:?^IC_\D?\ [91_PS3_ -3'_P"2/_VR
MO;Z*/]0>&_\ H%_\GJ?_ "0?ZS9M_P _O_)8_P"1XA_PS3_U,?\ Y(__ &RC
M_AFG_J8__)'_ .V5[?11_J#PW_T"_P#D]3_Y(/\ 6;-O^?W_ )+'_(\0_P"&
M:?\ J8__ "1_^V4?\,T_]3'_ .2/_P!LKV^BC_4'AO\ Z!?_ ">I_P#)!_K-
MFW_/[_R6/^1XA_PS3_U,?_DC_P#;*/\ AFG_ *F/_P D?_ME>WT4?Z@\-_\
M0+_Y/4_^2#_6;-O^?W_DL?\ (\0_X9I_ZF/_ ,D?_ME'_#-/_4Q_^2/_ -LK
MV^BC_4'AO_H%_P#)ZG_R0?ZS9M_S^_\ )8_Y'B'_  S3_P!3'_Y(_P#VRC_A
MFG_J8_\ R1_^V5[?11_J#PW_ - O_D]3_P"2#_6;-O\ G]_Y+'_(\0_X9I_Z
MF/\ \D?_ +91_P ,T_\ 4Q_^2/\ ]LKV^BC_ %!X;_Z!?_)ZG_R0?ZS9M_S^
M_P#)8_Y'B'_#-/\ U,?_ )(__;*/^&:?^IC_ /)'_P"V5[?11_J#PW_T"_\
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M\TE'D3T.[V<+\UE<****DT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** . ^(W_(T^#/\ K]_]GBKOZX#XC?\ (T^#/^OW_P!GBKOZ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YKXF_\ )-_%G_8)N_\
MT2]=+7-?$W_DF_BS_L$W?_HEZ<=T)[&5\#?^22^&?^O7_P!F:NZKA?@;_P D
ME\,_]>O_ +,U=U0]P6P4444AA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAO\ Y\M5_P"_47_QRC_AHOPW_P ^6J_]^HO_ (Y1_KAD'_07'\?\A_V%F?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#Y,_X*6?\ )"M"_P"QD@_]);JOA#X!_P#)=?AS_P!C)IO_ *51
MU]W_ /!2S_DA6A?]C)!_Z2W5?"'P#_Y+K\.?^QDTW_TJCK]FX<_Y$D_^WS\E
MS[_D<1_[=/VBHHHK\9/UH**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#@/B-_P C3X,_Z_?_ &>*N_K@/B-_R-/@S_K]_P#9XJ[^@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N:^)O\ R3?Q9_V";O\
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M_P CQ"OSO_;C^*/C/PE\=);#0_%VNZ-8C3K=Q:Z?J4T$6X[LMM1@,GUK]?\
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MFK6OZ[W/$**]O_X9I_ZF/_R1_P#ME'_#-/\ U,?_ )(__;*^'_U!XD_Z!?\
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ML_\ \FJ:'_V-=K_Z375<6(DO91A%62<;+_MY'?A8OVLIR=VU+_TEGO/[ _\
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MLKVVCN8)4.0\;J&5@?0@BIP_\"53[3DT_1:+[U^1=?\ BPAT4;KS;M?[MO\
MAC\_OV]/^"<LOCK4/#/C3X#^&K'0/&EO?JM_;Z9-#IL!CY=+L#*JLJ2*,E/F
M;?G!*UV?[>?[0'CGX"_L2Z,-1GBT[XE^(X[;0[R[TZ7*P3&$M=31,,8R(V"D
M<J9 1R*^C/VC/VCO"7[+WP_3QAXQ%])ILEY%8QPZ;$DD\DCAB-JLZ@@*K,>>
M@/6O@W_@K!XLL?C9^R?\*/B3X:2[?PW=:PSQM=6YBD"2PR!&93]T$Q''KD5R
MU6U0E".L>:-_*[5U\U]YO3_C1G+?EE;SM?7Y,Z'_ ()W_LT_ KP7\&M!\:^.
M+KPAXA\<:]$+\C7;JVF73HF.8HHXI"0C[<,S$;LL1G KT7]L;]G']GSXU?"?
MQ%<:3<>"- \;6-G+=Z9JND75I:RR31H66*;81YB-MVX8$KG*X->+?LX_\$K?
M@;\=/@;X*\=?\)7XV^TZSIL4]W'9ZA9"**Y VSQJ#:$@+(KK@DGCK7<>(/\
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M]OGY+GW_ ".(_P#;I^T5%%%?C)^M!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <!\1O^1I\&?\ 7[_[/%7?UP'Q&_Y&GP9_U^_^SQ5W] !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'R9_P %+/\ DA6A?]C)!_Z2W5?"'P#_ .2Z_#G_ +&33?\ TJCK
M[O\ ^"EG_)"M"_[&2#_TENJ^$/@'_P EU^'/_8R:;_Z51U^S<.?\B2?_ &^?
MDN??\CB/_;I^T5%%%?C)^M!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 <!\1O\ D:?!G_7[_P"SQ5W]<!\1O^1I\&?]?O\ [/%7?T %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S7Q-_Y)OXL_[!-W_Z
M)>NEKFOB;_R3?Q9_V";O_P!$O3CNA/8RO@;_ ,DE\,_]>O\ [,U=U7"_ W_D
MDOAG_KU_]F:NZH>X+8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "LSQ'XCT[PEHMQJVK7'V33[?;YLVQGV[F"CA02>6 X'>M.O-OVC/\
MDC/B+Z6__I1%3BKM(3V/2*6D7[H^E+2&%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %9E_XDT[2]8TO2KFX\J_U/S1:0[&/F>6NY^0,# .
M>2,]JTZ\U\>?\EC^%_\ O:G_ .DZTTKL3/2J***0PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ K,_X233AXD&@?:/^)L;3[<+?8W^IW[-
MV[&W[W&,Y]JTZ\U;_DX^/_L53_Z5TTKB9Z51112&%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %9FB^)-.\1'4!I]Q]H-A=R6-S\C+LF3&
MY?F SC(Y&1[UIUYK\%?]9X^_[&J^_P#9*=M&Q'I5%%%(84444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5F>'/$FG>+='@U72;C[783EA'-L
M9,[6*GA@#U!'3M6G7FO[.?\ R1[0_P#>N?\ THDIVTN+K8]*HHHI#"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,WQ%XBT[PGHUQJVJW'V
M73[?;YLVQGV[F"CA02>6 X'>M$'< 1TKSC]HK_DC7B+Z0?\ I1'7HT?^K7Z"
MG;2XNHZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MS-<\2:=X;6Q.HW'V<7MU'96_R,V^9\[%^4'&<'DX'O6G7FOQO_U/@?\ [&JP
M_F]>E4[:)BZA1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 9A\2:<OB0:";C_B;&U^VBWV-_J=^S=NQM^]QC.?:M.O-9/^3CH?^Q6;
M_P!*Z]*IM6$@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME278R9*L5;A@#U![5IUYK^SK_P DETG_ *ZW/_I1)3MI<76QZ51112&%%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#S7_A=O\ U(7CC_P3?_9UA^.OB_\ VGX)\0V?_"$^,+3[1IUQ%]HNM)V1
M1[HF&YVW\*,Y)[ &O9JYKXF_\DW\6?\ 8)N__1+U::OL2T[;GCWPS^/&E>%?
M >BZ5<Z!XAN)K6 *TMM9HT;9)(*DN,C!]*Z?_AIC1/\ H6O%'_@ G_QRNZ^&
M7_)-_"?_ &";3_T2E=+0VK[ KVW/(/\ AIC1/^A:\4?^ "?_ !RC_AIC1/\
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MH_\  !/_ (Y1_P -,:)_T+7BC_P 3_XY7K]%%UV"S[GD'_#3&B?]"UXH_P#
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M'_@ G_QRC_AIC1/^A:\4?^ "?_'*]?HHNNP6?<\@_P"&F-$_Z%KQ1_X )_\
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MM>*/_ !/_CE'_#3&B?\ 0M>*/_ !/_CE>OT4778+/N>0?\-,:)_T+7BC_P
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M.4?\-,:)_P!"UXH_\ $_^.5Z_11==@L^YY!_PTQHG_0M>*/_   3_P".4?\
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M%'_@ G_QRC_AIC1/^A:\4?\ @ G_ ,<KU^BBZ[!9]SR#_AIC1/\ H6O%'_@
MG_QRC_AIC1/^A:\4?^ "?_'*]?HHNNP6?<\@_P"&F-$_Z%KQ1_X )_\ '*/^
M&F-$_P"A:\4?^ "?_'*]?HHNNP6?<\@_X:8T3_H6O%'_ ( )_P#'*/\ AIC1
M/^A:\4?^ "?_ !RO7Z*+KL%GW/(/^&F-$_Z%KQ1_X )_\<H_X:8T3_H6O%'_
M ( )_P#'*]?HHNNP6?<\@_X:8T3_ *%KQ1_X )_\<H_X:8T3_H6O%'_@ G_Q
MRO7Z*+KL%GW/(/\ AIC1/^A:\4?^ "?_ !RC_AIC1/\ H6O%'_@ G_QRO7Z*
M+KL%GW/(/^&F-$_Z%KQ1_P" "?\ QRC_ (:8T3_H6O%'_@ G_P <KU^BBZ[!
M9]SYM^)GQRTKQ-'X9$&AZ];?8=<M;Y_M5HB;U3=E$PYRYSP./K79_P##3&B?
M]"UXH_\  !/_ (Y6K\;_ /4^!_\ L:K#^;UZ55-JRT$KW>IY!_PTQHG_ $+7
MBC_P 3_XY1_PTQHG_0M>*/\ P 3_ ..5Z_14W78=GW/(/^&F-$_Z%KQ1_P"
M"?\ QRC_ (:8T3_H6O%'_@ G_P <KU^BBZ[!9]SR#_AIC1/^A:\4?^ "?_'*
M/^&F-$_Z%KQ1_P" "?\ QRO7Z*+KL%GW/(/^&F-$_P"A:\4?^ "?_'*/^&F-
M$_Z%KQ1_X )_\<KU^BBZ[!9]SR#_ (:8T3_H6O%'_@ G_P <H_X:8T3_ *%K
MQ1_X )_\<KU^BBZ[!9]SR#_AIC1/^A:\4?\ @ G_ ,<H_P"&F-$_Z%KQ1_X
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M $_^.5Z_11==@L^YY!_PTQHG_0M>*/\ P 3_ ..4?\-,:)_T+7BC_P  $_\
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M.4?\-,:)_P!"UXH_\ $_^.5Z_11==@L^YY!_PTQHG_0M>*/_   3_P".4?\
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M>*/_   3_P".5Z_11==@L^YY!_PTQHG_ $+7BC_P 3_XY1_PTQHG_0M>*/\
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MM>*/_ !/_CE>OT4778+/N>0?\-,:)_T+7BC_ , $_P#CE'_#3&B?]"UXH_\
M !/_ (Y7K]%%UV"S[GD'_#3&B?\ 0M>*/_ !/_CE'_#3&B?]"UXH_P# !/\
MXY7K]%%UV"S[GD'_  TQHG_0M>*/_ !/_CE'_#3&B?\ 0M>*/_ !/_CE>OT4
M778+/N>0?\-,:)_T+7BC_P  $_\ CE'_  TQHG_0M>*/_ !/_CE>OT4778+/
MN>0?\-,:)_T+7BC_ , $_P#CE'_#3&B?]"UXH_\  !/_ (Y7K]%%UV"S[GD'
M_#3&B?\ 0M>*/_ !/_CE<9XL^.6E:MX^\%:K'H>O10Z6]V9(9K1%EE\R(*/+
M&_YL$9.2,"OI*O-?B!_R5SX8?]=-1_\ 2<546K["=^YE?\-,:)_T+7BC_P
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M   3_P".5Z_14W78=GW/(/\ AIC1/^A:\4?^ "?_ !RC_AIC1/\ H6O%'_@
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M%'_@ G_QRC_AIC1/^A:\4?\ @ G_ ,<KU^BBZ[!9]SR#_AIC1/\ H6O%'_@
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M:8T3_H6O%'_@ G_QRO7Z*+KL%GW/(/\ AIC1/^A:\4?^ "?_ !RC_AIC1/\
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M'_@ G_QRC_AIC1/^A:\4?^ "?_'*]?HHNNP6?<\@_P"&F-$_Z%KQ1_X )_\
M'*/^&F-$_P"A:\4?^ "?_'*]?HHNNP6?<\@_X:8T3_H6O%'_ ( )_P#'*/\
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MEC)!!*NJ C@D<'O7VN6<14\!@)8.5-MN^M^Y\AF&0U,;CHXI5$DK:6[''_\
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M $_^.5Z_11==@L^YY!_PTQHG_0M>*/\ P 3_ ..4?\-,:)_T+7BC_P  $_\
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M%%% !1110 4444 %%%% !1110 4444 %%%% 'GTFF7G_  OR+4/LD_V >&S
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MX\1W4\)FC9/-C(3#KD<J<'!'%>@T4[Z6$%%%%(84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5Y]\!M,O-'^&&F6M_:3V-TDMP6@N8VC=<
MSN1E2 1D$'\:]!HIWTL+K<****0PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#@OCMIMWK'PIUZTL+6:]NY%BV06\9DD;$R$X4#)X!/X5W
M-N"MO&",$*/Y5)13OI876X4444AA1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'GWQ@TR\U/_A"?L=I/=_9_$]C<3>1&S^7&N_<[8'"C(R3
MP,UZ#113OI804444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1117*=84444 %%%% !1110 4444 %%%% !1110 4444 %%>*?M4>-/BMX/\
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M?K7@?[8_[66K_"74]%^'OP\LDU;XDZ^46!602+9J[;$.P\-(S9VAOE !+9&
M<%2E*K[*&KO;3K_P#I=:,:/MJGNJUW?=>7KT/JJBOAZT_9!_:*UW31KFL?M&
M:OI?B>1?-.DV;W!L4?J$+)*B >NV$CTS7O/[+T?QDMO">IV?QC?3;C4K2\:W
ML+RTV^=<PKP9)-@"8)QM.%8C.X9ZZSHQC%M5$VNFOX::F-/$3E)*5-I/9Z?C
MKH>T4445R':%%%% !1110 4444 %%%% !1110 4444 %%%% !17P?X__ &C?
MBA^TQ\9M2^&/P*OH= T/2=RZIXJ<#+!6VLROABB;OE38-[$9R%SBUKO[+W[2
MGPNL&\0^"OCQJWCC5[<>8^BZR9/+F Y*QB>:6-C_ +P3Z@UV1P_NQE4DH\VU
M[_>[;'!+%/FE&E!RY=[6^Y7>K/N:BL/P._B&3P?H[>*X[&+Q(ULAU!--+&W6
M;'S!-W.,UKW%Q%9V\L\\BPP1*7DDD("JH&223T %<DER-IO8[8OG2:6Y+17Y
M9?%__@H-\3=;^+#S_#_6VT3X?'45TVR)TZVF^UE"OF2;Y8V8%@ZG (PK)P":
M_4VNFKAJE&G"I/[5].NEM_O.2CBZ=>K.E#[%M>CO=:?<PHHHKE.T**** "BB
MB@ HHHH **** "BBB@ HHHH ***\>_:+\,_&;Q)I^BI\'O%NC^%+N*60ZC)J
M\2R+,A"[ NZWFP0=V>%Z]Z<5S22VN3*7+%RM>Q[#17Q;_P *M_;=_P"BP^"_
M_ .+_P"5M>-_$[XJ?M9?#'XH>'?A[)\3]%\1^+-<VF&PT+3;64PAFPIE,ED@
M4'#-WPJDG QGOA@_:24(5(MOS?\ D>=4QWLXN<Z4DEY+_,_3:BO(/C#\0_&/
MP3^ HUNUT2?X@^+K&T@AN39Q!$><J%DN7C3#>7NRQ6,9Y'W1EA\[Z!^SG^TO
M\:-/7Q'XW^-FI_#B\NAYL&AZ&DB^0AY"2+#+"JD>A+M_>.<BL(45+F;DE%.U
M_P#);LZ*F(<>51@W)J]NWJ]E]Y]ST5^?OA/XZ_%C]DGXYZ+\.OB_KP\9>$-;
M9$L=?FRTL2LVP2^81N(#$!T<L0.5./O?H%15HNFHS3O&6S7EO\UU'1Q"JN4&
MK2CNGY[?)] HHHKF.H**** "BBB@ HHHH **** "BBB@ HHHH ***\(_;$_:
M2'[-7PM_M>SMXKWQ%J4WV/2[>?)C\S:6:1P.2J 9QD9)49&<TXIR:C%7;T)E
M)1BY2=DM3W>BOA+PO^S'^T9\5/#MKXM\3?'W6O"&M:A$MU%HFG"988E8!D60
M131(AP1E0C8]2<UT/[+G[1'Q"T;XUZI\#/C#+#J'B2UC:33-:C4*;I53?M)"
M@.&CRZO@-\K!LGIW/"_%&,TY13;6O3>SV=C@6,^&4H-1DTDW;KM=7NKGV917
MGWQX^,>E_ ;X7ZSXQU5#.EF@2WM5.&N9V.(XP>V3U/8 GM7QY\-/AG^T1^UC
MX='Q"UCXPZE\-M.U M)I.E:*LT:/$"0&*1RQX0XX9B[,.3P1G"E1=12FW:*W
M?GV\W^AO6KJDXP2YI2V2[=W?9>??0_02BOB7]G7]HCX@?#CXZ7'P+^-%\FKZ
MG*!_8OB# !GRI9%9L#>K@':Q&X."I)R-OVU2K472L[W3U374=&NJUU:SB[-/
MI_71A1116!TA1110 4444 %%%% !1110 4444 %%%% !117R=^VA^U!XF^&N
MN>&OAI\-H(Y_B#XF9!%<2(K_ &1'?RX]JM\N]F!Y;*J%)(Y&-*=.56:IP5VS
M.I4C1IRJ3=DCZQHKX=N/V0OVB['2CKUI^T7JUWXL5?/_ +'DDN/L#2]=@9I2
MA7/ S"![ 5Z+^Q+^TYK7QQTCQ!X:\:VL=GX\\+S""_,:",7*[F3>4'"NKHRL
M%^7.",9P.B6'7+*5.:ER[[_?KNCDCBGS1C4@X\VS=ON=GH_4^G:*^<OVUOVH
M+C]G'P-I\>A6T5[XPUZ5K?38IE+I$%QOE91][&Y0%[EAU (KR;2OV2_VC?%F
MBQ>(M>_:%UG0?%%Q&)SHMHTWV2)B,B-S%*D8(Z$+$P!SC=UJ*='GA[6<N6-[
M7[OR2[=32KB.2?LH1<I6O96T7FWWZ'W-17R%^R#^TEXVUKXC>)?@W\6%AD\;
MZ"KR0:E&JI]KC0C<K!0%)VLKJP W*3D9&3]>U-:BZ+2;NFKIK9I]2Z-:->+:
M5FG9I[IKH%%%%8'0%%%% !1110 4444 %%%% !1110 4444 %%%?!7BKXV?%
M3]K;XV:Y\.O@_KP\&>#=!9H]3\30@B:3#%"RN/F&6#!%0J6"EBV.FU*E*M+E
MCTU;Z)&%:M&A'FEU=DENVS[UHK\_OB)X6_:(_8STV/QO8?$Z\^+/A.UD7^UK
M'7$D9XXR0-V)))65,G&]'!!(RI&:^S?@Y\5-)^-7PWT3QEHNY;+4H=YA<Y>"
M0$K)$WNK C/?&>]:5*'+#VD)<T;V]'YIF5/$<T_95(N,K7UMJO)H[2BOF[]L
MK]JYOV>-!TW2?#UFFK^/->)33;-U+K"N0OFNHY;YB%5?XCGL"*\KT7]E']H_
MQ]I<?B#Q;^T#K'A3Q!<*)1HVEF7R(<C(1_)FBC5AT(5&'N:5.CSP]K-\L=K]
M_1+>W4=7$<D_90BY2WLNB\V]K]#[EHKP/]EO3?CGH*^(M'^+U]INL65A*D.E
M:M 0;B[&,LQ*@ QX( +J'W;LY'->^5G4@J<K)I^AM2J.I'F<6O)A11161J%%
M%% !1110 4444 %%%% !1110 445Y5^TE^T%I?[-GP\7Q5JNEWFKI+=I8PVM
MFR*3*R.PW,Q^5<(<D GD<&FDVTEU$VHIM[+7[CU6BOR\\&_\%#?BC\6_VB?!
M6F64]IX6\*:CK%I93:-:VT5PTD+RJK!YY$+EB"1E-GL,\U^H==5?"U,/&+J=
M?T.+#XREBI2C2UY;:^O;KT"BO$OVMOVCK;]FOX6RZXD,=[KU])]DTJSESL>8
M@DN^.=B 9..O R,YKYV\)_LY_M)_%SPI!XXUSXZ:OX1UW48A>6GA^V,T=NBL
M-T:RK%(B1DC&5$;X!YR<BII4>>+J2?+%:7\_)(TK8CV<U2A'FD];*VW=MZ(^
M]J*^1/V._P!IWQ7XF\:^(/A#\5@B_$'06D\J]5%3[;&A =6"@*7 (8,H 9#G
M&02WUW4UJ,J,DGJFKIK9I]450KQKQ;2LT[-/=-=&%%>/?M4?M 6/[.OPFU#Q
M#(8YM9N/]$TFS8_ZZY8'!(_NJ,LWL,=2*^</V _VC_BM\7/BYXL\.?$37GU&
M+3-+:86<FGVULT,XGC0Y,4:MD!F&"?UJZ.'G6A.I':/_  ^G]=3.OBZ>'G"G
M+>7;S=E?^NC/O"BBBN4[ HHHH **** "BBB@ HHHH **** "BBOG+]K;]LG3
MOV6UTFR?PY=>(-8U:"2:U19U@MT",%)=\,V<L. O/J*J,95)*$5=LB<XTX.I
M-V2W/HVBOSS_ &+_ -L;XF_'S]I"?2/$FK6R>')M/N;J/1[.RACBA9=FW;)M
M,IQD_><YS7Z&5T8C#SPSC&INU?\ K[CGPV*IXJ+E3V3M_7WA17C'[47[36E_
MLP>#K#6]1T:\UR;4+AK6UMK61(U\P(7^=VSM7 ZA6/M7QK\$?V]?BC\:OVHO
M".CS7EIH?A+4KPP2:'9VD4BF,1NPW3.AD+9 R591QP!58?"5<3=P6BZD8C&T
M<*U&;U?1'Z8T45\I_M+?$KXXZM\3K#X7_"7PX^BF\MA=3^,;Y%:!8\@.48AE
M0*2 <@R$D;5'!;FIP=2:A'=]]#JJ5%2@YRV7;5]CZLHKX:UK]D#]H?P]I,FN
M:%^T7KFM^)($\Y=)NY+A+65P,E%+SNAST&Z( ]\"O0?V'_VJM4^/6D:UX;\8
MV\=IX[\.,%NS'&(Q=1[BAD*#A75AM<#C)4@#.!U/#IQE*G-2Y=]_UW1R1Q34
MXQJP<>;9Z6]-'H_4^I****XCO"BBB@ HHHH **** "BBB@ HHHH ***^,?VL
MO^"A0^!'B_5? _A[PNVI>);2*,OJ&HRA;2(R1K(I5%.Z3 89!*<]S6E.G*K-
M4X*[,JE2%&#J5'9(^SJ*^-/^"=?[0WC[X^0^/9?'&N+K!TZ6S^QJMG!;B$2"
M8L!Y2*6'R+][)X^M?8]Q(T-O+(D33NBEA%&0&<@?=&2!D^Y K3$498:;ISW5
MMO-7,L+B(8NFJE/;5:^3L245\*12?M*_M:>*M8%GJ=U\#/ >GW4EFN(V6^E=
M&(."I5Y&!')5TC[ L0:YOXJ>%_VB/V+].A\<V'Q5OOB?X6@F1-3M=<$LFQ68
M ;DEDD(0D@;HW# D<8S6L<,M(RFE)VLM]]KM:(QEBI+FE"FW&-[O1;;V3LV?
MH?17$_!?XJ:;\:_ACH'C/2D:&VU2#>UNS9:"525DC)[[75AGOC/>OGK]L7]I
M[Q7X5\9>'_A%\*D23X@Z\4\R\**_V.-R0@4,"H<@%BS A5&<<@C%4*CJ^PM[
MU['0\125'ZPW[MKGUW17P3XM_9Q_:3^$_A2X\;Z'\=M7\5Z]I\)N[K0;@S26
M[*HRZQ++(Z2$#. 8TSVP<"OHC]D?]I"V_:6^%L>MO!'8Z_8R?8]6LXL[$F"@
MATR<[''(ST.X9.W)UEA[0<Z<E)1WM?2_Z>9C#%7G&G4@XN5[7MK;?;KY'MU%
M%%<9W!1110 4444 %%%% !1110 4444 %%%?G;^T=_P4[U/0]6U[PG\/O#QT
M[4;"ZFL)=<U8I(R/&[(S10#*]5R&=B/5*VI49UY<E-79A6KT\/#GJNR/T2HK
MYX_83^*WBGXR_ 6'Q'XQU3^V-9;4KFW-S]GB@^1"NT;8E5>,GG&:]F^('B2^
M\'^"=:UO3=$NO$=]8VKSPZ59%1+<L!D*N?Z9.!P"< JO3>'FX3Z!AZT<33C4
M@M&=#17P;X3^'O[3/[55J?%7B'XC7GP<\.W?[S3=)T>*2.X\O^%F1)(WVD=Y
M)"QZA0"*YSQ?X\^.7[!?C'0KCQ=XPN/BG\.-4G\F2>_+-< CE@&D9GCD"Y91
MO9& .>>G6L)>2IN:YWT_2^USD>-M%U53?(NOZVWM\MC]%:*I:+K%GXAT>QU7
M3YEN;"^@CN;>9>CQNH96'U!%?$WQ>^//Q-^//[0E_P#!?X.:K'X8LM)#C6O$
M>/WJ["!*5;!*JK,J )AF?^(+S7+3HSJ5/9K1J][]$M[G54KPI4U5>J=K6ZM[
M)>I]S45\!_$;X,_M$_LS^&;KQ]X<^-NJ_$*#2D^TZCI.M)*ZF <N526:4, .
M3@HP&2#FOJ[]F_XV6G[07PCT;QC;VZV5Q<!H+VS5MP@N$.'4'T/##/.UA6LZ
M"4'4IR4DM'Y?)]/,RIXARFJ=2#BWJMM?FNOD>G4445R':%%%% !1110 4444
M %%%% !1110 45F>)M>@\*^&]5UJZ226VTZTEO)4A +LL:%R%R0,X'&2*_,7
MXT_\%3/&7B>06GPXTV/P99H^3J%XL5Y=RCL-CJ8XQZC#GT85T4*%3$2Y::VW
M\CEQ&)I86"G5>^WG8_4VBN'^!OB34?&/P7\":]J]Q]KU74]#L[R[N-BIYDLD
M*,[;5 49))P !Z"H/CMXL\7^"/A;K>M>!O#B>*?$EK'NM].9FRPS@L$4;I"H
MY\L$%L8!S6=2FZ=1TWNG;]#6G456FJBV:O\ J=_17PWHG[-'[2WQ<L5U_P <
M?'+4_ %_<#S(M%T(2 0*>0D@@EA12/JY]3FN7T+X^?%S]D#XY:-\/_BUKX\;
M>#M7:,6NM3#=-'&[[!,)"-YVMC>CEL ?*>A/9'"<\O9PFG/MK^#VN<,L;[./
MM9TVH=W;3S:O=(_0RBBOA3XF?M(_$W]H;XU7_P */@1>0Z+I^EEUU;Q3(!_"
M=KLKD-L0,=HV#>QY!"YKDI4I5I<D?7R2[L[:U:%"'//TTW;?1'W717PSKG[+
M/[27PUTU_$/@WX^:QXSUJW7S&T;6#+Y4V.2D8GFEC8^@95'N*^Q?A])XEF\$
MZ+)XQBL8/%#6R'4(]-+&W6;'(3))_4C.<$BM*E*$8\T)J7WW_'H9TJTYRY9T
MW'KT:_#KY'0T445S'4%%%% !1110 4444 %%%% !1110 45Y_P#';XRZ9\ _
MAGJ?C35[&[U&SLFBC-M9;?,=I'"+]X@ 989/IV-?G-XB_P""EGQ/^(/Q(T*W
M\,FU\$Z!)>PP/91017DTR-(H/F2RQGG&<;%3&>_6NS"X2KBY6IK3:_0X,7C:
M."C>J];7LMVC]6:***XSO"BO#OVO/VB8/V=?A3<:G;%)O%&I$V>C6C#=NG(Y
MD*]U0'<?4[1_%7B'_!/G]H7XG_&+QMX[T?XB:ZVJ-HUO"([=[&VMV@E\UT<'
MR8U)/RXYSTKJI8>=:$JD=H_C;>WI^IR5L53HU(4I;R_#U]=?N/N"BBO/?CU\
M9=)^ OPOUCQ?JQ#BU39:VN<-=7#<1Q#ZGJ>P!/:N7T.OS9Z%17YX_L4_M4_%
M[XL?M$MX:\<Z]Y^DR:7-?KIO]G6T 3(C>(ADC#XVN,98Y!&<U^AU=6(P\\,U
M&?57T_KR./#8J&*BY4[V3MK_ %YA1117*=@4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'D?[6WB:X\(_LU_$34K60Q7*Z3+!'(O53+B+(]_GKR;_@F+X9@T
M7]F.WU%%'GZQJEU=2MCD[&$*CZ 1?J:[O]NRQ?4?V3_B%''U2TBF/&>$N(G/
MZ*:P?^"<MXMU^R3X2C7K;SWT3<YY^U2M_)A7?0TPM9K>\5\M_P SS:^N+HI]
M%+]#5_;X\+P^*/V5/&ZR+NDL(8M0B;&2K12H21_P'</QJG_P3U\43>*/V4_"
M/VB3S9M/:XT\L3D[8YFV#\$*#Z 5U'[9ETEI^RW\27<X#:3)&.<<L54?J17G
M7_!,VSDM?V5]-D?[MQJ=Y*GTWA/YJ:='_=*L>EXOY[?D%;3&49+=J2^6C_,^
MK****\\](**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RK]J7X;Z
MC\6_@!XS\*Z2 VJ7MF&M8R0/,ECD654R>!N*!<^]?.__  3W_:1\,6GP[T_X
M2^);F/PSXRT*XGM8K/4?W'VL-,S[5+8'FJSE3&?F.,C/./H+]J#X_67[./PH
MOO%$\*WNHNXM--LG; GN6!*AN^U0&9L=EQU(KY@\(_L$S_M%>$+CXA?%KQ'J
M%IX_\3JE]"--ABBBL8BG[I)(MGSG;M)&5(P!G()/HX7E]C457X&UZ\WE\M_\
MSR\7S>VINC_$5].G*][]M4K>?D2?\%!+A/C=\5OAC\&O#1%[XB-\UY?-#\WV
M*)U4 N1TP@>0CL%4]Q7WG#'Y,2(#D*H7)]J_+G0+'QK_ ,$U?C%'J/B33['Q
M=X,\1%;.37H8?](,2G)".WS12 88Q$E'"C!)&Y?T_P!*U2UUS2[/4;&=;FRO
M(4N()HSE9(W4,K#V((-/$04*%.--\T=7?S=KJW2R2L3A9NIB*DJJY9V2MY+K
M?K=MEJBBBO-/6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K$\<?\B5X
M@_[!]Q_Z+:MNL3QQ_P B5X@_[!]Q_P"BVK*K_#EZ,VH_Q(^J/A3_ ()%?\BW
M\2_^ONQ_] FK]!'<1HS,<*HR37Y]_P#!(K_D6_B7_P!?=C_Z!-7WWJ\;S:3>
MI'Q(T#JO&>2IQ7KYQ)QQ%22Z)?\ I*/ R-<V#II]Y?\ I;/SV_8#A'Q:_:A^
M+?Q1U/\ TB6V9UM9)!Q']HE<*1GIMBAV?1C7W%8_&?X?:GK@T6S\=>&KO6"_
MEC3X-7MWN-_]WRP^[/MBOR__ &&O@OXD^.DGC3PI)XENO#W@%)X)O$"::RQW
M>H2?O%B@#$'"?ZQFR". ,$XQ];?$G_@FC\)-:\$WMKX3TNZ\-^(HX&:TU!=0
MGG#R@?*)4E=E*D]=H4\\5T8V-&G.,:DGRQBDK*]E;=_CHNAE@IUZD)SIP5Y2
MDW=VUOLM^EKMV5]#Z\HKXQ_X)H_&C7_'G@;Q+X-\3WDM_J7A.XBC@N+E]\OV
M>3>!&S'EMC1, 3V8#H!7V=7G8BB\/4=-N_\ D]4>IAJZQ%-5+6>S79K1A111
M7,=04444 %%%% !1110 4444 %%%% !1110 445YY\=OC9H'P"^'>H^*M>F7
M$*E+2R#@27DY!V1)[D]3V )/2CT#;5GQ-_P4NNH_&GQR^$W@O1P+CQ$I^98^
M70W$\:Q*<=.8V;Z8-?HTJE5 )R0,9]:_/S]AGX2>(/C1\5-6_:(^($;-)<SR
M'189!\KR$&,RJ#TCB4>6GJ<G^')^H_VK/C]:_LZ_"'4?$9"S:Q.?L6DVS#(D
MNF4E2W^RH!8^H7'>O2Q*=*E2PBUE&[?K)[?(\G"R5:M5QKTC*R7^&*W^>Y\]
M?MJ?$76_CA\2=&_9S^'\VZZOI4F\17L9RD$8PXC<C^%%Q(WJ=B]217EW[1W@
M'2_A3^UA^S?X-T./RM)TA-)BBR &=CJ3%Y&QU9VRQ]R:U?V+/CO\#_@UH&K>
M*O&WCX77Q,\33-/JD\FE7TK6Z%RPA#K 5)+?.Y4X)*CD*#7#_M1_M$_#WXC?
MM;?"GQIX>\0?VAX:T-M/.H7WV*XB\GRKYI9/D>-7;"$'Y5.>@R>*]+#TIT,1
M1HJ+LFW)V=G+E:W[+9'F8BM2Q&&K5Y27,TE&-U=1YD]N[W?_  #]6Z*X/X2_
M'+P1\=-*OM2\#ZW_ &W964PM[B7[)/;[)"H8#$J(3P1R 17>5\]*$J;Y9JS/
MIH3C4CS0=UY!1114%A1110 4444 %%%% !1110 4444 %%%% !6/XH\8:%X)
MTN74O$&LV.B6$0W/<ZA<)"@_%B*V*^0_C1_P39\%?%WQ?K_BM?%.O:1KVL3M
M<R9\B>UC<@#B/8K8XZ&3/O6E-1E*TW9>ES*K*<8WIQN^U[?YGB?@.>3]J[_@
MH4/'OA6VF?P7X;DB>356B*HZPQ%8^H^]))T4\[ 3C@U^E%?GS\'?B]XS_8U^
M,>C?!#XAQ:7J'A#4GC32-:TVR2U*>:VR.1MBJ'!<;9-^7!.=[ <_H-7=BU:%
M-4_@2T??O?S[KH>?@6W.JZFE1O5=M-$M[JVSZA7YR?MK7D?C[]N+X1^%]#_?
M:QITEBMT\7)B+7/FX..1LC&\^@:OL3]I3]H+1/V<_AM>>(M2>.XU*0&'3--+
M[7N[@CA1WVCJS=@/4@'YE_X)^? [7/$WB;5OC]X_$DVN:XTC:2MPN&VR<27(
M'\((_=H/[NX]"II8%>SG];E\,/QDU9+\=1YA+VD/JD?BJ6^44TV_PLNY]XT4
M45YQZ@4444 %%%% !1110 4444 %%%% !1110 4444 <?\7/BAHWP9^'FL^+
M]=EV6.G0EQ&" \TAX2)/]IF( ^N>U?"_P3^&VO\ Q'\$?%S]I#QVF=:U?0M3
M70+>1<BWA^SR*95!Z*%'EIZJ'/.X&L']K#]H#PA\</VCM*\ ^)_$K>'OA1X5
MO&.J72033-?729$B*L2,WK$K8 &9&YX%>Y_$S]M[X ZA\%_%/A?P[XPC66;0
M;K3M/L8=&OHD!-NT<4:Y@"J/N@9( KT8T:E/#2G"+<JB:5EM'_.7Y'EO$4:F
M+C3J32A3:;NTKR_RC^?>QE_\$G_^2 ^)/^QEF_\ 26VKB/\ @I7-+XP^-7P:
M\"/(5L+N8-(@Z%I[B.'/X*I_,UE_\$X?VDOAS\*_AK?^$O%/B+^R_$&J^(C)
M9V?V&YF\U9(H(T.^.-E7+J1R1C&3QS6A^W<ATK]M/X&ZM)_J/,T\<\#]WJ!8
M\_\  Q7J3@_[6IR:T;T\[0_0\FG.+R>I&+U2U[J\_P +H_0Z"&.UACAB18XH
MU"(BC 4 8 %?GC^VI_Q;C]N+X.^,K0^1)>&S2X8?+N"7)C?)]XY-OTK]$J_.
MS_@I IU3]HKX)Z9#S<.Z #/]^[C5?U4UY67ZXVDGU;_])9Z^9KEP%:RV2M_X
M%$_1.BBBO//3"BBB@ HHHH **** "BBB@ HHHH **** "BBJNJ:G:Z+IEWJ%
M[,MO9VD+SSS-T1%4LS'Z &DVDKL:3;LCQ7]L']HJW_9U^%%SJ-NZ2>)]3W6>
MC6K#):8CF4CNL8.X^IVCO7QG\0?V>[WX,?L)>)_$7B8/)X[\7ZC8WFJ27',L
M,9G#I"Q/.[)WO_M''.T50T']HSX<?&K]JJZ^(_Q7\1C1O"?ALA/#.AS6-S<B
M8JQV2.(HW P1YC X)8H.0IKT7]N+]KWX2?&#]G[4_#7A'Q9_:^MS7EK+':_V
M;=PY5) S'=)$J\#WKVJ=&K0C3BH/FE*+D[;)232_67W'S]7$4<1*I*4URPC)
M15UK)Q:O^D?OZGTY^Q1_R:M\./\ L&_^U'KYU_X*'>&]<\!_%WX8_&RRTYM5
MT7P]+;P7T2CB)H[@RINXX#[V4-T! ]17??L,_M)?#G5/A=\/?AI;>(O-\;16
M#Q/I?V&Y&&3S)&'FF/R^%!/WOUK._:D^,7B?XH_%NT_9U^'$MO:WFI0_\5'K
M$\*S+:VS)N>,*<@8C.2>I+(H())I3C5IYCSQCKS2:OM;6[]+=?SV*IRHU,K5
M.<M.6*=M7?2RMWO;3\MSZ(^&W[0'@+XK^"I?%/A_Q'9S:9;0&>]6:01RV( )
M83H3F/&#R>#C()'-?*?[$-A/\4OVGOB_\9K&&2W\+7DDVFV$CKM%RSRQON ]
MDB0GT,H]ZR_B?_P2GTV/P_Y_PX\67UKK4=OY<MIK3*T%X< -AXU!BW<G!#C)
MQP*ZG]@W]H34+74I_@-XVT&V\-^*?#<3QV0MH5A6X6/F1'5?E,N"7WKQ("6Z
MC+.$*256IAI7=FK/=)_$_/9>G452I6DZ-/%QLN9.ZU3DOA7EN_7H?;5%%%>,
M>\%%%% !1110 4444 %%%% !1110 4444 %%%% 'YK? CXI^$O 7[<7QS\7>
M+_$%GH6FP_;K2*:\D(:5OM<8"QI]YVVQ$X52<"OL#P/^V9\%OB-K$>EZ'X^T
M^2_D8)'#?1361D8G 5#.B!F)Z 9)JII_[$OP=M/'VM>+[GPC!K&IZI,UQ+!J
MSF[M8Y'):1DA?*Y9B2=P;'\.T<5Y?^V)^Q1\/O$7PDU_Q#X3\,V'A;Q+H=G)
M?PMHUNMM%<I&I9XGB0!3E0<, "#CG&0?1=7#SC3C4O[L4KZ:6_,\J-'%4YU9
M4N5\TG*SOK?IY?B?8E?G5^RS$/C5_P % ?B9XXU%?M,6@FZ%D7Y$;"06L./I
M$LGX\U[;_P $Y?B[JOQ4_9_%MK5T][J?AZ];2_M,S;I)(0B/$6/<@.4R>H05
M\<_LK_"GQ9\7_C%\3_!MEXEN/#'AF>[=_$UU8$1WEQ$D\H6WC/.W>S-NXQA>
M<_=;HHT'AZ]6#>JB]?)VU^[_ ".;$8A8G#T:B3LYK3S5]/O_ ,S]//\ A='P
M^_MS^Q?^$[\,_P!L[_*_L_\ MBW^T;^FWR]^[/MBNRKY.\5_\$S_ (,ZMX0N
M-.T;2K[0]:\DK!K"ZC/,XD X9XW<QD$]0%7C.".M<5_P37^*WB2>X\;?";Q3
M?/J%SX3D_P!!>60NT4:R-#+"&/)17";?0,1TP*Y%1IU(2=*3O'5IJUUW6KV.
MUXBK2G%5HI*3LFG>SZ)Z+?R/N:BBBN$]$**** "BBB@ HHHH **** "BBB@
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MRYP/4]N%G%*K2D[<Z5GYIWU]3S\9";=*M!7]FVVNZ:MIYH^S/B-I.G:]\/\
MQ)IVL&%=+NM.N(;IK@@1K&T;!BQ/  '.>V*^+_\ @DSXGN+KP#X\\.22^;;:
M;J<-U!SD#SHV5L>V80?Q-;]U\.?VB/VAM/DM?C+=Z/\ #GP#;@S:EHOAN0-<
MZFB?-L:1990J'!S^\_X >"./_P""2NGE='^)U_$A6REO;.&$G_969B,^P=?S
MKIHTU3H8A.2;M';6WO=_/4Y*]:57$89J+2O+?1N\==.RLM7U>AF^'81\</\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#F_B3X+M_B-\/_ !'X7NCM@UC3Y[)F_N[T*AOP)!_"OB?_ ()P
M_%"+X<WGBOX(^,94T7Q)I^J23V,%VX3SF("2PH3U8% X Y8.2.!7WY7B'QW_
M &.?AI^T->+J/B/3;BRUQ4$?]L:1,(+EE'17RK(^.@+*2!P"*ZL/5C3YX3^&
M2L_*VJ:_4X\31E4Y*E/XH-M7V=U9K_(\5_X*5_&:QA^'EK\*M#N%U/Q9XCO(
M%FT^S;S)8H5<,H95Z,\@0*IY.&KZ3_9V^&;?!WX)^$/"$NTW>G6*BZ*]/M#D
MR2X/<;W:N#^!_P"PS\+?@/KB:YH]C?:SKL6?L^I:Y.L\EOD8/EJB(BG_ &MN
M[KSS7T%5U*E.%'V%)WN[M[7=K*R]#.G2J3K_ %BLK-*R2ULKW=WW;_ ****X
MCT HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /C/_@J-\/\ 5_%G
MP/TG6M+@DNH?#^I?:KV*,$E8'C*&4@=E.W)[!B>F:]S_ &<?CUX4^.7PYT>_
MT+4[9]1BM(DO]*\T?:+24* RLGWMN0<-C##D5ZI<VT5Y;RV]Q$D\$JE)(I%#
M*ZD8((/!!':OEGQY_P $T_@QXVU:2_MK35_"KRL7D@T&\1(23Z)+'($'LN /
M2NRE4@Z3HU=%>Z:Z:6V['!6I5%55>C9NUFGI?6ZL^_X'FW_!3KXJ>']>\&:%
M\,]&N(==\87>KQ7!L;$B:6V"JZJK!<X=VD "]2,\=*^OO@EX3O? ?P>\%>'-
M2;=J&EZ/:VEQ\VX"1(E5@#Z @@>PKS[X*_L4?"OX$ZI%JVAZ--J6NPY$6K:S
M-]HGBSW0 *B'MN50<$C/->[TZE2G&C["EKK=M][6T7H%.E4E7^L5;)VY4EKI
M>^K[W"BBBN([PHHHH **** "BBB@ HHHH **** "BBB@ HHHH *\E\=?M!?"
MU?#/B&Q/Q)\("]%G<0FV.NVOF>9L8;-OF9W9XQUS7K5?/>I?L!? 75M0NKZ[
M\">;=74K32R?VQ?C<[$EC@3X&23TJXQISO&JW9KH9RE5A:5%)M/K_P  ^5_^
M"7/Q.\'?#_0/B%'XI\6:'X:DNKFR:!=7U*&U,H5)MQ02,-P&1G'3(K]%_#/B
MS1/&FDIJGA[6-/U[3)&9%O-,NDN868'# .A*D@]>:\(_X=Y?L_?]"!_Y6=0_
M^2*]B^&?PO\ #'P?\*0^&O".F?V1HL,CRI:_:)9L,YRQW2,S<GWKT,96H8F;
MJQO=V[6T27<\S+\/B,)35&=G%7VO?5M]O,^%OA7J]K^Q?^VMXR\->)Y1I/@K
MQH#<:?J=P0ENF9&DA+,> JEY8B3T)!.!S7VY\4_C#X8^$?@&^\6:YJMK!I\,
M#26X\U2UV^W*1Q#/SLQQC'UZ<TWXN?!/P9\<O#HT;QEHL.JVT;%X)<F.:W8_
MQ1R*0RG@9P<''((KY_\ #G_!+_X,:#K:7]RWB+785;<-/U+4$%N?3/E11N1[
M;OK63G2Q$(JJW%Q5KK6Z6WH[?(VY*V'J3E1BI1D[V;M9O?IJOQ_,XW_@EOX)
MU8Z+X^^(FIP-;P>)KY([3(P)!&TK2NOJN^7:#ZHWI7W7572]+LM#TVUT_3K2
M&PL+6-88+6VC$<<2*,*JJ.  .PJU6>)K*O4<TK+1)>25C;"T70I\LG=ZMOS;
MN%%%%<IUA1110 4444 %%%% !1110 4444 %%%% '*?%#XG>'O@_X)U'Q3XG
MO5L=*LDR3P7E<_=CC7^)V/ '].:_,O1_%%I^W)\<W\3_ !2\7Z-X)^&^AR8M
MM)U'5H;5GC)!$$8=U)9\ R2CZ#'RX_2GXK_!CP;\<-!MM%\;:/\ VUIEO<"Z
MB@^U30;90K*&W1.I/#-P3CFO*?\ AWE^S]_T('_E9U#_ .2*[\)5I4&ZD[\W
M31:>>^_]=SS,;1KXA*G3MR=4VU?RT6W]=CN])^/GP7T'2[33=-^)'@6QT^TB
M6"WM;?7K-(XHU&%55$F  !C KI]2T'P1\9/#MA<:AIWA_P <:"[?:;.6Y@@U
M"U8X*^9&2&4G!8;A[BO'?^'>7[/W_0@?^5G4/_DBO</!/@O1OAUX5TWPWX>L
M_P"S]%TZ+R;6U\UY?+3).-SL6/)/4FLJCHVYJ;?-?K;_ #W-Z2KWY:L8J-NE
M_P#+8Y7_ (9M^$G_ $2WP7_X3UI_\;KX._:^^&OA'PS^VK\&]#T?PKHFE:+?
MOI@N]-L=.AAMKC?J#H_F1JH5\J IR#D<5^F]>=>-OV>_A_\ $;Q[H7C3Q%H'
M]H>)=#,1T^^^V7$7D^5*98_D214;#DGYE.>AR.*O#8AT:\*DVVEO]S(Q6%C6
MP\Z5-)2=K?>G^2.G\(^ ?#'@"UGM?"_AS2?#=M._F2PZ18Q6J2/C&YA&H!..
M,FMZBBN-R<G=G=&*BK)6"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH \6
M^,?[6?@;X%?$+PUX5\627=FVM1/,=26$M;6BAMJF0]<,V1\H.W&3@'->K:7X
MHT?7-&35].U:QO\ 2G3S%OK:X22 K_>#@[<>^:Q?B5\)_"'Q@T$Z-XQT"SUZ
MPR61;A2'B8C&Z.12&C;'=2#7S-J7_!*_X.WVH/<0ZCXKT^%FR+6VU"$QK[ R
M0,V/JU=--490M-M2[[I_+0Y*CQ$9N5-*4>U[-?/6YX=^U=XJT_\ :H_:[^'?
M@_P#<+K*:0Z07.J6+!XE)E$DSJXX*QHN=PXSD#-??GQH^,WAOX$> [WQ3XFN
MO*M81L@MHR/.NYB#MBC!/+''T !)P :SO@O^SA\/_@#8S0^#=!CL;FX4+<:A
M.YFNIQQPTC9(7(!VKA<\XJ]\7/@3X&^.VGZ?8^.-#_MNUL)6FMH_M<]OL=A@
MG,3H3QZYK2K4IRA3H0ORQOKUU=W_ , QHT:L:E7$3MSSMIT]U65_U/SC^&VH
M:9^V-\;)_B-\:_&GA[PSX-TF81V7A_4M7@M_. .Y;=$=U;R^ADD(RYX'?9^A
M]K^T1\';&UAMK;XF>![>WA01Q0Q:_9JB*!@*H$F  !C KS[_ (=Y?L_?]"!_
MY6=0_P#DBC_AWE^S]_T('_E9U#_Y(KIK5L-548+F48[))?Y[LY:%#%T7*;Y9
M2ENVW]VVB78^@M,U2SUK3;74-.NX+^PNHEFM[JUD62*:-AE71E)#*0000<$&
MK59GAGPWIW@[P[I>@Z/;_9-*TRVCL[2WWL_EQ1J%1=S$L<  9))]36G7ERY>
M9\NQ[,>;E7-N%%%%24%%%% !1110 4444 %%%% !1110 4444 >?WW[/?PLU
M.]N+R\^&G@^[N[B1I9KB?0;5Y)'8Y9F8QY)))))Y)-<'\;OV??A=I/P9\>7U
MC\-O"%G>VV@WTT%Q;Z%:QR12+;N5=6$>58$ @CD$5[Y6?X@T*Q\4:%J.C:G!
M]ITW4+>2TN8=[)YD3J5==RD$9!(R"#52G/E<5(F-.FIJ4HK?L?"7_!,#X8^#
MO%WP;UG6-=\):'K6KVGB21;?4-0TV&>XA"V]NRA)'4LH#$L,'@DFND_X*?\
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MH **** "BBB@#\X/^"ELS>)OV@OA#X5W,R,B$QC/6>Z6//\ Y#K]'E4*H &
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MFE^'O'/AO7M2=6=;/3-7M[F8J!DD(CDX ZG%>2?\.\OV?O\ H0/_ "LZA_\
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MM)M]*T73;/2-+M@5@LK"!((8@220J* JC))X'4FN*T/]GOP!X:^*.H_$73=
M^S>,M1$@NM2^V7#>9OQN_=M(8QG:.BCI7HM=%>O[6%*"O[L4GZJ^IRX?#^QJ
M59M+WI-KR3MI_6@4445QG<%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% &3XG\7:%X)TMM3\1:UI^@Z:KK
M&;S5+J.VA#'HN]R!D]AFL+PW\:/A[XRU:+2O#_COPSKFJ2AFCLM-UBWN)G"C
M+$(CEB  2>. *\Z_;D\)#QA^RSX]MMF^6TLUU&/ Y!@=9#_XZK#\:_+G]B'Q
M$/#'[5'P\NF?8DU^;)O?SHWB _-Q7IX+"1Q49W=FMONT_'0\C'XV6#G3LKQE
MO]^OX6/V[FFCMX7EE=8HHU+.[D!5 &223T%</I/Q[^&6O:G:Z=IGQ%\)ZCJ%
MU(L5O:6FN6LLLSDX"HBR$L2>@ S7.?M<>./^%>_LW^/M867R;C^S)+2!LX/F
MS8A3'OE\_A7XC>"O$T_@OQCH>OVI(N-+OH+V/']Z.17'\J> P:QCES.R5O\
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M)E8892.0.E>/AJ<*M7DJ2Y59Z_<>]BJLZ-%SI1YG=:'WS_PTE\)/^BI>"_\
MPH;3_P".4?\ #27PD_Z*EX+_ /"AM/\ XY7XK?%[X ^/?@/<:9!XYT'^PY=2
M21[5?MEO<>8J%0Q_<R/C&Y>N.M3?"']G7XA?'B/5'\"^'_[<73#&+L_;;>W\
MLR;MG^ND3.=C=,]*]I9;0E#VBJ>[WTMVW]=#YYYMB(S]FZ7O=M;]]O34_;;P
MW\:/A[XRU:+2O#_COPSKFJ2AFCLM-UBWN)G"C+$(CEB  2>. *L>+/BSX'\
MWT5CXF\9>'_#E[+'YT=OJVJ06LCQY(WA9'!*Y!&>F0:_/S]B7]C[XN_"+]H;
M0O$WBWPE_9.AVUO=)+=?VE9S;6>!U4;8YF8Y8@<"N8_X*Q?\EU\+_P#8NQ_^
ME,]<,L+2^L4Z-.=U):O33?\ R_$]&GC:_P!5JUZM/E<&K)WU7NZ_B_N/TX\)
M^._#7CZRFO/#'B'2O$=I#)Y4MQI-[%=1H^ =K-&Q ."#@^HK=KX<_P""3/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\C%\-/\ KUO_ /T."MG_ ()$?\>/Q._ZZ:?_ "N*QO\ @KM_R,7PT_Z];_\
M]#@K9_X)$?\ 'C\3O^NFG_RN*^CP_P#R*9_/_P!.'RF*_P"1U#_MW_TV?HC7
MY5?\%8O^2Z^%_P#L78__ $IGK]5:_*K_ (*Q?\EU\+_]B['_ .E,]>5@?][I
M^K_])9[>9?[E6]%_Z5$]R_X),_\ )%_%W_8?/_I/%7W'7PY_P29_Y(OXN_[#
MY_\ 2>*ON.MLS_WN7R_])1CE7^YP^?YL\\^/WQ@L?@3\)]>\97L:SM8Q;;:V
M8X\^X<[8H\^A8C/H 37XLZCJWC_]JCXN0K/+<>)?%FM3^5;PEL)&O+;$!.V.
M-!D]@ "3W-?H+_P5DU*XM_@WX1LHY"MO<ZYNE4?Q;()-N?\ OHUX#_P2ITRW
MO/VA-9NIHP\UGX?G>%C_  ,TT*DCWVDC\379ED(PI5,2U=J]ODK_ (O<\W-J
MDJE:EA4[)VOZMV_#IYW.$^+7[(OQB_9=\)W>NW5S;3^']1@-CJ<^@7<DL21R
M8'EW".B$J3C!P5# <@[:YS]B+_DZSX<?]A!O_14E?J3^W-_R:C\0_P#KRC_]
M'QU^6W[$7_)UGPX_["#?^BI*[,OQ4\5&;J+5?EN<688.GA)TE3;L^GGI^9^@
M?_!47_DV9/\ L-VO_H,E?)O_  2S_P"3EKO_ + %U_Z,AKZR_P""HO\ R;,G
M_8;M?_09*^3?^"6?_)RUW_V +K_T9#7'EO\ NF(_[>_](1WYI_O^'](_^EL^
MR/\ @I;_ ,FIZU_V$++_ -'"OB#_ ()G?\G4Z7_V#;W_ -%U]O\ _!2W_DU/
M6O\ L(67_HX5\0?\$SO^3J=+_P"P;>_^BZ>6_P"Z5_\ M[_TA$9M_OV&_P"W
M?_3C/J__ (*N_P#)!O#O_8P1_P#HB:O@CX/_ +0'BOX:_#CQ?X(\(?:XM8\6
MW=I&EU8Y,Z(HE5TB"_-YDA>-05YQG'.*^]_^"KO_ "0;P[_V,$?_ *(FKYB_
MX)=^']/UO]I6:YO;9+B;2]#N;RT9QGRIO,ABWCWV2N/QJLN47A*O.KJ][=[)
M/]!9IS_7J/LW:5DD^UW)?J6_V:OV'_BUIOQH\ ^(O%7@R?3?#EOJ46H7%Q<W
M=N701YD7?$)#(I+*HP5SSS7T-_P48^'GQA\777AF/P)?ZYJOAO4R=/N_#VE9
M15GY822E -T;+G/F$JI3MFON.O _VG?VR/!_[,MM!:7\4VN^*+J+SK;1;1PC
M;,D"260@B-"00#@DXX4@$CSYXRKB*M-\J;B]%W_K_@GIPP-'"T*BYVE):N^W
M]?CL? <?_!+_ .-#>&GU23_A'H;M8C)_8[:@S79(&=@*QF+=_P!M,>]>+? W
MXV>*?V;_ (E6^L:7-<6WV>X$.J:4[%8[J)6Q)%(G3(YP3RIY%?0VK_\ !2CX
MX?$?5FTWP5H.GZ;+(28+;2=-DO[O;[[RP8^XC'TKY \77>KZAXJUBZ\01RQ:
M[/>32WZ30""1;AG)D#1@ (=Q.5P,>@KZ+#O$2DUB4K-;?UT/EL4L+"*>%<KI
M[]/^'/V-_;,\#>)/CU^S?%8_#ZR;6-0U"YL[^WC2YBM]\&"V[?(ZKT8<9K\<
M/%/AK4_!OB35-!UFW^R:MIMS):7=OYBR>7*C%67<I*G!!Y!(K]WOV?V+? GX
M=%B23X=T_)/_ %[QU^+G[4/_ "<=\3/^QBOO_1[5YF7R='$U,-'X=7YZ61ZV
M:05?"4L7+XK17EJI2_,[7X;_ +$GQI\66GASQ/I7@S[5H=[Y%[;W7]JV2;X2
M0P;8TP8<=B ?:ON/_@JG_P FXZ7_ -C%;?\ HBXKW+]E'_DVGX9_]@"T_P#1
M8KPW_@JG_P FXZ7_ -C%;?\ HBXKGQ>)G5Q4*4EI">G_ ($E^AUX/!T\/A*E
M:+=YT]?_  &3T^\^6?\ @EG_ ,G+7?\ V +K_P!&0U]J?MU?M23_ +.?P^M;
M70'C_P"$QUUGBL6D4.+6)0/,G*G@D;E"@\9.2" 17Q7_ ,$L_P#DY:[_ .P!
M=?\ HR&G?\%2]3NKK]I&TM)78V]IH=L(4/0;GE9B/J?Y5V8VDJV-I4Y;-:_)
MR?\ 7D<.!K/#Y=5J1W3T^?*CR/X2?!#XE?MA>.-7FT^[_M/4(P)]2US7;I_+
MC+9"!WPS$G! 55/"G@ 5'\3_ (2_$K]CGXB::+V];1]7*?:-/UC1;IC%,H(#
M;'PIX. RLHZC(P1G[W_X)1Z7;6_P%\0WR1@75UX@E263N52"':/H-S?]]&L_
M_@K-I=M-\(/!^H/L%W;ZV88R0-Q1X'+ >V8T/X"KJXR5'%QH12Y-%]Z_2_W&
M5' QKX*6)FWSZN_H_P!;?>>M_L2?M/-^TE\-9I-6$47B[176VU-(@%68,"8[
MA5_A#X8$= RMC Q7P/\ \%-/^3I]1_[!=G_Z :ZO_@E!JES!\=_$M@CD6MSX
M>DED3L62X@"G\ [?F:Y3_@II_P G3ZC_ -@NS_\ 0#6;HQHYC#D5DU?\'_D:
M_6)XC*YN>K32_%?YE'X?VOQJ_;3T'0_AOH5U!:>$O">GPV[^=*]O8KMXC>X9
M0S22'&%4 X"D@#YC7COQB^#_ (H_9[^(4WACQ%Y4&KVJQW,-U83%HY$;E)(W
MPK8R".0""IK].O\ @E_9P0?LQK-'#''-/K-TTLBJ TA 0 L>^  .?2OE7_@J
MM_R<-H__ &+\'_HZ:MUB7#&^P@DHN]_-VO<YY815,O\ K-23<DE;R5^6WZGW
M'^PS\8-1^-'[/.BZKK5PUWK>GRR:7>7+G+3-%@J['NQC9,GN<FOH"OBG_@D_
M_P D!\2?]C+-_P"DMM7VM7AYA!4\3-1]?O5SZ++9RJ82$I;_ .3:"BBBO//3
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M75L\#;XGB.X);JQ^5SC##G'TKZ \>^!](^)7@W5_"^O6_P!JTG5+=K:>,<,
M1PRGLP."#V(!KT<7F"E5IU*#TCNN^NOX?B>3@\L<:-2G72O+9]OZ?W['PA_P
M3&_:;^V6[?"/Q%=YFA5[C0)I6Y9!EI;;)[CEU'IO'8"O=/VLOVVM'_9FUG0-
M&@TQ?$>M7CBXO;%9_*-M:<C=NP<.Q^Z".BMG&0:YCP[_ ,$P?AIX3U[3]:TC
MQ;XXL=4T^=+FVN(KZT#1R*05(_T7U%>M?'3]D?X<?M"(L_B?2Y(=;CC$2:YI
MKB"\"CH&."KCT#J<=L5CB:N&JXB-57:^TOZ[]?\ @G3A*.+HX:5%V37PO?\
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M[1@NCJ/J[>V!4WPK_P""6/@'P?JD.H>+=>OO&\D+ATL_(%E:-CM(@9W;GMO
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HK*\3>+-$\%Z2^J>(=8T_0M,1E1[W4[I+>%68X4%W( )/3FN=T'XX_#CQ5
MJUOI6B?$#PMK&J7!(ALK#6K:>:4@$D*B.6. ">!T!JHQE+5*Y$IQB[2=CMZ*
M*XOQ'\:_AYX/U>;2M>\>>&=$U2$*9;'4M8M[>=-P#+N1W##(((R.0122<G9%
M.2BKMG:45GZ#X@TOQ3I-OJNBZE9ZOI=R"T%[83I/#* 2"5=2589!'!Z@UH4-
M-.S!-25UL%%%%(84444 %%%% !1110 44C-M4GK@9K\[KK_@KI]EO)H/^%4;
MO+D9-W_"1XS@XS_QZ5O1H5,1)PI*[7ZG/7Q%+#14ZKLC]$J*K:;>?VAIUK=;
M/+\^)9=F<[=P!QGOUJS6+3B[,WC)22:"BBBD,**** "BBB@ HHHH **** "B
MBB@ HK/\0>(--\*Z)?:QK%[#IVEV,33W-U<-M2)%&2Q-?#7CG_@K1X6T?6);
M;PKX'O\ Q)8QL5^W7M^M@),?Q(GER-M/;=M/J!6U*C4KOEIJYSUL12P\>:K*
MR/O6BO!OV4/VK;7]J71=;O;;PQ>>''TF2**;SKA9X9&<,0$<!22 O.5'WA7O
M-*K2G1FX5%9E4:T*\%4INZ84445D;!1110 4444 %%%% !1110 45\D_M:?M
M\6O[.'C*V\):9X9_X2+6C;I=74EQ=&WA@5\[%&%8NQ R>@ (Z]O2?V4_VG],
M_:@\$WNKVVER:'J>FW MK[3WF$RH67<CH^!N5AGJ 05(]">A8>JZ7M[>[W^=
MOS.5XJBJWU?F]_M\K^FQ[;1117.=04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'RQ_P4M_Y-3UK
M_L(67_HX5^17A;Q-J/@SQ)I>O:1<-::GIMS'=VTR]4D1@RGW&1T[U^NO_!2W
M_DU/6O\ L(67_HX5^9OP5^%8^+'A7XD6EI!YNO:+HZZ[9;02SK#*%GC'^]'*
M3CU1:^CRFHJ5"I-[*7_ML3Y/.J;JXFE3CNXV7KS2T^9^SWP-^+&G?&[X6>'_
M !CII54U"W!G@5LFWG7Y98C_ +K@CW&#WK\G_P#@HM_R=OXP_P"N5E_Z215Z
MA_P2^^/G_"(^/+WX;:M<[-*\0DW&G>8WRQ7JKRH]/,08_P!Z-1WKS#_@HPI7
M]K;Q>2" 8;(CCK_HL5*GA_J^9)1^%Q;7WK3Y%5,5]:RR3E\2LG]ZU^9^D'["
M/_)I?P[_ .O2;_TIEKWJO!?V$?\ DTOX=_\ 7I-_Z4RU^6'[9G_)TGQ)_P"P
ML_\ Z"M<LZ'UK,*M*]M9/[I?\$ZZ6)^IY70K6OI!=MXW_0_<FBO'?V/?^37_
M (:?]@6'^1K\J_V[O^3M/B)_U]0?^DT-<]/">TQ4L-S;7U]&EM\SLK8WV.$A
MBN6_-RZ7[IO?Y'[;45X+^PC_ ,FE_#O_ *])O_2F6OR;_:;F>W_:4^),J':Z
M>)+UE/H1.Q%53P?M,7+#.5N6^MNS2VOY]S.IC_9X*&,4+\W+I?NF][>78_<S
MQ!XETCPGILFHZYJMEHVGQG#W>H7"01+]7<@#\ZS_  G\1O"?CY9CX8\4:-XC
M$/\ K3I.H0W6S/\ >\MCC\:_*^V^%_QW_P""A5Q?>-9KFPM-$L2;>PBU"XDM
M[,,!\T=LBJY+=-SM@$G!;C ^<O#OB+Q5\!_B8M]83S:)XGT"]:*15;[LD;%9
M(GP<,AP5(Z$$UU4LMC)NG.I:?;L<=;-I02J0I-PVOW]/T[^1^]VO>(M)\*Z9
M+J.M:G9Z/I\7^LN[^X2")/J[D ?G6=X3^(_A/Q\)CX8\4:+XC$/^M.DZA#=;
M/][RV./QK\L?^$%^./\ P48UG5?%JRV.G^']-<PV5OJ%Q)#8Q-C)A@"HQ>3&
M-SD=QEAP!\VZ3K'BKX%_$S[39SSZ'XI\/7S1/L?!26-BKQM@X93@J1T8$]0:
M*.6J?N5)VGO;>WJ.MFTH)5*=-NG>U]K^G]?<?O\ R_ZM_H:_G>U7_D,7G_7=
M_P#T(U^_WP[\90_$3X<^'?%$$?E1:QIL%^(\YV>9&&*_@3C\*_ '5B5U>](Z
M^>__ *$:O*(NGBJL9]+7^]DYQ-5,)"<=F[_@?OI=>/O#'P_\,Z._BCQ'I/AM
M)+:-4;5[Z*U#$(,@&1ADUN>'?%6B^,--74=!U>PUO3V.%NM.N4N(B?0.A(_6
MOR3TW]B#X\_'[P[+\1]4GM9[W4H_M4,&N7SI?7D>,H478512/NJS(,8P ,5X
MQ\(/C!XO_9M^)2:OH\L]C>V4YM]1TN9BL=RJL0\$R=^X]5/(Y%"R^%64HJHN
M?MT7]=_P)_M2I1A"4J3Y'U[_ -=OQ/WGJ*ZNH;*WDGN)8X((UW/+*P55 ZDD
M\ 5SV@?$+1?$'PZL?&T=TL&@W6FKJOVB4X$<)C\PEO0J,Y^AK\?_ -H;]H[Q
MQ^UW\38]$TC[8VA3W@M=$\-VI($I+81Y%SAI&ZDMPN2!@9->90PM2O5=):6W
M\CU\1C:6&HJL]4]O/^O\C];]+^./PXUO5$TS3OB!X6O]2=MBV=KK5M),S>@1
M7))_"NWK\<O'7_!./XN^ ? -YXKNUT2_ALK<W5UIVGWCR7<,:C+D@QA&VC)(
M5VZ'&:]Q_P"":/[4NMZMXA;X5>*=1FU.WDMFGT.YNI"\D)C&7M]QY*; 64'[
MNP@<$ =L\#3E"4Z%3F<=T<%/,:D:D88FGRJ6S/T<HK\_/^"N7_(J_#G_ *_;
MS_T7'7Q[\//CGXTT_P"#-U\'_!<-^;[Q#K374S::&:XGC:&-!;QA/F^8H2V.
MH&.A:L,/@98FBZL'K>UOGW_$Z,3F$,+75*:TM>_WZ6^5M^I^R]K\7O E]XC'
MA^W\:^';C7B_E#2XM5@:Z+_W?*#[L^V*ZZOR]_8U_8M^*/@7]H+PEXH\:>$7
MTC0; 3W7GR7EM*1)Y+B,%(Y&93N8'D#&*_4*LL51IT'&-.?-=:FV#Q%7$*4J
ME/EL]+A6/XF\8Z!X+L1>^(=<TW0;,G'VC4[N.WCSZ;G(%>4?M>?M%1?LW_"6
MXUR".*Y\07LGV+2;:8$HTQ!)=@.JHH+'U.!QFOR=\'^#_B;^V9\5IK>.^F\0
M^(9XVN+G4-3G*P6L(/5C@[$!8 (B]\!:K"X26)O)NT5N_P ?RZD8S'1PG+!+
MFG+9?A^>R/VM\)_$KPAX]:5?#/BK1/$31#,@TG48;K9]?+8XKI*_#WXW?LT_
M$C]DO6M%U#5[F&$W#EK'7- NY"BS+R5#E4=' YY R.A.#C]"/^"?_P"UI??'
MOPU?^&?%<Z3>,=#C63[5@*;^U)V^80/XU;"L1P=RGJ3716P*5)UJ$N9+<YZ&
M8R=94,1#DD]C/_X*G>*KW0OV?--TRUD:.'6=9BM[G:<;HTCDEV_0LBG\*^,?
MV!?@#X9^/_Q>U#3_ !=#+>:)I>F/?/8Q3/#]H?S$C56="&"C>3\I!R!SC-1?
MMK_ _P"('@?XG>*_&7B/2)+3POK?B&Z_LR\:^@E$H=GD3$:2,Z909^91C&/:
MO)?A+\$?&OQSUJ\TGP1HO]MZA9V_VJ>'[5!;[(]P7=F5T!Y8# .>:]3+Z<88
M5N,M9:M]FXK\OD>+F=:4\;%2AI%V2_F2D]O7YG[>_"+X)>#O@5H=[HW@K2CI
M.FW=T;R2%KB2<^845?O2,S8P@X)/>NZKR/\ 9-\"ZY\,_P!GGP9X9\2V/]FZ
MYI]O*ES:^;'+Y;&>1@-R,RGY6!X)ZUZY7S=>ZJR3ES6=K][:7/K,*^:A"7)R
M72=NU]6NGY!61XF\7:%X+T_[?XAUK3M"L<[?M6IW4=O%GTW.0*_#?]IR1H?V
MDOB4Z,4=?$=\RLIP01.W->N>%OV;_CQ^VU;7'Q U+5+>6V;=':7?B"Y>".<*
M<%+:..-@J C&<*I.>20:]&.7IT85Y3M%I-Z;7MMW/+GF;C7J8>%.\HMI:[V>
M[[?B?K+X4\?>&/'EO+<>&?$>D^(H(CMDETF^BNE0^A,;$"MZOP+M+[QQ^S9\
M5I1!-<^&O%V@W7ERK&_<$$HV#AXV&..58'T-?ME\ ?BS;_'#X0^&_&<$2V[Z
ME;YN;=#D0W",4E0>P=6QGMBL\5@O8TU6IRYHO^E]YI@\P>(J2H5(\LU^F_S1
MW=Y>V^G6LES=SQ6MO&-SS3.$11ZDG@5Q"?M ?"^2^%FGQ(\(M>%M@MUUVU,A
M;TV^9G-?G?\ M-?LV_M _%K]H36?#ZS:QXPT)9%O-.O[V46^G6UO(3M'\,2N
MGS*0@WG;G!S7EWQI_8#^)_P-\#S^+-6?1=7TFV*_:O['N999+96( =U>)/ER
M0"5SC/IS3HX6C*$95*J3ET#$8W$0G*%*BVH]?\C]G8Y$FC62-E=&&Y64Y!!Z
M$&J/B#4ET?0=2OV("VMM+.<^BH6_I7Y:?\$V/VC-:\*?%*Q^&^IW\MUX7UT2
M):6\SEA9W04NICS]U7VE2HX)*GUSZK_P4R^!OC_X@:_IOBSP]H[WWA?0]#D;
M4KH7L$2P[)'D8^6\@9L+@_*I_.L<3@?9550G*T97][MH]_N[]4:X;,%7H2KP
MA>4;>[WU6WR?;HSX=^ MT]]^T7\/+F0DR3>*=/D8DYY-W&3_ #K]Z*_G?\.^
M'[_Q9X@TS1-*@^U:GJ5S'9VL&]4\R61@B+N8A1EB!DD =S7WY^PU^R)\6O@[
M\?[#Q)XO\)_V1HL5C=0O=?VE:3X=TPHVQ2LW)]J]_,*,*E./--1Y4[>>BT_#
M\3YS+,35A5E:#ES-7?;5ZO3SOTV/H+]JC]@_0/VEO$EIXEA\0W'A7Q#'"MM/
M<+:BZAN(USMW1ET(89(W!NG4' KT/]F7]FO0OV9?!%QH6D7MQJMW>S_:;[4;
ME0C32!0H"H/N( .%R3R>3FOS[_X*K?\ )PVC_P#8OP?^CIJ^C/\ @D__ ,D!
M\2?]C+-_Z2VU>5&G5^H.:G[O:W]ZV_XGM2JT5F2I^S][^:_]V^WIH?:]<9KW
MQJ^'OA;4VTW6O'?AG2-14X:TO]8MX)0?0HS@_I7PE_P42_;$UK3O$US\+O!.
MIRZ7!:(!K>H6;E)I)&&?LZN.54*1NQR2=N< @^%_"W_@GC\6OBUX)MO%5HNC
MZ-8WL?GVD.LW4D4]S&1E9%5(WP&[;RN1ST(-94,&ITO;UI<L7MY_UT[FN)Q[
MIUOJ]"'--;^7]==K,_8S3]1M-6LH;RQNH;VTF7?%<6\@DC=?56!P1]*L5^+O
M[/\ \;_&O[&_QJDT'6WN;;1X;_['K^@R2;XL9"M*@R5WJ,,&7[P &<&OT]_:
MZFCN?V6?B/-$ZR12:',Z.IR&! ((K+%87ZNHSB^:,MF;8/&?6G*$H\LX[H]E
MKFO%GQ-\'^ I(D\3>*]#\./,,QKJVHPVI<>H\QAG\*_##X,?&3Q%\"_%TOB/
MPNT*:M)936*//'Y@02@#<%Z%E(!&<C(&01Q7L7C_ /8J^-=U\.=2^+?BN6WO
M)I(/[2OK2]O)'U41$9,DBE-HPO)7?N &, C%=M3+8T9)U*EH]_/M^MSSZ>;2
MKQ:I4FY]O+OM\K'[ Z#XBTKQ5IL6HZ+J=GK&GR_ZN[L+A)XGQZ.A(/YU<NKA
M;.UFG<X2)&=C[ 9-?C)^P3\:-5^%?[0/AW38KR0:#XDNH]+O[(L?+=I#MBDV
M]-RN5YZX+#O7UC_P4L^!7Q ^*5YX<UOPGHSZEHNB:9=R:G,+V"$1*&5\E))%
M9_E5C\H/2N;%8'V-2--SM&5_>?2R>_X?>=6%S#ZQ1G44+RC;W5UNTM-/7IT/
MS\\'ZLVO?'K1-3;EKSQ+!<GG/+W2MU_&OWRK^=G2=+NM<U6RTVQB\^]O)DMX
M(MP7?([!5&20!DD<DXK[P_8Q_8Y^+_PG_:)\->)_%7A'^RM#LTNA/=?VG9S;
M"]O(B_)',S'+,!P.]>WCL/3E2A%SY>5.WGHM-_+\3P<OQ=6-:<HTW+G:O;IJ
M]=GW_ _34G')X%<-J'QX^&FDZB^GWWQ$\*6=^C;6M;C6[9)5/H5+Y!KX)_X*
M>?M$>(8O&L/POT:_FTW1;>SCN=4^SR%&O)),E8W(Y**N#MZ$MSG KQ'X/_L!
M_$SXU_#>U\:Z%<:#;:9>&3[+;ZA>2)/.$<H2 L3*!N5@-S#IZ8KQ</@XSH^W
MK2Y8GNXG,)4ZWU>A#FEU/V8L[R#4+6*YM9X[FWE7='-"X='!Z$$<$5-7Y[?\
M$^/V??C'\,_B+KK^)[G5?"7A33<Q3:+*ZR6^IW#*,-&/F3:HP3*G).%!^\!^
MA-<N)HQHS483YDU<[<+7G7@Y3@XM.VH4445RG8%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% 'RQ_P4M_Y-3UK_L(67_HX5\9_\$N;@1_M*75NPW1W
M6@7<3J1D$;X6P?;Y:^S/^"EO_)J>M?\ 80LO_1PKXL_X)?\ _)T$?_8%N_YQ
MU]!EJOA,0G_>_P#2$?,9H[8_#6_N_P#I;.,_:T^$&H?LP_M$3/HADL=.EN%U
MK0;J/_EDN_<$!]8W!7Z!3WJ#]LSQY9_%CXC>'O'-DH1?$'ARSNIHU/$=PADA
MF3_@+Q,/H >]?HW^WY\ _P#A=GP1N[S3K;SO$OAO=J-CM7+RQ@?OH1Z[E&0/
M[R+7XUO/))''&\C,D8(168D*"<D =N>:Z<OJ+$TX*7Q4W^#5OQT^:./,Z3PM
M2;BO<JK\4TW]WY2/VS_81_Y-+^'?_7I-_P"E,M?EA^V9_P G2?$G_L+/_P"@
MK7ZG_L(_\FE_#O\ Z])O_2F6OS&_;N\-W?AO]JKQVMU&R+>W*7T#$</')&I!
M'MG</JIKGH?\C6K_ -O_ /I2.BNF\EH6_N?^DO\ S/U1_8]_Y-?^&G_8%A_D
M:_*O]N[_ ).T^(G_ %]0?^DT-?7?[,/[??PP^'?[..A:)XHU"\M?$N@VKVHT
MV&RED:["LQC,<BKY8RI4?.RX(/;!/Y]_&#XC:A\7/B5X@\9:G MM<ZS<M<"%
M!\J(/D10>^U5"Y[[36U"C4CF-6JU[OO:^K37X(SQ6(I3RRE2C+WO=T[6BT[_
M #9^PO["/_)I?P[_ .O2;_TIEK\F/VH?^3COB9_V,5]_Z/:OUG_81_Y-+^'?
M_7I-_P"E,M?DQ^U#_P G'?$S_L8K[_T>U9X?_D:5?^W_ /TI%8C_ )$M#_MS
M_P!(9^PO[(]I!9?LR_#2.WA2!&T.VD*QJ%!9DW,W'<L22>Y)K\A?VM46/]IC
MXEA5"C^W+DX QR7)-?K_ /LH_P#)M/PS_P"P!:?^BQ7Y _M<?\G,_$K_ +#=
MQ_Z%48;_ )&E7_M__P!*1OCO^132]8?^DR/UU_9!TNTTG]F/X;Q6=O';1R:-
M!.ZQK@-)(N]V/N68D_6OR*_:X_Y.9^)7_8;N/_0J_7[]E'_DVGX9_P#8 M/_
M $6*_(']KC_DYGXE?]ANX_\ 0J,/_P C2I_V_P#^E1#'?\BFEZP_])D?KC^R
M'_R:W\-_^P)#_(U^'^K?\AB\_P"N[_\ H1K]P/V0O^36_AO_ -@2'^1K\/M6
MXU>]/_3=_P#T(UT8)VS'$/S_ /;I&&._Y%M#_MW_ -)/Z$_#?_(NZ7_UZQ?^
M@"OQ+_;2LX;#]J;XD10((XSJAD*J,#<Z*S'\68G\:^_O!W_!3+X2+\+[6^U2
M74=/\26MHL;^'TLY)9)954#$<P7R]I(X+,IQU K\RO%6M:Y\=/BUJ.I16;W6
MO>)M49XK.#YB9)7PD:_3(4?2LL#AZL,9.<HV5FOO:V[[%9CBJ-3 PA"2;NG]
MR=[]MS]"=/UZ^L?^"3SW*2/YYTJ2TW<Y\I[\Q$?38Q'TK\Y?A]\0=?\ A;XN
ML?$_AB^73=<L2YM[IK>*?RRR%&(2164G:Q'(XSQ7[2K^SU!_PRB/A&98_,_L
M#^SC<8^7[5LW>9]/-^:OQ_\  /BOQ)^S+\<-/U>;3WM]>\-7[)=:=<90N!E)
M8B<<!D9@&Y^\",UO@JL*F)Q"7VFVO-:_AW]3GQ]&I2PF&YOLJS\G9?Y:>AWM
M_P#M_P#QZU2QN+.Y\=^;;7$;0RQ_V/8#<K @C(@ST)K+_8CDN8_VJ_AR;49D
M_M$AO]PQ.'_\=W5^C?A[_@I1\#=7T&*^O]?OM#OF3+Z9=:7<22HWINB1XS['
M=^5=K^SI^UQX._:6U'Q'9^'(;RQGT=T80ZBJI)<0-P)E56.!N!4C.1E2<;L"
M/K$Z*DXX?E[_ -6UW-?JL*[AS8KFUT6_ZZ;'S9_P5R_Y%7X<_P#7[>?^BXZ\
M]_X),^']/O\ XH>,]6N+9);_ $_2XDM9F&3$)9"'*^A(0#/H2.YKT+_@KE_R
M*OPY_P"OV\_]%QUQW_!(W_D=OB)_V#[7_P!&/6.!_P"1?4_[>-L<D\RI7\OS
M9^FE%%%?/'U!^9O_  5PU*Y?QE\/; NWV2.PNIU3MO:1%)^N$6NA_P""16EV
M_P!@^)>H^6#=^;8VXD[A,3-@?4X_(5W'_!4+X*7OCKX8Z3XVTJW:YN_"[R?;
M(XP2QLY=NY\=]C*I/H&8]J^3/V!_VH-'_9S\=:S;^*3/'X8UZ"-)[JWC,IMI
MHRQCD*#DKAW!V@GD<'%?1X/][ETZ,/B5_P#TKF_%:?@?*8[]SFE.O4^%V_\
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MXL>,K^[=I+FXUF\DD9CDY,SUZO8_\% /CUIEC;V=KXZ6"VMXUBBC71M/PB*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#@/CC\%M$^/WP_NO!_B&ZU"STRXFBG>73)$28-&VY0"Z.,9Z_+7F'
MP'_82\ _L\^/!XL\.:OXDO=1%K):>5JES;R0['QDX2!#GY1WKZ.HK:G6J4XN
M$'9/?[K?D85*%*K.-2<;M;???\Q#SP>17R!XF_X)=_"3Q-XBU+5O[4\5:8;Z
MXDN39V%Y;+!"78L5C#6[$*"> 2<5]@44J=2=&7-!V8ZM&G6CRU%='(_";X9Z
M7\&_AWHW@W19[RZTO2HVB@FOW1YF#.SG<555)RQZ*.,5YK^TW^Q]X0_:<MK.
MXU2>XT7Q#8H8K;5[)59O+)SY<B'AT!)(&002<$9.?>**7M)^T]K?WKWOY@J-
M-4O8V]VUK>2/@GP/_P $E_#&D:W%=>*?'-_XCT^-@WV&RL%L/,P?NN_FR':>
MAV[3Z$5[!\7O^"?OPO\ C!JND7ET^L>'(]+TZ/3+:S\/RP00"%&=ERKPN=V7
M/.>?KDU]+45T3QE>;4I2V.:&!PU.+C&"L]_S.1^$WPSTOX-_#O1O!NBSWEUI
M>E1M%!-?NCS,&=G.XJJJ3ECT4<8KYX\>?\$T?AA\1/&NN^*-2UWQ;!?ZQ>RW
MT\=K>6JQ+)(Y9@@:V)"Y/&23[U]:T5E&M4C4=52]Y]?4WEAZ4J2HN/NJUEZ:
M(Y[X>^";'X;>!]"\*Z9+<3Z?H]G'9027;*TK(BA07*JH)P.P'TKYP^(O_!-G
MX9_$WQUKGBO5-<\60:CJ]T]W/%9W=JL2NQR0@:W8@?4FOK"BE&M4C4=5/WGU
M]=QRH4ZE-4I1O%=/31'/?#WP38_#;P/H7A73);B?3]'LX[*"2[96E9$4*"Y5
M5!.!V ^E?.'Q%_X)L_#/XF^.M<\5ZIKGBR#4=7NGNYXK.[M5B5V.2$#6[$#Z
MDU]8441K5(U'53]Y]?7<)4*=2FJ4HWBNGIHCF?AQX!T_X8> =$\(Z5-<W&FZ
M3:K:02WC*TS(O0L5503] *^<?"G_  3-^%'A7QIIWB1=1\2ZK/97:W@L=2N;
M62UE8-N"R(+<%ESVS7UI13C7J1G*I&6LM_,4L/2G!4Y1O%;(^'OBK_P2M\&>
M,/$$VI^$?$UUX*BN',DFGM9B]MT)[1 R1L@]BS =L# KU7]F_P#8;\!_LZWR
MZU;M/XE\5!"BZOJ*J/(!&&\B(<1Y'&26;!(W8)%?1E%:?6Z_)[/G=OZZ[F/U
M'#>T]KR*_P#738*\-_:"_8Y^'G[1C+>Z[9SZ9X@C0(FM:6RQW!4=%D!!61?]
MX9 Z$5[E17-&3C)2B[-'9*,9Q<9*Z9^>*_\ !(>Q_M#>WQ1N#8[L^2-#42[?
M3?\ :,9]]OX5].?L^_L=?#W]G&XEU#P];WE_K\T)@EU?4Y]\QC)!**JA45<@
M=%SP,DU[E177/&XBI'EE/0XJ> PU*7/"&O\ 7<\>_:+_ &7?"O[3>GZ+9^*-
M0UBPBTF626 Z1-%&S%PH.[S(GR/E&,8K,_9U_8^\&_LRZIK-_P"%]3UV_FU6
M&."==7GAD551BP*^7"F#DGKFO=**PC6J0@Z<79,Z)4*4YJK*-Y+J%%%%8FXR
M:)+B)XI462-P59'&0P/4$=Q7QS\8/^"87P[^(&JW&J>%]3N_ EY<-ODMK:%;
MFRW$Y)6$E63/HKA1V K[)HK2G4G1ES0=F95:5.M'DJ*Z/A3X>_\ !)[P;H.J
M)=>+O%^H^*[>-@RV5I:C3XG_ -F0AY'(/^RRGWK[:\.^'=+\(Z'9:-HMA;Z7
MI5E&(;>TM4"1Q(.P _R:T:*UK8FK7TJ2N8T,)0P^M*-CRG]H;]G'PU^TMX9T
MW0O$]]JMA:6%Y]MB?29HHY"^QDPQDC<8PYZ '..:YC]GG]B_P3^S3XFU+7/#
M&J:_?W=_9_8I4U:X@DC";U?*B.%#G*CJ2,9XKWVBHC6J0BX1=DRYX>E4FJDX
MW:V"BBBL3H/P>_:A_P"3COB9_P!C%??^CVK[3\._\$Y?!OQP^#G@#Q7HVMW7
M@O6]0T.SEOA';B[M9Y/)7=((RR%68\G#X]LY-8'QD_X)H_$_XB?%CQAXHTW7
M?"4%AK&JW-]!'=7ETLJQR2,RAPML0&P><$CWK[W^"7@F^^&WPA\'^%=3EMY]
M0T?3(+*>2T9FB9T0*2A95)&1W ^E>_+%*&"I1I2M-<OY._XGS5/!NICJ\JT+
MPDY6_P# M/P/!_V?/^"=?@/X)Z[:^(=4O9_&OB&T826TU[ L-K;N.DB0 M\X
M[%F;!P0 1FOJZBBO'JUZE=WJ.Y[M'#TL/'EI1L?'7QZ_X)I^#?BYXKO/$F@:
M[<>"=3OI3->11VBW=K+(3EG6/>A1F/)PV,]A5SX&_P#!-GX>?"G4HM7U^[G\
M=ZQ%GROMT"PV<3=G6 %LL/5W8#J " :^N:*N.*K1I^R4O=_KYF4L%AYU?;2A
M[W]?(^4/ /\ P3:^&/PY\?:+XMTO6O%4FH:3>QWUO!<W=LT!=&W!6 MPQ7Z,
M#[U]7T45G4K5*UO:.]C:G0I46W3C:^Y\?_'K_@FOX)^+OB>\\1Z%K-SX)U:^
MD,UVD-LMU:2R$DLXB+(58DY.'Q[9)-1?LY_\$Z;'X!_$K3?&DGCV]UR_T_S!
M#;P:<EI$P>-HV$F9)"PPQZ$<@5]BT5K#%UZ</9QEIM\NQA/ X>I4]K*'O;_/
MN?/7[0'[$/@7]H_QE;>)?$NK>(;&_M[-+)8]*N8(XBBLS D20N<Y<]\=.*[3
M]GO]GGPY^S7X/OO#GAF]U2^L;R^:_DDU:6.242-&B$ QQH-N(U[9R3S7J-%9
M^VJ*G[*_N]OQ_,W^KTG5]LX^]W^5OR.-^*OP@\)?&KPO)H'C#1X=6T\MOC+$
MK+!)C >-Q\R-SU!YZ'(XKXO\2?\ !(W0KO4&DT#XCZAI=B>D&HZ6EY(/^!I+
M$/\ QVOT"HIT<15H?PY6)KX:CB4E5C?^NY\A?!__ ()F_#7X;ZK9ZOKE]J/C
M/5+5UEB6Z(MK19%(*N(D.XD$=&=E]J^F/B1X"T_XH^ ]<\)ZK-<V^G:Q:M:3
MRV;*LRHW4H65@#]0:Z6BE5KU*[O4E<='#TL.K4HV/D[X>_\ !-?X9?#7QSH7
MBK3-=\63ZCH]Y'>V\=W=VK1,Z,& <+;J2,CL0?>OIKQAX9M?&OA/6O#U])-%
M9:M936,\EN0)%CE0HQ4D$!L,<9!&>QK7HI5:U2NK5'<=&A2P[;I1L?(/A7_@
MF#\+/"/B?2-=L]?\82W>F7D-["D]Y:F-GC<.H8"V!(RHS@CZU]?444ZE>I6L
MJDKV%1P]*A?V4;7/DK]H3_@G/X)^-GB:[\2Z5JUUX,U^]?S+N2W@6YM9W/60
MPEE(<]RK@'J1DDUA_ '_ ()LV/P3^)6C^,YOB#>ZS>Z5*9;>"VTU+1&RK(RN
M3)(2I5B.,'GK7VC16M/%UZ</9QEH8U,%AZM3VLX>\?._QV_83^&'QVU"XUB\
MLKCP[XCG.Z75=&98VG;UEC8%'/JV Q_O5\\P?\$A[%=0#S?%&XDLMV3#'H:K
M)M]-YN",^^W\*_0ZBE2Q5>BN6$K+^NXZV"P^(ES5(7?W?D>2? #]E_P+^S?I
M-Q;^%;*:74+L!;O5K]Q)=7 !R%) "JH_NJ . 3D\UZW116%2I.K+FF[LZ*=.
M%&/)35D%%%%9FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 456DU.SAF,
M,EW!'*.L;2*&'&>F:3^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^
M?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_
M\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/
M^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?
MQ?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!
M:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[
M4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_
MVI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\
MY^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _
M<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+
M_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?
M\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6
MJ*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U
M+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG
M_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J-JUC&,M>VZCWE4?UI1JEDP!%Y
M 1_UU7_&@"U157^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7_&@"U157^U+/_G[@
M_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7
M_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U+/\ Y^X/^_B_
MXT?VI9_\_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U1
M57^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9
M_P#/W!_W\7_&@"U157^U+/\ Y^X/^_B_XT?VI9_\_<'_ '\7_&@"U157^U+/
M_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U15-M8L%8*;VW#'H#*N?YT[^U+/_G[
M@_[^+_C0!:HJK_:EG_S]P?\ ?Q?\:/[4L_\ G[@_[^+_ (T 6J*J_P!J6?\
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MVI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\
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M2S_Y^X/^_B_XT 6J*J_VI9_\_<'_ '\7_&C^U+/_ )^X/^_B_P"- %JBJO\
M:EG_ ,_<'_?Q?\:/[4L_^?N#_OXO^- %JBJO]J6?_/W!_P!_%_QH_M2S_P"?
MN#_OXO\ C0!:HJK_ &I9_P#/W!_W\7_&C^U+/_G[@_[^+_C0!:HJK_:EG_S]
MP?\ ?Q?\:/[4L_\ G[@_[^+_ (T 6J*J_P!J6?\ S]P?]_%_QH_M2S_Y^X/^
M_B_XT 6J*J_VI9_\_<'_ '\7_&C^U+/_ )^X/^_B_P"- %JBJO\ :EG_ ,_<
M'_?Q?\:/[4L_^?N#_OXO^- %JBJO]J6?_/W!_P!_%_QH_M2S_P"?N#_OXO\
MC0!:HJK_ &I9_P#/W!_W\7_&FMK%@K!3>VX;T,JY_G0!<HJK_:EG_P _<'_?
MQ?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!
M:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_VI9_\_<'_?Q?\:/[
M4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\ Y^X/^_B_XT 6J*J_
MVI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\
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M_<'_ '\7_&@"U157^U+/_G[@_P"_B_XT?VI9_P#/W!_W\7_&@"U157^U+/\
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MVI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\ &C^U+/\
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MXT 6J*J_VI9_\_<'_?Q?\:/[4L_^?N#_ +^+_C0!:HJK_:EG_P _<'_?Q?\
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M'_?Q?\:/[4L_^?N#_OXO^- %JBJO]J6?_/W!_P!_%_QH_M2S_P"?N#_OXO\
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M]_%_QH M455_M2S_ .?N#_OXO^-']J6?_/W!_P!_%_QH M455_M2S_Y^X/\
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MM2S_ .?N#_OXO^-']J6?_/W!_P!_%_QH M455_M2S_Y^X/\ OXO^-']J6?\
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M_C1_:EG_ ,_<'_?Q?\: +5%5?[4L_P#G[@_[^+_C2-JUDJY:\MP/4RK_ (T
M6Z*J+JUBXRMY;L/42K_C2_VI9_\ /W!_W\7_ !H M455_M2S_P"?N#_OXO\
MC1_:EG_S]P?]_%_QH M455_M2S_Y^X/^_B_XT?VI9_\ /W!_W\7_ !H M455
M_M2S_P"?N#_OXO\ C1_:EG_S]P?]_%_QH M455_M2S_Y^X/^_B_XT?VI9_\
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M .?N#_OXO^- %JBJO]J6?_/W!_W\7_&C^U+/_G[@_P"_B_XT 6J*J_VI9_\
M/W!_W\7_ !H_M2S_ .?N#_OXO^- %JBJO]J6?_/W!_W\7_&C^U+/_G[@_P"_
MB_XT 6J*J_VI9_\ /W!_W\7_ !H_M2S_ .?N#_OXO^- %JBJO]J6?_/W!_W\
M7_&ECU.SFF$,=W!)*>D:R*6/&>F: +-%%% !1110!Y'K>G_;_&EW:^9L\R4_
M-C./ESTJY_P@/_3]_P"0?_LJ+O\ Y*)+_P!=3_Z!76T@.2_X0'_I^_\ (/\
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MG&1]:N^._P#CRMO^NA_E6UHG_('LO^N*_P J .?_ .$!_P"G[_R#_P#94?\
M" _]/W_D'_[*NMHHL!R7_" _]/W_ )!_^RH_X0'_ *?O_(/_ -E76T46 Y+_
M (0'_I^_\@__ &5'_" _]/W_ )!_^RKK:*+ <E_P@/\ T_?^0?\ [*C_ (0'
M_I^_\@__ &5=;118#DO^$!_Z?O\ R#_]E1_P@/\ T_?^0?\ [*NMHHL!R7_"
M _\ 3]_Y!_\ LJ/^$!_Z?O\ R#_]E76T46 Y+_A ?^G[_P @_P#V5'_" _\
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M#_T_?^0?_LJZVBBP')?\(#_T_?\ D'_[*C_A ?\ I^_\@_\ V5=;118#DO\
MA ?^G[_R#_\ 94R;P+Y,+O\ ;<[5+8\KT'^]785#>?\ 'I/_ +C?RHL!P.@:
M#_;AG'G^3Y6W^#=G.?<>E:__  @/_3]_Y!_^RI/ 7WK[Z)_[-774 <E_P@/_
M $_?^0?_ +*C_A ?^G[_ ,@__95UM%%@.2_X0'_I^_\ (/\ ]E1_P@/_ $_?
M^0?_ +*NMHHL!R7_  @/_3]_Y!_^RH_X0'_I^_\ (/\ ]E76T46 Y+_A ?\
MI^_\@_\ V5'_  @/_3]_Y!_^RKK:*+ <E_P@/_3]_P"0?_LJ/^$!_P"G[_R#
M_P#95UM%%@.2_P"$!_Z?O_(/_P!E1_P@/_3]_P"0?_LJZVBBP')?\(#_ -/W
M_D'_ .RH_P"$!_Z?O_(/_P!E76T46 Y+_A ?^G[_ ,@__94?\(#_ -/W_D'_
M .RKK:*+ <E_P@/_ $_?^0?_ +*C_A ?^G[_ ,@__95UM%%@.2_X0'_I^_\
M(/\ ]E5+6/"?]E6$ES]J\W:0-OEXZG'7-=U6-XN_Y ,_U7_T(4 <[H_A3^UK
M%;C[5Y6XD;?+ST]\U>_X0'_I^_\ (/\ ]E6EX/\ ^0''_OM_.MN@#DO^$!_Z
M?O\ R#_]E1_P@/\ T_?^0?\ [*NMHHL!R7_" _\ 3]_Y!_\ LJ/^$!_Z?O\
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M^RKK:*+ <E_P@/\ T_?^0?\ [*C_ (0'_I^_\@__ &5=;118#DO^$!_Z?O\
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M0?\ [*C_ (0'_I^_\@__ &5=;118#DO^$!_Z?O\ R#_]E1_P@/\ T_?^0?\
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M^_\ (/\ ]E1_P@/_ $_?^0?_ +*NMHHL!R7_  @/_3]_Y!_^RH_X0'_I^_\
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M?O\ R#_]E76T46 Y+_A ?^G[_P @_P#V5'_" _\ 3]_Y!_\ LJZVBBP')?\
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MX0'_ *?O_(/_ -E1_P (#_T_?^0?_LJZVBBP')?\(#_T_?\ D'_[*C_A ?\
MI^_\@_\ V5=;118#DO\ A ?^G[_R#_\ 94?\(#_T_?\ D'_[*NMHHL!R7_"
M_P#3]_Y!_P#LJ/\ A ?^G[_R#_\ 95UM%%@.2_X0'_I^_P#(/_V5'_" _P#3
M]_Y!_P#LJZVBBP')?\(#_P!/W_D'_P"RH_X0'_I^_P#(/_V5=;118#DO^$!_
MZ?O_ "#_ /94?\(#_P!/W_D'_P"RKK:*+ <E_P (#_T_?^0?_LJKZAX-^P6,
MUQ]LW^6N[;Y6,_K7:UG>(?\ D"WG_7,T6 Y'0O#/]M6KS?:?)VOLV[-W8'/4
M>M:7_" _]/W_ )!_^RJUX%_Y!<__ %V/_H(KHZ .2_X0'_I^_P#(/_V5'_"
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MK:*+ <E_P@/_ $_?^0?_ +*C_A ?^G[_ ,@__95UM%%@.2_X0'_I^_\ (/\
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MJ\KYBNWR]W3\:O\ _" _]/W_ )!_^RJ_X+_Y O\ VT;^E;U ')?\(#_T_?\
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M[J?^A&NTKB_%?_(QVG^ZG_H1KM* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#B],_Y':;_KI)_(UVE<7IG_ ".TW_723^1KM*2
M****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0WG_'I/_N-_
M*IJAO/\ CTG_ -QOY4 <OX"^]??1/_9JZZN1\!?>OOHG_LU==20!1113 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K&\7?\@&?ZK_ .A"MFL;
MQ=_R 9_JO_H0H ;X/_Y <?\ OM_.MNL3P?\ \@./_?;^=;= !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7)^/?NV/U?_ -EKK*Y/Q[]V
MQ^K_ /LM)@=)I_\ QX6W_7)?Y"K%5]/_ ./"V_ZY+_(58I@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<7K7_(Y6O_72+^8KM*XO6O\
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M** "BBB@ HHHH **** "BBB@ K.\0_\ (%O/^N9K1K.\0_\ (%O/^N9H S?
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M;_R'+O\ ZYM_Z$*[2N+\&_\ (<N_^N;?^A"D!VE%%%, HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "LGQ5_R +K_@/_ *$*UJR?%7_( NO^ _\
MH0H K^"_^0+_ -M&_I6]6#X+_P"0+_VT;^E;U !1110 4444 %%%% !1110
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MATX2@\/14&[OKZA1117*=@4444 %%%% '%^*_P#D8[3_ '4_]"-=I7%^*_\
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MS-I+WI;OY[+?Y'T3^R'X&\;>"_A%:R?$#Q#JVN^)-5D^WR1ZM>27+V2,JA(
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M^/(I5W&WM$O$]FBE1\_H?SK _P"">VO2:W^RYX<CE?>UA<75F">RB9F4?@'
MJY2>(PTISUE%[]XOOZ,B,5A<5&G3TA-/3M)=O5?B?2%%%%>:>J%%%% !1110
M 5Q?AO\ Y&BZ_P"VG_H5=I7%^&_^1HNO^VG_ *%2 [2BBBF 4444 %%%% !7
M-_$CQ-J/@WP)KFMZ1HD_B/4[&U>>WTFU#&2Z<#A%VJS9/LIKI** /R:_:'_:
M@_:%U>YLY]>L_$/PLTIY&^R6MC:W6E^:0.<S-AY2 1D9V]#M%?J?X1GDNO">
MBS32-++)90.\CDEF8QJ223U)-?$?_!5S_D5_A[_U^7?_ *!'7VQX)_Y$W0?^
MO"W_ /1:UZM64*F$C*,5'WFCQJ$)T\9*,YN7NIZ^H>-/%VF^ O">K>(M7F\C
M3-,MGNIY.IVJ,X [D] .Y(KX.^'_ (5^(/\ P4$UK5_$OBGQ/J'A+X86]RUM
M::-ICE?/Q@[ #\K%006E<-\QPHQG;ZS_ ,%+O%DN@?L[IIL+LAUK58+63:<9
MC4-*1^<:UTWPK^(OP\_9C_9U^'FG>+/$5CH$DND0W9MFW23R/,/-D811AG8;
MW;D+BL\/'V=&5=*\KJ,?NNWZ]#7%2]I7CAV[1Y7*72^MDGY=6>>K^P/KWPIU
M_2=5^#GQ-UG02MU&+^WU9UE1X=PW-MC14DP,_NW3!_O"OLR)66-%=M[@ ,V,
M9/KBO.OAG^T7\-_C%<O:^$?%MCJUZH+&S(>"X*CJPBE57('<@8%>CUA7J5I6
MC6W7=:G1AZ5"%Y4-GV=U_D%%%%<IV!1110 4444 5-8_Y!-[_P!<'_\ 036#
MX#_X]KO_ 'U_E6]K'_()O?\ K@__ *":P? ?_'M=_P"^O\J .IHHHH ****
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M1^.OA7XFN_$NOZIXANX=9,4<^JWDERZ)Y$9VJSL2!DDX'K7UU7Q5_P $K_\
MDCWBS_L.G_TGBK[5KT,R2CBI)+M^2//RN3EA(-OO^;/E3]JSX_?&7P+XCD\-
M?#7X;ZEJ\+6B2GQ)!I=S?(C-NRJ*B; RX'WBPYY6O-O^"</Q.\;?$'QW\0$\
M7^)M9UQX;:&1;?4[N21()#*^[9&QVQ^F% QC':OO-_NM]*_/7_@FC_R5WXL_
M[J?^E$E5A90E2JPY5=1O?J9XN$XUJ53G=G)*W38_0NBBBO*/8"BBB@ HHHH
M**** .+N/^1Z'_71?_0!7:5Q=Q_R/0_ZZ+_Z *[2D 4444P"BBB@ HHHH **
M** /C7]LKXS>,M1^*'A3X)?#W49-#U?7A&]]JD3%)$21F545Q\R@*K.Q7YL
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M_:GQ:^*OBF_M=.5YHXI-1OIEC2/S7>:7+,<#)\K\A7TUI/[;'P1UK61I=O\
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MN/SE8_C7UC7%BZ2HUY0CMT]-T=^"K/$8>%26[6OJM&%%%%<AVA1110 4444
M%<GI/_)14_ZZ-_Z :ZRN3TG_ )**G_71O_0#2 ]/HHHI@%%%% 'E]W_R427_
M *ZG_P! KK:Y*[_Y*)+_ -=3_P"@5UM( HHHI@%%%% !1110 4444 %%%% !
M1110 4444 ?GG\1/^4HGAK_?M?\ TD:OM/X[?\D1^('_ &+]_P#^D[U\6?$3
M_E*)X:_W[7_TD:OM/X[?\D1^('_8OW__ *3O79B?]RH_X6<."_WRKZQ_(^;_
M /@EK_R0GQ%_V,4O_I-;UVW_  40_P"35O$O_7U9?^E,=<3_ ,$M?^2$^(O^
MQBE_])K>NV_X*(?\FK>)?^OJR_\ 2F.NO'?[^O\ %#_VTXL!_P BV7^&?Y2-
M;]@__DU/P-_USN?_ $JFKQ7_ (*L?\B#X$_["<__ **%>U?L'_\ )J?@;_KG
M<_\ I5-7BO\ P58_Y$'P)_V$Y_\ T4*57_D8O_'_ .W"H_\ (J7^#]#Z3U6]
MN--_9;NKNT)%U!X.:2(J"3O%ED8_&O@G]BWQ1\>/#O@/6U^$W@7P]XFTF;4L
MWEYJDZ),LPB3$>#=1':%((^4\LW/8?H[X#L(-5^$_AVRN4\RVN=$MX94/\2M
M H(_(U\'_!3QE<?L#_&[Q)X&\>17$/@C7)!-8ZPD32( I(CF  R05;:X )!5
M>,==*$OWN(II7<MD^MFVU^J,\1']SA:C;48[M;KFBDGZ75GZGJLWQ(_;-N(9
M(G^$?@YD=2K#[7'R",'_ )B-;O[ ?P6\<_!?POXOL_&VB_V)-J%_%<6T*W<,
MZLH0AB/*D<#G Y.>*]8U+]JCX0:7H[:E-\2/#<ENJ;S';:C'//CT$*$R$^VW
M-=/\+_BAX?\ C%X-M/%'AB[:[TJY>2-6D0HZLC%65E/*GC.#V(/>N:56HJ<X
MJDHIV3=GWNNIUPHTW5A)UG)J[2;7:SZ>9\.?MA?\GZ?"/_KII'_I>U?H?7YX
M_M^1R^ ?VG_A7X_OH)'T* VCO)&I/S6UUYLB9]=CJ0/K7VGX5^._P[\<:CI^
MGZ!XUT/6-1OT:2"RL[Z.2<@*7.8P=RD*"2& Z552+G@Z+BKV<_S"G*,,=74G
M:ZA;[C\_?&NO?$"W_P""AGBB]\!Z'I_B7Q=:N\=E8ZLX2(1BS568%I8N0A8C
MYNYX->\?\+._;/\ ^B2>#O\ P+C_ /EC7'_MC^"_$'P-^/WAWX_>&K!M0TV-
MXDU:*,']VZJ8CO(Z+)$=N[H&'/45])>"?VOOA#XX\/P:K#XZT;2#(@,EEK5[
M'9W,+8Y5DD89(Z97(/8FM^?FPU*4(*7*N5WOHUZ/9[HY534<56C.HX\SYE:R
M33]4]5L?._PS^%/QW\4?M>^&OBA\0O!&G^'K6WADMKR;2[ZW,006TL:'RQ<R
M.2691QGMP.:N_P#!53_DF'@O_L,/_P"B&KZ1^''[27P]^+7C#5O#7A/7X]7U
M'38%N)6B1A%(I;:3&Q W[3MR1Q\ZX)YQ\Y?\%4K>5_A3X/F6-FBCUEE=P.%)
M@?&?K@_E6'M)SKT5./+:UMUI>_7U-Y4H0P]=PGS-IW=T]4O+R/K/X:QK+\,_
M"R.H9&TBU#*PR"#"O%?&/BS]DKXL_L]^/=4\8_ 35DN-+O6WS:!*Z"0+N+>4
M4E_=RHN3M.0X!P.>3]4?#7XF>'9?@/I7B73]1CUK2]+T:(W)TO\ TF1'BMT+
MQ;$R?,'=#R,\XKBOA/\ MS_"CXGZ6);GQ#;>#]24?OM/\0SI;;?=96(C<?0Y
M]0*5ZU.O5E25[;JU]&W:Z_K\2OW%3#4H596NE9WL[I+9GFWP=_X*"/>>,+;P
M3\6_"TG@?Q')*MO]MV/%;B1C\HEBE^>$'CYMS#G)VCFOI+X[?\D1^('_ &+]
M_P#^D[U\-_M\>./"7Q\\7^ O"7P[FM?%WBT7$D37FDD3($DVA(O-7AAD%C@D
M* 22,FONKQQX6O=9^#FO>'(Y//U&ZT*>P60_QRM;L@/XDUGC(0^KJLH\K=]/
M3JOZ]#; U)K$NBY\\59W[7Z/I_6I\N_\$K_^2/>+/^PZ?_2>*OLK5M6L]!TN
M[U+4;F*RL+2)IY[B9@J1HHRS,3T  K\_O^"<7QG\(?#?PSXP\)>+M=L?"VJ#
M4A=I_;%PMK&X\L1N@9R '5DY4G/S<=#CZ3_:;U"/XK_LG>-;OP1>QZ[!=63/
M#/IS^8LZ13KYP0K][Y8Y!QUQ6^9Q?UERZ/EUZ;(Y\IE'ZM&'57TZ[L\EU+]N
MKQG\5?$MWH/P)^'$OB?[.VU]8U8,L'?#% R+&IP=IDD!/]T=*\-_;*L/V@)O
MAOI.J?%?4-!AT.34E6WT;3%0RPW!CD(8LJ'@*&'^M/4<'K7MW[ OQV^&'A3X
M"V?A_5/$VC>&=>M+JXEOH]4N4M#<%Y"4D5G(#_)L7@DC9C'3/FW[?/[1&B?&
MCP?#H/@FTNM=T30]0CN=2\2PQL+*.5E>..%&(^8G<QST^7C<,D=/L_8XE4J5
M/1-:O7Y]EY?YG&ZOUC"RK5:NK3]U:+9Z=WY^6^A]M_LXDM^S]\-B3D_\([I_
M_I.E?''PA_Y2<^,?]^__ /1*U]C?LW_\F^_#;_L7=/\ _2=*^)IO$5C\!_\
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M7+"C3[07WZW9PX)\\Z]1]9O[E9)?(****\\],**** "BBB@ KD_'OW;'ZO\
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M*347WBMOU"BBBO./4"BBB@ HHHH **** .+\%_\ (7NO^N9_]"%=I7%^"_\
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M?^0+>?\ 7,UHUG>(?^0+>?\ 7,T 9O@7_D%S_P#78_\ H(KHZYSP+_R"Y_\
MKL?_ $$5T= !1110 4444 %%%% !45U:PWMM+;W$23V\R&.2*50RNI&"I!X(
M([5+7F'[1?QFN/@1\-Y_%5MX<N_$IAN(XY+>V)58HR?GDD< [% !YQC)7--+
MF:CWT^\3ERIR?37[CHO /PE\&_"Z"XB\)^&M.T);B1I9FM( KN22<%NI R<+
MG '  '%?*'_!2+X'^'F^&R_$73-/M],\0Z;>0QW5S:H(S=12-L&_'WF5BA#=
M<9'T]R^'_P"V1\(?B#H<6H1>-M*T.5E!EL=>NH[&>%L<J1(P#8]4+#WKYD_;
M4_:)T[X]0Z3\(?A:S^+;^_OXY+NYL$+0N4R4B1NC 'YV<?* HYZX]"C3Q'UF
M&CYDU]U]=>UCS*]7"O"SU3BT[+S:=M.]SZQ_9;\=7OQ)_9_\$^(-1E:?4+BQ
M$5Q,WWI)(F:)G/NQ3)]S7JE<5\%?AVGPG^%/A?PBLJSOI5DD,LJ_=>4_-(P]
MB[,1[&NUKGQ,HRKS<-FW;TN=.$C..'IQJ?$DK^M@HHHKF.L**** "BBB@ KF
M_'7_ "#8/^NW_LIKI*YOQU_R#8/^NW_LII,#4\/_ /(%L_\ KF*T*S_#_P#R
M!;/_ *YBM"F 4444 %%%% !1110 445X/^TE^U(O[..M>%/[1\+:AJGA[4Y'
M6^U:V'RVH ^55SPTAY;:2N5!P?2X1=22A'=D5)QIP<Y;(E^)W[%?PG^+6O:G
MKVMZ'=1Z]J)#7&I6FH3I(6"A 0A8QC 4?P8XKYGO_$_C/]@7XT>&_#=QXFOO
M%?PIUK:L%MJ3;WM(@X1A&?X&CW*V%PKAON@\CZUT3]JOX0:_H\>I6_Q&\.P0
M.N[R[[4([6<>QBD*N#[8KXJ_:%\80?MP?M#>#O!O@".;4=!T?<+K5A$RQ['=
M#/-R 0BJB@$XW,<#J,^M@E6]M&C53]G]I/9))]]K'BXYT/8RK46O:?9:W;;7
MWWUO<_2L$, 1R**;'&(XU1?NJ !3J\8]Q7MJ%%%% PHHHH **** "N+\9?\
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M75I.*YO\74Y\ODY1J6=X*347_=Z?J%%%%><>H%%%% !1110 5Q?@W_D.7?\
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M:'5E]*5'"PA+>WYZA1117$>@%%%% !1110 5R>D_\E%3_KHW_H!KK*Y/2?\
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MBHKEBK(YSQ3\-_"7CBXMKCQ)X6T7Q!/:@K!+JFGPW+1 D$A"ZDKR!T]*Z,#
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MU:"ZC1U2,*"& SP2?6N@_P"$ZLO^>%Q^2_XT@.CHKG/^$ZLO^>%Q^2_XT?\
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M_&@#HZ*YS_A.K+_GA<?DO^-'_"=67_/"X_)?\: .CHKG/^$ZLO\ GA<?DO\
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M'Y+_ (T?\)U9?\\+C\E_QH Z.BN<_P"$ZLO^>%Q^2_XT?\)U9?\ /"X_)?\
M&@#HZ*YS_A.K+_GA<?DO^-'_  G5E_SPN/R7_&@#HZ*YS_A.K+_GA<?DO^-'
M_"=67_/"X_)?\: .CHKG/^$ZLO\ GA<?DO\ C1_PG5E_SPN/R7_&@#HZ*YS_
M (3JR_YX7'Y+_C1_PG5E_P \+C\E_P : .CHKG/^$ZLO^>%Q^2_XT?\ "=67
M_/"X_)?\: .CHKG/^$ZLO^>%Q^2_XT?\)U9?\\+C\E_QH Z.N+\-_P#(T77_
M &T_]"K1_P"$ZLO^>%Q^2_XUS^DZQ%I^LS7;H[1ONPJ@9Y.?6D!Z'17.?\)U
M9?\ /"X_)?\ &C_A.K+_ )X7'Y+_ (TP.CHKG/\ A.K+_GA<?DO^-'_"=67_
M #PN/R7_ !H Z.BN<_X3JR_YX7'Y+_C1_P )U9?\\+C\E_QH Z.BN<_X3JR_
MYX7'Y+_C1_PG5E_SPN/R7_&@#HZ*YS_A.K+_ )X7'Y+_ (T?\)U9?\\+C\E_
MQH Z.BN<_P"$ZLO^>%Q^2_XT?\)U9?\ /"X_)?\ &@#HZ*YS_A.K+_GA<?DO
M^-'_  G5E_SPN/R7_&@#HZ*YS_A.K+_GA<?DO^-'_"=67_/"X_)?\: .CHKG
M/^$ZLO\ GA<?DO\ C1_PG5E_SPN/R7_&@#HZ*YS_ (3JR_YX7'Y+_C1_PG5E
M_P \+C\E_P : -C6/^03>_\ 7!__ $$U@^ _^/:[_P!]?Y4E]XRM+JQN(5AF
M#21L@) QD@CUK-\-^((-&AG2:.1S(P(V >GN:0'>45SG_"=67_/"X_)?\:/^
M$ZLO^>%Q^2_XTP.CHKG/^$ZLO^>%Q^2_XT?\)U9?\\+C\E_QH Z.BN<_X3JR
M_P">%Q^2_P"-'_"=67_/"X_)?\: .CHKG/\ A.K+_GA<?DO^-'_"=67_ #PN
M/R7_ !H Z.BN<_X3JR_YX7'Y+_C1_P )U9?\\+C\E_QH Z.BN<_X3JR_YX7'
MY+_C1_PG5E_SPN/R7_&@#HZ*YS_A.K+_ )X7'Y+_ (T?\)U9?\\+C\E_QH Z
M.BN<_P"$ZLO^>%Q^2_XT?\)U9?\ /"X_)?\ &@#HZ*YS_A.K+_GA<?DO^-'_
M  G5E_SPN/R7_&@#HZ*YS_A.K+_GA<?DO^-'_"=67_/"X_)?\: )?&G_ "!O
M^VJ_UJSX6_Y -I]&_P#0C7/>(/$UMJVG^1%'*C;PV7 QQGWJ;1O%EKINFPVT
MD4S.F<E0,<DGU]Z74#L**YS_ (3JR_YX7'Y+_C1_PG5E_P \+C\E_P :8'1T
M5SG_  G5E_SPN/R7_&C_ (3JR_YX7'Y+_C0!T=%<Y_PG5E_SPN/R7_&C_A.K
M+_GA<?DO^- '1T5SG_"=67_/"X_)?\:/^$ZLO^>%Q^2_XT ='17.?\)U9?\
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ME_SPN/R7_&@#HZ*YS_A.K+_GA<?DO^-'_"=67_/"X_)?\: .CHKG/^$ZLO\
MGA<?DO\ C1_PG5E_SPN/R7_&@#HZ*YS_ (3JR_YX7'Y+_C1_PG5E_P \+C\E
M_P : .CHKG/^$ZLO^>%Q^2_XT?\ "=67_/"X_)?\: .CHKG/^$ZLO^>%Q^2_
MXT?\)U9?\\+C\E_QH SO!?\ R%[K_KF?_0A7:5YYX?UF'2;Z::5'=74J @&>
MH/K70?\ "=67_/"X_)?\:2 Z.BN<_P"$ZLO^>%Q^2_XT?\)U9?\ /"X_)?\
M&F!T=%<Y_P )U9?\\+C\E_QH_P"$ZLO^>%Q^2_XT ='17.?\)U9?\\+C\E_Q
MH_X3JR_YX7'Y+_C0!T=%<Y_PG5E_SPN/R7_&C_A.K+_GA<?DO^- '1T5SG_"
M=67_ #PN/R7_ !H_X3JR_P">%Q^2_P"- '1T5SG_  G5E_SPN/R7_&C_ (3J
MR_YX7'Y+_C0!T=%<Y_PG5E_SPN/R7_&C_A.K+_GA<?DO^- '1T5SG_"=67_/
M"X_)?\:/^$ZLO^>%Q^2_XT ='17.?\)U9?\ /"X_)?\ &C_A.K+_ )X7'Y+_
M (T ='6=XA_Y MY_US-9O_"=67_/"X_)?\:JZIXOM+[3YX$BF5Y%V@L!C^=(
M"UX%_P"07/\ ]=C_ .@BNCKAO#GB.WT>SDBFCD=FDW@H!CH!W/M6M_PG5E_S
MPN/R7_&@#HZ*YS_A.K+_ )X7'Y+_ (T?\)U9?\\+C\E_QI@='17.?\)U9?\
M/"X_)?\ &C_A.K+_ )X7'Y+_ (T ='17.?\ "=67_/"X_)?\:/\ A.K+_GA<
M?DO^- '1T5SG_"=67_/"X_)?\:/^$ZLO^>%Q^2_XT ='17.?\)U9?\\+C\E_
MQH_X3JR_YX7'Y+_C0!T=%<Y_PG5E_P \+C\E_P :/^$ZLO\ GA<?DO\ C0!T
M=%<Y_P )U9?\\+C\E_QH_P"$ZLO^>%Q^2_XT ='17.?\)U9?\\+C\E_QH_X3
MJR_YX7'Y+_C0!T=%<Y_PG5E_SPN/R7_&C_A.K+_GA<?DO^- '1US?CK_ )!L
M'_7;_P!E-+_PG5E_SPN/R7_&LGQ'XBM]8M(XH8Y$97W$N!CH1V/O2 ZGP_\
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M.?\ "=67_/"X_)?\:/\ A.K+_GA<?DO^- '1UQ?C+_D-6O\ US7_ -"-:/\
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M\)U9?\\+C\E_QH_X3JR_YX7'Y+_C0!T=%<Y_PG5E_P \+C\E_P :/^$ZLO\
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M?\:/^$ZLO^>%Q^2_XT ='17.?\)U9?\ /"X_)?\ &C_A.K+_ )X7'Y+_ (T
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MUZ12 R/^$1T?_H'P_E1_PB.C_P#0/A_*M>BF!D?\(CH__0/A_*C_ (1'1_\
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M /0/A_*C_A$='_Z!\/Y5KT4 9'_"(Z/_ - ^'\J/^$1T?_H'P_E6O10!D?\
M"(Z/_P! ^'\J/^$1T?\ Z!\/Y5KT4 9'_"(Z/_T#X?RH_P"$1T?_ *!\/Y5K
MT4 >>?$+1;'2["U>TMHX&:4@E!U&*W=!\,:5<Z)8RRV,3R/"C,Q'))'6L_XI
M?\@VR_Z['_T&NC\,_P#(O:;_ ->Z?^@BEU C_P"$1T?_ *!\/Y4?\(CH_P#T
M#X?RK7HI@9'_  B.C_\ 0/A_*C_A$='_ .@?#^5:]% &1_PB.C_] ^'\J/\
MA$='_P"@?#^5:]% &1_PB.C_ /0/A_*C_A$='_Z!\/Y5KT4 9'_"(Z/_ - ^
M'\J/^$1T?_H'P_E6O10!D?\ "(Z/_P! ^'\J/^$1T?\ Z!\/Y5KT4 9'_"(Z
M/_T#X?RH_P"$1T?_ *!\/Y5KT4 9'_"(Z/\ ] ^'\J/^$1T?_H'P_E6O10!D
M?\(CH_\ T#X?RH_X1'1_^@?#^5:]% &1_P (CH__ $#X?RH_X1'1_P#H'P_E
M6O10!Y;XPTNUL?%%G;V\"10ND99%'!RY!KN_^$1T?_H'P_E7'>//^1PL/]R/
M_P!#:O2*0&1_PB.C_P#0/A_*C_A$='_Z!\/Y5KT4P,C_ (1'1_\ H'P_E1_P
MB.C_ /0/A_*M>B@#(_X1'1_^@?#^5'_"(Z/_ - ^'\JUZ* ,C_A$='_Z!\/Y
M4?\ "(Z/_P! ^'\JUZ* ,C_A$='_ .@?#^5'_"(Z/_T#X?RK7HH R/\ A$='
M_P"@?#^5'_"(Z/\ ] ^'\JUZ* ,C_A$='_Z!\/Y4?\(CH_\ T#X?RK7HH R/
M^$1T?_H'P_E1_P (CH__ $#X?RK7HH R/^$1T?\ Z!\/Y4?\(CH__0/A_*M>
MB@#(_P"$1T?_ *!\/Y4?\(CH_P#T#X?RK7HH \MTG2[6;QY/9O C6JRR@1$<
M8 .*[O\ X1'1_P#H'P_E7':+_P E*N/^NTW\FKTBD!D?\(CH_P#T#X?RH_X1
M'1_^@?#^5:]%,#(_X1'1_P#H'P_E1_PB.C_] ^'\JUZ* ,C_ (1'1_\ H'P_
ME1_PB.C_ /0/A_*M>B@#(_X1'1_^@?#^5'_"(Z/_ - ^'\JUZ* ,C_A$='_Z
M!\/Y4?\ "(Z/_P! ^'\JUZ* ,C_A$='_ .@?#^5'_"(Z/_T#X?RK7HH R/\
MA$='_P"@?#^5'_"(Z/\ ] ^'\JUZ* ,C_A$='_Z!\/Y4?\(CH_\ T#X?RK7H
MH R/^$1T?_H'P_E1_P (CH__ $#X?RK7HH R/^$1T?\ Z!\/Y5!?>%=(CLKA
MUL(0RQL0<=#BMZJ^H?\ (/N?^N3?R- 'G?PZTFSU1K_[7;I/Y8CV[QTSNS_(
M5VO_  B.C_\ 0/A_*N6^%?WM3^D?_LU>@4@,C_A$='_Z!\/Y4?\ "(Z/_P!
M^'\JUZ*8&1_PB.C_ /0/A_*C_A$='_Z!\/Y5KT4 9'_"(Z/_ - ^'\J/^$1T
M?_H'P_E6O10!D?\ "(Z/_P! ^'\J/^$1T?\ Z!\/Y5KT4 9'_"(Z/_T#X?RH
M_P"$1T?_ *!\/Y5KT4 9'_"(Z/\ ] ^'\J/^$1T?_H'P_E6O10!D?\(CH_\
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M!\/Y5KT4 9'_  B.C_\ 0/A_*C_A$='_ .@?#^5:]% &1_PB.C_] ^'\J/\
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MKT4 9'_"(Z/_ - ^'\J/^$1T?_H'P_E6O10!D?\ "(Z/_P! ^'\J/^$1T?\
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M]#%(#L?^$1T?_H'P_E1_PB.C_P#0/A_*M>BF!D?\(CH__0/A_*C_ (1'1_\
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MD!T7_"(Z/_T#X?RH_P"$1T?_ *!\/Y5KT4P,C_A$='_Z!\/Y4?\ "(Z/_P!
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MUZ* ,C_A$='_ .@?#^5'_"(Z/_T#X?RK7HH R/\ A$='_P"@?#^5'_"(Z/\
M] ^'\JUZ* /+;K2[5/B MDL""U\U!Y6/EP4!_G7=_P#"(Z/_ - ^'\JXZ\_Y
M*@O_ %VC_P#18KTBD!D?\(CH_P#T#X?RH_X1'1_^@?#^5:]%,#(_X1'1_P#H
M'P_E1_PB.C_] ^'\JUZ* ,C_ (1'1_\ H'P_E1_PB.C_ /0/A_*M>B@#(_X1
M'1_^@?#^5'_"(Z/_ - ^'\JUZ* ,C_A$='_Z!\/Y4?\ "(Z/_P! ^'\JUZ*
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MC_\ 0/A_*C_A$='_ .@?#^5:]% &1_PB.C_] ^'\J/\ A$='_P"@?#^5:]%
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M/I=KJ&O7D-S DT21L55AP#O KU*O-_AU_P C+?\ _7)__0UI =C_ ,(CH_\
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M /0/A_*M>B@#(_X1'1_^@?#^5'_"(Z/_ - ^'\JUZ* ,C_A$='_Z!\/Y4?\
M"(Z/_P! ^'\JUZ* ,C_A$='_ .@?#^5'_"(Z/_T#X?RK7HH R/\ A$='_P"@
M?#^5'_"(Z/\ ] ^'\JUZ* ,C_A$='_Z!\/Y4?\(CH_\ T#X?RK7HH R/^$1T
M?_H'P_E1_P (CH__ $#X?RK7HH R/^$1T?\ Z!\/Y4?\(CH__0/A_*M>B@#(
M_P"$1T?_ *!\/Y5Q.GVL5I\2%AAC6.))6"JO0?(:]-KS>W_Y*@?^NS?^BS2
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MNJZ;<KO@O+&99H95SC*NI(89!Y!J]3::=F)--704444AA1110 4444 %%%%
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M4 %%%% !1110 4444 %%%% !1110 5YO\.O^1EO_ /KD_P#Z&M>D5YO\.O\
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MQD^7T>J_K[@HHHKS3U@HHHH **** "BBB@#S?1?^2E7'_7:;^35Z17F^B_\
M)2KC_KM-_)J](I %%%%, HHHH **** "BBB@"IJVJV>AZ7=ZCJ%Q'9V-I$T\
M]Q,VU(XU!+,3V  )K\??VG/%^N_M/?\ "8_%QVDL_ OA^]@T+0;>3(\TNQ8D
M _Q%!YC]QOC'05]8?MN_$K6_BSXXT3]G7X?2^9JVL2)+K]U&QV6T'WA&Y'10
MH\Q_8(.=V*H?MU?"[1?@S^Q)H?A#0(?+T_3M6M$,C ;YY"LI>5_5F;)/UP.
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M9U\/?!O0]"^+/PVLH_!FLZ;J<4,\>D 01?,"8Y4C7Y4964 [0 0W(XK]#Z^
M/^"FOQ.?Q5=>$O@MX:4ZCK^HWT-W=V\)RP8Y2WB/NS.6]@JGO7I4*U>MBJ?+
M+5M>ENOE:W]7/*Q&'PU'"5+Q5DGZWZ:[[V/LOX+^.I/B;\)?"'BN9%BN-7TR
M"[F11A5D9!O ]MV<>U=I7*?"GP/'\-/AGX6\*1N)1H^FP632J,"1D0!F_%@3
M^-=77+7Y/:S]G\-W;TOH=F'Y_8P]I\5E?UMJ%%%%8'0%%%% !1110 5SGQ _
MY%:Z_P!Y/_0A71USGQ _Y%:Z_P!Y/_0A0 SX=_\ (LP_]='_ )UTU<S\._\
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M*YSXI?\ (-LO^NQ_]!KH_#/_ "+VF_\ 7NG_ *"*74#3HHHI@%%%% !1110
M4444 9/BKPGH_CCP_>Z%K^FV^K:1>Q^7<6=TFY'7^A!P01R" 1S7RO=?\$M_
M@S<:Y]O2;Q+;6N_?_9<6HQFWQ_=RT1EQ_P #S[UZ]^TY\1OB'\,? =OK'P[\
M&_\ "97T=VAO8!N=H;8'+E8E^=RWW?ESMSNP<5X"W_!4KPY<6'V"R^&_BR?Q
MH1L&BF./R_._N>8&,A&?^F6?:NW#QQ%G.A\[/]/U//Q4L-=0Q*\U=?K^GH>:
M?MI?#WPY;_&#X&_!GP/I-MI=I#-YKV5FN2GVB>-/,<DDLVV%V+,22!DFOTH
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MPM_X\[__ *Z+_(UU/B#_ ) .I?\ 7M)_Z :Y;X6_\>=__P!=%_D: .YHHHH
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MB@ HHHH **** "BBB@ HHHH *\W^'7_(RW__ %R?_P!#6O2*\W^'7_(RW_\
MUR?_ -#6D!Z11113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK \=?\BK??1/_0UK?K \=?\ (JWWT3_T-: *GPW_ .1;_P"VS?TKJJY7X;_\
MBW_VV;^E=50 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
MY[\5/]=IO^[)_-:[NR_X\X/^N:_RKA/BI_KM-_W9/YK7=V7_ !YP?]<U_E2
MGHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YO;_\ )4#_
M -=F_P#19KTBO-[?_DJ!_P"NS?\ HLT@/2****8!1110!YO'_P E0/\ UU/_
M *+KTBO-X_\ DJ!_ZZG_ -%UZ12 ****8!1110 4444 %%%% !1110 4444
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MN?\ KDW\C0!P_P *_O:G](__ &:O0*\_^%?WM3^D?_LU>@4D 4444P"BBB@
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M;_\ ZY/_ .AK7I%>;_#K_D9;_P#ZY/\ ^AK2 ](HHHI@%%%% !1110 4444
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MXJS_ ,)%XN_Y\I__  #/^%(#TBBO-_\ A(O%W_/E/_X!G_"C_A(O%W_/E/\
M^ 9_PHN!Z117F_\ PD7B[_GRG_\  ,_X4?\ "1>+O^?*?_P#/^%%P/2**\W_
M .$B\7?\^4__ (!G_"C_ (2+Q=_SY3_^ 9_PHN!Z117F_P#PD7B[_GRG_P#
M,_X4?\)%XN_Y\I__  #/^%%P/2**\W_X2+Q=_P ^4_\ X!G_  H_X2+Q=_SY
M3_\ @&?\*+@>D45YO_PD7B[_ )\I_P#P#/\ A1_PD7B[_GRG_P# ,_X47 ](
MHKS?_A(O%W_/E/\ ^ 9_PH_X2+Q=_P ^4_\ X!G_  HN!Z117F__  D7B[_G
MRG_\ S_A1_PD7B[_ )\I_P#P#/\ A1<#TBBO-_\ A(O%W_/E/_X!G_"C_A(O
M%W_/E/\ ^ 9_PHN!Z117F_\ PD7B[_GRG_\  ,_X4?\ "1>+O^?*?_P#/^%%
MP/2**\W_ .$B\7?\^4__ (!G_"C_ (2+Q=_SY3_^ 9_PHN!Z117F_P#PD7B[
M_GRG_P# ,_X4?\)%XN_Y\I__  #/^%%P/2**\W_X2+Q=_P ^4_\ X!G_  H_
MX2+Q=_SY3_\ @&?\*+@>D45YO_PD7B[_ )\I_P#P#/\ A1_PD7B[_GRG_P#
M,_X47 ](HKS?_A(O%W_/E/\ ^ 9_PH_X2+Q=_P ^4_\ X!G_  HN!Z117F__
M  D7B[_GRG_\ S_A1_PD7B[_ )\I_P#P#/\ A1<#TBBO-_\ A(O%W_/E/_X!
MG_"C_A(O%W_/E/\ ^ 9_PHN!Z117F_\ PD7B[_GRG_\  ,_X4?\ "1>+O^?*
M?_P#/^%%P/2**\W_ .$B\7?\^4__ (!G_"C_ (2+Q=_SY3_^ 9_PHN!Z117F
M_P#PD7B[_GRG_P# ,_X4?\)%XN_Y\I__  #/^%%P/2**\W_X2+Q=_P ^4_\
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M_P"$B\7?\^4__@&?\*/^$B\7?\^4_P#X!G_"BX'I%%>;_P#"1>+O^?*?_P
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MX4?\)%XN_P"?*?\ \ S_ (47 ](JOJ'_ "#[G_KDW\C7G_\ PD7B[_GRG_\
M ,_X4V77O%LT;QM93[6!4_Z(>A_"BX%KX5_>U/Z1_P#LU>@5Y)HO_"0Z"9C9
MZ?<KYN-VZU8],X[>YK3_ .$B\7?\^4__ (!G_"@#TBBO-_\ A(O%W_/E/_X!
MG_"C_A(O%W_/E/\ ^ 9_PHN!Z117F_\ PD7B[_GRG_\  ,_X4?\ "1>+O^?*
M?_P#/^%%P/2**\W_ .$B\7?\^4__ (!G_"C_ (2+Q=_SY3_^ 9_PHN!Z117F
M_P#PD7B[_GRG_P# ,_X4?\)%XN_Y\I__  #/^%%P/2**\W_X2+Q=_P ^4_\
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M35Y9I=]XGT>S6VMK"X6)22 UJQ//X5;_ .$B\7?\^4__ (!G_"@#TBBO-_\
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M_P#"1>+O^?*?_P  S_A1_P )%XN_Y\I__ ,_X47 ](HKS?\ X2+Q=_SY3_\
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M!G_"C_A(O%W_ #Y3_P#@&?\ "BX'I%%>;_\ "1>+O^?*?_P#/^%'_"1>+O\
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M S_A1<#TBBO-_P#A(O%W_/E/_P" 9_PH_P"$B\7?\^4__@&?\*+@>D45YO\
M\)%XN_Y\I_\ P#/^%'_"1>+O^?*?_P  S_A1<#N/$'_(!U+_ *]I/_0#7+?"
MW_CSO_\ KHO\C67=:UXKO+:6"2QN#'*A1L6A'!&#VJGHTGB/08Y4M+"Y59""
MVZU8]/PH ]9HKS?_ (2+Q=_SY3_^ 9_PH_X2+Q=_SY3_ /@&?\*+@>D45YO_
M ,)%XN_Y\I__  #/^%'_  D7B[_GRG_\ S_A1<#TBBO-_P#A(O%W_/E/_P"
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M;>QN%ACSM#6C$\DGT]Z /4:*\W_X2+Q=_P ^4_\ X!G_  H_X2+Q=_SY3_\
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MA\7*H LI\ 8_X\S_ (4 >DT5YO\ \)%XN_Y\I_\ P#/^%'_"1>+O^?*?_P
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M#/\ A1<#TBBO-_\ A(O%W_/E/_X!G_"C_A(O%W_/E/\ ^ 9_PHN!Z117F_\
MPD7B[_GRG_\  ,_X4?\ "1>+O^?*?_P#/^%%P/2**\W_ .$B\7?\^4__ (!G
M_"C_ (2+Q=_SY3_^ 9_PHN!Z117F_P#PD7B[_GRG_P# ,_X4?\)%XN_Y\I__
M  #/^%%P/2**\W_X2+Q=_P ^4_\ X!G_  H_X2+Q=_SY3_\ @&?\*+@'PV_Y
M&"^_ZXM_Z&*](KR'28]?T6ZDGM=/NEDD7:Q:V8\9SZ>U:W_"1>+O^?*?_P
MS_A0!Z117F__  D7B[_GRG_\ S_A1_PD7B[_ )\I_P#P#/\ A1<#TBBO-_\
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M^$B\7?\ /E/_ . 9_P */^$B\7?\^4__ (!G_"BX'I%%>;_\)%XN_P"?*?\
M\ S_ (4?\)%XN_Y\I_\ P#/^%%P/2**\W_X2+Q=_SY3_ /@&?\*/^$B\7?\
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M*/\ A(O%W_/E/_X!G_"BX'I%%>;_ /"1>+O^?*?_ , S_A1_PD7B[_GRG_\
M ,_X47 ](HKS?_A(O%W_ #Y3_P#@&?\ "C_A(O%W_/E/_P" 9_PHN!Z117F_
M_"1>+O\ GRG_ / ,_P"%'_"1>+O^?*?_ , S_A1<#TBBO-_^$B\7?\^4_P#X
M!G_"C_A(O%W_ #Y3_P#@&?\ "BX'I%%>;_\ "1>+O^?*?_P#/^%'_"1>+O\
MGRG_ / ,_P"%%P/2**\W_P"$B\7?\^4__@&?\*/^$B\7?\^4_P#X!G_"BX'I
M%%>;_P#"1>+O^?*?_P  S_A1_P )%XN_Y\I__ ,_X47 ](HKS?\ X2+Q=_SY
M3_\ @&?\*/\ A(O%W_/E/_X!G_"BX'I%>;_$;_D9+#_KDO\ Z&U'_"1>+O\
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MX2+Q=_SY3_\ @&?\*+@>D45YO_PD7B[_ )\I_P#P#/\ A1_PD7B[_GRG_P#
M,_X47 ](HKS?_A(O%W_/E/\ ^ 9_PH_X2+Q=_P ^4_\ X!G_  HN!Z117F__
M  D7B[_GRG_\ S_A1_PD7B[_ )\I_P#P#/\ A1<#TBO-_AU_R,M__P!<G_\
M0UH_X2+Q=_SY3_\ @&?\*R=*CU_1[R2YMM/NEED4JQ:V8C!(/I[4 >O45YO_
M ,)%XN_Y\I__  #/^%'_  D7B[_GRG_\ S_A1<#TBBO-_P#A(O%W_/E/_P"
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M_P#0UKEO^$B\7?\ /E/_ . 9_P *K:EJ7BC5;*2UN+&X:&3&X+:,#P0?3U%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !116;/XETBUUZVT2;5;*+6KJ)IX--DN$
M6XEC7AG2,G<RCN0,"C<6VK-*BBB@84444 %%%% !1110 4444 %%87B3QYX:
M\&W&GV^O^(M)T.?49/*LHM2O8K=KE\@;8P[ N<LO"Y^\/6MVG9VN*ZO8****
M0PHHHH **** "BBB@ HHHH **** "BBHH;J&Y,@AECE,;%'V,#M8=0<=#[4
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M0 4444 %%%% !1110 4444 %%4-=U_3/"^DW&J:SJ-II&F6R[I[V^G6&&(9
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MB@ HHHH ***CN+B*UA>:>1(84&6DD8*JCU)/2@"2BD5@RAE.0>012T %%%%
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M-.BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZN/C&I'E?);O]IZ_U8]EHKY+_P""8?\ R:[;_P#88O/YI7 _MU?\G:?LX_\
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M"ZCH7@/XB:#)\!O ]U>1SW5UKMG>22SE6X4.8%Z9R 55<C+. *^R?VD-0M/
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M(Z:,YU(WG'E?8*^4/VD/VDO'UK\7M,^#GP>TJSN_&EW;"[O=3U !HK&,@D$
MG:"%&XLP(Y4!6)KZOKX:_; FNOV<_C]X:^-?A?4-/U#7=2A71[WPC=2'[1J,
M7"[H%4%NR G'#*A^;)6KPRC*M&,]G?[[:7\K[_Y$8J4XT)2@[6M]UU>U^MK_
M /#E/Q9\4/VI/V58;3Q7\2;[P]\1O!37$<.H#2XDCEM%8X!#+!"02> 2KKG
M.,@U]P>'=>L_%/A_3-9TZ3SK#4;:.[MY,8W1R*&4X^A%? /Q2_:XM?VRO#>F
M?!KP;HUSX;U_Q+>1P:K-XAEABBLXXG61EC.[,K%DX7:K':0%R>/O?P?X9M?!
M?A/1?#]D6:STJRAL86?[Q2- BD^^%KIQ$6J2=6"C*^ENL;;_ '[/J<>%FI56
MJ,W*%M;ZVE?;77;==-.]C8HHKX7UZ'_A2W_!3/1M14?9])^(&F&"1NBM,4V8
M^IE@B/\ P/WKCHT_;3]G>VCMYM*]OGJ=V(J^PI^TM=)J_DF[7^5T?=%%?'?_
M  4*AOOB1_PK?X1:1<>5J'BC4Y;N7"[BL-O$QR1W&6)_X!7>_L)_$$^,OV7?
M#,E[)MO-"272+O>>8_L[$)G_ +9>75*C?#NO?9[>7?[TT2Z]L0L/;=;^?;[M
M3Z'HKXI_X)^V[?$+Q_\ &?XNW"[_ .W-::QL9B.D*L9"![;6@'_ *Q=07Q;^
MWM\8/%^@V?BJ^\(?"#PE<_V?,NEMMFU6?+!LGH0=K$;MRJ-GRDL36CPS4U!N
MUHJ3\KI:>>Z7J9K%)P<TKWDXQ_O6;U\MF_)'WA17Y\_%;]FW5/V&/#L7Q0^$
MWC/79]/TJZA.LZ#K4Z207D#N$Y$:(I&6 Y7(W95@1S])?M _M+6OPI_9Q7XC
M:9"MS=:K;6_]CP3?=::X0/&6]0J[F([[<=ZF=%<JG2?,F^7:SOI9?.^A5.O+
MF<*T>5I<V]U;J_EUT['NE%?"OA7_ ()\7GQET.S\6_&?XA>)]2\7ZE$MW]GL
M+B)([#>-PB'F(XXR,A B@\#@9/3_ +,_B#Q;\%?VA->^ OBOQ'<>+-)&G#6/
M#NJ7S%KA8<@&%B23C&[C. 8SC ; T>&CK",[R5W:VFF]GU,HXJ3Y9RIVA*UG
M?77:ZZ7]?4YKXC_\I4OAO_V F_\ 2>^K[HKX7^(__*5+X;_]@)O_ $GOJN_'
MWQIKG[7'Q6D^!?P_NVMO".FR+)XQ\1P?,@"MG[.C="01C;_$XQ]U&)UE3=:%
M""_E=WV7/*[_ *]#*-54:M>;[QLN[Y59+^O,^VZ\X^/7PPU_XM^!1H7ASQUJ
M7P]U$74=Q_;&EB0R[%# Q_)+&<'(_B[=*Z;P!X#T3X8^#]+\,>'+)-/T?3HA
M#!"O7U+,?XF8DL6/)))KH:\]VC*\7>ST^7D>FKRA::M=:_/?7]3\U/VG/@9\
M7/V<?A;-XR_X:/\ &GB'R[N&U^Q?:;NVSYA(W;_MC],=-M=_X)_8W^+GC'P9
MH&O_ /#4?C2T_M73[>^^SYNW\KS8U?9N^W#=C=C.!G'05W?_  4X_P"36[S_
M +"UG_Z$U>^_!/\ Y(SX"_[ %A_Z3QUZ<<35>&E4=KJ5MEMRI]NYXLL)26,C
M25^5PON]^:W?L>4?M67'B#X7_L9:Z++Q/J3>(=(TZQMCX@MYY(+N:19H(WFW
MARZL_P Q/S$_,<DUU?[(>N:EXF_9K\ :IJ^H76JZE<Z?OGO+Z9III6\QQEG8
MDL< <DUSG[?G_)I'C_\ ZY6O_I7#6K^Q1_R:M\./^P;_ .U'KFB^?"U)O?G7
M_I)V6Y,53A'90E^#@>W5^:7A7PS\3_VB?VHOC!X7TWXV^+?!-AH.I74L$=K>
MW4\0C^TLBQI&MQ&$4#ICCC&*_2VOS2^!_P =/ _P+_;(^/&H>.-;_L2SOM0N
MK>WD^R3W&]Q=LQ&(D<CCN0!3P5_:RY5=\KMUUNA9A;V,.9V7/&_32TNIW7CC
M]F_]HOX)^';_ ,7>$_CYK'C2;2X'NI]-UD2D21H-S!$FEG1FP#P=OL<U]'_L
MF_'EOVBO@SIWBJYMHK/5HY7L=1@@SY8N(\$E,DD*RLC $G&[&3C->,_&;_@H
M=\.=0\$ZEH?PXGU#QOXMU>WDL;&UL]-N(U2212H9O-16;&<A4#$G XZCMOV.
M/AE>?LR_LQNWC ?8;W-SKVI09W&U3RP=A_VA'$I([$D=JVJ.?U><\3&UK<KM
M9];_ "L8TE36(IPPDKIWYE>ZZ<O5ZMGTI17Y]_#WX2^*O^"@\>H^/_B%XMU?
MP]\/I;N2WT3PQHTJH#'&V#(Q8,F0<@L49F(;[H !NW_@G6O^"?WQ0\!SZ!XN
MU77OA9XGU)='O]'UF4.;21R,2IM"H"!ELJJGY"#G(QFL*N94I2M-]//LWW_"
M^ES9XQ\KJQA>FNM^BW:7;\;=#[WHKXP_X**?$;Q-H<WPY\%Z7XAE\%Z!XIOW
M@U;Q#&[1B&,/$NUG&"$ D9V (R%P3C-5=/\ ^"<.G>$X;+Q#\+/BOXFT'Q)E
M)EU22>*>WN5.">(E0E6Z_,SJ1P00:SIT(RIJK4ERIMI:7VWOV-*N(G&JZ5*'
M,TDWK;?:W?\ (^V:*^=OV\(9+?\ 8]\<133M=2QVUHKSR*JM(PNH06(4  D\
M\ #FO!?@C^R1XD_:6^#_ (4U?XI_$;6D\,?V9!#HGASP_*D,<%O&@2.28NC*
MTA"Y/RD_[?\ ")I454IRJ2E91=OPOI_E^)57$2ISC3C"[DF_NMO]_P#P&?H'
M17YTZ+8^)_V _P!I3P;X2B\47WB'X6>,)5MX[6_;/V9FD$98*/E5T9XV+(%#
MJV"../=_VZOVB-=^#?A'0_#G@O\ Y'CQ;<FSL)%4,\" JK.@/&\LZ*N>A8GM
M52PS;I^Q?,IZ+IJMU\NOD3#%)*I[9<KAJ^NC5TT_/IYGT_17PWIG_!,6QUS1
MX]7\8_$GQ1>_$*5!++JEO<(\,4Y&>/,4R.%/\7F*3C.%K5_9!^,7C?PG\8?$
MWP$^)VJ/KNL:1&T^D:Q.Q:2XB4!BC.?F<&-ED4MDC#@DX&*^KPES*G.\DKVM
MT6]GUM\B%BIQ<75I\L9-)._5[772_P ]3[/HK\__ -MFZ\6VO[97PA'@6XM;
M3Q9<::]I87%X,PQ/*\T9=A@Y 5V/0].AZ'9\??\ !-N/Q!X5U#Q#JOQ,\4:_
M\2HK9[E-3O)D-J\R@L%$94R(N1@8DXZ@=JSC1@J4:U2=D[]+O1M?\'_,TE7J
M.M*A2AS25NMEJD_U_P"&/N>BOES_ ()U_%W6_BQ\ V'B*]FU'5M"U&33#>7+
M%I98@B21EV/+, Y7)YPHSSR?%?$5]XS_ &^/V@O%/@S2_$MYX7^$WA24V]ZU
MBQ!O&#E.0" [.R.5W9557.">#I+"2C7E1;^'5ORTU_%:$1QD)8>-=)^\[)=;
M]OP>I]+?MS?\FH_$/_KRC_\ 1\=6?V*/^35OAQ_V#?\ VH]?*O[1G[%,O[/7
MP-\5:Q\/OB#KRZ#]F5=9\/ZU)'-!>1-(@W+L155U)!!*D]<,._U%^QSJ$&D_
MLB^ ;ZZD$5K;:0TTLAZ*BO(6/X &JE&G3PM1PE=<RZ6M[K,H2J5,93C.%GRR
MZWZP_K8]VHK\_?!/@'Q3_P %$M2USQAXM\5ZMX8^%=O>O8Z1X=TB0(UP$P3(
MY8%<\C+,K$DL!M"\N\6?#K5_^">?BSP=XF\)>+M8UKX9ZKJ<>E:SH6LRB3RO
M,!/FIL54W;58@A5(* '<&("CA5S*G.5INVGF]DWW_4N6,?+*K"%Z:O=WZ+=I
M=4OD?H!17R%_P5#;_C&:-AS_ ,3NT(_[YDK#T#]C74_VE]$TGQU\8_&FN#4[
MZ"*[T[0=%GCCM-,@(#1QG>C[F*[2S+M.2<D]:SHT8U(.I.7*E*SZ]$]/O_#?
MH:UL1*G45*G'F;CS;VZM?I^.W4^V:JZKJ5OHNEWFH7<@AM+2%YYI&Z*BJ68_
M@ :GCC6&-(T&U% 4#T KYJ_X*%?$Q_A_^SEJUA9N?[5\32IHMLBYW%9,F7&/
M^F:L/JPKE495&H0W;LO5Z(ZW.-.+G4V2N_1:L^6OA/\ 'OXD6'QB\$_%+Q'X
MHUF;X=>./$M_I,>CW5[*UG:Q%E2)A&6**%:3C"C'DMZFOT]KXM_:/_9S&B_L
M#Z9X=M(@-7\%V=OJH= <^<@)NF&/7S)F_ 5]$?LW_$Q?C!\#_!_BLR"2ZO;%
M%N\=KB/]W,/^^U;\"*]/$\E2FW36D'R^J^R_S/)PCJ4ZB55ZU(\WI*_O+\8G
MI5%?FWXFTGX@>*O^"A'Q*\-?#[Q%%X3O-7TZ&'4-89"TEK9K%;,[1 '_ %F0
MJC&#\QY7[PN_M&?L&VWP;^'&J_$[P?X]\57'C'0PM]<WFH7:EYQN D='1%=&
M&=W+-T(]ZQ6'@HTYU)VYTGM??]//\#HEB:CG4A3IWY&UO;;]?+\3]%Z*\M_9
MA^)%[\7/@'X,\5:DP?4[ZRVW<@4+OFC=HG?'0;F0M@<<UX5XF_8:U?XKZEJV
ML?&GXO:WJEG]HD:SL-(DCM+2TA#'RR1(C(&V[<X08.?F;K63HJG5E3JRMR_H
M[:?TC6-=U*,:M*-^:S73=7U_IGV/7P[_ ,%8O^2-^#?^QA7_ -)YJX3X*ZM'
M^R[^UYH'PX\(_$%?'7PY\3QF(VJW\=T;&<APH81G:D@=%R0%W*_(X&.[_P""
ML7_)&_!O_8PK_P"D\U=M"C[+$T)1=U*4?+[6IR5*[K8>O"2M**=];[QNM3[;
MLO\ CS@_ZYK_ "J>OF?]O#X1/\5/V;;Z>QA\S6_#H36+,J#OQ&O[U1CUC+'Z
MJ*]"_9:^*R_&CX#^$O$[RB6_EM!;7_/(NHOW<I([;BNX>S"N'V?-3E43V=FO
M79_FOD=-.KRRITFMXW3\UNOQ3_X8]6HKXC^$,7_"_/V^_'?CI\7&@^ K8:-I
M[]5^T'=&2.W7[2?Q6N)^(6EW7[5G[9OBKX8^.O&]]X3\(Z'$%TW0[.=8'U!M
MJ$% X*,[;V?)5CM&%&,D:PPW-*$;[QYGY+]7:S^9,\6H1G+EO:7(O-_HKW5]
M=C]$J^>/VCOV/[7]H;X@>#?$\WBV^T ^'R UK;0"3SE$@DS&V]?*?(QOPW0<
M<5E_!/\ 8UOOV?/B/9ZAX2^)6OR>!_)D%[X9U/9,)Y"/D8, J#GG*HK?+C<0
MQKS+]N[_ ).@_9I_[#:?^EEI5X>FOK5*-&>K>CMMH^G];F>(J-X.M+$4]$E=
M7WU75:[OMT/NBBOF7_@H3\4_%/PI^ $E[X3N)].O=0U"*PFU.V)$EI$RNS,K
M ?*6*A=W!&[@YQ7D_@W_ ()U>%O$G@_3?&'AGXO>(YO&%U MS%XGT^[CDMFF
M(R64*!+C.1_K=P[\\5C2HQE3=6I*R3MM?6U_U_X!O6KRA45&G&\FK[VTO;^O
MS/O*LGQ=XFL_!?A76-?U%BEAI=I+>SE>NR-"S8]\"J?P[T/6/#/@?1-+\0ZW
M)XDUNUM4BO-5DC5#<2 ?,V !QV&>2!DY.35WQ9X;L_&7A?5]!U%2]AJ=I+9S
MJO79(A5L>^#7+47+S*+N=E*7-RN:MW1\(?#>T^//[<=IJ'C./XGW/PH\%?:Y
M+?3+'0U?S6V8SDQR1,P&0"S.<L&PH%>E_#WX<_M*_!/XB^'].;QG;?%GP#?7
M'E7]QK3F*ZLDP2TNYR\F<#"@/("3@JN=U>.^%=4^-G_!/,ZEHUYX3/Q#^%)N
M7NH;^QW!K93U<NH8PY&"RR*5+?=;DD_57P'_ &R/AI^T%*ECH6JR:;X@*[CH
MFK((;EL D^7@E9. 3\C$@#) KVZG,ES8>*E2]+].OVK^9X%'DD^7$R<:M^[7
M7[/V6O(]QHKYQ_;2^/.O?";PKX?\.>"E5_'GC&^&F:6[ '[/DJK2@'@MET49
MXRV><8KS*S_X)DZ;K5FFL>+?B=XMU/Q\Z^8^L6]PGEI-U&!(K2,%/?S%)Q_#
MT'FTZ490]I4E:.RZWMO]QZE6M*,_94X\TK7>MDD]M>_D?;=?,.O?&SQ;;_M[
M^'/AK;:L(_!\^@O>76G?9HCOG\N=@WF%/,'W$X# <=.M9O[)/C7Q/XHM_B;\
M%OB)JTNL:[X2E.GC6@Y,]U9S*ZJY9LY8 9#-DX=<Y()/R???L9>"X_VV[/X0
M_P!K>('\-W&F&^>\:Y@-[YGD/)C?Y.S&Y1_!G'>NNA0A&LXS=URMK3=.+=_D
MM?70X<5B*CH1E35GS)/6S34XJWS>C\M==C]8**\,\ _LIZ3\'O@CXO\ A]X'
M\0:Q9G7A<RQZIJ,L<D]M/+ L093&D? V*>F>O/3&5^Q5^SIXH_9O\ :QHGBC
MQ!:ZS<7M^;J&"PDD>WMEV@':9%4[F/)^4#@=:XW3I^^XSVM;3>^_I8[U4J^X
MI0WO?7:VWK<^B*^+-'\?>)Y/^"FFL>%G\1ZL_AF/2A(FBM?2FR5OL43;A#NV
M [B3G'4DU]IU^9WQ8^)&N?"G_@I!XC\0>'O!>H>/M2CTZ&)=%TPR"9U:RB!<
M;(I#A1R?E_*M,%'FKN/]R?WZ&..ER45+M*'W<RN?IC7QOX;\>>)9_P#@I9XG
M\+R>(M6D\-0Z(LL>C->RFS1_LUN=RP[M@.68Y ZD^M5?^&Z_BY_T:IXT_P"^
M[O\ ^0*\T_9M\?:Q\3O^"B6M>(M>\(WW@;5+K0G670]2+F>#9# BEM\<;?,%
M##*CAAUZUTX?"U(5)2FE;DGU3Z>ISU\92J1C&#=W*/1K[2\C]':*\P_:!\!^
M._B-X/MM&\!^-?\ A!;N:[47^HK#OE-J58.(R/F5\[2"I4G&-PKY)^*_[ GP
M^\!^'+W7Y_C'J^E>/(86N;;4_$&KVT,<TZ@L.JK(-Q& 1(2,YYKAIQIR5ZD[
M?*[/0JSJQ:5*'-\TE_7X>9^@M%?-W[ ?QGUGXU? "VO?$-S)?:UH][)I,][*
M<O<A$1T=SW;9(H)ZDKD\DUY[\0_^";?P:A;Q'XQ\0>*O%FFVI>XU.^F^W6BQ
M0@EI'(S;$@#)P,D_6M*E&-&K*G6E:W6U_P"M#&GB)5Z,:M"-[]&[?Y]3[3HK
M\V?^">/[.-GK7Q4U'XM:?'J5EX*TFXN+7PXFI2*US>,RM&TLA5%4JJ,PX4#<
MV.=AS]6_M"? GQW\;O$>DV.G?$J\\&> EMV_M.QTN/;=W,V[@"08^0J2"&)
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M39M84WZP:QX7NM4@FGECP2?,CB"@QD!ERR95BI!ST^U_VQKI+[]DWXA7$?\
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MMX@_8A\ ?\*@\7> O!D=QX)MO$CP2W%U;S2W9#PL&3(ED+,G7*;@.3TKT/\
M9_\ @]%\!OA/HO@F'5[C7%TX2$WUPGEEV>1G.U,G8H+<+DX]37AWQU^"VB?
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MBOA_QYI/Q2_8[TXZCHOQOT7Q%X;0,T/ASXC2XNG4#A()0?,D8#HJE%'I7?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]E#J.EWT+07-K<+N26-A@J16#J*%?VM)62E=+T=['4J3E0]E5=VXV;\[6O\
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MM(L8A#;6ENN$C4?S)ZDGDDDG)-:U>?+EYGR;=#TH<W*N??K;:Y\4_P#!5O\
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MIQ_R:W>?]A:S_P#0FKWWX)_\D9\!?]@"P_\ 2>.N:_:<^ __  T=\+9O!O\
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M[_*WS/';[]@?XIZE9SVEW^U)XPN[2XC:*:">&Z>.1&&&5E-_@@@D$'KFJ?\
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M6WZIGCT\#-X2E"I%.4&W9[-/=77R:/.I/^"4OP@A4-)XE\91@L%!:_LQDDX
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MLK*WW@2D\:'/J8_SKZ(^ /[.'@W]G'PS-I7A6UE>>Z97O=3O&#W-TPSC<P
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M".U9?BS_ ()TZ?;>*KS7?A9\1?$'PGGO23<6VE%WAY.=L>R6)U7.3M+,!GC
MXKO_ (!_LA6OP=\72^,M;\<>(O'WC26V:S;5-5N7$8A)!*B,NQ/('WW8 @$
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MMH#QD#HR,"I'8@BM[Q!H&G>*M$OM'U>RAU'2[Z%H+FUN%W)+&PP5(KX^O/\
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M57"QHSE9QYNE[IN^GGZF_P"^H8N5>G'F4E'K:SBK:^3WT.0_X),_\D7\7?\
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M[=Y [ #BNX^ _P"Q[;?"/QD?&OB#QWXC^('C/[.]H-2U6Z=8UB;JOEEW9O\
M@;L,X( (!KMJ8OG;J0JM7Z6_#M;]#SJ>!5-*G.BI6^U??SMO>W3N>/?MW?\
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MI_X9C\(ZWH?_  D?_"2_VEJ)U#S_ +#]E\O,:)LV^8^?NYSD=>E1?#[]F/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%?*?CK6K_XW?ME^&_ NG7UQ;>&/A["-?UIK29H_.O6 $$+,I!P
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MB@ HHHH **** "BBB@ HHHH **** "BBL3QQ'KLG@W7$\,200^(VLIAITET
M8EN-A\LMGC&['7BDW97&E=V-NBO#OV2K'XRV/@/44^--Q'/KAOF-DNZW>5;?
M:/OM!\A!;<1U('7L![C6U2G[.;C=/S6QC2J>U@I\K7D]PHHHK(U"BBO/_CU;
M^/+KX3^((OAI-#!XT:)?L#S>6!G>N\*9/D#%-P!;C..G6@#T"BO,OV<;7XC6
M?PCT>+XJSPS^,P9/M+1F(L$WGRPYB^0N%QDKQTY)R:Q? O[1J^-OVC?''PJ3
M0#:?\(Q9QW1U8WF_[06\KY?*\L;<>;UWG[O3GC=T7[25.+O9-Z;66[.=5X^S
MC4FG'F:6N]WLCV>BBBL#H"O-OVB/@[_POOX2ZSX(_M?^PO[1,)^W?9OM'E^7
M*LGW-Z9SMQ]X=:])HIK1IKIK]P/5-/J<I\*/ O\ PK#X:^&?"7V[^TO[%L(;
M'[9Y/E>=L4+OV;FVYQTR?K75T454YRJ2<Y;O4B$(TXJ$=EH%%%?GQ-JWQ:_;
M"_:/^(7AGP[\2]1^&?A+P=.UJG]DF19'82-&I81R1LY<H[$L^%   JZ-)UI.
M-[))MOR7_#F=>M[&"E:[;22\W_PQ^@]%<I\+?"NL>"?A_HNAZ_XAN/%>L6<)
MCN=8N@1)=-N)W$$D]"!R2>.2>M>1?M9:?\?;ZX\(GX*7=M;P+._]JB1K96ZI
MY;-YXP8P-^53+'(X-"IJ554U)6;M?9>HW4<:3J2B[I7MN_3S9]$5X9\/OV8_
M^$$_:2\;?%C_ (27[=_PDML;?^R/L'E_9LF(Y\[S#O\ ]5TV#[WMS[=:B86L
M(N"C7&P>88P0I;'.,]LU+4QG*E)N+W37R>XYTXUHQ4ULT_FMOS"BBBLS4***
M* "BBN0^+WQ!7X4_#'Q-XP:Q_M(:+8R7GV/S?*\XJ,A-^UMN3WP<>E '7T5Q
M'P3^)7_"XOA7X;\9_P!G?V1_;%M]H^P^?Y_D_,5V[]J[NG7:.M=O5SA*G)PE
MNM#.G4C5@JD'=-77S"BBFR<1L1Z&LI2Y8N78T'45\<_\$UO'?B7QWX)\>3^)
M?$.J^(9[;7/)@DU6]ENFB3R@=JF1CM&>PXK[&KJKT70J>S;OM^*N8T:BJQYD
MNK7W-K] HHKQG]I7]HQ?V>+#PG<'0/[??7]7CTL1_;/LWD!@29,^6^[''R\=
M>M90A*I)0CN]"JE2-*#J3=DE=_(]FHHHJ#0***YOXD>,D^'?P_\ $GBB2U-Z
MNCZ?/?FV$GE^;Y<9;9NP=N<8S@XST-)NRN-)MV1TE%>>?L__ !:_X7I\(] \
M;_V5_8G]JK*WV'[1]H\K9*\?^LV)NSLS]T=:]#K6I"5*;A-:K0RIU(UH*I!W
M3U04445F:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%?&GPB\
M>>)M2_X*+?%/PU>>(M6NO#EGI!EMM'GOI7M('Q9?,D);8I^=^0/XCZFOLNMJ
ME-TXPDW\45+[S"G55252*7P2<?N"BBBL3<**** "BBB@ HI&^Z?I7QU_P3G\
M=^)?'%E\46\1^(=5U]K/7%AMCJE[+<F!,/\ *F]CM' X''%:TZ;J*;7V4G][
ML8U*JIRA%KXG;\&_T/L:N&^+'P9\,_&S2=.TKQ7!<WNEV=XEZ;*&Y>&*X900
M$E"D;TR<[?51^/<T5FFXM-;HU:4DXO9D%C8V^F65O9V<$=K:6\:Q0P0H$2-%
M&%55'     %3T447OJP225D%%%>-?M66?Q:OOABL?P;GCA\3_;(S-EX4D:WP
MVX1M-\@.[83D@X!P:(KF:7<)/EBY=OZ^_L>RT5S'PPB\40_#OP['XUF@G\6+
M8Q#4Y+8*(VN-HWD;0%Z]=HQG..,5T]5./+)QO>Q,)<\5*UK]]PHHHJ"PHKQ?
M]LK7]3\+_LS^.]4T;4;O2-3MK1&@O;&=H9HCYT8RKJ0RG!(X/>K'[(>N:EXF
M_9K\ :IJ^H76JZE<Z?OGO+Z9III6\QQEG8DL< <DUK&FY4Y5.S2^]-_H8RJJ
M-6-*VZ;^YI?J>P4445D;!1110 4444 %%%% !1110 4444 %%?&OB?QYXFM_
M^"EGA?PO%XBU:/PU-HK2RZ,E]*+-W^S7!W-#NV$Y53DCJ!Z5]E5M.FX1A+^9
M7_%K]#"G652<X)?"[?@G^H5\H_$K]AG4OC#\2-2U?Q;\7/$5_P""[R]^UCP?
M KQP1  ;41FF9 !CJ(@>O0\U]745-.I*E+GAN55I0K0Y)[?UV]3.\.^'M-\)
MZ#8:+H]G%I^EV$*V]M:PC"1QJ,!1^%:-%%0VY.[W-(Q44HI:(X[XP?#W_A;'
MPO\ $O@_[?\ V5_;5D]G]M\GSO)W?Q;-R[OIN'UK-_9_^$O_  HOX1Z!X(_M
M7^V_[*65?MWV;[/YN^5Y/]7O?;C?C[QZ5Z'7C'[/_P"T:OQV\2?$72DT Z,O
MA#5?[,$YO//^U_/*OF;?+7R_]5TRWWNO%:P]HX2C';1OY:+_ -*_$PJ>SC4A
M*?Q.Z7S5W^$?P/9Z*\:_:LL_BU??#%8_@W/'#XG^V1F;+PI(UOAMPC:;Y =V
MPG)!P#@UWWPPB\40_#OP['XUF@G\6+8Q#4Y+8*(VN-HWD;0%Z]=HQG..,5*A
M[CG=;VMUVO?T_4T<[5%3L]KWZ;VMZ]?0Z>BBBLS0***\S_:-M?B->?"/6(OA
M5-%!XS)C^S-(8E)3>/,"&7Y Q7."W'N#@T=4A/1-GIE%>?\ P$M_'EK\)?#\
M?Q,FAG\:B)OM[P>7C.]M@8Q_(6";02O&0<9ZUZ!6E2/LYN-[VZK8BG/VD%.S
M5^CW"BBBLS0**^-/A%X\\3:E_P %%OBGX:O/$6K77ARST@RVVCSWTKVD#XLO
MF2$ML4_._('\1]37V76U2FZ<82;^**E]YA3JJI*I%+X)./W!1116)N%%%% !
M1110 4444 %%%4/$$CPZ#J4D;-'(EM(RLIP00AP0?6IE+EBY=BX1YY*/<OT5
M\A_\$R_''B/Q[\$?$%_XFU_5/$5]%X@EACN=6O9+J5(Q;VY"!I&)"Y9CCIDG
MUKZ\KJQ%%X>HZ;=[?Y7.+#5UB:2JI6O_ )V"BBBN<Z@HHHH **** "BBB@ H
MHKQGX%_M&)\;/'/Q*\/1Z =)3P;J0T\71O/.^V9>5=^SRU\O_5=,M][KQS<8
M2E=KHKOTNE^;1$IQA;F>[LO6S?Y)GLU%%%06%%%% !117C/P[_:,7X@?'[X@
M?#-= ^Q#PG%')_:GVSS/M1;9D>5Y8V8+?WFSBKA&51M1Z*_R7_#F<ZD::3D]
MVE\WM^1[-17G/[0EM\0;OX2:[%\+IH8/&K*GV-IC&,C>OF!3)\@<IN +<9[C
MK2?L]6_Q"M?A'H47Q1FAG\:JLGVQH3&2!O;RPYC^0N$V@E>,^O4N,+P<[K1V
MMU]?0)3M-0L]5>_1>3\ST>BO@+Q9KGQ7_:J_:I\:?#[PO\1;_P"&OA7PBI5I
MM*9UED92J%CY;QLY9R>"X554<9Z^E_%CX>_M'^#?A)X&T#X:^,9/%?B*RNYA
MK6LWQMX[BYC+[H6/VDL-B@D,-Q8X'WN:W]@N6FW))SLUZ/JWLCF^LWG4C&#:
MA=-Z;KHENSZRHJEHJWR:/8+JCPR:F+>,73VX(C:7:-Y4'^'=G'M5VN62LVCK
MB^9)V"BBBD4%%(WW3]*^.O\ @G/X[\2^.++XHMXC\0ZKK[6>N+#;'5+V6Y,"
M8?Y4WL=HX' XXK6G3=13:^RD_O=C&I55.4(M?$[?@W^A]C445\:^)_'GB:W_
M ."EGA?PO%XBU:/PU-HK2RZ,E]*+-W^S7!W-#NV$Y53DCJ!Z4Z5-U9<J[-_<
MF_T%7K*A#G:OJE][2_4^RJ***Q-PHHHH **** "BBB@ HHHH P?'?@G2?B1X
M/U?PQKMO]JTG5+=K:XC!P=I'53V8'!![$ T_P3X1L? /A'1_#>F/<2:?I=JE
MI;M=S&67RT&%W,>O _PXK;HI\S2<>C)Y4VI6U7Z_\,@HHHI%!17SK^W]XIUK
MP;^S#XBU7P_J]_H>J17-FL=[IMR]O,@:X0, Z$,,@D'GD&O2?V>=4O-:^ WP
M[U#4;N>_O[KP_837%U=2-)+-(UNA9W9B2S$DDDG))K:--RHNM?:7+^%S"551
MKJA;5QYOQL>@T445B;A17C7Q)_:*7X>_'?X>?#8:!_:#^+5D8ZE]L\K[($SC
M]WY9WYVG^)<5[+5\DE!3Z.]OEHR%.+G*"W5K_-77X!1114%A1110 45S?Q(\
M9)\._A_XD\426IO5T?3Y[\VPD\OS?+C+;-V#MSC&<'&>AK _9_\ BU_PO3X1
MZ!XW_LK^Q/[565OL/VC[1Y6R5X_]9L3=G9G[HZU:A)Q<ULK?C>WY,ASC&48-
MZN]OE:_YH]#HHHJ"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$\<?\B5X@_[!]Q_Z+:O
MD/\ X)/_ /) ?$G_ &,LW_I+;5]>>./^1*\0?]@^X_\ 1;5^8/[$G[$W@?\
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M:"\=?&VU\5:;X3^$W@NRN?MEK]HG\5ZM*/LEI\Q4ILX&\?*W.XD'A#@D?/\
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MQZK\6?$#:IXCU0BX73!9V]NFF1$96(^5&I9SG+;B<< ="3\)>(_&'Q&7X@>
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M^&?Q TOXJ^ ="\6Z,S-IVK6JW,2O]Y">&1O]I6!4^X-<5^UQ<65M^S-\2GU
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M3S5]H^&_^1=TO_KUB_\ 0!6K_P!S7^)_DB%_OK_P+\V:$DBQHSNP5%&2S'
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MA3^VQX/\+ZQK?G?#3Q=;B*SLY+6!1!=$&, 2A!(?WHCX9CQ-["OI;QKXJL_
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MF3^)M-^)OQ2OD/VOQ=X@E,3/][R8RS\'TW3,O_ *P?B/_P I4OAO_P!@)O\
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M*2,<-*I'?::]E_94_:)U#XW:1K^D>*M'7P[X_P#"]T++6M-C!$>X[@LB DD
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M'B/]I+PM\3OB?XT\,>(1I%K/92-IH:.=H7BE54"+:Q(</+G).<?@*ROVH/\
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M14;NVC;;:W[*W3N?,?[-7[6'BCQ%\3-0^$?Q<T.#P]\0[-&>VGMOE@OU5=Q
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M=^)U@T+]D%X,?^/&1$_[_FIF@/Q]_P""BQ+@S^'?AAIP/(RAO&Y'_ @\F?\
MMWK10A5K4JUO=:YFEM[NDE\Y)?>92J3HT:M"_OI\L6]_?UB_E%M_]NGT/\5O
M%GCKX9_"6VN_#7AV3XC>,$%O9M""L/FRL C7#JB@;0WS%5V@ GE0"1\YZWH_
M[;QTR?Q+'XE\(V9CC^T'PK9P0R2\#)B4M P)[?Z_Z&O9?VN/VF#^SAX-TV73
M=*_MWQ5KER;/2=/;=L:0 9=POS, 64;5P6+ 9'4>/VWP0_:M^+5L+WQA\7K;
MX>6UPHD72_#T.9K;/.QC%Y?(_P"NS_6L*-U"55J*5WK):=-$O+T\KFV(MS1I
M)R;2VB_75R\]M^E['LW[(/[13_M(_"O^V[^SBT[Q!I]RUAJEK "(Q* &#H"2
M0K*PX)."&&3C->!^)OVMOB?X>_:J^)'PZT&R/C&Y9(;7PQH;6\,45M<&.*1Y
M99E"N8U4R,=S^@RHY%?_ ()4QSV=C\6;&:X:Z-OJML#,X^:1L3!G/4Y.T'J:
MN?!90W_!4#XND@$KHK$9'3BQ%=KI4HXRI%*\>1RM\HO]?5'%[:M+!4Y<S4O:
M*-^NCFM>CV]&>Y_L^^&_CUHVLZY>?%_Q9H>MZ?/;H=.L-&A1?LTA8E]S"",D
M 8 RS]>M<7^P#\;/&GQL\(^-+WQIK/\ ;-SI^L?9;63[+!!Y<7E@[<1(H//<
MY-?4\O\ JW^AKX@_X)5_\B#\1?\ L8/_ &D*Y*<E5A7DXK2,;:;>\>A*+HRI
M14F[R=[O^ZSUCX[>-OCW=^/%\&_"?PAI]I9&U2YF\9:U*&MX]^X;$0C&]2O(
MQ(<$': <UX;XR^,/[3?[)FI:+X@^*>J:%X^\$7MVMK=MI5O&C6^><*RP0LKE
M0Q7<&4[<'!(KMOBS^TO\4/B%\;=5^$/P,TW3X=1TA/\ B;>)=5 :.U;@-M#
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M-;DL#H^NV%R^G:OIC9_T>Z0 L%SSM(((SR.0<D9KPO\ X5;^V[_T6'P7_P"
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MN6+5M==4GJ]W;I^IO_!'XHVOQH^%/AKQI:0?94U:U$LEONW>3*I*2)GN%=6
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MEW 5RTY2KU>;ECHO1+7=_EY]M#NJ1CAZ7+SRU?K)Z;*_I?I;OJ-T'X^_'/\
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M]);:O2C&$98IN*?+:W_@37]>AY3E4E3P:4VG)2N^_NQ?^>^U[[G.P_'WX_\
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M>K5XI_.S>GW'D7C&']M7P3H-[XSN/%'A/4;*QC-Y<>&["UB=Q&HW.HS;J6
M.=LV[C@DU])_LS?'*#]H;X/Z3XOCMDL;Z0O;7]I&25AN8SAPI/.T@JPSSAAG
MFOF_7O@!^T]X\\,ZGJ?CGXUQ>&(5M99SI/AV$_*H0DQ.8O)!X^7[S_4UH_\
M!**9Y/V??$*,<JGB28*,=,VUL:VG"%2A4NXWC;X?-VWZ_P# W.:$YT\122YN
M6?-\3WLD]%T_#?8L:O\ #7]M%;R]GM_C!X+MM/$CO&);6(>7%DD;B=./0=>>
MW6N=_8E^+7QU^,'Q=UO_ (23QM:^)? /A\S6UW>6FFV\5M?7!!6-8)%MXY"!
M_K,\< 9'S"NO_;0^+FN>*]?TGX _#F;?XO\ $^%U:ZC/&GV1&6#D?=W+EF[A
M!ZN*^B/@O\)=%^!_PXT?P?H2?Z+8Q_O;AE >YF/,DS_[3'GV& . *SC5Y:#G
M.,?>TCHK^<OT7GKT-9T>?$J-.<O==Y:NW=1^>[\K+J><_M!>.OC;:^*M-\)_
M";P797/VRU^T3^*]6E'V2T^8J4V<#>/E;G<2#PAP2/G_ .('Q(_:N_99MK+Q
MEX]UOPWX]\(?:8X;ZUT^"-/(5VP/F6WA=2?NAOG4$C(->B?'C]IWX@ZI\:3\
M&?@II%G=^*X8!-J>LZD 8;%2JL2 ?E&T.A+,&R6"A2:\,_:I^ ?QNT7X&Z]X
ML^)'QGDU^&U,'G>'=-B=+*<M,BC./*7Y2P89B/('3K1AUR1@YJ*4FM]6TW;3
MMV3T[ABI.I.:IN3<5T:2BTNKTOW:U[:'Z!+XRM_$7PO/BO1)S]FO-(.I64S*
M,[6A\Q"0<C/(X-?#GP(_::_:#_:&^'</AWP5]AN?%MM/*^L>-=:MHH;6SB8_
MN(DCCCVM(0&R1&V!CY?XA])_L]S/-^Q;X49SEO\ A%-O3L(6 _05Y;_P2I4+
M^SKK!  )\17&3CK^XMZ<:<*4\2FK\EK7_P 4E_7?KH*=2I5CA+2MS\U[?X8O
M^NU]-3U/_A97B;]FW]G.Z\3?&C6[7Q-XFL7D#R:4B1I=.TA$$,>(XQDC;DE!
MCYB<XKP;P/XL_;"_:!TN/QOX:U/PSX$\-77[W3]+U"W3_2H<G:P+02R$'^\6
M0-U  (J__P %89)U^$/@Q-T@LFU[]^%Z$B"3;G_Q[%?:'AF.QA\-Z3'I@C73
M5M(EM1#]P1!!LV^VW&*B,E&D\0XIR<K+31))/;N[_@:2C*5:.&4FHJ-WKJVV
MUOO96/SK^'/B;QOXG_X*.>#I/B)X=A\-^++32IK2ZAM7WV]QMM;@K/%R?D8,
M.-S<@\]A^D]?#/BS_E*MX1_[ +?^DMS7W-4XJ7-3HR2M[K_]*D/!Q<*M>+=_
M>6_^&)\O?M\_'#Q9\!_ OA#6?"FK?V3)=:[';7K?98I_-M_*D=DQ(C8SM'*X
M/O6#I/B']IWXZ:UIOBWPM=:)\-_AU/<QR6VG:G$DNHWMB6!,S!H9-K,F2%S'
MU'7ACSG_  5C_P"2-^#?^QA7_P!)YJ^VM/4)8VRJ JB-0 !@#@4X2C2P\:O*
MF^9K7TC]_EVU[A4C*KBI4N=J/*GIIUEL^GG;>R['AW[0GCSXT:=XCTGPM\)O
M!5GJ$FH6[3S^)]4E_P!$LL-M*%<@;^0PR6)!.$;!Q\^?$+X@?M:?LPV%OXV\
M;:[X:\>>$X[B.*^L;&WC3R5=@!EEMX74D_*&!< D9!KTC]H']I[Q[)\9(?@S
M\&=&M+_QCY GU#5M1P8;%&4-D G;\JLK%FR/F"A6)KP_]IWX _'/3?@7XF\6
M?$CXTR:S!9QPM/X=TN%TL[G=/&H#;?*7@L&YB/*_C58=>SC"4U%*3ZZMINVB
MZ+HGIWU(Q+=2<HTW)M?RM))VZO2[ZVU[:'V3X\U7QM\6O@GI6M?!K7M/T#6M
M8BMK^TOM7C#1K;NNYE(,4HW8('W3R#S7Y]_LC>$_VA?$FL?$IOAEX[T#P[=P
MZJHUV34X$<75P6FP\>;27 R).@3[PX]/O3]BV9Y_V6?ANSG<1I:KT[!V _0"
MO!?^"9__ "'OCE_V'XO_ $.YK:-L/+$TXI-*^ZO]J*^[R[ZG-4OBHX2I)M.5
MMG;[$G?UZ7[:'HG[6/Q*^(WP,_90TO6K?Q#!#X^MGL+34=5M;6&6*:9EQ.R)
M)%MVLP)'R+@= .E>X^ ?%;77PA\.>)=>O4#R:%;:C?WD@5%R;=9)9"%  'WC
MP !7S]_P4X_Y-;O/^PM9_P#H35L?%S[9_P .][O[!GS_ /A";3=C.?+^SQ>9
M_P".;JXOBPLZEE?G[;>ZOP\CT-88VG2N^7V???WK7];=3RK3?V@_C_\ M9>(
MM8;X(1Z5X*\#Z;<&W37]:A5WN7 S@[XY>2"&VI&=H(W-R*T/#W[4'Q;_ &>/
MB9HG@S]H*UTW4M&UIQ%9>+]+18T#$@;FVJBE%)4,-B,H.[YABO3_ /@GG_9W
M_#)?@S^S]N[==_:MN,^=]IDW;O?&WKVQ7GW_  55_L[_ (9_T;[3L_M#^WH?
MLG][_52[\>V.OX5V3=.EB5A>1.-U'S>MKW_'M;H<4%5K85XMU&I6<EV5M;6]
M-.]^I]GYSR.17CO[7OC_ %[X7_L[>+_$_AB__LS7+".!K:Z\F.786N(D;Y9%
M93E68<@]:[WX8?;?^%:^$O[2W?VC_9%I]I\S[WF^2F_/ONS7D7[?G_)I'C__
M *Y6O_I7#7ESCR55#>TDO_)DCV*<_:4U.UKJ_P"!U7P-^)5]K/[-/AGQSXJO
M&O;U]#_M+4+I(40R%4+.P1 %!P.@ %?+_@;XH?M4?M5VE]XO^'>K>&_A_P"$
M([E[>RM]0B21[C;U^9H)F8C@%L(N<XZ&OI#]DVQM]4_91^'ME=Q+/:W&@QPR
MQ.,JZ,I#*?8@FO%U_95^,/[.E]?W?P%\<6MYX:N)VNG\&^)4#1@_W8Y"",G@
M9!B) &YFQFO2E[*GBJRDDM7RW6BU=]/2UM/N/+_?5,+0<6VK+FL_>>BM9^M[
MZW9[?^SAXB^+NL:3K-C\7/#FG:3JFF7"P6VI:=,"FHH5R9!&"0 ./F!&2Q&Q
M2IKV*OG?]E[]JB\^-&M>(?!?B_PVWA#XB>'1G4-.5BT,J[@I>/))7#%<J2W#
M*0S \?1%<6(C*,_>25[;;/S7J=V&E&5/W9-V;6NZ\GZ'YFZCX^\8> ?^"AWQ
M4D\!^$V\8>*=2LAI]G9L^R&!FCM',\S<8C41\Y91EA\PKT'X@:]^V5\&='N?
M'FL:UX5\3Z%9#[3>Z%86T;"WAZL6_<QR%5'4K*Q'7D FK/P5_P"4GWQ?_P"P
M(W\K"OL;XBW%E:?#_P 33:DRIIT>F7+7#/T$8B;=G\,UU5J_L*%"2BF_9QWU
M^7]:G)A\/]8Q%>+FXKVDEH[==_\ @;'.? #XT:;\?OA7H_C+3(3:"[5H[FS9
MMQMKA#B2,G R >0<#((.!G%>%>+/$G[5OQ4\4:U8^"-%T+X6^'].NI+:#4]=
M=9Y[W8Q7S%S')\C !AB(#GAFKGO^"6EQ)H_[./BC4=0?R=,BUVXG61@<*B6T
M!D;Z<'\C67H/QN_:#_;!U+5KGX2R:5\._ %E=-:IK6I()+FY( )'*2?-M*MA
M%4+D N36E2@J>*J1II6C9Z[*]K?Y+<RI8AU<'3E4D^:5UIN[7O;\V]+&U\*?
MVA/C#\*?V@-'^%'QRDTW61X@3.E>(-.B2-6D.0@!1$5E+*4P45@S*>E>G?MD
M?M(ZQ\ O#?AZR\*Z5#J_C'Q/>FQTR*Y!,2$;06(!&YLNBA<@9;)X&#\<_%OX
M4^./A'^U)\"CXT^)%]\0=1U'6K62.6[1U2S47D*LD8>1AAMW8+T'%?>/[2'[
M.&A_M'^$;73-1O;G1M6TV;[5I>L6?,MI-CKMR-RG R,@_*""",TJT:5J-:5F
MFVI<NE[/^K][:#H2K<U>C&Z:2Y>9W:;CU>OJNW4\#^R_ML> X4\1W>J>%/'<
M"X>;PQ!%$DP4]0&6&'+ ?W96^C=_J/QQ\4++X6_"R[\:>,(UTN.PLDN+RT@E
M\XK,0!Y$;87>2Y" X&>O%?*FO^/_ -I;]DC2SJ7B]=)^+WP_LF59]3@S#J%O
M#PH9S@$'IEF67W<9S4'_  4$^($'Q2_8S\,^+/#3R/H&KZI:7,OF+AT0I+A'
M R 5D 4\_>'!-9UHNKR\O+RN25XZ6OT:_%77S-*,U1Y^9RYE%RY9.][=4_PT
M?R'>'_%O[7/[1&GQ^+_!]WX;^&7A6Z_>Z;9:G&DDUU ?NN2T$S'(_BQ&#U P
M0:]/_9I_:(\8^(O'VO?"GXKZ3;:1\0]&@%W%<6(Q;ZC;9 \Q1DC=\RGY>"">
M%*D5Y9X/^&_[95]X2T2YT7XO^"4T::RADLE6TBP(#&IC _XEQ_AQWK>^$'[,
M?QTL?VD]"^*'Q/\ &7AGQ";"QFL)6TL-'.\31R!$V+:Q(0'?.2<_7BNJI"E%
MS@W%12=M^:ZVUMKKHSCIU*TE"HE-R;5]N6SWTOHK:KT.H_:R_:RUGX5^)M#^
M'7PZT:/Q'\2=<VF*&52\=JC$A25!&YVPQ&2%4*6;C@\)<?\ #9'PZT*Z\0^(
MKKPS\0])-NQO?#EFL<5Y%$5^?RVC@C!=1GHTG^ZU8_P]\JX_X*I>-SJYWW,6
MEM_9OG8R&^S6_P!S_MF9?PS7W)XD_P"1=U3_ *]9?_0#7GU91P^&@^52<X\S
MOKO?3R]5J>G1C+%8J:<W%0ERJSMM:[\[MW5]+'QW_P $H<?\*#\2[1@?\)--
MC/\ U[6U?:U?%'_!)_\ Y(#XD_[&6;_TEMJ^UZWS+_>I?+\D895_N</G^;/D
M'X[?M5>.=6^,!^#OP/TBUU/Q; A;5-8O5#06' +  G:-NY=S-D9(4*6-<;XL
M^(W[6'[+]C'XM\>W/AWXE^$(Y%&H1Z;$D4EHA(&=R00LN2<;BLBCO47_  3R
M\K_A??[0']J8_P"$F_M/YO,^_P"7]IN/-VYYQO\ +S_P&OKWXY?V=_PICQU_
M:_E_V;_8EYY_F8V[?)?UJ*E2.$A!*"E[J;OK>ZOIV[:=>Y=*G+&3FW-QM)Q5
MM+6TN^[ZN_X%_P"&?Q&T?XL^ =&\7:!,TNEZI;B>+?@/&>0T; =&5@RD>JFO
MAGX)_M9?'WXL+XE\&^%M+MO$_BJ+5IL^)M6@BM[#2;+A45A$JAWW*Y&06Z\/
MT7U#_@EY]M_X9DF^U;_L_P#;=U]EW=/+V19V^V_?^.:YO_@E_P#\>'Q<_P"Q
M@7^4E;RHTZ-6O&UU%)KYM?YZ]SFAB*F(HX>5^5R;3^49?G;Y'/>*/CM^T=^R
M=XZ\,7'Q?U?1?&7@O6;D6\L^F6\2+",C?L9886#JIW ."K $9ZD?H$K"10RG
M*L,@U\4_\%7(U;X%^&F*@LOB&/!QR/W$U?8WAO\ Y%W2_P#KUB_] %856JN'
MC5Y4FI-:*U]$U^9UTHRHXATN9M.*>KO;5K\;'"?M'_&B'X ?"'6_&<EG_:,]
MH$BMK0L566:1@B!B.BY.3[ U\Q>&)OVT_'?ANP\>:?XA\)V-A?P+?6OA>:WB
M1Y(F&Y%R86*[E((W3@C(R0<U]=_%CX6Z%\9_ .K>$/$<4DNEZA&%9H6VR1."
M&21#@X96 (R"..01Q7RDOP[_ &E_V5=%*>"O$&F_%CP-ID?[G1=6A*7T$*\E
M8\$,=JC "R,..(^U3AI4XQES64KZ.6UK?<G?J^G4>*C5E.+C=PMJH[WO][5N
MBZGM5U=?&_XB?L]V5QI<.C_#?XJ7#H98[Q_/MH460AS@Q2[2ZC(7#XR/FKX1
M_91\)_M">(O&/Q3'PW\=:!H&JP:HH\03ZE C)>7!DGP\8-I)@;A*> GWAQZ?
MH3^S7^T)I'[27PY3Q/IEG+I=S#.UG?Z=,X=K:=0K%0V!N4AE(; SGD @BOG#
M_@G#_P E&_:!_P"P]'_Z.NZZZ3E1=>,H).U[6O\ :CIZ=?Q.&O&%=8>49MIN
MU[VZ2UZ:]+_(](_:@^(GQ)^!O[(UMK8\16Z_$*S-C;W^KVEM#+%+*SA961)(
M@F&Y_@&.P%<)I?Q$_:9_:2T.PU[X83Z)X!\*QP1K%J6O1(UQK$JJ!+(J&&4)
M'O#!?E7_ 'CT'9?\%+?^34]:_P"PA9?^CA7L_P"SVH3X"_#E5 4#P[I^ !_T
M[I6%.450G6<4WS]M/A3V[>6QTU8R>*A04VH^SN]=7:36_?SWTW.3^/7CKXM>
M"]'\-Z3\-_!L/C'Q#J@,%QJUW(([6Q9%4F25 5&&^8CYE (Q@D@'YX^(.K?M
MD_!/P[=^/-:\4>%/$^AZ</M%[HMG:QMY4/\ $6Q;Q.57N5D) &>:]5_:F_:B
M\2_#OQMX=^&/PST&'Q!\1M?C\V(7?^IM8B6 8C<H+'8[9+!5"$G(XKQSXN?L
M_?M%:M\*/%OB'XA?&U8K:RTNXNYM#T&%E@N(UC+&%R@A7! VG*L/]ZE1]V'M
M)**3;U:O?7HNRVV05_?J>Q@Y-I+2+M;M=NVKWW?H?3VB_$3Q!\?_ -FVV\5?
M#2]M/#_B?6;(-92ZE^\AM+A9-LR/^[?<%*R*#L.>#@5\"?!/PI^T-K'[2?Q3
MLO"?CO0-,\?6I*Z_JEW AM[O$@7]TIM' ^8 \1IQ7US_ ,$U9GD_91T)6.1'
M?WJKQT'G,?YDUP'[)7_)\W[0O_71_P#TI%=,4L/BJU."5N635]?Y;+TUU[G)
M4OB<)AZDY.[E%::=]?733MJ>L_$WQ-\4/@[^QOKFL^(/$EG>?$O2K0R2ZUI]
MO$T!<W("E8VA1#B-E7F,<@_6M+X4^)OB%\5_V1-#UK2M=M(OB+JVE>9!JU_
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MM:==<J7NK96^TOZ[EU*'LJU!\[?O/=W^Q+7R_(^XZ^&?%G_*5;PC_P!@%O\
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M^+?$=QY-A9^%]."1*1YEQ*;9-D48[LQ_+DG@$US_ /P4B_Y-+\3_ /7U8_\
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MCAZB<5=26ZO_ #;W[=.QC6IQK8JE)3=I1EL[;<NUN^[[GT+1117DGMA1110
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MKNI%0226]EW[ETL.J<G-R<G:UWV['GG[07PFC^./P?\ $G@MKH6,NI0 07+
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M[7[?Y[GQEK7P1^+7P]_;?N?B=X*T2PU_PKXE%O::M)<7,2/9VQ,"SD(TB,7
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M-;T3QMH_]BZG<ZY)>10?:H;C=$8($#;HG91\R,,$YXZ5]0T5T>WE^\_OVO\
M)WT^\YUAH)4E?^'>WS26OW>1\I_M[_!'QK\:M)\ 0^#-%_MF72]7:ZO%^U00
M>5&54;OWKKGH>!DU]6445FZC=-4^B;?WV_R-%2C&K*MU:2^Z[_5GDW[5G@;6
M_B5^S[XS\->'++^T=;U"U2.VM?-2+S&$J,1N=E4< ]2*G_9=\%ZS\.O@!X)\
M-^(;/^S]:TZQ\FZM?-27RWWL<;D8J>".A->I44HS<:;IK9M/[E;]1NFG457J
MDU]]G^A\H_$SX(>-?$'[=?P[^(>GZ+]H\'Z3IWD7NI?:H%\I]MR,>6SB1O\
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M=1NG&G;:_KKW_0V5-*K*K=W=E;IIV7GU"BBBLC8**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_-C&<<].:Z6G9V3[BNFVET"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
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M*2T7:<-F4-L&#P>>*\[^%7Q8_P"%W?LP6WC)XUAN]0T:X%W'']U;B-7CEQZ
MNC$>Q%?%/["/[,&G_M"?#1M1\=ZYJ.I>#-'U2:"Q\)VUP\%N;@HC232LA#$D
M.H&T@\?>QQ2AAM:L:CM[.U^N[:_30)XO2C*E&_M+VZ;)/]=?0_1;PE\2_"'C
MYIT\,>*M$\1M;@&9=)U&&Z,8/3=Y;''XUYI^V+\0]*\$_ 'QM;3>(K#1M;O]
M'N8]/MY[R.&XN&*[2(5+!G.&Q\H/6OD?]HKX+:%^QU\>_A%XR^&J76B6&HZE
M]EN]/^U23+@/&'4-(Q8K)'(P()(XXQ7TI^W=\'_"/CKX(>)?%.N:1]NU[PWI
M-S+I5W]IFC^SLVTD[$<*_*K]\'I4U*5+EA53;A*Z>FJM^';Y%TZU9RG2:2G&
MS6NCO\K]'TW/*_V!_"7P.OOA#X.BO8_!FI?$JZN)KUH;V6UFU9)HYG:/RT8F
M5 J1JP"@< MW)KV/P]\"?@_8_M3:KXXT_P 0QW'Q,\N2>XT!=6A<VY>,(\_V
M8#S5)1Q]X[?GR ,BO-?^"?\ ^SG\/%^$O@+XGCP]_P 5SMNV_M7[;<=3+-#_
M *KS/+_U?R_=]^O-8WPU_P"4I7Q$_P"P'_[2M*]*O[^,JQA)IJ,[_+HO)Z'E
MX5<N!I2G!--PM\^K\T?<Q..3P*Y*Q^+W@35/$']@V7C7P[=ZYO,?]F0:K ]S
MN'5?*#[L^V*^5/V^OB#XG\4^-O OP)\'W[:;=^+'5]3N8V*G[.SE%1B.=GRR
M.P'4(!T)!ZNS_P""9_P6M_",>ER:?JDNLK'@^(%U*5+GS/[XC#>2.>@V'\>M
M>9"E!4E5JMI.Z26^F[Z=?O/5J5JCJNC1BFU9MMV6NJ6SUM]QPW["/_)S7[1_
M_86_]NKFON2:9+>)Y976.- 69W. H'4D]A7P)_P3BT6X\-_&_P".^DW>I7&L
M7-A=Q6LFH71)EN62>X4R.22=S8R>3UJ?]J_Q]:?&;]I*Q^"NM^-[7P%\.])M
M5OM?O;B_CM/MLI576$/(0I.&CPIR 2S$':!756I>UJTZ<']B.ODH[VW^7>R.
M:C6]C2JU9K7GEIYN6U]M^OS/LK0?B]X$\4ZP=)T7QKX=U?55R#8V&JP3SC'7
MY%<MQ]*ZN21(8WDD98XT!9F8X  ZDFO@#XB?LX_LG2>!;X>#?'WAGP]XLM(&
MGL-5@\9)-(;A!N3<CSE>6 ^Z%(SQBO>/V2?BYJ/QH_95M-;UJX-WK5K;W6G7
MMPWWI7B!"NW^TR%"?4DFN6O1C"C.K3O[N]U;>^J^[U.G#UY3KPHU;>_M9WVM
M=/SUOV/:-+^(GA77/#<WB'3O$VCZAH$)82ZK:W\4EJA7[P:56*C&1G)XJ+PG
M\3O!WCZ:>+PSXLT/Q'+ ,RII.I0W31CU81L<?C7YQ?L%_LRV/[0WP[N[SQMK
MNHWO@C1M7ECM?"EK.T$$MT8HFDGE92&/RLBC!!X/S 9!V/VHO@CX?_8Z^+7P
MI\??#..ZT*VN-3^SW5@+J293M9"P#2,S8DC:164DCITKLE@Z4<0L,YOF>VFF
MJTOZ^1Y\<?6EAOK7(N57;UULM[:=/,_2NN5\4_%;P3X&NX[7Q)XQT#P_=2#*
M0ZIJ<%L[#U"NP)KR7]N3X[W_ ,!/@;=ZEHLGD^(-5N%TRPFP#Y#.K,TH![JB
M-CW(KR[X&?\ !.OP+?\ @>RU[XIP7_B_QCK4*WUZUSJ,\2V[R#=L!C=6=AGY
MF=FR0<8%<5*E&4'5J.T4[>;=KZ?YGHUJTHS5&DKR:OKLE>VOSZ?,^S=/U&UU
M:Q@O+&YAO;.=0\5Q;R"2.13T*L#@CW%5?$'B;1_"6FR:CKFJV.C:?']^[U"X
M2")?J[D ?G7F_P !_P!GOPY^S3H7B"RT'4M4N-)O;MKX0:C<F5+- @^2->@Z
M$EL;FX!)VBOBCP+J'P^_;$^)/B;QY\;/B%I>D>&M/O6L?#WA&\UV+3_W  /F
M,&=7P05RR8+-N^;"@54*,:LY*#]V*NW;77I;O?3MHV34Q$J-.+J17-)V2OIZ
MWMM;7OJD?HGX3\?>&?'EO+<>&?$>D^(K>([9)=)OHKI4/H3&Q -;U?FA\==
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MU<K;*EJ2X$1D9@ &$;_*2-Q*+T)!Q]0_9C_8XN/"4FEVGCSPW9ZMY.R/7/\
MA,XGN!)CAV0S>4>>H" >F*RIT(^S56I>SO9)7>FE_O\ O-ZN(DJKHT[75KMN
MRUUML^GW'WE6!I?C_P +ZY'JLFF^)-(U"/29&BU%[6^BE%FZYW+,58^61@Y#
M8(P:^?/^"?'Q5U7X@_"'5-%US55US4O"FJ2:2NI+()/M-N #"^_)W<;@&[A5
MY/6OF+]G#X)R_M ?&SXU>&]9UJ[LO -EXDDO]5TNQE,4FI3_ &FX$$;N.1&
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M&Z'J[^(_&$%[?6$%VWEWEKL1WC5C@?9LX!/'.?>L[X-WGCC]EC]K[1_@S?\
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MK[1\-_\ (NZ7_P!>L7_H KF?^YK_ !/\D=:_WU_X%^;-*BO//CK\$-"_:"\
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MY[<$\U\*?L^_LI_LP_&GX3Z3!IMX=8\62V"-?W$>KRPZC;SE1YA^S;]BA6R
M3&RD <MU/UUX'^&\'PC^#,7A*VU34-9@TS3Y8EO-3F,LSC:Q R>BC. HX
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MG"6ZT/1IS52"G'9ZA1114%A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1_9^%_Y]HYKX;^ M/^%W@/0_">E37-QIVCVJVD$MXRM,R+T+E54$_0"OF_\
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M^S\ ^"=#\+Z?+/-I^CV,.GP27+*TK1Q($4N5 !; &< #/85BY+ZG.C]IRO\
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M&?$NE0:UHLZ".2VNP6SCHP;.X,.H8$$'D&OF"7_@EI\&I-:^VK=>*(K;?O\
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M6NW%OX9\,1$:1X>2Y-NMVP$>0O.<L'9V*_.0  0%X_0^*)((DCC4)&@"JJC
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MH?#J]_X*1^ 8/AC!I,/AVQA-I(=$MUBMGN%@N2[*5 $G#*-XSG'4XKW[4_\
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M/:J7Q4^$7A/XT^%I/#_C#2(M6TYF\Q Q*20R 8#QNI#*W/4'D<'(XKP#P?\
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MXA^&/PS\,_MU>-=%^->E(_AOQ06U'1M2NKV>T@CFE</EI(Y$PI/FH2QP&4=
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M[0,G&,UWQK8?ZU'%MM.]VO-[Z]M7;0\]T,5'#2PD4FK63OTZ:=^F_P!YB?\
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MX  '  KHJ*=VMA63W"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y
MS1_AUX9\/^*M9\3:?H=E:>(-8V_;]2CB'GSA550"W4#"KP, D9Z\UT=%%.[=
MO(5DKVZA1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5SB_#KPROCF3QE_8=F?%+VJV9U9H@9Q"I.$5C]T?,<XP2, Y %='133:V$TG
MHPHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MO*?&7[-_AKQQ\;/"WQ1OK[5HM?\ #L @M+:WFB6U=09#F13&6)_>MT<=!^/J
MU%5&4H24HNS1,HJI%PDKI_\ #A1114E!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img42689296_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img42689296_1.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" >3#-@# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *\NN/VJ/@K9W$L$_P 7_ 4$\3%)(I/$UDK(P.""#+D$'M5[]H;X
MB+\)?@9X[\8%PDFD:/<W,.3C,PC(B7\7*C\:_&#]B?\ X)WWW[97@_Q%XIG\
M;_\ "(6>G:@+"-FTG[<;J3RQ)(<^?'MVAT]<[NV.8BY3G**6D4F_F[?UZER4
M8P4F]6[+Y*Y^Q\?[5GP3FD2./XP^ 9)'(557Q/9$DGH /-ZUZD#D9'(K\M--
M_P""'O\ 9^HVMU_PNGS/(E679_PBN-VT@XS]MXZ5^G>N:U8^%/#]_J^IW"VN
MFZ;:R75S</TCBC0L['Z $UK)PC3YV]=;^G?\S.//*?*E_P .9WCSXB>%_A?X
M?EUSQ=X@T[PWI$9VM>:G<I!&6/106/S,<<*,D]A7A_AW_@HW^SAXIUI-*LOB
MEIL5T[;0^H6EU909_P"NT\21C_OJOS0M=/\ B)_P5F_:?U(G4Y-!\$:0&>,R
MJ9(-(L2VV,+&& >XEQD\C<0>0J #Z.^)W_!%'P@O@>[D\ >--?'BV&(O#'KS
MV\MG<N!GR_W<2-%N/&[+8]#6:YHP52HM'K;K;^OZ9;Y7-TX/5=>ES]+[>XBN
MH(YX)$FAD4.DD;!E92,@@CJ"*DK\F/\ @E1^TUXD\ _%"_\ V>O'DEQ'"TEQ
M'I-O>L3)IU[#N,UJ.N$8*Y S@,AQ]^OUGK:44DI1=XO5,RC)W<9*S6X4C,%4
MLQP!R2:6OS!_X*O?M6>(O^$CTWX > )[A+_5$A.MM8$B>X,QQ!8J0<@."&<#
M[P=%Z%@>>4FFHQ5VW9(WC%.\I.R6K/K;QM_P4)_9X^'NO2:/K'Q0TPW\9VR+
MIMO<ZA&C9P5:2WBD0$'J"<CO7K7PS^+G@OXR:!_;7@CQ-IOB;30P1YM/G$AB
M8C.R1?O1M@@[6 /M7YZ_"7_@BGX5D\$VD_Q(\9:Z/%5Q&));;PZ\$5K:,1_J
M\RQ2-*0>K#8#V'<_,/C[P'\1O^"57[2VB:SI&J2:QX=O/WEM=*###J]F&'G6
ML\>2%=<CUP2CKZ#9<L9JG4>KZ]+_ -?YJYB^:47.FMNG6W]?\&Q^ZU%8/@/Q
MIIGQ'\$Z%XJT6;S])UFRAO[60C!,<B!ER.QP<$=B*WJ)1<6XRW01DI)26S"B
MBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTV*:1G+."QSP1_A3?[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H
MNT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15
M+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[
M15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O
M[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%
M4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_L
MF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52
M_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8
M?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^
MR8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_
MO/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)
MA_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\
M_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'
M^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_
M )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[
MS_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\
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M\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\
M"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_P
MH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P *
M/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C
M^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_
MLF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[
M)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R
M8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF
M'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A
M_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?
M[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^
M\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O
M/^8_PH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S
M_F/\* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_
MYC_"@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^
M8_PH NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F
M/\* +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC
M_"@"[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_
MPH NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\
M* +M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"
M@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH
M NT52_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\*
M+M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"
M[15+^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH N
MT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M
M%4O[)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[1
M5+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT5
M2_LF'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4
MO[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+
M^R8?[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_
MLF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[
M)A_O/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R
M8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF
M'^\_YC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A
M_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?
M[S_F/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^
M\_YC_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O
M/^8_PH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S
M_F/\*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_
MYC_"C^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^
M8_PH_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F
M/\*/[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC
M_"C^R8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_
MPH_LF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\
M*/[)A_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"
MC^R8?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH
M_LF'^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/
M[)A_O/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^
MR8?[S_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_PH_L
MF'^\_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)
MA_O/^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"C^R8
M?[S_ )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'
M^\_YC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_
MO/\ F/\ "@"[15+^R8?[S_F/\*/[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[
MS_F/\* +M%4O[)A_O/\ F/\ "C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\
M_P"8_P * +M%4O[)A_O/^8_PH_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/
M^8_PH NT52_LF'^\_P"8_P */[)A_O/^8_PH NT52_LF'^\_YC_"C^R8?[S_
M )C_  H NT52_LF'^\_YC_"C^R8?[S_F/\* +M%4O[)A_O/^8_PH_LF'^\_Y
MC_"@"[15+^R8?[S_ )C_  H_LF'^\_YC_"@"[15+^R8?[S_F/\*/[)A_O/\
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M!SE4A:U]WKZ:'R6$\0,!C:\:%+#UKN2C\$;)MVU]_2W4^FZ***^;/TX****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ^0?B1_P G86G_ &%=,_\ 08*^OJ^0?B1_R=A:?]A73/\ T&"OKZOILX_@
MX7_ OR1^7<&_[[FW_7^7YL****^9/U$**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0?B1_P G86G_ &%=,_\
M08*^OJ^0?B1_R=A:?]A73/\ T&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL**
M**^9/U$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ^0?B1_P G86G_ &%=,_\ 08*^OJ^0?B1_R=A:?]A73/\
MT&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL****^9/U$**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^0?B1_P G
M86G_ &%=,_\ 08*^OJ^0?B1_R=A:?]A73/\ T&"OKZOILX_@X7_ OR1^7<&_
M[[FW_7^7YL****^9/U$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^0?B1_P G86G_ &%=,_\ 08*^OJ^0?B1_
MR=A:?]A73/\ T&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL****^9/U$****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\Q_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\
M,?X4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S
M'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_P!Y_P Q
M_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_ 'G_ #'^% %VBJ7]DP_WG_,?
MX4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_ 'G_ #'^
M%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/\ >?\ ,?X4 7:*I?V3#_>?\Q_A
M1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\ ,?X4
M?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S'^%'
M]DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_P!Y_P Q_A1_
M9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_ 'G_ #'^% %VBJ7]DP_WG_,?X4?V
M3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_ 'G_ #'^%']D
MP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/\ >?\ ,?X4 7:*I?V3#_>?\Q_A1_9,
M/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\ ,?X4?V3#
M_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S'^%']DP_
MWG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_P!Y_P Q_A1_9,/]
MY_S'^% %VBJ7]DP_WG_,?X4?V3#_ 'G_ #'^% %VBJ7]DP_WG_,?X4?V3#_>
M?\Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_ 'G_ #'^%']DP_WG
M_,?X4 7:*I?V3#_>?\Q_A1_9,/\ >?\ ,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_
MS'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\ ,?X4?V3#_>?\
MQ_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,
M?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_P!Y_P Q_A1_9,/]Y_S'
M^% %VBJ7]DP_WG_,?X4?V3#_ 'G_ #'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_
MA0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_ 'G_ #'^%']DP_WG_,?X
M4 7:*I?V3#_>?\Q_A1_9,/\ >?\ ,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^%
M %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/\ >?\ ,?X4?V3#_>?\Q_A0
M!=HJE_9,/]Y_S'^%']DP_P!Y_P Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4
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MG_,?X4 7:*I?V3#_ 'G_ #'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/\
M>?\ ,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?
M\Q_A0!=HJE_9,/\ >?\ ,?X4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y
M_P Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S
M'^% %VBJ7]DP_P!Y_P Q_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_ 'G_
M #'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_WG_,?
MX4 7:*I?V3#_ 'G_ #'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/\ >?\
M,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^% %VBJ7]DP_WG_,?X4?V3#_>?\Q_A
M0!=HJE_9,/\ >?\ ,?X4?V3#_>?\Q_A0!=HJE_9,/]Y_S'^%']DP_P!Y_P Q
M_A0!=HJE_9,/]Y_S'^%']DP_WG_,?X4 7:*I?V3#_>?\Q_A1_9,/]Y_S'^%
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M5\^#WA#PC=-\.[J[\>>)IHV6TB%A/9VD,F.'F>=$8J.N$5B<8RN<CT[XY?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'R#\2/\ D["T_P"PKIG_ *#!7U]7
MR#\2/^3L+3_L*Z9_Z#!7U]7TV<?P<+_@7Y(_+N#?]]S;_K_+\V%%%%?,GZB%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 ?(/Q(_P"3L+3_ +"NF?\ H,%?7U?(/Q(_Y.PM/^PKIG_H,%?7U?39
MQ_!PO^!?DC\NX-_WW-O^O\OS84445\R?J(4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%)G')X%>2^)OVL/A+X1U233]2\:6?VN-
MBKK9PS72JP.""T2,H(],UO2H5<1+EHP<GY)O\C"M7I8>//6FHKNVE^9ZW17,
M>!?B;X5^)=BUYX7UZRUJ% #(MM*#)%GIO0X9,X_B KIZSG"=.3C-6:Z,NG4A
M5BITVFGU6H45RGCSXK>$/AC:I/XH\0V.C"09CCGDS+(!U*QC+-^ -<;X=_:V
M^$?BG4DL+'QM9K<N<+]MAFM$)]-\R*N?QK>GA<15A[2G3DX]TFU]YA4Q>'HS
M5.K4C&3Z-I/[CUVBD5@P!!R#R"*6N4ZPHHKD?B!\6_!WPMMHIO%7B"ST<2C,
M<4S%I9 .I6-078>X%7"$JDE""NWT1$YQIQ<YNR75G745Y1X2_:H^%/CC5(].
MTGQG9O>2$+'%=Q2VF]CP%4S(@8GL!R:]7K2M0JX=\M:#B_--?F94<11Q"YJ,
MU)>33_(**\S^/GQVT;X">#AK&I1-?7MPYAL=/B8*UQ)C)RW\*@<EL'&1P20*
M^7$_;R^*&BFSUS7_ (<6\/A&[<>3.MK=6_FJ>1LN')C8XYX7FO0PF4XK&P]I
M1CIMJTKOLK[GG8W-\)@)JG6EK:^B;LN[MLC[OHKF_AW\0-'^*'@W3?$NA3--
MIU]'O4. 'C8'#(XSPRD$'Z<9'-<Q^T-\8H?@A\,=0\1;89]2R+?3[6?)6:=O
MN@@$$J "QP1PIK@6'JRK+#\OOWM;SV/1^L4O8_6.;W+7OY6O?[CTNBO//@)X
ML\5^//ACI7B+QA::?8:EJ:FYAM=.BDC1+=O]66#NY+,/FZ]& QP:]#J:U*5"
MI*E+=.V@Z%:.(I1K06DE=7\PHHHK$W"BBB@ HHHH **** "BBB@#Y!^)'_)V
M%I_V%=,_]!@KZ^KY!^)'_)V%I_V%=,_]!@KZ^KZ;./X.%_P+\D?EW!O^^YM_
MU_E^;"BBBOF3]1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MT45O5Q%:NTZLW*W=M_F<]'#T</=48*-][)+\@HHHK Z HHHH **** "BBB@
MHHHH ^0?B1_R=A:?]A73/_08*^OJ^0?B1_R=A:?]A73/_08*^OJ^FSC^#A?\
M"_)'Y=P;_ON;?]?Y?FPHHHKYD_40HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?Y'-_:>!_P"?\/\ P)?YGT+17SU_PVM\%O\ HH#_ /@IOO\ XS1_PVM\%O\
MHH#_ /@IOO\ XS1_968?] \__ 9?Y!_:>!_Y_P /_ E_F?0M%?/7_#:WP6_Z
M* __ (*;[_XS1_PVM\%O^B@/_P""F^_^,T?V5F'_ $#S_P# 9?Y!_:>!_P"?
M\/\ P)?YGT+17SU_PVM\%O\ HH#_ /@IOO\ XS1_PVM\%O\ HH#_ /@IOO\
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M )^W_7_&@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\
MG[?]?\: +M%4OL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?
MM_U_QH NT52^PS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W
M_7_&@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]
M?\: +M%4OL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?M_U_
MQH NT52^PS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W_7_&
M@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]?\:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MYOXE?\DY\5?]@JZ_]$O7A'[&/^L\7_2T_P#:U>[_ !*_Y)SXJ_[!5U_Z)>O"
M/V,?]9XO^EI_[6KZ7"?\BG$^L?S1^79Q_P E?E?^&I_Z3(^FZ***^:/U$***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OPAK]
MWJ_"&OU'@C_F)_[<_P#;C\WXQ_YA_P#M[_VT****_4C\W"BBB@ HHHH ****
M /;?"W_)&YO^O.[_ )R5XE7MOA;_ )(W-_UYW?\ .2O$JXL/\53U/F\I_C8K
M_&_S84445VGT@4444 %%%% !1110!^[U%%%?RX?T@%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <W\2O\
MDG/BK_L%77_HEZ\(_8Q_UGB_Z6G_ +6KW?XE?\DY\5?]@JZ_]$O7A'[&/^L\
M7_2T_P#:U?2X3_D4XGUC^:/R[./^2ORO_#4_])D?3=%%%?-'ZB%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7X0U^[U?A#7Z
MCP1_S$_]N?\ MQ^;\8_\P_\ V]_[:%%%%?J1^;A1110 4444 %%%% 'MOA;_
M )(W-_UYW?\ .2O$J]M\+?\ )&YO^O.[_G)7B5<6'^*IZGS>4_QL5_C?YL**
M**[3Z0**** "BBB@ HHHH _=ZBBBOY</Z0"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .;^)7_ "3GQ5_V
M"KK_ -$O7A'[&/\ K/%_TM/_ &M7N_Q*_P"2<^*O^P5=?^B7KPC]C'_6>+_I
M:?\ M:OI<)_R*<3ZQ_-'Y=G'_)7Y7_AJ?^DR/INBBBOFC]1"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(
M_P"8G_MS_P!N/S?C'_F'_P"WO_;0HHHK]2/S<**** "BBB@ HHHH ]M\+?\
M)&YO^O.[_G)7B5>V^%O^2-S?]>=W_.2O$JXL/\53U/F\I_C8K_&_S84445VG
MT@4444 %%%% !1110!^[U%%%?RX?T@%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 <W\2O^2<^*O^P5=?\
MHEZ\(_8Q_P!9XO\ I:?^UJ]W^)7_ "3GQ5_V"KK_ -$O7A'[&/\ K/%_TM/_
M &M7TN$_Y%.)]8_FC\NSC_DK\K_PU/\ TF1]-T445\T?J(4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 445YG^TEIOB[5/@AXNB\"ZG=:5XH2R::SFL@/.<IAFC0D$
MAG4,H*X()&"*0!\7/VD?AQ\#X<^+_%%II]X5W)IT1,]VX[$0H"P!_O$!?>OD
MCQO_ ,%;M%M;AX?"/@&]U*+HMUK%ZMKSZ^5&LF1_P,5XS\)_^";?Q3^+,W]N
M>-K]?!MK>,9I)-5#76I3%N=[0[A@D]?,=6![5]6^"_\ @E_\'/#L:MK(UKQ7
M-@;_ +=?&"+/^RL 1@/JQ^M>W['!X?2M+F?9?U^I\_[?'XK6A#DCW>_]?+YG
MS+??\%8_BA)*39^%O",$>>%G@NI3CZB=?Y5IZ!_P5J\<6\P.M^"/#^H1<973
MY9[5O?EVE_E7V;9_L-? JQMUAC^'6G,B]#--/*W_ 'TTA)_.J6L?L"? ;6E/
MF> 8+9\8#V=]=08]\+* 3]0:?UC [>R=OZ\Q?5<QW]LK_P!>7Z'FGPT_X*E_
M#+Q7)%;>*M-U3P5<OUFD7[;:+[>9&!)_Y#Q[U];>%?&&A>.M&AU;P[K%CKFF
M3?<N]/G6:,GN,J3@CN.HKXI^(G_!)[P=JD,LW@OQ7JF@W9RRV^J*EY;_ .Z"
MH1U'N2WT->/_  1_9-^/?P&_:,\+6%M/=Z7H=[>+]NUS1)C-836T8+R)*I&
M2H95$J#YF&WUI>QP>(_A3Y'V>W]?-^A2KX_#/]]#GCW6_P#7R7J?J=1117BG
MOA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %?A#7[O5^$-?J/!'_,3_ -N?^W'YOQC_ ,P__;W_ +:%%%%?J1^;A111
M0 4444 %%%% 'MOA;_DC<W_7G=_SDKQ*O;?"W_)&YO\ KSN_YR5XE7%A_BJ>
MI\WE/\;%?XW^;"BBBNT^D"BBB@ HHHH **** /W>HHHK^7#^D HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#F_B5_R3GQ5_P!@JZ_]$O7A'[&/^L\7_2T_]K5[O\2O^2<^*O\ L%77_HEZ
M\(_8Q_UGB_Z6G_M:OI<)_P BG$^L?S1^79Q_R5^5_P"&I_Z3(^FZ***^:/U$
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** //_ (E?&S0_A9?65KJUKJ%Q)=1F
M5#9QQL  <<[G7FN-_P"&O_!O_0-US_OQ#_\ ':]'\9?"WPQ\0+JWN-?TS[?-
M;H8XF^T2Q[5)R1A&&>?6OF[]IKX:^&_A[%X=/A_3OL!NVN!-^_EDW;?+V_?8
MXQN/3UKZC+:.78IPP]2,O:.^O3J^_;R/RCBC&<2Y1"OF&'JT_J\;633<]6H]
MK;OOL>E?\-?^#?\ H&ZY_P!^(?\ X[7M=A>)J%C;W4898YXUE4-U 8 C/OS7
MC?P_^ /@+6_ OA[4+W0?.O+K3X)YI/MEPNYVC4L<"0 <GL*]FM;:.SM8;>%=
MD,*"-%R3A0, 9/M7G9A]2BU#"QDFF[W_ $U/I>'?[<J0=;-JE.49*+CR7NKZ
MN]TO+N2T445Y!]D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\
MU?MF_P"I\(_[UW_*&OI6OFK]LW_4^$?]Z[_E#7NY'_R,*7S_ /26? <>_P#)
M.8K_ +<_]+B>U_"K_DF7A/\ [!5K_P"BEKJJY7X5?\DR\)_]@JU_]%+755Y6
M(_C3]7^9];EO^XT/\$?R04445SGI!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'QI^U!_P3SM?BWXJU#QWX*\0S>'O&=S(MQ+#>.S6L\J@ ,KK
M\\+<#D;AQPHZUXWX9_:^^./[)6M6WACXT>&[SQ'H@;RX=0N6_P!)9!_%#=#*
M7&!R0^6Y ++7Z)>,_'7AWX=Z))K'B?6K'0=,C.#<W\ZQ(6[*,GYF/91DFOG3
MQ9^W9^S5XNT^XT'7M?AUS2;@%9H;O0KJ:W;'JK0\GT(';Z5Z.'K591]ER<\%
MT[>CZ'E8FA1C/VRJ>SF^M]_5/<^8_%W[+OP[_:ZU>^\7_ KQKING:Q>LUWJ/
MA'7 UO)!(W+L@4,RC)YPK)D\.!Q7%V7_  2^^--U?&"5?#UG$#C[5-J1,9]\
M(C-_X[7J6O?L5>!/BTC^-OV9OB';VVH6;"<:2;R13;O_  [).)[=C@X$@.3_
M !**7P1^W7\6/V<=>A\(_'?PI?:G;Q_*FI>6L=]L&!N5Q^ZNE''((.2<N3Q7
MJ4ZE2,?9X>6J^S+=>G<\>I2I2E[7%0T?VX.\7Z]OU/H']D;]AC1OV;KI_$6J
M:BOB/QG-"81=)'LM[-& WK"#R2>AD."1P N3GZDK@OA+\=/ WQPT?^T?!OB&
MUU944&>U!V7-OGM)$V&7G(R1@XX)KO:\/$5*M2I>MN?186G0ITTL/\+_ !"B
MBBN8ZPHHHH **** "BBB@ HHHH 0D*"2< 5Y[=_M&?">PUHZ/=?$_P &VVK!
M_+-A-X@M%G#?W?+,F[/MBOS9_P""J_[2WC+Q?\8+'X >![FZAL]MM%J-KI\A
M274[RYP8K9B,9C"O'\N<%G.[[HQ5T3_@B#XFO/"45WJGQ2TW3O$;P[VTN'2'
MGMDDQD(;CSE.,\%A$?8&HIR<X^TM[M[>MOZ\^A<XJ$E"_O6OZ7V/UPAFCN(4
MEB=98G 970@JP/0@CJ*?7XO_ +&'QK^)/[%7[5%O\"O'MQ-)X;OM3329]->8
MRP6L\Y'D75J3]U'+H3@ ,KDL PX_:"MG%.$:D'>+,4VI.$E9H**^*?\ @KE\
M2/\ A"/V1[[1XI3'=^*-2MM,4*>?+4F>0_3$(4_[]?GY\(?^"4/Q@^,WPU\/
M>-]*UKP?IFF:Y:B\MK;5+V[CN%C8G:75+9U&X ,,,>"/I6,).;E9:1:7S:N:
MR2BHW>LKOY)V/W9HK\R?V*?^"8_Q1_9P_:)\/>/?$NO>$;[1].BNHY8-*O+J
M2X8R0/&NU9+9%/+#.6'&:_3:MI122:=[_AJ9*3;::V"BBOSV_P""H_[;FM?!
MNUL?A9\/;R2S\9:U;B>_U*T/[^QMG)5(XL<K+(0?F'*J,CEE882ERV25V]$;
M1CS7;T2U9]I>+?CG\-_ .JC3/$_Q!\+>'-2(!%GJVM6UK,0>AV2.#^E=9I.K
MV.O:?!?Z9>V^HV%PH>&ZM)5EBD4]"K*2"/<5^0/PO_X(R^.O'_A&'Q#XX\?V
M_@_7=07[3_91TUM0G3>-W^D2&:,+)D\@;\>N<BO.?!WBSXM_\$K?VB+?0/$4
MTM_X/O)%FO+*UD9[#5K1B%:X@# ;9DQUP&!7:V5/.T4E-4ZCLW]WI_7W&3;<
M'4IJZ7W_ -?U<_<^BL_P[K]AXJT'3=:TJYCO=,U&VCN[6XB.5EB=0R,#Z$$&
MM"E).+:>XTU)76P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %?A#7[O5^$-?J/!'_ #$_]N?^W'YOQC_S#_\ ;W_M
MH4445^I'YN%%%% !1110 4444 >V^%O^2-S?]>=W_.2O$J]M\+?\D;F_Z\[O
M^<E>)5Q8?XJGJ?-Y3_&Q7^-_FPHHHKM/I HHHH **** "BBB@#]WJ***_EP_
MI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH YOXE?\DY\5?]@JZ_\ 1+UX1^QC_K/%_P!+3_VM7N_Q*_Y)
MSXJ_[!5U_P"B7KPC]C'_ %GB_P"EI_[6KZ7"?\BG$^L?S1^79Q_R5^5_X:G_
M *3(^FZ***^:/U$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ7V&;_G[?]?\:/L,W_/V_P"O^- %VBJ7V&;_ )^W_7_&C[#-_P _;_K_ (T
M7:*I?89O^?M_U_QH^PS?\_;_ *_XT 7:*I?89O\ G[?]?\:/L,W_ #]O^O\
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M^O\ C0!=HJE]AF_Y^W_7_&C[#-_S]O\ K_C0!=HJE]AF_P"?M_U_QH^PS?\
M/V_Z_P"- %VBJ7V&;_G[?]?\:/L,W_/V_P"O^- %VBJ7V&;_ )^W_7_&C[#-
M_P _;_K_ (T 7:*I?89O^?M_U_QH^PS?\_;_ *_XT 7:*I?89O\ G[?]?\:/
ML,W_ #]O^O\ C0!=HJE]AF_Y^W_7_&C[#-_S]O\ K_C0!=HJE]AF_P"?M_U_
MQH^PS?\ /V_Z_P"- %VBJ7V&;_G[?]?\:/L,W_/V_P"O^- %VBJ7V&;_ )^W
M_7_&C[#-_P _;_K_ (T 7:*I?89O^?M_U_QH^PS?\_;_ *_XT 7:*I?89O\
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M )^W_7_&@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\
MG[?]?\: +M%4OL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?
MM_U_QH NT52^PS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W
M_7_&@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]
M?\: +M%4OL,W_/V_Z_XT?89O^?M_U_QH NT52^PS?\_;_K_C1]AF_P"?M_U_
MQH NT52^PS?\_;_K_C1]AF_Y^W_7_&@"[15+[#-_S]O^O^-'V&;_ )^W_7_&
M@"[15+[#-_S]O^O^-'V&;_G[?]?\: +M%4OL,W_/V_Z_XT?89O\ G[?]?\:
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MK>]N(A*EGOCD<R[#\K,!&0H;(R<D$#!^G;.SM]-LX+2T@CM;6!%CB@A0(D:
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M*[3Z0**** "BBB@ HHHH _=ZBBBOY</Z0"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .;^)7_).?%7_8*N
MO_1+UX1^QC_K/%_TM/\ VM7N_P 2O^2<^*O^P5=?^B7KPC]C'_6>+_I:?^UJ
M^EPG_(IQ/K'\T?EV<?\ )7Y7_AJ?^DR/INBBBOFC]1"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KYJ_;-_U/A'_ 'KO^4-?2M?-7[9O^I\(_P"]=_RAKW<C
M_P"1A2^?_I+/@./?^2<Q7_;G_I<3VOX5?\DR\)_]@JU_]%+755ROPJ_Y)EX3
M_P"P5:_^BEKJJ\K$?QI^K_,^MRW_ '&A_@C^2"BBBN<](**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_"&OW>
MK\(:_4>"/^8G_MS_ -N/S?C'_F'_ .WO_;0HHHK]2/S<**** "BBB@ HHHH
M]M\+?\D;F_Z\[O\ G)7B5>V^%O\ DC<W_7G=_P Y*\2KBP_Q5/4^;RG^-BO\
M;_-A1117:?2!1110 4444 %%%% '[O4445_+A_2 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "OFK]LW_4^$?\ >N_Y0U]*U\U?
MMF_ZGPC_ +UW_*&O=R/_ )&%+Y_^DL^ X]_Y)S%?]N?^EQ/:_A5_R3+PG_V"
MK7_T4M=57*_"K_DF7A/_ +!5K_Z*6NJKRL1_&GZO\SZW+?\ <:'^"/Y(****
MYST@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWPM_R1N;_KSN_P"<E>)5Q8?XJGJ?-Y3_ !L5_C?YL****[3Z0**** "BBB@
MHHHH _=ZBBBOY</Z0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OFK]LW_4^$?\ >N_Y0U]*U\U?MF_ZGPC_ +UW_*&O
M=R/_ )&%+Y_^DL^ X]_Y)S%?]N?^EQ/:_A5_R3+PG_V"K7_T4M=57*_"K_DF
M7A/_ +!5K_Z*6NJKRL1_&GZO\SZW+?\ <:'^"/Y(****YST@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M17:?2!1110 4444 %%%% '[O4445_+A_2 4444 %%%% !1110 4444 %%%%
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M0\"5QCG."%'N_M7T17AWB?\ 9F_X3?X]Z7\1-?\ $G]H:?I6S[%X?^PE4B*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <W\2O^2<^*O^
MP5=?^B7KPC]C'_6>+_I:?^UJ]W^)7_).?%7_ &"KK_T2]>$?L8_ZSQ?]+3_V
MM7TN$_Y%.)]8_FC\NSC_ )*_*_\ #4_])D?3=%%%?-'ZB%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7S5^V;_J?"/\ O7?\H:^E:^:OVS?]3X1_WKO^4->[
MD?\ R,*7S_\ 26? <>_\DYBO^W/_ $N)[7\*O^29>$_^P5:_^BEKJJY7X5?\
MDR\)_P#8*M?_ $4M=57E8C^-/U?YGUN6_P"XT/\ !'\D%%%%<YZ04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5^8O_!0?]K_QE:_$[4?ASX0U
MJZ\.Z/I"QQWUQITIBN+J=D#E3(N&5%#!=JD9.[.> /TZK\C?^"B/PAN_A_\
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MT2\^P4445P'I!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %?A#7[O5^$-?J/!'_ #$_]N?^W'YOQC_S#_\ ;W_MH444
M5^I'YN%%%% !1110 4444 >V^%O^2-S?]>=W_.2O$J]M\+?\D;F_Z\[O^<E>
M)5Q8?XJGJ?-Y3_&Q7^-_FPHHHKM/I HHHH **** "BBB@#]WJ***_EP_I **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBODS_@I9_R0K0O^
MQD@_]);JN_ 87Z]BJ>&YK<SM??\ R.+&XGZGAIXBU^57ML?6=%?A#17Z%_J1
M_P!1/_DG_P!L?"?ZX_\ 4/\ ^3?_ &I^[U%?A#11_J1_U$_^2?\ VP?ZX_\
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MFV7?V7BGAN?FT3O:V_S9]EE>/_M+#+$<O+JU:]]OD@HHHKQCU@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OFK
M]LW_ %/A'_>N_P"4-?2M?-7[9O\ J?"/^]=_RAKW<C_Y&%+Y_P#I+/@./?\
MDG,5_P!N?^EQ/:_A5_R3+PG_ -@JU_\ 12UU5<K\*O\ DF7A/_L%6O\ Z*6N
MJKRL1_&GZO\ ,^MRW_<:'^"/Y(****YST@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9MIUXQM[V_EFC)$?!VLQ&17ZRUSVC^#?"FB:HTNE:%H]AJ,*#<]G:11S(K9
MR5 (!P?K@UT->1B\1'$S4HQM96_%_P"9[>!PLL)"4)3YKN_X)?H%%%%<)Z(4
M444 %%%% !1110 4444 %%?F9_P5%_;@\8> ?&%G\'/AE?W.D:Q-;QS:OJ>G
M9^V;IO\ 4VL##YD8J0Q9?F.] ".<_/>G_P#!*#]I/Q1I<?C&^U?1+3Q#,GVK
M['J>MSG5-^,A6D6)D#GWEX)Y(J(2YTYI>ZM+^A<HJ+46_>>MO4_;>BOR1_81
M_;8^)OPK^.UO\"OC5=:A?PW5[_9,$NMR&6^TR])Q&AF))DB<D*,E@-R%3MX/
MZVLP12S$*H&23T%;2BE%5$[Q?4Q4GS.#5FA:*_'O]J#]LWXK_M??&N7X1? &
M;4K?P]',]LLVC3?9Y]4*'$D\LX8>7;#G W $'+9W!5\_\5?\$S_VE?@'H5QX
M_P!#U>QO-1L(S<SKX0UBY74X4 )=AF./>0,Y",S'L#6,9>Y[26D7U_7^OF;2
MC:7LUK)=#]Q**^!_^"9O[>>I_M$6=[\/_']S'<>.M+@^TVFI!!&=3M00&WJ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M":OCZY^(7[&G@"YO9/-N]-BFTAFSD[;>5HX\_P#;,1U]/U\:_P#!)/3YK/\
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MJ7V&;_GZ?]?\:/L,W_/T_P"O^- %VBJ7V&;_ )^G_7_&C[#-_P _3_K_ (T
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M )^G_7_&@"[15+[#-_S]/^O^-'V&;_GZ?]?\: +M%4OL,W_/T_Z_XT?89O\
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M^.OW=$^LW_LE<-3_ 'B'S/F\5_R-<-Z2_)GD]%%%=Q](%%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*H(HV)0D\;GVJ.Y%'[4W[#?PV_:RM[>Y\2VUSI7B6TC\JV\0:2RQW*QYR(Y
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MIS=23G+=DPBJ<5%;(****@L**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(_YB?^W/_;C\WXQ_YA_^WO\
MVT****_4C\W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _=ZBBB
MOY</Z0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY,_X*6?
M\D*T+_L9(/\ TENJ^LZ^3/\ @I9_R0K0O^QD@_\ 26ZKWLA_Y&=#_$>)G?\
MR+JWH?FI1117]"GX4%%%% !1110 4444 :OA7_D:-'_Z_(?_ $,5Z'\=?NZ)
M]9O_ &2O//"O_(T:/_U^0_\ H8KT/XZ_=T3ZS?\ LE<-3_>(?,^;Q7_(UPWI
M+\F>3T445W'T@4444 %%%% !1110!]9_\$T_^2ZZ[_V+<_\ Z56M?I77YJ?\
M$T_^2ZZ[_P!BW/\ ^E5K7Z5U^'\6_P#(S?HC]CX7_P"1<O5A1117QA]:%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC)-:'[#/P_O]8;Q#\7?$H:?6O$4\D=G))G(AWYE<9Z!G&T>@C]#7FUJWF_\
M!2,_;3D#47">9[6)\O'X[<5]%2A3^L/"3]]4(2G+^]4TO?O:]OD?,UJE185X
MZG[CK2A3A;>%/6UNS=F_G=;%7Q-JWQ__ &2[[1_$/B3Q0WBG1KZ8136T^HRW
ML).-QB;S5#1L0#ADXXZGH?N[P/XPL/'_ (1TCQ'I;%K#4K9+F+=]Y0PY5O<'
M(/N#7@__  4",7_#/LOF;=_]J6WEYZ[OFSC\,UN?L/FX/[-7A?SQQYEWY6>N
MS[3)C]<UY.,E''99''3BHS4^716NK7_ ]?!QEE^:?4(3<J<J?/J[V?-;3R?Y
MGO%%%%?)GUX4444 %%%% !1110 5\U?MF_ZGPC_O7?\ *&OI6OFK]LW_ %/A
M'_>N_P"4->[D?_(PI?/_ -)9\!Q[_P DYBO^W/\ TN)[7\*O^29>$_\ L%6O
M_HI:ZJN5^%7_ "3+PG_V"K7_ -%+755Y6(_C3]7^9];EO^XT/\$?R04445SG
MI!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?FI1117]"GX4%%%% !1110 4444 :OA7_D:-'_Z_(?\ T,5Z'\=?NZ)]9O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7R9_P4L_Y(5H7_ &,D'_I+=5]9U\F?\%+/
M^2%:%_V,D'_I+=5[V0_\C.A_B/$SO_D75O0_-2BBBOZ%/PH**** "BBB@ HH
MHH U?"O_ "-&C_\ 7Y#_ .ABO0_CK]W1/K-_[)7GGA7_ )&C1_\ K\A_]#%>
MA_'7[NB?6;_V2N&I_O$/F?-XK_D:X;TE^3/)Z***[CZ0**** "BBB@ HHHH
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M.TXSUP:]O)</6ACZ<I0:6O1]F?!<=5Z53AW$QA)-^YU_OQ/HSX5?\DR\)_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M\&?M_P#[:WB'X5^(E^'G@*Z73=7%ND^IZN$5Y8 XRD,08$*Q7#%L9 88P>:^
M\Z_%;]M#3?/_ &S/&5KJDK6]O<:G:AYB/N0M##\P^BG]*]#+Z,<1BHTY[6;]
M=E^IY>:8B6%PDJL-[I>F[O\ A;YGDVL?&#QYXBF,NJ>-?$6HR$[MUUJL\AS^
M+UG?\)[XF_Z&+5O_  .E_P#BJ_1O_@H5^S[X1\"?LRZ3<>#?#6FZ+#HNJ6YF
MEL[95EEB='BW22 ;G)8QY+$DGO5K]B+1/A=^T!^RR_A'Q-HNC7>JZ.9K;4&>
M*..\2(NTD5P) -ZX5MH?/6,CIQ7N+&4W0G7A#2+L_3O^*/G98&LL1"A4J:RC
M=/5ZW>GX,\+_ .":]UXOU_\ :'M+^YEUO4M!M[*ZCGNI6FEM8Y#'\JLQRH8Y
MX!YYK]8J_)#]@7XL7'PI_:=D\%6&HMJ/A'Q#>3:=RV4=T+_9[A0.-QVA<CM(
M?05^M]>;FGO5(32T<=/QW^\]?)_=IU(-WDI._P!R6GEH%%%%>*>^%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^$-?
MN]7X0U^H\$?\Q/\ VY_[<?F_&/\ S#_]O?\ MH4445^I'YN%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!^[U%%%?RX?T@%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7R9_P4L_Y(5H7_8R0?\ I+=5]9U\F?\
M!2S_ )(5H7_8R0?^DMU7O9#_ ,C.A_B/$SO_ )%U;T/S4HHHK^A3\*"BBB@
MHHHH **** -7PK_R-&C_ /7Y#_Z&*]#^.OW=$^LW_LE>>>%?^1HT?_K\A_\
M0Q7H?QU^[HGUF_\ 9*X:G^\0^9\WBO\ D:X;TE^3/)Z***[CZ0**** "BBB@
M HHHH ^L_P#@FG_R777?^Q;G_P#2JUK]*Z_-3_@FG_R777?^Q;G_ /2JUK]*
MZ_#^+?\ D9OT1^Q\+_\ (N7JPHHHKXP^M"BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
MS^_;^_8_\7?%SXN>&/$?@323J-QJT'V#4F+K'%;-%RDTC'HI0D>O[L  D@5^
M@-<I\2OBGX5^$'AF77_%^M6^BZ9&=@DF)+2/C(2- "SMP?E4$\&MJ-25&K&I
M#=?KH85Z,:]*5*>S_37]#CF^#6I^-?V:4^&_CS4K?4M8N-&73[S4K-6*&90/
M+E&[EBI5&)(&2I.!G%?C7\5?@7XY^"OB:ZT7Q+H5[9R([1Q7D<3-;72?WXI
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K\(:_=ZOPAK]1X(_YB?^W/_;C\WXQ_YA_^WO\ VT****_4C\W"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH _=ZBBBOY</Z0"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY,_X*6?\D*T+_L9(/\ TENJ
M^LZ^3/\ @I9_R0K0O^QD@_\ 26ZKWLA_Y&=#_$>)G?\ R+JWH?FI1117]"GX
M4%%%% !1110 4444 :OA7_D:-'_Z_(?_ $,5Z'\=?NZ)]9O_ &2O//"O_(T:
M/_U^0_\ H8KT/XZ_=T3ZS?\ LE<-3_>(?,^;Q7_(UPWI+\F>3T445W'T@444
M4 %%%% !1110!]9_\$T_^2ZZ[_V+<_\ Z56M?I77YJ?\$T_^2ZZ[_P!BW/\
M^E5K7Z5U^'\6_P#(S?HC]CX7_P"1<O5A1117QA]:%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/_7Y-_Z&:QZV/&'_ "-FL_\ 7Y-_Z&:QZZ(?"CU,/_!AZ+\@HHHJSH"BBB@
MHHHH *_6;]AG_DUGP3_V_?\ I=<5^3-?K-^PS_R:SX)_[?O_ $NN*^"XS_Y%
M\/\ &O\ TF1]MPE_OT_\#_.)[Q1117XR?K04444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1110 4444 %%%% !1110!^[U%%%?RX?T@%%%% !1110 4444 %%%% !1110
M4444 ?(/Q(_Y.OM/^PKIG_H,%?7U?(/Q(_Y.OM/^PKIG_H,%?7U?39Q_!PO^
M!?DC\NX-_P!]S;_K_+\V%%%%?,GZB%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5\F?\%+/^2%:%_V,D'_I+=5]9U\F
M?\%+/^2%:%_V,D'_ *2W5>]D/_(SH?XCQ,[_ .1=6]#\U****_H4_"@HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*I>7??\ /5/R_P#K4>7??\]4_+_ZU %VBJ7EWW_/5/R_^M1Y=]_SU3\O_K4
M7:_"&OW1\N^_YZI^7_UJ_"ZOU'@C_F)_[<_]N/S?C'_F'_[>_P#;0HHHK]2/
MS<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]WJ*I>7??\ /5/R
M_P#K4>7??\]4_+_ZU?RX?T@7:*I>7??\]4_+_P"M1Y=]_P ]4_+_ .M0!=HJ
MEY=]_P ]4_+_ .M1Y=]_SU3\O_K4 7:*I>7??\]4_+_ZU'EWW_/5/R_^M0!=
MHJEY=]_SU3\O_K4>7??\]4_+_P"M0!=HJEY=]_SU3\O_ *U'EWW_ #U3\O\
MZU %VBJ7EWW_ #U3\O\ ZU'EWW_/5/R_^M0!\G?$C_DZ^T_["NF?^@P5]?5\
M>?$591^U1:AF!E_M33?F[?=@Q7UMY=]_SU3\O_K5]-G'\'"_X%^2/R[@W_?<
MV_Z_R_-EVBJ7EWW_ #U3\O\ ZU'EWW_/5/R_^M7S)^HEVBJ7EWW_ #U3\O\
MZU'EWW_/5/R_^M0!=HJEY=]_SU3\O_K4>7??\]4_+_ZU %VBJ7EWW_/5/R_^
MM1Y=]_SU3\O_ *U %VBJ7EWW_/5/R_\ K4>7??\ /5/R_P#K4 7:*I>7??\
M/5/R_P#K4>7??\]4_+_ZU %VBJ7EWW_/5/R_^M1Y=]_SU3\O_K4 7:*I>7??
M\]4_+_ZU'EWW_/5/R_\ K4 7:*I>7??\]4_+_P"M1Y=]_P ]4_+_ .M0!=HJ
MEY=]_P ]4_+_ .M1Y=]_SU3\O_K4 7:*I>7??\]4_+_ZU'EWW_/5/R_^M0!=
MHJEY=]_SU3\O_K4>7??\]4_+_P"M0!=HJEY=]_SU3\O_ *U'EWW_ #U3\O\
MZU %VBJ7EWW_ #U3\O\ ZU'EWW_/5/R_^M0!=HJEY=]_SU3\O_K4>7??\]4_
M+_ZU %VBJ7EWW_/5/R_^M1Y=]_SU3\O_ *U %VBJ7EWW_/5/R_\ K4>7??\
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M4_WB'S/F\5_R-<-Z2_)GD]%%%=Q](%%%% !1110 4444 ?6?_!-/_DNNN_\
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M^7_UJ +M%4O+OO\ GJGY?_6H\N^_YZI^7_UJ +M%5(H[L2*7D0IGD#_]56Z
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M3FZDG.6[)A%4XJ*V04445!84444 %%%% !1110 4444 %%%% !1110 4444
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M^Q;G_P#2JUK]*Z_-3_@FG_R777?^Q;G_ /2JUK]*Z_#^+?\ D9OT1^Q\+_\
M(N7JPHHHKXP^M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M110 4444 %%%% 'UG_P33_Y+KKO_ &+<_P#Z56M?I77YJ?\ !-/_ )+KKO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M /W>HHHK^7#^D HHHH **** "BBB@ HHHH **** "BBB@#Y!^)'_ "=?:?\
M85TS_P!!@KZ^KY!^)'_)U]I_V%=,_P#08*^OJ^FSC^#A?\"_)'Y=P;_ON;?]
M?Y?FPHHHKYD_40HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MABU(W%W+^+I)$/\ QVOLS]E?]HK4/C%\ ;CXA>,8+#2GM)[I;G^RX)?*2&$
MEPA9W)QD\$].E?%O[=W[*O@+]G3X0^"9/#%A,=:N-0-M?:M<W,DDET!"S$E"
MVQ/F&<*H_&OI?_@F7''-^RK'',JO"VJWJNKC(*G;D'VQ7IXB.&EA)U*$;6TN
M_D>1AZF+AC84\3*_,KV7S\M]#L?@+^VQX*_:&^)6N^$O#UK>VWV&U%U:7E\
MGVY0VV0K'U4+E",G)#'(7;7T-7XO_LHZA'X9_;?\.IH+;M/;7;JRA\LY#6SB
M5!]1L(/X5^T%<>,P\**IRIWM)==[_P!6/0P.)J5W4A5M>,K:;6_JX4445YIZ
MH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7X0U^[U?A#7ZCP1_S$_]N?\ MQ^;\8_\P_\ V]_[:%%%%?J1^;A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?N]1117\N'](!1110 4444
M%%%% !1110 4444 %%%% 'R#\2/^3K[3_L*Z9_Z#!7U]7R#\2/\ DZ^T_P"P
MKIG_ *#!7U]7TV<?P<+_ (%^2/R[@W_?<V_Z_P OS84445\R?J(4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R9_P4
ML_Y(5H7_ &,D'_I+=5]9U\F?\%+/^2%:%_V,D'_I+=5[V0_\C.A_B/$SO_D7
M5O0_-2BBBOZ%/PH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZS
M_P"":?\ R777?^Q;G_\ 2JUK]*Z_-3_@FG_R777?^Q;G_P#2JUK]*Z_#^+?^
M1F_1'['PO_R+EZL****^,/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%% !7X0U^[U?A#7ZCP1_S$_]N?\ MQ^;\8_\P_\ V]_[:%%%%?J1^;A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?N]1117\N'](!1110 4444
M%%%% !1110 4444 %%%% 'R#\2/^3K[3_L*Z9_Z#!7U]7R#\2/\ DZ^T_P"P
MKIG_ *#!7U]7TV<?P<+_ (%^2/R[@W_?<V_Z_P OS84445\R?J(4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(_YB?^W/_;C\WXQ_YA_^WO\
MVT****_4C\W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _=ZBBB
MOY</Z0"BBB@ HHHH **** "BBB@ HHHH **** /D'XD?\G7VG_85TS_T&"OK
MZOD'XD?\G7VG_85TS_T&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL****^9/U
M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M))ZG:T445Q'MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*^3/^"EG_)"M"_[&2#_TENJ^LZ^3/^"EG_)"M"_[&2#_ -);JO>R'_D9T/\
M$>)G?_(NK>A^:E%%%?T*?A04444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M?DI_P4N^-VJ^,OC5=>!H;R6/PYX;6-#:(Q"373H'>1Q_$0'"C/3!QU-?K77X
MS?MS:,W@K]LCQ%>7\'GV=U=6FJ+&PR)8C''N'TRCK^%>GED8SQD5/L[>NGZ7
M/(S><Z>"FZ>]U?TU_6R^9X]XK^"?CKP+X-TOQ5XA\,WVC:%JDHAL[J]41F9B
MI<8C)W@%02"5 (Z&M=?V:?B9+\,X_B##X3NKKPA)$9QJ5M+%-B,,59S&CF0
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M'EWW_/5/R_\ K4 7:*I>7??\]4_+_P"M1Y=]_P ]4_+_ .M0!=KY,_X*6?\
M)"M"_P"QD@_]);JOJ;R[[_GJGY?_ %J^4?\ @I(MROP-T/SG5E_X2.#@>OV:
MZ]J][(?^1G0_Q'B9W_R+JWH?FY1117]"GX4%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!]9_P#!-/\ Y+KKO_8MS_\ I5:U^E=?F?\ \$VUE;XY
M:YY+!6_X1R?D^GVFUK](_+OO^>J?E_\ 6K\/XM_Y&;]$?L?"_P#R+EZLNT52
M\N^_YZI^7_UJ/+OO^>J?E_\ 6KXP^M+M%4O+OO\ GJGY?_6H\N^_YZI^7_UJ
M +M%4O+OO^>J?E_]:CR[[_GJGY?_ %J +M%4O+OO^>J?E_\ 6H\N^_YZI^7_
M -:@"[15+R[[_GJGY?\ UJ/+OO\ GJGY?_6H NT52\N^_P">J?E_]:CR[[_G
MJGY?_6H NT52\N^_YZI^7_UJ/+OO^>J?E_\ 6H NT52\N^_YZI^7_P!:CR[[
M_GJGY?\ UJ +M%4O+OO^>J?E_P#6H\N^_P">J?E_]:@"[15+R[[_ )ZI^7_U
MJ/+OO^>J?E_]:@"[15+R[[_GJGY?_6H\N^_YZI^7_P!:@"[15+R[[_GJGY?_
M %J/+OO^>J?E_P#6H NT52\N^_YZI^7_ -:CR[[_ )ZI^7_UJ +M%4O+OO\
MGJGY?_6H\N^_YZI^7_UJ +M%4O+OO^>J?E_]:CR[[_GJGY?_ %J +M%4O+OO
M^>J?E_\ 6H\N^_YZI^7_ -:@"[15+R[[_GJGY?\ UJ/+OO\ GJGY?_6H NT5
M2\N^_P">J?E_]:CR[[_GJGY?_6H NT52\N^_YZI^7_UJ/+OO^>J?E_\ 6H N
MT52\N^_YZI^7_P!:CR[[_GJGY?\ UJ +M%4O+OO^>J?E_P#6H\N^_P">J?E_
M]:@"[15+R[[_ )ZI^7_UJ/+OO^>J?E_]:@"[15+R[[_GJGY?_6H\N^_YZI^7
M_P!:@"[15+R[[_GJGY?_ %J/+OO^>J?E_P#6H NT52\N^_YZI^7_ -:CR[[_
M )ZI^7_UJ +M%4O+OO\ GJGY?_6H\N^_YZI^7_UJ +M%4O+OO^>J?E_]:CR[
M[_GJGY?_ %J +M%4O+OO^>J?E_\ 6H\N^_YZI^7_ -:@"[15+R[[_GJGY?\
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M[_GJGY?_ %J +M%4O+OO^>J?E_\ 6H\N^_YZI^7_ -:@"[15+R[[_GJGY?\
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M %J/+OO^>J?E_P#6H NT52\N^_YZI^7_ -:CR[[_ )ZI^7_UJ +M%4O+OO\
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MR#W'F.^/;%>JT45I4FZDW-[LB$53BHKH%%%%9EA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %?A#7[O5^$-?J/!'_,3_P!N
M?^W'YOQC_P P_P#V]_[:%%%%?J1^;A1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?N]1117\N'](!1110 4444 %%%% !1110 4444 %%%% 'R#\
M2/\ DZ^T_P"PKIG_ *#!7U]7R#\2/^3K[3_L*Z9_Z#!7U]7TV<?P<+_@7Y(_
M+N#?]]S;_K_+\V%%%%?,GZB%%%% !1110 4444 %%%% !1110 4444 %%%%
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MM"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /D'P5_R=I<?]A?4/\ T":OKZOD'P5_
MR=I<?]A?4/\ T":OKZOI<]_BT?\ !']3\NX _P!UQO\ U_G^40HHHKYH_40H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M***XCO"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *_"&OW>K\(:_4>"/^8G_MS_ -N/S?C'_F'_ .WO_;0HHHK]2/S<
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]WJ***_EP_I ****
M"BBB@ HHHH **** "BBB@ HHHH ^0?B1_P G7VG_ &%=,_\ 08*^OJ^0?B1_
MR=?:?]A73/\ T&"OKZOILX_@X7_ OR1^7<&_[[FW_7^7YL****^9/U$****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY
M,_X*6?\ )"M"_P"QD@_]);JOK.ODS_@I9_R0K0O^QD@_]);JO>R'_D9T/\1X
MF=_\BZMZ'YJ4445_0I^%!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?6?\ P33_ .2ZZ[_V+<__ *56M?I77YJ?\$T_^2ZZ[_V+<_\ Z56M?I77
MX?Q;_P C-^B/V/A?_D7+U84445\8?6A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?DS^W-_R=-XV_[<?_2&WKP>O>/VYO\ DZ;Q
MM_VX_P#I#;UX/7]'95_R+\/_ ((_^DH_ <S_ -^K_P".7YL****]4\T****
M"BBB@ HHHH **** "BBB@ HHHH **** "OUF_89_Y-9\$_\ ;]_Z77%?DS7Z
MS?L,_P#)K/@G_M^_]+KBO@N,_P#D7P_QK_TF1]MPE_OT_P# _P XGO%%%%?C
M)^M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'R#X*_P"3M+C_ +"^H?\ H$U?7U?(/@K_ ).TN/\ L+ZA
M_P"@35]?5]+GO\6C_@C^I^7< ?[KC?\ K_/\HA1117S1^HA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?)G_!2S_DA6A?\
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M _W7&_\ 7^?Y1"BBBOFC]1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,_\ 08*^OJ^FSC^#A?\  OR1^7<&_P"^YM_U_E^;"BBBOF3]1"BBB@ HHHH
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M\EUUW_L6Y_\ TJM:_2NOP_BW_D9OT1^Q\+_\BY>K"BBBOC#ZT**** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH ^0?!7_ "=I<?\ 87U#_P! FKZ^KY!\%?\
M)VEQ_P!A?4/_ $":OKZOI<]_BT?\$?U/R[@#_=<;_P!?Y_E$****^:/U$***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_3\SP/\ 8Y_8_P!/_9C\/75W?W,.K^--414OK^%3Y4,8P1!#D [<\EB 6('
MP!7T?7Q?^S+_ ,%!)/CY\>+[P?>Z%!H6CWML[Z)\Y>Y,D0+.LS9VDM&&8!0-
MNS&6SFOM"N'&*O[12K[M7^1Z>"EA_9N&&VB[?,****X3T HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OPAK]WJ_"&O
MU'@C_F)_[<_]N/S?C'_F'_[>_P#;0HHHK]2/S<**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#]WJ***_EP_I **** "BBB@ HHHH **** "BBB@
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M=8_LV[-S-<K@R?9XPRQ9&1N)(['/&:G\>:;'XY^'MZFGLMSY\*W%LR<[RI#
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MPMZ?)6O\PHHHKZ,\4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3K[3_L*Z9_Z#!7U]7TV<?P<+_@7Y(_+N#?\ ?<V_Z_R_-A1117S)^HA1110
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MBBB@#\F?VYO^3IO&W_;C_P"D-O7@]>\?MS?\G3>-O^W'_P!(;>O!Z_H[*O\
MD7X?_!'_ -)1^ YG_OU?_'+\V%%%%>J>:%%%% !1110 4444 %%%% !1110
M4444 %%%% !7ZS?L,_\ )K/@G_M^_P#2ZXK\F:_6;]AG_DUGP3_V_?\ I=<5
M\%QG_P B^'^-?^DR/MN$O]^G_@?YQ/>****_&3]:"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYT_:D_9G\-?$NPUSQQJNI
MZU%JFD:+,;:VM9XEMOW222+E6B+<L><,/PKZ+KC_ (Q?\DD\;?\ 8$O?_1#U
MU86O5PU55*4K/N<^(P]+%4W2K1YHOH?FG^Q?_P G,>"_]^Z_])9J_5RORC_8
MO_Y.8\%_[]U_Z2S5^KE?7\7?[Y3_ ,'_ +=(^%X+_P!TJ_XOT1\G?M7?LN_$
M#X^>.K'4-)UC0[70[&T$%O;:A<3)(LA),C82%AS\HZ]%%=WX&_9)^'?A7X66
M^A>(/#FD:EJ'V3.I:O+$&E\TKF1XYF >-0<[<;< #(SFO=J^+?VYO ?Q5\2:
MXU_X:BUB[\$PZ6HOK:QO_P!R9 [ERUL'W/\ +MR=AX'M7E8/%XC&1IY?[94H
M+KM^-U?7\3W<9@\/A)U<R]BZM1I:;]EHK/9?A<^:/V>YKG0?VFO"T7ARYDN(
MAK7V5)4_Y;6I<JY/L8MQ/YU^M-?FC^P?XQ\%>%OBF(/$%G(OB#4 +72=3D<&
M&!VX,>W&5=_NA\GKMP,DG]+J]+BJ3^M4X.+]V.[Z_P##?F>1PC&/U:K5C)>]
M+X5]G_A_R2"O'OVHOCE'\#/AO-J%OY<FO7Y-KIL+\CS".9"/[J#GW.!WKV&O
MS!_;L^($_C#XZ7VEB1C8:!$EE#'VWD!Y6^I9@/\ @ KQLEP*S#&QI3^%:OT7
M3YNR/?SO,'EN!G7C\3TCZO\ R5W\C@O@SX-T_P"+?Q,5O&7B>QT72/,-[JFI
M:K?QV[SY;)1&D(W2.3^ R>V#^L?A*;0I?#MBGAJ>QGT2&)8;4Z;(DD"HHP%4
MJ2, "O@3P5_P3O\ $WB;P+!K6H>([71-6NH!/!I,EHTF PRJRR;AL;U 5L?I
M7DOPK^)_BK]F'XJ31R>="EK=&TUC2&?]W.BMAACIN R5?^8)!^VS+#4L\E*G
MA*Z<J:^&VGW_ (75TCX#*\57R&*KXS#OEJO6=[OOM^-G9OY'Z1_M*>=_PH/Q
M[Y&[S/[(G^[UQMY_3->)_P#!-WRO^%2^)-NWS_[;;?Z[?(AVY]L[OUKZEFBL
M/%GAYXW"W6F:G:E2.TD,B?U5OUKX0MO ?QJ_8_\ &6MCP'H4GC#PSJ;#R]EE
M)>*P!.PR1Q,)$D4$C/W3GOV^4RWEKX2O@')1G)IJ^B=GJO4^RS3FHXK#9A&+
ME"',G;5I26CMV[E;]J)6_P"&W/"7V3_CY,^D_P"K/S;_ #AC\<8KW+]N;XL3
M>#_AW!X0TAF?Q!XI?[*D4/,BV^0'P!W8D(/7<?2O.O@'\#?&OBSXL7/QC^+4
M#:2+0M>PVMXOER-(JX1C'UBCB49 ;!RJ]>34?P5C;]I3]I;7_BGJPV^$_"YV
MZ<LW"!ESY/7^Z-TI]&*U[-2-&]%5&I1PT+R:V<GM%/U_"YXU.I7_ ']2E%QG
MBIJ,$]'9+6=O):][V/I;]G?X2P_!CX4Z1X?V+_:)7[5J,B\[[EP"_/<+@(/9
M!7I5?"^N_M0?&'XX>.M4TKX*Z?Y.D:;S]I$%NTDJ9(#R/<?NTW$':HP<#OSC
MN_V:?VJ/$7B;QW<_#?XEV4=AXLA+I;W(B$+2R(-S12(/E#;06#+A2!TZ$^)B
MLJQM13Q55IS^*4;^\D^K71?D>UA,VP-!PP=)24$^12M[C?;FZO\ ,^K:***^
M9/J0HHHH **** "BBB@ HHHH ^0?!7_)VEQ_V%]0_P#0)J^OJ^0?!7_)VEQ_
MV%]0_P#0)J^OJ^ESW^+1_P $?U/R[@#_ '7&_P#7^?Y1"BBBOFC]1"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OSX^.W
M_!1KQM\%_C[XJ\)+X8T35- TJX2*%9A-#=,IB1B3('*\EB1\G0BOT'K\V_\
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M)^M_ZLYM_P ^?_)H_P"9[G17AG_#2DO_ $+Z?^!9_P#B*/\ AI27_H7T_P#
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M\Z]_YXI^?_UZ +M%4O.O?^>*?G_]>CSKW_GBGY__ %Z +M%4O.O?^>*?G_\
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M\4_/_P"O0!=HJEYU[_SQ3\__ *]'G7O_ #Q3\_\ Z] %VBJ7G7O_ #Q3\_\
MZ]'G7O\ SQ3\_P#Z] %VBJ7G7O\ SQ3\_P#Z]'G7O_/%/S_^O0!=HJEYU[_S
MQ3\__KT>=>_\\4_/_P"O0!D?$K_DG7BK_L%77_HEJ\(_8Q_UOB[_ ';3_P!K
M5[9\1I;P_#WQ0&A4+_9=UDY_Z8M[UX;^QV\RR^+/)0/\MKG/_;:OI<)_R*<3
MZQ_-'Y=G'_)7Y7_AJ?\ I,CZAHJEYU[_ ,\4_/\ ^O1YU[_SQ3\__KU\T?J)
M=HJEYU[_ ,\4_/\ ^O1YU[_SQ3\__KT 7:*I>=>_\\4_/_Z]'G7O_/%/S_\
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M=HJEYU[_ ,\4_/\ ^O1YU[_SQ3\__KT 7:*I>=>_\\4_/_Z]'G7O_/%/S_\
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M/_Z] %VBJ7G7O_/%/S_^O1YU[_SQ3\__ *] %VBJ7G7O_/%/S_\ KT>=>_\
M/%/S_P#KT 7:*I>=>_\ /%/S_P#KT>=>_P#/%/S_ /KT 7:*I>=>_P#/%/S_
M /KT>=>_\\4_/_Z] %VBJ7G7O_/%/S_^O1YU[_SQ3\__ *] %VBJ7G7O_/%/
MS_\ KT>=>_\ /%/S_P#KT 7:*I>=>_\ /%/S_P#KT>=>_P#/%/S_ /KT 7:*
MI>=>_P#/%/S_ /KT>=>_\\4_/_Z] %VBJ7G7O_/%/S_^O1YU[_SQ3\__ *]
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MU S(^XA(Q@?Q$!>/4U[K=?\ !./X@)>LMMKOA^6TSQ+++-'(1Z[!&P_\>KZ
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M,[1[*M>4_ .SOOVDOVCM=^*VH6QET'0Y!!I44H^42 $1  ]U4F0^C.IKZ_\
M%&AMXM\-ZIHE];JUGJ-M):S#C.UU*G'/7FOI,7)9?2I8*VJ:G/U>T?DOQ9\Y
M@U_:.)J8Z_NJ\*?HOBE\WL][*Q\S_P#!-NS@C^%?B:[50+F76C$[=RJP1%1^
M!=_SKRS]H9CHW[=WANYL%VW+WVDR,(S@NQ=%(/U4 5F^#/'WCK]A/Q)X@T'6
M/#!UK1-0E$D$SR-#%*RY"RQ2A6'*D;D(R,#ICGJO@%\.O&/QZ^.S_&#Q7I#Z
M;I,$ZW=I'*C(L\BJ%A2(-RR)A27Z$KCN<?3RA[''5LUE).C*+L[K6Z7NVW/D
M8R=7+J63QBU7C)75GHE)OFOM;_,^]**I>=>_\\4_/_Z]'G7O_/%/S_\ KU^9
M'ZH7:*I>=>_\\4_/_P"O1YU[_P \4_/_ .O0!=HJEYU[_P \4_/_ .O1YU[_
M ,\4_/\ ^O0!=HJEYU[_ ,\4_/\ ^O1YU[_SQ3\__KT 7:*I>=>_\\4_/_Z]
M'G7O_/%/S_\ KT ?)W@K_D[2X_["^H?^@35]?5\>>#6E'[5EP54&7^UK_P"7
MMG;-FOK;SKW_ )XI^?\ ]>OI<]_BT?\ !']3\NX _P!UQO\ U_G^42[15+SK
MW_GBGY__ %Z/.O?^>*?G_P#7KYH_42[15+SKW_GBGY__ %Z/.O?^>*?G_P#7
MH NT52\Z]_YXI^?_ ->CSKW_ )XI^?\ ]>@"[15+SKW_ )XI^?\ ]>CSKW_G
MBGY__7H NT52\Z]_YXI^?_UZ/.O?^>*?G_\ 7H NT52\Z]_YXI^?_P!>CSKW
M_GBGY_\ UZ +M%4O.O?^>*?G_P#7H\Z]_P">*?G_ /7H NT52\Z]_P">*?G_
M /7H\Z]_YXI^?_UZ +M%4O.O?^>*?G_]>CSKW_GBGY__ %Z +M%4O.O?^>*?
MG_\ 7H\Z]_YXI^?_ ->@"[15+SKW_GBGY_\ UZ/.O?\ GBGY_P#UZ +M%4O.
MO?\ GBGY_P#UZ/.O?^>*?G_]>@"[15+SKW_GBGY__7H\Z]_YXI^?_P!>@"[1
M5+SKW_GBGY__ %Z/.O?^>*?G_P#7H NT52\Z]_YXI^?_ ->CSKW_ )XI^?\
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M7_X'7?\ \BUK>)/^"M'C^YU!F\/^#?#>G6/\,6I&XNY?Q=)(A_X[7V9^RO\
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MS>[(A%4XJ*Z!1116984444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\F?VYO^3IO&W_;C_Z0V]>#
MU[Q^W-_R=-XV_P"W'_TAMZ\'K^CLJ_Y%^'_P1_\ 24?@.9_[]7_QR_-A1117
MJGFA1110 4444 %%%% !1110 4444 %%%% !1110 5^LW[#/_)K/@G_M^_\
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M/_0)J^OJ^ESW^+1_P1_4_+N /]UQO_7^?Y1"BBBOFC]1"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OQK_;P\07_Q$_:^
MUW2+BY\N"QGM='LQ(3LA0HA)QV!>1F/UK]E*_++_ (*<_ '5/#?Q*_X6=IMI
M)-H&M)%%?3Q+D6MVBA!OQT#JJX/]X$>F?1RV4(8N#J;:KYZ?I=?.W4\G-H5*
MF"FJ>^C?I_P]G\A/V[OV5? 7[.GPA\$R>&+"8ZU<:@;:^U:YN9))+H"%F)*%
MMB?,,X51^-?2_P#P3+CCF_95CCF57A;5;U75QD%3MR#[8K\\_C%^UGXN^.GP
MP\->$?%D-K=SZ'<^=%K$899[A?+*8E7.TMS]X8SCD9YJ;P;^V!XV^'?P+G^&
M/AD6NE65U-/)<ZL@9KQEEP&1#G:@P,9 +<\$5[,\-B*F&J4IN\F]+[6T_#R/
M IXK#4\53K07+%1ULM;Z_>_,W?V4=0C\,_MO^'4T%MVGMKMU90^6<AK9Q*@^
MHV$'\*_:"ORI_P""8OP'U+Q3\4O^%D7MJT7A[P^DL=K-(O%Q>.A3:OJ$1V8G
ML2GX?JM7!FC494Z=[N*U?]??\SU<HYI1J5K64I:+^ON^04445XA] %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^$-
M?N]7X0U^H\$?\Q/_ &Y_[<?F_&/_ ##_ /;W_MH4445^I'YN%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!^[U%%%?RX?T@%%%% !7Q[XZ_Y';Q#
M_P!A&X_]&M7V%7Q[XZ_Y';Q#_P!A&X_]&M7X=XJ?[EA?\3_(_1>"_P#>*WHO
MS,.BBBOYM/U@**** "BBB@ HHHH XS5/^1O3_KK%_):[.N,U3_D;T_ZZQ?R6
MNSK]W\2O^17P]_V"P_\ 28G\_>%W_(VXD_["ZG_I4@HHHK\(/Z!"BBB@ HHH
MH **** /L+P+_P B3X>_[!UO_P"BEK<K#\"_\B3X>_[!UO\ ^BEK<K^\\N_W
M*C_AC^2/YLQ7^\5/5_F%%%%>@<H4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5\F?\%+/^2%:%_P!C)!_Z2W5?6=?)G_!2S_DA6A?]C)!_Z2W5>]D/_(SH
M?XCQ,[_Y%U;T/S4HHHK^A3\*"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ^L_\ @FG_ ,EUUW_L6Y__ $JM:_2NOS4_X)I_\EUUW_L6Y_\ TJM:
M_2NOP_BW_D9OT1^Q\+_\BY>K"BBBOC#ZT**** "BBB@ HHHH **** "BBB@#
MF_B5_P DZ\5?]@JZ_P#1+5X1^QC_ *WQ=_NVG_M:O=_B5_R3KQ5_V"KK_P!$
MM7A'[&/^M\7?[MI_[6KZ7"?\BG$^L?S1^79Q_P E?E?^&I_Z3(^FZ***^:/U
M$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KBO%_C[X=JMSX=\4>)/#*?:U,$^E
M:M?VX,JMP4:)VY!Z8(KXJ_X*6?M3:YX4U6U^&'A/4I])>2V6ZUF]M)"DK*^=
MD"L.5!4;FQU#*.F0?S\\-_#CQ=XUM9[OP_X7UK7K:%MLL^FZ?-<HC8SAF12
M<<\UZN%P'UBG[6<K1/%QF9+#5/8TX\TOZ?ST^X_4KQG_ ,$R?@[XZNCJN@7F
MK^&HK@>8L.DW:36C9.=RB17(![;7VCL*;X,_X);?"3P[J$5WJ][K_B<1G/V.
M\NDAMV],B)%?_P ?Q7P+^S3^TYXM_9G\=0&.XNY/#;7(CU?0)R=CKG#LJ'[D
MJ]F&#D8.1D5^VNE:I:ZWI=GJ-C,MQ97D*7$$R'*O&ZAE8>Q!!K?$K$X-+EJ-
MQ?7^OP.?!O"8YRYJ24ENOZ_$AT'P_IGA71[32='L+;2],M$$<%G:1+'%$H[*
MH&!6A117B-MN[/H4E%604444AA1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %?A#7[O5^$-?J/!'_,3_ -N?^W'YOQC_
M ,P__;W_ +:%%%%?J1^;A1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?N]1117\N'](!1110 5\>^.O^1V\0_P#81N/_ $:U?85?'OCK_D=O$/\
MV$;C_P!&M7X=XJ?[EA?\3_(_1>"_]XK>B_,PZ***_FT_6 HHHH **** "BBB
M@#C-4_Y&]/\ KK%_):[.N,U3_D;T_P"NL7\EKLZ_=_$K_D5\/?\ 8+#_ -)B
M?S]X7?\ (VXD_P"PNI_Z5(****_"#^@0HHHH **** "BBB@#["\"_P#(D^'O
M^P=;_P#HI:W*P_ O_(D^'O\ L'6__HI:W*_O/+O]RH_X8_DC^;,5_O%3U?YA
M1117H'*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@#-\22O!X=U22-VCD2UE974X*D(2"#V->#_P#"4ZU_T%[_ /\
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M_P!?=Q_)Z];KKQ-.$G&\5L?"\)5)JAB?>?\ %E^434_X2G6O^@O?_P#@2_\
MC1_PE.M?]!>__P# E_\ &LNBN3V-/^5?<?=>UJ?S/[S4_P"$IUK_ *"]_P#^
M!+_XT?\ "4ZU_P!!>_\ _ E_\:RZ*/8T_P"5?<'M:G\S^\U/^$IUK_H+W_\
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M7&?_ "+X?XU_Z3(^VX2_WZ?^!_G$]XHHHK\9/UH**** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XO
MXT_8U^#GQ"\4:AXB\0^"X=1UG4)/-N;IKZZ0R-@#.U90HX Z 5B?\,!_ /\
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^L_^":?_)===_[%N?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#+
M\4_\BSJ__7G-_P"@&OG6OHKQ3_R+.K_]><W_ * :^=:^RR+^'/U/E,Y_B0]
MHHHKZ8^="BBB@ HHHH **** /)-%_P"2K2?]?=Q_)Z];KR31?^2K2?\ 7W<?
MR>O6ZZL1O'T/AN$_X&)_Z^R_*(4445RGW(4444 %%%% !6IX6_Y&;2/^OR'_
M -#%9=:GA;_D9M(_Z_(?_0Q65;^'+T9K2_B1]4?15%%%?EA^D!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?A#7[O5
M^$-?J/!'_,3_ -N?^W'YOQC_ ,P__;W_ +:%%%%?J1^;A1110 4444 %%%%
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M2 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3.<E!<SV[GZ84445!04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO1YU[_SQ3\__ *] %VBJ7G7O_/%/S_\ KT>=>_\ /%/S_P#KT 7:*I>=>_\
M/%/S_P#KT>=>_P#/%/S_ /KT 7:*I>=>_P#/%/S_ /KT>=>_\\4_/_Z] %VB
MJ7G7O_/%/S_^O1YU[_SQ3\__ *] %VBJ7G7O_/%/S_\ KT>=>_\ /%/S_P#K
MT 7:*I>=>_\ /%/S_P#KT>=>_P#/%/S_ /KT 7:*I>=>_P#/%/S_ /KT>=>_
M\\4_/_Z] %VODS_@I9_R0K0O^QD@_P#26ZKZF\Z]_P">*?G_ /7KY1_X*227
M#? W0Q+&J+_PD<'(]?LUU[U[V0_\C.A_B/$SO_D75O0_-RBBBOZ%/PH****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZS_P"":?\ R777?^Q;G_\
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MM\7?[MI_[6KVSXC2WA^'OB@-"H7^R[K)S_TQ;WKPW]CMYEE\6>2@?Y;7.?\
MMM7TN$_Y%.)]8_FC\NSC_DK\K_PU/_29'U#15+SKW_GBGY__ %Z/.O?^>*?G
M_P#7KYH_42[15+SKW_GBGY__ %Z/.O?^>*?G_P#7H NT52\Z]_YXI^?_ ->C
MSKW_ )XI^?\ ]>@"[15+SKW_ )XI^?\ ]>CSKW_GBGY__7H NT52\Z]_YXI^
M?_UZ/.O?^>*?G_\ 7H NT52\Z]_YXI^?_P!>CSKW_GBGY_\ UZ +M%4O.O?^
M>*?G_P#7H\Z]_P">*?G_ /7H NT52\Z]_P">*?G_ /7H\Z]_YXI^?_UZ +M%
M4O.O?^>*?G_]>CSKW_GBGY__ %Z +M%4O.O?^>*?G_\ 7H\Z]_YXI^?_ ->@
M"[15+SKW_GBGY_\ UZ/.O?\ GBGY_P#UZ +M%4O.O?\ GBGY_P#UZ/.O?^>*
M?G_]>@"[15+SKW_GBGY__7H\Z]_YXI^?_P!>@"[15+SKW_GBGY__ %Z/.O?^
M>*?G_P#7H NT52\Z]_YXI^?_ ->CSKW_ )XI^?\ ]>@"[15+SKW_ )XI^?\
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M]_YXI^?_ ->CSKW_ )XI^?\ ]>@"[15+SKW_ )XI^?\ ]>CSKW_GBGY__7H
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MO1YU[_SQ3\__ *] %VBJ7G7O_/%/S_\ KT>=>_\ /%/S_P#KT 7:*I>=>_\
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M0!=HJEYU[_SQ3\__ *]'G7O_ #Q3\_\ Z] %VBJ7G7O_ #Q3\_\ Z]'G7O\
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M%_):[.N,U3_D;T_ZZQ?R6NSK]W\2O^17P]_V"P_])B?S]X7?\C;B3_L+J?\
MI4@HHHK\(/Z!"BBB@ HHHH **** /L+P+_R)/A[_ +!UO_Z*6MRL/P+_ ,B3
MX>_[!UO_ .BEK<K^\\N_W*C_ (8_DC^;,5_O%3U?YA1117H'*%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %?)G_!2S_DA6A?]C)!_Z2W5?6=?)G_!2S_D
MA6A?]C)!_P"DMU7O9#_R,Z'^(\3._P#D75O0_-2BBBOZ%/PH**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#ZS_X)I_\ )===_P"Q;G_]*K6OTKK\
MU/\ @FG_ ,EUUW_L6Y__ $JM:_2NOP_BW_D9OT1^Q\+_ /(N7JPHHHKXP^M"
MBBB@ HHHH **** "BBB@ HHHH YOXE?\DZ\5?]@JZ_\ 1+5X1^QC_K?%W^[:
M?^UJ]W^)7_).O%7_ &"KK_T2U>$?L8_ZWQ=_NVG_ +6KZ7"?\BG$^L?S1^79
MQ_R5^5_X:G_I,CZ;HHHKYH_40HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HI"0H))P*SK7Q-H]]=?9K;5;&XN<X\F*Y1G_('-92JTX249
MR2;VUW]"XTYS3<5>QI445%<W4-G;R3W$L<$$8W/)(P55'J2>@K24E%.4G9(E
M)MV1+15;3]3L]6M_/L;N"\@SM\RWD61<CJ,@XJS2C*,XJ47=,<HN+M)68444
M51(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'Y,_MS?\G3>-O\ MQ_](;>O!Z]X_;F_Y.F\;?\ ;C_Z0V]>#U_1V5?\B_#_
M ."/_I*/P',_]^K_ ..7YL****]4\T**** "BBB@ HHHH **** "BBB@ HHH
MH **** "OUF_89_Y-9\$_P#;]_Z77%?DS7ZS?L,_\FL^"?\ M^_]+KBO@N,_
M^1?#_&O_ $F1]MPE_OT_\#_.)[Q1117XR?K04444 %%%% !1110 4444 %%%
M% !7S5^V;_J?"/\ O7?\H:^E:^:OVS?]3X1_WKO^4->[D?\ R,*7S_\ 26?
M<>_\DYBO^W/_ $N)[7\*O^29>$_^P5:_^BEKJJY7X5?\DR\)_P#8*M?_ $4M
M=57E8C^-/U?YGUN6_P"XT/\ !'\D%%%%<YZ04444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% &7XI_Y%G5_^O.;_P! -?.M
M?17BG_D6=7_Z\YO_ $ U\ZU]ED7\.?J?*9S_ !(>@4445],?.A1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWB'_ +"-Q_Z-:OP[Q4_W+"_XG^1^B\%_[Q6]%^9AT445_-I^L!1110 4444
M%%%% '&:I_R-Z?\ 76+^2UV=<9JG_(WI_P!=8OY+79U^[^)7_(KX>_[!8?\
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M17]"GX4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]9_P#!-/\
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M9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M?DS^W-_R=-XV_P"W'_TAMZ\'KWC]N;_DZ;QM_P!N/_I#;UX/7]'95_R+\/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-3_TF1]-T445\T?J(4444 %%%% !1110 4444 %<?\6M5?1_A]J\L3;9)(Q
M"/\ ;8*?T)KL*YKXC>'I?%'@S4]/@&;AT#Q#U96# ?CC'XUXF>0K5,KQ4,.K
MS<))6WORO;S['?@)4XXNE*K\*DK^ESY^^$O@.#QUKTL=X[+96L?F2K&<,^3@
M+GL.N?I79_%SX1Z1H/AQM7T:)K3[,RB:$R,ZNK,%R-Q)!!(]L5P7P[\<3_#O
M7Y9Y+9IH)%\FXMS\K<'J,]"#Z^]=1\3_ (RP>,-%&E:7:SV]M(RO/)<[0S8.
M0H )XS@YSVK^<L#7X;CPM5I8B,?K?O;KW^:_NV?2*5KZVWN?K6+IYK+-Z<Z+
M?L=.NEOM77?M\K&C^SKXBG74+[19)"ULT7VB)"?NL" V/J"/RKW>O$?V>/"M
MQ"][KL\9CADC^SV^X8W\@LP]N /SJQXW^.E_X=\5W.FV6G6\EM:OY<K7&[?(
M>^W! 4?4'U]J_4.'\YI</\-82KG$G'F;4=&W9MN/RY=5Y6MT/D<WP$\SS>K3
MP*3:2;ULK]?Z[GLU>$_'WQYY\R^&[*3]W&1)>,IZMU6/\.I]\>E>B>*OB%!H
M7@./7D0K-=Q*;6&3KYCKD ^PY)^E>!_#WPI<?$+Q<%N6>2 .;B]F8\D9R1GU
M8\?G7/QMFU;%RI<.Y:[U:]N;RB_\]WVBO,KAW+XT7/,L8K0I7MZK_+IY^AZ;
M\ _ OV"R;Q%>1XGN%*6JM_#'W;ZG^7UKV&F0PI;PI%$@2.-0JJHP  , "GU^
MD9/E=#)L#3P-#:*W[OJWZO\ R/E,PQU3,<3+$5.NR[+HCF/'W@.S\>Z2MK<.
M8+B([H+E5R8R>O'<'N/85YE'\"?$M\T%GJ?B*.3286^2-999"H_V48!5./>O
M=*IZQJMOH>EW5_=/LM[>,R.?8#H/<]!]:\?-N&\HQ]66-QL+-+WFI.*DE_-9
MJZ7Y'7@<WQV$@L/AY75]$TG9OM<\@^*&RQM-$^'N@+M,S(95!R<9^4,?<Y8_
M05+\3-=F\ >']'\(Z"[0W,T8#S1G#[<XX/8LV>?;WJ3X-Z7<>)]?U7QIJ2YD
MFD:.V!YV]B1[ 84?C6'\8<P?%O1)9N(=MLP9NFT2MG^M?G>-E7_LN>:QO3>*
MG"G&VCA0O:*7;F7O/_$C[##QIO&T\!/WO9*4Y=>:I:[OWL5->^%>N^ -%'B.
MWUIC>PE7N$A#*R9('#9^?D\Y KV#X;^+CXT\*V]_(%6Z4F&=5Z;QW'U!!_&F
M?%:5(?AYKC2' ,&T9]2P _4BN2_9SAEC\*ZC(P(BDN_D]\(N:^ARW"T\AXD6
M68"ZHU*7.XMMVDI-<VK;5]GW?R/)Q->>:91+%XFWM(3LG9+1I::=KGK-%%%?
MJ9\0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!^3/[<W_)TWC;_ +<?_2&WKP>O>/VYO^3IO&W_ &X_^D-O7@]?T=E7_(OP
M_P#@C_Z2C\!S/_?J_P#CE^;"BBBO5/-"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K]9OV&?^36?!/\ V_?^EUQ7Y,U^LW[#/_)K/@G_ +?O_2ZXKX+C
M/_D7P_QK_P!)D?;<)?[]/_ _SB>\4445^,GZT%%%% !1110 4444 %%%% !1
M110 5\U?MF_ZGPC_ +UW_*&OI6OFK]LW_4^$?]Z[_E#7NY'_ ,C"E\__ $EG
MP''O_).8K_MS_P!+B>U_"K_DF7A/_L%6O_HI:ZJN5^%7_),O"?\ V"K7_P!%
M+755Y6(_C3]7^9];EO\ N-#_  1_)!1117.>D%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!E^*?^19U?_KSF_\ 0#7S
MK7T5XI_Y%G5_^O.;_P! -?.M?99%_#GZGRF<_P 2'H%%%%?3'SH4444 %%%%
M !116<WB3248JVJ62LIP0;A 1^M-)O8QJ5J=*WM))>KL>:Z+_P E6D_Z^[C^
M3UZW7CNDWUM'\3'NGN(EMOM4S><S@)@A\'=TP<BO5K76M/OIA%;7]K<2XSLB
MF5F_(&NK$)W7H?#<*5J4:.(BY*[JRMKOHBY1117(??A1110 4444 %:GA;_D
M9M(_Z_(?_0Q676IX6_Y&;2/^OR'_ -#%95OX<O1FM+^)'U1]%4445^6'Z0%%
M%% !1110 4444 %%%% !1110 4444 ?(/@O_ ).TN/\ L+W_ /Z!-7U]7R#X
M+_Y.TN/^PO?_ /H$U?7U?39[_$H_X(_J?EW '^ZXW_K_ #_*(4445\R?J(44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU?'05*48Q@G>T597[OS"BBBOICQ0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /R9_;F_P"3IO&W_;C_ .D-O7@]>\?MS?\
M)TWC;_MQ_P#2&WKP>OZ.RK_D7X?_  1_])1^ YG_ +]7_P <OS84445ZIYH4
M444 %%%% !1110 4444 %%%% !1110 4444 %?K-^PS_ ,FL^"?^W[_TNN*_
M)FOUF_89_P"36?!/_;]_Z77%?!<9_P#(OA_C7_I,C[;A+_?I_P"!_G$]XHHH
MK\9/UH**** "BBB@ HHHH **** "BBB@ KYJ_;-_U/A'_>N_Y0U]*U\U?MF_
MZGPC_O7?\H:]W(_^1A2^?_I+/@./?^2<Q7_;G_I<3VOX5?\ ),O"?_8*M?\
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MW_K_ #_*(4445\R?J(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI:W*_O/+O]RH_P"&/Y(_FS%?[Q4]7^84445Z!RA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !7R9_P4L_Y(5H7_8R0?^DMU7UG7R9_P4L_Y(5H7_8R0?\
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M^]=_RAKW<C_Y&%+Y_P#I+/@./?\ DG,5_P!N?^EQ/:_A5_R3+PG_ -@JU_\
M12UU5<K\*O\ DF7A/_L%6O\ Z*6NJKRL1_&GZO\ ,^MRW_<:'^"/Y(****YS
MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "OPAK]WJ_"&OU'@C_F)_P"W/_;C\WXQ_P"8?_M[
M_P!M"BBBOU(_-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /W>H
MHHK^7#^D HHHH *^/?'7_([>(?\ L(W'_HUJ^PJ^/?'7_([>(?\ L(W'_HUJ
M_#O%3_<L+_B?Y'Z+P7_O%;T7YF'1117\VGZP%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!]A>!?^1)\/?\ 8.M__12UN5A^!?\ D2?#W_8.M_\
MT4M;E?WGEW^Y4?\ #'\D?S9BO]XJ>K_,****] Y0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KY,_X*6?\D*T+_L9(/\ TENJ^LZ^3/\ @I9_R0K0O^QD
M@_\ 26ZKWLA_Y&=#_$>)G?\ R+JWH?FI1117]"GX4%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!]9_\$T_^2ZZ[_P!BW/\ ^E5K7Z5U^:G_  33
M_P"2ZZ[_ -BW/_Z56M?I77X?Q;_R,WZ(_8^%_P#D7+U84445\8?6A7*_%#6K
MWP[X%U/4-/F^SWD/E;)-BMC,J*>&!'0GM755P_QJ_P"29ZS_ -L?_1T=>'GU
M2='*<74IR<91IS::T::B[-/HT>CEL8U,;0A-73G&Z^:/$?\ A=7C/_H,_P#D
MK#_\11_PNKQG_P!!G_R5A_\ B*X>BOXY_P!8LY_Z#:O_ (,G_F?O/]EX#_H'
MA_X#'_([C_A=7C/_ *#/_DK#_P#$4?\ "ZO&?_09_P#)6'_XBN'HH_UBSG_H
M-J_^#)_YA_9> _Z!X?\ @,?\CN/^%U>,_P#H,_\ DK#_ /$4?\+J\9_]!G_R
M5A_^(KAZ*/\ 6+.?^@VK_P"#)_YA_9> _P"@>'_@,?\ ([C_ (75XS_Z#/\
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M8?\ XBC_ (75XS_Z#/\ Y*P__$5P]%'^L6<_]!M7_P &3_S#^R\!_P! \/\
MP&/^1W'_  NKQG_T&?\ R5A_^(H_X75XS_Z#/_DK#_\ $5P]%'^L6<_]!M7_
M ,&3_P P_LO ?] \/_ 8_P"1[#\+_BAXF\1>.M,T_4-3^T6<WF[X_(B7.(G8
M<JH/4#O7OM?+/P5_Y*9HW_;;_P!$R5]35_1OAQC<5CLIJU,75E4DJC5Y-R=N
M6&EW?35GY3Q7AZ.'QL(48**Y%HDEUEV"BBBOU4^+"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#\F?VYO^3IO&W_;C_Z0V]>#U[Q^W-_R=-XV_P"W
M'_TAMZ\'K^CLJ_Y%^'_P1_\ 24?@.9_[]7_QR_-A1117JGFA1110 4444 %%
M%% !1110 4444 %%%% !1110 5^LW[#/_)K/@G_M^_\ 2ZXK\F:_6;]AG_DU
MGP3_ -OW_I=<5\%QG_R+X?XU_P"DR/MN$O\ ?I_X'^<3WBBBBOQD_6@HHHH
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M*^F/G0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *U/"W_(S:1_U^0_\
MH8K+K4\+?\C-I'_7Y#_Z&*RK?PY>C-:7\2/JCZ*HHHK\L/T@**** "BBB@ H
MHHH **** "BBB@ HHHH ^0?!?_)VEQ_V%[__ - FKZ^KY!\%_P#)VEQ_V%[_
M /\ 0)J^OJ^FSW^)1_P1_4_+N /]UQO_ %_G^40HHHKYD_40HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M444 %%%% !1110 4444 %%%% !1110!]A>!?^1)\/?\ 8.M__12UN5A^!?\
MD2?#W_8.M_\ T4M;E?WGEW^Y4?\ #'\D?S9BO]XJ>K_,****] Y0HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ KY,_X*6?\D*T+_L9(/\ TENJ^LZ^3/\
M@I9_R0K0O^QD@_\ 26ZKWLA_Y&=#_$>)G?\ R+JWH?FI1117]"GX4%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!]9_\$T_^2ZZ[_P!BW/\ ^E5K
M7Z5U^:G_  33_P"2ZZ[_ -BW/_Z56M?I77X?Q;_R,WZ(_8^%_P#D7+U84445
M\8?6A7#_ !J_Y)GK/_;'_P!'1UW%</\ &K_DF>L_]L?_ $='7S_$7_(FQO\
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M\C"E\_\ TEGP''O_ "3F*_[<_P#2XGM?PJ_Y)EX3_P"P5:_^BEKJJY7X5?\
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M?^19U?\ Z\YO_0#7SK7V61?PY^I\IG/\2'H%%%%?3'SH4444 %%%% !1110
M4444 %%%% !1110 4444 %:GA;_D9M(_Z_(?_0Q676IX6_Y&;2/^OR'_ -#%
M95OX<O1FM+^)'U1]%4445^6'Z0%%%% !1110 4444 %%%% !1110 4444 ?(
M/@O_ ).TN/\ L+W_ /Z!-7U]7R#X+_Y.TN/^PO?_ /H$U?7U?39[_$H_X(_J
M?EW '^ZXW_K_ #_*(4445\R?J(4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 ?FW_P6P^)/]D_"GP-X'AF*S:UJDFHSHIZPV\>T ^Q>=3]
M4]J[?]B7]K_]G;X<? SX>_#9/B5I=AKUGIR&]6^MKFT@6[ES+,#<31+%Q([#
M._'%;W[3G_!/^;]K[X]P^)/&?BBYT+P1H^EQ:=I^GZ0%:\N9"SR2REW#)$-S
MA?NL6V?P@#/A_P 9/^"*7AZ/PK<W7PN\9ZS_ &_;HTD=AXF:":&[('$8EBCC
M\HGLQ5AZXZC.E)TJ<W-?$[NV^ETOPL^K-*D54G!1?PJWEKJ_N>A^G=O<174$
M<T,B30R*'22-@RLI&001U!%25^4W_!)?]I7Q1H/Q U7]G_QK+<-';I</I$-Z
M29;"X@)\^TY_AP&8+_"8VQ]ZOU9KHE%)*47=-71SQDVW&2LT[,*_%=?#Y_;Y
M_P""G6L:?K<DEUX0TF^GCEAW8 TVQ8H(UQT$LF,XY_?,:_:=ONGZ5^/W_!)
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M_GU?]?\ "C[?+_SZO^O^% %VOPAK]T?M\O\ SZO^O^%?A=7ZCP1_S$_]N?\
MMQ^;\8_\P_\ V]_[:%%%%?J1^;A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 ?N]15+[?+_SZO\ K_A1]OE_Y]7_ %_PK^7#^D"[15+[?+_SZO\
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MQ?QDO))?AOJZM R ^3\QS_SV3VKY_B+_ )$V-_Z]5/\ TAGJ97_O^'_QQ_\
M2D?,5%%%?PX?T2%%%% !1110 4444 5M4_Y!EW_UQ?\ ]!-<]X'^]>_\ _\
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M ))EX3_[!5K_ .BEKJJXKX6WLB?#7PJHMG8#2[89YY_=+[5U'V^7_GU?]?\
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M"X/E^LU8PYG9<S2N^RONSY2CAZV(;5&#E;LF_P CB/BM\8+RQNM6\-V=DD!
M\A[QI"Q*LH)VK@8.#C.34/[/?A$-//XAEFC;8&@AA1P64G[S,!TXX /J37:^
M/O!VE>)-%U&:72(X;_RFE6]C0+)O5>"S ?,.,8/:O%O@[KEUH_CFQC@+-%=$
MPRQ \.,$C\CS7XEC(XK+>+\+6SB7MHU&U2MIR7E975M;75_6]VU8_1L&Z.+R
M2M2P*Y)17OWUYM-=;];/T['OOQ.\.R^*/!.HV5NN^ZVB6)?[S*0V![D C\:\
MY^%/Q6T?PSX7.E:S+):3VLCE/W3-O!.<<#@@YZXKV/[?+_SZO^O^%<QK7@/P
M]XAO3=WWA]9;ECEI$=XRQ]6VD9/UK]$S7*,P_M".:Y1."J\G))3ORN-[I^[J
MFG]_Y_)X''X:.%E@<=&3IM\R<;73VZZ69YK\+[>;QK\4K_Q,86BLH7DFRW0%
M@51<^H!R?I6CH@/Q6^*TVJ./,T32,"$$?*V"=GYMEOH *V/B=X@M_!/@T:+I
M-BMA-?YABCA&,*<;VQCDD$#/7YO:J%Y:S?#/X.W,$4+PZA<J!--T(>0@$=.R
MY ]Q7Q$<)'+F\)5E[2&%YL17:TYZKUA'Y6OKO97/IOK#Q*6(IQY95;4J2[1V
ME+]/(Z+7/CEX9T34'M-UU?/&VUY+2-612.HR6&?PS76>&_%&F^+-/%YIER+B
M'.UA@AD;T8'H:\N^#_@O2+GP@+V^TB+4I[MW^>= ^Q02H"Y''0G(YYK ^&]X
M_@_XL:AH\&_['-)+ (2>?ERR?B ,?B:]O!9]F]"M@JN9J#I8NRBHIIP<E>*;
M>][V?GZ6?G5\KP-2.(HX1R]I15VW:TK;^GD?0U%4OM\O_/J_Z_X4?;Y?^?5_
MU_PK]2/B"[15+[?+_P ^K_K_ (4?;Y?^?5_U_P * +M%4OM\O_/J_P"O^%'V
M^7_GU?\ 7_"@"[15+[?+_P ^K_K_ (4?;Y?^?5_U_P * +M%4OM\O_/J_P"O
M^%'V^7_GU?\ 7_"@"[15+[?+_P ^K_K_ (4?;Y?^?5_U_P * +M%4OM\O_/J
M_P"O^%'V^7_GU?\ 7_"@"[15+[?+_P ^K_K_ (4?;Y?^?5_U_P * +M%4OM\
MO_/J_P"O^%'V^7_GU?\ 7_"@"[15+[?+_P ^K_K_ (4?;Y?^?5_U_P * +M%
M4OM\O_/J_P"O^%'V^7_GU?\ 7_"@"[15+[?+_P ^K_K_ (4?;Y?^?5_U_P *
M +M%4OM\O_/J_P"O^%'V^7_GU?\ 7_"@"#Q3_P BSJ__ %YS?^@&OG6O?_$U
M](WAO55-LZ@VDHSSQ\A]J\ K[+(OX<_4^4SG^)#T"BBBOICYT**** "BBB@
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ME_Y]7_7_  H ^3O!?_)VEQ_V%[__ - FKZ^KX\\&S,O[5EQ((R6_M:_.SO\
M=FKZV^WR_P#/J_Z_X5]-GO\ $H_X(_J?EW '^ZXW_K_/\HEVBJ7V^7_GU?\
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M4 7:*I?;Y?\ GU?]?\*/M\O_ #ZO^O\ A0!=HJE]OE_Y]7_7_"C[?+_SZO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBOZ%/PH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZS_X)I_\
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M^]=_RAKW<C_Y&%+Y_P#I+/@./?\ DG,5_P!N?^EQ/:_A5_R3+PG_ -@JU_\
M12UU5<K\*O\ DF7A/_L%6O\ Z*6NJKRL1_&GZO\ ,^MRW_<:'^"/Y(****YS
MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** ,OQ3_P BSJ__ %YS?^@&OG6OHKQ3_P BSJ__ %YS?^@&OG6OLLB_AS]3
MY3.?XD/0****^F/G0HHHH **** "BBB@ HHHH **** "BBB@ HHHH *U/"W_
M ",VD?\ 7Y#_ .ABLNM3PM_R,VD?]?D/_H8K*M_#EZ,UI?Q(^J/HJBBBORP_
M2 HHHH **** "BBB@ HHHH **** "BBB@#Y!\%_\G:7'_87O_P#T":OKZOD'
MP7_R=I<?]A>__P#0)J^OJ^FSW^)1_P $?U/R[@#_ '7&_P#7^?Y1"BBBOF3]
M1"BBB@ HHHH **** "L;QEKS>&?"^I:FBHTEO"6C63.TN>%!QVR16S4%]8VV
MI6KVUY;Q75N^-T,Z!T;!R,@\'D"N7%PJU,/4A0ERS::3[.VC^3-J,H1J1E45
MXIJZ[KJ?/?\ PT7XD_Y\M*_[]2__ !RO<O!VL3>(/"^FZE<K&D]S")'6($*"
M?3))_6OG3XT:=::7X\NK>RM8;.!8HR(K>,(H)49X Q7OGPQ_Y)_H7_7JM?D?
M!>/S.KFV-P&88AU?9::[74FKH^[S_"X..7T,5A:2ASM/Y-7L=11117[,?GQX
MEXZ^-NN>&?%FHZ7:VFGR6]NX5&FCD+G*@\D.!W]*P?\ AHOQ)_SY:5_WZE_^
M.5[K>>$M#U"Y>XNM%T^YN)#EY9K6-W;MR2,FO*OC=/X>\,Z7'I>GZ-ID.IW8
MW-)':1AH8P>H('!)&!]#[5^(<0X//\KI8C,9YGRTTVU&VNK]V*\^GXGZ'E>(
MRS&3I818.\VDF_1:O]3!C_:(\32R*B6&EN['"JL,I))[?ZRO<M/U"]M/#*W^
MMK#'=QP&>X2V4A4P"Q49)Y ]^M>(_ CP'_;&J'7;R/-G9MB!6'#R^OT7^>/2
MO<?%5K)?>&=7MH5W2S6DT:+ZL4( KV.$)9Q/*JN9X^K*<IQ;IQ?9+1V[R>WE
MZG)Q!' 4\5#!X:FHV:YFO/I\EO\ \ \+\&>%YOC1KVJZMK=[/';Q$*JP$9&<
ME47(("@#T[TMHMS\&?B=!81W4D^E793<&XWQN2H)'3<I!Y]O?%;_ .S;>1?8
MM:M=P$XDCEV=]N",_G_.L;XS,-6^*>DV=L?-G2."%E7DAC(Q _)@?QKXZ&%H
M87)<!G>'_P!ZG5C>=VW)RE)2B^_:WEZGT7MJE3-*V6U/X"A;EMHDDM3WN\O(
M=/M)KFX<100HTDCMT50,D_E7COPQM)?'WCK4_&%ZA^S0/Y=HC= <84?\!7'X
MMFM/XY>(YFM;+PMIV7O]3=?,5>OE[L*O_ F_13ZUWOA'PY#X3\.V6F0X/DI\
M[@??<\LWXFOTZI_PM9XJ>]'":OLZK7NK_MR.OE)H^,I?\)V72J_\O*^B\H+=
M_-Z>AL4445]T?,!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5^$-?N]7X0U^H\$?\Q/_ &Y_
M[<?F_&/_ ##_ /;W_MH4445^I'YN%%%% !1110 4444 %%%% !1110 4444
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^L_^":?_)===_[%N?\
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MJ?\ VAZ_^I/_ %$?^2__ &Q]O45\0T4?\18_Z@?_ "I_]H'^I/\ U$?^2_\
MVQ]O45\0T4?\18_Z@?\ RI_]H'^I/_41_P"2_P#VQ]O45\0U]%_LZ?\ (DWO
M_81?_P!%15]1PWQY_K!CU@?JWL[IN_/S;>7*OS/&S;AK^R\,\1[;FU2MRVW^
M;/4Z***_63XD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P !8\%_"N/P3=7'B3Q%J"WU[ CREQEDCX)9RS<LV,]J]4KR?XX>()[I=/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(_YB?\ MS_VX_-^
M,?\ F'_[>_\ ;0HHHK]2/S<**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#]WJ***_EP_I **** "OCWQU_R.WB'_ +"-Q_Z-:OL*OCWQU_R.WB'_
M +"-Q_Z-:OP[Q4_W+"_XG^1^B\%_[Q6]%^9AT445_-I^L!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 ?87@7_D2?#W_ &#K?_T4M;E8?@7_ )$G
MP]_V#K?_ -%+6Y7]YY=_N5'_  Q_)'\V8K_>*GJ_S"BBBO0.4**** "BBB@
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M_2('X[QE_O\ #_ O_2I!1117["?"!1110 4444 %%%% !1110 4444 %%%%
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M9?\ 8.3_ -&RUY97J?[1?_([67_8.3_T;+7EE?Q;QA_R/\7_ (OT1_0&1?\
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M,Y_B0] HHHKZ8^="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K4\+?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K\(:_=ZOPAK]1X(_YB?\ MS_VX_-^,?\
MF'_[>_\ ;0HHHK]2/S<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#]WJ***_EP_I **** "OCWQU_R.WB'_ +"-Q_Z-:OL*OCWQU_R.WB'_ +"-
MQ_Z-:OP[Q4_W+"_XG^1^B\%_[Q6]%^9AT445_-I^L!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?87@7_D2?#W_ &#K?_T4M;E8?@7_ )$GP]_V
M#K?_ -%+6Y7]YY=_N5'_  Q_)'\V8K_>*GJ_S"BBBO0.4**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS:NGNKK6+:V\S^K,DSS+^(L%',<KJ>THRND[2CL[/223W78****\0]T****
M"BBB@#N/@K_R4S1O^VW_ *)DKZFKY9^"O_)3-&_[;?\ HF2OJ:OZB\+O^1-5
M_P"OLO\ TB!^.\9?[_#_  +_ -*D%%%%?L)\(%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'Y,_MS?\G3>-O^W'_TAMZ\'KWC]N;_ ).F\;?]N/\
MZ0V]>#U_1V5?\B_#_P""/_I*/P',_P#?J_\ CE^;"BBBO5/-"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K]9OV&?^36?!/_ &_?^EUQ7Y,U^LW[#/\
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M15^H^&__ "/X_P"&1\=Q9_R+'ZH]3HHHK^LC\3"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#+\4_\BSJ_P#UYS?^@&OG6OHKQ3_R+.K_ /7G-_Z
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M &X_-^,?^8?_ +>_]M"BBBOU(_-PHHHH **** "BBB@ HHHH **** "BBB@
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M:%</\:O^29ZS_P!L?_1T==Q7#_&K_DF>L_\ ;'_T='7S_$7_ ")L;_UZJ?\
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M;]AG_DUGP3_V_?\ I=<5^3-?K-^PS_R:SX)_[?O_ $NN*^"XS_Y%\/\ &O\
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MC;?]\M_\51_PGVH?\\;;_OEO_BJYJBC^UL=_S]8?4L-_(CI?^$^U#_GC;?\
M?+?_ !5'_"?:A_SQMO\ OEO_ (JN:HH_M;'?\_6'U+#?R(\3\+Z^\/[14U\M
MI;_:#J-XV[Y\9*RY.-WO7TC_ ,)]J'_/&V_[Y;_XJOEGPW_R7F;_ +"%U_Z#
M)7T#7Z%QICL3A\1A%2J-7HP;];R/QSPSP]*M@\>YQ3MB:B_"!TO_  GVH?\
M/&V_[Y;_ .*H_P"$^U#_ )XVW_?+?_%5S5%?GO\ :V._Y^L_8_J6&_D1TO\
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M"_XG^1^B\%_[Q6]%^9AT445_-I^L!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?87@7_D2?#W_8.M__ $4M;E8?@7_D2?#W_8.M_P#T4M;E?WGE
MW^Y4?\,?R1_-F*_WBIZO\PHHHKT#E"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "ODS_@I9_R0K0O^QD@_]);JOK.ODS_@I9_R0K0O^QD@_P#26ZKWLA_Y
M&=#_ !'B9W_R+JWH?FI1117]"GX4%%%% !1110 4444 %%%% !1110 4444
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MEP1\['NS9+$DDDFOR _X*0?LZQ_L?_'3PE\4/AFA\/Z5JUT;RVM[1=L6G:A
MRNRQ@<+&X(8)TXD ^7 '[4U\ _\ !:2U@E_9@\-SN%,\7BJW$9.,@-;7.['Y
M"LJLY0E&LG[R:_%V_P"#ZFM&$9QE1:]UI_@FS[.^#OQ$MOBU\*?"7C.T41PZ
M[I=O?^6/^6;21AF3_@+$C\*["OF?_@FU<27/[$_PP:5R[+:7" G^ZMU, /P
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M/?\ Q%'_  E6H_\ 0 NO_'O_ (B@#IJ*YG_A*M1_Z %U_P"/?_$4?\)5J/\
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M^$JU'_H 77_CW_Q% '345S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z %U_X]_\
M$4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_ (2K4?\ H 77_CW_ ,10!TU%<S_P
ME6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_\10!TU%<S_PE6H_] "Z_\>_^(H_X
M2K4?^@!=?^/?_$4 =-7R9_P4L_Y(5H7_ &,D'_I+=5]&_P#"5:C_ - "Z_\
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MHKTG_A2>H_\ /2Z_\ 6_^*H_X4GJ/_/2Z_\  %O_ (JC_4'B3_H%_P#)Z?\
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M1_PI/4?^>EU_X M_\51_J#Q)_P! O_D]/_Y(/]9LI_Y_?^2R_P CS:BO2?\
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MX]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !% '345S/\
MPE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$4 =-17,_\)5J/_0 NO\
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M1#_5W-/^?7_DT?\ ,^-J*^R?^'<NH_\ 0VW7_@A;_P"/T?\ #N74?^AMNO\
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M/_/2Z_\  %O_ (JOFO\ 4'B3_H%_\GI__)'K?ZS93_S^_P#)9?Y'FU%>D_\
M"D]1_P">EU_X M_\51_PI/4?^>EU_P" +?\ Q5'^H/$G_0+_ .3T_P#Y(/\
M6;*?^?W_ )++_(\VHKTG_A2>H_\ /2Z_\ 6_^*H_X4GJ/_/2Z_\  %O_ (JC
M_4'B3_H%_P#)Z?\ \D'^LV4_\_O_ "67^1Y!XBM[ZXAA%B9 X8[O+DV<8^HK
MG9]"UJZV^<DDNWIYDRMC\S7T#_PI/4?^>EU_X M_\51_PI/4?^>EU_X M_\
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ML^:X@SK 8[ NCAZG-*ZTM)?FD>H45S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z
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M (BC_A*M1_Z %U_X]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_ (2K4?\
MH 77_CW_ ,10!TU%<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_\10!TU%<
MS_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C_P! "Z_\>_\
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M_M7!_P _X/\ R#^S<7_)^*_S.6HKJ?\ A7^H_P#/&Z_\!6H_X5_J/_/&Z_\
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M']AYA_S[_&/^8?VCA?Y_P?\ D>L45S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z
M%U_X]_\ $5^L'Q)TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"S_P#%K_A>GPCT#QO_ &5_8G]JK*WV'[1]H\K9*\?^LV)NSLS]T=:^#_\
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M\1C0Y]11Y+5/L=Q<&14(#']S&^,%AUQGMTKTNOCW]N+]C^Y^.EQ<>.9/&O\
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MB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+-"^'T^U-W,"_'(=^57TY;L,ZW_!7+_D=?AW_P!@^Z_]&)7S1\0/V?;[P_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM53P-N[J>+/Q"_X)<^*O _PMO_$]MXOLM9UO3K5KNYT6"Q=%*HNYQ%.7)=@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-?[K?2G4U_NM]*B?
MPL:W/P=^'_\ R<KX<_[&VW_]+%K]Y*_!OX?_ /)ROAS_ +&VW_\ 2Q:_>2OH
MLR_@4/G^43YW+/\ >,3Z_K(XOQ'\:_AYX/U>;2M>\>>&=$U2$*9;'4M8M[>=
M-P#+N1W##(((R.016;_PTE\)/^BI>"__  H;3_XY7PA^VC^QS\7_ (L_M$^)
M/$_A3PC_ &KH=Y':K!=?VG9P[REO&C?)),K##*1R.U>(+_P3S_:!W#_B@/\
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M9?[QAO\ %^L3];Z***\,^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /A']K[_@G7=?%+Q=>^-OAW>65EJ]^QEU'2+]FCBGE[RQ.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K \?:#<>*O OB+1;1XX[K4=.N+2)YB0BO)&R*6(!(&2,X!K?H
MJ9)233ZE1DXM270_.[]FG_@G;\1_@W\</"WC+6M;\+76EZ5-))/#87=R\S!H
M70;0UNJGEAU8<9K]$:**[,1B:F):=3H<.&PM/"IJGU/G_P#:V_9(T?\ :>\-
MVO\ I8T;Q5IBM_9^I[-R%6Y,4JCDH2,Y'*GD9Y!_.S6O^";OQXTO4GM;;PQ9
M:Q IP+VSU:V6)O<"5T?\UK]DZ*TP^,JX5<L-NS,L5@*.+:E46O='Y[?LO_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>FV6HIJDUD(]*BDCBV(D; X=W.<N>^.G%>\5O5I2HS=.>Z.:A6AB*:J0V?\
MPP4445D;A1110 4444 %%%% !15'7-7A\/Z)J&J7"R/;V-O)<R+$ 7*HI8@
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M=@JC9&K,<DCH*-W9";LFWT.HHJKI>IVVM:79ZA92>=9W<*7$,FTKO1U#*<$
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M5YHT5F)Z ')[4X4YU+\D6[=B9U:=.RG)*_=GME%%%9FH4444 %%%% !1110
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M<']TW1#U%>MT.$E%2:T?Z#4XN3BGJM_GJ%%%%06%%%% !1110 4444 %%%%
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M3'J?B/X ^+]"\(-(JG6KII$^4G (5[=8R3Z>;^->Z_M)?'[X?? '1=*UCQI
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M91TM>UF^C^>_0^__ -H#]H3PO^SEX+7Q#XF:XF\^7[/9V-FH:>ZEP3M7)
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M2\86\=I_P5&^'\$*+%#%X99$11@*H@O  /;%=6&IO#N<9?$^=?*,9+\97_\
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MAXZ^TQ+(;:&"YB8CE)%GCP1^!(^A-;7[&-S+=_LM?#9YG+N-*5 3_=5F51^
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M^]_C/\;/"OP%\%S^)O%EZUM9JWE0V\*[Y[J4@D1Q)D98X/4@ #)('-?,J_\
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M_P"0*[7]E+]LK4OVF_%FO:0_P[G\+6FCVWF7%^^IFY"S%PJP,I@CVL1O/7^
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MJ_*_;H=1H>N6'B71[+5M*O(=0TV]A6>VNK=@R2QL,JRGN"#7RG8_\%%/#O\
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MSNY.2;:7:^R[=-O,^C_ '[0TNI?!?4OB)\0_">H?#&VTZ65;G3]1$LTZ1H5
MD*^2C_,6P!L[>E>(WW_!1+6M6CDU/P1\!_&7BSPNFX_VTR2PQE03EAY<$JXX
M[N/?%?4WQ3\6>%?!'@#6M8\;2VL7AB& B]6\B$L<J-\OE^60=Y8D*%P<YQ7R
MG:_MQ?$7XG(8_@Q\#-4U?1U_=6VL:N3#:G;QMPNV,8QT$WY4J455E*4:=UZV
M2]7_ ,$=:4J,8PE5LW?I=OT2_P CW_\ 9S_:0\,_M*>#YM:T!+BRNK.407^F
M7F/.MI",CD'#*PSM8=<'@$$#D/BY^V5H'P3^.6F>!?$^GK8Z-=:2^J3>(GNS
M^YP)2L0@$9+EC$%&&R2XXKYV_P"">^H^((?VIOC)8^(M*M= UBZ@:[U'2[!A
M]GM[A;D95 &<8!E;&&/4UL?M#>'=,\5_\%)/A5IFLV$&IZ=+I<;26MT@>-RG
MVIUW*>" RJ<'CBNCZO3^LPA]F4;[WM[K>CZV:NNYS1Q55X6I._OPE;56O[RW
M72Z=GV-_Q'_P4BU+2;==>L_@=XMG\!LRE/$M\7M8W0G =1Y#QG/;][S[5]5_
M"GXH:%\9? .D^+_#DSRZ7J,9=%F4+)$P)5XW )PRL"#@D<<$C!J?XFZ3::U\
M-?%.G7D"36=QI5S%)$R@J5,3#&*^7_\ @EC<27'[-NHQ2.S1Q>(+E$4_P@PP
M$@?B2?QKGM2JT:DH0LX6>^][K7_/\#=RK4:]*,Y\RGS+:UFDGI]_4O>//^"@
M<-KXYU3PM\-/AIX@^*E[I,C17\^E;TBC925.WRXI68 @C<54$C@D<UZ+^SK^
MU=I/Q^OM7T1_#>M>$?%NCQK)J&CZI;MB($X&)-H[D<.$8\X! )'SQX+T/XJ?
ML$^(O%<-A\/Y/B7\-]8OOMRZEHI/V^V'0>8@#-\J]05VYY#C)%?3'P!_:<^'
MG[0S7TWA:>2TU^"-?MVEZE L%]'&K$*6 )#H"QY5F"EN<$XJYTJ?LKTX\RM\
M5]4_-=/N^9$:M3V]JD^75VBUHU?2SZMKS^1\%_&C]H'QAJ_[9'@7Q;-\(M>T
M_6="A-M8^&Y_.%SJJ*\^)8LVX;!WM]U'^X>?3[83]IS7=/\ V:]?^*?B+X:Z
MCX7U+2F8'PQJEQ)#-(HD1 _F/ I4'?D?NSTKQG]H3_E)!\$?^P<O_H=W7MW[
M<W_)J/Q#_P"O*/\ ]'QT59P^JT4H[M]_YM?O_P"&*I4ZBQE9N>GN]%UBK?=M
MY]3NO@3\4_\ A=GPE\.^-O[,_L;^UXGE^P_://\ *VRNF-^U=WW,_='6N"\7
M?M3?\(K^U+X9^#?_  C'VK^VK1;K^VO[0V>3E9FV^3Y1W?ZGKO'WO;D_81_Y
M-+^'?_7I-_Z4RUX+\7/^4I7PS_[!,?\ Z+O*OV%/Z].C;W4Y?@G;\C*.(JO+
MZ==OWFH-OUM?RZGT[^T1^TEX6_9L\*VVK^(A<WEU>R&&PTRR4&:Y<#)QD@*H
MR,L>F1C)(%>#V'_!134=%N[6X^(/P2\7>!_#5U(L<>M2I+,F6/RDJ\$0(QS\
MK,?0&NP_;0_9[\5_%*Z\$>-O GV.\\5^"[PW=OI.H%1#>KOCDVY8A=P:)>&(
M!!/S @9P= _;WTFQU2#PM\:_ &L?#35+AO*,VH6YGTZ4@@%]Q4,%+8P0KJ.I
M?O6>'ITY4T^7FE=W5[-+I;O?YV[&N*J5(5;.?)"RL[73?6_:WROO<]U^.7QD
MC^#GP8UCX@PZ4VMQ6$,$Z6,DK6C2K)(B#+,C%"!)G!7/&,"M?X/?$+_A;'PO
M\->,/[/_ +*_MJR2\^Q>=YWD[OX=^U=WUVCZ5Y1^WE=0WW['_CFYMIH[BWFM
M[22.:)@R.INH2&4C@@@YR*@^#?B2Y\'_ +!6BZ[9!C>:;X.DNX=HR=Z0NRG\
M"!7/RQ6%J5;:J27RY;V^\ZXRE+$TZ2>CB_OO'7\3,^,G[>6@^ ?',W@CP9X5
MU;XG>,;=BEQ8:+D1Q./O1[U21F=>X5"!T)!!%5?A;^W]HGB;QO:^#?B#X-UG
MX5>);QE2U@UH,89&8X52[QQLA8\#<FW_ &L\5S__  2\\%Z?9_!/4_&#*ESX
M@U[59UNKU_FE\N,@+&3U^\7<^N\'TK6_X*9>!=)\0?LY7?B&XMXQK&@7=O+9
M7>,2*))5C= ?0A@<>J@]J[)4Z%"K'#SC?9-WZNVRVLK]3@A4Q&(I2Q-.5E9M
M1MT5]WO=VZ6/HKXL>//^%7_#/Q/XN^P_VG_8NGS7WV/SO*\[RU+;-^UMN<=<
M'Z5\TVW_  4;T;7O">A/X4\!ZYXS\<ZC:M=7'A?0MUS]@ <KB698B<D ,-L9
MX(SMR,]'XA\57WC;_@G;?ZYJ<C3:C>^!WDN)6ZR2?9R&<^[$9_&H_P#@F[X;
MTK2?V6?#FIV>GV]OJ.J37<E[=1Q@27#)<RQH7;J=JJ !T'XFH5&%*-7VBNX2
M2_\ 2OPT]2Y5ZE65'V3LIIOO_*U\^G;7R'_L^_MS:=\8/B)-X!\2^#M2^'GC
M':[0:?J,ID$NU=S(2T<;(^W+;2F" >>@/U!7PG^U99Q:5^WO\ M3M%$%[>/!
M!/(@P707#+@^ORR,/I7W96-:,'2IUJ:MS7T\T[?B;8>=15JE"I+FY;.^VDE?
M\#XV_P""J?\ R;CI?_8Q6W_HBXJ'_AOI8='L=-^&?PO\3?%2/2[2&"_U'389
MHK6*18QN4,L,K'&.I51Z$CFIO^"J?_)N.E_]C%;?^B+BOI[X4Z!IOAGX;^&M
M.TBPM]-L8M/@*6]K&(T!* L<#N222>I))-:T90CA9.:O[_\ [:C.M&<L9%0E
M;W-]_M2VZ'F/[-/[8'A3]I)K_3;2SN_#OBK3DWW>AZ@07"@A2\;C&]0Q"G(5
M@3RO()/CI^U)_P *5^+7PX\$_P#",_VS_P )A=1VWV[[?Y'V3=/'%NV>4V_'
MF9QN7ICWKY_^*VGP^ ?^"G7P[U#146WF\062-J$< QYC.L\+,P]U1"?]W/6I
M_P!NK_D[3]G'_L*P?^ET%;4J-*K7H-+W9WNO-)WUWMHC"M7K4</B$W[]/EL[
M=&XVTVO9M'WBS;5)ZX&:\)_93_:B_P"&G-,\3W?_  C/_"-_V+>I:;/M_P!J
M\[<I.[/E)MZ=.:]TE_U;_0U\*?\ !*?_ )%GXG?]AF'_ - >N*A",X5G+[*B
MU\Y6?X'?7J2A4HQB])2:?_@,G^:/7_'7[;'ASX8_&SQ/X'\4Z;_9FEZ'HRZK
M_;:W?F/<.WE;;=+?8/F/F8!#GIT R1>^ /[3?B;XW>,[W3KWX1^(/!7AY+)K
MVSUW63(BW8WHJJJ&%5W$/N^61N%/6O!]6\+:5XK_ ."J2Q:M91W\-GI4=[#%
M,-RB:.U!C<CN5/(]P#VK[9^(6M3^&_ /B75[;!N;#3;FZBSTW)$S#]0*=1TJ
M.'A-QO*4;_B]?7\#.E[;$5YPC*RC)+;?2+MZ:^I\^?&S]O30/AOXZ?P/X1\+
MZI\2O&43F.?3]()5(G'WH]ZH[,X[JJ$#N0017S/^V-^UI!\8?@?+X0\1>"=>
M^'/C2'4;:]72=9@DVSPC>I9':-#D9&=R*/0FO7_^"6O@O3S\+?$?CNX1;OQ-
MK.KS6UQ?2X:41(J-MSU&YW9CZ_+GH*V/^"I6GVL_[.-K=R6T,EU;ZU;B&9D!
M>,,DFX*W49P,XZXKJE"EAZT*,HW:<;N_6ZV7:_S\SC52MBL/4Q$9<L6IV5NB
M36K[ORT/ISX7''PQ\(D\#^Q[/_T2E?.?Q _X*!6%CXQO_#'PR^'^O?%K4].8
MI>2:,'%NA!P=K)%*SX((SL"GL374_''Q9?\ @K]AK4M5TQY(KU?"]I!'+%]Z
M/S8XHBP],!R<]L5\O_LN_M)>-?@[\&]%T3PM^S1XG\16<@:YEUZQ-R$U*1F.
M9<K9N",84?,<!0,T1H^UJU:C5^5VM>UV[[OR7;>X2Q'L:-&FG;FCO:]K);+N
M[]=%;S/JK]GW]L/0OC;XDN_"6IZ!J?@3QU:1F630-:4J[J!DF-B%+$ @E653
M@Y (!(T_VD/VG+/]G/4? L>H:.NH6'B/4OL-Q>R7PMUL(P4W3$%&W@!R<97[
MO6OD_7_B!\3/C;^TK\'_ !;_ ,*#\6> [G1-4CMK[4Y[6YE26TDD16$CM;1A
M%13+R21ASTKM/^"H%G#J4OP=M+F,2V]QKDD4L9Z,K>2"/Q!I_5X^VH)JW.[-
M7O\ BNCT\P6*DJ%=J5^173M;IV?5->FQT?BS_@HA(S7M[\//A%XI^(/A>Q9T
MN/$<4<MM9_+]YE98)?E]WV'VKW#]G']H[PY^TMX'DU_08I[&XM9OLU]IMT09
M;:3 (Y'#*0<AN^#P""!Z7I.CV&@:5:Z9IMG!8:=:QB&"UMHQ'%$@& JJ.  .
MU?#W_!/FUCT/X_?M#Z19CR=/M]5410* %0+<W04 =L XK*$:-6%2,8V<5=.^
M^J3OTZ]#HFZ]&<)RE=2=FK:*Z;5GOTZ_@?=M?(/[3DQ^)/[7/P,^&KD2:99S
M2^);Z'J',0=H@WM^Y<?\#KZ^KX]N_P!Y_P %/K+S_P#EGX,)M]QQ_$^<>O5_
MUK'"_P 92[*3^:BVOQU-\9K0<?YG%?)R2?X71]?7%Q%:0233RI##&I9Y)&"J
MH'4DGH*^>_B9^WI\(?AU<&PM]<D\8ZTS!(]-\,1_;&9B< >8"(\Y[;]WM73?
MM4?L^G]I3X8CPFNO-X>DCO8[Y+H6_GJS(KJ$9-R\'?G.>"!UKYJ^'_AWXS?L
M96PA7X->%_B#H<,>R37?!T7DZM(N?^6IVF20@<X$9'^U1AZ=*HFYRUZ+:_S>
MGE86)JU:;2IQTMJ][?\ ;JU>FMST_P  _&']H/XQ>-M$N;3X9VWPZ^'JW:/?
M7/B&0G4)X%8%U2-@K*67I^ZQSP_>N3_;7US5_BY\8_AY^S[HVH2Z=8Z\1J.N
MS0??-LI9@OT"Q2-@\%@GI7J'PC_;F^&'Q9UVV\.K=W_ACQ5/-]G31->M&AF:
M7.-BNNY,YX"E@Q]*^;OCQI/C/6O^"C%GI7@O5;;P_KVI:"EO!J]VGF?8X##)
MYTL:]Y JR!1ZGMU'73IOV\%*GRI7:\[1;5V]TFDSAJU%]7G*-1R;<4_*\DG9
M+9V;6NK/JZQ_8W^"UCX2'AX?#K0YK7RO*:ZGM5>];C!;[2?WH;OD,,=L5W'P
MI^%>@?!?P-I_A/PS#-!I-EN*"XE,LC,S%F9F/<DD\8'H*^1_&W_!-6UL-"OO
M$WAWXE>+I?B1;PM<IJU_=J5N)E&<951*F[& WF,1GO7K?[!OQLUKXW_ >&_\
M1RM=:[I%])I-S>,,-<;$1TD;_:VR*">Y4GO64TZE.<HU.:UN9:]=GYZ_/R-Z
M<E3J0A.DHWORO1[;K3;3Y>9]%LVU2>N!FO"?V4_VHO\ AIS3/$]W_P (S_PC
M?]BWJ6FS[?\ :O.W*3NSY2;>G3FO=)?]6_T-?"G_  2G_P"19^)W_89A_P#0
M'K"A",X5G+[*BU\Y6?X'37J2A4HQB])2:?\ X#)_FCWC]K3]J#_AEWPOH6L?
M\(U_PDW]J7QL_)^W_9/+PA?=N\J3/3&,#ZUZ/\4OB!_PK7X6^(_&/V#^T?['
MTV74/L7G>5YNQ"VS?M;;GIG:?I7R'_P5F_Y)?X%_[#;_ /HAJ^C?VH_^36_B
M-_V+EU_Z)-$H16&C42U<I+[E'_-BC4D\4Z=].5/YW9XW;?\ !1O1M>\)Z$_A
M3P'KGC/QSJ-JUU<>%]"W7/V !RN)9EB)R0 PVQG@C.W(ST7[/O[<VG?&#XB3
M> ?$O@[4OAYXQVNT&GZC*9!+M7<R$M'&R/MRVTI@@'GH"S_@F[X;TK2?V6?#
MFIV>GV]OJ.J37<E[=1Q@27#)<RQH7;J=JJ !T'XFO-OVK+.+2OV]_@%J=HH@
MO;QX()Y$&"Z"X9<'U^61A]*]"5*A];>%4=VU>^S2;^Y6MKJ^YY:K8E8-8R4]
MDFU9:ZI/YN]]+)=CZ'_:J_:(_P"&9?AQ:^*_^$?_ .$D\_48[#[)]M^R[=Z2
M/OW^6_3R\8QWZ\5=^,7QFU[X=_"[2O%?AWX?ZIX]O[]X%.C:29&EB22)G,A*
M12':I 4G;_$/I7AW_!5/_DW'2_\ L8K;_P!$7%?5?@O_ )$70O\ L&P?^BEK
MS&HQPLJS5VI?ARIV_P"#N>M*4OK/LD[)PO\ .[5_ZT/S&_8\_:8\<_#'2?&O
M_"._!CQ!\1(]6UEKZXN=*:?;:2,O^J;R[:0;N_.WZ5][?%?]IGP_\$/A+HWC
M3QE8WFGW>J00F'08EW77VAXP[0?,%QLY#,P7&.F2!7S]_P $J_\ D0?B+_V,
M'_M(5Z;^VQ^SSXC^-F@^%=:\'26DOBCPE?-?VFG7^!#>@E"8R6^4-F-,;L*>
M02,YKTL9[+ZQ&G)67NW?ERKI^'XG!A8UH49SC+F?OV5EOS/\W^9P-K_P48U7
M1VM]2\:_ WQ?X3\(SLH37F625,-]UL/!$I!SV<GTS7V/H^JV^NZ39:E9F1K2
M\A2XA:2)HV*.H9248!E."." 1W%?).C_ +>EMH%[#X8^.GPYUCX=W]S^X>\F
MMC<Z9/QAFY&[83_=$H]6[U]<Z;J-IK&GVU]87,5Y97,2S07$#AXY8V *LK#@
M@@@@CUKEQ$%&*:A9=T[I_P!?TCHPM1RDU*IS/LU9K_@?U<35-4L]#TVZU'4+
MF*RL;6)IY[B=PJ11J"69B>@ !.:^/-4_X*--KVM7UM\+OA%XH^)>FV+[)]2L
MUEB0?[05()6"GMOV'VK7_P""G'BR_P##?[-+V=D\D2ZSJMO8W+Q\?NMKRE2?
M0F-1[C->X_L\^ ]*^&OP5\'Z%H\,4=M%IL$LDD0'[^9T#R2D]RS$G/N/2HHP
M@J4JU17L[)?*]V77G4E6CAZ;M=<S>_6R2_&YQO[.O[8/@_\ :&NKS1K:VO/#
M7B^Q4M=:!JJA90%.&,;?QA3P00K#NH'-7_VH/VD(_P!FOP_X<U:70/[>BU;5
MDTQT^V_9O(#(S&3/EONQM^[QUZU\U?MJ:?!\+?VN?@IX\\/QI9:UJUZMM?\
MD_*;E5EBC)8#J6CF9">X ]*V_P#@K(-WP;\' ]/^$@'_ *3S5T0HTZLJ%2*]
MV<K->DK/7L_O.>=:M3A7I2E[T(W3MWC=:=U]QW&J?MT3ZSX\70_AQ\+_ !#\
M1-$BOTTZ\\368DBL89"X5BKK#(&5<YW,4'&1Q@U]55B>"?"^E^"_".D:'HMG
M'I^E6%M'!;V\(PJ* /S)ZDGDDDGDUMUQ573TC!;=>K_1?([:'M)+VE26]M.B
M^>[^?X'RWXS^*'[1'P?\8:U=7GP^L?B;X >[EELI?#LI34K6W9R8T>,#,A5,
M#"QG..7[UU/PQ_;>^%'Q*O!IK:XWA/7U?RY-'\3Q_89T?.-FYCY;-GC:&+>U
M2_%G]M;X5?"+4I](O=;DU[Q'%(83HF@0F[N?,!P8V((1'!XVLP/M7A?Q&\/?
M%;]M"U^S)\'/#O@#0)%*)XB\;1^9JRIGK"BJ)(CCG!4J>/FKHI0]I!<\++^:
M]OST?RU.:K4]G4E[.I>7\MK_ ):Q^>A]E>/O&5IX!\":_P")[OY[32;":^<
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M._X*;_\ (U? W_L,3_\ HRUK[QJ7"/U6G4ZMS3^35BXU)/$SIMZ*,7][E?\
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M?C/3KR%9K2XT:[C>-@",>2W\OZ5\Z_\ !+NZEN/V8V21RZ0:Y=QQ@_PKMB;
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MI-<K2U[.W3SW5]CW_P#:(_:S\)?L\-8:=>V]YXA\5:D,V7A_2E#SR G 9S_
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MO&MHFMS;M$A@*;#$5&W;C&,=,8[5\'?L)6B>!_VJ_CSX+TH;- M[AY(H8_\
M5Q&.Y9$4>A"RLO\ P'VK6"HUHSA&-FE=.][VM>_W]#.I*OAY0G.?-&346K6L
MVG:W7IUN>Z?';]LSPU\&O%2>#K#0=:\;>.9(Q(FAZ-:L6 9=REGP>H_N*Y'<
M"O/?"?\ P4.\GQQI?AWXF_"W7_A:NJ2"*TOM49VCW$@!G$D,15,D LN[&1G
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M(!&.17Q1^R'^T-XQ^#?PDM[+PO\ LZ^)?&:W]Q+=77B;3S<;+]][*.4M)!A
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MU[M;MWZ7VL,\&^,M%^(7A?3O$7AW4(M4T;4(A-;74.=KKT/!Y!!!!4@$$$$
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MXO\ ^@FO+Q,HRC)QC96_0];#1E!Q4Y<SOOMU/B+_ ()0_P#)-_'_ /V'5_\
M1*UZQ\2/VW/#/PB^.&J>!/%EA_9FE6.D+J?]N"Z+M-(P!6W2W$>2QR<$/VZ
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MSX6ZIJKK%82:H[M'(['"AQ)%$R!FPH8*PR1G YKM_P!LCXR^(OA/\/9H-"\
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MC<?,GB.Y4_40P5Q&J6/CK]@KXU>+?%&D>%;OQC\(_%4_VNZCTX$RZ>^YFR<
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MC(#9YQ7SQ\-_V]-0_9_\(V'@7XS^ ?$UEXCT6%;&WN[."-A>1H-J,?,= 3@
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M(_\ RE2^&_\ V F_])[ZONBBM?K;=557'[-O_)>6_P"MOD9?4TJ,J*EN[_\
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M>U_Q37ZG5B*2Q%&5%NW-;\&G^A\/^(O^"F45KI\F@Z?\+/%4'Q,9?*70KZW
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M"%)SC!<8Z,:@_8I\(^(O&?[0OQ$^-,_A*X\"^%-=MC;:?IMQ&8FN6=XF,H7
MR,1;BP&TM*<$X)K[BHKI6(A%2<(6DTUOI9[V7_!.5X6<W%5*EXQ::5E>ZVN_
M^ C\^?'?ASQW^Q'^T9XB^)?ACPS=>+?AKXI9IM4M;%6+6K,Q=MQ .PJY9E<C
M:0Y4D'D=UIO_  42?XIZIIVC?";X6^)?$VKRW$:W?]HI'!!;1;AO8O&[@<9
M9RB@D$YZ'[,HI1Q$'&,:L.9QT6MM%LGW_!CEAIJ<I4:G*I.[T3U>[7;\4?+'
M[='[/GB/XK:#X9\9>!5/_"<^#[G[9:6ZD!YX]RN50DXWJZ*P'?YAU(K@[#_@
MI]I^EZ2FD^)?AIXHM/B%&GE2:/# JPR3XP "["5 Q[>6Q&<?-UK[CHJ*=9*'
MLJD;QO=:V:OO\G^9I4P\I5/:TI<LFK/2Z=MKKNMO0^-?V-_@OXVUKXI^*OCM
M\3M.;1O$&O(T&FZ1,A22VA;;EF0\IA$1%5OFQN) R,XG[0G_ "D@^"/_ &#E
M_P#0[NON6BK6*:K0JVTCHEY6:M^-R/JJ]A.ES:S=V_.Z?Z6$K\_)(?'/_!/_
M .+WBW6+'PI>>,/@]XFN?MLC::"TFGMDGG PA7<R_-A77;\P(./T$HK"E4=*
M3=KIJS7=?UL=%:BJT4KV:=T^S_IZH^/-!_X*+6?Q/U:PTGX9_"WQ=XJU&6XC
M2Z%Q'#!%;1%AO<NCR 8&<;RBYQDBOL(<@<8]J6BG4G3E94XV^=Q4H58W=2?-
M\K'G7[1/@N7XB? OQSX=@7=<WVDSK OK*JEHQ_WTJUQ7[#'C)/&G[+?@:8/N
MN-/M6TN=,\HT#F, ^^P(?Q%>]5\U_ /X=^)?@C\?/B-X8M](N9OAMK[#Q%IF
MHQ@>197+G;-;G)ZGL!G 1?6JI23A4IOK9KUC?3YIM_(FM%QJ4ZJZ73])6U^3
M27S/G;]LSXCZ;\(_V\OAWXPUB"ZN=,TG289YXK%%>9EWW*X4,R@G+#JPKTO_
M (>P?"3_ *%WQI_X VG_ ,E5]I45K&O3]E&G4A?EOUMN[]C&>'J^VG5IU+<U
MM+7V5NY\_P#B2'0?VZOV5[UM%2[TNRUZ.1M/;5(U26"X@F949U1V&-\9Z,?E
M;UXKYX^%/[9FM_LH^$[3X<?&GP)XAANM#7['IVJ:;$DB74"\(N9'16"C #HQ
MR  0"#G]!Z*B-:,7*/+[DG>U]GTU[VTVU+GAYSY9\]IQ5KVW3Z-=NNY^?GA_
M1_&G[=WQ_P#"WC?6?"]YX3^$_A607%A'J2E9+Y@ROP"!O+LB;BN555(W$]?L
MCXZ> D^*'P=\8>%F7=)J6FS10\9Q,%W1G\'"G\*[NBLZU7VD%3@N6,;VZZO=
M^MS6A1]E.52;YI2M?IMLK=C\T/V"=3O_ (Q?&+P2=1@D6V^&'A>XLU,G_/S+
M<2(G_D%]O;F*O0_V]]7NO@;\8O 7Q;TV%V:XTO4- N_*XW,T+^1GZ&5F_P"V
M?M7W91716Q2JU54Y;)7NN_-S<WW\S.:C@_8T94^:[=K.VW+R\OW<J]3YY_8'
M\ GP#^R_X369-MYK"OK$Y/5C,V8R?^V0CKZ&HHKGKU77JRJ/JSIP]%8>E&DG
M>R^_N_F?#W[2GPU\=? W]HJS^/\ \.]"E\46-Q"+?Q#HMJK&5EV!&;:H)VLB
MH=P!V,@)!%5/$W_!20_$'0+CP[\*_A[XIO\ Q[>1F"..YM4:.T=A@R 1.[/M
M/]Y4'&21C%?=E%:1K0E35.M#F4=%K;3MZ&4L/-5)5*,^5RU>E]>Z\^^Y\\?L
M1?L[7W[/?PGDM]>*/XKURY_M#4]CA_).T!(=PX8J,DD<;G;!(P:\B_9*_P"3
MYOVA?^NC_P#I2*^Y**'B92JSK26LDUZ7M^5A?5(QHPHP>D9*7K:]_O;N%5-6
M_P"05>_]<7_]!-6Z*XI1YHN/<]",N629\+_\$H?^2;^/_P#L.K_Z)6GZE_RE
M:TK_ + #?^D<M?<M%>E4Q?/7=;EW35O^W>7_ ()Y:P=J"H\VTE*]NT^:WZ?B
M<%\?O^2%?$3_ +%W4/\ TFDKQ3_@FC_R:GHW_80O?_1IKZHHKEIU.2$X6^*W
MX-_YG94I\\Z<[_#S?.]O\C\YO%GCS4/V,?VUO''CCQ5X;U34O!GBVW(AO]-B
M#??,;X4L50LKQLI0L#@AO3/T5XLM=+_;P_9=U1-+L=0\/?V@[-IO]M0B*1)X
M7S$[!2PV-T)4GACUQ7T?16DJRE2A!KWHI)._;;3N8PP[A5G-2]V;;:MU>^O9
M]CX"^'/[;VN_LS^&K+P#\;_ /B*VU#18ELK/5M-ACD6\A0;4_P!8Z(V% &]'
M8-W .<_0G[/?[36J?M!>(M2DL_ASKGAWP7#:B2S\0:OMC^U2[@#&$Z'@DY1G
M VG)&17O-%74KTZEY2A[SZWTOWM_P2*>'J4K0C4]Q=+*]NU_^!<^&OVA/^4D
M'P1_[!R_^AW=?<M%%82J<U*%*WPW_%W.F-/EJSJW^*WX*Q\-?LR_\I"OCS_U
M[2?^CX*[[_@I;_R:GK7_ &$++_T<*^IZ*J5:[I.WP**]>5W_ !,HX?E5=7_B
M.3].96^=OD<!^S[_ ,D'^'7_ &+NG_\ I/'7RQ^S[_RDD^-G_8-?_P!#M*^Y
MJ*T6(M6J5;?$I+TYO\C.6%YJ%*CS? XN_?E3_,^0OVR/@OXWM_B%X2^-_P +
M[,:GXK\,IY-[I2H6DN[<%ONJ.7^5Y$91\Q5AMY%8MC_P5$\+M"FFWWPY\8P>
M,<>6VBP6\4B^=TV!BZR=>/\ 59]J^UZ*F%:/(J=6/,E>VMFK[_*Y52A)U'5I
M2Y6[7TNG;;3O;0\[^'NL:M\9/A )O&7A*Z\&WFM6UQ;W6BW<@>2*)]R DX!!
M*$'#*I!)R*^&?A#\6O$__!.W6O$'@/XB>%-5U;P/<WS7>FZWI<88,Q 7<A<J
MC!E5,H75D(/7-?I5113K*G*=H^[+=>FJU\AU,.ZD(7G[T=4].NCTVLS\P/VS
M_CYXI_:2^#8U/0_ >I>'OAAI5]!<R:UKRK%<7MPVZ.-8D#$%1O;)4L.F2O0_
M?^J?\D!N_P#L67_])37H%%*M5C4H.A"-DW?OTMK_ $NQ5&C.G76(G+F:5MK=
M;Z?T^]SX_P#^"6O_ ";/<_\ 8?NO_1<->(^!?BFW["7[0'Q1_P"%B^#=6OK+
MQ/?O<V&O:="CO)'YLD@"&1E5E82 L X*L@!![?I=16\L7S5I57'22LU?TZ_(
MY88'DP\**EK%W3MZ]/F?EG^V[\8/&W[0GPRTWQ##X"OO"?PQTW4HS;7VM@1W
MM_<21NJNL><",#</EW DCYNP_1;Q1X:G\9_!;5= MG6.YU30);&)FZ!I+<H"
M?;+5VU%85:T:E'V$8V5V_O27W_\ #6T.JC1E2K^WE*[LEMV=]/+_ (>^I^:7
M[+?[74/[*W@NX^%7CSP+XG_X26RU&9K6WT^U1FD\PY*LKNI^]G#('# C'O[E
M^V1\&/&>H^+/!GQL^%UI]O\ %WA=1Y^F>6?,N[;)8 )P6(#R*R##%7..0!7U
MW16U3%<U2->,;36_9Z6V[6,*>#Y*4L/*5X/;NM;[^3\CXGT__@J)X82&/3-6
M^'/C"T\8_P"K?1K>WBD7SNFP,SK)U_Z9Y]C7T_\ !?QQK_Q&^']AKWB7PC=^
M"-4N7D)T>]D#R)&&/EL> PRN,AE4@YXQC/<T5C4J4I+W(6?K^7],VITZT7[]
M2Z]$OO\ ^!8*\S^/_P ?O#W[./@JW\4>);/4[ZPFO4L5CTJ*.242,CL"1)(@
MVX0]\\CBO3**YU:ZN=3O9I;GY+?&#]LCP7\0/VKOAQ\3M.TS7H=!\-PQ1W=O
M=6\"W3E997/EJLQ4\2#JPZ&OT"_9S_:L\)?M.Q:[)X6T[6K :.T*W']L00Q[
MO-W[=GEROG_5G.<=1UKV>BNZI7I2I*FH6M>VO=W?0\ZGAZ\*SK2J7O:_N]E9
M==#Y!_;"0_$#]H;X ?#RV'FR?VPVO7BC^""$J<GTRJ3#\*^OJ^:O@7\._$GB
M;]H;XB_%OQIH]QHTN[_A'_#NGWH'F1V49!:88)&)" 00>\G:OI6L:C4:5.FO
M5^LM?P5EZG13BW6J5'Y)>D>OSE?Y6"BBBN8Z@HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBHYIX[:%Y9I%BB0
M99W8!5'J2>E $E%>7Z9^T[\+M<^)%IX"TOQE8ZKXIN]_DV>GK)<1DHC.P,R*
M8@0J,2"X/&.M>H5<HRBDY*UR(SC)M1=[!17.>//B-X8^&&AMK'BO7;'0=-4[
M1/>RA-[8SM0=6;_94$^U>??#_P#;"^#OQ0\01Z'X<\<V5WJLIVQ6MS!/:-,W
M98S,B!V]E)-.-.<TW&+=B9U:=-I3DE?NSV2BBBLS4**** "BBB@ HHHH ***
M* "BBOF_X6_M(>)O&W[6WQ$^%U]8Z3%X?\.VC3VES;PRK=.P: 8D8R%2/WK=
M$'0?CI3IRJMQCT3?R7_#F56K&BE*75J/S>WY'TA11169J%%>,_M&?M5>$_V8
MH="E\4Z?K5^NL-,MO_8\$,A7R@A;?YDJ8_U@QC/0]*\3_P"'L'PD_P"A=\:?
M^ -I_P#)5=%/#U:T>>G&Z.6KBJ-&7+4E9GVE17QG8_\ !53X3ZA>V]K'X>\9
MK)/(L2EK*TP"Q &?]*Z<U[W^T'^T/X<_9M\(V7B+Q-9:I?65W>+9)'I,4<D@
M<HS@D22(,80]\].*<\/5I\JG&U]%_7S%3Q5"MS.G*_*KOR6O^3/4:*J:3J,>
ML:79W\*LL-U"DZ+( &"LH8 X/7!JW7/).+:>Z.J,E))K8****0PHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BN.^('Q>\(_"V\\/VOBC5QIEQK
MUXNGZ:GV>64SSD@!/W:-MY8<M@<]:[&GRNW-;07,K\M]0HKYS^!?[66H_&+X
MX>./ %SX%O-!@\.^;C4I)R^=DHC"RH478S@EUP3P#UZU]&5<Z<J=G);JZ]&9
MPJ1J<W*]G9^J"BBBLS4**** "BBB@ HHHH **HZ[K5IX;T34-6OY/)L;&WDN
MIY/[L:*68_D#7Q)X)_;"_:!^-^H76N?#3X3:/>^ [>]^RF?4K@K<$ C)WF>,
M%MI!(2-]N<<UO1HRK-J/3=MV2OL<]:O##I.=]=DE=NV^B['W312+G:-V-V.<
M=*6L#H"BBB@ HHHH **I:WK5GX<T:_U;49Q;:?8P27-Q,5+".-%+,V "3@ G
M@9K(^'?Q&\/?%CPA8^*/"NH?VKH5Z9!;W7D20[]CLC?)(JL,,K#D=J=FTVEH
MOU_X9B<DFDWO^FYTE%?.?[2G[6.H? /XB>"/#5IX&N_$\?B)PK74,YC()D">
M7$H1M\G.[!(XP.^1]&5;IR4(U.CO;Y;F:J1=25)/WHVO\]@HHHK,U"BBB@ H
MHKCK'XO>$=2^)^H?#RVU<2^,;"S%_<Z;]GE'EP'9A_,*>6?]8G ;/S=.M-)R
M=DA.2BKMG8T444AA1110 4444 %%%>3_ +3WQONOV>_A/>^,+3P_)XCEAGB@
M^S+*8TC#DCS)&"L0HQZ=2!D9S32NTEUT^\3:BG)[+7[CUBBN+^#/Q"F^*_PO
M\.>+KC1I] EU:U%R=.N&W-%DD#YL#*D#<#@9# XI_@WXO>$?B!XH\3^'= U<
M:AK'AF=;;5K<6\L?V:1BX"[G0*_,;_<)Z5<J<XRE!K6._P G;\S.-6$X1J)Z
M2M;SOJCL:*\D_:J^+>L? WX':_XRT&VL;O5-/: 10ZC&[PG?,B'<$=6Z,<88
M<UTOP2\;7WQ)^$/@_P 5:G%;P:AK&F07L\=HK+$KN@8A S,0,GN3]:%3E*FZ
MJV3M\[7&ZD545-[M7^5[';4445F:!1110 4444 %%%<;I?Q@\(ZU\3-6^']E
MJXG\7:5;+>7FG"WE'E1,$(;S"GEG_6)P&)YZ<&G%.3LEYDRDHJ\G8[*BBBD4
M%%%% !1110 4444 %%%% !17GGQU^-^A?L^^ 9?%WB*TU"]TV.XCMC%I<<<D
MVYR0#AW08XYYKYP_X>P?"/\ Z%WQI_X VG_R56]*A5K)NG&]CFK8FCAVHU96
M;U/M*BO&/@;^UU\-/V@KI[#PQK$D6M)&96TC4H3!<[!U*C)5\=]C-COBM;]H
M/]H?PY^S;X1LO$7B:RU2^LKN\6R2/28HY) Y1G!(DD08PA[YZ<5,J52$U"4;
M-EQK4ZD'4A)-+KZ'J-%?%R_\%7OA&S 'P_XT4$_>-C:8'Y75>_\ P1_:8^'W
M[05K<-X.UK[3>VJ![G3;J)H;J%3QDHWWER0-REER0,YK6>%KTUS2@[&-/&8>
MI+EA--GJ5%(S!5))P!R2:^8_B9_P46^#?PUUB;2QJ.H>*;R!_+F'AZV2:.-A
MU'FR.B-_P!FK"$)5)<L%=G14J0I1YZCLCZ=HKP[X&_MF?#']H"^&F^']5FL-
M=(++H^L1"WN7 &24PS(_ )(1B0!D@"O<:=2G.D^6:LQ4ZU.M'FIRN@HKDOB=
M\5O"OP;\+MXB\8ZJ-'T=9DMS<?9Y9OWCYVKMC5FYP>U=1;7$=Y;Q3PMOBE0.
MC8(RI&0>?:HL[<UM-C3F5^6^N_R):***0PHHHH **** "BBB@ HHKR_]I#X[
M:?\ LZ_"O4/%]]9MJ4L<B6UG8J^S[1.^=JEL':,!F)P>%/!HW:2ZB;23;V6I
MZA17RQ^SK\9_VA_B5XIT2\\9_#;1-!^'VK6[W,6J6TA2XC0QEHB4:X=OF.T?
M-&O!S7U/6]:C*C+EE:_D[_TS"C7C7CS03MYJU_->04445@= 4457U"Z:QT^Y
MN5ADN6AB:00Q#+R$ G:ON<8I-J*NQI-NR+%%?/?[)/[4]_\ M,P^*WO?!EQX
M4&B7,<"N\YF24OOS&243$B;!N'/WATKZ$K:I2G1ER35G_GJ8TJL*T>>F[K_(
M****R-0HHHH ***9-,D$3RR,$C12S,>@ Y)I-VU8;CZ*^%M/_;2^-OQH\3:]
M)\%/AAI>O>$='N/(DO-6E*RS\G!5C/$H9E&=BAR 1GK7V[H\UY<:/8RZC#';
M:@\$;7,,3;DCE*@NJGN <C-=-2A.E%.>E^G7YHYJ>(A5DXPN[=;::;V?4N44
M45SG2%%%% !1110 445RGQ,^*7A?X.^%9?$GB_5/[(T6*5(7N?(EFP[G"C;&
MK,<GT%&[LA-V3;Z'5T5!8WL.I6-O=VS^9;W$:RQO@C<K $'!Y'![U/3:<79@
MFFKH**^<-%_:0\2ZC^VMKGP@DL=)7PU8Z8+V.Z6&7[87,,,F&?S-F,R-T0<
M<U]'U<J;C&$GM)77H1&I&;E%?9=G]R?ZA11169H%%%% !1110 44UF$:LS':
MJC))[5R'PO\ B[X2^,^@W&M>#=6_MG3+>Z>REG^SRP;9E"EEQ*BDX#+R!CGK
M32<KM+;<ER2:3>YV-%%1W%Q%:0O-/*D,*#<\DC!54>I)Z4BB2BO+]%_:<^%_
MB7XC0>!-'\8V.K^*)U=H[73UDN(SL5G8>>BF($!6R"^>/6O4*N491MS*UR(S
MC)M1=[;A17,^/_B9X5^%FAG5_%NO6.@:?G:LUY*%,C8SM1?O.V/X5!/M7"?#
MO]KSX/\ Q6UY-$\,^.+*]U60[8K6XAFM'F;^['YR)O/LN33C3G--Q3=B95:=
M-I3DDWYGL-%%%9FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M17+_ !*^)OAKX0^$[GQ-XMU/^R=$MW2.6Z\B2;#.P51LC5F.21T%&[LA-V3;
MZ'4455TO4[;6M+L]0LI/.L[N%+B&3:5WHZAE." 1D$<$9KY]U+]K+4+#]K2T
M^#:^!KR6SGC5O[;$Q!P8?,\T1[,&('Y"=W7/I@ZPISJ3]G%:Z_AN9SJPIP]I
M)Z:?CL?1E%%%9&H4444 %%%% !1110 4444 %%%% !1110 445\W?M*?M)>)
MO@W\9/A#X2T6QTFZT[Q?J*VE_+?PRO-&AN((\Q%9% .)6^\&Y _'2E3E6J1I
M1W?^5_T,JU2-&G*K/:._WI?J?2-%%%9FH4444 %%%% !117SG\1OVL=0\"?M
M.>%OA1%X&N]2M=:$.=82<J5$A(+I'L(9(\$L=P[],<Z4Z<JLU"&[_P"',JE2
M-&#J3=DO^&/HRBBBLS4**** "BBB@ HHHH **** "BBB@ HHHH **I:WK5GX
M<T:_U;49Q;:?8P27-Q,5+".-%+,V "3@ G@9K(^'?Q&\/?%CPA8^*/"NH?VK
MH5Z9!;W7D20[]CLC?)(JL,,K#D=J=FTVEHOU_P"&8G))I-[_ *;G24444AA1
M110 445D>+O%FE>!?#.I^(=<N_L.CZ; US=W)C9_+C499MJ@L>.P!- &O16'
MX)\::-\1?"NF^)/#UY_:&BZC%YUK=>4\7F)DC.UU##D'J!6Y3E%Q;C)6:)C)
M32E%W3"BBBD4%%%<9>?&#PA8?%"Q^'<^KA/&5]:-?6^F_9YCOA <EO,">6.(
MWX+ \=.E-1<G9(F4E%7D[?\ !T7WO0[.BLCQAJ\WA_PEK>J6ZQO<6-C/<QK*
M"4+)&S $ @XR.Q%>/?L8_'C7_P!HKX03>*O$EGIMEJ*:I-9"/2HI(XMB)&P.
M'=SG+GOCIQ5QIN<927V;7^>Q$ZL:<H0EO*]ODKL]XHHHK,U"BBB@ HHKC?$O
MQ?\ "/A#QUX=\':OJ_V3Q)X@WG3+'[/,_G[?O?.J%$Z?Q$4XQ<FHQ5VR9244
MY2=DCLJ***1045PWQN^)$_PA^%7B/QA;Z--X@FTFW\]=/@8JTGS!22V#A5!W
M$X. IK%_9H^--U\?OA+IOC*[\/R^&Y;J66+[+)(9$<(V/,C8JI*-].H(YQDZ
M1IRE"4ULM_F9RJ1C.,&]7>WRW/4Z***S- HKQ#]L/XWZ[^S[\&;CQ=X=M-/O
M=2COK>V$6J1R20[7)!.$=#GCCFO3OAWX@N?%WP_\,ZY>)%'=ZGIEK>S) "(U
M>2)78*"20,L<9)..]:*#=-U.B=OG:YDZL555%[M<WRO;\SH:***S-0HK%\5^
M-/#_ (%TN34O$>M:?H5@@RUQJ%RD*?0%B,GV'-<_\*/C?X)^.&FZA?\ @C6Q
MKEG83_9KB5;::$))MW8'FHN[@YR,CWJE&4DY):+<ESC%J+>KV\SNJ***DH**
M** "BBB@ HHHH **** "BBB@ HKQ[]HO]J+PK^S)I^BWGBC3]8OXM6EDB@&D
M0Q2,I0*3N\R5,#YAC&:\._X>P?"3_H7?&G_@#:?_ "5713P]6M'FIQNCEJXJ
MC0ERU)69]I45\8V__!5GX2W-Q%"OA[QH&D8(,V5IC)./^?JOH'X^?M >'OV=
M/ ]MXI\26>IWNGW%Y'9+'I44<DH=T=P2'D08PA[YZ<45,/5I\O/&U]%Z_P!,
M*>*H5N;DE?E5WY+^D>FT50T'68?$6A:=JULLB6]];1W42R@!PKJ& 8 D9P><
M$U?K"2<6T]SHC)22E'9A1112*"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **XWXB_%_P (_"=M$'BK5_[*.M7BZ?8#[/--YT[=$_=HVWJ.6P/>
MNRI\KMS6T)YE?EOJ%%?.7P:_:RU#XJ_M!>-?AM<>!;S1;?P_YVW5))BQ/ERA
M!YB% $\P'<N&/ []1]&U<J<H*+DMU=>C)A4C4<E%_"[/U04445F:!1110 44
M44 %%%% !1535M4MM%TN\U&\D\JTM(7GFD/\**I9C^0-?#_A/]LCX^_&[4M1
MUGX5?"?2=2\#V5V;8SZG.5N'Q@\.9XQNVD$JB/MR!SQG>C1E6;4>F[>B5]CG
MK5X4$G/=[)*[=M[+R/NNBF1;S$GF!1)@;@O3/?%/K WW"BBB@84444 %%5=5
MU2UT32[S4;V4065I"]Q/*03LC12S-@<G !Z5A?#?XE^&_BYX2M?$WA/4O[6T
M.Z9TBNO(EAW%&*L-LBJPP01R*:BVFTMOU$Y)-)O?]#IZ*^=/VH/VL-0_9X\7
M>"]%L_ ]UXI3Q!(5:>&<QX(=5\J,!&WR'=G!([>N1]%*VY0<$9'0U?LY*"J6
MT=[?+<S52+J2I)^\K-_/86BBBLS4**** "BBN.@^+WA&Y^*%Q\.XM7#^,;>S
M&H2Z;]GE^6 [?G\S9Y?\2\;L\]*:3D[)"<E'5L[&BBBD,**** "BBB@ HHKR
MW]I;XSW7P"^$NI^,K30)/$<MI)'']D20QJH=MOF.P5B%7OQW XSFA:M)==/O
M$W9-OIK]QZE17"_ _P")4_Q@^%/AWQC<Z+-X>FU:W,QT^X;>T>&900V!E6"A
ME.!D,*L^$_B]X1\<>,/$OA;1-7%]KOAMUCU6U%O*GV=F) &]D"O]T_=)Z5K*
MG.,Y4VM8[_+1F<*L)PC43TE:WSU1V-%>6_M/?%+5?@K\#?$_C/1+>SNM4TM(
M6AAU!'>!M\\<9W!&5CPYZ,.<5J_ ;Q[J'Q1^#?A#Q9JL-M;ZCK&GQW<\5FK+
M"KMU"!F8@?4FE&FY4W56R=OG:XW4BIJGU:;^ZW^9WM%%%9F@4444 %%%% !1
M17'6/Q>\(ZE\3]0^'EMJXE\8V%F+^YTW[/*/+@.S#^84\L_ZQ. V?FZ=::3D
M[)"<E%7;.QHHHI#"BBB@ HHHH **** "BBB@ HK@/CC\:=$^ /P_NO&'B&UU
M"\TRWFB@>+3(T>8M(VU2 [H,9Z_-7S9_P]@^$G_0N^-/_ &T_P#DJMZ5"K63
M=.-['-6Q-'#M1JRLWJ?:5%>*? []L+X9?M 7QTWPUK$MOK@0R?V1JD/D7+*.
MI7DJ^!R0C$@<G K?^/\ \?O#W[./@JW\4>);/4[ZPFO4L5CTJ*.242,CL"1)
M(@VX0]\\CBIE2G3DH25F_P!2X5J=2#J0DFE^FIZ917Q<O_!5[X1LP!\/>-%!
M/WC8VF!_Y-5[U\$/VH/AY^T)#.OA#6O.U"VC$MQI=Y$8+J)2<;BAX9<D LA8
M D GFM9X6O37-*#L8PQF'J2Y835SU>BDSCD\"OF?XH_\%$/@Y\+]8GTIM2O_
M !1?V[F.>/P];K.D;#J/,=TC;'?:QQTK"$)5)<L%=G14J0I1YJCLCZ9HKPGX
M&_MI?"_X_:BNE:#JEQIFO."T>D:U$+>XE &3L(9D<X!.U6)P"<8KW:JJ4YTG
MRS5F*G6IUES4Y7045RGQ,^*7A?X.^%9?$GB_5/[(T6*5(7N?(EFP[G"C;&K,
M<GT%=)8WL.I6-O=VS^9;W$:RQO@C<K $'!Y'![UGRNW-;38OF7-RWUW^1/11
M12*"BBB@ HHHH **** "BBO-?VA_C=I_[/GPKU7QCJ%J^H&W*0VUDC[#<3N<
M(F[!VCJ2<' !X/2C=I+J&B3;V1Z517RC^SQ\;OVB/BAXHT#4/%7PTT31/ASK
M$3SQZI!*5N8HS&SQ,4:=F.XA0"8U!W9KZNK>M1E1ERR:OY.]O7S.>C7CB(\T
M$[>:M?S7D%%%%8'0%%%5]0NFL=/N;E89+EH8FD$,0R\A )VK[G&*3:BKL:3;
MLBQ17SW^R3^U/?\ [3,/BM[WP9<>%!HES' KO.9DE+[\QDE$Q(FP;AS]X=*^
MA*VJ4IT9<DU9_P">IC2JPK1YZ;NO\@HHHK(U"BBB@ HHIDTR01/+(P2-%+,Q
MZ #DFDW;5AN/HKX6T_\ ;2^-OQH\3:])\%/AAI>O>$='N/(DO-6E*RS\G!5C
M/$H9E&=BAR 1GK7V[H\UY<:/8RZC#';:@\$;7,,3;DCE*@NJGN <C-=-2A.E
M%.>E^G7YHYJ>(A5DXPN[=;::;V?4N4445SG2%%%% !1110 445R_Q*^)OAKX
M0^$[GQ-XMU/^R=$MW2.6Z\B2;#.P51LC5F.21T%&[LA-V3;Z'4455TO4[;6M
M+L]0LI/.L[N%+B&3:5WHZAE." 1D$<$9JU3::=F":DKK8****0PHHHH ****
M "N(^,WPDT?XY?#O4_!NO7-]::7J!C,LVG2(DPV2*XVET9>JC.5/%=O11LT^
MP;JQ^9/@/X&:#^SS_P %'O ?A/PY=ZC>Z<+&6[\W5)(Y)M[V=SD91$&/E':O
MTVKX-\>?\I6O G_8(/\ Z1W=?>$F?+;'7!KT,;5E*C2J2U?*_P#TJ1Y>#IPI
M5JT(*RNO_24? O@7P?:_MQ?M2^./$7C+S-0^'_@:?^R]*T<NRPSR;V&YL'D'
MRV=AWW1@_*,'Z/\ &7[%_P &O&D.GI+X$TK2'L;B.XCFT.W6P=]C [',0&]6
M P<\X/!!P:^(/V-?@OXT^.&B^./#1\:77@WP/;ZV\FLQZ2<:CJ-PRA?*+YPL
M:JI/.02QRK=5ZGXZ_LXZM^PEIFF?$[X4>-=<:PM;Z*'4])U:972=7)"[_+5%
M="?E*LN1N!!!%=DHJ$Z=%5>6RC:U]W;5V[M^>FYR*3E&K5E2Y]97;MLFU97W
M22\NMC](441JJJ,*HP*=7A'Q>_:,\2^!/ O@SQ)X0^%NM?$=?$5NMR]KI+2A
MK-&B212_EP2]=^.0/NFN?^"7[5'Q"^*/Q$L?#WB#X">)O FEW$<KR:YJ37!A
MA*(653OM(URQ 4?,.3WZ5YBP]62D[;7OJNFYZ;Q=&/*K_%:VCZ[;(Z']G_\
M:@/QJ^('Q!\'7_AG_A%]8\(W7D-&;_[3]J7S)(V<?NDV@%%XY^^.:R?VM/VQ
MK/\ 9;NO#5JWAMO$UUK FD>)+[[,;>*,H-_^K?=DL0!Q]T\UY5>0_P#"E_\
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MVAO&GQFUW5K'Q1\'=>^&MO9VRSPWFKM.4N6+;3&OF6T0R!SP3]*\0_X*#?\
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M3V;,EU;Z+N$,;*<.H=$D9V4\':FT'C=G(JQ\'_V]- \=>.(/!/C;PIJWPO\
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MU+^T<G[,_@O2?$,F@_\ "01WVIQZ>T/VW[+Y09'8R;O+?.-G3 Z]:\M\8_\
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ML,\C&">L^"OBR_\ &O[ =MJFIR-->_\ "*WUL\KG+.(4FA5B>Y*QKD]ZY/\
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M(_)\KDYDC&=XZGCC%>6_LG7:_##]H;X\_#2Z;[/:IJ(\36",<#R9@#(1[ /
M/P-9G_!/RW;X@>-OC+\7;E=[:]KC6-E(1C$"$R$#VP\(_P" 5I[*FYRJ)>YR
M*27G*R7W-O[C/VU50C2<O?Y^5ORC=M_-)?\ @1[;^T1^U/X1_9RL;%-86ZU?
M7]1XL-#TU0]S/SC<<G"KGC)Y)Z X->-Z3_P41NM%U2R'Q,^#GBKX<:#>2K##
MK5XDLL0)Z%@\$7&.3L+' X!KPB7XS>(M!_;F^)OBNS^%FL?%;5M)D?2["UL/
M-W:7$C",2@)!+C<%8 X'^L;GFN_^+?[4GQ-^+GPV\0^$-1_95\8QV^K6;VXG
M=+N7R)"/DE"_81DHVUAR.G45I2PZ5*$W#FYDG\25K]%KVZOJ8U<6Y5IP53DY
M6U\+=VNKT>E^BL['WS:ZA:WVGPWUO<13V4T0FCN(W#1O&1D.&'!!'.?2ODOQ
MC_P4*M)/%5_H7PM^&_B#XM2Z>^R[O-(61;<'IE#'%*S#((W%5!QP2.:Y/6_$
M7C#X=?\ !+_;K%AJ6B>(X[#^QY(+V%X+F"![PPKN5@&7]R0!GL0:XK]G/]IS
MQS\(_@[X=\/^&/V8?%.L:<MN)VUBR-R$U*1QN:XRMDP(;C'S-A0H!P!13PBY
MJK7O*$N5:VOUO?TMMW\AU,:^2DG[CFN9Z-VZ62];[]O,^I?V>?VN?#_QXU;4
M/#D^CZCX,\;::GF77A[6%VR[>,M&2 6 R,@JK#(XQS7A_P"W=_R=!^S3_P!A
MM/\ TLM*Y*V\;_$GXQ?M=?"KQN_P*\4_#\Z=,=/U._N;2YDCFMI,J6ED:VB"
MA%=^N>HZ8K>_X*&Z[8^%_P!H/]GO6=3G%MINGZD;NYF()$<4=U:L[8')P 3Q
M6M&DJ6,P\[6NW=7O:RE^#5F8UJSJX+$P;YK*-G:U[RC^*=T?6WQT^->@? /X
M=ZAXKU^0&.$;+6S5PLEY.0=D*=>3CDXX )/ IOP5^).N?$GX:VGBWQ/X57P-
M]L0W$-A-?_:76VQE99"8H]A(R=N#@8)(S@?"&A?%W3/VHOVPO!FH_$G3K[3/
MA_*)AX,T^\C*VEY.DFU'ESPY=U((&1N6-#D9S^CWBC08O%/AG5M%G=HH-1M)
M;-W3[RK(A0D>X!K@K47AZ*YH^_+7TMT]>_;;S/2H5UB:[Y96A'3UOU]+;6WU
M?D?(^K?\%%I=<U[4+7X8?"'Q/\2]*T^3R[C5;$2QQY_O!8X)3M.,@OM)]*]O
M_9V_:4T']HS1=3N-,TO5-#U/29EMM2TW5+<HUO(0> X^5NC<<,,<J,C/R]\+
M_$?Q3_8'T6]\)^)?AM/XU^'T=[)=P^)O#/S2QHWWGE3![!>)/+QR-[#%?6'P
M)^/?@+X^:%=ZQX*O5DE5U;4+*:$0W<$A4!?.3OE5 # LIVX!.WCHK4Z<:;=*
M/-'3WK_FNG;9'+0K595$JT^66ONV_)]>][L].KY/^)O[?5KH/Q U+P9\._AY
MKOQ4UO2G:._&D[UBA93M<*4BE9MK<$[0,]":^L*^"]&\*_%7]AWXB>.-7T+P
M&?B=\/?$M[]NDFTIB-1M?F<@,JJS$*)&S\I4X!W)DBN3#QA*;4^VBO9-Z:7^
M\[,5*I"FG3[ZNUVEKJEUUMZ=CWC]G?\ :XTWXZZ]J7A>^\*:YX)\9Z;!]IN]
M'U2W<JD>0,B3:N.67AU0G=QGG%CQG^T[_P (C^TYX2^$'_"-?:_[?M/M7]L_
M;]GD<3';Y/E'=_J>N\?>]N;'P"_:I^'?[0E[>1^'WFTSQ1;Q8N](U:W6&]6-
M6(SP2'0,Q^ZQV[N0N:\$^,W_ "DY^$O_ &"?_9+RNJ%&,L3&$X<JL]+^3=UY
M:>9SRK2CA95(5.9IJSM_>2L_/5]O0^A/VIOVB%_9G^'=GXJ;0#XB6XU*+3S:
MB\^R[0Z2-OW>6^<>7TP.O6O*_&'_  4"@DU&\MOA=\-/$GQ8MM/;9>ZII44J
M6438SA9$AE+8YY*J#U!(YK-_X*I_\FXZ7_V,5M_Z(N*^F_A+X;TKPC\,_#.E
MZ+I]OIFGPZ?"4M[:,(H+(&9L#J2222>222:QI1IJ@ZLU=J5OP3U]-?OW-:TJ
MKQ"I4Y63C?:^O,UI^&_;8\[_ &7_ -K'P]^TYI.IFQT^YT#7]*91?:1=N)&0
M-D*Z. -ZY!!RJD$<CD$]+\>/VA_!_P"SKX636?%=W(&N&,=GI]HH>YNW R0B
MD@8'&6) &1SR ?E[]G^TBT/_ (*6_&2PLE%O:2Z7)</$@ 4NSV<A./\ >D8_
MC6?XNTFW^-'_  4YM-!\2)]JT3PMIR3VNGW(S'*R0+,/E/!!DE#'U"#/%;/#
MTZE6FX^[&4.=];*VMOZZG.L35ITJJE[THSY%TN[I)O[^G8Z6#_@H]J]K#%KF
MM? GQ=I?@60@CQ$I=T\L_=<!H$C.?3S?Q-?7VG^,M)U#P?;^*/M)M-$FLEU#
M[1?1M;^7 4W[G5P"F%Y.0,5K7%M#=V\D$\2302*4>*10RLI&""#P01VKY._X
M*<>++[PS^S2UE8M)"FL:I;V%PT? \G:\A4GT)C48[C-<TI4ZKC"G#E;:6]]]
M-?\ @6.R$:E%2J59\R2;M9+97T_X-_4R]5_X**2Z[K%Y%\,/A!XJ^)6D64AB
MGU:SCEBCR.ZJD$IP1R-^P^U>T?L[_M/^%_VBM.U%=+M[S1/$&E,(]2T+4U"7
M%N2<;AC[RY!&>"",$#BOFGX9_M:?$/X<^ ="\.:!^R?XN32=/M(X86@-T%EP
MHS(<6')<Y8G)R6)S5?X(Z]\0/B!^W%I_CV[^#GB3X;:5J6D3:?JS7UI/Y$K+
M&S+*\KP1+N+)"N",G:.:]&6%BN:'+9)/WN97TUU5^OEL>3#&S?+/GNVU>/*[
M:NVCMTO?5ZV/T KR?]H+]I;P?^SAX?MK_P 22SW5_>L4L-(L%#W-TPQD@$@!
M1D98G'.!DD ^L5^9?Q.^+.N:7_P4&\3:U;_#;4_BG=^&+-+33-%L/,W68$<1
M^TX2&4X#2O@[1S(IR"!7FX:C[>KR/9)M_+_-M'K8NO\ 5Z/M.K:2]7Z=DF_P
M/9;3_@HKJ6AW5O>>/?@CXN\%>%;B14379DED0;C\K%7@B!'?Y78^@-?7%KXH
ML-5\*IX@TJXBU/39K3[;;3P/E)HRFY2&]"*^*/'/[7GQ-\?>#=:\-ZE^R?XQ
MEL=4M)+259/M;@!U(W8^P=02"/<"O4OV)]+\3Z!^R/;Z1XLTC4=$U&P%_#%:
M:K;/!.(2SNA*. P'S$#(Z"M\51Y</.HH\KCMK>^_KJM/+4Y\'7]IB84G-S4M
M_=:MMY+1Z^>GF<AX5_X*7>&_$W@6TO8/!NJW_CF^NYK:T\&Z)(;ZX=452)6D
M$:[4;)'"%N#@$ D:/PO_ ."@D/B3XHZ=X$\?_#C6?ACJ^IND5B=3E9P[N2$$
MBO#$R!F^4$!AD\XZUR'_  2=\-Z4GPC\4Z^-/M_[:DUM[)K_ ,L>=Y"P0.L>
M[J%W.QP.I/L*9_P5!LXK-_A#KD*B+5+;6WBCN%'S!?W;XS[,H/YUVSHX>.+6
M&Y-)-*]]KK2W_!O^AYT,1BI8%XMSUBF[66MN_P!W2WZGJ/[<_P 9O$?PU^&^
MI:-H_@#5?%%AKNCWT%[K=EYGD:0A0(7F*Q.N,.3\S+]T\]Q\^_L9_M.>/?!?
MPI\%>#=+^!OB/Q-H0NY(?^$JLVN/LI66[<O)\MJZXC+L#^\_@.2.WV+^UA_R
M;/\ $[_L7[S_ -%&N&_X)W?\FA^"/]^^_P#2V>N;#RIQPTW*%]8WU>OQ6V[;
M';BH5)XJFH3Y;J5M%II&^_?_ (8W_CM^U)8? GXE?#[PSJ>D1S:?XHDE6?6)
M;X0)IZ(R NR&,[Q\^3\RXQWKB_!_[;&L?$_X@:?I7@KX0^(M8\(7T[P0^,+P
MRVMFQ4,2_P#J'4*2N!EP>>5!XKR[_@H=H5EXH_:"_9[T;4H?M.G:AJ1M+F$D
MCS(GNK577(]02*^\;.S@T^UAM;6&.VMH46.*&)0J(H& J@<  <8%9*-*.%A5
ME&\I<R^YV_RM^-S64JT\74I1E:,5![=XI_CU_"QXK^R]^TY#^T=I_B=;CP^W
MA77O#U_]BO=*>\^U%00=K[_+3JR2+C'&SKS6Q^TU\?K/]F[X7S^+;G3?[9G^
MTQ6EMIOVG[.9Y'/(W[6QA0S?=/W:^>;ZU_X9K_X*#65\@^S>$_BE;- _:-+[
M</U,H0_]O#5:_:@A_P"%Z?M>?"?X3I^^T?1L^(M9CQE=H.Y5;ZK'M_[;BJ5&
M%6I1E%6C+5^7+\:_!_>B77G2I5HR=YPT7GS? _Q7W,^O/!NL7OB+PGHVJZEI
MO]CW]]9Q7,^G^=YWV9W0,8R^U=Q4G&=HZ=*^7/\ @H1\9/$7@WX;ZWX2T_X?
MZKK>C:WI+"\\3V_F"TTW=)MVR8B9<G ZNOWA7UW7A'[<W_)J/Q#_ .O*/_T?
M'7#S1]HI<NE]O7SWT.]QG[/DYO>MO^MMM3Y\_8^_:<\>Z?X)^&W@:'X&^([S
MPZ3#8?\ "7QM<?9!$\I#7'%J4VKN.?WF/E/(KZJ^/O[1G@_]G+PO%K'BJYE:
M6Y8QV6FV:A[F[<#)"*2  ,C+$@#([D X/[%'_)JWPX_[!O\ [4>OG/Q/I\'Q
M@_X*?6>B^(D%SI'A734GM+&Y&8W=(%F4A3P?WDH?W$8KU:T85\9.G:UG)M]6
MEOY7_P SQ\-*IA\#"I?FNH**>R;LEMK;7\#H%_X*/ZQI,<.L>)O@3XNT'P9*
MPVZ\6=U*,?E8!X(XSGT$OXFOK7X=_$;P]\5O"%AXG\+ZC'JFCWJ[HYD!!!!P
MR,IY5@>"#R*V=8T>Q\0:3>:9J5K%?:?>1-!<6TZADEC8896!Z@@U\-?\$X;B
M;PG\3?C;\/;:9I= T?5/,LT+%A&RS2PDCW94CS_N5SJ-*O"?)'E<5=:WNNM[
M]>IUN5;#SASSYHR=GI:SM=6MTTZ_>?<>N:A+I6BZA>P6DE_/;6\DT=K%G?,R
MJ2$7 )RQ&!P>O2ORTU;]I;QO>_MJZ3X\/P:\0)XBL](:RB\%L9A>R1F*7][_
M ,>V\#$A;_5GA3SW'ZLU\-:E_P I6M*_[ #?^D<M+ RC&I+F5_=E_P"DRO\
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M/_T)J]\^"JB3X+^ U8!E;P_8 @C((^S1UPQO]2G;^?\ ]M1VRM_:,+_\^_\
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M5L'$5J"C4II1^+>*=W?71/7LGZ7-:.(<J51N7P[2:LK:;K35:KIK;T/(I/\
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M6OAK_@J5_P @'X5_]A]O_0%K'!?[U2_Q1_-!F7^Y5_\ !+\F?<M?&W_!5/\
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M^V-\4M>^&OPKO8M#\":IXV&L6MW974FF^9MTZ,PD&>79$_R@$]=HXZU\K_\
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MU.:[I86'O1Y;))V?,KZ:ZKS\MCS(8V;<).=VVDX\KLKZ:.W3S>I[I\7/VRM
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M 'A#P5X,USXI^+['1(&O].T")VCLN.DLB1R$-ST"''0D'BO;?V_/^32/'_\
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MT)##. <J<@<9\.M?VYO%GCP'3O@;\$=5\0Z-:_Z-!JMXIMK--O 0(B[% &,
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M2DOC-/\ A&?^$=_X1R\CM,_;_M7VC=YGS?ZI-F/+Z<]?:O3_ (8?\DO\)?\
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MX#?"74O'<5G*PEOK& VM@CLQ)D"I&WRLVX[G\O)R>>M8X>'/)^[S6\[+YO\
MX*-\54]G!>_RW?:[^2_X#/2OV;_VRM%^/GB'4O"M_P"'M0\$>-M/C,TVBZDV
MXL@(#;&*HVY<C*LBG!R,@''@O_!3+XR>(AX7U/X?'X?ZK%X=:XLY_P#A,F\P
M64CXW^2O[K:6SD?ZS/RGBN$T#Q1\1]0_X*&?#?6/B+X3L/!GB&^@\K[%IL@8
M36S0W"*\A$DF6ZCD@X1>!P:]_P#^"HO_ ";,G_8;M?\ T&2NRI3A2JT*B2M)
MK2]TGS):/RT?KH<$*M2M0Q%-R=XIZM6=N6^J\]5?MJBS^S+^TYX]\;:IX/\
M!^J_ WQ'X8T,Z>L7_"47C7'V;;%;Y1_FM47$A4 ?/_$,$]_K2N7^%O\ R3+P
MC_V![/\ ]$I745S8N495I<L;6;^>NYUX&,XT(\TKW2MMIHM HHHKC.\****
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MCU6X>T@E.$DF#VI16Y'!; ZCKU%?>M?#7_!1[_DH7[/W_8?D_P#1UI79@?\
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MNZ%XUUJ8(:[!96;:2 '9P@4! 0F22QR*_1*BM_K5.-3VT*?O;IMWL^]K'/\
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M(]!^D%%71K*G&4)J\96\M5?_ #)KT'4E"I"5I1OTOH[7T^1^:6FZQX^\8?\
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M@=S;, KC"\C<IS]XD5[)15U*U.:;]G:3\]/DO^#8QI4*M-I>TO%>2O\ -_\
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M:^2OAK^VAXA_99\,V7P]^-W@+Q!%<:)&+.PUG3(DD2[@0809D=$?:N '1SD
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M/A]/JSM=:SHBB2:QN!&F5="0NPKLP6*#.>3T'ZDZM_R"KW_KB_\ Z":^+?\
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M^$_A607%A'J2E9+Y@ROP"!O+LB;BN555(W$]?T#HK?ZVN?VRA^\[]+OK;O\
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M,L%7,;,I5@Q&X'-+\4/B7XR_X*(7VB^"?A]X5U;P]\.H[M+K5?$&L1! Q7@
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M])[ZNV_;F^ GBOQI-X1^)?P[A-SXV\&SB=+-!E[F%7$@V#^)E92=G\0=@.<
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M?, 5F4J=W4,>AKB_VX?AOKWQ4_9O\2Z)X;@>\U56@NTLXN7N%BD5V11W; )
M[D =:]ZHKDE)<ZE35K--==M3LC%^S<*CO=-/IOI^1\ _!7_@H!H_A#X;^'_A
M[9_"SQ3=>.M'LDTY=$TRU3RI9HUV[B<^:A8C<W[HD%CUZG)_9=C\9R?\%!O%
M6H^/M+M]$\3:IX?DOI]/M7#I CBV\M,@GD(%!YZ@U^BE%=WUN*G.I&&LDT]>
M_;YZ]3SXX*?)"G*I>,&FE;MM?OI==-]CX:_:\_Y/@_9U_P"OF+_TJ%?<4O\
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MOP?\+]+U&)+"/64"7VI7$J,//V@';&JY48."7X+=%^[?BYXM\>^"?@U8ZO\
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M!XW?3/[8&DQQN+$3^1YI>5(P-^UMO+Y^Z>E;?PS\9?\ "Q?AUX8\5?8_[/\
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MXZD_8W[(O[-GB;X3ZMXO\<?$'6+?6/'OBR59+O['S%;H&+%=V "Q8C( VJ$
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M]3_9G_Y-U^&/_8M:=_Z3)1^T=\'E^/'P;\1>"Q=+8W%]&KVURX)2.:-UDC+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %?/'[1_B']HBU\16NE?!_PMHM]HEU9!
M;G6M1GB$UK<%F!**\Z\*NT\QOR>G:OH>BJC)1DI-7\GL1.+E%Q3M?JMSPO\
M9-_9O/[/?@[43J^HKKGC37[G[=K>J*25DDY(1"P!*J68[B 278X&0![I115U
M*DJTW.6Y-*E&C!0C_7F%%%%9&H4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img42689296_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img42689296_2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" >#"DP# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTW_A%=1_Z#]U^3?_ != '345S/\ PBNH_P#0?NOR;_XNC_A%=1_Z#]U^3?\
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M345S/_"*ZC_T'[K\F_\ BZ/^$5U'_H/W7Y-_\70!TU%<S_PBNH_]!^Z_)O\
MXNC_ (174?\ H/W7Y-_\70!TU%<S_P (KJ/_ $'[K\F_^+H_X174?^@_=?DW
M_P 70!TU%<S_ ,(KJ/\ T'[K\F_^+H_X174?^@_=?DW_ ,70!TU%<S_PBNH_
M]!^Z_)O_ (NC_A%=1_Z#]U^3?_%T =-17,_\(KJ/_0?NOR;_ .+H_P"$5U'_
M *#]U^3?_%T =-17,_\ "*ZC_P!!^Z_)O_BZ/^$5U'_H/W7Y-_\ %T =-17,
M_P#"*ZC_ -!^Z_)O_BZ/^$5U'_H/W7Y-_P#%T =-17,_\(KJ/_0?NOR;_P"+
MH_X174?^@_=?DW_Q= '345S/_"*ZC_T'[K\F_P#BZ/\ A%=1_P"@_=?DW_Q=
M '345S/_  BNH_\ 0?NOR;_XNC_A%=1_Z#]U^3?_ != '345S/\ PBNH_P#0
M?NOR;_XNC_A%=1_Z#]U^3?\ Q= '345S/_"*ZC_T'[K\F_\ BZ/^$5U'_H/W
M7Y-_\70!TU%<S_PBNH_]!^Z_)O\ XNC_ (174?\ H/W7Y-_\70!TU%<S_P (
MKJ/_ $'[K\F_^+H_X174?^@_=?DW_P 70!TU%<S_ ,(KJ/\ T'[K\F_^+H_X
M174?^@_=?DW_ ,70!TU%<S_PBNH_]!^Z_)O_ (NC_A%=1_Z#]U^3?_%T =-1
M7,_\(KJ/_0?NOR;_ .+H_P"$5U'_ *#]U^3?_%T =-17,_\ "*ZC_P!!^Z_)
MO_BZ/^$5U'_H/W7Y-_\ %T =-17,_P#"*ZC_ -!^Z_)O_BZ/^$5U'_H/W7Y-
M_P#%T =-17,_\(KJ/_0?NOR;_P"+H_X174?^@_=?DW_Q= '345S/_"*ZC_T'
M[K\F_P#BZ/\ A%=1_P"@_=?DW_Q= '345S/_  BNH_\ 0?NOR;_XNC_A%=1_
MZ#]U^3?_ != '345S/\ PBNH_P#0?NOR;_XNC_A%=1_Z#]U^3?\ Q= '345S
M/_"*ZC_T'[K\F_\ BZ/^$5U'_H/W7Y-_\70!TU%<S_PBNH_]!^Z_)O\ XNC_
M (174?\ H/W7Y-_\70!TU%<S_P (KJ/_ $'[K\F_^+H_X174?^@_=?DW_P 7
M0!TU%<S_ ,(KJ/\ T'[K\F_^+H_X174?^@_=?DW_ ,70!TU%<S_PBNH_]!^Z
M_)O_ (NC_A%=1_Z#]U^3?_%T =-17,_\(KJ/_0?NOR;_ .+H_P"$5U'_ *#]
MU^3?_%T =-17,_\ "*ZC_P!!^Z_)O_BZ/^$5U'_H/W7Y-_\ %T =-17,_P#"
M*ZC_ -!^Z_)O_BZ/^$5U'_H/W7Y-_P#%T =-17,_\(KJ/_0?NOR;_P"+H_X1
M74?^@_=?DW_Q= '345S/_"*ZC_T'[K\F_P#BZ/\ A%=1_P"@_=?DW_Q= '34
M5S/_  BNH_\ 0?NOR;_XNC_A%=1_Z#]U^3?_ != '345S/\ PBNH_P#0?NOR
M;_XNC_A%=1_Z#]U^3?\ Q= '345S/_"*ZC_T'[K\F_\ BZ/^$5U'_H/W7Y-_
M\70!TU%<S_PBNH_]!^Z_)O\ XNC_ (174?\ H/W7Y-_\70!TU%<S_P (KJ/_
M $'[K\F_^+H_X174?^@_=?DW_P 70!TU%<S_ ,(KJ/\ T'[K\F_^+H_X174?
M^@_=?DW_ ,70!TU%<S_PBNH_]!^Z_)O_ (NC_A%=1_Z#]U^3?_%T =-17,_\
M(KJ/_0?NOR;_ .+H_P"$5U'_ *#]U^3?_%T =-17,_\ "*ZC_P!!^Z_)O_BZ
M/^$5U'_H/W7Y-_\ %T =-17,_P#"*ZC_ -!^Z_)O_BZ/^$5U'_H/W7Y-_P#%
MT =-17,_\(KJ/_0?NOR;_P"+H_X174?^@_=?DW_Q= '345S/_"*ZC_T'[K\F
M_P#BZ/\ A%=1_P"@_=?DW_Q= '345S/_  BNH_\ 0?NOR;_XNC_A%=1_Z#]U
M^3?_ != '345S/\ PBNH_P#0?NOR;_XNC_A%=1_Z#]U^3?\ Q= '345S/_"*
MZC_T'[K\F_\ BZ/^$5U'_H/W7Y-_\70!TU%<S_PBNH_]!^Z_)O\ XNC_ (17
M4?\ H/W7Y-_\70!TU%<S_P (KJ/_ $'[K\F_^+H_X174?^@_=?DW_P 70!TU
M%<S_ ,(KJ/\ T'[K\F_^+H_X174?^@_=?DW_ ,70!TU%<S_PBNH_]!^Z_)O_
M (NC_A%=1_Z#]U^3?_%T =-17,_\(KJ/_0?NOR;_ .+H_P"$5U'_ *#]U^3?
M_%T =-17,_\ "*ZC_P!!^Z_)O_BZ/^$5U'_H/W7Y-_\ %T =-17,_P#"*ZC_
M -!^Z_)O_BZ/^$5U'_H/W7Y-_P#%T =-17,_\(KJ/_0?NOR;_P"+H_X174?^
M@_=?DW_Q= '345S/_"*ZC_T'[K\F_P#BZ/\ A%=1_P"@_=?DW_Q= '345S/_
M  BNH_\ 0?NOR;_XNC_A%=1_Z#]U^3?_ != '345S/\ PBNH_P#0?NOR;_XN
MC_A%=1_Z#]U^3?\ Q= '345S/_"*ZC_T'[K\F_\ BZ/^$5U'_H/W7Y-_\70!
MTU%<S_PBNH_]!^Z_)O\ XNC_ (174?\ H/W7Y-_\70!TU%<S_P (KJ/_ $'[
MK\F_^+H_X174?^@_=?DW_P 70!TU%<S_ ,(KJ/\ T'[K\F_^+H_X174?^@_=
M?DW_ ,70!TU%<S_PBNH_]!^Z_)O_ (NC_A%=1_Z#]U^3?_%T =-17,_\(KJ/
M_0?NOR;_ .+H_P"$5U'_ *#]U^3?_%T =-17,_\ "*ZC_P!!^Z_)O_BZ/^$5
MU'_H/W7Y-_\ %T =-17,_P#"*ZC_ -!^Z_)O_BZ/^$5U'_H/W7Y-_P#%T =-
M17,_\(KJ/_0?NOR;_P"+H_X174?^@_=?DW_Q= '345S/_"*ZC_T'[K\F_P#B
MZ/\ A%=1_P"@_=?DW_Q= '345S/_  BNH_\ 0?NOR;_XNC_A%=1_Z#]U^3?_
M != '345S/\ PBNH_P#0?NOR;_XNC_A%=1_Z#]U^3?\ Q= '345S/_"*ZC_T
M'[K\F_\ BZ/^$5U'_H/W7Y-_\70!TU%<S_PBNH_]!^Z_)O\ XNC_ (174?\
MH/W7Y-_\70!TU%<S_P (KJ/_ $'[K\F_^+H_X174?^@_=?DW_P 70!TU%<S_
M ,(KJ/\ T'[K\F_^+H_X174?^@_=?DW_ ,70!TU%<S_PBNH_]!^Z_)O_ (NC
M_A%=1_Z#]U^3?_%T =-17,_\(KJ/_0?NOR;_ .+H_P"$5U'_ *#]U^3?_%T
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M\(KJ/_0?NOR;_P"+H_X174?^@_=?DW_Q= '345S/_"*ZC_T'[K\F_P#BZ/\
MA%=1_P"@_=?DW_Q= '345S/_  BNH_\ 0?NOR;_XNC_A%=1_Z#]U^3?_ !=
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M= '345S/_"*ZC_T'[K\F_P#BZ/\ A%=1_P"@_=?DW_Q= '345S/_  BNH_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN!^+GQW\"_ G
M3]/O?'.NC0[:_E:&V;[+/<&1U&2-L2.1@=R,<TTG)V6XG)13;V1WU%?.?_#P
MW]G[_H?_ /RC:A_\CT?\/#?V?O\ H?\ _P HVH?_ "/71]6K_P C^YG+];P_
M_/R/WH^C**\B\&_M<?!SQ]<1V^C?$/17N9&"1P7DQLY'8G "K,$+'V KUP$,
M 0<@UC*G.GI-6-X5(5%>$D_06BBBH- HHHH **** "BBL'QCX\\-_#W2CJ?B
M?7=.T"PSM%QJ-RD*LW]U2Q&X^PYH WJ*^?H_V^?@)+J0L5^(5N)B^S<VGWBQ
M9_ZZ&'9CWSBO;/#/BO1?&NCPZMX?U:RUO2YL^7>:?<+-$V.H#*2,CN.U:RI5
M(*\HM+T,85J51\L))OR9JT445D;!1110 4455U35++1-/GO]1O+>PL;=2\US
M=2K'%&HZLS,0 /<T 6J*\$US]N[X#^']1:RNOB)92S*<%K&TN;N+\)(8F0_@
M:],^'?Q>\%_%JQDN_!_B;3?$$48!E6SG#20YZ>9&?F3.#]X#I6KHU(QYG%V]
M#%5Z4I<BDK]KG7T445D;!12$XY/ KQOQQ^V+\&/AW?/9:W\0-+2[C8I)#8B2
M^:-AP5<0(^TCT.*J,93?+%79$IQIKFF[(]EHKS#X:_M-?"WXO7:V?A/QKINI
MW[YV6+LUO<O@9)6&55=L#T%>GTY0E3=IJPH5(5%>#37D%%%%0:!137=8U9F8
M*JC)9C@ >M>>R_M&?">"1XY/B?X,CD0E61O$%H"I'4$>9P:J,7+2*N3*48ZR
M=CT2BJFDZO8Z]IEMJ.F7MOJ.GW48E@N[2598ID(R&1U)# ^H-6Z333LQIIJZ
M"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ K\O_P#@K/XQ%_\ $CP7X9CDR--TV2]D7/ :>3:/QQ#^M?J!7XH?MZ>,
M#XR_:H\;2A]\&GS1Z9%@Y $,:JP_[[W_ )UZ&7PY\7#RN_PM^IY>:5/9X.?]
MZR_&_P"29\_45]B_\$M_!7_"0?M#7>N21[H=!TF:97QP)92L2C_OEI?RK]9Y
MH([F)HIHUEB889'4$$>X-?0XS'?59J"C>ZOO;JSYC Y:\93=1RY;.VU^B\T?
MSIU]??L*?MA:]\+?'6C>"?$6I3:CX&U6=+...Z<N=-E<[4>(G[L>X@,G3!+#
MD'/K'_!3[X!>#O"?A30O'GA_2+/0M6N-2^P7L=C$L,=TKQNX=D7 W@H?F R=
MW.<"OSMMY'AN(GC)616#*PZ@@\5OAJE/,*=I1T;LU_7KH<^)HU<LK+EEK:Z?
M^?W:G]%E%5=+>633+1YP%G:%#(!V;:,_K4\TR6\3RRNL<: LSN<!0.I)["OB
M)+E;1^@PESQ4EU'T5\U_%_\ X*!_"+X4>=:PZRWB_6(^/L/A_;.@;_:GR(QS
MUPQ8?W:^(?BY_P %-OBAX\\^T\,1VG@32Y. ;(>?>%?0SN,#ZHBD>M=E'!UZ
M^L8Z=WHOZ]#AKX_#X?2<M>RU?]>MC]1_'_Q6\'_"RQ2[\6>(]/T&*3_5+=S!
M9)CZ1QCYG/LH)KJE8,H(Y!Y%?SWPZEK?C;QE:W-]=7^OZS>7,8::XD>YN)FW
M#'))9C7]!+7$=G8F>=Q%%%'O=VX"J!DD_A6V,P:P=.$I2NW?\+?YG/@<>\=5
MG&,;)6]=;GB?[6?[46D_LR^!%OFCCU'Q-J.Z+2M+9B!(P^]+)CD1KD9[DD 8
MSD?C?\3/BIXJ^,'BBX\0>+=8N-7U&4G:96_=PKGA(TZ(H]%'OUYKKOVI/C==
M?'SXS:YXE>5VTM9#::7"QXBM4)"8'8MRY]V-?1/_  35_9ALOB+X@O/B-XGL
M5O-$T6<0:9:SINCN+P ,TC \,L8*X'0LP_NUZV#P\,)0^LUE[UK^G9>O?S\C
MQL=B:F.Q'U2B_=O;U?5OR[>7F?(&L?#7Q?X=T&VUS5?"NMZ9HMUM\C4KS3IH
M;:7(R-DC*%;(Z8-=Y^S'^TAK_P"SC\0K35]/N)IM!N)%35M)#_N[J'/)VG@2
M*,E6Z@\="0?VN^(?@W3_ (A>!M=\-ZK;1W5AJ5I);R1R#(Y4X8>A!P0>Q -?
MSZW4!M;F6%CDQN4)^AQ6V#QJQCG3G':WS3O_ )'/CL \ H5:<[W_  :_S_0_
MH?T36;/Q%HUAJNG3K=:??01W-O,G22-U#*P^H(-7:^=/^"?GB>?Q1^RCX->Y
M<R36(N+#<W]V*9P@_!-H_"OHNOF,12]C6E36R?X=#Z_"U77H0J/=K\>H4445
MSG4<E\5?BAH7P<\!ZKXM\1W/V?3-/CW$+R\KGA(T'=F. ![^E?C#^T=^U1XR
M_:0\12W&L7<EAX?BD)L=!MY#]G@7LS#CS),=7;U.,#BO<?\ @IW\=IO&GQ2@
M^'VGW#?V+X9 >Z13\LUZZ@DGUV(0H]"SUXS^QY^SXW[17QCL=$NUD7P[8I]N
MU>:,D'R%( C![,[$+Z@%CVKZ/+<+"-/ZU5]5Y+OZO?TVZGRF:XR<ZGU.CZ/S
M;Z?+KYWOLCS/2?AKXOU[P_<:]IGA76]1T.VW>?J=IITTMM%M^]NE52JX[Y/%
M1^ _'VO_  R\56/B/PSJ<^DZO9.'BN(&QGU5AT93T*G((X(K^@'1="T[P[H]
MII.EV4%AIEI$L$%I;QA(XXP,!0HX Q7X@_MA>";#X>?M*>.]%TN!+73H[X7$
M$$8PL:RQK+M [ %R /0"NK"Y@L36=+ELK77RLM?O./&96\)05;FN[I/YWV^X
M_7_]F_XUV?[0'PAT3Q?;1K;W,ZF"^M5.1!=)Q(@]LX8?[++7I%W=PV%K-=7,
MJ06\*-))+(=JHH&2Q/8 "OSZ_P""1OBB>;1?B)X==R;>WN+2_B3G :19$<_B
M(H_RKLO^"GWQUF\"_#;3_ 6E7#0ZGXGW->/&<%+)" R_]M&(7W"N*\3&8;EQ
M?L*7VK6^:O\ <M?N/H<%B^;!^WK?93O\M/O>GS9\S?MD_MV:W\8]8O\ PMX,
MOI]'\!PLT#R6[&.;5><%Y".1$>T?<'+9X"_+WA/P'XF\>74UMX9\.ZMXBN(5
MWRPZ38RW3QKZL(U) ]S3OA_X'U/XE>-M%\+Z-%YVIZM=):PJ>@+'EF]%498G
ML :_=3X)?!GP]\!_A]IWA7P[;+'#;H&N;HJ!+>3D?/-(>[$_D, < 5[E25++
M**C!7;_'NW_7H?.TH5LWKN51VBOP[)?UZGX+R17_ (?U5HY$N--U*SFP58-%
M-!(I]."K CZ@BOUS_P""?/[4%[\=O -YH/B6Z-UXN\.A%ENI#\][;-D1RMZN
M""K'O\I/+&OF3_@JYX'T[0?BMX6\16=O';W6N:?(MX8U \V2%U =O5MLBKGT
M05P/_!-?Q1/H'[5&B64;E8=8LKNRE7G# 1&8?^/0BG>.88)U&K.S?HXWO]]A
M*,LLQZIIW5TGZ2MOZ7/V+KY"_;*_;IO?V;/%ECX5T+PY9ZSJUS8+?/=7URXC
M@W.RJIC4 MG83]\5]>U\V?'']@OP%^T!\0+GQ?XDUSQ/;:C-#%;^1IUU;I!&
MB+@!0\#MZDY8\DU\O0]G[6+J_#U/L<1[7V4E0^+I]_\ D?F?\9/VROBM\<()
MK+7?$36.BR\-H^CI]EMF!ZJV"7D'L[,*\8L;.74+RWM8$,D\\BQ1H.K,QP!^
M9KZ%_;<_9_\ !O[./Q"T;PSX3U#6-0>?3OMMXVKSQ2,A:1E0+Y<28X1B<YZB
MN0_9(\'GQU^TG\/=**>9%_:T5W*N,@QP9F8'VQ&1^-?:825!TU.DK1^[;?\
M(_/\9'$*JZ=:5Y:>>ZNOS/VW\">&8O!?@GP_X?@ $.E:?;V28](XU3^E;M%%
M?#SDYR<I;L_1:<%3@H1V6@4445!84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_DF?6?\ P2I^'*>(?C%KWBVXB#P^'=/\N!B/NW%P2H(_[9I*/^!5^JM?#O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU;-W9,>OW6;>F?9R!V6OA_XP?L/_ !<^#?GW-_X<?7='CR3JN@DW4(4<EF4
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M=OPO_F=]_P %5/C=!;Z+HGPOTZX#W=S(NJ:HJ'_5Q+D0QM[LV7Q_L+ZU\)_
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M9$-P(]>UZ-]*TZ-3A\R+B20>R(6.?4J.]?BU;V\MU<1P0QM+-(P1(T&69B<
M =R37HWQZ^/_ (J_:(\:-XA\3W"#RU,5GI]N"MO9Q9SL0$GD]2QY)]@ /IK_
M ()R_LG77C;Q59_%#Q-9-%X:TF;S-*AG3'VZZ4\2 'K'&><]W '\+"L\'06
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !15'7-<T_PSHU]JVK7D.G:98PO<W-W<N$CAC0%
MF=F/   )S7-?!WXIZ7\:_AQH_C70XYH]'U82R6GGC#M$DSQJY';<$W8[;L4=
M_+^OT?W!V\_Z_5'9T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB(5SPJKG<"<\5]74549./-9[V_"_YW5_1$2CS.+[7_&WY6T]6%%%%(H****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \-_;<_P"37O&_^Y:?^ED%=C^SU_R0;X=?]B]8?^DZ5QW[;G_)
MKWC?_<M/_2R"NQ_9Z_Y(-\.O^Q>L/_2=*]^7_(GC_P!?9?\ I,3Q(_\ (UE_
MU[7_ *5(]!HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKG?$_
MQ&\)^";B"#Q%XGT;0)IU+Q1ZIJ$5LTB@X)4.PR,]Q6+_ ,+\^&/_ $4;PE_X
M/+7_ ..5T1P]::YHP;7HS"5>E!\LII/U1WE%<'_POSX8_P#11O"7_@\M?_CE
M=Q;W$5U;QSP2)-#(H=)(V#*RD9!!'4$=ZBI1J4OXD6O56*A5IU/@DGZ,DHHH
MK(U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBN3^*7Q+T;X1^!]3\4:Y-LL[-/EB4@23R'[D2 ]68_ER3P"
M:TITYU9JG!7;T2(J3C3BYS=DMSQ?]O?X@:%X>^ ^L>'+V^1-;USR4L;-?F>0
M1W$4CN0.B@*>3W(%=%^R%\6O#/Q"^#_AW1]'OO,U7P_I=I8ZA9RKLDC=(E3<
M!_$A*G##\<'BOS%^+GQ3UGXR>.]1\4:XX^TW+;8K="3';0C.R)/8 _B22>2:
M^OO^":_PMUFQNM>\?7:M;:/>6ITRS1B1]I82*SR >BE H/<LP'0U^EX_)*67
MY'RUI^^GS>7,[*WW+]=C\\P.<5<=G'-1A[C7+Y\JN[_?_EN?=U%%%?F!^C!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !114%]?6VFV<UW>7$5K:PH9)9YW")&H&2S,>  .YHV
MU8;D]%>::'^TU\(?$VM0Z1I'Q2\&ZGJL[^7#9V>O6LLLK?W459"6/L*[KQ%X
MBTOPEH=]K.M:A;:5I-C$T]U>WDHCBAC49+,QX %#]U<SV!:NRW-&BOA'Q5_P
M63^!7A_7)K"PT_Q=XDM8VQ_:6FZ="D$GN@GFC<_\"5:^BOV>_P!KKX7_ +3E
MC,_@;Q$MUJ-N@DNM'O(S;WMNIQRT;?>4$@%T++DXSFG%.2NA2:B[,]DHHHI#
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O!/C)^T
M5XV^&OC671="^#>O^-K!8(Y1JVGM.(F9ARGR6T@R/]ZO>Z*Z\-5I49\U:GSK
MLVU^5F<V(IU*L.6E4Y'W23_,^-;K]O;QC8^(K30+GX#ZY;Z[>1F6VTN6]F6Z
MF0;LLD1M-S#Y'Y _A/H:Z+1_VO/B3J6K65I/^SMXJLH;B=(GN9&N=L2LP!<Y
MLQP <]1TJI\4O^4AGPG_ .P#-_Z!?U]9U])C*F7X>%%QPB]^'-\4]-6N_D?/
MX2&.KSJJ6)?N2Y?AAKHGV\PHHHKY ^I"BBB@ HHHH KZAJ%MI-A<WU[/':V=
MM&TTT\K;4C102S$]@ ":_)[]K+]H^X^/GC?;8O+!X2TMFCTZV;*^:>C7#K_>
M;L#]U<#J3GV#]O']J >(;V?X;^%;W.F6K[=:NX6XN)5/_'N".JH1\WJPQ_"<
M_*/PV^'>L_%7QIIOAG0;<W%_>R;=V/DB0?>D<]E4<D_@.2!7ZWPUD\<%2_M'
M%Z.UU?[*[OS?X+U/R[B'-98RI]0PNJOK;J^WHOS]"/0/ &M>)/#'B/Q#:6I.
MC:!#'+?73<*IDE6.- >[%FSCT5CVK]>/V=HTA^ GP[5$5%_L"Q;"C R8$)/U
M))/XUXS\>/A'HOP3_8C\4^&=$3='#':R7%TXQ)=3&[@WRO[G' [  =J]H_9Z
M_P"2#?#K_L7K#_TG2O#S[,UFF#5:"M%5&EZ**U?WGLY)ESRW%NE)WDZ:;]7)
MZ?@>@T445\ ?<!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7XD_\ !5C]JSQ!\1_C1J_PPTV_
MFL_!7A>5;:>T@D*K?W@"M))* ?F"-\JJ> 5)ZGC]MJ_FV_:47^UOVL_B5'<,
M6%QXPOT<C .#=N/Y5DJ;K8BG2Z/\[I+[K_KT-U)4Z$ZG:R^5FW^0W3/V1_C+
MK/PY_P"$\L?ASKUSX4\G[0M_';9+P]?-6//F-'CG>%*XR<X&:U_&/[9/Q&\>
M?LZZ3\(-<U:?4-&T^_\ M7VZ>9FN)X%4"&UD)Y:.-]S#))^X.B+7]%.FV,%A
MI=K9V\216L,*11Q*H"J@4 *!Z #%?S7?'/PW9Z5^TEX]T&QC6UL(?%5]:01H
MN%BC%VZJH'H!@8]JVM[2NL,OAE^C5OS_ #74PAI1^L/1K]4_\OUZ'O7PO_X)
M3_''XI_#>Q\8VB^']%MM0MQ=V>FZQ?217EQ$R[D8*D3HNX$$!W4\\@5\]^#O
M%'C+]F'XU6FJ01W&A>+O"NI%+BUD."'C8K+"^."K#<I[$'BOZ7=-M8['3K6W
MA4)%#$L:*O0*  !^5?S_ /\ P4RM8K/]MSXEK$@0/-:2,!_>:S@)/XFDZKIX
MA>SVU_"UO^"%.G[;#MSWTO\ /?\ X!^^_AO7(/$_AW2M9M3FUU"TBNXCG/R2
M('7]"*TJ\\_9UN'N_P!G_P"&DTAR\GAK36; QS]ECKT.MZ\%3K3@MDVOQ,*$
MG.E"4MVE^04445@;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_7M?^E2/0:***\ ]L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **XOXG?&3P?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% '#?';_DA_Q#_P"Q=U'_ -)I*\^_87_Y-<\&_P"]>_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%\3^"?
M#OC:W@@\1:!I>OPP,7BCU2SCN5C8C!*AU.#CN*^1/^"@7PQ\'>#/@KI=]X?\
M):'H5Z^NP0M<Z;IL-O(R&"X)4LB@E254XZ<#TK[5KY0_X*3?\D'TC_L8;?\
M])[FOH\AK5%F%""D[<VU]#P,[I4W@*TW%7MO;4]OM_@)\,FMXB?ASX3)*C)_
ML.U]/^N==KI.D6&@Z;;Z?IEE;Z=86Z[(;6TB6**-?144  >P%36O_'M%_N#^
M52UX=2M5J:3DWZL]FG1IT]812]$%%%%8&P4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#AOCM_P D/^(?_8NZC_Z325Y]^PO_ ,FN
M>#?]Z]_]+9Z]!^.W_)#_ (A_]B[J/_I-)7GW["__ ":YX-_WKW_TMGKWX_\
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MU1116!L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5P_P =/^2)?$'_ +%[4/\ TFDKN*X?XZ?\D2^(/_8O:A_Z325U
M87_>*?JOS.?$_P "?H_R/._V%?\ DUWP?_O7O_I9-7OE>!_L*_\ )KO@_P#W
MKW_TLFKWRNO-O^1AB/\ '+\V<N6?[C0_P1_)!1117E'I!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_IJ_2(?7YO137YS_ !O_ &H/&_QUNGBU>^^P:$'W1:+8DI;K@\%^<R,/5OP
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MAB]O;G0;&:>YN-'MY))9&@0L[,4RS$DDD\G-?2O#Y2L*L5RU+.3C;FCT2?\
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MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#Q/_ - VV_[Z'_Q=']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\
M%T?VAXG_ .@;;?\ ?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#
M_P"+H Z:BN9_M#Q/_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_
M - VV_[Z'_Q=']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?V
MAXG_ .@;;?\ ?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+
MH Z:BN9_M#Q/_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - V
MV_[Z'_Q=']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_
M .@;;?\ ?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:
MBN9_M#Q/_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z
M'_Q=']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;
M;?\ ?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_
MM#Q/_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=
M']H>)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\
M?0_^+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/
M_P! VV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>
M)_\ H&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\ ?0_^
M+H Z:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/_P!
MVV_[Z'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>)_\
MH&VW_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\ ?0_^+H Z
M:BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/_P! VV_[
MZ'_Q=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>)_\ H&VW
M_?0_^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\ ?0_^+H Z:BN9
M_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/_P! VV_[Z'_Q
M=']H>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>)_\ H&VW_?0_
M^+H Z:BN9_M#Q/\ ] VV_P"^A_\ %T?VAXG_ .@;;?\ ?0_^+H Z:BN9_M#Q
M/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+H Z:BN9_M#Q/_P! VV_[Z'_Q=']H
M>)_^@;;?]]#_ .+H Z:BN9_M#Q/_ - VV_[Z'_Q=']H>)_\ H&VW_?0_^+H
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M'Z)X#T&VT7P]IEOI.EVXQ';6R;5'J3W+'NQR3W-;-<S_ &AXG_Z!MM_WT/\
MXNC^T/$__0-MO^^A_P#%U^9RE*;<I.[9^AQBHI1BK)'35\G_ /!2C_D@^C?]
MC%;_ /I-<U]%?VAXG_Z!MM_WT/\ XNOEW_@HA=:S-\$=(74+2&"#^WX"&C()
MW?9[CC[Q[9KW,A_Y&=#_ !'C9U_R+JWH?8L/^IC_ -T?RI]<M#J'B?R4_P")
M;;?='\0_^+I_]H>)_P#H&VW_ 'T/_BZ\$]I;'S5^V%^QM%\1H[OQIX)M4@\5
M*#)>Z=& J:B!U9>PF_\ 0^_/)_.-EN=,O2K"6TN[>3!!!22)U/Y@@CZ@BOVQ
M_M#Q/_T#;;_OH?\ Q=?+7[5G[(^I_%9KCQ;X<T>WLO%2)NN;>!U1-1 '4Y;
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M;;_OH?\ Q=?-'T)TU%<S_:'B?_H&VW_?0_\ BZ/[0\3_ /0-MO\ OH?_ !=
M'345S/\ :'B?_H&VW_?0_P#BZ/[0\3_] VV_[Z'_ ,70!TU%<S_:'B?_ *!M
MM_WT/_BZ/[0\3_\ 0-MO^^A_\70!YC^W!_R:[XW_ -VS_P#2R"NU_9]_Y(/\
M.O\ L7=/_P#2>.O+?VSKS7I?V:?&2WEC!#;%;3>Z,,C_ $N''\1[X[5V/P'O
MO$2?!'X?K!I]N\ T"P",S#)7[.F#]_TKWI?\B>/_ %]E_P"DQ/$C_P C67_7
MM?\ I4CV"BN9_M#Q/_T#;;_OH?\ Q=']H>)_^@;;?]]#_P"+KP3VSIJ*YG^T
M/$__ $#;;_OH?_%T?VAXG_Z!MM_WT/\ XN@#IJ*YG^T/$_\ T#;;_OH?_%T?
MVAXG_P"@;;?]]#_XN@#IJJ:O>2Z;I-[=P6SWLT$#RI;1YW2LJDA!@'DD8Z'K
M6)_:'B?_ *!MM_WT/_BZ/[0\3_\ 0-MO^^A_\736^HGMH?.7_#9'Q._Z-M\6
M_P#?5U_\A5D:/^WMXQ\1:AJ5AI7P'US4[[39/)OK:SO9I9;5\L-LJK:$H<JP
MPV#E3Z&OJ3^T/$__ $#;;_OH?_%U\M?LFW6LQ_'3]H-K2TAEG;75,ZL1A&^T
M7G ^8=\^O2OK\/4R^MAZ]9X17II/XIZWDEW\SY:O3QU&O1I+%/WVU\,-+)OM
MY'LWP*^.'BSXKZMJEIXB^%NL_#^&T@66*YU0S%;ABV"B[X(^0.>":]EKF?[0
M\3_] VV_[Z'_ ,71_:'B?_H&VW_?0_\ BZ^8Q%2G5J.5*'(NR;?XO4^BH4ZE
M."C4GSOO9+\M#IJ*YG^T/$__ $#;;_OH?_%T?VAXG_Z!MM_WT/\ XNN8Z#IJ
M*YG^T/$__0-MO^^A_P#%T?VAXG_Z!MM_WT/_ (N@#IJ*YG^T/$__ $#;;_OH
M?_%T?VAXG_Z!MM_WT/\ XN@!GB'XK>"?".I-I^N^,- T6_50YM=0U.""4*>A
MV.P.#ZXK,_X7Y\,?^BC>$O\ P>6O_P <K@_B%^SCX;^*OB1]>\4^"+;5-6>-
M(6N/[1N8<HHPHVQW"KQ]*^8?VBOV>?"?@'XB?"+2]*\)0Z5:Z_K!M+RW6_N)
M1=)YULNPL\S%.)&&5*GYNO Q]+E^#R[&2C1<YJ;3;TC;1-OK?IIH?/8[%8_"
M1E54(.":2UE?5I+I;KKJ?;UO\=/AM=W$<$'Q"\*S32,$2./6K9F=B<  !^23
MVKN*^:=/_8W^'^EWUM>VOP[MHKFWE6:)_P"UKP[74@@X-S@\@=:]P_M#Q/\
M] VV_P"^A_\ %UY&*6$37U1R??F27W6;/4PSQ33^LJ*[<K;^^Z1TU%<S_:'B
M?_H&VW_?0_\ BZ/[0\3_ /0-MO\ OH?_ !=<)VG345S/]H>)_P#H&VW_ 'T/
M_BZ/[0\3_P#0-MO^^A_\70!TU%<S_:'B?_H&VW_?0_\ BZ/[0\3_ /0-MO\
MOH?_ != '35P_P =/^2)?$'_ +%[4/\ TFDK2_M#Q/\ ] VV_P"^A_\ %UQ?
MQJOO$;?!OQXLVGVZ0G0+\.RL,A?L\F3]_P!*ZL+_ +Q3]5^9SXG^!/T?Y'._
ML*_\FN^#_P#>O?\ TLFKWROF?]B>\UV+]FGPFME9036P:\VN[#)_TN;/\0[Y
M[5[E_:'B?_H&VW_?0_\ BZZ\V_Y&&(_QR_-G+EG^XT/\$?R1TU%<S_:'B?\
MZ!MM_P!]#_XNC^T/$_\ T#;;_OH?_%UY1Z1TU%<S_:'B?_H&VW_?0_\ BZ/[
M0\3_ /0-MO\ OH?_ != '345S/\ :'B?_H&VW_?0_P#BZ/[0\3_] VV_[Z'_
M ,70!TU%<S_:'B?_ *!MM_WT/_BZ/[0\3_\ 0-MO^^A_\70!TU%<S_:'B?\
MZ!MM_P!]#_XNC^T/$_\ T#;;_OH?_%T =-17,_VAXG_Z!MM_WT/_ (NC^T/$
M_P#T#;;_ +Z'_P 70!TU%<S_ &AXG_Z!MM_WT/\ XNC^T/$__0-MO^^A_P#%
MT =-17,_VAXG_P"@;;?]]#_XNC^T/$__ $#;;_OH?_%T =-17,_VAXG_ .@;
M;?\ ?0_^+H_M#Q/_ - VV_[Z'_Q= '345S/]H>)_^@;;?]]#_P"+H_M#Q/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_)KG@W_>O?\ TMGKT'X[?\D/^(?_ &+NH_\ I-)7GW["_P#R:YX-_P!Z]_\
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M &+NG_\ I/'7O2_Y$\?^OLO_ $F)XD?^1K+_ *]K_P!*D=_1117@GMA1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY0_X*3?\
M)!](_P"QAM__ $GN:^KZ^4/^"DW_ "0?2/\ L8;?_P!)[FO>R'_D9T/\1XN=
M?\BZMZ'U5:_\>T7^X/Y5+45K_P >T7^X/Y5+7A/<]E;!1112&%%%% !1110
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MHH **** "BBB@ HHHH ^3/V//^2^?M(?]C"O_I3?5]9U\F?L>?\ )?/VD/\
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M$QO^^83UE_Z0SZSHHHKP3VPHHHH **** "BBB@ KY,_;._Y+-^SI_P!C(?\
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M5ES2[VM^&H4445@;!1110 4444 %%%% !1110 4444 %%%% !1110 5\H?\
M!2;_ )(/I'_8PV__ *3W-?5]?*'_  4F_P"2#Z1_V,-O_P"D]S7O9#_R,Z'^
M(\7.O^1=6]#ZJM?^/:+_ '!_*I:BM?\ CVB_W!_*I:\)[GLK8****0PHHHH
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M-/X>$_Z]K_TJ1]KEO\3$_P#7Q_\ I,0HHHKP#VPHHHH **** "BBB@ HHHH
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M4 %%%% !1110 5\F?$O_ )2*?"K_ +%Z;_T7J%?6=?)GQ+_Y2*?"K_L7IO\
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M</\ Z+T^O?RKX,5_UZ?_ *5$\3,_CPW_ %\7_I,CZSHHHKP#VPHHHH ****
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MG9'145P?_"_/AC_T4;PE_P"#RU_^.4?\+\^&/_11O"7_ (/+7_XY6_U7$?\
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M-=^-XEP.60^KX"*DUVTBOGU^7WG#@^'\9F,_;XV3BGWUD_\ +Y_<?G+^R_\
MLCZ?\6/&WCK1?&&H7FG2>$KF.TN+;3&3,LI>9''F,& 4&$C@<[NHQ7VUX+_9
M!^$G@?RWM/!UGJ%RO/VC5BUXQ/KMD)4'Z**\P_8\_P"2^?M(?]C"O_I3?5]9
MU\AGV:8V6+E255J-HZ)V6L4WMYOJ?59)EN$CA8U'33E>6K5WI)I?@B"SLK?3
MK:.VM+>*UMXQA(84"(H] !P*GHHKXW?5GUNP4444@"BBB@ HHHH ^3/VS/\
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M,NF17N1.Y6Y 99"GRC]^."#C:>M=!XN_X*2^/]7WQZ#HNC^'X6Z22*]W,O\
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M\>-?&'@?0?$NC>(-#DBU;3X+]+:\::%T$L:N%RJ,"1NQGBOL3]N#_DUWQO\
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M5\,/^@+XK_\  .V_^2*/^'E7PP_Z OBO_P  [;_Y(KX,_P"%#_$O_HG?BO\
M\$ES_P#$4?\ "A_B7_T3OQ7_ ."2Y_\ B*X_]7,D_G_\G.O^W\X_E_\ )3[S
M_P"'E7PP_P"@+XK_ / .V_\ DBC_ (>5?##_ * OBO\ \ [;_P"2*^#/^%#_
M !+_ .B=^*__  27/_Q%'_"A_B7_ -$[\5_^"2Y_^(H_U<R3^?\ \G#^W\X_
ME_\ )3[S_P"'E7PP_P"@+XK_ / .V_\ DBC_ (>5?##_ * OBO\ \ [;_P"2
M*^#/^%#_ !+_ .B=^*__  27/_Q%'_"A_B7_ -$[\5_^"2Y_^(H_U<R3^?\
M\G#^W\X_E_\ )3[S_P"'E7PP_P"@+XK_ / .V_\ DBC_ (>5?##_ * OBO\
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MJ2OQX_5@HHHH ^3/V0/^3@/VCO\ L/K_ .E-[7UG7R9^R!_R<!^T=_V'U_\
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M **** "BBB@#Y,_X)M_\D=\3_P#8R3?^D]O7UG7R9_P3;_Y([XG_ .QDF_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFP\U+\_NW+U>%?MQ?\FM^-OI9_\ I;!7NM>%?MQ?\FM^-OI9_P#I;!6N5?\
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M_I9!7:_L^_\ )!_AU_V+NG_^D\=<5^W!_P FN^-_]VS_ /2R"NU_9]_Y(/\
M#K_L7=/_ /2>.O>E_P B>/\ U]E_Z3$\2/\ R-9?]>U_Z5([^BBBO!/;"BBB
M@ HHHH **** "ODS]C[_ )+]^T?_ -C O_I3>U]9U\F?L??\E^_:/_[&!?\
MTIO:][ _[CC/\,?_ $N)XF-_WS">LO\ TAGUG1117@GMA1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^\,Z[?:)<YRS6<S(K^SK]UQ[,"*_:;Q-X2T3QIICZ=KVDV6LV+];>^@65/J
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M $#4*^LZ]_-?X>%_Z]K_ -*D>)EOQXG_ *^/_P!)B%%%%> >V%%%% !1110
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M7'1D<?Q*PR"/0U^NOP%^-VC?'CP';:]IK+!>)B+4-/WY>TGQRI]5/56[CW!
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M?WD?[NYM')$5U"2-T3^QQP>Q (Z5^L9A@L/Q+@HXG#/WUL_SB_ZTWVW_ #+
MXROP_C)8?$+W'NORDOZ\MS]IJ*Y#X4_%#1/C#X'T_P 3Z#-OM+I<20N1YEO*
M,;XG Z,I/X@@C@BNOK\6J4YT9NG45FM&C]=IU(U8*<'=/8****S+"BBB@#Y,
M_P"";?\ R1WQ/_V,DW_I/;U]9U\F?\$V_P#DCOB?_L9)O_2>WKZSKWL^_P"1
MG7]?T/$R7_D74?0*KZA?V^E6%S>W<RV]I;1----(<*B*"68^P )JQ7R?_P %
M"OC%_P (5\,X/!UA/LU7Q(2L^T\QV:$;_P#OMMJ>XWUPX#!SQ^)AAH?:?W+J
M_DCMQV*C@L//$3^ROQZ+[SX2^/7Q4N/C+\5-=\42EEMKB;R[*%O^65LGRQ+]
M=HR?=C7U7_P3=^#FZ35OB1J,'"[M-TO<._!FE'X80'W<5\6>#O"NH>.O%6D^
M'M*B\[4=2N8[6%>VYB!D^@'4GL 37[1_#OP/I_PU\#Z+X8TM<66EVRVZ-C!D
M(Y9S[LQ9C[L:_4>*,9#+\## 4-.96](K_/;[S\WX<PLL=C98VMKRZ^LG_EO]
MQT5%%%?CQ^K!7@GQD_9U\;?$KQK+K6A?&37_  38-!'$-)T]9S$K*.7^2YC&
M3_NU[W177AL55PD_:479[:I/\&FCFQ&'IXJ'LZJNO)M?DT?&MU^P3XQOO$5I
MK]S\>-<N-=LXS%;:I+93-=0H=V524W>Y1\[\ _Q'U-=%H_[(?Q)TW5K*[G_:
M)\57L-O.DKVTBW.V558$H<WAX(&.AZU]445ZDL^S":M*:?3X(?\ R)YD<EP,
M'>,7_P"!3_\ D@HHHKP#W HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KD?'OQ>\#?"N&*3QEXQT+PLLP)B&L:C#:M+CKL#L"WX9KY
MF_X*4?MD7_[+?PUT[2_"LD:>.O$QDCLKB10XL8$ \RXVD$%LLJH#QDDG.W!_
M(;X?_L\?&[]JR\U?Q/H'AS6O&LID9[[7=0ND1)) ,L#<7#JKN!C*AB0,<=*R
MC)S<N79;O^OS[Z&CBHI<V[V1^^?PR_:7^%WQFU^\T3P1XVTOQ-JEG";B>WL'
M9RD88*7SC!&Y@,@]Z[[2->TSQ!#--I>HVFI0PS/;RR6<ZRJDJ,5>-BI.&5@0
M5/((P:_'/_@BN&A_:(\;!@=R>&),@<]+J"OGSP[^T!\4_P!E']IKQ#XH2WU3
MP]K%SJTMWK'AW58Y($OHI)6D,<T3 9!#DJ^,C.Y3Z],E&,Z<&_BBW?L^:R^7
MY&"YW&I)+X6E;Y7/Z'J*YKX:^/=-^*7P_P##OB_1V9M+URPAO[??]Y5D0-M;
MW&<'W!KI:F47"3C+=#C)2BI+9A1114E'PY_P6$\97OAK]DM-,LY&B37M=M;"
MY*G&8562<KGW:%/UKZ7_ &;_ (3Z!\%?@KX3\+^'K*&TM;>PA>>2-1NN9V13
M),[#[S,Q)S] . *\R_X*(_ '4_VB/V8];T/0;<WGB/3)XM8TVU4X,\D08-&/
M]IHWD"CNQ6OEKX;_ /!83PUX(^"MGH7B_P (>(G^)>AV']G20)%$MK<W$2^6
MKR.SAXB2H+KY9*G.,U%.:A&M'JVG;NK6T^?0NI%SE1:V2:^=_P#+K\C.TNSC
M_:>_X+ :E-=JM_X?^'Z$I&PW(ILT5%'ID7<I;_@-?H3^T9X+TOXA_ ?Q]X?U
MB*.6PO-%N@QD7(C98F9)!P<%656![%0:^/\ _@DK\$_$.C^'/&OQC\96DUOK
MGCNZ\RT-S&4D>VWM*\^#R%ED?(]1&I'!!I?V_O\ @H1X.T#P'XK^%/@"]G\1
M_$/5#+H%U':6TJIIV_,<P+%1OE(+(JINPQR2, &,13E#"QPOV^77_%+=_BK]
MBJ$E/$RQ'V$U9_W8[?D[=SJO^"0/B2\UW]D""SNW:2/2=;O+*VW-G$1\N;'T
M#2O7VW7SS^P-\#]0_9__ &7?"7AK68/LVOSK)J>I0$<Q33MO\MO]I$V(?=37
MT-7?B&G4=NEE\TDG^)Q8>_L[]VW\FVU^ 4445S'0%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3]0**9#-'<0QRQ.LL4BADD0@JRD9!!'44^OQX_50HHHH ^3/^";?_)'?$_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_@F'U#/,S_C<R3_F=E]W_ /S>KT'P3^S]\1OB)Y;:!X.U6\@DQMNI(#! ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 >>?%?\ :"^'7P-;35\>^++#PP=2$AM/MI8>=LV[
M]N >F]?SKRCQ/^VA^RSXVTXZ?XB\>>$->L&Y-KJEM]IB/_ 7C(KP#_@L5\$]
M>^(7@_PAXOL[O2M/T#PK%>MJ-SJ=X(#NF, B2-<$R.QC8!5!).*_+GX._LW_
M !,^/UU<0^ /!NI>(UMSMFN856.VB; .UYY"L:M@YVELX[5G3;J736J-:B5-
M1DGO^9^R.F_&3]A71KR*\T\?"FQNXCNCN+;P];QR(?4,( 17I4/[?G[.J*D<
M?Q6\/HHPJJ&=0!V'W.!7XW^*/^";_P"TAX1T>?4[_P"%U_+:P+N==-OK.^FQ
M[103.[?@IKR7X4?!'QE\;O&3>$_!VEPZCXC"NXTZZU"VLI7V?>5!<21[V&"2
MJY8 $XP#6L?>?*M?(Q?NKF9_1'X,_:8^$OQ$U2+3/#7Q*\*ZUJ<QVQ6-IJ\#
MW$A_V8]VYOP%>EU_-_\ %[]C7XT? 7P^NO\ C?P'?:+HWF"-M0CG@NH8F) 7
M>T$CB/)( +8R3@<U^HO_  23_:BUWXT_#?7_  5XMU*;5M>\)M"UK?W3[YI[
M*0$*KL>6:-D(W'G#H.U7",:BERO5?U_P?34B4G3:YEH_Z_X'J??=%%%9F@45
MY+^TE^TIX;_9=\&Z?XH\5Z=J]]H]U?I822:/;K,]N61V$D@9UPGR8)!)RPP#
MFLGX6_MM_ [XQM#%X:^)&C/?2L(TT_4I3873N?X4BG",Y_W 1[T1]Z_+K8)>
M[9RZF]^U/J%UI/[-7Q2O;&YFLKVW\-:A+#<6\ACDB=;=RK*P.00>017SK_P2
M,\6ZYXS_ &8=2O\ Q!K.H:[?+XCNHA=:E=27$H00P$+N<DX!)X]S7UA\5_ J
M?%3X7^*O![7QTZ/7]+N---ZL?F^2)HV3>%R-V-V<9&?6O-_V._V78?V2?A7=
M>"X/$<GB=)]3EU'[9)9BU(+I&NS8'?IY><Y[]*JC[LJKEUBDO7FN_P  J^]"
MDH[J3;]'&R_$]THHK.\0>(M*\)Z+>:QK>I6FD:39QF6YOKZ98884'5G=B H]
MR:AM)78U=Z(T:*^==#_X*&_LZ^(O%*^'K/XI:4-1:3RE:Y@N+>V9LXXN9(UA
M.>QWX/:OHA'61596#*PR&4Y!'K56=N;H3UMU'4444AA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!Y9H'_)P?B7_L')_Z#;UZG7EF@?\ )P?B7_L'
M)_Z#;UZG7QW#/\+%_P#7^M_Z6SWLW^.C_P!>Z?\ Z2@HHHK[$\$**** "BBB
M@ HHKQKXZ_'#Q9\*-6TNT\._"W6?B!#=P-++<Z69@MNP; 1MD$G)'/)%=.'P
M]3%5%2I*[?FE^+:1SUZ]/#0=2H]%Y-_@KL]EHKXV\2_M[>,?!=@E]X@^ ^N:
M%922"%+G4KV:WC:0@D(&>T +$*QQUP#Z5J_\-D?$[_HVWQ9_WU=?_(5>O_8.
M8)*3@K/^_#_Y(\K^V\"VXJ;NO[L__D3ZTHJII%Y+J6DV5W/;/933P)*]M)G=
M$S*"4.0.03CH.E6Z\!JSLSW$[JZ"BBBD,*\,_:3_ &K/#WP!TUK-=FL>+KB/
M=:Z2C\1@]))R/NIZ#JW;C)'#?M6?MJ67PG^T^%O!SP:GXOP4N+HX>#3?J.CR
M_P"ST7^+^Z?S;UK6]0\2:M=ZIJMY-J&HW<AEGNKAR\DC'J237Z!D/#,L9;$X
MQ6I]%UE_DOQ?XGPV=<0QPM\/A'>?5]%_F_R-;X@?$+7_ (H>*;OQ#XDU"34-
M2N3RS<+&HZ(B]%4=@/YDU[1^RY^R#K'QQOH=9UI9]'\$Q/E[K&V6](/,<.>W
M8OT'09.0._\ V4_V'+KQ<UCXN^(5M)9Z"0)K319,K+>#JKR]TC_V?O-[#[WZ
M&V=G!I]K#:VL$=M;0H(XH84"(B@8"J!P !V%>UG?$E/!Q^IY=:ZTNMH^2\_P
M7KMY&3Y!/%R^MX^]GK9[R\WY?B_SS?"/@_1O ?A^TT/0-.ATO2[5=L5O N /
M4D]22>23DD\FOF3_ ()K_P#)$O$/_8R3_P#I-;5]9U\F?\$U_P#DB7B'_L9)
M_P#TFMJ^&P\I3RW%RD[MRI_G(^SKQ4<PPL8JR2G_ .VGUG1117SQ[H4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7A7[<7_ ":WXV^EG_Z6P5TW
MQU_:#\._L^Z3I>H>(K+5+V'4)VMXETN*.1E95W$MOD3C'H37RE^T;^W%X$^+
MWP9\1>$=&TGQ%;:EJ(MQ%+?6T"0KLN(I3N*S,1\J'& ><?6OILFRW%U<30Q,
M*;<%.+OTTDKGSN;9AA:>'K8>=1*;B]/5:'U]^S__ ,D)^'/_ &+FG_\ I-'7
M?5\2_"__ (*"_#OP3\-?"?AZ^T;Q/+>Z3I-K8SR6]K;F-I(H51BI,X)7*G&0
M#CL*^N/A[XXL/B5X*TCQ/ID5Q!8:I +B&.[55E522,,%9@#QV)KDS/+\5A:L
MZM:FXQE)V?XG5E^.PV)IQIT9IR25T=%1117B'L!1110 4444 %%%% !1110
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M$KZY^(?A&Q T*Y??JMC;KQ9RD_ZY5'2-B>1_"Q]#\OZAPQGBDEEV+>FT6_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/^$KU#_H W7_ (]_\10!TU%<S_PE>H?] &Z_\>_^(H_X2O4/^@#=?^/?_$4
M=-17,_\ "5ZA_P! &Z_\>_\ B*/^$KU#_H W7_CW_P 10!TU%<S_ ,)7J'_0
M!NO_ ![_ .(H_P"$KU#_ * -U_X]_P#$4 =-17,_\)7J'_0!NO\ Q[_XBC_A
M*]0_Z -U_P"/?_$4 =-17,_\)7J'_0!NO_'O_B*/^$KU#_H W7_CW_Q% '34
M5S/_  E>H?\ 0!NO_'O_ (BC_A*]0_Z -U_X]_\ $4 =-17,_P#"5ZA_T ;K
M_P >_P#B*/\ A*]0_P"@#=?^/?\ Q% '345S/_"5ZA_T ;K_ ,>_^(H_X2O4
M/^@#=?\ CW_Q% '345S/_"5ZA_T ;K_Q[_XBC_A*]0_Z -U_X]_\10!TU%<S
M_P )7J'_ $ ;K_Q[_P"(H_X2O4/^@#=?^/?_ !% '345S/\ PE>H?] &Z_\
M'O\ XBC_ (2O4/\ H W7_CW_ ,10!TU%<S_PE>H?] &Z_P#'O_B*/^$KU#_H
M W7_ (]_\10!TU%<S_PE>H?] &Z_\>_^(H_X2O4/^@#=?^/?_$4 =-17,_\
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M7J'_ $ ;K_Q[_P"(H_X2O4/^@#=?^/?_ !% '345S/\ PE>H?] &Z_\ 'O\
MXBC_ (2O4/\ H W7_CW_ ,10!TU%<S_PE>H?] &Z_P#'O_B*/^$KU#_H W7_
M (]_\10!TU%<S_PE>H?] &Z_\>_^(H_X2O4/^@#=?^/?_$4 =-17,_\ "5ZA
M_P! &Z_\>_\ B*/^$KU#_H W7_CW_P 10!TU%<S_ ,)7J'_0!NO_ ![_ .(H
M_P"$KU#_ * -U_X]_P#$4 =-17,_\)7J'_0!NO\ Q[_XBC_A*]0_Z -U_P"/
M?_$4 =-17,_\)7J'_0!NO_'O_B*/^$KU#_H W7_CW_Q% '345S/_  E>H?\
M0!NO_'O_ (BC_A*]0_Z -U_X]_\ $4 =-17,_P#"5ZA_T ;K_P >_P#B*/\
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M0_Z -U_X]_\ $4 =-17,_P#"5ZA_T ;K_P >_P#B*/\ A*]0_P"@#=?^/?\
MQ% '345S/_"5ZA_T ;K_ ,>_^(H_X2O4/^@#=?\ CW_Q% '345S/_"5ZA_T
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M?_$4?\)7J'_0!NO_ ![_ .(K])2459'RC;>K.FHKF?\ A*]0_P"@#=?^/?\
MQ%'_  E>H?\ 0!NO_'O_ (BF(Z:BN9_X2O4/^@#=?^/?_$4?\)7J'_0!NO\
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M]B>"%%%% !1110 4444 ?)O_  4J_P"2$Z)_V,=O_P"DUS7UA'_JU^E?)_\
MP4J_Y(3HG_8QV_\ Z37->T?&SX]^%_@/X7_M+7KGS+V5"++2X6'GW;@=%'90
M<9<\#W. ?I:E&IB,OPE*E&\G*I9+_MT^>IUJ=#'8JI5=HJ,-?_ CI?B%\1-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y,_9 _Y. _:._[#Z_^E-[7
MUG7R9^R!_P G ?M'?]A]?_2F]KZSKWL\_P!^?^&'_I$3Q,F_W-?XI_\ I<@H
MHHKP3VPHHHH **** "BBB@#R3XU?\C=X!_Z_'_\ 1D%>MUY)\:O^1N\ _P#7
MX_\ Z,@KUNOD,I_Y&^9_XJ?_ *:B>YC?]QPGI+_TMA1117UYX84444 %%%%
M!116?KVI3Z1H]W>6UE)J,\*;DM8L[I#Z# )_0UG5J1HTY5)[13;ZZ+R6OW%P
MBZDE".[.7^.?_)$_B#_V+VH?^DTE>=_L*_\ )KO@_P#W[W_TLFJS\0O'^O\
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MOV? 8O YHEBZ*3DE9WW76S^:NOP/R7&X7&9:WA:K:BW=6V?2Z^3U_$W?AWX
MUGXH>,M,\-:#;&YU&^E"+_=C7JTCGLJC))]!7[!_!OX2Z-\%? .G^&-&7='
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M)<?$/5I9KN]T/57M;*QP!"LJ1QNL['J6!DX'0$ \]OT$KY,_X)M_\D=\3_\
M8R3?^D]O7UG7T'$5>I6S*JJDKJ+LO)'A9#1ITLOIN"LY:OS84445\T?0A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR<DJK!22202<U.&FHTZE/N[I_-W7WO\ !?+3$1<I4ZC[;?<D_P /S/Z)  H
M P!T%+7XFK_P6@^.BJ ="\#,?4Z;=<_^35+_ ,/HOCG_ - 'P+_X+;O_ .2J
MHS/VQHKD?A#XLO/'GPI\&^)=12&._P!8T:SU"X2W4K&LDL*.P4$DA<L< D\=
MZZZKJ0=.;A+=:$0DJD5-;,****@L***S/$?B;1_!^CSZMKVK6.B:7!M\V^U*
MY2W@CW$*NYW(49) &3U(H TZ*SO#_B+2?%FD6^JZ'J=GK.EW )AOM/N$G@E
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \<_:"_9
M+^&W[3SZ(WQ TFYU0Z,)A9_9[Z6VV>;LWY\MAG/EKU]*\@_X=._LW_\ 0IZE
M_P"#NZ_^+K5_X*!?MJ?\,A^ =,&BV=MJGC;7GDCTVWO-Q@@C0#S)Y I!8 LJ
MA<C);KA37Y77W_!43]IB^NGE7XC_ &56)*PP:+IX1!Z#,!)_$DUE"46VHK;\
MS22DDG)_\,?IY_PZ=_9O_P"A3U+_ ,'=U_\ %T?\.G?V;_\ H4]2_P#!W=?_
M !=?E['_ ,%/?VFH6W+\3I"?]K1=.8?D;>L7Q9_P4._:+\:Z7+8:E\4]6BMY
M/O'2X;?3Y/IYEO'&P'L#6COT(7F?T$^%?#5AX+\,:1X?TJ-H=,TNTBLK6-W+
ME8HT"("QY)"J.36K7GG[.L\UU\ /AK-<2/-/)X;TYY))&+,S&VC)))Y))KT.
MMZ\7"K*,G=IO4QHR4J<915DT@HHHK$U"O-_VA_@?I?[1OPDUKP!K6H7FF:;J
MAA,MU8;/.3RY4E&W<".2@'(Z&O2**F45)6949.+NCS_X"?!O3?V?_A+H'@'2
M+ZZU+3M'22.&ZOMOG.'E>0[MH ZN1P.U;?Q,\"VOQ.^'GB7PA?7$UI9:[IT^
MFS3V^/,C26,HS+D$9 ;C(KI:PO'4KP>!_$,D;M'(FG7#*ZG!4B)B"#V-3B*E
MX3J5-=&WYCH1Y9QC#356/D_PM_P2I^#_ (9^'$OAQ9=5FUY+_P#M"Q\91R);
MZO82#9M$<D:A2JE"0&4@%B>N"/L33+-]/TVUM9+J>^>")8FNKHJ99BH WOM
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !117GGQ._:!\ _!N^LK/QAKW]D7-[&
MTT"?8[B?>@."<Q1L!SZUM2HU:\_9THN4NR5W^!E5JTZ,>>K)17=NR,?XU?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0@KM[$RE&G%SD[)&=\6OBQH/P9\%7GB3Q!/LMX1MAMXR/-N92#MBC'=CCZ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU'WG48SGGZU]"+^W)\$0H!\;=O\ H%7W_P 8KO?^%!_#'_HG/A+_ ,$=K_\
M&Z/^%!_#'_HG/A+_ ,$=K_\ &Z^AJ8S*JE"GAW"I:#;7O1O[UKW]WR/"AA<S
MIUIUU.G>=D])6TO;[7F=II]]!JEC;7EJ_FVUQ&LT3X(W(P!!P>1P1UJQ4=O;
MQ6MO'!!&D,,:A$CC4*JJ!@  = !VJ2OEG:^A](KVU"BBBD,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRM]N7?\ PKITW?I^PY#EM/)\++'8O235W_=7;U?7Y(YBO</V>_&7$_ARY?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKRS0?^3@_$?_ &#D_P#08*]3KRS0?^3@_$?_ &#D_P#08*^/XB_BY?\ ]?X_
M^D3/>ROX,5_U[?\ Z5$]3HHHK[ \$**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'0?[/7_/CXB_\&[?_$T?\.@_V>O^?'Q%_P"#=O\ XFO$_P#@I5^W-\1?@/\
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M&O\ P4F_:L^,5K)=>"O@AH_B2RC8H][8Z5?M;AAC*^;]HV;N1\N<^U-^)?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\?\ TB9[F5_!B?\ KV__ $J)ZY1117UYX84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!\F?\$V_P#DCOB?_L9)O_2>WKZSKY,_X)M_\D=\
M3_\ 8R3?^D]O7UG7O9]_R,Z_K^AXF2_\BZCZ!1117@GMA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 V2
M18XV=CM51DD]A7\VWQH\9:[^U#^TUKNJ0LU_JGB?7?L>F0N< 1M*(;6(>@">
M6OX9K^D:ZA%U:S0DX$B%"1[C%?S9?#O5_P#A0G[4.@W^N1,J^$O%<9OX]I+!
M;>Z EP/7"MBHI1C/&0C4V_S:O]VGWFDVXX6I*&__  '8_;?]DK]@;X=_LLZ;
MIVI6UDNN>/UM]EWXDNBQ?<RX=8$SMB3DC@;B/O,:^FZJ:3JUEKVEV>IZ==17
MNGWD*7%O<P,&CEC8!E=2.H(((/O5NMYRDW[W3\#GA&*7N]?Q/G[]I+]AOX4_
MM-6-]/X@T"'3?%4\>(O$^F((;U'"A4,A'$P 4#;(&X&!MX(_";7]'\5_LF_M
M"3V1G^S>*O!>LJT=Q"2$D:-@R..^R1-IP>JO@U_2P[K&C.[!549+,< #UK^=
M#]N/XCZ7\7OVLOB)XCT"1;O2KG4%M;6>+E9UAB2#S%(ZAC&6![@BN6FY4\1'
MV?K\TU;^NOR.J454H2Y_)???3^MOF?T-^$?$4'B_PIHNNVHQ;:I90WL7^[)&
MKC]&K6KCO@SX>N/"/PA\#Z'=J5NM-T.RLYE/4/' BL/S!KL:[*T8QJRC#9-V
M.*A*4J4)2W:7Y!1116)N%<7\8_A'X<^.OPWUOP1XKM6NM%U6'RY/+;;)$P(9
M)8VP<.C ,#@C(Y!&17.?M'>!_B-XT\%V<GPK\91^#O&&E7JW]NUW%YMI?J$=
M6M;A>?W;;P<[6P5! S@CYFT;_@IC>_"/7(/"/[27PUUCX<^(@=@UG2X3=Z7=
M@#YI4P2VSD#]V9N3R1T$6C4O"7X]?3^KE^]"TX_\-_7W'FEO^RA^V=^R[:R:
M'\%_B59^*_!<<I-GI]X;99H5)R1Y5XC)$,DG$4N"<G )Q22?LD?MC_M31P:-
M\<?B3;>%_!/G!KS3;)K8S3J#D 16B+')R!CS9#M.#M)&*^PO"W[>7[/GC"S6
MYL?BUX;MXV_AU2Z_L]_^^+@(WZ5'XM_;X_9[\%VOGW_Q8\/7*?W=)G;47_[Y
MMUD/Z5>W\37U(W^#3T/./VAOV,O&?B3X,^!/@[\&/%%G\/O %BDUMK[7$\HG
MO(&V\8C3]Z68S,ZL\:L6P>#@?0GP$^"VB?L]_";P_P" O#YDEL-)A*M<3 "2
MXE9B\DK8[L[,<=L@=J^2M0_X*6:[\;-;E\*?LU_"[5O'&L[O+DU[78OLVF68
M/25P&SM(!QYCQ'(X#'BOJ3]G7P/\0/ _@*5/B?XQ7QIXRU&\>_N[FWB\NUM=
MR(HMH%P/W:;.#M7)9CC))-QYFIR?VM;O=O\ R6OE\R)<JY(K[.FG3S]>G?Y'
MJ5%%%06%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,7":OR*G;R^+F_0]+-H8+"U:F%HTFI1=N;FO^%OU"BBBONSYL**** "BBB@
MKDM4^*WA;1=0GL;W5/)NH&V21_9Y6VGTR%(KK:R+KPCH5]<27%SHNG7$\AR\
MLMI&S,?4DC)KR\P6/E37]GR@I7UYU)JWERM:G9A7AE)_6E)K^ZTG?YIG/?\
M"ZO!G_09_P#)6;_XBK>E_%;PMK6H06-EJGG74[;(X_L\J[CZ9*@5P_B#PWI,
M/QO\.6$>EV4=C+9,\ELMN@B=L3<E<8)X'Y"O3K7PCH5C<1W%MHNG6\\9RDL5
MI&K*?4$#(KY++,;Q!CJU6,Y45&E4Y)6C.[LHMM>_II+2_4]S&8?+,/3@XJI>
M<>9:QTU:U]WR->BBBOT$^7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_)L\K#/$N+^LJ*?]UM_FD%%%%<9UA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?)G_!-O\ Y([XG_[&2;_TGMZ^LZ^3/^";?_)'?$__ &,DW_I/
M;U]9U[V??\C.OZ_H>)DO_(NH^@4445X)[84444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!LDBQ1L[L$11EF8X  [FL7_A.O#?\ T,&E
M?^!L7_Q5;$\*7,,D,B[HY%*,N<9!&"*XO_A2O@S_ * W_DU-_P#%UXN82S2+
MC_9T:;77G<EZ6Y8O\3T,*L&T_K3DNW*D_ONT;G_"=>&_^A@TK_P-B_\ BJN:
M;X@TO69'33]2L[YT&66VG20J/4[2<5XS\._A[X?UWQ5XRL[[3_/MM/O!%;)Y
MTB^6N^48R&!/"KUSTKU?PWX#T+PC---I-C]DDF4([>=(^0#G'S,:\'),RSG-
M(PQ-6G2C2;DG:4^;W6XZ+EMNN^WGH>EF&$P&#<J4)S<TDU=1MJD^]]GVW-^B
MBBON#YT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]?Y?^D4SWLT_AX7_ *]K_P!*D%%%%?8'@A1110 4444 %%%% !1110 4444
M%%%% !1110 445%=6ZWEK- Y(25&1BO7!&.*4KI-I:C5KZDM%>6?\,Z>&_\
MG]U7_O[%_P#&ZXOP/\*-(\3>)?%.GW5Q>QPZ5<^3"T+H&9=\@^;*')P@Z =Z
M^ KY]G.'KT</4P$>:JVH_ONJBY._[OLCZ:GEN JTZE6.)=H6;_=]W;^;NSZ'
MHKD/!/PQTOP'=7,^GW%Y,]P@1A<NC  '/&U177U]E@ZF)K45/%TU3GUBI<WX
MV7Y'@8B%*G4<:,^:/>UOPNPHHHKN.<**** "BBB@ KRSXP?\CA\/_P#L(_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KS?\
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MPO\ \51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\ Q5'_  G^G?\
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MX3_3O^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*H Z:BN9_P"$_P!._P">5S_WPO\
M\51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\ Q5'_  G^G?\ /*Y_
M[X7_ .*H Y+X2_\ (\_$/_K_ !_Z,FKU.O%/AGXHM--\8>-YY4F*75Z'0*H)
M \R4\\^XKT7_ (3_ $[_ )Y7/_?"_P#Q5?'<)?\ (HA_CJ_^G9GNYW_OTO\
M##_TB)TU%<S_ ,)_IW_/*Y_[X7_XJC_A/]._YY7/_?"__%5]B>$=-17,_P#"
M?Z=_SRN?^^%_^*H_X3_3O^>5S_WPO_Q5 '345S/_  G^G?\ /*Y_[X7_ .*H
M_P"$_P!._P">5S_WPO\ \50!TU%<S_PG^G?\\KG_ +X7_P"*H_X3_3O^>5S_
M -\+_P#%4 =-17,_\)_IW_/*Y_[X7_XJC_A/]._YY7/_ 'PO_P 50!TU%<S_
M ,)_IW_/*Y_[X7_XJC_A/]._YY7/_?"__%4 =-17,_\ "?Z=_P \KG_OA?\
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M7/\ WPO_ ,57Z'&49Q4HNZ9\LTXNS6ITU%<S_P )_IW_ #RN?^^%_P#BJ/\
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MYXAMU/SRMZ >GJ>@KF?%?QHTKP[9N(H9I[]E_=0, !GU8@\#^=?._B#Q%?\
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M_GE<_P#?"_\ Q5'_  G^G?\ /*Y_[X7_ .*H Z:BN9_X3_3O^>5S_P!\+_\
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M_A/]._YY7/\ WPO_ ,51_P )_IW_ #RN?^^%_P#BJ .FHKF?^$_T[_GE<_\
M?"__ !5'_"?Z=_SRN?\ OA?_ (J@#IJ*YG_A/]._YY7/_?"__%4?\)_IW_/*
MY_[X7_XJ@#IJ*YG_ (3_ $[_ )Y7/_?"_P#Q5'_"?Z=_SRN?^^%_^*H Z:BN
M9_X3_3O^>5S_ -\+_P#%4?\ "?Z=_P \KG_OA?\ XJ@#IJ*YG_A/]._YY7/_
M 'PO_P 51_PG^G?\\KG_ +X7_P"*H Z:BH+&\34+2*XC#!)!N 8<U/0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'+[*G?1W^%7MK]USJ-H]*-H]*6BO<.,3:/2O$/VA/!F/(\1VT?I!=[1^"/\
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MC8-T_P"5[6[PE_2[JYQ8K+LNXBI?6,/*T^ZW])+^GV=C[9VCTHVCTKPWX?\
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MU3^0-9EQ^TG=MGR-"AC_ .NEP7_DHKR:O'O#M+_F)OZ1F_\ VVQVPX:S6?\
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MH]*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#X!_X*Z?$#X?:/\-?#GA'QQX9U+5;O66N;
MK1]8TN6-)=,N(1&-Q#CYU82@,F1D \@A6'P[^RY_P4^^(W[-?@VU\'2Z5IWC
M/PM9%OL5OJ#O#<VJDD^6DRY&S))VLK$9P"!@5^J7[77[$/A;]L.3PP_B37M7
MT3^P1<"#^RO*_>>=Y>[=O1NGEC&/4U\[?\.2_A=_T/GB[_R5_P#C59TN:'-?
MJ_\ AOG8TJ\LE%+HO^'/.5_X+E7FT9^#4)/?'B4C_P!M*7_A^7=_]$9A_P#"
MF/\ \B5Z+_PY+^%W_0^>+O\ R5_^-4?\.2_A=_T/GB[_ ,E?_C5:&9]Y?#3Q
M@?B%\.?"_BEK06#:UI=MJ)M1)YGD^;$LFS=@;L;L9P,XZ"NEK!\!^$;?P!X'
M\/\ ABTFEN;71M/M].BFFQO=(HU16; QDA03BMZM:O)[27L_AN[>G0SI\W)'
MGWMKZA11161H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2T45^EQ322;N?)/?0****8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOMZ=GU7G='Y!FF6U<KQ#HU-5T?=?UN%%%%?3'D!1110 4444 %%%% !1110
M4444 %%%% !1110 5Y9\)O\ D>_B%_U_C_T9-7J=>5?"F18_''Q#9V"J+X$L
MQP!^\FKX[.-,VRS_ !U/_34CWL#_ +EB_P##'_TM'JM%<SJWQ*\,:+N%SK5J
M77JD+>:WTPF<5QFK?M%:+:Y6PL+N^8=&DQ$A_'D_I79C>)<GR^_UC%0371.[
M^Y7?X'/A\IQ^*_A49/Y67WNR/6:*^=-6_:&\07F5LK:TT].S;3(X_$\?I7&:
MMX_\1ZWD7FLW<B-UC60HA_X"N!^E?"8WQ.RFA=8:$ZC].5?>]?\ R4^DP_!^
M.J:UI1@OO?X:?B?56J^*-(T,'[?J=K:$?PRS*&_ 9R:XW5OCUX6T_<+>6XU%
MQ_S[PD#\WQ^E?-!))R>35K3])OM6D\NRL[B\?^[!$SG]!7P^*\3LUQ4O9X&A
M&%_6<OT7X'T='A#!45S8BHY6](K]?S/6M6_:0O)-RZ;I$, [/=2&0_7 VX_,
MUQNK?&#Q9JV0VK26R'^"T418_$#=^M3Z3\%?%FJ8)T];*,_QW<@3_P =&6_2
MNSTG]FY^&U/65'K':19_\>8_^RUP^SXXS[?VBB_2FON]VZ^\Z.;AW+=N1M?]
MOO\ 4\9NKVXOI3+<SRW$IZO*Y8_F:@KZ?TGX'^$]+VE[.6_<?Q74I/Z+@?I7
M,?%SPSI5OKW@?3X-/M[6TN;QHI8[>,1[U+P@@E<=B>?>N;'>'^9X'!SQV+JQ
MNG%63;;<I*.KMYWZFV&XFPF(Q$</0@[:ZZ+9-Z+Y>1Y5X3\?ZUX,F#:?=GR,
MY>UE^:)O^ ]OJ,&O=/!GQNT7Q)Y=O?$:1?MQMF;]TY_V7[?0X_&N)\9_L_7=
MEYESX?F-Y#U^R3$"4?[K=&_'!^M>27EG/I]S);W,,EO/&=KQ2J593Z$&G0S+
MB3@:JJ&(BW2Z*6L'_AET]$_5"J83*>(H.I2?O]UI)>JZ_/Y,^UP0P!!R#2U\
MI^#?BMKG@W9#%-]LL!_RZ7!)4#_9/5?PX]J]X\&_%G0_&.R%)OL.H-Q]DN"
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M4OC/+K#3:5H,K0Z?RDMVO#S>H7T7]3].N)\3/BQ=^-)WL[,O::,IXCSAIO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '@'[97[7V@?L@_
M#NWUO4+)M;UW4I6M])T:.81&X=1EW=\';&@(R0#RRCOD?FK??\%J/C7/=.UK
MX8\#6MOD[(VL;N1@.V6^U#)]P!]*O?\ !:W7[B\_:$\&Z0S'[)8^&UGC7/&^
M6XF#G\1$GY5Z1I?_  3(^'S?L)7'C)+6_P!1^)MWX77Q%!?R7CA()?)%Q]GC
MA0A"I4;,L&.22".,80;]E4Q$]HMK[K_Y-_@;SBO:PP\=Y)?C;\KI'D<?_!:3
MXY1MEO#O@.0?W6TZ\Q^EV*Q?%G_!83X_^)-+EM+$^%_#$K]+S2=+9IE]A]HE
ME7_QW-1?\$O?@+\*_P!H[QQXV\*_$;0&UF\@TV+4-,DCO[BV:)5D\N;B*10W
M,D1^8'&/>I/VO/V<- _8%_:2\&Z[8:+;>.?A[JFZ\BT+Q&HG5@C!;BV<XPV
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MUZ/H_-!1117O'FA1110 4444 %%%% !1110 4444 %%%% !1110 5Y3\5OC
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M6Q-;$.]:;D_-MA1117<<X5Y9\8/^1P^'_P#V$?\ VI#7J=>6?&#_ )'#X?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?E#_ ,%KO@WJ<FL>"?B?96CSZ6EHVAZC/&N1 XD:2 MZ!O,E&?50.XKT
MS_@E-^U1XC^.7@J_^%/B31;>XL?".CQPPZY',5>2W)\J*WDBVX+! PWAAD(
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MG1I4_A<IM>2?+I\A:***_8SX,**** "BBB@ HHHH *\L_9U_Y$V__P"PB_\
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M>O[5?K,O^-0MXFT=/O:M8K];E!_6L7BJ$=ZB^]&BHU7M%_<5_&__ ")>O_\
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M2S7VF09_++Y+#XAWI/\ \E_X'=?->?D'PE^+3^&I(](U>1GTECB*9N3;D_\
MLG\J^B8Y$FC62-E=& 964Y!!Z$&OC/7-#O?#>J3:?J$+07,1P5/0CL0>X/K7
MH?PE^+3^&I(](U>1GTECB*9N3;D_^R?RKX?@WC*IEM19/G#:BG:,GO![<LO+
ML_L[/3;Z+/LACBX_7L#JWJTOM>:\_P _7?W'QM_R)NO?]>%Q_P"BVKG_ ()_
M\DTTGZS?^CGK>\92)-X)UR2-E=&TZ=E93D$&)L$&L'X)_P#)--)^LW_HYZ_7
M:COQ+2:_Y\3_ /3D#X>/_(HG_P!?(_\ I,CNJ***^Q/!"BBB@ HHHH ****
M"O+-#_Y.#\0_]@Y?_08*]3KRS0_^3@_$/_8.7_T&"OCN(OXF7_\ 7^/_ *1,
M][*_@Q7_ %[?_I43U.BBBOL3P0HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M** "O+/$?_)P'AC_ *\'_P#0;BO4Z\L\1_\ )P'AC_KP?_T&XKX[B;^#A?\
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M'J2:Q%1P7=1YOU1G^)/^2_\ A?\ Z\'_ )3UZI7EG_#.GAO_ )_=5_[^Q?\
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M_P#M2&O4Z^.RG_D<9G_BI_\ IJ)[V._W#!^D_P#TMA1117V)X(4444 %%%%
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M% !1110 5Y9^SK_R)M__ -A%_P#T7'7J=>6?LZ_\B;?_ /81?_T7'7QV8?\
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MO+==--OU/).(X8F*P>8;O1-[/RE_GUZ^?<_#3XJ6GCBW%K<;+36(UR\&?EE
MZLG]1U'ZUWM?$UO<RV=Q'/!(T,T;!DDC)#*1T(-?0?PM^,D7B!8M*UN18-3^
M[%<'"I<>Q]&_0]O2OH>#^/(9ARX#-)6J[1ELI>3[2_!^3W\S/>&Y86^)P:O#
MJNJ].Z_+T/5JXCXT?\DSUGZ0_P#HY*[>N(^-'_),]9^D/_HY*_2N(?\ D38S
M_KU4_P#2&?(Y7_O^'_QQ_P#2D;7@/_D2/#__ &#[?_T6M;M87@/_ )$CP_\
M]@^W_P#1:U>UO7++P[ILU_J$ZV]M$,LS=3Z #N3Z5UX&I"CE]*I4:45"+;>B
M2Y48XB,JF*G""NW)_F3:EJ5KH]C->7LZ6UM"NYY)#@ ?Y[5\S_$[XI7/CBZ-
MM;;[;1HFS'#T:4C^-_Z#M53XB_$J^\>7V/FMM+B;,-KG_P >?U;^7;U.7X-\
M&ZAXVU9;*Q3"C!FN&'R1+ZG^@[U_/'%/%V)XCKK*<H3=.3MIO4?Z1\NN[['Z
MEDV1TLJI_7<<USK77:/_  ?Z1%X5\)ZAXQU9+#3XM[GEY&X2)>[,>P_G7U#X
M'\":?X%TS[/:+YEQ)@SW3#YY3_0>@JQX/\'Z?X+TE+&PCYZRS,/GE;U)_D.U
M;E?J'"/!M'(*:Q.)M+$/KTCY1_5]=EIO\=GF?5,SDZ5+2DOQ\W^B"BBBOTP^
M1"BBB@#RSX2_\CS\0_\ K_'_ *,FKU.O+/A+_P CS\0_^O\ '_HR:O4Z^.X2
M_P"11#_'5_\ 3LSW<[_WZ7^&'_I$0HHHK[$\(**** "BBB@ HHHH \L^+_\
MR./P^_["/_M2&O4Z\L^+_P#R./P^_P"PC_[4AKU.OC\I_P"1OF?^*G_Z:B>]
MCO\ <<'Z3_\ 2V%%%%?8'@A1110 4444 %%%% &)XW_Y$O7_ /L'W'_HMJP?
M@G_R3/2/K-_Z.>M[QO\ \B7K_P#V#[C_ -%M6#\$_P#DF>D?6;_T<]?'U/\
MDIJ7_7B?_IR![T?^11/_ *^1_P#29'<T445]@>"%%%% !1110 4444 <7<?&
M3P?:SR0R:OMDC8HR_9IC@@X(^Y7GND_$+P_:_&+6M<EU#;I=Q9K%%<>3(=S
M0C&W;N'W&ZCM7KDG@GP[+(SOH&EN['+,UG&22>Y^6F_\(+X;_P"A>TK_ , H
MO_B:_/L=EO$&.G2E.K17LIJ<?=GNDTK^_M9]+'U&&Q>68:,U&%3WX\KUCLVG
MI[OD5=!^)/ASQ1J L=,U'[3=%2XC\B1.!U.64"NFK,T_POHVDW N++2;&SG
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M85[V7QS2+E_:,J;6EN127K?FD_P/-Q3P;2^JJ2[\S3^ZR0ZBBBO://"BBB@
MHHHH BNKN"QMY+BYFCMX(QEY96"JH]23P*R/^$Z\-_\ 0P:5_P"!L7_Q5:.J
M:7;:UI\]C>Q>=:SKLDCW%=P],@@UR7_"E?!G_0&_\FIO_BZ\+,)9O&HO[/A3
M<;:\\I)W\N6+T/2PJP+B_K4II_W4FK?-HY+X#^)-(T?PI?0W^J65E*U^[K'<
M7"1L5\N,9 )Z9!_*O6=-UG3]9C=]/OK:^1#AFMIED"GT.TG%<G_PI7P9_P!
M;_R:F_\ BZZ#PWX1TGPC!-#I-I]DCF8.Z^8[Y(&,_,37B<.X'.<KH4<#BE2=
M*"M>,IN7EHXI;^9Z&:8C 8RI4Q%%SYY.]FHV^]-LV****^X/G0HHHH ****
M"BBB@ HHHH **** "BBB@#COB7\/[?QWHI10L>IP M;3GU_N-_LG].M?+-]8
MW&F7DUI=1-!<0L4DC<8*D=J^UZ\Q^,7PQ_X2JS.JZ;&/[6MU^:-1S<(.W^\.
MWKT]*_'./.$?[4IO,\#']]%>\E]M+_VY?BM.Q][PWGGU.:PF(?[M[/\ E?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.MA%&$JSE!*R345MMJE<****\8]8**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#RS]HK_D2++_L(1_\ HN2O4E^Z/I7EO[17_(D67_80C_\ 1<E>
MI+]T?2OCLO\ ^1_F'^"C_P"Y#W<5_P BS#?XJG_MHM%%%?8GA!1110 4444
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MB7!?]>J?_I*.O-?^1AB/\<OS84445]">6%%%% !1110 4444 %%%% !1110
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M4445F=X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHDY2>^NMEV2_'=GGYYFU?,<1*$](1;27ZONPHHHK[P^:"BBB@ HHHH ****
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M[>)88(U"I'&,*H'0 5+117[I&*BE&*LD?G+;;NPHHHIB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L7QM_R)FO\
M_8/N/_1;5M5B^-O^1,U__L'W'_HMJX,P_P!SK?X9?DSIPO\ 'I^J_,P/@G_R
M3/2/K-_Z.>NYKAO@G_R3/2/K-_Z.>NYKS>'?^1+@O^O5/_TE'7FO_(PQ'^.7
MYL****^A/+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \L^,'_(
MW?#_ /["/_M2&O4Z\L^,'_(W?#__ +"/_M2&O4Z^.RG_ )'&9_XJ?_IJ)[V.
M_P!PP?I/_P!+84445]B>"%%%% !1110 4444 8OC;_D3=>_Z\+C_ -%M7/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!>JG_I#/3RO_?\/_CC_P"E(VO ?_(D>'_^P?;_ /HM:W:PO ?_ ")'A_\
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M_P!@Y?\ T&"OCN(OXF7_ /7^/_I$SWLK^#%?]>W_ .E1/4Z***^Q/!"BBB@
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M\)YH7_/]_P"09/\ XF@#H**Y_P#X3S0O^?[_ ,@R?_$T?\)YH7_/]_Y!D_\
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M@R?_ !-'_">:%_S_ '_D&3_XF@#H**Y__A/-"_Y_O_(,G_Q-'_">:%_S_?\
MD&3_ .)H Z"BN?\ ^$\T+_G^_P#(,G_Q-'_">:%_S_?^09/_ (F@#H**Y_\
MX3S0O^?[_P @R?\ Q-'_  GFA?\ /]_Y!D_^)H Z"BN?_P"$\T+_ )_O_(,G
M_P 31_PGFA?\_P!_Y!D_^)H Z"BN?_X3S0O^?[_R#)_\31_PGFA?\_W_ )!D
M_P#B: .@HKG_ /A/-"_Y_O\ R#)_\31_PGFA?\_W_D&3_P")H Z"BN?_ .$\
MT+_G^_\ (,G_ ,31_P )YH7_ #_?^09/_B: .@HKG_\ A/-"_P"?[_R#)_\
M$T?\)YH7_/\ ?^09/_B: .@HKG_^$\T+_G^_\@R?_$T?\)YH7_/]_P"09/\
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M>'_^P?;_ /HM:W:X?P9XTT:U\'Z'!+>;)8[&%'7RG."(P"/NUL?\)YH7_/\
M?^09/_B:[\M_W*A_@C^2.;%?[Q4]7^9T%%<__P )YH7_ #_?^09/_B:/^$\T
M+_G^_P#(,G_Q->B<IT%%<_\ \)YH7_/]_P"09/\ XFC_ (3S0O\ G^_\@R?_
M !- '045S_\ PGFA?\_W_D&3_P")H_X3S0O^?[_R#)_\30!T%%<__P )YH7_
M #_?^09/_B:/^$\T+_G^_P#(,G_Q- '045S_ /PGFA?\_P!_Y!D_^)H_X3S0
MO^?[_P @R?\ Q- '045S_P#PGFA?\_W_ )!D_P#B:/\ A/-"_P"?[_R#)_\
M$T =!17/_P#">:%_S_?^09/_ (FC_A/-"_Y_O_(,G_Q- '045S__  GFA?\
M/]_Y!D_^)H_X3S0O^?[_ ,@R?_$T =!17/\ _">:%_S_ '_D&3_XFC_A/-"_
MY_O_ "#)_P#$T =!17/_ /">:%_S_?\ D&3_ .)H_P"$\T+_ )_O_(,G_P 3
M0!T%%<__ ,)YH7_/]_Y!D_\ B:/^$\T+_G^_\@R?_$T =!17/_\ ">:%_P _
MW_D&3_XFC_A/-"_Y_O\ R#)_\30!T%%<_P#\)YH7_/\ ?^09/_B:/^$\T+_G
M^_\ (,G_ ,30!T%%<_\ \)YH7_/]_P"09/\ XFC_ (3S0O\ G^_\@R?_ !-
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M3_XFC_A/-"_Y_O\ R#)_\30!T%%<_P#\)YH7_/\ ?^09/_B:/^$\T+_G^_\
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M ,30!T%%<_\ \)YH7_/]_P"09/\ XFC_ (3S0O\ G^_\@R?_ !- '045S_\
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M_P#2V=!17/\ _">:%_S_ '_D&3_XFC_A/-"_Y_O_ "#)_P#$U]B>"=!17/\
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MD_\ B:/^$\T+_G^_\@R?_$T =!17/_\ ">:%_P _W_D&3_XFC_A/-"_Y_O\
MR#)_\30!T%%<_P#\)YH7_/\ ?^09/_B:/^$\T+_G^_\ (,G_ ,30!T%%<_\
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M3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\
MZ!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_
M^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M
M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG
M_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9
M_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#
M/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^
M$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?
MA/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1
M_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH
M_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
M"M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^
M@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$
M?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B
M@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_
M]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_
M *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_
M .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_
MPH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!M
MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?
MTO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X
M1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX
M3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\
MZ!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_
M^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M
M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG
M_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9
M_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#
M/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^
M$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?
MA/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"M"B@#/_X1
M_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "M"B@#/_ .$?TO\ Z!MG_P!^$_PH
M_P"$?TO_ *!MG_WX3_"M"B@#/_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
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M*T**H1G_ /"/Z7_T#;/_ +\)_A1_PC^E_P#0-L_^_"?X5H44 9__  C^E_\
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M &?_ ,(_I?\ T#;/_OPG^%'_  C^E_\ 0-L_^_"?X5H44 9__"/Z7_T#;/\
M[\)_A1_PC^E_] VS_P"_"?X5H44 9_\ PC^E_P#0-L_^_"?X4?\ "/Z7_P!
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MLT/_ ).#\0_]@Y?_ $&"O4Z\LT/_ ).#\0_]@Y?_ $&"OCN(OXF7_P#7^/\
MZ1,][*_@Q7_7M_\ I43U.BBBOL3P0HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** ,7QM_R)NO?]>%Q_Z+:N?^"?\ R332
M?K-_Z.>N@\;?\B;KW_7A<?\ HMJY_P""?_)--)^LW_HYZ^/J?\E+2_Z\3_\
M3D#WH_\ (HG_ -?(_P#I,CNJ***^P/!"BBB@ HHHH **** "O+-#_P"3@_$/
M_8.7_P!!@KU.O+-#_P"3@_$/_8.7_P!!@KX[B+^)E_\ U_C_ .D3/>ROX,5_
MU[?_ *5$]3HHHK[$\$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#%\;?\B;KW_7A<?^BVKG_@G_ ,DTTGZS?^CGKH/&
MW_(FZ]_UX7'_ *+:N?\ @G_R332?K-_Z.>OCZG_)2TO^O$__ $Y ]Z/_ "*)
M_P#7R/\ Z3([JBBBOL#P0HHHH **** "BBB@ KRS0_\ DX/Q#_V#E_\ 08*]
M3KRS0_\ DX/Q#_V#E_\ 08*^.XB_B9?_ -?X_P#I$SWLK^#%?]>W_P"E1/4Z
M***^Q/!"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH Q?&W_(FZ]_UX7'_HMJY_X)_P#)--)^LW_HYZZ#QM_R)NO?]>%Q
M_P"BVKG_ ()_\DTTGZS?^CGKX^I_R4M+_KQ/_P!.0/>C_P BB?\ U\C_ .DR
M.ZHHHK[ \$**** "BBB@ HHHH *\LT/_ ).#\0_]@Y?_ $&"O4Z\LT/_ ).#
M\0_]@Y?_ $&"OCN(OXF7_P#7^/\ Z1,][*_@Q7_7M_\ I43U.BBBOL3P0HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,
M7QM_R)NO?]>%Q_Z+:N?^"?\ R332?K-_Z.>N@\;?\B;KW_7A<?\ HMJY_P""
M?_)--)^LW_HYZ^/J?\E+2_Z\3_\ 3D#WH_\ (HG_ -?(_P#I,CNJ***^P/!"
MBBB@ HHHH **** "O+-#_P"3@_$/_8.7_P!!@KU.O+-#_P"3@_$/_8.7_P!!
M@KX[B+^)E_\ U_C_ .D3/>ROX,5_U[?_ *5$]3HHHK[$\$**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#%\;?\B;KW_7
MA<?^BVKG_@G_ ,DTTGZS?^CGKH/&W_(FZ]_UX7'_ *+:N?\ @G_R332?K-_Z
M.>OCZG_)2TO^O$__ $Y ]Z/_ "*)_P#7R/\ Z3([JBBBOL#P0HHHH **** "
MBBB@ KRS0_\ DX/Q#_V#E_\ 08*OZ_\ ''0O#NL7>FW-IJ+SVS[':*.,J3[9
M<']*\\TWXKZ19_%+5?$KV]Z;&ZM5@2-43S0P$8R1NQCY#W]*_+.(.(LIE7PE
M-8B-Z==.7DE&:=_1NQ]GE>58U4Z\G2=ITVEYW<6OP/H>BO.] ^..A>(M8M--
MMK344GN7V(TL<84'WPY/Z5Z)7W^7YI@\TINK@JJG%.S:[GS&*P>(P<E#$0<6
M]=0HHHKU#C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBHKJ[@L;>2XN9H[>",9>65@JJ/4D\"E*2BG*3LD-)MV1E>-O^1-U[_KP
MN/\ T6U<_P#!/_DFFD_6;_T<]6/%WC/P_=>$]:AAUW3999+*=$C2\C+,QC8
M  \DFL/X0>*M$TSX>Z9;7FL6%I<(9=T,]TB.N97(R"<C@BO@ZF.PO^L=*?M8
MV]C-7YE:_/#S/I8X>M_9,X\CO[2/1_RR/3J*IZ;K.GZS&[Z??6U\B'#-;3+(
M%/H=I.*N5]S3J0JQ4Z;33ZK4^;E&4'RR5F%%%%:$A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+
M^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_
M;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH N
MT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[
M_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_ +7_ +_+_C1_;6G_ //_ &O_
M '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\ /_:_]_E_QH NT52_MK3_ /G_
M +7_ +_+_C1_;6G_ //_ &O_ '^7_&@"[15+^VM/_P"?^U_[_+_C1_;6G_\
M/_:_]_E_QH NU4U32[;6M/GL;V+SK6==DD>XKN'ID$&F_P!M:?\ \_\ :_\
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M_MK3_P#G_M?^_P O^-;F9=HJE_;6G_\ /_:_]_E_QH_MK3_^?^U_[_+_ (T
M7:*I?VUI_P#S_P!K_P!_E_QH_MK3_P#G_M?^_P O^- %VBJ7]M:?_P _]K_W
M^7_&C^VM/_Y_[7_O\O\ C0!=HJE_;6G_ //_ &O_ '^7_&C^VM/_ .?^U_[_
M "_XT 7:*I?VUI__ #_VO_?Y?\:/[:T__G_M?^_R_P"- %VBJ7]M:?\ \_\
M:_\ ?Y?\:/[:T_\ Y_[7_O\ +_C0!=HJE_;6G_\ /_:_]_E_QH_MK3_^?^U_
M[_+_ (T 7:*I?VUI_P#S_P!K_P!_E_QH_MK3_P#G_M?^_P O^- %VBJ7]M:?
M_P _]K_W^7_&C^VM/_Y_[7_O\O\ C0!=HJE_;6G_ //_ &O_ '^7_&C^VM/_
M .?^U_[_ "_XT 7:*I?VUI__ #_VO_?Y?\:/[:T__G_M?^_R_P"- %VBJ7]M
M:?\ \_\ :_\ ?Y?\:/[:T_\ Y_[7_O\ +_C0!=HJE_;6G_\ /_:_]_E_QH_M
MK3_^?^U_[_+_ (T 7:*I?VUI_P#S_P!K_P!_E_QH_MK3_P#G_M?^_P O^- %
MVBJ7]M:?_P _]K_W^7_&C^VM/_Y_[7_O\O\ C0!=HJE_;6G_ //_ &O_ '^7
M_&C^VM/_ .?^U_[_ "_XT 7:*I?VUI__ #_VO_?Y?\:/[:T__G_M?^_R_P"-
M %VBJ7]M:?\ \_\ :_\ ?Y?\:/[:T_\ Y_[7_O\ +_C0!=HJE_;6G_\ /_:_
M]_E_QH_MK3_^?^U_[_+_ (T 7:*I?VUI_P#S_P!K_P!_E_QH_MK3_P#G_M?^
M_P O^- %VBJ7]M:?_P _]K_W^7_&C^VM/_Y_[7_O\O\ C0!=HJE_;6G_ //_
M &O_ '^7_&C^VM/_ .?^U_[_ "_XT 7:*I?VUI__ #_VO_?Y?\:/[:T__G_M
M?^_R_P"- %VBJ7]M:?\ \_\ :_\ ?Y?\:/[:T_\ Y_[7_O\ +_C0!=HJE_;6
MG_\ /_:_]_E_QH_MK3_^?^U_[_+_ (T 7:*I?VUI_P#S_P!K_P!_E_QH_MK3
M_P#G_M?^_P O^- %VBF1RI-&KQNLB-R&4Y!_&GT %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,>3PCI,CL[6F68Y)\Q_\:;_ ,(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
MC1_PA^D?\^G_ )%?_&MJB@#%_P"$/TC_ )]/_(K_ .-'_"'Z1_SZ?^17_P :
MVJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\ QK:HH Q?^$/TC_GT_P#(
MK_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\ C1_PA^D?\^G_ )%?_&MJ
MB@#%_P"$/TC_ )]/_(K_ .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_
M^-'_  A^D?\ /I_Y%?\ QK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&M
MJB@#%_X0_2/^?3_R*_\ C1_PA^D?\^G_ )%?_&MJB@#%_P"$/TC_ )]/_(K_
M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M .-'_"'Z1_SZ?^17_P :VJ* ,7_A#](_Y]/_ "*_^-'_  A^D?\ /I_Y%?\
MQK:HH Q?^$/TC_GT_P#(K_XT?\(?I'_/I_Y%?_&MJB@#%_X0_2/^?3_R*_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%17-S#9V\MQ<2I!!$I>261@JHH&223P !W
MH EHI <C(Y%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 445%<74-HBO/-'"K.L:M(P4%F(55&>Y)  [DT
M2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%12W4,$D,<DT<<DS%(D9@#(P4L0H[G )X[ F@"6BBB@
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ML*IV_0_BK]D_PE\/_P!C'QO\*/!6EK#:SZ#=[99 &GO+P1%EGF?'S.71.>@
M     YIO]R\0]EK%=[=7V7;S.FGI5C16[:3?:_1>?Y'JOP%\<#XE_!+P'XJW
M!GU?1+.\DP<XD>%2X_!MP_"N\KX^_P""4?CK_A,_V-?#=H\WG7.@7EWI,N3R
MH$AEC'X1S(/PK[!KTL0DJTFMGJO1ZK\#SL/_  HKMI]V@4445S'0%%%% !11
M10 5P>L?';P#X?\ BII'PWU#Q186OC75K=KJSTB1_P!Y(B]L]%9N2JD@L%;
M.#7=L"RD E21U'45^:7C#_@DKK?BC1_''BZ_^)%]JGQ@N]8EU/1=5DF*PB-'
M8PI,P 82.NP[TP(RJA054YCF<9*Z]U;]_E^?HK;LKEO%V>O3_@^73YGZ745\
M-_L._MQ:GXOUV;X+?&F%_#OQ>T5C:))?*(O[6V#H>WGXYXXD'S+W%?<E;2C:
MS3NGL^YG&5[IJS6Z"BBBH*"BBB@ HHHH *X[XM?%KPM\#_ 6I^,/&&IQZ5HF
MGIN>1N7E<_=BC7J[L> HZ_3)KL:^0_\ @IK^S1>?M#?L^S76B">;Q-X3=]6L
M;2-B5NT"8FBV="Y097C.5P/O&L*TG"#DO^&75_):FM**G-1?]=E\SB/V-_C1
M\=?VL/CGJWQ2E<>$?@9!%)IUAH5W#YGV\@G:T9R"95;EYONC_5J&Y*_>=?EC
MX _X*5>,_%WPJ^'/PW^!OPTAUOXHKIJVVHV_V/9IU@L/[L/'&C(H5@%?<S+'
M'N .[H-/5OVT/VN?V7+K3=:^.WPPT[4/!%U.L5Q=Z;Y/FPYQPLUO-)&C<\+*
MOSD$!AU'7)1BU36D5HF^NN]_-G-'FE>;^)ZM+II^B/T[HKFOAK\1-"^+7@/1
M/&'AF\%]H>L6RW5M-C!VGJK#^%E(*D=B"*Z6IE%Q;C+=%1DI)26S"BBBI*"B
MBB@ J&\O(-.LY[NZFCMK6!&EEFE8*D:*,LS$\   G-35\S?\%)=6U31?V*_B
M7/I+R1SR6L%O*T8Y$$ES$DP^A1F!]B:RJS=.#DMS6E#VE2,.YX+XY_X*NZMX
ME\::GX=^!'PBUCXH1Z><2ZK#%/*L@#$;TMX(V?RSCAV92?[OKWW[,?\ P4NT
MCXQ?$@?#;Q_X-OOA=X\E?R;6SOW9HKB7;GRCO1'BD(SA64@XP&R0I[+_ ()I
M^%?"_AS]COP'<^&HH/,U6W>\U.YC \R:\,C++O(Y)0KL&>@05\]_\%FM(T/P
M[X7^&?CNQ,.G_$"RUL0V=Y#A;B2W1&E))')$<JQ$$_=+G'WC71+EPU10J:JZ
M3?J[77IVZK7R,(7Q$'*&CLVODKV?]>1^D]%8'P_\50^.O ?ASQ);D-!J^G6]
M^A7IMEB5Q_Z%6_1.+IR<);H4)*I%36S"BBBH+"BBB@ HHHH ^8_VKOV[O#'[
M-.K6'A2PT2^\?_$?4E5[3POI!(D"L?E:5PKE=V#M549CCH <UY-\&?\ @J5_
MPD'Q:TWX>_%GX8:I\*-5U61(;&XOI)"OF2'$:RQRQ1NBL<*'&X9/(49(YS]B
M/PGKMU_P4$_:0U_Q;X=N[G4;6[FM[77;B+]U:HT^8X48]WM_)*XY")V#<YO_
M  6/U[2Y/^%/^'K;1+S4_%\FL-?6LEG:,TIMU 1H(W ^9WD:,A%R1L!(&5S-
M&22HSJ:^TM==DWT\TM?/M8=1-NK"&G)?7NTKZ^3>GZW/TJHK\^=&_P""L,WA
M?QUI>A_%[X)>)OA1I6H$+!JFI22NZ+D#S'ADMH24&<LR%B/[IK] +.\@U"T@
MNK69+BVG198IHF#*Z,,A@1U!!!S6G*^7FZ$<VO*]R:BBBI*"BBB@ HHI&;:I
M."<#.!U- &+XV\;:'\.?"NI^)/$FIV^CZ'IL)GNKRY;:D:C^9)P !R20!DFO
MQN_:3_;?^(7QL^('A/XE:1I>I:'\#_"?BVSCT]F&Q+V[C;SM\W/SN8XV.T96
M,$ \MEO</%'A_P")_P#P4T^.VH>']6L-7^'7P)\%ZDUO>VMU&8;J]N8S@J5/
M#3D?58E;/+,-WMG_  4/^!>A:7^P+KWASPIHUOIFE^$A:ZA86=LN%A2*4+(W
MJ6\N24EB<DDDDDFLE/V48XJ?1Q:7E=/FE\M8K_MY]#7E4Y2PT>MTWYV:Y5\]
MW\NY]F6]Q'=6\4\3!XI%#HPZ$$9!J2O(?V1/'1^)7[,?PR\0O-Y]Q<Z%;1W$
MGK-&@BE_\?1J]>KJK0]G4E!=&T<M*;J4XS?5(****R-0HHHH **** "N#T+X
M[> ?$WQ0UKX=:7XHL+SQGHT"W%[I,;YDB5NP/1F7C<JDE=R[@,BNA\;:+?\
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MZ/8O>C2=,4-<3A<#('4*"06;!VJ"<'&*B<E"+E+9%1BYR48[LY;]I_\ :?\
M"/[*_P .9_$_B>?SKN3=%IFD0N!<7\^.$0=E'!9SPH]20#^>G[('Q]^*/BG_
M (*#:!KOQ5@NM*D\?^&[E='TZ;*00V)+36XAC)RJEK5L%L,V=W.X$^B_LP_L
MP^+_ -K[XCP_M#?M#0F739"LOACP?,I$ A!W1N\9Z0CJJ'F0_.V5(#ZO_!2)
M3\+_ -I;]FGXKP@6]O9:Q_9=]< 8Q")HW"GV\N2Y_6MJ<'2K4_:_%)\MOY5)
M-?.3;7IMU9G4DJE*HJ6T5>_\SBT__ ='Z[]C]$:*0'(R.12U!04444 %%%%
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MMXHXG88P&E;*YR >AQG%U8>PCHK6UV2=_P NQK&2A/VTM[WTW;5OS[_,[/\
MX(K66I0? 'QI<3+*FD7'B1C9>8#@E;>(2$=L?<''=37Z&UR/PG^%GAWX*_#W
M1?!GA2R^P:'I4/DPQDY=SDEI';^)V8EB>Y)KKJ[*TE*5X[))?<K'+3BXQUW;
M;^]W"BBBL34**** "J^H:?;:M87-C>0)<VES$T,T,@RLB,"&4CN""15BBDTI
M*SV&FT[H_-&?]BW]HK]D/XA:SJ_[,^OV.M^"]8G$TGA?6)XU,7)PKB8A&"C
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ME/VL857]J,7\[*_XW%&*ISG3723_ #NOP84445F6%%%% !7E/[4WQ'UOX/\
MP"\7^-O#T<$^JZ#;QWZ07*EHY8TF0RQMCD!H]ZY'(SGM7JU>7_M1:"?$_P"S
M;\4=+5=[W7AG441<$Y;[.Y7I[@5AB).%*4XNS2;^XVHQ4ZL8OJT4_P!F7]IK
MPA^U-\.;?Q3X6N/+F3;%J6DS,#<:?/C)C<=P>2KCAASUR!ZY7XX?!?X,^.O@
MU\!/AW^T[\!Y)[R]6PDB\8>$W9Y8]0BAGDCDD5,Y9<1Y91RI&],8(K[N^!__
M  47^$/QTUKP7X=TK4;NT\6^);>63^R);9V^Q31C+0RR ;<L Y1AP0G.TD ]
MTXIU)0C\2=FOU7>+MH_D]=^*G*2@I3V:NG^:?:2ZKYK0\Z_;@_8?U7Q3K\/Q
MK^"DS^'?B[HKB[EAL2(_[5V#J.WG[<CGB095NM=]^P[^V]IG[4?A^XT/7;=?
M#WQ1T--FKZ+(IC\W:=C3PJW(7=PR'E&.#P03]45S.@?#3PKX5\5:]XETCP_I
M^G:_KS1MJFHV\"I-=E!A=[#K@?F>3S7/3_=WA]GMV?EY=U_2WJ>_:7VOS7G^
MATU%%%, HHHH **** /D[X0_MP:7JG[2OCSX'^.)(-)\2Z;K,\.@7S?)#J5N
MQWQP'/W9E1@!V<#CYOO?4NL:19>(-)O=+U*VCO=/O8'MKFVF7<DL;J59&'<$
M$C\:_+/XL?LHZ3^T1_P4 ^.GA.>^FT+Q+)H-CXB\/:O"S@6]PD=M&=Z@_,C%
ML$CD8!&",'TSX'_\%#KGX(Z?XA^&_P"TY'>:)X[\(VY:#4T@,QUR%>$"XX:5
MAC:^0KCDE2&S%/EJ4(*I\3CK_>M=/YW3NBI\T*\G#:^GE>S7RU5GT>A]6_LN
M_LXZ%^R_\-IO".A;989-3N[Y[HK^\E625C"'/\3)"(H\]]F>]>"_\%=]=\-Z
M?^R+?Z?K#0-K.H:G:+HT3X,GGI(&D=.X B\P$_[8'\5>U_%_7?''QB_9SAUG
MX!:Y:6/B#78K2\TK5]07RD2W9U=V*R1OAB@*X9/XO:OE3X4_\$T_'OQ ^*%E
MX_\ VF_'\?CNXT]U>UT&UN)+B%\$,%D=T14C#<F*-,-GENH+J0E6E[.II9J[
M?E;9=>P0G&FO:1UO=I+SO]V]SZU_8WTK5-$_95^%-EK*R1ZC#X=LQ)'*"'0&
M,%%(/0A2H_"O9*:JK&JJJA548"@8 'I3JWJS]I4E/NVS&G'V<(P[*P4445D:
M!1110!\S?MC_ +6$W[).L?#;7=0L3J/@O6+ZXTW6HX5S/#E$>*>(]RFV3*$_
M,">X!'H/Q&\!^ OVQO@//I$U['K7A'Q':I<6>J:?("T; [HYHSV=&'0CL58=
M17S?_P %>M#M+_X >#M2O[<7.GZ;XPLI+N,EAN@>.9'&5((SD#\>M>7*?&7_
M  2J^)*SQ?VAXO\ V:/$MV&*\R3Z',_?V8#Z+*H[.,UG!1J1E"KLY63\[1=F
M^FK]U]'IVM4W.G*,Z?\ +=KYR5UWM;5=K-=;V?!O[-/[;G[.-C+X+^&WC_P[
MKW@F-G73IM1,1:T1FX8)/$S1D=?+5I$&3@$FO+_VP/V$_$?P_P#V:_%'Q?\
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MI^TA)QWDFU9=KM?C^(OA;X)_M^?#C0X_ VA?$'PQ>:!;JMM9:U>2Q326T(X
M#2VYEP!@897*\!3@5XS^U=^R9)^QMX?^%'Q9U+Q'?>,O'_\ PF,=YXBUZXD<
MB>7Y9XU0,2=JF"3YF^9BY)P,*OZ0_LB_M2:%^UG\)X/%NE6S:9J-O*;/5=)=
M][6ER "0&P-R,"&5L#(.#@@@;/[27[.GAK]J+X:OX)\57.H66F-=PWHN-+>-
M+A'C)QM:1'49#,#\IX)K6?M*4U/>:<7?K:Z>_FOO(I^SJ1<=HM-67>S7X?@>
MG6=U%?6D%S"P>&9%D1AT*D9!_(U-67X6\/P^$_#.D:';SW%U;Z;:0V<<]TP:
M:18T"!G( !8A020!SVK4I2Y>9\NQ,.;E7/OU"BBBI+"BBOBK]OC]H;XF:+KW
MA[X)?!_P[JC>./&4#$>(5B*0VUODK(()3P)%'+R9_=*0?O,"LR;NHQ5V]$BH
MI.[D[):MG'?MU?MS:XNM7WP3^!$=QKOQ FBE75]6TOYSI<:(6ECB8<"4*#N?
M.(QQG?\ <]1_X):^/G\>?L;>%%N)_M%YHUQ=Z5.S'+?),SIG/?RY$KH_V-_V
M*O#/[*O@6:!_+UWQKK$7_$[UZ1<M*3R88L\K$#^+'YF[ >!_\$I)F\ ^+OC_
M /"2;='_ ,(WXE,]O&W4H6D@8C\+>+_OH5K3BH2G2;YFXWOYIJ]O)*7YLSJ2
M<XQJI62E;Y-/?S;2_ _0R.-8HU1%"(HPJJ, #T%5X=,L[:^N;V&T@BO+H()[
MA(U$DH4$*&8#+8!.,],FK5?''[3/[!OC+XZ?%I/'7A[X]^)? \Z6WV2*Q@MV
M9+2/@LL#0S0%58@$AMQ)ZM@ #)MW6A=E9ZGD'[=$>D^,/V_OV<=&\'^1<>/K
M'48I]8>SQYL-JD\4T8F8?W8TN7VGD*V>C#/Z35\W_LI?L,>"?V69+W6;:[N_
M%OCK4E*WWBC5@#,X8Y=8ER?+5FY/+,3U8X 'TA6BM3I1I)WLV_G+_*Q,FYU'
M4M;1+[O^'^X****D8445YY^T!\7XO@-\'_$OCN;1;_Q FCVQG_L_3HRTDAR
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M/O'V@?"_P=JOBKQ1J<.D:#I<)GNKR?.U%'& !RS$D * 220 "37P/KW_  6
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M72K+7=,N]-U*TAO]/NXF@N+6YC$D<L; AD93P002"#ZU^<O[=7[$<OPLN/\
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M<X R<#A0  !@5Z/111*3D[L:2BK(****D84444 %%%% !1110 4444 %%%%
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M^[_1=C+64N=JW9=E^K_I>91114E!1110 4444 1Q6\4#2M'$D;2MOD*J 7;
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MX$LEU:QG9'+-M&T,<'!!^9=I8*Q(KW"BBMI2<WS/<QC%07*M@HHHJ"PHHHH
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M&.T4E]RL8QYFY3EO)M_>%%%%9EA1110 4QHT:17**74$*Q'(SUP?P'Y4^B@
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M$K_^S5T=?.W_  3[N/$+?LB_#ZR\4Z/J6A:UIMK)I\EGJEI);3".*5TA;9(
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M72O 'PXCEC;4M)\/O";G40A!Q^Z+@Y(_CDVJ<,(V(%?HU12@E!*.Z6R>J7_
M\MBI2<FY;-[M;O\ KON?G#_P3;TNW^"W[5G[1WP?M]UOI]G>)?:9:R.S%;>.
M5U4Y/)/EW$&2<DX%?H]7B.@_LG^&?#O[4&O?'*TU758_$>LV*V%QIJO$+)D$
M<2%BNS>6_<H?O 9'2O;JI2;ITU/62BD_5:?E8AQ2J3<?A;NO*Z7ZW"BBBD,*
M*** ,;QEXRT3X>^%]2\1^(]3M]'T/386N+N]NFVI$@[GU)X  Y)( !)I/!GC
M30_B'X7TWQ'X;U.WUC0]2A$]K>VK;DD0]_8CH0>0000"*^=/VTOV1?$'[6FL
M_#_21XSN-!\ :?=2S^(-+AX:Y "F)X^,&3AD^?*J'W $@AODVPOO'O\ P27^
M+2V%^U_XQ_9V\27?[FXQNEL)#UX& DZ@<KPLRKD88$(J;4FU4=KZ+_@]K]/3
M7?1S323AK;5_\#O;KZZ;:_=/[87[-.G_ +57P3U3P;<31V6JHPO=(U"1<BVN
MT!"%N^Q@S(V.SDCD"ODS]BG]N2?X1WA^ ?[0LC>$?%'AUA8:;K6J$)!+"H C
MAGDZ#"XV3$['3&3G!?\ 0?P7XTT3XB>%M,\2>&]3M]8T34H5GM;VV;<DB'^1
M'0@\@@@X(KS3]HK]D?X9_M1:3%;>.-#\W4+="EIK5B_D7UJ#GA9 #N7))V.&
M7/.W-"4J,Y::/=>:ZKSZ!>-6"UU6S]>GIU.\\?>.?"O@_P"'^J^(O$VJV-IX
M6BM&DN+NYE7R7B*G@'.&+9P ,EB0!G-?!W_!%FRNE^&?Q/OXH98/#UUX@C&G
MK)TW+%\^/4A6A!/M4-G_ ,$3? B:^KW?Q(\2W/AQ3N734MX$GSGG]_@KTQTB
M%??/PU^&OAOX0>"=+\)>$M+BT?0=-C\NWM8LGOEF9CRS,226)))))JZ:47.?
M622M\[Z_H1.\E&'9WO\ )K3[]?D=/1114E!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "N=^(7P]\/?%3P;JGA7Q5I<&LZ#J<1AN;2X&
M0PZ@@]58'!##!4@$$$5T5%*45)68TW%W1^5-C?>/?^"2_P 6UL+]K[QA^SMX
MDO#Y-QC=+82']$G51RO"S*N1A@0GZ>>#/&>B?$/PMIGB3PYJ4&KZ'J4*W%K>
MVS;DD0]_8CD$'D$$'!%0^/O 'AWXI>$=2\+^*])M];T'48_*N;*Z4E7&<@@C
M!5@0"&4@@@$$$5HZ#H.G>%]%L=(TBQM],TNQA6WM;.UC$<4,:C"HJC@  =*M
M2;ARSU:V?EV?IT?;Y$RBN?FAHGNO/NNU^J[[%^BBBI&%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117
MG'Q\_: \&_LV?#VY\8>-;][73HW$,%O;IYEQ=S$$K#"F1N8@$\D  $D@ FIE
M)15V5&+D[(]&+!2 2 6X ]:_(_\ :6UKX;ZU_P %"/&,/[3VH:O;> ]#TN'_
M (1G2H(KEK:Y5HXSU@^<!F,K$KC++AF 7:=;X\>(?VAOVNM4\$?&+X/_  R\
M:>$[7PWOGTFZNM<M%CNXFR?/2R<HQ9U^4X\Q9$(7D=?IK]F/X\?#7]N+2$TW
MXC> ] _X6QX4W1:EX?\ $6DQ336SJP5YK99U+*A<#<OWD;"MGY6:HTY2DIM:
MQOH^S5N9>:_ 4I*,7%/25M5WO?E?D_Q_/S&'_@JMX3TW1[5M'^"7C*X^#MDL
M>ER^)I+<"W@B $2ILVM&PQM7:TP)SC&>*W=?_P""4?[/7QHFMO&OAG4/$'AW
M1M<@2_@MO#UY"MD\<JAU>-)H79 0P.T$*. %&,5D?MC>*?C?^T-J^O?L\_#?
MX/ZAHG@^2Y@M;OQQJL,MO83VR&-V\DO$B*BN,91I&=4.U>:^W?A/X!@^%7PP
M\)^#;:X:[@T'2[;35N'&#+Y4:IO([9(SCWIQY:D'5EO?1]6K:M_.UOGO8EWI
MR5-;6U2V6UK>=KW^7H<G^SO^R]\/?V7_  O+HO@72&M3=%6O=2NY/.O+UE&
M99,#@<X50JC)PHR:]8HHIRDY.[!1459!1114C"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=_!'5-3CEG\&6^JW,>I1J"4+$P, <'J8TF [\-7CW[%/[:47[.O@_P >>#/
M7PW\5?%::3Q)=:EI]KINX0V^G[4C21W2.5PQ$>3F,#H<YR*^Q_A5^T!\(_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLW^)/VE/V?[;2?!NEC6/%6E:O!?V=I]HA@,J%7BE7?*RH,+)NY89V>M?G/\
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M \F[22&20+)PAR>?,0G&"*^CZ*F,5&BZ&\7_ %^6G_!U*E)RJJMM)?U^>O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH _%W_A?GQ._P"BC>+?_!Y=?_'*
M/^%^?$[_ **-XM_\'EU_\<K@Z*_IGZKA_P#GVON1_/'UJO\ \_'][.\_X7Y\
M3O\ HHWBW_P>77_QRC_A?GQ._P"BC>+?_!Y=?_'*X.BCZKA_^?:^Y!]:K_\
M/Q_>SO/^%^?$[_HHWBW_ ,'EU_\ '*/^%^?$[_HHWBW_ ,'EU_\ '*X.BCZK
MA_\ GVON0?6J_P#S\?WL[S_A?GQ._P"BC>+?_!Y=?_'*_3G]C?7]4\4?LW^$
M-3UG4;O5M2G^V>;>7T[332;;R=5W.Q).%  R>  *_(JOUF_89_Y-9\$_]OW_
M *77%?"\84:5/ 0<()/G6R_NR/L^%:U2IC9J<FUR/=^<3WBBBBOR _5 HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \>_:$UW4M%_L#^S]0NK#S/M&_[+,T>_'EXSM(SC
M)_.O'O\ A.O$G_0P:K_X&R__ !5>I_M+?\RY_P!O/_M*O$*_DGCK&XJCQ%B8
M4ZLDER:)M+X(G[?PWAZ,\KHRE!-^]T7\S-S_ (3KQ)_T,&J_^!LO_P 51_PG
M7B3_ *&#5?\ P-E_^*K#HKX/^T<;_P _I?\ @3_S/I?JN'_Y]K[D;G_"=>)/
M^A@U7_P-E_\ BJ/^$Z\2?]#!JO\ X&R__%5AT4?VCC?^?TO_  )_YA]5P_\
MS[7W(W/^$Z\2?]#!JO\ X&R__%5V'PB\6:WJ7Q#TFVO-8U"ZMW\[=#/=.Z-B
M%R,@G!Y /X5YG7<?!7_DIFC?]MO_ $3)7O</X_%SSC!QE6DTZM/[3_F7F>9F
M>&H1P-=J"OR2Z+LSZFHHHK^U#^?@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTMW,4JE3'-;2@ M%+&>489'L0002""?!_P!LS]OG_AD;QYX0\-_\(+_PE?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]KBP_9#^%4>O_8$UGQ'JDYLM(TV1RD;RA2S22$<^6@P2!R2RKD;MP^-_ ?\
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MU&';^J)_WZB_%$U?]ZDO[L/R84444RPHHHH \0_:6_YES_MY_P#:5>(5[?\
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M2""""U8CB3RXI)3(0?X<J#Z]J^W/^&0/@9_T1WP+_P"$]:?_ !NMOPG^SO\
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M4.&QD=1R*AIU%1H/WHN37KN^6_E;\[[FD;0E5K[-13_)7M\^G96V/K#]F_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^3C_ ()_]>P_]+%K]8Z**FG^[HJE_>D__ G?\!27-5=7NHK_ ,!O^=S\BO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **X35_CU\,_#^IW.FZI\
M1?">FZC:N8I[2\URUBEB<=5=&<%2/0BNOT?6M/\ $6EVVI:5?6VIZ==()(+R
MSF66&5#T9'4D,/<&JY96YK:$\T6^5/4N4445)04444 %%%% !1110 4444 %
M%%% !1110 45S_BSXA>%O <<4GB;Q+H_AV.7_5MJU_%:A_H9&&:/"OQ"\*^.
MXY'\->)M'\0I']]M*OXKH+]3&QQ5<K:YDM">9)\K>IT%%%%24%%%% !1110
M4444 %%%% !116)XO\;>'_A_HSZMXEUJPT'3$8(;K4+A88]QZ*"Q&2>P')H
MVZ*YSP/\1_"WQ*TV2_\ "GB'3?$-G$_ER2Z=<I,(VQG:VT_*<<X.*Z.FXN+L
MT3&2DKQ=PHHHI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA_:.^%%]XG\2V>F6-_!JLMBL>E121Q&-8XF!(DD<[LN>^.G%-8:HZ/M_L_\
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M8T'B8N\5^?\ PY\;Z/IWC7]I3XM6MC]KF\0>+O$%SM^T7LW4X+,S'^%$4$X
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MW'9E8%3].,C!KY1_:^_X* ZY\!_&UWX*\/>#%_M:&))?[5UQR;>1'&0T44;
MNO4;BZX*D%>*X(T:DJOL4O>['I2Q%*-'V[?N]_4^VJ*_&6^_X*-?'R[O6GB\
M8V]E$3D6T&CV9C'L"\3-C_@5?5'['G_!1"_^*7C&R\#_ !%M;*VU74#Y6G:Q
M8H8DGEQQ%*A) 9N<,N!G VC.:[YY9B(QYM'Y=3S:>;X:<^35>;V/O*OS>^//
M_!2CXB?#7XQ^+O"N@Z+X5NM)T>_DLX)KVUN7F;9@-N*W"J3NW=%%?2'[;W[2
MWB+]F;P5X>U?PYIVEZC<ZE?M:2+JB2.BJ(V;(".ASD>M?COXP\47GC?Q9K/B
M'41&M_JMY->SK""$#R.78*"20 3QDDX[FJRW"^VFZDU>*NOGI^AGFV,]A!4J
M;M-M/Y:_K8_H(\-ZC+K'AW2[^956:ZM8IW6,$*&9 Q R>F37QG_P4T^!WCOX
MK:#X1U;PCIUWK]IH[7"WFE6*F2?,FS9*L8Y?&QE.T$C<.,9QY)\!_P#@H]\2
MO%7Q#\">";O0_"D>E7U_9Z5)-#:7(G$3.L98$W!7=CN5(SVKZ6_;H_:B\5?L
MR:+X3O/"^GZ/?RZM<3Q3C5X99%4(J$;?+E3!^8YSFHJ8>IAL3"44M9/E_KT9
MK3Q5'&86<)-V4?>_X'W'B_\ P3+^ /Q#^'?B[Q-XH\4:+J'AC1KK3Q8Q66IQ
M-!-<S>8KA_);# (%8;F SYG&><?H57Q_^PQ^V#XR_::\1>*K#Q1IFA6$.E6L
M,\#:1;S1LS.[*0WF3/D8 Z8KVO\ :+_:*\-?LV^!CK^O;[NZG8PZ?I<! ENY
M<9P"?NJ!RS'H/4D SCW5G62J+5I62*RU4:>';I2O&[;;/5:*_'[QM_P4Q^-7
MB35GGT74]/\ "5CN/EVECI\-Q\O;<\ZN2?<;1["O4?V=?^"G^OIXCLM%^*T-
MI?Z3=2+%_;]G ()K5B<;Y47Y'0<9VA2!D_-TJ_[+Q'+S65^W7_+\3/\ MC"\
M_+=V[VT_S_ _3"BJ.I:A]GT6ZOK=HY0ENTT;9W(V%)!XZ@^U?FG\-O\ @JEX
MVU/QYH5IXQTKPKIOA>:Z2/4;RRLKH30PGAG7-P_(Z_=/TKBH8>IB'*,/LVO\
M[_Y'H8G%4L+&,JCTE>WRM_F?IU17Y7?''_@J%XX\0:]<6OPU2#PMH,+[8;VZ
MM8[B]N /XF$@:- ?[H4D?WNPV/V8/^"DOC.?X@:5X>^)US::UHNJ7"VO]K+:
MQVT]G(Y"HS"(*C1Y(!^4$ YSQ@]<,MQ$X<]OEU.&>;86%3DO?SZ'Z<U^<G[0
MO_!2+XA_"WXT^+?"6@:+X5N])TB\^RPS7UK<O,V%7=N9+A5)W;NBBOI#]MK]
MI#Q!^S/\/]#UWP[IVFZC=W^I_8G35$D:-5\IWR CJ<Y0=_6OQV\=>,+_ .(7
MC/6_$VIK"FHZO>2WUPMNI6-7D8L0H))"@GC)/'>M,MPOMINI-7BDU\]/T,LV
MQGL*:I4W:;:?RU7YV/W[\&:S-XB\'Z%JURL:7%]8074JQ A SQJQ"@DG&3QD
MFMFOR[^!?_!1[XE:MXR^'_@:;0_"BZ3<WUAHSS1VER)Q"TD<)8,;C;OVG.=N
M,]NU?;/[57[3NC_LQ^!8=5N[7^U=;U!V@TS2U?9YS@99W;!VHN1DXSR .M<^
M*PM2C46GQ-VM_7F=6#QM.O2O?6*5V_3_ (![717XX>)/^"DWQUUO4GN;'Q%8
M>'[<GBST_2K=XU_&=)'_ /'J]W_93_X*+>//'7C[1?!/BSPU'XKFU.401:AH
MT2P749P2TDD>1&R #)(V;0"><8K9Y7B%'FT]+_TOQ,(YQA93Y=?6VG^?X'Z,
M4445Y)[84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7D_[6'_)L_P 3O^Q?O/\ T4:]8KR?]K#_ )-G^)W_ &+]Y_Z*-)[#6Y^4
M'["UX+3]JSP"'4/%<7$]K(C?=99+:5"".X^:F?M#?#K6/V3_ -I2Y31GDLDL
MKU-8T*Z'3R2^^,>^T@H1WVGUK-_8W_Y.B^&O_88B_D:_1C_@HU\ _P#A:_P;
M?Q+IEMYOB+PH'NTV#+36A'[^/WP ''^X1WK[#%XCZMB:51[.Z?I?1_)O[FSX
M7!8?ZWA:M);JS7K9Z?-?C8^1O^"A7CJR^+EC\'O'^G@+;ZYH$NZ,-GRI8Y1Y
ML9]U=V7\*^HO^"57_)NFK?\ 8Q7'_HBWK\N;WQI>ZAX'TOPQ<?O+/3+VXO+5
MRQRGG+&)$QZ9B5OJ6]:_4;_@E5_R;IJW_8Q7'_HBWJ,115#!5*:VN[>CE?\
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MFD^([:$^;%#JUC%=)&Y&-RB12 <'&17X">*H8[?Q1K$42+%%'>3*B( %4!R
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17CUA
M?:[J%Q)%;W]T[J,D&X(XSCN:O_9?%/\ S]W'_@3_ /7I >I45Y;]E\4_\_=Q
M_P"!/_UZ/LOBG_G[N/\ P)_^O3 ]2HKRW[+XI_Y^[C_P)_\ KT?9?%/_ #]W
M'_@3_P#7H ]2HKRW[+XI_P"?NX_\"?\ Z]'V7Q3_ ,_=Q_X$_P#UZ /4J*\M
M^R^*?^?NX_\  G_Z]'V7Q3_S]W'_ ($__7H ]2HKRW[+XI_Y^[C_ ,"?_KT?
M9?%/_/W<?^!/_P!>@#U*BO+?LOBG_G[N/_ G_P"O1]E\4_\ /W<?^!/_ ->@
M#U*BO+?LOBG_ )^[C_P)_P#KT?9?%/\ S]W'_@3_ /7H ]2HKRW[+XI_Y^[C
M_P "?_KT?9?%/_/W<?\ @3_]>@#U*BO+?LOBG_G[N/\ P)_^O1]E\4_\_=Q_
MX$__ %Z /4J*\M^R^*?^?NX_\"?_ *]'V7Q3_P _=Q_X$_\ UZ /4J*\M^R^
M*?\ G[N/_ G_ .O1]E\4_P#/W<?^!/\ ]>@#U*BO+?LOBG_G[N/_  )_^O1]
ME\4_\_=Q_P"!/_UZ /4J*\M^R^*?^?NX_P# G_Z]'V7Q3_S]W'_@3_\ 7H ]
M2HKRW[+XI_Y^[C_P)_\ KT?9?%/_ #]W'_@3_P#7H ]2HKRW[+XI_P"?NX_\
M"?\ Z]'V7Q3_ ,_=Q_X$_P#UZ /4J*\M^R^*?^?NX_\  G_Z]'V7Q3_S]W'_
M ($__7H ]2HKRW[+XI_Y^[C_ ,"?_KT?9?%/_/W<?^!/_P!>@#U*BO'9[_7K
M?4$M)+^Z%PQ4!1<''/3OBM#[+XI_Y^[C_P "?_KT@/4J*\M^R^*?^?NX_P#
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M^[C_ ,"?_KT?9?%/_/W<?^!/_P!>@#U*BO+?LOBG_G[N/_ G_P"O1]E\4_\
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M45Y;]E\4_P#/W<?^!/\ ]>C[+XI_Y^[C_P "?_KTP/4J*\M^R^*?^?NX_P#
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M^O1]E\4_\_=Q_P"!/_UZ /4J*\M^R^*?^?NX_P# G_Z]'V7Q3_S]W'_@3_\
M7H ]2HKRN2'Q1'&SM>7 51D_Z3_]>J>F7FOZGYGV:_NGV8W;K@CKG'4^U(#V
M"BO+?LOBG_G[N/\ P)_^O1]E\4_\_=Q_X$__ %Z8'J5%>6_9?%/_ #]W'_@3
M_P#7H^R^*?\ G[N/_ G_ .O0!ZE17EOV7Q3_ ,_=Q_X$_P#UZ/LOBG_G[N/_
M  )_^O0!ZE17EOV7Q3_S]W'_ ($__7H^R^*?^?NX_P# G_Z] 'J5%>6_9?%/
M_/W<?^!/_P!>C[+XI_Y^[C_P)_\ KT >I45X[<7^O6]\EK)?W0G8J HN#CGI
MWQ6A]E\4_P#/W<?^!/\ ]>D!ZE17EOV7Q3_S]W'_ ($__7H^R^*?^?NX_P#
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M>C[+XI_Y^[C_ ,"?_KTP/4J*\M^R^*?^?NX_\"?_ *]'V7Q3_P _=Q_X$_\
MUZ /4J*\M^R^*?\ G[N/_ G_ .O1]E\4_P#/W<?^!/\ ]>@#U*BO+?LOBG_G
M[N/_  )_^O1]E\4_\_=Q_P"!/_UZ /4J*\BU*X\0Z;"KW-]<HC-M!6X)Y_ U
M-:KXFNK>.6*\N&C<94FX[?G2 ]7HKRW[+XI_Y^[C_P "?_KT?9?%/_/W<?\
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MC[+XI_Y^[C_P)_\ KT >I45Y;]E\4_\ /W<?^!/_ ->C[+XI_P"?NX_\"?\
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MV@XX&3WQ6A]E\4_\_=Q_X$__ %Z0'J5%>6_9?%/_ #]W'_@3_P#7H^R^*?\
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MC[+XI_Y^[C_P)_\ KT >I45Y;]E\4_\ /W<?^!/_ ->C[+XI_P"?NX_\"?\
MZ] 'J5%>.V-_KU_<O#!?W3RJ"6!N#V..Y]ZT/LOBG_G[N/\ P)_^O2 ]2HKR
MW[+XI_Y^[C_P)_\ KT?9?%/_ #]W'_@3_P#7I@>I45Y;]E\4_P#/W<?^!/\
M]>C[+XI_Y^[C_P "?_KT >I45Y;]E\4_\_=Q_P"!/_UZ/LOBG_G[N/\ P)_^
MO0!ZE17EOV7Q3_S]W'_@3_\ 7H^S>*1_R]W'_@3_ /7H ]2HKQ[3;[7M2D=;
M:_NG91D[K@C^9J_]E\4_\_=Q_P"!/_UZ0'J5%>6_9?%/_/W<?^!/_P!>C[+X
MI_Y^[C_P)_\ KTP/4J*\M^R^*?\ G[N/_ G_ .O1]E\4_P#/W<?^!/\ ]>@#
MU*BO+?LOBG_G[N/_  )_^O1]E\4_\_=Q_P"!/_UZ /4J*\M^R^*?^?NX_P#
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M_P#KT?9?%/\ S]W'_@3_ /7H ]2HKRW[+XI_Y^[C_P "?_KT?9?%/_/W<?\
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M3?\ D'VO_7)?Y"N;\>_ZNR^K_P#LM=)IO_(/M?\ KDO\A2Z@6****8!1110
M4444 %%%% !5;4O^0;=_]<G_ /035FJVI?\ (-N_^N3_ /H)H YWP'_JKS_>
M7^M=77*> _\ 57G^\O\ 6NKI( HHHI@%%%% !1110 4444 %%%% !7%^./\
MD)6O_7/_ -F-=I7%^./^0E:_]<__ &8TF!VE%%%, HHHH **** "BBB@ HHH
MH *Y+Q]_RX_]M/\ V6NMKDO'W_+C_P!M/_9:3 Z:Q_X\K?\ ZYK_ "%3U!8_
M\>5O_P!<U_D*GI@%%%% !1110 4444 %%%% %35O^05>_P#7%_\ T$U@^ _^
M/>[_ -Y?Y&M[5O\ D%7O_7%__036#X#_ ./>[_WE_D: .IHHHH **** "BBB
M@ HHHH H:]_R!KS_ *Y-_*LGP+_R#[C_ *Z_T%:VO?\ (&O/^N3?RK)\"_\
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MHHI@%%%% !1110 4444 <7-_R/0_ZZ+_ .@"NTKBYO\ D>A_UT7_ - %=I2
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M_D: .9\ _P#+]_VS_P#9JZVN2\ _\OW_ &S_ /9JZVD@"BBBF 4444 %%%%
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M:_S=D93JQIRA"6\KV^2NSZ*HHHK(U"BBB@#B]8_Y'.W_ .ND7\Q7:5Q>L?\
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M** "BN%^,WQF\-_ CP1/XH\32S"SCD6&.WM%5Y[B1CPD:LR@G )Y(  )K)^
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M<?\ /[MSFCC,/*7(I;Z>7W[?B>ZT445R':0WO_'G/_US;^5<OX!_Y?O^V?\
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M"I (((-:U,/5I1YI+3[_ ,C*EBJ-:7+!Z]M5^9NT445S'48WB[_D!3_[R_\
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MB;4-VV6U\-K'=&#_ 'W,BH#D8V[BP]*]XTO4(]6TRTOH598KJ%)D5P P5E!
M..^#6KISC!3:T9DJL)3=-/5%JLWQ'_R [S_<_J*TJS?$?_(#O/\ <_J*R-3/
M\#?\@F;_ *[G_P!!6NBKG? W_()F_P"NY_\ 05KHJ "BBCIR: "BOE7X@?M\
M:1IGC*Y\*_#KP7K'Q3UFT+"X&D;EA&TX;8R1R,^#P2$V^C&M;X-_MQ>&OB-X
MP3P;XGT'4OAWXQD<1Q:;K'W)9",B,.50ASV5T7.0 23BNJ.%K2CSJ.F_R]-S
MCEC*$9\CEKMY7[7VOY'TI1117*=@5D>+/^0!=?\  ?\ T,5KUD>+/^0!=?\
M ?\ T,4 0^#?^0*O_71JW:PO!O\ R!5_ZZ-6[0 444V21(8WDD=8XT!9F8X
M ZDF@!U%?)7BS_@H)83>*KO0?AC\/]<^*=Q9$BXN-+#I#@'!9-D4K,N>-Q50
M>Q(YKKO@;^VIX5^+_B9_"6J:7?\ @?QHI*C1]8&/-8#)2-R%)<#G:RJ?0'G'
M5]5K<O/R^?G;TW./ZY0Y^3FUV\K]K[7/H>BBBN4[ K"\9?\ (%;_ *Z+6[6%
MXR_Y K?]=%H F\)_\@"V_P"!?^A&M>LCPG_R +;_ (%_Z$:UZ "BBH[FX6UM
MY9W^Y&A=OH!DTFTE=C2;=D245\>/_P %2/A2CLO]@>,#@XRMG:8/_DS3K?\
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M>5S[RHK\^OBIX+_:(_9+TT>--)^*>H?$3P[;.G]H1:MYDQC4L "\4LDF(R2
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M=TKMKKJOA:^>OH<7ME4PD<))6;LD^FC^)/Y:==3]!:***^>/IR&]_P"/.?\
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MTOB[_D!3_P"\O_H0I/!__(#B_P!YOYTNH&U63XL\5:9X'\,ZGK^LW*V>EZ=
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M./\ D(VO_7/^IKM*Q-R*ZM8;VVEM[B))[>9#')%(H974C!!!Z@CM7/\ P_\
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M1KCP5X<D;[9?0G,;(&7[3.".,'"QH>YP>C5^C5M;Q6=O%!"@CAB0(B+T50,
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M88U")'&H554#   Z #M4E8?C;QII'P\\*:GXCUV[2RTK3H6GGF<]AT4#NQ.
M!W) JG)\O+?0E07-S):L^#?B!8P?"W_@I9X4D\-1BT77&MGOK>W&U";@/%-E
M1Z@"0^YS[U^AU?GQ^R%H.K_M)?M,^)/CAKML\&CZ=,\>G1O]WSBGEQ1KZ^7$
M<D_WF4]Z_0>O1Q:=.%*E+XHK7ROJE\CS,$U4J5JT/AE+3SMHW\V? G[4W["G
M@+P1\-_'/Q$L=7\1RZU$6OUM[BYMVMO,DF&X%1 &V_.<?-GIS7KW_!.7_DU[
M1_\ K_O/_1IKKOVV/^36_'__ %YI_P"CHZY'_@G+_P FO:/_ -?]Y_Z--73J
MSJ82JI.Z3BE^!$Z-.GC:<H*S?-<^G:***\H]@XOP?_R'KO\ ZYM_Z&M=I7%^
M#_\ D/7?_7-O_0UKM*2 P/'W@RR^(O@K6_"^I2W$%AJ]I)9SR6K*LJHZE25+
M @'![@_2OS(_;7_9'\'_ +-_AGPUJ/AK4M<OI]2O)+>9=6GAD555 P*^7$F#
MGU)K]5J^&/\ @JQ_R(/@3_L)S_\ HH5W8.K.G6C&+LFU?[SSL?1IU*$I35VD
M[?<?87PR_P"2;^$_^P3:?^B4KYG_ ."FOC2^\-_ O3](LY&B37-42WN64XS$
MB-(5^A94_ 5],?#+_DF_A/\ [!-I_P"B4KQC]N[X+ZG\9O@?+#H5L][KFBW2
MZE;6L?+SJ%99$4=VVL2!W*@=ZF3C'%7GLI?J5",I8+EANX:?^ GI/[/WP^TS
MX8_!WPIH6EP1PI'80S3R(N#-.Z!I)&]2S$_A@= *^3O^"@7AL_"+XB> /C1X
M:C6QU>._%O?-"-HN'0;T+XZ[D$B-ZK@5T?[/O_!0#X?Z?\--)T+X@WUWX:\2
M:+;)83B6QGF2X\H; RF-&*L0HW!@N&SUKQ7]M?X[:S^T!X!L]5T#0KK3?A=I
MVII##JNI1^5+J=XR2 -$O_/-%5^_5AG!X'H*G6ACO:6TYM^C3?XWZ+N><ZV'
MGE[I)Z\NRW32^]6:U?8_2W0]8M_$&B:?JEHVZUOK>.YB;U1U#*?R(JZWW3]*
MX;X$;O\ A2/P_P!^=W]@6&=W7_CW2NY;[I^E>56BJ=64%LFT>QAYNI1A.6[2
M?X'&^ _^/NZ_W!_.NSKC/ ?_ !]W7^X/YUV=8(Z#E?BC\.=-^+7@'6/".KSW
M5MINJ1"*:6Q=4F4!@WREE8 Y4=0:_+_]M?\ 9=\*_LV7/A!?#.H:Q?#5OM!G
M_M::*3;Y9CV[?+B3'WSG.>U?K57Y[?\ !5K_ (_/AK]+[^<%>KEE2<,92A%Z
M2EKYZ,\S,J-.IA:DY*[BM/+5'Z!V7_'G!_US7^5>"?MY76IVO[+7C)M,,JNP
MMXYS%U\AIT$F?;:2#[$U[W9?\><'_7-?Y5S_ ,3-6\,:)X!UV[\9O;)X76U=
M=0^V+NC:(C!4KU8G. !R20!S7FM\LU+LT_N>WS.VDN:DH]U;TNM_D>2_L(6.
MAV?[,/A%]$$):=99;]XP [77F,)-^/XAA5&?X0O;%>'?\%!]-AT+XR_!KQ%H
M,8B\93W_ )2F  23".:$PY]<,[*/9B*\E^#^F_&/P/=>(?'?P"T36;OX927C
M&WTK6O+D:]C4<L( X9]I&W?$=YX&3AL=A^S?\3-(^/'[5DGB7XM:@=*\9:=M
MM?#OAR:W:&TAD7<"H+DD2J22$;!+-D$D!1]#[)K&?6D[I7DU]I77PV^?W'S?
MMHO!?4Y*S?NJ7V7K\5_E?NW;<_1NH+[_ (\KC_KFW\C4]07W_'E<?]<V_D:^
M</JCF? /_+]_VS_]FKK:Y+P#_P OW_;/_P!FKK:2 XSXP?"K2?C5\/\ 4O"&
MN7%[:Z;?F,RRZ>Z),-CJXVEU8=5'4'BOS*_:U_9J\,?LW?$#P'8^&;[5KZ+5
M"9IFU::*1E9)4 "^7&F!@GKFOUHK\\/^"F__ "5/X5_]<I?_ $?'7KY74G'%
MTJ<7HWK]S_R1X>=4H3P%:I)>]&.C[:K_ #/T/K*\6>&[;QEX6UC0+UYHK/5+
M.:RF>W($BI(A1BI((!PQQD$>U:M%>0]=&>ZFT[H_+7]M+]COP9^SEX"T/6_#
M6IZ[?7=]J8LY$U6XAD0)Y3OE1'"ASE1U)[\5^A_P%_Y(?\/O^Q?L/_2=*^9?
M^"J'_)'?"7_8>'_I/+7TU\!?^2'_  ^_[%^P_P#2=*]>I5G6P7--W?/^AX5*
MC3H9ARTU9<G_ +<=W5/6?^01>_\ 7%__ $$U<JGK/_((O?\ KB__ *":\D]P
MP_ ?_'K=?[X_E745R_@/_CUNO]\?RKJ* .!^-WP7T3X]>!9/"GB"ZU"STZ2X
MCN3+ILB)-N0D@9='&.?2OSB^-'[/WA[]G3]J;X7:!X;O-3O;.\N=/O9'U66.
M20.;TI@%(T&,(.V>O-?JW7YX_MR?\GG?"'_<TW_TX/7JY94G'%4Z<7HWJOD_
M\D>1FE&G/"U*LE[T4K/M[R_S9^AU<[\1/ UA\3/ ^M>%=4EN(-/U:V:UGDM&
M5955NI4LK 'Z@UT5%>4>N?E'^VS^R;X1_9MT;PM=^&=1UJ^DU2XGBF&K3PR!
M0BJ1M\N),'YCUS7ZA>"?^1-T'_KPM_\ T6M?$_\ P5<_Y%?X>_\ 7Y=_^@1U
M]L>"?^1-T'_KPM__ $6M>K4JSK8.,JCN^9GCT:-.AC91IJRY5^9M5F^(_P#D
M!WG^Y_45I5F^(_\ D!WG^Y_45Y1[!G^!O^03-_UW/_H*UT5<[X&_Y!,W_7<_
M^@K714 %>-?MB>-+WP#^S?XVU73I&AOFM5M(I4.&C\Z18BP/8@.2/?%>RUYY
M^T%\-9/B]\&?%7A.!E2[U"T(M6D.%$Z$/'D]AO50?8T:77-M=7].OX!K]G?I
MZGD__!//X?Z9X1_9RT?6;:WC&J>());R\N0OSN%E>.-,_P!U57@=,LQ[U@_\
M%'OA7:^(/A#'XZLXOL_B+PQ<Q2+>0C;*;=W",NX<_*S(X],''4UYK^R3^UOH
M7P%\(S_"[XKQ7_A74=!N95@N)K.24!'<N8W5%9PP9F((4J5(YXYL_M1?M13_
M !Z^%_BC0?A;I=U?^$[*W^T:_P"*+ZV:"W6)64K!"'&=[-MZ@''08RP]K$4Z
MSQGMX;733Z<OKZ:?@?/X6K06"^KU/BLTX];]=.]]5VZGUE^SE\1I/BQ\$?"'
MBBX8/>7MDJW3#O/&3'*?Q=&/XUZ17S=_P3SW?\,K>&-V['VB]VY]/M,G3\<U
M](UPXR"IXBI&.UV>E@9RGAJ<I;V05D>+/^0!=?\  ?\ T,5KUD>+/^0!=?\
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M(U'PKXCMVGTR]4;C&VV2)P<K(C8.&4C(X/N".*Z*V(3J4FGS<BBF^KL[M_\
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M:A=?M)^+=3M;33[B>6RF6ZV7"+&S&-LWI&& P<@]>AKR']A?X$>+OB;X7O\
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MYKDK4^7WG-2;[7_'0[</4YER*FXI=[?A9E'7O^0->?\ 7)OY5D^!?^0?<?\
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M>3:7;U\WU,#QM_R!Q_UU7^1JUX7_ .0#:?1O_0C57QM_R!Q_UU7^1JUX7_Y
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M*Y_QY_J;/_>;^0KH-*_Y!=G_ -<4_P#012 M5';W$5W!'-!*DT,BADDC8,K
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MKMK?Y]/GL8'_  2VLIIO$7Q0U2UC:'1I#:Q1+CY2V^9E /JJG_QX5^@M>??
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MK\2CX]G\7^"[_P 4_:?MGVV_EGN )?X6V/:%?EXV\87 QC KU/\ X5E^V?\
M]%;\'?\ @)'_ /*ZNF,:=*CRTZBYI;O7;LM-N_?\#DE.I6K\]6E+DC\*LM_Y
MGKOV73\7]BT5XW^SWX7^-/AQ]=/Q=\7:-XI680_V:-)A5/((W^;OVV\.<YCQ
M][[IZ=_9*\FI#V<N5-/T/:IU'4CS.+7J<7XH_P"1EM/]V/\ ]"-=I7%^*/\
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MU251[MM_>=]&DJ-*-*.T4E]P5D>+/^0!=?\  ?\ T,5KUD>+/^0!=?\  ?\
MT,5D;$/@W_D"K_UT:MVL+P;_ ,@5?^NC5NT %%%<_P#$#0]6\3>"]8TK0M:;
MPYJ]W;-%;:HD(E:V<C[P4D9_/(SD<TF,A\4?"_P;XVNDN?$7A+0M?N(QM2;5
M--AN74>@+J2*^5_^"D'BC3_"_P %] ^'NC6L,-YKE_$MOIME&%"P0G=A8U'
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MG_LM=;7)>/O^7'_MI_[+28'36/\ QY6__7-?Y"IZ@L?^/*W_ .N:_P A4],
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M+\<?\A&U_P"N?]37:5Q?CC_D(VO_ %S_ *FNTH **** "BBB@ HHHH ****
M.+\4?\C+:?[L?_H1KM*XOQ1_R,MI_NQ_^A&NTH **** "BBB@ HHHH ****
M.+U?_D<[?_KI%_2NTKB]7_Y'.W_ZZ1?TKM*0!1113 **** "BBB@ HHHH XN
M;_D>A_UT7_T 5VE<7-_R/0_ZZ+_Z *[2D 4444P"BBB@ HHHH **** .+L?^
M1X?_ *Z2?^@FNTKB['_D>'_ZZ2?^@FNTI %%%%, HHHH **** "BBB@#B]!_
MY&ZZ_P!Z7^==I7%Z#_R-UU_O2_SKM*2 ****8!1110 4444 %%%% '%^#_\
MD/7?_7-O_0UKM*XOP?\ \AZ[_P"N;?\ H:UVE) %%%%, HHHH **** "D;[I
M^E+2-]T_2@#C? ?_ !]W7^X/YUV=<9X#_P"/NZ_W!_.NSI( HHHI@%%%% !1
M110 5!??\>5Q_P!<V_D:GJ"^_P"/*X_ZYM_(T <SX!_Y?O\ MG_[-76UR7@'
M_E^_[9_^S5UM) %%%%, HHHH **** "J>L_\@B]_ZXO_ .@FKE4]9_Y!%[_U
MQ?\ ]!- &'X#_P"/6Z_WQ_*NHKE_ ?\ QZW7^^/Y5U% !1110 4444 %%%%
M!6;XC_Y =Y_N?U%:59OB/_D!WG^Y_44 9_@;_D$S?]=S_P"@K715SO@;_D$S
M?]=S_P"@K714 %%%% !1110 4444 %9'BS_D 77_  '_ -#%:]9'BS_D 77_
M  '_ -#% $/@W_D"K_UT:MVL+P;_ ,@5?^NC5NT %%%% !1110 4444 %87C
M+_D"M_UT6MVL+QE_R!6_ZZ+0!-X3_P"0!;?\"_\ 0C6O61X3_P"0!;?\"_\
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M_P *OL/^?NY_\=_PH_X5?8?\_=S_ .._X4 +_;VG?\_D/_?5']O:=_S^0_\
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M_P *OL/^?NY_\=_PH_X5?8?\_=S_ .._X4 +_;VG?\_D/_?5']O:=_S^0_\
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M4G_"K[#_ )^[G_QW_"C_ (5?8?\ /W<_^._X4 +_ &]IW_/Y#_WU1_;VG?\
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M=_S^0_\ ?5']O:=_S^0_]]4G_"K[#_G[N?\ QW_"C_A5]A_S]W/_ ([_ (4
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M_P"?R'_OJD_X5?8?\_=S_P"._P"%'_"K[#_G[N?_ !W_  H 7^WM._Y_(?\
MOJC^WM._Y_(?^^J3_A5]A_S]W/\ X[_A1_PJ^P_Y^[G_ ,=_PH 7^WM._P"?
MR'_OJC^WM._Y_(?^^J3_ (5?8?\ /W<_^._X4?\ "K[#_G[N?_'?\* %_M[3
MO^?R'_OJC^WM._Y_(?\ OJD_X5?8?\_=S_X[_A1_PJ^P_P"?NY_\=_PH 7^W
MM._Y_(?^^J/[>T[_ )_(?^^J3_A5]A_S]W/_ ([_ (4?\*OL/^?NY_\ '?\
M"@#E=7O8)O%%O.DJO"KQDN#P,$9KJ_[>T[_G\A_[ZKD]6\.PZ?XHM],261HI
M'C4NV-PW$ UU?_"K[#_G[N?_ !W_  H 7^WM._Y_(?\ OJC^WM._Y_(?^^J3
M_A5]A_S]W/\ X[_A1_PJ^P_Y^[G_ ,=_PH 7^WM._P"?R'_OJC^WM._Y_(?^
M^J3_ (5?8?\ /W<_^._X4?\ "K[#_G[N?_'?\* %_M[3O^?R'_OJC^WM._Y_
M(?\ OJD_X5?8?\_=S_X[_A1_PJ^P_P"?NY_\=_PH 7^WM._Y_(?^^J/[>T[_
M )_(?^^J3_A5]A_S]W/_ ([_ (4?\*OL/^?NY_\ '?\ "@!?[>T[_G\A_P"^
MJ/[>T[_G\A_[ZI/^%7V'_/W<_P#CO^%'_"K[#_G[N?\ QW_"@#+\3ZM9W6CR
MQPW,<DA*X56R>HI/"^K6=KH\<<US''(&8E6;!ZT>)O MIH>CRW<5Q-(Z%0%?
M&.2!V%)X7\#6FN:1'=RW$T;LS#:F,<''<4 :_P#;VG?\_D/_ 'U1_;VG?\_D
M/_?5)_PJ^P_Y^[G_ ,=_PH_X5?8?\_=S_P"._P"% "_V]IW_ #^0_P#?5']O
M:=_S^0_]]4G_  J^P_Y^[G_QW_"C_A5]A_S]W/\ X[_A0 O]O:=_S^0_]]4?
MV]IW_/Y#_P!]4G_"K[#_ )^[G_QW_"C_ (5?8?\ /W<_^._X4 +_ &]IW_/Y
M#_WU1_;VG?\ /Y#_ -]4G_"K[#_G[N?_ !W_  H_X5?8?\_=S_X[_A0!C>+-
M4M+S2Q'!<1ROY@.U3DXP:L>'=7LK;1K:.6YCCD4'*LW(^8U6\6>"K7P_I8NH
M9YI',@3;)C'(/H/:K'AWP#9ZQH]M>2W$Z/*"2JXP,,1Z>U &G_;VG?\ /Y#_
M -]4?V]IW_/Y#_WU2?\ "K[#_G[N?_'?\*/^%7V'_/W<_P#CO^% "_V]IW_/
MY#_WU1_;VG?\_D/_ 'U2?\*OL/\ G[N?_'?\*/\ A5]A_P _=S_X[_A0 O\
M;VG?\_D/_?5']O:=_P _D/\ WU2?\*OL/^?NY_\ '?\ "C_A5]A_S]W/_CO^
M% "_V]IW_/Y#_P!]4?V]IW_/Y#_WU2?\*OL/^?NY_P#'?\*/^%7V'_/W<_\
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M 7^WM._Y_(?^^J/[>T[_ )_(?^^J3_A5]A_S]W/_ ([_ (4?\*OL/^?NY_\
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MK[#_ )^[G_QW_"@!?[>T[_G\A_[ZH_M[3O\ G\A_[ZI/^%7V'_/W<_\ CO\
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MJD_TKJ_^%7V'_/W<_P#CO^% "_V]IW_/Y#_WU1_;VG?\_D/_ 'U2?\*OL/\
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MK[#_ )^[G_QW_"@!?[>T[_G\A_[ZH_M[3O\ G\A_[ZI/^%7V'_/W<_\ CO\
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M_?5<[X/\)6_B.VN))YI8C&X4"/'/'N*Z'_A5]A_S]W/_ ([_ (4 +_;VG?\
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M %R/_H0KTBO-_AK_ ,AZ^_ZY'_T(5Z120!1113 **** "BBB@ HHHH ****
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M@ HHHH **** /-_$W_)0['_KK!_Z$*](KS?Q-_R4.Q_ZZP?^A"O2* "BBB@
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MB@ HHHH **** /-]-_Y*=)_UVE_] :O2*\WTW_DITG_7:7_T!J](I %%%%,
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M "+.H?\ 7/\ J*V:QO&'_(LZA_US_J* ,CX8?\@&X_Z^6_\ 0$KL*X_X8?\
M(!N/^OEO_0$KL* "BBB@ HHHH **** "N?\ 'O\ R*E[_P!L_P#T-:Z"N?\
M'O\ R*E[_P!L_P#T-: *_P .?^1;7_KJ_P#2NHKE_AS_ ,BVO_75_P"E=10
M4444 %%%% !1110 5R_Q&_Y%M_\ KJE=17+_ !&_Y%M_^NJ4 3^ ?^15LOJ_
M_H;5T-<]X!_Y%6R^K_\ H;5T- !1110 4444 %%%% !7'_$__D V_P#U\K_Z
M ]=A7'_$_P#Y -O_ -?*_P#H#TF!K^#_ /D6=/\ ^N?]36S6-X/_ .19T_\
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M754&Z:^UI]]M[?(_06BFQR+-&LB,'1@&5E.00>AIU>>>GOJ@HHHH \W\3?\
M)0['_KK!_P"A"O2*\W\3?\E#L?\ KK!_Z$*](H **** "BOD_P#:X_;PM?V;
M?$0\*:?X8FUOQ)-9)>)/<S"*SB5RZJ3MR[D%#E<+U^]7#?\ !/S]J+XC?M ?
M$;QG:^,]:BOM/M;%;JULH+*"".W9I@,*R('( ./G9OQ/-=E/"U:E-U4O=7Z'
M!5QM&E5C0;O)M?*_<^Z:**^/_P!K[]IOQ?H_Q!T'X-?"4(?'NM%/M%^R*_V-
M'!*JNX$!MH+LQ!VH,@9.1STZ<JLU3ANSJJU(T8.I/9'V!17P-XT_9Z_:1^"_
MA.X\=:%\<]7\8ZOIL1N[W0KSSI8&11ND$2RR2))@9X*(2!Q@X%?2G[*/[1%G
M^TG\*[;Q$L$=CK-K)]CU6RC)VQ7 4'<F3G8P(89Z9(R2I-;SP]H.=.2DEO:^
MG_ \SFAB6YJG4@XN6U[:VWVZ^1[+1117(=QS?Q!_Y%>Y_P!Y/_0A2?#W_D6(
M/]]__0J7X@_\BO<_[R?^A"D^'O\ R+$'^^__ *%2Z@=+117AO[57[5.E_LN>
M'-*O[W0KO7[S59)(K2WMY5ACW(%)\QSDJ/F'16JHIRDHQW9,I*$7*6R/<J*_
M-K]FO]N;XH?'/]JSPUHFHZA::7X2U)[D/H5G9Q% J6TSIF9E,I.Y5)(8 XZ
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MY&FM[VZ[=6;%%%%<AVG"_%/_ (]M/_WW_D*ZS0_^0)I__7O'_P"@BN3^*?\
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M ,AZ^_ZY'_T(5Z120!1113 **** "BBB@ HHHH *^;O^"A__ ":7XR_W[/\
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MFMVBBN24G.3E)W;.V,8TXJ$59(*X#XJ_\PO_ +:_^R5W]<!\5?\ F%_]M?\
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M7*_"S_CTO_\ ?7^1K$W.YHHHH _.'_@H?_R=C\&_]VT_]+J_1ZOSA_X*'_\
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MI_Y%W4?^N#?RK ^%_P#R";O_ *[_ /LHKSCU3M**** "OSA_X*7?\G"?!_\
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MOO\ KJO\J[>N(^%O_'A??]=5_E7;T %%%% !1110 4444 %8WC#_ )%G4/\
MKG_45LUC>,/^19U#_KG_ %% &1\,/^0#<?\ 7RW_ * E=A7'_##_ ) -Q_U\
MM_Z E=A0 4444 %%%% !1110 5S_ (]_Y%2]_P"V?_H:UT%<_P"/?^14O?\
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MD1J?^^CEB!P!W6I?L!? 75M0NKZ[\">;=74K32R?VQ?C<[$EC@3X&23TJO\
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M"P]%TE)S=Y2=V_-]O);(****YCK/-_$'_)1K3_KM!_,5Z17F_B#_ )*-:?\
M7:#^8KTB@ HHHH *_-_]G>;_ (37_@IM\0M6;,G]GG4BC8/ C*6P_0XK](*\
MT\#?LX?#OX;^/M7\:^'/#QT_Q-JPF6]OC?7,OFB6022?))(R#+J#PHQC P.*
MZL-5C1E.4NL91^^QQXJC+$0A%=)QE]U_\STNBBBN4[ HHHH \WN/^2H#_KLO
M_HL5Z17F]Q_R5 ?]=E_]%BO2*0!1113 *_-_]A69_&'[<'Q>\1S%I2L>H,KD
M' WWR!?_ !U2/SK]'Z\V^&/[.?P\^#GB#5M<\(>'SI.J:LI6]N#?7,_F@OO/
M$LC ?-SP!75AZL:+FWUBU]YQ8JC*NH*+^&2D_E<]*HHHKE.T**** /-]-_Y*
M=)_UVE_] :O2*\WTW_DITG_7:7_T!J](I %%%%,#P_X>_MD?#+XA^/-?\'P:
MTND:WI=Z]G'%JV+=;[8=I: L<-\V1M.&XSC%>A?$KXL>%/A%X7N=?\5:U:Z5
M80H77S9!YDY R$B3J['L%!KA?C)^Q_\ "SXYW<FH>(_#BQ:U(,-J^F2&VN6X
MQERORR$   NK8Q7E7AW_ ()<_!G0]52\NYO$FO0J<_8=1U"-86^ODQ1O_P"/
M5UQCAY17-)Q?72]_3;\4<4I8F$GRQ4DWIJU;UT?X,\M_X)Y^'-7^*7QZ^(WQ
MNO[-[32[V2Y@M-XX>:>59&53W\M%52?]L5^A]9WAWP[I?A'1;/1]%T^VTK2[
M-/+M[.TC$<4:^@4<#U^IK1I8BLJTER*T8I)+R0\+1E1B^=WE)MM^;"BBBN4[
M#S?PK_R4"^_WY_\ T(UZ17F_A7_DH%]_OS_^A&O2*2 *;)(L<;.QPJC)/M3J
M*8'A_P '_P!L;X9_&;6M3T73-972]9LKN2V2PU8K;R7:JQ DA!/S@XSM^\.Z
MC@GL_C)\;?"?P-\(WFN^)]5M[,1Q,UO9F0>?=R ?+'$G5B3Z# ZG !-<1\8/
MV*?A-\;-0GU/6O#QT_6Y^9-5T>4VT[G^\X&4=O\ :=2?>O//"7_!,'X,>&=6
MCO;O_A(/$J(<BSU:_3R<]B1#%&Q^A./45U\N&FE>3CWTO]ST_%'"Y8J$FE%2
M735K[U9_@SS;_@F/X%UC7?$OQ!^+^K6IM8==EDM;,E2!,SS&:X9<]55@BY[G
M<.QK] *J:3I-EH.FVVG:;9P:?86L8B@M;6,1Q1(!@*J@8 'H*MTL365:=XJR
M2LEY(K"T'AZ=I.\FVV^[84445RG8>;_#W_D:K_\ ZY2?^C%KTBO-_A[_ ,C5
M?_\ 7*3_ -&+7I%) %5-6TFQU[3+K3M3LK?4=/NHVBN+2[B66*9",%71@0P(
MZ@C%6Z*8'G/_  S;\)/^B6^"_P#PGK3_ .-U\G_\%*?A#X$\"? /3=0\->"O
M#OAZ_?7K>%KK2M*@M93&89R4+QH#M) .,XX%?>U<9\5?@_X1^-GAN+0?&FD?
MVSI,5PMVEO\ :9H,2JK*&W1.K=';C..:WA6G&<9-NR:?W,YJE"$J<XJ*NTUM
MU::1P/[*/PQ\':%\&OAUXBTWPEH>G^(+KPW9-/JUKIL,5W*7@C+EY54,Q8\G
M)Y/6O<:S/#/AO3O!WAW2]!T>W^R:5IEM'9VEOO9_+BC4*B[F)8X  R23ZFM.
MGB*GMJLIK9MV]+AAZ7L:,:;W25_6P4U_NM]*=37^ZWTKG.D\Z^%O_'_??]<E
M_G7H]><?"W_C_OO^N2_SKT>D@"FNZQHSNP5%&2S'  ]:=5;4]-M]8TV[L+R/
MSK2ZB>":/<5W(RE6&001D$]*'>V@U:^I^:_[7G[6%Q^T)XTA^#_P]UNQTOPM
M-<"#5/$%[>);6UV0<MF5B +=,9/>0C !& WT]^SWJGP"_9U^'MKX:T/XG>"9
MK@@2:AJ3Z[9K+>SXY=OWG '15R=HXY.29_\ AWE^S]_T('_E9U#_ .2*/^'>
M7[/W_0@?^5G4/_DBO7]MAE15&/,EUT6K\]?P_P" >'[#%NNZ\E%O9:NR7EIO
MW9[1X0^)7A'XA&Z'A;Q5HGB4VFW[1_8^HPW?D[L[=_EL=N=K8SUP?2NDKSCX
M0_L[_#WX#-JK>!?#_P#89U01"[_TVXN/-\O=L_UTCXQO;IC.>>U>CUYM3DYO
MW=[>9ZU/VG+^]M?R"JVI?\@V[_ZY/_Z":LU6U+_D&W?_ %R?_P!!-9FIQ/PJ
M_P"8I_VR_P#9Z[^N ^%7_,4_[9?^SUW]) %9?B3PMHOC+29=*\0:18:YI<I5
MI++4K9+B%RI!4E'!4D$ CC@BM2BF'D><_P##-OPD_P"B6^"__">M/_C=?"?_
M  5$^&?A#X?V?PX;POX4T3PV;J:^%P=(TZ&U\X*(-H?RU&[&XXSTR:_3*O._
MBY^S]X!^.\>EIXYT'^W%TMI&M!]LN+?RR^W?_JI$SG8O7/2NS#8ATL13JS;<
M8N[^YG'7P\:E*<(Q2;32-CP+\,?!W@&-KCPQX3T/PY/=1(L\NDZ;#:M*!R Y
MC4%@"3U]:ZRFQH(T5%&%48 IU<TI.3NV;TH*G!105G>(O^1?U+_KVD_]!-:-
M9WB+_D7]2_Z]I/\ T$U!J<S\+?\ CPOO^NJ_RKMZXCX6_P#'A??]=5_E7;T
M%%%% !1110 4444 %8WC#_D6=0_ZY_U%;-8WC#_D6=0_ZY_U% &1\,/^0#<?
M]?+?^@)785Q_PP_Y -Q_U\M_Z E=A0 4444 %%%% !1110 5S_CW_D5+W_MG
M_P"AK705S_CW_D5+W_MG_P"AK0!7^'/_ "+:_P#75_Z5U%<O\.?^1;7_ *ZO
M_2NHH **** "BBB@ HHHH *Y?XC?\BV__75*ZBN7^(W_ "+;_P#75* )_ /_
M "*ME]7_ /0VKH:Y[P#_ ,BK9?5__0VKH: "BBB@ HHHH **** "N/\ B?\
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M_P! :O2*\WTW_DITG_7:7_T!J](I %%%%, HHHH **** "BBB@#S?PK_ ,E
MOO\ ?G_]"->D5YOX5_Y*!??[\_\ Z$:](I( HHHI@%%%% !1110 4444 >;_
M  ]_Y&J__P"N4G_HQ:](KS?X>_\ (U7_ /URD_\ 1BUZ120!1113 **** "B
MBB@ IK_=;Z4ZFO\ =;Z4 >=?"W_C_OO^N2_SKT>O./A;_P ?]]_UR7^=>CTD
M 4444P"BBB@ HHHH *K:E_R#;O\ ZY/_ .@FK-5M2_Y!MW_UR?\ ]!- '$_"
MK_F*?]LO_9Z[^N ^%7_,4_[9?^SUW]) %%%%, HHHH **** "L[Q%_R+^I?]
M>TG_ *":T:SO$7_(OZE_U[2?^@F@#F?A;_QX7W_75?Y5V]<1\+?^/"^_ZZK_
M "KMZ "BBB@ HHHH **** "L;QA_R+.H?]<_ZBMFL;QA_P BSJ'_ %S_ *B@
M#(^&'_(!N/\ KY;_ - 2NPKC_AA_R ;C_KY;_P! 2NPH **** "BBB@ HHHH
M *Y_Q[_R*E[_ -L__0UKH*Y_Q[_R*E[_ -L__0UH K_#G_D6U_ZZO_2NHKE_
MAS_R+:_]=7_I744 %%%% !1110 4444 %<O\1O\ D6W_ .NJ5U%<O\1O^1;?
M_KJE $_@'_D5;+ZO_P"AM70USW@'_D5;+ZO_ .AM70T %%%% !1110 4444
M%<?\3_\ D V__7RO_H#UV%<?\3_^0#;_ /7RO_H#TF!K^#_^19T__KG_ %-;
M-8W@_P#Y%G3_ /KG_4ULTP"BBB@ HHHH \>\,^)!X=U"XN#;F?S$*;0^W'(/
MI[5TO_"U$_Z!K?\ ?[_[&NN&AZ<I)&GVH/\ UQ7_  IW]C:?_P ^-M_WY7_"
MD!Q__"U$_P"@:W_?[_[&C_A:B?\ 0-;_ +_?_8UV']C:?_SXVW_?E?\ "C^Q
MM/\ ^?&V_P"_*_X4P./_ .%J)_T#6_[_ '_V-'_"U$_Z!K?]_O\ [&NP_L;3
M_P#GQMO^_*_X4?V-I_\ SXVW_?E?\* ./_X6HG_0-;_O]_\ 8T?\+43_ *!K
M?]_O_L:[#^QM/_Y\;;_ORO\ A1_8VG_\^-M_WY7_  H X_\ X6HG_0-;_O\
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M .%J)_T#6_[_ '_V-'_"U$_Z!K?]_O\ [&NP_L;3_P#GQMO^_*_X4?V-I_\
MSXVW_?E?\* ./_X6HG_0-;_O]_\ 8T?\+43_ *!K?]_O_L:[#^QM/_Y\;;_O
MRO\ A1_8VG_\^-M_WY7_  H X_\ X6HG_0-;_O\ ?_8T?\+43_H&M_W^_P#L
M:[#^QM/_ .?&V_[\K_A1_8VG_P#/C;?]^5_PH X__A:B?] UO^_W_P!C1_PM
M1/\ H&M_W^_^QKL/[&T__GQMO^_*_P"%']C:?_SXVW_?E?\ "@#RG4?$@OO$
MD.JBW*"-XV\K?G.W'?'M73?\+43_ *!K?]_O_L:ZXZ'II;)T^U)]?)7_  IW
M]C:?_P ^-M_WY7_"D!Q__"U$_P"@:W_?[_[&C_A:B?\ 0-;_ +_?_8UV']C:
M?_SXVW_?E?\ "C^QM/\ ^?&V_P"_*_X4P./_ .%J)_T#6_[_ '_V-'_"U$_Z
M!K?]_O\ [&NP_L;3_P#GQMO^_*_X4?V-I_\ SXVW_?E?\* ./_X6HG_0-;_O
M]_\ 8T?\+43_ *!K?]_O_L:[#^QM/_Y\;;_ORO\ A1_8VG_\^-M_WY7_  H
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M/_Y\;;_ORO\ A2 Y#_A:B?\ 0-;_ +_?_8T?\+43_H&M_P!_O_L:[#^QM/\
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M\+43_H&M_P!_O_L:[#^QM/\ ^?&V_P"_*_X4?V-I_P#SXVW_ 'Y7_"@#C_\
MA:B?] UO^_W_ -C1_P +43_H&M_W^_\ L:[#^QM/_P"?&V_[\K_A1_8VG_\
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M*_X4?V-I_P#SXVW_ 'Y7_"@#C_\ A:B?] UO^_W_ -C1_P +43_H&M_W^_\
ML:[#^QM/_P"?&V_[\K_A1_8VG_\ /C;?]^5_PH X_P#X6HG_ $#6_P"_W_V-
M'_"U$_Z!K?\ ?[_[&NP_L;3_ /GQMO\ ORO^%']C:?\ \^-M_P!^5_PH X?4
M/B4E]87-L-/9/.B:/=YN<9!&>E9/A3Q<OAJ&X1K4W'FL&R'VXP/H:]-_L73S
MP;"V(_ZXK_A0NAZ<OW=/M1](5_PI <A_PM1/^@:W_?[_ .QH_P"%J)_T#6_[
M_?\ V-=A_8VG_P#/C;?]^5_PH_L;3_\ GQMO^_*_X4P./_X6HG_0-;_O]_\
M8T?\+43_ *!K?]_O_L:[#^QM/_Y\;;_ORO\ A1_8VG_\^-M_WY7_  H X_\
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M?]_O_L:[#^QM/_Y\;;_ORO\ A1_8VG_\^-M_WY7_  H X_\ X6HG_0-;_O\
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M9P ,]*[5M#TYOO:?:GZPK_A2_P!BZ>.!86W_ 'Y7_"D!R'_"U$_Z!K?]_O\
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MW_?[_P"QH_X6HG_0-;_O]_\ 8UV']C:?_P ^-M_WY7_"C^QM/_Y\;;_ORO\
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MI_\ SXVW_?E?\*/[&T__ )\;;_ORO^% ''_\+43_ *!K?]_O_L:/^%J)_P!
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M .%J)_T#6_[_ '_V-'_"U$_Z!K?]_O\ [&NP_L;3_P#GQMO^_*_X4?V-I_\
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M/_Y\;;_ORO\ A2 \J\*^)1X;N)Y&MS<>:H7 ?;C!SZ&NE_X6HG_0-;_O]_\
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M^%J)_P! UO\ O]_]C78?V-I__/C;?]^5_P */[&T_P#Y\;;_ +\K_A0!Q_\
MPM1/^@:W_?[_ .QH_P"%J)_T#6_[_?\ V-=A_8VG_P#/C;?]^5_PH_L;3_\
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M-M_WY7_"C^QM/_Y\;;_ORO\ A0!Q_P#PM1/^@:W_ '^_^QH_X6HG_0-;_O\
M?_8UV']C:?\ \^-M_P!^5_PH_L;3_P#GQMO^_*_X4 <?_P +43_H&M_W^_\
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M9\OR?+X_UG7>>G3FO9ZIQ<5&3VDKKT)C.,FTNFC^Z_ZA1114%A1110 4444
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M6GV+[7]JQY>/FW^6G7/3;7K5:U*<J4G":LT8TJL*T%4INZ8445R/BSXL>%?
M_BOPUX:UO5?L6M>))7@TJU^SRR?:'7&X;D0JF-P^^1UJ(IR:BM6S24E%.4G9
M(ZZBBBD,**** "BBB@ HHHH **** "BBB@ HHKQCX;_M&?\ "P/CY\0/AI_P
MCWV#_A$XT?\ M3[;YGVK=MX\KRQLQN_O-TJX1E4;4>BO\E_PYG.I&FDY/=I?
M-[?D>ST445!H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFMO6_6^WGI:_9R_:-T;]HKPSJ-[9:==:#K.DW/V/5=%OL&6TFYXS@;E.& )
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M8XE&P8R3EL\' 8\5[;\8/BE%\+?A'K_CJ"R77(-,LOML=LEQY2W"DKC$FUL
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MY ?3]U&/^V8KBH4U-RE+:*OZZI)?>]3OQ%65-1C#>3MZ:-M_<M//[CVOX?\
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MY7 /J,$'\P*PC[.G0IU91NVY7WZ2\NMM/T-Y.I4Q%6E&7*HJ-M%NXI]>E_\
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MLW>DWZ%D+KMDC8'#1NO\+*001[<$C!KI[BXBM+>2>>1888U+O(YPJJ!DDGL
M*^+_ /@E_(\/@3XC:?;L9-&M/$T@LVS\N#&H./P5#U[_ )^N?MT:SJ&A_LJ^
M/[C3=ZSO:1V[O&<%8I)HTD/_ 'PS#\:QQ5-4ZO)3V=K7_O6M?TN=6%J2J4E*
MINKIV\FT[>MCG+?]L37?B)J6II\'_A/JOQ)T;39FM[C7)=4@TJTD<<D0-*#Y
MO4<<'D'&"">Y^!O[36A?&C5-7\.RZ9?^$O'&B_\ (2\-:NH6>(9 WHPXD3)
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M OPR\"ZA\4?$^E@'4Q:7D5E8V1/\$EU("H?@_+CJ",Y! U?A'^TPGCKQS=^
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MGX(^%/@#4/BIK>D';J<]O?Q6%C:L"04-Q(&4L"",8 )!P3@X^??C_P#%2_\
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M>TG4 E6P>00<AN_< @@>4^'?VDOB[\;+7^T?A9\*+:R\,S$BT\1^--1^SQW
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M=?M#> =+M=*UD:%XFT6]35-*O)%+0B=00%D !(!S]X D$ X/(/E4?[6WQ,^
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M-EYM+]7=G;7G[7'Q"T70SXLUC]GWQ%8^!%3SY-335K>2^C@Z^8]CM#K@<G+
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MOJVM3W&H:^WBJTT^22?:O[MHI5+_ "[B<DX)D)KTOQAH?QO^,'QR^$?BF_\
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M )8O$<+(V.5/D3=*B_X*474]_P"%/A1H-S*\.A:MXAB74'#84@*H ;\'<_\
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MO_F;RIJ<X3>\;_C;_(^8_AQ\&_&&@_MP_$?X@7^D>1X1U?2([6RU'[3"WFR
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MUKN]5UV+'[4/P9\<_&KXN?!CQ7\/I+>WL-&$]\VO7!B>&U8^5+ S0LZO(KE
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MN$FDW>RM:][OI=7\FD>!>--<_:$\$^/]7OM"\,>'?B5X+NV4V.DPZ@NEW]D
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M#8!(4E=I(!P&Z'I7JE%3*LY1C!*RB[JW?3_+K^5D5##QC.51MMR23OU2O_\
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MJ<<@'.#_  GI7I7[,O[/VG_LY_#>/P]!>-JNJW4[7NJ:FZX-U<, "0"20H
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M?1)IVZO7H;WP7_:G/Q%^(^J?#OQ5X,U#X?\ CO3[;[8VF7=REU#+#\OS1S(
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M ^EZ*B-9Q7NQ2=K7ZVZ^7X&DJ'-*\I.U[VZ7W[7^5[!7YV?LRWGQ*T?XX?M
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M*"C)],Y//RY(/V!16JK<LFXQ23W6MG^-_P 3&5#FBE*3;6STNOPM^&O4^6O
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MHIE&03C.[&>0:]1\/?LYV&@_LPGX/_;VF@?1YM.DU IC,LH9FE"]AYCD@9Z
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M/G#]G[]G?Q+H_P 3-?\ B[\4+ZRO_B!K$7V:"QTTLUKI5M@#RT9OO-A57(X
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M! !N%A 5\_\ 74!J]?HK-U9.BJ'3\>K_  ;=O4TC1C&N\1U_#HORBE\CX_\
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M6VJN !DDUJ?L_6DW[/O[:7B?X.Z/J=Y/X$U#2!JFGZ9>3M*+*7"/A"V2!@R
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M? [6]3GCLM+FL'M$NIFVIYN;A=I)X&3-&/\ @0KZ<^/<R2? SXCJCJS)X>U
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M.[.5 ^P_ 7P6\&?#'Q!XFUSPUHW]FZIXDG%SJL_VJ:7[1(&=@VV1V5.9'.$
M'/L*YGXC?LD_"/XL^(CKWBGP59ZAJ[8\R[BGFMGE(  ,GDNGF'  RV>!70L1
M#VBEJO<4;]4THJZ^YKH[,PEAIN,EH[S<K=&G?1_>GU5T?(WQ)L_AAHG[;?P1
MT/X;66B68TV^,6J+H=NJH)BP*K)(HP[@ Y&25SSC->C?ML?\G*?LS_\ 8?/_
M *46U?18_9X^',=YX2N;?PG96,GA.9Y]&%B7MDM9'V[VV1LJN3M&=X;GGN:T
M?&WP;\'_ !&\2^&?$'B'2/[0U?PW<?:M*N/M,T7V>3<K;MJ.JORB\."./K54
M\3&,Z,G=\CDWW=[_ .?R[LB>$G*%=*R]HHI=E;^M^O9#_C)_R2+QO_V!+W_T
M0]>$?\$T?^34]&_["%[_ .C37TYK.D6GB#1[[2[^+S[&]@>VN(MQ7?&ZE67(
M((R">00:P?AG\+_#'P?\*0^&O".F?V1HL,CRI:_:)9L,YRQW2,S<GWKDIU%"
M%2+^UR_@W_F=M6FYU*4U]GFO\TO\C?U;_D%7O_7%_P#T$U\<_P#!*O\ Y(;X
MK_[&FX_])K:OLZ:)9XGC<;D=2K#U!X-<=\*O@WX/^"6AW>C^"](_L;3;JZ:]
MFA^TS3[IF55+;I78CA%& <<=*=&HJ<*L7]I12^3N%:FZDZ4E]EMOYJQ\H_!G
M4;7]G#]MCXH^&/%,R:3IWCUTU31-1NF"0W#^8[B(.> V9I%P3U0#JRY]#_;_
M /BAI7ASX%ZMX/AF2_\ %?BKR]-T[2+<[[B7?(NYP@^;  P#CEBH[U[I\1?A
M5X1^+6BC2O&'A^QU^Q4EHTNX\M$Q&"T;C#(<=U(-<E\,OV4_A/\ ![5_[5\)
M^"[+3M4&0E[-)+=319&#L>9W*9&1\I'!K3VE.HH>UO>*2T^TEMZ::/?Y&/LZ
MM.4_96M)MZ_9;WTZZZK;MJ>.?&+X6:KX)_X)Q7O@^2/SM5TK0;5[N-#NVLDT
M<TP!'4+A^?\ 9KTS]F'XD>&F_95\#:W+K5E;:7I6A6]M?74TZHEM)!$(Y%<D
M_*04/!]O6O:[B".Z@DAFC6:&12CQR*&5E(P00>H(KQ72_P!BGX(Z-XJ7Q%:?
M#W34U)9/.4/)-);JV<Y%NSF(8/0!,#M3]LJBJ1J:<TN;3775;76GS$L/*BZ?
MLM5%<MGIIIUL^W8\"_8>\06_BS]JSX^:W9Q7$5EJ+Q75N+J%H9&B>5V1RC<@
M,I##/8BM^T_Y2C7O_8HC_P!!2OIWP[\)?"GA3QUXA\8Z5I7V7Q'X@6-=2O?M
M$K^>(P @V,Y1< #[JCWJ-?@[X0C^*3_$9=(QXR>T^P-J7VF;F# &SR]_E]AS
MMS[U?UB"<&D[*'+_ .2M?K_P"?J]3EFFU=SYOES)_I_P3LZ\4_;2_P"36/B1
M_P!@MO\ T-:]KKQ3]M+_ )-8^)'_ &"V_P#0UKSGL>B9G[$OCKP]X@_9H\%6
M^G:U975QI.F1V^H0I,OF6DBY#"13RO3.3P1R,BO&O#^H0_M%?\%$(/%'AR1=
M1\)_#_2C:S:I"0\$T[),H5''!^>9L8Z^4QZ8KK?@9^RU\*OC)^SK\,M3\7>#
M++4]2&BP WL<DMK-)@8 =X71G '3<3BOI3P)\/?#7PQ\/Q:'X4T6ST+2HSN%
MO9QA0S8 +,>KL0!EF))QUKUZ]2%+$U9J_->2\E>Z;OZ-V5OF>-0IU*V%I4W;
MEM%ONTK.UO5*[O\ (^0/BPK_ !\_;8G^$GC;Q%>:/X TW28[VVT.UNC:KK4Y
M6-BKL,%_OOP#D"([<')KSC_@H)X&^#'PG^&.C^$_!6BZ%I?B]=2AN)8[*+S;
MV.T5)%8S3'<ZJ69,!V^8CC../N/XL?L\_#OXX"U/C;PM:ZW+:C;#<%Y()T7.
M=HEB97VYYVYQ[5D?\,F_",?#^?P5'X(L;?PY<31W$]O;R2Q2S21DE&>=7$KD
M9.-SGJ1TK/#XB%+V3=UR--I=;.][]_*WE=&U;#3J.KHGS)I-]/=M:W:^M[];
MV9Q_[>&EW.K?L@^,4MHS(\-O:W#J.NQ)XF8_@ 3]!79?LJZ]IVL?LX?#.2RO
M8+E%T*SM28Y <310JDB?[RLK CM@UZE=:?;7UA+8W-O'<V<T9ADMYE#HZ$8*
ML#P01P0:\E\%_LA?"'X>>-H?%WASP9!I6OP.TD-S#=W)6(L"K;(C(8U!#$8"
M@8-<\*D?93I2V;YEZVM;H;.C.,Z=2-FU'E?X.^S/$?A#_P I+/B__P!@"+^5
MG7GOQM^$O@#0_P!N:YOOB_I N? ?C:Q0Z?J=Q=S6UO;7R)&A$DD3KC_5D?,<
M#S5)X!(^WM'^#?@_0?B7K'Q L-(\CQ=J]N+6]U'[3,WFQC9A?++F-?\ 5IRJ
M@\>YK8\9>!_#_P 1-#ET;Q-HUEKNERD,UK?0K*FX=&&>C#L1R*TAB?9NE*/V
M8<KZ>MOP:]#.>$]I&K&7VI\RZ]K77WI^3/G;7/V)?V7O#.DQZGJ_AO3M,TV0
MJ([N\\1WL43EN%"LUR 2<C&.N:P?^"BGAW3O"/[',&AZ1;BTTK3;W3[2TMP[
M.(XDRJ+N8DG  &22:].\._L-_ OPOJRZE9?#O3Y+E3D+?SW%Y$#_ -<II'3_
M ,=KT?XE?"?PI\7_  F?#/BW21JNAF2.;[(L\MN-R?<(:)E88],XI3K7E!\\
MI)23U\FGW>NXX8>T*B5.,6XM:>::UT6FW<TO W_(D^'_ /L'V_\ Z+6OC[_@
MGK_R5K]HS_L9!_Z/O*^UK&RATVQM[2V3R[>WC6*-,D[54  9/)X'>N/^'OP5
M\&?"K5O$>I^%M&_LN^\17/VO4Y?M4TWVB7<[;L2.P7F1^% '/L*/;1YJS_G6
MG_@2?Z#EAY2C17\C3?\ X"UI]Y\M:--#X;_X*E>(&U.>.S&L^'$6P\YMOGMY
M4 VKGJ?W,G'^R:^J_B%\2_!'@>PLHO&.N:7IEAK%PVG1#4I%\F=RIW(V?E"X
M!!+849 )Y%9OQ8_9]^'OQQCM%\;^&+77'M,B"=I)()HP>2HEB97VYYVYQ[4F
MG?L]?#C3/A[#X%C\(:=<>$X7:6+3+U6ND1V))=6E+,&R2=P.>:SE.$Z=.,KW
MBK>JN^O>S[&L85*=2;C:TM?1V2V[77='RW^UU^SE\-?A/\/;_P"*_@'4#\-_
M%M@4FT^?0[PPP7SLRCRDB#8&03_J\# .01FOK'X'^(M;\7?![P9K7B2'R-=O
M])M[B\39L_>-&"6V_P .>N.V<5P?AK]B'X'>$M=BUC3OA]8_;HGWH;RXN+J)
M6SD$12R,F0>GR\5[E6E2M&5+V:;EK>[Z*VRU?]+8RI491JNJTHZ6LNNN[T6W
MSWW/DO\ ;^^(6O\ ANV^&_A73?$,_@_0_%>L_8=8UZV<Q26UN#&"!)_ ")'8
M\CB/KC-9?QA^ ?[/G[/OP+\27$FC:0^L7^ESP:;?ZPWV^^O+QXF$3Q;]QWEB
M&S&H"_>X S7U/X\^'OAOXG^'9]!\5:-:ZYI,Q#-;729 8=&4CE6&3AE((SUK
MA? '[)GPC^%[W<GAOP18V5Q=1/!)<S22W,PC=2KJDDKLR J2#M(SFHA44:+I
MW:=WMU[)OI;Y][&DJ4G752RDK+?IJ]4NM^NVVYY-^QU_RC\L_P#L&:S_ .C[
MFKO_  31_P"34]&_["%[_P"C37O7@[X4>%? 'P^3P1H.E_8/"Z130K8_:)9,
M)*S-(/,=R_)=OXN,\8XJ3X9_"_PQ\'_"D/AKPCIG]D:+#(\J6OVB6;#.<L=T
MC,W)]ZVJXB$YXB27QM6^3;U^\PHX:=.%"+:]SFO\TMON/C#]N+X;^&M/_:6^
M'7CWX@Z1)JOPTU"W&BZQ(LLL:VL@,ABD9HF5P 9 W!Y$;#GI7J<G[$_[+L/A
ML>(7\.Z:F@&/SO[4;Q)>"VV8SN\W[3MQ[YKZ7U[0-,\4:1=:5K&GVNJZ9=)Y
M<]G>0K+%*OHRL""*\4M?V$?@/9ZT-4C^'=BUSO\ ,\N6ZN9(,_\ 7%I3'CVV
MX]JFGB&J2IN3C:^JZW=]5=>>O;T'5PJE5E54(RYK73Z65M'9[JVG?6^IZ?\
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M[!HVFPK;VMMYCR>7&.@W.2Q^I)-;-%%5*3DW*3NV3&*BE&*LD%%%%24%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC?O6O;K;?TVUM>_D="Q,'JD^6]K]+[>N^E[6\RAH?QB\7WG[>7B#X=3:OO\
M!MKX>6^ATW[-"-LQ6$[_ # GF'[[<%L<]*^FJ^,O#/\ RE$\5?\ 8II_Z#;U
M]FTJB2I46EO']6.C)N=5-[2_]MB?,O[6/QT\8^#_ !Q\._AI\/KBSTOQ-XQN
M2C:Q?0B=;*$,J[EC;*LQ)8\@\)C&3D>N_"/PEXY\(Z7?6_CKQZOC^\DF#VUX
MNCPZ;Y,>T90I$2&.<G/TKXB_:F\%^/?^&U/A;;_\+' OM5N9)-"O!H4'_$CC
M,IVQ[-V+G']Y\$U]4?$#XIW_ .RG\ Y]>^('B4_$#7[>1H8+I;"+3FOYY&8Q
M1"*,E4"KU89X0G&>*VY5'"TW&SE)OIJ];)+32VSM:[[G.IN6,J*5U&"771:7
M;>NM]U=.R[,]RHKY6\/^%_VH/'OABW\67'Q+T+P5J-Y$+JW\(1>'8KBW12-R
M1S7#DR(Q!&[;NQZUV'[+O[1M]\8QXD\,>+=)B\/?$3PK<?9=6T^!B89!D@31
M9).TD$$9./E.2&%92P\H\UFFX[I=/T?RN;QQ,9<MTTI;-[/KZKRNE<]YHKX9
M\1?M0_%V']J#XE_"_P 'V2>*-0)MHM MKJ"&.TTI?*1Y[B>10KLHW\!F/) '
M93]&_L[^'OB[X?T+5E^+_B?2O$VK370:R;2(52."'8,J=L,63N)Z@]!S2>'E
M&FJLFDFDUW=_\ON".(C*K*E%-N+:?96_SZ=>Z1ZS17B7[9GQ&\0_"C]G?Q+X
MG\*ZA_9>N6;6P@NO(CFV;YT1OED5E.58CD=Z\:\%^.OVF?VBK/P]XG\'76C_
M  _\$!;<-+K$,;WNK* HGF5/)D"J6#[0/+!&.3G-%&A*M%S322=FWZ7_ *ZC
MK8B-&2@TVVKI+UM_5]/,^TJ*^9OBK\=_&OBWXU?\*<^$/V"UUVSMA=Z_XFU.
M+SH=+B(4A4CZ/)\R\'(RP&/O%<+QA\0/B_\ LI:EH&L_$'QCI_Q/^'NI7T>G
MZC?C1XM,O-+:3[LH6(E73@YSDG&.,@T0H2FHZI.6R[]%][VO:XJF)C!RT;4?
MB:Z=?P6KM>W4^MJ*^8_VZOCAXL^!O@_P1K'A"]\B6\\0PVUW"L,,GVNW\MW,
M.9$8)NV@;EP1ZU:U3P?^TOXRTM]<M_B%X?\ A]J+(9+?PG:Z+'?PKW6.>\DR
MV_LS1IMSTI1HMP]HVDKM?=;HM>O3YVT*EB$INE%-RLGIV=UNVETZ_*^I])45
MX!^R/^T9J7QQT/Q#I'BK3H=(\=^%;TV&L6MN"(G.6"R("3C)1U(R>5R." .4
MU3XU?$7X^_%WQ'X%^#^IZ?X4\/>%W%OK7C.^LUO9#<Y(\FVA8[&P58'=UVDY
M'R[F\/-5'3[*]^EN_IJOO$L3!TU4[NUNM^UN^C^Z^Q]545\M:?\ %#XF_ 'X
MN>$?!WQ1U_3_ !WX8\7S&RTWQ1;Z>FGW%M><;8IH8R4VL64 CGYLYX(KU;XS
M1_%N^GT?3_AE+X<TVWN3(-2UC7%DEDLU&-IAB7AV.6^]Q\O.,YJ)4FN5III]
M>FF^]K?UW*C64N9---=.NNVU[_+S['I]<[\1/%Z?#_P#XC\326_VM='T^XO_
M +/YGE^;Y<;/LW8.W.,9P<9Z&OE'XQ>-/CS^R;8Z5XVU_P"(&G_%/P>;V.UU
M73I= @TV6W5SPT31')/! +'@E<J03CNOVT+?Q/XI_9WUGQ'X2\<?V!X>31)[
MJ^T]=*BN3JUO)&I5/-<AH/E)Y4$_-[4Y4;14E)6;:OKH[7UTO^ 0Q"<W"4&F
ME>VFJO;36WXH]9^!/Q3_ .%V?"7P[XV_LS^QO[7B>7[#]H\_RMLKIC?M7=]S
M/W1UKO:^,/V&_AY\3I?A#\.M>A^+GD>"MLDI\(_\(U:MF(3R!HOM9;S.6!;=
MC(SBN]^-'QZ\7ZE\8+'X-_"6&P_X2Z2V^W:OKFIH9+?2+; (.P?>D(9>#D?,
M@P=V5Z,1ATL3*E2[O371+NWV7FSDPF)E+"0K5NT==-6[;)=WTLM]CZ2HKY&\
M>^-OC1^RC'I?BOQKXTL/BKX"EO(K35S_ &)%IEYIRR':LL0B)5P">0V2>!@9
MW#U#]IW]I&Q_9_\ AG;Z]:VJZYK.K2I::+IZL=MS*XR&)'.P#DXY.0!C.:PE
M1EHX/FN[:=]--;=T=4:\=547+97U[:ZZ7[,]IKYD_8N^,?C#XLZE\5XO%>K_
M -JQZ'XA>QT\?9H8?)A#2 )^[1=WW1RV3QUIOAOP7^U#-I$'B74/B7X;BUJ1
M/M!\$W'A^,V"$C(A:[1A,".A(W8/=AR>#_X)IS7=Q)\9Y;^V6SOI/$Q>>W23
MS%BD/F%D#?Q '(SWQ71&BHPJW:;2^Y\T?^#JK_B<DZ\IU*-DTG)[]5RR\_31
MV_ ^V:**^*OAK\;OC;\4/C+\8/ 7A^\TS[+HVN/!!X@U:WC,>BV@DE18T@C5
M6N)6V_*7; \L[CS7)3IRJMJ/17^5TOU_IG=5JQHJ+EU=OG9O]+?\#4^U:*^'
M_&WQR^-/[*?Q:\.:#XRUBW^,>B>*HWATT6NF0:7=B[!")$HC^4 N\8)8MPQ(
MP1@]+\76_:7\"_#[4OB3_P )]X>@ETN'[?=^"+/0TDM5@4Y=!=N3*[!>3C;G
M!VD<5K]7T4^9<KZZVWM;:^G72R[F*Q-W*'(^9;K2]M[[V]-;^1]=T5YC\.?C
MKI'C+X Z9\4M1*Z7I<FEMJ%\N=PMS&&$RCUPR,!W/%>*?#WQ1\>/VI=+G\:>
M'/%^G_"'P5/-(FBVIT2+5+R^B5BOFS>:=J D'&WT/! #-/L)J<HRTY=_+^K/
M8KZS!PA.&O/JDNO]76_<^N:*^?OV?OC7XLU3XC>*OA1\28K'_A-_#T*7L&IZ
M:I2#5+)R )@A^XP+)D#CYN@VFK_CW0?CYXP\<:E8>&_%/AOX?>#(0GV35DT[
M^TM2N"5!;,4I$2@$D=CP.N>)=)QDDVK-7OTM_73<I5E*+DD[IVMUO_76]NMS
MW*BOD?PK\8OBA\%?VCO#_P +OBEK]CXWT;Q5"SZ1XD@TZ.QG289Q&\4?RXR-
MN.3\Z'=U%=%^T7\;_&FG_&7P1\'OA[<:?HGB#Q+!)>3Z_J<(G6S@7S/]5$>'
M?$4APV1P!WR+^KR<H*+34KV?32]][6M9W(^LQ49N::<+73WUM;:^]U8^EJ*\
M)\#^"_CYX/\ '&E+KGQ'T'XA>$9RW]HR7NAIIM[; *2OD+ =C9; )<\ ]*YS
MXV?&+Q?X1_:W^#O@O2=7^R>&?$$<S:E8_9H7\\KOQ\[(77H/NL*4://4C3A)
M/FOWZ)OM?H5*OR4Y59Q:Y;=NK2Z.W7N?3-%>;?M(^+M6\ _ ?QQXBT&[^P:Q
MINF2W%K<^6DGER <-M<%3]""*Y_]FCXA^(/B!^R_X;\7:_J'V_Q#>:?<SSWG
MDQQ[W2655.Q%"# 5>@[5DXM4I5ND;?BF_P!#55$Z\,/UDF_+1I?^W(]IHK\\
MO@7^T-^TA^TE\.X='\$S:?;ZW832_P!L>.-<MH8H 6;,,$,<<3*6"?>/E-U&
M<9!/NGQ2^._C3X&_#[P#X0N%L_&WQN\3!+*!8U$=HT^0))W"JF(U+ # 7."3
M@ UU5,)4IR5-M.3=DNOKZ>OKMJ<E+&TZL'42:BE=MK1>7KZ7[;Z'TS17RAXN
MTO\ :6^$_A&[\<S?$C0_'+Z; ;W4/"+>'XK6#RE&Z58+E")&*J#@L!G'0]*Z
MSXC?M96/AW]E*+XQ:'IXOC?6T)L[&=OECN)'\LI(1C(C?<#C&=O&,YK&5%I7
MBU+5+3N]M[;]]O,VC73=IIQT;U[+=Z7VZK?R/H.BOE;0_"'[3>L>$M.\76GQ
M=\.W.IWMM'?)X5N/#L*Z> ZAQ%]K0F4@ XW8Z]^]?3>A_P!I?V+8?VQ]E_M;
MR$^U_8@P@\[:-_E[B6V[LXSSC%%2E[.Z<DVM'O\ Y?D.E6]K9J+2>J;M_G^=
MB]17S'^V1\8/&7P-U[X7^(]'UC[)X.N=;73_ !!9&UAD6:-BK [V0NGR++]U
MAVKK_P!KSXI:Y\+O@[)=>$KI+;Q=J^H6FDZ/(T:28GFE SM=64_('Z@TE2DX
MPDOM/E^=U_FF-UHQE.+^RN9^FOY69[;575/MG]F7?]G^5]O\E_L_GY\OS-IV
M[L<XSC..U>.?L@_%C5_BU\$++5/$]TMSXHTZ[NM,UB7RTB_TB&0\E4 4?(4/
M  YKD_V2_C!XQ^,T?Q5\5:MJ_P!J\,V^M36'AVT6VA06\409BV]4#/E7BY<M
M]T^]*K1E#VB;^!7;7;1*WK>Z\@IXB,O9M+6;M9]'JW?TM9^9V'[+I^-!\*ZS
M_P +I%B-7^WM]@^R^1N^SX'WO(^3;G[N?FQG=VJUX3_:"3Q5^T=XR^%*:)Y'
M_".Z=#?'5_MF[SRXB)3R?+&W'F]=YSMZ<\><?L6_%'Q]\?/@!XGU#7/%('BC
M^U;K3['6#IT!%H!#$8V\E%1'VLY.#UZ$U\\_!_P'\4]<_;0^*^DZ?\7SI/BN
MQL5%_P")CX:M9_M\8, "?9F;9%C*<J?X/<UZ'L.;$3A5LK1O97MLM?EU\WLS
MS)8AT\-3G2N[SMK:^[NOG9I>6[6A]7?MQ?%#Q/\ !_\ 9^U/Q+X1U/\ LC6H
M;RUBCNOL\4V%>0*PVR*R\CVKV#P#J=SK7@7PYJ%[)YUY=Z;;7$TFT+O=XE9C
M@  9)/ &*^6OV]])UG0_V*;BP\0Z]_PD^M07EDMUJ_V-+3[4_G_?\E"53C P
M/2MSP=HGQ[^)WPS\/7^B>+M-^$=A%IENFG::^D1:I=W:+$H62YDD.V'?C(1%
M8J",DGBL(4XO#S=UI.U_+E7E?Y6^1TSJR6*@K/6%[>?,_.U^E[_,^IZ*^=?V
M-OC]XC^,>B>*]"\:V]M%XS\(:D=-U":S79%<<N%D"] <QN#C@X! &<#Z*KFJ
MTW2EROR_%77X'72JQK1YX^:^:=FOO/&?A;^T5_PLKXV_$;X>_P#"/_V=_P (
M>\:?VC]M\W[7N)'^K\M=F,?WFKUW4KS^S].NKK9YGD1-+LSC=M!.,]NE?#GP
M)^(7A;X?_MI_M"3>*/$NC^&X;FXA2"35[^*U65@Q)"F1AN(!'3UKZ7\0?M&_
M":;0=2CC^*'@R21[:155?$%H224. !YG6KQ%*4:,)TUJX)_.Q&&K1E6G"K)6
M4VNVB9G?LJ_M%?\ #37PYN_%7_"/_P#"-_9]1DL/LGVW[5NV)&^_?Y:8SYF,
M8[=>:]FKXT_X)5?\FZ:M_P!C%<?^B+>M'3?BW\5/VFOBIXTT'X9^)=/^'7@W
MPC=?8)]>FTM-1O+VY!8$)%(=@3*-Z$#!R=V!U8G#J.)G3IZ))/T5E^K.+!XJ
M4L+"K5=Y2;7FW=_HO334^NJ^9/V@/C'XP\$_M1?!7PCHNK_8O#WB*:1=4L_L
MT,GV@!U ^=T+KP3]TBO)(-:_:+T_]I:#X1^(/CC'IKZAISZCI.L6OA2PN$NT
M7<2C1E4,9Q')_$W*XYSFKO[:VH:SI'[5OP!NM"TQ->UR$S&UL9)Q;I<2^8@
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MWM=I?>[&TI<L7*U[)O[E<^@**\G\>_&RWT+]F?4?B=92*BMX?74[,G!'FRQ
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M$V,A49,2W,F9><8!*CZCK2Y%>7-))+KK^B97M)6CRP;;Z:?JTCZDKR+X2_M
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MMG@C4KO6+[3*'</MXY##/&['-;'["_C+XA_%SP8/'7BSXEOXGL9A-82>'Y-
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M_O;6[LM+=;;JU];?25%>"?L;?'_5OC[\-;ZZ\26<-EXIT/4)-*U);<;8Y'4
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M/9>'])LM+TZVCL]/LH4M[>WB&%BC10JJ/8  5I6J1E3]YJ4K[I6TMUT5W?\
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MCY%. 1FNR=>G+%3FG[LHN-_5+_(Y%AJGU2%.WO1FI6[I2>G;9W.>_P""EO\
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M]U(0C%O-C7D\9R.E>N7GP%^/E_:3VUQ^TJ)8)D:.1#X"T_#*1@C[_H:ZK4O
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M^Y 523[!F0_A6I\._A?\;/%/@'P[J^A_M,1C1[S3X)K1(_ FGLJ1E!M3._\
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ME%J_)RJ/FH2YEZ73Y?Q."_X)]^&[V[^!_B7QK=#RM9\<ZQ>ZGYS?>"[FC3\
MXE(_WJ\0_87^'_Q/U[P3XLTGPK\91\/[K2-=FBU/0V\+VFH2"8JH\YI)6#?,
M49<= 8S7WU\+_ 5I\+?AUX<\)64GGV^C6,5F)MFPRLJ@-(5R<%FRV,GK7E'Q
M$_9+M]:^(5Q\0/ 'C#4_ACXVNUV7E[IL*7-K>].9[9R%<\#N 2,D$\T?6(*M
M5Y?ADDEI>RC\.C\M_D[#^K5)4*7-\46VU>UW+XM5UN]/FKZG+:I^R-\1_&GC
M3P3KOCCXX_\ "4P>%=6AU6VLU\)6UDS,CJS+YD4H(#! .0P'I7D_Q(\.>+I_
M^"CEY:Z)X['P]U/7/#T?]EZK+I$.HB5%C3? L<I"@DQ2-N!S\N/XJ^E?A[\#
M?'6B^,;+Q)XU^,^O>-+BR5UATZVL+?2]/<,I4^=!&&$A&<@Y!!%;'QV_9T\,
M?'S3].&KR7NDZYI,OGZ7KVDR^3>64F0<HV#D94'!] 00>:B-?V=2+;36JT5K
M<RM>UE?IOYHN6&]I3ERQ:D[;R;ORN^]W;KMZGE_B[]F/XV>//#&I^'M=_:-%
M_H^I0-;75L? MBGF1L,$;ED##Z@@BN6_;%\ GX5_\$_3X0.H-JW]BQZ;9?;6
MB\HS;+B,;MFYMOTR<>M=VO[-?Q8U:%=,\0?M&^(+SP^,*T&DZ):Z=>LHZ W:
MEGSZDCFN]_:&^!I^/7P;O? ;:_)I#7+6['5);47+_NI%?+(&C!+;><$=>G:I
ME5LX+F37-%NRML]]EYZ%1HWC4?(TW&25Y7W6RU>[MKH?!W_"&_&/0/!/@?\
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MSWA\:?%2?XAV[P)!;0S:+!8?9]I^^6C9FD8C@ECFLS]F3]G7_AG/0?$NF_\
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M79Z&,<+4Y:J2M><9QUWM&.[\[-==>ZLSU^OB?_@H0C?\+3_9T?:=@\2D%L<
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MWMYOH?;5?%_[!W_);/VDO^QD7_T==U]H5XO\!_V<O^%)>-OB3X@_X2'^VO\
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MP?\ "0_\(_\ V!JR:IN^Q?:?/VC'E_ZQ-O\ O<_2MC]I'X*?\-!_"74_!/\
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M'RIRYKJ/AW^R0-)^)4'Q#^(OC;4/B?XRLUVZ?<WUJEI:6(_O16R%E5ADX(.
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M%*",A<9(('7!Q77_ !*_9-M?$?Q!E^(/@;Q;J?PS\=3Q^7=:CI<23V]Z./\
M7V[X60_*.X!P"02 :O> ?@7X]TGQCI_B+QM\:M>\8RZ?N\C3K/3[?2K&3<I4
M^?#&&$O!X.00<$&NYXKG<:L9*+26\4W=+H[/MI=JWR.7ZKR\U.47)-O:32LW
M?577?6R=_F>W5^>B^$_&UU_P4)^)FEZ!\1!\.=:U73HKNSO9=%@U+[;;!(?W
M2+,P"XVDY7D^6WH:_0NO(OCI^S3X=^.%QI.K37VH>&O%VC-NTSQ'HTOE75OS
MG:3T9<\XZC)P1DYX</45&KS/9IK[^MNNJ6G:YW8JBZ]+D6Z:DNFW2ZVT;U[V
M/,?'G[*?QD^)WA/4/#/B;]HD:GH>H*J7-J? ]E'O"L&'S)*K##*#D$=*Y'_@
MH-X7/@G]C#PUX=-VU^=)O--L/M3)L,WE0NF_;DXSMSC)QGJ:]-M?V</BIJLU
MM!XJ_:(\0:EH\$BR"VT31;72KARI!4/<(79AP,@@Y[UUO[4'[/Y_:0^&*>$#
MKY\/E;V&\^VFS^U$[ PV[-Z==W7/;I71[7EG3O)-*46[*VS6NRZ7.>-&\:C4
M&I.,DKRONGIN^MC._:3T/POX@_93\16WC"\ET_0TTB*=[N"/S)(I4"-$RK_$
M?,"#;D9SC(ZUX_\ !_QU^TO9_!'POH6G_"_1]2DETF!-,\5W6O0PQ06YC'DO
M/:\NSJFW.T\\<=:]+_;2\1Z%X%_9BU?3->L9-9BU2.'1+6VBD$!DN&_U;[R"
M$"F/?T/W,5SG@C]FWX[^$?!^C:-9?M&M86]E:1PK:'PA:7HAVJ!L6:5][JO0
M%NP' Z4Z?+*G4YK<LI=;VT6NVM[-7Z6L9U%.-2DHI\T8N]K7LVK?%I:ZE\[G
MI7[+?P'_ .&>OA7#X>N;]=5UJ[NI-2U2]C!"2W,@4-LR,[0%503@G&<#.!X7
M_P $]_\ DHG[1/\ V-1_]'75=%\'?C#\2_"_[3]_\%_'^N:?XY0Z7_:=MK]G
M8+931\ A98X_D (R,8SDKR<XKT?]GO\ 9Q_X4/XB^(FJ_P#"0_VY_P )=JIU
M/R?L7V?[)\\K;,^8^_\ UN,X7[O3GBI2<?:2J-/GCI;_ !1^ZW*_N)C#G=*-
M.+7LYN]]_@EKOK=R6U]SP_\ X*#$K\6/V<B#@_\ "2G_ -'VE=3_ ,%-U9OV
M6KX@$A=5LR<#H-S#^HKT/]H3]FO_ (7QXK^'.M?\)'_8?_"'ZD=0\C[#]H^U
M_/"^S=YB;/\ 4XSAOO=..>]^+GPLT3XT?#W5_!_B%)3IFHQA6D@8+)$ZL&21
M"01N5@",@CCFN=5(QH48]8R;:\N9/\;';*E*52KVE#E7K:2_"Z+'PM_Y)CX1
M_P"P/9_^B4KJ*\*^"/P%^('PEOM+M-2^,5YXL\(:7;M;6F@W&AP0%4V[8PUP
M':1MG&,\<8Z5[K48CE=1R@[IZ]1X7GC2C"<;-)+IT72W3[GY'P%H_C'_ (9=
M^-7[3ND9^SV=UH[>*]*7. 96X 7ZR7 7_MG5/QU\/9_@G^R;\!?'4<;+JG@[
M5K36]0.#O:.\?S)U8]<Y:-#["O<_VFOV++7]HSQUHOB,>*I/#1M;06&H6\-C
MYYU"W$PE"%O-3;@YZANH/:O8OBY\,++XL?"OQ!X(N)186NJ61M$G6+S/L[#!
MC<)D9VL%.,CIU%=,<1&G3IS6LDXW](72U_O)G*\-*=2I!Z0?-9^<TKZ?W6GO
MWTZGSK\.V3XN?\% O&GB="+G2/!&@P:79R@Y43SC<2.W1K@?E7G/B[PSXQN/
M^"C?B2QT/Q^/AYJVM:#%)INIR:/!J/VB%8XMT"1RD*#F&1MPY_=D=Z^E_P!E
MK]FE?V;?#NNV<_B-_%FJZQ?"[N=4EM/LS%5C")&5\Q\[?F.=W\?2M?X[?LX^
M&OCS;Z7/J,]]HGB+1Y/.TOQ!I$ODWEF^0?E;'*Y .#Z9!!YI^VIT:T.1WBH\
MM[=]6[/^\]NVA/L*M:C-S5IRES6OV:25U_=2UZ/T/+_&7[+_ ,:?B#X6U+PY
MX@_:,&H:-J4)@NK4^!K&/S$/4;DD##IU!!KR;]N;X=ZA\,?@G\"=+CUR1M.\
M*ZG;6%SK360=8V6)5CN&A9B"!Y;D(6(/W<U[?'^S7\5]72/3_$O[1GB&^T%2
M,P:-HMKIEXR@\ W2%F/OD'/>O;/&_P /=#^)'@N]\+>)K,:QI%["(IXY^&?&
M"'RN-K@@,"N,$<4O;NG*,E)-*2=DK;?)=V7]756,XN+BW%J[=]_F_+L>)V_P
M7^/MU;QSP_M.++#(H=)$\!Z<592,@@[^016U^S[^SK?? #0_';:EXN_X2_4/
M$EY)JEQ<C35L564HV\B-9'7+$D\8'08KF=%_93^)/@/3TT+P1^T#K>B>$H1L
MM]-U+0K74IX(_P"XEPY!4 < !0!Z5[3\.?AW/X!\#_\ "/7'B?6O%4S&5WU3
M7IEGN&:0DL,@#Y02<*<X!QG %98B=Z4XTY)\RM;E2??73R74TP]/EJPE4B[Q
M=[\S:[::ON]T?EQ^SM\%?B9^TE\(?$/@_1KU-#\":7?W6I-,X.-3U,QH(K=C
MGE5"*2>B[LG)VX^_/V,_CD/B_P#"U--U2!--\9>%F&D:UIH01F.2/*)($'W5
M8*> ,!E<#@"MO]EO]GG_ (9J^']_X9_M_P#X2/[5J<NH_:OL7V7;O2-=FWS'
MSC9G.>_2J/\ PS+_ &-^TF?BUX8\2_V#]OMOLVNZ%]A\Z'4^V_>)%\MN$.=K
M?,F>Y![,1B:=:<J?V6DT_P"\EUZZ_#Y61QX?"U*$8U4O?3::O]EOITT^+YON
M8OQB_8UTSQWXYE\?^#/%6K?#;Q](N)=5TALQ71&!^^BRN[(4 X8 X^8-7.?
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M34O[)UU+NU@@NO)BFVAY0'&R164Y4,.GO7L_A6]FU+POH]W<OYEQ<6<,LCX
MW,R DX' Y/:M%3;INKT3M^%S)U$JJI=;7^5VOT-6BOC+]D'_ ).Z_:5_["4/
M_HV>OLVG4I\B@[_%%/[U<5.ISN:M\,FON=@HHHK(V"BBJ&O:B='T/4;]5WM:
MVTDX4]]JEL?I4RERIR?0J,7)J*ZE^BO@#]B[X(^&/VG/"6J_%3XF)?\ BCQ?
M+K\JP74VH3QK:K&(W58T1PNW+GY2"    *^C/"O[,)\,?M+^(?BW_P )EJ=V
MNK6QM_["=,11Y"C!DW'<B[<JFT;3W.*[JE"-&?LYRU2UTTO9-)>O>RL>=2Q,
MJ\/:TXWBW9:ZVNTV].EMKNY[G1117&=X444R601QNY(4*"23T%3*2BFWT ?1
M7SE^PO\ &#Q1\:OA;KVN>*]3_M6]@\075G;R>1%#L@5(F1,1(H.-YY(R<]:^
MC:WJTY49\DM]/Q5S*G456/-'NU]SM^@445Y/^UA_R;/\3O\ L7[S_P!%&LC8
M]8HKP7]A'_DTOX=_]>DW_I3+7O5;UZ?L:LZ5[\K:^YG+AJWUBA"M:W,D[>JN
M%%%%8'2%%%% !1110 4444 %%?%O_!/?_DHG[1/_ &-1_P#1UU7VE6U6G[*2
MC>^B?WI/]3GH5O;1<K6LY+_P&3C^-KA117SE^W7\8?$WP6^$>E:OX2U0:3J]
MWKEM9>?Y$,Q,3+(SC;*K#G8.<9'K44X.I.--;R:7WNQI4FJ=.526T4W]RN?1
MM%,B8M$A/)(!-/J"T[JX4444#"BBB@ HHHH **** "BBOEC_ (*6_P#)J>M?
M]A"R_P#1PJHKFG&/=I?>[$3ER0E/LF_N39]3T5R_PM_Y)EX1_P"P/9_^B4J/
MXM>([CP?\+?&&NV<PM[S3=(N[N"4A3MD2%F4X8$'D#@@BBJO92DM[7_ *$O;
M1A):<UOQ.LHKQO\ 9 ^(&O\ Q2_9V\(^)_$]_P#VGKE^EP;BZ\F.+>5N)$7Y
M8U51A5 X Z5[)5UJ;HU)4Y;IV^XBC5C7I1JQVDKA11161L%%%% !117S=^W1
M\9/%'P9^'?AB_P#"6J_V1J>H>(;>RDF\B&;="4D+IME1ASA>0,C'6M*<'5G&
MG'>32^]V,JU14:4ZLMHIO[E<^D:***S-0HHHH **** "BBB@#Q;]J#]G'_AI
M+P[X=TK_ (2'_A'?['U5-3\[[%]J\W:C+LQYB;?O9SD].E>TT5Y1^U3X^U;X
M7_L^^,_$^A7@T_6;"T5K2Z,:2>7(TB(#M<%3][H0:MSERJ'2_P"+LOT1FJ<5
M-U$M6DODKM?FSU>BN'^!OB34?&/P7\":]J]Q]KU74]#L[R[N-BIYDLD*,[;5
M 49))P !Z"NXIU(.E.5-[IV^X*=1581J1V:O]X4445F:!1110 4444 %%%%
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MC0:Y86=VE]%;7.[R_-0$*6 (W#DY5LJ>X->:_&_]F$_&;XH> O&(\9:EX?\
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MB'W6 ./K7T?6C@XPC/I*_P"#:_-&:J*525/K&WXI/]0HHHK,T"BBB@ HHHH
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MY]ONIMRR*C.-DDK*,E0>!QCBO//^"G6FW%]^R_<S0QETM-6M)IB!]U"63/\
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MX*;:1:>'_P!EWPUI>GPBWL+'7+*VMX02PCC2WG55R22<  <G-?9EE_QYP?\
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M2O<O^"BVL7&L?#+PA\/]+?=J'C?Q!:V$84_>B5@Q/TWF+\ZYKX6?!^X^(/[
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MSK@?VC_A;I'[(?CWP-XF^"^J7F@>(];U>*RF\'PW;SP:A$2<GRF);;N(7!R
M7&W:0*[[]N[/_"[/V9LC!_X2I>/^WBSK:C>6)P]7F;3DUKNK+7\S.I:%&O2Y
M%%J-]-FG>W:ST?X:L3]N>QD^%/Q0^$WQRL8V"Z+J2:7J[1CEK60L>?\ @)G7
MZNM>Z_M/?%:+X5_L^^+/%5O<)Y_V Q6$BG(::;"1$>O+AOH*T_VBOAA'\8_@
MKXM\)LBM<7UDQM"PSMN$^>(_]]JOZU\*Z+X\F_:@\(_LZ_!Z=WDNK6]D?Q/
MQ^9(+#**L@]7B!Z_Q$5RT::Q5)49?9EK_@EJ_NM+[T=->H\)6E77VH_^3QTB
MOG=+Y'K_ (9UJ;]B?]@?3]8CM5?Q5?Q)=+'.O'VZ[(*[QW\N/;D=_+QWK>\
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MM8&7]W]KN8T(R/[JEBV/1<4O[?G_ ":1X_\ ^N5K_P"E<->8?%[X8ZG\4O\
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M5^!?Q[UGQ/\ L7Q?$?4(CJ7B#3='O'FXYN9K7S%#MC^_Y:L<>IKBOB5^S_\
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M9A4EM"$)?="-O_)FON.B3?U6I3CO.<X_?.5__)4SM?VD[D? W]LKX2?$M?\
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M;K2?@Q=>,]77.O\ CK4I]<NI&'S>6S$1#/IC<X_ZZ5Y5X=\.V7[6G[5GQ/\
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M5/R>NG6R/=OA%^S7X6^ NO:MJ'A34-;L=$N[=4'AZXU*6?3[5@<M*B.2=Q
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MWWQQT6W\-_MK?LUZ3:;OLMA8O:P[SEMB*ZKD]S@"O5OV /\ DTCP%_USNO\
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M4U@_M5?"'X=?L_WGA2'X'RWOA[XN76K0PVVEZ+JUQ<S31'=GS8WD<A2VT8.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!(KZ5^&_Q+\-_%SPE:^)O">I?VMH=TSI%=>1+#N*,58;9%5A@@CD5C_L^_\
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M'NBZ[X33Q!\9_B%XC\>7$EK]LOA?:U)::1;@KO)CCC9=J*.^X XSA<XKF/\
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M_'/Q$^+U]K\LT$HN/"=DDD>FPR.,+L'F!"$R<?N@<@'/<^??ML?\G*?LS_\
M8?/_ *46U?:%<D9^SPE-Q6K<U?RO_7F=DJ:JXR:DW:*@TK];?\#T"BBBN ](
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8#'W6W+Z@UW_ ,%?@+X<^ MEXAM/#4M\]MK6J2:K-%>/&RPR. /+B"(NV,
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img42689296_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img42689296_3.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" =>#*H# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH_\ 0 NO_'O_ (BC_A*M1_Z %U_X]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\
MXBC_ (2K4?\ H 77_CW_ ,10!TU%<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_
M (]_\10!TU%<S_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C
M_P! "Z_\>_\ B*/^$JU'_H 77_CW_P 10!TU%<S_ ,)5J/\ T +K_P >_P#B
M*/\ A*M1_P"@!=?^/?\ Q% '345S/_"5:C_T +K_ ,>_^(H_X2K4?^@!=?\
MCW_Q% '345S/_"5:C_T +K_Q[_XBC_A*M1_Z %U_X]_\10!TU%<S_P )5J/_
M $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !% '345S/\ PE6H_P#0 NO_ ![_ .(H
M_P"$JU'_ * %U_X]_P#$4 =-17,_\)5J/_0 NO\ Q[_XBC_A*M1_Z %U_P"/
M?_$4 =-17,_\)5J/_0 NO_'O_B*/^$JU'_H 77_CW_Q% '345S/_  E6H_\
M0 NO_'O_ (BC_A*M1_Z %U_X]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_
M (2K4?\ H 77_CW_ ,10!TU%<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_
M\10!TU%<S_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C_P!
M"Z_\>_\ B*/^$JU'_H 77_CW_P 10!TU%<S_ ,)5J/\ T +K_P >_P#B*/\
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M (BC_A*M1_Z %U_X]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_ (2K4?\
MH 77_CW_ ,10!TU%<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_\10!TU%<
MS_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C_P! "Z_\>_\
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M_H 77_CW_P 10!TU%<S_ ,)5J/\ T +K_P >_P#B*/\ A*M1_P"@!=?^/?\
MQ% '345S/_"5:C_T +K_ ,>_^(H_X2K4?^@!=?\ CW_Q% '345S/_"5:C_T
M+K_Q[_XBC_A*M1_Z %U_X]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^
M@!=?^/?_ !% '345S/\ PE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$
M4 =-17,_\)5J/_0 NO\ Q[_XBC_A*M1_Z %U_P"/?_$4 =-17,_\)5J/_0 N
MO_'O_B*/^$JU'_H 77_CW_Q% '345S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z
M%U_X]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_ (2K4?\ H 77_CW_ ,10
M!TU%<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_\10!TU%<S_PE6H_] "Z_
M\>_^(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C_P! "Z_\>_\ B*/^$JU'_H 7
M7_CW_P 10!TU%<S_ ,)5J/\ T +K_P >_P#B*/\ A*M1_P"@!=?^/?\ Q% '
M345S/_"5:C_T +K_ ,>_^(H_X2K4?^@!=?\ CW_Q% '345S/_"5:C_T +K_Q
M[_XBC_A*M1_Z %U_X]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?
M^/?_ !% '345S/\ PE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$4 =-
M17,_\)5J/_0 NO\ Q[_XBC_A*M1_Z %U_P"/?_$4 =-17,_\)5J/_0 NO_'O
M_B*/^$JU'_H 77_CW_Q% '345S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z %U_X
M]_\ $4 =-17,_P#"5:C_ - "Z_\ 'O\ XBC_ (2K4?\ H 77_CW_ ,10!TU%
M<S_PE6H_] "Z_P#'O_B*/^$JU'_H 77_ (]_\10!TU%<S_PE6H_] "Z_\>_^
M(H_X2K4?^@!=?^/?_$4 =-17,_\ "5:C_P! "Z_\>_\ B*/^$JU'_H 77_CW
M_P 10!TU%<S_ ,)5J/\ T +K_P >_P#B*/\ A*M1_P"@!=?^/?\ Q% '345S
M/_"5:C_T +K_ ,>_^(H_X2K4?^@!=?\ CW_Q% '345S/_"5:C_T +K_Q[_XB
MC_A*M1_Z %U_X]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?^/?_
M !% '345S/\ PE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$4 =-17,_
M\)5J/_0 NO\ Q[_XBC_A*M1_Z %U_P"/?_$4 =-17,_\)5J/_0 NO_'O_B*/
M^$JU'_H 77_CW_Q% '345S/_  E6H_\ 0 NO_'O_ (BC_A*M1_Z %U_X]_\
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MM1_Z %U_X]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !%
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MS/\ PE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$4 =-17,_\)5J/_0
MNO\ Q[_XBC_A*M1_Z %U_P"/?_$4 =-17,_\)5J/_0 NO_'O_B*/^$JU'_H
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MX]_\10!TU%<S_P )5J/_ $ +K_Q[_P"(H_X2K4?^@!=?^/?_ !% '345S/\
MPE6H_P#0 NO_ ![_ .(H_P"$JU'_ * %U_X]_P#$4 =-17,_\)5J/_0 NO\
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M/^$JU'_H 77_ (]_\10!TU%<S_PE6H_] "Z_\>_^(H_X2K4?^@!=?^/?_$4
M=-17,_\ "5:C_P! "Z_\>_\ B*/^$JU'_H 77_CW_P 10!TU%<S_ ,)5J/\
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MOSA+^5-?>[EFBBBF,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[Z?<C[O^('_!2'X*^!;Z2SM]4U'Q7/&VR3_A'[02QJ?:21HT<>Z,PJ?X:_\
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ML+;QQXGBT2YOD:2W@%M/<2,JG!8K"CE1GC) !P<=#7GW_#PW]G[_ *'_ /\
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M/W_0@?\ E9U#_P"2*7UW _\ /K\$']GYC_S^_P#)I?Y'YS_\/#?V@?\ H?\
M_P HVG__ "/7V=_P3D_:(^(7QXF\?+XZ\0?VX-+6Q-I_H5O;^5YAGW_ZF-,Y
MV+USC''>O2O^'>7[/W_0@?\ E9U#_P"2*]%^$/[._P /?@,VJMX%\/\ ]AG5
M!$+O_3;BX\WR]VS_ %TCXQO;IC.>>U8UL7A)TI0A3M)[.R[HZ,/@L=3JQG4J
MWBMU=GS=_P %0OC9-X)^%VG>!M-G,6H>*'8W;(V&6SC(W+_P-RJ^X5Q7YC>
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MGCY%?EJ+I=?U^04445\\?4'EG[3GQ>7X&_!'Q-XL4J;^W@\BP1OXKF0[(_J
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M"=F/XU]9FE10P_*]Y/\ +7_+[SXG)Z,JF)Y^D5^>G^?W'<4445\@?=!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^S-.=3E955B9)1[.Y.#W4+7@8*DZV(@NBU?RV_&WXGTN85E0PLY=6K+YZ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .9^)OBJ/P/\ #GQ/XAE?8FEZ;<7F[W2-F'Z@5_/Q//)=3232L7ED8NS'
MJ23DFOZ!/BA\/+#XL> -;\(ZI=WECIVK0?9[B;3W1)PF02%+JRC.,'*G@FOE
M;_AT_P#"3_H8O&G_ ('6G_R+7JY=B*6&E.53K;\+_P"9XN:8:MBXPA2Z7O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8GB1_P"1K+_KVO\ TJ1WU%%%> >V%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M8WC3_D3]=_Z\)_\ T6U<[\$?^2:Z5_O3?^C7KHO&G_(GZ[_UX3_^BVKG?@C_
M ,DUTK_>F_\ 1KU\?5_Y*6E_UXG_ .EP/>A_R*)_]?(_^DR.[HHHK[ \$***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!Q/QH_Y)GK/TA_]')6QX#_Y$?P__P!@^#_T6M8_QH_Y)GK/TA_]
M')6QX#_Y$?P__P!@^#_T6M?'P_Y*:I_UXA_Z<F>]+_D41_Z^2_\ 28F]1117
MV!X(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG)@F7B2,_1@?J,'O795^*5*<Z,Y4ZBLT[,_7J=2-6"J0=T]4%%%%9F@4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '$_&C_DF>L_2'_T
M<E;'@/\ Y$?P_P#]@^#_ -%K6/\ &C_DF>L_2'_T<E;'@/\ Y$?P_P#]@^#_
M -%K7Q\/^2FJ?]>(?^G)GO2_Y%$?^ODO_28F]1117V!X(4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%>8W?[07AVSNIK=[
M+5"\3M&Q6*/&0<<?O*\C,,VP.5*,L=54%+:_6VYW87 XG&MK#P<K;V/3J*\L
M_P"&B_#?_/EJO_?J+_XY72>"?B=I?CRZN8-/M[R%[= [&Y1%!!..-K&N#"\3
M9/CJT</AL3&4Y;)=>ITULHQ^'INK5I-16[.OHHHKZ8\@**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH QO&G_(GZ[_UX3_\ HMJYWX(_\DUTK_>F_P#1KUT7C3_D3]=_
MZ\)__1;5SOP1_P"2:Z5_O3?^C7KX^K_R4M+_ *\3_P#2X'O0_P"11/\ Z^1_
M])D=W1117V!X(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '$?&C
M_DF>L_2'_P!')6UX#_Y$CP__ -@^W_\ 1:UB_&C_ ))GK/TA_P#1R5M> _\
MD2/#_P#V#[?_ -%K7QT/^2FJ?]>(?^G)GNR_Y%$?^ODO_28F[1117V)X1'/!
M'=0R0S1K-#(I1XY%#*RD8((/4$5^0G[4WP3E^!OQ8U#2H8V&A7N;W2Y3D@P,
M3^[SZHV5/? 4]Z_7^O"_VPO@;_PNSX3W,=A;^;XDT?=>Z9M&6D('[R$?[ZC
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M#_T6M?'P_P"2FJ?]>(?^G)GO2_Y%$?\ KY+_ -)B;U%%%?8'@A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45F:AXHT;2;@V][JU
MC9S@ F*XN41L'H<$YJM_PG7AO_H8-*_\#8O_ (JN&6.PE.3C.K%-?WE_F=$<
M/7DKQ@VO1FY16+'XV\.RR*B:]I;NQPJK>1DDGL/FK:K:CB*.(NZ,U*W9I_D1
M.E4I_'%KU04445T&04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >6?";_ )'OXA?]?X_]&35ZG7EGPF_Y'OXA?]?X_P#1DU>IU\=P
ME_R*8_XZO_IV9[N=_P"^O_##_P!(B%%%%?8GA!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &-XT_Y$_7?^O"?_ -%M7._!'_DFNE?[TW_HUZZ+QI_R)^N_]>$__HMJ
MYWX(_P#)-=*_WIO_ $:]?'U?^2EI?]>)_P#I<#WH?\BB?_7R/_I,CNZ***^P
M/!"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .)^-'_ "3/6?I#
M_P"CDK8\!_\ (C^'_P#L'P?^BUK%^-3*OPTU@$@%O) R>I\U#6M\/;B*X\#Z
M%Y4J2[+*%&V,#M8( 0?0BOC827^L]17U]A'_ -.3/?DG_8\7_P!/'_Z3$Z*B
MBBOLCP HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ?7Y?D_(^"X:QTL)B)8"OHF]/*2Z?/\ ,^WZ***_(C]2"BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 <1\:/^29ZS](?_1R5M> _^1(\/_\ 8/M__1:UB_&C_DF>L_2'_P!')6UX
M#_Y$CP__ -@^W_\ 1:U\=#_DIJG_ %XA_P"G)GNR_P"11'_KY+_TF)>UK0[#
MQ%8266HVT=U;/U1QT/J#U!]Q7@?C_P"!U]H/FWNB[]1T\99H<9FB'T_B'N.?
M;O7T716F?<,9?Q!3MB8VFMIKXE_FO)_*SU)RW.,5E<[T7>/6+V?^3\T?$D<D
MEO*LD;-'(ARK*<%2.X/8U['X ^/4MKY=CXDW3P_=6_09=?\ ? ^\/<<_6NW\
M??!W2_&'F7=KMTW53R9D7Y)3_MK_ %'/UKYY\3>%-4\(WYM-3M6@?JC]4D'J
MK=Z_GS$Y?G_ .*^L4)7I/[2UA+RDNC_J+/U"CBLLXEH^RJ*TUT?Q+S3Z_P!7
M1]?V-_;ZG:175I/'<V\@W))&P92/K5BOD3P=X]U?P3=^983Y@8YEM9.8Y/P[
M'W'-?17@7XH:1XXB6.)_LFI 9>SE/S?53_$/U]17[3PWQO@,^2H5/W=?^5O1
M_P"%]?3?UW/S_-N'L3EMZD/?I]UT]5^NQ\W_ /!0KX%CQ9X.@^(&E09U70T\
MJ_5%&9K,G.\^IC8Y_P!UV/85^?O@OQ?J7@'Q9I7B+1YO(U+3;A;B%^HR#RI'
M=2,@CN"17[>WEG!J-G/:7423VT\;12Q2#*NC##*1W!!(K\?/VEO@O/\  WXJ
MZEH2J[:1,?M>ESMD[[9B=JDGJR$%#[KGN*_J#A/,HXBC++J^MMK]8O=?+\GY
M'X+Q/E[H58X^CI??R?1_/\_4_5[X6_$73?BQX!T;Q5I3?Z+J$ D,18%H9!P\
M;8[JP(_#-=77YP?\$]?CH?"/C.;P!JMQMTC7G\RQ9V.(;P#&T>@D48_WE0=S
M7Z/U\%G.6RRO&2H_9>L?3_@;'VV4Y@LQPL:WVMGZ_P#!W"BBBO#/9"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHJO?:A:Z7:O<7EQ%:P)]Z29PJC\34RE&$7*3LD.,7)VBKLL4C,$4
MLQ"JHR2> *\G\5?M!:7IN^'1;=M3G''G292$?^S-^GUKQ[Q1\0]>\7,PU"^?
M[.3D6L/R1#_@(Z_CDU^8YQXA93EMZ>'?MI]H_#\Y;?=<^PP'"^.Q=I55[./G
MO]W^=CWKQ5\;/#WAS?%!*=6NUX\NU(* ^[]/RS7CGBKXS>(O$V^*.X_LRT;C
MR;0E21[OU/X8'M7$VMK/?3I!;PR3S.<+'$I9F^@'6O3/"OP#UG5]DVJR+I%L
M>=C#?,1_NC@?B<^U?DM;/^)^+ZCH8*+4.T-%_P!O3?ZM)]C[>GEF3Y%%5,0T
MY=Y:OY1_X%_,\OR6;)R237;^%?@[XB\4;)3;?V=9MSY]X"N1_LKU/\O>O>_"
MOPQ\/^$=CVEF)KM?^7JYP\F?4=E_ "NKKZW)_"^,;5<VJW_NP_63_1+U/#Q_
M&#=X8&%O.7Z+_/[CSSPK\$/#_AW9+=(=7NUYWW0'E@^R=/SS7H*(L:*B*%11
M@*HP /2G45^TY?E>"RJG['!4E"/DM_5[OYL_/\5C,1C)\^(FY/S_ $6R^1Q/
MQH_Y)GK/TA_]')6QX#_Y$?P__P!@^#_T6M8_QH_Y)GK/TA_]')6QX#_Y$?P_
M_P!@^#_T6M>'#_DIJG_7B'_IR9Z4O^11'_KY+_TF)O5G:QX>TSQ!#Y6I6$%Z
MF,#SD!*_0]1^%:-%?5U:5.M!TZL5*+W35U]QXD)RIR4H.S78\D\1?L\:5>;I
M-(O)M.D[12_O8_IS\P_,UYCXB^#_ (G\.[G:P-];K_RVLCY@^NW[P_*OJFBO
MSC-/#W)<PO*E!T9=X;?^ O3[K'U>#XHS#"V4Y<Z_O;_?O]]SXB92C%6!5@<$
M$<BN@\/?$#Q!X7VKI^IS1PK_ ,L)#OC_ .^6R!^%?4/B#P3H?BA3_:6FP7#D
M8\[;MD'_  (8/ZUYEXB_9SADWR:)J31-VM[P;E_[[49'Y&ORW%^'^>Y/4^L9
M75Y[=8ODG]U_RD_0^RH<3Y;CH^RQD.6_=<T?Z^1%X=_:-'RQZWIF.QN+(_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMI7@N8762*6,X9&4Y# ]B"*_8+]F;XTP_'+X4Z;KCO&-9@'V35(4P-EPH&6
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MMUZ1PH%7\A5FOT[)_#7+L%:IF$G6GVVC]V[^;L^Q\AC^+<5B+PPJ]G'ON_\
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MOCO5M!U'09_)U&RGLY.PF0KGZ'O^%0Z?J5WI5PL]E<S6DR])(7*-^8KT<O\
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M117V!X(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /S _X*K?L>^%--\%^+OCLVO^)+[Q?<7ME;BSNKF!
MK"*-F2$(D8A#@!1Q\YYR3G-?='[)G_)KGPB_[%+2_P#TDCKPW_@K7_R9;XB_
M["6G_P#I0M>Y?LF?\FN?"+_L4M+_ /22.GAM*%:*V4XV_P# 6%;6K3D]W%_^
ME(]7HHHI %%%% !16=K&N0:''&\ZR,)#M'E@'^9%97_"?Z=_SQN?^^%_^*H
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M_P 57U=*G"C3C2IJT8I)+LEL>).<JDG.3NWJ=-17,_\ "?Z=_P \;G_OA?\
MXJC_ (3_ $[_ )XW/_?"_P#Q5:D'345S/_"?Z=_SQN?^^%_^*H_X3_3O^>-S
M_P!\+_\ %4 :^M:'8>(K"2RU&VCNK9^J..A]0>H/N*\#^('P.OM \V]T7?J.
MGC+-#C,T0^G\0]QS[=Z]E_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \;G_OA?\
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MG_OA?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\ A/\
M3O\ GC<_]\+_ /%4 =-17,_\)_IW_/&Y_P"^%_\ BJ/^$_T[_GC<_P#?"_\
MQ5 '345S/_"?Z=_SQN?^^%_^*H_X3_3O^>-S_P!\+_\ %4 =-17,_P#"?Z=_
MSQN?^^%_^*H_X3_3O^>-S_WPO_Q5 '345S/_  G^G?\ /&Y_[X7_ .*H_P"$
M_P!._P">-S_WPO\ \50!R7PE_P"1Z^(7_7^/_1DU>IUXI\-?%%KIWC#QO/+'
M,R75X'0*HR!YDIYY]Q7HO_"?Z=_SQN?^^%_^*KX[A+_D4P_QU?\ T[,]W._]
M^E_AA_Z1$Z:BN9_X3_3O^>-S_P!\+_\ %4?\)_IW_/&Y_P"^%_\ BJ^Q/".F
MHKF?^$_T[_GC<_\ ?"__ !5'_"?Z=_SQN?\ OA?_ (J@#IJ*Y6X^)&DVD32S
M">*->K.% _\ 0JXSQ%^T1IEI&T>CV4U[<=/,N,)&/?@DG]/K7AYIG>79/#GQ
MU90\MV_1+5_<>C@\OQ6/ERX>FY>?3[]CUQF"*68A549)/ %<!XJ^-GA[PYOB
M@E.K7:\>7:D% ?=^GY9KP7Q1\0]>\7,PU"^?[.3D6L/R1#_@(Z_CDUST4,EQ
M(L<2-([<!5&2?PK\3S?Q.K5FZ.3TK7^U+5_**T^]OT/T+ \'TX+VF.G?R6B^
M;_RMZG<>*OC-XB\3;XH[C^S+1N/)M"5)'N_4_A@>U<+DLV3DDFNQ\/\ PZGO
MI%?4Y6L+;J1&@>4_AD ?B?PKUSPK8^#O".Q[33;B:[7_ )>KE5>3/J.<+^ %
M>%A>$>(^)ZJQ693<(OK.]_\ MV'3T]U'HUL\RK)X.CA(J3[1V^<O^'9Y3X5^
M#OB+Q1LE-M_9UFW/GW@*Y'^RO4_R]Z]C\*_!#P_X=V2W2'5[M>=]T!Y8/LG3
M\\UN_P#"?Z=_SQN?^^%_^*H_X3_3O^>-S_WPO_Q5?L.3\"Y/E-IRA[6HOM3U
M^Z.R_%^9\)C^),?CKQ4N2/:/ZO?]/(Z1$6-%1%"HHP%48 'I3JYG_A/]._YX
MW/\ WPO_ ,51_P )_IW_ #QN?^^%_P#BJ_1-CY8Z:BN9_P"$_P!._P">-S_W
MPO\ \51_PG^G?\\;G_OA?_BJ .FHKF?^$_T[_GC<_P#?"_\ Q5'_  G^G?\
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M_GC<_P#?"_\ Q5'_  G^G?\ /&Y_[X7_ .*H Z:BN9_X3_3O^>-S_P!\+_\
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M_GC<_P#?"_\ Q5'_  G^G?\ /&Y_[X7_ .*H Z:BN9_X3_3O^>-S_P!\+_\
M%4?\)_IW_/&Y_P"^%_\ BJ .FHKE7^)&DQ_?$R_[P0?^S5 _Q7\/Q_?N"O\
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M_A/]._YXW/\ WPO_ ,51_P )_IW_ #QN?^^%_P#BJ .FHKF?^$_T[_GC<_\
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M?\\;G_OA?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\
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M ,)_IW_/&Y_[X7_XJC_A/]._YXW/_?"__%4 =-17,_\ "?Z=_P \;G_OA?\
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MHYVD0RY**".9&/K[U\?4_P"2EI?]>)_^G('O0_Y%$_\ KY'_ -)D>K45S/\
MPG^G?\\;G_OA?_BJ/^$_T[_GC<_]\+_\57V!X)TU%<S_ ,)_IW_/&Y_[X7_X
MJC_A/]._YXW/_?"__%4 =-17,_\ "?Z=_P \;G_OA?\ XJC_ (3_ $[_ )XW
M/_?"_P#Q5 '345S/_"?Z=_SQN?\ OA?_ (JC_A/]._YXW/\ WPO_ ,50!TU%
M<S_PG^G?\\;G_OA?_BJ/^$_T[_GC<_\ ?"__ !5 '345S/\ PG^G?\\;G_OA
M?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\ A/\ 3O\
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M?\\;G_OA?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\
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M?\\;G_OA?_BJ/^$_T[_GC<_]\+_\50!TU%<S_P )_IW_ #QN?^^%_P#BJ/\
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M ,)_IW_/&Y_[X7_XJC_A/]._YXW/_?"__%4 =-17,_\ "?Z=_P \;G_OA?\
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M]2OWA^&:]0TC7M.U^V$^G7L-Y%W:%P<>Q'4'ZU^R97G^69Q&^"K*3[;2_P#
M79_A8^"QF68S .V(IM+ONOO6A>HI:*^@/+$HI:* $HI:* $HI:* $HI:* $H
MI:* $HI:* $HI:* .)^,W_)--9^D7_HY*V/ 7_(C^'_^O"#_ -%K6/\ &?\
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M )12T4 )12T4 )12T4 )12T4 8OC3_D3M=_Z\)__ $6U<]\$?^2:Z5_O3?\
MHUZZ+QI_R)VN_P#7A/\ ^BVKGO@C_P DUTK_ 'IO_1KU\?4_Y*6E_P!>)_\
MIR![T/\ D43_ .OD?_29'<T4M%?8'@B44M% "44M% "44M% "44M% "44M%
M"44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M% "44M%
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M?_29'=44M%?8'@B44M% "44M% "44M% "44M% "4M%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]>(?^G)GO2_Y%$?^ODO_ $F)O4445]@>"%%%% !1110 4444 %%%% !1110
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MX*L,$'T(KQ\/Q9Q-PS46'S&+E'M43O\ *>[];R1WU,DRC-XNKA6D^\?UCT_
M^V^O(I:^1_#7Q&\0>%-BV.H2?9U_Y=IOWD7TP>GX8KUCPS^T1876V+6[)[&3
MH;BWS)']2OWA^&:_5,I\1,GS"T,2W1G_ 'OA_P# E^J1\9CN%<=A;RI+VD?+
M?[O\KGL%%4-'U[3O$%OY^G7L-Y%W,3@D?4=0?K5^OTZG5A6@JE*2E%[-:I_,
M^0E"5.3C-6:"BBBM" HHHH **** "BBB@ HHHH XGXS_ /)--9^D7_HY*V/
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M1110!C>-/^1/UW_KPG_]%M7._!'_ ))KI7^]-_Z->NB\:?\ (GZ[_P!>$_\
MZ+:N=^"/_)-=*_WIO_1KU\?5_P"2EI?]>)_^EP/>A_R*)_\ 7R/_ *3([NBB
MBOL#P0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8WC3_D3M=_Z\)_\
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M *4>[F_QT/\ KW#_ -)"BBBOL3P@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH QO&G_(GZ[_UX3_^BVKG?@C_ ,DUTK_>F_\ 1KUT
M7C3_ )$_7?\ KPG_ /1;5SOP1_Y)KI7^]-_Z->OCZO\ R4M+_KQ/_P!+@>]#
M_D43_P"OD?\ TF1W=%%%?8'@A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOC^+?^1/4_Q4_P#T[ ]W(_\ ?H^D_P#TB1ZG1117V!X04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'EGPG_ .1\^(/_ %_#
M_P!&35ZG7EGPG_Y'SX@_]?P_]&35ZG7QW"7_ "*8_P".K_Z=F>[G?^^O_##_
M -(B%%%%?8GA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK1Q&&PT8SCLUTZ&];-\?B*;I5:K<7N@HHHKZ8\@**** "BBB@ HHHH ****
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MB>I_BI_^G8'NY'_OT?2?_I$CU.BBBOL#P@HHHH **** "BBB@ HHHH ****
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRSXQ?\C9X
M_P"PC_[4AKU.O+/C%_R-G@#_ +"/_M2&OC^+O^1/4_Q4_P#T[ ][(_\ ?X>D
M_P#TB1ZG1117V!X(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'EFB_\G!Z]_P!@Y?\ T&&O4Z\LT7_DX/7O^P<O_H,->IU\
M=PS_  \7_P!?ZW_I1[N;_'0_Z]P_])"BBBOL3P@HHHH **** "BBB@ HHHH
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MOX.%_P"O]'_TM'O9/_$K?]>ZG_I+/4Z***^P/!"BBB@ HHHH **** "BBB@
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M=6_\[3MZ6C$\_%8J.)::I1A;^5-7];MA1117KG"%%%% !1110 4444 %%%%
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M=7CMW/\ #<HT6/Q(Q^M?9X3BK),;;V.+A?LWRO[I69X%;)<QP_\ $HR^2O\
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MD2/4Z***^P/!"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M# _6NYT?]G_PY8;6O7NM3?N)'\M/R7!_6O3J*_0L#P+D.!LU0YWWF^;\/A_
M^7Q/$>98G1U.5?W=/QW_ !,K2/"NCZ"!_9^F6MHP_CCB ?\ %NI_.M6BBON*
M-&EAX*G1BHQ71*R_ ^=G4G4ES3;;\PHHHK8S,;QI_P B?KO_ %X3_P#HMJYW
MX(_\DUTK_>F_]&O71>-/^1/UW_KPG_\ 1;5SOP1_Y)KI7^]-_P"C7KX^K_R4
MM+_KQ/\ ]+@>]#_D43_Z^1_])D=W1117V!X(4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%>J5]7E^/ECXR<L/.E;^=)7]+2D>-BL,L,TE5C._\K;MZW2"BBBO6.(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#B?C/\ \DTUGZ1?^CDK8\!?\B/X?_Z\(/\ T6M8_P 9_P#DFFL_
M2+_T<E;'@+_D1_#_ /UX0?\ HM:^/A_R4U3_ *\1_P#3DSW9?\BB/_7R7_I,
M3>HHHK[ \(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "O+/C!_R-O@#_ +"/_M2&O4Z\L^,'_(V^ /\ L(_^U(:^/XM_Y$]3_%3_
M /3L#W<C_P!^CZ3_ /2)'HFHZ#INL*1?:?:W@Z?OX5?^8KE-2^"OA+4LD:<U
MHY_BMI67]"2/TKNJ*]O%93E^._WJA"?K%-_?:YY]'&XG#?P:DH^C9XUJ7[-U
ME)DZ?K,\/HMS$LGZC;_*N3U+]GWQ+9Y-L]G?KV$<I1OR8 ?K7TC17QF+\/L@
MQ6L:3IO^[)_D[K\#WZ/%&9T=YJ2\TOTLSY#U+X>^)=(R;K1+Q5'5XXS(H_X$
MN17/NC1L5=2K#@JPP17VY5/4-'L-67;>V-O>+TQ/$K_S%?&8OPJI/7"8IKRE
M%/\ %-?D>_0XTFM*]%/T=OP=_P SXPBF>"0/&[1N.C*<$?C71:;\2?%&DX^S
MZW=[5Z+,_FJ/P?(KZ#U+X->$M2R3I8M7/\5M(R8_#./TKD]2_9OTZ7)T_5[F
MW/9;B-91].-M?,2X!XERR3G@:B?^";B_QY?S/8CQ-E&,7+B8V_Q1NOPN<IIO
M[0OB*UPMW!9WR]RT91_S4X_2NKTW]I#3I<#4-(N;8]VMY%E'Z[:Y34OV>_$5
MIDVD]G?+V"R%'_)AC]:Y/4OAOXGTC)N=$N]J]6A3S5'XID5']K<;Y-_&51Q7
M\T>=?^!6?YC^H\/8_P#AN*?D^5_==?D?0>F_&3PEJ6 -4%JY_AN8VCQ^.,?K
M75:?K%AJR[K*]M[Q>N8)5?\ D:^,)8GAD*2(T;CJK#!'X4B2-&P9&*L.0RG!
M%>EA?%+'TW;%X:,O1N+_ !YCEK<&X:>M"JUZV?\ D?;E%?(>F_$/Q+I&!:ZW
M>*HZ))(9%'X-D5U>F_M!>);/ N8[._7N9(BC?FI _2OLL)XGY36TQ%.=-^BD
MOP=_P/ K<'XZGK2E&7WI_P"7XGTC17C6F_M(V4F!J&C3P>K6TJR?H0O\ZZS3
M?C5X2U+ .HFT<_PW,3+^N"/UK[/"<79%C;>RQ<;_ -Y\O_I5CP*V1YEA_CHO
MY:_E<[FBJ.G:]INL*#8ZA:W@Z_N)E?\ D:O5]53J0JQYZ<DUW6IXTHR@^62L
MPHHHK0@**** "BBB@#RSX3_\CY\0?^OX?^C)J]3KRSX3_P#(^?$'_K^'_HR:
MO4Z^.X2_Y%,?\=7_ -.S/=SO_?7_ (8?^D1"BBBOL3P@HHHH **** "BBB@
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M':UT+;3(SU\Z3>_Y+G]2*[G1_P!G32+7:VI:A<WS]UB B3^I_45ZW17Z'@>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ%?.Y/\ Q*W_ %[J?^DL]_-?@H_]?(?^E(^LZ***\ ]L**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH XGXS_P#)--9^D7_HY*V/ 7_(C^'_ /KP@_\ 1:UC_&?_ ))IK/TB_P#1
MR5L> O\ D1_#_P#UX0?^BUKX^'_)35/^O$?_ $Y,]V7_ "*(_P#7R7_I,3>H
MHHK[ \(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O+/C!_R-O@#_L(_^U(:]3KRSXP?\C;X _["/_M2&OC^+?\ D3U/\5/_ -.P
M/=R/_?H^D_\ TB1ZG1117V!X04444 %%%% !1110 4444 5;[2[/4X]EY:07
M:=-L\:N/U%<MJ7P?\):IDMI,=NY_BMG:/'X X_2NSHKS<5EN"QRMBJ,9_P"*
M*?YHZZ.+Q&'_ (-1Q]&T>0ZE^SCI<V38:K=6I["=%E'Z;:Y/4OV=]?M<M9W=
MG>KV&YHW/X$8_6OHJBOC<7P#P_BKM4>1]XR:_!W7X'O4>)LSHZ.IS+S2_P"'
M_$^2=2^&/BG2<F?1+IE'5H%$P^OR$US<]O+:R&.:-XI!U612I'X&OMJJ]YI]
MKJ$?EW5M#<Q_W9HPX_(U\9B_"K#RUPF*E'RDE+\5R_D>_1XTJK^/13]';\[G
MQ4K%6!!P1R"*W=-\>>(M'P+36KR-1T1I2Z?]\MD?I7TAJ7PD\)ZIDR:-# Q_
MBMBT6/P4@?I7*:E^SGH]QDV.I7EFQ[2A95'X?*?UKY6IX>\19=+VF!JJ3_NS
M<7^-OS/:CQ1E>*7+B(->L4U^%_R.&TWX_>*++ N/LFH+W,T.UOS0@?I76:;^
MTE;-@:AHLL?J]M,'_P#'6 _G6!J7[.NN6^397UG>*.S%HV/X8(_6N4U+X5^*
M])R9M%N)%'\5N!,/_'":S_M#CG)?XBJ-+O'VB_\  K2_,KZKP[F'P<B?D^5_
M=I^1[KIOQN\):C@-?263G^&YA8?J,C]:ZS3?$>E:QC[#J5I=D]H9E8_D#7QQ
M<VD]G(8[B&2"0?PR(5/Y&HNG(KOPWBCF5%\N+P\96[7B_P#V[\CFK<'82HKT
M*K7K9K]/S/MVBOCS3?&VOZ/@6>L7D*CHGG,4_P"^3Q^E=9IOQ[\56.!/):Z@
MH_Y[P@'\TVU]CA/%#*ZMEB:4X/Y27YI_@>#6X.QD-:4XR^]/]5^)Z)\)_P#D
M?/B#_P!?P_\ 1DU>IU\Q>$OBY+X7UG7M1.F)=2ZM,)F3SBBQG<YP.#G[_P"E
M=!-^TAJ;?ZK1[5/]^1F_PK'(.-LDR_+HT:]5J7-4=N63TE4E)=+;-=33,^'L
MQQ6*=2G#W;15[KI%)]>Z/?:*^=)OVBO$;_ZNSTV,?]<Y"?\ T.J4WQ[\5R?=
MEM8O]RW']2:]:?B5D4-N=^D?\VCBCPEF4M^5?/\ R1],45\LS?&KQC-_S%_+
M'HEO$/\ V6J4WQ4\63?>URZ'^X0O\A7GS\4LI7P4:C^45_[<SICP;CG\52*^
M;_R/K.BOCZ;QYXDN/OZ_J1'H+IP/R!JE-X@U2X_UNI7DG^_.Y_K7!4\5<*OX
M>%D_627Z,ZH\%UOM5E]S_P" ?9K,%&2<#U-5)M8L+?\ UM[;Q?[\JC^M?&$D
MTDQS([.?5B33*\^?BO+_ )=X+[Y__:'3'@I?:Q'_ )+_ /;'V+-XT\/V_P#K
M-<TU/9KN,'^=49OB9X5A^]KUF?\ <DW?RKY(HKSY^*F/?\/#07JV_P#(ZH\&
M8;[567W+_@GU5-\9/!T/765;_<@E;^2U1F^.WA&/[MW<2_[ENW]0*^9.O2K,
M.EWEQ_JK2>3_ '(F/]*XGXFYY5=J=*G\HR?_ +<="X0RZ&LYR^]?Y'T+-^T-
MX9C^[;ZC+_NPH/YN*HS?M'Z.O^JTJ^?_ 'RB_P!37BL/@_7KC_5:)J,G^[:2
M'^E7H?AMXIF^[H-\/]^$K_.E_KKQ;B/X5/[J;?Z,?^K^24_CE]\_^&/3YOVE
M(5_U6@2/_OW87_V0U1F_:3NV_P!5H<*?[]P6_P#917%P_!_QA/\ =T60?[\L
M:_S:KT/P+\7R?>L88O\ ?N4_H31_;7'>(^&%2WE22_'D#^S^&Z6\H?\ @?\
M]L;,W[1NNM_JM-T]/]\2-_[,*I3?M!>*)/NI81?[D!_JQI8?V>_$\GWI=/B_
MWYF_HIJ]#^SCK;?ZW4[!/]S>W_LHHMQ[B/\ GZONC_D'_&-4OY/Q?^9A3?'+
MQA)]W4(HO]RVC_J#5&;XO>+Y_O:W,/\ <CC7^2UW$/[-=RW^MUZ)/]RV+?\
MLPJ]#^S7;+_K=>E?_<M@O_LQH_L/CO$?'.I;SK)?ASA_:/#=/X8P_P# /_M3
MRR;XC>*)_O:_J _W)V7^1JE-XLURX_UNLZA)_OW3G^M>VP_LXZ*O^MU._?\
MW-B_^RFKT/[/?AB/[TNH2_[\R_T44?ZD\65_XM3[ZC?^8?ZPY+3^"/W0_P"&
M/G:;4+JXSYMS-+G^_(3_ #K6\/>.==\+8&FZE-!$#GR2=\?O\IR*]N\0_!?P
MMI/AO5;N&TF:>WM)98V>X<X94)!QGU%<+X5^"G_"8>#++5K34OLUY-Y@:&9,
MQG:[*,$<C@#L:\JIPCQ#EN-C2P\KUN5S7)-IV32>KY=;M:';#/,KQ6'<ZJM3
MNH^]'2[3>ROV-?P_^T=/'MCUK3%F'>>S;:W_ 'PW!_,5Z7X?^)_AKQ)M6UU.
M*.=O^6%S^Z?/H-W!_ FOGGQ!\*?$WAW<T^FO<0+_ ,MK3]ZOUXY'X@5R1!4D
M$8(KU</QQQ'D=14,RI\_E.+C+Y-6OZM,XJO#N59C'VF$ER_X7=?=_P ,?;M%
M?(?A_P"('B'PQM6PU2:.%>D$A\R/_OEL@?A7I7A_]HYUVQZUI88=Y[)L'_OA
MC_[-7Z5EGB1D^,M'%)T9>>L?O7ZI'R6+X3QV'NZ-JB\M']S_ $;/<J*YCP_\
M2O#GB7:MGJ<(F;_EA.?+DSZ -U_#-=/7Z;A<9A\;3]KAJBG'O%IK\#Y"M0JX
M>7)6BXOS5@HHHKK, HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\L^,7
M_(V> /\ L(_^U(:]3KRSXQ?\C9X _P"PC_[4AKX_B[_D3U/\5/\ ].P/>R/_
M '^'I/\ ](D>IT445]@>"%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 452U36M/T.W\[4+V"SB_O32!<_3/6O.O$'[06A:;N3389M5E'1@/*C_,
MC/Z5X>8YYEN4J^-KQAY7U^45=O[CT<+EV+QKMAZ;EY]/OV/4JS]7\0:;H,/F
MZC?062=1YT@4GZ#J?PKYR\0?'#Q-K6Y(+A-+@/\ #:+AO^^SD_EBN#N;J:\F
M::XFDGE;[TDC%F/U)K\IS/Q1PM*\,NHN;[R]U?=JW_Y*?:8/@ZM.TL5445V6
MK^_;\SZ#\0?M"Z+8;H]+M9M4E' D;]U'^9&X_D*\T\0?&KQ1KNY([M=,@;_E
MG9#8?^^SEOR(KE=%\-:KXBE\O3=/N+PYP3$A*K]6Z#\37I'A_P#9WU:\VR:M
M>PZ='WBB_>R?3^Z/S-?#O-N+^*GRX924'_(N2/\ X%^CDSZ+ZED62J]:W,OY
MO>?W?Y(\HFGDN96EFD:61CEG=B2?J34MCIMWJ<WE6=K-=R_W((R[?D!7K_A'
MP#H^G_%_4=$EMQJ-E:V0E1;P!\N1$<D8P?O'M7N%K9V]C"(K:".WB'2.) JC
M\!71D?A[7S55*N*KJ').4&DN9WB[/6Z6_74SS'BBG@G&%&GS<T5)7=E9K3N?
M,>C_  3\5ZMM9K)+",_QWD@7_P =&6_2NYT?]F^!=K:KJ\DGK':1A1_WTV?Y
M5[317ZI@?#O(L'9U82JO^\]/NC9??<^+Q/%695](24%Y+]7<X_1_A+X5T7:8
M])BN9!_RTNR93^3<?D*ZR&&.WC6.*-8HUX"(H 'X"I**^_PF PF CR86E&"_
MNI+\CYFMB:^)?-6FY/S;84445WG,%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!C>-/^1/UW_KPG_P#1;5SOP1_Y)KI7^]-_Z->NB\:?\B?KO_7A
M/_Z+:N=^"/\ R372O]Z;_P!&O7Q]7_DI:7_7B?\ Z7 ]Z'_(HG_U\C_Z3([N
MBBBOL#P0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[TY/UD_TL>)+BK,Y;22^2_4\/A_9J;_EKXA ]DL\_KOJ[#^S;IZ_ZW6KE_\
M<B5?ZFO8Z*]"GP)P[3VPM_64W^<CEEQ)FLMZWX1_R/*H?V=/#R_ZR^U*0^TD
M8'_H%78?@#X5C^\EY+_OS_X 5Z117?3X1R&GMA(?-7_.YS2SS,I;UY??;\CA
M8?@EX.BZZ4TA_P!NYE_HU78?A/X2A^[H=N?]\LW\S76T5Z$,@RBG\&$IK_MR
M/^1RRS/'3^*O-_\ ;S_S,"'P!X9@^YH&F_\  K5&_F*NP^&](M_]5I5E%_N6
MZ#^E:5%>A3P&$I?PZ,5Z12_0YI8FO/XIM_-D45M%!_JHDC_W5 J6BBNU)15D
MCG;;W"BBBF(**** "BBB@ HHHH **** ,;QI_P B=KO_ %X3_P#HMJY[X(_\
MDUTK_>F_]&O70^-/^1.UW_KPG_\ 1;5SWP1_Y)KI7^]-_P"C7KX^I_R4M+_K
MQ/\ ].0/>A_R*)_]?(_^DR.ZK!U_P+H/B<-_:.F03R'_ );*NR3_ +Z&#6]1
M7T^(PU#%TW2Q$%.+Z-)K[F>-2K5*,N>E)Q?=.QXOX@_9RMY-TFBZFT+=H;Q=
MR_\ ?:\C\C7FGB#X7>)?#>YKG3))8%_Y;VO[U,>IQR/Q KZSHK\VS/PYR;'7
MEATZ,O[KNO\ P%_HT?6X/BK'X>RJM5%Y[_>OUN?$5=)X?^(WB+PSM6RU280K
M_P L)CYD?TVMG'X8KZ8\0> ?#_B?<=0TR&25O^6Z#9)_WTN"?QKS3Q!^SC&V
MZ31=4*'M!>KD?]]J/_937YEBN <_R:I[?+*O/;K!N$ON;_!-GU]'B;+,?'V>
M,AR_XES+[_\ @(9X?_:.^['K6E_6>R;_ -D8_P#LU>E^'_B)X=\3;5L=3A:9
MO^6$I\N3Z;6QG\,U\V^(/AIXD\-;FN]+F:%?^6]N/-3'J2O3\<5R]+#<><0Y
M+4]AF=/GMTG%QE]Z2^]ICK<-Y7F$?:8.?+_A=U]W_!1]O45\D^'_ (F>)/#>
MU;35)6@7_EA<'S4QZ -T_#%>E^'_ -HZ-ML>M:64/>>R;(_[X8\?]]&OTS+/
M$?)L;:.(O1E_>5U_X$OU2/D,7PIC\/=TK5%Y:/[G^ESVNBN?\/\ C[P_XGVC
M3]3AEE;I YV2?]\M@G\*Z"OTO#XJAC*:JX>:G%]4TU]Z/DJM&I0ER58N+[-6
M"BBBNDQ"BBB@ HHHH **** "BBB@ KRSXQ?\C9X _P"PC_[4AKU.O+/C%_R-
MG@#_ +"/_M2&OC^+O^1/4_Q4_P#T[ ][(_\ ?X>D_P#TB1ZG1117V!X(4444
M %%%% !1110 4444 %%%% !15:^U*TTNW:>\N8;2%>LDSA%_,UY_X@^/7AS2
M=R61FU:8<?N5VQ_BS?T!KQ\PSC+\KCS8VM&'J]?DMW\D=V%P.*QCMAZ;EZ+3
M[]CTFJFI:M9:/;F>^NX;.$?QSR!!^M?.WB#X]>(]6W)9>3I,)X_<KNDQ[LW]
M *\^O]2N]4N&GO+F:[F;K),Y=OS-?E>9^*&!HWAE])U'W?NQ_5O[D?:8/@[$
M5+2Q4U!=EJ_\OS/HCQ!\?O#VE[DL$FU:8=#&/+C_ .^F&?R!KS/Q!\=?$NL;
MDM9(M*@/&VV7+X]W.3^6*X?2]%U#7+CR=/LI[R7^[#&6Q]<=*]%\/_L^Z[J6
MV34IX=*B/52?-D_(''ZU\%+/>+N*&X8-24'_ ,^URQ^<W^LCZ59;D>3+FKM.
M7]YW?_@/_ /-+R^N-0N&GNIY;F9NLDSEV/U)JSI'A_4M?F\K3K&XO7S@^3&6
M ^IZ#\:^C?#_ ,#_  SHNUY[=]4G'\5VV5_[X&!^>:[RVM8;.%8;>&.")>%C
MC4*H^@%>UEWAAC,0_:YG74;[J/O2^;=DG_X$>?BN,*%-<F#I\WF]%]V_Y'SY
MX?\ V>M:O]LFJ74.EQ'DQK^]D_(':/S->F>'_@KX8T+:\EHVISC_ ):7IWC_
M +X&%_,&N\HK]6RS@K),KM*%!3DNL_>?W/1?)(^+QG$&8XRZE4Y5VCI_P?O9
M'#!';1+%#&L42C"HB@ ?0"I***^X2459'SM[ZL\LT7_DX/7O^P<O_H,->IUY
M9HO_ "<'KW_8.7_T&&O4Z^/X9_AXO_K_ %O_ $H]S-_CH?\ 7N'_ *2%%%%?
M8GA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C>-
M/^1/UW_KPG_]%M7._!'_ ))KI7^]-_Z->NB\:?\ (GZ[_P!>$_\ Z+:N=^"/
M_)-=*_WIO_1KU\?5_P"2EI?]>)_^EP/>A_R*)_\ 7R/_ *3([NBBBOL#P0HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M +X7_P"*KIJ2@#FO^$_T[_GC<_\ ?"__ !5'_"?Z=_SQN?\ OA?_ (JNEHH
MYK_A/]._YXW/_?"__%4?\)_IW_/&Y_[X7_XJNEHH YK_ (3_ $[_ )XW/_?"
M_P#Q5'_"?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \
M;G_OA?\ XJNEHH YK_A/]._YXW/_ 'PO_P 51_PG^G?\\;G_ +X7_P"*KI:*
M .:_X3_3O^>-S_WPO_Q5'_"?Z=_SQN?^^%_^*KI:* .:_P"$_P!._P">-S_W
MPO\ \51_PG^G?\\;G_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\
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MG_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\ /&Y_[X7_ .*KI:*
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M?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \;G_OA?\
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MX3_3O^>-S_WPO_Q5'_"?Z=_SQN?^^%_^*KI:* .:_P"$_P!._P">-S_WPO\
M\51_PG^G?\\;G_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\ /&Y_
M[X7_ .*KI:* .:_X3_3O^>-S_P!\+_\ %4?\)_IW_/&Y_P"^%_\ BJZ6B@#F
MO^$_T[_GC<_]\+_\51_PG^G?\\;G_OA?_BJZ6B@#FO\ A/\ 3O\ GC<_]\+_
M /%4?\)_IW_/&Y_[X7_XJNEHH YK_A/]._YXW/\ WPO_ ,51_P )_IW_ #QN
M?^^%_P#BJZ6B@#FO^$_T[_GC<_\ ?"__ !5'_"?Z=_SQN?\ OA?_ (JNEHH
MYK_A/]._YXW/_?"__%4?\)_IW_/&Y_[X7_XJNEHH YK_ (3_ $[_ )XW/_?"
M_P#Q5'_"?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \
M;G_OA?\ XJNEHH YK_A/]._YXW/_ 'PO_P 51_PG^G?\\;G_ +X7_P"*KI:*
M .:_X3_3O^>-S_WPO_Q5'_"?Z=_SQN?^^%_^*KI:* .:_P"$_P!._P">-S_W
MPO\ \51_PG^G?\\;G_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\
M/&Y_[X7_ .*KI:* .:_X3_3O^>-S_P!\+_\ %4?\)_IW_/&Y_P"^%_\ BJZ6
MB@#R[XK>,++5/ .JVT4<ZR2"/!=0!Q*A]?:M/P;XVL;/PCHD#Q7!>.RA0E57
M&0@']ZK/QF_Y)IK/TB_]')6QX"_Y$?P__P!>$'_HM:^/A_R4U3_KQ'_TY,]V
M7_(HC_U\E_Z3$K_\)_IW_/&Y_P"^%_\ BJ/^$_T[_GC<_P#?"_\ Q5=+17V!
MX1S7_"?Z=_SQN?\ OA?_ (JC_A/]._YXW/\ WPO_ ,572T4 <U_PG^G?\\;G
M_OA?_BJ/^$_T[_GC<_\ ?"__ !5=+10!S7_"?Z=_SQN?^^%_^*H_X3_3O^>-
MS_WPO_Q5=+10!S7_  G^G?\ /&Y_[X7_ .*H_P"$_P!._P">-S_WPO\ \572
MT4 <U_PG^G?\\;G_ +X7_P"*H_X3_3O^>-S_ -\+_P#%5TM% '-?\)_IW_/&
MY_[X7_XJC_A/]._YXW/_ 'PO_P 572T4 <U_PG^G?\\;G_OA?_BJ/^$_T[_G
MC<_]\+_\572T4 <U_P )_IW_ #QN?^^%_P#BJ/\ A/\ 3O\ GC<_]\+_ /%5
MTM% '-?\)_IW_/&Y_P"^%_\ BJ/^$_T[_GC<_P#?"_\ Q5=+10!S7_"?Z=_S
MQN?^^%_^*H_X3_3O^>-S_P!\+_\ %5TM% '-?\)_IW_/&Y_[X7_XJO.OBAXH
MM-2\3>"YHHYE6VOM[[U )&^(\<^U>U5Y9\8/^1M\ ?\ 81_]J0U\?Q;_ ,B>
MI_BI_P#IV![N1_[]'TG_ .D2.N_X3_3O^>-S_P!\+_\ %4?\)_IW_/&Y_P"^
M%_\ BJZ6BOL#PCFO^$_T[_GC<_\ ?"__ !5'_"?Z=_SQN?\ OA?_ (JNEHH
MYK_A/]._YXW/_?"__%4?\)_IW_/&Y_[X7_XJNEHH YK_ (3_ $[_ )XW/_?"
M_P#Q5'_"?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \
M;G_OA?\ XJNEHH YK_A/]._YXW/_ 'PO_P 51_PG^G?\\;G_ +X7_P"*KI:*
M .:_X3_3O^>-S_WPO_Q5'_"?Z=_SQN?^^%_^*KI:* .:_P"$_P!._P">-S_W
MPO\ \51_PG^G?\\;G_OA?_BJZ6B@#FO^$_T[_GC<_P#?"_\ Q5'_  G^G?\
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MO^>-S_WPO_Q5=+10!S7_  G^G?\ /&Y_[X7_ .*H_P"$_P!._P">-S_WPO\
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M_P#A/]._YXW/_?"__%4?\)_IW_/&Y_[X7_XJOG7P_P#%;Q-X=VK!J3W$"_\
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M:J\L^,/_ "-G@'_L(_\ M2&OC^+O^1/4_P 5/_T[ ][(_P#?X>D__2)'7?\
M"?Z=_P \;G_OA?\ XJC_ (3_ $[_ )XW/_?"_P#Q5=+17V!X)S7_  G^G?\
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M_P!T?^ <#J6K7NL7!GOKN:\F/\<\A<_K45K9SWLGEV\,DS_W8U)-?1_A_P"
MOAS2=KWOG:M,.?WS;(\^RK_4FO0+'3;32[<06=K#:PKTCAC"+^0KU<O\,LPQ
M4O:YG74+[I>]+YO;YW9Q8KB_"T5R8.FY6[Z+[M_R/E?2/AS?7DBF]D%A">IP
M)'_[YR!^9%>C>'_!/@G1]KW5K?:K./XKD*$S[(& _/->U45^JY9P-D>66DJ/
MM)+K/WOP^'\#XS&<19CC+IU.5=HZ?CO^)REGXRT;3[=8+6RDMH5Z1PPHBCZ
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M/_?"_P#Q5=+10!S7_"?Z=_SQN?\ OA?_ (JC_A/]._YXW/\ WPO_ ,572T4
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M?Z=_SQN?^^%_^*KI:* .:_X3_3O^>-S_ -\+_P#%4?\ "?Z=_P \;G_OA?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8_XZO_IV9[N=_P"^O_##_P!(B%%%%?8GA!1110 4444 %%%% !1110 4444
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MEGB%DF/M&K-T9=I+3_P)77WV/C\7POF&&NX14UY;_<]?NN>O5Y9\8O\ D;/
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MC'M33T]9N[7WH^IADN393%3Q33?]Y_E'K]S..UCQ!J6OS>;J-]<7KYR/.D+
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MYB4I2?-)W844459(4444 %%%% !1110 4444 %%%% 'D&B_\G&:]_P!>J_\
MHF&O7Z\@T7_DXS7O^O5?_1,->OU\APW_  \7_P!?ZO\ Z4>YFWQT?^O</_20
MHHHKZ\\,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M ,;QI_R)^N_]>$__ *+:N=^"/_)-=*_WIO\ T:]=%XT_Y$_7?^O"?_T6U<[\
M$?\ DFNE?[TW_HUZ^/J_\E+2_P"O$_\ TN![T/\ D43_ .OD?_29'=T445]@
M>"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\=_&[P[IGB
M[]OCX:Z/K-A!J>EWGAN:.>UN4#HZ[-0/(/<$ @]00".17V)7R9\3/^4B?PI_
M[%Z;_P! U"OH,EDXU:THNS5.I_Z2SP\W2E3I)K3VD/\ TI'EG[0'_!/.^T?[
M3K?PR>34K$?.^@W#YN(QU/DR'_6#_9;YO0L:^+KZQN=,O)K2\MY;2ZA8I+!.
MA1T8=0RGD'V-?NO7D/QT_9?\%_'BS>35;3^SM>5 L.MV2A;A<#A7[2+[-T[$
M=:^FRGBVI1M1Q_O1_FZKU[_GZGSN:<+TZMZN"]U_R]/EV_+T/B#]G_\ ;L\5
M?"[[/I'BGSO%GAE,(OF/F]M5 P!'(Q^=1_=?V 917Z(?#7XK>%OBYH"ZQX5U
M:'4[7@2HIVRP,1G9(AY4_7KCC(YK\K?CI^R]XT^ ]V\NJVG]HZ SA8=;LE+0
M-D\*_>-O9N#V+5Y_X(\>^(/AOK\&M>&M5N-(U*'I-;MPP_NLIX93_=8$5[^.
MR# YQ3^M8&2C)]5\+]5T?]-,\/!9YC,IG]6QL6XKH]UZ/JOZ3/V_HKY"_9]_
M;_T+QM]FT3Q^L'AO6V(CCU)3BQN#CJQ/^I8^^5]QTKZZBF2>))8G62-P&5U.
M0P/((/<5^58W+\3E]3V6(A9_@_1GZ9@\=A\=3]IAY77XKU0^BBBO/.X****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 >6?"?_D?/B#_U_#_T9-7J=>6?"?\ Y'SX@_\ 7\/_ $9-
M7J=?'<)?\BF/^.K_ .G9GNYW_OK_ ,,/_2(A1117V)X04444 %%%% !1110
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MH]S-OCH_]>X?^DA1117UYX84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 8WC3_D3]=_Z\)_\ T6U<[\$?^2:Z5_O3?^C7KHO&G_(G
MZ[_UX3_^BVKG?@C_ ,DUTK_>F_\ 1KU\?5_Y*6E_UXG_ .EP/>A_R*)_]?(_
M^DR.[HHHK[ \$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 %%%% !1110 4444 %%%% 'EGPG_P"1\^(/_7\/_1DU>IUY9\)_^1\^(/\
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MP0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>VQX^4T:M6G'$5*\V[RTNK:-KM?IWW"BBBOE#Z8**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ->$_P#Z+:N=^"/_ "372O\ >F_]&O7Q]7_DI:7_ %XG_P"EP/>A_P BB?\
MU\C_ .DR.[HHHK[ \$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N(^*OP9\(_&C
M0SI?BG2H[Q5_U%U'\EQ;GUCD'(^G(/<&NWHK6G5G1FJE.34EU1G4IPK0<*BN
MGT9^6/[0'[$GB[X/_:=6T82>*?"J?,;JWC_TBV7_ *:Q#L/[ZY'<[>E?/>DZ
MO?:#J5MJ.FWD^GW]LXDANK:0QR1L.A5@<@U^Z5?+_P"T!^PIX5^*7VG5_"_D
M^$_$SY=O+3%E<L3DF2-1\C'^^GN2K&OTW*N+5)*AF*_[>_S7ZK[C\[S/A=Q;
MK8!_]N_Y/_/[SRK]GW_@H;)#]ET/XGH9(\K''XBM8_F4>L\:]?\ >09]5/)K
M[FT/7M.\3:3;:II-];ZEIUT@DANK6021R+ZAA7XO?$KX4^*?A%K[:1XITF;3
M+GDQ2,-T4Z@XWQN.&'TZ9YP>*V_@S^T%XR^!FK"Y\.:B38R.&N=*N<O:W'^\
MN?E/^TI!]\<5UYEPOA\='ZSETE%O6WV7Z=OR]#DR_B/$8.7U?'IM+2_VEZ]_
MS]3]E:*\(^ 7[7_@SXXQ06!E'A_Q25 ?2+R0?O6[^0_ D'MPWMCFO=Z_+,3A
M:V#J.E7BXR7?^M3]*P^)HXJFJM"7-%A1117*=)\F?L>_\E^_:/\ ^Q@7_P!*
M;VOK.ODS]CW_ )+]^T?_ -C O_I3>U]9U[V>?[]+_##_ -(B>)DW^Y1]9_\
MI<@HHHKP3VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>)_^EP/>A_R*)_\ 7R/_ *3([NBBBOL#P0HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7D/QP_Y&OP'_P!?4G_H
MR"O7J\A^.'_(U^ _^OJ3_P!&05\AQ9_R**G^*G_Z=@>YDO\ OT?27_I$CUZB
MBBOKSPPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO^>5S_WPO_Q5 '345S/_  G^G?\ /*Y_[X7_ .*H_P"$_P!._P">5S_WPO\
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M?Z=_SRN?^^%_^*H Z:BN9_X3_3O^>5S_ -\+_P#%4?\ "?Z=_P \KG_OA?\
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MX3_3O^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*H Z:BN9_P"$_P!._P">5S_WPO\
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MPO\ \51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\ Q5'_  G^G?\
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MG?\ /*Y_[X7_ .*H Z:BN9_X3_3O^>5S_P!\+_\ %4?\)_IW_/*Y_P"^%_\
MBJ .FHKF?^$_T[_GE<_]\+_\51_PG^G?\\KG_OA?_BJ .FHKF?\ A/\ 3O\
MGE<_]\+_ /%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_A/]._YY7/\ WPO_ ,51_P )
M_IW_ #RN?^^%_P#BJ .FHKF?^$_T[_GE<_\ ?"__ !5'_"?Z=_SRN?\ OA?_
M (J@#IJ*YG_A/]._YY7/_?"__%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_ (3_ $[_
M )Y7/_?"_P#Q5'_"?Z=_SRN?^^%_^*H Z:BN9_X3_3O^>5S_ -\+_P#%4?\
M"?Z=_P \KG_OA?\ XJ@#IJ*YG_A/]._YY7/_ 'PO_P 51_PG^G?\\KG_ +X7
M_P"*H Z:BN9_X3_3O^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*H Z:BN9_P"$_P!.
M_P">5S_WPO\ \51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\ Q5'_
M  G^G?\ /*Y_[X7_ .*H Z:BN9_X3_3O^>5S_P!\+_\ %4?\)_IW_/*Y_P"^
M%_\ BJ .FHKF?^$_T[_GE<_]\+_\51_PG^G?\\KG_OA?_BJ .FHKF?\ A/\
M3O\ GE<_]\+_ /%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_A/]._YY7/\ WPO_ ,51
M_P )_IW_ #RN?^^%_P#BJ .FHKF?^$_T[_GE<_\ ?"__ !5'_"?Z=_SRN?\
MOA?_ (J@#IJ*YG_A/]._YY7/_?"__%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_ (3_
M $[_ )Y7/_?"_P#Q5'_"?Z=_SRN?^^%_^*H Z:BN9_X3_3O^>5S_ -\+_P#%
M4?\ "?Z=_P \KG_OA?\ XJ@#IJ*YG_A/]._YY7/_ 'PO_P 51_PG^G?\\KG_
M +X7_P"*H Z:BN9_X3_3O^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*H Z:BN9_P"$
M_P!._P">5S_WPO\ \51_PG^G?\\KG_OA?_BJ .FHKF?^$_T[_GE<_P#?"_\
MQ5'_  G^G?\ /*Y_[X7_ .*H Z:BN9_X3_3O^>5S_P!\+_\ %4?\)_IW_/*Y
M_P"^%_\ BJ .FHKF?^$_T[_GE<_]\+_\51_PG^G?\\KG_OA?_BJ .FHKF?\
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MF?\ A/\ 3O\ GE<_]\+_ /%4?\)_IW_/*Y_[X7_XJ@#IJ*YG_A/]._YY7/\
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M*Y_[X7_XJOKSPSIJ*YG_ (3_ $[_ )Y7/_?"_P#Q5'_"?Z=_SRN?^^%_^*H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOG;3;22,-@;&N)#MD4Y5HV?=E<@8.!XA^V=\1M _;6_::^#7PS^$MQ'XKNM
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M;1Z4M% ";1Z4;1Z4M% ";1Z5Y#\;Q_Q5?@/C_EZD_P#1D%>OUY#\</\ D:_
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MZIJ5KHNGSWU[)Y-K N^23:6VCUP 35NN8^)C:ZG@+6V\-:39ZYKPMS]CT[4
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MT[:LY?:4ZOOTDU%[*7Q)>>VHFT>E&T>E+15@)M'I1M'I2T4 )M'I1M'I2T4
M)M'I1M'I2T4 )M'I12T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ'W9$/*G]#C@D5V5?B!X(\>:_P##CQ!;ZWX;U2XTG4X?NS0-]X=U93PRGNK
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O(?CA_R-?@/_KZD_\ 1D%=?XV\%ZIXHNK:73_$UYH*1(5:
M.V#XD).<G:ZU\Z_'>35?AGXT^&FD7FLWGB&7Q-J9L8;J>5T:P/F0*9%!9]W^
MM!P"OW!SZ?#YY2SG-H3RS 8%SNXM2YZ:34&IO24DUI%K4^@P-7+\O<<;BL2H
MI737+-M<R<5LGU:/KFBO+/\ A47B3_HHFJ_E+_\ 'J].M86M[6&)Y#,\:*K2
M-U8@8R?K7O9?C,9BG)8K"NC;:\H2O_X"W:WF>?BJ%"BE[&LJE^RDK?>D2T44
M5[1YX4444 %%%% !15/5-9T_0[5KK4KZVT^V7K-=3+$@_%B!7D_BS]L#X0^#
M]ZW/C6QOIEX$6EA[PL?0-$&4?B1751PM?$.U&FY>B;.>MB:.'5ZTU'U:1[)1
M7QKXL_X*8^$K#>GAWPIJVL..!)?2QVD9]QCS#CZ@5XSXL_X*/?$G6=\>C:?H
MOAZ(_=>.!KB8?\"D;:?^^*^AP_"^:5]73Y5YM+\-7^!X-;B/+J.T^9^2?_ 7
MXGZ85S_BCXA>%_!,9?Q!XBTK10!G_3[R.$GZ!B"?PK\B?%G[2'Q/\;;UU?QQ
MK$L3_>AM[@VT3?6.+:OZ5YU)(\TC22.TCL<LS'))]2:^CP_!,WKB*R7HK_B[
M?D>!6XOCM0HW]7^BO^9^J_BS]O#X/^%]Z0Z[<Z].O6+2;-W_ "=]B'\&KQGQ
M9_P4Z@7?'X9\#R2?W;C5KP+CZQQJ?_0Z^&-*T;4-=NEM=-L;G4+END-K"TKG
M\%!->L>$_P!C[XO>,-C6W@N]L86Y,NJLEF%'J5D*L?P!KV5P[DN!5\3*_P#B
ME;\K'DO/LWQKMAXV_P ,;_G<ZKQ9^W]\7?$F];34M/\ #L+<;-+LESC_ 'I=
M[#Z@BO&?%7Q4\9>.&?\ X2#Q3K&L(W6*\O9)(Q[!"=H'L!7U%X3_ ."9OBV^
MV/XB\5Z3I"'DQV,4EVX]CGRQGZ$U[+X3_P""</PVT;8^LW^M>(91]Y))UMX3
M]%C4,/\ ONG_ &QD&7?P$KK^6.OWZ?F+^RL[Q_\ &;M_>E^G_ /S/KH?"_P]
M\4^-I GA_P .:KK1)QFPLY)@/J5! _&OUU\)_LX_##P3L.D>!]'AE3[L]Q;"
MXE7Z22[F_6O1HXTAC5(U5$4855& !Z 5YF(XV@M,/1;]7;\%?\ST:/"$]Z]:
MWHOU=OR/RG\)_L'_ !@\4;&FT.UT&%NDNK7B)^:)O<?BM>S>$_\ @F+,VR3Q
M-XXC3^];Z39EORDD8?\ H%?>E%?.8CBS,ZWP24/1?YW/?H\,9?2^).7J_P#*
MQ\X^$_V _A%X;V-=Z9J'B&9>=^J7K8S_ +L6Q3]"#7LOA7X6>#O ZI_PC_A;
M2-'=>DEG91QR'W+@;B?<FNIHKYVOF&+Q7\:K*7JW;[MCWJ.!PN&_@TTO1+\S
MX'^(/P5TOX]?MN?$?PSJEU/8;="@N[:[M\$PSK#9JK%3PRX=@5XR#P0<$?+/
MQF^!_BGX&^)GTGQ%9D1.2;34803;W:#^)&]?53R.XZ9^Z_ __*1KX@_]BW%_
MZ+L:^DO'O@#0?B;X9N_#_B33HM2TRX'S1R##(W9T8<JPSPPYK[N&?U<JJ4*<
MUS4G3A==5[NZ_P OR/BYY'2S.G6J1?+452>O1Z[/_,_);X"_M&>*?@!KK7.C
MRB\TBX8&]T>X8^1/VW#^X^.CC\01Q7ZC_!?XZ>%?CIX;75/#MX/M$:C[7ILQ
M N+1CV=>X]&'!_,#\Z_VF/V/M?\ @9=2ZMI?G:]X,=LK?JF9;3/1)P.GH''R
MG_9)Q7C'@3Q[KWPU\36FO^&]1ETS5+8_++&>&7NCJ>&4]U/!KW\?E."XAH_6
M\))*??OY27]->9X>!S/%Y%6^K8J+<.W;SB_Z3/V^HKYU_9E_;$T'XX6L.CZN
M8-"\:*,&R+8BO,#EX">_<H3D=MP!-?15?D.+PE? U71Q$;27]:=T?JF%Q5'&
M4E6H2NG_ %J%%%%<9U!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M <5\;O\ DB_C[_L7]0_])I*\V_82_P"37_"?_72]_P#2N:O2?C=_R1?Q]_V+
M^H?^DTE>;?L)?\FO^$_^NE[_ .E<U>_#_D45/^OD?_29'B3_ .1K#_KW+_TJ
M)[]1117@'MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8D'X* *O445XS;D[L]9)15D%%%%(84444 %%%% !1110!\F>!_\ E(U\0?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHK,\0^)]'\(Z:VH:[JUCHM@K!#=:A<I!$&/0;W(&3Z9JHQ<G
MRQ5V*4E%7;LC3HK@_P#A?GPQ_P"BC>$O_!Y:_P#QRC_A?GPQ_P"BC>$O_!Y:
M_P#QRNCZKB/^?<ON9S_6J'_/Q?>CO**S/#WB?1_%VFKJ&A:M8ZU8,Q076GW*
M3Q%AU&]"1D>F:TZYY1<7RR5F=$9*2NG=!1114C"BBB@ HHHH **** "BBB@
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M,KQ+>;'\2>,-,TM>K1Z;;R73?3+>6 ?S_&O9?"?_  3H^&&B;'U>?6/$<O\
M$MQ=""(_18@K#_OHU]3T5\YB.(\TQ&]5I>5E^*U_$]ZCD&74-J5WYZ_GI^!Y
M_P"$_P!G_P"&_@C8=&\$Z+:RI]VX>T6:8?\ ;1]S?K7?JH50J@!0, #H*6BO
M J5JE9\U63D_-W/<ITJ=%<M.*2\E8****Q-0HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /DSP/_ ,I&OB#_ -BW%_Z+L:^LZ^3/ _\ RD:^(/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\D'^'7_8NZ?_ .D\=<5^W!_R:[XW_P!VS_\ 2R"NU_9]_P"2#_#K_L7=/_\
M2>.O?E_R)X_]?9?^DQ/$C_R-9?\ 7M?^E2._HHHKP#VPHHHH **** "BBB@
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MZ][//]^?^&'_ *1$\3)O]S7^*?\ Z7(****\$]L**** "BBB@ HHHH ****
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MJUI.4FIZO_!(^RS.A3P^7.E1C:*<=%_CB?6=%%%?,GT04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R9X'_ .4C7Q!_[%N+
M_P!%V-?6=?)G@?\ Y2-?$'_L6XO_ $78U]9U[^<?'0_Z]4__ $D\3*OAK?\
M7R?YA1117@'MA1110 4R:&.XA>*5%EBD4JZ.,JP(P01W%/HH ^%?VH/V"UG^
MT^*/AA:+&^#)=>'$. >Y:V]#_P!,_P#OGLM?"3I<:;>,CK+:W=O)@JP*/&ZG
MIZ@@C\,5^Z]?.G[37['>@_&^UGUC1U@T+QHHW"\"XAO,#A9P._82 9'?<  /
MTC).*)4;8;'N\>DNJ]>Z\]_4_/\ ..&U5OB,$K2ZQZ/T[/RV/$?V7?V]'L5M
M?"WQ.NWFAR([7Q&_S,G8+<^H_P"FG4?Q9Y8?>EM<Q7EO%<6\J3P2H)(Y8V#*
MZD9# C@@CO7XC>.O >O?#7Q-=Z!XCTZ73-4MC\\4@X9>SHPX93V89!KVC]F;
M]L+7_@;=1:3JOGZ]X,<X:Q9\RVF>KP$]/4H?E/\ LDYKT<YX9IXJ/UO+;7>M
MEL_./;\GY'#E/$53#2^JX^]EI=[KU_JY^JU%<]X#\?:#\3/#-IX@\-ZC%J>F
M7(^62,X*-W1U/*L,\J>170U^4SA*G)PFK-=#],C*-2*E!W3"BBBH*"BBB@ H
MHHH **** "BBB@#BOC=_R1?Q]_V+^H?^DTE>;?L)?\FO^$_^NE[_ .E<U>D_
M&[_DB_C[_L7]0_\ 2:2O-OV$O^37_"?_ %TO?_2N:O?A_P BBI_U\C_Z3(\2
M?_(UA_U[E_Z5$]^HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<_[E+UC_ .EQ/K.BBBO!/;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR**G_7R/_I,CQ)_\C6'_ %[E_P"E1/?J***\ ]L**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAZ3_ /2)'B9S_N4O6/\ Z7$^LZ***\$]L**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#Y,_9"_Y.#_:-_P"P\O\ Z47E?6=?
M)G[(7_)P?[1O_8>7_P!*+ROK.O>SS_?G_AA_Z1$\3)O]S7^*?_I<@HHHKP3V
MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XGXX?\
MD5\?_P#8OZA_Z325YQ^PG_R:]X1_W[W_ -+)J]'^.'_)%?'_ /V+^H?^DTE>
M<?L)_P#)KWA'_?O?_2R:O?A_R)Y_]?(_^DR/$E_R-8?]>Y?^E1/?:***\ ]L
M**** "BBB@ HHHH **** "BBB@ KE/B3\4O#'PD\.R:UXHU6'3;-<B-6.99W
M SLC0<NWL.G4X'->-_M'?MI>&O@J+G1M&$7B/Q@GR-9HY\BT/K.X[C_GFOS>
MI7K7YM?$?XG^)OBQXBEUOQ1JDVIWK9"*QQ' N<[(T'"+[#ZG)YK[7)^&:^86
MK8CW*?XOT\O-_*Y\AFW$-' WI4/?J?@O7_+[['L7[1W[9WB;XUM<:/I/F^'/
M![?(;&-_WUV/6=QV/]P?+Z[NM>#^&_#.K>,=:M=(T33KC5-3NFV16MK&7=C]
M!T [D\ <FO3?@)^R_P"+_CYJ"OIT']E^'HW*W&N7:'R5QU5!P9'_ -D<#N17
MZ9_!3]G_ ,(_ C1/L?AZRW7\R!;O5;C#7-R1SRW\*YZ*N /<\U]KC<VP'#U+
MZKA(IS71=/.3[_CZ'R&#RO'9[5^LXF347U?Y17](\'_9O_8(TKP5]E\0?$)8
M-;UY2)(=)4[[.U/;?_SU<?\ ? _VN#7V"JA%"J JJ,  8 I:*_)L=F&(S&K[
M7$2N_P %Z(_3\'@:& I^RH1LOQ?JPHHHKSCO"BBB@ KY,_;2_P"2O?L\_P#8
MR'_THLZ^LZ^3/VTO^2O?L\_]C(?_ $HLZ]_(O]_AZ3_](D>)G7^Y2]8_^EQ/
MK.BBBO /;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH ^3/ _P#RD:^(/_8MQ?\ HNQKZSKY,\#_ /*1KX@_]BW%_P"B[&OK
M.O?SCXZ'_7JG_P"DGB95\-;_ *^3_,****\ ]L**** "BBB@ HHHH **** &
MLJR*590RL,%2,@BOBC]J+]@^'76O?%?PVMX[34"#+=>'D 2*<]2UOV1O]C[I
M[8/!^V:*]/+\QQ&6U?:X>5NZZ/U//QV H9A2]E75^SZKT/PHN[2YTN]EMKF&
M6TN[=RDD,R%)(W!P00>00>U?9W[+O[>%QX=6R\*?$B>2\TP8BMO$#$O-;CH%
MG[NG^W]X=]PY'T9^TI^R-X>^/5HVI6ACT+QA$F(M21/DN,#A)U'WAV##YE]P
M-M?F'\0OASXA^%GB:YT#Q+ILNG:A > XRDJ]GC;HZGU'TZ@BOUS#XK+^*,-[
M&JK373JO.+[?TT?EM?#8[ARO[6D[Q?7H_)K^O)G[96-];:I9PW=G<17=I.@D
MBG@</'(I&0RL."#ZBIZ_)O\ 9L_:V\1? .\73YP^N>$)GS-I<C_-!D\O Q^Z
MW<K]UO8_,/T]^'7Q*\._%;PS;Z]X9U*/4;"88;:<20OCE)%ZJP]#]1D$&OS+
M-\DQ&4SO+WH/:7^?9_TC]$RO.*&9P]W2:WC_ )=T=/1117SI[P4444 %%%%
M'%?&[_DB_C[_ +%_4/\ TFDKS;]A+_DU_P )_P#72]_]*YJ])^-W_)%_'W_8
MOZA_Z325YM^PE_R:_P"$_P#KI>_^E<U>_#_D45/^OD?_ $F1XD_^1K#_ *]R
M_P#2HGOU%%%> >V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 >%_MP?\FN^-_]VS_]+(*X7PK^QU\-/BY\$? FH7FDMHVM
MW'A^QDDU/2'$,DCFW0EG3!1R3R25R>>>:[K]N#_DUWQO_NV?_I9!7:_L^_\
M)!_AU_V+NG_^D\=?44<57PF50J4)N+]K+;_#$^<K8>CBLSE"M!27LUO_ (I'
MPE\3O^"=/CKPMYUUX3O;7Q?8KEA ,6MV!_N,=C<>C9/9>U?,7B3PMK/@_4Y-
M.UW2KS1[^/[UO?0-$_UPP&1[U^Y-8GBSP3H'CO2VT[Q%HUCK5D?^6-] LH4^
MJY'RGW&#7MX'C'$TK1Q<%-=UH_\ )_@>/C.$\/4O+"R<'V>J_P _S/QD\"_$
M[Q9\,[XWGA?Q!?Z),3EUM9B(Y/\ ?0_*X]F!KZL^&/\ P4HUS3?*M?'>@0ZS
M .#J&E8@N,>K1D['/T*"O3/B?_P3A\'^(O.NO!NJ77A:\;)%I<9NK0GT&3YB
M_7<WTKY&^)_[(7Q/^%?G37OA^35],CY_M+1LW,6/5@!O0>[*!7U*Q61Y\K5+
M<[[^[+[^OR;/FGALYR5WIWY5V]Z/W=/N1^DWPQ_:9^''Q:\J+0?$EN-1D_YA
MM\?L]SGT"-C>?]PL/>O4:_"+D'T->S?##]KWXG_"OR8;+Q!)J^F1\?V;K.;F
M+'HI)WH/96 KP\;P8U>6"J?*7^:_R^9[6#XN6D<73^<?\G_G\C]=Z*^0?AA_
MP4>\'^(O)M?&6EW7A:\; -W;YNK0^YP/,7Z;6^M?4?A/QMH'CO2UU'P[K-CK
M5D?^6UC.LH4^C8/RGV/-? XS+<7@';$4W'SZ??L?;87,,+C5>A43\NOW;FW1
M117FGH!1110 4444 %%%% !1110 4444 %%%% !7R9^V=_R6;]G3_L9#_P"E
M-E7UG7R9^V=_R6;]G3_L9#_Z4V5>_D7^_P /2?\ Z1(\3.?]REZP_P#2XGUG
M1117@'MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >&?MO?\FN^-_\ <M/_ $L@KL_V>_\ D@_PZ_[%ZP_])TKC/VWO
M^37?&_\ N6G_ *605V?[/?\ R0?X=?\ 8O6'_I.E>_+_ )$\?^OLO_28GB1_
MY&LO^O:_]*D>@4445X![84444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %?)G[:'_)8OV=_^QD/_I195]9U\F?MH?\ )8OV=_\ L9#_
M .E%E7O9'_O\/2?_ *1(\3.?]REZQ_\ 2XGUG1117@GMA1110 4444 %%%%
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M0=0;A@?E'^PO/J1R*^A_V>?V2/"?P'M8K[8NN^*V3$VK7*#]T>ZP)_RS'O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS]DU*&VN$W*^^1/D#$;QF)ON\].*XOQ-X-U[P7>FTU_1=0T6YSCRK^V>%C]
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M7]0_])I*\V_82_Y-?\)_]=+W_P!*YJ])^-W_ "1?Q]_V+^H?^DTE>;?L)?\
M)K_A/_KI>_\ I7-7MP_Y%%3_ *^1_P#29'D3_P"1K#_KW+_TJ)[]1117@'MA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1RW,4
M#Q))*D;3-LC5F +M@G ]3@$X'8&H-6U:RT'2[S4M2NH;'3[.%I[BZN'"1Q1J
M"S.S'@  $DGTK\SOAI^V1J7[4G_!2'P+:Z8;BT^&^D1:G_8=O(C1B^/V6>-[
MU@>I8JRK_=4$<,7RX?O*BIK>S?R2;_&UE_P&$O<INH]E^;_K^M#]/****0!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI_P3?^%U]DVU_P"(].;L(;R)U_)XB?UKD=4_X)B:#-G^SO'6HVOI]JL8Y_\
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MO77:7_P4[T&;']H^!=1M?7[+?1S_ /H2)7!/AG-8?\NK^CC_ )G=#B++)_\
M+VWJG_D?;%?)G[:'_)8OV=_^QD/_ *4656=+_P""D'PNOL"YL/$>G-W,UG$Z
M_FDI/Z5Y#^TI^TYX ^)7Q ^#>M:%J=Q<6?AW6C>ZD)+.6-X8O.MFR 1\QQ$_
M"YZ>XKKRG*<?A\;&56C)*TM;:?#)'+FF9X+$8.4:=5-WCU_O(_0BBOD_7/\
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M1_CA_P D5\?_ /8OZA_Z325YQ^PG_P FO>$?]^]_]+)J]^'_ ")Y_P#7R/\
MZ3(\27_(UA_U[E_Z5$]]HHHKP#VPHHK#\9>-M"^'OA^YUSQ'J=OI.EV_W[BX
M; R>BJ!RS'LH!)["JC&4Y*,5=LF4HP3E)V2-ROEG]I#]N;0/A;]JT'PCY'B3
MQ4 4>96W6=DW3YV!^=Q_<4\=R,8/SI^TA^W5KWQ+-UH/@LW'AOPP2T<ETK;;
MR]4\'<1_JT/]U3D]SSBOES2]+O=<U"WL-.M)KZ^N'$<-M;QF221CT55')/TK
M].R?A2R6(S';?E_^2?Z??V/SK->)KMT,!_X%_E_G]W<U?''CS7OB1XBN==\2
M:G/JNJ7!^::8_='954<*H[*  *]4_9Y_9*\6?'BZBO@C:'X45\3:O<H?W@'5
M8$_Y:-VSPH[G/!^A_P!F_P#X)^PV8M?$7Q/1;F<A9(/#L;92,]1]H8?>/^PO
M'J3R*^W[6UAL;:*WMH8[>WA01QQ1*%1% P% '  '85TYMQ12PL?JV6I-K2_1
M>BZ_EZG/E?#=3$2^L9@VD];=7Z]OS]#B?A'\%?"?P3\/+I/AC3EM]V#<7LV'
MN;EO[TCXY]@,*.P%=W117Y75JU*TW4JRO)[MGZ73IPHP5.FK)=$%%%%9&@44
M44 %%%% !1110 4444 %%%% !7R9^VE_R5[]GG_L9#_Z46=?6=?)G[:7_)7O
MV>?^QD/_ *46=>_D7^_P])_^D2/$SK_<I>L?_2XGUG1117@'MA1110 4444
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MM"O;>SU14VPW[FW<*C@<)*3@#^%B>QP#[S^PE_R:_P"$_P#KI>_^E<U? 8O
M8C+LMJ4<1&S]I'T?NRU1]OA<=0Q^84ZM!W7LY>J]Z.C/?J***^0/J@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO^>5S_WPO_Q5'_"?Z=_SRN?^^%_^*KI=H]*-H]* .:_X3_3O^>5S_P!\+_\
M%4?\)_IW_/*Y_P"^%_\ BJZ7:/2C:/2@#FO^$_T[_GE<_P#?"_\ Q5'_  G^
MG?\ /*Y_[X7_ .*KI=H]*-H]* .:_P"$_P!._P">5S_WPO\ \51_PG^G?\\K
MG_OA?_BJZ7:/2C:/2@#FO^$_T[_GE<_]\+_\51_PG^G?\\KG_OA?_BJZ7:/2
MC:/2@#FO^$_T[_GE<_\ ?"__ !5'_"?Z=_SRN?\ OA?_ (JNEVCTHVCTH YK
M_A/]._YY7/\ WPO_ ,51_P )_IW_ #RN?^^%_P#BJZ7:/2C:/2@#FO\ A/\
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M_P 51_PG^G?\\KG_ +X7_P"*KI=H]*-H]* .:_X3_3O^>5S_ -\+_P#%4?\
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M[7UGM'I7O9Y_OS_PP_\ 2(GB9-_N:]9_^ER.:_X3_3O^>5S_ -\+_P#%4?\
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M?3[5%;S_ /H(2ONS:/2C:/2O0IY]F=/:O+YZ_G<X9Y+EU3>BOEI^1^<NJ?\
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MC]R?YGFVAV?P_P##.W^R/"&G:7MZ&STR"(C_ +YQ72?\)_IW_/*Y_P"^%_\
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M"_XGU.&SC 8K2G55^ST?XG?_ /"?Z=_SRN?^^%_^*H_X3_3O^>5S_P!\+_\
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M"_\ Q5'_  G^G?\ /*Y_[X7_ .*KI=H]*-H]* .:_P"$_P!._P">5S_WPO\
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M=_SRN?\ OA?_ (JC_A/]._YY7/\ WPO_ ,572[1Z4;1Z5X![9S7_  G^G?\
M/*Y_[X7_ .*H_P"$_P!._P">5S_WPO\ \572[1Z4;1Z4 <U_PG^G?\\KG_OA
M?_BJ/^$_T[_GE<_]\+_\572[1Z4;1Z4 <U_PG^G?\\KG_OA?_BJ/^$_T[_GE
M<_\ ?"__ !5=+M'I1M'I0!S7_"?Z=_SRN?\ OA?_ (JC_A/]._YY7/\ WPO_
M ,572[1Z4;1Z4 <U_P )_IW_ #RN?^^%_P#BJ/\ A/\ 3O\ GE<_]\+_ /%5
MTNT>E&T>E '-?\)_IW_/*Y_[X7_XJC_A/]._YY7/_?"__%5TNT>E&T>E '-?
M\)_IW_/*Y_[X7_XJC_A/]._YY7/_ 'PO_P 572[1Z4;1Z4 <U_PG^G?\\KG_
M +X7_P"*H_X3_3O^>5S_ -\+_P#%5TNT>E&T>E '-?\ "?Z=_P \KG_OA?\
MXJC_ (3_ $[_ )Y7/_?"_P#Q5=+M'I1M'I0!S7_"?Z=_SRN?^^%_^*H_X3_3
MO^>5S_WPO_Q5=+M'I1M'I0!S7_"?Z=_SRN?^^%_^*H_X3_3O^>5S_P!\+_\
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M97UNYCFMYT*NC#L0:^P_V"OVDM0T'5K?X::M%]KT299YM.DC4"6VD :5T/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%</\8_ .L?$KP5+HNA>+K[P3?M/'*-6T\.9553DI\DD9P?]ZM:48SFHSERI
M]=[?=J9U)2C!RA'F:Z=_O.#_ &X/^37?&_\ NV?_ *605VO[/O\ R0?X=?\
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M*?*C/^Q&,(O_  $"L/0O#^J>*-2BT[1M-N]5OY?N6ME"TTC?15!-?H5\,?\
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MBTW]9<7VY4U]]VR2BBBO/.X**** "BBB@ HHHH **** "BBB@ HHHH ****
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M][:)XEUO2';HMR(KJ-?H-J-CZM7D_B7_ ()G^-+'>VA>*=%U9%Z+=I+:.WT
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M_!=]O;0_%.M:2[=%NTBND7Z ",X^K5]BT5[%'.LQP_\ #KR^;O\ G<\JME&
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MB@ KY,_;0_Y+%^SO_P!C(?\ THLJ^LZ^3/VT/^2Q?L[_ /8R'_THLJ][(_\
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M;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH XKXW?\D7\??]B_J'_I-)7FW["7_)K_A/_KI>_P#I7-7I/QN_Y(OX
M^_[%_4/_ $FDKS;]A+_DU_PG_P!=+W_TKFKWX?\ (HJ?]?(_^DR/$G_R-8?]
M>Y?^E1/?J***\ ]L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *^3/VSO^2S?LZ?\ 8R'_ -*;*OK.ODS]L[_DLW[.
MG_8R'_TILJ]_(O\ ?X>D_P#TB1XF<_[E+UA_Z7$^LZ***\ ]L**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y,_8_P#^3@/V
MCO\ L/K_ .E-[7UG7R9^Q_\ \G ?M'?]A]?_ $IO:^LZ][//]^?^&'_I$3Q,
MF_W->L__ $N04445X)[84444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5F>(?#.C^+M-;3]=TFQUJP9@YM=0MDGB+#H=C@C(]<5IT549.+YH
MNS%**DK-71P?_"@_AC_T3GPE_P"".U_^-T?\*#^&/_1.?"7_ (([7_XW7>45
MT?6L1_S\E][.?ZM0_P"?:^Y&9X>\,Z/X1TU=/T+2;'1;!6+BUT^V2"(,>IV(
M ,GUQ6G117/*3D^:3NSHC%15DK(****D84444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5\F?MH?\EB_9W_[&0_^E%E7UG7R9^VA_P EB_9W
M_P"QD/\ Z465>]D?^_P])_\ I$CQ,Y_W*7K'_P!+B?6=%%%>">V%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ROK'Q"_:PAU:]C
MT_X8^%9[!9W6WEDN8PSQACL8_P"G#DC'8?2OJBBN["XJ.&;;I1G?^9-V]+-'
M%B<,\0DE4E"W\MM?6Z9\$_#CPK^T_P###QCXU\2Z5\-]#N+[Q9=B\OH[R^MV
MBC</*^(@MXI S,WWBW '/K[W\&_&'[0.M>-8K;XC>!M T#PT8)&>\T^='E$@
M'R+@74G!.?X?Q%>]T5Z.*S=XM2]I0IW:M=*5U965O>Z(X,-E2PK7)7G9.]FU
M;>[O[O4****\ ]P**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .)^.'_)%?'__ &+^H?\ I-)7G'["?_)KWA'_ '[W_P!+)J]'^.'_
M "17Q_\ ]B_J'_I-)7G'["?_ ":]X1_W[W_TLFKWX?\ (GG_ -?(_P#I,CQ)
M?\C6'_7N7_I43WVBBBO /;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH XKXW?\ )%_'W_8OZA_Z325YM^PE_P F
MO^$_^NE[_P"E<U>D_&[_ )(OX^_[%_4/_2:2O-OV$O\ DU_PG_UTO?\ TKFK
MWX?\BBI_U\C_ .DR/$G_ ,C6'_7N7_I43WZBBBO /;"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-7];MG?AL,\.FG4E._\ -;3TLD%%%%<)VA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!\F?L?_P#)P'[1W_8?7_TIO:^LZ^3/V/\
M_DX#]H[_ +#Z_P#I3>U]9U[V>?[\_P###_TB)XF3?[FO6?\ Z7(****\$]L*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#B?CA_R17Q__P!B_J'_ *325YQ^PG_R:]X1_P!^]_\ 2R:O1_CA
M_P D5\?_ /8OZA_Z325YQ^PG_P FO>$?]^]_]+)J]^'_ ")Y_P#7R/\ Z3(\
M27_(UA_U[E_Z5$]]HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** .*^-W_ "1?Q]_V+^H?^DTE>;?L)?\
M)K_A/_KI>_\ I7-7I/QN_P"2+^/O^Q?U#_TFDKS;]A+_ )-?\)_]=+W_ -*Y
MJ]^'_(HJ?]?(_P#I,CQ)_P#(UA_U[E_Z5$]^HHHKP#VPHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^3/
MV/\ _DX#]H[_ +#Z_P#I3>U]9U\F?L?_ /)P'[1W_8?7_P!*;VOK.O>SS_?G
M_AA_Z1$\3)O]S7K/_P!+D%%%%>">V%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!Q/QP_P"2*^/_ /L7]0_]
M)I*\X_83_P"37O"/^_>_^EDU>C_'#_DBOC__ +%_4/\ TFDKSC]A/_DU[PC_
M +][_P"EDU>_#_D3S_Z^1_\ 29'B2_Y&L/\ KW+_ -*B>^T445X![84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'%?&[_DB_C[_ +%_4/\ TFDKS;]A+_DU_P )_P#72]_]*YJ])^-W_)%_'W_8
MOZA_Z325YM^PE_R:_P"$_P#KI>_^E<U>_#_D45/^OD?_ $F1XD_^1K#_ *]R
M_P#2HGOU%%%> >V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS36'<9M)7Y[I626W*NB[GG8' 8K!\L'74H)MVY+;MO?F?5A1117SQ[P4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%</\8_ .L?$KP5+HNA>+K[P3?M/'*-6T\.9553DI\DD9P?\ >KN**UI5)49J
MI#=:]_P>AG4IQJP=.>S^7Y'R+??L4_$75+*XL[S]HKQ1=V=Q&T,UO/#<O'*C
M AE93>8(()!!X(-5M!_87\=>%M+ATS1?V@/$.D:;#N,=G86L\$*;B6;:BW@
MR22<#J37V'17M_V]F%N7G5O\$/\ Y$\;^Q,#?FY'?_%/_P"2.'^#G@'6/AKX
M*BT77?%U]XVOUGDE.K:@'$K*QR$^>20X'^]7<445XE6I*M-U)[O7M^"T/9IT
MXTH*G#9?/\PHHHK(T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#BOC=_R1?Q]_V+^H?^DTE>;?L)?\FO^$_^NE[_ .E<
MU>D_&[_DB_C[_L7]0_\ 2:2O-OV$O^37_"?_ %TO?_2N:O?A_P BBI_U\C_Z
M3(\2?_(UA_U[E_Z5$]^HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#BOC=_R1?Q]_V+^H?^DTE>;?L)?\FO^$_^NE[_ .E<
MU>D_&[_DB_C[_L7]0_\ 2:2O-OV$O^37_"?_ %TO?_2N:O?A_P BBI_U\C_Z
M3(\2?_(UA_U[E_Z5$]^HHHKP#VPHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG_A8&G_\\;K_ +Y7_P"*H_X6!I__ #QNO^^5_P#BJ .FHKF?^%@:?_SQNO\
MOE?_ (JC_A8&G_\ /&Z_[Y7_ .*H Z:BN9_X6!I__/&Z_P"^5_\ BJU=&UR#
M7(Y'@21!&=I\P ?R)H T:*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBU[2-9JSB[I+:_\ EY&4D_9RI)W4E9M[V_S\SIZ***@H**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJLUJR;J]@HKSCXQ?M%_#;]G_ $^"[^('B_3_  VMP"8()BTEQ, <$QP1AI'
M)&2JD#/-8WP=_:[^#WQ^OWL/ GCS3M:U)06_L]UEM+IE R66&=$=E'<JI I1
M]Z_+K8<O=WT/8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBL[4?$&FZ3J&EV-Y>PV]YJDS064$C8>XD6-I&51WPB,Q] * -&BB
MO.=<_:2^$?AG6;O2-8^*7@O2=6M)##<6-]XAM(9X9!U1XVD#*P]",T;NW4/,
M]&HI%8,H(.0>012T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$/PIX9U7RUF^PZQK=M:3[&SM;9(X;!P<'&#@UA_\-8_!#_HLGP__ /"HL?\
MX[2O?8#U6BO,;#]J+X-:K?6]E9?%OP+>7ES(L,%O;^);)Y)9&("HJB7+,20
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHX1M07,4C12E1V4LA8#L&%=3DJRFUIKJNFM[?+=',HRI.";OV?FM_GU/-?\
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M%O5?^O27_P! -? ?_!%#_DW?QG_V-#_^DMO4X?25=+;E7_I9=;6-)O\ F?\
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M !1110!\)?\ !5OXO^)/#7@7P/\ #'PI>OIFH_$34FT^YO(V*L+93&C1;AR
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMYA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y/\
MM,?M(>%?V7OAA?>+_$TV]AF'3]-C8":_N2"5B3TZ99NB@$GT/Y;?LY_M!?"/
MXD_'C4OCI^TK\08?^$EMK@#P]X572K^ZMM/5#F-_W<#IM3/R(&)W;G;YL&OU
MR\<?!_P%\3KBUG\8^"/#GBR>T5DMY-<TFWO6A5B"P0RHVT$@9 ]*YG_AD[X(
M?]$;^'__ (2]C_\ &JFGS0FZCWZ>7GZ^?3IKJ5.TH>S6W7S\O3RZ]>Q5^!_[
M6_PG_:.U34].^'7BO_A(;S385N+N/^SKNU\N-FVJ<SQ(#SV!)KYU^/O[;_Q#
M_97_ &GH;3XC^$X_^%'ZE"(--UC1X&EE\PA6,LCL<&12'#0C:=IW+NP,_7/@
M?X.> ?AE=75SX/\  _AOPG<W2".>;0])M[-YE!R%<Q(I8 \X-='K.BZ=XBTV
M?3M6L+74]/N%V36EY"LT4B^C(P((^HIO2491Z;I[/^OSU[$K:49==K;K;^O0
M^%OCU_P50^&=YX!O="^#]QJ7Q \?:Y"VGZ99V>DW,2P32#:'82QJSD9R$C#%
MB . <UZA_P $X_V:=6_9F_9YATOQ)$+?Q3KEX^K:C:A@WV4LB)'"2."51%)Q
MD;F89(&:]U\%_!OP!\-[J:Z\)>!O#?A>YF&V2;1=(M[-W'HS1HI(^M=C5QM!
M2:WE9/T6ME\];[BE>7*GM&[7J]+_ / "BBBI&%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5^>WQ6_:V^*W['O[6UY%\5[J_P#$7P'U\L-'O;72
M[=?[/WX8#?'&K2-$0R,CL6*$.-QX/Z$U2UC1=/\ $6FW&G:K86NIZ?<+LFM+
MR%98I%]&1@01[$5.L9*:Z7T>SO\ UH^A6CBXOK]Z_KMU/SS_ &N/^"B_PX^+
M7P?U?X:?!Y]1^(?C'QG VCPVUII5S"L"RC:Y(EC1G<J6"A 1GDD <_5?[&'P
M3U']GW]FGP;X(U>56UJSMY)[[RV#+'/-*\KH#T.POMST.W-=[X+^#?@#X;WD
M]WX2\#>&_"]W.NV6?1=(M[-Y!Z,T:*2/K78UHK1C)+>5K_*]DOO;_P"&(E>3
MC?:-[>KZO\C\X?"_[<'Q"_93_:%\5> _VF]1O]3\*7DC2>'?%4.D0QHL*LVU
M]MM$AE1T90VT,R.N,8)(YW]M3]L'P[^V7X4T[X%_ BUOO'>L^)+ZWDNM06QF
MMH+:**0/_P M45QAE4LY4(J@\DGC]*?%'A'0O'&DR:7XCT33M?TR0@O9:I:1
MW,+$="4<%3^59_@GX7^#?AK!/#X0\):%X5AG.Z:/1--ALUD/JPC5<_C6:BI1
MC&KKRVVTO9Z7_5K<N4FI2E3T;OZ*^]OT70J_!OP /A5\)_!W@W[1]K.@Z3:Z
M<UP!@2M%$J%A[$@G\:[&BBM9S=23G+=ZF<8J$5%= HHHJ"@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *\L_:2^%'BCXV_"W4?!WACQS_P *_;4_W-]J
MD>FF]F>V((>*/]]%Y9;@%LD[<@ 9R/4Z*F45-<LMBHR<7=;GYR>#_P#@E/\
M$KX=Z/\ V3X5_:O\5^&=*\QI?L.CZ=<VD&]L;FV1ZB%R<#)QVKYZ\3?LG_$3
M2_V_/"7PUN/V@/$]]XKOM!:^@\>2+<_;K6()<G[.H-V7VD1N.)0/WAXZY_:"
MN>N/AWX5N_&5MXNG\,Z/-XLMH?L\&O26$37T46&'EK.5WJN';Y0<?,?4UI&3
MC.,GTO\ DTOQM\M#-KW'%;O_ #3-JR@>ULX(9)6GDCC5&E;JY P6/UK\[/\
M@M=_R1WX<?\ 8QM_Z3O7Z-5SGC;X;>$?B59VUIXO\+:+XJM+:3SH(-;TZ&\2
M*3&-ZK(K!6P2,CGFE>\XS?247]TD_P!#2FU3T\FOPL;EE_QYP?\ 7-?Y5/2*
MH50 , < "EH>KN90CRQ4>P4444BPHHHH **** "BBB@ HHHH **** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\[_:&^%*_''X(^,_
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MHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5S?Q)\(_\)_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ:OEGX*_\E,T;_MM_P"B9*^IJ_J+PN_Y$U7_ *^R_P#2('X[QE_O\/\  O\
MTJ04445^PGP@45^7_BK_ (+9?\(SXHUC1_\ A3/VG^S[R:T\[_A*=GF>6Y3=
MM^QG&<9QDUE_\/SO^J)_^77_ /<51"<:D5..SU*E%PDXRW1^JE%?G/\ #/\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^3/\ @I9_R0K0O^QD@_\
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MXD_6HP_\2IS=E?TYM+>?X&F(O[&GR_S2MZ\JO?R_$_56BBB@D**** "BBB@
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MX(L_$#4O$/P*\7>%[V:2>T\/:NK66\Y$45PA=HU]MZ.WUD->$_M:?\%0+O\
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MD=20P]P:^:-5_P""8O[.6I>$9-!A\ )IY,96/4[:_N?MD3D$"02-(=Q!.=K
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5\F?\%+/^2%:%_V,D'_I+=5]9U\F
M?\%+/^2%:%_V,D'_ *2W5>]D/_(SH?XCQ,[_ .1=6]#\U****_H4_"@HHHH
M**** "BBB@#]WJ***_EP_I *_([_ (+>?\E ^%'_ &#KW_T;%7ZXU^1W_!;S
M_DH'PH_[!U[_ .C8JR_Y?T?\7Z,VA\$_3]4?J]H/_(M:=_UZ1_\ H K\K/\
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MMN/_ $DM*^5O^"B?@>;Q=_P4ATC0KW7)/#,&OC1[>VUE8S(;-7Q$)0NY,[9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP#D$8XR>A8>JZ7M[>[W_  .7ZU15;ZOS>_V^5_38]GHHHKG.H**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!\G?\%./^36[S_L+6?_ *$U?)'_  2QF7_AH;6K.5/,AN_#
MES&\; %3^^@//MC(_&OK?_@IQ_R:W>?]A:S_ /0FKY!_X)9_\G+7?_8 NO\
MT9#7OY<D\'B$_P"]_P"D(^9S/_?\-Z1_]+9YW^T[\*=3_95_:,E&BM)96<=U
M'K6@72@_+'OW(H/<QN"A_P!T'O47[9OC6P^)_P 5].\<:< D/B30;&_>,'/E
MRA##*G_ 7A9?^ U^BG_!0GX!?\+D^"L^KZ;;>=XE\+A[^UV+EY8,?OXAW.5
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MK#_TF1^P'[,__)JOP_\ ^Q:M_P#T2*_#BX_Y"$O_ %U/\Z_<?]F?_DU7X?\
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M.!N#+C)(PN<;L5G]8E14VL/RZ:]/+MKN:K"PK2AS8KFUT6_GWTV/ES_@KO\
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MI&K860J,[@2O+ 9RI!\S_:O_ &F?V:?C9\(]7=&&L^-C:8TIDTB>"]MY_P"
M-.T878#]Y=[ C. 3BN/"5*U.C&,Z?/3>WW_EVVTZG9C:.'J5Y3A5Y*D=];+;
M^D[7]+GMG[)/[<.A_M*2RZ#?Z>/#GC.WA\XV0E\R"[C&-SPL<'(ZE#R <@M@
MD?3M?BS_ ,$_-#U/6?VKO!DFFK)ML3<7=W(@XC@$#JV[V)95^KBOVFK',L/3
MP]2/L]+J]CIRK%5<32E[75IVN%%%%>0>V%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAB@50J*N0#PN>!DG%>V45USQF(J1Y93T.*G@,-2ESPAK]_YGC/[1G[*OA/\
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M8\F_:(_9K\,?M,>']*T?Q/?:M86VG71NXFTB:*-V<H5PQDC<$8/8"L#]G?\
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M85*DZLN:;NSIITX48J%-604445F:!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\]I_^_R?XT >HT5Y=GQ;_P ]I_\ O\G^-&?%O_/:?_O\G^- 'J-%>79\6_\
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M_P"_R?XT9\6_\]I_^_R?XT >HT5Y=GQ;_P ]I_\ O\G^-&?%O_/:?_O\G^-
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M^- 'J-%>3WUWXGL[=I;BZN(XA@%A,OK['-%C>>)KVW66WNKB2(D@,9E_J<T
M>L45Y=GQ;_SVG_[_ "?XT9\6_P#/:?\ [_)_C0!ZC17EV?%O_/:?_O\ )_C1
MGQ;_ ,]I_P#O\G^- 'J-%>79\6_\]I_^_P G^-&?%O\ SVG_ ._R?XT >HT5
MY=GQ;_SVG_[_ "?XT9\6_P#/:?\ [_)_C0!ZC17EV?%O_/:?_O\ )_C1GQ;_
M ,]I_P#O\G^- 'J-%>79\6_\]I_^_P G^-&?%O\ SVG_ ._R?XT >HT5Y=GQ
M;_SVG_[_ "?XT9\6_P#/:?\ [_)_C0!ZC17EV?%O_/:?_O\ )_C1GQ;_ ,]I
M_P#O\G^- 'J-%>79\6_\]I_^_P G^-&?%O\ SVG_ ._R?XT >HT5Y=GQ;_SV
MG_[_ "?XT9\6_P#/:?\ [_)_C0!ZC17EV?%O_/:?_O\ )_C1GQ;_ ,]I_P#O
M\G^- 'J-%>79\6_\]I_^_P G^-5-2U'Q'I\:-=7=Q$K' (E'7\#0!ZY17E=O
M-XJN((Y([B=HV4%6\Y>1^)I^?%O_ #VG_P"_R?XT >HT5Y=GQ;_SVG_[_)_C
M1GQ;_P ]I_\ O\G^- 'J-%>79\6_\]I_^_R?XT9\6_\ /:?_ +_)_C0!ZC17
MEV?%O_/:?_O\G^-&?%O_ #VG_P"_R?XT >HT5Y=GQ;_SVG_[_)_C1GQ;_P ]
MI_\ O\G^- 'J-%>79\6_\]I_^_R?XT9\6_\ /:?_ +_)_C0!ZC17EV?%O_/:
M?_O\G^-&?%O_ #VG_P"_R?XT >HT5Y=GQ;_SVG_[_)_C1GQ;_P ]I_\ O\G^
M- 'J-%>79\6_\]I_^_R?XT9\6_\ /:?_ +_)_C0!ZC17EV?%O_/:?_O\G^-&
M?%O_ #VG_P"_R?XT >HT5Y=GQ;_SVG_[_)_C1GQ;_P ]I_\ O\G^- 'J-%>7
M9\6_\]I_^_R?XT9\6_\ /:?_ +_)_C0!ZC17C^HZMX@T^1$NKVXB9AD 2]1^
M!J_GQ;_SVG_[_)_C0!ZC17EV?%O_ #VG_P"_R?XT9\6_\]I_^_R?XT >HT5Y
M=GQ;_P ]I_\ O\G^-&?%O_/:?_O\G^- 'J-%>79\6_\ /:?_ +_)_C1GQ;_S
MVG_[_)_C0!ZC17EV?%O_ #VG_P"_R?XT9\6_\]I_^_R?XT >HT5Y=GQ;_P ]
MI_\ O\G^-&?%O_/:?_O\G^- 'J-%>79\6_\ /:?_ +_)_C1GQ;_SVG_[_)_C
M0!ZC17EV?%O_ #VG_P"_R?XT9\6_\]I_^_R?XT >HT5Y=GQ;_P ]I_\ O\G^
M-&?%O_/:?_O\G^- 'J-%>79\6_\ /:?_ +_)_C1GQ;_SVG_[_)_C0!ZC17EV
M?%O_ #VG_P"_R?XT9\6_\]I_^_R?XT >HT5Y=GQ;_P ]I_\ O\G^-&?%O_/:
M?_O\G^- 'J-%>79\6_\ /:?_ +_)_C5";5O$$6H+:O>W"W)( 3S>,GIWQ0![
M!17EV?%O_/:?_O\ )_C1GQ;_ ,]I_P#O\G^- 'J-%>79\6_\]I_^_P G^-&?
M%O\ SVG_ ._R?XT >HT5Y=GQ;_SVG_[_ "?XT9\6_P#/:?\ [_)_C0!ZC17E
MV?%O_/:?_O\ )_C1GQ;_ ,]I_P#O\G^- 'J-%>79\6_\]I_^_P G^-&?%O\
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M_D_QHSXM_P">T_\ W^3_ !H ]1HKR[/BW_GM/_W^3_&C/BW_ )[3_P#?Y/\
M&@#U&BO+L^+?^>T__?Y/\:,^+?\ GM/_ -_D_P : /4:*\N+>+5!)GGQ_P!=
MD_QJCINJ^(-09UM;VXE*C+9E''YF@#U^BO+L^+?^>T__ '^3_&C/BW_GM/\
M]_D_QH ]1HKR[/BW_GM/_P!_D_QHSXM_Y[3_ /?Y/\: /4:*\NSXM_Y[3_\
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M\]I_^_R?XT >HT5Y=GQ;_P ]I_\ O\G^-&?%O_/:?_O\G^- 'J-%>79\6_\
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MO_/:?_O\G^-&?%O_ #VG_P"_R?XT >HT5Y=GQ;_SVG_[_)_C1GQ;_P ]I_\
MO\G^- 'J-%>79\6_\]I_^_R?XT9\6_\ /:?_ +_)_C0!ZC17EV?%O_/:?_O\
MG^-&?%O_ #VG_P"_R?XT >HT5Y=GQ;_SVG_[_)_C1GQ;_P ]I_\ O\G^- 'J
M-%>79\6_\]I_^_R?XT9\6_\ /:?_ +_)_C0!ZC17EV?%O_/:?_O\G^-&?%O_
M #VG_P"_R?XT >HT5X_?:MX@L;A(KB]N(Y6 *J)>HSCL<5?SXM_Y[3_]_D_Q
MH ]1HKR[/BW_ )[3_P#?Y/\ &C/BW_GM/_W^3_&@#U&BO+L^+?\ GM/_ -_D
M_P :,^+?^>T__?Y/\: /4:*\NSXM_P">T_\ W^3_ !HSXM_Y[3_]_D_QH ]1
MHKR[/BW_ )[3_P#?Y/\ &C/BW_GM/_W^3_&@#U&BO+L^+?\ GM/_ -_D_P :
M,^+?^>T__?Y/\: /4:*\NSXM_P">T_\ W^3_ !HSXM_Y[3_]_D_QH ]1HKR[
M/BW_ )[3_P#?Y/\ &C/BW_GM/_W^3_&@#U&BO+L^+?\ GM/_ -_D_P :,^+?
M^>T__?Y/\: /4:*\NSXM_P">T_\ W^3_ !HSXM_Y[3_]_D_QH ]1HKR[/BW_
M )[3_P#?Y/\ &C/BW_GM/_W^3_&@#U&BO+L^+?\ GM/_ -_D_P :,^+?^>T_
M_?Y/\: /4:*\NSXM_P">T_\ W^3_ !I-&U;64\46EK=7DY;S5$D;297!'ITZ
M4 >I4444P"BBB@ HHHH **** "BBB@ HHHH **** "N4^)/_ "+H_P"NZ_R-
M=77*?$G_ )%T?]=U_D:3 I>%O^0#:?1O_0C6K65X6_Y -I]&_P#0C6K3 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!72US7@7_D'7'_77^@KI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK;U##H1FEKA/0WU"BBB@ HHHH **** "N+\#_P#(2NO^N?\ [,*[2N+\#_\
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M^A&M6F 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M**** "BBB@ HHHH QO%W_("G_P!Y?_0A2>#_ /D!Q?[S?SI?%W_("G_WE_\
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M2/Y?.>/$D1;'7*B13ZK@=J^Y]!UB#Q%H6G:K:G=;7UM'=1'U1U#+^A%?)O\
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M-"IR)II25NJ=GIZFY^R1IG]D_LT_#J +MW:1%/C&/]9F3/3_ &Z]<KXLTO\
M8Y^-]SX3TBWNOC_?^'[G3K..TMM)T.&6*TA2-0J)OBEBW8  +&,GZU@_!O\
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MKN!;>;5/+S*47(&.P)'!8 $@ $D 8@^#/_)'_ W_ & K'_TG2M+Q]>>(-/\
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MV@+&#X8_\%#/AUJOAM5M+K7);&2_AMQM#M-.]O*2!_?CY/J<GWK[B^)WPO\
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M@7RQ$5V>7$F/OG.<]J_5+P[_ ,B_I?\ UZQ?^@"OA/\ X*O?\>/PT_Z[7_\
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M?-VL=F+I2K0A&'2<9?)7N>M:K_R"[S_KB_\ Z":^!/\ @E3_ ,A3XJ?73_\
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MNDDE8C][_KDP0 !T-8W[+O[*>M^ O&6K?$SXEZK%K_Q$U7=@Q-OCLP_WSNP
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MGT6JQM:->O*I#;3\$D1E]">'PT:=3?7\6W8****X3T0HHHH **** "J&O?\
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MUKX%\;^%+B!+77M,U?S[F-E"RE'0( W<[7B<>V?>OJOX2Z;XQT?X?Z5:>/\
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M )#EI_US7_T(UVE !1110 4444 %%%% !1110 5^>'[87_)^GPC_ .NFD?\
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M_KH?Y4F!M:+_ ,@>R_ZXK_*KM4M%_P"0/9?]<5_E5VF 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '%^.O^/ZV_ZY_UKM*X
MOQU_Q_6W_7/^M=I2 ****8!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5Q>I?\CM#_UTC_D*[2N+U+_D=H?^ND?\A2 [2BBBF 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '%Z-
M_P CE=?]=)?YFNTKB]&_Y'*Z_P"NDO\ ,UVE) %%%%, HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ;)_JV^AKC_ ?_'S=_[B_P Z
M["3_ %;?0UQ_@/\ X^;O_<7^=(#LJ***8!1110 4444 %%%% !1110 4444
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M^\W\A28'0:7_ ,@RT_ZXI_Z"*M55TO\ Y!EI_P!<4_\ 015JF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '%^,O^0Y:?\
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MF_[X%'_"K;7_ )_IO^^!0!8_MJP_Y_;?_OZO^-']M6'_ #^V_P#W]7_&J_\
MPJVU_P"?Z;_O@4?\*MM?^?Z;_O@4 6/[:L/^?VW_ ._J_P"-']M6'_/[;_\
M?U?\:K_\*MM?^?Z;_O@4?\*MM?\ G^F_[X% %C^VK#_G]M_^_J_XT?VU8?\
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MW_? H_X5;:_\_P!-_P!\"@"Q_;5A_P _MO\ ]_5_QJIJVK64FEW:)=P,[0N
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M?Z;_ +X% %C^VK#_ )_;?_OZO^-']M6'_/[;_P#?U?\ &J__  JVU_Y_IO\
MO@4?\*MM?^?Z;_O@4 6/[:L/^?VW_P"_J_XT?VU8?\_MO_W]7_&J_P#PJVU_
MY_IO^^!1_P *MM?^?Z;_ +X% %C^VK#_ )_;?_OZO^-']M6'_/[;_P#?U?\
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MO_PJVU_Y_IO^^!1_PJVU_P"?Z;_O@4 6/[:L/^?VW_[^K_C1_;5A_P _MO\
M]_5_QJO_ ,*MM?\ G^F_[X%'_"K;7_G^F_[X% %C^VK#_G]M_P#OZO\ C1_;
M5A_S^V__ ']7_&J__"K;7_G^F_[X%'_"K;7_ )_IO^^!0!8_MJP_Y_;?_OZO
M^-']M6'_ #^V_P#W]7_&J_\ PJVU_P"?Z;_O@4?\*MM?^?Z;_O@4 6/[:L/^
M?VW_ ._J_P"-<[XSOK:[M+<03QS$.20C@XXK:_X5;:_\_P!-_P!\"L'Q=X0A
M\-VL$L=P\QD<J0R@8XS0!M:1JUE%I=HCW<".L2@JT@!!Q5S^VK#_ )_;?_OZ
MO^-9NE_#FVU#3;6Y:\E1IHU<J%&!D9JU_P *MM?^?Z;_ +X% %C^VK#_ )_;
M?_OZO^-']M6'_/[;_P#?U?\ &J__  JVU_Y_IO\ O@4?\*MM?^?Z;_O@4 6/
M[:L/^?VW_P"_J_XT?VU8?\_MO_W]7_&J_P#PJVU_Y_IO^^!1_P *MM?^?Z;_
M +X% %C^VK#_ )_;?_OZO^-']M6'_/[;_P#?U?\ &J__  JVU_Y_IO\ O@4?
M\*MM?^?Z;_O@4 6/[:L/^?VW_P"_J_XT?VU8?\_MO_W]7_&J_P#PJVU_Y_IO
M^^!1_P *MM?^?Z;_ +X% %C^VK#_ )_;?_OZO^-']M6'_/[;_P#?U?\ &J__
M  JVU_Y_IO\ O@4?\*MM?^?Z;_O@4 6/[:L/^?VW_P"_J_XT?VU8?\_MO_W]
M7_&J_P#PJVU_Y_IO^^!1_P *MM?^?Z;_ +X% %C^VK#_ )_;?_OZO^-']M6'
M_/[;_P#?U?\ &J__  JVU_Y_IO\ O@4?\*MM?^?Z;_O@4 6/[:L/^?VW_P"_
MJ_XT?VU8?\_MO_W]7_&J_P#PJVU_Y_IO^^!1_P *MM?^?Z;_ +X% %C^VK#_
M )_;?_OZO^-']M6'_/[;_P#?U?\ &J__  JVU_Y_IO\ O@4?\*MM?^?Z;_O@
M4 6/[:L/^?VW_P"_J_XT?VU8?\_MO_W]7_&J_P#PJVU_Y_IO^^!1_P *MM?^
M?Z;_ +X% %C^VK#_ )_;?_OZO^-']M6'_/[;_P#?U?\ &J__  JVU_Y_IO\
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MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\
M3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_
M .%6VO\ S_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]
MM_\ OZO^-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\
M:/[:L/\ G]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_
M #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_W
MP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5M
MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\
M3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_
M .%6VO\ S_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&N2U"[@D\
M713K,C0AXR9 PV\ 9YKI?^%6VO\ S_3?]\"N6OO#D=IXJCTD3,T;.B^80,_,
M!_C0!V/]M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\ 3?\ ? H_
MX5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_ .%6VO\
MS_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^
M-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\
MG]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W
M]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_WP* +']M6
M'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5MK_S_ $W_
M 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\ 3?\ ? H_
MX5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_ .%6VO\
MS_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W]7_&C^VK#_G]M_\ OZO^
M-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_WP* +']M6'_/[;_\ ?U?\:/[:L/\
MG]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5MK_S_ $W_ 'P* +']M6'_ #^V_P#W
M]7_&C^VK#_G]M_\ OZO^-5_^%6VO_/\ 3?\ ? H_X5;:_P#/]-_WP* +']M6
M'_/[;_\ ?U?\:/[:L/\ G]M_^_J_XU7_ .%6VO\ S_3?]\"C_A5MK_S_ $W_
M 'P* .:TF[@C\67$SS(L)>0B1F 4Y)QS76_VU8?\_MO_ -_5_P :X[2_#D=_
MXGGTMIF2.-Y%$@ R=I(_I74_\*MM?^?Z;_O@4("Q_;5A_P _MO\ ]_5_QH_M
MJP_Y_;?_ +^K_C5?_A5MK_S_ $W_ 'P*/^%6VO\ S_3?]\"@"Q_;5A_S^V__
M ']7_&C^VK#_ )_;?_OZO^-5_P#A5MK_ ,_TW_? H_X5;:_\_P!-_P!\"@"Q
M_;5A_P _MO\ ]_5_QH_MJP_Y_;?_ +^K_C5?_A5MK_S_ $W_ 'P*/^%6VO\
MS_3?]\"@"Q_;5A_S^V__ ']7_&C^VK#_ )_;?_OZO^-5_P#A5MK_ ,_TW_?
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M_;5A_P _MO\ ]_5_QH_MJP_Y_;?_ +^K_C5?_A5MK_S_ $W_ 'P*/^%6VO\
MS_3?]\"@"Q_;5A_S^V__ ']7_&C^VK#_ )_;?_OZO^-5_P#A5MK_ ,_TW_?
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M_;?_ +^K_C1_;5A_S^V__?U?\:K_ /"K;7_G^F_[X%'_  JVU_Y_IO\ O@4
M6/[:L/\ G]M_^_J_XT?VU8?\_MO_ -_5_P :K_\ "K;7_G^F_P"^!1_PJVU_
MY_IO^^!0!8_MJP_Y_;?_ +^K_C1_;5A_S^V__?U?\:K_ /"K;7_G^F_[X%'_
M  JVU_Y_IO\ O@4 6/[:L/\ G]M_^_J_XT?VU8?\_MO_ -_5_P :K_\ "K;7
M_G^F_P"^!1_PJVU_Y_IO^^!0!8_MJP_Y_;?_ +^K_C1_;5A_S^V__?U?\:K_
M /"K;7_G^F_[X%'_  JVU_Y_IO\ O@4 6/[:L/\ G]M_^_J_XT?VU8?\_MO_
M -_5_P :K_\ "K;7_G^F_P"^!1_PJVU_Y_IO^^!0!8_MJP_Y_;?_ +^K_C1_
M;5A_S^V__?U?\:K_ /"K;7_G^F_[X%'_  JVU_Y_IO\ O@4 6/[:L/\ G]M_
M^_J_XT?VU8?\_MO_ -_5_P :K_\ "K;7_G^F_P"^!1_PJVU_Y_IO^^!0!8_M
MJP_Y_;?_ +^K_C1_;5A_S^V__?U?\:K_ /"K;7_G^F_[X%'_  JVU_Y_IO\
MO@4 9WBS4K6ZTADAN8I7WJ=J.":E\,ZG:6^BV\<MU#&XW95G (^8U4\4>!X-
M!TLW<=S)*P=5VLH YJ7P[X"@UK1X+Q[J2)I-V5500,,1_2@#:_MJP_Y_;?\
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M 6/[:L/^?VW_ ._J_P"-']M6'_/[;_\ ?U?\:K_\*MM?^?Z;_O@4?\*MM?\
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M^F_[X% %C^VK#_G]M_\ OZO^-']M6'_/[;_]_5_QJO\ \*MM?^?Z;_O@4?\
M"K;7_G^F_P"^!0!8_MJP_P"?VW_[^K_C1_;5A_S^V_\ W]7_ !JO_P *MM?^
M?Z;_ +X%'_"K;7_G^F_[X% %C^VK#_G]M_\ OZO^-']M6'_/[;_]_5_QJO\
M\*MM?^?Z;_O@4?\ "K;7_G^F_P"^!0!S7BN[ANM8MGAF25%1061@0/F-=;_;
M5A_S^V__ ']7_&N.\3>'(]!U6WM(YFE65%8LP (RQ']*ZG_A5MK_ ,_TW_?
MH L?VU8?\_MO_P!_5_QH_MJP_P"?VW_[^K_C5?\ X5;:_P#/]-_WP*/^%6VO
M_/\ 3?\ ? H L?VU8?\ /[;_ /?U?\:/[:L/^?VW_P"_J_XU7_X5;:_\_P!-
M_P!\"C_A5MK_ ,_TW_? H L?VU8?\_MO_P!_5_QH_MJP_P"?VW_[^K_C5?\
MX5;:_P#/]-_WP*/^%6VO_/\ 3?\ ? H L?VU8?\ /[;_ /?U?\:/[:L/^?VW
M_P"_J_XU7_X5;:_\_P!-_P!\"C_A5MK_ ,_TW_? H L?VU8?\_MO_P!_5_QH
M_MJP_P"?VW_[^K_C5?\ X5;:_P#/]-_WP*/^%6VO_/\ 3?\ ? H L?VU8?\
M/[;_ /?U?\:/[:L/^?VW_P"_J_XU7_X5;:_\_P!-_P!\"C_A5MK_ ,_TW_?
MH L?VU8?\_MO_P!_5_QH_MJP_P"?VW_[^K_C5?\ X5;:_P#/]-_WP*/^%6VO
M_/\ 3?\ ? H L?VU8?\ /[;_ /?U?\:/[:L/^?VW_P"_J_XU7_X5;:_\_P!-
M_P!\"C_A5MK_ ,_TW_? H L?VU8?\_MO_P!_5_QH_MJP_P"?VW_[^K_C5?\
MX5;:_P#/]-_WP*/^%6VO_/\ 3?\ ? H L?VU8?\ /[;_ /?U?\:/[:L/^?VW
M_P"_J_XU7_X5;:_\_P!-_P!\"C_A5MK_ ,_TW_? H L?VU8?\_MO_P!_5_QH
M_MJP_P"?VW_[^K_C5?\ X5;:_P#/]-_WP*/^%6VO_/\ 3?\ ? H L?VU8?\
M/[;_ /?U?\:YJUGCF\?P21R*\;2KAE.0?E ZUN_\*MM?^?Z;_O@5S]GI*:3X
M\MK)9&D2*9"&(P3\H:@#U>BBBF 4444 %%%% !1110 4444 %%%% !1110 5
MRGQ)_P"1='_7=?Y&NKKE/B3_ ,BZ/^NZ_P C28%WP/\ \BK8?1O_ $-JWJP?
M _\ R*MA]&_]#:MZF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 >;_#'_D,7O_7'_P!F%>D5YO\ #'_D,7O_ %Q_]F%>D4D 4444P"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\W^&?\
MR&K[_KE_[,*](KS?X9_\AJ^_ZY?^S"D!Z11113 **** "BBB@ HHHH ****
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M<\?;5*K1=*SO=-737]?@.C75:ZM9IV:?3_@=F%%%%8'2%%%% !1110 4444
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M*** "BBB@ KA/BI_Q[Z=_OO_ "%=W7"?%3_CWT[_ 'W_ )"DP.MT/_D":?\
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MB_\ (RV'_7)/_0VKTBO-_B+_ ,C+8?\ 7)/_ $-J](H **** "BBB@ HHHH
M**** "BBB@ HJMJ6I6NCZ?=7][/':V=K$TTT\K;4C102S$]@ ":_,'Q+^W[\
M4?%_QVTMO">L-H?PZU'7(=-L;9M.MI#<Q++&LC%Y(V<,PD!(!&W> .1FNK#8
M>>*J>SI[_A_7^3.3%8JG@Z?M*GX;_P!?\ _4>BBBN4ZPHHHH **** "BBB@
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MO66']OR-TM%??1?*_P#D;8KZNYJ-5.3MI'5_.RT^;,3]B7XK>-/AI^T!XD^
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M2?\ H)K1K.\1?\B_J7_7M)_Z": .9^%O_'A??]=5_E7;UQ'PM_X\+[_KJO\
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M9-J_1JVRMZ]3.%2<\5%8B/*TG;JG?=I^B6AZK1117E'L!1110 4444 %%%%
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MJG_W37GGPM_X_;__ *YK_,UZ'-_JG_W37GGPM_X_;_\ ZYK_ #-(#T:BBBF
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MK,5W@89A@'HQ'>M^E6Q"G[+V:Y>16779MK\-PHX5Q=7VKYN??INK/_@'QO\
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MO^O:3_T$UHUG>(O^1?U+_KVD_P#030!S/PM_X\+[_KJO\J[>N(^%O_'A??\
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MX,>#=6CO[JWUKQ28V#I;ZY>HT((.1E(8XPP]FR#W%?5%G9V^GVD%K:P1VUK
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M\-Z?'"*'Q/XLTWX>?";0Y/-2+5M1@M7,><9 =P'N) ,9&5C'K_'^@GA/XS?
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MB@ HHHH \W^*'_(4LO\ KB?_ $(UZ17F_P 4/^0I9?\ 7$_^A&O2* "BBB@
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MZ**LOGW"BBBN,[PHHHH **** "BBB@ K)\5?\BWJ/_7%JUJR?%7_ "+>H_\
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MP.MT/_D":?\ ]>\?_H(J]5'0_P#D":?_ ->\?_H(J]3 **** "BBB@ HHHH
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M@%%%% !1110 4444 %%%% !1110 4444 %<I\2?^1='_ %W7^1KJZY3XD_\
M(NC_ *[K_(TF!=\#_P#(JV'T;_T-JWJP? __ "*MA]&_]#:MZF 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 >;_#'_D,7O\ UQ_]F%>D5YO\
M,?\ D,7O_7'_ -F%>D4D 4444P"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *\W^&?_ "&K[_KE_P"S"O2*\W^&?_(:OO\
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M_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
M"@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$
M?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_
M]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ
M/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A
M:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_
MSX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX
M3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_
M^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG
M_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BN
MH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5
MM_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W
M_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
M"@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$
M?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_
M]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ
M/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A
M:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_
MSX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX
M3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_
M^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5M_SX2_\ ?8KJ/^$?TO\ Z!MG
M_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W_/A+_P!]BC_A:5M_SX2_]]BN
MH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\ "@#E_P#A:5M_SX2_]]BC_A:5
MM_SX2_\ ?8KJ/^$?TO\ Z!MG_P!^$_PH_P"$?TO_ *!MG_WX3_"@#E_^%I6W
M_/A+_P!]BC_A:5M_SX2_]]BNH_X1_2_^@;9_]^$_PH_X1_2_^@;9_P#?A/\
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M8KJ/^$?TO_H&V?\ WX3_  H_X1_2_P#H&V?_ 'X3_"@#E_\ A:5M_P ^$O\
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M .%I6W_/A+_WV*/^%I6W_/A+_P!]BNH_X1_2_P#H&V?_ 'X3_"C_ (1_2_\
MH&V?_?A/\* .7_X6E;?\^$O_ 'V*/^%I6W_/A+_WV*ZC_A']+_Z!MG_WX3_"
MC_A']+_Z!MG_ -^$_P * .7_ .%I6W_/A+_WV*/^%I6W_/A+_P!]BNH_X1_2
M_P#H&V?_ 'X3_"C_ (1_2_\ H&V?_?A/\* .7_X6E;?\^$O_ 'V*/^%I6W_/
MA+_WV*ZC_A']+_Z!MG_WX3_"C_A']+_Z!MG_ -^$_P * .7_ .%I6W_/A+_W
MV*/^%I6W_/A+_P!]BNH_X1_2_P#H&V?_ 'X3_"C_ (1_2_\ H&V?_?A/\* .
M7_X6E;?\^$O_ 'V*/^%I6W_/A+_WV*ZC_A']+_Z!MG_WX3_"C_A']+_Z!MG_
M -^$_P * .7_ .%I6W_/A+_WV*/^%I6W_/A+_P!]BNH_X1_2_P#H&V?_ 'X3
M_"C_ (1_2_\ H&V?_?A/\* .7_X6E;?\^$O_ 'V*/^%I6W_/A+_WV*ZC_A']
M+_Z!MG_WX3_"C_A']+_Z!MG_ -^$_P * .7_ .%I6W_/A+_WV*/^%I6W_/A+
M_P!]BNH_X1_2_P#H&V?_ 'X3_"C_ (1_2_\ H&V?_?A/\* .7_X6E;?\^$O_
M 'V*/^%I6W_/A+_WV*ZC_A']+_Z!MG_WX3_"C_A']+_Z!MG_ -^$_P * .7_
M .%I6W_/A+_WV*/^%I6W_/A+_P!]BNH_X1_2_P#H&V?_ 'X3_"C_ (1_2_\
MH&V?_?A/\* .7_X6E;?\^$O_ 'V*JZG\2+>_TVZMELI$,T31ABXXR",UV7_"
M/Z7_ - VS_[\)_A1_P (_I?_ $#;/_OPG^% 'G'A'Q=%X;M[B.2W>8R.&!5@
M,8%;_P#PM*V_Y\)?^^Q74?\ "/Z7_P! VS_[\)_A1_PC^E_] VS_ ._"?X4
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M2MO^?"7_ +[%'_"TK;_GPE_[[%=1_P (_I?_ $#;/_OPG^%'_"/Z7_T#;/\
M[\)_A0!R_P#PM*V_Y\)?^^Q1_P +2MO^?"7_ +[%=1_PC^E_] VS_P"_"?X4
M?\(_I?\ T#;/_OPG^% '!^)/'<.N:3+9I:21,Y4[F8$<'-)X:\=0Z%I,=H]K
M)*RLQW*P Y.:[W_A']+_ .@;9_\ ?A/\*/\ A']+_P"@;9_]^$_PH Y?_A:5
MM_SX2_\ ?8H_X6E;?\^$O_?8KJ/^$?TO_H&V?_?A/\*/^$?TO_H&V?\ WX3_
M  H Y?\ X6E;?\^$O_?8H_X6E;?\^$O_ 'V*ZC_A']+_ .@;9_\ ?A/\*/\
MA']+_P"@;9_]^$_PH Y?_A:5M_SX2_\ ?8H_X6E;?\^$O_?8KJ/^$?TO_H&V
M?_?A/\*/^$?TO_H&V?\ WX3_  H Y?\ X6E;?\^$O_?8H_X6E;?\^$O_ 'V*
MZC_A']+_ .@;9_\ ?A/\*/\ A']+_P"@;9_]^$_PH Y?_A:5M_SX2_\ ?8H_
MX6E;?\^$O_?8KJ/^$?TO_H&V?_?A/\*/^$?TO_H&V?\ WX3_  H Y?\ X6E;
M?\^$O_?8H_X6E;?\^$O_ 'V*ZC_A']+_ .@;9_\ ?A/\*/\ A']+_P"@;9_]
M^$_PH Y?_A:5M_SX2_\ ?8H_X6E;?\^$O_?8KJ/^$?TO_H&V?_?A/\*/^$?T
MO_H&V?\ WX3_  H Y?\ X6E;?\^$O_?8H_X6E;?\^$O_ 'V*ZC_A']+_ .@;
M9_\ ?A/\*/\ A']+_P"@;9_]^$_PH Y?_A:5M_SX2_\ ?8H_X6E;?\^$O_?8
MKJ/^$?TO_H&V?_?A/\*/^$?TO_H&V?\ WX3_  H Y?\ X6E;?\^$O_?8H_X6
ME;?\^$O_ 'V*ZC_A']+_ .@;9_\ ?A/\*/\ A']+_P"@;9_]^$_PH Y?_A:5
MM_SX2_\ ?8H_X6E;?\^$O_?8KJ/^$?TO_H&V?_?A/\*/^$?TO_H&V?\ WX3_
M  H Y?\ X6E;?\^$O_?8K!\6^+XO$EK!%';O"8W+$LP.>,5Z-_PC^E_] VS_
M ._"?X4?\(_I?_0-L_\ OPG^% '&Z7\1H-/TVUMFLI':&-8RP<<X&,U:_P"%
MI6W_ #X2_P#?8KJ/^$?TO_H&V?\ WX3_  H_X1_2_P#H&V?_ 'X3_"@#E_\
MA:5M_P ^$O\ WV*/^%I6W_/A+_WV*ZC_ (1_2_\ H&V?_?A/\*/^$?TO_H&V
M?_?A/\* .7_X6E;?\^$O_?8H_P"%I6W_ #X2_P#?8KJ/^$?TO_H&V?\ WX3_
M  H_X1_2_P#H&V?_ 'X3_"@#E_\ A:5M_P ^$O\ WV*/^%I6W_/A+_WV*ZC_
M (1_2_\ H&V?_?A/\*/^$?TO_H&V?_?A/\* .7_X6E;?\^$O_?8H_P"%I6W_
M #X2_P#?8KJ/^$?TO_H&V?\ WX3_  H_X1_2_P#H&V?_ 'X3_"@#E_\ A:5M
M_P ^$O\ WV*/^%I6W_/A+_WV*ZC_ (1_2_\ H&V?_?A/\*/^$?TO_H&V?_?A
M/\* .7_X6E;?\^$O_?8H_P"%I6W_ #X2_P#?8KJ/^$?TO_H&V?\ WX3_  H_
MX1_2_P#H&V?_ 'X3_"@#E_\ A:5M_P ^$O\ WV*/^%I6W_/A+_WV*ZC_ (1_
M2_\ H&V?_?A/\*/^$?TO_H&V?_?A/\* .7_X6E;?\^$O_?8H_P"%I6W_ #X2
M_P#?8KJ/^$?TO_H&V?\ WX3_  H_X1_2_P#H&V?_ 'X3_"@#E_\ A:5M_P ^
M$O\ WV*/^%I6W_/A+_WV*ZC_ (1_2_\ H&V?_?A/\*/^$?TO_H&V?_?A/\*
M.7_X6E;?\^$O_?8H_P"%I6W_ #X2_P#?8KJ/^$?TO_H&V?\ WX3_  H_X1_2
M_P#H&V?_ 'X3_"@#E_\ A:5M_P ^$O\ WV*/^%I6W_/A+_WV*ZC_ (1_2_\
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M\* .7_X6E;?\^$O_ 'V*Y>^\1QW?BF/5A"RHKHWEDC/R@=_PKU#_ (1_2_\
MH&V?_?A/\*/^$?TO_H&V?_?A/\* .7_X6E;?\^$O_?8H_P"%I6W_ #X2_P#?
M8KJ/^$?TO_H&V?\ WX3_  H_X1_2_P#H&V?_ 'X3_"@#E_\ A:5M_P ^$O\
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M_P +2MO^?"7_ +[%=1_PC^E_] VS_P"_"?X4?\(_I?\ T#;/_OPG^% '+_\
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M_P#PM*V_Y\)?^^Q1_P +2MO^?"7_ +[%=1_PC^E_] VS_P"_"?X4?\(_I?\
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M]^$_PH Y?_A:5M_SX2_]]BC_ (6E;?\ /A+_ -]BNH_X1_2_^@;9_P#?A/\
M"C_A']+_ .@;9_\ ?A/\* .7_P"%I6W_ #X2_P#?8H_X6E;?\^$O_?8KJ/\
MA']+_P"@;9_]^$_PH_X1_2_^@;9_]^$_PH Y?_A:5M_SX2_]]BC_ (6E;?\
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M$O\ WV*ZC_A']+_Z!MG_ -^$_P */^$?TO\ Z!MG_P!^$_PH Y?_ (6E;?\
M/A+_ -]BC_A:5M_SX2_]]BNH_P"$?TO_ *!MG_WX3_"C_A']+_Z!MG_WX3_"
M@#E_^%I6W_/A+_WV*/\ A:5M_P ^$O\ WV*ZC_A']+_Z!MG_ -^$_P */^$?
MTO\ Z!MG_P!^$_PH Y?_ (6E;?\ /A+_ -]BC_A:5M_SX2_]]BNH_P"$?TO_
M *!MG_WX3_"C_A']+_Z!MG_WX3_"@#E_^%I6W_/A+_WV*/\ A:5M_P ^$O\
MWV*ZC_A']+_Z!MG_ -^$_P */^$?TO\ Z!MG_P!^$_PH Y?_ (6E;?\ /A+_
M -]BC_A:5M_SX2_]]BNH_P"$?TO_ *!MG_WX3_"C_A']+_Z!MG_WX3_"@#E_
M^%I6W_/A+_WV*/\ A:5M_P ^$O\ WV*ZC_A']+_Z!MG_ -^$_P */^$?TO\
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M]^$_PH Y?_A:5M_SX2_]]BC_ (6E;?\ /A+_ -]BNH_X1_2_^@;9_P#?A/\
M"C_A']+_ .@;9_\ ?A/\* .7_P"%I6W_ #X2_P#?8H_X6E;?\^$O_?8KJ/\
MA']+_P"@;9_]^$_PH_X1_2_^@;9_]^$_PH Y?_A:5M_SX2_]]BC_ (6E;?\
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MZ/\ \(_I?_0-L_\ OPG^%.BT/3H)%DCT^UCD4Y5EA4$'U!Q0!>HHHI@%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M),B20#)9A@.?N]JKV,O9^U>B]=7K;1>I/UB'M?8J[:WTT6E]7ML>G4445@=
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MU?H)48JDJ3BTK75[7O;5K?Y7^9OA*SK*2;O9[VM=63V_#Y'AOQ0_::_X5O\
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M7B9HW4,I*. R\$<$"ODO2OV\)O!MQ!X<^//PTUCP%=S?Z-)J4=N;K3+CCYV
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MO[_/;H>C7K:0M/ENKVM>3^6OY;]3Z.^ ?QZ\-?M$> X_$_AIIHHUE:WNK*Z
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M7@KP)X.UGXI^*[,E;NTT0-Y4# X9-Z)(S,IZ[4(!XSG(&C\#?VUM*^*'C9?
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MZP6ZX!9D#,Q/5F)))8Y))YIT7".%DY*_O[?]NK<5:-26+BH.WN;_ /;TMO\
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M#]IW_AI[PWK^K?\ "-?\(U_95^++R?M_VOS<H&W9\I-O7&,'ZUR'QD_;KL/
M?Q$N_ ?@GP-K7Q.\6V/_ !^V>DAE2 @ E=R1R,S+D9PF!G&<Y \Z_P""4/\
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M%'-:U:-]:T/X#^+]7\#HS%O$$9DVB-3AF(6!HP1@\>;VY(KZE^#WQ:T+XW^
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MI?A#X#^ [#2+**QM6T:UN72(8WRR1*\CL>[,S$DGUKTFHQ'LX2=.$=F]>_\
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MK6S\6?A1\3/@?^TMJWQP^'?AJW^(6G:S:"WU70]^R\A 6,,8>,G/DI@J&/+
MH1S6GLZ#K0;TA*/,E?JUHF^WF9JK7]A.*UG"3BW;HGJTNKMT.S^#G[;R>//B
M#8>!O&?PW\2_#?Q3J08V%MJ$$DL<X ).28HW7@$Y*;1@Y85\Y_\ !4#XIZ]K
M<EGX+N? >J:9H6DZK'<6WBJ?S/LFH.UNV8H\Q!<C>W1V/R'CT^G?@S^VIX"^
M,'BZV\+ZKI>H>"?'D1*1Z/XBMA&_F%?F2&3^]CC#!&;LIKRO_@K%_P D;\&_
M]C"O_I/-6U&*AC*-Z?+=KK=;JS7IZM&=23J82K:KS63Z6>VJ:\_1,]F_9]_:
M&\7_ !4L_$3>)_A)K?PYBT>TCFMY-6>;;?$A\JADMXL8V#.-WWA^-O\ 9,_:
M:_X:B\%ZOK__  C?_",_V?J'V'[/]N^U^9^[1]^[RX\??QC!Z=:]9U?_ )%&
M]_Z\7_\ 19KXT_X),_\ )%_%W_8?/_I/%6$8TZT:\U&W*HVU?5M/[S6,JE'Z
MM#FOS<U]%TBFON/:_P!J;]J3_AFB/PBW_",_\)'_ &_>/:?\?_V7R-NSYO\
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M^_?Y:8SYF,8[=>:R_P!HK]L3PC^SW?6>B36EYXG\87RAK;0=* ,N&.%,C<[
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M<#)KUG_@F_\ \FF>&/\ KZOO_2F2O2_VI+"VU']G3XC17=O%<QKH5W*J3('
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M3A)3YDY).T?=U[/_ (+NCZ2^,G[86A? WXV>'_!'B73TM-%U+2I-3G\1279
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M &'H_P#T==TWXC_\I4OAO_V F_\ 2>^K[HHK=8FU55+;1Y?_ "7EO^OX'/\
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ME\I49X:-1J$DTM+M7\^WXVTN%>3_ +6'_)L_Q._[%^\_]%&O6**\L]D^;O\
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M?$?[37P*UA_!W@#5M)^'.G/!>:EXAU]%A>9A*JQQ0*K,K'>P)(9N.NWO]D^
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M_P#I'P/^SW:ZW^T-^V3+\;-,\&WO@OP1::>\ N+V+RGU21HVC#''#L=V25W
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MMV^WR78UIX>?M%5K3YFM%I9*^_S?<^'/^"7_ /QX?%S_ +&!?Y25=_X*M_\
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MM>9=HKS/XJ?M*?#+X*W45KXS\766CWLBAULU22XN-IZ,8HE=PI]2 *TOA?\
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MR3ZZ-/\ R/N:BLWQ%XDTGPCHUUJ^N:E:Z1I=JN^:\O9EBBC'NS$ <UY!X?\
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MNOX,L!!^H-=M\)?VH/AE\<]:O-)\$>)?[;U"SM_M4\/V"ZM]D>X+NS+$@/+
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M?_;2^*WCW6/$_P!E\*ZU81VVFW_V&ZD\XK]G&/+6(NO$;'YE'3Z5]UZ?\>/
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M)QNVXKT&E*$H.TE9E0G&HN:#NO(****@L**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MA;Q#I?B.VM=.NH9I]*NX[F-'-NS;2R$C."#UKP3_ ():_P#)L]S_ -A^Z_\
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M@+]BV+XAI(/[?G\.V4D,K<XNKB.-0_/7#2;L>U<[_P %+?\ DU/6O^PA9?\
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M\B>GWGUMX4^$?@7P'J3ZAX9\%^'O#M_)$87NM)TJ"UE:,D$H6C0$J2JG&<9
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MU1E]2CLY1?\ V[;F?_D\?Q.:_;N_Y.@_9I_[#:?^EEI7NW[9/@GP[XB_9_\
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MO1B>?D*@'H!7AG_!,&>ZT2/XM^#&N'GT_0M<06^XYPS&6-S^(@0U]S5\,_\
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M-&"CW)&*ZJ[7U/F::2EI=WTMJ^EMOU.##W^O\B:;<->565^;1;N^C_&QF_\
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MN+B>4CY%9$),8SC)?&/KQ45?:?5J/L;VY>G\]W?YW_X!I2]E]9K^WM?FTO\
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M_9M1D<_=F@!21F],[-_T85X5^PC8R_%CXM?%OXXWT1*ZKJ#:5I+N#\MNI5F
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M\:K70[/]E'QK'X:MK*ST ^%[N2QATV)8K<1- S*8U4!0I!SP.]<)_P $W_\
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MU&5@=+OGU#3E=OO(K"-V'^\AMV_.NM^&JGP3_P %&OB9IDYV1>*/#\&IVV>
M[1^4I ]>DO\ WR:TE&*Q4YP^&<)-?.S_ ,_N,XRD\+"G/XH5(QE\FU^;BS[
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M*W'KQ,E3A]JK_N?^WP*Q6OLDM^=?^DSN?7]?GW\9=/N/VN/VY(/A5J=Y<1>
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M_P $J_%UUK7P7\1Z'-<23VNC:P19K)UCBEC#[?0#>'; [L:\OT/X*Z'\=O\
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M)\H  F=V,Y8USW_!4;2[/1/ 'PJT_3[6&RL+756@M[:W0)'%&L2A551P
M!Z5[Y^PC_P FE_#O_KTF_P#2F6O'?^"JVAWEQ\)?"&NP0--;Z3K8-PR]$62,
MA2?8LH&?5AZUUSJ/^TDI/15%^$CCHTT\IYHKWI4[_?&Y]L0?ZF/_ '1_*OA'
M]A3_ ).N_:(_["$G_I9-7O4G[;'P<LOAS!XI?QOI<P:V64:1;W"R:CO('[K[
M.#O#9XY '?..:^<O^"=FI7NM?M#_ !NU/4=+GT2]U!DO9-.N@1+;^;<22!&R
M!R P["L,/2G"55R5K1DOR_K_ (<ZJU:G.%!1E>\HO\'_ %_PPOQET^X_:X_;
MD@^%6IWEQ%X#\(6WVN]L[>0IY[!$:0Y'\3-+''GJJ[L8)KZ;U[]C3X+>(/"_
M]A2?#O1+*V50J75A;+!=KCH?M"XD8_[S'/?-?+_Q@UB?]D;]NZ/XG:M9W#^!
M?&%K]ENKRWC+"$E(UD&!U97BCDV]2I.,D5]0^(OVRO@OX=\*MKTGQ#T2_M_+
M\Q+/3KI;B\DR.%$"G>K'I\P&.Y%*7M%AZ/L;VMK;^>^OS[?@.'LGB:_M[7OI
M?^2RMO\ CY[F7^UI\-?"5Q^S9XOEF\,:/<3:!X=N8])FGL8I)-/58OE$#,I,
M>-J_=(^Z/2O//V!?@]X"\0?LR^"=?U3P1X<U+7?-NY/[4O-)MY;K<EY,$;S6
M0ME0J@'/&!CI7KWQTU&+XF?LI^,]0\.A]0M]9\,7%S9;$(:5'@+K\O7.#TZU
MX9^P#^T'\.O#_P"S5X?\/:UXQT;1-:TRYN8);'4;V."9S)</(AC1B"X(D ^7
M/((ITO:^PJP5^9./K]J_XDUO8^WH3=N5J7IM&WX&'^VA_P GI_L[_P#7Y;_^
MEJ5]RZM_R"KW_KB__H)KX4_X*&71\ _'CX%_$*^@E;0M,O@MU-&,[?+N(Y2,
M>I3>0.^TU[S\2OVS/A=X=\$R7>B>)]/\9:SJ$?D:;H6@W*W-W=3N,1QE$RT>
M21DN!CI@G //4ISJX"G&"N[S6G=O0WIU(4LPK2J.RM!Z]E'7[CQ3_@E#_P D
MW\?_ /8=7_T2M<9XV^%MI\9/^"E'BKPMJM[=6^@7&EV\VIVMK(T9OH([:W<6
M[,""%:18R<<X7C!P1VW_  2E@FM?AW\08;F)H+B/7PDD3#E&$*@J?<&CPM_R
ME6\6?]@!?_26VKU*CMF,Y+I3;_\ )8GGTUS8&*?6:_\ 3A],R^"? 7[/O@[Q
M%XH\-^#]%T!M-TJ:::73K*."2:.)#)L=U 9\E1]XDYK\_OV</B9\ -6NM=^(
M/QYUVV\0?$/6;Z23[#JNDW=[;6D P$ 187B8GMG.U0H '.?TO\?>%8O''@?Q
M!X=F8)%JVGSV+,1G;YD;)G\,YK\\/V2-:^$/PW.M_"OXY>#O"ND^,M(U"40Z
MMXDTBW=+F)N=K3R(<8Y*EB%967!KCP<N;VKE=RLMM[7UM^%SIQT>3V*@DHW=
M[KW;V7+?\;>9D?&SXO? GPS\2/A]\0/@5J-MIOB33]6CBU33=)TNYL+>YLF^
M_E'B2/.,H0O)#\@X!'ZAJP901R#R*^94U[]DQ/&&@^']/TSX9ZEK>K7*V]DF
MDZ1970\T\KNDBC94). -Q!)(Q7I/[0'[1WA/]FWPS8ZUXK6_GCOKG[+;6NFP
MK+-(V-S'#,J@ <DEAU&,U%=\\*=.,9;NU_.VB]'^9>'BZ<ZE2<HVLK\O2U]7
MKU7Y'J5%8_@_Q7IOCKPKI'B+1YFN-+U2UCO+:1E*EHW4,N0>0<'I6Q7!*+BW
M&2LT>G&2DE*+NF%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY;Z&G+'FYK:G"ZU\$/!7B#XG:1\0]0T7[1XPTF'R++4OM4Z^4F'&/+#B-O\
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M=18Y>]A:2UGD[#?)"R,_']XFMSX7_ [P'\%[*:V\%>&+'05F $TT*L\\H!R
M\KEG8#G +'&:[JBE[2:CR*3MVZ#]E3<_:.*YN]M?O"N=\>_#SPW\4/#DV@^*
M]&M=<TF8AFMKI,@,.C*1RK#)PRD$9ZUT5%9FIYC\)_V:?AI\#M0N[[P3X6AT
M6]NHO)FN?M,]Q(T>0=NZ5V(&5!P/05J> _@AX*^&?B;Q)XA\-:+_ &;K'B*;
MS]4N/M4\OVA][/G;([*OS.Q^4 <_2NZHK5U:DFVY.[TWZ=C*-&G%*,8I*]]N
MO?U.5^)?PO\ #'Q@\*3>&O%VF?VOHLTB2R6OVB6'+(=RG=&RMP?>MKP_H-AX
M5T'3M%TN#[+ING6\=I:P;V?RXD4*B[F))P !DDFM"BHYGR\M]-_F7RQYN>VN
MU_+L>5_$[]EKX5?&+4O[1\6^"['4M1.-U[$TEK/)@8&^2%D9\#^\36M\+_@-
M\/\ X+V\D7@OPK8:&THVR7$:M)<2+G.UII"TC#/8MBN^HJE4FH\BD[=NA#I4
MW/VCBN;O;4*X7QY\#_!7Q,\4>&O$7B71?[2UGPW.+G2KG[5/%]GD#HX;:CJK
M_-&APX(X^M=U14QDX24HNS1<HQG%QDKI]#GO'_@#0?BAX1U#PQXGL/[3T._"
MK<VOG21;PKJZ_/&RL,,JG@CI5CP?X1TGP#X7TSP[H-I]@T;385M[6V\QY/+C
M'0;G)8_4DFMFBCF:BXIZ;_,.57YK:G"ZE\#_  5JWQ4TWXD7>B^;XTTZ#[-:
MZG]JG7RX]KKM\H/Y9XE<9*D_-["NKUW0=-\4:1=:5K%A;:IIETACGL[R)98I
M5/9E8$$5?HI.3DDF]$"BHMR2U9X?H'[$OP/\,^(EUNQ^'NGB_1_,7[3-/<0J
MV<Y$,DC1C!Z87CM7?^&?A#X1\'^./$7B_1](^Q^(O$&S^T[P7$K^?L^[\C.4
M7'^RHKL:*T=:I+>3[;].QG&C2C\,4M;[=>_J9WB#P[I7BS1[G2=:TVUU;3+E
M=DUG>PK+%(/1E8$&O%K+]A+X$:?K2ZI%\.[%KE7\P1S75S+!GW@>4QD>VW'M
M7O5%*%2=/6#:]"ITX5+*<4[=RK:V%MI>G1V=E;0VEI!'Y<5O @2.-0,!54<
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MA3A37+"*2\CQ7P3^QA\%OAYKL6LZ)X"L8M2A8/%->3SW@B8'(9%GD=58'D$
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MCCZUW/7@\BEHHYFXJ+>B_7<?*N9SMJ]WZ;?<>(:A^Q/\$=4\4-XAN/A]I_\
M:;2^<WES3QP%\YSY"R"+K_LUVGQ ^!_@GXI:YX<U?Q1HO]IZCX=G^TZ9-]JG
MA^SR;D;.V-U#<QH<,"./K7=T5?M:GN^\_=VUV].Q'L:?O>ZO>WTW]>X5POPW
M^"/@KX1ZEX@O_">B_P!E7>OW NM2D^U3S>?(&=@V)'8+S(_"X'/L*[JBH4G&
MZ3W+E&,K-J]@KS'XJ_LS_#'XV7T-[XS\(VFKWT*A%O%DEMIRHZ*TD+HS*,G
M)(&:].HHC)Q?-%V82BIIQDKIGE7_  RS\*E^'=YX%B\%V-MX8O7CDNK2U>6&
M2X:-@R-),CB5R".I<^G2O2-$T:S\.Z+8:3IT/V?3[&WCM;>'<S;(T4*BY8DG
M  &22:NT4Y5)RNI.]]?F3&G"+3C%*RM\M[>ESQ'7OV*?@EXF\42>(-0^'^GR
M:G)+YTAAFGAA=\Y):%)!&V3URO/>NQU;X$> M:\1>$M<N/#ENFH^$P5T1K62
M2WCLEX^58HV5".!@,I [5WM%5[6IHN9Z;:[>A/L:3YFXKWM]-^NO<BNK6&^M
MI;>XBCN+>9#')%*H9'4C!4@\$$=J\9T+]B_X+>&?&%OXGTSP'9VFLVTZW,$J
MW%P8HI58,K)"9/+4@@$87C'%>UT5,)SIN\';T*G3A424TG;N8WB[P;H7CW0Y
M]&\1Z19ZWI4_^LM+Z%98R1T.".".Q'([5Y-X9_8B^!WA'7$U?3OA[8&]C;>G
MVR>>[B5LY!$4TCH"#T^7BO<J*<*DZ=^1M7["G2IU+<\4[=T(H"@ # '  KA_
M"7P1\%>!?'7B'QCH>B_8?$?B DZE>_:IY//RVX_([E%YY^517<T5"DXNZ?D7
M*,9)*2O;7Y]PKS'XH?LS?"_XS7BWGC#P=8ZM?J OVU3);W# < -+$R.P'8$D
M"O3J*(R<7S1=F$HJ2Y9*Z/._A;^SW\.?@L)#X,\)6&BSR J]VH::Y93_  F:
M0M)M]MV*^6_VU/'VDW'[1?P[\!?$V:XTSX.RVYU*\>(.$O;H>8J+(Z#>$1A&
M"%Z>9D]B/NBN:\>?#7PM\4-%_LGQ9H%CK^GAMZPWT(?RVQC<AZHV.ZD&MX5F
MJL:M3WK?Y?FMUYHYZE!2HRHTO=OV7FM/1K1^3/D;4/@W^PY9Z?)?RZAX3,6T
MN5M_%]S)+Z\1)<EL^P7\*Y7_ ()YZ';_ /"__BAJ_P /5U2+X/>1]ELSJ!8+
M-<;XS'C=U*J)L9^8+(N[EJ^A]/\ V!_@)I>H)>0_#VV>9&W!;B_O)X\^\;S%
M2/8C%>Y:'H.F>%])M]+T?3K72M-MEV0V=E"L,,:]<*B@ #Z"NUXJ,8R492E=
M6UV7GUU[;' L'*4HN48QY7?W5J[=+V6G?<Y3P'\$/!7PS\3>)/$/AK1?[-UC
MQ%-Y^J7'VJ>7[0^]GSMD=E7YG8_* .?I7=445YCDY6NSUU%1O9;GE?Q._9:^
M%7QBU+^T?%O@NQU+43C=>Q-):SR8&!ODA9&? _O$UK?"_P" WP_^"]O)%X+\
M*V&AM*-LEQ&K27$BYSM::0M(PSV+8KOJ*I5)J/(I.W;H0Z5-S]HXKF[VU.)^
M)GP5\#?&.QCM/&?ABPU](@1%)<1E9H@>H252'3/?:PS7-_#/]E'X3?"#5QJO
MA3P58Z?JB_ZN\GDENYHN,$QO,[E#@D?*1UKUJBB-2<$XQDTF$J5.<E*44VO(
MYWQS\._#'Q,T5M(\5:%8Z_IQ.X07T"R!&QC<I/*M_M*0?>O-/!O[%?P3\!:[
M%K&C^ +%-0A8/%)>3SWBQL#D,J3R.JL#R"!D=J]MHHA4G3NH2:OV"=*G4:<X
MIV[HP?'7@;1/B5X3U'PUXCLO[1T34$$=S:^:\7F*&# ;D96'('0BG>"?!>C?
M#KPKIOAOP]9_V?HNG1>3:VOFO+Y:9)QN=BQY)ZDUN45',TN5/0OE5^:VIP'Q
M<^ _@3X[6&GV?CG05URWT^5IK8?:9K=HV88;#1.A(( X)QP/2NM\-^'--\'^
M']-T/1[5;'2M.MX[6UMD)(CB10JKDDDX ')))[UI44^:7+R7T["Y(\W/;7:_
M6Q3U;1['7]-N=.U.RM]1T^Y0QSVMU$LL4J'JK*P((]C7B'_#"/P'.L_VI_PK
MNR^T[_,\O[7<^1G.<>3YOEX]MN/:O>Z*<*DZ;O!V]!3IPJ*TXI^I3TC1[#P_
MIMOIVEV5OINGVR".&TM(EBBB4=%5%  'L!5RBBI;;=V6DDK(X7X;_!'P5\(]
M2\07_A/1?[*N]?N!=:E)]JGF\^0,[!L2.P7F1^%P.?84OQ8^"?@OXY:-9:5X
MWT;^V["SN/M4$/VJ>WV2[2N[,3J3PQ&"<<UW-%5[2?,I7U5K?+;[NA/LX<KC
M;1WO\]_OZC8T$:*BC"J, 5P_P\^!_@KX4ZYXDUCPMHO]EZCXCG%SJDWVJ>;[
M1(&=PVV1V"?-*YPH ^;V%=U124I*]GN#A%VNMMC&\7>#="\>Z'/HWB/2+/6]
M*G_UEI?0K+&2.AP1P1V(Y':O)O#/[$7P.\(ZXFKZ=\/; WL;;T^V3SW<2MG(
M(BFD= 0>GR\5[E150J3IWY&U?L3.E3J6YXIV[H10%  & . !7(?%+X1^$OC3
MX9'A_P 9Z.NM:2LZW*P--+"5D4$!@\;*PX8C@\YKL**B[3NC1I--/9G/> ?
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M5/G]IRKF[VU^\*^?_P!MSX5WWQ)^"5U>Z&C'Q1X7N8]>TIHQE_,AY95]RF[
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MWE)B"$9VW#:""PX (W5]PU6M]-M+.ZNKF"UA@N+IE>XFCC"O,P4*"Y RQ"@
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MIW\Y24./+9S&O,:?=4=/<UW5%'/*][ZVM\NWIY![.%N7E5KW^??UU>I@^.O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
3!1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img42689296_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img42689296_4.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" =X#WD# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2G*DJ=6C*+O&3BU_X$M'YHGVSJ4:\9JTHQDFO^W6TUY-'LW[*/\ R;3\,_\
ML 6G_HL5Z#XD\7:'X-T\W_B#6M/T*Q!P;K4KJ.WBSZ;G(%>??LH_\FT_#/\
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M^S^Q2IJUQ!)&$WJ^5$<*'.5'4D8SQ7OM>;4C"+M"5UZ6/4I2J25ZD>5^M_\
M(****R-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /DS_@I9_R0K0O^QD@_]);JOS4K]*_^"EG_ "0K0O\
ML9(/_26ZK\U*_<.$O^18O\3/QSBC_D8OT04445]F?)!1110 4444 %?N]7X0
MU^[U?EO&_P#S#?\ ;_\ [:?I'!W_ #$?]N_^W!1117Y<?I!^;_[>7_)[OP:_
MW-,_].,E?HKJW_(*O?\ KB__ *":_.K]O+_D]WX-?[FF?^G&2OT5U;_D%7O_
M %Q?_P!!-=F*_P"1=2_[B?F<6'_Y&-;_ +A_^DGY_P#_  25^[\5?^OBQ_\
M;BOJK]L+_DV#XE_]@6?^0KY5_P""2OW?BK_U\6/_ +<5]5?MA?\ )L'Q+_[
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M\>? ?Q!^)7C7PEXA_P"$<O('9K/?#-]G24R%%6.SC5CDMC<>_6NR_P""HO\
MR;,G_8;M?_09*[[X._MG^#OCM\3;KPIX0TS6[ZRM[5IWUZ2R9+3>",(?XDR"
MV#(%R5P <BN-_P""FVDW>I_LOW<MK \R66JVMS<%!G9'EDW'VW.OYUS5)U?:
M48U(\J4HM*UMY+H=5.G1]E7G1ES-QDF[WVB[:_,]:_91_P"3:?AG_P!@"T_]
M%BO"_P!H#]@*Y\4>/KCXB_"?Q2_@7QC*[7$L*O)#!+,?O2)+'\\1;)W !@Q)
MX&3GT/\ 8H^+/A[QO^SAX>M= N)=3U+PQI<%AJ5C'$R2QSI%PB[\*V[;P0<<
M\D<X\^\$?\%)?#-IK6I:!\6/#FJ_#76[2=U FM99X_+W'8'55\Q7QCHI4XR"
M,XK:I&O'&594?B3;^3?;JG_D^QE"6'E@J2KM<K27S2[]&OEU7<\YT7]L?XU?
MLQ^+=.\,_'SPY_:FBW#[(]>MXT68Q@@&1)(OW4P48)0A7Y&3G@_>FH:I:ZWX
M*N=1L9TNK&[T]KB">,Y62-HRRL/8@@U^>?[9_P"T5X;_ &M;#PM\,?A-9WOC
M#5YM42\-XEE)"J81TVJ)%5@/G+,Q 50N2?3[W^'W@9_!_P )?#W@^>X$TNFZ
M-!I<EPO1F2%8RP_$$UCC*?-A>><.6;NK;75M[=-=/,VP-3DQ?)"?/323OO9W
MVOUTU/A[_@D1_P >/Q._ZZ:?_*XK]!M6U6TT+2[S4M0N$M;&SA>XGGD.%CC5
M2S,?8 $U^7_[&_Q?T3]C'XI?$;P1\4/M.@I<21(E]]EDF57A:0*2J*S%)%D#
M*R@CCWK[<U;QMH/[6/[.OCR/X=ZD=1COK*\TB":6)X,W'E<#:X# '>O) ZUM
MFBE4J/$05XM)WZ;)'/E#C2IK#5'::DTU?7=L^>/^&N?C5^T]XLU+1/@'X<M-
M&\.V4GER^)]8169<GASO!1,CD1A)'QSZ@><?M<? ;XS^&/@C?^*OB3\8IO$T
M<=U;QR>'K))!9.SR85NL:_+G(_=?E6I^PM^U5X&_9U\$Z]\/OB2;WPEK%MJT
MUTTTUA+*&+)&AC=8U9U=3&>JXP1S5O\ ;$_:0O\ ]I+X/>(++X<^%KZ\^'FC
MRPW6K^+-0A:".1ED4)';JV"QW,I;(W =5 YKHE3E0K0C1@N5./O/6ZTOJ]/N
M^1RPJ1Q%"<L1-\[4ER)M6>J2Y5J_.]_,^I/V$?\ DTOX=_\ 7I-_Z4RU\L^)
MO^4M6F_]=(/_ $UU]3?L(_\ )I?P[_Z])O\ TIEKY2_:NFNOV>_V\/"OQ9U7
M3[FZ\+7OD2-<0ID#;";>9%[;U3#A21G(_!0:6:5+]>=?-O\ X!2_Y%%)]HP?
MY'Z3T5X]\*/VMOA=\;O%3>'?!OB%]6U1;-KUXVLI[<*BLJD9E1<MEQP,\ U[
M#7C3ISINTU;U/?IU(55>G)->04445F:!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?)G_!2S_DA6A?]C)!_
MZ2W5?FI7Z@_\%!O".N^-/@SHUCX>T74==O8]?AF>WTRTDN)%C%M<@N50$A06
M49Z98>M?GU_PH/XG?]$Y\6_^".Z_^-U^T\*UZ5/+5&<TG=[M'Y%Q-1JU,P;A
M%M670X.BN\_X4'\3O^B<^+?_  1W7_QNC_A0?Q._Z)SXM_\ !'=?_&Z^P^M8
M?_GXOO1\K]6K_P#/M_<S@Z*[S_A0?Q._Z)SXM_\ !'=?_&Z/^%!_$[_HG/BW
M_P $=U_\;H^M8?\ Y^+[T'U:O_S[?W,X.BN\_P"%!_$[_HG/BW_P1W7_ ,;H
M_P"%!_$[_HG/BW_P1W7_ ,;H^M8?_GXOO0?5J_\ S[?W,X.OW>K\7?\ A0?Q
M._Z)SXM_\$=U_P#&Z_:*OS+C2K3J_5_9R3MS;._\I^B<(TJE/V_/%KX=U_B"
MBBBOS,_0PHHHH **** "BBB@ IDL23QO'(BR1N-K(PR"#U!%/HH X6'X#_#2
MWU(:C%\._"D6H!_,^UIHEL)=W][?LSGWS7<JH50JC '  I:*IR<MV2HQCJD1
M7-M#>6\L%Q$D\$JE)(I%#*ZD8((/!!KD]!^#?@#PKJ@U+1? WAO1]1!R+RPT
MBW@FSZ[T0']:[&BDI..S!Q4MT%<AXD^#O@'QEJ!O_$'@?PYKM\1C[5J6DV]Q
M+_WTZ$UU]%";B[H;2DK/8HZ+H>F^'-/BL-)T^UTNQBXCM;*%88D^BJ !5B\L
M[?4;2:UNX([JVF0QRPS('1U(P593P0?0U-12>NXU[NQS_A+X>^%? ,=S'X8\
M,Z/X<2Z8/.NDV$5J)6&<%Q&HW$9/7U-.\5> O#/CJW2#Q)X<TGQ##'RD>JV,
M5RJ_0.IQ6]15.3;NWJ2HQBN5+0P/"?P_\+> X98O#/AK2/#L4QS)'I-A%:JY
M]Q&HS^-;]%%)MR=V-1459(YOQ9\-/"'CYH6\3^%-$\1M",1-JVG0W1C'HOF*
M<?A6GH/AW2?"VGI8:+I=GI%BGW+6PMT@B7Z*H %:-%',[<M]!<JOS6U.4\4?
M"?P1XVOTOO$7@WP_K][& J7.J:7!<R*!T 9T)%=)96-OIMI%:VEO%:VT*A(X
M84"(BCH HX ^E3T4<SM;H/E5^:VH5GZ[X>TKQ1ILNG:SIEGJ^GR_ZRTOK=)X
MG^J,"#^5:%%(9S7A3X9^#_ <DC^&O"FA^'7D&';2=.AM2P]_+49KI:**;DY.
M[9,8J*M%6"BBBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_"ZO!G_ $&?_)6;_P"(H_UBR;_H-I?^#(?YA_9>/_Z!Y_\ @,O\CN**X?\
MX75X,_Z#/_DK-_\ $4?\+J\&?]!G_P E9O\ XBC_ %BR;_H-I?\ @R'^8?V7
MC_\ H'G_ . R_P CN**X?_A=7@S_ *#/_DK-_P#$5W%>AA,QP6/YOJE:-3EW
MY9*5K[7LW:]F<M?"XC#6]O3<;[735_O"BBBO0.4**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MEHG;Y[_D1SQ4_9MZVO\ *]K_ 'G0T445!84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#RS]HO_D2;+_L(I_Z*EKYTKZ+_:+_
M .1)LO\ L(I_Z*EKYTK^3?$C_D?R_P ,?R/VSA/_ )%B]6%%%%?EQ]B%%%%
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M8D:2632[I$11DLQB8 "O(Q-6=6$G-WT/8PM&G1G&--6U1\9_\$E/^25^./\
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M9;:?/8\^Y_D*_1.OS,\#ZE-_P3S_ &K-=L/$UO<)\-?%886VI0Q%T2/>6B?
M^\8BS(ZCG#;@#P#]A>.OVT_@[X(\(3ZZ/'6CZXRQ[H--T>\CN;N9L?*GEJ24
M)/=]H'<BML=>O..(IJ\9)6\K*UO6_0PR]K#PGAZLO>BW>^ETW=/TMU/D;P.Q
MT/\ X*P:Q;::-EO=75T+A8R,$/8&5\_]M.?K7Z55\ ?L _#'Q#\1/BQXL_:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=TR0[C:W\"RIN'1@".&'8CD5Y+H/[#/P*\-ZPFIV?P[L)+I&W!;VXN+N'/\
MURED:/\ \=KW:BG"I.G?DDU?L3.E3J6YXIV[H9##';PI%$BQQ(H540850.
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M/10&8\ U,I*"YF5&+D[(\Y_;B_;$TC]DOX9-=Q^3J'C?5E>#0])<YW/C!GD
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M )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\
MGT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?
M1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'
M_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]
M?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_
MPH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"
M@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\*
M+M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH N
MT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[1
M5+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4
MOMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^
MW3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=
M-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW
M_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\
M^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ
M/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_
MZ_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K
M_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^
M%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4
M?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]
MNF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ
M;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO
M^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y
M]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT
M?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_
MU_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7
M_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\
M* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH
M NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"
M[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M
M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT5
M2^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+
M[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OM
MTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3
M?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_
MSZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/
MH_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C
M_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^
MO^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_
MX4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A
M1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'
MVZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;
MIO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF
M_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_
M )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\
MGT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?
M1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'
M_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]
M?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_
MPH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"
M@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\*
M+M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH N
MT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[1
M5+[=-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4
MOMTW_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^
MW3?\^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=
M-_SZ/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW
M_/H_Z_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\
M^C_K_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ
M/^O^%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_
MZ_X4?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K
M_A1]NF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^
M%'VZ;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4
M?;IO^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]
MNF_Y]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ
M;_GT?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO
M^?1_U_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y
M]'_7_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT
M?]?\* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_
MU_PH NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7
M_"@"[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\
M* +M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH
M NT52^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"
M[15+[=-_SZ/^O^%'VZ;_ )]'_7_"@"[15+[=-_SZ/^O^%'VZ;_GT?]?\* +M
M%4OMTW_/H_Z_X4?;IO\ GT?]?\* +M%4OMTW_/H_Z_X4?;IO^?1_U_PH NT5
M2^W3?\^C_K_A1]NF_P"?1_U_PH NT52^W3?\^C_K_A1]NF_Y]'_7_"@"[15+
M[=-_SZ/^O^%'VZ;_ )]'_7_"@!VI:38ZQ L-_9V]]"K;Q'<Q+(H;!&<$'G!/
MYUG?\(+X;_Z%[2O_  "B_P#B:O\ VZ;_ )]'_7_"C[=-_P ^C_K_ (5R5,'A
MJTN>K3C)]VDS>%>K37+";2\FRA_P@OAO_H7M*_\  *+_ .)H_P"$%\-_]"]I
M7_@%%_\ $U?^W3?\^C_K_A1]NF_Y]'_7_"LO[.P7_/F/_@*_R+^M8C_GX_O9
M0_X07PW_ -"]I7_@%%_\31_P@OAO_H7M*_\  *+_ .)J_P#;IO\ GT?]?\*/
MMTW_ #Z/^O\ A1_9V"_Y\Q_\!7^0?6L1_P _'][*'_""^&_^A>TK_P  HO\
MXFC_ (07PW_T+VE?^ 47_P 35_[=-_SZ/^O^%'VZ;_GT?]?\*/[.P7_/F/\
MX"O\@^M8C_GX_O90_P"$%\-_]"]I7_@%%_\ $UN52^W3?\^C_K_A1]NF_P"?
M1_U_PKHHX>CA[^Q@HW[)+\C*=6I4MSR;MW9=HJE]NF_Y]'_7_"C[=-_SZ/\
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M_P#+^NQ<8)4[1>M^O;^OZ9^K^H:C:Z187%]?7,-G96\;2S7%PX2.)%&69F/
M  R2:_%S3?$5M^U1_P %:-.\1>"5:\T2'7K6[%Y&I*/;6,,:O/[*YA^4GKO7
MN<4Y?V"?VT_C)LT'QYKNJP:'N5F/BSQG]OM1@\'RHIIR2.WR_B*_1;]C/]AW
MPE^R#X=NFLKAO$/C#4D5-1U^>(1DH#D0PID^7'GDC)+$ D\*%NC'DK1KR?P[
M+S_K^NT5).5*5&*^+1OR_K^K7/<_'_CS0_A?X+UCQ7XEOUTS0M)MVNKNZ=2V
MQ%]% )8DX 4#)) '6O'?V8?VXOAI^UE>ZSI_@Z74[+5M*7S9=.UJW2&:2$D+
MYT>QW5DW$ \[@2,@9&>X_:.^"]O^T+\$_%?P^N;]]+76K98X[U$W^3*DBR1L
M5R-RAT7(R,C(R*^6?^"??_!.G7/V4/'6O^,O&'B+2]7UBYLVTRQMM%,K0I"S
MH[R2-(B'>3&H"@8'/)SQG2UJ25316T]?^'LO37TNII3BX?%?7TT_X/W??\^?
M\%;/!.L?";]H_P"'?QLT:$F&86Z^=M.Q+^SE\R,,1TWIMQZ^4WI7Z;? _P"-
M'ASX_?#/1?&OA>\CN;#4(5:2%7!DM9L#S() /NNA."/H1P0:/CA\%?#'[07P
MUU;P3XMM#<Z5?I\LL9 FMI1RDT3$':ZGD'&#R"""0?R@\1?\$T_VH_@#XDOO
M^%/>)KS5=*NVP+WPUX@_L6Y>,?=%Q&\L8SR>%=Q[\XJ*4O9P=&2TNVGZ[W_K
MMYE5(\\E5B];6:]-K?UW\CZM_P""M7[2&E?#CX#W?PYLKZ.3Q;XN"1-:1N#)
M;V*N&EE<?PA]OEKGKN?'W370_P#!)[X.WGPM_94LM3U.![;4?%E[)K7ER##+
M;E5C@_!DC\P>TE?.O[-__!)OQAXF\>1>-_VAM86]7S5N9=#^WM?7E_(.UU<9
M("\#(1G+#C*]_P!5+>WBM8(X(8UAAC4(D<8 55 P  .@ K:G%48S;=Y3_!+I
M]_Z]S*<G4E%)6C'\6_\ @?IV)****@H**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRW-W'=S;>Y2.!F5C[,Z_6O6>&R^I[W/H^E_Z9X:Q69P_=^SN^]OZB0?\$T?
MM_XP_:8M_$0C9K+P_:7%Y<W&,+YDL;0HOU/F,<>B&OUZKS7X!_ 'PM^SMX(3
MP[X9A=O,;SKS4+C!GO)<8WN0.@' 4< >Y)/I5>?C\3'$U4X;)67Y_J>KEV%G
MA:3]H_>D[O\ K^M0HHHKS3U0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=4\'>']'\-7FF6MO;RI+J5K</,3)&&;)2=%QD\?+7C7_  ]@^+?_ $+O@O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRM2UIRDK-;-I>\UWZ:]0HHHKY0^M"BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM%
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M )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\
MG[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?
MM_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W
M_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]
M?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_
MQJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&
MKM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\ G[?]?\:N
MT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?M_U_QJ[1
M0!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W_7_&KM%
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M )^W_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 4OL,W_/V_Z_XT?89O\
MG[?]?\:NT4 4OL,W_/V_Z_XT?89O^?M_U_QJ[10!2^PS?\_;_K_C1]AF_P"?
MM_U_QJ[10!2^PS?\_;_K_C1]AF_Y^W_7_&KM% %+[#-_S]O^O^-'V&;_ )^W
M_7_&KM% %+[#-_S]O^O^-'V&;_G[?]?\:NT4 ?+_ .V1^T1XJ_9W_P"$0_X1
MZ'3K_P#MC[9Y_P#:<<K[/*\C;MV2KC/FMG.>@Z5\V?\ #Q_XG?\ 0)\,_P#@
M-=?_ "17HG_!43_FF?\ W$__ &TKX0K]CX?RC XK+:5:M24I.]W_ -O-'Y/G
MF:8W#YA4I4JK45;3_MU'U7_P\?\ B=_T"?#/_@-=?_)%'_#Q_P")W_0)\,_^
M UU_\D5\J45]#_8.6?\ /A'A?VWF/_/YGU7_ ,/'_B=_T"?#/_@-=?\ R11_
MP\?^)W_0)\,_^ UU_P#)%?*E%']@Y9_SX0?VWF/_ #^9]5_\/'_B=_T"?#/_
M (#77_R11_P\?^)W_0)\,_\ @-=?_)%?*E%']@Y9_P ^$']MYC_S^9]5_P##
MQ_XG?] GPS_X#77_ ,D4?\/'_B=_T"?#/_@-=?\ R17RI11_8.6?\^$']MYC
M_P _F?5?_#Q_XG?] GPS_P" UU_\D4?\/'_B=_T"?#/_ (#77_R17RI11_8.
M6?\ /A!_;>8_\_F?5?\ P\?^)W_0)\,_^ UU_P#)%'_#Q_XG?] GPS_X#77_
M ,D5\J44?V#EG_/A!_;>8_\ /YGU7_P\?^)W_0)\,_\ @-=?_)%'_#Q_XG?]
M GPS_P" UU_\D5\J44?V#EG_ #X0?VWF/_/YGU7_ ,/'_B=_T"?#/_@-=?\
MR11_P\?^)W_0)\,_^ UU_P#)%?*E%']@Y9_SX0?VWF/_ #^9]5_\/'_B=_T"
M?#/_ (#77_R11_P\?^)W_0)\,_\ @-=?_)%?*E%']@Y9_P ^$']MYC_S^9]5
M_P##Q_XG?] GPS_X#77_ ,D4?\/'_B=_T"?#/_@-=?\ R17RI11_8.6?\^$'
M]MYC_P _F?5?_#Q_XG?] GPS_P" UU_\D4?\/'_B=_T"?#/_ (#77_R17RI1
M1_8.6?\ /A!_;>8_\_F?K'^R/\8O$/Q^^&^I>(=>6SL;RVU:2P2/3DD2,HL,
M+@D/(QW9E;OC '%>W?89O^?M_P!?\:^6?^":?_)"M=_[&2?_ -);6OK.OQ3.
M*-/#YA6I4E:*>B/U_*:LZV!I5*CO)K5E+[#-_P _;_K_ (T?89O^?M_U_P :
MNT5XQZQ2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^
MW_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]A
MF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\
MC1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O
M^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_
M #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT4 4O
ML,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?\:NT
M4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M_P!?
M\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89O^?M
M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_XT?89
MO^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_ *_X
MT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?\_;_
M *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2^PS?
M\_;_ *_XT?89O^?M_P!?\:NT4 4OL,W_ #]O^O\ C1]AF_Y^W_7_ !J[10!2
M^PS?\_;_ *_XU:B4QQJI;>1_$>]/HH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KPK]N#7M3\,_LN>.-2T?4;O2M1@BMC%>6,[0S1YNH@=KJ01D$C@]":]UK.
M\0>'=*\6:1<:5K>F6>LZ7< ":QU"W2>"7!##<C@J<$ \CJ!1U3[-/[G<#\'?
M^&@/BA_T4CQ=_P"#VZ_^.4?\- ?%#_HI'B[_ ,'MU_\ '*_:W_AFWX2?]$M\
M%_\ A/6G_P ;K\J?VE[W1/B!^UL_@ZVL=+\'>$=/UN+0572[.*TCA3S5CGG<
M*H!;.X[CV51T%?68;%4L565*%/\ +^NJ/BL7@JV#HNM.KY==_P#ADSRC_AH#
MXH?]%(\7?^#VZ_\ CE'_  T!\4/^BD>+O_![=?\ QROV@T7]EGX/Z'I-GI\/
MPS\*7,5M$L2S7FC6]Q,X QN>1T+.Q[DDDUB_$K]D?X/>+O!.K:=-X%\.^'P\
M#LNIZ3IL%E/;,%)$@DC4' /)!R#CD&N6>9X>-W[/1>AUQRG%2LO:Z_,^-?\
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M04445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_  5$_P":9_\ <3_]
MM*^$*^[_ /@J)_S3/_N)_P#MI7PA7[UPQ_R**/\ V]_Z5(_$^(O^1I5_[=_]
M)04445]2?-A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!^E?_  33_P"2%:[_ -C)/_Z2VM?6=?)G_!-/_DA6N_\ 8R3_ /I+:U]9
MU_/6??\ (SK_ .(_=<D_Y%U'T"BBBO!/;"BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /A#_ (*B?\TS_P"XG_[:5\(5]W_\%1/^:9_]Q/\
M]M*^$*_>N&/^111_[>_]*D?B?$7_ "-*O_;O_I*"BBBOJ3YL**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /TK_P"":?\ R0K7?^QD
MG_\ 26UKZSKY,_X)I_\ )"M=_P"QDG_]);6OK.OYZS[_ )&=?_$?NN2?\BZC
MZ!1117@GMA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJWN_JU^1UY/4E4IU+MM*3LWOLO\ A_F%%%%>*>\%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 ?"'_  5$_P":9_\ <3_]M*^$*^[_ /@J)_S3/_N)_P#MI7PA7[UP
MQ_R**/\ V]_Z5(_$^(O^1I5_[=_])04445]2?-A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!^E?_  33_P"2%:[_ -C)/_Z2VM?6
M=?)G_!-/_DA6N_\ 8R3_ /I+:U]9U_/6??\ (SK_ .(_=<D_Y%U'T"BBBO!/
M;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^#_B=_P5&_
MX5Q\2?$OA/\ X5G_ &C_ &-J4^G_ &S^W_*\[RW*;]GV9MN<9QDX]:^[89/.
MACDQC<H;'ID5O.A4ITXU9+W9;?U\SGAB*52I*E%^]'?\A]%>+S?MD?!^W^(9
M\#2>+]OBG^TAI'V#^S+P_P"E&3RQ'YGD[/OG&[=M[YQ7M%9N$HI2:T>WF:QJ
M0E)QB[M;^7J%%%%06%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ,/#?V@?^A__ /*-I_\ \CUZ,</CK*U1?C_D>?6Q67QJ24Z3;N[Z+_,^TO\
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MBBOFCZT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ()I_P#)"M=_[&2?_P!);6OK.ODS_@FG_P D*UW_ +&2?_TEM:^LZ_GK/O\
MD9U_\1^ZY)_R+J/H%%%%>">V%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_(U:GA3_ (*/_LZ^-_%&D>'=%^(?VW6-6NXK&RMO[$U&/S9I7"1IN>W"KEF
MRQ &>2*^%OV&_P#@F'X%_:*^ .G^/O'&M>*--OM3O+A;2#1;FWAB^S1OY89A
M+;R$L723D$#&WBOI_P"'_P#P2(^#WPW\=^'?%FF>)/'$^HZ%J-OJ=M%=W]FT
M+R0R+(H<+:*2I*C(!!QW%=:@H5%&KMI?T_S.?F<H-PWU/N"BBBL#41F"*68A
M549)/ %?'GQ:_P""K7P%^%/B";1H]2U;QI>6[F.X?PO:1SP1,.H\V62-'^L;
M,/>O*?\ @K]^T]JO@'PGHWPF\,7<EKJ?BB%[C5I;<XD%CN*+ ,<CS7#@XZK&
M5Z,:F_99_P""2/PYTOX;Z;JGQ?TRZ\3>+-2@2XGTW[=-:V^F[AD1#R'1G< X
M9F8C(P!QDQ3YJBE-:13MZO\ K^MKW/EI\L7K)Z^B_K^GT^C_ -G?]O'X/_M,
M7ZZ5X6UZ6Q\1,I=="UN$6MVX ).P99)" "2(W8@#) KZ%K\7?^"@G[!J?LE7
M.C_%7X47FH6/AJ*^B66 W#//H]UG=#+'+]XQDJ "Q+*V.3N&/TQ_8N_: /[2
MW[//AKQE<A$UHHUCJT<8 5;N([7('8.-K@=@XK:/+5@YPT<=&OU_KNN^F,N:
MG-1EM+9_U\_N?S]QHHHJ"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<YVL!C:/UD\(_#[PM\/[>X@\+^&M(\-P7#!YH](L(K596 P"PC49('<T>-/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!\(?\ !43_ )IG_P!Q/_VTKX0K[O\ ^"HG_-,_^XG_ .VE?"%?O7#'_(HH
M_P#;W_I4C\3XB_Y&E7_MW_TE!1117U)\V%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'Z5_\ !-/_ )(5KO\ V,D__I+:U]9U\F?\
M$T_^2%:[_P!C)/\ ^DMK7UG7\]9]_P C.O\ XC]UR3_D74?0****\$]L****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
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M/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\
ML^W_ .>?_CQ_QH_L^W_YY_\ CQ_QH D^TP_\]4_[Z%'VF'_GJG_?0J/^S[?_
M )Y_^/'_ !H_L^W_ .>?_CQ_QH D^TP_\]4_[Z%'VF'_ )ZI_P!]"H_[/M_^
M>?\ X\?\:/[/M_\ GG_X\?\ &@"3[3#_ ,]4_P"^A1]IA_YZI_WT*C_L^W_Y
MY_\ CQ_QH_L^W_YY_P#CQ_QH D^TP_\ /5/^^A1]IA_YZI_WT*C_ +/M_P#G
MG_X\?\:/[/M_^>?_ (\?\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ
M_P :/[/M_P#GG_X\?\: )/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'
M_&C^S[?_ )Y_^/'_ !H D^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?
M\:/[/M_^>?\ X\?\: )/M,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&
MC^S[?_GG_P"/'_&@"3[3#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S
M[?\ YY_^/'_&@"3[3#_SU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W
M_P">?_CQ_P : )/M,/\ SU3_ +Z%'VF'_GJG_?0J/^S[?_GG_P"/'_&C^S[?
M_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\ L^W_ .>?_CQ_QH_L^W_Y
MY_\ CQ_QH D^TP_\]4_[Z%'VF'_GJG_?0J/^S[?_ )Y_^/'_ !H_L^W_ .>?
M_CQ_QH D^TP_\]4_[Z%'VF'_ )ZI_P!]"H_[/M_^>?\ X\?\:/[/M_\ GG_X
M\?\ &@"3[3#_ ,]4_P"^A1]IA_YZI_WT*C_L^W_YY_\ CQ_QH_L^W_YY_P#C
MQ_QH D^TP_\ /5/^^A1]IA_YZI_WT*C_ +/M_P#GG_X\?\:/[/M_^>?_ (\?
M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
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M/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\
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M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
MSU3_ +Z%'VF'_GJG_?0J/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]
M4_[Z%'VF'_GJG_?0J/\ L^W_ .>?_CQ_QH_L^W_YY_\ CQ_QH D^TP_\]4_[
MZ%'VF'_GJG_?0J/^S[?_ )Y_^/'_ !H_L^W_ .>?_CQ_QH D^TP_\]4_[Z%'
MVF'_ )ZI_P!]"H_[/M_^>?\ X\?\:/[/M_\ GG_X\?\ &@"3[3#_ ,]4_P"^
MA1]IA_YZI_WT*C_L^W_YY_\ CQ_QH_L^W_YY_P#CQ_QH D^TP_\ /5/^^A1]
MIA_YZI_WT*C_ +/M_P#GG_X\?\:/[/M_^>?_ (\?\: )/M,/_/5/^^A1]IA_
MYZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\: )/M,/_/5/^^A1]IA_P">
MJ?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H D^TP_P#/5/\ OH4?:8?^
M>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/M,/_ #U3_OH4?:8?^>J?
M]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3#_SU3_OH4?:8?^>J?]]"
MH_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_SU3_OH4?:8?\ GJG_ 'T*
MC_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\ SU3_ +Z%'VF'_GJG_?0J
M/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\
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M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
MSU3_ +Z%'VF'_GJG_?0J/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]
M4_[Z%'VF'_GJG_?0J/\ L^W_ .>?_CQ_QH_L^W_YY_\ CQ_QH D^TP_\]4_[
MZ%'VF'_GJG_?0J/^S[?_ )Y_^/'_ !H_L^W_ .>?_CQ_QH D^TP_\]4_[Z%'
MVF'_ )ZI_P!]"H_[/M_^>?\ X\?\:/[/M_\ GG_X\?\ &@"3[3#_ ,]4_P"^
MA1]IA_YZI_WT*C_L^W_YY_\ CQ_QH_L^W_YY_P#CQ_QH D^TP_\ /5/^^A1]
MIA_YZI_WT*C_ +/M_P#GG_X\?\:/[/M_^>?_ (\?\: )/M,/_/5/^^A1]IA_
MYZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\: )/M,/_/5/^^A1]IA_P">
MJ?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H D^TP_P#/5/\ OH4?:8?^
M>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/M,/_ #U3_OH4?:8?^>J?
M]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3#_SU3_OH4?:8?^>J?]]"
MH_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_SU3_OH4?:8?\ GJG_ 'T*
MC_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\ SU3_ +Z%'VF'_GJG_?0J
M/^S[?_GG_P"/'_&C^S[?_GG_ ./'_&@"3[3#_P ]4_[Z%'VF'_GJG_?0J/\
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M\: )/M,/_/5/^^A1]IA_YZI_WT*C_L^W_P">?_CQ_P :/[/M_P#GG_X\?\:
M)/M,/_/5/^^A1]IA_P">J?\ ?0J/^S[?_GG_ ./'_&C^S[?_ )Y_^/'_ !H
MD^TP_P#/5/\ OH4?:8?^>J?]]"H_[/M_^>?_ (\?\:/[/M_^>?\ X\?\: )/
MM,/_ #U3_OH4?:8?^>J?]]"H_P"S[?\ YY_^/'_&C^S[?_GG_P"/'_&@"3[3
M#_SU3_OH4?:8?^>J?]]"H_[/M_\ GG_X\?\ &C^S[?\ YY_^/'_&@"3[3#_S
MU3_OH4?:8?\ GJG_ 'T*C_L^W_YY_P#CQ_QH_L^W_P">?_CQ_P : )/M,/\
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M[KDG_(NH^A)]IA_YZI_WT*/M,/\ SU3_ +Z%1_V?;_\ //\ \>/^-']GV_\
MSS_\>/\ C7@GMDGVF'_GJG_?0H^TP_\ /5/^^A4?]GV__//_ ,>/^-']GV__
M #S_ /'C_C0!)]IA_P">J?\ ?0H^TP_\]4_[Z%1_V?;_ ///_P >/^-']GV_
M_//_ ,>/^- $GVF'_GJG_?0H^TP_\]4_[Z%1_P!GV_\ SS_\>/\ C1_9]O\
M\\__ !X_XT 2?:8?^>J?]]"C[3#_ ,]4_P"^A4?]GV__ #S_ /'C_C1_9]O_
M ,\__'C_ (T 2?:8?^>J?]]"C[3#_P ]4_[Z%1_V?;_\\_\ QX_XT?V?;_\
M//\ \>/^- $GVF'_ )ZI_P!]"C[3#_SU3_OH5'_9]O\ \\__ !X_XT?V?;_\
M\_\ QX_XT 2?:8?^>J?]]"C[3#_SU3_OH5'_ &?;_P#//_QX_P"-']GV_P#S
MS_\ 'C_C0!)]IA_YZI_WT*/M,/\ SU3_ +Z%1_V?;_\ //\ \>/^-']GV_\
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M_'C_ (T 2?:8?^>J?]]"C[3#_P ]4_[Z%1_V?;_\\_\ QX_XT?V?;_\ //\
M\>/^- $GVF'_ )ZI_P!]"C[3#_SU3_OH5'_9]O\ \\__ !X_XT?V?;_\\_\
MQX_XT 2?:8?^>J?]]"C[3#_SU3_OH5'_ &?;_P#//_QX_P"-']GV_P#SS_\
M'C_C0!)]IA_YZI_WT*/M,/\ SU3_ +Z%1_V?;_\ //\ \>/^-']GV_\ SS_\
M>/\ C0!)]IA_YZI_WT*/M,/_ #U3_OH5'_9]O_SS_P#'C_C1_9]O_P \_P#Q
MX_XT 2?:8?\ GJG_ 'T*/M,/_/5/^^A4?]GV_P#SS_\ 'C_C1_9]O_SS_P#'
MC_C0!)]IA_YZI_WT*/M,/_/5/^^A4?\ 9]O_ ,\__'C_ (T?V?;_ ///_P >
M/^- $GVF'_GJG_?0H^TP_P#/5/\ OH5'_9]O_P \_P#QX_XT?V?;_P#//_QX
M_P"- $GVF'_GJG_?0H^TP_\ /5/^^A4?]GV__//_ ,>/^-']GV__ #S_ /'C
M_C0!)]IA_P">J?\ ?0H^TP_\]4_[Z%1_V?;_ ///_P >/^-']GV__//_ ,>/
M^- $GVF'_GJG_?0J16#*"#D>HJO_ &?;_P#//_QX_P"-3QH(U"J,*.E #J**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH _$W]KOXJ^-?&'QR\=>'=3\4ZG>:
M)9ZY<VEKIDUXRVD2),RH/+R$& !\Q&>.370?"[_@G;\5_BA8Q:C$= T?2Y<,
MEW=:K'<*ZGNHMO-Y]FQ7OW[1G_!,WQ3XV\=>)?&/A'Q3IM]-K%]-J#Z7J<3V
MS1F1BQ1)5WA^3QN"?6OD/Q5\"_C3^SOJ#:C>^'_$7AAX!N_MC2I',*#/_/S
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M;ZVU2R@O+.XBN[2XC66&X@</'(C#*LK#@@@@@CK7A?[2_P"U58? C[)I&GV
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9\3O^@%X2_\  .Z_^2:/]4LS[+[P_P!:,N[O[C]*Z*_-3_AY9\3O^@%X2_\
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M^WO_ $J1^)\1?\C2K_V[_P"DH****^I/FPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _2O\ X)I_\D*UW_L9)_\ TEM:^LZ^3/\
M@FG_ ,D*UW_L9)__ $EM:^LZ_GK/O^1G7_Q'[KDG_(NH^@4445X)[84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF7,EKIXMEN]2\MBIG9R=D;'^Z -V.Y8>E?=]>7>//V8_AI\3?$DVO>)?#?\
M:6K3(D;W'V^YBRJC"C;'(J\#VKU\JQ&'PF+C7Q,7*,>UGKTW:_X<\C-L/B,7
M@YT,+)1E+2[NM.NR>^Q\3_!_]A36_BM\-+;Q8_B2VT62^5Y+&QDM&E\Q 2H:
M1PXV;B#C"MQ@]\5Y/\//&7B']G?XP1W*N]K>Z5>M9ZE:JQV3QJ^V6)O4'!P>
MQ (Y K]2O$NO>&?@#\+9+MT73] T*T6&VM0Y9FVC;'$I8DLQ.!R2><GO7Y>_
M#_P[JG[0WQYMH7C9I]:U-[Z^=>1#"7,DK9] N0,]3@=Z_0<IS*MF4L34Q/\
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MV9427-PV#+(S'[J X4,<\*H .*Y[X;?\%$/#/BSQ%!I?B/P]/X4AN'$<5_\
M;!=0JQZ>;\B%![@,!GG R:X<9A,5F+=3!TVZ--<L?1=5U=WKH=N#QF%RU*&.
MJI5ZKYI>3>R?9)62N_0^MJ*0,& (.0>AI:^4/KPHHHH **** "BBB@ HHHH
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MN60A@022 V"#UYK#'T:,,/'%4E9/IZJZ.K+<17GB9X.N[M=?1V9[+17XM_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /A#_@J)_S3/_N)_P#MI7PA7W?_ ,%1
M/^:9_P#<3_\ ;2OA"OWKAC_D44?^WO\ TJ1^)\1?\C2K_P!N_P#I*"BBBOJ3
MYL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /N_\
MX)=_\U,_[AG_ +=U]WU\(?\ !+O_ )J9_P!PS_V[K[OK\%XG_P"1O6_[=_\
M28G[9P[_ ,BNE_V]_P"E,****^6/I HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X0_P""HG_-,_\
MN)_^VE?"%?=__!43_FF?_<3_ /;2OA"OWKAC_D44?^WO_2I'XGQ%_P C2K_V
M[_Z2@HHHKZD^;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#]*_\ @FG_ ,D*UW_L9)__ $EM:^LZ^3/^":?_ "0K7?\ L9)__26U
MKZSK^>L^_P"1G7_Q'[KDG_(NH^@4445X)[84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '#WGP3\
M%ZC\1K?QY=:-]I\56^!#?2W4["/"E1MB+^6, G'R]3GKS7<445I.I.HDIR;M
MHK]%V1G&G"FY2A%)O5Z;ON^YA^,/!&@_$#19-(\1Z5;:QITAR8+E-P![,IZJ
MWN"#7)> ?V<?AM\,=6_M/PWX4M;'41]RZEDEN)(\\'8TK,4X)'RXX->DT5I#
M$5J<'3A-J+W2;L_5&<\/1JSC4G!.2V;2NO1] HHHKG.@**** "BBB@ HHHH
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M>:!;O?PRC^\/*!90?1U4^U?N!17=A<94PMU'5/H>=C,#2QEG/1KJC\>?@/\
M\$[_ (E_%#6K6;Q1I=SX&\,JVZXNM23R[MU!Y2* _,&/JX51UYQ@_K1X%\$:
M/\-_!^D^&- M%LM'TR!;>WA!R0HZDGNQ.23W))K>HIXG&U,4E&6B706$R^E@
M[RCK)]6?E#\5/^";_P 7-3^,>L-HD%EJWA_5-0ENDUVXOHXA"DCEOWT9;S-R
MYYV*V>HZXK]// _A%?"7P_T'PQ<3_P!IIINFP:=)-,N?/$<2QEF!S]['3WKH
MJ*SJ8FI5HQHRV7_#:FM+!TJ-:5>'Q2_X?0_+3]J/_@F]XJ\.^);[7OA=I_\
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MK''3P=.GB)XE-\TKW[:NX4445QG>%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!\(?\ !43_ )IG_P!Q/_VTKX0K[O\ ^"HG_-,_^XG_ .VE?"%?O7#'_(HH
M_P#;W_I4C\3XB_Y&E7_MW_TE!1117U)\V%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'W?_P2[_YJ9_W#/_;NON^OA#_@EW_S4S_N
M&?\ MW7W?7X+Q/\ \C>M_P!N_P#I,3]LX=_Y%=+_ +>_]*84445\L?2!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% 'PA_P5$_YIG_W$_\ VTKX0K[O_P""HG_-,_\ N)_^VE?"%?O7
M#'_(HH_]O?\ I4C\3XB_Y&E7_MW_ -)04445]2?-A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!^E?_!-/_DA6N_]C)/_ .DMK7UG
M7R9_P33_ .2%:[_V,D__ *2VM?6=?SUGW_(SK_XC]UR3_D74?0****\$]L**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *B
MNKJ*QM9KB>18H(4,DDCG 50,DGV KY%TW_@HQX4\/_%[Q5X#\?Z=+X=&EZM<
M6%MK=N&FMI(TD94,R8WQG 7D;@3D_**^B_%9M/BM\(]?A\,ZI:ZC;ZWI-U;6
M5_8SK)$[21,BLKJ2."?PQ5U:=2G351K1JZ^ZYG2K4JM5TE+5.S\M;/\ X<_.
MCXV?\%$/B5\3/'$_AWX/Q7&EZ2)6AM7L+$76HZ@!G+X*ML!QD*B[@.K=AY[_
M ,+6_:[\#B?6KN3XC65M#^]EGU;1YY+9 !U(FB* 8'ICK2_L7_M$:/\ LE_$
M;Q5;^-_#EX[7B+8SSVL2M=V$D3MN38Q7*L3\V#G*+P:^U-;_ ."GOP7T[2VN
M+.37-7N2F5LX-.*-G'0M(RJ/J"?QKZ.I!851A0H\ZMOO?^O^&/E:<WBG*>(K
MN#3?NWM;^OO[E3]B']N*?]H*\G\'^+[6VL_&%O ;BWNK12D-_&N _P A)VR+
MD$@'!&2 N,5]AU^3'["&FZA\5OVT+KQQIFE+I.C6<M_JMU!;_P"IM5G25(X0
M< $[I.!QD(QQQ7ZSUYN84H4YQ<5RMI-KL]3ULLK3JTYJ4N91DTGW04445Y9[
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?
M\%1/^:9_]Q/_ -M*^$*^[_\ @J)_S3/_ +B?_MI7PA7[UPQ_R**/_;W_ *5(
M_$^(O^1I5_[=_P#24%%%%?4GS84444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?=_\ P2[_ .:F?]PS_P!NZ^[Z^$/^"7?_ #4S_N&?
M^W=?=]?@O$__ "-ZW_;O_I,3]LX=_P"172_[>_\ 2F%%%%?+'T@4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!\(?\ !43_ )IG_P!Q/_VTKX0K[O\ ^"HG_-,_^XG_ .VE?"%?O7#'
M_(HH_P#;W_I4C\3XB_Y&E7_MW_TE!1117U)\V%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'Z5_\ !-/_ )(5KO\ V,D__I+:U]9U
M\F?\$T_^2%:[_P!C)/\ ^DMK7UG7\]9]_P C.O\ XC]UR3_D74?0****\$]L
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'PA_P5$_YIG_W$_P#VTKX0
MK[O_ ."HG_-,_P#N)_\ MI7PA7[UPQ_R**/_ &]_Z5(_$^(O^1I5_P"W?_24
M%%%%?4GS84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ?=_P#P2[_YJ9_W#/\ V[K[OKX0_P""7?\ S4S_ +AG_MW7W?7X+Q/_ ,C>
MM_V[_P"DQ/VSAW_D5TO^WO\ TIA1117RQ](%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_!43_F
MF?\ W$__ &TKX0K[O_X*B?\ -,_^XG_[:5\(5^]<,?\ (HH_]O?^E2/Q/B+_
M )&E7_MW_P!)04445]2?-A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!^E?\ P33_ .2%:[_V,D__ *2VM?6=?)G_  33_P"2%:[_
M -C)/_Z2VM?6=?SUGW_(SK_XC]UR3_D74?0****\$]L**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS^U;X=_:>\+W%S8P-H_B'3]HU'1Y9 [1;ONR1M@;XS@C. 01@CH3[C7XW?\
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M3?\ /H_Z_P"%'VZ;_GT?]?\ "OECZ0NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\
M"@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?
M]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;
M_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%
M'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z
M_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\
M/H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W
M3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT
M52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_P
MH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_
M %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_
MY]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1
M]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\
MK_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_S
MZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[
M=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[
M15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\
M"@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?
M]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;
M_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%
M'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z
M_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\
M/H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W
M3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT
M52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_P
MH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_
M %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_
MY]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1
M]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\
MK_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_S
MZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[
M=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[
M15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\
M"@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?
M]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;
M_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%
M'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z
M_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\
M/H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W
M3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT
M52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_P
MH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_Y]'_
M %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1]NF_
MY]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\ K_A1
M]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_SZ/\
MK_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[=-_S
MZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[15+[
M=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\ "@"[
M15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?]?\
M"@"[15+[=-_SZ/\ K_A1]NF_Y]'_ %_PH NT52^W3?\ /H_Z_P"%'VZ;_GT?
M]?\ "@#X=_X*B?\ -,_^XG_[:5\(5]T_\%/+AYO^%:[XFBQ_:6-W?_CT]J^%
MJ_>N&/\ D44?^WO_ $J1^)\1?\C2K_V[_P"DH****^I/FPHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _2O\ X)I_\D*UW_L9)_\
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M/\)[4 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV<C^$8\GTO6OV_?V>-+M_!VF:;XY;3;1!';QVNAPZ_%%&.%1)Q%/M4 8"A\
M8P!76_ O_@G=\:?VG/BE;^/?VAKG4].T7>DUQ'K-P&U*_0'(MTB!_P!'CZ@Y
M";0<*O.14J?M9Q<'9)WOV_K\A1J.E%\RU:M;O_6Y^C_P-CU'XM?L@^#8/%#R
M2ZAXA\'P07TTW+R&:U",[>[!MQ^M?F]_P2E^(@^ /[3'CKX0>+W&F7VM/]@C
M\X[5_M"TDD BY_OJ\F#W*J.<BOV"L;&WTRRM[.TA2VM;>-8H88UVK&B@!5 [
M   5^?O_  4,_P""<NJ?&[Q$/B?\*S!;>.E5?[1TMYA;_P!HL@ CFBE)"I.
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MSXC$0PM*5:I\,=SW"BOS4_X>6?$[_H!>$O\ P#NO_DFC_AY9\3O^@%X2_P#
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MO^@%X2_\ [K_ .2:/]4LS[+[P_UHR[N_N/TKHK\U/^'EGQ._Z 7A+_P#NO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *^3/^"EG_)"M"_[&2#_TENJ^LZ^3
M/^"EG_)"M"_[&2#_ -);JO>R'_D9T/\ $>)G?_(NK>A^:E%%%?T*?A04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?6?_!-/_DNN
MN_\ 8MS_ /I5:U\F5]9_\$T_^2ZZ[_V+<_\ Z56M>!GW_(LK^A[>2?\ (QH^
MI^E=%%%?SV?NH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_!43_FF?_<3
M_P#;2OA"ON__ (*B?\TS_P"XG_[:5\(5^]<,?\BBC_V]_P"E2/Q/B+_D:5?^
MW?\ TE!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'W?_ ,$N_P#FIG_<,_\ ;NON^OA#_@EW_P U,_[AG_MW7W?7X+Q/
M_P C>M_V[_Z3$_;.'?\ D5TO^WO_ $IA1117RQ](%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_
M  5$_P":9_\ <3_]M*^$*^[_ /@J)_S3/_N)_P#MI7PA7[UPQ_R**/\ V]_Z
M5(_$^(O^1I5_[=_])04445]2?-A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!^E?_  33_P"2%:[_ -C)/_Z2VM?6=?)G_!-/_DA6
MN_\ 8R3_ /I+:U]9U_/6??\ (SK_ .(_=<D_Y%U'T"BBBO!/;"BBB@ HHHH
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M#7SE^R#_ ,%!?%GQR^,EIX-\8:7X?T^VU"UF-G-I,$\4AN$&\*QDF<%2BR<
M9R!S7V;\3_$UUX*^&WBOQ#8QPRWNDZ5=7T$=PI,;211,ZA@""5RHS@@X[BJQ
M_MXS4L1O:_E9/_.]R<M^KSIN&%O9NWG=K_AK,^'O^"9O[,VN^#]:U[XA>+=)
MNM'ND232=-L[Z(Q2YW#SY2K#( *A >_S^U?H/7Q#^Q/^V]XZ_:0^*VH^&/$V
MD^'K&PM](EOTDTFVGCE,BRPH 3),XVXD;MG('-?;U5F'MG53K*SMI;M_P]R<
ML5!46J#;5W>_?_AK!1117F'K!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^WO_ $J1^)\1?\C2K_V[_P"DH****^I/FPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH _2O\ X)I_\D*UW_L9)_\ TEM:^LZ^3/\
M@FG_ ,D*UW_L9)__ $EM:^LZ_GK/O^1G7_Q'[KDG_(NH^@4445X)[84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^7?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'PA_P %1/\ FF?_ '$_
M_;2OA"ON_P#X*B?\TS_[B?\ [:5\(5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?
M_24%%%%?4GS84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?=__!+O_FIG_<,_]NZ^[Z^$/^"7?_-3/^X9_P"W=?=]?@O$_P#R-ZW_
M &[_ .DQ/VSAW_D5TO\ M[_TIA1117RQ](%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?"'_!43_FF
M?_<3_P#;2OA"ON__ (*B?\TS_P"XG_[:5\(5^]<,?\BBC_V]_P"E2/Q/B+_D
M:5?^W?\ TE!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'Z5_\$T_^2%:[_V,D_\ Z2VM?6=?)G_!-/\ Y(5KO_8R3_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *^3/^"EG_)"M"_[&2#_ -);
MJOK.ODS_ (*6?\D*T+_L9(/_ $ENJ][(?^1G0_Q'B9W_ ,BZMZ'YJ4445_0I
M^%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]9_
M\$T_^2ZZ[_V+<_\ Z56M?)E?6?\ P33_ .2ZZ[_V+<__ *56M>!GW_(LK^A[
M>2?\C&CZGZ5T445_/9^ZA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\%1
M/^:9_P#<3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7[UPQ_P BBC_V]_Z5(_$^
M(O\ D:5?^W?_ $E!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% 'W?_P $N_\ FIG_ '#/_;NON^OA#_@EW_S4S_N&?^W=
M?=]?@O$__(WK?]N_^DQ/VSAW_D5TO^WO_2F%%%%?+'T@4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M\(?\%1/^:9_]Q/\ ]M*^$*^[_P#@J)_S3/\ [B?_ +:5\(5^]<,?\BBC_P!O
M?^E2/Q/B+_D:5?\ MW_TE!1117U)\V%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'Z5_\$T_^2%:[_P!C)/\ ^DMK7UG7R9_P33_Y
M(5KO_8R3_P#I+:U]9U_/6??\C.O_ (C]UR3_ )%U'T"BBBO!/;"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$7_(TJ_]N_\ I*"BBBOJ3YL**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /N__ ()=_P#-3/\ N&?^W=?=]?"'_!+O_FIG_<,_]NZ^
M[Z_!>)_^1O6_[=_])B?MG#O_ "*Z7_;W_I3"BBBOECZ0**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M (*6?\D*T+_L9(/_ $ENJ][(?^1G0_Q'B9W_ ,BZMZ'YJ4445_0I^%!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]9_\$T_^2ZZ
M[_V+<_\ Z56M?)E?6?\ P33_ .2ZZ[_V+<__ *56M>!GW_(LK^A[>2?\C&CZ
MGZ5T445_/9^ZA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\%1/^:9_P#<
M3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7[UPQ_P BBC_V]_Z5(_$^(O\ D:5?
M^W?_ $E!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'W?_P $N_\ FIG_ '#/_;NON^OA#_@EW_S4S_N&?^W=?=]?@O$_
M_(WK?]N_^DQ/VSAW_D5TO^WO_2F%%%%?+'T@4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\%1/^
M:9_]Q/\ ]M*^$*^[_P#@J)_S3/\ [B?_ +:5\(5^]<,?\BBC_P!O?^E2/Q/B
M+_D:5?\ MW_TE!1117U)\V%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'Z5_\$T_^2%:[_P!C)/\ ^DMK7UG7R9_P33_Y(5KO_8R3
M_P#I+:U]9U_/6??\C.O_ (C]UR3_ )%U'T"BBBO!/;"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\N^_YZI^7_UJNT4 4O+OO^>J?E_]:CR[[_GJGY?_ %JNT4 4O+OO^>J?E_\
M6H\N^_YZI^7_ -:KM% %+R[[_GJGY?\ UJ/+OO\ GJGY?_6J[10!2\N^_P">
MJ?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\ 6J[10!2\N^_Y
MZI^7_P!:CR[[_GJGY?\ UJNT4 4O+OO^>J?E_P#6H\N^_P">J?E_]:KM% %+
MR[[_ )ZI^7_UJ/+OO^>J?E_]:KM% %+R[[_GJGY?_6H\N^_YZI^7_P!:KM%
M%+R[[_GJGY?_ %J^4?\ @I(MROP-T/SG5E_X2.#@>OV:Z]J^NZ^3/^"EG_)"
MM"_[&2#_ -);JO>R'_D9T/\ $>)G?_(NK>A^:E%%%?T*?A04444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %?5W_!-M96^.6N>2P5O^
M$<GY/I]IM:^4:^L_^":?_)===_[%N?\ ]*K6O S[_D65_0]O)/\ D8T?4_1[
MR[[_ )ZI^7_UJ/+OO^>J?E_]:KM%?SV?NI2\N^_YZI^7_P!:CR[[_GJGY?\
MUJNT4 4O+OO^>J?E_P#6H\N^_P">J?E_]:KM% %+R[[_ )ZI^7_UJ/+OO^>J
M?E_]:KM% %+R[[_GJGY?_6H\N^_YZI^7_P!:KM% %+R[[_GJGY?_ %J/+OO^
M>J?E_P#6J[10!2\N^_YZI^7_ -:CR[[_ )ZI^7_UJNT4 4O+OO\ GJGY?_6H
M\N^_YZI^7_UJNT4 4O+OO^>J?E_]:CR[[_GJGY?_ %JNT4 4O+OO^>J?E_\
M6H\N^_YZI^7_ -:KM% %+R[[_GJGY?\ UJ/+OO\ GJGY?_6J[10!2\N^_P">
MJ?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\ 6J[10!2\N^_Y
MZI^7_P!:CR[[_GJGY?\ UJNT4 4O+OO^>J?E_P#6H\N^_P">J?E_]:KM% %+
MR[[_ )ZI^7_UJ/+OO^>J?E_]:KM% %+R[[_GJGY?_6H\N^_YZI^7_P!:KM%
M%+R[[_GJGY?_ %J/+OO^>J?E_P#6J[10!2\N^_YZI^7_ -:CR[[_ )ZI^7_U
MJNT4 4O+OO\ GJGY?_6H\N^_YZI^7_UJNT4 4O+OO^>J?E_]:CR[[_GJGY?_
M %JNT4 4O+OO^>J?E_\ 6H\N^_YZI^7_ -:KM% %+R[[_GJGY?\ UJ/+OO\
MGJGY?_6J[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO
M^>J?E_\ 6J[10!2\N^_YZI^7_P!:CR[[_GJGY?\ UJNT4 4O+OO^>J?E_P#6
MH\N^_P">J?E_]:KM% %+R[[_ )ZI^7_UJ/+OO^>J?E_]:KM% %+R[[_GJGY?
M_6H\N^_YZI^7_P!:KM% %+R[[_GJGY?_ %J/+OO^>J?E_P#6J[10!2\N^_YZ
MI^7_ -:CR[[_ )ZI^7_UJNT4 4O+OO\ GJGY?_6H\N^_YZI^7_UJNT4 4O+O
MO^>J?E_]:CR[[_GJGY?_ %JNT4 4O+OO^>J?E_\ 6H\N^_YZI^7_ -:KM% %
M+R[[_GJGY?\ UJ/+OO\ GJGY?_6J[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[
M10!2\N^_YZI^7_UJ/+OO^>J?E_\ 6J[10!2\N^_YZI^7_P!:CR[[_GJGY?\
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M[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\
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M[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\
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M[10!2\N^_P">J?E_]:CR[[_GJGY?_6J[10!2\N^_YZI^7_UJ/+OO^>J?E_\
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MEWW_ #U3\O\ ZU'EWW_/5/R_^M5VB@"EY=]_SU3\O_K4>7??\]4_+_ZU7:*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY_U2;_RY/_N2C_A[Y_U2;_RY/_N2C_AT'_U5G_RV_P#[KH_X=!_]59_\MO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY,_X*6?\
M)"M"_P"QD@_]);JOK.ODS_@I9_R0K0O^QD@_]);JO>R'_D9T/\1XF=_\BZMZ
M'YJ4445_0I^%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5]9_\ !-/_ )+KKO\ V+<__I5:U\F5]9_\$T_^2ZZ[_P!BW/\ ^E5K
M7@9]_P BROZ'MY)_R,:/J?I71117\]G[J%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% 'PA_P5$_YIG_W$_P#VTKX0K[O_ ."HG_-,_P#N)_\ MI7PA7[UPQ_R
M**/_ &]_Z5(_$^(O^1I5_P"W?_24%%%%?4GS84444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?=_P#P2[_YJ9_W#/\ V[K[OKX0_P""
M7?\ S4S_ +AG_MW7W?7X+Q/_ ,C>M_V[_P"DQ/VSAW_D5TO^WO\ TIA1117R
MQ](%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?"'_!43_FF?\ W$__ &TKX0K[O_X*B?\ -,_^XG_[
M:5\(5^]<,?\ (HH_]O?^E2/Q/B+_ )&E7_MW_P!)04445]2?-A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^E?\ P33_ .2%:[_V
M,D__ *2VM?6=?)G_  33_P"2%:[_ -C)/_Z2VM?6=?SUGW_(SK_XC]UR3_D7
M4?0****\$]L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M17]"GX4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7UG_P $T_\ DNNN_P#8MS_^E5K7R97UG_P33_Y+KKO_ &+<_P#Z56M>!GW_
M "+*_H>WDG_(QH^I^E=%%%?SV?NH4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M ?"'_!43_FF?_<3_ /;2OA"ON_\ X*B?\TS_ .XG_P"VE?"%?O7#'_(HH_\
M;W_I4C\3XB_Y&E7_ +=_])04445]2?-A1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!]W_ /!+O_FIG_<,_P#;NON^OA#_ ()=_P#-
M3/\ N&?^W=?=]?@O$_\ R-ZW_;O_ *3$_;.'?^172_[>_P#2F%%%%?+'T@44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!\(?\%1/^:9_P#<3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7
M[UPQ_P BBC_V]_Z5(_$^(O\ D:5?^W?_ $E!1117U)\V%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'Z5_P#!-/\ Y(5KO_8R3_\
MI+:U]9U\F?\ !-/_ )(5KO\ V,D__I+:U]9U_/6??\C.O_B/W7)/^1=1] HH
MHKP3VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_\ 2JUKP,^_Y%E?T/;R3_D8T?4_2NBBBOY[/W4**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /A#_ (*B?\TS_P"XG_[:5\(5]W_\%1/^:9_]Q/\ ]M*^$*_>
MN&/^111_[>_]*D?B?$7_ "-*O_;O_I*"BBBOJ3YL**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** /N__@EW_P U,_[AG_MW7W?7PA_P
M2[_YJ9_W#/\ V[K[OK\%XG_Y&];_ +=_])B?MG#O_(KI?]O?^E,****^6/I
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#X0_X*B?\TS_[B?\ [:5\(5]W_P#!43_FF?\ W$__ &TK
MX0K]ZX8_Y%%'_M[_ -*D?B?$7_(TJ_\ ;O\ Z2@HHHKZD^;"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]*_^":?_)"M=_[&2?\
M]);6OK.ODS_@FG_R0K7?^QDG_P#26UKZSK^>L^_Y&=?_ !'[KDG_ "+J/H%%
M%%>">V%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 >(_$K]LWX2?"/QA>^%O%/B673M;LQ&TUNNG7,P4.@=?F2,J<JP/!K\
MK/VROB7X=^+?[17B'Q3X6OFU'0[Q+40W#0R0EBEO&C?*ZAAAE(Y':OL7]K3_
M ()^>._CE\9M:\;>'-<\/P6E_' HM-2FGBE7RX4C/*1.#DKGJ.M? 'Q@^$>O
M?!#Q]>^$/$?V8ZM:+&[M9R&2)E= ZE6(&>#Z=<U]'E4*"G3JQE^\MM]U_P"K
MGR^;5<3RSIN'[O37^GW\C]8;7_@HI\!([:)&\93!E0 _\2>]]/\ KE69XN_X
M*2?!#3_#>H3:;K5YX@OA"PBTZ'3+B,S,00%+2HJ@>I)Z=C7P-'_P3U_: D17
M7P#E6&0?[9T__P"2*N:;_P $YOCY?7213^#K?3HV.#/<ZQ9E%]R(Y6;\@:4L
M#@9)IU=_-?Y&=/,,PBERT=O[LO\ ,/\ @GI<7+_M?>$7M4V1RK?><B=!&;64
MX^F=M?LU7R=^Q?\ L/Q_LWW%WXE\1ZC;:SXRNX#;+]C#&VLHB065&8!G9L#+
M$# & .I/UC7)F5>G6J1]GJHJWXM_J>EE>'JT*<G5T<G?\%_7W!1117D'M!11
M10 4444 %)2U^</_  5O_:<\1^#[/PY\'/!-U<VNL>)X?M&IR6)(GDMG<Q16
MR$<_O7#[L<D*!T8BLYR<;1BKMNR7F:0BI7;=DM6SZ>^(7[?7[/\ \+]:DTCQ
M!\3=+348W:.6'3H9]0\IP<%7-M'($8'@AB"*]*^%?QK\"?&[17U;P)XJTWQ/
M91D"4V,P,D!(R!+&</&2.S@&OSW^#/\ P15\-W'@NTN_BAXPUR/Q)<QK+)8>
M''@AALR0"8F>6*4RL#U8!1V&>I^>?CC\!_B%_P $M_C5X9\=^"_$,NL>&KR9
MH[6\D0QB91AI+&\0':VY>01UVE@%9>-O=A)0JO?2ZVO_ %_P+Z)Y>].+G37G
M;J?N)6=X@\1:5X3T6[U?7-3L]'TFS0RW%]?SK!!"H_B=V(51[DUD_#'Q]8?%
M+X=^&O&&EAET_7-/@U"%7^\BR(&VGW&<'W%?D-^U%\3O'7_!1/\ :RB^#_@.
M\:+P9I-[+;6R[F6U;R21<:A<8^\ 0P3V*@89SF)J:JJA%>]K\K;OY?UIJ5!P
M=-UI/W5^NR_K\]#]"O\ AY)^S;_;W]D?\+2L/M?F>5YGV&\^SYSC/G^3Y6W_
M &MV/>OH7P_XBTKQ9HUIJ^B:E::OI5Y&);>^L9UFAF0]&1U)##W!K\[KK_@B
M1\/3X.:"V^('B9?%?DX&H2QVYL3+CK]G";PN>WG9]S7SS^Q7\7O&O["O[5US
M\&?'TKP^&]4U%-.O;5I"]O!<2;1;WL/HK[D!/&48%N4 &E-1G/V5_>>W9^7]
M?\$SFY1@ZMO=6_=>?]?\!_M11114%A7AWQ5_;=^!OP5UN31O%_Q%TRPU:)BD
MUC:1S7TT##^&5+=)#&>>CX->$?\ !4[]KW4_V?\ X<Z=X-\(7KV'C'Q6DFZ^
MA8K+862_*\B$?=D=CM5NH <C! -> _LO?\$?[/XA_#VP\6_%SQ'KFDZAK,*W
MEOHVBF**>WC<;E:XDFCDR[ @E HV]R3D"(<U3FE'X8Z7\_+^N_8N7+3Y5+XG
MT\O/^NW<_2#X0_M%?#7X]V<MQX!\8Z9XD\E0\UO;R%+F%2<!G@<+(@)Z%E -
M>C5^&_[5W[(?C/\ X)W^/O#7Q'^'GB6^N_#WVL+8ZPRA+FRN "?L]P%PLBN@
M;G 5AO5E'&[]=/V8/CI8_M'_  /\,>/;.-;:74("E[:J21;W49*31C/8."1Z
MJ5/>MH\M2#G#IHUV_K_+NC&7-3FHSZZI_P!?UOV/5****@L**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ KY,_X*6?\ )"M"_P"QD@_]);JOK.ODS_@I9_R0K0O^QD@_]);JO>R'_D9T
M/\1XF=_\BZMZ'YJ4445_0I^%!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5]9_\ !-/_ )+KKO\ V+<__I5:U\F5]9_\$T_^2ZZ[
M_P!BW/\ ^E5K7@9]_P BROZ'MY)_R,:/J?I71117\]G[J%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% 'PA_P5$_YIG_W$_P#VTKX0K[O_ ."HG_-,_P#N)_\
MMI7PA7[UPQ_R**/_ &]_Z5(_$^(O^1I5_P"W?_24%%%%?4GS84444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?=_P#P2[_YJ9_W#/\
MV[K[OKX0_P""7?\ S4S_ +AG_MW7W?7X+Q/_ ,C>M_V[_P"DQ/VSAW_D5TO^
MWO\ TIA1117RQ](%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?"'_!43_FF?\ W$__ &TKX0K[O_X*
MB?\ -,_^XG_[:5\(5^]<,?\ (HH_]O?^E2/Q/B+_ )&E7_MW_P!)04445]2?
M-A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^E?\
MP33_ .2%:[_V,D__ *2VM?6=?)G_  33_P"2%:[_ -C)/_Z2VM?6=?SUGW_(
MSK_XC]UR3_D74?0****\$]L**** "BBB@ HHHH **** "BBB@ HHHH ****
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M:/[.M_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\ N?J:/[.M_P"Y^IH
ME^T1?\]4_P"^A1]HB_YZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:
M(O\ GJG_ 'T*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:(O^>J?]]"HO[.
MM_[GZFC^SK?^Y^IH E^T1?\ /5/^^A1]HB_YZI_WT*B_LZW_ +GZFC^SK?\
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M4IF23X%Z$%=6/_"20=#G_EUNJ^K?[.M_[GZFOD__ (*36L4'P-T)D7!_X2.
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M?]]"C[1%_P ]4_[Z%1?V=;_W/U-']G6_]S]30!+]HB_YZI_WT*/M$7_/5/\
MOH5%_9UO_<_4T?V=;_W/U- $OVB+_GJG_?0H^T1?\]4_[Z%1?V=;_P!S]31_
M9UO_ '/U- $OVB+_ )ZI_P!]"C[1%_SU3_OH5%_9UO\ W/U-']G6_P#<_4T
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M[Z%1?V=;_P!S]31_9UO_ '/U- $OVB+_ )ZI_P!]"C[1%_SU3_OH5%_9UO\
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M +Z%'VB+_GJG_?0J+^SK?^Y^IH_LZW_N?J: )?M$7_/5/^^A1]HB_P">J?\
M?0J+^SK?^Y^IH_LZW_N?J: )?M$7_/5/^^A1]HB_YZI_WT*B_LZW_N?J:/[.
MM_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\ N?J:/[.M_P"Y^IH E^T1
M?\]4_P"^A1]HB_YZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:(O\
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M E^T1?\ /5/^^A1]HB_YZI_WT*B_LZW_ +GZFC^SK?\ N?J: )?M$7_/5/\
MOH4?:(O^>J?]]"HO[.M_[GZFC^SK?^Y^IH E^T1?\]4_[Z%'VB+_ )ZI_P!]
M"HO[.M_[GZFC^SK?^Y^IH E^T1?\]4_[Z%'VB+_GJG_?0J+^SK?^Y^IH_LZW
M_N?J: )?M$7_ #U3_OH4?:(O^>J?]]"HO[.M_P"Y^IH_LZW_ +GZF@"7[1%_
MSU3_ +Z%'VB+_GJG_?0J+^SK?^Y^IH_LZW_N?J: )?M$7_/5/^^A1]HB_P">
MJ?\ ?0J+^SK?^Y^IH_LZW_N?J: )?M$7_/5/^^A1]HB_YZI_WT*B_LZW_N?J
M:/[.M_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\ N?J:/[.M_P"Y^IH
ME^T1?\]4_P"^A1]HB_YZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:
M(O\ GJG_ 'T*B_LZW_N?J:/[.M_[GZF@"7[1%_SU3_OH4?:(O^>J?]]"HO[.
MM_[GZFC^SK?^Y^IH E^T1?\ /5/^^A1]HB_YZI_WT*B_LZW_ +GZFC^SK?\
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MYZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\
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MYZI_WT*B_LZW_N?J:/[.M_[GZF@"7[1%_P ]4_[Z%'VB+_GJG_?0J+^SK?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M KY,_P""EG_)"M"_[&2#_P!);JOK.ODS_@I9_P D*T+_ +&2#_TENJ][(?\
MD9T/\1XF=_\ (NK>A^:E%%%?T*?A04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %?6?\ P33_ .2ZZ[_V+<__ *56M?)E?6?_  33
M_P"2ZZ[_ -BW/_Z56M>!GW_(LK^A[>2?\C&CZGZ5T445_/9^ZA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!\(?\ !43_ )IG_P!Q/_VTKX0K[O\ ^"HG_-,_
M^XG_ .VE?"%?O7#'_(HH_P#;W_I4C\3XB_Y&E7_MW_TE!1117U)\V%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'W?_P2[_YJ9_W#
M/_;NON^OA#_@EW_S4S_N&?\ MW7W?7X+Q/\ \C>M_P!N_P#I,3]LX=_Y%=+_
M +>_]*84445\L?2!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'PA_P5$_YIG_W$_\ VTKX0K[O_P""
MHG_-,_\ N)_^VE?"%?O7#'_(HH_]O?\ I4C\3XB_Y&E7_MW_ -)04445]2?-
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^E?_!-
M/_DA6N_]C)/_ .DMK7UG7R9_P33_ .2%:[_V,D__ *2VM?6=?SUGW_(SK_XC
M]UR3_D74?0****\$]L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHKE=3^*7A71[YK.ZUB%;A3M98T>0*?0E00#]37'B<9AL%%3Q56,$]+
MR:7YG11P];$/EHP<GY)O\CJJ*KZ?J%MJEI'=6<\=S;R#*2Q,&4_C5BNN,E)*
M47=,PE%Q;4E9A16'H_C71O$&J76GZ?>?:KJUSYRK$X5<'!^8KM//H>:W*QH8
MBCBH*K0FI1[IIK31ZKL]#2I2J49<M6+B_-6"BBBMS(**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *XWXJ?&#PA\%?#;:[XQUJ#1[#=
MLCW@O).^,[(XU!9V]@..IP*[*OQM_;.\8:]\>/VM]0\,6\WF1V>IQ^'-)M78
MB.-]ZQL?8M*22?3'H*ZL+AWBJRI)VZ_+3_,XL9B5@Z#K-7Z+U?\ PS_(^J=<
M_P""L_@2UO&CTGP9X@U&W4D>=<R0VY/N%#/Q]<?2OJ3X+?&O2OC+\(M,^(,5
MN^A:7>),[QZA*@\@12O&Y9P=N,H3GT]*_+/]L7]D/3/V6_#W@=[?7KO7=5U@
MW*WLDL:Q0*8Q$1Y2#+ 9D;[S'H.E?<7[%?A73_'/[!^B^']5B2;3M2M=3M9U
MDZ;6NK@9]L=<]L5WXJCAHX)XBAK9VO\ ??\ (\W"XC%RQD:&)LDU<]N^&/Q\
M\"?&35M?T_P=K\&N3Z(\:7;0*WE_.#M9&( =<JPW+D9'7I7H-?CW_P $W_%%
MUX3_ &K=-TB&4M;:Q:WFGSA3\KA(VF5L?[T(_,U^PE<^-PJPLXJ+NFK_ *?H
M=F!Q4L5&?.K.+:_K\OD%%%%><>F%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %?)G_  4L_P"2%:%_V,D'_I+=
M5]9U\F?\%+/^2%:%_P!C)!_Z2W5>]D/_ ",Z'^(\3._^1=6]#\U****_H4_"
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^L_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "ODS_@I9_R0K0O^QD@_]);JOK.ODS_@I9_R0K0O^QD@_P#26ZKWLA_Y
M&=#_ !'B9W_R+JWH?FI1117]"GX4%%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'PA_P %1/\ FF?_ '$__;2OA"ON_P#X
M*B?\TS_[B?\ [:5\(5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?_24%%%%?4GS8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?I7_P $
MT_\ DA6N_P#8R3_^DMK7UG7R9_P33_Y(5KO_ &,D_P#Z2VM?6=?SUGW_ ",Z
M_P#B/W7)/^1=1] HHHKP3VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3MY;'+@\RQ>7MO#3Y;[[/\'='E7BB'3O@S\/[BVTIF_M&_/E),Y_>.Q'+\=
MHSC'0D>M4=.AD^$GPAFOU4)K-_M.YARCO]T?\!7)^N:JK_Q=CXM9_P!9H6C=
M/[KX/_LS#_OE:Z']H*UDN/ D<B+E8;R-W]@59<_FP_.OS6M)RP6.SG!1Y:=&
M$J5"VRBM)U%ZO9[VCJ?81]VKA\#B7>=62G4O_P"2Q?RW7F<=X'^"\/C+PU_;
M.IZC=1WEX7>(H01U(W/D$MD@GJ*T?@5XFO+/5[_PK?2&00;S#N.=C(V'4>W?
M\#7=_".\ANOAWH[1N"(HC&_^RP8Y!KR[X4YUCXQ:IJ%OEK;?=3EATVNY"_\
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M$85XF-2,/=4;-66]][>FAX5+"XQ8:=.53WV]'=Z+3KN?G'_P\8^/G_0Y0?\
M@GL__C5'_#QCX^?]#E!_X)[/_P"-5^@W_#NGX!'D>#)B/^PQ>_\ QZC_ (=S
M_ +_ *$R;_P<7O\ \=KJ^N8'_GU^"_S./ZAF/_/[_P FE_D>(?L!_M9?$_XY
M_&;5- \9Z_'JFEP:)->1PI86\!$JS0*&W1HIZ.W&<<U^@E>$?!WX!_!#X*_$
M:X_X09+'3_&,UC)#)9?VW)<7)M]Z,Y\EY6( 94^;;QZ\U[O7EXRI2JSC*C'E
M5NUNK['L8&E6HTW&O+F=^[?1=PHHHKA/1"BBB@ HHHH **** "BBB@ HHHH
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M=U]WU^"\3_\ (WK?]N_^DQ/VSAW_ )%=+_M[_P!*84445\L?2!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "ODS_@I9_R0K0O^QD@_]);JOK.ODS_@I9_R0K0O^QD@_P#26ZKWLA_Y
M&=#_ !'B9W_R+JWH?FI1117]"GX4%%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% 'PA_P %1/\ FF?_ '$__;2OA"ON_P#X
M*B?\TS_[B?\ [:5\(5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?_24%%%%?4GS8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?I7_P $
MT_\ DA6N_P#8R3_^DMK7UG7R9_P33_Y(5KO_ &,D_P#Z2VM?6=?SUGW_ ",Z
M_P#B/W7)/^1=1] HHHKP3VPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7HU?F1_P2B^'%_-XZ\1>.DOM.?3+?3Y-(ELUG)O$E>2&1',>W C(C?#9Y((
MX./TWKR<;AX8:HJ<'?37^O2Q[> Q,\52]I-6UT_KUN%%%%<!Z04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\
MF?\ !2S_ )(5H7_8R0?^DMU7UG7R9_P4L_Y(5H7_ &,D'_I+=5[V0_\ (SH?
MXCQ,[_Y%U;T/S4HHHK^A3\*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ KZS_P"":?\ R777?^Q;G_\ 2JUKY,KZS_X)I_\ )===
M_P"Q;G_]*K6O S[_ )%E?T/;R3_D8T?4_2NBBBOY[/W4**** "BBB@ HHHH
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MBBB@ HHHH **** "BBB@ HHHH ^$/^"HG_-,_P#N)_\ MI7PA7W?_P %1/\
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MH_M'&_\ /Z7_ ($_\P^JX?\ Y]K[D;G_  G7B3_H8-5_\#9?_BJ/^$Z\2?\
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M<?<-W\(_#^H_"3_A7-\EQ?\ ATZ8NE'[5,9)VB5 JL7/\8P"#V(%?F'\1/\
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M/S4HHHK^A3\*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KZS_X)I_\ )===_P"Q;G_]*K6ODROK/_@FG_R777?^Q;G_ /2JUKP,
M^_Y%E?T/;R3_ )&-'U/TKHHHK^>S]U"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?_24%%%%?4GS84444 %%%% !1110
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M NT52_M6'^Z_Y#_&C^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\:
M+M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"
M[15+^U8?[K_D/\:/[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH N
MT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A_NO\ D/\ &C^U8?[K_D/\: +M
M%4O[5A_NO^0_QH_M6'^Z_P"0_P : +M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[1
M5+^U8?[K_D/\:/[5A_NO^0_QH NT52_M6'^Z_P"0_P :/[5A_NO^0_QH NT5
M2_M6'^Z_Y#_&C^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4
MO[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"[15+
M^U8?[K_D/\:/[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH NT52_
MM6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A_NO\ D/\ &C^U8?[K_D/\: +M%4O[
M5A_NO^0_QH_M6'^Z_P"0_P : +M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U
M8?[K_D/\:/[5A_NO^0_QH NT52_M6'^Z_P"0_P :/[5A_NO^0_QH NT52_M6
M'^Z_Y#_&C^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A
M_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"[15+^U8?
M[K_D/\:/[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH NT52_M6'^
MZ_Y#_&C^U8?[K_D/\: +M%4O[5A_NO\ D/\ &C^U8?[K_D/\: +M%4O[5A_N
MO^0_QH_M6'^Z_P"0_P : +M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K
M_D/\:/[5A_NO^0_QH NT52_M6'^Z_P"0_P :/[5A_NO^0_QH NT52_M6'^Z_
MY#_&C^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A_NO^
M0_QH_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"[15+^U8?[K_D
M/\:/[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH NT52_M6'^Z_Y#
M_&C^U8?[K_D/\: +M%4O[5A_NO\ D/\ &C^U8?[K_D/\: +M%4O[5A_NO^0_
MQH_M6'^Z_P"0_P : +M%4O[5A_NO^0_QH_M6'^Z_Y#_&@"[15+^U8?[K_D/\
M:/[5A_NO^0_QH NT52_M6'^Z_P"0_P :/[5A_NO^0_QH NT52_M6'^Z_Y#_&
MC^U8?[K_ )#_ !H NT52_M6'^Z_Y#_&C^U8?[K_D/\: +M%4O[5A_NO^0_QH
M_M6'^Z_Y#_&@"[15+^U8?[K_ )#_ !H_M6'^Z_Y#_&@"[15+^U8?[K_D/\:/
M[5A_NO\ D/\ &@"[15+^U8?[K_D/\:/[5A_NO^0_QH ^'?\ @J)_S3/_ +B?
M_MI7PA7W3_P4\NDNO^%:[ PV_P!I9S_VZ5\+5^]<,?\ (HH_]O?^E2/Q/B+_
M )&E7_MW_P!)04445]2?-A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!^E?\ P33_ .2%:[_V,D__ *2VM?6=?(G_  3;OH[;X&ZX
MK!B3XCG/ _Z=K6OJ[^U8?[K_ )#_ !K^>L^_Y&=?_$?NN2?\BZCZ%VBJ7]JP
M_P!U_P A_C1_:L/]U_R'^->">V7:*I?VK#_=?\A_C1_:L/\ =?\ (?XT 4/'
M7_(D^(?^P=<?^BFKX]KZW\;:E%)X,U]0'RVGW ' _P">;>]?)%?S=XJ?[[A?
M\+_,_6>"_P#=ZWJOR"BBBOPT_1 HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH W/ O_([>'O\ L(V__HU:^PJ^._!+"/QGH#'HNH6Y
M/_?Q:^M_[5A_NO\ D/\ &OZ2\*_]RQ/^)?D?D_&G^\4?1_F7:*I?VK#_ '7_
M "'^-']JP_W7_(?XU^XGYT7:*I?VK#_=?\A_C1_:L/\ =?\ (?XT 7:*I?VK
M#_=?\A_C1_:L/]U_R'^- %VBJ7]JP_W7_(?XT?VK#_=?\A_C0!=HJE_:L/\
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M](K^NA]UT5';R&:WCD(P64-^8J2N#8[XR4DFNH4444B@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^3
M/^"EG_)"M"_[&2#_ -);JOK.ODS_ (*6?\D*T+_L9(/_ $ENJ][(?^1G0_Q'
MB9W_ ,BZMZ'YJ4445_0I^%!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5]9_\$T_^2ZZ[_V+<_\ Z56M?)E?6?\ P33_ .2ZZ[_V
M+<__ *56M>!GW_(LK^A[>2?\C&CZGZ5T445_/9^ZA1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!\(?\%1/^:9_P#<3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7
M[UPQ_P BBC_V]_Z5(_$^(O\ D:5?^W?_ $E!1117U)\V%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'W?_P $N_\ FIG_ '#/_;NO
MN^OA#_@EW_S4S_N&?^W=?=]?@O$__(WK?]N_^DQ/VSAW_D5TO^WO_2F%%%%?
M+'T@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% &YX%_P"1V\/?]A&W_P#1JU]A5\>^!?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "ODS_@I9_R0K0O^QD@_]);JOK.ODS_@I9_R0K0O
M^QD@_P#26ZKWLA_Y&=#_ !'B9W_R+JWH?FI1117]"GX4%%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=A\OG4QCPM1\O+?F?91W?^7R/2Q&94Z>!6,IJ_,ERKJW+X5_G\S[&T?6M/\
M$6FP:CI5_;:GI\X+17=G,LL4@!()5U)!Y!'![5=K/T#0[+PQH=AI&FP+;:?8
MP);P0KT5%4 #\A6A7ESY>9\FW0]6GS\BY]^MMKA1114%A1110 4444 %%%%
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M)/ !<$GIFOH^G4I5*3M4C8FE6IUE>G),****R-@HHHH **** "BBB@ HHHH
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M=0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<._\BNE_V]_Z4PHHHKY8^D"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ8FT:>(Z?CY^?]>9ZV"IX1.57#=?P\O+O_P+!1117GGJ!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:6OH3_@I1^RG_8.H2_%GPM9A=.O'"Z]:PCB&9CA;D#LKG ;_ &L'^(FOGO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'PA_P %1/\ FF?_ '$__;2OA"ON_P#X*B?\
MTS_[B?\ [:5\(5^]<,?\BBC_ -O?^E2/Q/B+_D:5?^W?_24%%%%?4GS84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?I7_P $T_\
MDA6N_P#8R3_^DMK7UG7R9_P33_Y(5KO_ &,D_P#Z2VM?6=?SUGW_ ",Z_P#B
M/W7)/^1=1] HHHKP3VPHHHH P_'7_(D^(?\ L'7'_HIJ^/:^PO'7_(D^(?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?_MI7PA7W?\ \%1/^:9_]Q/_ -M*^$*_>N&/^111_P"WO_2I'XGQ%_R-*O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4 %?)G_!2S_DA6A?]C)!_P"DMU7UG7R9_P %+/\ DA6A?]C)!_Z2W5>]D/\
MR,Z'^(\3._\ D75O0_-2BBBOZ%/PH**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "OK/\ X)I_\EUUW_L6Y_\ TJM:^3*^L_\ @FG_
M ,EUUW_L6Y__ $JM:\#/O^197]#V\D_Y&-'U/TKHHHK^>S]U"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#X0_P""HG_-,_\ N)_^VE?"%?=__!43_FF?_<3_
M /;2OA"OWKAC_D44?^WO_2I'XGQ%_P C2K_V[_Z2@HHHKZD^;"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[O_X)=_\ -3/^X9_[
M=U]WU\(?\$N_^:F?]PS_ -NZ^[Z_!>)_^1O6_P"W?_28G[9P[_R*Z7_;W_I3
M"BBBOECZ0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'_Y_2^Y!_K?7_P"?2^]G[1?\+\^&/_11O"7_ (/+7_XY1_POSX8_]%&\)?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG@VRLC.%QN*"6S7<!N7..F1ZU^X/A6]FU+POH]W<OYEQ<6<,LCX W,R DX'
MY/:ORN_X+C?\C)\(?^O34_\ T.VK]2_ _P#R)7A__L'V_P#Z+6M:,O:4)2:U
MYK?^E+]#&JN2M&*>EK_^D_YFW7YZ_P#!0C_@HYJ7P5\1'X8?"I8;OQVP5=0U
M1H1<#3F< QPQ1$%9)R&!^8%5! VL3\OWGXP\10^$/"6MZ[<#-OI=E->R#U6.
M-G/Z+7Y%_P#!*/X<CX^?M,>.?B[XNC&IWFBO]OC,XW*=1NY)")>>I14EQZ%E
M/85E&/MJWL[VBE=_I]^OSMW-I2]E2=2UVW9?J_EI_2.2NO!7_!0*QTMO'TMY
M\1A:JOVTP+KJLX7[W.FB8L/^N?D^VVOK#_@G5_P4:U#X]ZU_PK;XF&VB\;+$
MTFFZM#&L*ZF$&7CDC&%68 %OE 5@&^52OS?H17XK_P#!2CX?C]EK]LCPM\2_
M!T*Z7'K#Q:_'%;_NT6^@F'V@ #H'_=LP[F1_6M85(QJQIS^"6GIUO^'EM;KI
MG*G*=.4X_%'7U\C]J**HZ#JT6OZ'IVJ6_P#J+VWCN8_]UU##]#5ZB47%N+W0
MHR4HJ2V9X_\ M3_M+^'/V5OA1>^,=>4WEP6^S:9I<;[)+ZZ()6,'!VK@%F;!
MVJ#P3@'\I['XI?ML_MN7M]XA\"W/B2RT&"9EBC\-:@FAV$/K$DS2Q&9AWW.[
M#/;(%=M_P5*U;4_C?^VA\/?A#9W#QVMLEG8QJ,D)<WLPWR$>T?D_]\FOUB^'
M_@31OACX)T7PIX>LTL-%TBU2TM8$'15&,GU8G))/)))/6LJ454INO+NTEZ;O
M^N_WZU).$E1CV3;]=E_7^5OR ^%?[>G[0'['OQ1MO!WQU@UC7=$W)]LL]> E
MOX86)'VBVNLGS@.?O,ZMM*@J>1^QOAKQ)IOC#P]INN:->1:AI.I6\=W:74)R
MDL3J&5@?0@BOD?\ X*I? G3OBM^S#K/B1;2,^(_!H_M2SNPHW^0"!<Q$XSM*
M9?']Z-37._\ !'CXG7?C7]F&[\/7TK32>%=7ELK=G8L1;R*LR#GL&>0 =@!6
MU.?M8SC/XH6?JGI^?Y/R,:D?9RA*/PRNO1K7\OS7F?=E%%%06%%%% !1110
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MM*^$*_>N&/\ D44?^WO_ $J1^)\1?\C2K_V[_P"DH****^I/FPHHHH ****
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M*_>C\3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MK[O_ ."7?_-3/^X9_P"W=?"%?=__  2[_P":F?\ <,_]NZ^6XG_Y%%;_ +=_
M]*B?2<._\C2E_P!O?^DL^[Z***_!3]L"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#X0_X*B?\TS_ .XG_P"VE?"%?=__  5$_P":9_\ <3_]M*^$*_>N&/\
MD44?^WO_ $J1^)\1?\C2K_V[_P"DH****^I/FPHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH _2O\ X)I_\D*UW_L9)_\ TEM:^LZ^
M3/\ @FG_ ,D*UW_L9)__ $EM:^LZ_GK/O^1G7_Q'[KDG_(NH^@4445X)[844
M44 8?CK_ )$GQ#_V#KC_ -%-7Q[7V%XZ_P"1)\0_]@ZX_P#135\>U_-WBI_O
MN%_PO\S]9X+_ -WK>J_(****_#3]$"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#<\"_\CMX>_P"PC;_^C5K["KX]\"_\CMX>_P"P
MC;_^C5K["K^DO"O_ '+$_P")?D?D_&G^\4?1_F%%%%?N)^=!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7XF_M!7"^ OVUO$^HZ_9-J5G9>*EU*>T
M<#_2+?S5F"<\$&,@>E?ME7R3^VC^PW'^T5<0^*?#%[;Z1XTMX1!(MWD6]_&O
MW0[*"4=<X#8.1P1T([\!7CAL2JDMK-?D_P!#S<RP\L5A72AO=/UM=6_$WO$W
M[?GP*_X0*]OQXICU?S[5U715LYOM$Y*D>2R,@"YZ$L0OOBOAS_@G/\0?#/P[
M^,?BO7?$NOZ?X;T[_A'[A(DOK@1+,YFA<1H6(#, APO4]A69I'_!-?XZ:CKB
MV-SX?T_2K0OM.I76JV[0 ?WML;-)C_@&:]R^(W_!*.>+P3H?_"$^)8+GQ3;1
ME=4_M;=%;WK$D[HBH8QE?NA2"" "2#G/I\F#P\9Q53^(K=[*S_S_ *U/&E+'
M8J4'*G;V;OVN]--?3I_D?._[!][;?\-B>#+N:YAM8&N+PJUQ($#,]M,J*,]6
M)8 #N37:?\%1/%FG>(OVBK6QL)X[B71]'AL[MHV#;)C))(4..X5UR/>NGU7_
M ()6^,]-^$]UJ46LV6I^/8YQ(FC6DF+:2W"G*+*ZKF8G!&<+P1GG->;_  3_
M & ?BAX_\>65EXE\,WWA3PY!.#J.H:BHC/E@Y98ESEV89 *@J,Y)KLY\-6KP
MJ^T2]FK?GK^+^9R2CBZ="I3E2;=5W_&]OPOZ'ZF_LZ036OP ^&T5QN\]/#FG
MA]V<Y^SI7HE0V=G#I]G!:V\:Q6\"+%'&O1548 'T J:OEZT_:5)375MGU]"F
MZ5*%-]$E]R"BBBL3<**** "BBB@#\F?^"XW_ ",GPA_Z]-3_ /0[:OU+\#_\
MB5X?_P"P?;_^BUK\M/\ @N-_R,GPA_Z]-3_]#MJ_4OP/_P B5X?_ .P?;_\
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M4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VB@"EYU[_ ,\4_/\
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M4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VB@"EYU[_ ,\4_/\
M^O1YU[_SQ3\__KU=HH I>=>_\\4_/_Z]'G7O_/%/S_\ KU=HH I>=>_\\4_/
M_P"O1YU[_P \4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VB@#X
M*_X*>/.W_"M?.0)_R$L8_P"W3WKX6K[O_P""HG_-,_\ N)_^VE?"%?O7#'_(
MHH_]O?\ I4C\3XB_Y&E7_MW_ -)04445]2?-A1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!]T_P#!,-YU_P"%E>2@?_D&YS_V]^]?
M='G7O_/%/S_^O7P[_P $N_\ FIG_ '#/_;NON^OP7B?_ )&];_MW_P!)B?MG
M#O\ R*Z7_;W_ *4REYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5VBOECZ0I>=>_\
M\4_/_P"O1YU[_P \4_/_ .O5VB@"EYU[_P \4_/_ .O1YU[_ ,\4_/\ ^O5V
MB@"EYU[_ ,\4_/\ ^O1YU[_SQ3\__KU=HH I>=>_\\4_/_Z]'G7O_/%/S_\
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M?^>*?G_]>CSKW_GBGY__ %ZNT4 4O.O?^>*?G_\ 7KX7_P""GCSM_P *U\Y
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M\Z]_YXI^?_UZNT4 4O.O?^>*?G_]>CSKW_GBGY__ %ZNT4 4O.O?^>*?G_\
M7H\Z]_YXI^?_ ->KM% %+SKW_GBGY_\ UZ/.O?\ GBGY_P#UZNT4 4O.O?\
MGBGY_P#UZ/.O?^>*?G_]>KM% %+SKW_GBGY__7H\Z]_YXI^?_P!>KM% %+SK
MW_GBGY__ %Z/.O?^>*?G_P#7J[10!2\Z]_YXI^?_ ->CSKW_ )XI^?\ ]>KM
M% %+SKW_ )XI^?\ ]>CSKW_GBGY__7J[10!2\Z]_YXI^?_UZ/.O?^>*?G_\
M7J[10!2\Z]_YXI^?_P!>CSKW_GBGY_\ UZNT4 4O.O?^>*?G_P#7H\Z]_P">
M*?G_ /7J[10!2\Z]_P">*?G_ /7H\Z]_YXI^?_UZNT4 4O.O?^>*?G_]>CSK
MW_GBGY__ %ZNT4 4O.O?^>*?G_\ 7H\Z]_YXI^?_ ->KM% %+SKW_GBGY_\
MUZ/.O?\ GBGY_P#UZNT4 4O.O?\ GBGY_P#UZ/.O?^>*?G_]>KM% %+SKW_G
MBGY__7H\Z]_YXI^?_P!>KM% %+SKW_GBGY__ %Z/.O?^>*?G_P#7J[10!2\Z
M]_YXI^?_ ->CSKW_ )XI^?\ ]>KM% %+SKW_ )XI^?\ ]>CSKW_GBGY__7J[
M10!2\Z]_YXI^?_UZ/.O?^>*?G_\ 7J[10!2\Z]_YXI^?_P!>CSKW_GBGY_\
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M>=>_\\4_/_Z]7:* .8\;2W9\&:^&A4+_ &?<9.>WEM[U\D5]A>.O^1)\0_\
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M_/\ ^O5J(NT:EQM?N!3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
M)_CY^TYX%_9QTFWNO%E_*U[= FTTJP02W=P!U8*2 JC^\Q [9SQ7K%?B;^UY
MK>M?%K]K?Q98Q+)>7HU<:%IUKD<"-Q"B+V&Y\GZN:[,'A_K5=4KV5K_E_F<&
M.Q/U/#NJE=W27J[_ .3/J;5?^"O&GPW3KIOPPN;NVS\LEUK:P.1[JL#@?]]&
MJ?\ P]\_ZI-_Y<G_ -R5\V?M+?L:Z]^S'X2\+ZOK>N66JW.L32P36UC$XCM7
M558 2-@OD%OX5QM[YKLM-_X)X^(/%WP"TKXD^$/$]KXAN;VP6_.A&T,$@ !\
MR-)?,8.ZL",$+G!Z'BO;]CE\:?M7\-[7UW_KKL?/>WS257V2^*U[6CM_73<^
MR/V4_P!O'_AISXBWOA7_ (0?_A&OLVFR:C]K_M?[5NV21)LV>0F,^9G.>W3F
MOK&OS+_X)26_@S_A-O$DTDVH6_C^*Q>)+>69/LD]DTD9<HFP,)$=$SEB,,,#
MKC]-*\O,*-.C54*:LK'LY96JUZ#G5E=W_P @HHHKS#UPHHHH **** "BBB@#
MY,_;D_8+_P"&SM2\(7?_  G/_"'_ /"/Q746S^R/MWG^<T1SGSXMN/+]\Y[8
MKZET/3?[%T73]/\ ,\[[);QP>9MV[MJA<XR<9QTS5ZBB/N1<([-W^>O^;"7O
M24WNM/R_R05\X?MA?L.>"_VOM$M6U2>7P_XMT^-H]/\ $-G$)'1"<^5-&2/-
MCSSMRI!SM898'Z/HJ914MRHR<=C\;(?^")?Q1;Q (9?'?A!-"\S'VU/M37.S
M/WO(\H+G'\/FX]Z_1/\ 9(_8O\$?LB^&9[;0?,UCQ'?*HU+Q#>1JL]QCG8BC
M/E1 \A 3[EB :^@**TC)Q5D9RBI.[.*^-'PET3XZ?"_Q#X$\1><ND:U;^1+)
M;,%EB8,'21"01N5U5AD$9'(-?/?[%O\ P3N\/?L?^)-<\2#Q/<>+_$&H0&R@
MNI;(6D=K;%E=D"!WW.Q5<N2.%  '.?KFBIC[DG*.C:L5+WHJ$MD[_,Y[X@>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/A#_ (*B?\TS_P"XG_[:5\(5]W_\%1/^:9_]Q/\ ]M*^$*_>N&/^111_[>_]
M*D?B?$7_ "-*O_;O_I*"BBBOJ3YL**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /N__@EW_P U,_[AG_MW7W?7PA_P2[_YJ9_W#/\
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M *2@HHHKZD^;"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7R9_P4L_Y(5H7_ &,D'_I+=5]9U\F?\%+/^2%:%_V,D'_I+=5[
MV0_\C.A_B/$SO_D75O0_-2BBBOZ%/PH**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "OK/_@FG_P EUUW_ +%N?_TJM:^3*^L_^":?
M_)===_[%N?\ ]*K6O S[_D65_0]O)/\ D8T?4_2NBBBOY[/W4**** "BBB@
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M44 %%%% !1110 4444 %%%% !1110 5]W_\ !+O_ )J9_P!PS_V[KX0K[O\
M^"7?_-3/^X9_[=U\MQ/_ ,BBM_V[_P"E1/I.'?\ D:4O^WO_ $EGW?1117X*
M?M@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ?"'_  5$_P":9_\ <3_]M*^$
M*^[_ /@J)_S3/_N)_P#MI7PA7[UPQ_R**/\ V]_Z5(_$^(O^1I5_[=_])044
M45]2?-A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M^E?_  33_P"2%:[_ -C)/_Z2VM?6=?)G_!-/_DA6N_\ 8R3_ /I+:U]9U_/6
M??\ (SK_ .(_=<D_Y%U'T"BBBO!/;"BBB@##\=?\B3XA_P"P=<?^BFKX]K["
M\=?\B3XA_P"P=<?^BFKX]K^;O%3_ 'W"_P"%_F?K/!?^[UO5?D%%%%?AI^B!
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!N>!?^1V
M\/?]A&W_ /1JU]A5\>^!?^1V\/?]A&W_ /1JU]A5_27A7_N6)_Q+\C\GXT_W
MBCZ/\PHHHK]Q/SH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \?^('
M[7/PD^%?BJ[\->*?&$6DZW:!&FM&LKF0H'0.OS)&RG*L#P>]?E'^VE\1/#WQ
M2_:0\1^)?"VI+JNAW26@ANUB>,.4MXT;Y756&&4CD=J^KOVPOV#?B5\9?C9K
M_C?PS/H4^G7T=NL5K<7CQ7 ,<"1MD&/8,E#CYNA'2O@CXG?"_P 1_!_QG>>%
M?%-BMAK5J$:2%)4E7:ZAE(920001W]NM?1Y53HQG3K1E^\MM]U]-SY;-JV(Y
M9TG#]WIK_7F?K[:_M]? 2.UA5OB# &5%!']G7GI_UQK.\6?\%"/@18>&]1FM
M_%O]MSB!Q'IUMIUT'N&*G" O&JC/3+$"OS;3]A[XYR(K+\.M2*L,@^=!_P#'
M*MZ?^P7\>=2F$<?P]NHSW:XO;6)1^+2BE+ X*5TZN_FB:>88^"7+1V\I&Q_P
M3SOKB/\ :]\)&T7RH;A;Y)8UZ",VLK8^@(7\J_9JOCO]A_\ 8=NOV?=0N?%_
MB^[M;SQ;<6YMK>ULV+PV,38+Y<@;I&P <# &0"<YK[$KDS.M3K58^S=TE;\6
M_P!3T,IH5:-*4JJLY.]ODOZ^X****\@]L**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^3/^"EG_)"M"_[&2#_
M -);JOK.ODS_ (*6?\D*T+_L9(/_ $ENJ][(?^1G0_Q'B9W_ ,BZMZ'YJ444
M5_0I^%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5]9_\$T_^2ZZ[_V+<_\ Z56M?)E?6?\ P33_ .2ZZ[_V+<__ *56M>!GW_(L
MK^A[>2?\C&CZGZ5T445_/9^ZA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(
M?\%1/^:9_P#<3_\ ;2OA"ON__@J)_P TS_[B?_MI7PA7[UPQ_P BBC_V]_Z5
M(_$^(O\ D:5?^W?_ $E!1117U)\V%%%% !1110 4444 %%%% !1110 4444
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M!LO_ ,56'11_:.-_Y_2_\"?^8?5</_S[7W(W/^$Z\2?]#!JO_@;+_P#%4?\
M"=>)/^A@U7_P-E_^*K#HH_M'&_\ /Z7_ ($_\P^JX?\ Y]K[D;G_  G7B3_H
M8-5_\#9?_BJ/^$Z\2?\ 0P:K_P"!LO\ \56'11_:.-_Y_2_\"?\ F'U7#_\
M/M?<C<_X3KQ)_P!#!JO_ (&R_P#Q5'_"=>)/^A@U7_P-E_\ BJPZ*/[1QO\
MS^E_X$_\P^JX?_GVON1N?\)UXD_Z&#5?_ V7_P"*H_X3KQ)_T,&J_P#@;+_\
M56'11_:.-_Y_2_\  G_F'U7#_P#/M?<C<_X3KQ)_T,&J_P#@;+_\51_PG7B3
M_H8-5_\  V7_ .*K#HH_M'&_\_I?^!/_ ##ZKA_^?:^Y&Y_PG7B3_H8-5_\
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M10 4444 %%%% !1110 4444 %?"'_!43_FF?_<3_ /;2ON^OA#_@J)_S3/\
M[B?_ +:5]3PQ_P C>C_V]_Z3(^;XB_Y%=7_MW_TI'PA1117[T?B84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?=_P#P2[_YJ9_W
M#/\ V[KX0K[O_P""7?\ S4S_ +AG_MW7RW$__(HK?]N_^E1/I.'?^1I2_P"W
MO_26?=]%%%?@I^V!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\(?\%1/^:9_
M]Q/_ -M*^$*^[_\ @J)_S3/_ +B?_MI7PA7[UPQ_R**/_;W_ *5(_$^(O^1I
M5_[=_P#24%%%%?4GS84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?I7_P33_Y(5KO_8R3_P#I+:U]9U\F?\$T_P#DA6N_]C)/_P"D
MMK7UG7\]9]_R,Z_^(_=<D_Y%U'T"BBBO!/;"BBB@##\=?\B3XA_[!UQ_Z*:O
MCVOL+QU_R)/B'_L'7'_HIJ^/:_F[Q4_WW"_X7^9^L\%_[O6]5^04445^&GZ(
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &YX%_Y'
M;P]_V$;?_P!&K7V%7Q[X%_Y';P]_V$;?_P!&K7V%7])>%?\ N6)_Q+\C\GXT
M_P!XH^C_ #"BBBOW$_.@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X
M0_X*B?\ -,_^XG_[:5\(5]W_ /!43_FF?_<3_P#;2OA"OWKAC_D44?\ M[_T
MJ1^)\1?\C2K_ -N_^DH****^I/FPHHHH **** "BBB@ HHHH **** "BBB@
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M2\*_]RQ/^)?D?D_&G^\4?1_F%%%%?N)^=!1110 4444 %%%% !1110 4444
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M#B9XJFYU(\K3M^04445PGH!1110 4444 %%%% !1110 4444 %%%% !1110
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M?\BBC_V]_P"E2/Q/B+_D:5?^W?\ TE!1117U)\V%%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?"'_!4
M3_FF?_<3_P#;2ON^OA#_ (*B?\TS_P"XG_[:5]3PQ_R-Z/\ V]_Z3(^;XB_Y
M%=7_ +=_]*1\(4445^]'XF%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7W?_ ,$N_P#FIG_<,_\ ;NOA"ON__@EW_P U,_[AG_MW
M7RW$_P#R**W_ &[_ .E1/I.'?^1I2_[>_P#26?=]%%%?@I^V!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9J":!I%B'PGG%E1V]-S2D@GT51VKJPM!XJLJ2]?E_31QXS$K"4'6DK]%ZO\
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MWUI#K6DW%LS;K>[A:,LO=67&1^!KY8^*MU:7GQ UF6R*M 90-R="X4!R/^!
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MG@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^$/\ @J)_S3/_ +B?
M_MI7PA7W?_P5$_YIG_W$_P#VTKX0K]ZX8_Y%%'_M[_TJ1^)\1?\ (TJ_]N_^
MDH****^I/FPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH ^[_^"7?_ #4S_N&?^W=?=]?"'_!+O_FIG_<,_P#;NON^OP7B?_D;UO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %?C3^V=X1USX$_M<:GXCMHVB%YJ4?B32;IE)1V+B0_4K*&!'ICUK]EJ\
MY^.7P#\(_M">$3H/BRR:18R9+2^MR$N;.0C&^-L'\5(*G R#@5U83$/"UU52
MOT?I_2.+&X98R@Z-[/=>J_X=_F?E_P#MG_M:Z#^U#X5\ -I^EWNCZUI)NCJ5
MK<!6B5I%AP8I <NN4;J%/M70^ ?V\+/X2_LDZ9\./#>F7DOC/RKR"74I@J6U
MHLT\KATY+.X5Q@$* 3G)Q@]!XT_X)->.;/5)/^$5\7:%JNFDY1M5$UI.H]"J
M)(IQZY&?05:\ _\ !)GQ9=:G&WC3QCI&FZ:K O'HBRW4[C/*YD2-4./XOFQZ
M&O>4L!*A['F]R][:^?SMJ?-N.91KJKR^^E:^GW]CD?\ @E_\,KWQ3\>Y/%K0
M-_9?AJSE=K@CY3<3(8D3/KM:1O\ @/O7ZTUQOPE^$?ACX)^"[3POX3L!8Z;
M2[,QW2SR'&Z61_XG.!ST      '95Y&.Q*Q57FCLE9?U\SW<NPCP='EE\3=V
M%%%%><>H%%%% !1110 4444 %%%% !4<\\=K#)--(L4,:EWDD8*JJ!DDD] !
M4E>"_MV?$G_A5/[)GQ)UM)C#=R:6^G6K*<,)KDB!2/<>9N_X#656;ITW);K\
M^AK2A[2:B^ITO_#6/P0_Z+)\/_\ PJ+'_P".U9TW]I[X.:UJ-KI^G_%KP-?7
M]U*L%O:VWB2SDEFD8A51%64EF)(  Y)-?D)^QU_P3%O?VK?A(WCNY\??\(=;
M27\UG:VO]B_;3.D84-+N^T1X^<LN,'[AYKZ6^&W_  1A_P"%>_$3POXI_P"%
MP_VA_8FJ6NI?9/\ A&/+\[R95DV;_MAVYVXS@XST-=2@HS4:FBT^Y_\  .;F
MYHMPUW^]?\$_3&BBBLC02OG[X@?M^_L^_#'7I=&U_P")NF)J4+%)8=.@N-0$
M3 D%7:VCD56!!!4D$=Z^6O\ @K+^UMKO@_\ LOX*^!;JXMM:UR!9]8N+$L+@
M02,4BM8RO(,A#%L<E=HZ.:P_@C_P19\/WW@.SOOBEXLURU\3W<2S/IOAUX(H
M;'(SY3O)%)YK#N5VC.0,@;C$.:HG-?"G;U?6WI_72]SY86B_B>OHO/\ K];?
MH=\+?C3X%^-FB-JW@7Q3IOB>QC($K6,P9X21D+)&</&2.S &NUK\*OC)\'?B
M+_P2W_:"\/>*O"^M3:IX?NG9[#4=OEQWT((\ZRND!(S@CV.5=<,N%_:KX4_$
M;2OB]\-_#?C316+:9KEC'>PJWWDW+DHW^TK94^ZFMERSI^TAM>S\G_7];-XO
MFA/V<^JNO-?U_6]NKHHHJ"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*^<SC@; YKBWC:=25&I+XN5Z/Y=WUUL^JN>EE_$>)P5!8>45.*VOT/G[X>?
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M445]0>(%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS _]Q/\ VP_3^"?^8C_MW_VX****_GT_3@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *^WJ^(:^WJ_H+PG_YCO\ N'_[>?F/&W_,
M/_V]_P"VA1117] GY@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %?"'_!43_FF?\ W$__ &TK[OKX0_X*B?\
M-,_^XG_[:5]3PQ_R-Z/_ &]_Z3(^;XB_Y%=7_MW_ -*1\(4445^]'XF%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7W?_P $N_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %[75>]D/_(SH?XCQ,[_ .1=6]#\W****_H4_"@HHHH **** "BBB@ HHHH
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MN_\ I2/A:BBBOWH_$PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\Q_A0!=HJE_947]]_P Q_A1_947]]_S'^% %VBJ7]E1?WW_,?X4?V5%_??\
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M\*/[*B_OO^8_PH NT52_LJ+^^_YC_"C^RHO[[_F/\* +M%4O[*B_OO\ F/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KZS_X)I_\
M)===_P"Q;G_]*K6ODROK/_@FG_R777?^Q;G_ /2JUKP,^_Y%E?T/;R3_ )&-
M'U/TKHHHK^>S]U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*_>C\3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *^3/^"EG_ "0K0O\ L9(/_26ZKZSKY,_X*6?\D*T+_L9(/_26
MZKWLA_Y&=#_$>)G?_(NK>A^:E%%%?T*?A04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?6?_  33_P"2ZZ[_ -BW/_Z56M?)E?6?
M_!-/_DNNN_\ 8MS_ /I5:UX&??\ (LK^A[>2?\C&CZGZ5T445_/9^ZA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!\(?\%1/^:9_]Q/\ ]M*^$*^[_P#@J)_S
M3/\ [B?_ +:5\(5^]<,?\BBC_P!O?^E2/Q/B+_D:5?\ MW_TE!1117U)\V%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'W?\ \$N_
M^:F?]PS_ -NZ^[Z^$/\ @EW_ ,U,_P"X9_[=U]WU^"\3_P#(WK?]N_\ I,3]
MLX=_Y%=+_M[_ -*84445\L?2!1110 5\0U]O5\0U_/WBQ_S _P#<3_VP_3^"
M?^8C_MW_ -N"BBBOY]/TX**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "OMZOB&OMZOZ"\)_\ F._[A_\ MY^8\;?\P_\ V]_[:%%%
M%?T"?F 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\PQ=2BL/.HW!=+Z!1117L' %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/:_F[Q4_WW"_X7^9^L\%_P"[UO5?D%%%%?AI^B!1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ KY,_X*6?\D*T+_L9(/\ TENJ^LZ^3/\
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M>_\ 26?=]%%%?@I^V!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$SO_ )%U;T/S4HHHK^A3\*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KZS_ .":?_)===_[%N?_ -*K6ODROK/_ ()I_P#)===_
M[%N?_P!*K6O S[_D65_0]O)/^1C1]3]*Z***_GL_=0HHHH **** "BOFWQ7\
M7?%NF^*-8L[;5O+M[>\FBB3[-"=JJY &2F3P.]9?_"ZO&?\ T&?_ "5A_P#B
M*_)*WB9D]"K*E*E5O%M;1Z:?SGV]/A''5(*:G"S5]W_\B?4U%?+/_"ZO&?\
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MIJ*^6?\ A=7C/_H,_P#DK#_\11_PNKQG_P!!G_R5A_\ B*/^(HY-_P ^JO\
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MG_<,_P#;NON^OP7B?_D;UO\ MW_TF)^V<._\BNE_V]_Z4PHHHKY8^D"BBB@
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M*** "BBB@ K[O_X)=_\ -3/^X9_[=U\(5]W_ /!+O_FIG_<,_P#;NOEN)_\
MD45O^W?_ $J)])P[_P C2E_V]_Z2S[OHHHK\%/VP**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /A#_@J)_P TS_[B?_MI7PA7W?\ \%1/^:9_]Q/_ -M*^$*_
M>N&/^111_P"WO_2I'XGQ%_R-*O\ V[_Z2@HHHKZD^;"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#]*_^":?_ "0K7?\ L9)__26U
MKZSKY,_X)I_\D*UW_L9)_P#TEM:^LZ_GK/O^1G7_ ,1^ZY)_R+J/H%%%%>">
MV%%%% &'XZ_Y$GQ#_P!@ZX_]%-7Q[7V%XZ_Y$GQ#_P!@ZX_]%-7Q[7\W>*G^
M^X7_  O\S]9X+_W>MZK\@HHHK\-/T0**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** -SP+_ ,CMX>_["-O_ .C5K["KX]\"_P#([>'O
M^PC;_P#HU:^PJ_I+PK_W+$_XE^1^3\:?[Q1]'^84445^XGYT%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 ?D!_P4B^,6H^/OCY?^&!<.-"\+!;2"V#
M?(T[(K2RD?WLD)[!/<UD_#7_ ()W_%SXG^";+Q19PZ/I5C?1"XM(-5NWCGGB
M(RKA5C8*&'3<0>0>AS7FW[4#M+^TE\2B[%C_ ,)%>C+'L)F 'Y5^W>C^)O#=
MAI-C;0:QID4$,"1QQK=1@*H4  <]@*^C]M+!X"BZ>\E^B;^]L^4^KQQV8UE5
M>D6U]SLOP1^)7A;6O''[(7QUMKB\M;C1O$&AW*K>V#.-MS V"\9*G:Z.AX()
M'((Y K]RM#UBV\0Z+I^JV3^99WUO'=0/_>C=0RG\B*_*C_@J;-IM[\>- N].
MFM[DS:!%YTMO(K@L)Y@,D'J!BOT(_9Q\7:/'^S[\-EN-9L4G7PYIXD62Z0,&
M%NF003P:QQ4_K.#IXB2]Z]OS_P M/4Z,%3^J8ZKAH.\;)_E_G9^AZ[15"QU_
M3-4F,5GJ-I=R@;C'!.KL!ZX!Z<BK]>$?1A1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'PA_P5$_YIG_ -Q/_P!M*^$*^[_^"HG_ #3/
M_N)_^VE?"%?O7#'_ "**/_;W_I4C\3XB_P"1I5_[=_\ 24%%%%?4GS84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?I7_ ,$T_P#D
MA6N_]C)/_P"DMK7UG7R9_P $T_\ DA6N_P#8R3_^DMK7UG7\]9]_R,Z_^(_=
M<D_Y%U'T"BBBO!/;"BBB@##\=?\ (D^(?^P=<?\ HIJ^/:^PO'7_ ")/B'_L
M'7'_ **:OCVOYN\5/]]PO^%_F?K/!?\ N];U7Y!1117X:?H@4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ;G@7_D=O#W_ &$;?_T:
MM?85?'O@7_D=O#W_ &$;?_T:M?85?TEX5_[EB?\ $OR/R?C3_>*/H_S"BBBO
MW$_.@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\)OVGM.NY/VB_B6
MR6LS*WB&^(98R0?W[>U>8_V7>_\ /I/_ -^F_P *_HGHKW*.9NC2C3Y+\J2W
M[?(^=Q&3JO6G5Y[<S;V[N_<_G8_LN]_Y])_^_3?X4?V7>_\ /I/_ -^F_P *
M_HGHK;^V'_)^/_ ,/["7_/S\/^"?E%_P2LL[BW_:(UII8)(E_P"$;N!N="!_
MQ\6U?J[117EXO%?6IJ=K65OQ?^9[."PGU.FZ?->[O^"_R"BBBN$] **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *^3/^"EG_)"M"_[&2#_ -);JOK.ODS_ (*6?\D*T+_L9(/_ $ENJ][(?^1G
M0_Q'B9W_ ,BZMZ'YJ4445_0I^%!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5]9_\$T_^2ZZ[_V+<_\ Z56M?)E?6?\ P33_ .2Z
MZ[_V+<__ *56M>!GW_(LK^A[>2?\C&CZGZ5T445_/9^ZA1110 4444 ?'OCK
M_D=O$/\ V$;C_P!&M6'6YXZ_Y';Q#_V$;C_T:U8=?P9F/^^UO\4OS9_2>%_W
M>GZ+\@HHHKSSJ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#[>HHHK_0,_F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /A#_ (*B?\TS_P"XG_[:5\(5]W_\
M%1/^:9_]Q/\ ]M*^$*_>N&/^111_[>_]*D?B?$7_ "-*O_;O_I*"BBBOJ3YL
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /N__@EW
M_P U,_[AG_MW7W?7PA_P2[_YJ9_W#/\ V[K[OK\%XG_Y&];_ +=_])B?MG#O
M_(KI?]O?^E,****^6/I HHHH *^(:^WJ^(:_G[Q8_P"8'_N)_P"V'Z?P3_S$
M?]N_^W!1117\^GZ<%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7V]7Q#7V]7]!>$_P#S'?\ </\ ]O/S'C;_ )A_^WO_ &T****_
MH$_, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KX0_P""HG_-,_\ N)_^VE?=]?"'_!43_FF?_<3_ /;2OJ>&
M/^1O1_[>_P#29'S?$7_(KJ_]N_\ I2/A"BBBOWH_$PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *^[_^"7?_ #4S_N&?^W=?"%?=
M_P#P2[_YJ9_W#/\ V[KY;B?_ )%%;_MW_P!*B?2<._\ (TI?]O?^DL^[Z***
M_!3]L"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X0_X*B?\ -,_^XG_[:5\(
M5]W_ /!43_FF?_<3_P#;2OA"OWKAC_D44?\ M[_TJ1^)\1?\C2K_ -N_^DH*
M***^I/FPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M _2O_@FG_P D*UW_ +&2?_TEM:^LZ^3/^":?_)"M=_[&2?\ ]);6OK.OYZS[
M_D9U_P#$?NN2?\BZCZ!1117@GMA1110!A^.O^1)\0_\ 8.N/_135\>U]A>.O
M^1)\0_\ 8.N/_135\>U_-WBI_ON%_P +_,_6>"_]WK>J_(****_#3]$"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#<\"_P#([>'O
M^PC;_P#HU:^PJ^/? O\ R.WA[_L(V_\ Z-6OL*OZ2\*_]RQ/^)?D?D_&G^\4
M?1_F%%%%?N)^=!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /A#_@J)_P TS_[B?_MI7PA7W?\ \%1/^:9_]Q/_
M -M*^$*_>N&/^111_P"WO_2I'XGQ%_R-*O\ V[_Z2@HHHKZD^;"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[O\ ^"7?_-3/^X9_
M[=U]WU\(?\$N_P#FIG_<,_\ ;NON^OP7B?\ Y&];_MW_ -)B?MG#O_(KI?\
M;W_I3"BBBOECZ0**** "OB&OMZOB&OY^\6/^8'_N)_[8?I_!/_,1_P!N_P#M
MP4445_/I^G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5]O5\0U]O5_07A/_ ,QW_</_ -O/S'C;_F'_ .WO_;0HHHK^@3\P"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "OA#_@J)_P TS_[B?_MI7W?7PA_P5$_YIG_W$_\ VTKZGAC_ )&]'_M[
M_P!)D?-\1?\ (KJ_]N_^E(^$****_>C\3"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K[O\ ^"7?_-3/^X9_[=U\(5]W_P#!+O\
MYJ9_W#/_ &[KY;B?_D45O^W?_2HGTG#O_(TI?]O?^DL^[Z***_!3]L"BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\6/A9YV@:#=Z@J&TMG;_ (E6H+F6-X6))"/L8A?X60@<, /U&_97^-"?M!?
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M*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\
MX4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\
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M_/E_Y%3_ .*KA_U=SG_H"J_^"Y_Y'3_:F _Z"(?^!1_S,&BM[_A!=<_Y\O\
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MO^$%US_GR_\ (J?_ !5'_""ZY_SY?^14_P#BJ/\ 5W.?^@*K_P""Y_Y!_:F
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M*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\
MX4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\
MPH VJ*Q?^$PTC_G[_P#(3_X4?\)AI'_/W_Y"?_"@#:HK%_X3#2/^?O\ \A/_
M (4?\)AI'_/W_P"0G_PH VJ*Q?\ A,-(_P"?O_R$_P#A1_PF&D?\_?\ Y"?_
M  H VJ*Q?^$PTC_G[_\ (3_X4?\ "8:1_P _?_D)_P#"@#:HK%_X3#2/^?O_
M ,A/_A1_PF&D?\_?_D)_\* -JBL7_A,-(_Y^_P#R$_\ A1_PF&D?\_?_ )"?
M_"@#:HK%_P"$PTC_ )^__(3_ .%'_"8:1_S]_P#D)_\ "@#:HK%_X3#2/^?O
M_P A/_A1_P )AI'_ #]_^0G_ ,* -JBL7_A,-(_Y^_\ R$_^%'_"8:1_S]_^
M0G_PH VJ*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\
MG[_\A/\ X4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\
M/W_Y"?\ PH VJ*Q?^$PTC_G[_P#(3_X4?\)AI'_/W_Y"?_"@#XJ_X*B?\TS_
M .XG_P"VE?"%?HC^WI\/?$'QH_X0;_A#;#^V/[-^W?:_WT<'E^9]GV?ZUESG
MRWZ9QCGJ*^3/^&2_BO\ ]"K_ .5&T_\ CM?M?#N88.AE=*G5K1C)<VCDD_B?
M1L_(<^P.+K9C5G2I2DG;51;7PKR/(:*]>_X9+^*__0J_^5&T_P#CM'_#)?Q7
M_P"A5_\ *C:?_':^C_M7+_\ H(A_X%'_ #/G_P"S,=_SXG_X"_\ (\AHKU[_
M (9+^*__ $*O_E1M/_CM'_#)?Q7_ .A5_P#*C:?_ !VC^U<O_P"@B'_@4?\
M,/[,QW_/B?\ X"_\CR&BO7O^&2_BO_T*O_E1M/\ X[1_PR7\5_\ H5?_ "HV
MG_QVC^U<O_Z"(?\ @4?\P_LS'?\ /B?_ ("_\CR&BO7O^&2_BO\ ]"K_ .5&
MT_\ CM'_  R7\5_^A5_\J-I_\=H_M7+_ /H(A_X%'_,/[,QW_/B?_@+_ ,CR
M&BO7O^&2_BO_ -"K_P"5&T_^.T?\,E_%?_H5?_*C:?\ QVC^U<O_ .@B'_@4
M?\P_LS'?\^)_^ O_ "/(:*]>_P"&2_BO_P!"K_Y4;3_X[1_PR7\5_P#H5?\
MRHVG_P =H_M7+_\ H(A_X%'_ ##^S,=_SXG_ . O_(\AHKU[_ADOXK_]"K_Y
M4;3_ ..T?\,E_%?_ *%7_P J-I_\=H_M7+_^@B'_ (%'_,/[,QW_ #XG_P"
MO_(\AHKU[_ADOXK_ /0J_P#E1M/_ ([1_P ,E_%?_H5?_*C:?_':/[5R_P#Z
M"(?^!1_S#^S,=_SXG_X"_P#(\AHKU[_ADOXK_P#0J_\ E1M/_CM'_#)?Q7_Z
M%7_RHVG_ ,=H_M7+_P#H(A_X%'_,/[,QW_/B?_@+_P CR&BO7O\ ADOXK_\
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MI'_/W_Y"?_"@#:HK%_X3#2/^?O\ \A/_ (4?\)AI'_/W_P"0G_PH VJ*Q?\
MA,-(_P"?O_R$_P#A1_PF&D?\_?\ Y"?_  H VJ*Q?^$PTC_G[_\ (3_X4?\
M"8:1_P _?_D)_P#"@#:HK%_X3#2/^?O_ ,A/_A1_PF&D?\_?_D)_\* -JBL7
M_A,-(_Y^_P#R$_\ A1_PF&D?\_?_ )"?_"@#:HK%_P"$PTC_ )^__(3_ .%'
M_"8:1_S]_P#D)_\ "@#:HK%_X3#2/^?O_P A/_A1_P )AI'_ #]_^0G_ ,*
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MC^U<O_Z"(?\ @4?\P_LS'?\ /B?_ ("_\CR&BO7O^&2_BO\ ]"K_ .5&T_\
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M*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\ G[_\A/\
MX4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\ /W_Y"?\
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M0G_PH VJ*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\ D)_\* -JBL7_ (3#2/\
MG[_\A/\ X4?\)AI'_/W_ .0G_P * -JBL7_A,-(_Y^__ "$_^%'_  F&D?\
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M )4;3_X[1_PR7\5_^A5_\J-I_P#':/[5R_\ Z"(?^!1_S#^S,=_SXG_X"_\
M(\AHKU[_ (9+^*__ $*O_E1M/_CM'_#)?Q7_ .A5_P#*C:?_ !VC^U<O_P"@
MB'_@4?\ ,/[,QW_/B?\ X"_\CR&BO7O^&2_BO_T*O_E1M/\ X[1_PR7\5_\
MH5?_ "HVG_QVC^U<O_Z"(?\ @4?\P_LS'?\ /B?_ ("_\CR&BO7O^&2_BO\
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MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
M"KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_
M (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\K_A1_8NG_P#/A:_]^5_P
MJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\ "KM% %+^Q=/_ .?"U_[\
MK_A1_8NG_P#/A:_]^5_PJ[10!2_L73_^?"U_[\K_ (4?V+I__/A:_P#?E?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2@$H1CEHVZ/&?=6#*?I72U^,U_:>UG[;XKN_K?7\3]QP_LO8P]A\%E;TMI^
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MY5A\/UJ-S?Y1_ X'XE?"U_B!>6EP=6^PQVL118OL_F9).2<[Q[=NU?-VB?\
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MPM;RL?*\2ND\SJ>R\K^MM?Z[A1117W1\N%%%% !1110 4444 %%%% !1110
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MTN_\?7'B[^VY]5U@A[/^SO(V&;S),[_-;.-N,8[]J_2&OEW_ (*)?\D)L?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M**^K/ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME\,?BQKG_"-^'O$BZGJ5Q#(PM6L[F N@7YL-)&HSC)P#GKZ5\W_M9_L>^"_
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MZ?+:K;'[+#!Y8<2[O]4BYSM7KGI7L\38+&5D\5*4?90M97=]6E?:U_GL?/\
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MD;]LVXE^*G[07P\^&=J[&%6C:Y"_PF=QN;_@,2;OQ-?<+,%4LQP ,DFOAO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#(/HRJ#74T454ZDZCO-W]2(4X4U:"27D%%%%0:!1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=."3>]DE<UE5J5$E.3:7F%%%%;F04444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M**Y?XD?$SPW\(_"5UXF\6ZE_9.AVSQI+=>1+-M9V"*-L:LQRQ X%&[LA-V3;
MZ'445\Y_\/#?V?O^A_\ _*-J'_R/1_P\-_9^_P"A_P#_ "C:A_\ (]=/U:O_
M "/[F<OUO#_\_(_>CZ,HK@?A5\=_ WQMT74=6\%ZY_;6GZ?+Y-S-]DG@\M]N
M[&)44G@YX!KS)_\ @H5^S_&[*WC[#*<$?V-J'_R/4>QJN3@HNZZ6[FCQ%%14
MW-6>SNK'T717SG_P\-_9^_Z'_P#\HVH?_(]>@2?M(_#F'X1Q_$Y_$6/ TC^6
MNJ_8;GEO.,./*\OS/]8"OW??IS3E0JP5Y0:Z;/=[(4<11F[1FGUW6RW/3**^
M<_\ AX;^S]_T/_\ Y1M0_P#D>C_AX;^S]_T/_P#Y1M0_^1ZKZM7_ )']S(^M
MX?\ Y^1^]'T917!_"7XY>"/CII5]J7@?6_[;LK*86]Q+]DGM]DA4,!B5$)X(
MY (K5\??$[PG\+=(&I^+?$&G^'[)B0DE].$,C 9*HOWG..R@FL90E"7+)69T
M1J1G'GB[KN=/17@V@_MU? CQ)JB:?:?$2QBN'. U]:W-G%^,LT:(/Q:O=;>X
MBNH(YX)$FAD4.DD;!E92,@@CJ"*<Z<Z?QQ:]285J=3X))^C)****S-0HHHH
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MS\6ZCX9\2^,?[-US3W5+FU_LN]E\MBH<#='"RGY6!X)ZU@_\/#?V?O\ H?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !17 ?'#XV>'OV?_ -QXN\2K=S:?%-'
M;K;V"(\\LCG 5%9E4G&2<L.%-<7^SK^V)X'_ &F=3UC3O#%KK&G7VEPQW$D&
ML0PQ-+&S%=T?EROD*0 <XQO7KFM84IU(N<5=+<QG6ITYQISE9O8]SHHI"<#)
MX%9&PM%?,'Q._P""C'P=^&>N3Z3]NU+Q1>6[F.?_ (1^V2:*-AU'F22(C?\
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MU/>LS0OT5YS_ ,-)?"3_ **EX+_\*&T_^.5W]C?6^IV=O>6=Q%=VEQ&LL-Q
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MV;]%\1:?X2M]);^VVC:6ZU"W>66%HU<*8\2*O\9^\K#@5&!4Y8*HJ7Q7T_\
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MYZ<5@?LX_LI>+?VGGU]?"VHZ+8'11 ;C^V)YH]WF^9MV>7$^<>6V<XZCK7Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7X*?'Z%KG]H'X@0J0&D\17J#/3)N'%?O77X-?'#_DX[QQ_P!C
M-=_^E+5[>3KFQ=GV_5'@9Z^7!77\R_*1[KK7_!+7XR:7IK75I=^%]:E"[A:6
M.H2K*WL#-#&OYL*\-\)^+_B)^RC\5'FMA>>&?$FFR".\TZZ4B.=,Y,<J9Q)&
MPY!''1E.<&OW>@_U,?\ NC^5?G+_ ,%;O".GP7'@#Q-%"L>IW N;">15&98T
MV.F3_LEGQ_O5KALQJ3K1I54FI:?U^1S8G*Z4,.ZU%M2BK[_U\C[F^"GQ6TWX
MV?"_0/&6EKY4&I0;I+<G)@F4E9(R?]EPPSW ![U^'?QN_P"2S^/O^Q@U#_TI
MDK]'_P#@D_K%Q>?!#Q/I\I9H;/7F:+/0!X(B0/Q7/_ J_/KQQ:PWW[37B"VN
M(UF@F\7W$<D;C*LIO6!!'H16^%HJCF$Z4-K:?.S_ %.?'8B5;+*=6>]]?ES+
M]#[1_P""97[4'VB'_A47B2[_ 'L8>;P_<3-]Y>6DM<^W+K[;QV45]'?M^?\
M)I'C_P#ZY6O_ *5PU^;/[5_P'U?]E'XV17&ARW%KHMQ/_:?A_4HV.Z+:X;R]
MW]^)L#W&T]Z^O?B5^T18_M'_ /!/'QGK@,<'B"SBM+36+)#_ *JX%U#\ZC^X
MX^9?Q7)*FN3&4XUU3QE'9RC?UYE_PS\_4[LOJSP\Y8"ONMO-?UJO+T/"/^"4
MW_)Q6M_]BU<?^E-M7UK_ ,%--:_LK]EO4+;<5.HZI9VHP<9PYE(_\A5\E?\
M!*;_ ).*UO\ [%JX_P#2FVKW+_@K9K0M_AIX&TD, UUJTMR5SR1'"5_G**VS
M"/-C**_P_A)LQRR7+@*[_P 7_I)^9VCZC>^']2L-8LF>"XL[E)[>X4'Y948,
M"#Z@X-?OKX!^(FG^./A?HGC2.58M/U#3(]1=B>(@8]S@_P"Z=P/T-?DSX3^"
M_P#PE7[ _BCQC#!OU'1?%/VE65?F-L(88I1GT!D#?\ KT+X5?M+#P_\ \$\_
M'/AI[K;K=A=_V)9)NPWV>]W/D?0"Z^@45OF,?K%*48?%!I?^!)?JU]S.7*Y?
M5:L)3?NU(M_^ M_HF_FCY3^+_CBZ^*GQ0\6>+I0[C4K^6Z'R_P"KB+XC4^F%
MV+^%?HQ_P2:U_P"V?!_Q?HY8%K'6Q<!>X66! /PS$WZU\G_#7X+M=?L/_%7Q
M]+;[KA]2L;>T8CD0PS)YS#V)F _[9^U>U?\ !(W7O)\3?$712P_TBTM+Q5[_
M +MY$8_^15_2MJRA]5JX>'V$E]RB_P OR,,.Y_7*.*G_ ,O')_-N2_.S]&;/
M[2O_  3M^(_QD^.'BKQEHNM^%K72]5GCD@AO[NY290L*(=P6W90<H>C'C%?G
M_P".O!E[\/?&VN>%M1EMYM0TB]EL)Y+5F:)I(W*L4+ $KD<9 /M7]"5?A!^T
MY_R<E\2O^QCOO_1[5R93B)U*T,-+X4OR:1Z&<82E3I2Q*^*4M?GS-GTSX#_X
M)??%3P_XP\.ZW<:_X/>UL;^WO)$BO+HN4217( -L!G [D?6O;O\ @I/J7Q.U
M[0-"\#^ _#/B/5])U!9+G6+G0]-GN%=5($<#M&A !.YBN><+VK[1LO\ CS@_
MZYK_ "J>O+JXRI5J0E42:BV[?U\F>GA\#3I49*DVG-*[_KU:/S4_9Y_X)CV'
MCOX70:]\0M2\0^&_$%_YC0:5!"ENUFH8JOGI+&69CC=M&S (KYV^'/B?Q/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /C;_@JG_R;CI?_
M &,5M_Z(N*\K_P""0W_'Q\4_]S3/YW5?0W[?WP?\7?&SX*V&@^"](_MG5HM9
MANWM_M,,&(EBF4MNE=5ZNO&<\UP'_!.3]G?XA? :;Q\WCKP__88U1;$6G^FV
M]QYOEF??_J9'QC>O7&<\=Z]G"U(1P->$FDV]%W^$\+&4YRQ]"<8MI+5]-Y'V
M7JW_ ""KW_KB_P#Z":_!GX+?V-_PO3P;_P )%]A_L'^W;;[?_:FS[+Y'G+O\
MW?\ +LVYSNXQG-?O3J$3SZ?<QH-SO$RJ/4D$"OQGNO\ @GK^T!)<RLO@'*LY
M(/\ ;.G^O_7Q1E-2%.K4<VEI'?YBSJE.M1IJG%MW>VO1'Z*?\8D?]46_\I%>
MT?#O_A$/^$0L?^$$_L3_ (1;,GV3_A'?)^Q??;?Y?D_)]_=G'\6<\YK\?_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML/1CW K\5KC4/%/PHNO&'@ZY$VF27J_V7K&GS#AO*F609'JKQ@AAV)QPU?T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY%_X*8?%S_A ?@*?
M#EI-LU/Q5/\ 8]JD;A;)AYCCT/R)_P #KZZK\Y_VZOV=/CC^T!\9OMOA_P &
MO>^%=)M$L].E;5;*(2Y^>638\P9<L=O(!P@KHPT(U*T%-VCN[^7^;LO2YRXN
M<Z>'G*FFY6LK>>GX;^I\*_"_XL>*O@QXG_X2+P=J:Z1K/D/;BZ:UAN"(VQN
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M32OB)X/T?Q-HEP+G2M4MDNK>3OM89P1V8'(([$$5\$_M\?\ )XOP/_ZZ6/\
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MMG "R31HA)/3!Y[5[>#D9'(KFG3G3^.+7J=4*M.I?DDG;LQ:*Q/%WC;P_P"
M=)?5/$FMZ?H.G*<&YU&Y2%,^@+$9/L.:\:C_ &]_@+)JBV ^(=J)V?RP[6%V
ML.?>4P[ /?=CWHA3G4^"+?H%2K3I?Q))>KL?0%%4]'UFP\1:7:ZEI5[;ZEIU
MT@E@N[2598I4/1E9201[BL[Q-X\\->"FLE\0^(=*T%KZ3RK4:G>Q6QN'X^6/
M>PW'D<#)Y%1RN_+;4OF5N:^ANT5YO\5OVC/AQ\$'MH_&OBNTT6XN!NBM=DD\
M[+TW>5$K.%R"-Q&..M=7X?\ '&A>*/!]IXJT[4H9?#UU;?;(M0DS#&8<9WG>
M 5&/[P%/EER\]M._07/'G]G?WNW7[C=HKP34OV[_ (#Z7JS:=-\1+-[A6VE[
M>TNIX<^TR1&,CW#8KV'PCXTT#Q]HL6K^&]9L==TR0X6[T^X6:/(ZJ2I.".X/
M([U<J52*YI1:7H3&M3G+EC)-^IM445E>)O%FB>"])?5/$.L:?H6F(RH][J=T
MEO"K,<*"[D $GIS61KYFK17#^//C=X#^&7A6T\2>)?%.G:=HMXJO:70E\X72
MD!@85C#-*""#\@/!STJU\+_BQX4^,WAG_A(?!NK+K.C^<UO]H$$L.)% +*5D
M56! 8=N]7R3LY6T1G[2',H\RN]O,ZZBO/OBA^T!\._@ND?\ PF?BRPT2:1=Z
M6KLTMRZ]-PAC#2%?<+BJ/PN_::^%_P 9[QK/P?XQL=5OU!/V)UDMKA@.25BF
M5'8#N0"!3C3G*//&+:[BE5IQDH2DDWTOJ>GT45S6D_$SP?K]MJUQI?BO0]2M
M]).-1EM-1AE6RQG/G%6(C^ZWWL?=/I4>9I=72[G2T5X-+^W5\"(=<_LEOB)8
M&ZW^7YBVUPUOG_KN(_*Q[[L>]>W:5JUEKNFVVH:;>6^H6%S&)8+JUE62*5#R
M&5E)!!]15RIS@E*46DS.-6G-N,))M>9;HK"\5>._#7@2WMY_$OB'2O#T%S)Y
M,$NJWL5JLKXSM4R, QQV'-<U\5OV@?AY\$8;63QKXIM-$:Z&8(&5YIY%_O"*
M)6<K_M8Q[U*C*5DEN6Y1C=M['H5%87@CQMHGQ'\*Z=XD\.7RZEHFH(9+:Z6-
MXQ(H8J3M<!AR".0.E<3\3OVHOA7\';_[!XM\:6&F:@,;K*)9+JX3(R"\4*NR
M@C^\!3Y)<W);7MU)]I#D]IS+E[]/O/4Z*X+X7?'CX?\ QHMY9?!?BFQUUH1N
MEMXV:.XC7.-S0N%D49[E<5WM*490=I*S'"<:BYH.Z\@HKQ?QU^V5\&/AOK4N
MDZ]X]L8=1A8I+!9PSWAB8=5<P(X4CT.#7:?#;XS>!_C!8O=^#?$^GZ^D8#2Q
MVLO[Z('H9(FPZ9_VE%5[.IR\_*[=[:$^VI\_L^9<W:^OW':44E>*>,_VTO@I
MX!UJ32=9\?Z>M_&Q22.QAGO1&P."K-!&ZJ0>H)R*F,93?+%794YQIKFF[+S/
M;**YOP'\2/"_Q0T-=8\)Z[8Z_IQ.TS64P?8V,[7'5&P1\K 'GI6EXB\3:/X0
MTF;5=>U6QT32X=OFWNHW"6\,>2 -SN0HR2 ,GJ:)1<7RR5F.,HR7-%W1I45R
M7B3XM>#/"/@Z+Q7J_BC2K/PW,BO!J;72-#.&&5\IE)\PD<@+DGM7$_#[]L'X
M._%'Q!%H?AOQS97>K3-LAM;F">T:9NRQ^=&@=O9<FKC2J2ORQ;MOIL1*M3A;
MFDE?;7<]CK O/B!X7T_Q5:^&;KQ)I%MXDND\R#1YKZ)+R9<,=R0EM[#"MR!_
M"?2M/5]8L/#^FW&HZI?6VFZ?;KOFN[R58HHU]6=B !]37YP_$#XK>$=2_P""
MEWA'Q'%XIT63PU8VL<$FLIJ$1LT(MILAIMVP89\=>IQUK7#4?;U.3U_!-F.*
MK_5Z?/UT_-(_2JBN5\)?%;P3X^O)K/PQXQT#Q'=PQ^;+;Z3JD%U(B9 W,L;$
M@9(&3QDBNJKG<7'1HZ8RC+6+N4-=U_3/"^DW&J:SJ-II&F6R[I[V^G6&&(9
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M,***^=/$/[=WPR\#_%K7? 'BR>^\.W^ES)#_ &C/;F6SEW1HXPT>YE/S\[E
M&.M*G3E5ERP5W:_]?>.I4A1CSU'97M\]?\CZ+HK&\*^,M \=:4FI^'-:T_7=
M.<X%UIURD\>?3<I(!]NM;-2TXNS+34E=&=X@\1:5X3TBXU76]3L]&TNW ,U]
MJ%PD$$62%&YW(49) Y/4BN*_X:2^$G_14O!?_A0VG_QRO+?^"C&H_P!G_LF^
M*U!(-Q/9P<$C.;F,_P#LM>>_LR_L-_!SQM\!/!'B#Q/X..I:[J>GK=W-T=4O
M8O,+DLIVI*JCY2HX Z=^M==&E3E1E6J-V4N73TN<->M5C6C0I)-N+EKVO;H?
M4OA_XW?#KQ;K%OI.A^/O"^M:I<;O)L=/UFVGGDPI8[41RQPH).!T!-=K7BOP
M^_8S^#OPK\7V'BCPOX/_ ++UVP+FVNO[3O)MF]&1ODDF93E68<@]:L?M;?&*
M?X&_ ?Q)XFL65=7V+9Z>6 .+B4[5;'?:"7Q_LUC45.Z5&[OW[MZ?H=%)U;-U
M[*W:^W7<M?$S]JSX3_![5O[+\6>-++3M3'W[.&.6ZFC[C>D*.4X_O 5U'PU^
M+_@SXPZ2^I>#?$=CK]K&0)?LSD20DYP)(V ="<'&X#.*^5/V&_V3?"6I_"FU
M^('C_0K/QAXG\5%[XMKL"W:10LYV$)("I=_OER,_,!VY\X_:+\)0?L+_ +17
M@OXD^ X6TKPEKCM;:II%N3Y.U64S1JN>%9&#*.BLF1V%=_U:C[7ZKS/GVOTO
MV[^5SSOK5?V/UKE7)O;7FY>_;SMVZGZ15XEX@_;4^"7A?Q._A_4?B#I\>II)
MY+K#%-/#&^<$--&C1K@]<L,=\5B_MS_$Z\\ ?LN^(M6T.Z:&[U)8;"WNH6*L
MBSL SJ1T/E[L'U(K$^"7[$OPNL_@'HND:]X1T[5M7U738[C4-6NK=6O%FEC#
M-Y4I&Z(+NPH4C[H)R22>2G3AR2JU;V3M9;WM?KV1UU:L_:1I4;7:YKO:U[=-
M[N_W'TQIFIV>M:?;7^GW4-]8W,:S07-O()(Y4895E8<$$<@BF:UK-EX=T>]U
M34KF.ST^RA>XN+B4X6.-069C[  U\>?\$YM:U+PY-\4_A1J%W)>0>"]::.R>
M4\B-Y)490.PW1;L>LAKHOVRO$>H_$KQ)X2^ /ABY:+4_%4JW6NW,)YL]+C;<
MY;TW;3@'KLQ_%3J8?]\J5-W4K-/R:O=^BU?H%/$_N95:JLXW37FG:R]7MZGT
M7\/?B'H'Q4\)V7B;PQ>2:AHEYN^SW4EK+;^8%8J2%E16QD$9Q@XXKHZS/#/A
MS3_!_AW3-#TFV6TTS3K>.UMH$'"1HH51^0K3KGGR\SY-NESII\_(O:?%UMM<
M***YKP[\3/"'C#5KS2M!\5Z)K>J688W-EIVHPW$T #;271&++AN#D=>*E)O8
MMR4=V=+117.7'Q(\)6?BR+PO/XIT6#Q-+CR]%DU"%;Q\KN&(2V\Y4$].@S0D
MV[(&U%79T=%9'BCQ=H?@G2)=5\0ZQ8Z'IL7W[O4+A((Q[;F(&?:O%I/V]_@)
M'J7V _$*V,^_9N6PNVBSG'^M$.S'ONQ5PISJ?!%OT,ZE6G2UJ22]78^@**S]
M \0:7XJT>UU;1=1M=6TRZ3?!>64RRQ2KZJRD@U2\5>._#7@2WMY_$OB'2O#T
M%S)Y,$NJWL5JLKXSM4R, QQV'-3RN_+;4OF5N:^ANUP_QF^+^A? OX>ZCXP\
M1_:7TVS*)Y-G&'FE=V"JB@D#))[D >M5?BM^T#\//@C#:R>-?%-IHC70S! R
MO-/(O]X11*SE?]K&/>HM:UKX:_&KX,S:KK-WINJ_#C5+?S9;S4F:UMS&KXWL
MTFQHR'7ACM((XIJ$K*;7NWW_ $OW)=2/,Z::YK7M^MNVQ6_9[_:&\,_M)>#;
MCQ%X9AO[2"UNFL[BUU*)4ECD"JW\+,I!5@00?RKU"O/O@;X5^''A'P'%9_"T
M:2WA9IG<3:/>"\BEEX#EIM[EV& .6)  '8"NF\7>-O#_ (!TE]4\2:WI^@Z<
MIP;G4;E(4SZ L1D^PYK2MR>T?LTTO/<SH<_LDZK3?5K8VZ*^?X_V]_@+)JBV
M ^(=J)V?RP[6%VL.?>4P[ /?=CWKW31]9L/$6EVNI:5>V^I:==()8+NTE66*
M5#T964D$>XJ94JD%>46EZ%PK4ZC:A)-KLRY16%XF\>>&O!+62^(O$6DZ"U])
MY5J-3O8K8W#\?+'O8;CR.!GJ*Y[XI?'KX?\ P5MX)?&OBBRT(SC=%!)NEGD4
M<%EBC#.1GN%Q4*+=K+<MRC&]WL=]17G'PI_:+^&_QN>XB\%>++/6KF!=\EIM
MD@N%7@;_ "I55RN2!N QR.:ZWQ5XV\.^!K*.\\2:]IGA^SD?RTN-5O([:-FP
M3M#.P!. 3CV-.4)P?+)69,:D*D>:#31'HOC[PQXDUS4=&TGQ'I.J:QII*WNG
MV5]%-<6I#;2)8U8LF&X^8#GBMZOS3_8G^+'A+0_VHOC5KNO^*M$T73=4FN'M
M+S4=0BMX;@&\9E\MW8!LK@\$\<U^B/A/QQX<\>Z?+?\ AG7]+\16,4IADN=)
MO8[J))  2A:-B V&4XZX(]:WK8>5)1?=)OYG-A\3&LYJZTDTO-+J;=%%8WBO
MQEH/@729-4\1ZS8:%IT?#76H7"0QY],L1D^W6N4[39HKY_\ ^&]_@)_:8L/^
M%A6OGE_+W?8+ORLYQ_K?)V8]]V/>O<M#US3O$VDVNJ:1?VVJ:;=)YD%Y9RK+
M%*OJK*2"/I6LJ52"O*+2]#&%:G4;C"2;79GSG^W+^TWXH_9E\+>&-2\+V&D7
M\^J7LMO,NKPRR*JJ@8%?+D0@Y]2:^B?#>HRZQX=TN_F55FNK6*=UC!"AF0,0
M,GIDU\,_\%;_ /DGO@#_ +"EQ_Z*%?;?@;_D2?#_ /V#[?\ ]%K71R1^J\]M
M>:WX'-SR^MN%].6_SNSYO^!G[5OBWXF_M7_$'X8ZIIVBP:!X?6^-K<6<$RW3
M^3<QQ)YC-*RG*N2<*.<=.E?5E?G7^R/_ ,I&/C/_ +FK?^E\%?HI2Q$(QA1<
M5O!-^NH\-.4YUU)[3DEZ+H%%>0_$;]KCX0?"C6'TKQ-XYL+/4XVVRVEM'+>2
MPM_=D6!'*'V;!KK/AK\8O!7QATN2_P#!OB2QU^WCQYJVTF)8<YQYD; .F<'&
MX#.*Y_9SY>?E=N_0Z?:T^?V?,N;M?7[A_P 7_%]Y\/\ X5^+?$NG1037^D:7
M<7L$=TK-$SQQEE#!2"1D<X(/O7E_[%7[0'B']H[X47WB?Q+9Z98W\&JRV*QZ
M5%)'$8UCB8$B21SNRY[XZ<5VG[3'_)O/Q(_[%^]_]$M7S_\ \$JO^3=-6_[&
M*X_]$6]=-&$94*TFM5RV^;.7$5)1Q%",7I)ROYV2L?9=%07E[;Z;:375W/%:
MVL*&26:9PB(H&2S,>  .YKPW4/VZ_@1IFM'2YOB)8O<A]GF6]M<S09_Z[I&8
M\>^[%<L(2J.T%=^1USJ0IJ\VDO,]YHK.\/\ B+2O%FCVVK:)J5KJ^EW2[X+R
MRF6:*09QE64D'G(_"M&I::=F6FI*Z$9@JDDX Y)-?#FK?MQ_$_XJ_$[6O"WP
M$^'VF^*+31V83:EJTAV3*&V^8#YT*1J2#M#.2P&<#D#ZO^+7CSP]X'\&ZG)K
MWB'3/#[7-G<):MJ-[';&5Q&>$WL-S9(X'/(KX._X)>?$;P1\/?"WCU_%'BO0
M?#=]>7MJ(UU?4H;5Y8T1^5$C D L>GK7=A*:E&K5E&_(E9=VW;\#S<;6<)4J
M,9<O.W=]4DK_ (]S[J^">O\ CCQ-\/;+4/B)H%IX9\4O)*MQIMG)OC15<JK9
MW/\ > W<,>".:[RL;5/&?A_0_#8\0ZEKNFZ?H#1I*-5NKR.*U*/C8WFL0N&W
M#!SSD8ZUA^,/C5X$\ ^#;?Q7KOBK3++P[=*&M=06<2I= C(\G9N,N1S\@/'-
M<LKRDVHVUZ=^QW0M"*3E?3=]NYVM%<7\*OC)X/\ C=X?FUSP5K UO2X;AK62
M<6\L&V4*K%2LJ*V<,IZ=Z@^)_P =/ /P9MHIO&GBFPT(RC=%;S.7N)%S@LD*
M!I&&>X4BI<)1ER-:]NHXU(2ASIIKOT.[HKRKX8_M3?"KXQ:E_9WA+QI8ZEJ1
MSLLI4DM9Y,#)V1S*C/@ D[0<5ZK1.$Z;M-6]0A4A45X237D%%<O\0OBAX3^%
M.B_VMXNU^QT"P)VI)>2A6D8#.U$^\[8[*":X3X>_M@?!WXI:Y'H_ASQU8W6J
M2L$BM;J*:S>9CT6/ST3>WLN33C3G--QBVD*=6G3:4Y)-]V>QT5@Z'X^\,>)]
M6U'2M&\1Z3JVJ::VR^LK&^BFFM6R5Q*BL60Y!'S <@TGB[X@>%_A_;V]QXH\
M2:1X;@N'*0RZO?Q6JRL!DJID8 D#L*BSTTW+YEJ[[&_145K=0WUK#<VTT=Q;
MS(LD4T3!D=2,AE(X((.016!XL^)7A#P%/:0^)O%6B>'9KP,;:/5M1AM6FP0#
ML$C#=@D9QZBFHMOE2U!R27,WH=)12 Y&1R*Y/XB_%GP=\)-)74O&'B.P\/VK
MY$9NY</*1U$:#+.?9034[NP[Z7.MHKQSX??MA?!SXHZU'H_ASQW8W.IRL$BM
M;N*:S>9CT6/ST3>Q]%R:]CK2=.=/2::]2(5(5%>$D_0**PM/\>>&=6\27OAV
MQ\1:3>^(+%=]WI-O?1275NO',D0;<H^9>2!]X>M>8^-/VT?@K\/]>ET76O'U
MC'J,+;)8K.">\$; X*L\,;JI!Z@G([THTYS:45=L)5(03E*221[716+X0\9Z
M%X_T&VUOPWJUGK>DW _=7EE*)(R1U&1T(Z$'D'@UM5+3B[-:EQDI*\7=!17C
MWQ _:^^#OPOU:33/$7CO3[;48V*2VMHDMY)$PZJX@1]A]FP:Z;X7_'3P%\9[
M66?P7XIL-=\D;I8(6*3Q+G +PN%=03W*@&K]G/EY^5V[]#/VU/G]GS+F[7U^
MX[NBN:T'XF^#_%6N7FBZ)XKT/6-8LPQN=/L-1AGN(-K!6WQHQ9<,0IR."<5T
MM0TUN:*2>S"BN<O?B1X2TWQ3;^&;OQ1HMKXDN-IAT>;4(4O)=P)7;"6WG.#C
M [&NCHL[7"Z;L@KP3Q1^TGJ$7[47AWX1>%M$MM<+6CWGB"\EG:/^SX\ H5(!
M&0O)4CDR1C*Y)KVCQ-X@M?"GAO5=:OG"6>G6LMW,Q.,)&A9OT%?(7_!.71;K
MQC;?$/XQZVIDUKQ;K$D,4DG)2WC.XJI_N[W"_P#;%?2NG#PC)SJ35U!?>WHO
MU?R.7$U)1Y*<':4W:_9+63_)?,^@]+_:3^'&M?%:X^&UIXBW^-8))(GTN2QN
M8SNC0NP$C1B,_*">&.1TS7IM?FQ^W#8R_ 7]L3X>_%FS0QV5^\$UT8QC<\#"
M.=2?]J!D'YU^D=O<1W4$<T+K)%(H='4Y#*1D$'TQ3J4HJA3K1^U=/U6_R[$T
MZTI8BK0G]FS7HUI\UU,;QSXXT/X;>$]1\2^)+]=,T33T$ES=-&\FQ2P4?*@+
M$DD# !/-4/AC\5/#'QC\+)XC\(:DVK:+)*\"736LUN&=#A@%E16(!XSC&0>>
M#7RA_P %4?B$VB_"/0/!UJ^;OQ%J(DDC4_,T, #8Q[R/%^5?3'[/GPY7X2_!
M7P=X4"+'/I^GQBYV]#<,-\Q_&1GI1I1^K.M+=RLODM7]^@Y5I?6E0CMRW?WV
M2_4W?B-\2O#?PE\)W?B;Q9J:Z1HEJR++=-%)+@NP50$C5F))(Z UF_";XV>"
MOCEHEWJ_@C6UUNPM;C[+/(+>: I)M#8*RHK=&'.,>_!KY._X*/>(+CQUXJ^%
MOP9TN4_:M?U2.ZNU0_=0OY,6X>F6E;_@%8W[)C1_L]_MK_$OX2<VVBZSNNM+
MB8\ H/.B5<_],9)!GOY8K>CAHU*#FW[SYFO2-KW^]V]#GQ&+E2Q"II>ZN52[
MIRO:WEHK^I^@5>3?%;]JKX6_!'Q%#H7C7Q1_8NJS6ZW26_\ 9]U/F)F90VZ*
M)EZJW&<\5ZS7YF_MX>'[#Q9^W+\+]$U6#[5IFI1Z79W4&]D\R*2]='7<I##*
MDC((([&L,+16(KQI2V?^3.G&5I8?#SK1W5OS2_4^IO\ AX;^S]_T/_\ Y1M0
M_P#D>NG^&_[8/PB^+OBVU\,^$O%O]K:Y<I(\5K_9MY#N5%+,=TD*J,*">37,
M?\.\OV?O^A _\K.H?_)%=/\ #?\ 8^^$7PB\6VOB;PEX2_LG7+9)$BNO[2O)
MMJNI5AMDF93E21R*V?U*SMS7Z;;]#F7]H<ROR6NK_%M?6WG;;S,GPO\ M)7\
MO[47B'X1>*=%MM#86B7GA^[CF:0ZA& 6<DD 9*Y(4#CRY 2>#7O=?&'_  48
MT:[\&6_P]^,FAKLUKPCJ\<4KCC? YW!6]5WKMQZ2MZU]>>&?$%IXL\.:5K>G
MOYECJ5K%>0/ZQR('4_D16$H1="%6*VO%^JU3^::^=SIC4E'$3HR>]I+T>C7R
M:^YHTZ**QO%7C3P]X$TU-0\2Z[IGAZP>00K=:K>1VL1D()"!Y& W$ G&<\&N
M8Z_,V:*X/XF?';P!\'='M-4\7^*+'1[2\&ZVR6FDN%X.Z..,,[KR.5! R/6M
M?X=_$CPY\6/"=IXE\*:D-6T2Z+K#=+%)%N*L58;9%5A@@CD=JODERN5M"/:0
MYE"^KUL=+17FOQ1_:0^&?P7F2W\8^,+#1[Q@&%D-\]SM/1C#$K.%/J5Q4GPM
M_:*^&_QJ:6/P9XML=:N8U+O9C?!<A1C+>3*JOMY'S;<<TU3G*/.HNW<EU:<9
M<CDK]KZGHU%%<-\4/CCX#^#%G%<^-/$]CH*S#,4,S%YY0."4B0,[ =R%(%0D
MV[+<T;45=[&UX^UZX\*^!?$6M6B1R76G:=<7<23 E&>.-G4, 02,@9P17A/[
M#G[2OB?]ICP7XCU?Q18Z387.FZ@MI$ND0RQHR&,-EA)(Y)R>Q%:][^TM\,?C
M?\,_'&G>"_%]EK&I?V)>XL622VN''D/DK%,J,P'<@$"O#_\ @DI_R2OQQ_V&
MH_\ T0M=]&BU2K^TC9Q4;7\Y,\ZM74JV']E*ZDYWMUM%6/NZBN;\5?$OPAX%
MN[2U\2>*M$\/75X";:'5=1AMGFP0#L5V!;D@<>M=)7!9VOT/1YE=QOJ@HKF]
M:^)?A#PWX@L]!U;Q5HFEZY>E!:Z9>ZC##<S[VVILB9@S;FX&!R>!7246=KA=
M7L%%<3\2OC5X&^#UG'<^,O%&GZ LH+117$F9I0.I2)<NX'^RIKC_  '^V1\&
M?B7K4>DZ!X\L)]1E8)%;WD,UD96/ 5//1 S'T7)K2-*I-<T(MKT,YUJ=-J,Y
M)/S9[))(D,;R2,L<: LS,<  =236)X3\=^&O'UE->>&/$.E>([2&3RI;C2;V
M*ZC1\ [6:-B <$'!]17,_&OXG>%O /@G78]<\2Z/HM]-I=R]K;:A?102SGRV
M "(S MEL#COQ7QM_P3&^*_@GP#\)/%-GXG\8Z!X<NYM;,L5OJVJ06LCIY$0W
M*LC D9!&1Z&M:-!U:=2?\J5O.[L_N,*^(5&K2I_S<U_*R37WW/O/QEXLTWP'
MX4U?Q'K$K0:7I=K)>7,BJ681HI9L =3@=*\I_9Q_:Z\&_M.3:U!X:M-6TZ[T
MD1O-;ZK"B%HW)"NI1W!&5(()!Z5ZDNI>&_'?@^:ZCO=-U[POJ%M(LES%/'/9
MSPX*R?."59>&!YQP:\^_9[\#?!GP?8ZR_P (#H$\%Q,O]H7&BZF-0.[!*(\G
MF.5')(3( R<"IIJ"C-5$[JUO)^9=24W*FZ<E9WOYJW0]>HI&81J68A549))P
M *\.\4?MO? [P?J[Z9J/Q"T]KM#M;[#!/>QJ<XP9((W0'\:RC"51\L%=FTYQ
MIKFF[+S/<J*YWP+\1/#'Q-T1=7\*:[8Z_IQ.TSV,PD"-C.UP.4;!'RL >>E=
M!)(D,;R2,L<: LS,<  =234R3@[25BHR4TG%WN.HKFM%^)GA#Q)H%[KND^*M
M$U31+(LMUJ5EJ,,UM 54,P>16*J0I!.3T(->6P_MT? FXUX:.GQ%T\79D\L2
M/;W"V^<_\]S&(L?[6['O6D:523<8Q;?H9RK4X14I223\SW>BHK:YAO+>*XMY
M4G@E021RQL&5U(R&!'!!'>I:R-=]4%%1SSQVL+S32+%%&I9Y)&"JH'4DGH*\
M1\4_MO? WP=J#66H_$33I)U.&_LZ&>^0'T+P1NOZU<82J/E@KLB<XTUS3=EY
MGN5%<=\-?C!X+^,.E2:CX-\1V.OVT1 E%LY$D).<"2-@'3.#C<!G%=@S"-2S
M$*JC)). !2E&4':2LQQE&HN:#NA:*\+\3?MQ? WPCK$FF:A\0K%KN-MK_8;>
MXO(P<X(\R&-T_6O3O 7Q,\*?%'1_[4\)>(-/\06((#R6,ZR&-B,A77JC8_A8
M U;I5%'G<7;O8A5J<I<BDK]KZG34450UW7],\+Z3<:IK.HVFD:9;+NGO;Z=8
M88AD#+.Q"J,D#D]ZR-2_17*ZQ\5?!N@^"U\77WBC28/"[KNCU?[9&UM*"2!L
M<$AR2" %R21Q7 >!_P!LSX,?$;Q%#H6@^/+*?5)FV0P74$]H)6)P%1IHT5F)
MZ*"2>U:QI5)7Y8MVWT,I5J<+<TDK[:[^A[3117-Z=\2O"&L>)[GPW8>*M$O?
M$5MN\_2+?489+N+;][="&WKC(SD<9K-)O8T;4=SI***YOP[\2_"'B[6+S2="
M\5:)K6J608W5CIVHPW$\&UMK;T1BRX;@Y'7BA)O8')1W9TE%8_BCQCH'@?3/
M[2\1ZYIOA_3MXB^UZI=QVT6\YPN]R!DX/&>U8/Q"^-7@7X5^';;7?%7BC3])
MTNZ4-;3/)YAN00"#$B M)P0?E!X-"3>PG)+=^9VU%>9_"G]I/X:?&ZZN+7P7
MXMM-9O(%WO9F.6WGVCJPBE5&*C(RP! R*E^*W[1?PW^"+01^-?%EGHMS.-T=
MKMDGN"O][RHE9PO!^8C''6K=.<9*#B[OH1&K3E%SC)-+K?0]'HKB?A?\:O _
MQHTR:_\ !7B2SUZ" @3)"626'.<;XG"NF<'&Y1G!Q7;5,HR@^62LRHSC47-!
MW045YW\4?VAOAQ\%]B^,_%MAHMQ(H9;1BTUR5/1A#&&DV^^W%5_A;^TI\,OC
M1=/:^#?&%CJ]ZH+&R8/;W)4=6$4JJY4=R!BJ5.<H\ZB[=R95:<9<DI)/M?4]
M,HHKFM(^)G@_Q!IVJ7^E^*]$U.QTO(O[JSU&&:*TP"3YK*Q"8 )^;'0UGW?8
MTOJEW.EHKRGX>?M2_"WXL>,)_"WA+Q;#K6N0QO*UO#:SJA1" S+(T81@,CE6
M/6NM\>?%+PC\+]/6^\6^)--\/VS9V&_N5C:3'9%)W.?9035RA.#2DK7(C4A-
M-Q:=CJ:*\$T7]N[X#Z]JT>G6OQ#LH[B1MJM>6ES:PY]Y98E0?4M7N\,\=S#'
M-#(LL,BATD1@592,@@CJ,4YTYT]9Q:]10K4ZE^22?HS%\6^/?#/@&U@N?$_B
M+2?#EM</Y4,VK7T5JDCXSM4R, 3CG K=5@R@@Y!Y!%?G#_P5*^*'A;Q=X?\
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MJ1D$$=01WKGM9^)W@[P[XBM- U;Q9H>EZ[>%!;:7>:C##=3;VVILB9@S;F!
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M#33LSTDU)76P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6_\ ),O"/_8'L_\ T2E5&M5C@TXR:M*V_2VQFZ%*6/:E!-.-]EOS;^I\U?\
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M?-:WQ\_9Q\&?M&^&X=*\5VDHFM6+V>I6;B.YM6/78Q!!!P,JP(.!QD CXO\
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M16 D201@!P5)^]D@@&L+_@DS_P D7\7?]A\_^D\5?07[87_)L'Q+_P"P+/\
MR%=N959PQ+4':UG\[)_/_+38X\LH4YX2+FKWNM>UW]WRZZ[G'_\ !/;QM?\
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MF8-ZB.(;@IX+L,]!7TGH?[&WP7T/PFGA]/AWH=[;"+RWO+ZT6:\?(Y8W##S
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M*V=]I D9HHRTHC; )^ZK21R+Z?,HX.*]]_X*'_\ )I?C+_?L_P#TJBKR]O\
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MDLLCGDLV!G "J..BCODGO*^>/V+_ -J8_M-^ [Z;4K*+3O%&BR)!J,-L"(9
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MO0O$4:<L=2YHIWB[Z;ZFY^U]IEMHO[(OCW3[*/R;.TT46\,>XML1"BJ,DDG
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M%8Q +TXMT'%?+O\ P5;TV.X^ ?A^\8#S+;Q!$JG'.'@FS_(5])_L\:[%XE^
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MBXB4E.A4C2Y/>2OI>STM9?KL=U_P5O\ ^2>^ /\ L*7'_HH5]M^!O^1)\/\
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MKXR_W;O_ -)8Z_16EB*DHT*$8NUX1_7^D&%IQGB,3.2NU4DE^#_X?Y'YT_\
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M\95M?'7B/7;<-IVG7T2RV&G6G(15@.4+-RQR#C/][),__!47_DV9/^PW:_\
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M>+;.\U:YBM([7^S&NF2T<HQ*R,JX8G! P&"G'(-4?C%^QK\*O&WPUUG2M/\
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M^%'_ '"?_2F6OT8J:DY1PE)1=K\WYCI0C4QU=R5[<MOFO^ ?FG\ M%'[.O\
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M7[P^VZ*VEB(U(+GA>25K]--KKK^7E8QAAITYR<*EHMWMUUWL^GYKO?4^.?\
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M  #YW_;O^#&M_&[X WFE>'(C=ZSIUY%J=O9@@-<[%=6C7/\ %MD8@=R .]>
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MD1#<JR*"1D$9'H:^QJ*BG5=.%2"7QV_!W-*E%5)TYM_!?\4E^A\>?MM?LO\
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MBS1[KPS\+OA[XIN/'MTK6ZQ7]FI:S<@@NL43.\C+V!"C/)Z8/HO[!O[+.I?
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M>91T6MFEV].P2PTE4E4HSY7+5Z73??IJ^O<\F_9U^*WC'XN>&-1UCQ=X O/
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M+_Y*K!7YX_\ !73/V#X7XZ^=J&/RMZ_0ZOSR_P""N?\ QX_"[_KOJ'\K>ML
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M$K>FMSJJ4?:<EW\+OZZ&/XQ@DNO".N0PQM--)8SHD<:EF9C&P  '4DU\>_\
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MV_@31_%-Q>W&K3:9.EHT1VB0K,5V;2L4A0YY,_?(K]<HXTAC2.-0B( JJHP
M!T%/HKNQ&*EB(Q4EM^+TU_ \_#8.&&E)Q>^WDM7;\3\[/VGO#OBW]G']L*Q^
M/%AX<N?$_A2=5-U]F!Q 3;FWD1V .SY<,K$8).*]*M?V]-9^-=G_ &1\$OAE
MXAU?Q#<?NCJ6N0QPZ=IY(_UDCI(X('HQ3/N>#]DT4E7BZ<:=2%^71:VT[/\
MI \-.-652E/EYM6K)Z[77_!N?GU^PW\&?B#\,OVK/B'<>,](U%A-I]PK^(&L
M)8K&^N'N89&:&5D56W'<0!V!X&*[7_@I]X!\3^/_ (:^#[7PQX<U;Q)<P:N\
MDL.D6,MT\:>2PW,L:D@9XR:^T**)XJ4YTZC6L;?AJ*G@XTZ=2DF[3;?WJQSG
MPWM9K'X=^%[:YADM[B'2K6.6&52KHPA4%6!Y!!&"#7"?M<:'J/B3]FWQ_IFD
M:?=:KJ5UIQ2"SLH6FFE;>ORJB@EC[ 5Z]17-4E[23D^IV4X>SA&"Z*Q\V?\
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M=JA>=[>0*69%'+%613@<X)/:L/X=_P#!3"UUKPW8:$WPW\5:Y\1XX! ^FZ7
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MF^JBXV]7>X4445@=1\#_ +0'P+\>_L^?M #XZ_"71Y/$-C>.TFM:#;1EW!?
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M6R3XFG)V%U ; (/&>HK[OHHJJU9UI*36R2^X*-%44TGNV_O"BBBN<Z HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ KG/#/PX\)>"[^]OO#WA?1="O;[FZN=,T^&WDN.2?WC(H+<DGG/)-='133
M:V$TGN%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %<[XN^'/A/X@+:KXH\+
MZ-XD%J6-N-7T^*Z\DMC<4\Q3MSM&<=<"NBHIIM.ZW$TFK,15"J !@#@ 4M%%
M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+\QS6L\+4IIMVTW5U=>J,:>,I5))1OKL[.SZZ.Q[917S!^TM^V<WPD\;:?\
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M -F\SR_-\J-GV;L';G;C.#C/0TJU*5%)RV?5:ICHUHXA\L-UHT]&ODS?HKY
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MMK--MW>6C/MSC.!G%?/7[)/[7O\ PU+=>+8?^$3_ .$8_L$V_P W]I?:_/\
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M -[2O_2V2OT6K\UOVX/$NG>#?V[OA?KVKS_9=+TV#3KNZFV%MD27<K,< $G
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MEY86DVBZ]IDBPZIHMTP:2V<YP0V!N0D, < Y4@@5\Q_\%</^17^''_7]=_\
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MG[/YGF2K']_8^,;L_=/2LZE&=&:A):NUO.^QK1KTZT'4@]%>_E;<])HKS?\
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M5]C_ +/_ +:TVWU'[)YOF^3YL:OLWX7=C=C.!G'05^??_!1CX]>*?$GAW4?
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MD+$<[1T%_P (_MY>)? ?CJR\'?'[P'_P@5]>$"'6;)F:RY( )!9P4SP9$D<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_45SRJTYSH0@G[KBM>W,FON.F-&I3IXB=1J\HR>G^!K\3K/V$?\ DTOX=_\
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MVFOTST^^@U2QMKVUE6:UN(UFBD4Y#HP!4CV((KX=_:R_8/\ AAX4^ OBC7_
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MVNDN7_@'Z%S1K+#(CJ'1E(96&001R"*_./\ X)<QI#\7_BY'&JHBQQJJJ,
M7$N !7Z,7UY!I]E<75U-';6T,;22S2L%1% R68G@ #N:_.;_ ();SQW7Q<^+
M<T+K)%)%&Z.IR&4W$I!!],5RX+_E]_A_S.S&[T?\:_(_2"N.^,G_ "2+QO\
M]@2]_P#1#UV-<=\9/^21>-_^P)>_^B'KRJO\.7HSUZ/\2/JCXW_X),>$](7P
M%XQ\2_88CKK:F-/^W,,R+;B*-_+'H"S$G'7 SG QZ_\ \%&].@OOV3_%$DR!
MGM;BSGB;NK_:$7(_!F'XUYM_P29_Y(OXN_[#Y_\ 2>*O4O\ @H?_ ,FE^,O]
M^S_]*HJ]S,&_KZ]8?^VG@9;%?V?MNI_J8G_!-7P7H_A_]F/2-<LK-(M5UVXN
M9K^ZQEY3'<211KG^ZJIP.F68]S7FW_!6VQ@?X<^ [TQ*;J/59H4DQR$:'+#Z
M$HOY5[)_P3N_Y-#\$?[]]_Z6SUY'_P %:_\ DE?@C_L-/_Z(:G7;_M)^4_UM
M^1%%)97I_*_U/L#X1WTNI_"?P7>7#;Y[C1+*61O5F@0D_F:^"_\ @GC_ ,G=
M?&/_ *Y7O_I>M?=OP3_Y(SX"_P"P!8?^D\=?"'["$R>'_P!MWXO:/<_N;F9=
M22-)#AF*7Z$C'<[>?P-.G_'Q"7\L_P S.K=X7"M_S0_(_1C5O^05>_\ 7%__
M $$U^>?_  23_P"0I\6OKIW_ *%=5]]>.O$FE^#_  ;K.LZU?0Z;IEG:R23W
M5PVU$7:?U)P .I) %? G_!(^02:C\6'7[K?V<1^=U6&#_@XI_P!V/_I1W8YK
MVF'7]Y_DCUO_ (*B_P#)LR?]ANU_]!DKUO\ 8]_Y-?\ AI_V!8?Y&O)O^"H<
M;-^S("JDA=;M"Q Z#;(.?Q(KU?\ 8YD2;]E[X:LC*ZC1XERISR,@C\""/PJ*
M?^XS_P"OB_\ 2!U/^1C#_KV__2SV&:*.:,I*BR1GJK@$5XE\1/VUO@S\,;R:
MRU;QM9W6HQ$J]GI2/>NK X*L8@RJP/9F!KQ[_@J%\4]>\"_"?0=!T2\DT^/Q
M'=R07T\+%7:"- 3%D<@,6&<=0".A->A?L]?L4_"[X7^#M'N)_#FG^)_$,UM%
M/<ZMJ\"W),A4,3$C@K&H)XV@'&,DGFHI48.DZU5NU[)+=_Y&E6M4]JJ%%*]K
MMO9:V^?X'P]\5/C]X6^,G[:WPW\:^!;?4+)([_3+6YDOX4A>:1;K:6 5VRIC
M95R<'C&*_5[Q)_R+NJ?]>LO_ * :_.']MR^TN7]M_P"$ECILUJQT\Z7!/;VI
M7_1W-\S!&4?=.UE./0BOT?\ $2E_#^IJH)8VLH '?Y#6F.<7@*;@K+W_ #[$
M9>I1S"JIN[]S96Z?,_/_ /X)$?\ 'C\3O^NFG_RN*_0]_NM]*_.[_@D4RK;_
M !0B) E#Z>2AZ@8N!TK]$7^ZWTK3./\ >)^B_P#24<N2Z82*\W^;/SO_ ."7
M7_)3?C-_UTM__1UQ4/\ P4JUJ]\>?&WX6_"R&XDBL+IX9I$0?>FN+CR%;'<J
MJMC_ 'S4W_!+K_DIOQF_ZZ6__HZXJ#_@I5H][X"^-_PM^*<5O)-86KPPR,I.
M!-;7'GJN>Q96;'^X:[?=_M##\VUH_P#I/]?,PJ<WU#$\N]Y>OQ*_X7^5S]!_
M#?AW3_"/A_3M$TFV2STS3[=+6VMXQA4C10JC\A7PW_P58\"V\/A/P9\0;)?L
MNMZ=J(TYKN([9#&ZO+'R.<H\9(]-YK[E\.^(-/\ %F@Z=K6DW,=[IFH0)<VU
MQ&<K)&ZAE(_ U\.?\%6?'5O+X0\&?#^S/VK6]1U(:B;6(;I!&B-$G YRSR$#
MUVM7E4/:_6X6OS\WS\_PN>IB/9?4ZG\G*_3;3\;6/KSX)^-9OB-\'?!WB>YQ
M]JU32+>ZGP./-:,;\?\  LU\'?\ !,SPCH^L?&[XGZY?:?#=:II#*MA<2KN-
MOYLTPD9!T#$(!NZX)'0G/WA\$_!<WPY^#?@WPQ=8^UZ7I%O:W&WIYJQC?CVW
M9KXF_P""77_)3?C-_P!=+?\ ]'7%=E-Q57%.GM9V].;_ ".*:<J.&53>\;W[
M\K/NSXG:9;ZU\-_%5A=QK+;7.E744B,,@J8F!KXP_P""2-U*_P .?'MNSDP1
MZK!(J=@S0X8_B%7\J^VO''_(E>(/^P?<?^BVKX@_X)'_ /(A_$'_ +"5M_Z*
M:N?"_P #$^D/_2F=&,_WG">L_P#TE'WU3)8DGC:.1%DC8896&01Z$4^OD3_@
MIA\5M>^&_P #["QT"\DTZ7Q!J'V"YNH6*R" 1L[HK#D;L $CMD=ZX8Q<Y*$=
MVTOO/0G-4X.<MDF_N/4OB1^V1\'?A7>36.N>-K)]2B)5['35>\E1AU5O*5@C
M>SD5^>/[2/[1GA'XU_M-?#OQAX$MM2M+C3KBS@N+B_@6$S/'=!HV7:[$C#8Y
MP>G%?:?[+O[%OPP\"_#GP[K&H>'K#Q5XBU&P@O;C4=7A6Y56D17VPQN"B*N[
M (&X]S7SG_P49NM)3]HKX4:7ILEHLMA'")[2U*@P;KI2H95^[D<C/:O<P<:-
M+'4Z<;RDFU?9;/I_P3Y['3Q%;+ZE9VC%I.V[W5M=/78_2V7_ %;_ $-?G+_P
M2A_Y';XL?[EI_P"C9Z_1J3_5O]#7YR?\$IOW/C[XLP2?),$M?W;<-Q+.#Q[$
MC\ZX<%\.(_PK\V>GC/BH_P"+]&?H]1117GGHGYP?MF:9::U_P4!^$EAJ%K#>
MV-RNEQ36UP@>.5#>2 JRG@@CJ#7Z.HBQJJJH55& JC  ]*_.7]L2\M]/_P""
M@_P@N;J>.VMHO[*>2:9PB(HO9,DD\ 5^CE>C6_W2CZR_,\RC_OV(](?^DGYK
M?\%*K1?AI^T!\,?B'I$?V75'02RS1Y&^2UF1D)QU.U]ON !7Z2QLMQ K%<K(
MN=IYX(Z5^:W[?EY'\<OVK/AU\,=";[9>6.RUNS'\PADN)%9PV/[D2*Y] :^J
M?VZ?B9K7PC_9MUS4_#ERUCJEQ)!IT5W&</ LC89U/9MH(![$Y'2G43>"P\>K
M<K?.22^7Z$4Y*./Q,U\*C&_RCK\UK?S.K^)G[4WPG^#,[6'B;QCI]C?PX0Z;
M:AKFXCXX#11*S)Q_> %?G'^WI^T]X!_:%U#PE<^"X=474M%:=);^\ME@22-]
MC($.\MPRL>5&,U]/?L2?L=_#J7X2^'O'GB;1K;QCXDUZ WSR:N@N((%9CA%B
M;*EL $LP+;LX('%>>_\ !5S^P]'\/_#K0=,6PLIX)KJ8Z=:*D9CB*HJMY:]%
M)! ..QK>E&EA\7""O*:=K[)/6_=OJ<]:=;$X.=1VC!QO;=M=+[)=.A]F?$KP
MGJ'Q?_9WUK0+6=(=4U[0#%')(<)YKP@C<>P+<'V-?#W[(7[6FF?LK:7??"?X
MK:!J7AJ>SU"69=02V+^67QN$T8^8C*Y5T#[@1Q@9/Z&>$KRWT_X?Z+=74\=M
M;0Z9!)+-,X1$41*2S,>  .YJE\1/A+X,^+ND_8/%WAS3O$%KM(C:ZA!DBSU,
M<@PZ'W4@US^UC1J5:<HWC)^EK/2QUNA*M3I5(2M.*TZIW2O<N>!?B-X7^)VB
MKJ_A37K#7]/. 9K&99-A(SM<#E&_V6 /M7PY_P %5/'4GVKX=^!9KUM/T2^G
M?4=1F4,V%5UC1B%!+!0TK8 /...E<%XH^'[_ +%7[;/@.Q^'^JW;Z-XEEMDF
MTN:3S&$$UP87@?\ OJ,;D)Y! Y)&3WG_  53\(W=G??#CQ\EDE_IVG3O8W<4
MT>^(DNLL:N#QM;;(ISP>G>MJ-&E'$8>K%WA)O?HU??YV.:O6K3PV)HRC:I%+
M;JG9Z7_NWW/9?"?[<O[-G@GPSI>@:/XV6TTO3;=+6WA31=0 5%  _P"7?KQR
M>Y)KY?\ VV/VC?AM\2/'7PO\8_#3Q$NJ>)]!O\SR+8W-LPC$D<D63+$@8!@_
M )^\?6OM[P+\(O@=\1O!^D>)M$^&W@B[TO5+9+F"5?#]GT8<J?W?# Y!'8@B
MM]?V</A+&RLOPN\%JRG(8>'[0$'U_P!72C5H4,0JLE+FB[[K?KT'*CB,1AG2
MC*/))65D]NEM>FEC!_:^;?\ LN_$EL8SHDQ_05Y=_P $P_\ DUVW_P"PQ>?S
M2O4OVP!C]E_XE # _L6;^0KRW_@F'_R:[;_]AB\_FE8T?]VK?]N_FS:O?ZUA
M[_WOR1X_^VU_R?I\#?\ ?TG_ -.3U^@7B3_D7=4_Z]9?_0#7Y^_MM?\ )^GP
M-_W])_\ 3D]?H%XD_P"1=U3_ *]9?_0#6.*_Y%U/_N)^9U83_D9U?^X?_I)^
M>?\ P23\(Z/>R^/?$=QI\,VMV+6MK:WDBY>".193($]-VU<D<X&.E?:O[2FE
MV^L_L^_$>TN4#PMH%Z^".ZPLRG\"H/X5\A?\$BO^1;^)?_7W8_\ H$U?9/Q^
M_P"2%?$3_L7=0_\ 2:2NG.&_K$_)+_TE'%D$4\+3OUE+_P!*:_+0^:O^"4EU
M+-^SWKT3N6CA\1SK&IZ*#;VY('XDFO$_BW\5/".K_P#!1&2_^)^J"P\&>#6$
M%K');37"&6*,.BF.-&/,SEB<8(0 U[/_ ,$G_P#D@/B3_L99O_26VKR#XBZ!
MX>^%O_!2!KCX@Z/INI^#?%;"5&UFT2XMAY\017(D!4;9UP3_  @YZ5Z,K?VG
M+ORNWKRK;SM>QYBO_9,+;<ROVY>9WOY7M<^JO^'AO[/W_0__ /E&U#_Y'KYJ
M^"OQ,\+:]_P4EN]5^'6HK?\ ACQ58S"Y>.WEMU:06WFR?)(BMGS80V<?Q'GF
MOMK_ (9N^$?_ $2WP5_X3UI_\;K3\._!/X>>#]7AU70? 7AC1-4A#"*^T[1[
M>WGCW JVUT0,,@D'!Z$UYE.KAZ+<HJ5VFMUU7H>K5HXJLHQG*-DT]$^COW^7
MS.TIKJLBLK*&5A@JPR"/2G5\Y?M^?%#7/A5^SEJU_P"'KI[#4]0NH=-6\B.)
M($DW%V0]FVJ0".1NR.17GI.345NVE][L>JY*,7-[)-_<KG8_$S]JWX2_!NY>
MP\2>,M/M-0A^1M-LPUU<1G'"M'$K%./[V*_.']NS]ISP-\?_ !-X/U/P1#JD
M6HZ()HYKZ\ME@$BED>+9ARQVL'/S 8SQUKZL_8M_8W^&]O\ "7PUXU\1:):^
M,/$FNVBZA)-J\8N((!)\RHD393(&,LP+;LX('%>5?\%7WT338?AGH>F?8;2>
MU^VS/I]H$0Q1MY(1BB_=!*L!QSM/I7MX>%+#XZG35Y34K7V5[.^FM_O/"Q$J
M^)P<YRM&#C>V[MTN]%VZ'Z&+=->^$Q</]^:R\QOJ8\FOSS_X)0^$='U#Q+\1
M/$-UI\-QK.FFVM[.[D7+6Z2^=YFST+;%!/7 (Z$Y_0>Q_P"1(M_^P<O_ **%
M?"'_  25^[\5?^OBQ_\ ;BL,/[L<7;M'_P!*:-<3[SPG-K[S_P#2;GV?\>]*
MM];^"'CZQNHQ)!-H5Z&4C/2%R#^! /X5\N_\$G;J63X'^*8&<M%%X@<HIZ+F
MWASC\A7U;\9/^21>-_\ L"7O_HAZ^3?^"3/_ "1?Q=_V'S_Z3Q5EA?X&)](?
M^E,Z,5_O&&?G/_TE'F?Q>@7]HC_@I1HO@S6?W_A[0Y8[?[*YRCQPP&ZE4C_;
M?*GVQZ5^EJJL:JJJ%51@*!@ >E?FCX\NH?@C_P %0M/U_666TT?6)XI5N93A
M EQ:FW+DGH%ESD]@#7Z856(_W7#\NW+_ .3?:_0SPW^]XGFWYE_X#;W?P/S9
M_:JACB_X*2?"UDC5&DDT9G*@ LWVIQD^IP /P%?I-7YJ?M1ZE::A_P %)OAF
MEK<PW#VL^CP3K$X8Q2?:G;8V.C893@\X85^E=%;_ '2A_P!O?F+#_P"^XC_M
MS\@KF_&WC[PK\,]+?6/%&MZ;X>LW.W[3?3I%YI X5<\N<9^49-=)7YB?!GP/
M!^V]^UAX]U/XDWMS?Z+X=>06NBQS-&AC$[1Q1 J<J@"DMM(+,0<\FN6A1]M)
MINR2;?R.S$5_813BKMM)+S??R/8/VA/V_O@AXH^&OBKPG:7FJ>)FU;3I[)&L
MM-9(ED9"$8F8QG ;:<@'IQFJ_P#P2;U*>X^#7BZR=RT%MKN^-2?N[X(]V/\
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MGZJHS7U'^VO\'S\9OV>_$>F6T FUC3D_M33^,MYL0)*K[LF]?^!"OF/XL?\
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M\!?]<[K_ -*YJ^A:^>/^"?LB2?LD> ]C*VU+M3M.<$7<W%?0]+'?[W5_Q/\
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MD<EZZ$@2M)<"%-^#RB<MMZ$D'L*^F_A/^R+\*O@_IEK!I'A'3[[4(0"VKZK
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M7Q#T33-4\)^+)&D@;6K2.YM@;A!LDQ("H(G4H6[ GM7WC_PS;\)/^B6^"_\
MPGK3_P"-UI4]C]7H<Z?P]+;_ &NF]]S*G[?ZSB/9M7YNJ=[?9V>UMOF?$W[/
M/Q&\,ZS_ ,%'-?OOAYJ"WWA/Q58SM(T<$MNK2"!9I#Y<B*P/FQL>G\1]:W?^
M"N'_ "*_PX_Z_KO_ - CK[/\-_!?X>^#=6BU7P_X$\,Z'JD098[W3='M[>9
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MT%JHIZ_-:_(X,'25>AB*-1W3DU=?)Z?,^=O@S^WY\)?BZMM:RZS_ ,(CKLH
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M&+]]@>BK*[?1:D_8G\'_  ?^,G[/GAR]G^'_ (.U'7M-B&FZJUQH=K)/Y\?
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MGMO_  4V^#OB?QUX/\*^+/#EE)JR>&)IWO;&&,R/Y4GEGS0@^\JF/Y@.S9Z
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M2VWIDYZ@8^I?A7^R7\*OA!IMK!HOA#3KF^A )U;4X$NKQWQ@OYC@[<^B;5]
M*[84:<:*K56[2;22\M'=G!4K595Y4**5XI7;\]4DEY>9\$_L]_$_1OB!_P %
M(H/$_A&WN]/T/Q#-=G[/>1K%(<V3M)N5&8<R(6ZGJ#UKZ1_X*7?!GQ+\4/A7
MHFK>&K.35)?#EU)<W5A I:5X70 NBC[Q4J,@<X)/:O%=&U2PU;_@K)%/IMS;
MW=JMS-")+9PZ!DTMT=<CC*LI!'8@BOTGFOK:WN+>"6XBBGN"RPQ.X#2$#)"@
M\G !)QVKJQ4^2.%JTU:T(M==FSCPM/FGBJ51WO)WMIJUJ^MCY(^ /_!1CX:>
M.-'TO1_%=S_P@WB*.*.WE6^7%C(X&"4F'"+QG$FS&<9.,U];6-]:ZI9PWEE<
M0W=I.@DBN('#QR*1PRL."#ZBO(/C3^R)\,?CI;W+Z[X=M[/6I@=NN:8HM[Q7
MQ@,S*,28]) PKY:_X)M^(M>\'_%WXE?":;4WU;PYHIGFMWY*1317(A9DZ[1(
M&R5SC*_7.;A2Q2G.G[LDKVW7G9_YFBJ5L&X4ZK4H-J*>SOTNO\C]#*_/[_@K
M%XZOH-%\">"+1V2WU2XFO[E5.!(8]J1*?;,C'Z@>E?H#7YY?\%:/"UTD/PZ\
M6PQEK>UEN+"5\$A7;9)'GZ[)/RK#!<CQ=+VGPWU^YV_&QU8[G6#K>S^+E_X?
M\+GV]\(OAWIWPH^&OAWPII42Q6NF6<<)*C'F28S)(?\ :9RS'W-?(_\ P5HA
MC;X.^#93&IE77MHDP-P4V\I(!]#@?D*^Q/AQXTT_XB> M \3:7,L]AJEE%<Q
MLASC<HRI]U.5([$$5\;?\%:-2M%^%/@RP-S"+Z36C.ML7'F-&L$BLX7KM!91
MGIDBJCSO%KG^+FU];ZF4^18!\GP\FGW:'U%\$]032?V<_ U](,QVOA>RF8>R
MVJ$_RK\]/V+_ -H3X;>&?BI\0/B;\5O$8L/%>K38L#)8W-R421F:8J8HW"\"
M-!D@A01T-?H7\$]/35OV<O UC(<1W7A>RA8CL&M4!_G7P;^P'X.\%Z7\7/B#
M\*OB3X3T'5O$4,V=/_MS3(;ART!=9DC,BD\J4< =0I-=U/E]OBN;>SVWMS/F
MM^%_(\ZKS_5L'RVM=7OM?E]V_P [VMU/J?4?V_?V==6T^YL;SQREQ:7,30S0
MR:+J!5T8$,I'V?D$$BO&_P#@E;KZ/_PMGP]I]R;GP]9:E;W=@QW#*R><F[#
M$;DACZ@'CI7UG_PS;\)/^B6^"_\ PGK3_P"-UT7A#X:^$?AZ;H^%O"NB>&C=
M[?M']CZ=#:>=MSMW^6HW8W-C/3)]:XU5H4Z=2--.\DEJUT:?;^KGH.CB:E2G
M*I*/NN^B?56?7K_D?GU^U!X7TOQI_P %(_ FBZU9I?Z5>1Z<EQ:RYV2KF0[6
M]0<<CO7Z2P01VL$<,,:PPQJ$2.-0JJH&  !T %?G=\>/^4H/PY_W=/\ _:M?
MHK16;^JT5_B_,6'2^N5W_A_(_.3PK;KH?_!634X;(^1%=-.\J)P&WZ=YC9^K
M_-]:]$_X*I>/KWPY\%]"\.V<S0IK^I8NMN1OAA7?L^A<QG_@-<!IO_*6RX^C
M_P#IKKOO^"JG@.]\1?!?0?$5G"TR:!J6;K:"=D,R[-Y]@XC'_ JVE;_8N;;E
MA^;M^)A'F3QW)OS2_P#25<^AOV8/AS8_"SX#^#-"L8%A?^SH;J[;&&DN94#R
MNWON8CGH !VKS7_@HI\.;'QQ^S/KVHS0H=1\/-'J5I.1\R8=4D4'T9&/'J!Z
M5Z7^S%\1K'XI_ ?P9KMC.LSG3H;:Z56R8KB) DJ-W!W*3SU!![UYK_P42^(E
MCX'_ &9=?T^:9!J'B!H]-M(21N?+J\C8] BMSZD>M<V(Y_K;_FYOQOI\OT.O
M#>S^I1_EY=?2VO\ 7<N?\$^OB!>?$#]E_P -R7\S7%YI,DVDM*QR2L3?NP?I
M&T8_"OF/P?X3TCQ=_P %3O$T&LV,6H06ES-?0Q3#*":.WC,;D=]IY&>X![5]
M-_\ !/GP!>?#_P#9?\-IJ$+6]WJTDVK-$PP525AY>?K&J-^-?/7PK_Y2J^,O
M]V[_ /26.O232Q]=Q_DG]^E_Q/)DI/+L,I_ST_N]ZWX'Z'WEO'>6LT$R"2&5
M&1T8<,I&"#^%?F-_P3)^'^AZA\>/'>I75BES=^'H2NFM* 1 7F=&<#^]M7 /
M8,WK7Z>O]UOI7YR?\$O?^2Q?%_\ W(__ $HEKAP+:]M;^7_,]+'14G1NOMK^
MOP/LO]J:Q@U+]G'XDP7$8EB_L&[?:?[RQEE/X$ _A7@/_!*:]EN/V>=<AD;=
M';^(YTC'H#;V[']2:^A?VF/^3>?B1_V+][_Z):OG/_@D_P#\D!\2?]C+-_Z2
MVU&'_P!VQ'_;OYCQ7^]8;UG_ .DHX3_@HI_R<Y\$?^ND/_I:E?H?+_JW^AK\
M\/\ @HI_R<Y\$?\ KI#_ .EJ5^A\O^K?Z&L<1_R+:7_<3\RJ7_(PK^E/_P!)
M/S9_X)6^$='U;XA_$K7[S3X;G5])^SQ6-U(NYK<3-<"4IV!81J-W7&1T)S]\
M?&32[?7/A)XUL+N-9;:XT:\C=&&0087KX?\ ^"3O_(>^,'_72P_]#NZ^[/B9
M_P DW\5_]@F[_P#1+UMG#?M&NT5_Z2F7E:5WIO-_F?'?_!)>ZED^$?C.W9V,
M,>N*Z)V!:!,G\=H_*OMG6]6TOP]I\VK:O>6FFV5HA:6^O95BCA4XR2[$!1P.
M_I7Q#_P24_Y)7XX_[#4?_HA:X_\ :F_M+]HS]N7PY\&-5UBYTSP=:>46@MV"
M[V-L;B23D8,A7]VI(.WL.3GKQE%U\>Z:=M$WY)15V>=@:WU?+HU&KVOIW;DT
M?0WC7_@HI\#O",DUNGB.X\13QDJT6C6,DJGZ2.%C8>X8BOES_@FWXFL]4_:O
M^(C:%'-:>'M4TZ\O+>UF4*R1B\B,2LJD@%5D(X)QSS7WE\/_ -GGX8_".PB'
MAWP=HVF-;)SJ$MNLES@<DM/)ESZ\M@5\/?L-:C::O^WI\5KZPN(KNRN+;598
M+B!@R2(U_ 592."".014X7V/[V--/X):O_+_ ((\6J_[F55KXXZ+_-O]#WG_
M (*<?\FMWG_86L__ $)J]#_8H_Y-6^''_8-_]J/7GO\ P4V1F_99OB%)"ZK9
MDX'0;B,_F17H'[$DB2_LJ_#@HRN!IQ4E3GD2N"/P(KDI_P"XS_Z^+_T@ZJG_
M ",J?_7I_P#I9X9_P5:\?7N@_"?PQX7M)6BBU[4'DN@O_+2*!58(?;?(A_X"
M*^G/V=?AS8?"GX*>$/#EA L(M]/BDN& P9+AU#RN?<NS?A@=J^8O^"KG@.\U
MWX4^%_$]K$TL6@Z@\=T5_P"6<4ZJH<^V^-%_X$*^GOV=_B-8?%;X*^$/$=A,
MLPN-/BCN%5LF*X10DJ'W#@]>V#WJH_[@^7^?7[M/P"5O[07-_)I_X%J>._\
M!2+X<V/C/]FO5=8DA0ZGX<FBOK6<CYE5I%CE7/H5;./55]*Z7]@OQ_>?$/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3NTNC;:^ZX5S7Q*M/$VH> ]<M?!LUC;>)[BU:*PN-2D>."&1ACS&*(S?*"6
M"G) ''6NEHKA:NK,]!.SNCRS]FKX)0? +X3:7X8,T=YJS%KS5;Z,EA=7DF#(
M^2 2!@*"0#M49YS6W\:/A#H?QT^'6J>#_$"N+*]4%+B''F6\JG*2IGN#^8R#
MP:[BBM:E252;J2WW_P"&].G8QITXTH*G';^M^]^O<^#9/V,_VB-0\-)\.+[X
MT:=)\,%46^U87-Z;<=(ROE;BN !L,Y4 8Z<5]B_"GX8Z)\'/A_H_A#P_$\>F
M:;%Y:-*09)6)+/(Y  +,Q+'  YXP*ZVBMJF)J58\LO5Z)7?=F%+"TJ,N:-]-
M%=MV797V04445RG8?%_QH_X)L:7\7OC-J?CA?&C:+9ZE<17-UI":5YI9@%$F
M)?.7&_:3]PX+'K7V9;V\=K;Q00HL<,:A$11@*H& !^%245M*M4E3C2D_=CL8
M0H4Z=256*]Z6Y\V_$G]CH_%']I3P]\4]8\7[].T1K8VWAW^S<C$)+J#/YW>4
MEC^[Z<>]?25%%3*I*4(TV]([?,J-.$9RJ):RM?Y;%35]+MM<TF]TV\C$MI>0
MO;S1GHR.I5A^1-?/O[)G[(MU^RS>^)A%XU/B32M9\IA8OIGV8P21EMK[_.?=
M\K$'Y1G /;%?1M%$*DJ:DHO26C^05*4*CC*:UB[KR/F[3?V.O[/_ &MKGXW?
M\)=YGG.[_P!A?V9C&ZU^SX\_SO\ @7W/;WKZ1HHHE4E.,8R>D59>B"%*%.4Y
MQ6LG=^;85\._M2Q_\+]_;"^%?PHMA]ITO0"=;UL*,HBY#E7],I&J\]YQZU]P
MMG:<'![9%>#?L[_LVWWPH\;>/_&WBG6;?Q-XO\47[/\ VA!"T:Q6F0RQA6)V
MDMU ) "1C/%;8:<:57VLOLIM>;V7W7O\C'%4Y5J7LHKXFD_);O[[6^9[U111
M7*=9\Y_M4?L@_P##3'B+P?JO_"6?\(W_ ,(]YO[G^S?M7VC>\;=?-3;CR\=#
MU]J^C***T=23IQI-^[&]OGJS)4H*K*LE[TK)O_#HON/G;]FG]D7_ (9W\>>-
M?$G_  EG_"0?\)(V[[+_ &;]F^S_ +UY/O>:^_[^.@Z5] :E9_VAIUU:[_+\
M^)HM^,[=P(SC\:LT4JDG624];*WR*I0C1=Z>FM_F?/G[(O[)O_#*VF^);3_A
M*O\ A*/[:E@EW_V=]D\GRU<8QYLF[._VQBOH.BBJJU9UINI4=W_EH9T:-/#P
M5.DK)7_%W?XGB'[4'[+NG_M*Z+I44WB+4_#6K:/*T^GWEFY>))#CYGAR-Q&!
MA@58>N.*\3C^ /[8&EV?]B6/QQT2?1%'E+=W:,U[LZ9+M:N^['?S<^]?;=%7
M3KSIQY-&NS5R*N'A5ESZJ7=-I_@> _LM?LCZ/^S?!JFI3:K-XH\8ZP?]/UNY
M382I;<412S$ M\S,6)8@$XP /E[_ (*7Z3;>(/V@O@_I=XK/9WT:6TRJQ4E'
MNU5@#VX)K]'Z^,?VT/V>_'_Q8^.GPL\0^%- _M71]%>(W]S]LMX?)Q=*Y^62
M16;Y03\H-=6%K.IC:52L]+^B2Y7]QR8O#JG@*M*C'5I>;;YE\V%]^RW^T-\.
M+<Z'\)_C;&/"7W8+/Q1&'N+./&!''+Y$QP!TV^6!V%=5^S-^P_9?!OQ9<>._
M&.OR^.?B#<%G_M"X5O+MF<8=E+DM)(<D>8V.#@*.2?J2BL?K56S5]7HW97:\
MV;_4Z/,G9V6J5W9/R6PC*&4@C(/!!KXT^(?[ VJZ%\0+GQW\#?&S_#S7+@LT
MVFRAOL;%F!8*R@[8R1GRV1USC&  *^S**PIU)T9<T'9G35I0K1Y*BNOU[H^*
M9OV8_P!ISXF0G2OB+\<[&QT!N)H_#-OMEF7NC%(;?@CCDL/8U]CZ#I;Z'H>G
MZ=)>W.I/:6\<!O+PJ9IRJ@;W*@ L<9. .3TJ_15U*TJBY6DEY)(SI8>-)\R;
M;\VV?*'[0G["-I\1O' ^(7P_\2S_  _\>*_G/<VX807$H&/,RA#1N>[+D'NI
M))KD+[]F3]J;XC6+>'O'7QPTJU\,RKLG.B0'[1*G0JVR" L".H:0@]\U]O45
M4,3.$%#1I;72=O2Y%3"TYS=35-[V;5_6QQ/@WX8P^"?A+9>!+;5K[4+>TTYM
M.BU#46$L^TJ5!. H(4' '&  ,]Z\X_9'_95_X99T'Q!IO_"4?\)/_:US'<>;
M_9_V3RMB%=N/-DW9SUR*]]HK/VU3W]?CW\[._P"9I]7I_N]/@OR^5U;\NYXG
M^U=^S;_PT]X#T[PU_P )%_PC7V/4%O\ [5]A^U[\1NFS;YB8^_G.>W2O3/A]
MX5_X03P'X<\-_:OMW]CZ=;V'VKR_+\WRHU3?MR=N=N<9.,]37045/M)<GL[Z
M7O\ /8OV<'4]K;WK6^5[_F?.OQM_9$_X7%\>O WQ)_X2S^R/^$8:T/\ 9G]F
M^?\ :?(N6G_UOFKLW;MOW6QC//2OHJBBAU)2A&FWHKV^>XU3C&I*JEK*U_DK
M(^//BM^P5>+\0Y_B%\&/&,GPY\43LTD]IAA:2NQRQ!3E%8\LA5U)[#I69+^S
M;^U-\1(&TCQY\=-.T[09!ME/ANVQ/(O=24@MS@C@Y<CU!K[6HK:.)J1BH.S2
MVND[?><\L)3E-S5TWO9M7];&/X/\/-X2\*Z1HC:C=ZN=/M8[7[=?LK3S[%"A
MG*@ L<<G%?*WQ[_8-N?%7Q(/Q*^%7BK_ (0/QHTAN)E(=;>68\-(KIEHRP)W
M#:RMDY R<_8-%9QK5(5/:Q?O?Y[FLZ%.I3]C)7C_ );'QWI?[*?QL^*8BT[X
MY?%Y-5\*Q.K2Z'X8C$ OE'\$TJPPG;G&05;/8J<&N\_9K_8^LOV;?'GC77M-
M\0#4-/\ $! M]+%AY L8Q*[J@D\UMX 8+G:O3-?1%%:O%5-5&R3Z));_ -;F
M,<'233E=M:IMMO\ KRV"L?QEX>_X2[PCK>A_:/LG]IV,]G]HV;_+\R-DW;<C
M.,YQD9QUK8HKC:4E9G=%N+31X=^R9^S+_P ,N^"]7T#_ (23_A)O[0U#[=]H
M^P_9/+_=HFS;YDF?N9SD=>E=1^T1\'?^%]_"76?!']K_ -A?VB83]N^S?:/+
M\N59/N;TSG;C[PZUZ316]2M.K4]K-WEI^&WY&%.C"C3]E!6CK^.YYO\ L[_!
MW_A0?PAT3P-_:_\ ;O\ 9IG/V_[-]G\SS)GE_P!7O?&-^/O'.,^U<A^UM^R]
M_P -2>%=#T;_ (2;_A&?[,O6O//^P?:_,S&4V[?-CQUSG)^E>[T42K3E4]LW
M[U[_ #%&C3C2]BE[MK6\C%\$^&_^$.\&:!H'VC[7_96GV]C]HV;/-\J-4W[<
MG&=N<9.,]37RE^T#^PWXC\2?%]?BG\)?%T'@_P 7R.);B.[,B1-+MVF19$5R
M-R\,A0JV3GJ17V/13C6J0J^V3][7\=R98>E.BJ$E[JM;RMM\T?)GA3]D_P")
M'Q$U;3KW]H+XCQ>-],TV83P>%])@6'3YY!]U[C;%%YH']TI_P+!(/9_LP_LF
MP_LU>(/'6H6WB-=:M_$L\4L=HNG"U%DL;S,$!$C[QB;'1?N].>/H"BKEB:C3
MBM$^B22W3_-+7<B.%I1:;NVNK;;_ *UVV.*^,OPGTCXW?#?6O!NMF2.RU&,
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MDG<7\>K3)''%$%^4@-/%DECV8_=/'-/GE44:;>BV^9/)"FY5$M7OYV1\I_\
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M(TAB\SW5I2/K7U%\"?@3X9_9[\"0>&?#,+F/=YUU>W&#/=S$ &1R!Z   <
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M?UL>0?LW_LQ^%/V:/"LNFZ")+[4[PJ^H:Q=*!-=,,X&!PB#)P@Z9Y).35O\
M:6^!O_#1'PIO?!?]M_\ "/\ VFXAG^W?9/M.WRW#8V;TSGIG=Q7JE%9SJSJ5
M/:R=Y73^[8TA1ITZ?LH*T;-?)[G$?!/X:_\ "G?A7X;\&?VC_:_]CVWV?[=Y
M'D>=\Q;=LW-MZ]-QZ5Q7[5W[-O\ PT]X#T[PU_PD7_"-?8]06_\ M7V'[7OQ
M&Z;-OF)C[^<Y[=*]LHH=2<JGM6_>O?YWN.-*$:7L4O=M;Y6M^1S_ ,/O"O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6%J.LZ'VDK_+3\[_ .8GBZ2HJO\ 9;2_3\+:_A<^ZZ*^ OBSXP_;#^!F@O\
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M^%N:*?@S_P +($JC1/[&_MG=N_Y9^5YFWZ_PX]>*_,:7P[J-K8? SQIK2_\
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M[#"AF8@8 ZDUP/[?G_)I'C__ *Y6O_I7#7DG[+O[;'P7^'7P \$^&_$/C/\
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M=.QY.&E'ZK3JSYDY2@F[_$VKWW^%]=F[;'U;17@G[4W[3$_P/M=$T#PSH_\
MPD_Q$\22^1H^D8)3J%\V3!!*Y( 4$9YY !->.W=I^VUX8T^7Q;<:WX1UJ*%#
M<R>$8H(S)M R8P5A4L0.RSDGL37F4Z+G'GE)1CW?7O\ =UZ'L5,0J<_9QBY2
M[);7VOZ]%N?;M%>8?L[_ !TTWX__  IT_P 86D']G2L7M[^RD;/V6XC_ -8F
M>Z\A@?[K#.#D5\Q:E^TY\:/VFOB5K7AGX 1:;H?AK19/+N/%.IQ)(LAR0&RZ
M.H5B#M58V8@;B0,@-8>HZDJ3T<=^R^?Y=^@I8JE&E&JG=2V[M]K?GVZG>?\
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M'&"T>#U5:]%_8C_:5U;]H7P/K,7BBTAL_%WAV[%GJ @0QI*&!V2;"?E;*.K
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MU7V%*=6WPIOY]/Q/6_V2/A_JOP^^!^BIX@OKN_\ $6L%]:U.2[E9RD]P?,*
M$X7:" 0.-P8]Z]EK%\8>,-'^'OA74?$.O7:Z=HNFPF:YN3&SB-!QG:H+'J.
M#7R_>_MR:_\ $F62R^!_PIU[QPY9HEUS4XS9Z:C#ON)Y'L[QFM9*>)J2G"/^
M2[>2,HRAA:<83EK][;ZNV[/KJLOQ1XGTKP7X>U#7=;OHM-TFPA:>YNICA8T
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MK&I7OA7XFV$DJ+<:':K'!+&C, 2'$$)!&>H+XZ[2 :^Q;BS&K:3+:WT*!;F
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M#X/\5:G%;P:AK&F07L\=HK+$KN@8A S,0,GN3]:\7_X*1?\ )I?B?_KZL?\
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M+P)HNJVUCX-\.:CXQWRA)+NXE_LZ *>,IN1W8^S(OUK[:C;?&K8QD9K\[?\
M@I9\+?!GP_\ #7P\N/"_A'0O#<]QK$B32Z1ID-JTJA%(5C&H) /8U^B$'^IC
M_P!T?RKT:T:/L(3I)K5IW\E'Y=3RJ$Z_UF=.LTU9-67=M>O0^6/$VM7WP&_;
M2T:[N+VYE\&?%"V73Y$N)F>.TU*'B+9DG:&W*H48&9&]*^JZ^4_^"DFDNW[/
M</B2URFI>&M:L]1MIE^]&V_R\_FX/X5],>%]:3Q+X9TC5XL>7J%G#=KCIB1
MP_G6+7/AXSZQ;C^37X.WHD=$7[/$RATDE+\7%_DGZMFI1117*=@4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\\8VGV.2TO+K4CEIUDSO4#)*H-Q"@DD#')Q7RQH/P,_:/_9+U#4M-^#[Z/\
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MC..%4.5IJI>V^G,W]WG\STO]L15?]E_XEA@&']C3'D=Q@BN=_8!_Y-(\!?\
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MI5TWNHV^]GI8F,I5\.TM$YW\KQ5KGD_P5_Y2??%__L"-_*PKT?\ X*2?;?\
MAE'Q!]DW>7]LL_M.W/\ JO.7T[;ME<3\;OV>_B_X$_:4N/C-\%[;3M>N]4MQ
M!J&CZA,D8SL5&!WO&&0B-&X=6##TKW3P%X;\;?%SX+ZUH7QRT+2M/U'6&FMY
MM/T>7=&ELRKL.=[X<-N((9NBG-:U&I4J%2+7N**:ZWB_ZU,Z:<:N(I237M)2
M:=M+27?NNQ\Q_"/X>?M>:I\+?"5WX3^+/@RS\,S:7;-IMLUK$6AM_+78C?\
M$O;YE& ?F/(/)KJ/ _[,'[05_P#M">!_B)\3?''A;Q!'X=,D>[3PT4_DNCJ4
M54M(E;)?^(\ GZ5C^&_A)^U%^RK]H\/?#)]#^)7@@RO)86>L2)'):!CDY#RP
ME223D+(RDY. 6->V_ '3_P!H35/%USXC^+.H:#HVC26C00>%-)B$ACE+*1*9
M S8( (_UDF03PO6NVI6]Z5:FX6U:T][7IWOT."C0M&-&JIW5D]7RZ?A;J>.?
MM>?\GP?LZ_\ 7S%_Z5"ON6OD7]M+X%_$CQC\1OAM\1OAEIUGK>M^%IB6TZ\G
MCB#$2+)&W[QT#+D,& 8'D8]OJ?PS<ZG>>&]*GUJTCL-8EM(GO;6)@R0SE 9$
M4@D$!L@')Z=37G2:>$II/5.5UUU=T>E",HXVK)K22A9]-%9_B>'_ +?G_)I'
MC_\ ZY6O_I7#7.?LA_ KX:^)OV:_ &J:O\/?"NJZE<Z?OGO+[1+:::5O,<99
MV0EC@#DFO0_VO? &O?%#]G;Q?X8\,6']IZY?QP+;6OG1Q;RMQ$[?/(RJ,*K'
MDCI6C^R[X+UGX=? #P3X;\0V?]GZUIUCY-U:^:DOEOO8XW(Q4\$=":*4^7"U
M$G9N:^[E_(=2GSXJ#:NN67I>\?\ @GC'[;GP/^'/A/\ 9?\ &^JZ)X \+Z-J
MEO%;F&^T_1K:">+-S$IVNB!AD$C@]":]2_9(NHK']E7X=7,[B."'0HI)'/15
M"DD_D*D_:]\ :]\4/V=O%_ACPQ8?VGKE_' MM:^='%O*W$3M\\C*HPJL>2.E
M:/[/_@'4?"O[._A'PAXELS9:E;:.MC?6HE1S&Q4JR[T)4\'J"12]I)X.I%N\
MN=6O_A_*Y2IQCBX24;1Y7>R\XGS)I'QV^/G[7VM:R?@X^E> ? 6GW1M1KVIQ
MA[BX( ./F1_F*D-M1!MR 7YKQGX[?"?QW\(_VA/@?/XU^)5]\0=2U#6H9H6N
MD=8['9=6^5C#.PPQ8$X5?NC@]O4OA]\(?VH?V4+W6/"_PUT?P[XW\&7MXUU;
M7&I3QIY!;"[BK3PNK;57<!O7Y>.IS!\0?V2?CGXP^)'PW\?>*-8A\9:]!K<,
M^HZ?I\T5O8Z+9I+&X$(D9"YX?=M4DX'WCR?7P\J5'$4I4Y15/3?XGIUZK7T1
MXU>%:M0J0JQDZGE?E5G?3H]-.KN:G_!4C^V/MGP?%A=06-O_ &M-LNKI<P0W
M.8?+>0%6&T#<>0> W!Z5T/\ PJW]MP\CXP^"B/\ KTB_^5M?0G[17P$T7]HS
MX:W?A75Y6LI=XN+'4(T#/:W"@A7 /48)!7(R">0<$?-/A^W_ &T/@WI\/A;3
M-&\+_$;2K-1#::Q?7*>8L0X526N('.!_>5C[FN'#U$Z"I+EYDV_>ZI^;V:V]
M+=CNQ5)JO[5\W*TE[K=TU?=+=:_)W[G:?LO?LV_%CX<_&[Q9\0OB7XFT#7[O
M7M-%K.^CEU>257BV,R?9XD "1D9'//U-<3\-?^4I7Q$_[ ?_ +2M*^C/V>=#
M^+>EZ1J]Y\6]?TK5=4U"X6>UT_2H L>G)MP8MX W=N,'!!^=L\>6>!_@AXUT
M?]OCQG\1KO1?)\&:AI7V:VU+[5 WF2>7;C;Y0?S!S&_)4#CW%5"I^_ESM65.
M25M%TLE^7Y Z-J"Y%*[J1;OJ]]6_S_,]+_;$57_9?^)88!A_8TQY'<8(KE?V
M$+&WU3]CGP597<2W%K<6UY#+$XRKHUU,&4^Q!(KT3]I'PCJWC[X#^./#N@VG
MV[6-2TR6WM;;S$C\R0CA=SD*/J2!7$?L\_"'Q;X6_9%TKP#JEU/X+\6"RN[9
MKJV>*XDLGDGE9'4HQ1CM8'AN_4'IQQDOJM2+W;CI\I'7*,OKE*2V2EKVUB>7
M+^RK\8?V=+Z_N_@+XXM;SPU<3M=/X-\2H&C!_NQR$$9/ R#$2 -S-C->D_LO
M?M47GQHUKQ#X+\7^&V\(?$3PZ,ZAIRL6AE7<%+QY)*X8KE26X92&8'CRVS_X
M;3^%-N/#UAIWA?XG6,(\NWUR^G19Q&.%W[YX&9L<DLKG/\35V?[,'[./CCX<
M^)/&_P 4OB#J%GK7Q(\20%!963 0PJ,-Y9? 7)9(UP/E4(/F.>.R;BZ<I5I*
M22T:^*_3S];G%!252$:$)1;>J?PVZZ[>EOF1_MK_ !RUC2X=*^$'P]8W/Q%\
M9$6P\A\/8VK9#2$C[A8!@&_A4.W85[!^SQ\#M(_9[^%^F>$]+VSS1CSK^^V[
M6N[E@-\A]N  .RJHKX<\ _#?]K/P#\6?$GQ(7X5Z#K_BS6\A[S6M2M9?LB$\
MI $O4V#:%7G)VJ ",G/T#\-/B)^UKJGCW0[3QI\+_"FD>%)KE5U&^L[F-IH8
M>[(!?N2>G\#?2AT>6BJ<)QN]9:K?HO1?B]1+$<]=U:D)66D?=>W5^K_!61\_
M?$+2OBIKG_!13QC9_#SQ)I7A;Q4^FQ_8KS68U>)[06\!:.,-#*-QP3PO17YZ
MY]6O/A%^VO?6LUM<?%[P5)!,C1R(;2/#*1@C_D'>AKT']JC]E'4_BQXBT3X@
M> ->7PI\2]! 6UO')6*Y122J.P!((W, <,"&*L"#D<%:^)/VW=4C70I/"O@S
M2"P\H^)Y98F*]O-V+<.,]\>1_P !ITZBJ4(07+>*LU)+IU3??JNX5*3IUYSE
MSVD[IQ;[+2RVMT?:W8]7_9.^!_B+]GOX#77A+Q-J&GZA?I<W5TCZ9)(\*1NH
MPH+HASD,3Q_%7C__  2F_P"21^-?^QC?_P!$15];> M#U_2_A_I.E>+=8BU[
MQ!%:""^U.WA\E;B3&"P7UQWXR1G S@?+O[%/P9^+?[._CKQ9X2UW0]/E^'5Y
M--?6^NPW,32R7 *+'A!)O"M&#D-'PP'S8ZQ&I[1XCGDKR2L]D^5]/EMW-?9*
ME'#\D7:+>F[7,NOH]^B/LFOACXS?\I.?A+_V"?\ V2\K[GKY'_:^_9Q\?^+/
MB9X.^+'PJEM9O%_AY%A;3KN18Q.BNS*5+D(?ONK*Q7(/!KFPDXTZ\92=EJOO
M31UXR,IX><8*[TT]))_DCUW]K;[;_P ,S_$K^S]WVG^Q+C[N<[-OSXQ_L;J^
M+_V6/ _[4&O_  .\/7?PU^)OA/1/"!,ZVNGWEM&T\#"9_,$A-C(<E]S<N>&'
MTKZ_^ =]\8_&FD^(XOC;X6T#0X+A$@L[#2I!()(R'$PE FE&""F/F]>!7@-K
M^SG\>?V4_$FJR_ N]TWQ=X)U*<W \,ZY*JM Y&,_.\8X  WI(I8 ;E.T&NF@
MU1]I1DU=V:>\=+Z?COZHX<1%U_9UXJ5E=-+26MM5]VJ(-:_95_:>^(WC#P5J
M7C_XB^#];L?#>KP:E"MNAAECVR(SE/+LH]Q(7@,V,@=.M?0?[2W[+NF_M"6N
MC7\.M7GA3QAH,AFTG7K')>!LAMK*"I(W*""&!!&0>H/(_!Z']J#Q=\0-+UOX
MCR>&O!/A:Q\P7'A[3(UGDOBR$ EEDDVX)!SYO! ^0UI_M%?#KXW7?C+3/&GP
MD\:PPO8VOV:;PGJBA;2Y&[<6!(*EV^4?-M( ^5UR14U*D^>G'FC&UW>/1OO;
MO9?)ZETJ</9U)<DI7LFI;M>5WTNWTUV/*->^-_[0O[),=M=_%33=*^)/@(3K
M!+XAT?$-W"&.$W@!1G'9DPQP/,R<GV/]JWQ%8^+OV-O&FN:7-]HTW4M!2\MI
M<8WQ2%&4X[<$5X/XX^'?[5_[4>EQ>#/'FD>%_AYX3DGCEOKJRE25YU1@0-J3
MS,Q!&X+E 2!DBOJ_Q5\%=+U_X"W?PNMYY+32VT5=&M[AOF>-4C"1N?4@JI([
MXJ<3R^RO*W/?[/:W6VE[]B\*YNK:/-[.WVNCOTOK:W?J<7^PC_R:7\._^O2;
M_P!*9:]ZKX1^!/A']K+X%VND_#VS\->%]5\&6-[D:S=7:,R6[2[Y%CQ,KX.7
MQNA)&[TQC[NI8U)UI58R34FVK??KVW#+^:&'A0G%IP23NNRMIWV/G?\ :'_9
M-?XK>,-*\?\ @[Q5=>!/B-I4?E0:K;J7BG09PDJ@@_Q,N1D%6(96& /+Q^T_
M\8_V9_$VB:/\>]"TS6?#&I3BTA\9:#\N'[M(@ 4X'.W9&<!B-V,5VOQH\!_M
M%>&?B;?^-_A5XKLO$FDWD<:2>#=<VI%%L7 $62JX))8L'C;G!+#IYCKOP-_:
M)_:TU[P_:?&2ST'P+X)TF\6[GT[295DENB!@[0LLWS$97+. H8G:QXK;"\K4
M55E%PZI[KO;K]UT8XJ\92=*,E4Z-;/M?I]]G8[__ (*;,&_99NV4Y!U6S((_
MWFKW[X)_\D9\!?\ 8 L/_2>.N8_:B^![?'[X*:QX.M+N.POY/+N+&:;/EK-&
MVY0^ 3M(RI(!(SG!QBO%_P!G-/VI_!^I>$_!GBWPMX<C\"Z.%M)]::ZC>[EM
M40J@79.<D#;C,0)"\GJ:QHJ,\/.GS)/FOKIIRV_I&U;FIXJ%9Q;7)RZ:Z\U_
MN\SF_%RAO^"JWA#(!QH3$9'3_1;FON2:9+>&265@D<:EF8]  ,DU\J^(O@CX
MUOO^"@'ASXDP:+O\%6FDFUFU/[5 -DGV>=-OE%_,/S.HR%QS7U1=6R7EK-;R
MC,4J-&PSC@C!K+$2O1I*.ZB_OYI&V&BU7K.:T<E]W+'8^&;#X^?'?]KCQ)KM
MO\%6TKP1X%TNY-J?$>J('FN&'.!N23!*D,%5/E!&YQD5XI^T9\(_'WPF^,'P
M;O/&_P 3;[X@:AJ&LQO"MQ&ZQ6)2X@SY89V&&W#.%7[HZ]O5O OP9_:;_9-U
M;7?#WPNTCP_XW\%:A>-=V[ZG/&GD$@+N96GA</M500"ZG;D=:J?%']DGX[^/
MO&'@/QUXIU>W\7^(H=:ADN](TV:*WL=&LED1_P!WYK)O;(.=H).!R_6O7P\J
M5&O2E3E%0TW^)Z=>VOHK'C8B-6M1JQJ1DZFNU^5:Z6[Z>K;/HC]OS_DTCQ__
M -<K7_TKAKH?V/?^37_AI_V!8?Y&NF^.OPNB^-'PD\3>"Y+G[$=6M?+BN"NX
M12JP>-B.X#JN1Z9KY;_9^\/_ +6'PA7PW\/[GPQX9O/ ^F7B1R:W/=QO*+/S
M=TBQE9@WW2VW=#D9%>9ATIT)T>9)N2EKII:QZU=RIUX5>5M6DM-=6XM?D1_M
M0?\ *0#X!_\ 7-/_ $?+7MO[<W_)J/Q#_P"O*/\ ]'QUQ?QX^"/C7QG^V!\(
MO&^C:+]L\,:"BC4;[[5 GD8E=C\C.';AA]U3UKU+]JSP-K?Q*_9]\9^&O#EE
M_:.MZA:I';6OFI%YC"5&(W.RJ. >I%92DOJ]&/5.7_I9<(OZW6E;1J'X1,K]
MBC_DU;X<?]@W_P!J/7@_[/O_ "DD^-G_ &#7_P#0[2OI3]EWP7K/PZ^ '@GP
MWXAL_P"S]:TZQ\FZM?-27RWWL<;D8J>".A->2?!WX(^-?"O[;?Q1\?:IHOV7
MPEK5DT-AJ'VJ!_.8M;G'EJYD7B-_O*.GN*[>>/URO*^CC.WG=JWWG![.?U'#
M0Y7=2IW7:R=[^G4\/_:BL?'^J_\ !0CPQ:>"-<T_PYXFET6-=&U#5D#VZ#R[
M@R##12C<W[U1\AY(Z5Z7_P *L_;=_P"BP^"__ .+_P"5M>G_ +6/[*__  T!
M8Z/K6@:P?#/C[P\_FZ3JH+*I^8,(W*_,H# ,&7)4YX.2*\KL?$G[;UE"F@R>
M$_!UZ5'D_P#"33S0[CV\TJMPOU_U'_ :*513HQ@N7FC>_-;NVK-^NJ[CK47#
M$3G+FY96MRM]DFFEZ:/L;?P9^ ?CG]G?]FOXPV'B35M,U'6M4AU#5+9]$=V1
M9&M""?GBCPQ9>@7 P/I3/^"7$>GK^S5,]H$^V-K=U]L*CYMX6/;G_@&ROH?X
M2^&_%VC?#>QTKXB:Y:>*_$A607U]:V_E12!V8[,8 8 ';G:N0!\HKX_M_P!F
M_P"//[*7CW6[_P"!?]E^+/!VL3>:?#^JSHGDGG:&$DD?*@X#I("PQN' J8U%
M4G6ISDDY**36B]WI]VQ<J;IPH5(1;4')M/67O=?/7?KJ=?\ \%4_^3<=+_[&
M*V_]$7%?5O@;_D2?#_\ V#[?_P!%K7P=\>OV<?VD_P!HGX?R:QXQN--&KVDT
M1TSP)H,T45NI+8DFEEDEV%E7.!YC]3@CD'[X\*V4VF^%]'M+E/+N+>SABD3(
M.UE0 C(X/([5G*,:>&<.9-\U]/\ #^/Y=#:$I5<4JG*TN2VO^)OY>CUZFE+_
M *M_H:^(/^"5?_(@_$7_ +&#_P!I"ON"0%HV ZD5\K_L _!/QI\$_"/C2R\:
M:-_8USJ&L?:K6/[5!/YD7E@;LQ.P'/8X-98>2C3KIO=1MY^\;UXMU*+2VD__
M $EGFL.S_AZY-_;FW=_9/_$HW],_8AC&>^//Z=\U]YU\V?M8_LIZA\9M3T+Q
MMX(UI/#'Q(\/$&ROI"5CG16W*CL 2I5B2&P1\S @@Y'ENK?\-L?$#19?!][H
MOA?PM;7,9MKCQ1;W,2S,A&&;Y)Y"I89Y2%2,\;:TY5B*-.,9)."Y6F[=6T_G
M?7J<_,\-6J.46XS:::5^B37X:=#/_P""=^W_ (7Q^T!_96?^$=_M(>3L_P!7
MG[3<^7CM]W=CVQ5WX+*&_P""H'Q=) )716(R.G%B*^B_V8?V=-)_9J^'*>'K
M&Y.I:E<R_:M2U)DV&YF( X&3M10, 9]3U)KR_P"%_P #_&WAW]N_XC_$34-%
M^S^#M7TLVUEJ7VJ!O-DQ:?+Y:N9%_P!5)RR@?+[C/3&K3^L2L]%3<;]W:*_'
MIY'/*C4^KPO'WG54FEK9-R_+JSZNIDO^K?Z&GTR7_5O]#7A5?X<O1GN+<^(/
M^"5?_(@_$7_L8/\ VD*],_X*+7%A#^R;XK6](#R36:6P/4R_:(R,?\!#?D:^
M/_V+?#_QLM]!\9>*?A#K.EW/V75C;7WA76EQ;WOR;ED1L@*_./O)P!ECTKV*
M_P#V=_C_ /M9>+-'?XXOIG@SP3I<XG;0='F1VN&'4J$DEY897>\A*@G:O)KZ
M'%48SQ2G*:27(WWT2>W6]NAX=*O*%&<(TVVW-+L[M[]EWO8]8\ PW=O_ ,$[
MX4O01/\ \('<L <_<-K(8_\ QPK5+_@FBH7]E31R  6U&])P.O[TC^E>Z?%#
MPG-JGP9\5^&M!LE:XN-!NM.L+.-EC7<UNT<<8+$*HR0.2 *\V_8=^%_B?X/_
M +/VF>&O%VF?V1K4-Y=2O:_:(IL*\A*G=&S+R/>N7VT:GUB>W,TU][9T*C*G
M]6AORJ2;^45^-CC/^"G'_)K=Y_V%K/\ ]":MCXN?;/\ AWO=_8,^?_PA-INQ
MG/E_9XO,_P#'-U:G[=7PJ\4_&3X"7/ASP?I?]KZR^HVTZVWVB*#*(3N.Z5E7
MC/KFO5/ /A-K?X0>'/#.O6:EX]"MM.O[.1@ZY%NL<L9*D@C[PR#CT-<ZDOJD
MH]>>]O\ MU?@:RBWCX3M[OL[7\^=_C8\A_X)Y_V=_P ,E^#/[/V[MUW]JVXS
MYWVF3=N]\;>O;%>??\%5?[._X9_T;[3L_M#^WH?LG][_ %4N_'MCK^%8.F?L
M^_M ?LF^(-73X(S:5XV\$:E.;A-!UN54>V<C&3ODB&0 !N20;@!N7@5?\/\
M[+_Q;_:(^)FB>,OV@KO3=-T717$EGX0TIPZ%@0<-M9U"D@;CO=F V_*,5W35
M.KB5B>=*-U+S6M[6_#M;J<$'5HX5X1TVYV<?)WTO?\>]^AVW[5OVW_AW]J7]
MI;O[1_L/2OM/F?>\WS;;?GWW9KT;]CM0G[+_ ,-0H"C^QH3P/7)-'[7GP_U[
MXH?LZ^+_  OX8L/[2UR_C@6VM/.CAWE;B)V^:1E4852>2.E;7[-OA'5_ /P'
M\#^'=>M/L&LZ;ID5O=6WF))Y<@'(W(2I^H)%<OM%/#U;Z-U$[>7*=L:3IUJ2
MW48-7^<?SL>DU\.?\%9N?@SX/'_4P#_TGFK[CKY5_P""AGP3\:?'+X9^&M)\
M$:-_;>H6>L"ZGA^U06^R+R9%W9E=0>6 P#GFL<,TJ]-RVNOS-\4G*A426K3_
M "/#?C!_P3*\-Z'\&+_Q)X%U3Q%J/B:ULTOEL-1G@DBG0*&D1%2%&W[<E>3R
M,=\U[E_P3IOOA]K/P+@O/"&@66AZ]$PM/$"PEGFDN$'#L[LSE'!W*N=JEF Z
M&OIW1+>2TT6P@F7;+%;QHZY!PP4 CBOD3PO\ /'WP!_:\O?$O@#0O[5^%WBO
M!UFUAO((?L+LQ)81R2*6\MR7&T'Y7=1S7>L1*O[2A4GH]4^EUT?DUMTN>9]5
MCA_98BE#5:25M;/JO-/?NO0Y3_@JE&DUG\)XY$62-]6G5E89!!$601Z5]53?
MLT_"*:-HV^%O@T*PP2F@6JG\"(\BO#?^"A'P.\?_ !GTWP&? 6@KKMUH]]/<
MW$;7<%N$!6/9GS9$R"5/0UC2?$W]MZX4QCX2>#+8MQYRW<1*>_.H'^1K*FG/
M"QA&234I7N[;VM^3-*C5/%RG.#DG&*5E?5.5_P T<EX\\-V?['_[8GPQB^'$
MEQI?AWQO.EIJOAN.=Y+8[IEB\P*Q.,>8&7^Z4;&%)%2_M<7(^$_[='P>^(NI
M-Y.@7,4=E-=.,)%MDDCE)/\ LI<*WYUV_P $/V2/'VK?&*U^+GQQ\26VM^)K
M$?\ $MTBQPT-J0#L+$*JKLW,0B C<0Q8G(/O/[0GP#\/?M%?#VX\,:]OMW#^
M?9:A"H,MI. 0'7/48)!7N">AP1I[>-&5%R?.XWYFNJ=]+];)_H2L/*O&NHKD
MC.W*GT:M=VZ7:_4]+5@ZAE(96&01R#2U\+>&_#W[8_P"T^/PQX?L_#?Q0T"U
M'E6-WJ%PBR01#[JY>>!^F.&+@< ' %=]\%_@W\;_ !+\5M/^)/QA\7QZ8VG0
MR1V'A+0) +=1(,.LV,J5Z'&78D+\XV@'FEAXJ\E47+^/EIN=4<5-VBZ34OP\
M]=K'U77PU_P4>_Y*%^S]_P!A^3_T=:5]RU\U?MP?LVZ[^T!X/T"[\)7D-KXL
M\-WC7=DEP_EI,&"[E#]%;*(P)X^7!QG(SPLXTL32J2V3U_%?J;8J$JF'J0AN
MT_R/I6OAK]DM1_PW1^T(V!N#R ''/_'R/\!7KO[.OB+]H[6?$TD/Q=\*^'M!
M\/P6+)'/I\R-<W%QN3:[".>5<;0^<!!DCCM7.?L[_!'QKX%_:M^,?C'7-%^P
M^'/$#L=-O?M4$GGYF##Y$<NO'/S**VI15&K-2DM82V?FM/7R.:M-XBE3<8M6
MJ1T:UT3U]/,^B?B'XYTWX9^!]<\5:N7&FZ1:27<PC&78*,[5'J3@#W-?&7@_
MQ=^T_P#M=:;_ ,))X8UG1_A/X"N9'2T;RQ+=7$88J65BC,Q!!&X&($@X%?8'
MQ<^'L'Q8^&7B7P?<W#6D6L64EK]H49,3$?*^.^& ..^*^./A?X4_;#^".@0?
M#O0= \):SX=LW:*RU^_N$9;>-F+94"9)"H+$X:)B,XY&!4X90M-NW-I;FVZW
M\K[;E8MU$X)7Y-;\N]]+>=M]C@OA_P##[Q-\*?\ @H]X&T7Q/XVO?'FK26$L
MTFK7RN'V-9W.(AO=SM7;QR.O05Z=_P %'O\ DH7[/W_8?D_]'6E0> _V2OBK
MX/\ VO/ OQ"\2:M)XYB-K<3Z]KQFBBCM;AX+B-8(HF<2&,;H@-J ?,>%' ]
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M6;X$_9^^,_QI^.'A?XE?' Z1H%IX7?SM-\.Z2ZN?-!#*<J[@+N"L29&)V!<
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M@EXT^-W@_P &6/@K1?[:NM/UC[5<Q_:H(/+B\LC=F5U!Y/09-?4\2E8D!X(
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M_P#T4M?%7[-3!O\ @HW\;R#D?9+CI_UWMJL_#W1_VS;'PQ8_#R2Q\,Z!I5G
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MW]MS[;_PRK\1OL&?._LX;\9_U7FIYO\ XYNK-_8%_LW_ (9.\"?V;MV^5/\
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MNCO=WZ_(]&_87^._B/XO^"?$.B^,9$N_%/A'4/[-N[^, "Z7Y@CG  W91P2
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M+(RDY. 6->V_ '3_ -H35/%USXC^+.H:#HVC26C00>%-)B$ACE+*1*9 S8(
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MCSMDD26%689 ."03R.]9?AFX_;%^(FO:9#K]IX1^&&CVMS'/=7%LJ74MU&K
MM&$6>;(.,$;H^,_-7M'[4OPIU#XU_ ?Q3X1TJ2*/5;V%'M?.;:C2QR+(JD]@
MVS&>V:PK5)1Y(MQMS)OE\FM=/+YZ>AOAZ<9.4TI7Y6O>OUOIKY_GZC?V5?\
MDV7X:_\ 8OVG_HH5\[?\$J_^1!^(O_8P?^TA7M7['.C_ !+\+_!JV\,_$OP_
M:Z#?:(5L--%K<12F>S6-0C.8Y77?NW#^'( X[GC?V ?@GXT^"?A'QI9>--&_
ML:YU#6/M5K']J@G\R+RP-V8G8#GL<&MJDHJIBW=>]:VN_O7T^6_8FE&3I8;W
M6K;Z;6BU^9PFI?\ *5K2O^P W_I'+7U-^T%&LOP'^(JNH9?^$=U#AAD?\>[U
MXE??!'QK-_P4$T_XE)HN?!46D&U?5/M4'$GV9TV^5O\ ,^\P&=N.:]^^+VA7
MWBCX3^,]&TR#[3J6H:->6EM#O5/,E>!U1=S$ 9) R2!7!BFI4::CNHO_ -*D
M=F"BXXBK*2LG-/Y<D%^C/F7]A4WG_#"MX=/S]OV:M]GQG/F?/MZ>^*^>/V+?
M!_[17B3X4WDWPE^(?AGPUX?CU25+BPU*WC>X%QLC+.Q-G*<%2F/F[=!7VC^P
M]\+O$WP?_9]TWPUXOTS^R=:AO+J62U\^*?"O(2IW1LRG(]Z\B\3?LN_%K]G_
M .)&M>,OV?-2L+O2-:D,U_X0U5U2/>23A-Q52H+-@[T90=N2":]65:"Q-977
MOJ-F]5==_6_R:/)6'J2PM!V=X7NEH[/MZ6VZIG,_$[]E+]K'XS>'HM"\9?$O
MP5K&E1W*7:0;# 5E4$*P:*P5L@,W?O7WU8Q26]G;Q3/YLR1JKR 8W,!@G\Z^
M5/ +_M;^/_&&BW'C"'PK\-_#EA=QSWUM9(MS+J$0.6B 6:; (XSO3&<\XQ7U
ME7#B)RY5!\N[?N_+>WI^!WX6$>9S2E>UO>OYNROK_P .?,/_  4B_P"32_$_
M_7U8_P#I3'7H_P"RC_R;3\,_^P!:?^BQ6!^VS\,_$GQ=_9XUWPSX2TW^UM<N
M;BU>*U\^*'<J3H['=(RJ,*">37:_L^^%=4\#_ _P-X?UNU^Q:OIND6]K=V_F
M))Y<BH R[D)4X/<$BIA)+!SC?7G3^7+N:3C)XV$[:>SM?SYWIZGYT_ /]EGP
MI^TY\>_C;;>*=0UFP31]9GD@.D311EC)=7 ;?YD3Y^X,8QWKZN\ _P#!-;X,
M>!]6BU"XLM6\5R1,'CAUZ[62$,#D9CBCC5Q[.&!]*H_L<_ KQQ\*_C-\9M=\
M4Z)_9>E>(=0,^F7'VN";[0GVB=\[8W9E^5U/S =?K7UO716Q52"A&E/3ECMW
MMJ<M#!TIRG.K#7FENNER.&&.UA2*)%AAC4*B( JJH&  !T %<[X[^&OA3XIZ
M*=+\5Z!I_B#3V!*QWL*N4)&-R-]Y&Q_$I!]ZG\?>$4\>^"]:\.2ZA>:5'JEK
M):M>:?)Y<\088+(V.#7QMH/PW_:T_9MMQH7@B^T'XJ>%(/W=A!J\BQRV\8Z#
M$DL3* . HE=0 ,8KAI051N\K/I?KWUZ'H5JCI)6@VNMNG;3KU//OVF_V>Y?V
M(;W2?BS\(?$%_H]FVH1VEWHMS.9(\,"RID\R1'804?<1D$-Z?HEX3\0)XH\*
MZ+K2QFW34[."[6)^J^9&'"_49KXMO/V<_CO^U9XFT6?XZ7.D^$O!FES_ &@^
M&]$D#O.__ 7D R,KO:1BH)VKR37OW[3'[/-U\</ >EZ1H'BF]\%ZGHEPEYID
MMD[+ )$7"!U4AAM_A93E3R >E=E:2=.%.M/FE?=:VCIUZ]6<-"#56=2C#EC;
M9Z7EKLNFED;'Q@_9C^&WQS@D/BSPS:W&H,NU=5M1Y%ZG&!^]7!8#LK;E]J^0
M/A5I?B+]C#]L;0?A39>(KS7_  !XKB\Z"SNFR8-_F!7VCY5D5XL,R@!E.2.!
MCN+/7/VW? ]NNBCPSX1\=+%\BZY-/$KL.@)_TB GZF/)[YKI?@!^RKXV_P"%
MP2_&/XT:Y:ZSXT$1BT[3;#YH+!2I7DX"Y568!5R!N+%F8Y&E']Q?GJ)PL]+W
MOVTZ._7H95_]HMR4VJB:UM:VNMWU5KJQ]:U\,_M?*&_;>_9V# $?:8N"/^GL
M5]S5\I_M&_!'QKX\_:H^#'C#0M%^W>'?#T\;ZG>?:H(_LX%P')V.X=OEY^4&
MN/!R4<53E)V2;_\ 26=F81E/!5815VTM/^WD?5E?"_P5_P"4GWQ?_P"P(W\K
M"ONBOE'X7_ _QMX=_;O^(_Q$U#1?L_@[5]+-M9:E]J@;S9,6GR^6KF1?]5)R
MR@?+[C+P<E&I-R=O<DOGIH/'1E.G345>U2#^2YM?0[3]I+]E6V^.6J:+XHT7
MQ%>>"O'VAC&GZ[9@M\N2P21002,EL$$8W-D,#BO&]3_:*^.O[*=]IJ_&O1M+
M\9^"KF<6Q\5Z !'-&QY&]0%4D*"=IC3.#ASBO2/CW\/OCY8_$5?'/PE\86M]
M:?94MI_!NL!5MF"Y.8\_*68DDL61ATWD<#R#QA\(OVG?VL_[-\-_$^P\._#O
MP9;W27-VNF2I++<[<@;56:8E@"<!F1><G.!6^&UC%2E%POJGTUUMU\].IS8K
M2<I0C)3MHX[/32_31Z:]#L?^"FU]!JG[*]G>VLJS6MQJ]G-%(O1T9)"I'U!%
M?+OBK7/B=X\\.^"OCQK?AJ&]^&7@RZLK*P\.W)+"6WC"I)<E<8(9U"ESW*C!
M53G[._;>^"7B3XG?L\6/@[P%H_\ :E[9WUH8K/[3%#M@B1USOE=5X!7OFO9_
M#O@>TN/A'I/A'7=-A>T.BPZ;>Z>P4QX\E4=/EXQU&1^%%"O'#TI2@KM3NK]N
M5?GM?I=DXC#3Q5>,:CLG3L[=^9Z?+>W6R-3P/XTTGXB^$=)\2Z%=+>:3JENM
MS;RCKM(Z$=F!R".Q!%;M?*G[(OPI^)?[//C'Q;X"U/3)-3^%S7$EYH.O?;(&
M:$D@F-HO,\P!@>?DP'0GH^:^JF!92 =I(X/I7'7C"$KTG>+U7?7H_-;'H8><
MYPM55I+1]M.J\GNCY.^(O['_ (O\-_$;6?B)\#/'*^#-?U=C+J6BZA'YFGWD
MA.6;[K!<DL<,C8+$J4S4GP9_:N\:V_Q?MOA'\9_"EOX<\7WD;2:;J>F/FTO@
M%8C@LV-P1L,K8R-I537/ZCX5_:W^"NNZH/!^JZ/\7O#][<R7$$>OND5Q;;V+
M$'=+#@9. JR,HQPJ]*G^#_[//Q:^('QZTOXP_&VXTS3+W1H&BTKP[I3AUA8A
MP-Q5F4*-[-]]V8D9( P>^GRN"5647!+_ +>6FB77?OH>?5YE4;HQDIM_]NO7
M5OIMVUN<=\.?*?\ X*H>.?[=P;Q=-?\ LKS.S?9[?&W/_3'S>GO7WQ7RW^U?
M^R1K'Q4\5:+\1_ASK<?AGXD:*%$<\S%(KI$)*98 [77)'(*L#M;BN(^V?MM>
M-K$>&;O2/"O@N*1?*E\4QS1&?;T+ )-+AB.ZQ*1VV]LK1Q%&DHR2<%RM-VVZ
M_,U4I86M5<HMJ<N9-*^Z6GRZ>17_ ."L'VG_ (5/X*^__9G]N_Z3L_O>2^SV
MZ;^M?:/AO[#_ ,([I7]E^7_9GV6+[+Y/W/*V#9M]MN,5P/Q%^!MM\8/@C_P@
M'C/4WU2Z>SACEUJ*$12&ZC48N53) .X9*YP02.]?,7A7PS^V'^S_ *-'X,\,
MZ9X9^(GAVS'DZ?J5].BO;P_PH \\+<#^%@X7H"0!2ARU*3H*234FUT3326_?
M3KT8YN=.M'$.+:<;/JT[M[=M>G5%?]JSR_\ AX!\"O[(_P"0U_HWVOR?O^3]
MI?[V.VSS>O:M#_@IJH?4/@LK ,IU]P01D'F&NW_9K_9/\4>'OB9?_%WXNZY!
MXA^(5XC);6]J=T%@K+M)!P 6V90*HVJ"W+$Y#_VYO@CXU^,5[\+Y/"&B_P!K
MIHNL-=7Y^U00>3&3%\W[UUW?=;A<GBMZ4X4ZN&I\R?([M]-7??LNYRUJ=2K2
MQ5;E:YXV2ZZ1MMW?8^JZ_,#P_H?QD\1?ML?&FU^&7BS1?"?B83RR7$FLQ*_G
M68E01K'NMYN@,1. .W)K]/Z^5?VDOV3_ !-XD^(UC\6?A'X@B\,?$6SC6.>.
MX^6"^0#:,G:PW;?E(92K #.,9/'A*D:5;FGLTUWWMOY::G?CJ4JU%1ANI*7:
M]KWL^^NGH<-XB^!G[9OBS0-2T35OBQX)O-+U&WDM+JW:U11)$ZE67*Z<",@G
MD$$=J^COV7?A9K7P5^!GAKP9X@O+._U72UG62:P=WA(>>210I=58X5P.5'(-
M>!0ZU^VSXRC_ +#G\.^#?!*2#8_B(2QR.@[L%6>;D_\ 7+\J^P/#=IJ.G^'M
M,MM8OH]3U6&VCCN[V*'REGE"@/($R=H8Y.,G&:WQ$Y*GR-QLVOAMTOV]3GP]
M.#J*:4[I/XK];=^]NFFAC_%:T>_^%_C"VB_UDVCWD:_4PN!7B7_!.>ZCN/V2
M/""(<M!-?1O[-]KE;^3"OI.>%+F&2&10\<BE&4]P1@BODK]@K=\/=1^*WPAO
M3Y=[X7\027=K&QY>SG \ME]OD#?]M!7/1UIUH>47_P" MI_^E'5B-*E&?1.2
M_P# E=?^DG#_ /!4W_4?"3_L,3?RBK[QKY$_X*$? [Q_\9]-\!GP%H*Z[=:/
M?3W-Q&UW!;A 5CV9\V1,@E3T-9'_  M+]MW_ *(]X+_\#(O_ )95O""JX6$%
M))J4MW;>UOR.6<W1Q<YN+:<8K1-[.5_S1[O^UI]M_P"&9_B5_9^[[3_8EQ]W
M.=FWY\8_V-U<!_P3C_LW_AD[PO\ 8-OG?:;S[9MQN\_[0_WL=]GEX]MM=U\!
M=5^*WC;PEKL/QJ\(Z/X<O))C;V]GI<BR17%LT>'+XN)N<DCJ..U?.=G^SK\>
M?V4/%&LR_ R;2_&'@K5)_/'AS6I55K=^F3ODC!(&%WK("P W*< T4THJIAY2
M2;Y6G?32^C?S^]%592E*EB81;2YDU;76VJ7R^YZ'4?\ !4K^SO\ AG"T^U^7
M]N_MNW^Q[L;MVR3?C_@&[-=O\2_AY>_%#]AG^PK^)IM;;PG:W2K(/G^U0P1R
M@'_:+)C\37E.E_LP_&']I3XB:)XH_:!N=-T?P[HTGFVWA'29 ZR-D$JVUG55
M; W,9'8@;1MSD?<#1(T9C**8R-I7'&/2LZG[G#^RC).3ES:;*R26OROY&E*]
M;$^WE%J*CRZZ7U;>GX'YQ:G\6[KQY_P3Q\ >$[&X9O$/B'5;;P:%!R?W<V0#
M[&-80?\ ?KU'QYHEM\ ?VTO@QJM@IMM"\0Z*?",PZ+F)0L()]23!_P!\5Q'P
M7_8_^)'A#]I#3(M7T:.'X4>'?$.HZ]IEV+R!_,>2-5@_=B0N,>7%U08PWJ*]
M_P#VVO@_XF^+'PUT:?P18K?^,O#VM6VJZ=$9HX22I(8;I&51C(;DC.RNZ=:F
MJL)Q>DY.4O)27+9]K:OR//IT:KHSA):TX\L?-P;E==^:T5?K:QYI\ 8S\5_V
M\OC!XZ?$^G^%X$T"R;J%DR(R5/\ VQF_[^5]I5\[?L0_!GQ'\(?ACJ\GC2P7
M3_&'B#6;C5-0A$T<VW<0J#?&S*> 6X)QO]:^B:\_$-)QIQ=U&*7X:_BV>GA4
M[3J25G.3?RO9?@D?!7QRV?\ #S;X4?V[_P @K[!#]B\S[GFXN?+QGC/G;/QQ
MWK[UKY__ &MOV64_:*T'2KW2-4_X1[QQH$AGTG5,L%!R&\MROS*-RJP9<E2,
M@'D'QY[_ /;?N]+/A1M$\+6^Y/LY\8+/ )L=/-P)C@X[B#/MFM%:O0A!22E&
M^CT6KNG?\^NAE)RP^(G4<6XSMJE=Z*UG^G0R_P!EW9_P\.^-_P#8^/[%^S7'
MG^3_ *OS_M$&>G&=_G?K5_5%#?\ !5K2<@'&@L1D=/\ 0Y:]O_9,_9>M?V;?
M"=^MUJ/]N^+=:E6XU?5<'#L,[8TW?,54LQW'EBQ)QP!Q5]\$?&LW_!033_B4
MFBY\%1:0;5]4^U0<2?9G3;Y6_P S[S 9VXYKH52FJL8*5U&#C?N^1_J[(Y)4
MJCHRFXZSJ1E;>RYXO\$KL^K****\@]T^#OV,_P#D]O\ :'_Z^KG_ -+35O\
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M9_C7ZUP3K.<.3E7R6OWGIPH*%1U.9N]]&W;7R_(^.O\ @JU_R*7PT_[#4O\
MZ+6ONF#_ %,?^Z/Y5^;'[07P]_:V_:0T[0[+Q-\+-!L8M'NFNX#I.HVL;,Y
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MW?\ 4****P-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !17P3\5(1\ ?^"C7@SQ8O\ H^B>.H!97;9P
MIE<"!L_1Q;N?K7WM6\Z7+3A53NI)_)IV:^7<YX5N:K4I-6<6OFFKI_\  "BO
MA3X;1?\ "^/^"C7C#Q0V+C1/ %H;"U<'<@G ,('_ 'VURP_W!7T#^V/\4/\
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M-=2Q@C(WK"CE,@@C=C(.:]$\+>*-*\;>'=/UW0[V/4=(OXA/;748(61#T(R
M?S%?F]^R7<?"#Q=\9/C-XE^*VI^$=0GFU4C2Y/%5W;-!-&\TY=XEF.U^%B 8
M9P",8SS^B":WX/\ A['X?\,_VEHWAX7*K::/I4ES%;F8+A5C@C)!?&5&%!ZB
MNZM0C2C&-GSM)^6JO9==-#SZ&(E6G.5TH)M>>CM=]+/^F=-17-ZA\2O".D^)
M;?P[?>*M%L_$%P56'2;C488[N4M]T+$6W$GM@<UMZCJ5IH]C->7]U#96<*[Y
M;BXD$<:+ZLQ. /K7%9VN=Z:;LMRS17+^%?BEX,\=W,MMX:\7:#XAN(1NDATK
M4H;IT'J1&Q(_&NHH<7'1H49*2O%W"BN8\5_%#P;X#N(8/$OBW0O#L\PS%'JV
MI0VK./51(PS^%6+KX@>%[ :,;GQ)I%N-:<1:9YM_$OVYSC"P9;]X3D<+GJ*:
MBW9I Y13:;V-^BLGQ/XNT+P3I;:GXBUK3] TU76,WFJ74=M"&/1=[D#)[#-7
MM/U"UU:PMKZQN8;VRN8UF@N;>021RQL,JZL#AE((((X.:5G:X[J]NI8HK M_
M'_AB[\53^&(/$FD3>)8$\R71H[Z)KR-< [FA#;P,,IR1T(]:WB<<G@4--:L+
MIZ(6BN0M?C%X!OM?_L*V\;^'+C6]_E_V;%JUNUSO_N^6'W9]L5U]#36Z$I)W
M2>P45AZ+XZ\-^)/[3_LGQ#I6J?V7*T-_]BO8IOLD@SE)=K'8PP<AL'@UG^'?
MBYX%\8:JVEZ#XT\/:WJ2@EK/3M5@N)@!U)1')X^E/EEV#FCW.LHHKGO%GQ%\
M*> DB?Q-XGT;PZDO^K;5M0BM0_T\QAFEN[(;=E=G0T5DZ;XNT+6M!.N:?K6G
MWVBA&E.I6UU');!%&6;S%)7  .3GC%-\+>,M \<Z8=2\-ZYIOB#3A(8C=Z7=
MQW,0< $KO0D9 (XSW%/E>NFPN9::[FQ167XD\4:-X-TF75=?U>QT/2X2HDO=
M2N4MX4+$!07<A1DD <]35;4?'?AK1_#,7B._\0Z59>'ID22/5KB]BCM'5\;&
M$I;80V1@@\YXI6;5T.Z3LS=HJ&SO(-0M8;JUFCN;:9%DBFA<.DBD9#*PX((Y
M!%/E_P!6_P!#43?)%OL-:[#Z*_(W]B_XI:G^S_X]MO$^I38^'?BO6)_#NI2<
M[+6ZC"212MG@8$W7^Z9/05^M\AS"Q'(VFNS&8=X1<U[JWX]OZZ-''A\2L1*4
M;6<7;Y;7_!_-,?17Q1_P2Q_Y);X\_P"QFD_]$Q5%^U=\0?&OQ1_:.\+? #P?
MXCG\&V5_;"[U75K5F6:12CR% 5(;:(XS\H(W%L$X%:3PLHU_81=^M_ES/[D+
MZU&-%UI+9M6[^]RK[V?;E%?%$W_!,'P]H,)U+P;\2/&&@>+8QNBU22YC*B3U
M(B2-P#[/GGO7TQ\"]#\=^'/AKIFG_$?6[/Q!XIAWK->V<9563<0@9L#>VW&6
MVKG/()!8Y3ITE&\)W^5ON*IU:TI<M2G;SO?[]OU._HHHKF.L**** "BL?Q1X
MRT#P181WWB/7--T"RDE6!+G5+N.VC:0@D(&<@%B <#KP:J^+/B-X3\!QP2>)
MO$^C>'4G_P!4VK:A%:B3_=,C#/X4[-["<DMV=%15#1->TSQ-ID.I:/J-IJNG
MS#,5W8SK-%(/574D'\#5UW6-&=V"HHR68X 'K0]-&":EJAU%<=IOQF^'^L:X
M-&L/'7AJ^U@ML&GVVKV\EP6'\/EARV?;%==--';0R332+%%&I=Y'("JH&223
MT%#3CJT$9*6D7<?17P[XT_:7TK_AO+P5!:?$RSB^'D.B2"_,.O(NDFX*7)'F
MD2>49 ?+^]SG;[5]B^$_'?AKQ]937GACQ#I7B.TAD\J6XTF]BNHT? .UFC8@
M'!!P?45O.C.$(S:W5_35K]/Q.>GB(5*DZ:?PM+UT3_6WR-VBBN0USXQ> O"^
ML?V3K/C?PYI.JY ^PWVK6\,^3T&QG#?I6"3D[(Z&U%7>QU]<UX7^)GA+QMJF
MJ:;X?\2Z5K6H:6_EWMK8W:326[9QAU4DCD$?4$=1711R)<1+)&RR1NNY64Y#
M ]"#Z5\__LZ_ GX/_#7XA>-M;^'GB&/7=>NG,&IVJ:M#>?V8&E9C#LC&Z/+H
M?]82W[O&>#6E.,7S<W1?CYF524H\O);5]>WEYGT'1574]4LM%L9KW4+N"PLH
M5WRW%U*L<<:^K,Q  ^M<&?VD/A(I(/Q2\%@C_J8;3_XY41C*7PJYI*48_$['
MHU%<[X5^(WA3QU9W=WX;\3Z-XAM;0XN)]*U"*Y2$XSAV1B%X!//I2Z7\1/"N
MN>&YO$.G>)M'U#0(2PEU6UOXI+5"OW@TJL5&,C.3Q0XM7NM@4HRM9[G0UE>)
M_%6C>"M#N=9U_5+31M*M@#->7TRQ1)DX&68XR20 .Y.*SO"?Q.\'>/IIXO#/
MBS0_$<L S*FDZE#=-&/5A&QQ^-<[^T-X!\%_$KX4:OHGQ U1=$\,.8Y)]2:]
MCM!;,KC8_FR?(IW8'S @YQBCE<6E+38%)2BW'7_,[?P_XBTOQ9HUKJ^BZC:Z
MMI=TF^"\LY5EBE7.,JRD@\@CZBO/_BI^TY\+_@GJ,.G^,_%UKI&H3()%LUBE
MN9@IZ,T<*.R@X."P .*L?";0? 7P4^"^CV7A[7+0>!]/@,L.M7>H1/#(LCEC
M*TX(0[G<\C YP,=*^%_@AJ7PE\=_M??&?Q)\3-8\)ZIIBW4BZ-/XBO;9K&X0
MS%%:/S6V2XC1 ",X!R.H-=E.A"I6G%7Y8IOSTV7DV<-;$3I4(2=N:32WTUOK
MYI6_'<^\(_V@OANWA'1/%$GC31[/0=:=H]/OKZY%LMPRL58*)-IR""#D<=\5
MZ K!U#*0RL,@CD&OFWX__L]_ KQYX5\$6?BS6=/\%Z%ITC_V)]AU.VT^"=)=
MKM%'O!5E;Y6^3GG@C-?1EC8P:98V]G;1^5;6\:Q11@D[54  ?D*PG&FHWC>]
MWOVZ:]^_]7WIRJ.7+*VRV[^G;M_5IZ*YOQ9\2O"'@)HE\3>*M$\.M-S&-6U&
M&U+_ $\QAFM;1=<T[Q)IL&HZ3J%KJFGSC=%=V4RS12#U5U)!_ UC9VYK:&_,
MK\M]2]16;X@\3:/X3TY]0US5;'1K!#AKK4+E((A]6<@5G>$OB1X2\?>?_P (
MQXIT7Q'Y&/-_LG4(;KR\]-WEL<?C0HMIM('))I-[G1T50UW7],\+Z3<:IK.H
MVFD:9;+NGO;Z=888AD#+.Q"J,D#D]ZSM3^(?A71?#MMX@U'Q-H]AH-TBR0:I
M=7\4=K*K#*LDK,%8$$$$'D46;V'=(Z"BL;POXS\/^.-/-_X<UW3?$%BK;#<Z
M7>1W,8;TW(2,U\U?\%"/C5!X%^".J:7X>\:QZ)XV:[M EKIFJBWU)(BX9F"H
MXD"E1R0,8/H:J,)2FJ=M6TOO9$JD8TY5+Z)-_<CZNHKR[X/_ !L\$>,/#GA;
M2K/Q[H&M^)9M-@,EC!K$%Q>22+"&DR@<N6&&+9&>#FO4:JI3E2DXR)HU8UH*
M<>H4445D;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF,(-1C>.JCY2C:_WNVAYY_P2J_Y-TU;_ +&*X_\ 1%O6'\-?^4I7Q$_[ ?\
M[2M*V?\ @E3*C?L[ZRBNI=?$5QN4'D9@@QFL3X<2+'_P5,^(*NP1I-$P@8X+
M'R;0X'KP"?PKNJ?[_6_Z]R_])B<.&_Y%U'_''_TIFK^WA\5KR^\<>"O@O9>*
MK;P3IOB,?:M?UZZN5MTAL]S*$,C$ !@DF02-Q"+G#'.%<_LQ_L;2>$WTJ'QW
MX<AU3R=B:X?&<37(?'#E/.\DG/./+ K!_P""@'@?0-#_ &DOAKX[\<Z3-JWP
M[OX5TK5UC>5-A1I#DM&P8$+*' 4@GRV'->U:+^Q'^S!XD\/QZ[I7AFQU#19(
M_-74+?Q%?/!M]=XN<#^E<U.4*>$A+FDKN5W'O?KJNEK?>=-:-2KC)QY8RLHV
M4NS6ME9];W^XB_X)Z_%+4_&WPS\0>&-8UA/$-YX.U5]+@U1)!(+FTP?)??D[
MA\K@-DY4+R:X+]A#_DYG]H__ +"W_MU<U](_L]_"_P"%/P]\.W]U\)K:R71M
M4G_TBZL-1EO8YI(BR8#R2/\ =.X8!Q7S9^PE(J_M/?M'1,P60ZJ6"$\D"ZN<
MG'XC\Q3YXU*M:45O#KIK>-W\WJ5[.=*A1A-K2?356]^RU[*R*/[5_CZT^,W[
M25C\%=;\;VO@+X=Z3:K?:_>W%_':?;92JNL(>0A2<-'A3D EF(.T"JOQ$_9Q
M_9.D\"WP\&^/O#/A[Q9:0-/8:K!XR2:0W"#<FY'G*\L!]T*1GC%<K^T)\//
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MRG_C_P#;4>O4_P"1A#_KV_\ TMGSAX!_Y2J>-O\ L$-_Z36U;'[='Q3N-?\
MB7X-^"$/BRV\#Z'KD?VWQ%KEU<K;*EJ2X$1D9@ &$;_*2-Q*+T)!X+]GSX@:
M3\4O^"DWBOQ-H+R3:/>:9<+:W$B%/.6..&(R*/[I*$CVQTZ4_P#;N\#^&_#_
M .U5\/?&WQ!TJ75?AOJULNF:GY;RH(W0R#):)@XVB1),*<D1L,'FNZ-->TPD
M*B^PM/-*5E]_XG%.H_8XN=)_;>OE[MW]U_EJ=%J'[,?['%QX2DTNT\>>&[/5
MO)V1ZY_PF<3W DQP[(9O*//4! /3%>H?\$^/BKJOQ!^$.J:+KFJKKFI>%-4D
MTE=2602?:;< &%]^3NXW -W"KR>M)I?[$/[,.N>'X]=T_P ,V%[HLD?FKJ$'
MB*]> I_>WBYQC\:]1_9]^&?PN^'OA6ZG^%%O9IH.J7!DEN;'4);V*>2,F,D2
M22/T*L.#CK656M"5.<&Y-Z;VT=_732Z-*.'J1J4YQC"*U^%O56]-=;,^#_V<
M_@.W[0GQN^->AZSXDU#3O ]AXCDN]3T73Y/*.IRFYN1"KOV1=CD]^1C!^8=%
M^W!^R?X,_9Z\":'\1OAC;77A75M*U6!'$5]-,#NR4D4RNS*ZNJ]#@@GBNX_X
M)Y_\EP_:0_[#J?\ I3>UV_\ P4X_Y-;O/^PM9_\ H35=2O4I5J,82LOW?SNH
MWOW^9G##TJE#$2G&[_>?*UWIVUUT/1_BM\>I/AU^RW+\3/)1]0ET:UNK:!Q\
MIN;A4$8(] T@)]@:^;_V8?V*]#^-G@^#XI?&>XU'QAK_ (G!O(K6:]EACB@)
M/ELQC96+$#( 8*JE0%XKTSX\_#[4/B3_ ,$_['3=*A>YU"V\.:7J$4$8):3R
M8HI&4 =24#8'<UL?L'?'/P[\3/@3X8T&WU&WC\2^'[&/3;S2V<+,%B 1)57J
MR,@4[AQG(/(I)>RA7E2TDI6](Z_=K^0T_;/#1K:Q<+^LM-^]EJO5G5_!/]DS
MP9\ _$GB;4/"LVJ1Z;KD,<+:+=7CRVD 7.XJI/SDY R^Y@,@'#$5X1^Q^LO[
M/_[3OQ.^"=XS1Z5?/_;FA!^%9, X7U)B90?> U]>Z9\2O"NM>,+[PII_B#3[
MWQ'8P"YNM-MYU>6&,MMRP'0YQD=1D9'(S\N_MX:+<_#GQ9\-/CKI,+&X\+:E
M'9ZKY8^:2SD;H?;F1/\ ML*YZ%2=2JHU7I47+=_^2OSM+\V=>(HPIT7.BK.F
M^:R_\F7E>-_P*W_!0*^NOB1XH^%GP3TN5UN?$VJK>7_E]8[:,[0Q'H,RO_VR
MKV']I+]ES3/V@_A7I7@J+5Y?"\.DW$,UE-! )XT$<9C"-%N7<-C$#YA@@'VK
MQ_\ 9]>#X^_MG?$;XJ12K?>'?#%M'H.B7"<QN[+AW0]\ 2GCM,*^H_B9\5O"
MGP<\,MX@\8ZS%HFDK*L(GD1Y"TC9PJHBLS'@G !X!/05,^:C3I4U\7Q/O=VY
M5;NDD.GRUZE6J]8VY5Z)>]KVNY?<)\)_AY:_"?X;^'?!]G=S7UMH]HEJMS<
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M42WFO7,!PTB%6D*GGE5C3(4\,SC/04OP5_Y2??%__L"-_*PK+^.>J1_L[_\
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M***Y#N"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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5%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>gern-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-16T10:10:11.9553+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="gern-20221231.xsd#StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="gern-20221231.xsd#StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail" xlink:href="gern-20221231.xsd#Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1" xlink:href="gern-20221231.xsd#Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" xlink:href="gern-20221231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureLICENSEAGREEMENTSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails" xlink:href="gern-20221231.xsd#DisclosureCommitmentsAndContingenciesLitigationSettlementDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails" xlink:href="gern-20221231.xsd#Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASESDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails" xlink:href="gern-20221231.xsd#Role_DisclosureDEBTAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails" xlink:href="gern-20221231.xsd#DisclosureStockholdersEquityWarrantExercisesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="gern-20221231.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtTheMarketOfferingMember" xlink:label="gern_AtTheMarketOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingOfCommonStockAndWarrantsMember" xlink:label="gern_PublicOfferingOfCommonStockAndWarrantsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_AtTheMarketOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_PublicOfferingOfCommonStockAndWarrantsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingOfCommonStockAndWarrantsMember" xlink:label="gern_PublicOfferingOfCommonStockAndWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PreFundedWarrantsMember" xlink:label="gern_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_StockPurchaseWarrantsMember" xlink:label="gern_StockPurchaseWarrantsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_PublicOfferingOfCommonStockAndWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_PreFundedWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_StockPurchaseWarrantsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:label="us-gaap_RestrictedCashAndInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CashAndCashEquivalentsUnrealizedGains" xlink:label="gern_CashAndCashEquivalentsUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_RestrictedCashAndCashEquivalentsUnrealizedGains" xlink:label="gern_RestrictedCashAndCashEquivalentsUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CashAndCashEquivalentsUnrealizedLosses" xlink:label="gern_CashAndCashEquivalentsUnrealizedLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" xlink:label="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInLessThanOneYearMember" xlink:label="gern_USTreasurySecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsAtFairValue" xlink:label="us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInOneToTwoYearsMember" xlink:label="gern_USTreasurySecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInLessThanOneYearMember" xlink:label="gern_MunicipalSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_MunicipalSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CommercialPaperDueInLessThanOneYearMember" xlink:label="gern_CommercialPaperDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" xlink:label="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentHoldingsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="gern_CashAndCashEquivalentsUnrealizedGains" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="gern_RestrictedCashAndCashEquivalentsUnrealizedGains" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_RestrictedCashAndInvestmentsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="gern_CashAndCashEquivalentsUnrealizedLosses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CertificatesOfDepositMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USTreasurySecuritiesDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="us-gaap_RestrictedInvestmentsAtFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USTreasurySecuritiesDueInOneToTwoYearsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_MunicipalSecuritiesDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_MunicipalSecuritiesDueInOneToTwoYearsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CommercialPaperDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInLessThanOneYearMember" xlink:label="gern_USTreasurySecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInOneToTwoYearsMember" xlink:label="gern_USTreasurySecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInLessThanOneYearMember" xlink:label="gern_MunicipalSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_MunicipalSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CommercialPaperDueInLessThanOneYearMember" xlink:label="gern_CommercialPaperDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" xlink:label="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USTreasurySecuritiesDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USTreasurySecuritiesDueInOneToTwoYearsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_MunicipalSecuritiesDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_MunicipalSecuritiesDueInOneToTwoYearsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CommercialPaperDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryNotesSecuritiesMember" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:label="us-gaap_CorporateNoteSecuritiesMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CertificatesOfDepositMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryNotesSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MunicipalBondsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CostMethodInvestmentsCostBasis" xlink:label="gern_CostMethodInvestmentsCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="us-gaap_InvestmentOwnedBalanceShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="us-gaap_InvestmentOwnedAtFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" xlink:label="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NumberOfSharesSoldFromEquityInvestment" xlink:label="gern_NumberOfSharesSoldFromEquityInvestment"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EquityInvestmentReverseStockSplit" xlink:label="gern_EquityInvestmentReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CostMethodInvestmentOwnershipPercentage" xlink:label="gern_CostMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentHoldingsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_EquitySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="gern_CostMethodInvestmentsCostBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentOwnedBalanceShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentOwnedAtFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_RealizedInvestmentGainsLosses" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="gern_NumberOfSharesSoldFromEquityInvestment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="gern_EquityInvestmentReverseStockSplit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="gern_CostMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_JanssenBiotechIncMember" xlink:label="gern_JanssenBiotechIncMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementNumberOfStudies" xlink:label="gern_CollaborativeArrangementNumberOfStudies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_FormerCollaborativeArrangementMember" xlink:label="gern_FormerCollaborativeArrangementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementCostSharingPercentageOfEntity" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfEntity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClinicalSupplyAgreementMember" xlink:label="gern_ClinicalSupplyAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementCostSharingPercentageOfCounterparty" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity" xlink:label="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DueToCounterParty" xlink:label="gern_DueToCounterParty"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="gern_JanssenBiotechIncMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_CollaborativeArrangementNumberOfStudies" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="gern_FormerCollaborativeArrangementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_CollaborativeArrangementCostSharingPercentageOfEntity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="gern_ClinicalSupplyAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_DueToCounterParty" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClassActionStipulationMember" xlink:label="gern_ClassActionStipulationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceClaimsMember" xlink:label="us-gaap_InsuranceClaimsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencySettlementAgreementDate" xlink:label="us-gaap_LossContingencySettlementAgreementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DerivativeStipulationMember" xlink:label="gern_DerivativeStipulationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountPaidInCashOrKind" xlink:label="gern_LitigationSettlementAmountPaidInCashOrKind"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountAccruedLiabilitiesRecognized" xlink:label="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized" xlink:label="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" xlink:label="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountToBePaid" xlink:label="gern_LitigationSettlementAmountToBePaid"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="gern_ClassActionStipulationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_InsuranceClaimsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingencySettlementAgreementDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="gern_DerivativeStipulationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_LitigationCaseAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PaymentsForLegalSettlements" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountPaidInCashOrKind" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountToBePaid" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails">
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SeverancePlanLineItems" xlink:label="gern_SeverancePlanLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SeverancePlanTable" xlink:label="gern_SeverancePlanTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceClaimsMember" xlink:label="us-gaap_InsuranceClaimsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod" xlink:label="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" xlink:label="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_SeverancePlanTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_InsuranceClaimsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="gern_SeverancePlanTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="gern_SeverancePlanTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_SeverancePlanLineItems" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MenloParkOfficeSpaceLeaseMember" xlink:label="gern_MenloParkOfficeSpaceLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OperatingLeaseTermAdditionalPeriodExtension" xlink:label="gern_OperatingLeaseTermAdditionalPeriodExtension"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NewJerseyOfficeSpaceLeaseMember" xlink:label="gern_NewJerseyOfficeSpaceLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_FosterCityOfficeSpaceLeaseMember" xlink:label="gern_FosterCityOfficeSpaceLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToTerminate" xlink:label="us-gaap_LesseeOperatingLeaseOptionToTerminate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OperatingLeaseRentAbatementPeriod" xlink:label="gern_OperatingLeaseRentAbatementPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="gern_MenloParkOfficeSpaceLeaseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="gern_OperatingLeaseTermAdditionalPeriodExtension" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="gern_NewJerseyOfficeSpaceLeaseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="gern_FosterCityOfficeSpaceLeaseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToTerminate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="gern_OperatingLeaseRentAbatementPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NewJerseyLeaseAndFosterCityLeaseMember" xlink:label="gern_NewJerseyLeaseAndFosterCityLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="gern_NewJerseyLeaseAndFosterCityLeaseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheOneMember" xlink:label="gern_TrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_HerculesAndSiliconValleyBankMember" xlink:label="gern_HerculesAndSiliconValleyBankMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SecondAmendmentMember" xlink:label="gern_SecondAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheTwoMember" xlink:label="gern_TrancheTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_HerculesMember" xlink:label="gern_HerculesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheThreeMember" xlink:label="gern_TrancheThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SiliconValleyBankMember" xlink:label="gern_SiliconValleyBankMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheFourMember" xlink:label="gern_TrancheFourMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_BorrowingAvailableStartDate" xlink:label="gern_BorrowingAvailableStartDate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OptionOneMinCashDebtCovenantMember" xlink:label="gern_OptionOneMinCashDebtCovenantMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ExpiryDateOfTranche" xlink:label="gern_ExpiryDateOfTranche"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OptionTwoMinCashDebtCovenantMember" xlink:label="gern_OptionTwoMinCashDebtCovenantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" xlink:label="us-gaap_LineOfCreditFacilityBorrowingCapacityDescription"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OptionThreeMinCashDebtCovenantMember" xlink:label="gern_OptionThreeMinCashDebtCovenantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtDescription" xlink:label="us-gaap_LongTermDebtDescription"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheAMember" xlink:label="gern_TrancheAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheBMember" xlink:label="gern_TrancheBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheCMember" xlink:label="gern_TrancheCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_InterestOnlyPeriodPaymentTermDescription" xlink:label="gern_InterestOnlyPeriodPaymentTermDescription"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtInstrumentEndOfTermChargePercentage" xlink:label="gern_DebtInstrumentEndOfTermChargePercentage"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtInstrumentMinimumPrepaymentAmount" xlink:label="gern_DebtInstrumentMinimumPrepaymentAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PercentageOfPrepaymentCharge" xlink:label="gern_PercentageOfPrepaymentCharge"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount" xlink:label="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinimumCashBalance" xlink:label="gern_DebtCovenantMinimumCashBalance"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MarketCapMinimumToUseOptionTwo" xlink:label="gern_MarketCapMinimumToUseOptionTwo"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantPercentageOfProductRevenueAgainstForecast" xlink:label="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod" xlink:label="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate" xlink:label="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinCashUponLicensingTransaction" xlink:label="gern_DebtCovenantMinCashUponLicensingTransaction"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinCashUponRegulatoryMilestone" xlink:label="gern_DebtCovenantMinCashUponRegulatoryMilestone"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PercentageOfInterestOnPastDueOutstanding" xlink:label="gern_PercentageOfInterestOnPastDueOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedEndOfTermCharge" xlink:label="gern_AccruedEndOfTermCharge"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedEndOfTermCharges" xlink:label="gern_AccruedEndOfTermCharges"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" xlink:label="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="gern_HerculesAndSiliconValleyBankMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="gern_SecondAmendmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheTwoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="gern_HerculesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VestingAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheThreeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="gern_SiliconValleyBankMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheFourMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_BorrowingAvailableStartDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_OptionOneMinCashDebtCovenantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_ExpiryDateOfTranche" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_OptionTwoMinCashDebtCovenantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_OptionThreeMinCashDebtCovenantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheAMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheBMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheCMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_InterestOnlyPeriodPaymentTermDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtInstrumentEndOfTermChargePercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtInstrumentMinimumPrepaymentAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_PercentageOfPrepaymentCharge" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantMinimumCashBalance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_MarketCapMinimumToUseOptionTwo" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantMinCashUponLicensingTransaction" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantMinCashUponRegulatoryMilestone" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_PercentageOfInterestOnPastDueOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_AccruedEndOfTermCharge" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_AccruedEndOfTermCharges" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails">
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingLineItems" xlink:label="gern_PublicOfferingLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingTable" xlink:label="gern_PublicOfferingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_UnderwrittenPublicOfferingMember" xlink:label="gern_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoPreFundedWarrantMember" xlink:label="gern_TwoThousandTwentyTwoPreFundedWarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" xlink:label="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember" xlink:label="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PreFundedWarrantsMember" xlink:label="gern_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="gern_PublicOfferingLineItems" xlink:to="gern_PublicOfferingTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="gern_PublicOfferingTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_UnderwrittenPublicOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_TwoThousandTwentyTwoPreFundedWarrantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="gern_PublicOfferingTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_PublicOfferingLineItems" xlink:to="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_PreFundedWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember" xlink:label="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" xlink:label="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyPreFundedWarrantsMember" xlink:label="gern_TwoThousandTwentyPreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_UnderwrittenPublicOfferingMember" xlink:label="gern_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyStockPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyStockPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PurchaseWarrantsMember" xlink:label="gern_PurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_TwoThousandTwentyPreFundedWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_UnderwrittenPublicOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_TwoThousandTwentyStockPurchaseWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_PurchaseWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails">
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:label="gern_AtMarketIssuanceSalesAgreementsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceSalesAgreementsTable" xlink:label="gern_AtMarketIssuanceSalesAgreementsTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CommonStockAggregateOfferingPrice" xlink:label="gern_CommonStockAggregateOfferingPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember" xlink:label="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MaximumCommissionRate" xlink:label="gern_MaximumCommissionRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember" xlink:label="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="gern_AtMarketIssuanceSalesAgreementsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="gern_CommonStockAggregateOfferingPrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="gern_AtMarketIssuanceSalesAgreementsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="gern_MaximumCommissionRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncentiveAwardPlan2011Member" xlink:label="gern_IncentiveAwardPlan2011Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_FirstDirectorOptionMember" xlink:label="gern_FirstDirectorOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandAndEighteenEquityIncentivePlanMember" xlink:label="gern_TwoThousandAndEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SubsequentDirectorOptionMember" xlink:label="gern_SubsequentDirectorOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DirectorsPlan2006Member" xlink:label="gern_DirectorsPlan2006Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandAndEighteenInducementAwardPlanMember" xlink:label="gern_TwoThousandAndEighteenInducementAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DirectorsMarketValueStockPurchasePlanMember" xlink:label="gern_DirectorsMarketValueStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock" xlink:label="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_IncentiveAwardPlan2011Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="gern_FirstDirectorOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_TwoThousandAndEighteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="gern_SubsequentDirectorOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_DirectorsPlan2006Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_TwoThousandAndEighteenInducementAwardPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_DirectorsMarketValueStockPurchasePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandAndEighteenInducementAwardPlanMember" xlink:label="gern_TwoThousandAndEighteenInducementAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PerformanceBasedStockOptionsMember" xlink:label="gern_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_TwoThousandAndEighteenInducementAwardPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="gern_PerformanceBasedStockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PerformanceBasedStockOptionsMember" xlink:label="gern_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="gern_PerformanceBasedStockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:label="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ConsultantsMember" xlink:label="gern_ConsultantsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:to="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="gern_ConsultantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OperatingLossCarryforwardsSubjectToExpiration" xlink:label="gern_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="gern_OperatingLossCarryforwardsSubjectToExpiration" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember" xlink:label="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" xlink:label="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyTwoPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" xlink:label="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyPurchaseWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyTwoPurchaseWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>gern-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-16T10:10:08.6740+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="gern-20221231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="gern-20221231.xsd#StatementConsolidatedStatementsOfOperations" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS" xlink:href="gern-20221231.xsd#Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="gern-20221231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" xlink:href="gern-20221231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails" xlink:href="gern-20221231.xsd#Role_DisclosureACCRUEDLIABILITIESDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails2" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails" xlink:href="gern-20221231.xsd#Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESDEFERREDTAXESDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermDebtNoncurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DebtCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_NontradeReceivablesCurrent" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="gern_DepositsAndOtherAssetsNoncurrent" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="us-gaap_NontradeReceivablesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DepositsAndOtherAssetsNoncurrent" xlink:label="gern_DepositsAndOtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_InterestExpense" order="2" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="4" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="2" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainOnSaleOfInvestments" order="4" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="5" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AssetsFairValueAdjustment" order="6" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="7" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="8" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DefinedContributionPlanCostRecognized" order="9" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="11" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" order="12" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="13" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" order="14" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="15" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="16" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="gern_IncreaseDecreaseDueToCounterparty" order="17" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" order="18" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="gern_IncreaseDecreaseInOperatingLeaseLiabilities" order="19" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" xlink:label="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="us-gaap_GainOnSaleOfInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueAdjustment" xlink:label="us-gaap_AssetsFairValueAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" xlink:label="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncreaseDecreaseDueToCounterparty" xlink:label="gern_IncreaseDecreaseDueToCounterparty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="gern_IncreaseDecreaseInOperatingLeaseLiabilities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="gern_RestrictedCashAndCashEquivalentsUnrealizedGains" order="0" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="gern_CashAndCashEquivalentsUnrealizedGains" order="0" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="gern_CashAndCashEquivalentsUnrealizedLosses" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedInvestmentsAtFairValue" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="2" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_RestrictedCashAndCashEquivalentsUnrealizedGains" xlink:label="gern_RestrictedCashAndCashEquivalentsUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CashAndCashEquivalentsUnrealizedGains" xlink:label="gern_CashAndCashEquivalentsUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" xlink:label="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CashAndCashEquivalentsUnrealizedLosses" xlink:label="gern_CashAndCashEquivalentsUnrealizedLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsAtFairValue" xlink:label="us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" order="1" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="gern_AccruedManufacturingActivitiesCurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_InterestPayableCurrent" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" xlink:label="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedManufacturingActivitiesCurrent" xlink:label="gern_AccruedManufacturingActivitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_VariableLeaseCost" order="1" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="gern_LongTermDebtGross" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="gern_LongTermDebtGross" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="gern_LongTermDebtGross" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="2" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="gern_DebtInstrumentUnamortizedEndOfTermCharge" order="4" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtCurrent" order="5" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LongTermDebtGross" xlink:label="gern_LongTermDebtGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtInstrumentUnamortizedEndOfTermCharge" xlink:label="gern_DebtInstrumentUnamortizedEndOfTermCharge"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" xlink:label="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="gern_DeferredTaxAssetsFederalAndStateCredits" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxLiabilities" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="gern_DeferredTaxAssetsOperatingLeaseLiabilities" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="5" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" xlink:label="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxAssetsFederalAndStateCredits" xlink:label="gern_DeferredTaxAssetsFederalAndStateCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:label="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:label="gern_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>gern-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-16T10:10:09.0722+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.geron.com/20221231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:gern="http://www.geron.com/20221231" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gern-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gern-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gern-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gern-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION" id="Role_DocumentDOCUMENTANDENTITYINFORMATION">
        <link:definition>100000 - Document - DOCUMENT AND ENTITY INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" id="StatementConsolidatedStatementsOfOperations">
        <link:definition>100030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS" id="Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>100040 - Statement - STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" id="StatementConsolidatedStatementsOfStockholdersEquity">
        <link:definition>100050 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" id="StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
        <link:definition>100060 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" id="Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>100080 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS" id="Role_DisclosureFAIRVALUEMEASUREMENTS">
        <link:definition>100090 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT" id="Role_DisclosurePROPERTYANDEQUIPMENT">
        <link:definition>100100 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureLicenseAgreement" id="DisclosureLicenseAgreement">
        <link:definition>100110 - Disclosure - LICENSE AGREEMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIES" id="Role_DisclosureACCRUEDLIABILITIES">
        <link:definition>100120 - Disclosure - ACCRUED LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES" id="Role_DisclosureCOMMITMENTSANDCONTINGENCIES">
        <link:definition>100130 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASES" id="Role_DisclosureOPERATINGLEASES">
        <link:definition>100140 - Disclosure - OPERATING LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBT" id="Role_DisclosureDEBT">
        <link:definition>100150 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITY" id="Role_DisclosureSTOCKHOLDERSEQUITY">
        <link:definition>100160 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXES" id="Role_DisclosureINCOMETAXES">
        <link:definition>100170 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsData1" id="DisclosureConsolidatedStatementsOfCashFlowsData1">
        <link:definition>100180 - Disclosure - CONSOLIDATED STATEMENTS OF CASH FLOWS DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEvents" id="DisclosureSubsequentEvents">
        <link:definition>100190 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" id="Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>100200 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables" id="Role_DisclosureFAIRVALUEMEASUREMENTSTables">
        <link:definition>100210 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables" id="Role_DisclosurePROPERTYANDEQUIPMENTTables">
        <link:definition>100220 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESTables" id="Role_DisclosureACCRUEDLIABILITIESTables">
        <link:definition>100230 - Disclosure - ACCRUED LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESTables" id="Role_DisclosureOPERATINGLEASESTables">
        <link:definition>100240 - Disclosure - OPERATING LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTTables" id="Role_DisclosureDEBTTables">
        <link:definition>100250 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables" id="Role_DisclosureSTOCKHOLDERSEQUITYTables">
        <link:definition>100260 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTables" id="Role_DisclosureINCOMETAXESTables">
        <link:definition>100270 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataTables" id="DisclosureConsolidatedStatementsOfCashFlowsDataTables">
        <link:definition>100280 - Disclosure - CONSOLIDATED STATEMENTS OF CASH FLOWS DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail" id="Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail">
        <link:definition>100290 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1" id="Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1">
        <link:definition>100300 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESUSEFULLIVESOFASSETSDetails" id="Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESUSEFULLIVESOFASSETSDetails">
        <link:definition>100310 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - USEFUL LIVES OF ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails" id="Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails">
        <link:definition>100320 - Disclosure - FAIR VALUE MEASUREMENTS - SECURITY TYPE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails" id="Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails">
        <link:definition>100330 - Disclosure - FAIR VALUE MEASUREMENTS - SECURITIES WITH UNREALIZED LOSSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails" id="Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails">
        <link:definition>100340 - Disclosure - FAIR VALUE MEASUREMENTS - RECURRING BASIS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails" id="Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails">
        <link:definition>100350 - Disclosure - FAIR VALUE MEASUREMENTS - EQUITY INVESTMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSCREDITRISKDetails" id="Role_DisclosureFAIRVALUEMEASUREMENTSCREDITRISKDetails">
        <link:definition>100360 - Disclosure - FAIR VALUE MEASUREMENTS - CREDIT RISK (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" id="Role_DisclosurePROPERTYANDEQUIPMENTDetails">
        <link:definition>100370 - Disclosure - PROPERTY AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails" id="Role_DisclosureLICENSEAGREEMENTSDetails">
        <link:definition>100380 - Disclosure - LICENSE AGREEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails" id="Role_DisclosureACCRUEDLIABILITIESDetails">
        <link:definition>100390 - Disclosure - ACCRUED LIABILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails" id="DisclosureCommitmentsAndContingenciesLitigationSettlementDetails">
        <link:definition>100400 - Disclosure - COMMITMENTS AND CONTINGENCIES - Litigation Settlement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails" id="Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails">
        <link:definition>100410 - Disclosure - COMMITMENTS AND CONTINGENCIES - Severance Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails" id="Role_DisclosureOPERATINGLEASESDetails">
        <link:definition>100420 - Disclosure - OPERATING LEASES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails" id="Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails">
        <link:definition>100430 - Disclosure - OPERATING LEASES - COMPONENTS OF LEASE COSTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails" id="Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails">
        <link:definition>100440 - Disclosure - OPERATING LEASES - UNDISCOUNTED FUTURE NON-CANCELLABLE LEASE PAYMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails2" id="Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails2">
        <link:definition>100450 - Disclosure - OPERATING LEASES - UNDISCOUNTED FUTURE NON-CANCELLABLE LEASE PAYMENTS (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails" id="Role_DisclosureDEBTAdditionalInformationDetails">
        <link:definition>100460 - Disclosure - DEBT - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails" id="Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails">
        <link:definition>100470 - Disclosure - DEBT - Schedule of Future Minimum Payments Under Term Loan Facility (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYAUTHORIZEDCOMMONSTOCKDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYAUTHORIZEDCOMMONSTOCKDetails">
        <link:definition>100480 - Disclosure - STOCKHOLDERS' EQUITY - AUTHORIZED COMMON STOCK (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails">
        <link:definition>100490 - Disclosure - STOCKHOLDERS' EQUITY - PUBLIC OFFERING (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails" id="DisclosureStockholdersEquityWarrantExercisesDetails">
        <link:definition>100500 - Disclosure - STOCKHOLDERS' EQUITY - WARRANT EXERCISES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails">
        <link:definition>100510 - Disclosure - STOCKHOLDERS' EQUITY - SALES AGREEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails">
        <link:definition>100520 - Disclosure - STOCKHOLDERS' EQUITY - EQUITY PLANS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails">
        <link:definition>100530 - Disclosure - STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails">
        <link:definition>100540 - Disclosure - STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Parenthetical) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails">
        <link:definition>100550 - Disclosure - STOCKHOLDERS' EQUITY - EMPLOYEE STOCK PURCHASE PLAN (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails">
        <link:definition>100560 - Disclosure - STOCKHOLDERS' EQUITY - PERFORMANCE BASED STOCK OPTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails">
        <link:definition>100570 - Disclosure - STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION EXPENSE FOR EMPLOYEES AND DIRECTORS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails">
        <link:definition>100580 - Disclosure - STOCKHOLDERS' EQUITY - PRICING MODEL ASSUMPTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails">
        <link:definition>100590 - Disclosure - STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION TO SERVICE PROVIDERS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails" id="Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails">
        <link:definition>100600 - Disclosure - STOCKHOLDERS' EQUITY - COMMON STOCK RESERVED FOR FUTURE ISSUANCE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails" id="Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails">
        <link:definition>100610 - Disclosure - INCOME TAXES - EFFECTIVE INCOME TAX RATE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails" id="Role_DisclosureINCOMETAXESDEFERREDTAXESDetails">
        <link:definition>100620 - Disclosure - INCOME TAXES - DEFERRED TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails" id="Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails">
        <link:definition>100630 - Disclosure - INCOME TAXES - OPERATING LOSS CARRYFORWARDS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails" id="Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails">
        <link:definition>100640 - Disclosure - INCOME TAXES - TAX CREDIT CARRYFORWARDS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESCARESACTIMPACTDetails" id="Role_DisclosureINCOMETAXESCARESACTIMPACTDetails">
        <link:definition>100650 - Disclosure - INCOME TAXES - CARES ACT IMPACT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails" id="Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails">
        <link:definition>100660 - Disclosure - INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails" id="DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails">
        <link:definition>100670 - Disclosure - CONSOLIDATED STATEMENTS OF CASH FLOWS DATA - Supplemental Investing Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>100680 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="gern_CARESActImpactAbstract" name="CARESActImpactAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_LicenseAgreementDisclosureAbstract" name="LicenseAgreementDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" name="AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_AccruedEndOfTermCharge" name="AccruedEndOfTermCharge" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="gern_AccruedEndOfTermCharges" name="AccruedEndOfTermCharges" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_AccruedManufacturingActivitiesCurrent" name="AccruedManufacturingActivitiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_BorrowingAvailableStartDate" name="BorrowingAvailableStartDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_CashAndCashEquivalentsUnrealizedGains" name="CashAndCashEquivalentsUnrealizedGains" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_CashAndCashEquivalentsUnrealizedLosses" name="CashAndCashEquivalentsUnrealizedLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" name="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity" name="CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty" name="CollaborativeArrangementCostSharingPercentageOfCounterparty" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_CollaborativeArrangementCostSharingPercentageOfEntity" name="CollaborativeArrangementCostSharingPercentageOfEntity" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_CollaborativeArrangementNumberOfStudies" name="CollaborativeArrangementNumberOfStudies" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_CommonStockAggregateOfferingPrice" name="CommonStockAggregateOfferingPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_CostMethodInvestmentOwnershipPercentage" name="CostMethodInvestmentOwnershipPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="gern_CostMethodInvestmentsCostBasis" name="CostMethodInvestmentsCostBasis" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_DebtCovenantMinCashUponLicensingTransaction" name="DebtCovenantMinCashUponLicensingTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_DebtCovenantMinCashUponRegulatoryMilestone" name="DebtCovenantMinCashUponRegulatoryMilestone" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_DebtCovenantMinimumCashBalance" name="DebtCovenantMinimumCashBalance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount" name="DebtCovenantMinimumCashBalancePercentageOfLoanAmount" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast" name="DebtCovenantPercentageOfProductRevenueAgainstForecast" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_DebtInstrumentEndOfTermChargePercentage" name="DebtInstrumentEndOfTermChargePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_DebtInstrumentMinimumPrepaymentAmount" name="DebtInstrumentMinimumPrepaymentAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_DebtInstrumentUnamortizedEndOfTermCharge" name="DebtInstrumentUnamortizedEndOfTermCharge" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment" name="DeferredTaxAssetsCapitalizedResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_DeferredTaxAssetsFederalAndStateCredits" name="DeferredTaxAssetsFederalAndStateCredits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_DeferredTaxAssetsOperatingLeaseLiabilities" name="DeferredTaxAssetsOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" name="DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_DepositsAndOtherAssetsNoncurrent" name="DepositsAndOtherAssetsNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate" name="DollarPrepaymentCharge36MonthsAfterEffectiveDate" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_DueToCounterParty" name="DueToCounterParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" name="EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" name="EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_EmployerTaxReceivable" name="EmployerTaxReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_EquityInvestmentReverseStockSplit" name="EquityInvestmentReverseStockSplit" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ExpiryDateOfTranche" name="ExpiryDateOfTranche" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_IncreaseDecreaseDueToCounterparty" name="IncreaseDecreaseDueToCounterparty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" name="IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_IncreaseDecreaseInOperatingLeaseLiabilities" name="IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_InterestOnlyPeriodPaymentTermDescription" name="InterestOnlyPeriodPaymentTermDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" name="IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" name="IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized" name="LitigationSettlementAmountAccruedLiabilitiesRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" name="LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized" name="LitigationSettlementAmountInterestAndOtherReceivableRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_LitigationSettlementAmountPaidInCashOrKind" name="LitigationSettlementAmountPaidInCashOrKind" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_LitigationSettlementAmountToBePaid" name="LitigationSettlementAmountToBePaid" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_LongTermDebtGross" name="LongTermDebtGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" name="LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod" name="LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity" name="LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment" name="LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_MarketCapMinimumToUseOptionTwo" name="MarketCapMinimumToUseOptionTwo" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_MaximumCommissionRate" name="MaximumCommissionRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod" name="MinimumPercentageOfNetProductRevenuesMaintenancePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_NumberOfFinancialInstitutions" name="NumberOfFinancialInstitutions" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="gern_NumberOfSharesSoldFromEquityInvestment" name="NumberOfSharesSoldFromEquityInvestment" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_OperatingLeaseRentAbatementPeriod" name="OperatingLeaseRentAbatementPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_OperatingLeaseTermAdditionalPeriodExtension" name="OperatingLeaseTermAdditionalPeriodExtension" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_OperatingLossCarryforwardsSubjectToExpiration" name="OperatingLossCarryforwardsSubjectToExpiration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_PercentageOfInterestOnPastDueOutstanding" name="PercentageOfInterestOnPastDueOutstanding" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_PercentageOfPrepaymentCharge" name="PercentageOfPrepaymentCharge" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" name="PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" name="ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues" name="PublicOfferingStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues" name="PublicOfferingStockIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets" name="ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" name="RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="gern_RestrictedCashAndCashEquivalentsUnrealizedGains" name="RestrictedCashAndCashEquivalentsUnrealizedGains" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock" name="ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet" name="ShareBasedCompensationForfeituresAndExpirationsInPeriodNet" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" name="ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="gern_AtMarketIssuanceSalesAgreementsLineItems" name="AtMarketIssuanceSalesAgreementsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_PublicOfferingLineItems" name="PublicOfferingLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_SeverancePlanLineItems" name="SeverancePlanLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember" name="AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember" name="AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_AtTheMarketOfferingMember" name="AtTheMarketOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_ClassActionStipulationMember" name="ClassActionStipulationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_ClinicalSupplyAgreementMember" name="ClinicalSupplyAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_CommercialPaperDueInLessThanOneYearMember" name="CommercialPaperDueInLessThanOneYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_ConsultantsMember" name="ConsultantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" name="CorporateNoteSecuritiesDueInLessThanOneYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" name="CorporateNoteSecuritiesDueInOneToTwoYearsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_DerivativeStipulationMember" name="DerivativeStipulationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_DirectorsMarketValueStockPurchasePlanMember" name="DirectorsMarketValueStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_DirectorsPlan2006Member" name="DirectorsPlan2006Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_FirstDirectorOptionMember" name="FirstDirectorOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_FormerCollaborativeArrangementMember" name="FormerCollaborativeArrangementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_FosterCityOfficeSpaceLeaseMember" name="FosterCityOfficeSpaceLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember" name="GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember" name="GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_HerculesAndSiliconValleyBankMember" name="HerculesAndSiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_HerculesMember" name="HerculesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_IncentiveAwardPlan2011Member" name="IncentiveAwardPlan2011Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_JanssenBiotechIncMember" name="JanssenBiotechIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_MenloParkOfficeSpaceLeaseMember" name="MenloParkOfficeSpaceLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_MunicipalSecuritiesDueInLessThanOneYearMember" name="MunicipalSecuritiesDueInLessThanOneYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_MunicipalSecuritiesDueInOneToTwoYearsMember" name="MunicipalSecuritiesDueInOneToTwoYearsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_NewJerseyLeaseAndFosterCityLeaseMember" name="NewJerseyLeaseAndFosterCityLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_NewJerseyOfficeSpaceLeaseMember" name="NewJerseyOfficeSpaceLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_OptionOneMinCashDebtCovenantMember" name="OptionOneMinCashDebtCovenantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_OptionThreeMinCashDebtCovenantMember" name="OptionThreeMinCashDebtCovenantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_OptionTwoMinCashDebtCovenantMember" name="OptionTwoMinCashDebtCovenantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_PerformanceBasedStockOptionsMember" name="PerformanceBasedStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_PreFundedWarrantsMember" name="PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_PublicOfferingOfCommonStockAndWarrantsMember" name="PublicOfferingOfCommonStockAndWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_PurchaseWarrantsMember" name="PurchaseWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_SecondAmendmentMember" name="SecondAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_SiliconValleyBankMember" name="SiliconValleyBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_StockPurchaseWarrantsMember" name="StockPurchaseWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_SubsequentDirectorOptionMember" name="SubsequentDirectorOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TrancheAMember" name="TrancheAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TrancheBMember" name="TrancheBMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TrancheCMember" name="TrancheCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TrancheFourMember" name="TrancheFourMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TrancheOneMember" name="TrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TrancheThreeMember" name="TrancheThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TrancheTwoMember" name="TrancheTwoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandAndEighteenEquityIncentivePlanMember" name="TwoThousandAndEighteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandAndEighteenInducementAwardPlanMember" name="TwoThousandAndEighteenInducementAwardPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandTwentyPreFundedWarrantsMember" name="TwoThousandTwentyPreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember" name="TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandTwentyPurchaseWarrantsMember" name="TwoThousandTwentyPurchaseWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandTwentyStockPurchaseWarrantsMember" name="TwoThousandTwentyStockPurchaseWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember" name="TwoThousandTwentyThreeUnderwrittenPublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandTwentyTwoPreFundedWarrantMember" name="TwoThousandTwentyTwoPreFundedWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandTwentyTwoPurchaseWarrantsMember" name="TwoThousandTwentyTwoPurchaseWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember" name="TwoThousandTwentyTwoStockPurchaseWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember" name="TwoThousandTwentyTwoUnderwrittenPublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_UnderwrittenPublicOfferingMember" name="UnderwrittenPublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember" name="USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember" name="USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_USTreasurySecuritiesDueInLessThanOneYearMember" name="USTreasurySecuritiesDueInLessThanOneYearMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_USTreasurySecuritiesDueInOneToTwoYearsMember" name="USTreasurySecuritiesDueInOneToTwoYearsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_AtMarketIssuanceSalesAgreementsTable" name="AtMarketIssuanceSalesAgreementsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_PublicOfferingTable" name="PublicOfferingTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_SeverancePlanTable" name="SeverancePlanTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>gern-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-16T10:10:08.6875+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION" xlink:href="gern-20221231.xsd#Role_DocumentDOCUMENTANDENTITYINFORMATION" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="gern-20221231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="gern-20221231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:href="gern-20221231.xsd#StatementConsolidatedStatementsOfOperations" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS" xlink:href="gern-20221231.xsd#Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:href="gern-20221231.xsd#StatementConsolidatedStatementsOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="gern-20221231.xsd#StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="gern-20221231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:href="gern-20221231.xsd#Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTS" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT" xlink:href="gern-20221231.xsd#Role_DisclosurePROPERTYANDEQUIPMENT" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureLicenseAgreement" xlink:href="gern-20221231.xsd#DisclosureLicenseAgreement" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIES" xlink:href="gern-20221231.xsd#Role_DisclosureACCRUEDLIABILITIES" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES" xlink:href="gern-20221231.xsd#Role_DisclosureCOMMITMENTSANDCONTINGENCIES" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASES" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASES" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBT" xlink:href="gern-20221231.xsd#Role_DisclosureDEBT" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITY" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITY" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXES" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXES" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsData1" xlink:href="gern-20221231.xsd#DisclosureConsolidatedStatementsOfCashFlowsData1" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEvents" xlink:href="gern-20221231.xsd#DisclosureSubsequentEvents" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:href="gern-20221231.xsd#Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables" xlink:href="gern-20221231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESTables" xlink:href="gern-20221231.xsd#Role_DisclosureACCRUEDLIABILITIESTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESTables" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASESTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTTables" xlink:href="gern-20221231.xsd#Role_DisclosureDEBTTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTables" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataTables" xlink:href="gern-20221231.xsd#DisclosureConsolidatedStatementsOfCashFlowsDataTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail" xlink:href="gern-20221231.xsd#Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1" xlink:href="gern-20221231.xsd#Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESUSEFULLIVESOFASSETSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESUSEFULLIVESOFASSETSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSCREDITRISKDetails" xlink:href="gern-20221231.xsd#Role_DisclosureFAIRVALUEMEASUREMENTSCREDITRISKDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" xlink:href="gern-20221231.xsd#Role_DisclosurePROPERTYANDEQUIPMENTDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureLICENSEAGREEMENTSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails" xlink:href="gern-20221231.xsd#Role_DisclosureACCRUEDLIABILITIESDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails" xlink:href="gern-20221231.xsd#DisclosureCommitmentsAndContingenciesLitigationSettlementDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails" xlink:href="gern-20221231.xsd#Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASESDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails" xlink:href="gern-20221231.xsd#Role_DisclosureDEBTAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails" xlink:href="gern-20221231.xsd#Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYAUTHORIZEDCOMMONSTOCKDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYAUTHORIZEDCOMMONSTOCKDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails" xlink:href="gern-20221231.xsd#DisclosureStockholdersEquityWarrantExercisesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails" xlink:href="gern-20221231.xsd#Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESDEFERREDTAXESDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESCARESACTIMPACTDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESCARESACTIMPACTDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails" xlink:href="gern-20221231.xsd#Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails" xlink:href="gern-20221231.xsd#DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="gern-20221231.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="80.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="81.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="82.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="83.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="84.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="85.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="86.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="us-gaap_NontradeReceivablesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DepositsAndOtherAssetsNoncurrent" xlink:label="gern_DepositsAndOtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_NontradeReceivablesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DebtCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="gern_DepositsAndOtherAssetsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenuesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_3"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_4"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtTheMarketOfferingMember" xlink:label="gern_AtTheMarketOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingOfCommonStockAndWarrantsMember" xlink:label="gern_PublicOfferingOfCommonStockAndWarrantsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_AtTheMarketOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_PublicOfferingOfCommonStockAndWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" xlink:label="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" xlink:label="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="us-gaap_GainOnSaleOfInvestments"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueAdjustment" xlink:label="us-gaap_AssetsFairValueAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncreaseDecreaseDueToCounterparty" xlink:label="gern_IncreaseDecreaseDueToCounterparty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="gern_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainOnSaleOfInvestments" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AssetsFairValueAdjustment" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="gern_IncreaseDecreaseDueToCounterparty" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="gern_IncreaseDecreaseInOperatingLeaseLiabilities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DefinedContributionPlanCostRecognized" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureLicenseAgreement" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LicenseAgreementDisclosureAbstract" xlink:label="gern_LicenseAgreementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_LicenseAgreementDisclosureAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIES" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASES" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBT" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITY" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXES" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsData1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:label="us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DebtPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingOfCommonStockAndWarrantsMember" xlink:label="gern_PublicOfferingOfCommonStockAndWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PreFundedWarrantsMember" xlink:label="gern_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_StockPurchaseWarrantsMember" xlink:label="gern_StockPurchaseWarrantsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_PublicOfferingOfCommonStockAndWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_PreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_StockPurchaseWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESUSEFULLIVESOFASSETSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAbstract" xlink:label="us-gaap_DepreciationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DepreciationAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_DepreciationAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:label="us-gaap_RestrictedCashAndInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CashAndCashEquivalentsUnrealizedGains" xlink:label="gern_CashAndCashEquivalentsUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_RestrictedCashAndCashEquivalentsUnrealizedGains" xlink:label="gern_RestrictedCashAndCashEquivalentsUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CashAndCashEquivalentsUnrealizedLosses" xlink:label="gern_CashAndCashEquivalentsUnrealizedLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" xlink:label="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInLessThanOneYearMember" xlink:label="gern_USTreasurySecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsAtFairValue" xlink:label="us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInOneToTwoYearsMember" xlink:label="gern_USTreasurySecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInLessThanOneYearMember" xlink:label="gern_MunicipalSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_MunicipalSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CommercialPaperDueInLessThanOneYearMember" xlink:label="gern_CommercialPaperDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" xlink:label="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_InvestmentHoldingsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="gern_CashAndCashEquivalentsUnrealizedGains" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="gern_RestrictedCashAndCashEquivalentsUnrealizedGains" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_RestrictedCashAndInvestmentsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_InvestmentHoldingsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="gern_CashAndCashEquivalentsUnrealizedLosses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CertificatesOfDepositMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USTreasurySecuritiesDueInLessThanOneYearMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="us-gaap_RestrictedInvestmentsAtFairValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USTreasurySecuritiesDueInOneToTwoYearsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_MunicipalSecuritiesDueInLessThanOneYearMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_MunicipalSecuritiesDueInOneToTwoYearsMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CommercialPaperDueInLessThanOneYearMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInLessThanOneYearMember" xlink:label="gern_USTreasurySecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInOneToTwoYearsMember" xlink:label="gern_USTreasurySecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInLessThanOneYearMember" xlink:label="gern_MunicipalSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_MunicipalSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CommercialPaperDueInLessThanOneYearMember" xlink:label="gern_CommercialPaperDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" xlink:label="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USTreasurySecuritiesDueInLessThanOneYearMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_USTreasurySecuritiesDueInOneToTwoYearsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_MunicipalSecuritiesDueInLessThanOneYearMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_MunicipalSecuritiesDueInOneToTwoYearsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CommercialPaperDueInLessThanOneYearMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryNotesSecuritiesMember" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:label="us-gaap_CorporateNoteSecuritiesMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CertificatesOfDepositMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasuryNotesSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MunicipalBondsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CommercialPaperMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CostMethodInvestmentsCostBasis" xlink:label="gern_CostMethodInvestmentsCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="us-gaap_InvestmentOwnedBalanceShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="us-gaap_InvestmentOwnedAtFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" xlink:label="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NumberOfSharesSoldFromEquityInvestment" xlink:label="gern_NumberOfSharesSoldFromEquityInvestment"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EquityInvestmentReverseStockSplit" xlink:label="gern_EquityInvestmentReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CostMethodInvestmentOwnershipPercentage" xlink:label="gern_CostMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_InvestmentHoldingsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_EquitySecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="gern_CostMethodInvestmentsCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentOwnedBalanceShares" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentOwnedAtFairValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_InvestmentHoldingsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="gern_NumberOfSharesSoldFromEquityInvestment" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="gern_EquityInvestmentReverseStockSplit" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="gern_CostMethodInvestmentOwnershipPercentage" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSCREDITRISKDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract" xlink:label="us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NumberOfFinancialInstitutions" xlink:label="gern_NumberOfFinancialInstitutions"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract" xlink:to="gern_NumberOfFinancialInstitutions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LicenseAgreementDisclosureAbstract" xlink:label="gern_LicenseAgreementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_JanssenBiotechIncMember" xlink:label="gern_JanssenBiotechIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementNumberOfStudies" xlink:label="gern_CollaborativeArrangementNumberOfStudies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_FormerCollaborativeArrangementMember" xlink:label="gern_FormerCollaborativeArrangementMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementCostSharingPercentageOfEntity" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfEntity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClinicalSupplyAgreementMember" xlink:label="gern_ClinicalSupplyAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementCostSharingPercentageOfCounterparty" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity" xlink:label="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DueToCounterParty" xlink:label="gern_DueToCounterParty"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_LicenseAgreementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="gern_JanssenBiotechIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_CollaborativeArrangementNumberOfStudies" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="gern_FormerCollaborativeArrangementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_CollaborativeArrangementCostSharingPercentageOfEntity" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="gern_ClinicalSupplyAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="gern_DueToCounterParty" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" xlink:label="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedManufacturingActivitiesCurrent" xlink:label="gern_AccruedManufacturingActivitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="gern_AccruedManufacturingActivitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_InterestPayableCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClassActionStipulationMember" xlink:label="gern_ClassActionStipulationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceClaimsMember" xlink:label="us-gaap_InsuranceClaimsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencySettlementAgreementDate" xlink:label="us-gaap_LossContingencySettlementAgreementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DerivativeStipulationMember" xlink:label="gern_DerivativeStipulationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountPaidInCashOrKind" xlink:label="gern_LitigationSettlementAmountPaidInCashOrKind"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountAccruedLiabilitiesRecognized" xlink:label="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized" xlink:label="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" xlink:label="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountToBePaid" xlink:label="gern_LitigationSettlementAmountToBePaid"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="gern_ClassActionStipulationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_InsuranceClaimsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingencySettlementAgreementDate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="gern_DerivativeStipulationMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_LitigationCaseAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_PaymentsForLegalSettlements" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountPaidInCashOrKind" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="gern_LitigationSettlementAmountToBePaid" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceClaimsMember" xlink:label="us-gaap_InsuranceClaimsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SeverancePlanLineItems" xlink:label="gern_SeverancePlanLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod" xlink:label="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SeverancePlanTable" xlink:label="gern_SeverancePlanTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" xlink:label="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_InsuranceClaimsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_SeverancePlanTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="gern_SeverancePlanTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_SeverancePlanTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_SeverancePlanTable" xlink:to="gern_SeverancePlanLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_SeverancePlanLineItems" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MenloParkOfficeSpaceLeaseMember" xlink:label="gern_MenloParkOfficeSpaceLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OperatingLeaseTermAdditionalPeriodExtension" xlink:label="gern_OperatingLeaseTermAdditionalPeriodExtension"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NewJerseyOfficeSpaceLeaseMember" xlink:label="gern_NewJerseyOfficeSpaceLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_FosterCityOfficeSpaceLeaseMember" xlink:label="gern_FosterCityOfficeSpaceLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToTerminate" xlink:label="us-gaap_LesseeOperatingLeaseOptionToTerminate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OperatingLeaseRentAbatementPeriod" xlink:label="gern_OperatingLeaseRentAbatementPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="gern_MenloParkOfficeSpaceLeaseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="gern_OperatingLeaseTermAdditionalPeriodExtension" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="gern_NewJerseyOfficeSpaceLeaseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="gern_FosterCityOfficeSpaceLeaseMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToTerminate" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="gern_OperatingLeaseRentAbatementPeriod" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_VariableLeaseCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NewJerseyLeaseAndFosterCityLeaseMember" xlink:label="gern_NewJerseyLeaseAndFosterCityLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="gern_NewJerseyLeaseAndFosterCityLeaseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheOneMember" xlink:label="gern_TrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_HerculesAndSiliconValleyBankMember" xlink:label="gern_HerculesAndSiliconValleyBankMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SecondAmendmentMember" xlink:label="gern_SecondAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheTwoMember" xlink:label="gern_TrancheTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_HerculesMember" xlink:label="gern_HerculesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheThreeMember" xlink:label="gern_TrancheThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SiliconValleyBankMember" xlink:label="gern_SiliconValleyBankMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheFourMember" xlink:label="gern_TrancheFourMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_BorrowingAvailableStartDate" xlink:label="gern_BorrowingAvailableStartDate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OptionOneMinCashDebtCovenantMember" xlink:label="gern_OptionOneMinCashDebtCovenantMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ExpiryDateOfTranche" xlink:label="gern_ExpiryDateOfTranche"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OptionTwoMinCashDebtCovenantMember" xlink:label="gern_OptionTwoMinCashDebtCovenantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" xlink:label="us-gaap_LineOfCreditFacilityBorrowingCapacityDescription"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OptionThreeMinCashDebtCovenantMember" xlink:label="gern_OptionThreeMinCashDebtCovenantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtDescription" xlink:label="us-gaap_LongTermDebtDescription"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheAMember" xlink:label="gern_TrancheAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheBMember" xlink:label="gern_TrancheBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheCMember" xlink:label="gern_TrancheCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_InterestOnlyPeriodPaymentTermDescription" xlink:label="gern_InterestOnlyPeriodPaymentTermDescription"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtInstrumentEndOfTermChargePercentage" xlink:label="gern_DebtInstrumentEndOfTermChargePercentage"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtInstrumentMinimumPrepaymentAmount" xlink:label="gern_DebtInstrumentMinimumPrepaymentAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PercentageOfPrepaymentCharge" xlink:label="gern_PercentageOfPrepaymentCharge"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount" xlink:label="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinimumCashBalance" xlink:label="gern_DebtCovenantMinimumCashBalance"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MarketCapMinimumToUseOptionTwo" xlink:label="gern_MarketCapMinimumToUseOptionTwo"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantPercentageOfProductRevenueAgainstForecast" xlink:label="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod" xlink:label="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate" xlink:label="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinCashUponLicensingTransaction" xlink:label="gern_DebtCovenantMinCashUponLicensingTransaction"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinCashUponRegulatoryMilestone" xlink:label="gern_DebtCovenantMinCashUponRegulatoryMilestone"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PercentageOfInterestOnPastDueOutstanding" xlink:label="gern_PercentageOfInterestOnPastDueOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedEndOfTermCharge" xlink:label="gern_AccruedEndOfTermCharge"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedEndOfTermCharges" xlink:label="gern_AccruedEndOfTermCharges"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" xlink:label="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="gern_HerculesAndSiliconValleyBankMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="gern_SecondAmendmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="gern_HerculesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VestingAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheThreeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="gern_SiliconValleyBankMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheFourMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_BorrowingAvailableStartDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_StatementScenarioAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_OptionOneMinCashDebtCovenantMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_ExpiryDateOfTranche" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_OptionTwoMinCashDebtCovenantMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_OptionThreeMinCashDebtCovenantMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtDescription" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheAMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheBMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="gern_TrancheCMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_InterestOnlyPeriodPaymentTermDescription" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtInstrumentEndOfTermChargePercentage" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtInstrumentMinimumPrepaymentAmount" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_PercentageOfPrepaymentCharge" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantMinimumCashBalance" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_MarketCapMinimumToUseOptionTwo" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsGross" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantMinCashUponLicensingTransaction" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_DebtCovenantMinCashUponRegulatoryMilestone" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_PercentageOfInterestOnPastDueOutstanding" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_AccruedEndOfTermCharge" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_AccruedEndOfTermCharges" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LongTermDebtGross" xlink:label="gern_LongTermDebtGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtInstrumentUnamortizedEndOfTermCharge" xlink:label="gern_DebtInstrumentUnamortizedEndOfTermCharge"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="gern_LongTermDebtGross" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="gern_DebtInstrumentUnamortizedEndOfTermCharge" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYAUTHORIZEDCOMMONSTOCKDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingTable" xlink:label="gern_PublicOfferingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingLineItems" xlink:label="gern_PublicOfferingLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_UnderwrittenPublicOfferingMember" xlink:label="gern_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoPreFundedWarrantMember" xlink:label="gern_TwoThousandTwentyTwoPreFundedWarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" xlink:label="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember" xlink:label="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PreFundedWarrantsMember" xlink:label="gern_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_PublicOfferingTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_SharesIssuedPricePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_UnderwrittenPublicOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="gern_PublicOfferingTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_TwoThousandTwentyTwoPreFundedWarrantMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_PublicOfferingTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_PublicOfferingLineItems" xlink:to="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_PublicOfferingTable" xlink:to="gern_PublicOfferingLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_PreFundedWarrantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_PublicOfferingLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember" xlink:label="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" xlink:label="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyPreFundedWarrantsMember" xlink:label="gern_TwoThousandTwentyPreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_UnderwrittenPublicOfferingMember" xlink:label="gern_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyStockPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyStockPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PurchaseWarrantsMember" xlink:label="gern_PurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_TwoThousandTwentyPreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_UnderwrittenPublicOfferingMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="gern_TwoThousandTwentyStockPurchaseWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_PurchaseWarrantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:label="gern_AtMarketIssuanceSalesAgreementsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CommonStockAggregateOfferingPrice" xlink:label="gern_CommonStockAggregateOfferingPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceSalesAgreementsTable" xlink:label="gern_AtMarketIssuanceSalesAgreementsTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember" xlink:label="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MaximumCommissionRate" xlink:label="gern_MaximumCommissionRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember" xlink:label="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="gern_CommonStockAggregateOfferingPrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="gern_AtMarketIssuanceSalesAgreementsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_AtMarketIssuanceSalesAgreementsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="gern_MaximumCommissionRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_AtMarketIssuanceSalesAgreementsTable" xlink:to="gern_AtMarketIssuanceSalesAgreementsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncentiveAwardPlan2011Member" xlink:label="gern_IncentiveAwardPlan2011Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_FirstDirectorOptionMember" xlink:label="gern_FirstDirectorOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandAndEighteenEquityIncentivePlanMember" xlink:label="gern_TwoThousandAndEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SubsequentDirectorOptionMember" xlink:label="gern_SubsequentDirectorOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DirectorsPlan2006Member" xlink:label="gern_DirectorsPlan2006Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandAndEighteenInducementAwardPlanMember" xlink:label="gern_TwoThousandAndEighteenInducementAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DirectorsMarketValueStockPurchasePlanMember" xlink:label="gern_DirectorsMarketValueStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock" xlink:label="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_IncentiveAwardPlan2011Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="gern_FirstDirectorOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="us-gaap_SharePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_TwoThousandAndEighteenEquityIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="gern_SubsequentDirectorOptionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_DirectorsPlan2006Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_TwoThousandAndEighteenInducementAwardPlanMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_StatementScenarioAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_DirectorsMarketValueStockPurchasePlanMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet" xlink:label="gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:to="gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandAndEighteenInducementAwardPlanMember" xlink:label="gern_TwoThousandAndEighteenInducementAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PerformanceBasedStockOptionsMember" xlink:label="gern_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="gern_TwoThousandAndEighteenInducementAwardPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="gern_PerformanceBasedStockOptionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PerformanceBasedStockOptionsMember" xlink:label="gern_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="gern_PerformanceBasedStockOptionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:label="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ConsultantsMember" xlink:label="gern_ConsultantsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="gern_ConsultantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="us-gaap_AwardTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" xlink:label="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceAbstract" xlink:label="us-gaap_ValuationAllowanceAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxAssetsFederalAndStateCredits" xlink:label="gern_DeferredTaxAssetsFederalAndStateCredits"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:label="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:label="gern_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" xlink:label="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationAllowanceAbstract" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="gern_DeferredTaxAssetsFederalAndStateCredits" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ValuationAllowanceAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="gern_DeferredTaxAssetsOperatingLeaseLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OperatingLossCarryforwardsSubjectToExpiration" xlink:label="gern_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_OperatingLossCarryforwardsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="gern_OperatingLossCarryforwardsSubjectToExpiration" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_TaxCreditCarryforwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESCARESACTIMPACTDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CARESActImpactAbstract" xlink:label="gern_CARESActImpactAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EmployerTaxReceivable" xlink:label="gern_EmployerTaxReceivable"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="gern_CARESActImpactAbstract" xlink:to="gern_EmployerTaxReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_5"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets" xlink:label="gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_InterestPaidNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember" xlink:label="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" xlink:label="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyTwoPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" xlink:label="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyPurchaseWarrantsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="gern_TwoThousandTwentyTwoPurchaseWarrantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>gern-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-16T10:10:11.7471+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:label="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseOptionToTerminate" xlink:label="us-gaap_LesseeOperatingLeaseOptionToTerminate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantPercentageOfProductRevenueAgainstForecast" xlink:label="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:label="gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingTable" xlink:label="gern_PublicOfferingTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain" xlink:label="srt_LitigationCaseTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:label="gern_AtMarketIssuanceSalesAgreementsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MenloParkOfficeSpaceLeaseMember" xlink:label="gern_MenloParkOfficeSpaceLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAbstract" xlink:label="us-gaap_DepreciationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount" xlink:label="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OperatingLeaseTermAdditionalPeriodExtension" xlink:label="gern_OperatingLeaseTermAdditionalPeriodExtension"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CommercialPaperDueInLessThanOneYearMember" xlink:label="gern_CommercialPaperDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_MunicipalSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryNotesSecuritiesMember" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SiliconValleyBankMember" xlink:label="gern_SiliconValleyBankMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember" xlink:label="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OptionTwoMinCashDebtCovenantMember" xlink:label="gern_OptionTwoMinCashDebtCovenantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinCashUponLicensingTransaction" xlink:label="gern_DebtCovenantMinCashUponLicensingTransaction"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInOneToTwoYearsMember" xlink:label="gern_USTreasurySecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementCostSharingPercentageOfEntity" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfEntity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheBMember" xlink:label="gern_TrancheBMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DirectorsMarketValueStockPurchasePlanMember" xlink:label="gern_DirectorsMarketValueStockPurchasePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtTheMarketOfferingMember" xlink:label="gern_AtTheMarketOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MunicipalSecuritiesDueInLessThanOneYearMember" xlink:label="gern_MunicipalSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingLineItems" xlink:label="gern_PublicOfferingLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CostMethodInvestmentOwnershipPercentage" xlink:label="gern_CostMethodInvestmentOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OperatingLeaseRentAbatementPeriod" xlink:label="gern_OperatingLeaseRentAbatementPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" xlink:label="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyTwoPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DueToCounterParty" xlink:label="gern_DueToCounterParty"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:label="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LicenseAgreementDisclosureAbstract" xlink:label="gern_LicenseAgreementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxAssetsFederalAndStateCredits" xlink:label="gern_DeferredTaxAssetsFederalAndStateCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheOneMember" xlink:label="gern_TrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" xlink:label="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheAMember" xlink:label="gern_TrancheAMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet" xlink:label="gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedEndOfTermCharge" xlink:label="gern_AccruedEndOfTermCharge"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate" xlink:label="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_JanssenBiotechIncMember" xlink:label="gern_JanssenBiotechIncMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract" xlink:label="us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityPolicyTextBlock" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandAndEighteenInducementAwardPlanMember" xlink:label="gern_TwoThousandAndEighteenInducementAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:label="gern_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock" xlink:label="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" xlink:label="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoPreFundedWarrantMember" xlink:label="gern_TwoThousandTwentyTwoPreFundedWarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_HerculesAndSiliconValleyBankMember" xlink:label="gern_HerculesAndSiliconValleyBankMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_BorrowingAvailableStartDate" xlink:label="gern_BorrowingAvailableStartDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="us-gaap_InvestmentOwnedAtFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CommonStockAggregateOfferingPrice" xlink:label="gern_CommonStockAggregateOfferingPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceClaimsMember" xlink:label="us-gaap_InsuranceClaimsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainOnSaleOfInvestments" xlink:label="us-gaap_GainOnSaleOfInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CashAndCashEquivalentsUnrealizedLosses" xlink:label="gern_CashAndCashEquivalentsUnrealizedLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LongTermDebtGross" xlink:label="gern_LongTermDebtGross"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceSalesAgreementsTable" xlink:label="gern_AtMarketIssuanceSalesAgreementsTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PercentageOfInterestOnPastDueOutstanding" xlink:label="gern_PercentageOfInterestOnPastDueOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares" xlink:label="us-gaap_InvestmentOwnedBalanceShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencySettlementAgreementDate" xlink:label="us-gaap_LossContingencySettlementAgreementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtDescription" xlink:label="us-gaap_LongTermDebtDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NewJerseyOfficeSpaceLeaseMember" xlink:label="gern_NewJerseyOfficeSpaceLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MarketCapMinimumToUseOptionTwo" xlink:label="gern_MarketCapMinimumToUseOptionTwo"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MaximumCommissionRate" xlink:label="gern_MaximumCommissionRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NumberOfFinancialInstitutions" xlink:label="gern_NumberOfFinancialInstitutions"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_StockPurchaseWarrantsMember" xlink:label="gern_StockPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract" xlink:label="us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtInstrumentMinimumPrepaymentAmount" xlink:label="gern_DebtInstrumentMinimumPrepaymentAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ConsultantsMember" xlink:label="gern_ConsultantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ExpiryDateOfTranche" xlink:label="gern_ExpiryDateOfTranche"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod" xlink:label="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SeverancePlanLineItems" xlink:label="gern_SeverancePlanLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod" xlink:label="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountToBePaid" xlink:label="gern_LitigationSettlementAmountToBePaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:label="us-gaap_RestrictedCashAndInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DirectorsPlan2006Member" xlink:label="gern_DirectorsPlan2006Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyPreFundedWarrantsMember" xlink:label="gern_TwoThousandTwentyPreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PercentageOfPrepaymentCharge" xlink:label="gern_PercentageOfPrepaymentCharge"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_UnderwrittenPublicOfferingMember" xlink:label="gern_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:label="gern_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CostMethodInvestmentsCostBasis" xlink:label="gern_CostMethodInvestmentsCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CARESActImpactAbstract" xlink:label="gern_CARESActImpactAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" xlink:label="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity" xlink:label="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingOfCommonStockAndWarrantsMember" xlink:label="gern_PublicOfferingOfCommonStockAndWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:label="us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" xlink:label="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheFourMember" xlink:label="gern_TrancheFourMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementNumberOfStudies" xlink:label="gern_CollaborativeArrangementNumberOfStudies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandAndEighteenEquityIncentivePlanMember" xlink:label="gern_TwoThousandAndEighteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontradeReceivablesCurrent" xlink:label="us-gaap_NontradeReceivablesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountPaidInCashOrKind" xlink:label="gern_LitigationSettlementAmountPaidInCashOrKind"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueAdjustment" xlink:label="us-gaap_AssetsFairValueAdjustment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNoteSecuritiesMember" xlink:label="us-gaap_CorporateNoteSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DepositsAndOtherAssetsNoncurrent" xlink:label="gern_DepositsAndOtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClinicalSupplyAgreementMember" xlink:label="gern_ClinicalSupplyAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncreaseDecreaseDueToCounterparty" xlink:label="gern_IncreaseDecreaseDueToCounterparty"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PurchaseWarrantsMember" xlink:label="gern_PurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" xlink:label="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinimumCashBalance" xlink:label="gern_DebtCovenantMinimumCashBalance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements" xlink:label="us-gaap_PaymentsForLegalSettlements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedEndOfTermCharges" xlink:label="gern_AccruedEndOfTermCharges"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems" xlink:label="us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SeverancePlanTable" xlink:label="gern_SeverancePlanTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" xlink:label="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember" xlink:label="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SecondAmendmentMember" xlink:label="gern_SecondAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember" xlink:label="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_FosterCityOfficeSpaceLeaseMember" xlink:label="gern_FosterCityOfficeSpaceLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_InterestOnlyPeriodPaymentTermDescription" xlink:label="gern_InterestOnlyPeriodPaymentTermDescription"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" xlink:label="us-gaap_LineOfCreditFacilityBorrowingCapacityDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized" xlink:label="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtCovenantMinCashUponRegulatoryMilestone" xlink:label="gern_DebtCovenantMinCashUponRegulatoryMilestone"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AccruedManufacturingActivitiesCurrent" xlink:label="gern_AccruedManufacturingActivitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EmployerTaxReceivable" xlink:label="gern_EmployerTaxReceivable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" xlink:label="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OptionOneMinCashDebtCovenantMember" xlink:label="gern_OptionOneMinCashDebtCovenantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_IncentiveAwardPlan2011Member" xlink:label="gern_IncentiveAwardPlan2011Member"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" xlink:label="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable" xlink:label="us-gaap_InvestmentHoldingsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis" xlink:label="srt_LitigationCaseAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PerformanceBasedStockOptionsMember" xlink:label="gern_PerformanceBasedStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_HerculesMember" xlink:label="gern_HerculesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceAbstract" xlink:label="us-gaap_ValuationAllowanceAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OperatingLossCarryforwardsSubjectToExpiration" xlink:label="gern_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" xlink:label="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember" xlink:label="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" xlink:label="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CashAndCashEquivalentsUnrealizedGains" xlink:label="gern_CashAndCashEquivalentsUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtInstrumentUnamortizedEndOfTermCharge" xlink:label="gern_DebtInstrumentUnamortizedEndOfTermCharge"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_RestrictedCashAndCashEquivalentsUnrealizedGains" xlink:label="gern_RestrictedCashAndCashEquivalentsUnrealizedGains"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyStockPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyStockPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheTwoMember" xlink:label="gern_TrancheTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DerivativeStipulationMember" xlink:label="gern_DerivativeStipulationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheCMember" xlink:label="gern_TrancheCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable" xlink:label="us-gaap_TaxCreditCarryforwardTable"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TrancheThreeMember" xlink:label="gern_TrancheThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_OptionThreeMinCashDebtCovenantMember" xlink:label="gern_OptionThreeMinCashDebtCovenantMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LitigationSettlementAmountAccruedLiabilitiesRecognized" xlink:label="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USTreasurySecuritiesDueInLessThanOneYearMember" xlink:label="gern_USTreasurySecuritiesDueInLessThanOneYearMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent" xlink:label="us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember" xlink:label="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_FormerCollaborativeArrangementMember" xlink:label="gern_FormerCollaborativeArrangementMember"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets" xlink:label="gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract" xlink:label="us-gaap_LeaseCostAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" xlink:label="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CollaborativeArrangementCostSharingPercentageOfCounterparty" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_DebtInstrumentEndOfTermChargePercentage" xlink:label="gern_DebtInstrumentEndOfTermChargePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" xlink:label="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_SubsequentDirectorOptionMember" xlink:label="gern_SubsequentDirectorOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember" xlink:label="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" xlink:label="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NewJerseyLeaseAndFosterCityLeaseMember" xlink:label="gern_NewJerseyLeaseAndFosterCityLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_EquityInvestmentReverseStockSplit" xlink:label="gern_EquityInvestmentReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember" xlink:label="us-gaap_EquitySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_NumberOfSharesSoldFromEquityInvestment" xlink:label="gern_NumberOfSharesSoldFromEquityInvestment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_PreFundedWarrantsMember" xlink:label="gern_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedInvestmentsAtFairValue" xlink:label="us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_FirstDirectorOptionMember" xlink:label="gern_FirstDirectorOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ClassActionStipulationMember" xlink:label="gern_ClassActionStipulationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="gern-20221231.xsd#gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems" xlink:label="us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Duration of the new offering period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Duration Of New Offering Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the duration of new offering period in a case where the fair market value of common stock on the purchase date is less than the fair market value at the beginning of the offering period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule reconciles the federal statutory tax rate to the effective income tax rate from continuing operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Capitalized research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Capitalized Research And Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount before allocation of valuation allowances of deferred tax asset attributable to the treatment of research and development costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of accrued liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToTerminate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease term, option to terminate lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToTerminate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Option to Terminate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with at market offering, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield (as a percent)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Percentage of Discount Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Discount Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Minimum cash balance requirement to be met as a percentage of six-month product revenue against forecast</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt covenant percentage of product revenue against forecast</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum percentage of six-month product revenue forecast to satisfy minimum cash balance debt covenant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of common stock reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Common Stock Reserved For Future Issuance Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tabular disclosure of common stock reserved for future issuance, which may include but is not limited to outstanding options and outstanding warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total fair value of restricted stock that vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public Offering [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Offering [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares of common stock authorized for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Loss Carryforwards [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Government-sponsored enterprise securities (due in less than one year)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Government Sponsored Enterprise Securities Due In Less Than One Year [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Government sponsored enterprise securities due in less than one year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_LitigationCaseTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Case [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceSalesAgreementsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">At Market Issuance Sales Agreements [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceSalesAgreementsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">At Market Issuance Sales Agreements [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceSalesAgreementsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At Market Issuance Sales Agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating leases, right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sales of securities available for sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Litigation settlement, amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MenloParkOfficeSpaceLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Menlo Park Office Space Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MenloParkOfficeSpaceLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Menlo Park Office Space Lease [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MenloParkOfficeSpaceLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Menlo park office space lease.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum cash balance as a percentage of loan amount outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt covenant minimum cash balance percentage of loan amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of loan amount outstanding to be held as minimum cash balance under debt covenant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OperatingLeaseTermAdditionalPeriodExtension_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease term, additional period extension</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OperatingLeaseTermAdditionalPeriodExtension_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Term Additional Period Extension</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OperatingLeaseTermAdditionalPeriodExtension_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease term additional period extension.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CommercialPaperDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial paper (due in less than one year)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CommercialPaperDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper Due In Less Than One Year [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CommercialPaperDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to unsecured promissory note (generally negotiable) that provides institutions with short-term funds ), due in less than one year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncurrent operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits, if recognized would impact effective tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MunicipalSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Municipal securities (due in one to two years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MunicipalSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Municipal Securities Due In One To Two Years [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MunicipalSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Municipal securities due in one to two years member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock reserved for future issuance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares reserved for future issuance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryNotesSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Notes Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Silicon Valley Bank [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Silicon Valley Bank.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Public Offering of Common Stock and Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Public Offering Of Common Stock And Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2020 Public Offering of Common Stock and Warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OptionTwoMinCashDebtCovenantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Two Min Cash Debt Covenant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OptionTwoMinCashDebtCovenantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Option two min cash debt covenant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Stock options cancelled/forfeited/expired (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Employee stock purchase</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinCashUponLicensingTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt covenant minimum cash balance upon licensing transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinCashUponLicensingTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Covenant Min Cash Upon Licensing Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinCashUponLicensingTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum cash covenant required upon certain licensing transactions being executed.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USTreasurySecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury securities (due in one to two years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USTreasurySecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">U S Treasury Securities Due In One To Two Years [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USTreasurySecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">US Treasury securities due in one to two years member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Issuance Costs and Debt Discounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation and benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of costs to be paid by Geron</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Cost Sharing Percentage Of Entity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the percentage of costs that Geron must pay during certain phases of the agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">OPERATING LEASES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Leases [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuances of common stock under equity plans (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche B [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche B [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche B [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease,remaining lease term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders' equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DirectorsMarketValueStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Directors Market Value Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DirectorsMarketValueStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Directors Market Value Stock Purchase Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DirectorsMarketValueStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Directors&#8217; market value stock purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options to be granted to purchase shares (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options To Be Granted To Purchase Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the number of options to be granted to purchase shares in each year during the optionee's service on the Board of Directors.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtTheMarketOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">At The Market Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtTheMarketOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">At The Market Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtTheMarketOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At The Market Offering Member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MunicipalSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Municipal securities (due in less than one year)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MunicipalSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Municipal securities (due in less than a year)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MunicipalSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Municipal Securities Due In Less Than One Year [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MunicipalSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Municipal securities due in less than one year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public Offering [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Offering [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection exercise of warrants (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock In Connection With Warrant Exercise Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of new shares issued during the period in connection with exercise of warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards, expire beginning 2028 through 2041</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Nature [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CostMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost method investments ownership percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CostMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Method Investment Ownership Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CostMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost method investment ownership percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OperatingLeaseRentAbatementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, rent abatement period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OperatingLeaseRentAbatementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Rent Abatement Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OperatingLeaseRentAbatementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease rent abatement period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recurring basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock-Based Compensation to Service Providers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Goods and Nonemployee Services Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ACCRUED LIABILITIES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CRO and clinical trial costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Clinical Research Organizations And Clinical Trial Costs Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical related costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Liabilities, Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022 Purchase Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Two Purchase Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty two purchase warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DueToCounterParty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount due to Janssen Biotech, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DueToCounterParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Due To Counter Party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DueToCounterParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Carrying amount as of the balance sheet date of obligations due to counterparty. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Goods And Nonemployee Services Transaction [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Goods and Nonemployee Services Transaction [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LicenseAgreementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LicenseAgreementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">No definition available.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Issuance or Sale of Equity, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net proceeds from public offering after deducting underwriting discount and other offering expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance or Sale of Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxAssetsFederalAndStateCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal and state tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxAssetsFederalAndStateCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Federal And State Credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxAssetsFederalAndStateCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets federal and state credits.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of consecutive purchase periods in an offering period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Number Of Consecutive Purchase Periods In Each Offering Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the number of consecutive purchase periods in an offering period in the purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (decrease) in fair value of equity investment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Equity Securities, FV-NI</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche one.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Of Common Stock Issued During Period Shares New Issues Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of new shares of common stock issued during the period in connection with public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares used in computing basic net loss per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the period (in dollars)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche A [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche A [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche A [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options cancelled/forfeited/expired (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Forfeitures And Expirations In Period Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of shares under options that were cancelled or that expired during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average estimated fair value of employee stock options granted (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease term, option to extend additional period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Renewal Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less Than 12 Months - Estimated Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedEndOfTermCharge_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued end of term charge</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedEndOfTermCharge_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued End Of Term Charge</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedEndOfTermCharge_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued end of term charge.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Charge for prepayment occurring 36 months after effective date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dollar prepayment charge 36 months after effective date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepayment charge assessed upon debt prepayment occurring 36 months after June 30, 2022 under second amendment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Government-sponsored enterprise securities (due in less than one year)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">U S Government Sponsored Enterprises Debt Securities Due In Less Than One Year [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae, due in less than one year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_JanssenBiotechIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Janssen Biotech</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_JanssenBiotechIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Janssen Biotech Inc [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_JanssenBiotechIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to the Janssen Biotech Inc.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Noncurrent portion of debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncurrent debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted net loss per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weight Average Remaining Contractual Life (in years) - Options Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Life [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Weighted Average Remaining Contractual Life (In years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Included in cash and cash equivalents:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Gain (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional disclosures</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Additional Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandAndEighteenInducementAwardPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Inducement Award Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandAndEighteenInducementAwardPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Eighteen Inducement Award Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandAndEighteenInducementAwardPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and eighteen inducement award plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase decrease in operating lease liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum expiration term of stock options granted to employees having more than 10 % outstanding common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation By Share Based Payment Award Options Maximum Expiration Term For Options Granted To Optionees With Ownership Of More Than10 Percentage Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the maximum expiration term of options granted to employees having more than 10 % outstanding common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest and other receivables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Accrued Interest Receivable Net And Other Receivables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The increase (decrease) during the reporting period in the amount due for interest payments related to marketable securities and in other amounts due to the reporting entity, which are not otherwise defined in the taxonomy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoPreFundedWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022 Pre-Funded Warrant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoPreFundedWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Two Pre Funded Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoPreFundedWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2022 pre-funded warrant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at December 31, 2022 and 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certificate of deposit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Certificates of Deposit [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation for equity-based awards to employees and directors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Lease, Liability, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_HerculesAndSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Hercules and Silicon Valley Bank [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_HerculesAndSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Hercules And Silicon Valley Bank [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_HerculesAndSiliconValleyBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Hercules and Silicon Valley Bank. member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_BorrowingAvailableStartDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Start date to borrow under a tranche for a debt instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_BorrowingAvailableStartDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Borrowing Available Start Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_BorrowingAvailableStartDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">First date to available to drawdown any amount under a tranche.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, increase in shares reserved for future issuance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, increase in option reserves (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Other Increases (Decreases) in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of equity investment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Owned, at Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Available For Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Roll Forward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares Available For Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CommonStockAggregateOfferingPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate offering price of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CommonStockAggregateOfferingPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock Aggregate Offering Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CommonStockAggregateOfferingPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the aggregate offering price for which the entity may elect to issue and sell shares of its common stock under the sales agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to purchase common stock, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InsuranceClaimsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Insurance Claims</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InsuranceClaimsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Insurance Claims [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Percentage applied to common stock market value in calculating purchase price under purchase plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainOnSaleOfInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gain on sales of available for sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainOnSaleOfInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain on Sale of Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CashAndCashEquivalentsUnrealizedLosses_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gross Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CashAndCashEquivalentsUnrealizedLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CashAndCashEquivalentsUnrealizedLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the gross unrealized losses for cash and cash equivalents.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of lease costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of cash equivalents, restricted cash and marketable securities by security type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">FAIR VALUE MEASUREMENTS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options exercisable at the end of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash received from exercise of stock options (in dollars)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of common stock from at market offerings, net of paid issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of property and equipment, stated at cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LongTermDebtGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LongTermDebtGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LongTermDebtGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Aggregate value of term loan, including accrued interest payable and end of term charge.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceSalesAgreementsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">At Market Issuance Sales Agreements [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceSalesAgreementsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">At Market Issuance Sales Agreements [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceSalesAgreementsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At Market Issuance Sales Agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PercentageOfInterestOnPastDueOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional percentage of interest on past due amounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PercentageOfInterestOnPastDueOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Interest On Past Due Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PercentageOfInterestOnPastDueOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Added percentage to current interest rate under debt instrument to past due amounts.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuances of common stock from equity plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum borrowing capacity under term loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentOwnedBalanceShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares owned</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentOwnedBalanceShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Owned, Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency, Nature [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Unrealized Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencySettlementAgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlement agreement date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencySettlementAgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency, Settlement Agreement, Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SUBSEQUENT EVENTS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of maturity date terms for term loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares used in computing diluted net loss per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of offering periods in which an employee can participate at a time</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Offering Periods In Which Employee May Participate At One Time</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the number of offering periods in which an employee can participate at a time in the purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NewJerseyOfficeSpaceLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Jersey Office Space Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NewJerseyOfficeSpaceLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Jersey Office Space Lease [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NewJerseyOfficeSpaceLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">New jersey office space lease.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental schedule of non-cash operating and investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial paper</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: amount representing interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MarketCapMinimumToUseOptionTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Minimum market capitalization requirement for option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MarketCapMinimumToUseOptionTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Market cap minimum to use option two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MarketCapMinimumToUseOptionTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum market capitalization required for this option to be available to meet the minimum cash balance debt covenant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MaximumCommissionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum commission rate (as a percent)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MaximumCommissionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Commission Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MaximumCommissionRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the percentage of maximum commission rate, based on gross proceeds of sale price per share of common stock sold through sales agent under the sales agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NumberOfFinancialInstitutions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of financial institutions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NumberOfFinancialInstitutions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Financial Institutions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NumberOfFinancialInstitutions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of financial institutions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_StockPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Purchase Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_StockPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Purchase Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_StockPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock purchase warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risks, Types, No Concentration Percentage [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of assumptions used to estimate the fair value of employee stock purchases under the purchase plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection exercise of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock In Connection With Warrant Exercise Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity impact of the value of stock issued in connection with exercise of warrants during the period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental operating and investing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant components of deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtInstrumentMinimumPrepaymentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum amount of prepayment allowed under debt instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtInstrumentMinimumPrepaymentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Minimum Prepayment Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtInstrumentMinimumPrepaymentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum amount allowed to be prepaid under debt instrument.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ConsultantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consultants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ConsultantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consultants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ConsultantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to consultants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">INCOME TAXES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ExpiryDateOfTranche_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Last date to drawdown any amounts under a tranche.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ExpiryDateOfTranche_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Expiry Date Of Tranche</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ExpiryDateOfTranche_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration date to borrow under a tranche for a debt instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period within which employee is terminated by entity without cause following a change of control</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Triggering Event Employee Termination Without Cause Following Change Of Control Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the number of months following a change in control when an employee is terminated without cause to be classified as a triggering event for severance payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in connection with at market offering, net of issuance costs (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SeverancePlanLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Severance Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SeverancePlanLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Severance Plan [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SeverancePlanLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Severance plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Minimum percentage of net product revenues maintenance period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum percentage of net product revenues maintenance period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum percentage of net product revenues maintenance period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options cancelled/forfeited/expired (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum interest rate (as a percentage)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountToBePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlement amount to be paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountToBePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Settlement Amount to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountToBePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Litigation settlement amount to be paid.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndInvestmentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash and Investments [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unamortized debt discount and issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unamortized Debt Issuance Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional legal and accounting fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total - Estimated Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DirectorsPlan2006Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2006 Directors Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DirectorsPlan2006Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Directors Plan2006 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DirectorsPlan2006Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to the 2006 Directors Plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net unrealized loss on marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options exercisable at the end of the period (in dollars)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Duration of the purchase period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Duration Of Purchase Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the duration of the purchase period under the employee stock purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyPreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Pre-Funded Warrant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyPreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Pre Funded Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyPreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2020 Pre-funded warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balances</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balances</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PercentageOfPrepaymentCharge_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment charge (as a percentage)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PercentageOfPrepaymentCharge_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Prepayment Charge</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PercentageOfPrepaymentCharge_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of prepayment amount to be paid upon prepayment under debt instrument.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total - Gross Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Gain (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_UnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwritten Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_UnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwritten Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_UnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwritten Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value; 675,000,000 shares authorized; 390,262,524 and 323,731,591 shares issued and outstanding at December 31, 2022 and 2021, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Deposit Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deposit and other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Deposit Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Operating Lease Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets operating lease liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: unamortized debt discount and issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CostMethodInvestmentsCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost method investments cost basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CostMethodInvestmentsCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost Method Investments Cost Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CostMethodInvestmentsCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cost method investments cost basis.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from exercise of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Warrant Exercises</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CARESActImpactAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">C A R E S Act Impact [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CARESActImpactAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CARES act impact.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Issuance Costs, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Government-sponsored enterprise securities (due in one to two years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Government Sponsored Enterprise Securities Due In One To Two Years [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae) due in 1 to 2 years.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplier</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplier [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum percentage of ownership required for granting stock options at least 110% of fair market value of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Minimum Percentage Of Ownership Required For Granting Options At Minimum110 Percent Of Fair Market Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the minimum percentage of ownership required for granting of options at a price not less than 110 percent of the fair market value of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">12 Months or Greater - Gross Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from maturities of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to purchase common stock exercised, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of warrants exercised during the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of costs to be paid by Geron after termination of Collaboration Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement After Termination Cost Sharing Percentage Of Entity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the percentage of costs that the company must pay after the termination of the Collaboration Agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term range</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Compensation cost related to unvested stock awards not yet recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease Liabilities, Payments Due</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities Available For Sale [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingOfCommonStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public Offering of Common Stock and Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingOfCommonStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Offering Of Common Stock And Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingOfCommonStockAndWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Public Offering of Common Stock and Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility range, maximum (as a percent)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion, and Amortization [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss not benefitted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Net Operating Loss Not Benefitted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax Rate reconciliation net operating loss not benefitted.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Depletion and Amortization, Nonproduction, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Assets, Fair Value Disclosure, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average estimated fair value of other than employee stock options granted (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Four [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche four.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementNumberOfStudies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of agreed upon studies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementNumberOfStudies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Number Of Studies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementNumberOfStudies_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the number of agreed upon studies.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Combined public offering price per share of pre-funded warrants and accompanying stock purchase warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LICENSE AGREEMENT</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options exercised (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandAndEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandAndEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Eighteen Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandAndEighteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2018 equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NontradeReceivablesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Nontrade Receivables, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NontradeReceivablesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and other receivables</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NontradeReceivablesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nontrade Receivables, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum duration of offering period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Maximum Duration Of Offering Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the maximum duration of the offering period under the employee stock purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan interest rate description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Basis for Effective Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountPaidInCashOrKind_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlement to be paid in cash or shares as elected by company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountPaidInCashOrKind_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Settlement Amount Paid in Cash or Kind</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountPaidInCashOrKind_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of the settlement to be paid by the company in either cash or shares, at the company's election.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CONSOLIDATED STATEMENTS OF CASH FLOWS DATA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of equity investment, including foreign currency translation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Adjustment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateNoteSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate notes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateNoteSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Note Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DepositsAndOtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deposits and other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DepositsAndOtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deposits And Other Assets Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DepositsAndOtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer; and amount of noncurrent assets classified as other.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of financial instruments measured at fair value on recurring basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ClinicalSupplyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Clinical Supply Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ClinicalSupplyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Clinical Supply Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ClinicalSupplyAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Clinical supply agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Future Minimum Payments Under Term Loan Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign currency translation adjustment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of assumptions used to estimate the fair value of stock options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncreaseDecreaseDueToCounterparty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount due to Janssen Biotech, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncreaseDecreaseDueToCounterparty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease Due To Counterparty</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncreaseDecreaseDueToCounterparty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The increase (decrease) during the reporting period for amount due to counterparty.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan maturity date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation for employees and directors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of remaining term commitments held under loan agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Remaining Term Commitments Held Under Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of remaining term commitments held under loan agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options fully vested and expected to vest at the end of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt discount under second amendment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Unamortized Discount, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: unamortized debt discount and issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuances of common stock under equity plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options fully vested and expected to vest at the end of the period (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration term of stock options from date of grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinimumCashBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt covenant minimum cash balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinimumCashBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Covenant Minimum Cash Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinimumCashBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Covenant Minimum Cash Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlement to be paid by insurers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForLegalSettlements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Legal Settlements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License fees and royalties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedEndOfTermCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accrued end of term charge</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedEndOfTermCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued End Of Term Charges</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedEndOfTermCharges_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued end of term charges.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants outstanding (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense included in operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentHoldingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Equity Investments [Line Item]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentHoldingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Holdings [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentHoldingsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Holdings [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value on a Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SeverancePlanTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Severance Plan [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SeverancePlanTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Severance Plan [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SeverancePlanTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Severance plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate notes (due in less than one year)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Note Securities Due In Less Than One Year [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest), due in less than one year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period for recognition of compensation cost on weighted average basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance at the end of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Undiscounted future non-cancellable lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of reconciliation of the beginning and ending amounts of unrecognized tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Sales Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">At Market Issuance Two Thousand And Twenty Sales Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At market issuance two thousand and twenty sales agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balances (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balances (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accretion and amortization on investments, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">DEBT</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SecondAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Second Amendment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SecondAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Second Amendment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SecondAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Second amendment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Issuance of Long-Term Debt, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from debt financing, net of paid debt issuance costs and debt discounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-Sale, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase related to current year tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options to be granted to purchase shares upon appointment (shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options To Be Granted To Purchase Shares Upon Appointment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the number of options to be granted to purchase shares upon appointment to Board of Directors.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022 Underwritten Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Two Underwritten Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Information by type of sale of the entity's stock. = 2022 Underwritten Public Offering [Member].</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_FosterCityOfficeSpaceLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foster City Office Space Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_FosterCityOfficeSpaceLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foster City Office Space Lease [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_FosterCityOfficeSpaceLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Foster City office space lease.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_InterestOnlyPeriodPaymentTermDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest only period payment term description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_InterestOnlyPeriodPaymentTermDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Only Period Payment Term Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_InterestOnlyPeriodPaymentTermDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest only period payment term description.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Purchase Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Purchase Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty purchase warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (Decrease) in Stockholders' Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityBorrowingCapacityDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration date to borrow under a tranche for a debt instrument, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityBorrowingCapacityDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Borrowing Capacity, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation related to issuance of common stock and options in exchange for services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate range, maximum (as a percent)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period within which no comparable employment is offered by the entity following a change of control</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Triggering Event Period Following Change Of Control During Which No Comparable Employment Is Offered By Entity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the period following change of control within which an employee is not offered comparable employment (new or continuing) by the entity or its successor or acquired and to be considered as triggering event for severance payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlement amount, Interest and other receivable recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Settlement Amount, Interest and other receivable Recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Litigation Settlement Amount, Interest and other receivable Recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options exercisable at the end of the period (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accrued liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income tax, net of federal benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Offering Stock Issued During Period Value New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Public offering stock issued during period value new issues.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenues:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Compensation cost not yet recognized, net of estimated forfeitures (in dollars)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Realized Investment Gains (Losses), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized investment gains (losses)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Realized Investment Gains (Losses)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinCashUponRegulatoryMilestone_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt covenant minimum cash balance upon regulatory milestone achievement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinCashUponRegulatoryMilestone_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Covenant Min Cash Upon Regulatory Milestone</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtCovenantMinCashUponRegulatoryMilestone_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum cash covenant required upon achievement of certain regulatory milestones.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total pretax intrinsic value of stock options exercised (in dollars)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income , net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Income (Expense), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: current portion of debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-Term Debt, Current Maturities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: current portion of debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Current Maturities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedManufacturingActivitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Manufacturing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedManufacturingActivitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Manufacturing Activities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AccruedManufacturingActivitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Carrying value as of the balance sheet of obligations incurred through the date and payable for manufacturing related costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EmployerTaxReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee retention credit, CARES Act</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EmployerTaxReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employer Tax Receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EmployerTaxReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Carrying amount as of the balance sheet date of employer taxes paid to tax authorities representing refunds based on calculated eligible credits. Also called employer tax refund receivable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Decrease related to prior year tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Operating leases, right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Operating Leases Right Of Use Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities operating leases right of use assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, initial term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OptionOneMinCashDebtCovenantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option one min cash debt covenant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OptionOneMinCashDebtCovenantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Option one min cash debt covenant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (decrease) in valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncentiveAwardPlan2011Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2011 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncentiveAwardPlan2011Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incentive Award Plan2011 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_IncentiveAwardPlan2011Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to the 2011 Incentive Award Plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents Gross Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash and cash equivalents gross unrealized losses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentHoldingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Holdings [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentHoldingsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Holdings [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assumptions used to estimate fair value of awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_LitigationCaseAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Litigation Case [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less accumulated depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PerformanceBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance-Based Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PerformanceBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance Based Stock Options [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PerformanceBasedStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance based stock options.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_HerculesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Hercules [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_HerculesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Hercules.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options and awards available for grant (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the period (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the period (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options fully vested and expected to vest at the end of the period (in dollars)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Employee Related Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued compensation and benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">General and administrative expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortization of Debt Issuance Costs and Discounts, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt issuance costs/debt discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the period (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the period (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OperatingLossCarryforwardsSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards, expire beginning 2023 through 2037</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OperatingLossCarryforwardsSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Subject To Expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OperatingLossCarryforwardsSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards subject to expiration.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate range, minimum (as a percent)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario Forecast [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forecast [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease assets obtained in exchange for operating lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Combination Cost Of Acquired Entity Equity Interests Issued And Issuable Fair Value Method</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Fair Value Method</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2018 Sales Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">At Market Issuance Two Thousand And Eighteen Sales Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">At market issuance, 2018 sales agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sales of equity investment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale of Other Assets, Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money market funds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlement amount, General and administrative expense recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Litigation settlement amount, General and administrative expense recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Litigation settlement amount, General and administrative expense recognized.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options fully vested and expected to vest at the end of the period (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of aggregate stock option and award activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CashAndCashEquivalentsUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Unrealized Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CashAndCashEquivalentsUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash And Cash Equivalents Unrealized Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CashAndCashEquivalentsUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the gross unrealized gains for cash and cash equivalents.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">12 Months or Greater - Estimated Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax at statutory rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtInstrumentUnamortizedEndOfTermCharge_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: unamortized end of term charge</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtInstrumentUnamortizedEndOfTermCharge_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Unamortized End Of Term Charge</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtInstrumentUnamortizedEndOfTermCharge_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument unamortized end of term charge.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_RestrictedCashAndCashEquivalentsUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Unrealized Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_RestrictedCashAndCashEquivalentsUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash And Cash Equivalents Unrealized Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_RestrictedCashAndCashEquivalentsUnrealizedGains_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash and cash equivalents unrealized gains.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate shares issued under plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Aggregate Shares Issued Under Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the aggregate number of share instruments issued under a share-based compensation plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Vesting period of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">STOCKHOLDERS' EQUITY</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options exercisable at the end of the period (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyStockPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Stock Purchase Warrant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyStockPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Stock Purchase Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyStockPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand Twenty Stock Purchase Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Municipal securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Municipal Bonds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Equity Securities, FV-NI, Unrealized Gain (Loss), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of equity investment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period within which employee resigns following a change of control due to material change in terms of employment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Triggering Event Period Following Change Of Control Within Which Employee Resigns Due To Material Change In Terms Of Employment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the period within which employee resigns following a change of control due to material change in terms of employment and to be considered as triggering event for severance payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Stock options granted (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options granted (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options granted (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of term loan payment terms</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Payment Terms</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Two [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche two.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DerivativeStipulationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative Stipulation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DerivativeStipulationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Stipulation [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DerivativeStipulationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Derivative stipulation.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-Term Debt, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Carrying value of term loan, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche C [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche C [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche C [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options outstanding (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at the beginning of the period (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance at the end of the period (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Closing stock price (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic net loss per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price Per Share - Options Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum percentage of annual salary that can be withheld</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Maximum Percentage Of Annual Salary That Can Be Withheld</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the maximum percentage of annual salary that an employee can choose to have withheld to purchase common stock under the purchase plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASSETS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total net deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Three [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche three.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility range, minimum (as a percent)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OptionThreeMinCashDebtCovenantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option three min cash debt covenant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_OptionThreeMinCashDebtCovenantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Option three min cash debt covenant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Settlement amount, Accrued liabilities recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Litigation settlement amount, Accrued liabilities recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Litigation settlement amount, Accrued liabilities recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Combined public offering price per share of common stock and accompanying stock purchase warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options and warrants excluded from diluted net loss per share calculation due to net loss position</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USTreasurySecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasury securities (due in less than one year)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USTreasurySecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">U S Treasury Securities Due In Less Than One Year [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USTreasurySecuritiesDueInLessThanOneYearMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">US Treasury Securities Due In less than one Year Member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">STOCKHOLDERS' EQUITY</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Shares - Options Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Underwritten Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Three Underwritten Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2023 Underwritten Public Offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Government-sponsored enterprise securities (due in one to two years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">U S Government Sponsored Enterprises Debt Securities Due In One To Two Years [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae), due in one to two years.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gain (loss) related to foreign currency translation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants to purchase common stock, exercise price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants exercise price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_FormerCollaborativeArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Former Collaboration Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_FormerCollaborativeArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Former Collaborative Arrangement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_FormerCollaborativeArrangementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Former collaborative arrangement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification between prepaid and other current assets and deposits and other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification Between Prepaid And Other Current Assets And Deposits And Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reclassification between prepaid and other current assets and deposits and other assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncurrent marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of significant components of the entity's deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less Than 12 Months - Gross Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of cash equivalents and marketable securities with unrealized losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payables and Accruals [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net gain on exchange and sales of equity investment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock and warrants in public offering, net of paid issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Public Offering Issuance Of Common Stock And Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from public offering issuance of common stock and warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Available remaining loan principal under second amendment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of costs to be paid by Janssen</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Cost Sharing Percentage Of Counterparty</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the percentage of costs that Janssen must pay during certain phases of the agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum exercise price as a percentage of fair market value for employees having more than 10 % outstanding common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Minimum Exercise Price Of Options Granted To Employees With More Than10 Percentage Of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award minimum exercise price of options granted to employees with more than 10 percentage of common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtInstrumentEndOfTermChargePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">End of term charge for loan, percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtInstrumentEndOfTermChargePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument End Of Term Charge Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_DebtInstrumentEndOfTermChargePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of outstanding loan amount payable upon maturity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net unrealized loss on marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of allocation of stock-based compensation expense related to share-based payment awards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Offering Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Public offering stock issued during period shares new issues.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net effect of unrealized gains and exchange rates on cash, cash equivalents and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effect Of Unrealized Losses And Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of increase (decrease) from effect of unrealized losses and exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by (used in) investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and computer equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Stock options exercised (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock-based compensation for services by non-employees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation for services by non-employees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period of base salary to be considered for severance payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Period Of Current Base Salary To Be Paid Under Severance Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loss contingency period of current base salary to be paid under severance plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SubsequentDirectorOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Director Option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SubsequentDirectorOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Director Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_SubsequentDirectorOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to the stock options to be granted by the entity subsequent to the grant upon first appointment to the Board of Directors.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Government-sponsored enterprise securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government-sponsored Enterprises Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage added to prime rate for debt instrument interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022 Stock Purchase Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty Two Stock Purchase Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2022 Stock Purchase Warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares issued (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation related to issuance of common stock and options in exchange for services (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate notes (due in one to two years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Note Securities Due In One To Two Years [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest), due in one to two years.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NewJerseyLeaseAndFosterCityLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Jersey Lease And Foster City Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NewJerseyLeaseAndFosterCityLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Jersey Lease And Foster City Lease [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NewJerseyLeaseAndFosterCityLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">New Jersey lease and Foster city lease member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplier</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplier [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated useful lives of assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization related to 401(k) contributions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal and state tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal amount outstanding under term loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EquityInvestmentReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity investment reverse stock split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EquityInvestmentReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Investment Reverse Stock Split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_EquityInvestmentReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reverse stock split ratio for equity investment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity investment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NumberOfSharesSoldFromEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number Of Shares Sold From Equity Investment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NumberOfSharesSoldFromEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Shares Sold From Equity Investment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_NumberOfSharesSoldFromEquityInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total number of shares from equity investment that have been sold during the period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gross Unrealized Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre-funded warrants purchase.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-Funded Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Funded Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedInvestmentsAtFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedInvestmentsAtFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Investments, at Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_FirstDirectorOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First Director Option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_FirstDirectorOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">First Director Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_FirstDirectorOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents information pertaining to the stock options to be granted by the entity to a person who first becomes a non-employee director.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ClassActionStipulationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Action Stipulation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ClassActionStipulationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class Action Stipulation [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ClassActionStipulationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class action stipulation.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Awards granted (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PROPERTY AND EQUIPMENT</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options granted (in dollars per share)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value - Options Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional shares authorized (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential dilutive securities excluded from diluted earnings (loss) per share calculation (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:to="gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToTerminate" xlink:to="us-gaap_LesseeOperatingLeaseOptionToTerminate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast" xlink:to="gern_DebtCovenantPercentageOfProductRevenueAgainstForecast_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PublicOfferingTable" xlink:to="gern_PublicOfferingTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember" xlink:to="gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LitigationCaseTypeDomain" xlink:to="srt_LitigationCaseTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_AtMarketIssuanceSalesAgreementsLineItems" xlink:to="gern_AtMarketIssuanceSalesAgreementsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="us-gaap_LitigationSettlementAmountAwardedToOtherParty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_MenloParkOfficeSpaceLeaseMember" xlink:to="gern_MenloParkOfficeSpaceLeaseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAbstract" xlink:to="us-gaap_DepreciationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount" xlink:to="gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_OperatingLeaseTermAdditionalPeriodExtension" xlink:to="gern_OperatingLeaseTermAdditionalPeriodExtension_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CommercialPaperDueInLessThanOneYearMember" xlink:to="gern_CommercialPaperDueInLessThanOneYearMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_MunicipalSecuritiesDueInOneToTwoYearsMember" xlink:to="gern_MunicipalSecuritiesDueInOneToTwoYearsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasuryNotesSecuritiesMember" xlink:to="us-gaap_USTreasuryNotesSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_SiliconValleyBankMember" xlink:to="gern_SiliconValleyBankMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember" xlink:to="gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_OptionTwoMinCashDebtCovenantMember" xlink:to="gern_OptionTwoMinCashDebtCovenantMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DebtCovenantMinCashUponLicensingTransaction" xlink:to="gern_DebtCovenantMinCashUponLicensingTransaction_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_USTreasurySecuritiesDueInOneToTwoYearsMember" xlink:to="gern_USTreasurySecuritiesDueInOneToTwoYearsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CollaborativeArrangementCostSharingPercentageOfEntity" xlink:to="gern_CollaborativeArrangementCostSharingPercentageOfEntity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TrancheBMember" xlink:to="gern_TrancheBMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DirectorsMarketValueStockPurchasePlanMember" xlink:to="gern_DirectorsMarketValueStockPurchasePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_AtTheMarketOfferingMember" xlink:to="gern_AtTheMarketOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_MunicipalSecuritiesDueInLessThanOneYearMember" xlink:to="gern_MunicipalSecuritiesDueInLessThanOneYearMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PublicOfferingLineItems" xlink:to="gern_PublicOfferingLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares" xlink:to="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CostMethodInvestmentOwnershipPercentage" xlink:to="gern_CostMethodInvestmentOwnershipPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_OperatingLeaseRentAbatementPeriod" xlink:to="gern_OperatingLeaseRentAbatementPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent" xlink:to="gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandTwentyTwoPurchaseWarrantsMember" xlink:to="gern_TwoThousandTwentyTwoPurchaseWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DueToCounterParty" xlink:to="gern_DueToCounterParty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable" xlink:to="us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LicenseAgreementDisclosureAbstract" xlink:to="gern_LicenseAgreementDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquity" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DeferredTaxAssetsFederalAndStateCredits" xlink:to="gern_DeferredTaxAssetsFederalAndStateCredits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TrancheOneMember" xlink:to="gern_TrancheOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering" xlink:to="gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TrancheAMember" xlink:to="gern_TrancheAMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet" xlink:to="gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_AccruedEndOfTermCharge" xlink:to="gern_AccruedEndOfTermCharge_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate" xlink:to="gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember" xlink:to="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_JanssenBiotechIncMember" xlink:to="gern_JanssenBiotechIncMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="us-gaap_StockholdersEquityPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandAndEighteenInducementAwardPlanMember" xlink:to="gern_TwoThousandAndEighteenInducementAwardPlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="gern_IncreaseDecreaseInOperatingLeaseLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock" xlink:to="gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables" xlink:to="gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandTwentyTwoPreFundedWarrantMember" xlink:to="gern_TwoThousandTwentyTwoPreFundedWarrantMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_HerculesAndSiliconValleyBankMember" xlink:to="gern_HerculesAndSiliconValleyBankMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_BorrowingAvailableStartDate" xlink:to="gern_BorrowingAvailableStartDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CommonStockAggregateOfferingPrice" xlink:to="gern_CommonStockAggregateOfferingPrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InsuranceClaimsMember" xlink:to="us-gaap_InsuranceClaimsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainOnSaleOfInvestments" xlink:to="us-gaap_GainOnSaleOfInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CashAndCashEquivalentsUnrealizedLosses" xlink:to="gern_CashAndCashEquivalentsUnrealizedLosses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="us-gaap_FairValueByBalanceSheetGroupingTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LongTermDebtGross" xlink:to="gern_LongTermDebtGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_AtMarketIssuanceSalesAgreementsTable" xlink:to="gern_AtMarketIssuanceSalesAgreementsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PercentageOfInterestOnPastDueOutstanding" xlink:to="gern_PercentageOfInterestOnPastDueOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceShares" xlink:to="us-gaap_InvestmentOwnedBalanceShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_LossContingencyNatureDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencySettlementAgreementDate" xlink:to="us-gaap_LossContingencySettlementAgreementDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtDescription" xlink:to="us-gaap_LongTermDebtDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_NewJerseyOfficeSpaceLeaseMember" xlink:to="gern_NewJerseyOfficeSpaceLeaseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_MarketCapMinimumToUseOptionTwo" xlink:to="gern_MarketCapMinimumToUseOptionTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_MaximumCommissionRate" xlink:to="gern_MaximumCommissionRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_NumberOfFinancialInstitutions" xlink:to="gern_NumberOfFinancialInstitutions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_StockPurchaseWarrantsMember" xlink:to="gern_StockPurchaseWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract" xlink:to="us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue" xlink:to="gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DebtInstrumentMinimumPrepaymentAmount" xlink:to="gern_DebtInstrumentMinimumPrepaymentAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ConsultantsMember" xlink:to="gern_ConsultantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ExpiryDateOfTranche" xlink:to="gern_ExpiryDateOfTranche_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod" xlink:to="gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_SeverancePlanLineItems" xlink:to="gern_SeverancePlanLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod" xlink:to="gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LitigationSettlementAmountToBePaid" xlink:to="gern_LitigationSettlementAmountToBePaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndInvestmentsAbstract" xlink:to="us-gaap_RestrictedCashAndInvestmentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DirectorsPlan2006Member" xlink:to="gern_DirectorsPlan2006Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandTwentyPreFundedWarrantsMember" xlink:to="gern_TwoThousandTwentyPreFundedWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PercentageOfPrepaymentCharge" xlink:to="gern_PercentageOfPrepaymentCharge_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_UnderwrittenPublicOfferingMember" xlink:to="gern_UnderwrittenPublicOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInDepositOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="gern_DeferredTaxAssetsOperatingLeaseLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CostMethodInvestmentsCostBasis" xlink:to="gern_CostMethodInvestmentsCostBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CARESActImpactAbstract" xlink:to="gern_CARESActImpactAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsGross" xlink:to="us-gaap_DeferredFinanceCostsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember" xlink:to="gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised" xlink:to="gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity" xlink:to="gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PublicOfferingOfCommonStockAndWarrantsMember" xlink:to="gern_PublicOfferingOfCommonStockAndWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:to="us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted" xlink:to="gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TrancheFourMember" xlink:to="gern_TrancheFourMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CollaborativeArrangementNumberOfStudies" xlink:to="gern_CollaborativeArrangementNumberOfStudies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandAndEighteenEquityIncentivePlanMember" xlink:to="gern_TwoThousandAndEighteenEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NontradeReceivablesCurrent" xlink:to="us-gaap_NontradeReceivablesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate" xlink:to="us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LitigationSettlementAmountPaidInCashOrKind" xlink:to="gern_LitigationSettlementAmountPaidInCashOrKind_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueAdjustment" xlink:to="us-gaap_AssetsFairValueAdjustment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateNoteSecuritiesMember" xlink:to="us-gaap_CorporateNoteSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DepositsAndOtherAssetsNoncurrent" xlink:to="gern_DepositsAndOtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ClinicalSupplyAgreementMember" xlink:to="gern_ClinicalSupplyAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_IncreaseDecreaseDueToCounterparty" xlink:to="gern_IncreaseDecreaseDueToCounterparty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PurchaseWarrantsMember" xlink:to="gern_PurchaseWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement" xlink:to="gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DebtCovenantMinimumCashBalance" xlink:to="gern_DebtCovenantMinimumCashBalance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLegalSettlements" xlink:to="us-gaap_PaymentsForLegalSettlements_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_AccruedEndOfTermCharges" xlink:to="gern_AccruedEndOfTermCharges_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsLineItems" xlink:to="us-gaap_InvestmentHoldingsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_SeverancePlanTable" xlink:to="gern_SeverancePlanTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember" xlink:to="gern_CorporateNoteSecuritiesDueInLessThanOneYearMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember" xlink:to="gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_SecondAmendmentMember" xlink:to="gern_SecondAmendmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember" xlink:to="gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_FosterCityOfficeSpaceLeaseMember" xlink:to="gern_FosterCityOfficeSpaceLeaseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_InterestOnlyPeriodPaymentTermDescription" xlink:to="gern_InterestOnlyPeriodPaymentTermDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandTwentyPurchaseWarrantsMember" xlink:to="gern_TwoThousandTwentyPurchaseWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityBorrowingCapacityDescription" xlink:to="us-gaap_LineOfCreditFacilityBorrowingCapacityDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity" xlink:to="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized" xlink:to="gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues" xlink:to="gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DebtCovenantMinCashUponRegulatoryMilestone" xlink:to="gern_DebtCovenantMinCashUponRegulatoryMilestone_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_AccruedManufacturingActivitiesCurrent" xlink:to="gern_AccruedManufacturingActivitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_EmployerTaxReceivable" xlink:to="gern_EmployerTaxReceivable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets" xlink:to="gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_OptionOneMinCashDebtCovenantMember" xlink:to="gern_OptionOneMinCashDebtCovenantMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_IncentiveAwardPlan2011Member" xlink:to="gern_IncentiveAwardPlan2011Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses" xlink:to="gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentHoldingsTable" xlink:to="us-gaap_InvestmentHoldingsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_LitigationCaseAxis" xlink:to="srt_LitigationCaseAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PerformanceBasedStockOptionsMember" xlink:to="gern_PerformanceBasedStockOptionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_HerculesMember" xlink:to="gern_HerculesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceAbstract" xlink:to="us-gaap_ValuationAllowanceAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_OperatingLossCarryforwardsSubjectToExpiration" xlink:to="gern_OperatingLossCarryforwardsSubjectToExpiration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod" xlink:to="us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember" xlink:to="gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized" xlink:to="gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CashAndCashEquivalentsUnrealizedGains" xlink:to="gern_CashAndCashEquivalentsUnrealizedGains_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DebtInstrumentUnamortizedEndOfTermCharge" xlink:to="gern_DebtInstrumentUnamortizedEndOfTermCharge_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_RestrictedCashAndCashEquivalentsUnrealizedGains" xlink:to="gern_RestrictedCashAndCashEquivalentsUnrealizedGains_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandTwentyStockPurchaseWarrantsMember" xlink:to="gern_TwoThousandTwentyStockPurchaseWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MunicipalBondsMember" xlink:to="us-gaap_MunicipalBondsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment" xlink:to="gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPaymentTerms" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TrancheTwoMember" xlink:to="gern_TrancheTwoMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DerivativeStipulationMember" xlink:to="gern_DerivativeStipulationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TrancheCMember" xlink:to="gern_TrancheCMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardTable" xlink:to="us-gaap_TaxCreditCarryforwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TrancheThreeMember" xlink:to="gern_TrancheThreeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_OptionThreeMinCashDebtCovenantMember" xlink:to="gern_OptionThreeMinCashDebtCovenantMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized" xlink:to="gern_LitigationSettlementAmountAccruedLiabilitiesRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockCompensationPlanMember" xlink:to="us-gaap_StockCompensationPlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_USTreasurySecuritiesDueInLessThanOneYearMember" xlink:to="gern_USTreasurySecuritiesDueInLessThanOneYearMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtCurrent" xlink:to="us-gaap_DebtCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember" xlink:to="gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember" xlink:to="gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossUnrealized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_FormerCollaborativeArrangementMember" xlink:to="gern_FormerCollaborativeArrangementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets" xlink:to="gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants" xlink:to="gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:to="us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty" xlink:to="gern_CollaborativeArrangementCostSharingPercentageOfCounterparty_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_DebtInstrumentEndOfTermChargePercentage" xlink:to="gern_DebtInstrumentEndOfTermChargePercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues" xlink:to="gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan" xlink:to="gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_SubsequentDirectorOptionMember" xlink:to="gern_SubsequentDirectorOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember" xlink:to="gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember" xlink:to="gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_NewJerseyLeaseAndFosterCityLeaseMember" xlink:to="gern_NewJerseyLeaseAndFosterCityLeaseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_EquityInvestmentReverseStockSplit" xlink:to="gern_EquityInvestmentReverseStockSplit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesMember" xlink:to="us-gaap_EquitySecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_NumberOfSharesSoldFromEquityInvestment" xlink:to="gern_NumberOfSharesSoldFromEquityInvestment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_PreFundedWarrantsMember" xlink:to="gern_PreFundedWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedInvestmentsAtFairValue" xlink:to="us-gaap_RestrictedInvestmentsAtFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_FirstDirectorOptionMember" xlink:to="gern_FirstDirectorOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ClassActionStipulationMember" xlink:to="gern_ClassActionStipulationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract" xlink:to="gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardLineItems" xlink:to="us-gaap_TaxCreditCarryforwardLineItems_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566188511168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DOCUMENT AND ENTITY INFORMATION - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 09, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GERON CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503,187,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508,722,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GERN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-20859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">75-2287752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">919 East Hillsdale Blvd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">473-7700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Jose, California<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:90.0%;"/>
      <td style="width:1.0%;"/>
      <td style="width:9.0%;"/>
     </tr>
     <tr style="height:7.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Document</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form 10&#8209;K<br/>Parts</span></p></td>
     </tr>
     <tr style="height:8.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portions of the Registrant&#8217;s definitive proxy statement for the 2023 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days of the Registrant&#8217;s fiscal year ended December 31, 2022.</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">III</span></p></td>
     </tr>
    </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566184901328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 56,845<span></span>
</td>
<td class="nump">$ 34,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">115,901<span></span>
</td>
<td class="nump">148,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NontradeReceivablesCurrent', window );">Interest and other receivables</a></td>
<td class="nump">3,144<span></span>
</td>
<td class="nump">1,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">3,992<span></span>
</td>
<td class="nump">1,357<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">180,246<span></span>
</td>
<td class="nump">187,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Noncurrent marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">793<span></span>
</td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases, right-of-use assets</a></td>
<td class="nump">4,147<span></span>
</td>
<td class="nump">4,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DepositsAndOtherAssetsNoncurrent', window );">Deposits and other assets</a></td>
<td class="nump">5,389<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">190,575<span></span>
</td>
<td class="nump">226,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,190<span></span>
</td>
<td class="nump">6,687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">11,534<span></span>
</td>
<td class="nump">8,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">925<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Debt</a></td>
<td class="nump">20,945<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">33,100<span></span>
</td>
<td class="nump">29,834<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">76,694<span></span>
</td>
<td class="nump">45,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liabilities</a></td>
<td class="nump">3,671<span></span>
</td>
<td class="nump">4,267<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Noncurrent debt</a></td>
<td class="nump">30,212<span></span>
</td>
<td class="nump">49,830<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">110,577<span></span>
</td>
<td class="nump">99,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at December 31, 2022 and 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 675,000,000 shares authorized; 390,262,524 and 323,731,591 shares issued and outstanding at December 31, 2022 and 2021, respectively</a></td>
<td class="nump">390<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,493,469<span></span>
</td>
<td class="nump">1,398,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,413,642)<span></span>
</td>
<td class="num">(1,271,741)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(219)<span></span>
</td>
<td class="num">(173)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">79,998<span></span>
</td>
<td class="nump">126,416<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 190,575<span></span>
</td>
<td class="nump">$ 226,034<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DepositsAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer; and amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DepositsAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NontradeReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NontradeReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566188420448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">675,000,000<span></span>
</td>
<td class="nump">675,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">390,262,524<span></span>
</td>
<td class="nump">323,731,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">390,262,524<span></span>
</td>
<td class="nump">323,731,591<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566186996320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">License fees and royalties</a></td>
<td class="nump">$ 596<span></span>
</td>
<td class="nump">$ 1,393<span></span>
</td>
<td class="nump">$ 253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development</a></td>
<td class="nump">95,518<span></span>
</td>
<td class="nump">85,727<span></span>
</td>
<td class="nump">51,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">43,628<span></span>
</td>
<td class="nump">29,665<span></span>
</td>
<td class="nump">25,678<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">139,146<span></span>
</td>
<td class="nump">115,392<span></span>
</td>
<td class="nump">77,166<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(138,550)<span></span>
</td>
<td class="num">(113,999)<span></span>
</td>
<td class="num">(76,913)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">2,529<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(6,882)<span></span>
</td>
<td class="num">(3,740)<span></span>
</td>
<td class="num">(760)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Change in fair value of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income , net</a></td>
<td class="nump">1,002<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (141,901)<span></span>
</td>
<td class="num">$ (116,112)<span></span>
</td>
<td class="num">$ (75,617)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net loss per share</a></td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net loss per share</a></td>
<td class="num">$ (0.37)<span></span>
</td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computing basic net loss per share</a></td>
<td class="nump">380,784,846<span></span>
</td>
<td class="nump">327,631,814<span></span>
</td>
<td class="nump">271,460,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computing diluted net loss per share</a></td>
<td class="nump">380,784,846<span></span>
</td>
<td class="nump">327,631,814<span></span>
</td>
<td class="nump">271,460,265<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187709632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (141,901)<span></span>
</td>
<td class="num">$ (116,112)<span></span>
</td>
<td class="num">$ (75,617)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net unrealized loss on marketable securities</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(251)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (141,947)<span></span>
</td>
<td class="num">$ (116,363)<span></span>
</td>
<td class="num">$ (75,671)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187253792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Gain (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2019</a></td>
<td class="nump">$ 135,155<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 1,214,835<span></span>
</td>
<td class="num">$ (1,080,012)<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,814,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(75,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs</a></td>
<td class="nump">140,184<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">140,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,049,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with at market offering, net of issuance costs</a></td>
<td class="nump">4,075<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">4,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with at market offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,496,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue', window );">Issuance of common stock in connection exercise of warrants</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares', window );">Issuance of common stock in connection exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation related to issuance of common stock and options in exchange for services</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock-based compensation related to issuance of common stock and options in exchange for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances of common stock under equity plans</a></td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuances of common stock under equity plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation for equity-based awards to employees and directors</a></td>
<td class="nump">6,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2020</a></td>
<td class="nump">210,947<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
<td class="nump">1,366,188<span></span>
</td>
<td class="num">(1,155,629)<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">310,566,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(116,112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116,112)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(251)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with at market offering, net of issuance costs</a></td>
<td class="nump">20,385<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">20,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with at market offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,571,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue', window );">Issuance of common stock in connection exercise of warrants</a></td>
<td class="nump">2,479<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares', window );">Issuance of common stock in connection exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,906,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation related to issuance of common stock and options in exchange for services</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock-based compensation related to issuance of common stock and options in exchange for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances of common stock under equity plans</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuances of common stock under equity plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">666,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation for equity-based awards to employees and directors</a></td>
<td class="nump">8,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2021</a></td>
<td class="nump">$ 126,416<span></span>
</td>
<td class="nump">$ 324<span></span>
</td>
<td class="nump">1,398,006<span></span>
</td>
<td class="num">(1,271,741)<span></span>
</td>
<td class="num">(173)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Dec. 31, 2021</a></td>
<td class="nump">323,731,591<span></span>
</td>
<td class="nump">323,731,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (141,901)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141,901)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs</a></td>
<td class="nump">69,916<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">69,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,333,334<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue', window );">Issuance of common stock in connection exercise of warrants</a></td>
<td class="nump">15,163<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">15,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares', window );">Issuance of common stock in connection exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,663,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock-based compensation related to issuance of common stock and options in exchange for services</a></td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock-based compensation related to issuance of common stock and options in exchange for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances of common stock under equity plans</a></td>
<td class="nump">2,185<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuances of common stock under equity plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,518,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation for equity-based awards to employees and directors</a></td>
<td class="nump">8,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Dec. 31, 2022</a></td>
<td class="nump">$ 79,998<span></span>
</td>
<td class="nump">$ 390<span></span>
</td>
<td class="nump">$ 1,493,469<span></span>
</td>
<td class="num">$ (1,413,642)<span></span>
</td>
<td class="num">$ (219)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balances (in shares) at Dec. 31, 2022</a></td>
<td class="nump">390,262,524<span></span>
</td>
<td class="nump">390,262,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new shares issued during the period in connection with exercise of warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock issued in connection with exercise of warrants during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public offering stock issued during period shares new issues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public offering stock issued during period value new issues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187580464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=gern_AtTheMarketOfferingMember', window );">At The Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=gern_PublicOfferingOfCommonStockAndWarrantsMember', window );">Public Offering of Common Stock and Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance costs</a></td>
<td class="nump">$ 5,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,808<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=gern_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=gern_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=gern_PublicOfferingOfCommonStockAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=gern_PublicOfferingOfCommonStockAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566184776736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (141,901)<span></span>
</td>
<td class="num">$ (116,112)<span></span>
</td>
<td class="num">$ (75,617)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">288<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion and amortization on investments, net</a></td>
<td class="num">(965)<span></span>
</td>
<td class="nump">1,424<span></span>
</td>
<td class="nump">818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs/debt discount</a></td>
<td class="nump">1,327<span></span>
</td>
<td class="nump">893<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on sales of available for sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Net gain on exchange and sales of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,233)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueAdjustment', window );">Change in fair value of equity investment, including foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock-based compensation for services by non-employees</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation for employees and directors</a></td>
<td class="nump">8,001<span></span>
</td>
<td class="nump">8,080<span></span>
</td>
<td class="nump">6,895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets</a></td>
<td class="nump">580<span></span>
</td>
<td class="nump">568<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables', window );">Interest and other receivables</a></td>
<td class="num">(1,381)<span></span>
</td>
<td class="num">(1,041)<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid and other current assets</a></td>
<td class="num">(2,630)<span></span>
</td>
<td class="nump">1,317<span></span>
</td>
<td class="num">(1,286)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDepositOtherAssets', window );">Deposit and other assets</a></td>
<td class="num">(594)<span></span>
</td>
<td class="num">(3,807)<span></span>
</td>
<td class="num">(206)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">3,503<span></span>
</td>
<td class="num">(232)<span></span>
</td>
<td class="nump">5,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="nump">3,435<span></span>
</td>
<td class="num">(119)<span></span>
</td>
<td class="nump">3,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_IncreaseDecreaseDueToCounterparty', window );">Amount due to Janssen Biotech, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,269)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">3,266<span></span>
</td>
<td class="nump">14,909<span></span>
</td>
<td class="nump">7,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(572)<span></span>
</td>
<td class="num">(509)<span></span>
</td>
<td class="num">(452)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(127,379)<span></span>
</td>
<td class="num">(95,556)<span></span>
</td>
<td class="num">(66,652)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(431)<span></span>
</td>
<td class="num">(207)<span></span>
</td>
<td class="num">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(258,007)<span></span>
</td>
<td class="num">(177,434)<span></span>
</td>
<td class="num">(313,201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of securities available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of marketable securities</a></td>
<td class="nump">320,505<span></span>
</td>
<td class="nump">247,994<span></span>
</td>
<td class="nump">200,262<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities', window );">Proceeds from sales of equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,594<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">62,067<span></span>
</td>
<td class="nump">71,947<span></span>
</td>
<td class="num">(105,320)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuances of common stock from equity plans</a></td>
<td class="nump">2,185<span></span>
</td>
<td class="nump">797<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants', window );">Proceeds from issuance of common stock and warrants in public offering, net of paid issuance costs</a></td>
<td class="nump">69,916<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuances of common stock from at market offerings, net of paid issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,385<span></span>
</td>
<td class="nump">4,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">15,163<span></span>
</td>
<td class="nump">2,479<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from debt financing, net of paid debt issuance costs and debt discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,895<span></span>
</td>
<td class="nump">23,863<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">87,264<span></span>
</td>
<td class="nump">48,556<span></span>
</td>
<td class="nump">168,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Net effect of unrealized gains and exchange rates on cash, cash equivalents and restricted cash</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">21,974<span></span>
</td>
<td class="nump">24,947<span></span>
</td>
<td class="num">(3,626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">35,235<span></span>
</td>
<td class="nump">10,288<span></span>
</td>
<td class="nump">13,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">$ 57,209<span></span>
</td>
<td class="nump">$ 35,235<span></span>
</td>
<td class="nump">$ 10,288<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of unrealized losses and exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_IncreaseDecreaseDueToCounterparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period for amount due to counterparty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_IncreaseDecreaseDueToCounterparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due for interest payments related to marketable securities and in other amounts due to the reporting entity, which are not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from public offering issuance of common stock and warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which an asset could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDepositOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDepositOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of other assets recognized in investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566271139168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="note_1_" style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Organization</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The terms &#8220;Geron&#8221;, the &#8220;Company&#8221;, &#8220;we&#8221; and &#8220;us&#8221; as used in this report refer to Geron Corporation. Geron was incorporated in the State of Delaware on November 28, 1990. We are a late-stage clinical biopharmaceutical company that is focused on the development and potential commercialization of imetelstat, an innovative therapeutic for hematologic malignancies. We have global rights to imetelstat, a first in class telomerase inhibitor, which was discovered and developed at Geron. Principal activities to date have included obtaining financing, securing operating facilities and conducting research and development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated financial statements include the accounts of Geron and our wholly-owned subsidiary, Geron UK Limited, or Geron UK, a United Kingdom company. Geron UK was incorporated in September 2021, and its operations commenced in January 2022. We have eliminated intercompany accounts and transactions. We prepare the financial statements of Geron UK using the local currency as the functional currency. We translate the assets and liabilities of Geron UK at rates of exchange at the balance sheet date and translate income and expense items at average monthly rates of exchange. The resultant translation adjustments are included in accumulated other comprehensive income (loss), a separate component of stockholders&#8217; equity, on our consolidated balance sheets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Loss Per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of shares of common stock outstanding for the periods presented without consideration of potential common shares. In April 2022, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,095,238</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, also known as the 2022 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. In May 2020, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,335,239</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, or the 2020 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. The 2022 pre-funded warrant and 2020 pre-funded warrant each are exercisable immediately at an exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. We included the 2022 pre-funded warrant and 2020 pre-funded warrant in the computation of basic net loss per share, as applicable, since their exercise price is negligible, and they may be exercised at any time. See Note 9 on Stockholders' Equity for further discussion of the April 2022 public offering.</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diluted net income per share would be calculated by adjusting the weighted-average number of shares of common stock outstanding for the dilutive effect of additional shares of common stock that would have been outstanding if potentially dilutive securities had been issued, as determined using the treasury-stock method. Potential dilutive securities consist of outstanding stock options and warrants to purchase our common stock. Diluted net loss per share excludes potential dilutive securities for all periods presented as their effect would be anti-dilutive. Accordingly, basic and diluted net loss per share is the same for all periods presented in the accompanying consolidated statements of operations. Since we incurred a net loss for 2022, 2021, and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the diluted net loss per share calculation excludes potential dilutive securities of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">145,726,765</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105,725,875</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101,881,391</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares, respectively, related to outstanding stock options and warrants as their effect would have been anti-dilutive.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to accrued liabilities, revenue recognition, fair value of marketable securities and equity investments, operating leases, right-of-use assets, lease liabilities, income taxes, and stock-based compensation. We base our estimates on historical experience and on various other market specific and relevant assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Equivalents and Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. We are subject to credit risk related to our cash equivalents and marketable securities. Our marketable debt securities include U.S. Treasury securities, municipal securities, government-sponsored enterprise securities, commercial paper and corporate notes.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We classify our marketable debt securities as available for sale. We record available for sale debt securities at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) in stockholders&#8217; equity. Realized gains and losses are included in interest income and are derived using the specific identification method for determining the cost of securities sold and have been insignificant to date. Dividend and interest income are recognized when earned and included in interest income on our consolidated statements of operations. We recognize a charge when the declines in the fair values below the amortized cost bases of our available for sale securities are judged to be other than temporary. We consider various factors in determining whether to recognize an other than temporary charge, including whether we intend to sell the security or whether it is more likely than not that we would be required to sell the security before recovery of the amortized cost basis. Declines in market value judged as other than temporary result in a charge to interest income. We have not recorded any other&#8209;than&#8209;temporary impairment charges on our available&#8209;for&#8209;sale securities for the years ended December 31, 2022, 2021 and 2020. See Note 2 on Fair Value Measurements.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity Investments</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure our investment in equity securities at fair value at each reporting date. Changes in fair value resulting from observable price changes are included in change in fair value of equity investment and changes in fair value resulting from foreign currency translation are included in other expense on our consolidated statements of operations.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating leases are included in operating leases, right-of-use assets and lease liabilities on our consolidated balance sheets. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of remaining lease payments over the expected lease term. The present value of remaining lease payments within the 12 months following the balance sheet date are classified as current lease liabilities. The present value of lease payments not within the 12 months following the balance sheet date are classified as noncurrent lease liabilities. The interest rate implicit in lease contracts is typically not readily determinable. As such, to calculate the net present value of lease payments, we apply our incremental borrowing rate, which is the estimated rate to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment as of the lease commencement date. We may adjust the right-of-use assets for certain adjustments, such as initial direct costs paid or incentives received. In addition, we include any options to extend or terminate the lease in the expected lease term when it is reasonably certain that we will exercise any such option. Lease expense is recognized on a straight-line basis over the expected lease term.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For lease agreements entered into after January 1, 2019 that include lease and non-lease components, such components are generally accounted for separately. We have also elected not to recognize on our consolidated balance sheets leases with terms of one year or less.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Debt Issuance Costs and Debt Discounts</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Debt issuance costs include legal fees, accounting fees, and other direct costs incurred in connection with the execution of our debt financing. Debt discounts represent costs paid to the lenders. Debt issuance costs and debt discounts are deducted from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt using the effective interest method.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers, or Topic 606. In determining the appropriate amount and timing of revenue to be recognized under this guidance, we perform the following five steps: (i) identify the contract(s) with our customer; (ii) identify the promised goods or services in the agreement and determine whether they are performance obligations, including whether they are distinct in the context of the agreement; (iii) measure the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations based on stand-alone selling prices; and (v) recognize revenue when (or as) we satisfy each performance obligation. <br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A performance obligation is a promise in an agreement to transfer a distinct good or service to the customer and is the unit of account in Topic 606. Significant management judgment is required to determine the level of effort required and the period over which completion of the performance obligations is expected under an agreement. If reasonable estimates regarding when performance obligations are either complete or substantially complete cannot be made, then revenue recognition is deferred until a reasonable estimate can be made. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We allocate the total transaction price to each performance obligation based on the estimated relative stand-alone selling prices of the promised goods or services underlying each performance obligation. Estimated selling prices for license rights are calculated using an income approach model and include the following key assumptions, judgments and estimates: the development timeline, revenue forecast, commercialization expenses, discount rate and probabilities of technical and regulatory success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following is a description of the principal activities from which we generate revenue. License fees and royalty revenue primarily represent amounts earned under agreements that out-license our technology to various companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">License Agreements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br/>We previously entered into several license agreements with various oncology, diagnostics, research tools and biologics production companies, whereby we granted certain rights to our non-imetelstat related technologies. Under these agreements, non-refundable upfront fees and annual license maintenance fees were considered fixed consideration, while milestone payments and royalties were identified as variable consideration. Since June 30, 2021, no active license agreements remain. The license related to our specialized oligonucleotide backbone chemistry, as well as patent rights covering the synthesis of monomers, the building blocks of oligonucleotides, terminated effective April 2021.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the divestiture of Geron&#8217;s human embryonic stem cell assets, including intellectual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on sales of certain research or commercial products utilizing Geron&#8217;s divested intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Licenses of Intellectual Property</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If we determine the license to intellectual property is distinct from the other performance obligations identified in the agreement and the licensee can use and benefit from the license, we recognize revenue from non-refundable upfront fees allocated to the license upon the completion of the transfer of the license to the licensee. For such licenses, we recognize revenue from annual license maintenance fees upon the start of the new license period. For licenses that are bundled with other performance obligations, we assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable upfront fees or annual license maintenance fees. At each reporting date, we reassess the progress and, if necessary, adjust the measure of performance and related revenue recognition.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Milestone Payments.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> At the inception of each agreement that includes milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. For milestones that we do not deem</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to be probable of being achieved, the associated milestone payments are fully constrained and the value of the milestone is excluded from the transaction price with no revenue being recognized. For example, milestone payments that are not within our control, such as regulatory-related accomplishments, are not considered probable of being achieved until those accomplishments have been communicated by the relevant regulatory authority. Once the assessment of probability of achievement becomes probable, we recognize revenue for the milestone payment. At each reporting date, we assess the probability of achievement of each milestone under any current agreements.<br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Royalties</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For agreements with sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (a) when the related sales occur, or (b) when the performance obligation, to which some or all of the royalty has been allocated, has been satisfied (or partially satisfied). At each reporting date, we estimate the sales incurred by each licensee during the reporting period based on historical experience and accrue the associated royalty amount.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash consists of funds maintained in separate money market or certificate of deposit accounts for credit card purchases.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses currently consist of expenses incurred in developing and testing imetelstat and research related to potential next generation telomerase inhibitors. These expenses include, but are not limited to, payroll and personnel expense, lab supplies, non-clinical studies, clinical trials, including support for investigator-led clinical trials, raw materials to manufacture clinical trial drugs, manufacturing costs for research and clinical trial materials, sponsored research at other labs, consulting, costs to maintain technology licenses and research-related overhead.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current imetelstat clinical trials are being supported by contract research organizations, or CROs, and other vendors. We accrue expenses for clinical trial activities performed by CROs based upon the estimated amount of work completed on each trial. For clinical trial expenses and related expenses associated with the conduct of clinical trials, the significant factors used in estimating accruals include the number of patients enrolled, the number of active clinical sites, and the duration for which the patients have been enrolled in the trial. We monitor patient enrollment levels and related activities to the extent possible through internal reviews, review of contractual terms and correspondence with CROs. We base our estimates on the best information available at the time. However, additional information may become available to us which will allow us to make a more accurate estimate in future periods. In that event, we may be required to record adjustments to research and development expenses in future periods when the actual level of activity becomes more certain.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation and Amortization</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We record property and equipment at cost and calculate depreciation using the straight&#8209;line method over the estimated useful lives of the assets, generally </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Leasehold improvements are amortized over the shorter of the estimated useful life or remaining term of the lease.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock&#8209;Based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain various stock incentive plans under which stock options and restricted stock awards can be granted to employees, non-employee directors and consultants. We also have an employee stock purchase plan for all eligible employees. We recognize stock-based compensation expense based on grant-date fair values of service-based stock options on a straight-line basis over the requisite service period, which is generally the vesting period. For performance-based stock options with vesting based on the achievement of certain strategic milestones, stock-based compensation expense is recognized over the period from the date the performance condition is determined to be probable of occurring through the date the applicable condition is expected to be met and is reduced for estimated forfeitures, as applicable. If the performance condition is not considered probable of being achieved, no stock-based compensation expense is recognized until such time as the performance condition is considered probable of being met, if at all. If the assessment of probability of the performance condition changes, the impact of the change in estimate would be recognized in the period of the change. The determination of grant-date fair values for our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">service-based and performance-based stock options and employee stock purchases using the Black Scholes option pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables. The grant-date fair value for service-based restricted stock awards is determined using the fair value of our common stock on the date of grant. We evaluate whether an adjustment to the assumptions of fair value of our common stock and historical volatility are required if observed prices of our common stock materially differ from historical information.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure share-based payments to non-employees based on the grant-date fair value of the equity awards to be issued. We recognize stock-based compensation expense for the fair value of the vested portion of non-employee stock-based awards on our consolidated statements of operations. For additional information, see Note 9 on Stockholders&#8217; Equity.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated Other Comprehensive Gain (Loss)</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other comprehensive gain (loss) includes certain changes in stockholders&#8217; equity which are excluded from net income (loss). Accumulated other comprehensive loss on our consolidated balance sheets as of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, is comprised of net unrealized losses on marketable securities and cumulative translation adjustments.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are subject to tests of recoverability. Our deferred tax assets include net operating loss carryforwards, federal and state tax credits and capitalized research and development. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Our net deferred tax asset has been fully offset by a valuation allowance because of our history of losses. Any potential accrued interest and penalties related to unrecognized tax benefits would be recorded as income tax expense.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our executive management team represents our chief decision maker. We view our operations as a single segment, the development of therapeutic products for oncology. As a result, the financial information disclosed herein materially represents all of the financial information related to our principal operating segment.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New Accounting Pronouncements &#8211; Issued But Not Yet Adopted</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU 2016-13,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2016-13. The main objective of ASU 2016-13 is to provide financial statement users with more decision-useful information about an entity's expected credit losses on financial instruments and other commitments to extend credit at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology currently used today with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to develop credit loss estimates. Subsequent to issuing ASU 2016-13, the FASB issued ASU 2018-19, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Codification Improvements to Topic 326, Financial Instruments &#8211; Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2018-19, for the purpose of clarifying certain aspects of ASU 2016-13. In May 2019, the FASB issued ASU 2019-05, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments &#8211; Credit Losses (Topic 326): Targeted Transition Relief</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2019-05, to provide entities with more flexibility in applying the fair value option on adoption of the credit impairment standard. In November 2019, the FASB issued ASU 2019-11, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Codification Improvements to Topic 326, Financial Instruments &#8211; Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which expands the scope of the practical expedient that allows entities to exclude the accrued interest component of amortized cost from various disclosure. Entities that elect to apply the practical expedient must disclose the total amount of accrued interest that they exclude from their disclosures of amortized cost. ASU 2018-19, ASU 2019-05 and ASU 2019-11 have the same effective date and transition requirements as ASU 2016-13. ASU 2016-13 will be effective for fiscal years beginning after December 15, 2022, using a modified retrospective approach, for smaller reporting companies. Early adoption is permitted. We plan to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adopt ASU 2016-13 and related updates as of January 1, 2023. We do not expect the adoption of this standard to have a material impact on our financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the FASB issued ASU 2020-06, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2020-06. The key elements of ASU 2020-06 aim to reduce unnecessary complexity in GAAP for certain financial instruments with characteristics of liabilities and equity. In addressing the complexity, the FASB focused on amending the guidance on convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#8217;s own equity. For convertible instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock. For contracts in an entity&#8217;s own equity, the FASB observed that the application of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically similar contracts as equity. The FASB also decided to improve and amend the related earnings per share guidance. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years for public business entities that are not smaller reporting companies. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. We plan to adopt ASU 2020-06 as of January 1, 2024. We do not expect the adoption of this standard to have a material impact on our financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on our financial statements.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566271018256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. FAIR VALUE MEASUREMENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash Equivalents and Marketable Securities</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents, restricted cash and marketable securities by security type at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.972%;"/>
        <td style="width:1.354%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in cash and cash equivalents:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,771</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,771</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,771</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,771</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">364</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">364</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,983</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,921</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities (due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities <br/>&#160;&#160;&#160;(due in less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,860</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,846</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper (due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,285</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,199</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,014</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,959</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">116,142</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">247</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115,901</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents, restricted cash and marketable securities by security type at December 31, 2021 were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.972%;"/>
        <td style="width:1.354%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in cash and cash equivalents:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,499</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,499</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31,706</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31,706</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">364</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">364</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,585</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,567</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities (due in <br/>&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,524</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,521</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities (due in <br/>&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,000</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities <br/>&#160;&#160;&#160;(due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,500</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,493</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper (due in less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84,398</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84,362</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,444</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,429</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in one to two years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,224</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,145</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">177,675</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">177</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">177,502</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents and marketable securities with unrealized losses that have been in a continuous unrealized loss position for less than 12 months and 12 months or longer at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.719%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.868%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.162%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.613%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.404%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.627%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.122%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less Than 12 Months</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12 Months or Greater</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="4" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury <br/>&#160;&#160;&#160;securities (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,424</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,497</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,921</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities <br/>&#160;&#160;&#160;(due in less than a<br/>&#160;&#160;&#160;year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored <br/>&#160;&#160;&#160;enterprise securities <br/>&#160;&#160;&#160;(due in less than <br/>&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,845</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,845</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper<br/>&#160;&#160;&#160;(due in less than<br/>&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52,454</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52,454</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,998</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,962</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,960</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75,721</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">165</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,435</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104,156</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">247</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury <br/>&#160;&#160;&#160;securities (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,567</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,567</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury <br/>&#160;&#160;&#160;securities (due in <br/>&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,521</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,521</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities <br/>&#160;&#160;&#160;(due in one to two <br/>&#160;&#160;&#160;years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored <br/>&#160;&#160;&#160;enterprise securities <br/>&#160;&#160;&#160;(due in less than <br/>&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,500</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,993</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,493</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper<br/>&#160;&#160;&#160;(due in less than<br/>&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66,872</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66,872</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,001</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,001</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in <br/>&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,145</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,145</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">128,591</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">170</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,993</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133,584</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">177</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The gross unrealized losses related to U.S. Treasury securities, municipal securities, government-sponsored enterprise securities, commercial paper and corporate notes as of December 31, 2022 and 2021 were due to changes in interest rates and not credit risk. We determined that the gross unrealized losses on our cash equivalents and marketable securities as of December 31, 2022 and 2021 were temporary in nature. Our exposure to unrealized losses may increase in the future due to the economic pressures or uncertainties associated with local or global economic recessions as a result of the ongoing COVID-19 pandemic and ongoing geopolitical events, such as the current military conflict between Ukraine and Russia, as well as recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure. We review our investments quarterly to identify and evaluate whether any investments have indications of possible other-than-temporary impairment. Factors considered in determining whether a loss is temporary include the length of time and extent to which the fair value has been less than the amortized cost basis and whether we intend to sell the security or whether it is more likely than not that we would be required to sell the security before recovery of the amortized cost basis. We currently do not intend to sell these securities before recovery of their amortized cost bases.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value on a Recurring Basis</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We categorize financial instruments recorded at fair value on our consolidated balance sheets based upon the level of judgment associated with inputs used to measure their fair value. The categories are as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
    <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
     <tr style="visibility:collapse;">
      <td style="width:1.453%;"/>
      <td style="width:6.624%;"/>
      <td style="width:2.137%;"/>
      <td style="width:89.786%;"/>
     </tr>
     <tr style="height:10.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></p></td>
     </tr>
     <tr style="height:10.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#8217;s anticipated life.</span></p></td>
     </tr>
     <tr style="height:10.0pt;">
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
      <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</span></p></td>
     </tr>
    </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A financial instrument&#8217;s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Below is a description of the valuation methodologies used for financial instruments measured at fair value on our consolidated balance sheets, including the category for such financial instruments.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds and certificates of deposit are categorized as Level 1 within the fair value hierarchy as their fair values are based on quoted prices available in active markets. Commercial paper, U.S. Treasury securities, municipal securities, government-sponsored enterprise securities and corporate notes are categorized as Level 2 within the fair value hierarchy as their fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents information about our financial instruments that are measured at fair value on a recurring basis as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 and indicates the fair value category assigned.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:44.762%;"/>
        <td style="width:1.196%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.81%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.978%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.006%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.978%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.935%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.978%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.359%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements at Reporting Date Using</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted Prices in</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Active Markets for</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identical Assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)(2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,864</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,864</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of deposit</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(2)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,921</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,921</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,846</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,846</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,199</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,199</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,959</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,959</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,135</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115,901</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">156,036</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)(4)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,088</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,088</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(4)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,493</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,493</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)(3)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91,861</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91,861</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)(4)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,574</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,574</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">185,001</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">209,208</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:74.074%;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in cash and cash equivalents on our consolidated balance sheets.</span></div></div><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in restricted cash on our consolidated balance sheets.</span></div></div><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in current portion of marketable securities on our consolidated balance sheets.</span></div></div><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in noncurrent portion of marketable securities on our consolidated balance sheets.</span></div></div></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Investment</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2007, we received </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,842,625</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> ordinary shares in Sienna Cancer Diagnostics Limited, or Sienna, in connection with a license we granted to them for our hTERT technology for use in human diagnostics. The shares, which represented less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% ownership, were recorded at a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> cost basis under the cost method of accounting, upon receipt. Since the adoption of ASU 2016-01 on January 1, 2018, we reassessed the fair value of our equity investment in Sienna at each reporting date and any resulting change in fair value was recognized on our consolidated statements of operations. In April 2020, Sienna announced its merger with BARD1 Life Sciences Limited, or BARD1, subject to approval by Sienna&#8217;s shareholders. Effective August 3, 2020, the merger was complete, and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">we received 13 BARD1 shares for every five shares of Sienna ordinary shares, resulting in our ownership of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35,990,825</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of BARD1.</span></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the first quarter of 2021, we sold all of our holdings in BARD1 and recognized a net gain of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,233,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the sales, including gains from foreign currency translation adjustments, which has been included in other income and expense on our consolidated statements of operations. As of March 31, 2021, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> value remained for our equity investment in BARD1.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently place our cash, restricted cash, cash equivalents and marketable securities with </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> financial </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">institutions in the United States. Generally, these deposits may be redeemed upon demand and therefore, bear minimal risk. Deposits with banks may exceed the amount of insurance provided on such deposits. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents and marketable securities. Cash equivalents and marketable securities currently consist of money market funds,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">government-sponsored </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">enterprise securities, U.S. Treasury securities, municipal securities, commercial paper and corporate notes. Our investment policy, approved by the audit committee of our board of directors, limits the amount we may invest in any one type of investment issuer, thereby reducing credit risk concentrations. However, we are exposed to credit risk in the event of default by the financial institutions holding our cash and cash equivalents to the extent recorded in our consolidated balance sheets. We have not experienced any losses in such accounts and we believe that we are not exposed to significant credit risk of our financial position at the depository institutions in which those deposits are held.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566271099216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. PROPERTY AND EQUIPMENT</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, stated at cost, is comprised of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.186%;"/>
        <td style="width:1.214%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.701%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.214%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.686%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and computer equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,554</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,171</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">129</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,689</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less accumulated depreciation and amortization</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">896</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">650</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">793</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">650</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189654272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LICENSE AGREEMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LicenseAgreementDisclosureAbstract', window );"><strong>License Agreement Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">LICENSE AGREEMENT</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. LICENSE AGREEMENT</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Janssen Pharmaceuticals, Inc. License Agreement</span></p><p style="text-indent:4.587%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On September 15, 2016, we entered into the License Agreement with Janssen Pharmaceuticals whereby we granted to Janssen Pharmaceuticals an exclusive worldwide license, or the Exclusive License, under our proprietary patents for the research, development and commercialization of products based on specialized oligonucleotide backbone chemistry and novel amidates for ribonucleic acid interference. In addition to the Exclusive License, we granted to Janssen Pharmaceuticals a non&#8209;exclusive worldwide license, or the Non&#8209;Exclusive License, under our patents covering the synthesis of monomers. This agreement was terminated effective April 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LicenseAgreementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LicenseAgreementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI https://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566271014736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">ACCRUED LIABILITIES</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued liabilities consisted of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;">&#160;</p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:58.192%;"/>
        <td style="width:1.964%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.933%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.964%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.948%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CRO and clinical trial costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,040</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,804</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing activities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,321</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,123</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Professional legal and accounting fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,030</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest payable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">561</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">510</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">541</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,100</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,834</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189514240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. COMMITMENTS AND CONTINGENCIES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purported Securities Lawsuits</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 23, 2020 and March 5, 2020, three securities class action lawsuits were filed against us and certain of our officers. One of the lawsuits was voluntarily dismissed on March 19, 2020. The other two lawsuits, filed in the U.S. District Court, or the Court, for the Northern District of California, or the Northern District, were consolidated by the Court on May 14, 2020, and on August 20, 2020, the lead plaintiffs filed a consolidated class action complaint. The consolidated class action complaint alleges violations of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in connection with allegedly false and misleading statements made by us related to IMbark during the period from March 19, 2018, to September 26, 2018. The consolidated class action complaint alleges, among other things, that we violated Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5 by failing to disclose facts related to the alleged failure of IMbark to meet the two primary endpoints of the trial, spleen response rate and Total Symptom Score, and that our stock price dropped when such information was disclosed. The plaintiffs in the consolidated class action complaint seek damages and interest, and an award of reasonable costs, including attorneys&#8217; fees. On October 22, 2020, lead plaintiffs filed an amended consolidated class action complaint.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">filed a motion to dismiss the amended consolidated class action complaint on November 23, 2020. On April 12, 2021, the Court granted in part and denied in part our motion to dismiss. Our answer to the amended consolidated class action complaint was filed on May 13, 2021. On September 30, 2021, lead plaintiffs filed their motion for class certification, and on April 2, 2022, the Court granted the lead plaintiffs&#8217; motion for class certification. On </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 2, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the parties agreed to a settlement and entered into a Stipulation and Agreement of Settlement, or the Stipulation, which is subject to court approval. On October 13, 2022, the Court preliminarily approved the parties&#8217; settlement, permitted notice to be distributed to the class members, and scheduled a final approval hearing for March 30, 2023. Final approval of the settlement is subject to a number of conditions and contingencies out of our control. There can be no guarantee that all of these conditions and contingencies will occur. Should a material condition or contingency to the settlement fail to occur, one or both of the parties to the settlement may exercise their right to terminate the settlement agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the Stipulation, in exchange for the release and dismissal with prejudice of all claims against the defendants in the consolidated class action complaint, we agreed to pay and/or to cause our insurance carriers to pay a total of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, comprised of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash, which was paid into an escrow account under our available D&amp;O insurance coverage and, at our election, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in either shares of our common stock and/or cash which is payable after final approval of the settlement by the Court. The proposed settlement does not constitute an admission of fault or wrongdoing by Geron or our Chief Executive Officer. The proposed settlement remains subject to final approval by the Court and certain other conditions. As of December 31, 2022, our portion of the settlement amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has been included in accrued liabilities on our consolidated balance sheets and recognized as general and administrative expense on our consolidated statements of operations for the year ended December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Between April 23, 2020 and June 8, 2021, seven shareholder derivative actions were filed, naming as defendants certain of our current officers and certain current and former members of our board. Of these actions, or the Derivative Lawsuits, two were filed in the Northern District, two were filed in the Court of Chancery of the State of Delaware, two were filed in the U.S. District Court for the District of Delaware, and one was filed in the Superior Court of California for the County of San Mateo, respectively. The plaintiffs in the Derivative Lawsuits allege breach of fiduciary duty and/or violations of Section 14 of the Exchange Act, based on the same underlying facts as the consolidated class action lawsuit described above. The plaintiffs seek damages, corporate governance reforms, equitable relief, restitution, and an award of reasonable costs, including attorneys&#8217; fees. The status of the seven Derivative Lawsuits is currently as follows:</span></p><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On July 2, 2021, we filed a motion to dismiss the consolidated shareholder derivative actions filed in the Court of Chancery of the State of Delaware, or the Chancery Court Derivative Lawsuits. On September 1, 2021, the plaintiffs filed a consolidated amended complaint in the Chancery Court Derivative Lawsuits. On October 12, 2021, we filed our motion to dismiss the consolidated amended complaint. The Court of Chancery of the State of Delaware heard oral argument on the motion on February 15, 2022, and, on June 22, 2022, issued an order staying its decision on our motion to dismiss until after final resolution of the consolidated class action lawsuit described above. On December 21, 2022, the parties in the Chancery Court Derivative Lawsuits entered into a Stipulation of Settlement, or the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the Chancery Court Derivative Lawsuits. A final approval hearing regarding the Derivative Stipulation has been scheduled for May 17, 2023. Final approval of the settlement is subject to a number of conditions and contingencies out of our control. There can be no guarantee that all of these conditions and contingencies will occur. Should a material condition or contingency to the settlement fail to occur, one or more of the parties to the settlement may exercise their right to terminate the settlement agreement;</span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated shareholder derivative actions filed in the U.S. District Court for the District of Delaware have been stayed pending the ruling on our motion to dismiss the Chancery Court Derivative Lawsuits. On </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 21, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the parties in the consolidated District of Delaware derivative actions entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated District of Delaware derivative actions;</span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated shareholder derivative actions filed in the Northern District were initially stayed through the ruling on our motion to dismiss in the consolidated class action lawsuit described above and then subsequently were stayed through the ruling on the lead plaintiffs&#8217; motion for class certification in the consolidated class action lawsuit. Subsequent to the grant of class certification in the consolidated class action lawsuit, on May 3, 2022, the Northern District entered an order providing plaintiffs until June 7, 2022, to file an amended complaint. On June 7, 2022, plaintiffs filed an amended shareholder derivative complaint. On July 6, 2022, the Northern District entered an order staying the consolidated shareholder derivative actions filed in the Northern District until the earlier of either a public </span></div></div><div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"/><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">announcement of a settlement in the consolidated class action lawsuit or a final, non-appealable judgment in the consolidated class action lawsuit. The stay has subsequently been extended on a number of occasions and the case is currently stayed through March 31, 2023. On December 21, 2022, the parties in the consolidated derivative actions in the Northern District entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated derivative actions in the Northern District; and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our motion to dismiss the shareholder derivative action pursuant to the forum selection clause in our amended and restated bylaws was filed in the Superior Court of California for the County of San Mateo on August 5, 2021. At the hearing on the motion to dismiss on November 2, 2021, the court granted our motion to dismiss and stayed the case until April 19, 2022. At the case management conference on April 19, 2022, the court continued the stay until June 14, 2022. At the case management conference on June 14, 2022, the court continued the stay until December 13, 2022. On December 13, 2022, the court dismissed the action without prejudice.</span></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the Derivative Stipulation, in exchange for the release and dismissal with prejudice of all claims against the defendants in the consolidated shareholder derivative actions filed in the Northern District, we agreed to pay and/or to cause our insurance carriers to pay a total of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,350,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, comprised of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">525,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash, which is payable under our available D&amp;O insurance coverage and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">825,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash payable by us. The proposed settlement remains subject to final approval by the Court and certain other conditions, upon which the settlement amounts are payable. The proposed settlement does not constitute an admission of fault or wrongdoing by our current officers or current and former members of our board. As of December 31, 2022, we have recorded the total settlement amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,350,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as accrued liabilities and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">525,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as interest and other receivables on our consolidated balance sheets. For the year ended December 31, 2022, we have recognized our portion of the settlement of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">825,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as general and administrative expense on our consolidated statements of operations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The pending lawsuits and any other related lawsuits are subject to inherent uncertainties, and the actual defense and disposition costs will depend upon many unknown factors. The outcome of the pending lawsuits and any other related lawsuits is necessarily uncertain. We could be forced to expend significant resources in the defense against the pending lawsuits and any other related lawsuits, and we may not prevail. In addition, we have and may continue to incur substantial legal fees and costs in connection with such lawsuits. As discussed above, we have recorded the total settlement amount for the Derivative Stipulation on our consolidated balance sheets as of December 31, 2022 and our portion of the settlement amount under the Stipulation remains accrued on our consolidated balance sheets as of December 31, 2022. We currently are not able to estimate the possible additional costs to us, if any, from these matters, and we cannot be certain how long it may take to resolve the pending lawsuits or the possible amount of any damages or legal costs that we may be required to pay. Such amounts could be material to our consolidated financial statements if we do not prevail in the defense against the pending lawsuits and any other related lawsuits, or even if we do prevail. We have not established any reserve for any potential liability relating to the pending lawsuits and any other related lawsuits, other than settlement amounts under the Stipulation and the Derivative Stipulation. It is possible that we could, in the future, incur judgments or enter into settlements of claims for monetary damages.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indemnifications to Officers and Directors</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our corporate bylaws require that we indemnify our directors, as well as those who act as directors and officers of other entities at our request, against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceedings arising out of their services to Geron. In addition, we have entered into separate indemnification agreements with each of our directors and officers which provide for indemnification of these directors and officers under similar circumstances and under additional circumstances. The indemnification obligations are more fully described in our bylaws and the indemnification agreements. We purchase standard insurance to cover claims or a portion of the claims made against our directors and officers. Since a maximum obligation is not explicitly stated in our bylaws or in our indemnification agreements and will depend on the facts and circumstances that arise out of any future claims, the overall maximum amount of the obligations cannot be reasonably estimated.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">have an Amended and Restated Severance Plan, or Severance Plan, that applies to all employees that are (i) above the Vice President level, (ii) hired by the Company before January 1, 2022, or (iii) not subject to performance improvement plans, and provides for, among other benefits: (i) a severance payment upon a Change of Control Triggering Event and Separation from Service and (ii) a severance payment for each non&#8209;executive employee upon a Non&#8209;Change of Control Triggering Event and Separation from Service. As defined in the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Severance </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Plan, a Change of Control Triggering Event and Separation from Service requires a &#8220;double trigger&#8221; where: (i) an employee is terminated by us without cause in connection with a change of control or within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months following a change of control provided, however, that if an employee is terminated by us in connection with a change of control but immediately accepts employment with our successor or acquirer, the employee will not be eligible for the benefits outlined in the Severance Plan, (ii) an employee resigns because in connection with a change of control, the offered terms of employment (new or continuing) by us or our successor or acquirer within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> days after the change of control results in a material change in the terms of employment, or (iii) after accepting (or continuing) employment with us after a change of control, an employee resigns within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months following a change of control due to a material change in the terms of employment. Under the Severance Plan, a Non&#8209;Change of Control Triggering Event and Separation from Service is defined as an event where a non&#8209;executive employee is terminated by us without cause. Severance payments range from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_a1a45976-6577-45f6-bd62-311e76651aed;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months of base salary, depending on the employee&#8217;s position with us, payable in a lump sum payment. The Severance Plan also provides that the provisions of employment agreements entered into between us and executive or non&#8209;executive employees supersede the provisions of the Severance Plan. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, all our executive officers have employment agreements with provisions that may provide greater severance benefits than those in the Severance Plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risks Related to Global Economic Conditions, COVID-19 and the Military Conflict Between Ukraine and Russia</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of the date of this filing, significant uncertainty exists concerning the ultimate duration and severity of the COVID-19 pandemic and the military conflict between Ukraine and Russia. Both of these events have caused widespread, continually evolving and unpredictable impacts on global societies, economies, financial markets and business practices. With respect to the COVID-19 pandemic, we are closely monitoring the impact of the pandemic, the identification of new variants of the COVID-19 virus and related developments, and our focus remains on promoting employee health and safety while continuing to advance the development of imetelstat. For both our Phase 3 clinical trials, IMerge and IMpactMF, we have limited ongoing clinical trial activity in Ukraine and Russia, but we have experienced, and may continue to experience, delays and suspensions in clinical trial activities at clinical sites in Ukraine and Russia due to the current political and civil unrest conditions. With support from our CRO, we are monitoring the impact of the conflict on our clinical trial activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Due to the dynamic and unpredictable effects of the COVID-19 pandemic, we have had and expect to continue to have disruptions and/or delays in our imetelstat development program, including with respect to our ability to initiate trial sites, enroll and assess patients, maintain patient enrollment, ensure patient clinical and lab collection visits, conduct monitoring visits, supply study drug, report trial results, and interact with regulators or other important agencies due to limitations in employee resources or otherwise. Restrictions on travel, availability of site personnel, and diversion of hospital staff and resources to COVID-19 patients, have disrupted our trial operations, as well as patient recruitment in many areas, resulting in a slowdown in patient enrollment and/or deviations from or disruptions in key clinical trial activities, such as clinical trial site initiation and monitoring. If the effects of the COVID-19 pandemic continue and/or become more severe, we could experience significant disruptions to our clinical development timelines, delays in clinical site initiation and patient enrollment in IMpactMF, IMproveMF and the investigator-led trial IMpress, and other disruptions that could severely impact our business and the imetelstat development program.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have taken and intend to take those actions with regard to COVID-19 that may be required by federal, state or local authorities or that we determine are in the best interests of our patients, investigators, employees and stockholders. In response to the COVID-19 pandemic and previous &#8220;shelter in place&#8221; and similar orders issued by state and local governments, we have allowed voluntary access to our offices in California and New Jersey to employees who have been vaccinated, and almost all of our employees continue to work remotely without any significant disruption to our business. Our increased reliance on personnel working remotely could increase our cybersecurity risk, create data accessibility concerns and make us more susceptible to communication disruptions, any of which could adversely impact our business operations. These and similar, and perhaps more severe, disruptions in our operations could occur which would negatively impact our business and business prospects, our financial condition and the future of imetelstat.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The effects of the COVID-19 pandemic and the military conflict between Ukraine and Russia, including the significant sanctions imposed against Russia, as well as broader economic conditions, including inflation, rising interest rates, the prospects for recession, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure have increased market volatility and could result in a significant long-term disruption of global financial markets, reducing or eliminating our ability to raise additional capital, which could negatively affect our liquidity, our ability to complete IMpactMF, IMproveMF and the investigator-led trial IMpress and to commence, conduct and complete any other potential future clinical trials of imetelstat. In addition, the global</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">economic slowdown caused by, among other things, the COVID-19 pandemic and the military conflict between Ukraine and Russia, as well as inflation, rising interest rates, the prospects for recession, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures could materially and adversely affect our business and the value of our common stock.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The extent to which global economic conditions, including those resulting from the COVID-19 pandemic, the military conflict between Ukraine and Russia and recent and potential future bank failures, ultimately impact our business, our regulatory and clinical development activities, clinical supply chain and other business operations, as well as the value of and market for our common stock, will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time, such as the ultimate duration and severity of the pandemic, travel restrictions, quarantines, social distancing and business closure requirements in the United States, or U.S., and in other countries, the effectiveness of actions taken globally to contain and treat COVID-19, whether the military conflict between Ukraine and Russia resolves in a timely manner, or at all, and whether the U.S. and/or international banking system stabilizes in light of recent and potential future bank failures. Accordingly, we do not yet know the full extent of potential delays or impacts on our business, our regulatory and clinical development activities, clinical supply chain and other business operations or the global economy as a whole. However, these effects could materially and adversely affect our business and business prospects, our financial condition and the future of imetelstat.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189654272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING LEASES</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7. OPERATING LEASES</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">New Jersey Office Space Lease</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2019, we entered into an operating lease agreement for office space located at 3 Sylvan Way, Parsippany, New Jersey, or the New Jersey Lease. The initial term of the New Jersey Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years with an option to extend for an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one-time option to terminate the New Jersey Lease without cause as of the 103</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">rd</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> month anniversary of the commencement date of the lease</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The New Jersey Lease commenced on October 1, 2019, upon our control of the office space on that date. Based on the initial term of the New Jersey Lease of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years, the right-of-use asset and corresponding operating lease liability was approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,356,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which represented the present value of lease payments over the initial lease term, net of a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seven-month</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> rent abatement period, using an incremental borrowing rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% based on information available as of October 1, 2019. Under the New Jersey Lease, we are also obligated to pay certain variable expenses separately from the base rent, including electricity and common area maintenance. Such costs are being expensed in the period they are incurred. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the remaining lease term for the New Jersey Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.8</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foster City Office Space Lease</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2019, we entered into an operating lease agreement for office space located at 919 East Hillsdale Boulevard, Foster City, California, or the Foster City Lease. The initial term of the Foster City Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months with an option to extend for an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Foster City Lease commenced on March 10, 2020, upon the substantial completion of all tenant improvements. As of the lease commencement date, the right-of-use asset and corresponding operating lease liability was approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,426,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which represented the present value of remaining lease payments using an incremental borrowing rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% over the initial lease term of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months, net of a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three-month</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> rent abatement period. Under the Foster City Lease, we are also obligated to pay certain variable expenses separately from the base rent, including taxes and common area maintenance. Such costs are considered non-lease components and have been excluded from the calculation of the right-of-use asset and corresponding operating lease liability and are being expensed in the period they are incurred. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the remaining lease term for the Foster City Lease is </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of lease costs included in operating expenses on our consolidated statements of operations for the New Jersey Lease, the Foster City Lease and a lease from a former location in Menlo Park, California, were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:18.733%;"/>
        <td style="width:21.617%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.904%;"/>
        <td style="width:1.0%;"/>
        <td style="width:2.524%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.754000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:3.125%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.342%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">944</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">946</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,143</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable lease costs</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">&#160;(1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">310</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">252</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">293</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,254</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,198</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,436</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:10.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:60.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div><div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.588888888888889%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable lease costs represent non-lease components, such as common area maintenance charges.</span></div></div></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undiscounted future non-cancellable lease payments under the New Jersey Lease and the Foster City Lease as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 were as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:35.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.834%;"/>
        <td style="width:2.869%;"/>
        <td style="width:1.0%;"/>
        <td style="width:26.296%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">962</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">987</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,014</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,040</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">717</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,050</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,770</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,174</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,596</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189407856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8. DEBT</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On September 30, 2020, or the Closing Date, we, Hercules Capital, Inc., or Hercules, and Silicon Valley Bank, or SVB, entered into a term loan facility, or the Term Loan, up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which was amended in August 2021, or the Original Loan Agreement. On June 30, 2022, or the Effective Date, we entered into a second amendment to the Original Loan Agreement, or as amended, the Loan Agreement. Under the second amendment, the aggregate principal amount available to us increased from $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, with such principal being available in a series of tranches, subject to certain terms and conditions. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, a total of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> has been drawn under the Loan Agreement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the second amendment, the $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in remaining loan principal as of December 31, 2022 can be drawn as follows: (a) the first tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is available within the </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">earlier of 30 days of the achievement of certain clinical and financial milestones or September 15, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, subject to the achievement of such milestones; (b) the second tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is available from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 1, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> until </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 15, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain other requirements; (c) the third tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is available from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 15, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> until </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 15, 2024</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain capitalization requirements; and (d) the final tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> is available through </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2024</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, subject to approval by an investment committee comprised of Hercules and SVB (or its successor, if any). However, on March 10, 2023, the Federal Deposit Insurance Corporation, or FDIC, issued a press release stating that SVB was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. Of the remaining term commitments under the Loan Agreement, Hercules and its affiliates hold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% were held by SVB. As a result of the closure of SVB, we do not know whether and to what extent we would be able to draw down the remaining $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million under the Loan Agreement, even if we meet the conditions set forth in the Loan Agreement necessary for additional draw downs, and it is possible that we will not be able to access any additional funding under the Loan Agreement. With the exception of the final tranche, and subject to achievement of the applicable milestones and other requirements with respect to each tranche, draw downs are at our election.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the second amendment, the maturity date, interest only payment dates, end of term charges, collateral, events of default, representations, warranties and covenants remain consistent with the terms of the Original Loan Agreement, except as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </span></p><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beginning June 1, 2022 and prior to the regulatory approval for imetelstat, or the potential Regulatory Approval, if any, we are required to maintain a minimum cash balance in an amount equal to the greater of: </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the outstanding principal amount under the Loan Agreement or $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span></div></div><div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After the potential Regulatory Approval, if any, the minimum cash requirement may be satisfied through one of the following three options, as elected by us: (a) maintaining a cash balance in an amount not less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the outstanding principal amount under the Loan Agreement; (b) maintaining a cash balance in an amount not less than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the outstanding principal amount under the Loan Agreement, if our market cap is or exceeds $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">750,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">; or (c) maintaining </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">six month</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> net product revenues of at least </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of net product revenues forecasted by us, should any potential Regulatory Approval for imetelstat be obtained.</span></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On the Effective Date of the second amendment, we paid $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as a facility charge that we recognized as a debt discount and are amortizing such cost to interest expense over the life of the loan using the effective interest rate method. Additional facility charges applied to future draw downs will be treated similarly. We incurred approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">legal fees in connection with the second amendment, which we recognized as debt</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">issuance </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">costs and are amortizing such cost to interest expense over the life of the loan using the effective interest rate method. Future debt issuance costs will be treated similarly. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the second amendment, if we choose to prepay the principal with respect to any future draw down after the Effective Date, any such prepayment within the first 36 months after the Effective Date will be subject to a prepayment charge equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount prepaid. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> prepayment charge will be assessed for any prepayment occurring more than 36 months after the Effective Date.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unchanged from the Original Loan Agreement, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the Term Loan matures on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">October 1, 2024</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or the Loan Maturity Date, and may be extended up to an additional 12 months upon the achievement of certain clinical, regulatory and financial milestones.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Term Loan bears interest at a floating rate per annum equal to the greater of either (i) 9.0% or (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% plus the prime rate as reported in The Wall Street Journal (7.5% as of December 31, 2022) less 3.25%.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The Term Loan provided for an initial interest-only payment period from the Closing Date until November 1, 2022. As of December 31, 2022, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the interest-only period expires May 1, 2023. Upon the achievement of certain regulatory and financial milestones, the interest-only period may be extended for another six months until November 1, 2023.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Following the expiration of the interest-only period, we will repay the Term Loan in equal monthly amortization payments of principal and interest until the Loan Maturity Date. Upon full repayment of the Term Loan, we are also obligated to pay an end of term charge in an amount equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.55</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the amount of the Term Loan actually borrowed. Such end of term charge is being accrued to interest expense over the term of the Term Loan using the effective interest rate method. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At our option, upon at least five business days&#8217; prior written notice to Hercules, we may prepay all or any portion greater than or equal to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of the outstanding loan by paying the entire principal balance (or portion thereof) and all accrued and unpaid interest. Such prepayment is subject to a prepayment charge of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the prepayment amount, if the prepayment is made in any of the first 36 months following the Closing Date for any draw downs prior to the second amendment. Thereafter, any prepayment is not subject to a prepayment charge.</span></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Term Loan is secured by substantially all of Geron&#8217;s assets, except our intellectual property, which is the subject of a negative pledge. The Term Loan contains certain representations and warranties, affirmative covenants, negative covenants and conditions that are customarily required for similar financings. We are in compliance with the covenants under the Term Loan as of December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the event of default (subject, in certain instances, to specified grace periods), the principal, interest and any other monetary obligations on all the then outstanding amounts under the Term Loan may become due and payable immediately. Upon the occurrence of an event of default, a default interest rate of an additional </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% may be applied to the outstanding principal balance, and Hercules, as the administrative agent, may declare all outstanding obligations immediately due and payable (subject, in certain instances, to specified grace periods) and take such other actions as set forth in the Term Loan. Upon the occurrence of certain bankruptcy and insolvency events, the obligations under the Term Loan would automatically become due and payable.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Embedded Derivatives and Debt Discounts</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The conditional exercisable call option related to the event of default is considered to be an embedded derivative which is required to be bifurcated and accounted for as a separate financial instrument. In the periods presented, the value of the embedded derivative is not material and therefore, no amount has been recognized. If an event of default becomes more probable than is currently estimated, then the embedded derivative could become material in future periods and would be recognized as a separate financial instrument at that time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the net carrying value of the Term Loan was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51,157,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which includes the principal amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> less the net unamortized discounts and debt issuance costs of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">628,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> plus accrued end of term charge of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,785,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The carrying value of the debt approximates the fair value as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022. The debt discounts and debt issuance costs are being amortized to interest expense over the life of loan amounts under Term Loan using the effective interest rate method.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Future Minimum Payments</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents future minimum payments, including interest and the end of term charge, under the Term Loan as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:61.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.622%;"/>
        <td style="width:12.76%;"/>
        <td style="width:1.0%;"/>
        <td style="width:19.618%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,843</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,160</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61,003</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  amount representing interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,728</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  unamortized debt discount and issuance costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">628</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  unamortized end of term charge</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,490</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  current portion of debt</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,945</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noncurrent portion of debt</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,212</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566186076656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9. STOCKHOLDERS&#8217; EQUITY</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Authorized Common Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2021, our stockholders approved an amendment to our Restated Certificate of Incorporation to increase the total number of authorized shares of common stock from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">450,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">675,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public Offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On April 1, 2022, we completed an underwritten public offering of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53,333,334</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock and a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,095,238</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, or the 2022 pre-funded warrant, together with accompanying warrants to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35,714,286</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, also known as the 2022 stock purchase warrants. The shares of common stock and the 2022 pre-funded warrant were immediately separable from the 2022 stock purchase warrants. All of the securities were issued separately. The combined public offering price of the common stock and accompanying 2022 stock purchase warrants was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.05</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. The 2022 stock purchase warrants have an exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.45</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share and are exercisable immediately. The term of the 2022 stock purchase warrants expires on the earlier to occur of (a) the date that is 30 business days following the date on which we first issue a press release disclosing, if applicable, that the United States Food and Drug Administration, or FDA, has accepted for filing a New Drug Application submitted to the FDA for imetelstat in Low or Intermediate-1 risk myelodysplastic syndromes and (b) April 1, 2027. The combined public offering price of the 2022 pre-funded warrant and accompanying 2022 stock purchase warrant was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.049</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. The 2022 pre-funded warrant has an exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share and may be exercised at any time until the 2022 pre-funded warrant is exercised in full. As of December 31, 2022, none of the 2022 pre-funded warrant and 2022 stock purchase warrants have been exercised. The net cash proceeds from this offering were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69,916,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, after deducting the underwriting discount and other offering expenses paid by us, and exclude any future proceeds from the exercise of the 2022 pre-funded warrant and 2022 stock purchase warrants.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon the issuance of the 2022 pre-funded warrant and 2022 stock purchase warrants, we evaluated the terms of each warrant to determine the appropriate accounting and classification pursuant to FASB Accounting Standards Codification Topic 480, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and FASB Accounting Standards Codification Topic 815,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Derivatives and Hedging</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Warrants are classified as liabilities when the warrant terms allow settlement of the warrant exercise in cash and classified as equity when the warrant terms only allow settlement in shares of common stock. The terms of the 2022 pre-funded warrant and the 2022 stock purchase warrants include certain provisions related to fundamental transactions and a cashless exercise provision in the event registered shares are not available, and do not include any mandatory redemption provisions. Based on our evaluation, we concluded the 2022 pre-funded warrant and the 2022 stock purchase warrants should be classified as equity with no subsequent remeasurement as long as such warrants continue to be classified as equity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Exercises</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the year ended December 31, 2022, warrants to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,663,387</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock were exercised for net cash proceeds of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,163,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The warrants were issued in connection with an underwritten public offering of common stock and a pre-funded warrant, together with accompanying stock purchase warrants in May 2020. As of December 31, 2022, the pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,335,239</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">common stock was outstanding and stock purchase warrants to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44,110,079</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock associated with the May 2020 public offering remained outstanding.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On September 4, 2020, we entered into an At Market Issuance Sales Agreement, or the 2020 Sales Agreement, with B. Riley Securities, Inc., or B. Riley, pursuant to which we may elect to issue and sell shares of our common stock having an aggregate offering price of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in such quantities and on such minimum price terms as we set from time to time through B. Riley as our sales agent. We agreed to pay B. Riley an aggregate commission rate equal to up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the gross proceeds of the sales price per share for common stock sold through B. Riley under the 2020 Sales Agreement. In connection with the 2020 Sales Agreement, we terminated the 2018 Sales Agreement. For the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we sold an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,571,556</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock pursuant to the 2020 Sales Agreement, resulting in net cash proceeds to us of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,385,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, after deducting sales commissions and other offering expenses paid by us. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock were sold pursuant to the 2020 Sales Agreement for the year ended December 31, 2022. The 2020 Sales Agreement will expire upon the earlier of: (a) the sale of all common stock subject to the 2020 Sales Agreement, or (b) September 4, 2023.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity Plans</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2011 Incentive Award Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2011, our stockholders approved the adoption of the 2011 Incentive Award Plan, or 2011 Plan. The 2011 Plan provided for grants of either incentive stock options or nonstatutory stock options and stock purchase rights to employees (including officers and employee directors) and consultants (including non&#8209;employee directors). Upon the adoption of the 2018 Equity Incentive Plan in May 2018 (see below), no further grants of stock options or stock purchase rights were made from the 2011 Plan. Stock options granted under the 2011 Plan expire no later than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of grant. Stock option exercise prices were equal to the fair market value of the underlying common stock on the date of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Service&#8209;based stock options under the 2011 Plan generally vested over a period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of the stock option grant. Other stock awards (restricted stock awards and restricted stock units) had variable vesting schedules which were determined by our board of directors on the date of grant. All outstanding awards granted under the 2011 Plan remain subject to the terms of the 2011 Plan and the individual award agreements thereunder.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Equity Incentive Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On May 15, 2018, our stockholders approved the adoption of the 2018 Equity Incentive Plan, or 2018 Plan, as the successor to the 2011 Plan. The 2018 Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, other stock awards, and performance awards that may be settled in cash, stock, or other property. Eligible participants under the 2018 Plan include our employees, consultants and non-employee directors. The number of shares reserved for issuance under the 2018 Plan (subject to adjustment for certain changes in capitalization) is equal to the sum of (i) the unallocated shares of common stock remaining available for grant under the 2011 Plan as of May 15, 2018, (ii) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> newly reserved shares of common stock and (iii) the number of shares subject to awards granted under the 2002 Equity Incentive Plan, and the 2011 Plan as such shares become available from time to time, referred to as the Prior Plans&#8217; Returning Shares. Such Prior Plans&#8217; Returning Shares become available for issuance under the 2018 Plan if outstanding stock awards granted under the 2002 Equity Incentive Plan and the 2011 Plan, after May 15, 2018, expire or terminate for any reason prior to exercise or settlement or are forfeited, cancelled or otherwise returned to us because of the failure to meet a contingency or condition required for the vesting of such shares, or, subject to certain exceptions, are reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection with a stock award. In May 2022, May 2021 and June 2020, our stockholders approved amendments to our 2018 Equity Incentive Plan to increase the total number of shares issuable under such plan by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,700,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options granted under the 2018 Plan expire no later than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of grant. Stock option exercise prices shall be equal to the fair market value of the underlying common stock on the date of grant. If, at the time we grant a stock option, the optionee directly or by attribution owns stock possessing more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the total combined voting power of all classes of our stock, the stock option exercise price shall be at least </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">110</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fair </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">market value of the underlying common stock and shall not be exercisable more than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> after the date of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We grant service-based and performance-based stock options to employees under the 2018 Plan. Service-based stock options generally vest over a period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of the stock option grant. Performance-based stock options vest upon the achievement of specified milestones. Other stock awards (restricted stock awards and restricted stock units) have variable vesting schedules as determined by our board of directors on the date of grant.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under certain circumstances, stock options may be exercised prior to vesting, subject to our right to repurchase the shares underlying such stock option at the exercise price paid per share. Our repurchase rights would generally terminate on a vesting schedule identical to the vesting schedule of the exercised stock option. During 2022 and 2021, we did not repurchase any shares under the 2018 Plan. As of December 31, 2022, we have no shares outstanding subject to repurchase under the 2018 Plan.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, our Non&#8209;Employee Director Compensation Policy adopted by our board of directors in March 2014 and amended and restated in February and March 2022 provides for the automatic grant to non&#8209;employee directors of the following types of equity awards under the 2018 Plan:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">First Director Option.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Each person who becomes a non&#8209;employee director, whether by election by our stockholders or by appointment by our board of directors to fill a vacancy, will automatically be granted a stock option to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">200,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, or First Director Option, on the date such person first becomes a non&#8209;employee director. The First Director Option vests annually over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon each anniversary date of appointment to our board of directors.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Subsequent Director Option.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  Each non&#8209;employee director (other than any director receiving a First Director Option on the date of the annual meeting) will automatically be granted a subsequent stock option to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">125,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, a Subsequent Director Option, on the date of the annual meeting of stockholders in each year during such director&#8217;s service on our board of directors. The Subsequent Director Option vests in full on the earlier of: (i) the date of the next annual meeting of our stockholders or (ii) the first anniversary of the date of grant.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2006 Directors&#8217; Stock Option Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"><br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2006 Directors&#8217; Stock Option Plan, or 2006 Directors Plan, was terminated by our board of directors and replaced by the 2011 Plan in March 2014. No further grants of stock options were made from the 2006 Directors Plan upon the 2006 Directors Plan&#8217;s termination. All outstanding awards granted under the 2006 Directors Plan remain subject to the terms of the 2006 Directors Plan and the individual award agreements thereunder.<br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The stock options granted to non-employee directors under the 2006 Directors Plan were nonstatutory stock options, and they expire no later than </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of grant. The option exercise price was equal to the fair market value of the underlying common stock on the date of grant. The first director option granted to non-employee directors under the 2006 Directors Plan vested annually over </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> upon each anniversary date of appointment to the board of directors. The subsequent director option granted to non-employee directors on the date of the annual meeting of stockholders in each year during such director&#8217;s service on our board of directors under the 2006 Directors Plan vested </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from the date of grant.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2018 Inducement Award Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In December 2018, our board of directors approved the adoption of the 2018 Inducement Award Plan, or the Inducement Plan, pursuant to which we reserved </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock to be used exclusively for grants of inducement awards to individuals who were not previously Geron employees or non-employee directors, other than following a bona fide period of non-employment. As of December 31, 2022, an aggregate total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,100,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock have been reserved under the Inducement Plan.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Inducement Plan provides for the grant of nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and other stock awards, and all awards under the Inducement Plan are intended</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to meet the standards under Rule 5635(c)(4) of the Nasdaq Listing Rules. The terms and conditions of the Inducement Plan and the inducement awards to be granted thereunder are substantially similar to our stockholder-approved 2018 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Directors&#8217; Market Value Stock Purchase Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2018, our board of directors adopted a Directors&#8217; Market Value Stock Purchase Plan, or the Directors Market Plan. A total of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock has been reserved for the Directors Market Plan. Under the Directors Market Plan, non-employee directors may purchase shares of our common stock at the prevailing market price on the purchase date with cash compensation payable to them for their services as a board member. As stated in Geron&#8217;s Non-Employee Director Compensation Policy, each non-employee director receives annual cash compensation, payable quarterly in arrears, for their services on the board and various committees of the board. As provided in the Non-Employee Director Compensation Policy, a non-employee director may elect to receive fully vested shares of common stock in lieu of cash and such shares shall be issuable from the Directors Market Plan.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the years ended December 31, 2022, 2021 and 2020, we issued </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,962</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,783</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,986</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock, respectively, from the Directors Market Plan. The weighted average grant date fair value of stock granted during the years ended December 31, 2022, 2021 and 2020 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.92</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.38</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.60</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively. The total fair value of vested stock grants during 2022, 2021 and 2020 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate stock option and award activity for the 2011 Plan, 2018 Plan, 2006 Directors Plan, Inducement Plan and Directors Market Plan is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:34.976%;"/>
        <td style="width:0.086%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.64%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.086%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.681%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.712%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.086%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.904%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.086%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.663%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding Stock Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intrinsic</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Available</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contractual Life</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For Grant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,763,393</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,952,409</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.06</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional shares authorized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,755,000</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options granted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,747,760</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,747,760</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.37</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Awards granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,962</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,181,711</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.52</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options cancelled/forfeited/expired</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,616,058</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,616,058</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.70</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,370,729</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65,902,400</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.87</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.56</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,205</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options exercisable at <br/>&#160;&#160;December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,085,389</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.17</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.09</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,878</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options fully vested and expected<br/>&#160;&#160;&#160;&#160;to vest at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,539,649</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.52</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48,951</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:76.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.13%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Includes </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,791,750</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> performance-based stock options granted that have not achieved certain strategic milestones.</span></div></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on Geron&#8217;s closing stock price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.42</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, which would have been received by the option holders had all the option holders exercised their stock options as of that date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have not granted any stock options with an exercise price below or greater than the fair market value of our common stock on the date of grant in 2022, 2021, and 2020. As of December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,085,389</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,459,136</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,721,508</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> exercisable stock options outstanding at weighted average exercise prices per share of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.35</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.54</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The total pretax intrinsic value of stock options exercised during 2022, 2021, and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">787,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. Cash received from the exercise of stock options in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> totaled approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,799,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">556,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2014, our board of directors adopted the 2014 Employee Stock Purchase Plan, or 2014 Purchase Plan. The 2014 Purchase Plan was approved by our stockholders in May 2014. The 2014 Purchase Plan replaced the 1996 Employee Stock Purchase Plan, or 1996 Purchase Plan, which was terminated effective as of the date the 2014 Purchase Plan was approved by our stockholders. In May 2022, our stockholders approved an amendment to our 2014 Purchase Plan to increase the total number of shares issuable under such plan by </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, for an aggregate total reserve of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, an aggregate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">868,236</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock have been issued under the 2014 Purchase Plan since its adoption.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2014 Purchase Plan is comprised of a series of offering periods, each with a maximum duration (not to exceed </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months) with new offering periods commencing on January 1st and July 1st of each year. The date an employee enters the offering period will be designated as the entry date for purposes of that offering period. An employee may participate only in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> offering period at a time. Each offering period consists of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> consecutive purchase periods of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">six months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8217; duration, with the last day of such period designated a purchase date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of the 2014 Purchase Plan, employees can choose to have up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of their annual salary withheld to purchase our common stock. An employee may not make additional payments into such account or increase the withholding percentage during the offering period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The purchase price per share at which common stock is purchased by the employee on each purchase date within the offering period is equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the lower of (i) the fair market value per share of our common stock on the employee&#8217;s entry date into that offering period or (ii) the fair market value per share of our common stock on the purchase date. If the fair market value per share of our common stock on the purchase date is less than the fair market value at the beginning of the offering period, a new </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> month offering period will automatically begin on the first business day following the purchase date with a new fair market value.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock&#8209;Based Compensation for Employees and Directors</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure and recognize compensation expense for all share&#8209;based payment awards made to employees and directors, including employee stock options, restricted stock awards and employee stock purchases, based on grant&#8209;date fair values for these instruments. We use the Black Scholes option&#8209;pricing model to estimate the grant&#8209;date fair value of our service-based and performance-based stock options and employee stock purchases. The fair value for service&#8209;based restricted stock awards is determined using the fair value of our common stock on the date of grant.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As stock&#8209;based compensation expense recognized on the consolidated statements of operations for the years ended December 31, 2022, 2021 and 2020 is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures, but at a minimum, reflects the grant&#8209;date fair value of those awards that actually vested in the period. Forfeitures have been estimated at the time of grant based on historical data and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In 2022 and 2021, our board of directors awarded </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,741,750</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">550,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> performance-based stock options, respectively, to certain employees. These performance-based stock options are included in the outstanding stock options table above. Performance-based stock options vest only upon achievement of discrete strategic milestones. Stock-based compensation expense for performance-based stock options is recognized over the period from the date the performance condition is determined to be probable of occurring through the date the applicable condition is expected to be met and is reduced for estimated forfeitures, as applicable. If the performance condition is not considered probable of being achieved, no stock-based compensation expense is recognized until such time as the performance condition is considered probable of being achieved, if ever. None of the performance-based stock options have vested.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize stock&#8209;based compensation expense for service-based stock options on a straight&#8209;line basis over the requisite service period, which is generally the vesting period. We have not recognized any stock-based compensation expense for performance-based stock options on our consolidated statements of operations for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020, as the achievement of the specified strategic milestones was not considered probable during that time. The following table summarizes the stock&#8209;based compensation expense related to service-based stock options and employee stock purchases for the years ended December 31, 2022, 2021 and 2020 which was allocated as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.977%;"/>
        <td style="width:1.268%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.517999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.268%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.517999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.268%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.183%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,720</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,597</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,337</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,281</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,483</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,558</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation expense<br/>&#160;&#160;&#160;included in operating expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,001</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,080</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,895</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of stock options granted in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020 has been estimated at the date of grant using the Black Scholes option&#8209;pricing model with the following assumptions:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.489%;"/>
        <td style="width:1.242%;"/>
        <td style="width:16.253%;"/>
        <td style="width:1.242%;"/>
        <td style="width:16.253%;"/>
        <td style="width:1.255%;"/>
        <td style="width:16.266%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.772</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.817</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.775</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.783</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.781</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.793</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate range</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.69</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.57</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.51</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.31</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.62</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;yrs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;yrs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.25</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;yrs</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of employee stock purchases in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020 has been estimated using the Black Scholes option&#8209;pricing model with the following assumptions:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:39.984%;"/>
        <td style="width:1.242%;"/>
        <td style="width:22.503%;"/>
        <td style="width:1.255%;"/>
        <td style="width:16.8%;"/>
        <td style="width:1.255%;"/>
        <td style="width:16.96%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.614</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.865</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.507</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.707</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.478</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.818</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate range</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.79</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.09</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.57</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;- </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;mos</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;- </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;mos</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;- </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;mos</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield is based on historical cash dividend payments and we have paid no cash dividends to date. The expected volatility range is based on historical volatilities of our stock, since traded options on our common stock do not correspond to option terms and the trading volume of options is limited. The risk&#8209;free interest rate range is based on the U.S. Zero Coupon Treasury Strip Yields for the expected term in effect on the date of grant for an award. The expected term of stock options is derived from actual historical exercise and post&#8209;vesting cancellation data and represents the period of time that stock options granted are expected to be outstanding. The expected term of employees&#8217; purchase rights is equal to the purchase period.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on the Black Scholes option&#8209;pricing model, the weighted average estimated fair value of stock options granted during the years ended December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.92</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.88</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively. The weighted average estimated fair value of employees&#8217; purchase rights for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.48</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.56</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.62</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, total compensation cost related to unvested share&#8209;based payment awards not yet recognized, net of estimated forfeitures and assuming no probability of achievement for outstanding performance-based stock options, was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,791,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which is expected to be recognized over the next </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> months on a weighted&#8209;average basis.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock&#8209;Based Compensation to Service Providers</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We grant stock options to consultants from time to time in exchange for services performed for us. In general, the stock options vest over the contractual period of the consulting arrangement. The fair value of stock options held by consultants is recorded as operating expenses over the vesting term of the respective equity awards. With the adoption of Accounting Standards Update 2018-07, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Improvements to Nonemployee Share-Based Payment Accounting</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2018-07, in the first quarter of 2019, the measurement date of stock options granted to consultants was fixed at the grant date.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recorded stock&#8209;based compensation expense of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">235,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the vested portion of the fair value of stock options held by consultants in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock Reserved for Future Issuance</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for future issuance as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:73.896%;"/>
        <td style="width:1.674%;"/>
        <td style="width:1.0%;"/>
        <td style="width:22.43%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65,902,400</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options and awards available for grant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,370,729</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,131,764</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106,254,842</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">191,659,735</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566188322064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. INCOME TAXES</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table reconciles the federal statutory tax rate to the effective income tax rate from continuing operations:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.158%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.196000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:3.305%;"/>
        <td style="width:5.199%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.808%;"/>
        <td style="width:1.0%;"/>
        <td style="width:3.122%;"/>
        <td style="width:4.295%;"/>
        <td style="width:1.0%;"/>
        <td style="width:7.612%;"/>
        <td style="width:1.0%;"/>
        <td style="width:3.305%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax at statutory rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income tax, net of federal benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.9</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal and state tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net operating loss not benefitted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective tax rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of our deferred tax assets are as follows:</span></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.802%;"/>
        <td style="width:1.432%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.742%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.448%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.576%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">254,500</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">241,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal and state tax credits</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56,700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,600</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,800</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,900</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,800</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,200</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,400</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,600</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,600</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">350,700</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">312,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">349,600</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">310,700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,100</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating leases, right-of-use assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,100</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,100</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total net deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We record net deferred tax assets to the extent we believe these assets will more likely than not be realized. In making such determination, we consider all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. Because of our history of losses, the net deferred tax assets have been fully offset by a valuation allowance. The valuation allowance increased by $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38,900,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,500,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we had domestic federal net operating loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">993,100,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Of this, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">685,300,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> will expire at various dates beginning in 2023 through 2037 and the remaining will carryforward indefinitely under the new tax laws, but is subject to an 80% taxable income limitation for tax years beginning after 2020. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we had state net operating loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">658,400,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> expiring </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at various dates beginning in 2028 through 2041, if not utilized. We also had</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">federal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">tax credit carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62,700,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> expiring at various dates beginning in 2023 through 2042, if not utilized. Our state tax credit carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,900,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> carry forward indefinitely.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Utilization of net operating loss and tax credit carryforwards may be subject to an annual limitation due to ownership change limitations provided by the Internal Revenue Code and similar state provisions. Annual limitations may result in expiration of net operating loss and tax credit carryforwards before some or all of such amounts have been utilized. The impact of any limitations that may be imposed due to such ownership changes has not yet been determined.</span></p><p style="text-indent:4.587%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March and December 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act, or the CARES Act, and the Consolidated Appropriations Act, 2021 were passed into law and provide additional economic stimulus to address the impact of the COVID-19 pandemic, including among other items, several U.S. income tax provisions related to, among other things, net operating loss carrybacks, alternative minimum tax credits, modifications to interest expense limitations, and an option to defer payroll tax payments for a limited period. In 2021, we assessed our eligibility to claim a refund of employer taxes available under the Employee Retention Credit provisions of the CARES Act. For the years ended December 31, 2022 and 2021, we calculated eligible credits of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">483,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,152,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, provided by the CARES Act, which have been recognized as offsets to salaries costs in operating expenses in 2022 and 2021, respectively. As of December 31, 2022, the aggregate eligible credit amount has been accrued as a receivable on our consolidated balance sheets.</span></p><p style="text-indent:4.587%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We adopted the provision of the standard for accounting for uncertainties in income taxes on January 1, 2007. Upon adoption, we recognized no material adjustment in the liability for unrecognized tax benefits. At December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, we had approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,700,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of unrecognized tax benefits, none of which would currently affect our effective tax rate if recognized due to our net deferred tax assets being fully offset by a valuation allowance.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.199%;"/>
        <td style="width:1.923%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.878%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decrease related to prior year tax positions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increase related to current year tax positions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,400</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If applicable, we would classify interest and penalties related to uncertain tax positions in income tax expense. Through December 31, 2022, there has been no interest expense or penalties related to unrecognized tax benefits.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not currently expect any significant changes to unrecognized tax benefits during the fiscal year ended December 31, 2023. In certain cases, our uncertain tax positions are related to tax years that remain subject to examination by the relevant tax authorities. Tax years for which we have carryforward net operating loss and credit attributes remain subject to examination by federal and most state tax authorities.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189461888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS DATA<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">CONSOLIDATED STATEMENTS OF CASH FLOWS DATA</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. CONSOLIDATED STATEMENTS OF CASH FLOWS DATA</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;">&#160;</p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:44.689%;"/>
        <td style="width:1.747%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.706000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.747%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.706000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.747%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.659%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental operating and investing activities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net unrealized loss on <br/>&#160;&#160;&#160;marketable securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">251</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Reclassification between prepaid and other<br/>&#160;&#160;&#160;current assets and deposits and other assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease assets obtained in<br/>&#160;&#160;&#160;exchange for operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,575</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest paid</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,154</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,704</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">388</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566186076656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12. SUBSEQUENT EVENTS</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public Offering</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On January 10, 2023, we completed an underwritten public offering of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68,007,741</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock and a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, or the 2023 pre-funded warrant. The net cash proceeds from this offering are approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">213,300,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, after deducting the underwriting discount and other offering expenses paid by us, and excludes any future proceeds from the exercise of the 2023 pre-funded warrant, which has not been exercised.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant Exercises</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From January 1, 2023 through March 9, 2023, we have received $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46,716,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash proceeds from the exercise of the 2020 purchase warrants, representing </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35,935,577</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From January 1, 2023 through March 9, 2023, we have received $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,119,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in cash proceeds from the exercise of the 2022 purchase warrants, representing </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,047,617</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566288797232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated financial statements include the accounts of Geron and our wholly-owned subsidiary, Geron UK Limited, or Geron UK, a United Kingdom company. Geron UK was incorporated in September 2021, and its operations commenced in January 2022. We have eliminated intercompany accounts and transactions. We prepare the financial statements of Geron UK using the local currency as the functional currency. We translate the assets and liabilities of Geron UK at rates of exchange at the balance sheet date and translate income and expense items at average monthly rates of exchange. The resultant translation adjustments are included in accumulated other comprehensive income (loss), a separate component of stockholders&#8217; equity, on our consolidated balance sheets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net Loss Per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of shares of common stock outstanding for the periods presented without consideration of potential common shares. In April 2022, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,095,238</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, also known as the 2022 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. In May 2020, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,335,239</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of our common stock, or the 2020 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. The 2022 pre-funded warrant and 2020 pre-funded warrant each are exercisable immediately at an exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. We included the 2022 pre-funded warrant and 2020 pre-funded warrant in the computation of basic net loss per share, as applicable, since their exercise price is negligible, and they may be exercised at any time. See Note 9 on Stockholders' Equity for further discussion of the April 2022 public offering.</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diluted net income per share would be calculated by adjusting the weighted-average number of shares of common stock outstanding for the dilutive effect of additional shares of common stock that would have been outstanding if potentially dilutive securities had been issued, as determined using the treasury-stock method. Potential dilutive securities consist of outstanding stock options and warrants to purchase our common stock. Diluted net loss per share excludes potential dilutive securities for all periods presented as their effect would be anti-dilutive. Accordingly, basic and diluted net loss per share is the same for all periods presented in the accompanying consolidated statements of operations. Since we incurred a net loss for 2022, 2021, and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the diluted net loss per share calculation excludes potential dilutive securities of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">145,726,765</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">105,725,875</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101,881,391</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares, respectively, related to outstanding stock options and warrants as their effect would have been anti-dilutive.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to accrued liabilities, revenue recognition, fair value of marketable securities and equity investments, operating leases, right-of-use assets, lease liabilities, income taxes, and stock-based compensation. We base our estimates on historical experience and on various other market specific and relevant assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value of Financial Instruments</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Equivalents and Marketable Securities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. We are subject to credit risk related to our cash equivalents and marketable securities. Our marketable debt securities include U.S. Treasury securities, municipal securities, government-sponsored enterprise securities, commercial paper and corporate notes.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We classify our marketable debt securities as available for sale. We record available for sale debt securities at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) in stockholders&#8217; equity. Realized gains and losses are included in interest income and are derived using the specific identification method for determining the cost of securities sold and have been insignificant to date. Dividend and interest income are recognized when earned and included in interest income on our consolidated statements of operations. We recognize a charge when the declines in the fair values below the amortized cost bases of our available for sale securities are judged to be other than temporary. We consider various factors in determining whether to recognize an other than temporary charge, including whether we intend to sell the security or whether it is more likely than not that we would be required to sell the security before recovery of the amortized cost basis. Declines in market value judged as other than temporary result in a charge to interest income. We have not recorded any other&#8209;than&#8209;temporary impairment charges on our available&#8209;for&#8209;sale securities for the years ended December 31, 2022, 2021 and 2020. See Note 2 on Fair Value Measurements.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity Investments</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure our investment in equity securities at fair value at each reporting date. Changes in fair value resulting from observable price changes are included in change in fair value of equity investment and changes in fair value resulting from foreign currency translation are included in other expense on our consolidated statements of operations.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating leases are included in operating leases, right-of-use assets and lease liabilities on our consolidated balance sheets. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of remaining lease payments over the expected lease term. The present value of remaining lease payments within the 12 months following the balance sheet date are classified as current lease liabilities. The present value of lease payments not within the 12 months following the balance sheet date are classified as noncurrent lease liabilities. The interest rate implicit in lease contracts is typically not readily determinable. As such, to calculate the net present value of lease payments, we apply our incremental borrowing rate, which is the estimated rate to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment as of the lease commencement date. We may adjust the right-of-use assets for certain adjustments, such as initial direct costs paid or incentives received. In addition, we include any options to extend or terminate the lease in the expected lease term when it is reasonably certain that we will exercise any such option. Lease expense is recognized on a straight-line basis over the expected lease term.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For lease agreements entered into after January 1, 2019 that include lease and non-lease components, such components are generally accounted for separately. We have also elected not to recognize on our consolidated balance sheets leases with terms of one year or less.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Issuance Costs and Debt Discounts</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Debt Issuance Costs and Debt Discounts</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Debt issuance costs include legal fees, accounting fees, and other direct costs incurred in connection with the execution of our debt financing. Debt discounts represent costs paid to the lenders. Debt issuance costs and debt discounts are deducted from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt using the effective interest method.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Revenue Recognition</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers, or Topic 606. In determining the appropriate amount and timing of revenue to be recognized under this guidance, we perform the following five steps: (i) identify the contract(s) with our customer; (ii) identify the promised goods or services in the agreement and determine whether they are performance obligations, including whether they are distinct in the context of the agreement; (iii) measure the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations based on stand-alone selling prices; and (v) recognize revenue when (or as) we satisfy each performance obligation. <br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A performance obligation is a promise in an agreement to transfer a distinct good or service to the customer and is the unit of account in Topic 606. Significant management judgment is required to determine the level of effort required and the period over which completion of the performance obligations is expected under an agreement. If reasonable estimates regarding when performance obligations are either complete or substantially complete cannot be made, then revenue recognition is deferred until a reasonable estimate can be made. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We allocate the total transaction price to each performance obligation based on the estimated relative stand-alone selling prices of the promised goods or services underlying each performance obligation. Estimated selling prices for license rights are calculated using an income approach model and include the following key assumptions, judgments and estimates: the development timeline, revenue forecast, commercialization expenses, discount rate and probabilities of technical and regulatory success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Following is a description of the principal activities from which we generate revenue. License fees and royalty revenue primarily represent amounts earned under agreements that out-license our technology to various companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">License Agreements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><br/>We previously entered into several license agreements with various oncology, diagnostics, research tools and biologics production companies, whereby we granted certain rights to our non-imetelstat related technologies. Under these agreements, non-refundable upfront fees and annual license maintenance fees were considered fixed consideration, while milestone payments and royalties were identified as variable consideration. Since June 30, 2021, no active license agreements remain. The license related to our specialized oligonucleotide backbone chemistry, as well as patent rights covering the synthesis of monomers, the building blocks of oligonucleotides, terminated effective April 2021.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the divestiture of Geron&#8217;s human embryonic stem cell assets, including intellectual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on sales of certain research or commercial products utilizing Geron&#8217;s divested intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Licenses of Intellectual Property</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. If we determine the license to intellectual property is distinct from the other performance obligations identified in the agreement and the licensee can use and benefit from the license, we recognize revenue from non-refundable upfront fees allocated to the license upon the completion of the transfer of the license to the licensee. For such licenses, we recognize revenue from annual license maintenance fees upon the start of the new license period. For licenses that are bundled with other performance obligations, we assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable upfront fees or annual license maintenance fees. At each reporting date, we reassess the progress and, if necessary, adjust the measure of performance and related revenue recognition.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Milestone Payments.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> At the inception of each agreement that includes milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. For milestones that we do not deem</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">to be probable of being achieved, the associated milestone payments are fully constrained and the value of the milestone is excluded from the transaction price with no revenue being recognized. For example, milestone payments that are not within our control, such as regulatory-related accomplishments, are not considered probable of being achieved until those accomplishments have been communicated by the relevant regulatory authority. Once the assessment of probability of achievement becomes probable, we recognize revenue for the milestone payment. At each reporting date, we assess the probability of achievement of each milestone under any current agreements.<br/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Royalties</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. For agreements with sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (a) when the related sales occur, or (b) when the performance obligation, to which some or all of the royalty has been allocated, has been satisfied (or partially satisfied). At each reporting date, we estimate the sales incurred by each licensee during the reporting period based on historical experience and accrue the associated royalty amount.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted Cash</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash consists of funds maintained in separate money market or certificate of deposit accounts for credit card purchases.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses currently consist of expenses incurred in developing and testing imetelstat and research related to potential next generation telomerase inhibitors. These expenses include, but are not limited to, payroll and personnel expense, lab supplies, non-clinical studies, clinical trials, including support for investigator-led clinical trials, raw materials to manufacture clinical trial drugs, manufacturing costs for research and clinical trial materials, sponsored research at other labs, consulting, costs to maintain technology licenses and research-related overhead.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current imetelstat clinical trials are being supported by contract research organizations, or CROs, and other vendors. We accrue expenses for clinical trial activities performed by CROs based upon the estimated amount of work completed on each trial. For clinical trial expenses and related expenses associated with the conduct of clinical trials, the significant factors used in estimating accruals include the number of patients enrolled, the number of active clinical sites, and the duration for which the patients have been enrolled in the trial. We monitor patient enrollment levels and related activities to the extent possible through internal reviews, review of contractual terms and correspondence with CROs. We base our estimates on the best information available at the time. However, additional information may become available to us which will allow us to make a more accurate estimate in future periods. In that event, we may be required to record adjustments to research and development expenses in future periods when the actual level of activity becomes more certain.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock', window );">Depreciation and Amortization</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation and Amortization</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We record property and equipment at cost and calculate depreciation using the straight&#8209;line method over the estimated useful lives of the assets, generally </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Leasehold improvements are amortized over the shorter of the estimated useful life or remaining term of the lease.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock&#8209;Based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain various stock incentive plans under which stock options and restricted stock awards can be granted to employees, non-employee directors and consultants. We also have an employee stock purchase plan for all eligible employees. We recognize stock-based compensation expense based on grant-date fair values of service-based stock options on a straight-line basis over the requisite service period, which is generally the vesting period. For performance-based stock options with vesting based on the achievement of certain strategic milestones, stock-based compensation expense is recognized over the period from the date the performance condition is determined to be probable of occurring through the date the applicable condition is expected to be met and is reduced for estimated forfeitures, as applicable. If the performance condition is not considered probable of being achieved, no stock-based compensation expense is recognized until such time as the performance condition is considered probable of being met, if at all. If the assessment of probability of the performance condition changes, the impact of the change in estimate would be recognized in the period of the change. The determination of grant-date fair values for our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">service-based and performance-based stock options and employee stock purchases using the Black Scholes option pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables. The grant-date fair value for service-based restricted stock awards is determined using the fair value of our common stock on the date of grant. We evaluate whether an adjustment to the assumptions of fair value of our common stock and historical volatility are required if observed prices of our common stock materially differ from historical information.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure share-based payments to non-employees based on the grant-date fair value of the equity awards to be issued. We recognize stock-based compensation expense for the fair value of the vested portion of non-employee stock-based awards on our consolidated statements of operations. For additional information, see Note 9 on Stockholders&#8217; Equity.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Accumulated Other Comprehensive Gain (Loss)</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated Other Comprehensive Gain (Loss)</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other comprehensive gain (loss) includes certain changes in stockholders&#8217; equity which are excluded from net income (loss). Accumulated other comprehensive loss on our consolidated balance sheets as of December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively, is comprised of net unrealized losses on marketable securities and cumulative translation adjustments.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We maintain deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are subject to tests of recoverability. Our deferred tax assets include net operating loss carryforwards, federal and state tax credits and capitalized research and development. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Our net deferred tax asset has been fully offset by a valuation allowance because of our history of losses. Any potential accrued interest and penalties related to unrecognized tax benefits would be recorded as income tax expense.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Segment Information</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our executive management team represents our chief decision maker. We view our operations as a single segment, the development of therapeutic products for oncology. As a result, the financial information disclosed herein materially represents all of the financial information related to our principal operating segment.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">New Accounting Pronouncements &#8211; Issued But Not Yet Adopted</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU 2016-13,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2016-13. The main objective of ASU 2016-13 is to provide financial statement users with more decision-useful information about an entity's expected credit losses on financial instruments and other commitments to extend credit at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology currently used today with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to develop credit loss estimates. Subsequent to issuing ASU 2016-13, the FASB issued ASU 2018-19, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Codification Improvements to Topic 326, Financial Instruments &#8211; Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2018-19, for the purpose of clarifying certain aspects of ASU 2016-13. In May 2019, the FASB issued ASU 2019-05, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments &#8211; Credit Losses (Topic 326): Targeted Transition Relief</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2019-05, to provide entities with more flexibility in applying the fair value option on adoption of the credit impairment standard. In November 2019, the FASB issued ASU 2019-11, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Codification Improvements to Topic 326, Financial Instruments &#8211; Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, which expands the scope of the practical expedient that allows entities to exclude the accrued interest component of amortized cost from various disclosure. Entities that elect to apply the practical expedient must disclose the total amount of accrued interest that they exclude from their disclosures of amortized cost. ASU 2018-19, ASU 2019-05 and ASU 2019-11 have the same effective date and transition requirements as ASU 2016-13. ASU 2016-13 will be effective for fiscal years beginning after December 15, 2022, using a modified retrospective approach, for smaller reporting companies. Early adoption is permitted. We plan to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">adopt ASU 2016-13 and related updates as of January 1, 2023. We do not expect the adoption of this standard to have a material impact on our financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In August 2020, the FASB issued ASU 2020-06, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, or ASU 2020-06. The key elements of ASU 2020-06 aim to reduce unnecessary complexity in GAAP for certain financial instruments with characteristics of liabilities and equity. In addressing the complexity, the FASB focused on amending the guidance on convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#8217;s own equity. For convertible instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock. For contracts in an entity&#8217;s own equity, the FASB observed that the application of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically similar contracts as equity. The FASB also decided to improve and amend the related earnings per share guidance. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years for public business entities that are not smaller reporting companies. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. We plan to adopt ASU 2020-06 as of January 1, 2024. We do not expect the adoption of this standard to have a material impact on our financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on our financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21459-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566181853440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of cash equivalents, restricted cash and marketable securities by security type</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents, restricted cash and marketable securities by security type at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.972%;"/>
        <td style="width:1.354%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in cash and cash equivalents:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,771</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,771</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,771</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,771</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">364</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">364</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,983</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,921</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities (due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities <br/>&#160;&#160;&#160;(due in less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,860</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,846</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper (due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,285</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,199</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,014</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,959</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">116,142</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">247</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115,901</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents, restricted cash and marketable securities by security type at December 31, 2021 were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.972%;"/>
        <td style="width:1.354%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.366%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.145%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in cash and cash equivalents:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,499</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,499</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31,706</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31,706</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market fund</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of deposit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">364</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">364</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketable securities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,585</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,567</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities (due in <br/>&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,524</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,521</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities (due in <br/>&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,000</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities <br/>&#160;&#160;&#160;(due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,500</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,493</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper (due in less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84,398</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84,362</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,444</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,429</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in one to two years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,224</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,145</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">177,675</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">177</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">177,502</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of cash equivalents and marketable securities with unrealized losses</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents and marketable securities with unrealized losses that have been in a continuous unrealized loss position for less than 12 months and 12 months or longer at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:27.719%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.868%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.162%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.613%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.404%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.627%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.122%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less Than 12 Months</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12 Months or Greater</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Estimated</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="4" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury <br/>&#160;&#160;&#160;securities (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,424</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,497</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,921</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities <br/>&#160;&#160;&#160;(due in less than a<br/>&#160;&#160;&#160;year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored <br/>&#160;&#160;&#160;enterprise securities <br/>&#160;&#160;&#160;(due in less than <br/>&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,845</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,845</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper<br/>&#160;&#160;&#160;(due in less than<br/>&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52,454</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52,454</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,998</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,962</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,960</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75,721</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">165</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28,435</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104,156</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">247</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury <br/>&#160;&#160;&#160;securities (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,567</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,567</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury <br/>&#160;&#160;&#160;securities (due in <br/>&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,521</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,521</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities <br/>&#160;&#160;&#160;(due in one to two <br/>&#160;&#160;&#160;years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored <br/>&#160;&#160;&#160;enterprise securities <br/>&#160;&#160;&#160;(due in less than <br/>&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,500</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,993</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,493</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper<br/>&#160;&#160;&#160;(due in less than<br/>&#160;&#160;&#160;one year)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66,872</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66,872</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in <br/>&#160;&#160;&#160;less than one year)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,001</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,001</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes (due in <br/>&#160;&#160;&#160;one to two years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,145</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,145</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">128,591</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">170</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,993</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">133,584</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">177</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of financial instruments measured at fair value on recurring basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents information about our financial instruments that are measured at fair value on a recurring basis as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021 and indicates the fair value category assigned.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:44.762%;"/>
        <td style="width:1.196%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.81%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.978%;"/>
        <td style="width:1.0%;"/>
        <td style="width:12.006%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.978%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.935%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.978%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.359%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair Value Measurements at Reporting Date Using</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quoted Prices in</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Active Markets for</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unobservable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identical Assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Observable Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inputs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)(2)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,864</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39,864</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certificate of deposit</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(2)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">271</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,921</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,921</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,976</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,846</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,846</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,199</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,199</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,959</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,959</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40,135</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">115,901</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">156,036</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. Treasury securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)(4)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,088</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,088</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(4)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,985</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government-sponsored enterprise securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,493</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,493</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)(3)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91,861</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91,861</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate notes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(3)(4)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,574</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60,574</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24,207</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">185,001</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">209,208</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in cash and cash equivalents on our consolidated balance sheets.</span></div></div><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in restricted cash on our consolidated balance sheets.</span></div></div><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in current portion of marketable securities on our consolidated balance sheets.</span></div></div><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Included in noncurrent portion of marketable securities on our consolidated balance sheets.</span></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189560064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment, stated at cost</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, stated at cost, is comprised of the following:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.186%;"/>
        <td style="width:1.214%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.701%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.214%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.686%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furniture and computer equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,554</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,171</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">129</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,689</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less accumulated depreciation and amortization</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">896</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">650</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">793</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">650</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189600336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued liabilities</a></td>
<td class="text">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:58.192%;"/>
        <td style="width:1.964%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.933%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.964%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.948%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CRO and clinical trial costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,040</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,804</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Manufacturing activities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,321</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,123</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Professional legal and accounting fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,030</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest payable</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">561</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">510</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">541</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,100</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,834</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189576192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of lease costs</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The components of lease costs included in operating expenses on our consolidated statements of operations for the New Jersey Lease, the Foster City Lease and a lease from a former location in Menlo Park, California, were as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:18.733%;"/>
        <td style="width:21.617%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.904%;"/>
        <td style="width:1.0%;"/>
        <td style="width:2.524%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.754000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:3.125%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.342%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">944</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">946</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,143</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable lease costs</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">&#160;(1)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">310</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">252</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">293</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,254</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,198</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,436</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.588888888888889%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Variable lease costs represent non-lease components, such as common area maintenance charges.</span></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Undiscounted future non-cancellable lease payments</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The undiscounted future non-cancellable lease payments under the New Jersey Lease and the Foster City Lease as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 were as follows (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:35.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:68.834%;"/>
        <td style="width:2.869%;"/>
        <td style="width:1.0%;"/>
        <td style="width:26.296%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">962</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">987</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,014</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2026</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,040</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2027</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">717</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Thereafter</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,050</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,770</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,174</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,596</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566188400096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Future Minimum Payments Under Term Loan Facility</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents future minimum payments, including interest and the end of term charge, under the Term Loan as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:61.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.622%;"/>
        <td style="width:12.76%;"/>
        <td style="width:1.0%;"/>
        <td style="width:19.618%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26,843</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34,160</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61,003</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  amount representing interest</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,728</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  unamortized debt discount and issuance costs</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">628</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  unamortized end of term charge</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,490</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less:  current portion of debt</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,945</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Noncurrent portion of debt</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30,212</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566288788048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of aggregate stock option and award activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate stock option and award activity for the 2011 Plan, 2018 Plan, 2006 Directors Plan, Inducement Plan and Directors Market Plan is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:34.976%;"/>
        <td style="width:0.086%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.64%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.086%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.08%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.681%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.712%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.086%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.904%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.086%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.663%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding Stock Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intrinsic</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Available</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contractual Life</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For Grant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,763,393</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,952,409</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.06</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional shares authorized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,755,000</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options granted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,747,760</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,747,760</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.37</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Awards granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,962</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,181,711</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.52</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options cancelled/forfeited/expired</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,616,058</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,616,058</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.70</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,370,729</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65,902,400</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">(1)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.87</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.56</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50,205</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options exercisable at <br/>&#160;&#160;December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36,085,389</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.17</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.09</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22,878</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options fully vested and expected<br/>&#160;&#160;&#160;&#160;to vest at December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64,539,649</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.88</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.52</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48,951</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:76.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.13%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Includes </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,791,750</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> performance-based stock options granted that have not achieved certain strategic milestones.</span></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of allocation of stock-based compensation expense related to share-based payment awards</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize stock&#8209;based compensation expense for service-based stock options on a straight&#8209;line basis over the requisite service period, which is generally the vesting period. We have not recognized any stock-based compensation expense for performance-based stock options on our consolidated statements of operations for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, 2021 and 2020, as the achievement of the specified strategic milestones was not considered probable during that time. The following table summarizes the stock&#8209;based compensation expense related to service-based stock options and employee stock purchases for the years ended December 31, 2022, 2021 and 2020 which was allocated as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.977%;"/>
        <td style="width:1.268%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.517999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.268%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.517999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.268%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.183%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,720</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,597</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,337</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,281</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,483</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,558</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation expense<br/>&#160;&#160;&#160;included in operating expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,001</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,080</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,895</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used to estimate the fair value of stock options granted</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of stock options granted in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020 has been estimated at the date of grant using the Black Scholes option&#8209;pricing model with the following assumptions:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.489%;"/>
        <td style="width:1.242%;"/>
        <td style="width:16.253%;"/>
        <td style="width:1.242%;"/>
        <td style="width:16.253%;"/>
        <td style="width:1.255%;"/>
        <td style="width:16.266%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.772</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.817</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.775</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.783</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.781</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.793</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate range</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.69</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.57</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.51</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.31</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.62</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;yrs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;yrs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.25</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;yrs</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used to estimate the fair value of employee stock purchases under the purchase plan</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of employee stock purchases in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022, 2021, and 2020 has been estimated using the Black Scholes option&#8209;pricing model with the following assumptions:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:39.984%;"/>
        <td style="width:1.242%;"/>
        <td style="width:22.503%;"/>
        <td style="width:1.255%;"/>
        <td style="width:16.8%;"/>
        <td style="width:1.255%;"/>
        <td style="width:16.96%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend yield</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.614</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.865</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.507</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.707</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.478</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.818</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate range</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.79</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.09</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% to </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.57</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term range</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;- </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;mos</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;- </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;mos</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;- </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;mos</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of common stock reserved for future issuance</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock reserved for future issuance as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 is as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:73.896%;"/>
        <td style="width:1.674%;"/>
        <td style="width:1.0%;"/>
        <td style="width:22.43%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Outstanding stock options</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65,902,400</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options and awards available for grant</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,370,729</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,131,764</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106,254,842</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">191,659,735</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of common stock reserved for future issuance, which may include but is not limited to outstanding options and outstanding warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566190039216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule reconciles the federal statutory tax rate to the effective income tax rate from continuing operations</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table reconciles the federal statutory tax rate to the effective income tax rate from continuing operations:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:47.158%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.196000000000002%;"/>
        <td style="width:1.0%;"/>
        <td style="width:3.305%;"/>
        <td style="width:5.199%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.808%;"/>
        <td style="width:1.0%;"/>
        <td style="width:3.122%;"/>
        <td style="width:4.295%;"/>
        <td style="width:1.0%;"/>
        <td style="width:7.612%;"/>
        <td style="width:1.0%;"/>
        <td style="width:3.305%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Tax at statutory rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income tax, net of federal benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.9</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal and state tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.8</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net operating loss not benefitted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Effective tax rate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.0</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of significant components of the entity's deferred tax assets</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of our deferred tax assets are as follows:</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.802%;"/>
        <td style="width:1.432%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.742%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.448%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.576%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">254,500</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">241,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal and state tax credits</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56,700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49,600</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capitalized research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,800</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,900</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,800</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,200</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,400</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,600</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,600</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">350,700</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">312,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">349,600</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">310,700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,100</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating leases, right-of-use assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,100</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,100</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,300</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total net deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of reconciliation of the beginning and ending amounts of unrecognized tax benefits</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:80.199%;"/>
        <td style="width:1.923%;"/>
        <td style="width:1.0%;"/>
        <td style="width:15.878%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decrease related to prior year tax positions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increase related to current year tax positions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,400</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,700</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566185605936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental schedule of non-cash operating and investing activities</a></td>
<td class="text">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:44.689%;"/>
        <td style="width:1.747%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.706000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.747%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.706000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.747%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.659%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2020</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental operating and investing activities:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net unrealized loss on <br/>&#160;&#160;&#160;marketable securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">251</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Reclassification between prepaid and other<br/>&#160;&#160;&#160;current assets and deposits and other assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease assets obtained in<br/>&#160;&#160;&#160;exchange for operating lease liabilities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,575</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest paid</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,154</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,704</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">388</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566184878384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail) - Pre-Funded Warrants - Public Offering of Common Stock and Warrants - $ / shares<br></strong></div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>May 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock, shares</a></td>
<td class="nump">18,095,238<span></span>
</td>
<td class="nump">8,335,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=gern_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=gern_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=gern_PublicOfferingOfCommonStockAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=gern_PublicOfferingOfCommonStockAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566186970256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail1) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Stock options and warrants excluded from diluted net loss per share calculation due to net loss position</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from diluted earnings (loss) per share calculation (in shares)</a></td>
<td class="nump">145,726,765<span></span>
</td>
<td class="nump">105,725,875<span></span>
</td>
<td class="nump">101,881,391<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189600336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - USEFUL LIVES OF ASSETS (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAbstract', window );"><strong>Depreciation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives of assets</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566179814560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - SECURITY TYPE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Included in cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Amortized Cost</a></td>
<td class="nump">$ 39,771<span></span>
</td>
<td class="nump">$ 31,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Estimated Fair Value</a></td>
<td class="nump">39,771<span></span>
</td>
<td class="nump">31,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsAbstract', window );"><strong>Restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Amortized Cost</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsAtFairValue', window );">Estimated Fair Value</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">116,142<span></span>
</td>
<td class="nump">177,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(247)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">115,901<span></span>
</td>
<td class="nump">177,502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Included in cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Amortized Cost</a></td>
<td class="nump">39,771<span></span>
</td>
<td class="nump">24,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Estimated Fair Value</a></td>
<td class="nump">39,771<span></span>
</td>
<td class="nump">24,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsAbstract', window );"><strong>Restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Amortized Cost</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsAtFairValue', window );">Estimated Fair Value</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Included in cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsAbstract', window );"><strong>Restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Amortized Cost</a></td>
<td class="nump">271<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsAtFairValue', window );">Estimated Fair Value</a></td>
<td class="nump">271<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInLessThanOneYearMember', window );">U.S. Treasury securities (due in less than one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">12,983<span></span>
</td>
<td class="nump">15,585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">12,921<span></span>
</td>
<td class="nump">15,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInOneToTwoYearsMember', window );">U.S. Treasury securities (due in one to two years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInLessThanOneYearMember', window );">Municipal securities (due in less than one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">2,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInOneToTwoYearsMember', window );">Municipal securities (due in one to two years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember', window );">Government-sponsored enterprise securities (due in less than one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">9,860<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">9,846<span></span>
</td>
<td class="nump">12,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_CommercialPaperDueInLessThanOneYearMember', window );">Commercial paper (due in less than one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">64,285<span></span>
</td>
<td class="nump">84,398<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">64,199<span></span>
</td>
<td class="nump">84,362<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInLessThanOneYearMember', window );">Corporate notes (due in less than one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">26,014<span></span>
</td>
<td class="nump">36,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 25,959<span></span>
</td>
<td class="nump">36,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember', window );">Corporate notes (due in one to two years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Marketable securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestmentsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of all restricted investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12.6(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611133-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Footnote 11(c)))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestmentsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInOneToTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInOneToTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInOneToTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInOneToTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_CommercialPaperDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_CommercialPaperDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187559376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - SECURITIES WITH UNREALIZED LOSSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months - Estimated Fair Value</a></td>
<td class="nump">$ 75,721<span></span>
</td>
<td class="nump">$ 128,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months - Gross Unrealized Losses</a></td>
<td class="num">(165)<span></span>
</td>
<td class="num">(170)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Greater - Estimated Fair Value</a></td>
<td class="nump">28,435<span></span>
</td>
<td class="nump">4,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Greater - Gross Unrealized Losses</a></td>
<td class="num">(82)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total - Estimated Fair Value</a></td>
<td class="nump">104,156<span></span>
</td>
<td class="nump">133,584<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total - Gross Unrealized Losses</a></td>
<td class="num">(247)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInLessThanOneYearMember', window );">U.S. Treasury securities (due in less than one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months - Estimated Fair Value</a></td>
<td class="nump">11,424<span></span>
</td>
<td class="nump">15,567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months - Gross Unrealized Losses</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Greater - Estimated Fair Value</a></td>
<td class="nump">1,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Greater - Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total - Estimated Fair Value</a></td>
<td class="nump">12,921<span></span>
</td>
<td class="nump">15,567<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total - Gross Unrealized Losses</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInOneToTwoYearsMember', window );">U.S. Treasury securities (due in one to two years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months - Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months - Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total - Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total - Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInLessThanOneYearMember', window );">Municipal securities (due in less than a year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Greater - Estimated Fair Value</a></td>
<td class="nump">2,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Greater - Gross Unrealized Losses</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total - Estimated Fair Value</a></td>
<td class="nump">2,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total - Gross Unrealized Losses</a></td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInOneToTwoYearsMember', window );">Municipal securities (due in one to two years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months - Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months - Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total - Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total - Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember', window );">Government-sponsored enterprise securities (due in less than one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months - Estimated Fair Value</a></td>
<td class="nump">9,845<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months - Gross Unrealized Losses</a></td>
<td class="num">(14)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Greater - Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Greater - Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total - Estimated Fair Value</a></td>
<td class="nump">9,845<span></span>
</td>
<td class="nump">6,493<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total - Gross Unrealized Losses</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_CommercialPaperDueInLessThanOneYearMember', window );">Commercial paper (due in less than one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months - Estimated Fair Value</a></td>
<td class="nump">52,454<span></span>
</td>
<td class="nump">66,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months - Gross Unrealized Losses</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total - Estimated Fair Value</a></td>
<td class="nump">52,454<span></span>
</td>
<td class="nump">66,872<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total - Gross Unrealized Losses</a></td>
<td class="num">(92)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInLessThanOneYearMember', window );">Corporate notes (due in less than one year)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months - Estimated Fair Value</a></td>
<td class="nump">1,998<span></span>
</td>
<td class="nump">16,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months - Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 Months or Greater - Estimated Fair Value</a></td>
<td class="nump">23,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 Months or Greater - Gross Unrealized Losses</a></td>
<td class="num">(53)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total - Estimated Fair Value</a></td>
<td class="nump">25,960<span></span>
</td>
<td class="nump">16,001<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total - Gross Unrealized Losses</a></td>
<td class="num">$ (55)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember', window );">Corporate notes (due in one to two years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months - Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months - Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total - Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,145<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total - Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInOneToTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_USTreasurySecuritiesDueInOneToTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInOneToTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_MunicipalSecuritiesDueInOneToTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_CommercialPaperDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_CommercialPaperDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInLessThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInLessThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566188558384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - RECURRING BASIS (Details) - Recurring basis - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 156,036<span></span>
</td>
<td class="nump">$ 209,208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">39,864<span></span>
</td>
<td class="nump">24,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Certificate of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">U.S. Treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">12,921<span></span>
</td>
<td class="nump">17,088<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">2,976<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Government-sponsored enterprise securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">9,846<span></span>
</td>
<td class="nump">12,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">64,199<span></span>
</td>
<td class="nump">91,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">25,959<span></span>
</td>
<td class="nump">60,574<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">40,135<span></span>
</td>
<td class="nump">24,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">39,864<span></span>
</td>
<td class="nump">24,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Certificate of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">115,901<span></span>
</td>
<td class="nump">185,001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | U.S. Treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">12,921<span></span>
</td>
<td class="nump">17,088<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">2,976<span></span>
</td>
<td class="nump">2,985<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Government-sponsored enterprise securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">9,846<span></span>
</td>
<td class="nump">12,493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">64,199<span></span>
</td>
<td class="nump">91,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Corporate notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value on a Recurring Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 25,959<span></span>
</td>
<td class="nump">$ 60,574<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryNotesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryNotesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateNoteSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566188491280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - EQUITY INVESTMENT (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 03, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2007</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Equity Investments [Line Item]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Number of shares owned</a></td>
<td class="nump">35,990,825<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,842,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod', window );">Business Combination Cost Of Acquired Entity Equity Interests Issued And Issuable Fair Value Method</a></td>
<td class="text">we received 13 BARD1 shares for every five shares of Sienna ordinary shares, resulting in our ownership of 35,990,825 shares of BARD1.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized investment gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,233,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Equity Investments [Line Item]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_CostMethodInvestmentOwnershipPercentage', window );">Cost method investments ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Equity Investments [Line Item]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_CostMethodInvestmentsCostBasis', window );">Cost method investments cost basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_CostMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost method investment ownership percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_CostMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_CostMethodInvestmentsCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost method investments cost basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_CostMethodInvestmentsCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The method of determining the fair value of the equity interests of the acquirer, including the number of instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189404128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - CREDIT RISK (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Institution</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract', window );"><strong>Credit Risk</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_NumberOfFinancialInstitutions', window );">Number of financial institutions</a></td>
<td class="nump">5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_NumberOfFinancialInstitutions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of financial institutions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_NumberOfFinancialInstitutions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566184579456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 1,689<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(896)<span></span>
</td>
<td class="num">(650)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">793<span></span>
</td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,554<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 135<span></span>
</td>
<td class="nump">$ 129<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566179631600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED LIABILITIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent', window );">CRO and clinical trial costs</a></td>
<td class="nump">$ 17,040<span></span>
</td>
<td class="nump">$ 22,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_AccruedManufacturingActivitiesCurrent', window );">Manufacturing activities</a></td>
<td class="nump">5,321<span></span>
</td>
<td class="nump">4,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional legal and accounting fees</a></td>
<td class="nump">9,668<span></span>
</td>
<td class="nump">2,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="nump">561<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">510<span></span>
</td>
<td class="nump">541<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 33,100<span></span>
</td>
<td class="nump">$ 29,834<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical related costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_AccruedManufacturingActivitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet of obligations incurred through the date and payable for manufacturing related costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_AccruedManufacturingActivitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187692896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Litigation Settlement (Details) - Insurance Claims - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 21, 2022</div></th>
<th class="th"><div>Sep. 02, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember', window );">Class Action Stipulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencySettlementAgreementDate', window );">Settlement agreement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">September 2, 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement to be paid by insurers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LitigationSettlementAmountPaidInCashOrKind', window );">Settlement to be paid in cash or shares as elected by company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LitigationSettlementAmountAccruedLiabilitiesRecognized', window );">Litigation settlement amount, Accrued liabilities recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized', window );">Settlement amount, General and administrative expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember', window );">Derivative Stipulation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencySettlementAgreementDate', window );">Settlement agreement date</a></td>
<td class="text">December 21, 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement, amount</a></td>
<td class="nump">$ 1,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Settlement to be paid by insurers</a></td>
<td class="nump">525,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LitigationSettlementAmountAccruedLiabilitiesRecognized', window );">Litigation settlement amount, Accrued liabilities recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized', window );">Settlement amount, Interest and other receivable recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">525,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized', window );">Settlement amount, General and administrative expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 825,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LitigationSettlementAmountToBePaid', window );">Settlement amount to be paid</a></td>
<td class="nump">$ 825,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LitigationSettlementAmountAccruedLiabilitiesRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation settlement amount, Accrued liabilities recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LitigationSettlementAmountAccruedLiabilitiesRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation settlement amount, General and administrative expense recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement Amount, Interest and other receivable Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LitigationSettlementAmountPaidInCashOrKind">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the settlement to be paid by the company in either cash or shares, at the company's election.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LitigationSettlementAmountPaidInCashOrKind</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LitigationSettlementAmountToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation settlement amount to be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LitigationSettlementAmountToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencySettlementAgreementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective date of a duly executed litigation settlement agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencySettlementAgreementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_InsuranceClaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=gern_ClassActionStipulationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=gern_ClassActionStipulationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=gern_DerivativeStipulationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=gern_DerivativeStipulationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566188465632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Severance Plan (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_SeverancePlanLineItems', window );"><strong>Severance Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod', window );">Period within which employee is terminated by entity without cause following a change of control</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity', window );">Period within which no comparable employment is offered by the entity following a change of control</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment', window );">Period within which employee resigns following a change of control due to material change in terms of employment</a></td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_SeverancePlanLineItems', window );"><strong>Severance Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan', window );">Period of base salary to be considered for severance payments</a></td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_SeverancePlanLineItems', window );"><strong>Severance Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan', window );">Period of base salary to be considered for severance payments</a></td>
<td class="text">18 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss contingency period of current base salary to be paid under severance plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of months following a change in control when an employee is terminated without cause to be classified as a triggering event for severance payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the period following change of control within which an employee is not offered comparable employment (new or continuing) by the entity or its successor or acquired and to be considered as triggering event for severance payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the period within which employee resigns following a change of control due to material change in terms of employment and to be considered as triggering event for severance payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_SeverancePlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Severance plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_SeverancePlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566180187040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING LEASES (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 10, 2020</div></th>
<th class="th"><div>Oct. 01, 2019</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,147,000<span></span>
</td>
<td class="nump">$ 4,727,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=gern_NewJerseyOfficeSpaceLeaseMember', window );">New Jersey Office Space Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Operating Lease, Percentage of Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,356,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,356,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, initial term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease term, option to extend additional period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToTerminate', window );">Operating lease term, option to terminate lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">one-time option to terminate the New Jersey Lease without cause as of the 103rd month anniversary of the commencement date of the lease<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_OperatingLeaseRentAbatementPeriod', window );">Operating lease, rent abatement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease,remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=gern_FosterCityOfficeSpaceLeaseMember', window );">Foster City Office Space Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Operating Lease, Percentage of Discount Rate</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating Lease, Right-of-Use Asset</a></td>
<td class="nump">$ 3,426,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 3,426,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, initial term</a></td>
<td class="text">87 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">87 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease term, option to extend additional period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_OperatingLeaseRentAbatementPeriod', window );">Operating lease, rent abatement period</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease,remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_OperatingLeaseRentAbatementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease rent abatement period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_OperatingLeaseRentAbatementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToTerminate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to terminate lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToTerminate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=gern_NewJerseyOfficeSpaceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=gern_NewJerseyOfficeSpaceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=gern_FosterCityOfficeSpaceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=gern_FosterCityOfficeSpaceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187445968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING LEASES - COMPONENTS OF LEASE COSTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 944<span></span>
</td>
<td class="nump">$ 946<span></span>
</td>
<td class="nump">$ 1,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">$ 1,254<span></span>
</td>
<td class="nump">$ 1,198<span></span>
</td>
<td class="nump">$ 1,436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566179630880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING LEASES - UNDISCOUNTED FUTURE NON-CANCELLABLE LEASE PAYMENTS (Details) - New Jersey Lease And Foster City Lease<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Lease Liabilities, Payments Due</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">1,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">1,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">5,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(1,174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating Lease, Liability</a></td>
<td class="nump">$ 4,596<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=gern_NewJerseyLeaseAndFosterCityLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=gern_NewJerseyLeaseAndFosterCityLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566181186672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 01, 2022</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 10, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity under term loan</a></td>
<td class="nump">$ 125,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount outstanding under term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtDescription', window );">Description of maturity date terms for term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Term Loan matures on October 1, 2024, or the Loan Maturity Date, and may be extended up to an additional 12 months upon the achievement of certain clinical, regulatory and financial milestones.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate', window );">Term loan interest rate description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Term Loan bears interest at a floating rate per annum equal to the greater of either (i) 9.0% or (ii) 9.0% plus the prime rate as reported in The Wall Street Journal (7.5% as of December 31, 2022) less 3.25%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Term loan maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Percentage added to prime rate for debt instrument interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_InterestOnlyPeriodPaymentTermDescription', window );">Interest only period payment term description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the interest-only period expires May 1, 2023. Upon the achievement of certain regulatory and financial milestones, the interest-only period may be extended for another six months until November 1, 2023.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DebtInstrumentEndOfTermChargePercentage', window );">End of term charge for loan, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DebtInstrumentMinimumPrepaymentAmount', window );">Minimum amount of prepayment allowed under debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Description of term loan payment terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">At our option, upon at least five business days&#8217; prior written notice to Hercules, we may prepay all or any portion greater than or equal to $5,000,000 of the outstanding loan by paying the entire principal balance (or portion thereof) and all accrued and unpaid interest. Such prepayment is subject to a prepayment charge of 1.5% of the prepayment amount, if the prepayment is made in any of the first 36 months following the Closing Date for any draw downs prior to the second amendment. Thereafter, any prepayment is not subject to a prepayment charge.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PercentageOfInterestOnPastDueOutstanding', window );">Additional percentage of interest on past due amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value of term loan, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,157,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt discount and issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">628,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_AccruedEndOfTermCharges', window );">Accrued end of term charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,785,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Available remaining loan principal under second amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PercentageOfPrepaymentCharge', window );">Prepayment charge (as a percentage)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Description of term loan payment terms</a></td>
<td class="text">Under the second amendment, if we choose to prepay the principal with respect to any future draw down after the Effective Date, any such prepayment within the first 36 months after the Effective Date will be subject to a prepayment charge equal to 1.5% of the principal amount prepaid. No prepayment charge will be assessed for any prepayment occurring more than 36 months after the Effective Date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount', window );">Minimum cash balance as a percentage of loan amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DebtCovenantMinimumCashBalance', window );">Debt covenant minimum cash balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount under second amendment</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate', window );">Charge for prepayment occurring 36 months after effective date</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member] | Second Amendment [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Available remaining loan principal under second amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member] | Tranche One [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity under term loan</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityBorrowingCapacityDescription', window );">Expiration date to borrow under a tranche for a debt instrument, description</a></td>
<td class="text">earlier of 30 days of the achievement of certain clinical and financial milestones or September 15, 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member] | Tranche Two [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity under term loan</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_BorrowingAvailableStartDate', window );">Start date to borrow under a tranche for a debt instrument</a></td>
<td class="text">Jan.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ExpiryDateOfTranche', window );">Expiration date to borrow under a tranche for a debt instrument</a></td>
<td class="text">Dec. 15,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member] | Tranche Three [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity under term loan</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_BorrowingAvailableStartDate', window );">Start date to borrow under a tranche for a debt instrument</a></td>
<td class="text">Sep. 15,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ExpiryDateOfTranche', window );">Expiration date to borrow under a tranche for a debt instrument</a></td>
<td class="text">Sep. 15,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member] | Tranche Four [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity under term loan</a></td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ExpiryDateOfTranche', window );">Expiration date to borrow under a tranche for a debt instrument</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member] | Option one min cash debt covenant [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount', window );">Minimum cash balance as a percentage of loan amount outstanding</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member] | Option Two Min Cash Debt Covenant [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount', window );">Minimum cash balance as a percentage of loan amount outstanding</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_MarketCapMinimumToUseOptionTwo', window );">Minimum market capitalization requirement for option</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember', window );">Hercules and Silicon Valley Bank [Member] | Option three min cash debt covenant [Member] | Second Amendment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DebtCovenantPercentageOfProductRevenueAgainstForecast', window );">Minimum cash balance requirement to be met as a percentage of six-month product revenue against forecast</a></td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod', window );">Minimum percentage of net product revenues maintenance period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_HerculesMember', window );">Hercules [Member] | Second Amendment [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement', window );">Percentage of remaining term commitments held under loan agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=gern_SiliconValleyBankMember', window );">Silicon Valley Bank [Member] | Second Amendment [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement', window );">Percentage of remaining term commitments held under loan agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_AccruedEndOfTermCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued end of term charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_AccruedEndOfTermCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_BorrowingAvailableStartDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>First date to available to drawdown any amount under a tranche.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_BorrowingAvailableStartDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DebtCovenantMinimumCashBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Covenant Minimum Cash Balance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DebtCovenantMinimumCashBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of loan amount outstanding to be held as minimum cash balance under debt covenant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DebtCovenantPercentageOfProductRevenueAgainstForecast">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of six-month product revenue forecast to satisfy minimum cash balance debt covenant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DebtCovenantPercentageOfProductRevenueAgainstForecast</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DebtInstrumentEndOfTermChargePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding loan amount payable upon maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DebtInstrumentEndOfTermChargePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DebtInstrumentMinimumPrepaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount allowed to be prepaid under debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DebtInstrumentMinimumPrepaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayment charge assessed upon debt prepayment occurring 36 months after June 30, 2022 under second amendment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ExpiryDateOfTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Last date to drawdown any amounts under a tranche.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ExpiryDateOfTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_InterestOnlyPeriodPaymentTermDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest only period payment term description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_InterestOnlyPeriodPaymentTermDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_MarketCapMinimumToUseOptionTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum market capitalization required for this option to be available to meet the minimum cash balance debt covenant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_MarketCapMinimumToUseOptionTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of net product revenues maintenance period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_PercentageOfInterestOnPastDueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Added percentage to current interest rate under debt instrument to past due amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_PercentageOfInterestOnPastDueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_PercentageOfPrepaymentCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of prepayment amount to be paid upon prepayment under debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_PercentageOfPrepaymentCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining term commitments held under loan agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of any adjustments made to the stated rate to determine the effective rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityBorrowingCapacityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the credit facility's borrowing capacity including discussion of how the borrowing capacity is determined (for example, borrowing capacity based on the amount of current assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityBorrowingCapacityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gern_HerculesAndSiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=gern_SecondAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=gern_SecondAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=gern_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=gern_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=gern_TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=gern_TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=gern_TrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=gern_TrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=gern_TrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=gern_TrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=gern_OptionOneMinCashDebtCovenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=gern_OptionOneMinCashDebtCovenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=gern_OptionTwoMinCashDebtCovenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=gern_OptionTwoMinCashDebtCovenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=gern_OptionThreeMinCashDebtCovenantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=gern_OptionThreeMinCashDebtCovenantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gern_HerculesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gern_HerculesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=gern_SiliconValleyBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=gern_SiliconValleyBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187557200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Schedule of Future Minimum Payments Under Term Loan Facility (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 26,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">34,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_LongTermDebtGross', window );">Total</a></td>
<td class="nump">61,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Less: amount representing interest</a></td>
<td class="num">(7,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount and issuance costs</a></td>
<td class="num">(628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DebtInstrumentUnamortizedEndOfTermCharge', window );">Less: unamortized end of term charge</a></td>
<td class="num">(1,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current portion of debt</a></td>
<td class="num">(20,945)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Noncurrent portion of debt</a></td>
<td class="nump">$ 30,212<span></span>
</td>
<td class="nump">$ 49,830<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DebtInstrumentUnamortizedEndOfTermCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument unamortized end of term charge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DebtInstrumentUnamortizedEndOfTermCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_LongTermDebtGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of term loan, including accrued interest payable and end of term charge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_LongTermDebtGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566181860112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - AUTHORIZED COMMON STOCK (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 12, 2021</div></th>
<th class="th"><div>May 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">675,000,000<span></span>
</td>
<td class="nump">675,000,000<span></span>
</td>
<td class="nump">675,000,000<span></span>
</td>
<td class="nump">450,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566179730512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - PUBLIC OFFERING (Details) - 2022 Underwritten Public Offering<br></strong></div></th>
<th class="th">
<div>Apr. 01, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PublicOfferingLineItems', window );"><strong>Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Combined public offering price per share of common stock and accompanying stock purchase warrants</a></td>
<td class="nump">$ 1.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering', window );">Issuance of common stock in connection with public offering | shares</a></td>
<td class="nump">53,333,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from public offering after deducting underwriting discount and other offering expenses | $</a></td>
<td class="nump">$ 69,916,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember', window );">2022 Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PublicOfferingLineItems', window );"><strong>Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase common stock, exercise price</a></td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock, shares | shares</a></td>
<td class="nump">18,095,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Combined public offering price per share of pre-funded warrants and accompanying stock purchase warrants</a></td>
<td class="nump">$ 1.049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember', window );">2022 Stock Purchase Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_PublicOfferingLineItems', window );"><strong>Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants to purchase common stock, exercise price</a></td>
<td class="nump">$ 1.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock, shares | shares</a></td>
<td class="nump">35,714,286<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_PublicOfferingLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_PublicOfferingLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new shares of common stock issued during the period in connection with public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=gern_TwoThousandTwentyTwoPreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=gern_TwoThousandTwentyTwoPreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187695456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - WARRANT EXERCISES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">$ 15,163<span></span>
</td>
<td class="nump">$ 2,479<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember', window );">2020 Public Offering of Common Stock and Warrants | 2020 Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock, shares</a></td>
<td class="nump">8,335,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=gern_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering | 2020 Stock Purchase Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised', window );">Warrants to purchase common stock exercised, shares</a></td>
<td class="nump">11,663,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">$ 15,163,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock, shares</a></td>
<td class="nump">44,110,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants exercised during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=gern_TwoThousandTwentyPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=gern_TwoThousandTwentyPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=gern_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=gern_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=gern_TwoThousandTwentyStockPurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=gern_TwoThousandTwentyStockPurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187651504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - SALES AGREEMENTS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 04, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_AtMarketIssuanceSalesAgreementsLineItems', window );"><strong>At Market Issuance Sales Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with at market offering, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,385,000<span></span>
</td>
<td class="nump">$ 4,075,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember', window );">2020 Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_AtMarketIssuanceSalesAgreementsLineItems', window );"><strong>At Market Issuance Sales Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_CommonStockAggregateOfferingPrice', window );">Aggregate offering price of common stock</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_MaximumCommissionRate', window );">Maximum commission rate (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with at market offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,571,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with at market offering, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,385,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_AtMarketIssuanceSalesAgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>At Market Issuance Sales Agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_AtMarketIssuanceSalesAgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_CommonStockAggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate offering price for which the entity may elect to issue and sell shares of its common stock under the sales agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_CommonStockAggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_MaximumCommissionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of maximum commission rate, based on gross proceeds of sale price per share of common stock sold through sales agent under the sales agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_MaximumCommissionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566180926784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - EQUITY PLANS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2022</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
<th class="th"><div>May 15, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,659,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value - Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total pretax intrinsic value of stock options exercised (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 787,000<span></span>
</td>
<td class="nump">$ 93,000<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from exercise of stock options (in dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,799,000<span></span>
</td>
<td class="nump">$ 556,000<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares - Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable at the end of the period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,085,389<span></span>
</td>
<td class="nump">30,459,136<span></span>
</td>
<td class="nump">25,721,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price Per Share - Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Stock options exercisable at the end of the period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.17<span></span>
</td>
<td class="nump">$ 2.35<span></span>
</td>
<td class="nump">$ 2.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_IncentiveAwardPlan2011Member', window );">2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_IncentiveAwardPlan2011Member', window );">2011 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term of stock options from date of grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_TwoThousandAndEighteenEquityIncentivePlanMember', window );">2018 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue', window );">Minimum percentage of ownership required for granting stock options at least 110% of fair market value of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock', window );">Minimum exercise price as a percentage of fair market value for employees having more than 10 % outstanding common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock', window );">Maximum expiration term of stock options granted to employees having more than 10 % outstanding common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod', window );">Common stock, increase in shares reserved for future issuance (in shares)</a></td>
<td class="nump">11,000,000<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="nump">5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_TwoThousandAndEighteenEquityIncentivePlanMember', window );">2018 Plan | First Director Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment', window );">Stock options to be granted to purchase shares upon appointment (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_TwoThousandAndEighteenEquityIncentivePlanMember', window );">2018 Plan | Subsequent Director Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares', window );">Stock options to be granted to purchase shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_TwoThousandAndEighteenEquityIncentivePlanMember', window );">2018 Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term of stock options from date of grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_DirectorsPlan2006Member', window );">2006 Directors Plan | First Director Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_DirectorsPlan2006Member', window );">2006 Directors Plan | Subsequent Director Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_DirectorsPlan2006Member', window );">2006 Directors Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term of stock options from date of grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_TwoThousandAndEighteenInducementAwardPlanMember', window );">2018 Inducement Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_DirectorsMarketValueStockPurchasePlanMember', window );">Directors Market Value Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=gern_DirectorsMarketValueStockPurchasePlanMember', window );">Directors Market Value Stock Purchase Plan | Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,962<span></span>
</td>
<td class="nump">20,783<span></span>
</td>
<td class="nump">17,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="nump">$ 1.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of restricted stock that vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award minimum exercise price of options granted to employees with more than 10 percentage of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum percentage of ownership required for granting of options at a price not less than 110 percent of the fair market value of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of options to be granted to purchase shares in each year during the optionee's service on the Board of Directors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of options to be granted to purchase shares upon appointment to Board of Directors.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum expiration term of options granted to employees having more than 10 % outstanding common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The addition or reduction in the number of reserved shares that could potentially be issued under the option plan attributable to reasons other than grants, exercises, forfeitures, and expirations during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=gern_IncentiveAwardPlan2011Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=gern_IncentiveAwardPlan2011Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=gern_TwoThousandAndEighteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=gern_TwoThousandAndEighteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=gern_FirstDirectorOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=gern_FirstDirectorOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=gern_SubsequentDirectorOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=gern_SubsequentDirectorOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=gern_DirectorsPlan2006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=gern_DirectorsPlan2006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=gern_TwoThousandAndEighteenInducementAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=gern_TwoThousandAndEighteenInducementAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=gern_DirectorsMarketValueStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=gern_DirectorsMarketValueStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187483888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward', window );"><strong>Shares Available For Grant</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Balance at the beginning of the period (in shares)</a></td>
<td class="nump">18,763,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional shares authorized (in shares)</a></td>
<td class="nump">16,755,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="num">(19,747,760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Awards granted (in shares)</a></td>
<td class="num">(15,962)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet', window );">Stock options cancelled/forfeited/expired (in shares)</a></td>
<td class="nump">2,616,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Balance at the end of the period (in shares)</a></td>
<td class="nump">18,370,729<span></span>
</td>
<td class="nump">18,763,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares - Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at the beginning of the period (in shares)</a></td>
<td class="nump">49,952,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="nump">19,747,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock options exercised (in shares)</a></td>
<td class="num">(1,181,711)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Stock options cancelled/forfeited/expired (in shares)</a></td>
<td class="num">(2,616,058)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at the end of the period (in shares)</a></td>
<td class="nump">65,902,400<span></span>
</td>
<td class="nump">49,952,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock options exercisable at the end of the period (in shares)</a></td>
<td class="nump">36,085,389<span></span>
</td>
<td class="nump">30,459,136<span></span>
</td>
<td class="nump">25,721,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Stock options fully vested and expected to vest at the end of the period (in shares)</a></td>
<td class="nump">64,539,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price Per Share - Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 2.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Stock options granted (in dollars per share)</a></td>
<td class="nump">1.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Stock options exercised (in dollars per share)</a></td>
<td class="nump">1.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Stock options cancelled/forfeited/expired (in dollars per share)</a></td>
<td class="nump">1.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at the end of the period (in dollars per share)</a></td>
<td class="nump">1.87<span></span>
</td>
<td class="nump">$ 2.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Stock options exercisable at the end of the period (in dollars per share)</a></td>
<td class="nump">2.17<span></span>
</td>
<td class="nump">$ 2.35<span></span>
</td>
<td class="nump">$ 2.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Stock options fully vested and expected to vest at the end of the period (in dollars per share)</a></td>
<td class="nump">$ 1.88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract', window );"><strong>Weight Average Remaining Contractual Life (in years) - Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at the end of the period</a></td>
<td class="text">6 years 6 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Stock options exercisable at the end of the period</a></td>
<td class="text">5 years 1 month 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Stock options fully vested and expected to vest at the end of the period</a></td>
<td class="text">6 years 6 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value - Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Balance at the end of the period (in dollars)</a></td>
<td class="nump">$ 50,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Stock options exercisable at the end of the period (in dollars)</a></td>
<td class="nump">22,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Stock options fully vested and expected to vest at the end of the period (in dollars)</a></td>
<td class="nump">$ 48,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life (In years)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Available For Grant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled or that expired during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566186884880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Parenthetical) (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding (in shares)</a></td>
<td class="nump">65,902,400<span></span>
</td>
<td class="nump">49,952,409<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=gern_PerformanceBasedStockOptionsMember', window );">Performance-Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding (in shares)</a></td>
<td class="nump">8,791,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=gern_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=gern_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187422592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - EMPLOYEE STOCK PURCHASE PLAN (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>Item </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,659,735<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan', window );">Aggregate shares issued under plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">868,236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod', window );">Common stock, increase in shares reserved for future issuance (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod', window );">Maximum duration of offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime', window );">Number of offering periods in which an employee can participate at a time | Item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod', window );">Number of consecutive purchase periods in an offering period | Item</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod', window );">Duration of the purchase period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld', window );">Maximum percentage of annual salary that can be withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percentage applied to common stock market value in calculating purchase price under purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod', window );">Duration of the new offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate number of share instruments issued under a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the duration of new offering period in a case where the fair market value of common stock on the purchase date is less than the fair market value at the beginning of the offering period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the duration of the purchase period under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum duration of the offering period under the employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of offering periods in which an employee can participate at a time in the purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum percentage of annual salary that an employee can choose to have withheld to purchase common stock under the purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the number of consecutive purchase periods in an offering period in the purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The addition or reduction in the number of reserved shares that could potentially be issued under the option plan attributable to reasons other than grants, exercises, forfeitures, and expirations during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187605264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - PERFORMANCE BASED STOCK OPTIONS (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="nump">19,747,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=gern_PerformanceBasedStockOptionsMember', window );">Performance-Based Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted (in shares)</a></td>
<td class="nump">2,741,750<span></span>
</td>
<td class="nump">550,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=gern_PerformanceBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=gern_PerformanceBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566181190240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION EXPENSE FOR EMPLOYEES AND DIRECTORS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-Based Compensation Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense included in operating expenses</a></td>
<td class="nump">$ 8,001<span></span>
</td>
<td class="nump">$ 8,080<span></span>
</td>
<td class="nump">$ 6,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-Based Compensation Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense included in operating expenses</a></td>
<td class="nump">3,720<span></span>
</td>
<td class="nump">3,597<span></span>
</td>
<td class="nump">2,337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-Based Compensation Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense included in operating expenses</a></td>
<td class="nump">$ 4,281<span></span>
</td>
<td class="nump">$ 4,483<span></span>
</td>
<td class="nump">$ 4,558<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566180813824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - PRICING MODEL ASSUMPTIONS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract', window );"><strong>Compensation cost related to unvested stock awards not yet recognized</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized, net of estimated forfeitures (in dollars)</a></td>
<td class="nump">$ 17,791,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Period for recognition of compensation cost on weighted average basis</a></td>
<td class="text">26 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions used to estimate fair value of awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility range, minimum (as a percent)</a></td>
<td class="nump">77.20%<span></span>
</td>
<td class="nump">77.50%<span></span>
</td>
<td class="nump">78.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility range, maximum (as a percent)</a></td>
<td class="nump">81.70%<span></span>
</td>
<td class="nump">78.30%<span></span>
</td>
<td class="nump">79.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate range, minimum (as a percent)</a></td>
<td class="nump">1.69%<span></span>
</td>
<td class="nump">0.51%<span></span>
</td>
<td class="nump">0.31%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate range, maximum (as a percent)</a></td>
<td class="nump">4.57%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.62%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term range</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 3 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Additional disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value of employee stock options granted (in dollars per share)</a></td>
<td class="nump">$ 0.92<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="nump">$ 0.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions used to estimate fair value of awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility range, minimum (as a percent)</a></td>
<td class="nump">61.40%<span></span>
</td>
<td class="nump">50.70%<span></span>
</td>
<td class="nump">47.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility range, maximum (as a percent)</a></td>
<td class="nump">86.50%<span></span>
</td>
<td class="nump">70.70%<span></span>
</td>
<td class="nump">81.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate range, minimum (as a percent)</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.09%<span></span>
</td>
<td class="nump">0.16%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate range, maximum (as a percent)</a></td>
<td class="nump">2.79%<span></span>
</td>
<td class="nump">0.16%<span></span>
</td>
<td class="nump">1.57%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract', window );"><strong>Additional disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value of other than employee stock options granted (in dollars per share)</a></td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Employee Stock Purchase Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions used to estimate fair value of awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term range</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Employee Stock Purchase Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions used to estimate fair value of awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term range</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">12 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566179893296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION TO SERVICE PROVIDERS (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems', window );"><strong>Stock-Based Compensation to Service Providers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock-based compensation for services by non-employees</a></td>
<td class="nump">$ 264,000<span></span>
</td>
<td class="nump">$ 91,000<span></span>
</td>
<td class="nump">$ 85,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=gern_ConsultantsMember', window );">Consultants | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems', window );"><strong>Stock-Based Compensation to Service Providers</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock-based compensation for services by non-employees</a></td>
<td class="nump">$ 235,000<span></span>
</td>
<td class="nump">$ 62,000<span></span>
</td>
<td class="nump">$ 56,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=gern_ConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=gern_ConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566188366624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - COMMON STOCK RESERVED FOR FUTURE ISSUANCE (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>STOCKHOLDERS' EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options outstanding (in shares)</a></td>
<td class="nump">65,902,400<span></span>
</td>
<td class="nump">49,952,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock options and awards available for grant (in shares)</a></td>
<td class="nump">18,370,729<span></span>
</td>
<td class="nump">18,763,393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">106,254,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">191,659,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>STOCKHOLDERS' EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance (in shares)</a></td>
<td class="nump">1,131,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566181186784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - EFFECTIVE INCOME TAX RATE (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Tax at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal benefit</a></td>
<td class="nump">6.80%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="nump">6.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Federal and state tax credits</a></td>
<td class="nump">4.90%<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted', window );">Net operating loss not benefitted</a></td>
<td class="num">(4.30%)<span></span>
</td>
<td class="num">(5.40%)<span></span>
</td>
<td class="num">(6.90%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(27.50%)<span></span>
</td>
<td class="num">(28.90%)<span></span>
</td>
<td class="num">(25.50%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax Rate reconciliation net operating loss not benefitted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187020816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - DEFERRED TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Significant components of deferred tax assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 254,500,000<span></span>
</td>
<td class="nump">$ 241,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DeferredTaxAssetsFederalAndStateCredits', window );">Federal and state tax credits</a></td>
<td class="nump">56,700,000<span></span>
</td>
<td class="nump">49,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment', window );">Capitalized research and development</a></td>
<td class="nump">21,800,000<span></span>
</td>
<td class="nump">6,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">10,800,000<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">5,600,000<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">350,700,000<span></span>
</td>
<td class="nump">312,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(349,600,000)<span></span>
</td>
<td class="num">(310,700,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets', window );">Operating leases, right-of-use assets</a></td>
<td class="num">(1,100,000)<span></span>
</td>
<td class="num">(1,300,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(1,100,000)<span></span>
</td>
<td class="num">(1,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceAbstract', window );"><strong>Valuation allowance</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance</a></td>
<td class="nump">$ 38,900,000<span></span>
</td>
<td class="nump">$ 33,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to the treatment of research and development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DeferredTaxAssetsFederalAndStateCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets federal and state credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DeferredTaxAssetsFederalAndStateCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities operating leases right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187496160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - OPERATING LOSS CARRYFORWARDS (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 993,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_OperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards, expire beginning 2023 through 2037</a></td>
<td class="nump">685,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 658,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_OperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards subject to expiration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_OperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566187716336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - TAX CREDIT CARRYFORWARDS (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 62,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="nump">$ 20,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566189991696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - CARES ACT IMPACT (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_CARESActImpactAbstract', window );"><strong>C A R E S Act Impact [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_EmployerTaxReceivable', window );">Employee retention credit, CARES Act</a></td>
<td class="nump">$ 483,000<span></span>
</td>
<td class="nump">$ 1,152,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_CARESActImpactAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>CARES act impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_CARESActImpactAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_EmployerTaxReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of employer taxes paid to tax authorities representing refunds based on calculated eligible credits. Also called employer tax refund receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_EmployerTaxReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566190039088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized tax benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits, if recognized would impact effective tax rate</a></td>
<td class="nump">$ 23,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at the beginning of the period</a></td>
<td class="nump">21,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year tax positions</a></td>
<td class="nump">2,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at the end of the period</a></td>
<td class="nump">$ 23,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566184581888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS DATA - Supplemental Investing Activities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental operating and investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Net unrealized loss on marketable securities</a></td>
<td class="num">$ (68)<span></span>
</td>
<td class="num">$ (251)<span></span>
</td>
<td class="num">$ (54)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets', window );">Reclassification between prepaid and other current assets and deposits and other assets</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease assets obtained in exchange for operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 5,154<span></span>
</td>
<td class="nump">$ 2,704<span></span>
</td>
<td class="nump">$ 388<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification between prepaid and other current assets and deposits and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140566181161952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 10, 2023</div></th>
<th class="th"><div>Mar. 09, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,163,000<span></span>
</td>
<td class="nump">$ 2,479,000<span></span>
</td>
<td class="nump">$ 16,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2023 Underwritten Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering', window );">Issuance of common stock in connection with public offering</a></td>
<td class="nump">68,007,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock, shares</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity', window );">Net proceeds from public offering after deducting underwriting discount and other offering expenses</a></td>
<td class="nump">$ 213,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2020 Purchase Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised', window );">Warrants to purchase common stock exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,935,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,716,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2022 Purchase Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised', window );">Warrants to purchase common stock exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,047,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,119,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants exercised during the period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new shares of common stock issued during the period in connection with public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>gern_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyPurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyPurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyTwoPurchaseWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=gern_TwoThousandTwentyTwoPurchaseWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>gern-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:gern="http://www.geron.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="gern-20221231.xsd" xlink:type="simple"/>
    <context id="C_7067ae1e-fdcb-4353-ba94-faa3c668d9a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_4cae8e78-c215-4912-8bd0-8a601c68ba56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gern:AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-04</startDate>
            <endDate>2020-09-04</endDate>
        </period>
    </context>
    <context id="C_0bcef938-7207-4be9-86d3-25661bdb92a4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_4c2322a1-867d-4db1-bcb9-a772d5cbd539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_eb51ffc8-633d-41e3-86c8-d3c430b99a37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c435dd46-e5e9-46ae-a67c-f00cecd6b5ca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_d8e95986-943a-430c-9308-147c97f446ca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CorporateNoteSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5a8fb967-a98b-480a-b077-c269bd33b318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_8af4ea7a-14b9-439a-947c-122628bbe8e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USTreasurySecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_2300d06c-433b-4ed1-92b5-9487bbe32374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_00475ab1-e9e1-429c-8b5f-a7102a011121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5972d6c9-9d7e-481d-990f-61c5b5a57683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:ClassActionStipulationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-02</startDate>
            <endDate>2022-09-02</endDate>
        </period>
    </context>
    <context id="C_65c0c19d-b9d5-425b-8f80-5c1480a5777f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_17094203-716a-4cd1-bfc5-d68528adcc58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2007-12-31</instant>
        </period>
    </context>
    <context id="C_81527741-3307-4f06-998a-99b34c4ab029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9a854c1d-782a-4c0f-9f77-518042e397b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyTwoStockPurchaseWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoUnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="C_baba9cae-f153-4485-a773-5ab5408054ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9ec15f2a-f73b-4dc2-aa8c-a5bb91e19d44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:IncentiveAwardPlan2011Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_40862263-7a78-4142-96a9-9c68851d893e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_4b658edd-fed5-40c3-886d-f2742643a130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c1282d3f-c653-4ad5-895b-9c6f061f0d82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7ec69a5c-401a-4250-9b22-6bf9e011ced3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_9bb1cd79-e4c2-4cca-9bd9-1694bdbca8bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_4ee2c259-7a89-4422-9ee1-25f729319635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_5fc3a521-0418-415b-ac73-ad0099a49a25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_39a6cda9-f091-4e32-8ec9-20bf358a8724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:PublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_b2e14894-763e-4f1a-963f-b97397735098">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="C_77f8406a-f6d2-4060-81b8-e54a35afa90b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d1078eed-3e6a-4e01-b62d-1ba7e0711b75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_a981f541-3690-49c7-8693-645d2e5d3905">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_07596f55-6ae2-4a67-8b3a-4ad996e8ecda">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:OptionThreeMinCashDebtCovenantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_4128807c-b8ab-4df3-874f-d7528b109faf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_119d0654-c503-470b-bd38-81fafe81f4a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_50d35c3d-da63-429d-b83a-be9fed64780e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_a5a96aa2-9ab9-4312-a1d6-6a03ed292708">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:FosterCityOfficeSpaceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-10</startDate>
            <endDate>2020-03-10</endDate>
        </period>
    </context>
    <context id="C_c3b7b4b9-7629-4b56-93a5-2b3ac17f8fa9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:PublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-27</instant>
        </period>
    </context>
    <context id="C_e324494e-e119-4b64-9797-465da2721c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyThreeUnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-10</startDate>
            <endDate>2023-01-10</endDate>
        </period>
    </context>
    <context id="C_6a7a9685-7310-4141-b7de-f1f3a5fe3099">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">gern:ConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_2a620b62-e7da-4c15-931d-242b957c2e33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsMarketValueStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_4dd4d649-9e3f-43f2-a911-a45ce22da643">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-10</instant>
        </period>
    </context>
    <context id="C_f4b65990-18fd-492e-bb4e-3100622411aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">gern:ConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_45b58f62-d075-497a-b48c-39eed3349c1e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_df267c14-3ea1-4c00-bdd8-a254e98ace01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_b3526ab0-c75e-405c-863a-c481f65b0e53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_510d1c51-dbe3-4e7b-b27f-0d63cbea1e18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:DerivativeStipulationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USTreasurySecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_e1ca1ecd-84e7-44b0-9101-90008f265fe7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:DerivativeStipulationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-21</startDate>
            <endDate>2022-12-21</endDate>
        </period>
    </context>
    <context id="C_46064b1d-9be0-4b4a-b281-d673cc14f9ce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0c264877-8e22-46f9-81fb-86523d23e816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2020-08-03</instant>
        </period>
    </context>
    <context id="C_b2a2ed0b-eacb-4d70-8bd1-ea1bfa4295ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7499ed6b-e67c-4f6e-a715-1f45f02f42a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7173b90d-0319-4205-a8c0-5d652abfb4d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-01</instant>
        </period>
    </context>
    <context id="C_de7e0e4c-33d2-4fbd-abef-d98a0ee733d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_08938cfb-9117-4cc5-bf8f-c64669b9d0c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_67437463-073a-4955-8276-418e60d06173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_c2932c3c-e846-4bca-b1d9-5fb417e16d20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a1d6bb34-0ef3-4d19-8ba5-2d252c631a2d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:FirstDirectorOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsPlan2006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_97fcaa43-bed8-4b86-a62c-6f9d8b9c790c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7721473b-e44a-495b-a88c-6dcad8f4774e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2023-03-09</instant>
        </period>
    </context>
    <context id="C_d86d7526-9741-423f-bbce-ccac767d714b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-03</endDate>
        </period>
    </context>
    <context id="C_c72685f3-ef5b-4333-a58d-7abf3242e43e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_dbfbf1d8-b44a-4e72-892f-10af9a860032">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:DerivativeStipulationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a277aece-144d-41bf-ac57-a96d6580356c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_cdf85569-9ffa-4bd1-9243-691e0be460f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_8dde9c08-9af2-47ef-968f-e8dd40116f7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_b32a587f-ad3d-4276-b2dd-b2191eb465c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_763fcb27-2540-444d-aa95-1260c6a8a319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_8a321658-2588-4571-b73d-e0f5a7ae11d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_48f80dba-88b9-464b-b378-7d4f9dec15e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_53f68612-65e0-46e6-9f29-f76b1403dad8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_edd74574-ef0b-4838-bc41-a10ed60b1539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsPlan2006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_2df5fcf2-ae81-4411-9005-55dc5786810b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_a42e573b-f7ea-45fe-a906-765e787d71d7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:OptionOneMinCashDebtCovenantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_2160f3d4-592d-437d-adaa-f0dadac52a38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-30</instant>
        </period>
    </context>
    <context id="C_a9d34b21-3b42-469c-8d2b-2b3121f04885">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_6f3c409b-23a5-42d9-b49c-56b851f33720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2df0f37c-c30d-41b8-bfdd-adc5d10dafdf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:FosterCityOfficeSpaceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-10</instant>
        </period>
    </context>
    <context id="C_a27088b6-011b-4c88-b5b1-4d7e58876f27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_4eef0fe5-3ea8-493b-b90b-931244691f4b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_6c35c921-9678-4686-aae9-1f7c867e1bf1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1dbff205-2f6f-4aba-8edf-3911a28267ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8cfe8a11-2aaf-4633-afe2-e2611965102d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_cc50e10a-98c8-4c05-bd82-9e1ea746a195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-15</instant>
        </period>
    </context>
    <context id="C_eb5e283e-aa95-4522-b670-5622af075da2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CorporateNoteSecuritiesDueInOneToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_de96a085-6c20-4cd2-b653-9124bc246e53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2021-05-12</instant>
        </period>
    </context>
    <context id="C_e0cb6378-4392-4819-891f-21cef9a108eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_49598f56-03d9-4dbd-bdcf-22537e7a9cdc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_cb27a432-0c32-4ac0-85da-f75446291e71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:OptionTwoMinCashDebtCovenantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_51f08322-078d-49e5-a68a-9be92cd9298d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2007-12-31</instant>
        </period>
    </context>
    <context id="C_648decac-61a1-4e4b-9ed3-d82a76be83ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b0bbca5f-033b-4845-9d80-bbded572734a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CorporateNoteSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4179612c-6be5-467d-9224-83de62d460cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_d81bd636-0218-4286-b8c2-3cccfc33f5fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_61a9529a-15e0-492a-891c-e7c1701d7744">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_3ddd7b62-3be3-4f53-81bf-05b1841c6fb1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_cd9ae385-7003-4516-b937-03283c53b8c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_bef8e8ac-62e3-46f1-91db-450c61420e02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5c61e68e-3e69-41cb-8620-6254f8ecadab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_6c5c907c-4ae9-4b51-a14d-03a3b5e1c929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsMarketValueStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9d9caad1-b187-4705-af84-3d4912060cb5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:MunicipalSecuritiesDueInOneToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_133df937-8209-4564-b4d5-073c7409a5c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsMarketValueStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="C_9c4a1e4a-ddee-40c4-b8df-5752dec9177f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_ccde2552-23ce-42cd-8f03-8868e1c3afee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:USTreasurySecuritiesDueInOneToTwoYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e7b46167-4167-4419-ac2b-387a17bd683b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenInducementAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_15ca08dc-811e-4853-9a21-7cadf99c377c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_cdb043ed-5bb6-48a5-9edc-3b464d5cb5cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="C_7763dbfa-0c47-4691-b0c0-db932124a4fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_a9eac63f-ff18-4e30-bd6c-4d89efb022b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_368cb29f-d2a8-456f-a097-df828e4c375b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_a6f63570-90af-4655-9959-2d2b2d53203e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_20457731-c8fd-4ab5-9a21-4c427a763c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:FosterCityOfficeSpaceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0d35dd6e-fea6-436e-9ee7-9ee08382b573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="C_fb131e02-2952-4669-a8d3-c6f166ff823e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoPurchaseWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-09</endDate>
        </period>
    </context>
    <context id="C_964ca538-6017-4a3b-b8a2-c9d92e9678f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_54fac2af-1b06-465c-8688-a1f93e1c62db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoPurchaseWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-09</instant>
        </period>
    </context>
    <context id="C_c5ddc099-a29b-4862-ab9f-bc6cd0c2eeb4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20b70013-d0fe-4f60-92b2-60c28f12e1f9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyStockPurchaseWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_904fa704-ef5e-41de-bcb5-2bf7706d0288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1bd32fc3-5385-4fc1-8876-a5ae5a63137b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_626b835f-8e2e-4400-9c68-0c1fa598c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_09482968-6804-42ef-b55a-7e47a1585b7a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:SubsequentDirectorOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_36ec7de2-c549-426b-84af-98fe5ccaae70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_1e9362c9-abee-4e6e-9b1f-44d66edd6913">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2007-12-31</instant>
        </period>
    </context>
    <context id="C_aecbaf53-81e4-4762-8e18-b6fdfe03ee7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-01</endDate>
        </period>
    </context>
    <context id="C_7edff532-41dd-4915-82d0-0b9e814e4cc5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_c9710e3f-58c2-40a2-971c-f2229ca8bfa7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-10-01</endDate>
        </period>
    </context>
    <context id="C_e89875f1-6be5-42d0-a126-eaeafb581f48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:PublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c1b00895-a644-46d2-a56f-b109682d7aff">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_9a7438fe-fa93-48c8-875b-77ecf443a7b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_47db9b05-7d9e-4426-bef0-d9bcedf945c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_73738e9e-def3-4ee6-be15-64304b5e3b63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9097bf2a-3ae2-4f30-af86-bb131d89eb94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:SiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-10</instant>
        </period>
    </context>
    <context id="C_638535ad-bd14-404f-b802-160cfe13fd2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_55d50b28-7933-42d2-89ca-ec42b87d67cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_1d4e0718-b0bc-4bde-abe3-dd33013adfd1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="C_bb6bcd2c-ccc9-458c-9e1a-1799ed2c561e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_6dfbe752-26a8-4b61-804f-713c8b76e3b2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_04fded04-be5d-4eb8-81d5-fec058c4ac52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gern:AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_603a7d01-dfd6-49d7-a945-469443432a26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">gern:ConsultantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_82638e68-0f41-4c08-bac3-823ad702cd9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_acfe2948-7468-4c15-a637-904a59f62dc4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:ClassActionStipulationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_edb3e230-dfab-42f5-babc-05523982f83c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_8e72c6e8-4130-431a-9367-bbc923943f0f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_944921c7-37fd-48a6-87d7-c57fd7ba68ce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_cedb5760-788e-4697-a91b-595a15fe918f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryNotesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_a85bc201-e73d-4e53-910e-2be441096a11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyOfficeSpaceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-30</startDate>
            <endDate>2019-04-30</endDate>
        </period>
    </context>
    <context id="C_00c2bd33-0379-417c-a384-344e1e28579a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:PerformanceBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_57eb8407-20bb-4fe8-b65e-a963754a7c2b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoUnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="C_a5f6ada7-da6a-4619-8ac7-5fa8e6c89e2d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b8581e38-a6e8-4457-9acf-b0368e005111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyStockPurchaseWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8265167c-6a10-47c2-8235-d350b2140d50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_60c0161f-8996-404d-9368-ce41e9ce095e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_a42ef773-e97a-473e-b41a-016b95e3980a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CommercialPaperDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_50b6ef82-13c8-416b-8944-219722e7b07e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_fd3dace5-dba8-440f-ae0b-9ef36f749a0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:FirstDirectorOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_51e2839a-be67-48c5-84d2-a44bd56bb75e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_193c3b80-125b-49fe-affd-e5219ad32f26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_1bf14810-4b41-4fda-8ccf-f5f7c92e07e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="C_9985ac27-b487-43dc-84e4-99f5eb3e2ee4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_50af7db3-82da-48d8-bf5d-ca3bb07f1a6d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyPurchaseWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-09</endDate>
        </period>
    </context>
    <context id="C_1acf8b0f-f8d1-4664-927d-c462800c5922">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyPurchaseWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-09</instant>
        </period>
    </context>
    <context id="C_c1671901-1570-4d9b-ac8b-2fea04dc608d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_7912cfc0-c229-4fc9-8043-9b98680b2a7e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:IncentiveAwardPlan2011Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a3cf8441-940c-4769-a1c9-ba37e4bc2812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:PublicOfferingOfCommonStockAndWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="C_e1b24643-c361-410f-bc44-b8aaa587644d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_80155c28-6ebb-4859-b15c-960beb5fc480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_8188c97d-d82a-44e3-b0a5-e6f672e559c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2a6d46ff-973f-470e-82a2-82e94b643f46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-31</endDate>
        </period>
    </context>
    <context id="C_efcc9f37-8c8e-44d9-845b-1357eb47cb94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="C_876ba767-8660-41ef-8db0-cd6ad696ef32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateNoteSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:NewJerseyLeaseAndFosterCityLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_dbeb080e-402b-4949-8760-3551ff83fae6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4ee8d9b9-dc68-4df6-9be2-6f4529782e09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">gern:AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_54a3bd1a-57e5-404b-8439-d921de6bd8fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1254ade3-fe72-434a-a6db-19a268f35273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_51546caa-efa4-41ff-89e0-38e80356cf4c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_ae8e381a-0b3e-4435-957f-00dcf58c3b45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_ceb4ddb1-f869-4bd6-84c2-9da20049ed84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_4ff1bc89-e218-42c3-bcc6-62cce404dde7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:ClassActionStipulationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_dd0bdc01-735d-4224-95b4-e75ddebf918f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">gern:TwoThousandTwentyTwoPreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoUnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="C_a7e69a6d-c732-438a-9a6d-1aab2a5533f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7cb51813-f174-40c0-8540-44661459217d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyTwoUnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="C_3d47e697-4d40-47ed-be0f-6e5c7c2ad573">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:OptionTwoMinCashDebtCovenantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_7b1c8d57-8ddb-43ec-96da-0180f39ff551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_80164d16-83fd-44b2-b84d-550276c31ca8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:CommercialPaperDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_c25e7348-7048-4607-8352-1048d40e8f79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">gern:MunicipalSecuritiesDueInLessThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_2fbdf3b1-b70e-4491-98dc-8a732e4ad69a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_549c9ca4-a070-4d8b-8dea-097cccf0168e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4f5a5bab-8021-4724-80ff-5ed5222dffe6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ad743706-922f-45c0-83cd-2d0300569661">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">gern:DerivativeStipulationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:InsuranceClaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-21</instant>
        </period>
    </context>
    <context id="C_f076ddd2-9af8-4327-95c6-3a61cf5015db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_ff678df4-6021-4567-a09d-3093fe7f6409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:FirstDirectorOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_b205ee9d-75ed-48cf-b5e9-efc423b1fd1d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">gern:SubsequentDirectorOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsPlan2006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_7d2260f7-9b52-4e12-9966-22d0182d746c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:DirectorsMarketValueStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c12dd335-911a-4fd2-9a2d-0514622f97e4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_76e00114-46f1-4f21-825f-b517b415c860">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">gern:TrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-30</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="C_0dfd4851-82fe-4cb9-8ea1-8e34b2a9c816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8f1b3c92-0ecb-4923-9ca5-2be4cf72dc09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">gern:TwoThousandAndEighteenInducementAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="C_0ec8418b-4210-4aed-a7a0-402e2cb1fc9b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">gern:TwoThousandTwentyThreeUnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-10</instant>
        </period>
    </context>
    <context id="C_1ac565cd-3589-476a-8008-a137d294bc33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_88b14be1-08cb-441b-9cd9-8b8e631765f9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">gern:HerculesAndSiliconValleyBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">gern:SecondAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-10</instant>
        </period>
    </context>
    <context id="C_affcd469-d055-47cc-bca1-8f79424c3ea3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_ee96da23-ae41-4e87-8c4d-c559a324f7a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
        </entity>
        <period>
            <instant>2021-05-11</instant>
        </period>
    </context>
    <context id="C_0b8de677-089a-4241-b514-5dc0cbded8a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_3fa5ac2d-7b0a-4dc7-b48d-d537f56e2330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_4183e218-4909-4bf2-b115-abdea99d97df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d2345eb5-3285-459c-8d09-b6264509d71b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_537e337a-f742-4d0a-a5b6-5cf335eb225f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">gern:FosterCityOfficeSpaceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="C_771ba2f2-3a2e-49fa-95cf-19050fec9326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886744</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="U_Item">
        <measure>gern:Item</measure>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_Institution">
        <measure>gern:Institution</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_484f1f7c-80da-4a5f-a649-6ee82880af52">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_52f00f46-0bfb-40c9-82a1-760c37619fda">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_2979800c-ed6f-41d1-96e0-3d396f1f479c">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_9bf61295-c017-4436-ab49-b8f01772ba7d">0000886744</dei:EntityCentralIndexKey>
    <us-gaap:DebtCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      id="F_bfd71529-05f4-48f8-877b-c43d276239bd"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      id="F_6f65910a-85b0-43bb-9607-4708c982ad15"
      unitRef="U_USD"
      xsi:nil="true"/>
    <gern:LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan
      contextRef="C_8af4ea7a-14b9-439a-947c-122628bbe8e3"
      id="F_a1a45976-6577-45f6-bd62-311e76651aed">P3M</gern:LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      id="F_3aabcce5-1c7c-451e-b4c2-7b744fe20a51"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      id="F_92ef33b6-8618-4974-b348-ee7b47f16ded"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      id="F_fac1e377-c483-4a1a-9d83-c9d6e9abca35"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_f2aa927c-4f78-4c01-a1e1-d87e8f202cae">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_69bf5653-4a82-4354-9371-214de132bbef">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_734a0184-8b33-4634-ba09-f50c5138d347">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_64b5deea-ce57-479e-8f34-137d998c326a">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_2fe185cd-c261-4251-b86a-61a3a71e9397">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_690e2fd5-6bb6-4098-8348-6c8702a25138">000-20859</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_93c1fae8-f8b9-403e-a801-d224f2ab5808">GERON CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_130335de-1e36-42f7-bbdc-a03246363f82">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_6ca44e7d-60f6-4e57-9c49-99eed9b1b540">75-2287752</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_6853e19d-df88-40ee-bb60-46e418a91243">919 East Hillsdale Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_30319888-c475-4d37-ba6a-dec7ab02cd54">Suite 250</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_9adea57a-741f-4ce2-bcce-b47c3e6217b2">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_37e451d2-16f9-416e-908b-dd8f548a9b9d">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_5ec00ccb-2b3b-4e0e-8dab-8b088fd572ac">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_4d4409bc-b038-43df-882d-08708b936449">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_7f1e49d5-46c5-4806-ba4e-83b2023017a4">473-7700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_eede46c0-e876-4dd0-afac-cd858c2f51d7">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_8b4643d3-a520-40a8-83cd-82036c390abf">GERN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_837d9c06-bc18-404a-89de-06fb7367149e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_d6163a24-427d-40dd-a3f6-8e7d58914f21">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_254d8a3e-2b1a-4724-b44b-61af554c3ca3">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_c19a3a4b-3412-47fe-ba07-6699eaf0cb39">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_5c0f82af-9dc1-432a-bd11-4d0d6b526168">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_596210b6-f042-4005-90b1-f78a2a307282">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_3bfb09b6-dc37-46cb-91a2-ce18ffbe2b8a">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_fe80016e-d66b-4b77-8418-1c7b67fd05d8">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_eb667325-5ce5-477a-81e5-48bb6b3a243b">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_e7776162-35b3-4bc4-a76a-8241abc57b60">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_36ec7de2-c549-426b-84af-98fe5ccaae70"
      decimals="0"
      id="F_82c7d575-0adc-4c81-b97f-e0c5a96a65b5"
      unitRef="U_USD">503187000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_7721473b-e44a-495b-a88c-6dcad8f4774e"
      decimals="INF"
      id="F_152675b8-fe8e-4025-81b9-5a18be3024ef"
      unitRef="U_shares">508722486</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_f4274a34-0498-49ec-9027-7b190793664a">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;DOCUMENTS INCORPORATED BY REFERENCE:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:2.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
     &lt;tr style="visibility:collapse;"&gt;
      &lt;td style="width:90.0%;"/&gt;
      &lt;td style="width:1.0%;"/&gt;
      &lt;td style="width:9.0%;"/&gt;
     &lt;/tr&gt;
     &lt;tr style="height:7.0pt;"&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Document&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:1.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Form 10&#x2011;K&lt;br/&gt;Parts&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
     &lt;/tr&gt;
     &lt;tr style="height:8.0pt;"&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Portions of the Registrant&#x2019;s definitive proxy statement for the 2023 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days of the Registrant&#x2019;s fiscal year ended December 31, 2022.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;III&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
     &lt;/tr&gt;
    &lt;/table&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_73160013-6f74-4557-ba53-d4f4cdacb8a5">42</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_0f45602c-287f-4002-99f4-42a3218cddd7">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_1c746ef1-da76-4f9e-b585-37771e94678c">San Jose, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_6a4e7752-58f9-4213-81a4-1fcd1cb3d748"
      unitRef="U_USD">56845000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_b3089e38-cd3d-479f-996e-d4c6ab468b43"
      unitRef="U_USD">34871000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_672f70c7-7ed6-4ab0-958f-a6eb016efd81"
      unitRef="U_USD">364000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_0bf7f884-3690-4052-bd35-a686e51670a1"
      unitRef="U_USD">364000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_43be23eb-ae0d-4971-8d7c-f8b8b7139a41"
      unitRef="U_USD">115901000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_ce4fa24e-fabf-4224-b18b-a2db3346a7f3"
      unitRef="U_USD">148851000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_6ec8210f-ac0b-4a89-804a-bada57f9e6c6"
      unitRef="U_USD">3144000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_c22585f1-327c-4c12-ba41-4b13157a7039"
      unitRef="U_USD">1763000</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_81f301c3-c402-45da-ab3a-e8e909aed91b"
      unitRef="U_USD">3992000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_bc69a405-c759-4f80-9123-8279bb6399e3"
      unitRef="U_USD">1357000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_cb7dd2e4-e243-4c31-871c-f1278fa06322"
      unitRef="U_USD">180246000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_c78b130e-2633-426d-95ca-0631dc3fce17"
      unitRef="U_USD">187206000</us-gaap:AssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_7d244d34-ef87-499a-a51e-9ccda04876a0"
      unitRef="U_USD">28651000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_69d161ec-39de-48c5-a883-0ce837b5c8b5"
      unitRef="U_USD">793000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_e9384700-f7bd-4aba-a76b-b4b4da3f2a1f"
      unitRef="U_USD">650000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_b2ded67e-0435-42ba-8faa-c811ca2581b0"
      unitRef="U_USD">4147000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_97b09004-4302-450b-9545-1a7f8b25478f"
      unitRef="U_USD">4727000</us-gaap:OperatingLeaseRightOfUseAsset>
    <gern:DepositsAndOtherAssetsNoncurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_3f89c538-8934-4caf-8fb7-f43d2ad15925"
      unitRef="U_USD">5389000</gern:DepositsAndOtherAssetsNoncurrent>
    <gern:DepositsAndOtherAssetsNoncurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_66bc76bb-f5a2-4d39-bbf2-f08e2685fd85"
      unitRef="U_USD">4800000</gern:DepositsAndOtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_77151c3b-4c66-41bd-a867-3a5b436041fa"
      unitRef="U_USD">190575000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_6cb685b4-89c5-43ec-986c-0916e51ff3bf"
      unitRef="U_USD">226034000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_8cc71ad3-a398-422b-bde3-3cb6ac70ac7c"
      unitRef="U_USD">10190000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_0e7c9bdd-1119-4e65-859b-885fe28cbeab"
      unitRef="U_USD">6687000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_d5dca84e-3e36-4a95-b266-6c9ca97a0aeb"
      unitRef="U_USD">11534000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_437efe52-1ce9-4872-98ab-67c4ac0c2e3c"
      unitRef="U_USD">8099000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_afe7cf7b-62a8-4a73-9a68-97896ee4beaf"
      unitRef="U_USD">925000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_2f4be026-89c6-4e7e-8e4c-cb8d8d3e5200"
      unitRef="U_USD">901000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DebtCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_0e4035de-7bb5-479f-b341-dbb2f2849c54"
      unitRef="U_USD">20945000</us-gaap:DebtCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_3232b013-5673-4fbd-99ed-2b53641fc358"
      unitRef="U_USD">33100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_74e5c0ed-edb9-4705-a1ae-c4941865f587"
      unitRef="U_USD">29834000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_d0c08085-3cf6-4473-9f02-f47c4fdb6f1f"
      unitRef="U_USD">76694000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_19aa9f41-2e2e-4e4f-a1c4-af652a678f8f"
      unitRef="U_USD">45521000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_5eee7547-9d39-4393-8e59-468a71ae06ab"
      unitRef="U_USD">3671000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_0ef17723-c369-43a4-a1df-0224ad45c257"
      unitRef="U_USD">4267000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_94148843-3bd4-45b3-8166-320885b5149e"
      unitRef="U_USD">30212000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_7e370b91-f490-4701-9b05-f0ca699b355e"
      unitRef="U_USD">49830000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_a46a1d75-a9fa-47ac-9a20-22b2912f2c5b"
      unitRef="U_USD">110577000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_d0943329-6c1e-4d51-ac4b-b02eb6f6bc18"
      unitRef="U_USD">99618000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_9900e465-02ed-4ff1-81f8-7f0549b9e145"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_b7e9b7b5-670d-4c66-9ba4-531e9f8e3de6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_f730a31e-f976-4181-9534-7c0627c79fce"
      unitRef="U_shares">3000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_86e428b3-872c-4d4c-beb3-39830969033b"
      unitRef="U_shares">3000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_869426ba-6dcd-4c9a-8134-2dcce4aff2c1"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_a91e2273-52c2-4795-8c99-17440e52a01e"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_c25f62ad-4d28-4ed3-91db-3a6ae7ff1029"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_f4f8cce6-490f-40ac-bd5b-9c69457ddde7"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_b59fe16d-6ca2-4407-be81-9fd475269724"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_d7bb2b29-4be6-405b-a379-2ce41f92f5c5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_7d8cfa84-5935-4fac-8cf7-c26d1356a5e4"
      unitRef="U_shares">675000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_5875c55e-37c2-4d9e-9f45-49a40167e046"
      unitRef="U_shares">675000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_a907270a-3c79-4750-ba69-ba287ca923ba"
      unitRef="U_shares">390262524</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_844715c6-c644-477b-af5d-45080b6cbab1"
      unitRef="U_shares">390262524</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_1ed973b4-ac0d-40d1-bdb5-54203baaf0a3"
      unitRef="U_shares">323731591</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_01d09bd7-a91e-40e2-b7e6-437accd81e96"
      unitRef="U_shares">323731591</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_be6f50b7-32d7-438e-96d0-ae25292a9e94"
      unitRef="U_USD">390000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_0fd7ed36-4c0a-4a31-8589-e80e6f8d1ccb"
      unitRef="U_USD">324000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_c32b25fe-388d-40c1-ad66-efd49182869f"
      unitRef="U_USD">1493469000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_e1942698-5fd3-48b1-a65e-d5ab68085e6c"
      unitRef="U_USD">1398006000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_6405a894-1434-4473-bdac-3bf40420bd2a"
      unitRef="U_USD">-1413642000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_c773b24a-cb70-439f-a851-0cfdf9166bf9"
      unitRef="U_USD">-1271741000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_f3f8fd81-f81e-42de-9a64-897ecd8fd8ba"
      unitRef="U_USD">-219000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_ad839b1c-506f-4cf9-930c-c46a80c8f58d"
      unitRef="U_USD">-173000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_315a8036-6d2b-47ee-a969-955ba735d782"
      unitRef="U_USD">79998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_a62186c3-ecd9-48ba-9822-43ca12e7b41d"
      unitRef="U_USD">126416000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_f0366b66-aae4-4a30-92a1-26d645a85e44"
      unitRef="U_USD">190575000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_2fc2d719-e5c3-4137-937c-3100411b195b"
      unitRef="U_USD">226034000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_af030d1f-fcee-4113-b041-d252a3081e26"
      unitRef="U_USD">596000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_8ae7db40-db22-491d-a6f3-cb0a6912e781"
      unitRef="U_USD">1393000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_35676ee6-9f06-4d92-adf7-62909acc23ef"
      unitRef="U_USD">253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_554ab0e2-c028-4e40-803b-c7f091428859"
      unitRef="U_USD">95518000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_26cb0ea0-13e5-40cf-96f4-5672fcd09c92"
      unitRef="U_USD">85727000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_c57dc5c3-6cef-4416-91ed-24d863c7a30f"
      unitRef="U_USD">51488000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_6273a42d-bc2e-4595-b41a-cbdcc3c991db"
      unitRef="U_USD">43628000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_aeaae356-c4c4-4add-b018-e11ab23ccc75"
      unitRef="U_USD">29665000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_c5a245dd-25ca-43ba-94de-15759605721b"
      unitRef="U_USD">25678000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_cf34ca36-7dbc-4d14-b87a-cf8dbadfceaf"
      unitRef="U_USD">139146000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_dc956681-347a-4f71-9d7d-548b0e18e8cf"
      unitRef="U_USD">115392000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_777f1447-0a08-4b85-844e-8a83dd9c589d"
      unitRef="U_USD">77166000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_19c876f8-9af7-4d5c-b3ea-dd3d503caecc"
      unitRef="U_USD">-138550000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_b3ccf320-aeb5-4234-b7a9-49c3870d3ce8"
      unitRef="U_USD">-113999000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_3d28a6a4-e25b-4c48-8c2a-e4fcfa706e21"
      unitRef="U_USD">-76913000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_9a131b6b-fa8f-4fb6-b55a-6f7613a20632"
      unitRef="U_USD">2529000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_3c582a40-03c8-4406-9608-45b63333b0b4"
      unitRef="U_USD">527000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_fc2c065b-f484-486c-8a8b-27cfe39a38f1"
      unitRef="U_USD">1828000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_0f99228b-d54d-4c11-9008-6fb6ffa0f49e"
      unitRef="U_USD">6882000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_43bfccde-999f-496c-8391-216f57cd8f13"
      unitRef="U_USD">3740000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_ee990f6c-17f9-4145-b570-16cc4f0ee05f"
      unitRef="U_USD">760000</us-gaap:InterestExpense>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_bd69d3cc-36af-46bf-bdab-56155c7694c5"
      unitRef="U_USD">60000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_8399c80b-8ff7-48e7-a130-802008327592"
      unitRef="U_USD">1002000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_48837b9c-0ebd-45f2-b94f-ad99ce7e5d1f"
      unitRef="U_USD">1100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_a9e7a449-78fc-4a2e-bf88-32405d5cbd85"
      unitRef="U_USD">168000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_e9ab3479-b48c-4885-bc6c-281dde70ca03"
      unitRef="U_USD">-141901000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_d65d64f8-ce7e-416a-91aa-67e3d8610661"
      unitRef="U_USD">-116112000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_d131cb29-9ded-4884-bc6b-30f5aaff57e0"
      unitRef="U_USD">-75617000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="2"
      id="F_7cbea338-1d8c-4549-a5b7-40302163af60"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="2"
      id="F_b3ac7dc4-846a-4676-afce-908d81be232d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="2"
      id="F_7229ce44-c80d-46a7-a7b6-9a1d2cf4e249"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="2"
      id="F_90d641fc-bb1e-45a4-8971-8139f0c23d85"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="2"
      id="F_f9574b19-3a8c-4850-9d7a-9500cbffdd5e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.28</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="2"
      id="F_b69b658f-5620-4c79-9b61-4ee16e8323c6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.28</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="0"
      id="F_de147963-b9a8-4186-b51c-15a8888da1c0"
      unitRef="U_shares">380784846</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="0"
      id="F_0c2cd245-eb3f-48d3-8822-ba8d1ba21e04"
      unitRef="U_shares">380784846</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="0"
      id="F_285c23d9-4c88-4316-8c9f-34c588ea23d7"
      unitRef="U_shares">327631814</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="0"
      id="F_e195a5c2-2973-48bc-8217-a4b68f71f735"
      unitRef="U_shares">327631814</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="0"
      id="F_76c220cd-0a6d-4a6e-be48-78ea39422e2d"
      unitRef="U_shares">271460265</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="0"
      id="F_dddce6d6-6ac8-4e2e-9e03-ab1acb7d7519"
      unitRef="U_shares">271460265</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_6056d41a-bded-42f2-83bb-9a814e8f5558"
      unitRef="U_USD">-141901000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_d48641ab-97d5-41bb-bd9b-813055ec5edd"
      unitRef="U_USD">-116112000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_02f05444-d7ba-422a-b309-5ba9ab53631d"
      unitRef="U_USD">-75617000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_5d3c5339-9a61-4afa-9b3e-c024d2f40325"
      unitRef="U_USD">-68000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_d348fff8-0da2-4b69-b9cc-f7a8e392c76c"
      unitRef="U_USD">-251000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_d8b4e255-431b-408a-b33d-2a65bb490f2e"
      unitRef="U_USD">-54000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_35a08788-3273-4a30-9766-a1d18a1601b2"
      unitRef="U_USD">22000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_a29be249-70ea-4a7a-a87d-4524f0e63d74"
      unitRef="U_USD">-141947000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_bfaa974c-fc9d-4ea5-8368-b22841cf6a1c"
      unitRef="U_USD">-116363000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_10f1a73e-f149-46da-9b86-76f3ba48f20c"
      unitRef="U_USD">-75671000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_193c3b80-125b-49fe-affd-e5219ad32f26"
      decimals="INF"
      id="F_05838b4b-3737-47bc-80d9-d7ded659261b"
      unitRef="U_shares">199814581</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_193c3b80-125b-49fe-affd-e5219ad32f26"
      decimals="-3"
      id="F_06f436ad-4f0c-4b1d-9de3-4884a7204ad0"
      unitRef="U_USD">200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9bb1cd79-e4c2-4cca-9bd9-1694bdbca8bd"
      decimals="-3"
      id="F_92231a29-dcfa-45d2-8fee-459c6c02ab34"
      unitRef="U_USD">1214835000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_4128807c-b8ab-4df3-874f-d7528b109faf"
      decimals="-3"
      id="F_aab6ef5c-30b1-45ad-84ce-5988e0035ef6"
      unitRef="U_USD">-1080012000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_ae8e381a-0b3e-4435-957f-00dcf58c3b45"
      decimals="-3"
      id="F_830378ba-4958-44af-9680-af2db0a09862"
      unitRef="U_USD">132000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_51546caa-efa4-41ff-89e0-38e80356cf4c"
      decimals="-3"
      id="F_a7ebe6ce-04d2-4e16-ab28-ceac51285e63"
      unitRef="U_USD">135155000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_763fcb27-2540-444d-aa95-1260c6a8a319"
      decimals="-3"
      id="F_90cf9aa0-9732-4fea-b457-a5257df835a4"
      unitRef="U_USD">-75617000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_d9b3ed2d-9499-4d3a-83b4-14f5f8b82c8d"
      unitRef="U_USD">-75617000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_df267c14-3ea1-4c00-bdd8-a254e98ace01"
      decimals="-3"
      id="F_7aabbad5-65a5-41ca-8621-b1775d31e737"
      unitRef="U_USD">-54000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_59c137da-304f-4728-a214-2aea92cc33aa"
      unitRef="U_USD">-54000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_39a6cda9-f091-4e32-8ec9-20bf358a8724"
      decimals="-3"
      id="F_39994dd6-056c-4dcc-87c9-824a2568b3b0"
      unitRef="U_USD">9808000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <gern:PublicOfferingStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480"
      decimals="INF"
      id="F_8811c34a-8110-48f0-9885-8b61fbff3c34"
      unitRef="U_shares">107049375</gern:PublicOfferingStockIssuedDuringPeriodSharesNewIssues>
    <gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues
      contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480"
      decimals="-3"
      id="F_f4111d7b-e0d7-4dcd-b224-a325976e8e72"
      unitRef="U_USD">107000</gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues>
    <gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues
      contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b"
      decimals="-3"
      id="F_66c93545-68f0-460b-979c-a84cac887b5a"
      unitRef="U_USD">140077000</gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues>
    <gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_57264c80-e940-4949-be71-98c29d3bbfcf"
      unitRef="U_USD">140184000</gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_e0cb6378-4392-4819-891f-21cef9a108eb"
      decimals="-3"
      id="F_a974305a-7a4b-43b6-9069-a0f9137befb5"
      unitRef="U_USD">144000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480"
      decimals="INF"
      id="F_be3b20d7-88aa-49f9-917e-ff2d410d4030"
      unitRef="U_shares">3496616</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480"
      decimals="-3"
      id="F_02b40011-1708-48c7-968a-884db4656d03"
      unitRef="U_USD">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b"
      decimals="-3"
      id="F_c10f8e56-e9cf-4ba7-916c-aac2649674dd"
      unitRef="U_USD">4072000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_3e3a0ad2-bd2f-453c-a8da-f0e5ad5b0bfe"
      unitRef="U_USD">4075000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseShares
      contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480"
      decimals="INF"
      id="F_32aebbcf-32ae-495c-af41-ee47c7f45732"
      unitRef="U_shares">12500</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseShares>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue
      contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b"
      decimals="-3"
      id="F_06001011-3eee-4a12-9799-95d97a8a277d"
      unitRef="U_USD">16000</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_c2202dea-a193-43fb-942e-cbbfa6b6c652"
      unitRef="U_USD">16000</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480"
      decimals="INF"
      id="F_978f4579-c376-494e-9200-3ff00fb58475"
      unitRef="U_shares">17986</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b"
      decimals="-3"
      id="F_722b9700-4a31-45de-8c21-a9a2172e6eba"
      unitRef="U_USD">85000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_c54edd4a-e6fa-477b-a037-a6c79c827a9a"
      unitRef="U_USD">85000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_80155c28-6ebb-4859-b15c-960beb5fc480"
      decimals="INF"
      id="F_8a3030b8-a0c7-4fd8-bbd9-46fef82a65eb"
      unitRef="U_shares">175795</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b"
      decimals="-3"
      id="F_20eb2ed7-fdb3-4034-8aed-a1e3ddfe72fe"
      unitRef="U_USD">208000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_adf48940-9ad5-4ced-a42b-10c10e3a4a73"
      unitRef="U_USD">208000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_368cb29f-d2a8-456f-a097-df828e4c375b"
      decimals="-3"
      id="F_5a9c321c-ae10-4a7e-8a1a-20891f43dcb0"
      unitRef="U_USD">6895000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_cd66b4b6-b3a4-4424-a444-f7eca2b3ada9"
      unitRef="U_USD">6895000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_c12dd335-911a-4fd2-9a2d-0514622f97e4"
      decimals="INF"
      id="F_cdf2b3c6-bd79-471d-8265-47562b7d4f35"
      unitRef="U_shares">310566853</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_c12dd335-911a-4fd2-9a2d-0514622f97e4"
      decimals="-3"
      id="F_e213e19c-a3da-418e-af2c-f3e0406d8066"
      unitRef="U_USD">310000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_40862263-7a78-4142-96a9-9c68851d893e"
      decimals="-3"
      id="F_4853d264-b478-4bdd-957e-3b14c8fadc3f"
      unitRef="U_USD">1366188000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a9d34b21-3b42-469c-8d2b-2b3121f04885"
      decimals="-3"
      id="F_e59eda13-1588-42d0-b31e-c18adf387222"
      unitRef="U_USD">-1155629000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_8a321658-2588-4571-b73d-e0f5a7ae11d0"
      decimals="-3"
      id="F_d2c00759-b7b1-4283-a941-b8333db6e742"
      unitRef="U_USD">78000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a"
      decimals="-3"
      id="F_ae2fc0fb-464d-4239-a9d3-2da09c942430"
      unitRef="U_USD">210947000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_b3526ab0-c75e-405c-863a-c481f65b0e53"
      decimals="-3"
      id="F_00c883f3-8988-48b4-9080-74b2a8be1f8b"
      unitRef="U_USD">-116112000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_862ed909-0807-428c-a383-bcfc68f828bd"
      unitRef="U_USD">-116112000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_4179612c-6be5-467d-9224-83de62d460cc"
      decimals="-3"
      id="F_eeb7f005-5b72-436d-962f-e0de82951d24"
      unitRef="U_USD">-251000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_d402b0a9-f5e7-430d-9e2b-57422a5748cf"
      unitRef="U_USD">-251000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_edb3e230-dfab-42f5-babc-05523982f83c"
      decimals="-3"
      id="F_1ed617b0-f8bd-4893-8f04-123a93ff7e2f"
      unitRef="U_USD">470000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e"
      decimals="INF"
      id="F_1e8965c2-790f-4864-8348-d540154171c2"
      unitRef="U_shares">10571556</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e"
      decimals="-3"
      id="F_2205c81d-d5b1-4ba5-ad43-f8a696de7a4f"
      unitRef="U_USD">11000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e"
      decimals="-3"
      id="F_51d63600-b968-4798-b9e3-9dea06ef403a"
      unitRef="U_USD">20374000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_7f95e69c-3f83-4167-99ee-29dee3531077"
      unitRef="U_USD">20385000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseShares
      contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e"
      decimals="INF"
      id="F_7a3013c9-483b-44f8-bfec-413b86b44347"
      unitRef="U_shares">1906341</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseShares>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue
      contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e"
      decimals="-3"
      id="F_87bfc9cb-20e9-4bf3-be5e-966ce043bc53"
      unitRef="U_USD">2000</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue
      contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e"
      decimals="-3"
      id="F_3921435b-629f-4cf3-b6ba-594c560d7269"
      unitRef="U_USD">2477000</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_9726fb4e-f586-4c3d-92c4-5214c2bb5229"
      unitRef="U_USD">2479000</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e"
      decimals="INF"
      id="F_8b6c68d1-d258-4940-9b8d-ca3c85a30d27"
      unitRef="U_shares">20783</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e"
      decimals="-3"
      id="F_5ad9a52c-0826-48b7-933e-c54eb811bc30"
      unitRef="U_USD">91000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_c8505175-3be4-46b5-a7cc-281fe169c063"
      unitRef="U_USD">91000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e"
      decimals="INF"
      id="F_20c106e3-467a-4291-b0b1-119632a61797"
      unitRef="U_shares">666058</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_45b58f62-d075-497a-b48c-39eed3349c1e"
      decimals="-3"
      id="F_56f2dbd3-68b7-4c2a-a2af-8e70d16c0357"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e"
      decimals="-3"
      id="F_b1f0f895-ccfa-4720-b0c0-4afacbd28edf"
      unitRef="U_USD">796000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_7f22ebcd-718d-46e3-b2a2-f881bbf00171"
      unitRef="U_USD">797000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_51e2839a-be67-48c5-84d2-a44bd56bb75e"
      decimals="-3"
      id="F_418c1558-5683-4d66-810d-5ca310a1ed45"
      unitRef="U_USD">8080000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_e79027a6-30d9-484a-aaee-02f831965460"
      unitRef="U_USD">8080000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_904fa704-ef5e-41de-bcb5-2bf7706d0288"
      decimals="INF"
      id="F_cb88d58d-ef14-49f5-a284-31b25d65d28e"
      unitRef="U_shares">323731591</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_904fa704-ef5e-41de-bcb5-2bf7706d0288"
      decimals="-3"
      id="F_d6d81bb2-baf6-4554-831d-a606ee1c3a89"
      unitRef="U_USD">324000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_50b6ef82-13c8-416b-8944-219722e7b07e"
      decimals="-3"
      id="F_0de39e4d-8552-4551-abbc-8343443edad4"
      unitRef="U_USD">1398006000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_626b835f-8e2e-4400-9c68-0c1fa598c173"
      decimals="-3"
      id="F_671ebb1f-afa9-4e98-b9fd-4b25f672d05e"
      unitRef="U_USD">-1271741000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_54a3bd1a-57e5-404b-8439-d921de6bd8fd"
      decimals="-3"
      id="F_a4d33ebc-616f-4fd5-9c00-4e62959f256e"
      unitRef="U_USD">-173000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_4e80fede-c30a-4a54-a42d-acb8af978484"
      unitRef="U_USD">126416000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="C_77f8406a-f6d2-4060-81b8-e54a35afa90b"
      decimals="-3"
      id="F_d44ef83c-b1f0-4160-957b-ad8cf05c3644"
      unitRef="U_USD">-141901000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_c14b2ae3-5c86-4c64-9919-e29f989ed3ba"
      unitRef="U_USD">-141901000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_5a8fb967-a98b-480a-b077-c269bd33b318"
      decimals="-3"
      id="F_b670c059-604c-43bc-9913-1e1d40bb021b"
      unitRef="U_USD">-68000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_10d6e57a-1c30-4e05-a869-b9e90ac7a8df"
      unitRef="U_USD">-68000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_5a8fb967-a98b-480a-b077-c269bd33b318"
      decimals="-3"
      id="F_d4db1b9a-d5cc-4f04-94c9-f55d2dddc3c4"
      unitRef="U_USD">22000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_54e17294-5a3c-4760-9af8-46e0ca3e604d"
      unitRef="U_USD">22000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_e89875f1-6be5-42d0-a126-eaeafb581f48"
      decimals="-3"
      id="F_2e5c0732-1a6b-40bc-a9df-e7d065560057"
      unitRef="U_USD">5066000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <gern:PublicOfferingStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7"
      decimals="INF"
      id="F_c3bac345-b690-4541-b43e-4bb10213bd1f"
      unitRef="U_shares">53333334</gern:PublicOfferingStockIssuedDuringPeriodSharesNewIssues>
    <gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues
      contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7"
      decimals="-3"
      id="F_fc6d694e-780d-446c-b1e7-c33649cbdad2"
      unitRef="U_USD">53000</gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues>
    <gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues
      contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27"
      decimals="-3"
      id="F_4f8a1d2a-a435-44c3-aa49-d661fab21677"
      unitRef="U_USD">69863000</gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues>
    <gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_1ee4c047-4a64-49fa-9300-0f2187a9ebbd"
      unitRef="U_USD">69916000</gern:PublicOfferingStockIssuedDuringPeriodValueNewIssues>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseShares
      contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7"
      decimals="INF"
      id="F_17c1860e-f82a-4a8b-ba94-b2168a80330b"
      unitRef="U_shares">11663387</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseShares>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue
      contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7"
      decimals="-3"
      id="F_b434e291-76e0-42b3-86ac-96b93bc0f382"
      unitRef="U_USD">12000</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue
      contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27"
      decimals="-3"
      id="F_5d84c025-ae82-484a-a3d6-cab7aee8b94f"
      unitRef="U_USD">15151000</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue>
    <gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_5bef8967-34c3-4e2f-90db-53623fd4980d"
      unitRef="U_USD">15163000</gern:IssuanceOfCommonStockInConnectionWithWarrantExerciseValue>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7"
      decimals="INF"
      id="F_0ecaeb0b-30bd-4db3-a460-a8c1ab1269f7"
      unitRef="U_shares">15962</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27"
      decimals="-3"
      id="F_479fc55c-b3c5-4fe3-915f-4bedb314d805"
      unitRef="U_USD">264000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_f63de7dd-f5ab-4b3e-a866-dc430675a1e5"
      unitRef="U_USD">264000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7"
      decimals="INF"
      id="F_02bf9773-1d1e-4c1c-a8d1-0d28c40a2886"
      unitRef="U_shares">1518250</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_094c908f-8256-41a2-bbaf-71e73b2ebaa7"
      decimals="-3"
      id="F_9ecc0b88-0b1c-48c1-bae7-622b2c91a22b"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27"
      decimals="-3"
      id="F_f34f365c-eedb-4d22-b1ed-20c4741f8aa8"
      unitRef="U_USD">2184000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_654d8820-41da-435b-8ab7-605d02dd6c35"
      unitRef="U_USD">2185000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_a27088b6-011b-4c88-b5b1-4d7e58876f27"
      decimals="-3"
      id="F_6021cc13-a069-447d-8b31-b9b8489b51d6"
      unitRef="U_USD">8001000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_099c797a-acc7-40db-8e6d-242140f2b9fb"
      unitRef="U_USD">8001000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_8188c97d-d82a-44e3-b0a5-e6f672e559c8"
      decimals="INF"
      id="F_92b76267-282d-45e7-aabe-505782f6fbdc"
      unitRef="U_shares">390262524</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_8188c97d-d82a-44e3-b0a5-e6f672e559c8"
      decimals="-3"
      id="F_e6c26d05-2076-47c2-8ed1-4cad6526869d"
      unitRef="U_USD">390000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_bef8e8ac-62e3-46f1-91db-450c61420e02"
      decimals="-3"
      id="F_9fc6e48b-e5dd-416d-b68e-e55a0aca4ab6"
      unitRef="U_USD">1493469000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_119d0654-c503-470b-bd38-81fafe81f4a6"
      decimals="-3"
      id="F_2fc1a4cd-9381-4bd4-9fa8-142d7e7d1c81"
      unitRef="U_USD">-1413642000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_46064b1d-9be0-4b4a-b281-d673cc14f9ce"
      decimals="-3"
      id="F_8e5e41a5-15f5-447b-bc07-e47c950625cf"
      unitRef="U_USD">-219000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_395fbd7e-6540-44c8-be1a-0ae97905427b"
      unitRef="U_USD">79998000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_f082eb0a-7b30-4ade-9d35-5755917a1d53"
      unitRef="U_USD">-141901000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_e167e31d-b299-40ac-aaf3-351ac7ccca4a"
      unitRef="U_USD">-116112000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_6e6f3698-6d69-4d7e-b69d-a3d86fc4086d"
      unitRef="U_USD">-75617000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_0f3dc8b8-6be4-4fbf-b12e-7c22ea27b45d"
      unitRef="U_USD">288000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_2d69c767-7d98-40e4-ad10-e6c6910d2b70"
      unitRef="U_USD">215000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_650f448f-4527-461b-b21d-2169af9cf99a"
      unitRef="U_USD">158000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_0c55ede8-a47f-41fd-990a-135bd7e13e08"
      unitRef="U_USD">965000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_0c4197f4-1894-4a51-93cf-b960854bad5c"
      unitRef="U_USD">-1424000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_297739f5-5d02-45f4-b6b7-5d03cf11e2f7"
      unitRef="U_USD">-818000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_2cb2a94a-146b-4071-b568-171b28cfb464"
      unitRef="U_USD">1327000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_92c97860-da80-4f9d-bf0d-6ba5441c65b2"
      unitRef="U_USD">893000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_46d017d3-418f-435c-b126-ae4a5b5db4c0"
      unitRef="U_USD">179000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:GainOnSaleOfInvestments
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_162929d7-911f-40f1-8025-d55b55459ba7"
      unitRef="U_USD">19000</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_0f7ba09e-6d45-4c76-8382-1732f4e2ba9e"
      unitRef="U_USD">1233000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_31fe77c2-1b11-4959-82a0-ada2a67f0aca"
      unitRef="U_USD">148000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:AssetsFairValueAdjustment
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_a3b23995-09ad-4b5c-9f7b-7cf6d9f2619f"
      unitRef="U_USD">-163000</us-gaap:AssetsFairValueAdjustment>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_ecb039af-b1ce-47b7-abbf-801b723682b7"
      unitRef="U_USD">264000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_aa4b4b8b-747b-4004-b95c-67863d26f6db"
      unitRef="U_USD">91000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_6308f842-b043-4ea8-b014-8d30f0534f56"
      unitRef="U_USD">85000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ShareBasedCompensation
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_7b561054-88be-4f46-a4fc-8f71391f2cb6"
      unitRef="U_USD">8001000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_dc2d529c-43e5-453e-a5b8-928de7588a82"
      unitRef="U_USD">8080000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_3c7f2b98-490b-4e02-b3e1-2fff0bf2964f"
      unitRef="U_USD">6895000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_e2966367-bc33-45ab-bca6-febeae6db84a"
      unitRef="U_USD">580000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_3d3c0355-fb15-4833-a1f4-9bd7e02e759e"
      unitRef="U_USD">568000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_a0307698-ea22-41bb-b298-f7bc73b5e1ff"
      unitRef="U_USD">777000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <gern:IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_3ec171eb-d811-4f98-982e-a22b931addd3"
      unitRef="U_USD">1381000</gern:IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables>
    <gern:IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_759dd907-2344-4670-a5eb-668ec875e7e7"
      unitRef="U_USD">1041000</gern:IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables>
    <gern:IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_4e85e49c-24ee-4783-9b5e-7293dff0699a"
      unitRef="U_USD">-80000</gern:IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_009f3ba0-52b7-4556-8ec7-b8f0069c715b"
      unitRef="U_USD">2630000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_6a369f44-53e2-4aaa-9582-671d11218525"
      unitRef="U_USD">-1317000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_15e5c0a0-e94a-4cb2-84ce-99d2b5aaafdb"
      unitRef="U_USD">1286000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_773e2a05-e783-4ba6-b5ca-05bbd76974a4"
      unitRef="U_USD">594000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_08f75a3f-9a6a-45e0-a3d7-22d4a1a115ec"
      unitRef="U_USD">3807000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInDepositOtherAssets
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_08090a4d-643b-4f8e-a850-eca05ad09c89"
      unitRef="U_USD">206000</us-gaap:IncreaseDecreaseInDepositOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_11df9547-ca5a-4c34-9017-5bf7de2d1a56"
      unitRef="U_USD">3503000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_a0db9131-92d2-4a07-bb0c-6964509d3a84"
      unitRef="U_USD">-232000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_10a5bf87-9ff1-4d9e-a525-fec3f0fbd2b6"
      unitRef="U_USD">5731000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_e0d081bf-ccc5-42a0-9899-7b80b2432f00"
      unitRef="U_USD">3435000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_d1680281-f48f-4f0e-8f8e-3c86ef376803"
      unitRef="U_USD">-119000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_b88df068-c059-4f30-81a4-9d519386d546"
      unitRef="U_USD">3388000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <gern:IncreaseDecreaseDueToCounterparty
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_5b88ad73-a6bb-4f20-9cff-ef816d6a27ab"
      unitRef="U_USD">-14269000</gern:IncreaseDecreaseDueToCounterparty>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_48c93487-93ba-494e-94c1-6d19315d5952"
      unitRef="U_USD">3266000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_a7b6cf10-9941-4aac-a0c7-7a9486ab27ce"
      unitRef="U_USD">14909000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_a6ee52bc-dfb8-401d-af16-1c5e56a9eb86"
      unitRef="U_USD">7397000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <gern:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_35130f1d-5ae0-4adf-b79a-707278b4e9af"
      unitRef="U_USD">-572000</gern:IncreaseDecreaseInOperatingLeaseLiabilities>
    <gern:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_186838b8-b398-4b79-b292-e3631a51c4f3"
      unitRef="U_USD">-509000</gern:IncreaseDecreaseInOperatingLeaseLiabilities>
    <gern:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_f1f7b348-8b0c-417a-81fe-c90c38d3257b"
      unitRef="U_USD">-452000</gern:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_dfdf563e-816c-44c9-ba55-7e4bd305d0bd"
      unitRef="U_USD">-127379000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_7fe88aef-5228-4fa4-b99a-984bf0d8f4b9"
      unitRef="U_USD">-95556000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_7b5c5cf2-199a-400a-a560-91460561a4d3"
      unitRef="U_USD">-66652000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_da3b823a-c4da-437f-839a-10086c2e741f"
      unitRef="U_USD">431000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_490676cc-ae65-4a3b-bc37-0e6001490be3"
      unitRef="U_USD">207000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_9a6385c5-0584-46e1-8fb6-0277c604fcdd"
      unitRef="U_USD">401000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_bef3112b-60da-4e2f-80f3-4b3300aba6f1"
      unitRef="U_USD">258007000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_31972792-4d98-4949-9400-c4da08975143"
      unitRef="U_USD">177434000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_243f3805-8476-4ada-a737-2156afb610a5"
      unitRef="U_USD">313201000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_acc73bf3-a0f1-49c6-9581-0079227ad2dc"
      unitRef="U_USD">7681000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_d85be2a2-bc13-48a8-9b9a-85fb39781e7a"
      unitRef="U_USD">320505000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_d0278309-8d26-44b7-97b4-21fd3def9f28"
      unitRef="U_USD">247994000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_26de0290-c7cc-4c4d-8a56-f58d4b4296c6"
      unitRef="U_USD">200262000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_4893a616-5a1e-4bcb-86cf-92b2bfc1f548"
      unitRef="U_USD">1594000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_3148e7b9-f258-4180-8ec7-d0dc855fa705"
      unitRef="U_USD">339000</us-gaap:ProceedsFromSaleOfOtherAssetsInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_3e12d844-b91d-4893-951f-ed68f5a29a3c"
      unitRef="U_USD">62067000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_409de623-5fbd-4432-8f34-2885238090c5"
      unitRef="U_USD">71947000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_67f0c97d-f43f-4c78-9a4f-64084af155a9"
      unitRef="U_USD">-105320000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_45cb6da8-5f38-46e2-aa95-dda13fd42bb9"
      unitRef="U_USD">2185000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_0e28fe2d-132a-440a-8cc5-2c5055d91e44"
      unitRef="U_USD">797000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_17f819c5-f6c8-46e0-8880-25b132a2c970"
      unitRef="U_USD">208000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <gern:ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_9a94db49-3bb6-456f-9696-514884132502"
      unitRef="U_USD">69916000</gern:ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants>
    <gern:ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_6e4c34a6-1be5-4ea4-8880-369c8e2a2146"
      unitRef="U_USD">140184000</gern:ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_0cd61be1-3f71-4854-94c8-637e94282fd9"
      unitRef="U_USD">20385000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_dbc8e168-3c12-45a9-9e0e-afbfdacfe13f"
      unitRef="U_USD">4075000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_5d503dcb-2763-4b21-8ad8-e706d4e9ebc7"
      unitRef="U_USD">15163000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_71ebaba7-1159-404e-acf5-90cfc4fa99c5"
      unitRef="U_USD">2479000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_8d3750b5-8886-4e58-aa99-07d4ce2786ce"
      unitRef="U_USD">16000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_397a92a9-4056-4868-b5fa-3b2181bd64a6"
      unitRef="U_USD">24895000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_9c8becf7-e6a6-4af9-8c68-45e9a3a924ef"
      unitRef="U_USD">23863000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_071b0cd1-05de-4ae9-9f5b-cd2d81bc12e8"
      unitRef="U_USD">87264000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_0360477a-1633-4b56-ba39-605a6739e077"
      unitRef="U_USD">48556000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_fe0c7ab3-6b28-4db6-bdd0-2c7d6d6c2e95"
      unitRef="U_USD">168346000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <gern:EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_b3108787-95e8-4481-b1df-3624bf9ea7f3"
      unitRef="U_USD">22000</gern:EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_a1b3a5ee-1535-40b5-906c-329f69d53cac"
      unitRef="U_USD">21974000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_ed550659-1bdd-4fcc-a910-87c68d54aa08"
      unitRef="U_USD">24947000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_b8a4a8e9-24e4-401d-bb4b-d7e40b123bdd"
      unitRef="U_USD">-3626000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_0c5beedc-8053-4d2a-8248-7d13b2a10470"
      unitRef="U_USD">35235000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a"
      decimals="-3"
      id="F_278349d7-ad27-44c5-b7b0-e2ae1557eafe"
      unitRef="U_USD">10288000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_51546caa-efa4-41ff-89e0-38e80356cf4c"
      decimals="-3"
      id="F_578486fd-044c-46d7-8364-6043208874d9"
      unitRef="U_USD">13914000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_b43adf78-2b8a-430d-b6dc-a79cdea8f185"
      unitRef="U_USD">57209000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_e9439bd5-c6ec-4879-a1ed-1b23fccb550b"
      unitRef="U_USD">35235000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a"
      decimals="-3"
      id="F_670e1ffe-5194-4bff-af2d-f669757c19e7"
      unitRef="U_USD">10288000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_3975b0bc-5d3b-4385-acbf-c476632218a0">&lt;p id="note_1_" style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Organization&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The terms &#x201c;Geron&#x201d;, the &#x201c;Company&#x201d;, &#x201c;we&#x201d; and &#x201c;us&#x201d; as used in this report refer to Geron Corporation. Geron was incorporated in the State of Delaware on November 28, 1990. We are a late-stage clinical biopharmaceutical company that is focused on the development and potential commercialization of imetelstat, an innovative therapeutic for hematologic malignancies. We have global rights to imetelstat, a first in class telomerase inhibitor, which was discovered and developed at Geron. Principal activities to date have included obtaining financing, securing operating facilities and conducting research and development.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The consolidated financial statements include the accounts of Geron and our wholly-owned subsidiary, Geron UK Limited, or Geron UK, a United Kingdom company. Geron UK was incorporated in September 2021, and its operations commenced in January 2022. We have eliminated intercompany accounts and transactions. We prepare the financial statements of Geron UK using the local currency as the functional currency. We translate the assets and liabilities of Geron UK at rates of exchange at the balance sheet date and translate income and expense items at average monthly rates of exchange. The resultant translation adjustments are included in accumulated other comprehensive income (loss), a separate component of stockholders&#x2019; equity, on our consolidated balance sheets.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of shares of common stock outstanding for the periods presented without consideration of potential common shares. In April 2022, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,095,238&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock, also known as the 2022 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. In May 2020, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,335,239&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock, or the 2020 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. The 2022 pre-funded warrant and 2020 pre-funded warrant each are exercisable immediately at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share. We included the 2022 pre-funded warrant and 2020 pre-funded warrant in the computation of basic net loss per share, as applicable, since their exercise price is negligible, and they may be exercised at any time. See Note 9 on Stockholders' Equity for further discussion of the April 2022 public offering.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Diluted net income per share would be calculated by adjusting the weighted-average number of shares of common stock outstanding for the dilutive effect of additional shares of common stock that would have been outstanding if potentially dilutive securities had been issued, as determined using the treasury-stock method. Potential dilutive securities consist of outstanding stock options and warrants to purchase our common stock. Diluted net loss per share excludes potential dilutive securities for all periods presented as their effect would be anti-dilutive. Accordingly, basic and diluted net loss per share is the same for all periods presented in the accompanying consolidated statements of operations. Since we incurred a net loss for 2022, 2021, and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the diluted net loss per share calculation excludes potential dilutive securities of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;145,726,765&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;105,725,875&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;101,881,391&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares, respectively, related to outstanding stock options and warrants as their effect would have been anti-dilutive.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to accrued liabilities, revenue recognition, fair value of marketable securities and equity investments, operating leases, right-of-use assets, lease liabilities, income taxes, and stock-based compensation. We base our estimates on historical experience and on various other market specific and relevant assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. We are subject to credit risk related to our cash equivalents and marketable securities. Our marketable debt securities include U.S. Treasury securities, municipal securities, government-sponsored enterprise securities, commercial paper and corporate notes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We classify our marketable debt securities as available for sale. We record available for sale debt securities at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) in stockholders&#x2019; equity. Realized gains and losses are included in interest income and are derived using the specific identification method for determining the cost of securities sold and have been insignificant to date. Dividend and interest income are recognized when earned and included in interest income on our consolidated statements of operations. We recognize a charge when the declines in the fair values below the amortized cost bases of our available for sale securities are judged to be other than temporary. We consider various factors in determining whether to recognize an other than temporary charge, including whether we intend to sell the security or whether it is more likely than not that we would be required to sell the security before recovery of the amortized cost basis. Declines in market value judged as other than temporary result in a charge to interest income. We have not recorded any other&#x2011;than&#x2011;temporary impairment charges on our available&#x2011;for&#x2011;sale securities for the years ended December 31, 2022, 2021 and 2020. See Note 2 on Fair Value Measurements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Equity Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We measure our investment in equity securities at fair value at each reporting date. Changes in fair value resulting from observable price changes are included in change in fair value of equity investment and changes in fair value resulting from foreign currency translation are included in other expense on our consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating leases are included in operating leases, right-of-use assets and lease liabilities on our consolidated balance sheets. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of remaining lease payments over the expected lease term. The present value of remaining lease payments within the 12 months following the balance sheet date are classified as current lease liabilities. The present value of lease payments not within the 12 months following the balance sheet date are classified as noncurrent lease liabilities. The interest rate implicit in lease contracts is typically not readily determinable. As such, to calculate the net present value of lease payments, we apply our incremental borrowing rate, which is the estimated rate to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment as of the lease commencement date. We may adjust the right-of-use assets for certain adjustments, such as initial direct costs paid or incentives received. In addition, we include any options to extend or terminate the lease in the expected lease term when it is reasonably certain that we will exercise any such option. Lease expense is recognized on a straight-line basis over the expected lease term.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For lease agreements entered into after January 1, 2019 that include lease and non-lease components, such components are generally accounted for separately. We have also elected not to recognize on our consolidated balance sheets leases with terms of one year or less.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Debt Issuance Costs and Debt Discounts&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Debt issuance costs include legal fees, accounting fees, and other direct costs incurred in connection with the execution of our debt financing. Debt discounts represent costs paid to the lenders. Debt issuance costs and debt discounts are deducted from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt using the effective interest method.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We recognize revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers, or Topic 606. In determining the appropriate amount and timing of revenue to be recognized under this guidance, we perform the following five steps: (i) identify the contract(s) with our customer; (ii) identify the promised goods or services in the agreement and determine whether they are performance obligations, including whether they are distinct in the context of the agreement; (iii) measure the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations based on stand-alone selling prices; and (v) recognize revenue when (or as) we satisfy each performance obligation. &lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A performance obligation is a promise in an agreement to transfer a distinct good or service to the customer and is the unit of account in Topic 606. Significant management judgment is required to determine the level of effort required and the period over which completion of the performance obligations is expected under an agreement. If reasonable estimates regarding when performance obligations are either complete or substantially complete cannot be made, then revenue recognition is deferred until a reasonable estimate can be made. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We allocate the total transaction price to each performance obligation based on the estimated relative stand-alone selling prices of the promised goods or services underlying each performance obligation. Estimated selling prices for license rights are calculated using an income approach model and include the following key assumptions, judgments and estimates: the development timeline, revenue forecast, commercialization expenses, discount rate and probabilities of technical and regulatory success.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Following is a description of the principal activities from which we generate revenue. License fees and royalty revenue primarily represent amounts earned under agreements that out-license our technology to various companies.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;License Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&lt;br/&gt;We previously entered into several license agreements with various oncology, diagnostics, research tools and biologics production companies, whereby we granted certain rights to our non-imetelstat related technologies. Under these agreements, non-refundable upfront fees and annual license maintenance fees were considered fixed consideration, while milestone payments and royalties were identified as variable consideration. Since June 30, 2021, no active license agreements remain. The license related to our specialized oligonucleotide backbone chemistry, as well as patent rights covering the synthesis of monomers, the building blocks of oligonucleotides, terminated effective April 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In connection with the divestiture of Geron&#x2019;s human embryonic stem cell assets, including intellectual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on sales of certain research or commercial products utilizing Geron&#x2019;s divested intellectual property.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Licenses of Intellectual Property&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. If we determine the license to intellectual property is distinct from the other performance obligations identified in the agreement and the licensee can use and benefit from the license, we recognize revenue from non-refundable upfront fees allocated to the license upon the completion of the transfer of the license to the licensee. For such licenses, we recognize revenue from annual license maintenance fees upon the start of the new license period. For licenses that are bundled with other performance obligations, we assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable upfront fees or annual license maintenance fees. At each reporting date, we reassess the progress and, if necessary, adjust the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Milestone Payments.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; At the inception of each agreement that includes milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. For milestones that we do not deem&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;to be probable of being achieved, the associated milestone payments are fully constrained and the value of the milestone is excluded from the transaction price with no revenue being recognized. For example, milestone payments that are not within our control, such as regulatory-related accomplishments, are not considered probable of being achieved until those accomplishments have been communicated by the relevant regulatory authority. Once the assessment of probability of achievement becomes probable, we recognize revenue for the milestone payment. At each reporting date, we assess the probability of achievement of each milestone under any current agreements.&lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Royalties&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. For agreements with sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (a) when the related sales occur, or (b) when the performance obligation, to which some or all of the royalty has been allocated, has been satisfied (or partially satisfied). At each reporting date, we estimate the sales incurred by each licensee during the reporting period based on historical experience and accrue the associated royalty amount.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash consists of funds maintained in separate money market or certificate of deposit accounts for credit card purchases.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses currently consist of expenses incurred in developing and testing imetelstat and research related to potential next generation telomerase inhibitors. These expenses include, but are not limited to, payroll and personnel expense, lab supplies, non-clinical studies, clinical trials, including support for investigator-led clinical trials, raw materials to manufacture clinical trial drugs, manufacturing costs for research and clinical trial materials, sponsored research at other labs, consulting, costs to maintain technology licenses and research-related overhead.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Our current imetelstat clinical trials are being supported by contract research organizations, or CROs, and other vendors. We accrue expenses for clinical trial activities performed by CROs based upon the estimated amount of work completed on each trial. For clinical trial expenses and related expenses associated with the conduct of clinical trials, the significant factors used in estimating accruals include the number of patients enrolled, the number of active clinical sites, and the duration for which the patients have been enrolled in the trial. We monitor patient enrollment levels and related activities to the extent possible through internal reviews, review of contractual terms and correspondence with CROs. We base our estimates on the best information available at the time. However, additional information may become available to us which will allow us to make a more accurate estimate in future periods. In that event, we may be required to record adjustments to research and development expenses in future periods when the actual level of activity becomes more certain.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We record property and equipment at cost and calculate depreciation using the straight&#x2011;line method over the estimated useful lives of the assets, generally &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Leasehold improvements are amortized over the shorter of the estimated useful life or remaining term of the lease.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock&#x2011;Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We maintain various stock incentive plans under which stock options and restricted stock awards can be granted to employees, non-employee directors and consultants. We also have an employee stock purchase plan for all eligible employees. We recognize stock-based compensation expense based on grant-date fair values of service-based stock options on a straight-line basis over the requisite service period, which is generally the vesting period. For performance-based stock options with vesting based on the achievement of certain strategic milestones, stock-based compensation expense is recognized over the period from the date the performance condition is determined to be probable of occurring through the date the applicable condition is expected to be met and is reduced for estimated forfeitures, as applicable. If the performance condition is not considered probable of being achieved, no stock-based compensation expense is recognized until such time as the performance condition is considered probable of being met, if at all. If the assessment of probability of the performance condition changes, the impact of the change in estimate would be recognized in the period of the change. The determination of grant-date fair values for our&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;service-based and performance-based stock options and employee stock purchases using the Black Scholes option pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables. The grant-date fair value for service-based restricted stock awards is determined using the fair value of our common stock on the date of grant. We evaluate whether an adjustment to the assumptions of fair value of our common stock and historical volatility are required if observed prices of our common stock materially differ from historical information.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We measure share-based payments to non-employees based on the grant-date fair value of the equity awards to be issued. We recognize stock-based compensation expense for the fair value of the vested portion of non-employee stock-based awards on our consolidated statements of operations. For additional information, see Note 9 on Stockholders&#x2019; Equity.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accumulated Other Comprehensive Gain (Loss)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accumulated other comprehensive gain (loss) includes certain changes in stockholders&#x2019; equity which are excluded from net income (loss). Accumulated other comprehensive loss on our consolidated balance sheets as of December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively, is comprised of net unrealized losses on marketable securities and cumulative translation adjustments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We maintain deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are subject to tests of recoverability. Our deferred tax assets include net operating loss carryforwards, federal and state tax credits and capitalized research and development. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Our net deferred tax asset has been fully offset by a valuation allowance because of our history of losses. Any potential accrued interest and penalties related to unrecognized tax benefits would be recorded as income tax expense.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Our executive management team represents our chief decision maker. We view our operations as a single segment, the development of therapeutic products for oncology. As a result, the financial information disclosed herein materially represents all of the financial information related to our principal operating segment.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;New Accounting Pronouncements &#x2013; Issued But Not Yet Adopted&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU 2016-13,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2016-13. The main objective of ASU 2016-13 is to provide financial statement users with more decision-useful information about an entity's expected credit losses on financial instruments and other commitments to extend credit at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology currently used today with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to develop credit loss estimates. Subsequent to issuing ASU 2016-13, the FASB issued ASU 2018-19, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Codification Improvements to Topic 326, Financial Instruments &#x2013; Credit Losses&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2018-19, for the purpose of clarifying certain aspects of ASU 2016-13. In May 2019, the FASB issued ASU 2019-05, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Targeted Transition Relief&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2019-05, to provide entities with more flexibility in applying the fair value option on adoption of the credit impairment standard. In November 2019, the FASB issued ASU 2019-11, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Codification Improvements to Topic 326, Financial Instruments &#x2013; Credit Losses&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which expands the scope of the practical expedient that allows entities to exclude the accrued interest component of amortized cost from various disclosure. Entities that elect to apply the practical expedient must disclose the total amount of accrued interest that they exclude from their disclosures of amortized cost. ASU 2018-19, ASU 2019-05 and ASU 2019-11 have the same effective date and transition requirements as ASU 2016-13. ASU 2016-13 will be effective for fiscal years beginning after December 15, 2022, using a modified retrospective approach, for smaller reporting companies. Early adoption is permitted. We plan to&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;adopt ASU 2016-13 and related updates as of January 1, 2023. We do not expect the adoption of this standard to have a material impact on our financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2020-06. The key elements of ASU 2020-06 aim to reduce unnecessary complexity in GAAP for certain financial instruments with characteristics of liabilities and equity. In addressing the complexity, the FASB focused on amending the guidance on convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#x2019;s own equity. For convertible instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock. For contracts in an entity&#x2019;s own equity, the FASB observed that the application of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically similar contracts as equity. The FASB also decided to improve and amend the related earnings per share guidance. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years for public business entities that are not smaller reporting companies. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. We plan to adopt ASU 2020-06 as of January 1, 2024. We do not expect the adoption of this standard to have a material impact on our financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on our financial statements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_2528a059-393c-4007-8c46-6708a5075428">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The consolidated financial statements include the accounts of Geron and our wholly-owned subsidiary, Geron UK Limited, or Geron UK, a United Kingdom company. Geron UK was incorporated in September 2021, and its operations commenced in January 2022. We have eliminated intercompany accounts and transactions. We prepare the financial statements of Geron UK using the local currency as the functional currency. We translate the assets and liabilities of Geron UK at rates of exchange at the balance sheet date and translate income and expense items at average monthly rates of exchange. The resultant translation adjustments are included in accumulated other comprehensive income (loss), a separate component of stockholders&#x2019; equity, on our consolidated balance sheets.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_0c6ad84f-f882-4e95-80f2-509aa8482316">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net Loss Per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted-average number of shares of common stock outstanding for the periods presented without consideration of potential common shares. In April 2022, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,095,238&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock, also known as the 2022 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. In May 2020, we entered into an underwriting agreement in connection with a public offering of our common stock, pursuant to which we issued a pre-funded warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,335,239&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock, or the 2020 pre-funded warrant, together with accompanying warrants to purchase shares of our common stock. The 2022 pre-funded warrant and 2020 pre-funded warrant each are exercisable immediately at an exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share. We included the 2022 pre-funded warrant and 2020 pre-funded warrant in the computation of basic net loss per share, as applicable, since their exercise price is negligible, and they may be exercised at any time. See Note 9 on Stockholders' Equity for further discussion of the April 2022 public offering.&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Diluted net income per share would be calculated by adjusting the weighted-average number of shares of common stock outstanding for the dilutive effect of additional shares of common stock that would have been outstanding if potentially dilutive securities had been issued, as determined using the treasury-stock method. Potential dilutive securities consist of outstanding stock options and warrants to purchase our common stock. Diluted net loss per share excludes potential dilutive securities for all periods presented as their effect would be anti-dilutive. Accordingly, basic and diluted net loss per share is the same for all periods presented in the accompanying consolidated statements of operations. Since we incurred a net loss for 2022, 2021, and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the diluted net loss per share calculation excludes potential dilutive securities of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;145,726,765&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;105,725,875&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;101,881,391&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares, respectively, related to outstanding stock options and warrants as their effect would have been anti-dilutive.&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_a3cf8441-940c-4769-a1c9-ba37e4bc2812"
      decimals="INF"
      id="F_58b3229b-3040-4c8d-9e83-b836fcdfc565"
      unitRef="U_shares">18095238</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_c3b7b4b9-7629-4b56-93a5-2b3ac17f8fa9"
      decimals="INF"
      id="F_3fa850a2-817f-4c90-86e8-6f99744f4f6e"
      unitRef="U_shares">8335239</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_a3cf8441-940c-4769-a1c9-ba37e4bc2812"
      decimals="3"
      id="F_15a02dbb-3748-4cca-b938-1b2f808d3f8d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_c3b7b4b9-7629-4b56-93a5-2b3ac17f8fa9"
      decimals="3"
      id="F_caab1f25-eeff-4d45-9364-e447dfee1dc2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_4183e218-4909-4bf2-b115-abdea99d97df"
      decimals="INF"
      id="F_d3a419a9-30b6-470a-8c38-f28c9ac298b6"
      unitRef="U_shares">145726765</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_bb6bcd2c-ccc9-458c-9e1a-1799ed2c561e"
      decimals="INF"
      id="F_665b3b68-97a8-439d-8c31-83b36526b068"
      unitRef="U_shares">105725875</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_a9eac63f-ff18-4e30-bd6c-4d89efb022b6"
      decimals="INF"
      id="F_e3d2c35e-d5f4-415b-b904-342713b72ca0"
      unitRef="U_shares">101881391</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:UseOfEstimates
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_fcbbe5dd-93df-44ea-8a01-d0b6cf84b8b1">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP. The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to accrued liabilities, revenue recognition, fair value of marketable securities and equity investments, operating leases, right-of-use assets, lease liabilities, income taxes, and stock-based compensation. We base our estimates on historical experience and on various other market specific and relevant assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_7098855d-a8be-44f2-92e3-8b51c4490ea4">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. We are subject to credit risk related to our cash equivalents and marketable securities. Our marketable debt securities include U.S. Treasury securities, municipal securities, government-sponsored enterprise securities, commercial paper and corporate notes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We classify our marketable debt securities as available for sale. We record available for sale debt securities at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) in stockholders&#x2019; equity. Realized gains and losses are included in interest income and are derived using the specific identification method for determining the cost of securities sold and have been insignificant to date. Dividend and interest income are recognized when earned and included in interest income on our consolidated statements of operations. We recognize a charge when the declines in the fair values below the amortized cost bases of our available for sale securities are judged to be other than temporary. We consider various factors in determining whether to recognize an other than temporary charge, including whether we intend to sell the security or whether it is more likely than not that we would be required to sell the security before recovery of the amortized cost basis. Declines in market value judged as other than temporary result in a charge to interest income. We have not recorded any other&#x2011;than&#x2011;temporary impairment charges on our available&#x2011;for&#x2011;sale securities for the years ended December 31, 2022, 2021 and 2020. See Note 2 on Fair Value Measurements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Equity Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We measure our investment in equity securities at fair value at each reporting date. Changes in fair value resulting from observable price changes are included in change in fair value of equity investment and changes in fair value resulting from foreign currency translation are included in other expense on our consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_a9af653a-f921-4f45-89af-07c3cad0e193">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At the inception of an arrangement, we determine whether the arrangement is or contains a lease based on the unique facts and circumstances present. Operating leases are included in operating leases, right-of-use assets and lease liabilities on our consolidated balance sheets. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease liabilities and their corresponding right-of-use assets are recorded based on the present value of remaining lease payments over the expected lease term. The present value of remaining lease payments within the 12 months following the balance sheet date are classified as current lease liabilities. The present value of lease payments not within the 12 months following the balance sheet date are classified as noncurrent lease liabilities. The interest rate implicit in lease contracts is typically not readily determinable. As such, to calculate the net present value of lease payments, we apply our incremental borrowing rate, which is the estimated rate to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment as of the lease commencement date. We may adjust the right-of-use assets for certain adjustments, such as initial direct costs paid or incentives received. In addition, we include any options to extend or terminate the lease in the expected lease term when it is reasonably certain that we will exercise any such option. Lease expense is recognized on a straight-line basis over the expected lease term.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For lease agreements entered into after January 1, 2019 that include lease and non-lease components, such components are generally accounted for separately. We have also elected not to recognize on our consolidated balance sheets leases with terms of one year or less.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_f0261caa-66ec-42f3-bd4d-7d21c60d907c">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Debt Issuance Costs and Debt Discounts&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Debt issuance costs include legal fees, accounting fees, and other direct costs incurred in connection with the execution of our debt financing. Debt discounts represent costs paid to the lenders. Debt issuance costs and debt discounts are deducted from the carrying amount of the debt liability and are amortized to interest expense over the term of the related debt using the effective interest method.&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_402db6cb-e1eb-42ba-8d6a-9454a1f8eaf0">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We recognize revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers, or Topic 606. In determining the appropriate amount and timing of revenue to be recognized under this guidance, we perform the following five steps: (i) identify the contract(s) with our customer; (ii) identify the promised goods or services in the agreement and determine whether they are performance obligations, including whether they are distinct in the context of the agreement; (iii) measure the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations based on stand-alone selling prices; and (v) recognize revenue when (or as) we satisfy each performance obligation. &lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A performance obligation is a promise in an agreement to transfer a distinct good or service to the customer and is the unit of account in Topic 606. Significant management judgment is required to determine the level of effort required and the period over which completion of the performance obligations is expected under an agreement. If reasonable estimates regarding when performance obligations are either complete or substantially complete cannot be made, then revenue recognition is deferred until a reasonable estimate can be made. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We allocate the total transaction price to each performance obligation based on the estimated relative stand-alone selling prices of the promised goods or services underlying each performance obligation. Estimated selling prices for license rights are calculated using an income approach model and include the following key assumptions, judgments and estimates: the development timeline, revenue forecast, commercialization expenses, discount rate and probabilities of technical and regulatory success.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Following is a description of the principal activities from which we generate revenue. License fees and royalty revenue primarily represent amounts earned under agreements that out-license our technology to various companies.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;License Agreements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&lt;br/&gt;We previously entered into several license agreements with various oncology, diagnostics, research tools and biologics production companies, whereby we granted certain rights to our non-imetelstat related technologies. Under these agreements, non-refundable upfront fees and annual license maintenance fees were considered fixed consideration, while milestone payments and royalties were identified as variable consideration. Since June 30, 2021, no active license agreements remain. The license related to our specialized oligonucleotide backbone chemistry, as well as patent rights covering the synthesis of monomers, the building blocks of oligonucleotides, terminated effective April 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In connection with the divestiture of Geron&#x2019;s human embryonic stem cell assets, including intellectual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on sales of certain research or commercial products utilizing Geron&#x2019;s divested intellectual property.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Licenses of Intellectual Property&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. If we determine the license to intellectual property is distinct from the other performance obligations identified in the agreement and the licensee can use and benefit from the license, we recognize revenue from non-refundable upfront fees allocated to the license upon the completion of the transfer of the license to the licensee. For such licenses, we recognize revenue from annual license maintenance fees upon the start of the new license period. For licenses that are bundled with other performance obligations, we assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable upfront fees or annual license maintenance fees. At each reporting date, we reassess the progress and, if necessary, adjust the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Milestone Payments.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; At the inception of each agreement that includes milestone payments, we evaluate whether the milestones are considered probable of being achieved and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. For milestones that we do not deem&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;to be probable of being achieved, the associated milestone payments are fully constrained and the value of the milestone is excluded from the transaction price with no revenue being recognized. For example, milestone payments that are not within our control, such as regulatory-related accomplishments, are not considered probable of being achieved until those accomplishments have been communicated by the relevant regulatory authority. Once the assessment of probability of achievement becomes probable, we recognize revenue for the milestone payment. At each reporting date, we assess the probability of achievement of each milestone under any current agreements.&lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Royalties&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. For agreements with sales-based royalties, including milestone payments based on the level of sales, where the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (a) when the related sales occur, or (b) when the performance obligation, to which some or all of the royalty has been allocated, has been satisfied (or partially satisfied). At each reporting date, we estimate the sales incurred by each licensee during the reporting period based on historical experience and accrue the associated royalty amount.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_2bdce74c-dee9-41c1-8507-a92a336b03ab">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted Cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash consists of funds maintained in separate money market or certificate of deposit accounts for credit card purchases.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_fd38318d-5d37-4629-ac37-b896911393f6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses currently consist of expenses incurred in developing and testing imetelstat and research related to potential next generation telomerase inhibitors. These expenses include, but are not limited to, payroll and personnel expense, lab supplies, non-clinical studies, clinical trials, including support for investigator-led clinical trials, raw materials to manufacture clinical trial drugs, manufacturing costs for research and clinical trial materials, sponsored research at other labs, consulting, costs to maintain technology licenses and research-related overhead.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Our current imetelstat clinical trials are being supported by contract research organizations, or CROs, and other vendors. We accrue expenses for clinical trial activities performed by CROs based upon the estimated amount of work completed on each trial. For clinical trial expenses and related expenses associated with the conduct of clinical trials, the significant factors used in estimating accruals include the number of patients enrolled, the number of active clinical sites, and the duration for which the patients have been enrolled in the trial. We monitor patient enrollment levels and related activities to the extent possible through internal reviews, review of contractual terms and correspondence with CROs. We base our estimates on the best information available at the time. However, additional information may become available to us which will allow us to make a more accurate estimate in future periods. In that event, we may be required to record adjustments to research and development expenses in future periods when the actual level of activity becomes more certain.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_704ee8fb-46a9-485b-9037-e39c28a978d3">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We record property and equipment at cost and calculate depreciation using the straight&#x2011;line method over the estimated useful lives of the assets, generally &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Leasehold improvements are amortized over the shorter of the estimated useful life or remaining term of the lease.&lt;/span&gt;&lt;/p&gt;</us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_3ce01217-2353-40ef-ab52-41ec5c82dfde">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_5e283e79-d3f3-42c6-bb45-08a278c7b799">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock&#x2011;Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We maintain various stock incentive plans under which stock options and restricted stock awards can be granted to employees, non-employee directors and consultants. We also have an employee stock purchase plan for all eligible employees. We recognize stock-based compensation expense based on grant-date fair values of service-based stock options on a straight-line basis over the requisite service period, which is generally the vesting period. For performance-based stock options with vesting based on the achievement of certain strategic milestones, stock-based compensation expense is recognized over the period from the date the performance condition is determined to be probable of occurring through the date the applicable condition is expected to be met and is reduced for estimated forfeitures, as applicable. If the performance condition is not considered probable of being achieved, no stock-based compensation expense is recognized until such time as the performance condition is considered probable of being met, if at all. If the assessment of probability of the performance condition changes, the impact of the change in estimate would be recognized in the period of the change. The determination of grant-date fair values for our&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;service-based and performance-based stock options and employee stock purchases using the Black Scholes option pricing model is affected by our stock price as well as assumptions regarding a number of complex and subjective variables. The grant-date fair value for service-based restricted stock awards is determined using the fair value of our common stock on the date of grant. We evaluate whether an adjustment to the assumptions of fair value of our common stock and historical volatility are required if observed prices of our common stock materially differ from historical information.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We measure share-based payments to non-employees based on the grant-date fair value of the equity awards to be issued. We recognize stock-based compensation expense for the fair value of the vested portion of non-employee stock-based awards on our consolidated statements of operations. For additional information, see Note 9 on Stockholders&#x2019; Equity.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:StockholdersEquityPolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_871908f0-a3e1-43cd-b1b8-46c7d1daa42c">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accumulated Other Comprehensive Gain (Loss)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accumulated other comprehensive gain (loss) includes certain changes in stockholders&#x2019; equity which are excluded from net income (loss). Accumulated other comprehensive loss on our consolidated balance sheets as of December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively, is comprised of net unrealized losses on marketable securities and cumulative translation adjustments.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_59585682-51c4-47a1-a83f-d031edd0e576">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We maintain deferred tax assets and liabilities that reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are subject to tests of recoverability. Our deferred tax assets include net operating loss carryforwards, federal and state tax credits and capitalized research and development. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Our net deferred tax asset has been fully offset by a valuation allowance because of our history of losses. Any potential accrued interest and penalties related to unrecognized tax benefits would be recorded as income tax expense.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_fc018ea6-34e4-4bc7-b7af-8fabe7ddf0d5">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Our executive management team represents our chief decision maker. We view our operations as a single segment, the development of therapeutic products for oncology. As a result, the financial information disclosed herein materially represents all of the financial information related to our principal operating segment.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_fde7a27b-7e9f-4c3d-a33a-7966bce24dd1">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;New Accounting Pronouncements &#x2013; Issued But Not Yet Adopted&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU 2016-13,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2016-13. The main objective of ASU 2016-13 is to provide financial statement users with more decision-useful information about an entity's expected credit losses on financial instruments and other commitments to extend credit at each reporting date. To achieve this objective, the amendments in this update replace the incurred loss impairment methodology currently used today with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to develop credit loss estimates. Subsequent to issuing ASU 2016-13, the FASB issued ASU 2018-19, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Codification Improvements to Topic 326, Financial Instruments &#x2013; Credit Losses&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2018-19, for the purpose of clarifying certain aspects of ASU 2016-13. In May 2019, the FASB issued ASU 2019-05, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Targeted Transition Relief&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2019-05, to provide entities with more flexibility in applying the fair value option on adoption of the credit impairment standard. In November 2019, the FASB issued ASU 2019-11, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Codification Improvements to Topic 326, Financial Instruments &#x2013; Credit Losses&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which expands the scope of the practical expedient that allows entities to exclude the accrued interest component of amortized cost from various disclosure. Entities that elect to apply the practical expedient must disclose the total amount of accrued interest that they exclude from their disclosures of amortized cost. ASU 2018-19, ASU 2019-05 and ASU 2019-11 have the same effective date and transition requirements as ASU 2016-13. ASU 2016-13 will be effective for fiscal years beginning after December 15, 2022, using a modified retrospective approach, for smaller reporting companies. Early adoption is permitted. We plan to&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;adopt ASU 2016-13 and related updates as of January 1, 2023. We do not expect the adoption of this standard to have a material impact on our financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2020-06. The key elements of ASU 2020-06 aim to reduce unnecessary complexity in GAAP for certain financial instruments with characteristics of liabilities and equity. In addressing the complexity, the FASB focused on amending the guidance on convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#x2019;s own equity. For convertible instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock. For contracts in an entity&#x2019;s own equity, the FASB observed that the application of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically similar contracts as equity. The FASB also decided to improve and amend the related earnings per share guidance. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years for public business entities that are not smaller reporting companies. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. We plan to adopt ASU 2020-06 as of January 1, 2024. We do not expect the adoption of this standard to have a material impact on our financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on our financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_6832f1bb-0954-4120-98fe-bbb4476d65d4">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2. FAIR VALUE MEASUREMENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents, restricted cash and marketable securities by security type at &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:41.972%;"/&gt;
        &lt;td style="width:1.354%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market fund&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificate of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,983&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored enterprise securities &lt;br/&gt;&#160;&#160;&#160;(due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,860&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;116,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;115,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents, restricted cash and marketable securities by security type at December 31, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:41.972%;"/&gt;
        &lt;td style="width:1.354%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market fund&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificate of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities (due in &lt;br/&gt;&#160;&#160;&#160;one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,524&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities (due in &lt;br/&gt;&#160;&#160;&#160;one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored enterprise securities &lt;br/&gt;&#160;&#160;&#160;(due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;84,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;84,362&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,444&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,429&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;177,675&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;177,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents and marketable securities with unrealized losses that have been in a continuous unrealized loss position for less than 12 months and 12 months or longer at &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.719%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.868%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.162%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.613%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.404%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.627%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.122%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less Than 12 Months&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12 Months or Greater&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="4" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury &lt;br/&gt;&#160;&#160;&#160;securities (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,424&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,497&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities &lt;br/&gt;&#160;&#160;&#160;(due in less than a&lt;br/&gt;&#160;&#160;&#160;year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored &lt;br/&gt;&#160;&#160;&#160;enterprise securities &lt;br/&gt;&#160;&#160;&#160;(due in less than &lt;br/&gt;&#160;&#160;&#160;one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;br/&gt;&#160;&#160;&#160;(due in less than&lt;br/&gt;&#160;&#160;&#160;one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;52,454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;52,454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,960&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;82&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;104,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2021:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury &lt;br/&gt;&#160;&#160;&#160;securities (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury &lt;br/&gt;&#160;&#160;&#160;securities (due in &lt;br/&gt;&#160;&#160;&#160;one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities &lt;br/&gt;&#160;&#160;&#160;(due in one to two &lt;br/&gt;&#160;&#160;&#160;years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored &lt;br/&gt;&#160;&#160;&#160;enterprise securities &lt;br/&gt;&#160;&#160;&#160;(due in less than &lt;br/&gt;&#160;&#160;&#160;one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,993&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;br/&gt;&#160;&#160;&#160;(due in less than&lt;br/&gt;&#160;&#160;&#160;one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in &lt;br/&gt;&#160;&#160;&#160;one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;128,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,993&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;133,584&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The gross unrealized losses related to U.S. Treasury securities, municipal securities, government-sponsored enterprise securities, commercial paper and corporate notes as of December 31, 2022 and 2021 were due to changes in interest rates and not credit risk. We determined that the gross unrealized losses on our cash equivalents and marketable securities as of December 31, 2022 and 2021 were temporary in nature. Our exposure to unrealized losses may increase in the future due to the economic pressures or uncertainties associated with local or global economic recessions as a result of the ongoing COVID-19 pandemic and ongoing geopolitical events, such as the current military conflict between Ukraine and Russia, as well as recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure. We review our investments quarterly to identify and evaluate whether any investments have indications of possible other-than-temporary impairment. Factors considered in determining whether a loss is temporary include the length of time and extent to which the fair value has been less than the amortized cost basis and whether we intend to sell the security or whether it is more likely than not that we would be required to sell the security before recovery of the amortized cost basis. We currently do not intend to sell these securities before recovery of their amortized cost bases.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value on a Recurring Basis&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We categorize financial instruments recorded at fair value on our consolidated balance sheets based upon the level of judgment associated with inputs used to measure their fair value. The categories are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
     &lt;tr style="visibility:collapse;"&gt;
      &lt;td style="width:1.453%;"/&gt;
      &lt;td style="width:6.624%;"/&gt;
      &lt;td style="width:2.137%;"/&gt;
      &lt;td style="width:89.786%;"/&gt;
     &lt;/tr&gt;
     &lt;tr style="height:10.0pt;"&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. An active market for the asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
     &lt;/tr&gt;
     &lt;tr style="height:10.0pt;"&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#x2019;s anticipated life.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
     &lt;/tr&gt;
     &lt;tr style="height:10.0pt;"&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
      &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
     &lt;/tr&gt;
    &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A financial instrument&#x2019;s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Below is a description of the valuation methodologies used for financial instruments measured at fair value on our consolidated balance sheets, including the category for such financial instruments.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds and certificates of deposit are categorized as Level 1 within the fair value hierarchy as their fair values are based on quoted prices available in active markets. Commercial paper, U.S. Treasury securities, municipal securities, government-sponsored enterprise securities and corporate notes are categorized as Level 2 within the fair value hierarchy as their fair values are estimated by using pricing models, quoted prices of securities with similar characteristics or discounted cash flows.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents information about our financial instruments that are measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 and indicates the fair value category assigned.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:44.762%;"/&gt;
        &lt;td style="width:1.196%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.81%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.978%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.006%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.978%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.935%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.978%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.359%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements at Reporting Date Using&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted Prices in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Active Markets for&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Identical Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Observable Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificate of deposit&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored enterprise securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;115,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;156,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2021:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,088&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,088&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored enterprise securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91,861&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91,861&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;185,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;209,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:74.074%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;"&gt;(1)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in cash and cash equivalents on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;"&gt;(2)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in restricted cash on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;"&gt;(3)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in current portion of marketable securities on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;"&gt;(4)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in noncurrent portion of marketable securities on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Equity Investment&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In December 2007, we received &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,842,625&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; ordinary shares in Sienna Cancer Diagnostics Limited, or Sienna, in connection with a license we granted to them for our hTERT technology for use in human diagnostics. The shares, which represented less than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% ownership, were recorded at a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; cost basis under the cost method of accounting, upon receipt. Since the adoption of ASU 2016-01 on January 1, 2018, we reassessed the fair value of our equity investment in Sienna at each reporting date and any resulting change in fair value was recognized on our consolidated statements of operations. In April 2020, Sienna announced its merger with BARD1 Life Sciences Limited, or BARD1, subject to approval by Sienna&#x2019;s shareholders. Effective August 3, 2020, the merger was complete, and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;we received 13 BARD1 shares for every five shares of Sienna ordinary shares, resulting in our ownership of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35,990,825&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of BARD1.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;During the first quarter of 2021, we sold all of our holdings in BARD1 and recognized a net gain of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,233,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; from the sales, including gains from foreign currency translation adjustments, which has been included in other income and expense on our consolidated statements of operations. As of March 31, 2021, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; value remained for our equity investment in BARD1.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We currently place our cash, restricted cash, cash equivalents and marketable securities with &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; financial &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;institutions in the United States. Generally, these deposits may be redeemed upon demand and therefore, bear minimal risk. Deposits with banks may exceed the amount of insurance provided on such deposits. Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents and marketable securities. Cash equivalents and marketable securities currently consist of money market funds,&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;government-sponsored &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;enterprise securities, U.S. Treasury securities, municipal securities, commercial paper and corporate notes. Our investment policy, approved by the audit committee of our board of directors, limits the amount we may invest in any one type of investment issuer, thereby reducing credit risk concentrations. However, we are exposed to credit risk in the event of default by the financial institutions holding our cash and cash equivalents to the extent recorded in our consolidated balance sheets. We have not experienced any losses in such accounts and we believe that we are not exposed to significant credit risk of our financial position at the depository institutions in which those deposits are held.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_0f88f58a-5811-401f-bc4c-4f211e3e5181">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents, restricted cash and marketable securities by security type at &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:41.972%;"/&gt;
        &lt;td style="width:1.354%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market fund&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificate of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,983&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored enterprise securities &lt;br/&gt;&#160;&#160;&#160;(due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,860&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;116,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;115,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents, restricted cash and marketable securities by security type at December 31, 2021 were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:41.972%;"/&gt;
        &lt;td style="width:1.354%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.366%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.145%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in cash and cash equivalents:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;31,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Restricted cash:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market fund&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificate of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;364&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Marketable securities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities (due in &lt;br/&gt;&#160;&#160;&#160;one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,524&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities (due in &lt;br/&gt;&#160;&#160;&#160;one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored enterprise securities &lt;br/&gt;&#160;&#160;&#160;(due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;84,398&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;84,362&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,444&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,429&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;177,675&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;177,502&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a"
      decimals="-3"
      id="F_9dc22b00-2af5-43e2-af09-102567944b4b"
      unitRef="U_USD">39771000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a"
      decimals="-3"
      id="F_b9c8e91d-d12d-40e0-af33-2bbfb268223c"
      unitRef="U_USD">39771000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_94e28d5c-398d-479f-887e-12344c345851"
      unitRef="U_USD">39771000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_0b1c945f-bc2b-4f78-9603-26a11abf0260"
      unitRef="U_USD">39771000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a"
      decimals="-3"
      id="F_614a1881-2064-4618-a066-f6df9e12b20a"
      unitRef="U_USD">93000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="C_4a2adb7f-4903-4a37-bcd6-4dfc71bd717a"
      decimals="-3"
      id="F_cacadd3b-f44f-45d6-b68b-40c4aa116f2c"
      unitRef="U_USD">93000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_a7e69a6d-c732-438a-9a6d-1aab2a5533f7"
      decimals="-3"
      id="F_40304cb9-fc07-4c85-bce1-44adc45e33b2"
      unitRef="U_USD">271000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="C_a7e69a6d-c732-438a-9a6d-1aab2a5533f7"
      decimals="-3"
      id="F_818b1258-e21c-475c-9b4a-e3dee30b540d"
      unitRef="U_USD">271000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_b8f4f439-adc0-4543-a676-85dbc9bbb4b4"
      unitRef="U_USD">364000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_66eb6fca-d36f-4266-a243-5edf7f1cce5f"
      unitRef="U_USD">364000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"
      decimals="-3"
      id="F_f18bb94f-c046-4555-9e3a-85becb8103ce"
      unitRef="U_USD">12983000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"
      decimals="-3"
      id="F_320966ac-a879-4972-956d-0523c9caa679"
      unitRef="U_USD">62000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"
      decimals="-3"
      id="F_b8dc489d-f768-4f2b-9812-64281a32a44e"
      unitRef="U_USD">12921000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79"
      decimals="-3"
      id="F_d0869d39-ad70-474c-b4e3-d3e2dc79763d"
      unitRef="U_USD">3000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79"
      decimals="-3"
      id="F_d1632bb7-0112-4d54-9856-646ecf180109"
      unitRef="U_USD">24000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79"
      decimals="-3"
      id="F_111548c9-67ec-4b80-8ae3-be06255d98af"
      unitRef="U_USD">2976000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_9c4a1e4a-ddee-40c4-b8df-5752dec9177f"
      decimals="-3"
      id="F_ace861dc-9ab0-440c-97a8-1bef01aaa8b6"
      unitRef="U_USD">9860000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_9c4a1e4a-ddee-40c4-b8df-5752dec9177f"
      decimals="-3"
      id="F_c814777e-9e11-4ca5-a4a8-681ebf963158"
      unitRef="U_USD">14000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_9c4a1e4a-ddee-40c4-b8df-5752dec9177f"
      decimals="-3"
      id="F_1473d82a-b21c-4e59-9494-809235f0e25a"
      unitRef="U_USD">9846000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a"
      decimals="-3"
      id="F_75e483b8-1e0a-4f23-adf9-2a6a08d2c2ea"
      unitRef="U_USD">64285000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a"
      decimals="-3"
      id="F_c0f2e2c4-be3d-458d-b457-bd77ce7e2ffd"
      unitRef="U_USD">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a"
      decimals="-3"
      id="F_c047bc0f-8242-417b-8956-86caf9147468"
      unitRef="U_USD">92000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a"
      decimals="-3"
      id="F_f0f0432f-a980-43f9-a3f8-ba6841452741"
      unitRef="U_USD">64199000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a"
      decimals="-3"
      id="F_73e26987-d4a9-4c92-833d-1cab4235bbd6"
      unitRef="U_USD">26014000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a"
      decimals="-3"
      id="F_f8e99436-4e05-41fc-b223-f33c7be42ec0"
      unitRef="U_USD">55000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a"
      decimals="-3"
      id="F_4d69e3ad-d1d7-4872-97ed-1dd987fc83fd"
      unitRef="U_USD">25959000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_c2ac75e9-6156-4f2b-bbcf-eb8e0ecc6452"
      unitRef="U_USD">116142000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_f038aea0-00b9-4ffa-b367-c16d9ef87b83"
      unitRef="U_USD">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_e74dbd8a-69cb-49e9-be46-2ab5da7a97e2"
      unitRef="U_USD">247000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_a0a056b3-de05-4d20-9e21-43c5c36f6c63"
      unitRef="U_USD">115901000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_9d9caad1-b187-4705-af84-3d4912060cb5"
      decimals="-3"
      id="F_aaab3370-ddf8-4357-b656-706e508ab8c0"
      unitRef="U_USD">24207000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_9d9caad1-b187-4705-af84-3d4912060cb5"
      decimals="-3"
      id="F_e06f5d91-7d20-4f7d-ab7e-d1a168b264fb"
      unitRef="U_USD">24207000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_9985ac27-b487-43dc-84e4-99f5eb3e2ee4"
      decimals="-3"
      id="F_fbe3e244-e788-4e72-87f8-4a16f9850e28"
      unitRef="U_USD">7499000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_9985ac27-b487-43dc-84e4-99f5eb3e2ee4"
      decimals="-3"
      id="F_9af715ca-0c22-4583-920c-77456e1469c8"
      unitRef="U_USD">7499000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_e6641fd1-8d4a-4957-9168-1424884beabd"
      unitRef="U_USD">31706000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_9b8e351e-de79-4a6a-a5d2-c09fda66f175"
      unitRef="U_USD">31706000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_9d9caad1-b187-4705-af84-3d4912060cb5"
      decimals="-3"
      id="F_ba329412-440d-4b0c-adcc-c2725b0c7951"
      unitRef="U_USD">93000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="C_9d9caad1-b187-4705-af84-3d4912060cb5"
      decimals="-3"
      id="F_3350b496-5399-4962-978f-3cb0e6d55c27"
      unitRef="U_USD">93000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_d81bd636-0218-4286-b8c2-3cccfc33f5fe"
      decimals="-3"
      id="F_7673bdd8-8247-431b-8990-695a1fe22869"
      unitRef="U_USD">271000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="C_d81bd636-0218-4286-b8c2-3cccfc33f5fe"
      decimals="-3"
      id="F_fbf993e9-1df6-4957-b935-708f1fe69c25"
      unitRef="U_USD">271000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_86364816-8ed9-4013-889e-14a5921458df"
      unitRef="U_USD">364000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_2dbf901e-c9a7-4a08-aca1-d43cc0620339"
      unitRef="U_USD">364000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f"
      decimals="-3"
      id="F_8790f419-0a54-441e-abc3-237789540475"
      unitRef="U_USD">15585000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f"
      decimals="-3"
      id="F_354f6a08-51f8-4317-98b1-23e406e6046e"
      unitRef="U_USD">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f"
      decimals="-3"
      id="F_20578b79-2285-4b2f-bf38-b22663a5436a"
      unitRef="U_USD">15567000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee"
      decimals="-3"
      id="F_eb580a13-05f2-4f01-bf56-75d8c7386e36"
      unitRef="U_USD">1524000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee"
      decimals="-3"
      id="F_ac902949-fb01-4141-a800-8c9fba785016"
      unitRef="U_USD">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee"
      decimals="-3"
      id="F_16db4d2b-5e31-4779-a6b5-0b81ca431ca6"
      unitRef="U_USD">1521000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf"
      decimals="-3"
      id="F_74c6c496-a7ea-40ac-9ce8-0c56c393d3f2"
      unitRef="U_USD">3000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf"
      decimals="-3"
      id="F_1859e99f-3aad-4dfb-a841-74ba5a80fb57"
      unitRef="U_USD">15000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf"
      decimals="-3"
      id="F_e262b3b0-017b-4827-ae91-31681b17077a"
      unitRef="U_USD">2985000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_1dbff205-2f6f-4aba-8edf-3911a28267ba"
      decimals="-3"
      id="F_9c5892c2-4509-4ed1-a8ea-b26bee1c9a6a"
      unitRef="U_USD">12500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_1dbff205-2f6f-4aba-8edf-3911a28267ba"
      decimals="-3"
      id="F_e86b4054-0146-47c6-8a9a-8e8b9b770969"
      unitRef="U_USD">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_1dbff205-2f6f-4aba-8edf-3911a28267ba"
      decimals="-3"
      id="F_9b8cc09b-2283-4e60-85d3-2bdf5b1a8411"
      unitRef="U_USD">12493000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8"
      decimals="-3"
      id="F_48aff92e-4c74-46a5-b610-ae1e93a801d5"
      unitRef="U_USD">84398000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8"
      decimals="-3"
      id="F_ff112f6e-2892-431a-b3f5-798c4a5baa3d"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8"
      decimals="-3"
      id="F_cf8e645c-7d24-4900-9eab-7e20faffbe31"
      unitRef="U_USD">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8"
      decimals="-3"
      id="F_64e07ced-a1a5-44d6-82a3-1313fe160a5c"
      unitRef="U_USD">84362000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_d8e95986-943a-430c-9308-147c97f446ca"
      decimals="-3"
      id="F_69bb0795-24ba-414c-83bd-733a1bbefaed"
      unitRef="U_USD">36444000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_d8e95986-943a-430c-9308-147c97f446ca"
      decimals="-3"
      id="F_030bbd83-23ba-4cc6-b2f5-62d30a868e66"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_d8e95986-943a-430c-9308-147c97f446ca"
      decimals="-3"
      id="F_33fc6f72-7d80-4dc8-8a58-89f99fc78046"
      unitRef="U_USD">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_d8e95986-943a-430c-9308-147c97f446ca"
      decimals="-3"
      id="F_633085cb-9be6-42ee-84f6-b6e6ef60d697"
      unitRef="U_USD">36429000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2"
      decimals="-3"
      id="F_88f84b9d-f939-4472-be28-c5eedf34289b"
      unitRef="U_USD">24224000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2"
      decimals="-3"
      id="F_9fdadcd2-2ffe-48bb-8ae2-de4c09c4352a"
      unitRef="U_USD">79000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2"
      decimals="-3"
      id="F_1f350e84-b01d-4413-8408-6326f9d6415a"
      unitRef="U_USD">24145000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_e6cca21d-47db-465c-8d85-50b6c8ea7834"
      unitRef="U_USD">177675000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_0d19f4e9-bdf3-4c67-b446-a5ef914ed400"
      unitRef="U_USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_ce146d44-ed83-4fd5-949e-a885828c42b4"
      unitRef="U_USD">177000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_59454cc2-4e28-4b86-b62a-dca24bb30964"
      unitRef="U_USD">177502000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_adfe7e92-ba3d-4c09-a6db-3ec87a30377d">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents and marketable securities with unrealized losses that have been in a continuous unrealized loss position for less than 12 months and 12 months or longer at &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:27.719%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.868%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.162%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.613%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.404%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.627%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.122%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less Than 12 Months&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12 Months or Greater&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Estimated&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="4" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury &lt;br/&gt;&#160;&#160;&#160;securities (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,424&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,497&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities &lt;br/&gt;&#160;&#160;&#160;(due in less than a&lt;br/&gt;&#160;&#160;&#160;year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored &lt;br/&gt;&#160;&#160;&#160;enterprise securities &lt;br/&gt;&#160;&#160;&#160;(due in less than &lt;br/&gt;&#160;&#160;&#160;one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;br/&gt;&#160;&#160;&#160;(due in less than&lt;br/&gt;&#160;&#160;&#160;one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;52,454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;52,454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;92&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,998&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,960&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28,435&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;82&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;104,156&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2021:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury &lt;br/&gt;&#160;&#160;&#160;securities (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,567&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury &lt;br/&gt;&#160;&#160;&#160;securities (due in &lt;br/&gt;&#160;&#160;&#160;one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,521&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities &lt;br/&gt;&#160;&#160;&#160;(due in one to two &lt;br/&gt;&#160;&#160;&#160;years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored &lt;br/&gt;&#160;&#160;&#160;enterprise securities &lt;br/&gt;&#160;&#160;&#160;(due in less than &lt;br/&gt;&#160;&#160;&#160;one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,993&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;br/&gt;&#160;&#160;&#160;(due in less than&lt;br/&gt;&#160;&#160;&#160;one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;66,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in &lt;br/&gt;&#160;&#160;&#160;less than one year)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes (due in &lt;br/&gt;&#160;&#160;&#160;one to two years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,145&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;128,591&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,993&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;133,584&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"
      decimals="-3"
      id="F_acacc255-0a77-4719-8988-d44f03265df2"
      unitRef="U_USD">11424000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"
      decimals="-3"
      id="F_2222e890-fb61-4fd8-b90f-8da56c47dd89"
      unitRef="U_USD">57000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"
      decimals="-3"
      id="F_252cfda5-bf97-4fe4-b7b5-864207a2ca5e"
      unitRef="U_USD">1497000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"
      decimals="-3"
      id="F_95b9b147-7da6-4318-b623-63b48fd2d2d9"
      unitRef="U_USD">5000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"
      decimals="-3"
      id="F_ba52538e-b488-49c5-8405-a8f4aab91e37"
      unitRef="U_USD">12921000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_0a437c23-9a03-43d2-ab9a-a189c6bd674e"
      decimals="-3"
      id="F_12be089b-d98b-4dc1-9970-12173be8e73b"
      unitRef="U_USD">62000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79"
      decimals="-3"
      id="F_e69b2ea8-3285-4cfb-bcef-002c5dc8b75a"
      unitRef="U_USD">2976000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79"
      decimals="-3"
      id="F_290b6c49-f90e-46e6-9fb0-4150a0327d50"
      unitRef="U_USD">24000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79"
      decimals="-3"
      id="F_0544c403-ca06-4ea4-86a7-6d2d2a22a4b8"
      unitRef="U_USD">2976000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_c25e7348-7048-4607-8352-1048d40e8f79"
      decimals="-3"
      id="F_b5fc6dd9-f9b2-404f-933e-d7db2ae1e3d5"
      unitRef="U_USD">24000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_53f68612-65e0-46e6-9f29-f76b1403dad8"
      decimals="-3"
      id="F_5680c1ba-477c-4cbc-af08-da95eae440c8"
      unitRef="U_USD">9845000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_53f68612-65e0-46e6-9f29-f76b1403dad8"
      decimals="-3"
      id="F_955287d7-e941-4437-a513-e21c0c736141"
      unitRef="U_USD">14000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_53f68612-65e0-46e6-9f29-f76b1403dad8"
      decimals="-3"
      id="F_98a5970f-ace7-49b1-a3c6-de5e87fa4e59"
      unitRef="U_USD">9845000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_53f68612-65e0-46e6-9f29-f76b1403dad8"
      decimals="-3"
      id="F_9c805caf-60a3-4415-89b7-e3832ffc5aba"
      unitRef="U_USD">14000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a"
      decimals="-3"
      id="F_5a8628e3-f143-44a6-86ce-bf6eff095852"
      unitRef="U_USD">52454000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a"
      decimals="-3"
      id="F_91058098-2f70-4d38-985c-4f6fb9da9588"
      unitRef="U_USD">92000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a"
      decimals="-3"
      id="F_93eb7484-1c1f-444b-b042-f0634e7ad131"
      unitRef="U_USD">52454000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_a42ef773-e97a-473e-b41a-016b95e3980a"
      decimals="-3"
      id="F_b7eab686-f265-46de-8a6c-746a705fd486"
      unitRef="U_USD">92000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a"
      decimals="-3"
      id="F_7a459aad-3f3d-4333-a80c-3b39a390de15"
      unitRef="U_USD">1998000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a"
      decimals="-3"
      id="F_c855abaf-0fef-4fca-91a7-33ff542b485b"
      unitRef="U_USD">2000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a"
      decimals="-3"
      id="F_d002185a-f326-4bba-a002-9b1894b98af8"
      unitRef="U_USD">23962000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a"
      decimals="-3"
      id="F_faebfb0b-d828-46d8-b3aa-52322b33cb2e"
      unitRef="U_USD">53000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a"
      decimals="-3"
      id="F_6c0ed0d3-b529-4861-a00b-0a072102ace1"
      unitRef="U_USD">25960000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_b0bbca5f-033b-4845-9d80-bbded572734a"
      decimals="-3"
      id="F_cfcf8239-a10f-4b45-b3f9-ff06ddfac053"
      unitRef="U_USD">55000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_81c674a0-805e-4b55-9ddd-f1273e6bc532"
      unitRef="U_USD">75721000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_aa412174-5f53-4d37-9964-5360f95a07fb"
      unitRef="U_USD">165000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_3a071ece-145a-4d9c-bbf2-1e63fa997414"
      unitRef="U_USD">28435000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_803ff372-d584-4864-b569-4d667a8a053f"
      unitRef="U_USD">82000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_db8129c5-4882-4395-9cd5-32c18c4340a1"
      unitRef="U_USD">104156000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_b892f14b-de82-4239-901c-2630ca350f2f"
      unitRef="U_USD">247000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f"
      decimals="-3"
      id="F_b7aeb44a-2018-481d-8f4e-a51cb8f7811a"
      unitRef="U_USD">15567000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f"
      decimals="-3"
      id="F_42b1167e-b89e-48f9-9db5-954a96df04b8"
      unitRef="U_USD">18000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f"
      decimals="-3"
      id="F_5c5af7dd-589a-4fb0-92d0-867e9f1436f2"
      unitRef="U_USD">15567000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_e1b94872-27d1-4a8f-ba6a-5bccc80b084f"
      decimals="-3"
      id="F_ceaade37-73c8-4b04-9dab-82d7d5f5467a"
      unitRef="U_USD">18000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee"
      decimals="-3"
      id="F_097a3468-bdda-4869-91b0-0ad37cff817b"
      unitRef="U_USD">1521000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee"
      decimals="-3"
      id="F_70e31606-454a-4775-875c-156fd195e980"
      unitRef="U_USD">3000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee"
      decimals="-3"
      id="F_e1c82064-ffa5-4d74-a7e6-a150b1236cd9"
      unitRef="U_USD">1521000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_ccde2552-23ce-42cd-8f03-8868e1c3afee"
      decimals="-3"
      id="F_5ad40101-9a82-4816-a14d-df208c974d0c"
      unitRef="U_USD">3000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf"
      decimals="-3"
      id="F_88dadd29-1d36-49c7-888b-9d1f48b9f81a"
      unitRef="U_USD">2985000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf"
      decimals="-3"
      id="F_038c2053-3d26-4e0d-bfb1-e58e4a60caa8"
      unitRef="U_USD">15000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf"
      decimals="-3"
      id="F_6533b4a3-7483-42c9-aed9-9103a566b1b4"
      unitRef="U_USD">2985000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_f4af7fbd-4d88-4bd2-b0a0-7b7ca69876cf"
      decimals="-3"
      id="F_19ce5250-30f9-4e3f-b45e-fc7e4d378a4a"
      unitRef="U_USD">15000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7"
      decimals="-3"
      id="F_600ec2f3-db17-4e45-8118-d708f1243941"
      unitRef="U_USD">1500000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7"
      decimals="-3"
      id="F_a57de996-546d-4518-bcfb-b5774fdf74e1"
      unitRef="U_USD">4993000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7"
      decimals="-3"
      id="F_cd5bc296-d84a-4412-ae11-e6b5690945df"
      unitRef="U_USD">7000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7"
      decimals="-3"
      id="F_88fed3b2-6114-40ad-90f5-f936a60e2f79"
      unitRef="U_USD">6493000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_48f80dba-88b9-464b-b378-7d4f9dec15e7"
      decimals="-3"
      id="F_deab422e-6816-440b-8fd9-2e93b3f3d467"
      unitRef="U_USD">7000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8"
      decimals="-3"
      id="F_d1286eaa-f548-462b-a3fa-3a05ca49b1d8"
      unitRef="U_USD">66872000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8"
      decimals="-3"
      id="F_27d37435-fd85-448c-a5d4-393a1fbf43b9"
      unitRef="U_USD">38000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8"
      decimals="-3"
      id="F_888482e2-fc4b-455f-8aea-bbae6142229e"
      unitRef="U_USD">66872000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_80164d16-83fd-44b2-b84d-550276c31ca8"
      decimals="-3"
      id="F_a52aeb7f-8dbc-4232-ac26-780f4aca0ae9"
      unitRef="U_USD">38000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_d8e95986-943a-430c-9308-147c97f446ca"
      decimals="-3"
      id="F_5f6730ad-8164-4646-8133-caaf46ae1a91"
      unitRef="U_USD">16001000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_d8e95986-943a-430c-9308-147c97f446ca"
      decimals="-3"
      id="F_2b5adaf1-a22d-4680-beec-bec76b407b88"
      unitRef="U_USD">17000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_d8e95986-943a-430c-9308-147c97f446ca"
      decimals="-3"
      id="F_8910c82c-6d78-4d4a-a012-33121b8214f5"
      unitRef="U_USD">16001000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_d8e95986-943a-430c-9308-147c97f446ca"
      decimals="-3"
      id="F_fff5f4ef-0195-42ed-ab2b-e00b81a11a14"
      unitRef="U_USD">17000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2"
      decimals="-3"
      id="F_579ebedc-8d65-47c7-abf6-fe1eeefb9f5a"
      unitRef="U_USD">24145000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2"
      decimals="-3"
      id="F_a51236a1-37cd-49c5-9bf8-b97756febc47"
      unitRef="U_USD">79000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2"
      decimals="-3"
      id="F_13387a18-0b8b-409e-9289-4b29753ac6bf"
      unitRef="U_USD">24145000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_eb5e283e-aa95-4522-b670-5622af075da2"
      decimals="-3"
      id="F_93865a5e-544c-4921-a4bd-6c400a6b25fe"
      unitRef="U_USD">79000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_c50dd786-391d-43a4-a313-9bbb0d14627e"
      unitRef="U_USD">128591000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_be45d567-f6ff-4dbb-85fa-72a2158d5588"
      unitRef="U_USD">170000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_6c3925d7-5d64-4f8a-af26-93e411d6944d"
      unitRef="U_USD">4993000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_662de451-395a-438c-be5e-ad51d75b7eb2"
      unitRef="U_USD">7000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_d8960360-9c11-4144-b401-16371d0f143f"
      unitRef="U_USD">133584000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_2c2323fa-cf21-454f-8ee2-bf1f7095c02c"
      unitRef="U_USD">177000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_9fa638eb-a216-4331-91a8-65e8b7cebb0d">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents information about our financial instruments that are measured at fair value on a recurring basis as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021 and indicates the fair value category assigned.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:44.762%;"/&gt;
        &lt;td style="width:1.196%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.81%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.978%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:12.006%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.978%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.935%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.978%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.359%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair Value Measurements at Reporting Date Using&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Quoted Prices in&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Active Markets for&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unobservable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Identical Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Observable Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;39,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certificate of deposit&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;271&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,921&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,976&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored enterprise securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,959&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40,135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;115,901&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;156,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2021:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. Treasury securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,088&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,088&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Government-sponsored enterprise securities&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,493&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)(3)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91,861&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91,861&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate notes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(3)(4)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60,574&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,207&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;185,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;209,208&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;"&gt;(1)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in cash and cash equivalents on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;"&gt;(2)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in restricted cash on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;"&gt;(3)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in current portion of marketable securities on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;"&gt;(4)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Included in noncurrent portion of marketable securities on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1bd32fc3-5385-4fc1-8876-a5ae5a63137b"
      decimals="-3"
      id="F_6af94f60-d14c-46f9-8d81-f6e285dee2b4"
      unitRef="U_USD">39864000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_b2a2ed0b-eacb-4d70-8bd1-ea1bfa4295ef"
      decimals="-3"
      id="F_5f777006-9859-4b19-aa7b-a77d7850a6f3"
      unitRef="U_USD">39864000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_a277aece-144d-41bf-ac57-a96d6580356c"
      decimals="-3"
      id="F_11dbd71a-8e2c-4046-b773-4ac04c59485a"
      unitRef="U_USD">271000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_15ca08dc-811e-4853-9a21-7cadf99c377c"
      decimals="-3"
      id="F_33fa973f-91c2-419e-8db5-584f2cb4a498"
      unitRef="U_USD">271000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c1282d3f-c653-4ad5-895b-9c6f061f0d82"
      decimals="-3"
      id="F_73f06beb-fc41-46e1-9985-2de7cb4820bf"
      unitRef="U_USD">12921000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_8cfe8a11-2aaf-4633-afe2-e2611965102d"
      decimals="-3"
      id="F_f1df1cd0-58a9-4ae5-ad23-e514cba34ea3"
      unitRef="U_USD">12921000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_771ba2f2-3a2e-49fa-95cf-19050fec9326"
      decimals="-3"
      id="F_24d3ff94-4ced-4072-a2fd-b2c0f1dda975"
      unitRef="U_USD">2976000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_5c61e68e-3e69-41cb-8620-6254f8ecadab"
      decimals="-3"
      id="F_83be3b42-c0ad-4e9c-8273-d1664ed0ffe1"
      unitRef="U_USD">2976000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_3ddd7b62-3be3-4f53-81bf-05b1841c6fb1"
      decimals="-3"
      id="F_93485a8c-38d0-4436-97fd-44c4857433db"
      unitRef="U_USD">9846000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_2fbdf3b1-b70e-4491-98dc-8a732e4ad69a"
      decimals="-3"
      id="F_d3f4aa34-1298-4b1f-aea7-d9ccf55026fa"
      unitRef="U_USD">9846000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_65c0c19d-b9d5-425b-8f80-5c1480a5777f"
      decimals="-3"
      id="F_34d0f506-694b-4e3f-9062-a6cc4b00dcda"
      unitRef="U_USD">64199000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_549c9ca4-a070-4d8b-8dea-097cccf0168e"
      decimals="-3"
      id="F_c7230486-97cb-4c58-a514-5f3ac50a9a09"
      unitRef="U_USD">64199000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_97fcaa43-bed8-4b86-a62c-6f9d8b9c790c"
      decimals="-3"
      id="F_15c6376b-e2ec-443e-9f0e-49283bc71b60"
      unitRef="U_USD">25959000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_876ba767-8660-41ef-8db0-cd6ad696ef32"
      decimals="-3"
      id="F_af2b65ce-2ec5-448c-bbd7-9f4ee16cf3e8"
      unitRef="U_USD">25959000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_dbeb080e-402b-4949-8760-3551ff83fae6"
      decimals="-3"
      id="F_6c7c4330-c6e2-47cd-81f2-02315263588a"
      unitRef="U_USD">40135000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_5fc3a521-0418-415b-ac73-ad0099a49a25"
      decimals="-3"
      id="F_179ec6aa-97bb-40f1-9028-5cef2f13b020"
      unitRef="U_USD">115901000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_6dfbe752-26a8-4b61-804f-713c8b76e3b2"
      decimals="-3"
      id="F_c48372ea-f181-451f-bdfd-79f0dae05c45"
      unitRef="U_USD">156036000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1d4e0718-b0bc-4bde-abe3-dd33013adfd1"
      decimals="-3"
      id="F_505d5fdb-b051-4e32-bd6c-4e11c6e68cb8"
      unitRef="U_USD">24207000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_6c35c921-9678-4686-aae9-1f7c867e1bf1"
      decimals="-3"
      id="F_06275670-892a-4005-89bc-60b7343dfce0"
      unitRef="U_USD">24207000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_cedb5760-788e-4697-a91b-595a15fe918f"
      decimals="-3"
      id="F_4f5e7a78-5677-450b-a9fa-48628fe677d5"
      unitRef="U_USD">17088000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_2df5fcf2-ae81-4411-9005-55dc5786810b"
      decimals="-3"
      id="F_3582f90f-3775-4e1f-ae86-a776d587bed6"
      unitRef="U_USD">17088000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_0dfd4851-82fe-4cb9-8ea1-8e34b2a9c816"
      decimals="-3"
      id="F_887d520a-f9ba-4ee6-a8cc-908bd6f8c62b"
      unitRef="U_USD">2985000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_82638e68-0f41-4c08-bac3-823ad702cd9a"
      decimals="-3"
      id="F_93274db8-4a19-4b24-8ab3-f2058ace4c3a"
      unitRef="U_USD">2985000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_2df0f37c-c30d-41b8-bfdd-adc5d10dafdf"
      decimals="-3"
      id="F_6c6b974f-bc70-477c-b36f-9d7101cf1bc2"
      unitRef="U_USD">12493000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_648decac-61a1-4e4b-9ed3-d82a76be83ef"
      decimals="-3"
      id="F_9144d2f2-c38a-4590-8d25-7c4ccae27ce5"
      unitRef="U_USD">12493000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_67437463-073a-4955-8276-418e60d06173"
      decimals="-3"
      id="F_557acbea-1636-4a35-ba40-6a892a0128fd"
      unitRef="U_USD">91861000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4f5a5bab-8021-4724-80ff-5ed5222dffe6"
      decimals="-3"
      id="F_6fdf8edc-7923-4996-aca2-f95942d6f1f1"
      unitRef="U_USD">91861000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_00475ab1-e9e1-429c-8b5f-a7102a011121"
      decimals="-3"
      id="F_6cc28668-a96c-4fc1-a9df-13699b24add0"
      unitRef="U_USD">60574000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_73738e9e-def3-4ee6-be15-64304b5e3b63"
      decimals="-3"
      id="F_9383275d-10e9-425c-8ad5-675667c6a6bf"
      unitRef="U_USD">60574000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_49598f56-03d9-4dbd-bdcf-22537e7a9cdc"
      decimals="-3"
      id="F_58a9cf0f-a89d-4c04-869c-f52b8e86c4d4"
      unitRef="U_USD">24207000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_d2345eb5-3285-459c-8d09-b6264509d71b"
      decimals="-3"
      id="F_8f3d3a80-45cb-4f08-98c5-01bfe9e94915"
      unitRef="U_USD">185001000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_638535ad-bd14-404f-b802-160cfe13fd2e"
      decimals="-3"
      id="F_2e8deb56-e867-4ed0-9cf1-1ecff95a437e"
      unitRef="U_USD">209208000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="C_51f08322-078d-49e5-a68a-9be92cd9298d"
      decimals="INF"
      id="F_ae3c75c7-3228-49cc-911b-544e56289a04"
      unitRef="U_shares">13842625</us-gaap:InvestmentOwnedBalanceShares>
    <gern:CostMethodInvestmentOwnershipPercentage
      contextRef="C_17094203-716a-4cd1-bfc5-d68528adcc58"
      decimals="INF"
      id="F_c96825ad-dd63-4670-91a0-c4d07da81615"
      unitRef="U_pure">0.20</gern:CostMethodInvestmentOwnershipPercentage>
    <gern:CostMethodInvestmentsCostBasis
      contextRef="C_1e9362c9-abee-4e6e-9b1f-44d66edd6913"
      decimals="0"
      id="F_b08b7af9-73cd-43c6-921c-689e296b6a68"
      unitRef="U_USD">0</gern:CostMethodInvestmentsCostBasis>
    <us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod
      contextRef="C_d86d7526-9741-423f-bbce-ccac767d714b"
      id="F_240d987c-0fbd-4137-92bd-904baf57be45">we received 13 BARD1 shares for every five shares of Sienna ordinary shares, resulting in our ownership of 35,990,825 shares of BARD1.</us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="C_0c264877-8e22-46f9-81fb-86523d23e816"
      decimals="0"
      id="F_3ed7d8e4-5cab-46de-9c3b-c515d50d7d4f"
      unitRef="U_shares">35990825</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="C_7ec69a5c-401a-4250-9b22-6bf9e011ced3"
      decimals="0"
      id="F_b8cc4a44-dad6-4969-abd5-c34772fc8c84"
      unitRef="U_USD">1233000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="C_ceb4ddb1-f869-4bd6-84c2-9da20049ed84"
      decimals="INF"
      id="F_e0bbdae5-bd56-49aa-88f1-3661d4804891"
      unitRef="U_shares">0</us-gaap:InvestmentOwnedBalanceShares>
    <gern:NumberOfFinancialInstitutions
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_a62c9782-7a2f-4a0a-943a-c1c36a91dbeb"
      unitRef="U_Institution">5</gern:NumberOfFinancialInstitutions>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_1e444280-68c2-4619-8fd4-ceff34c38238">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3. PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, stated at cost, is comprised of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.186%;"/&gt;
        &lt;td style="width:1.214%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.701%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.214%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.686%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,554&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,171&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,689&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;896&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;793&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_bb82eae4-9dd5-4509-8dc8-f9d93517ae07">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment, stated at cost, is comprised of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.186%;"/&gt;
        &lt;td style="width:1.214%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.701%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.214%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.686%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Furniture and computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,554&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,171&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;135&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;129&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,689&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;896&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;793&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;650&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_7763dbfa-0c47-4691-b0c0-db932124a4fd"
      decimals="-3"
      id="F_5ee07adf-2cb7-4a2d-9b2a-54fef239fd83"
      unitRef="U_USD">1554000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_c5ddc099-a29b-4862-ab9f-bc6cd0c2eeb4"
      decimals="-3"
      id="F_9a787a4f-a0f3-4a69-a0a5-0d85c9a13acf"
      unitRef="U_USD">1171000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_7edff532-41dd-4915-82d0-0b9e814e4cc5"
      decimals="-3"
      id="F_54cb97ee-8818-416d-83c8-b1d55c24e2c3"
      unitRef="U_USD">135000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_7499ed6b-e67c-4f6e-a715-1f45f02f42a6"
      decimals="-3"
      id="F_0e957d55-68ad-4dce-b706-98badae66e1c"
      unitRef="U_USD">129000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_be23151a-21ee-4858-a612-513d152cd6c7"
      unitRef="U_USD">1689000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_8e3dbe35-b2c9-43c6-b10c-43c244ced846"
      unitRef="U_USD">1300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_c04e4b9f-698a-42f6-9d6f-d314c384ded9"
      unitRef="U_USD">896000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_ba1f9e7c-84ac-4ac7-8fdb-0d59c8d89f00"
      unitRef="U_USD">650000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_d2298e9f-305e-4326-9f1e-f6abb67a748c"
      unitRef="U_USD">793000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_e01d2a13-d419-487c-ad9a-c4667a468d33"
      unitRef="U_USD">650000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_f3a24461-5e06-427a-805e-26811dfde2ce">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4. LICENSE AGREEMENT&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Janssen Pharmaceuticals, Inc. License Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.587%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On September 15, 2016, we entered into the License Agreement with Janssen Pharmaceuticals whereby we granted to Janssen Pharmaceuticals an exclusive worldwide license, or the Exclusive License, under our proprietary patents for the research, development and commercialization of products based on specialized oligonucleotide backbone chemistry and novel amidates for ribonucleic acid interference. In addition to the Exclusive License, we granted to Janssen Pharmaceuticals a non&#x2011;exclusive worldwide license, or the Non&#x2011;Exclusive License, under our patents covering the synthesis of monomers. This agreement was terminated effective April 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_830f0a46-343a-4026-89c3-ccc4263dd07f">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued liabilities consisted of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&#160;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:58.192%;"/&gt;
        &lt;td style="width:1.964%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.933%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.964%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.948%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;CRO and clinical trial costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Manufacturing activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,321&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,123&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Professional legal and accounting fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,030&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;561&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;510&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,834&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_800086c0-1420-4494-9098-962e4ad2693f">
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:58.192%;"/&gt;
        &lt;td style="width:1.964%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.933%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.964%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.948%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;CRO and clinical trial costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Manufacturing activities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,321&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,123&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Professional legal and accounting fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,030&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;561&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;510&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;541&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,834&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <gern:AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_3833a5b2-4063-4313-b885-7f4dc4551d21"
      unitRef="U_USD">17040000</gern:AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent>
    <gern:AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_a5d1d4e7-7353-422d-ba11-9abcaa779033"
      unitRef="U_USD">22804000</gern:AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent>
    <gern:AccruedManufacturingActivitiesCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_76079f50-66f8-4597-811c-715cdc7815c7"
      unitRef="U_USD">5321000</gern:AccruedManufacturingActivitiesCurrent>
    <gern:AccruedManufacturingActivitiesCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_a0cdd597-3b9d-4203-93a8-363c74e5afb2"
      unitRef="U_USD">4123000</gern:AccruedManufacturingActivitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_6a38c90e-e8eb-453a-8dbb-4adf9d0b6902"
      unitRef="U_USD">9668000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_f81e58e2-2568-46a0-8c13-1841dfb5b8bb"
      unitRef="U_USD">2030000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_5d5e19f6-9879-4871-8e6d-9f55f2be135e"
      unitRef="U_USD">561000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_a44238b8-a01b-42f6-a5c1-57d70f5dca07"
      unitRef="U_USD">336000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_047209bf-b12d-46a5-a705-3a6a3386368a"
      unitRef="U_USD">510000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_ece60b8c-f941-46d0-9dbe-e59f5f1c3d6d"
      unitRef="U_USD">541000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_93c72b3c-7b8c-4097-b701-a9e21311ea4d"
      unitRef="U_USD">33100000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_6b883de7-ca2d-4277-a20b-185e2e33e9c5"
      unitRef="U_USD">29834000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_b06fe4c6-8182-4870-8f9a-82854693a01a">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6. COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Purported Securities Lawsuits&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Between &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;January 23, 2020 and March 5, 2020, three securities class action lawsuits were filed against us and certain of our officers. One of the lawsuits was voluntarily dismissed on March 19, 2020. The other two lawsuits, filed in the U.S. District Court, or the Court, for the Northern District of California, or the Northern District, were consolidated by the Court on May 14, 2020, and on August 20, 2020, the lead plaintiffs filed a consolidated class action complaint. The consolidated class action complaint alleges violations of the Securities Exchange Act of 1934, as amended, or the Exchange Act, in connection with allegedly false and misleading statements made by us related to IMbark during the period from March 19, 2018, to September 26, 2018. The consolidated class action complaint alleges, among other things, that we violated Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5 by failing to disclose facts related to the alleged failure of IMbark to meet the two primary endpoints of the trial, spleen response rate and Total Symptom Score, and that our stock price dropped when such information was disclosed. The plaintiffs in the consolidated class action complaint seek damages and interest, and an award of reasonable costs, including attorneys&#x2019; fees. On October 22, 2020, lead plaintiffs filed an amended consolidated class action complaint.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;filed a motion to dismiss the amended consolidated class action complaint on November 23, 2020. On April 12, 2021, the Court granted in part and denied in part our motion to dismiss. Our answer to the amended consolidated class action complaint was filed on May 13, 2021. On September 30, 2021, lead plaintiffs filed their motion for class certification, and on April 2, 2022, the Court granted the lead plaintiffs&#x2019; motion for class certification. On &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;September 2, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the parties agreed to a settlement and entered into a Stipulation and Agreement of Settlement, or the Stipulation, which is subject to court approval. On October 13, 2022, the Court preliminarily approved the parties&#x2019; settlement, permitted notice to be distributed to the class members, and scheduled a final approval hearing for March 30, 2023. Final approval of the settlement is subject to a number of conditions and contingencies out of our control. There can be no guarantee that all of these conditions and contingencies will occur. Should a material condition or contingency to the settlement fail to occur, one or both of the parties to the settlement may exercise their right to terminate the settlement agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under the terms of the Stipulation, in exchange for the release and dismissal with prejudice of all claims against the defendants in the consolidated class action complaint, we agreed to pay and/or to cause our insurance carriers to pay a total of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;24,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, comprised of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in cash, which was paid into an escrow account under our available D&amp;amp;O insurance coverage and, at our election, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in either shares of our common stock and/or cash which is payable after final approval of the settlement by the Court. The proposed settlement does not constitute an admission of fault or wrongdoing by Geron or our Chief Executive Officer. The proposed settlement remains subject to final approval by the Court and certain other conditions. As of December 31, 2022, our portion of the settlement amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; has been included in accrued liabilities on our consolidated balance sheets and recognized as general and administrative expense on our consolidated statements of operations for the year ended December 31, 2022.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Between April 23, 2020 and June 8, 2021, seven shareholder derivative actions were filed, naming as defendants certain of our current officers and certain current and former members of our board. Of these actions, or the Derivative Lawsuits, two were filed in the Northern District, two were filed in the Court of Chancery of the State of Delaware, two were filed in the U.S. District Court for the District of Delaware, and one was filed in the Superior Court of California for the County of San Mateo, respectively. The plaintiffs in the Derivative Lawsuits allege breach of fiduciary duty and/or violations of Section 14 of the Exchange Act, based on the same underlying facts as the consolidated class action lawsuit described above. The plaintiffs seek damages, corporate governance reforms, equitable relief, restitution, and an award of reasonable costs, including attorneys&#x2019; fees. The status of the seven Derivative Lawsuits is currently as follows:&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On July 2, 2021, we filed a motion to dismiss the consolidated shareholder derivative actions filed in the Court of Chancery of the State of Delaware, or the Chancery Court Derivative Lawsuits. On September 1, 2021, the plaintiffs filed a consolidated amended complaint in the Chancery Court Derivative Lawsuits. On October 12, 2021, we filed our motion to dismiss the consolidated amended complaint. The Court of Chancery of the State of Delaware heard oral argument on the motion on February 15, 2022, and, on June 22, 2022, issued an order staying its decision on our motion to dismiss until after final resolution of the consolidated class action lawsuit described above. On December 21, 2022, the parties in the Chancery Court Derivative Lawsuits entered into a Stipulation of Settlement, or the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the Chancery Court Derivative Lawsuits. A final approval hearing regarding the Derivative Stipulation has been scheduled for May 17, 2023. Final approval of the settlement is subject to a number of conditions and contingencies out of our control. There can be no guarantee that all of these conditions and contingencies will occur. Should a material condition or contingency to the settlement fail to occur, one or more of the parties to the settlement may exercise their right to terminate the settlement agreement;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The consolidated shareholder derivative actions filed in the U.S. District Court for the District of Delaware have been stayed pending the ruling on our motion to dismiss the Chancery Court Derivative Lawsuits. On &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 21, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the parties in the consolidated District of Delaware derivative actions entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated District of Delaware derivative actions;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The consolidated shareholder derivative actions filed in the Northern District were initially stayed through the ruling on our motion to dismiss in the consolidated class action lawsuit described above and then subsequently were stayed through the ruling on the lead plaintiffs&#x2019; motion for class certification in the consolidated class action lawsuit. Subsequent to the grant of class certification in the consolidated class action lawsuit, on May 3, 2022, the Northern District entered an order providing plaintiffs until June 7, 2022, to file an amended complaint. On June 7, 2022, plaintiffs filed an amended shareholder derivative complaint. On July 6, 2022, the Northern District entered an order staying the consolidated shareholder derivative actions filed in the Northern District until the earlier of either a public &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.528%;text-indent:0;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"/&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;announcement of a settlement in the consolidated class action lawsuit or a final, non-appealable judgment in the consolidated class action lawsuit. The stay has subsequently been extended on a number of occasions and the case is currently stayed through March 31, 2023. On December 21, 2022, the parties in the consolidated derivative actions in the Northern District entered into the Derivative Stipulation, that, subject to final approval by the Court of Chancery of the State of Delaware, will resolve the consolidated derivative actions in the Northern District; and&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Our motion to dismiss the shareholder derivative action pursuant to the forum selection clause in our amended and restated bylaws was filed in the Superior Court of California for the County of San Mateo on August 5, 2021. At the hearing on the motion to dismiss on November 2, 2021, the court granted our motion to dismiss and stayed the case until April 19, 2022. At the case management conference on April 19, 2022, the court continued the stay until June 14, 2022. At the case management conference on June 14, 2022, the court continued the stay until December 13, 2022. On December 13, 2022, the court dismissed the action without prejudice.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under the terms of the Derivative Stipulation, in exchange for the release and dismissal with prejudice of all claims against the defendants in the consolidated shareholder derivative actions filed in the Northern District, we agreed to pay and/or to cause our insurance carriers to pay a total of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,350,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, comprised of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;525,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in cash, which is payable under our available D&amp;amp;O insurance coverage and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;825,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in cash payable by us. The proposed settlement remains subject to final approval by the Court and certain other conditions, upon which the settlement amounts are payable. The proposed settlement does not constitute an admission of fault or wrongdoing by our current officers or current and former members of our board. As of December 31, 2022, we have recorded the total settlement amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,350,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; as accrued liabilities and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;525,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; as interest and other receivables on our consolidated balance sheets. For the year ended December 31, 2022, we have recognized our portion of the settlement of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;825,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; as general and administrative expense on our consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The pending lawsuits and any other related lawsuits are subject to inherent uncertainties, and the actual defense and disposition costs will depend upon many unknown factors. The outcome of the pending lawsuits and any other related lawsuits is necessarily uncertain. We could be forced to expend significant resources in the defense against the pending lawsuits and any other related lawsuits, and we may not prevail. In addition, we have and may continue to incur substantial legal fees and costs in connection with such lawsuits. As discussed above, we have recorded the total settlement amount for the Derivative Stipulation on our consolidated balance sheets as of December 31, 2022 and our portion of the settlement amount under the Stipulation remains accrued on our consolidated balance sheets as of December 31, 2022. We currently are not able to estimate the possible additional costs to us, if any, from these matters, and we cannot be certain how long it may take to resolve the pending lawsuits or the possible amount of any damages or legal costs that we may be required to pay. Such amounts could be material to our consolidated financial statements if we do not prevail in the defense against the pending lawsuits and any other related lawsuits, or even if we do prevail. We have not established any reserve for any potential liability relating to the pending lawsuits and any other related lawsuits, other than settlement amounts under the Stipulation and the Derivative Stipulation. It is possible that we could, in the future, incur judgments or enter into settlements of claims for monetary damages.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Indemnifications to Officers and Directors&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Our corporate bylaws require that we indemnify our directors, as well as those who act as directors and officers of other entities at our request, against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred in connection with any proceedings arising out of their services to Geron. In addition, we have entered into separate indemnification agreements with each of our directors and officers which provide for indemnification of these directors and officers under similar circumstances and under additional circumstances. The indemnification obligations are more fully described in our bylaws and the indemnification agreements. We purchase standard insurance to cover claims or a portion of the claims made against our directors and officers. Since a maximum obligation is not explicitly stated in our bylaws or in our indemnification agreements and will depend on the facts and circumstances that arise out of any future claims, the overall maximum amount of the obligations cannot be reasonably estimated.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Severance Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;have an Amended and Restated Severance Plan, or Severance Plan, that applies to all employees that are (i) above the Vice President level, (ii) hired by the Company before January 1, 2022, or (iii) not subject to performance improvement plans, and provides for, among other benefits: (i) a severance payment upon a Change of Control Triggering Event and Separation from Service and (ii) a severance payment for each non&#x2011;executive employee upon a Non&#x2011;Change of Control Triggering Event and Separation from Service. As defined in the&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Severance &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Plan, a Change of Control Triggering Event and Separation from Service requires a &#x201c;double trigger&#x201d; where: (i) an employee is terminated by us without cause in connection with a change of control or within &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months following a change of control provided, however, that if an employee is terminated by us in connection with a change of control but immediately accepts employment with our successor or acquirer, the employee will not be eligible for the benefits outlined in the Severance Plan, (ii) an employee resigns because in connection with a change of control, the offered terms of employment (new or continuing) by us or our successor or acquirer within &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; days after the change of control results in a material change in the terms of employment, or (iii) after accepting (or continuing) employment with us after a change of control, an employee resigns within &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months following a change of control due to a material change in the terms of employment. Under the Severance Plan, a Non&#x2011;Change of Control Triggering Event and Separation from Service is defined as an event where a non&#x2011;executive employee is terminated by us without cause. Severance payments range from &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_a1a45976-6577-45f6-bd62-311e76651aed;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months of base salary, depending on the employee&#x2019;s position with us, payable in a lump sum payment. The Severance Plan also provides that the provisions of employment agreements entered into between us and executive or non&#x2011;executive employees supersede the provisions of the Severance Plan. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, all our executive officers have employment agreements with provisions that may provide greater severance benefits than those in the Severance Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risks Related to Global Economic Conditions, COVID-19 and the Military Conflict Between Ukraine and Russia&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of the date of this filing, significant uncertainty exists concerning the ultimate duration and severity of the COVID-19 pandemic and the military conflict between Ukraine and Russia. Both of these events have caused widespread, continually evolving and unpredictable impacts on global societies, economies, financial markets and business practices. With respect to the COVID-19 pandemic, we are closely monitoring the impact of the pandemic, the identification of new variants of the COVID-19 virus and related developments, and our focus remains on promoting employee health and safety while continuing to advance the development of imetelstat. For both our Phase 3 clinical trials, IMerge and IMpactMF, we have limited ongoing clinical trial activity in Ukraine and Russia, but we have experienced, and may continue to experience, delays and suspensions in clinical trial activities at clinical sites in Ukraine and Russia due to the current political and civil unrest conditions. With support from our CRO, we are monitoring the impact of the conflict on our clinical trial activities.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Due to the dynamic and unpredictable effects of the COVID-19 pandemic, we have had and expect to continue to have disruptions and/or delays in our imetelstat development program, including with respect to our ability to initiate trial sites, enroll and assess patients, maintain patient enrollment, ensure patient clinical and lab collection visits, conduct monitoring visits, supply study drug, report trial results, and interact with regulators or other important agencies due to limitations in employee resources or otherwise. Restrictions on travel, availability of site personnel, and diversion of hospital staff and resources to COVID-19 patients, have disrupted our trial operations, as well as patient recruitment in many areas, resulting in a slowdown in patient enrollment and/or deviations from or disruptions in key clinical trial activities, such as clinical trial site initiation and monitoring. If the effects of the COVID-19 pandemic continue and/or become more severe, we could experience significant disruptions to our clinical development timelines, delays in clinical site initiation and patient enrollment in IMpactMF, IMproveMF and the investigator-led trial IMpress, and other disruptions that could severely impact our business and the imetelstat development program.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We have taken and intend to take those actions with regard to COVID-19 that may be required by federal, state or local authorities or that we determine are in the best interests of our patients, investigators, employees and stockholders. In response to the COVID-19 pandemic and previous &#x201c;shelter in place&#x201d; and similar orders issued by state and local governments, we have allowed voluntary access to our offices in California and New Jersey to employees who have been vaccinated, and almost all of our employees continue to work remotely without any significant disruption to our business. Our increased reliance on personnel working remotely could increase our cybersecurity risk, create data accessibility concerns and make us more susceptible to communication disruptions, any of which could adversely impact our business operations. These and similar, and perhaps more severe, disruptions in our operations could occur which would negatively impact our business and business prospects, our financial condition and the future of imetelstat.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The effects of the COVID-19 pandemic and the military conflict between Ukraine and Russia, including the significant sanctions imposed against Russia, as well as broader economic conditions, including inflation, rising interest rates, the prospects for recession, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failure have increased market volatility and could result in a significant long-term disruption of global financial markets, reducing or eliminating our ability to raise additional capital, which could negatively affect our liquidity, our ability to complete IMpactMF, IMproveMF and the investigator-led trial IMpress and to commence, conduct and complete any other potential future clinical trials of imetelstat. In addition, the global&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;economic slowdown caused by, among other things, the COVID-19 pandemic and the military conflict between Ukraine and Russia, as well as inflation, rising interest rates, the prospects for recession, and recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures could materially and adversely affect our business and the value of our common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The extent to which global economic conditions, including those resulting from the COVID-19 pandemic, the military conflict between Ukraine and Russia and recent and potential future bank failures, ultimately impact our business, our regulatory and clinical development activities, clinical supply chain and other business operations, as well as the value of and market for our common stock, will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time, such as the ultimate duration and severity of the pandemic, travel restrictions, quarantines, social distancing and business closure requirements in the United States, or U.S., and in other countries, the effectiveness of actions taken globally to contain and treat COVID-19, whether the military conflict between Ukraine and Russia resolves in a timely manner, or at all, and whether the U.S. and/or international banking system stabilizes in light of recent and potential future bank failures. Accordingly, we do not yet know the full extent of potential delays or impacts on our business, our regulatory and clinical development activities, clinical supply chain and other business operations or the global economy as a whole. However, these effects could materially and adversely affect our business and business prospects, our financial condition and the future of imetelstat.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencySettlementAgreementDate
      contextRef="C_5972d6c9-9d7e-481d-990f-61c5b5a57683"
      id="F_1a254a5e-8af0-4782-8ee4-6475a505731a">September 2, 2022</us-gaap:LossContingencySettlementAgreementDate>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="C_5972d6c9-9d7e-481d-990f-61c5b5a57683"
      decimals="0"
      id="F_38155b31-d7da-43f5-8742-81fef595ed2f"
      unitRef="U_USD">24000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="C_5972d6c9-9d7e-481d-990f-61c5b5a57683"
      decimals="0"
      id="F_0ee9ba9a-e302-4601-9a48-cd9c5bd17434"
      unitRef="U_USD">17000000</us-gaap:PaymentsForLegalSettlements>
    <gern:LitigationSettlementAmountPaidInCashOrKind
      contextRef="C_5972d6c9-9d7e-481d-990f-61c5b5a57683"
      decimals="0"
      id="F_ddc0d484-a4a1-4485-ae16-2b587d3714b3"
      unitRef="U_USD">7000000</gern:LitigationSettlementAmountPaidInCashOrKind>
    <gern:LitigationSettlementAmountAccruedLiabilitiesRecognized
      contextRef="C_acfe2948-7468-4c15-a637-904a59f62dc4"
      decimals="0"
      id="F_7aeba221-ab95-40e1-85b9-3d08c8deeef6"
      unitRef="U_USD">7000000</gern:LitigationSettlementAmountAccruedLiabilitiesRecognized>
    <gern:LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized
      contextRef="C_4ff1bc89-e218-42c3-bcc6-62cce404dde7"
      decimals="0"
      id="F_fcfe520e-a486-41b3-a967-fa62cabe74a5"
      unitRef="U_USD">7000000</gern:LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized>
    <us-gaap:LossContingencySettlementAgreementDate
      contextRef="C_e1ca1ecd-84e7-44b0-9101-90008f265fe7"
      id="F_765c81e5-7098-40b7-a283-6b0f09043b20">December 21, 2022</us-gaap:LossContingencySettlementAgreementDate>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="C_e1ca1ecd-84e7-44b0-9101-90008f265fe7"
      decimals="0"
      id="F_90011956-ec57-4ca8-8b75-0eb5bea7bcad"
      unitRef="U_USD">1350000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="C_e1ca1ecd-84e7-44b0-9101-90008f265fe7"
      decimals="0"
      id="F_fa3e44d8-8331-40ba-ba26-ab832ba9d8e3"
      unitRef="U_USD">525000</us-gaap:PaymentsForLegalSettlements>
    <gern:LitigationSettlementAmountToBePaid
      contextRef="C_ad743706-922f-45c0-83cd-2d0300569661"
      decimals="0"
      id="F_26dc1a00-c96d-42f2-9058-441bc53c7d15"
      unitRef="U_USD">825000</gern:LitigationSettlementAmountToBePaid>
    <gern:LitigationSettlementAmountAccruedLiabilitiesRecognized
      contextRef="C_dbfbf1d8-b44a-4e72-892f-10af9a860032"
      decimals="0"
      id="F_817eaa41-0241-432c-a5fc-de09227715b0"
      unitRef="U_USD">1350000</gern:LitigationSettlementAmountAccruedLiabilitiesRecognized>
    <gern:LitigationSettlementAmountInterestAndOtherReceivableRecognized
      contextRef="C_dbfbf1d8-b44a-4e72-892f-10af9a860032"
      decimals="0"
      id="F_dd7f432e-a448-4150-93dd-196bdd8eb9a2"
      unitRef="U_USD">525000</gern:LitigationSettlementAmountInterestAndOtherReceivableRecognized>
    <gern:LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized
      contextRef="C_510d1c51-dbe3-4e7b-b27f-0d63cbea1e18"
      decimals="0"
      id="F_ff19dec7-2015-47ff-bc5b-356dfcabb6bc"
      unitRef="U_USD">825000</gern:LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized>
    <gern:LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_09e760f4-d1ea-46db-8d04-b97c51b8556b">P12M</gern:LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod>
    <gern:LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_88ca92b5-fb2a-4bbf-9677-8f395c1fe46a">P30D</gern:LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity>
    <gern:LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_eee41229-4689-4d9f-a92b-9e1c66b475f1">P12M</gern:LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment>
    <gern:LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan
      contextRef="C_baba9cae-f153-4485-a773-5ab5408054ab"
      id="F_1087b65f-5751-4d71-bfb8-11827646016b">P18M</gern:LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_5009d16e-1fdf-4017-858d-f67ef64ecea8">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7. OPERATING LEASES&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;New Jersey Office Space Lease&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In April 2019, we entered into an operating lease agreement for office space located at 3 Sylvan Way, Parsippany, New Jersey, or the New Jersey Lease. The initial term of the New Jersey Lease is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years with an option to extend for an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one-time option to terminate the New Jersey Lease without cause as of the 103&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;rd&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; month anniversary of the commencement date of the lease&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The New Jersey Lease commenced on October 1, 2019, upon our control of the office space on that date. Based on the initial term of the New Jersey Lease of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years, the right-of-use asset and corresponding operating lease liability was approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,356,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which represented the present value of lease payments over the initial lease term, net of a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;seven-month&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; rent abatement period, using an incremental borrowing rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% based on information available as of October 1, 2019. Under the New Jersey Lease, we are also obligated to pay certain variable expenses separately from the base rent, including electricity and common area maintenance. Such costs are being expensed in the period they are incurred. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the remaining lease term for the New Jersey Lease is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.8&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foster City Office Space Lease&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In October 2019, we entered into an operating lease agreement for office space located at 919 East Hillsdale Boulevard, Foster City, California, or the Foster City Lease. The initial term of the Foster City Lease is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;87&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months with an option to extend for an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Foster City Lease commenced on March 10, 2020, upon the substantial completion of all tenant improvements. As of the lease commencement date, the right-of-use asset and corresponding operating lease liability was approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,426,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which represented the present value of remaining lease payments using an incremental borrowing rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% over the initial lease term of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;87&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months, net of a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three-month&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; rent abatement period. Under the Foster City Lease, we are also obligated to pay certain variable expenses separately from the base rent, including taxes and common area maintenance. Such costs are considered non-lease components and have been excluded from the calculation of the right-of-use asset and corresponding operating lease liability and are being expensed in the period they are incurred. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the remaining lease term for the Foster City Lease is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The components of lease costs included in operating expenses on our consolidated statements of operations for the New Jersey Lease, the Foster City Lease and a lease from a former location in Menlo Park, California, were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:18.733%;"/&gt;
        &lt;td style="width:21.617%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.904%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:2.524%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.754000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:3.125%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.342%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,143&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;&#160;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;310&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,254&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,436&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:10.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:60.0%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.588888888888889%;"&gt;(1)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Variable lease costs represent non-lease components, such as common area maintenance charges.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The undiscounted future non-cancellable lease payments under the New Jersey Lease and the Foster City Lease as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:35.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.834%;"/&gt;
        &lt;td style="width:2.869%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:26.296%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;717&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,770&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,174&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6"
      id="F_2840dc8f-02ec-4055-8df9-3ed3d4cf8418">P11Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_2160f3d4-592d-437d-adaa-f0dadac52a38"
      id="F_2a1d9d1e-6f06-405a-bde9-6b9fef282624">P11Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_2160f3d4-592d-437d-adaa-f0dadac52a38"
      id="F_521584fa-c8ce-4f1d-815b-94c747ea92f2">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseOptionToTerminate
      contextRef="C_a85bc201-e73d-4e53-910e-2be441096a11"
      id="F_b7a52ad0-dee9-4ade-b242-3ac2e928f051">one-time option to terminate the New Jersey Lease without cause as of the 103rd month anniversary of the commencement date of the lease</us-gaap:LesseeOperatingLeaseOptionToTerminate>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6"
      id="F_4d0c8433-8df2-4748-afe6-8a5f184c6bf2">P11Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6"
      decimals="0"
      id="F_46595661-86eb-46de-96f8-a9d9eb8103cf"
      unitRef="U_USD">2356000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6"
      decimals="0"
      id="F_d0ab8ed7-63af-41ff-91c1-531d50ac743f"
      unitRef="U_USD">2356000</us-gaap:OperatingLeaseLiability>
    <gern:OperatingLeaseRentAbatementPeriod
      contextRef="C_c9710e3f-58c2-40a2-971c-f2229ca8bfa7"
      id="F_48f2f8e2-230b-4509-a631-eee3967935c1">P7M</gern:OperatingLeaseRentAbatementPeriod>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="C_7173b90d-0319-4205-a8c0-5d652abfb4d6"
      decimals="INF"
      id="F_06d931b5-3e09-46e0-8c5b-e669f5bb6902"
      unitRef="U_pure">0.08</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_eb51ffc8-633d-41e3-86c8-d3c430b99a37"
      id="F_fe208b5a-aee1-429f-b4a5-a1264e1c9fc8">P7Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_537e337a-f742-4d0a-a5b6-5cf335eb225f"
      id="F_b867f02d-7f6c-4999-9464-7f269f1a10ff">P87M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="C_537e337a-f742-4d0a-a5b6-5cf335eb225f"
      id="F_b00c550f-4bf7-49f4-b2b9-9f05235489d2">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b"
      decimals="0"
      id="F_9aeca14e-54d9-4781-8bc6-b984c62188d6"
      unitRef="U_USD">3426000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b"
      decimals="0"
      id="F_d40d40c7-ac47-4a55-9802-a804bf6c53ab"
      unitRef="U_USD">3426000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b"
      decimals="INF"
      id="F_f954f64c-a70b-440e-8a0e-7e66976b3870"
      unitRef="U_pure">0.07</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_4ba7d7a7-8cef-4793-99e5-25d7901e081b"
      id="F_b9e7c974-0aab-4faa-9ed9-6c312a047b76">P87M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <gern:OperatingLeaseRentAbatementPeriod
      contextRef="C_a5a96aa2-9ab9-4312-a1d6-6a03ed292708"
      id="F_719ec7f7-ec1f-4aa0-af60-f1ba0cc6912f">P3M</gern:OperatingLeaseRentAbatementPeriod>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_20457731-c8fd-4ab5-9a21-4c427a763c88"
      id="F_a1ecad3a-59ea-488b-9ae3-2e47a341a3d6">P4Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_161fdccc-61a6-431c-901c-55e6af7ed0f3">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The components of lease costs included in operating expenses on our consolidated statements of operations for the New Jersey Lease, the Foster City Lease and a lease from a former location in Menlo Park, California, were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:18.733%;"/&gt;
        &lt;td style="width:21.617%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.904%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:2.524%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.754000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:3.125%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.342%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;946&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,143&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Variable lease costs&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;&#160;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;310&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Arial&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,254&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,198&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,436&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;div style="margin-left:10.0%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.588888888888889%;"&gt;(1)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Variable lease costs represent non-lease components, such as common area maintenance charges.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_cebdfb35-3d03-4bf5-8e20-dfde0b67795c"
      unitRef="U_USD">944000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_cde9534d-d8e0-4c7f-ad0a-b0567f5858be"
      unitRef="U_USD">946000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_2f6ef6ae-d1c1-456e-ac9a-919bab91bf40"
      unitRef="U_USD">1143000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_79b62e59-a9fe-461c-9fdb-14dc7e5831b1"
      unitRef="U_USD">310000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_7a541b0b-a77e-4ad5-9615-88b9c78ff17c"
      unitRef="U_USD">252000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_59042701-01b4-4c33-b5a5-c859e7351f67"
      unitRef="U_USD">293000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_8e6f9e96-e608-4d3d-b3b9-cdce265fa5fe"
      unitRef="U_USD">1254000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_f5f86042-5d67-4f94-91d9-0bf3c0af14ef"
      unitRef="U_USD">1198000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_648b2a89-daa1-4e80-becf-3a1e003ebd47"
      unitRef="U_USD">1436000</us-gaap:LeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_1756aa3a-f44a-4bcb-8d4f-e5e55c9f4586">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The undiscounted future non-cancellable lease payments under the New Jersey Lease and the Foster City Lease as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:35.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:68.834%;"/&gt;
        &lt;td style="width:2.869%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:26.296%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;717&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,050&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,770&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,174&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,596&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"
      decimals="-3"
      id="F_02530a9a-004a-4774-85d8-138e8144a63a"
      unitRef="U_USD">962000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"
      decimals="-3"
      id="F_c7eb1234-ddbe-4028-a953-8d72ea3fdbdd"
      unitRef="U_USD">987000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"
      decimals="-3"
      id="F_99188610-3f7f-44ee-9343-4131eca5bb62"
      unitRef="U_USD">1014000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"
      decimals="-3"
      id="F_874e1a72-9b18-4d79-858d-67bcdbb61c59"
      unitRef="U_USD">1040000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"
      decimals="-3"
      id="F_36e59dd8-24be-4b90-b783-e36ce0137b68"
      unitRef="U_USD">717000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"
      decimals="-3"
      id="F_7f253b66-a9b2-47d9-8ca1-1c32a7895f72"
      unitRef="U_USD">1050000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"
      decimals="-3"
      id="F_0003e8cd-2eb0-4e24-9e67-96feff35a604"
      unitRef="U_USD">5770000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"
      decimals="-3"
      id="F_a6478d92-486a-43ea-9613-d289b5a9d4b6"
      unitRef="U_USD">1174000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f"
      decimals="-3"
      id="F_41d33d20-b5fc-4dce-ae59-c31224d4bf71"
      unitRef="U_USD">4596000</us-gaap:OperatingLeaseLiability>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_39aff3ee-409d-4b0b-bbaa-eb95f51d36b7">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8. DEBT&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On September 30, 2020, or the Closing Date, we, Hercules Capital, Inc., or Hercules, and Silicon Valley Bank, or SVB, entered into a term loan facility, or the Term Loan, up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which was amended in August 2021, or the Original Loan Agreement. On June 30, 2022, or the Effective Date, we entered into a second amendment to the Original Loan Agreement, or as amended, the Loan Agreement. Under the second amendment, the aggregate principal amount available to us increased from $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, with such principal being available in a series of tranches, subject to certain terms and conditions. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, a total of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; has been drawn under the Loan Agreement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under the second amendment, the $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in remaining loan principal as of December 31, 2022 can be drawn as follows: (a) the first tranche of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; is available within the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;earlier of 30 days of the achievement of certain clinical and financial milestones or September 15, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, subject to the achievement of such milestones; (b) the second tranche of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; is available from &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; until &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 15, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain other requirements; (c) the third tranche of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; is available from &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;September 15, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; until &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;September 15, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, subject to the achievement of certain clinical and regulatory milestones, and satisfaction of certain capitalization requirements; and (d) the final tranche of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; is available through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, subject to approval by an investment committee comprised of Hercules and SVB (or its successor, if any). However, on March 10, 2023, the Federal Deposit Insurance Corporation, or FDIC, issued a press release stating that SVB was closed by the California Department of Financial Protection and Innovation, which appointed the FDIC as receiver. Of the remaining term commitments under the Loan Agreement, Hercules and its affiliates hold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;65&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% were held by SVB. As a result of the closure of SVB, we do not know whether and to what extent we would be able to draw down the remaining $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;55.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million under the Loan Agreement, even if we meet the conditions set forth in the Loan Agreement necessary for additional draw downs, and it is possible that we will not be able to access any additional funding under the Loan Agreement. With the exception of the final tranche, and subject to achievement of the applicable milestones and other requirements with respect to each tranche, draw downs are at our election.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under the second amendment, the maturity date, interest only payment dates, end of term charges, collateral, events of default, representations, warranties and covenants remain consistent with the terms of the Original Loan Agreement, except as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;   &lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Beginning June 1, 2022 and prior to the regulatory approval for imetelstat, or the potential Regulatory Approval, if any, we are required to maintain a minimum cash balance in an amount equal to the greater of: &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the outstanding principal amount under the Loan Agreement or $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;After the potential Regulatory Approval, if any, the minimum cash requirement may be satisfied through one of the following three options, as elected by us: (a) maintaining a cash balance in an amount not less than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the outstanding principal amount under the Loan Agreement; (b) maintaining a cash balance in an amount not less than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the outstanding principal amount under the Loan Agreement, if our market cap is or exceeds $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;750,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;; or (c) maintaining &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;six month&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; net product revenues of at least &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;70&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of net product revenues forecasted by us, should any potential Regulatory Approval for imetelstat be obtained.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On the Effective Date of the second amendment, we paid $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; as a facility charge that we recognized as a debt discount and are amortizing such cost to interest expense over the life of the loan using the effective interest rate method. Additional facility charges applied to future draw downs will be treated similarly. We incurred approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;legal fees in connection with the second amendment, which we recognized as debt&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;issuance &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;costs and are amortizing such cost to interest expense over the life of the loan using the effective interest rate method. Future debt issuance costs will be treated similarly. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under the second amendment, if we choose to prepay the principal with respect to any future draw down after the Effective Date, any such prepayment within the first 36 months after the Effective Date will be subject to a prepayment charge equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the principal amount prepaid. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; prepayment charge will be assessed for any prepayment occurring more than 36 months after the Effective Date.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unchanged from the Original Loan Agreement, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;the Term Loan matures on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;October 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or the Loan Maturity Date, and may be extended up to an additional 12 months upon the achievement of certain clinical, regulatory and financial milestones.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Term Loan bears interest at a floating rate per annum equal to the greater of either (i) 9.0% or (ii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% plus the prime rate as reported in The Wall Street Journal (7.5% as of December 31, 2022) less 3.25%.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; The Term Loan provided for an initial interest-only payment period from the Closing Date until November 1, 2022. As of December 31, 2022, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;the interest-only period expires May 1, 2023. Upon the achievement of certain regulatory and financial milestones, the interest-only period may be extended for another six months until November 1, 2023.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; Following the expiration of the interest-only period, we will repay the Term Loan in equal monthly amortization payments of principal and interest until the Loan Maturity Date. Upon full repayment of the Term Loan, we are also obligated to pay an end of term charge in an amount equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.55&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the amount of the Term Loan actually borrowed. Such end of term charge is being accrued to interest expense over the term of the Term Loan using the effective interest rate method. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;At our option, upon at least five business days&#x2019; prior written notice to Hercules, we may prepay all or any portion greater than or equal to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of the outstanding loan by paying the entire principal balance (or portion thereof) and all accrued and unpaid interest. Such prepayment is subject to a prepayment charge of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the prepayment amount, if the prepayment is made in any of the first 36 months following the Closing Date for any draw downs prior to the second amendment. Thereafter, any prepayment is not subject to a prepayment charge.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Term Loan is secured by substantially all of Geron&#x2019;s assets, except our intellectual property, which is the subject of a negative pledge. The Term Loan contains certain representations and warranties, affirmative covenants, negative covenants and conditions that are customarily required for similar financings. We are in compliance with the covenants under the Term Loan as of December 31, 2022.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In the event of default (subject, in certain instances, to specified grace periods), the principal, interest and any other monetary obligations on all the then outstanding amounts under the Term Loan may become due and payable immediately. Upon the occurrence of an event of default, a default interest rate of an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% may be applied to the outstanding principal balance, and Hercules, as the administrative agent, may declare all outstanding obligations immediately due and payable (subject, in certain instances, to specified grace periods) and take such other actions as set forth in the Term Loan. Upon the occurrence of certain bankruptcy and insolvency events, the obligations under the Term Loan would automatically become due and payable.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Embedded Derivatives and Debt Discounts&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The conditional exercisable call option related to the event of default is considered to be an embedded derivative which is required to be bifurcated and accounted for as a separate financial instrument. In the periods presented, the value of the embedded derivative is not material and therefore, no amount has been recognized. If an event of default becomes more probable than is currently estimated, then the embedded derivative could become material in future periods and would be recognized as a separate financial instrument at that time.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the net carrying value of the Term Loan was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;51,157,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which includes the principal amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; less the net unamortized discounts and debt issuance costs of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;628,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; plus accrued end of term charge of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,785,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The carrying value of the debt approximates the fair value as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022. The debt discounts and debt issuance costs are being amortized to interest expense over the life of loan amounts under Term Loan using the effective interest rate method.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Future Minimum Payments&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents future minimum payments, including interest and the end of term charge, under the Term Loan as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:61.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.622%;"/&gt;
        &lt;td style="width:12.76%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:19.618%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26,843&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,160&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;61,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less:  amount representing interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less:  unamortized debt discount and issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less:  unamortized end of term charge&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less:  current portion of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Noncurrent portion of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,212&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0d35dd6e-fea6-436e-9ee7-9ee08382b573"
      decimals="INF"
      id="F_64b7d170-5434-4bac-a1e5-328c5c110321"
      unitRef="U_USD">75000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0d35dd6e-fea6-436e-9ee7-9ee08382b573"
      decimals="INF"
      id="F_0a2a6464-c6aa-40fc-8638-4f501c95ac6b"
      unitRef="U_USD">75000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_d1078eed-3e6a-4e01-b62d-1ba7e0711b75"
      decimals="INF"
      id="F_0d6b901c-7bdf-46f8-8eb9-274a9f0776c6"
      unitRef="U_USD">125000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff"
      decimals="INF"
      id="F_90ad4614-12df-4936-983d-c3004c93a1dd"
      unitRef="U_USD">50000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="C_7b1c8d57-8ddb-43ec-96da-0180f39ff551"
      decimals="INF"
      id="F_b57691bf-dfcc-4627-b4a6-35389672524f"
      unitRef="U_USD">75000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_964ca538-6017-4a3b-b8a2-c9d92e9678f0"
      decimals="INF"
      id="F_2a6ca239-620a-4f56-8bdd-b042d528cac2"
      unitRef="U_USD">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityBorrowingCapacityDescription
      contextRef="C_4c2322a1-867d-4db1-bcb9-a772d5cbd539"
      id="F_7f967be2-35c8-49e7-b3cb-5bf98a9e85e5">earlier of 30 days of the achievement of certain clinical and financial milestones or September 15, 2023</us-gaap:LineOfCreditFacilityBorrowingCapacityDescription>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_c435dd46-e5e9-46ae-a67c-f00cecd6b5ca"
      decimals="INF"
      id="F_52a067da-1224-4f7c-b82c-53b0e1660e09"
      unitRef="U_USD">10000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <gern:BorrowingAvailableStartDate
      contextRef="C_b32a587f-ad3d-4276-b2dd-b2191eb465c3"
      id="F_5cb18157-d17c-487c-817e-6f4d885250a5">2023-01-01</gern:BorrowingAvailableStartDate>
    <gern:ExpiryDateOfTranche
      contextRef="C_b32a587f-ad3d-4276-b2dd-b2191eb465c3"
      id="F_fd25b100-9ea6-4ae2-a94c-24ede5b94d66">2023-12-15</gern:ExpiryDateOfTranche>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_47db9b05-7d9e-4426-bef0-d9bcedf945c6"
      decimals="INF"
      id="F_7184006f-9d3d-434d-95e6-827f2e5751a9"
      unitRef="U_USD">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <gern:BorrowingAvailableStartDate
      contextRef="C_76e00114-46f1-4f21-825f-b517b415c860"
      id="F_3c5dbc2f-cd1c-46ae-bf10-38775ca1b8dd">2023-09-15</gern:BorrowingAvailableStartDate>
    <gern:ExpiryDateOfTranche
      contextRef="C_76e00114-46f1-4f21-825f-b517b415c860"
      id="F_44b5e0fc-7829-4d7d-a021-19a0487e1120">2024-09-15</gern:ExpiryDateOfTranche>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_de7e0e4c-33d2-4fbd-abef-d98a0ee733d6"
      decimals="INF"
      id="F_67fdb34f-1599-4075-897c-1ca10d2fccf6"
      unitRef="U_USD">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <gern:ExpiryDateOfTranche
      contextRef="C_f076ddd2-9af8-4327-95c6-3a61cf5015db"
      id="F_7739ded1-9b99-4ab8-807b-751d63402504">2024-12-31</gern:ExpiryDateOfTranche>
    <gern:PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement
      contextRef="C_4dd4d649-9e3f-43f2-a911-a45ce22da643"
      decimals="2"
      id="F_b8f9b066-8fce-400d-924f-0cc26e442841"
      unitRef="U_pure">0.65</gern:PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement>
    <gern:PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement
      contextRef="C_9097bf2a-3ae2-4f30-af86-bb131d89eb94"
      decimals="2"
      id="F_852f6543-7425-4e0b-becf-66e316e95f3a"
      unitRef="U_pure">0.35</gern:PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="C_88b14be1-08cb-441b-9cd9-8b8e631765f9"
      decimals="-5"
      id="F_233881b9-5e4f-44dd-888f-0845d2551299"
      unitRef="U_USD">55000000.0</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <gern:DebtCovenantMinimumCashBalancePercentageOfLoanAmount
      contextRef="C_aecbaf53-81e4-4762-8e18-b6fdfe03ee7f"
      decimals="2"
      id="F_480ff979-4b5b-4f2f-ab0a-5ef5c6eedc77"
      unitRef="U_pure">0.50</gern:DebtCovenantMinimumCashBalancePercentageOfLoanAmount>
    <gern:DebtCovenantMinimumCashBalance
      contextRef="C_aecbaf53-81e4-4762-8e18-b6fdfe03ee7f"
      decimals="INF"
      id="F_c67c2947-e217-418c-9c62-4bad3c262d84"
      unitRef="U_USD">30000000</gern:DebtCovenantMinimumCashBalance>
    <gern:DebtCovenantMinimumCashBalancePercentageOfLoanAmount
      contextRef="C_a42e573b-f7ea-45fe-a906-765e787d71d7"
      decimals="2"
      id="F_fe602f76-2bea-4413-988e-d6f616665552"
      unitRef="U_pure">0.40</gern:DebtCovenantMinimumCashBalancePercentageOfLoanAmount>
    <gern:DebtCovenantMinimumCashBalancePercentageOfLoanAmount
      contextRef="C_cb27a432-0c32-4ac0-85da-f75446291e71"
      decimals="2"
      id="F_52a4fde6-48c0-40ef-8de8-1d334a848334"
      unitRef="U_pure">0.25</gern:DebtCovenantMinimumCashBalancePercentageOfLoanAmount>
    <gern:MarketCapMinimumToUseOptionTwo
      contextRef="C_3d47e697-4d40-47ed-be0f-6e5c7c2ad573"
      decimals="INF"
      id="F_5cb9078e-3ab0-4a11-82ff-3dab1f811079"
      unitRef="U_USD">750000000</gern:MarketCapMinimumToUseOptionTwo>
    <gern:MinimumPercentageOfNetProductRevenuesMaintenancePeriod
      contextRef="C_07596f55-6ae2-4a67-8b3a-4ad996e8ecda"
      id="F_2ea1abc6-4610-4e3d-9fbe-9698df34dd85">P6M</gern:MinimumPercentageOfNetProductRevenuesMaintenancePeriod>
    <gern:DebtCovenantPercentageOfProductRevenueAgainstForecast
      contextRef="C_07596f55-6ae2-4a67-8b3a-4ad996e8ecda"
      decimals="2"
      id="F_19094e9b-3601-41b2-a8be-efddd153a491"
      unitRef="U_pure">0.70</gern:DebtCovenantPercentageOfProductRevenueAgainstForecast>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_9a7438fe-fa93-48c8-875b-77ecf443a7b2"
      decimals="INF"
      id="F_a383182e-7ccd-40ad-b2d6-ecafcf19fd97"
      unitRef="U_USD">100000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="C_9a7438fe-fa93-48c8-875b-77ecf443a7b2"
      decimals="0"
      id="F_42600a5c-a1ec-40d1-87f2-9008d5f82d8f"
      unitRef="U_USD">75000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="C_55d50b28-7933-42d2-89ca-ec42b87d67cf"
      id="F_a6cc656c-25ff-4a0b-a130-e3c163718704">Under the second amendment, if we choose to prepay the principal with respect to any future draw down after the Effective Date, any such prepayment within the first 36 months after the Effective Date will be subject to a prepayment charge equal to 1.5% of the principal amount prepaid. No prepayment charge will be assessed for any prepayment occurring more than 36 months after the Effective Date.</us-gaap:DebtInstrumentPaymentTerms>
    <gern:PercentageOfPrepaymentCharge
      contextRef="C_55d50b28-7933-42d2-89ca-ec42b87d67cf"
      decimals="3"
      id="F_f4d59ba5-aa91-4e5a-bd76-ae5288cab8d3"
      unitRef="U_pure">0.015</gern:PercentageOfPrepaymentCharge>
    <gern:DollarPrepaymentCharge36MonthsAfterEffectiveDate
      contextRef="C_55d50b28-7933-42d2-89ca-ec42b87d67cf"
      decimals="INF"
      id="F_c2e07432-6efc-4f45-9232-60c7cc6ea5ef"
      unitRef="U_USD">0</gern:DollarPrepaymentCharge36MonthsAfterEffectiveDate>
    <us-gaap:LongTermDebtDescription
      contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8"
      id="F_733a473f-72e4-4415-986e-16cf990c576a">the Term Loan matures on October 1, 2024, or the Loan Maturity Date, and may be extended up to an additional 12 months upon the achievement of certain clinical, regulatory and financial milestones.</us-gaap:LongTermDebtDescription>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8"
      id="F_95a97b8a-176a-401c-9854-4a33d4414671">2024-10-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateBasisForEffectiveRate
      contextRef="C_cd9ae385-7003-4516-b937-03283c53b8c7"
      id="F_1f2b60bd-80da-46db-a513-d23baa5a3c7d">The Term Loan bears interest at a floating rate per annum equal to the greater of either (i) 9.0% or (ii) 9.0% plus the prime rate as reported in The Wall Street Journal (7.5% as of December 31, 2022) less 3.25%.</us-gaap:DebtInstrumentInterestRateBasisForEffectiveRate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8"
      decimals="INF"
      id="F_ddca00d5-9a18-4eb1-86cb-1c9ff741646a"
      unitRef="U_pure">0.090</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <gern:InterestOnlyPeriodPaymentTermDescription
      contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8"
      id="F_3890a213-531e-405a-968b-41ccd882df58">the interest-only period expires May 1, 2023. Upon the achievement of certain regulatory and financial milestones, the interest-only period may be extended for another six months until November 1, 2023.</gern:InterestOnlyPeriodPaymentTermDescription>
    <gern:DebtInstrumentEndOfTermChargePercentage
      contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8"
      decimals="INF"
      id="F_d44ae4b0-b034-400a-9fec-955f2cfe2e58"
      unitRef="U_pure">0.0655</gern:DebtInstrumentEndOfTermChargePercentage>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8"
      id="F_bc4ea700-0b1a-43d8-a4f6-7b015809bb8f">At our option, upon at least five business days&#x2019; prior written notice to Hercules, we may prepay all or any portion greater than or equal to $5,000,000 of the outstanding loan by paying the entire principal balance (or portion thereof) and all accrued and unpaid interest. Such prepayment is subject to a prepayment charge of 1.5% of the prepayment amount, if the prepayment is made in any of the first 36 months following the Closing Date for any draw downs prior to the second amendment. Thereafter, any prepayment is not subject to a prepayment charge.</us-gaap:DebtInstrumentPaymentTerms>
    <gern:DebtInstrumentMinimumPrepaymentAmount
      contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8"
      decimals="INF"
      id="F_497475d6-5e7d-491f-a299-874386748518"
      unitRef="U_USD">5000000</gern:DebtInstrumentMinimumPrepaymentAmount>
    <gern:PercentageOfPrepaymentCharge
      contextRef="C_55d50b28-7933-42d2-89ca-ec42b87d67cf"
      decimals="3"
      id="F_49615cbf-55d7-406f-acc3-2ebbfb425653"
      unitRef="U_pure">0.015</gern:PercentageOfPrepaymentCharge>
    <gern:PercentageOfInterestOnPastDueOutstanding
      contextRef="C_0bc88138-bc80-467f-a62e-7cb4a38ab6d8"
      decimals="INF"
      id="F_689a0d66-835c-4944-b4b8-3f79457431a9"
      unitRef="U_pure">0.05</gern:PercentageOfInterestOnPastDueOutstanding>
    <us-gaap:LongTermDebt
      contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff"
      decimals="0"
      id="F_ea7898d9-275e-470a-af8e-0b9ba1a545e8"
      unitRef="U_USD">51157000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff"
      decimals="0"
      id="F_e959572a-d135-495c-b8fa-2940799a3c3a"
      unitRef="U_USD">50000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff"
      decimals="0"
      id="F_fd958ceb-4ae7-485d-8583-445e781eb43f"
      unitRef="U_USD">628000</us-gaap:UnamortizedDebtIssuanceExpense>
    <gern:AccruedEndOfTermCharges
      contextRef="C_c1b00895-a644-46d2-a56f-b109682d7aff"
      decimals="0"
      id="F_156bb9c2-288c-466a-b483-809019fb9f43"
      unitRef="U_USD">1785000</gern:AccruedEndOfTermCharges>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_a63e070f-1fb1-4bf0-b0e8-b104fb71af41">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents future minimum payments, including interest and the end of term charge, under the Term Loan as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:61.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.622%;"/&gt;
        &lt;td style="width:12.76%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:19.618%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26,843&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34,160&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;61,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less:  amount representing interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less:  unamortized debt discount and issuance costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less:  unamortized end of term charge&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,490&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less:  current portion of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,945&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Noncurrent portion of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,212&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_748e85e9-e064-42a9-bbed-32c6a0d3efd0"
      unitRef="U_USD">26843000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_0b0e620e-d3cb-4e6e-84a0-5bf840b5a88e"
      unitRef="U_USD">34160000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <gern:LongTermDebtGross
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_1f67d879-19c1-4092-b9c6-fc68f6e3d34d"
      unitRef="U_USD">61003000</gern:LongTermDebtGross>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_b5cd3aac-cae6-41ed-8b33-2bf31a19616c"
      unitRef="U_USD">7728000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_fac356a1-fb7b-4059-a0b8-954123bb825b"
      unitRef="U_USD">628000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <gern:DebtInstrumentUnamortizedEndOfTermCharge
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_35557bac-db95-45c7-83fc-b6d4e567fe68"
      unitRef="U_USD">1490000</gern:DebtInstrumentUnamortizedEndOfTermCharge>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_4f6c4b44-398a-432c-a79c-75c64097ba0e"
      unitRef="U_USD">20945000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_bc127c92-0e7d-48ef-9a50-e991de49a8ef"
      unitRef="U_USD">30212000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_d82dd132-687f-4ab6-94f7-0a6424fc4820">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9. STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Authorized Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In May 2021, our stockholders approved an amendment to our Restated Certificate of Incorporation to increase the total number of authorized shares of common stock from &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;450,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;675,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On April 1, 2022, we completed an underwritten public offering of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;53,333,334&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock and a pre-funded warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,095,238&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock, or the 2022 pre-funded warrant, together with accompanying warrants to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35,714,286&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock, also known as the 2022 stock purchase warrants. The shares of common stock and the 2022 pre-funded warrant were immediately separable from the 2022 stock purchase warrants. All of the securities were issued separately. The combined public offering price of the common stock and accompanying 2022 stock purchase warrants was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.05&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share. The 2022 stock purchase warrants have an exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.45&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share and are exercisable immediately. The term of the 2022 stock purchase warrants expires on the earlier to occur of (a) the date that is 30 business days following the date on which we first issue a press release disclosing, if applicable, that the United States Food and Drug Administration, or FDA, has accepted for filing a New Drug Application submitted to the FDA for imetelstat in Low or Intermediate-1 risk myelodysplastic syndromes and (b) April 1, 2027. The combined public offering price of the 2022 pre-funded warrant and accompanying 2022 stock purchase warrant was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.049&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share. The 2022 pre-funded warrant has an exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share and may be exercised at any time until the 2022 pre-funded warrant is exercised in full. As of December 31, 2022, none of the 2022 pre-funded warrant and 2022 stock purchase warrants have been exercised. The net cash proceeds from this offering were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;69,916,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, after deducting the underwriting discount and other offering expenses paid by us, and exclude any future proceeds from the exercise of the 2022 pre-funded warrant and 2022 stock purchase warrants.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon the issuance of the 2022 pre-funded warrant and 2022 stock purchase warrants, we evaluated the terms of each warrant to determine the appropriate accounting and classification pursuant to FASB Accounting Standards Codification Topic 480, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, and FASB Accounting Standards Codification Topic 815,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Derivatives and Hedging&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Warrants are classified as liabilities when the warrant terms allow settlement of the warrant exercise in cash and classified as equity when the warrant terms only allow settlement in shares of common stock. The terms of the 2022 pre-funded warrant and the 2022 stock purchase warrants include certain provisions related to fundamental transactions and a cashless exercise provision in the event registered shares are not available, and do not include any mandatory redemption provisions. Based on our evaluation, we concluded the 2022 pre-funded warrant and the 2022 stock purchase warrants should be classified as equity with no subsequent remeasurement as long as such warrants continue to be classified as equity.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrant Exercises&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the year ended December 31, 2022, warrants to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,663,387&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock were exercised for net cash proceeds of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,163,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The warrants were issued in connection with an underwritten public offering of common stock and a pre-funded warrant, together with accompanying stock purchase warrants in May 2020. As of December 31, 2022, the pre-funded warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,335,239&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;of&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;our &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;common stock was outstanding and stock purchase warrants to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;44,110,079&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock associated with the May 2020 public offering remained outstanding.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Sales Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On September 4, 2020, we entered into an At Market Issuance Sales Agreement, or the 2020 Sales Agreement, with B. Riley Securities, Inc., or B. Riley, pursuant to which we may elect to issue and sell shares of our common stock having an aggregate offering price of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in such quantities and on such minimum price terms as we set from time to time through B. Riley as our sales agent. We agreed to pay B. Riley an aggregate commission rate equal to up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the gross proceeds of the sales price per share for common stock sold through B. Riley under the 2020 Sales Agreement. In connection with the 2020 Sales Agreement, we terminated the 2018 Sales Agreement. For the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, we sold an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,571,556&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock pursuant to the 2020 Sales Agreement, resulting in net cash proceeds to us of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,385,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, after deducting sales commissions and other offering expenses paid by us. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock were sold pursuant to the 2020 Sales Agreement for the year ended December 31, 2022. The 2020 Sales Agreement will expire upon the earlier of: (a) the sale of all common stock subject to the 2020 Sales Agreement, or (b) September 4, 2023.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Equity Plans&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2011 Incentive Award Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In May 2011, our stockholders approved the adoption of the 2011 Incentive Award Plan, or 2011 Plan. The 2011 Plan provided for grants of either incentive stock options or nonstatutory stock options and stock purchase rights to employees (including officers and employee directors) and consultants (including non&#x2011;employee directors). Upon the adoption of the 2018 Equity Incentive Plan in May 2018 (see below), no further grants of stock options or stock purchase rights were made from the 2011 Plan. Stock options granted under the 2011 Plan expire no later than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; from the date of grant. Stock option exercise prices were equal to the fair market value of the underlying common stock on the date of grant.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Service&#x2011;based stock options under the 2011 Plan generally vested over a period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; from the date of the stock option grant. Other stock awards (restricted stock awards and restricted stock units) had variable vesting schedules which were determined by our board of directors on the date of grant. All outstanding awards granted under the 2011 Plan remain subject to the terms of the 2011 Plan and the individual award agreements thereunder.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2018 Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On May 15, 2018, our stockholders approved the adoption of the 2018 Equity Incentive Plan, or 2018 Plan, as the successor to the 2011 Plan. The 2018 Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, other stock awards, and performance awards that may be settled in cash, stock, or other property. Eligible participants under the 2018 Plan include our employees, consultants and non-employee directors. The number of shares reserved for issuance under the 2018 Plan (subject to adjustment for certain changes in capitalization) is equal to the sum of (i) the unallocated shares of common stock remaining available for grant under the 2011 Plan as of May 15, 2018, (ii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; newly reserved shares of common stock and (iii) the number of shares subject to awards granted under the 2002 Equity Incentive Plan, and the 2011 Plan as such shares become available from time to time, referred to as the Prior Plans&#x2019; Returning Shares. Such Prior Plans&#x2019; Returning Shares become available for issuance under the 2018 Plan if outstanding stock awards granted under the 2002 Equity Incentive Plan and the 2011 Plan, after May 15, 2018, expire or terminate for any reason prior to exercise or settlement or are forfeited, cancelled or otherwise returned to us because of the failure to meet a contingency or condition required for the vesting of such shares, or, subject to certain exceptions, are reacquired or withheld (or not issued) by us to satisfy a tax withholding obligation in connection with a stock award. In May 2022, May 2021 and June 2020, our stockholders approved amendments to our 2018 Equity Incentive Plan to increase the total number of shares issuable under such plan by &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12,500,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,700,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options granted under the 2018 Plan expire no later than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; from the date of grant. Stock option exercise prices shall be equal to the fair market value of the underlying common stock on the date of grant. If, at the time we grant a stock option, the optionee directly or by attribution owns stock possessing more than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the total combined voting power of all classes of our stock, the stock option exercise price shall be at least &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;110&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;of the&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;fair &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;market value of the underlying common stock and shall not be exercisable more than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; after the date of grant.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We grant service-based and performance-based stock options to employees under the 2018 Plan. Service-based stock options generally vest over a period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; from the date of the stock option grant. Performance-based stock options vest upon the achievement of specified milestones. Other stock awards (restricted stock awards and restricted stock units) have variable vesting schedules as determined by our board of directors on the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under certain circumstances, stock options may be exercised prior to vesting, subject to our right to repurchase the shares underlying such stock option at the exercise price paid per share. Our repurchase rights would generally terminate on a vesting schedule identical to the vesting schedule of the exercised stock option. During 2022 and 2021, we did not repurchase any shares under the 2018 Plan. As of December 31, 2022, we have no shares outstanding subject to repurchase under the 2018 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, our Non&#x2011;Employee Director Compensation Policy adopted by our board of directors in March 2014 and amended and restated in February and March 2022 provides for the automatic grant to non&#x2011;employee directors of the following types of equity awards under the 2018 Plan:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;First Director Option.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  Each person who becomes a non&#x2011;employee director, whether by election by our stockholders or by appointment by our board of directors to fill a vacancy, will automatically be granted a stock option to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;200,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock, or First Director Option, on the date such person first becomes a non&#x2011;employee director. The First Director Option vests annually over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; upon each anniversary date of appointment to our board of directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Subsequent Director Option.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  Each non&#x2011;employee director (other than any director receiving a First Director Option on the date of the annual meeting) will automatically be granted a subsequent stock option to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;125,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock, a Subsequent Director Option, on the date of the annual meeting of stockholders in each year during such director&#x2019;s service on our board of directors. The Subsequent Director Option vests in full on the earlier of: (i) the date of the next annual meeting of our stockholders or (ii) the first anniversary of the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2006 Directors&#x2019; Stock Option Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;&lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The 2006 Directors&#x2019; Stock Option Plan, or 2006 Directors Plan, was terminated by our board of directors and replaced by the 2011 Plan in March 2014. No further grants of stock options were made from the 2006 Directors Plan upon the 2006 Directors Plan&#x2019;s termination. All outstanding awards granted under the 2006 Directors Plan remain subject to the terms of the 2006 Directors Plan and the individual award agreements thereunder.&lt;br/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The stock options granted to non-employee directors under the 2006 Directors Plan were nonstatutory stock options, and they expire no later than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; from the date of grant. The option exercise price was equal to the fair market value of the underlying common stock on the date of grant. The first director option granted to non-employee directors under the 2006 Directors Plan vested annually over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; upon each anniversary date of appointment to the board of directors. The subsequent director option granted to non-employee directors on the date of the annual meeting of stockholders in each year during such director&#x2019;s service on our board of directors under the 2006 Directors Plan vested &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; from the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2018 Inducement Award Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In December 2018, our board of directors approved the adoption of the 2018 Inducement Award Plan, or the Inducement Plan, pursuant to which we reserved &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock to be used exclusively for grants of inducement awards to individuals who were not previously Geron employees or non-employee directors, other than following a bona fide period of non-employment. As of December 31, 2022, an aggregate total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,100,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock have been reserved under the Inducement Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Inducement Plan provides for the grant of nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and other stock awards, and all awards under the Inducement Plan are intended&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;to meet the standards under Rule 5635(c)(4) of the Nasdaq Listing Rules. The terms and conditions of the Inducement Plan and the inducement awards to be granted thereunder are substantially similar to our stockholder-approved 2018 Plan.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Directors&#x2019; Market Value Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In October 2018, our board of directors adopted a Directors&#x2019; Market Value Stock Purchase Plan, or the Directors Market Plan. A total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock has been reserved for the Directors Market Plan. Under the Directors Market Plan, non-employee directors may purchase shares of our common stock at the prevailing market price on the purchase date with cash compensation payable to them for their services as a board member. As stated in Geron&#x2019;s Non-Employee Director Compensation Policy, each non-employee director receives annual cash compensation, payable quarterly in arrears, for their services on the board and various committees of the board. As provided in the Non-Employee Director Compensation Policy, a non-employee director may elect to receive fully vested shares of common stock in lieu of cash and such shares shall be issuable from the Directors Market Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the years ended December 31, 2022, 2021 and 2020, we issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,962&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,783&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,986&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock, respectively, from the Directors Market Plan. The weighted average grant date fair value of stock granted during the years ended December 31, 2022, 2021 and 2020 was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.92&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.38&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.60&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, respectively. The total fair value of vested stock grants during 2022, 2021 and 2020 was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate stock option and award activity for the 2011 Plan, 2018 Plan, 2006 Directors Plan, Inducement Plan and Directors Market Plan is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:34.976%;"/&gt;
        &lt;td style="width:0.086%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.64%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.086%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.681%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.712%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.086%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.904%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.086%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.663%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding Stock Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Remaining&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Available&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Contractual Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For Grant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,763,393&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,952,409&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Additional shares authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,755,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,747,760&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,747,760&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Awards granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,181,711&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options cancelled/forfeited/expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,616,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,616,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,370,729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;65,902,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.56&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,205&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options exercisable at &lt;br/&gt;&#160;&#160;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,085,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.09&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options fully vested and expected&lt;br/&gt;&#160;&#160;&#160;&#160;to vest at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,539,649&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.52&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;48,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:76.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.13%;"&gt;(1)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Includes &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,791,750&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; performance-based stock options granted that have not achieved certain strategic milestones.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The aggregate intrinsic value in the preceding table represents the total intrinsic value, based on Geron&#x2019;s closing stock price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.42&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, which would have been received by the option holders had all the option holders exercised their stock options as of that date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We have not granted any stock options with an exercise price below or greater than the fair market value of our common stock on the date of grant in 2022, 2021, and 2020. As of December 31, 2022, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,085,389&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;30,459,136&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,721,508&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; exercisable stock options outstanding at weighted average exercise prices per share of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.17&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.35&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.54&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The total pretax intrinsic value of stock options exercised during 2022, 2021, and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;787,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;93,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively. Cash received from the exercise of stock options in &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022, 2021, and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; totaled approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,799,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;556,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In March 2014, our board of directors adopted the 2014 Employee Stock Purchase Plan, or 2014 Purchase Plan. The 2014 Purchase Plan was approved by our stockholders in May 2014. The 2014 Purchase Plan replaced the 1996 Employee Stock Purchase Plan, or 1996 Purchase Plan, which was terminated effective as of the date the 2014 Purchase Plan was approved by our stockholders. In May 2022, our stockholders approved an amendment to our 2014 Purchase Plan to increase the total number of shares issuable under such plan by &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock, for an aggregate total reserve of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;868,236&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock have been issued under the 2014 Purchase Plan since its adoption.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The 2014 Purchase Plan is comprised of a series of offering periods, each with a maximum duration (not to exceed &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months) with new offering periods commencing on January 1st and July 1st of each year. The date an employee enters the offering period will be designated as the entry date for purposes of that offering period. An employee may participate only in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; offering period at a time. Each offering period consists of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; consecutive purchase periods of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;six months&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2019; duration, with the last day of such period designated a purchase date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Under the terms of the 2014 Purchase Plan, employees can choose to have up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of their annual salary withheld to purchase our common stock. An employee may not make additional payments into such account or increase the withholding percentage during the offering period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The purchase price per share at which common stock is purchased by the employee on each purchase date within the offering period is equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the lower of (i) the fair market value per share of our common stock on the employee&#x2019;s entry date into that offering period or (ii) the fair market value per share of our common stock on the purchase date. If the fair market value per share of our common stock on the purchase date is less than the fair market value at the beginning of the offering period, a new &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; month offering period will automatically begin on the first business day following the purchase date with a new fair market value.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock&#x2011;Based Compensation for Employees and Directors&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We measure and recognize compensation expense for all share&#x2011;based payment awards made to employees and directors, including employee stock options, restricted stock awards and employee stock purchases, based on grant&#x2011;date fair values for these instruments. We use the Black Scholes option&#x2011;pricing model to estimate the grant&#x2011;date fair value of our service-based and performance-based stock options and employee stock purchases. The fair value for service&#x2011;based restricted stock awards is determined using the fair value of our common stock on the date of grant.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As stock&#x2011;based compensation expense recognized on the consolidated statements of operations for the years ended December 31, 2022, 2021 and 2020 is based on awards ultimately expected to vest, it has been reduced for estimated forfeitures, but at a minimum, reflects the grant&#x2011;date fair value of those awards that actually vested in the period. Forfeitures have been estimated at the time of grant based on historical data and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In 2022 and 2021, our board of directors awarded &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,741,750&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;550,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; performance-based stock options, respectively, to certain employees. These performance-based stock options are included in the outstanding stock options table above. Performance-based stock options vest only upon achievement of discrete strategic milestones. Stock-based compensation expense for performance-based stock options is recognized over the period from the date the performance condition is determined to be probable of occurring through the date the applicable condition is expected to be met and is reduced for estimated forfeitures, as applicable. If the performance condition is not considered probable of being achieved, no stock-based compensation expense is recognized until such time as the performance condition is considered probable of being achieved, if ever. None of the performance-based stock options have vested.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We recognize stock&#x2011;based compensation expense for service-based stock options on a straight&#x2011;line basis over the requisite service period, which is generally the vesting period. We have not recognized any stock-based compensation expense for performance-based stock options on our consolidated statements of operations for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020, as the achievement of the specified strategic milestones was not considered probable during that time. The following table summarizes the stock&#x2011;based compensation expense related to service-based stock options and employee stock purchases for the years ended December 31, 2022, 2021 and 2020 which was allocated as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.977%;"/&gt;
        &lt;td style="width:1.268%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.517999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.268%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.517999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.268%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.183%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,720&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,597&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,337&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation expense&lt;br/&gt;&#160;&#160;&#160;included in operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,895&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of stock options granted in &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022, 2021, and 2020 has been estimated at the date of grant using the Black Scholes option&#x2011;pricing model with the following assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.489%;"/&gt;
        &lt;td style="width:1.242%;"/&gt;
        &lt;td style="width:16.253%;"/&gt;
        &lt;td style="width:1.242%;"/&gt;
        &lt;td style="width:16.253%;"/&gt;
        &lt;td style="width:1.255%;"/&gt;
        &lt;td style="width:16.266%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.772&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.817&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.775&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.783&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.781&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.793&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.69&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.57&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.51&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.30&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.31&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.62&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;yrs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;yrs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.25&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;yrs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of employee stock purchases in &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022, 2021, and 2020 has been estimated using the Black Scholes option&#x2011;pricing model with the following assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:39.984%;"/&gt;
        &lt;td style="width:1.242%;"/&gt;
        &lt;td style="width:22.503%;"/&gt;
        &lt;td style="width:1.255%;"/&gt;
        &lt;td style="width:16.8%;"/&gt;
        &lt;td style="width:1.255%;"/&gt;
        &lt;td style="width:16.96%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.614&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.507&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.707&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.478&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.40&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.79&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.09&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.16&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.16&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.57&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;mos&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;mos&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;mos&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Dividend yield is based on historical cash dividend payments and we have paid no cash dividends to date. The expected volatility range is based on historical volatilities of our stock, since traded options on our common stock do not correspond to option terms and the trading volume of options is limited. The risk&#x2011;free interest rate range is based on the U.S. Zero Coupon Treasury Strip Yields for the expected term in effect on the date of grant for an award. The expected term of stock options is derived from actual historical exercise and post&#x2011;vesting cancellation data and represents the period of time that stock options granted are expected to be outstanding. The expected term of employees&#x2019; purchase rights is equal to the purchase period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Based on the Black Scholes option&#x2011;pricing model, the weighted average estimated fair value of stock options granted during the years ended December 31, 2022, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.92&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.17&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.88&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, respectively. The weighted average estimated fair value of employees&#x2019; purchase rights for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.48&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.56&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.62&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, respectively. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, total compensation cost related to unvested share&#x2011;based payment awards not yet recognized, net of estimated forfeitures and assuming no probability of achievement for outstanding performance-based stock options, was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,791,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, which is expected to be recognized over the next &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;26&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; months on a weighted&#x2011;average basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock&#x2011;Based Compensation to Service Providers&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We grant stock options to consultants from time to time in exchange for services performed for us. In general, the stock options vest over the contractual period of the consulting arrangement. The fair value of stock options held by consultants is recorded as operating expenses over the vesting term of the respective equity awards. With the adoption of Accounting Standards Update 2018-07, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Improvements to Nonemployee Share-Based Payment Accounting&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, or ASU 2018-07, in the first quarter of 2019, the measurement date of stock options granted to consultants was fixed at the grant date.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We recorded stock&#x2011;based compensation expense of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;235,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;56,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for the vested portion of the fair value of stock options held by consultants in &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022, 2021, and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common Stock Reserved for Future Issuance&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for future issuance as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:73.896%;"/&gt;
        &lt;td style="width:1.674%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:22.43%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;65,902,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options and awards available for grant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,370,729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,131,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrants outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;106,254,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;191,659,735&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_ee96da23-ae41-4e87-8c4d-c559a324f7a6"
      decimals="INF"
      id="F_57f0894e-7d07-453a-aa24-e0dd449cf363"
      unitRef="U_shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_de96a085-6c20-4cd2-b653-9124bc246e53"
      decimals="INF"
      id="F_e8f48a10-47de-48b4-aa47-2e44bbd7d78f"
      unitRef="U_shares">675000000</us-gaap:CommonStockSharesAuthorized>
    <gern:ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering
      contextRef="C_7cb51813-f174-40c0-8540-44661459217d"
      decimals="INF"
      id="F_77a57e34-fada-4f9f-aefc-f0cbc8f06226"
      unitRef="U_shares">53333334</gern:ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_dd0bdc01-735d-4224-95b4-e75ddebf918f"
      decimals="INF"
      id="F_1ba8796f-4fb6-4b3e-995c-eb8fab5ead22"
      unitRef="U_shares">18095238</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_9a854c1d-782a-4c0f-9f77-518042e397b3"
      decimals="INF"
      id="F_407d6526-be33-45bc-9b00-ccada9e4f419"
      unitRef="U_shares">35714286</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="C_57eb8407-20bb-4fe8-b65e-a963754a7c2b"
      decimals="2"
      id="F_2a371f13-5921-4e37-9181-66ab969f8f18"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.05</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_9a854c1d-782a-4c0f-9f77-518042e397b3"
      decimals="2"
      id="F_c6e0e946-f12b-4614-9f75-56ef2b814b5f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.45</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_dd0bdc01-735d-4224-95b4-e75ddebf918f"
      decimals="3"
      id="F_61c61bda-6b38-4263-8e99-56d427418217"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.049</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_dd0bdc01-735d-4224-95b4-e75ddebf918f"
      decimals="3"
      id="F_1fd68fac-588a-4bfd-9e3b-b9ab8ae334f8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="C_7cb51813-f174-40c0-8540-44661459217d"
      decimals="0"
      id="F_d5de05ff-fe76-48da-8e88-fa8193ff26e9"
      unitRef="U_USD">69916000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <gern:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised
      contextRef="C_b8581e38-a6e8-4457-9acf-b0368e005111"
      decimals="INF"
      id="F_5e398bc6-c699-411c-b4d9-4afb7208edd8"
      unitRef="U_shares">11663387</gern:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_20b70013-d0fe-4f60-92b2-60c28f12e1f9"
      decimals="-3"
      id="F_52b238e9-2f06-493b-829b-d6cdd489e418"
      unitRef="U_USD">15163000000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_4b658edd-fed5-40c3-886d-f2742643a130"
      decimals="INF"
      id="F_4a0693b6-003d-4b4e-882c-3a5793ad5686"
      unitRef="U_shares">8335239</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_b8581e38-a6e8-4457-9acf-b0368e005111"
      decimals="INF"
      id="F_6f723d24-f914-4024-89af-0009ac0d7d96"
      unitRef="U_shares">44110079</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <gern:CommonStockAggregateOfferingPrice
      contextRef="C_4cae8e78-c215-4912-8bd0-8a601c68ba56"
      decimals="INF"
      id="F_0805f1de-babe-49c3-9b08-f7cd24fc29e4"
      unitRef="U_USD">100000000</gern:CommonStockAggregateOfferingPrice>
    <gern:MaximumCommissionRate
      contextRef="C_4cae8e78-c215-4912-8bd0-8a601c68ba56"
      decimals="INF"
      id="F_d95bccae-bec1-4f18-8fcd-4268c58ebad0"
      unitRef="U_pure">0.030</gern:MaximumCommissionRate>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_04fded04-be5d-4eb8-81d5-fec058c4ac52"
      decimals="INF"
      id="F_c4109632-d7ae-4f85-bf2e-874109b0bb7e"
      unitRef="U_shares">10571556</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_04fded04-be5d-4eb8-81d5-fec058c4ac52"
      decimals="0"
      id="F_01018e86-6815-471f-b8d6-eadd63b22e70"
      unitRef="U_USD">20385000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_4ee8d9b9-dc68-4df6-9be2-6f4529782e09"
      decimals="INF"
      id="F_3e7adb5d-b0d2-4d63-bc5e-aac5f76e7cae"
      unitRef="U_shares">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_9ec15f2a-f73b-4dc2-aa8c-a5bb91e19d44"
      id="F_5044c048-b181-42ae-ba50-8a690e9934f3">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_7912cfc0-c229-4fc9-8043-9b98680b2a7e"
      id="F_40243fb9-db42-478b-bdc0-0a6f1dc267bc">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_cc50e10a-98c8-4c05-bd82-9e1ea746a195"
      decimals="INF"
      id="F_3293bddf-61bf-4770-b221-37c2ec5d3dc3"
      unitRef="U_shares">10000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod
      contextRef="C_2a6d46ff-973f-470e-82a2-82e94b643f46"
      decimals="INF"
      id="F_a4c89f37-81b2-4377-81c2-0d0e3d21fe84"
      unitRef="U_shares">11000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod
      contextRef="C_b2e14894-763e-4f1a-963f-b97397735098"
      decimals="INF"
      id="F_63146c85-f4b6-4eb8-bc24-29aa22611be6"
      unitRef="U_shares">12500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod
      contextRef="C_efcc9f37-8c8e-44d9-845b-1357eb47cb94"
      decimals="INF"
      id="F_80b5ceaa-b89e-4db5-88f2-82139d2351cb"
      unitRef="U_shares">5700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_81527741-3307-4f06-998a-99b34c4ab029"
      id="F_fcbcf33d-1ad1-42d7-85b8-74d41b528f65">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue
      contextRef="C_c2932c3c-e846-4bca-b1d9-5fb417e16d20"
      decimals="INF"
      id="F_41bc07bc-1ac9-4cfe-9618-8399d011d3ff"
      unitRef="U_pure">0.10</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock
      contextRef="C_c2932c3c-e846-4bca-b1d9-5fb417e16d20"
      decimals="INF"
      id="F_cf7a47fb-780e-43c7-aac5-68d4e2e40600"
      unitRef="U_pure">1.10</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock>
    <gern:ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock
      contextRef="C_2300d06c-433b-4ed1-92b5-9487bbe32374"
      id="F_f69636d6-7ce4-470b-8043-2d30f64cc2e1">P5Y</gern:ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_2300d06c-433b-4ed1-92b5-9487bbe32374"
      id="F_54ac5b91-ae14-4bbe-864a-07f26bf14f3c">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment
      contextRef="C_ff678df4-6021-4567-a09d-3093fe7f6409"
      decimals="INF"
      id="F_ef950d16-2bdc-4631-84b9-42c01bbacc60"
      unitRef="U_shares">200000</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_fd3dace5-dba8-440f-ae0b-9ef36f749a0b"
      id="F_eca4dd0b-c89e-4b54-9077-269df70d7325">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares
      contextRef="C_09482968-6804-42ef-b55a-7e47a1585b7a"
      decimals="INF"
      id="F_d123ad63-376a-42bc-9615-5bfaf109cc97"
      unitRef="U_shares">125000</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_edd74574-ef0b-4838-bc41-a10ed60b1539"
      id="F_0aeccd82-7dfb-4a83-a9f5-cd839cf130d3">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_a1d6bb34-0ef3-4d19-8ba5-2d252c631a2d"
      id="F_aa59f26b-9ad7-476d-b474-7cd6c7e3bb59">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_b205ee9d-75ed-48cf-b5e9-efc423b1fd1d"
      id="F_523911fb-e01d-437d-a5cc-7ddf336bdb50">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_8f1b3c92-0ecb-4923-9ca5-2be4cf72dc09"
      decimals="INF"
      id="F_6ef2fb4a-0f2e-4040-8c83-1361fcf808f3"
      unitRef="U_shares">3000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_e7b46167-4167-4419-ac2b-387a17bd683b"
      decimals="INF"
      id="F_f2949ceb-6e69-4a47-87a3-ad128dbb54bc"
      unitRef="U_shares">21100000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_133df937-8209-4564-b4d5-073c7409a5c5"
      decimals="INF"
      id="F_3b8510b4-b7a0-4524-995c-3146d8e6384a"
      unitRef="U_shares">1000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_6c5c907c-4ae9-4b51-a14d-03a3b5e1c929"
      decimals="INF"
      id="F_7d6146f9-b512-4380-9eaa-f98b81ae8a7f"
      unitRef="U_shares">15962</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_7d2260f7-9b52-4e12-9966-22d0182d746c"
      decimals="INF"
      id="F_4eece075-5aa4-45a3-8a12-4ff7558ebf29"
      unitRef="U_shares">20783</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="C_2a620b62-e7da-4c15-931d-242b957c2e33"
      decimals="INF"
      id="F_eb73cf49-96f9-4bad-8e32-d3bd6f9b9a1e"
      unitRef="U_shares">17986</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_6c5c907c-4ae9-4b51-a14d-03a3b5e1c929"
      decimals="2"
      id="F_33b66040-dea7-4ee4-acab-81ffa5018099"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_7d2260f7-9b52-4e12-9966-22d0182d746c"
      decimals="2"
      id="F_a8cd68d1-3fa1-412b-8465-61e9aa215ecd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_2a620b62-e7da-4c15-931d-242b957c2e33"
      decimals="2"
      id="F_b3fa92f4-52d5-4acd-8928-8cab305dc4ca"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_6c5c907c-4ae9-4b51-a14d-03a3b5e1c929"
      decimals="INF"
      id="F_280b10c4-27fb-4671-984c-440187db7a39"
      unitRef="U_USD">29000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_7d2260f7-9b52-4e12-9966-22d0182d746c"
      decimals="INF"
      id="F_491d3759-3aa9-4cdb-a39f-d6cab71f31cf"
      unitRef="U_USD">29000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_2a620b62-e7da-4c15-931d-242b957c2e33"
      decimals="INF"
      id="F_3974ee1d-ab23-4a66-8d1b-0ff77a059f79"
      unitRef="U_USD">29000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_4003598e-554e-4006-9156-455dfd9de929">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate stock option and award activity for the 2011 Plan, 2018 Plan, 2006 Directors Plan, Inducement Plan and Directors Market Plan is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:34.976%;"/&gt;
        &lt;td style="width:0.086%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.64%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.086%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.08%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.681%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.712%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.086%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.904%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.086%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.663%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding Stock Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Remaining&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Available&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Contractual Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For Grant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,763,393&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,952,409&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Additional shares authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,755,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,747,760&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19,747,760&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.37&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Awards granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15,962&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,181,711&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options cancelled/forfeited/expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,616,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,616,058&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,370,729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;65,902,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.87&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.56&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50,205&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options exercisable at &lt;br/&gt;&#160;&#160;December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36,085,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.09&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22,878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options fully vested and expected&lt;br/&gt;&#160;&#160;&#160;&#160;to vest at December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;64,539,649&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.88&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.52&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;48,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:76.667%;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.13%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.13%;"&gt;(1)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Includes &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,791,750&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; performance-based stock options granted that have not achieved certain strategic milestones.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_78975e5b-bb8b-44c4-99dd-5f610fe10464"
      unitRef="U_shares">18763393</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_43e1ea6a-af0b-448d-9370-cd7f4c87356a"
      unitRef="U_shares">49952409</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="2"
      id="F_e26b17db-95d2-4b83-97c3-1cd337c15ae2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="INF"
      id="F_ae77cab6-4a01-4d5b-b622-dfdcbc6f48ce"
      unitRef="U_shares">16755000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="INF"
      id="F_1fdd3b76-7b58-4bf2-84d3-48b4918b5d88"
      unitRef="U_shares">19747760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="INF"
      id="F_69ded81d-3629-4329-ba13-442e034addcc"
      unitRef="U_shares">19747760</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="2"
      id="F_20ddb810-a42c-41ea-8a7c-1ae2f2b662de"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="INF"
      id="F_7412d7c6-516c-499c-af27-cfc26681e0d4"
      unitRef="U_shares">15962</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="INF"
      id="F_40d0f99a-fbb0-4dfb-8ff9-e93262897a46"
      unitRef="U_shares">1181711</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="2"
      id="F_bfc43d39-39db-4a4c-b9ad-a088c618d573"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.52</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <gern:ShareBasedCompensationForfeituresAndExpirationsInPeriodNet
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="INF"
      id="F_2a878ebb-a078-4a38-b0ff-4a6ff5791972"
      unitRef="U_shares">2616058</gern:ShareBasedCompensationForfeituresAndExpirationsInPeriodNet>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="INF"
      id="F_a4f177dd-90cf-4b32-b9ac-625ed68635eb"
      unitRef="U_shares">2616058</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="2"
      id="F_11f83080-d707-49a3-b941-f30ac39addf2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.70</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_8fa9b5f8-f191-41c8-bf19-567d6b416b95"
      unitRef="U_shares">18370729</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_70e6805c-5c34-4388-8411-ad1221efb6a0"
      unitRef="U_shares">65902400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="2"
      id="F_a5be2351-45c1-4785-a1bf-146d6ff21aff"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_6a97a782-88ea-433f-be0c-c880adb326b3">P6Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_a010dc66-8dba-4b6a-87be-3672fc37a9a9"
      unitRef="U_USD">50205000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_db5373d0-3fd3-4240-9709-00ac1a69118e"
      unitRef="U_shares">36085389</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="2"
      id="F_61b7ae74-bab5-4d5b-a659-7f45763973ae"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_d68afe90-84f6-43cd-a1a5-5e320809f8c1">P5Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_4f92ed98-0783-4fb1-bd6c-4289e69902de"
      unitRef="U_USD">22878000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_9afdc9d7-0d70-4bf0-a3e5-6c491c1ad227"
      unitRef="U_shares">64539649</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="2"
      id="F_7e9c0a5d-f017-433e-8f54-bd78e46625b8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_c663ff87-b555-47f1-bacb-64fa9f9600f9">P6Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_5a995545-ff4b-4fc9-88ce-56c78337d012"
      unitRef="U_USD">48951000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_6f3c409b-23a5-42d9-b49c-56b851f33720"
      decimals="INF"
      id="F_5c7508a6-c43d-411a-9566-168b3966cd51"
      unitRef="U_shares">8791750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharePrice
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="2"
      id="F_c375c8f3-0750-41fd-8b6b-f7e98e9e5522"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.42</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="0"
      id="F_d4d94ea1-c802-4102-9ab1-e4fa377af158"
      unitRef="U_shares">36085389</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="INF"
      id="F_5389326c-f841-4104-ade2-e5dc940e4fa8"
      unitRef="U_shares">30459136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a"
      decimals="INF"
      id="F_670b339a-2ab9-4606-a883-5fa0811c082c"
      unitRef="U_shares">25721508</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="2"
      id="F_6388fbd7-6eb0-4da5-bc61-dbca10a2a813"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="2"
      id="F_577ccbeb-6f67-408e-9fd6-4ff8db17dba8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_0dccb036-3808-41c2-8f88-d8acdca9fd5a"
      decimals="2"
      id="F_527833c3-1f74-4a7c-b2e0-5fc81f1f4753"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="0"
      id="F_8667204c-1b75-4bd1-9722-49758de99956"
      unitRef="U_USD">787000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="0"
      id="F_db80b270-2928-46d0-966a-65b0bfd7465b"
      unitRef="U_USD">93000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="0"
      id="F_f3f80ba8-e3fa-42ad-8b33-4ebd406264f1"
      unitRef="U_USD">17000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="0"
      id="F_93671365-8478-4a48-8097-5c1b658fe714"
      unitRef="U_USD">1799000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="0"
      id="F_2e76dd25-141d-4727-bbc5-0cd59b53575b"
      unitRef="U_USD">556000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="0"
      id="F_afeeac90-b249-495e-b49f-0e165e49cfa6"
      unitRef="U_USD">25000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod
      contextRef="C_cdb043ed-5bb6-48a5-9edc-3b464d5cb5cb"
      decimals="INF"
      id="F_f6f3fb59-fd50-4db4-af0c-56fcedf3c2f0"
      unitRef="U_shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_1bf14810-4b41-4fda-8ccf-f5f7c92e07e4"
      decimals="INF"
      id="F_7c508dff-6c01-484e-bddf-4e24bba62fbc"
      unitRef="U_shares">2000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="INF"
      id="F_7d7e2849-c504-4599-81c4-af26b498ada0"
      unitRef="U_shares">868236</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      id="F_cbe68772-3d59-4f3a-b684-9fb6feebab68">P12M</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="INF"
      id="F_9af148f0-300a-4bb4-a061-c56a68348f43"
      unitRef="U_Item">1</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="INF"
      id="F_6c281951-79ee-4323-a96f-dc615a1a2128"
      unitRef="U_Item">2</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      id="F_c24b8de3-304d-4bdf-bae4-65876e98ea4c">P6M</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="INF"
      id="F_ef52b3c9-798e-4b37-ba78-b3a1886fa1fe"
      unitRef="U_pure">0.10</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="INF"
      id="F_bb3769b2-a22f-4c42-bbb0-53c344faf637"
      unitRef="U_pure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      id="F_2a5101e7-0999-4ff4-81b6-64307d3141f3">P12M</gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_61a9529a-15e0-492a-891c-e7c1701d7744"
      decimals="INF"
      id="F_f9a0436e-5d8a-41d9-aac3-5526ad258cb0"
      unitRef="U_shares">2741750</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_00c2bd33-0379-417c-a384-344e1e28579a"
      decimals="INF"
      id="F_73788897-4dc4-4a41-ac4a-b0a88c1ff7e0"
      unitRef="U_shares">550000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_692b9105-0ff6-4de5-a951-63d71904a617">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We recognize stock&#x2011;based compensation expense for service-based stock options on a straight&#x2011;line basis over the requisite service period, which is generally the vesting period. We have not recognized any stock-based compensation expense for performance-based stock options on our consolidated statements of operations for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, 2021 and 2020, as the achievement of the specified strategic milestones was not considered probable during that time. The following table summarizes the stock&#x2011;based compensation expense related to service-based stock options and employee stock purchases for the years ended December 31, 2022, 2021 and 2020 which was allocated as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.977%;"/&gt;
        &lt;td style="width:1.268%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.517999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.268%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.517999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.268%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.183%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,720&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,597&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,337&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,483&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,558&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation expense&lt;br/&gt;&#160;&#160;&#160;included in operating expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,080&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,895&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_944921c7-37fd-48a6-87d7-c57fd7ba68ce"
      decimals="-3"
      id="F_a6cb26e9-922b-4662-89ef-7aac836a0bfd"
      unitRef="U_USD">3720000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_08938cfb-9117-4cc5-bf8f-c64669b9d0c1"
      decimals="-3"
      id="F_3c150b93-4fc0-4785-ad77-c6fb1c540009"
      unitRef="U_USD">3597000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_50d35c3d-da63-429d-b83a-be9fed64780e"
      decimals="-3"
      id="F_be6dc5cf-fece-4566-b85d-297266670a46"
      unitRef="U_USD">2337000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c1671901-1570-4d9b-ac8b-2fea04dc608d"
      decimals="-3"
      id="F_8083e590-7173-4c88-bd99-bcfd0c474e2d"
      unitRef="U_USD">4281000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_a5f6ada7-da6a-4619-8ac7-5fa8e6c89e2d"
      decimals="-3"
      id="F_eb62d023-bf08-4273-90af-d419cdae3d66"
      unitRef="U_USD">4483000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_affcd469-d055-47cc-bca1-8f79424c3ea3"
      decimals="-3"
      id="F_13f8cc92-ffcd-476d-a566-6449b5b87b69"
      unitRef="U_USD">4558000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_107ddf3f-49c9-48a6-8e6a-04304f15d038"
      unitRef="U_USD">8001000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_669f3af8-2fdd-4611-99f1-18621516f17d"
      unitRef="U_USD">8080000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_6adfe4e5-e613-484c-a380-be83f9edc1aa"
      unitRef="U_USD">6895000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_f29b4a3e-8816-4680-b247-57c20d832212">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of stock options granted in &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022, 2021, and 2020 has been estimated at the date of grant using the Black Scholes option&#x2011;pricing model with the following assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.489%;"/&gt;
        &lt;td style="width:1.242%;"/&gt;
        &lt;td style="width:16.253%;"/&gt;
        &lt;td style="width:1.242%;"/&gt;
        &lt;td style="width:16.253%;"/&gt;
        &lt;td style="width:1.255%;"/&gt;
        &lt;td style="width:16.266%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.772&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.817&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.775&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.783&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.781&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.793&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.69&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.57&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.51&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.30&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.31&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.62&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;yrs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;yrs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.25&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;yrs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50"
      decimals="2"
      id="F_94b5212e-04ac-43a3-95cb-10cb875f1f27"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b"
      decimals="2"
      id="F_c8c09e4b-04e5-4182-80d2-a280cd0844f4"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635"
      decimals="2"
      id="F_00885e1e-50bd-45a9-b077-2e4fef99b8b7"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50"
      decimals="3"
      id="F_99417dd2-ee29-4197-8af9-f48331977e7a"
      unitRef="U_pure">0.772</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50"
      decimals="3"
      id="F_26e88c1a-e91e-4641-ae71-8647f3c862c8"
      unitRef="U_pure">0.817</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b"
      decimals="3"
      id="F_7c73d077-9ba3-4899-a291-2f74879d227d"
      unitRef="U_pure">0.775</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b"
      decimals="3"
      id="F_6222972e-0df7-4256-aadc-44aa219435a8"
      unitRef="U_pure">0.783</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635"
      decimals="3"
      id="F_8abe3a11-e1e7-4da7-8952-608f20be61e3"
      unitRef="U_pure">0.781</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635"
      decimals="3"
      id="F_8acbcb8d-3ad8-414c-bf7f-920d4d4d4463"
      unitRef="U_pure">0.793</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50"
      decimals="4"
      id="F_e0c654db-8431-4e67-90c1-6d700fff1549"
      unitRef="U_pure">0.0169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50"
      decimals="4"
      id="F_521c297e-6941-43b7-87c7-4727e819017c"
      unitRef="U_pure">0.0457</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b"
      decimals="4"
      id="F_9c314aae-9e5e-4dc7-8479-25b653d4665c"
      unitRef="U_pure">0.0051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b"
      decimals="4"
      id="F_4205fafc-d4aa-4328-a999-9e9a982ab7cb"
      unitRef="U_pure">0.0130</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635"
      decimals="4"
      id="F_94defa0d-b9f9-4fea-8e2a-760c870431ff"
      unitRef="U_pure">0.0031</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635"
      decimals="4"
      id="F_83518215-7d74-4038-9d19-35210167e622"
      unitRef="U_pure">0.0162</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50"
      id="F_4add4c93-5ca3-48cf-981a-3e52a6965910">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b"
      id="F_87bd930e-6a76-4b9f-9b3e-646c43b9c4a2">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635"
      id="F_914bd34b-6c90-40dd-acb3-bc04015c8c1b">P5Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_8441ac1b-0b11-4056-a5bc-dfd5f3201c46">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of employee stock purchases in &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022, 2021, and 2020 has been estimated using the Black Scholes option&#x2011;pricing model with the following assumptions:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:39.984%;"/&gt;
        &lt;td style="width:1.242%;"/&gt;
        &lt;td style="width:22.503%;"/&gt;
        &lt;td style="width:1.255%;"/&gt;
        &lt;td style="width:16.8%;"/&gt;
        &lt;td style="width:1.255%;"/&gt;
        &lt;td style="width:16.96%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="5" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.614&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.865&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.507&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.707&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.478&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.40&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.79&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.09&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.16&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.16&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.57&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term range&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;mos&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;mos&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;- &lt;/span&gt;&lt;span style="font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;mos&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="2"
      id="F_8e120d1c-d920-49b0-b746-2a374305dc35"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1"
      decimals="2"
      id="F_bd3f921e-5078-412f-bd6b-0ffa60382fa0"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4"
      decimals="2"
      id="F_6c830b3c-5ac3-447d-a605-6f92f15705d0"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="3"
      id="F_bac49b16-5680-4113-959c-015999089997"
      unitRef="U_pure">0.614</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="3"
      id="F_92861eae-f85d-48c3-8fba-d76243f31ac1"
      unitRef="U_pure">0.865</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1"
      decimals="3"
      id="F_7425c6fc-d05b-4b88-816c-969a43f8a22d"
      unitRef="U_pure">0.507</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1"
      decimals="3"
      id="F_9d4a01b9-e3fb-45e3-87e9-3200c79c580e"
      unitRef="U_pure">0.707</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4"
      decimals="3"
      id="F_1a7c0f08-b6fd-4717-a507-57fe83eb2aa5"
      unitRef="U_pure">0.478</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4"
      decimals="3"
      id="F_e7b38077-f7d8-4661-be15-09796b9a284c"
      unitRef="U_pure">0.818</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="4"
      id="F_420abcc6-6ede-4efe-99e6-c6fd0db16c7d"
      unitRef="U_pure">0.0040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="4"
      id="F_3dbf9dce-21da-4147-81ad-e5f3d0c4101f"
      unitRef="U_pure">0.0279</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1"
      decimals="4"
      id="F_3857abea-3b22-4c48-918d-8c03ef0567be"
      unitRef="U_pure">0.0009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1"
      decimals="4"
      id="F_26a365fb-4db9-41ea-a060-de8741c2d63c"
      unitRef="U_pure">0.0016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4"
      decimals="4"
      id="F_a8d99c73-22dc-4251-89a3-4f83054dc1c5"
      unitRef="U_pure">0.0016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4"
      decimals="4"
      id="F_34c59e6a-a6b1-4bf1-bbd3-fc2a3a5fcfe1"
      unitRef="U_pure">0.0157</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_c72685f3-ef5b-4333-a58d-7abf3242e43e"
      id="F_74938194-0f3a-4ebe-96ba-fb5223eade33">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_3fa5ac2d-7b0a-4dc7-b48d-d537f56e2330"
      id="F_b2ca85c4-7c02-4ff4-83bb-585417657de2">P12M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_7067ae1e-fdcb-4353-ba94-faa3c668d9a8"
      id="F_09ca2a70-89d2-4737-8fb0-73f7f18791be">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_4eef0fe5-3ea8-493b-b90b-931244691f4b"
      id="F_925ce1c2-b27f-48d7-ba9b-932d503a64ff">P12M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_8dde9c08-9af2-47ef-968f-e8dd40116f7c"
      id="F_180d1f71-92d8-4d7c-ba64-727fa389c35f">P6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_60c0161f-8996-404d-9368-ce41e9ce095e"
      id="F_ceff665a-4ea1-44a7-b4e7-e080dbfd21e5">P12M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_8265167c-6a10-47c2-8235-d350b2140d50"
      decimals="2"
      id="F_a646c813-0323-49ea-92bc-da49892d2895"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0e287ecc-4cd5-4e08-b01f-2a01098df55b"
      decimals="2"
      id="F_ca990e4a-d1d3-4069-a435-957bd9be665c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_4ee2c259-7a89-4422-9ee1-25f729319635"
      decimals="2"
      id="F_3e99de40-f854-4e29-bbfc-fa031eada372"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_a6f63570-90af-4655-9959-2d2b2d53203e"
      decimals="2"
      id="F_e933395d-2e24-4d27-9177-3ed7b5419a76"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_cdf85569-9ffa-4bd1-9243-691e0be460f1"
      decimals="2"
      id="F_c9c56c84-2d26-42e8-9d34-bf8504575571"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0bcef938-7207-4be9-86d3-25661bdb92a4"
      decimals="2"
      id="F_3d746ea8-1664-49e7-99d9-80eb696b88d8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="0"
      id="F_a13a28ea-c255-43f7-86b4-c680f9846574"
      unitRef="U_USD">17791000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_9177bb69-8dbe-4250-8b8d-797400b86900">P26M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="C_6a7a9685-7310-4141-b7de-f1f3a5fe3099"
      decimals="0"
      id="F_4b54841a-d454-4b45-b63f-2533a5924e19"
      unitRef="U_USD">235000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="C_603a7d01-dfd6-49d7-a945-469443432a26"
      decimals="0"
      id="F_3bc7ca2c-8daa-4f73-939e-ce306aead7dc"
      unitRef="U_USD">62000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="C_f4b65990-18fd-492e-bb4e-3100622411aa"
      decimals="0"
      id="F_57ff2c8e-7e57-4bba-a61e-a116dcebe278"
      unitRef="U_USD">56000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <gern:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_75b7465a-44ed-4757-b91d-166ff5c00b7e">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Common stock reserved for future issuance as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:73.896%;"/&gt;
        &lt;td style="width:1.674%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:22.43%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Outstanding stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;65,902,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options and awards available for grant&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,370,729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,131,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrants outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;106,254,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;191,659,735&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</gern:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_4317b650-712f-47bf-a3ca-56afb6a76673"
      unitRef="U_shares">65902400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_dd681b18-d799-40e5-90f8-7a921c72cbef"
      unitRef="U_shares">18370729</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_8e72c6e8-4130-431a-9367-bbc923943f0f"
      decimals="INF"
      id="F_47cf329a-f086-4e1f-b7b7-cca02adb21b4"
      unitRef="U_shares">1131764</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_430e7b38-80ef-45db-bc8b-1876345cda71"
      unitRef="U_shares">106254842</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="INF"
      id="F_b0d72299-89dd-48db-aa53-a55f0205e38e"
      unitRef="U_shares">191659735</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_f0b9250e-8eee-445b-9a1e-7973b16a4b68">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10. INCOME TAXES&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table reconciles the federal statutory tax rate to the effective income tax rate from continuing operations:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.158%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.196000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:3.305%;"/&gt;
        &lt;td style="width:5.199%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.808%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:3.122%;"/&gt;
        &lt;td style="width:4.295%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:7.612%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:3.305%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Tax at statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal and state tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net operating loss not benefitted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Effective tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant components of our deferred tax assets are as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.802%;"/&gt;
        &lt;td style="width:1.432%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.742%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.448%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.576%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;254,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;241,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal and state tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;56,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Capitalized research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;350,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;312,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;349,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;310,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating leases, right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We record net deferred tax assets to the extent we believe these assets will more likely than not be realized. In making such determination, we consider all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. Because of our history of losses, the net deferred tax assets have been fully offset by a valuation allowance. The valuation allowance increased by $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;38,900,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,500,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, we had domestic federal net operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;993,100,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Of this, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;685,300,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; will expire at various dates beginning in 2023 through 2037 and the remaining will carryforward indefinitely under the new tax laws, but is subject to an 80% taxable income limitation for tax years beginning after 2020. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, we had state net operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;658,400,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; expiring &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;at various dates beginning in 2028 through 2041, if not utilized. We also had&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;federal &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;tax credit carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62,700,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; expiring at various dates beginning in 2023 through 2042, if not utilized. Our state tax credit carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,900,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; carry forward indefinitely.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Utilization of net operating loss and tax credit carryforwards may be subject to an annual limitation due to ownership change limitations provided by the Internal Revenue Code and similar state provisions. Annual limitations may result in expiration of net operating loss and tax credit carryforwards before some or all of such amounts have been utilized. The impact of any limitations that may be imposed due to such ownership changes has not yet been determined.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.587%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In March and December 2020, in response to the COVID-19 pandemic, the Coronavirus Aid, Relief and Economic Security Act, or the CARES Act, and the Consolidated Appropriations Act, 2021 were passed into law and provide additional economic stimulus to address the impact of the COVID-19 pandemic, including among other items, several U.S. income tax provisions related to, among other things, net operating loss carrybacks, alternative minimum tax credits, modifications to interest expense limitations, and an option to defer payroll tax payments for a limited period. In 2021, we assessed our eligibility to claim a refund of employer taxes available under the Employee Retention Credit provisions of the CARES Act. For the years ended December 31, 2022 and 2021, we calculated eligible credits of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;483,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,152,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively, provided by the CARES Act, which have been recognized as offsets to salaries costs in operating expenses in 2022 and 2021, respectively. As of December 31, 2022, the aggregate eligible credit amount has been accrued as a receivable on our consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.587%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We adopted the provision of the standard for accounting for uncertainties in income taxes on January 1, 2007. Upon adoption, we recognized no material adjustment in the liability for unrecognized tax benefits. At December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, we had approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,700,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of unrecognized tax benefits, none of which would currently affect our effective tax rate if recognized due to our net deferred tax assets being fully offset by a valuation allowance.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.199%;"/&gt;
        &lt;td style="width:1.923%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.878%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;If applicable, we would classify interest and penalties related to uncertain tax positions in income tax expense. Through December 31, 2022, there has been no interest expense or penalties related to unrecognized tax benefits.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;We do not currently expect any significant changes to unrecognized tax benefits during the fiscal year ended December 31, 2023. In certain cases, our uncertain tax positions are related to tax years that remain subject to examination by the relevant tax authorities. Tax years for which we have carryforward net operating loss and credit attributes remain subject to examination by federal and most state tax authorities.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_263edaef-b8d1-47d8-b7e7-c19c6d417f3d">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table reconciles the federal statutory tax rate to the effective income tax rate from continuing operations:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:47.158%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.196000000000002%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:3.305%;"/&gt;
        &lt;td style="width:5.199%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.808%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:3.122%;"/&gt;
        &lt;td style="width:4.295%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:7.612%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:3.305%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="4" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Tax at statutory rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal and state tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net operating loss not benefitted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Effective tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:top;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="3"
      id="F_663b0887-8c46-48b6-be2c-bf3f24be2e5c"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="3"
      id="F_8125d794-557e-4ea6-8c47-1932b98aa85a"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="3"
      id="F_8a0ea1c5-d1a2-40c8-a5c3-09e5b87a306e"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="3"
      id="F_52e8f4bd-d59d-4ca2-9d12-1f07b88f09c2"
      unitRef="U_pure">0.068</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="3"
      id="F_b905c28d-8a54-4787-bfe1-930c87715bc4"
      unitRef="U_pure">0.090</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="3"
      id="F_2cafafa5-3037-4110-9022-efaa121d3065"
      unitRef="U_pure">0.069</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="3"
      id="F_7e41f91b-cee3-4ba7-ada2-0f0f3ecd493a"
      unitRef="U_pure">0.049</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="3"
      id="F_e2d6d1a2-405e-4fbb-9306-21cc2e8541c0"
      unitRef="U_pure">0.057</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="3"
      id="F_3dabcfaf-66d5-4293-b1c1-373323c89ade"
      unitRef="U_pure">0.053</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="3"
      id="F_5b5a3ffc-2881-4bfb-a9e0-65734c429d35"
      unitRef="U_pure">-0.008</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="3"
      id="F_3319b949-eda0-46de-921a-b34846190b69"
      unitRef="U_pure">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="3"
      id="F_420b24a2-7a77-444d-bd70-1b405fba49d1"
      unitRef="U_pure">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <gern:EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="3"
      id="F_ffe1583a-96b7-4a02-abcf-67602c4da093"
      unitRef="U_pure">-0.043</gern:EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted>
    <gern:EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="3"
      id="F_1ac3bba0-fae9-45dd-9dcd-aef636d1ec17"
      unitRef="U_pure">-0.054</gern:EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted>
    <gern:EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="3"
      id="F_74ba33ea-8bab-42f5-8f99-0518ca078a8f"
      unitRef="U_pure">-0.069</gern:EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="3"
      id="F_53c450d3-fd94-40e5-bc8f-1c6c2c5fbd9c"
      unitRef="U_pure">-0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="3"
      id="F_bf5a659b-01e5-499b-a3d0-1c1412f09fdf"
      unitRef="U_pure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="3"
      id="F_db60b346-06f9-456a-9671-3b0d0e8beae1"
      unitRef="U_pure">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="3"
      id="F_5e84938c-ec39-46f0-88f1-ef8b90af8467"
      unitRef="U_pure">-0.275</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="3"
      id="F_e52c015a-5db4-4b43-889c-d52907b31993"
      unitRef="U_pure">-0.289</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="3"
      id="F_5606259a-ce75-4137-ac11-6dd070d7cd85"
      unitRef="U_pure">-0.255</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="3"
      id="F_4a3c68ff-e709-42a3-b056-647d5bc6ef47"
      unitRef="U_pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="3"
      id="F_4c783bf8-4ff0-47f4-b9d8-c250cd1e74e5"
      unitRef="U_pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="3"
      id="F_96f3a6c2-5e8c-4711-a6a1-821f2410337c"
      unitRef="U_pure">0.000</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_80d31dd6-508e-40da-b423-4f1b23a496d9">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant components of our deferred tax assets are as follows:&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.802%;"/&gt;
        &lt;td style="width:1.432%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.742%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.448%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.576%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;254,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;241,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal and state tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;56,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;49,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Capitalized research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;350,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;312,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;349,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;310,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating leases, right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_50c004f5-168e-4850-995e-e071522fe564"
      unitRef="U_USD">254500000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_ed4d3eba-766f-4251-9395-15497c05ad4e"
      unitRef="U_USD">241300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <gern:DeferredTaxAssetsFederalAndStateCredits
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_1569532b-aac8-4c64-8dc7-f3de84f5d604"
      unitRef="U_USD">56700000</gern:DeferredTaxAssetsFederalAndStateCredits>
    <gern:DeferredTaxAssetsFederalAndStateCredits
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_34a57cff-4c6c-4883-80d6-f0459cedaa75"
      unitRef="U_USD">49600000</gern:DeferredTaxAssetsFederalAndStateCredits>
    <gern:DeferredTaxAssetsCapitalizedResearchAndDevelopment
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_2e87225f-9e14-48fb-9411-5f31bd8a7259"
      unitRef="U_USD">21800000</gern:DeferredTaxAssetsCapitalizedResearchAndDevelopment>
    <gern:DeferredTaxAssetsCapitalizedResearchAndDevelopment
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_7238106c-db4b-4863-9887-d4e01a75257d"
      unitRef="U_USD">6900000</gern:DeferredTaxAssetsCapitalizedResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_ca8817c5-2515-4d34-930f-1bc5acbb15ba"
      unitRef="U_USD">10800000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_41f62b2b-232d-449f-93d0-232a7958de40"
      unitRef="U_USD">10200000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <gern:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_66f5b7ec-6c07-4edb-b65a-aea04ceaebcc"
      unitRef="U_USD">1300000</gern:DeferredTaxAssetsOperatingLeaseLiabilities>
    <gern:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_29aed149-5329-407c-a4c2-60ac099b1d0a"
      unitRef="U_USD">1400000</gern:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_ff92e230-529e-47a1-808e-b74c6ccdff4d"
      unitRef="U_USD">5600000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_118b7347-7db9-4de9-b6d1-513d7ca1a256"
      unitRef="U_USD">2600000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_eda03375-e7b4-4afb-aa55-54d04abc60ae"
      unitRef="U_USD">350700000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_bfaf21bb-9c97-4ea9-8b8f-1e0ddd64304c"
      unitRef="U_USD">312000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_fcdf3b29-519d-4bd8-8c2c-75dca6544e8e"
      unitRef="U_USD">349600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_868bcf2c-9027-4eff-83af-19860740f9fd"
      unitRef="U_USD">310700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_b3c88b19-3bd4-4711-a3b2-246f2e919625"
      unitRef="U_USD">1100000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_b30bf350-2d4c-41dd-be70-843cec22216d"
      unitRef="U_USD">1300000</us-gaap:DeferredTaxAssetsNet>
    <gern:DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_3efa7186-e792-4a30-aa5b-06a3e0327ec3"
      unitRef="U_USD">1100000</gern:DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets>
    <gern:DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_1cf58660-11f4-4dec-a246-82df8cbac171"
      unitRef="U_USD">1300000</gern:DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_46a831cc-df1f-4ae3-8ac6-025b7129a298"
      unitRef="U_USD">1100000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_3152c719-efc0-46f3-9db3-a91a373a9718"
      unitRef="U_USD">1300000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="0"
      id="F_ce8db30f-5635-4b01-b870-d1a8337e38d6"
      unitRef="U_USD">38900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="0"
      id="F_6156854b-66f2-4f13-a093-28feccac61b4"
      unitRef="U_USD">33500000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_a981f541-3690-49c7-8693-645d2e5d3905"
      decimals="0"
      id="F_4538ca73-251b-4780-8836-33e3d98a47c7"
      unitRef="U_USD">993100000</us-gaap:OperatingLossCarryforwards>
    <gern:OperatingLossCarryforwardsSubjectToExpiration
      contextRef="C_a981f541-3690-49c7-8693-645d2e5d3905"
      decimals="0"
      id="F_84b5ac81-d266-4ee6-84d8-8c4122cf95f7"
      unitRef="U_USD">685300000</gern:OperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0b8de677-089a-4241-b514-5dc0cbded8a3"
      decimals="0"
      id="F_b6fcbbb0-1a8d-45fd-ad79-52d36c2a595b"
      unitRef="U_USD">658400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_a981f541-3690-49c7-8693-645d2e5d3905"
      decimals="0"
      id="F_f5021f36-8181-4bff-8c71-b7f3744ebadd"
      unitRef="U_USD">62700000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_0b8de677-089a-4241-b514-5dc0cbded8a3"
      decimals="0"
      id="F_e88c8327-3f41-450f-b31b-d8f90a24b237"
      unitRef="U_USD">20900000</us-gaap:TaxCreditCarryforwardAmount>
    <gern:EmployerTaxReceivable
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="0"
      id="F_c81c25ed-a957-4a9e-9a32-aa93a4524256"
      unitRef="U_USD">483000</gern:EmployerTaxReceivable>
    <gern:EmployerTaxReceivable
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="0"
      id="F_287deafe-57d7-4fa2-8b34-eabcf641d4e4"
      unitRef="U_USD">1152000</gern:EmployerTaxReceivable>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="0"
      id="F_4a1d3424-c816-483c-968e-7fbbdf2a2761"
      unitRef="U_USD">23700000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_bcb53bbf-2b6e-44e4-8405-bcfd1fb16afa">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:80.199%;"/&gt;
        &lt;td style="width:1.923%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:15.878%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Decrease related to prior year tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_1254ade3-fe72-434a-a6db-19a268f35273"
      decimals="-3"
      id="F_1b6bf3da-b733-47e9-b3fd-d8f8770fc4a2"
      unitRef="U_USD">21300000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_79df34f5-6212-4c3b-b0c5-e3355f5e27ae"
      unitRef="U_USD">2400000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_1ac565cd-3589-476a-8008-a137d294bc33"
      decimals="-3"
      id="F_3e0f8e13-c33c-4f4b-8955-3f7c49bb7f64"
      unitRef="U_USD">23700000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_157eb80c-2dad-42d4-9bb6-37fb88b8e028">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11. CONSOLIDATED STATEMENTS OF CASH FLOWS DATA&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&#160;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:44.689%;"/&gt;
        &lt;td style="width:1.747%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.706000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.747%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.706000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.747%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.659%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Supplemental operating and investing activities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net unrealized loss on &lt;br/&gt;&#160;&#160;&#160;marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;251&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Reclassification between prepaid and other&lt;br/&gt;&#160;&#160;&#160;current assets and deposits and other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease assets obtained in&lt;br/&gt;&#160;&#160;&#160;exchange for operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_0c57187c-7e21-44f8-be5f-f15f24c6f9d6">
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:44.689%;"/&gt;
        &lt;td style="width:1.747%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.706000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.747%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.706000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.747%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.659%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Supplemental operating and investing activities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net unrealized loss on &lt;br/&gt;&#160;&#160;&#160;marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;68&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;251&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Reclassification between prepaid and other&lt;br/&gt;&#160;&#160;&#160;current assets and deposits and other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease assets obtained in&lt;br/&gt;&#160;&#160;&#160;exchange for operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,575&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Interest paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,704&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_fded01e9-1d1a-407e-ac5f-95e55067edb3"
      unitRef="U_USD">-68000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_85f4ea7d-2400-43e4-80ef-52eb48e547a9"
      unitRef="U_USD">-251000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_2dbad9ff-d362-4f2b-a38d-c94f452ac3d9"
      unitRef="U_USD">-54000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <gern:ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_babb2620-3e4b-4250-80f2-3a4df8c41885"
      unitRef="U_USD">-5000</gern:ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_0bb55348-6db6-4e4d-a862-bc63c312b200"
      unitRef="U_USD">3575000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:InterestPaidNet
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      decimals="-3"
      id="F_9e0f2654-9ffb-433c-bcfb-923a89b33cb5"
      unitRef="U_USD">5154000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_05ddd28f-b8fe-4ce9-a237-31058693c7d7"
      decimals="-3"
      id="F_1d9d8d28-22a4-446a-962d-4dd72b5df8f1"
      unitRef="U_USD">2704000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_367bc429-6a6f-4f2c-b924-c0b90d1ffc26"
      decimals="-3"
      id="F_e88b74ee-cab4-4486-b46c-6d156f3425ea"
      unitRef="U_USD">388000</us-gaap:InterestPaidNet>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_e1b24643-c361-410f-bc44-b8aaa587644d"
      id="F_2613244d-1124-4d10-8baa-3dbbb28c0c58">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12. SUBSEQUENT EVENTS&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On January 10, 2023, we completed an underwritten public offering of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;68,007,741&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock and a pre-funded warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock, or the 2023 pre-funded warrant. The net cash proceeds from this offering are approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;213,300,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, after deducting the underwriting discount and other offering expenses paid by us, and excludes any future proceeds from the exercise of the 2023 pre-funded warrant, which has not been exercised.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrant Exercises&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From January 1, 2023 through March 9, 2023, we have received $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;46,716,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in cash proceeds from the exercise of the 2020 purchase warrants, representing &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35,935,577&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;From January 1, 2023 through March 9, 2023, we have received $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,119,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in cash proceeds from the exercise of the 2022 purchase warrants, representing &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,047,617&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of our common stock.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <gern:ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering
      contextRef="C_e324494e-e119-4b64-9797-465da2721c25"
      decimals="INF"
      id="F_9adf0ee4-16bc-46db-8dc2-907162ce24fa"
      unitRef="U_shares">68007741</gern:ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0ec8418b-4210-4aed-a7a0-402e2cb1fc9b"
      decimals="INF"
      id="F_88da9e23-7713-4693-bbd6-9068b9d66e4b"
      unitRef="U_shares">25000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOrSaleOfEquity
      contextRef="C_e324494e-e119-4b64-9797-465da2721c25"
      decimals="0"
      id="F_a452d4c7-3022-4054-b7fa-0a7e1e485760"
      unitRef="U_USD">213300000</us-gaap:ProceedsFromIssuanceOrSaleOfEquity>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_50af7db3-82da-48d8-bf5d-ca3bb07f1a6d"
      decimals="0"
      id="F_310502ed-aad8-40d5-ba91-6e8724eba8c7"
      unitRef="U_USD">46716000</us-gaap:ProceedsFromWarrantExercises>
    <gern:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised
      contextRef="C_1acf8b0f-f8d1-4664-927d-c462800c5922"
      decimals="INF"
      id="F_cf30b420-05b8-4bbb-9a9a-99a10452de8c"
      unitRef="U_shares">35935577</gern:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_fb131e02-2952-4669-a8d3-c6f166ff823e"
      decimals="0"
      id="F_56ef7f71-5921-40e9-a2fe-697b554c382d"
      unitRef="U_USD">13119000</us-gaap:ProceedsFromWarrantExercises>
    <gern:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised
      contextRef="C_54fac2af-1b06-465c-8688-a1f93e1c62db"
      decimals="INF"
      id="F_8690c25b-6e79-455e-a909-305f6232480b"
      unitRef="U_shares">9047617</gern:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>86
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MR_Z#S>Y<SZN!(&6<)/M@<0=)A'>?\&T/XB2@;9T)</8!SG<!]KDKN/L MVR
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M)8KF<L.HAFT,].]K(=33C7E-<7@M-?L/4$L#!!0    ( %: <%80_ 8:_ (
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MPF>DSW.\QHF^7RL@-RSB.9!OO:E4 J_*]Z;LE^Q.,[LN'Q=R02/H&D@L0:S
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MF2@B+KREMF<2B>QZFHW3V&FG'QD*LMA0I):D[.3?%Z1D4;@((KU'F^1#+-G
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MD*@F'"/D."X.)':N2>GY>A"+.BJ#S%BFQTKBD=J"9!]3I.(67J>.Z_J.#&9
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MN9%'U9$KOL0!=#59*#BP%6CNQP^F8WS;Y]$QR;PCD>WX9]?^V8W^C3C/,0D
M!92+O?>S$?]>WTJR=D&F:N_*M2_D-5AMV_$ZQK3M.F9'9;M6V6Y4.<EG:1+4
MUP/1" UHELD*ZPL:+)#\;Z(GS!@F^SUH9'^O!\<D\XY$MN.J4[OJ_.?=<5X=
M9=MPG-WS'C1N\EX_7N_X]=*X?'%[]*W.D &;%QV62QDY$64AK5?K)MXK>M>+
M];YL[F4O_D=3?AG(@C1/"$<I1)+2.+^0*;&RVY8309=%_YE1(;M9,8SE!PHP
M%2#?1Y2*S41M4'_RN'\!4$L#!!0    ( %: <%8]WA4D)PD  #$M   8
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M$3Z"W--J/ 8@1CFH_1J>KMWNSW+,@D0B2,"A),T.PS)(J7\EGR]L <^BS#<
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M>/7PPBLRZM9QJ@0,=@T"5(FA.UH2,97D2V(A65<!#6\6:BN)7<19$82QL-U
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MAZ"$YE14R%A$-$AKTV:M:=:N'JJG!U$\[*0("P'[RG0E\]K&8B]SC!BQU@G
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M031M9=43YO![S,$PV ;&/ACNS.I083ATT-C51VNLWY",B15 ]EBU'NPWI'\
MD!/H=>Q@<D8H:7\?&W$V\Q;S&@V[VQZ,GC8BRIV17\'AD>#MT9,T+/I56'@D
M?GN4(!*FGRZ=-\Q';"XK\G=.:,P9CY'TVA#Z>2O%AN'B&!)SF3 < *E/94)/
MI#UV\\3FR6G, \IV],]54$<G83^$=)"3% =N(^#E!HL4X3CV1,TBB)9%91 4
M$?A!U0%>O@S%KU@H,2W%$3*VB:!X1"T ?5WF1W7:(RGG:<P7,B61H5_PG84%
M3NI#\1-VDE]W?&XGT8[924-:$)%MV&N(]75)JRMUT!N)7*93%0DZL]LF ))'
MF44HQU"=.C:-AAG(Y)PD$QW!)IBV2?0*OVH:.20QU*)BT4(JQ<ND(!EI*^0Y
MK;*-N/SIET]7K_PEK)K%DM:1O-7H1NJ=3J ?VD/>VYK>E-&62!(9:"_'6Y$J
MS"*M8/=U@M(3";K84XZ^^Y*#=<ED;THP%'JT>"^3A/X3EUA/HSOX$&3$3I5F
ME,G+7<$B4*J/(D[A6JS"[$M5E-JT+;.8^"4O547*EG9ZY;GK4"5L*7A1+N^I
M)T?>H;)[>)V=_GL9YG"OY($6J9@X63\P7Q*^4Y*3[[<2,I/K/QPLY8)$@0/4
MR\PL= S>C"(/T[3D%=4=KUJ^D^Z0?VGU$)DX*G1N2',&^^;VI%'Y.DE5[VNK
M&F4.O)!/)VP,:&$#CR +J]1J7'XEG9)(^ZV"V=CO*/7?<^K?P@)<237%$<T(
MZX-41">C56B4C9R*D[WDF,T8=@R9DI;5YS=8I)J)^,5:T -[ZHLD]=(N%-X<
MPZ"TUV42@PU8!H&:RQ-$5W)-5. P!%L/E2/W\<IV=JZ)'6/-^QUS?%BJ]V\
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M0>NLZX&JIDHE&%FX3EY*0W/!'5,:Q*BL =VOI#0[P0:H1_OD#U!+ P04
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MT"SH/43C V@^T]JM.WZ!_H6=_P502P,$%     @ 5H!P5DN%E\S  @  P 4
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M'1PM& )<<8,;%$:5WJU60-!Z"8N%#J1@&X8=)'I0E7B@DOF?Z;48Z"$2"<:
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MV("$]HX#3DS;ZSF(=ML:=TTL1[(2Q"'J8TC/[RH=D ".@>35VK8C/*%TB1I
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M=37]<VD0$^(-<'WN0-SR!VZ0/C7[_)]02P,$%     @ 5H!P5G/XS75:!@
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M1$M\ [1'>W]@O.%=82.1>_M7E'U=6?1G7X:\XD?B96?O^E$M0UI>P"A-_><
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M-(W;PWXK"$Y]X73I7ZG'VN$+NE_..,-RT 9\/M':U1?DH/F-Y?0?4$L#!!0
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M4<;##B1MP1!OU'#JSV:'D'26= X(1_<5Q,^H]MNE)J,DI-@A!U1 P2^;0?'
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M5.#WEA;@^=P8GS[0 <W/)9__%U!+ P04    " !6@'!6?L;/6Z(=  #K:
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M3]V9CFX!6/E.'5]:)C ;('%[0.:RO=Q%.<SV8P_-9G[<-RL:!CRV2!T9KC.
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MSJ0C,C6391X^V]4_5&7/F/2E-O?\7ZSBVN&P(]+2!UM4PD!0:!,_Y4/EAY;
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M.C,/<G.-VWS:EB^6F79?V)1W6TT/XK4V,M^"24'.13FRU^WO\ ;0"3X 1%M
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M"-(L@S-(4@*RMP''8@%7P*8@@YW!6)W3"0TL"9@*\L5A(:^K0"MC5F*O@5W
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MOB71N^@=U/P1_=Q=O(!J^%K /VSTXOP+1T;7]&PX,"HEKN")LQ-0XR=)0V]
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M#=Z"MWC$F_+J_.IYN&+P_.HC_7*"37W947!D_ 67ZWZ*/G3X'A2J)V3C<,R
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M,\D%F!!:5&Q$)CLA&)M1T$:Q$04ZO<"XYD5!Q2(#D3;)!B+RF#2!9SJ13P*
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MHY'VP*ONS$AVR)0+M$2>I;HFG"<YT":8 K\HRS.=9&VT_@>%5V&X/8F 74$
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M#$1A?-MB1HU+-MR7=^@?0NZ4RTPXO#+J+SGWJW%T'L$<%Z)2_MYL_L1M/B'
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M]HE*\"-:AR\0#KH=5C^0/[1P)?UV&82>@]A&L["FI D_+J2D3!$P.:H[U,K
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M&@^@^$9KMY_X!,._9?$?4$L#!!0    ( %: <%;(;/8V?P<  %04   9
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M]VN4A.8_U.J2X_&L+A-,X(%P3DHI]&R]R6D,BS1%3LLML!1\5A3JET:2Q8]
MRG?P;V""R A'X9I2!=:VS;@+=]6&LP^$\RH^ &MX!+9EVY_0_:_I<_("]GG#
MMMZS3=7EOM5VWVJ[D3LY(->'D@RJFL>9VGT0M]&%CG[T1=!6^JR1UB?S:3(<
M61>GMC-RS:?]2'\#1XZC<!<][IUYIS?O_)]Y?$8>4^6\XC3&SZRV0N=[#JR!
M90T_^/P7JG5I[NUL?:O,"=_24D".J>)9@_-3 WA[4MM"LJK9[!LFU=%IAIFZ
MW)!K@%I/&9-OA3X__74Y>0502P,$%     @ 5H!P5HOL6]0D P  S@@  !D
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M\=TM-O%8!U-.I7W"KK'U'$@KJ7C1@+4'1<[J-WEM=-@#^,,#@* !!!\!_0.
M7@/H?170;P!]JTP=BM4A(HI,1H+O0!AKS68&5DR+UN'GS*0]44+OYAJG)HO5
M33B/_PT?XL4<PGD$R>/]?;CZ!Q;7D,0W\_@ZGH;S!PBGT\7C_"&>W\!R<1=/
MXUD"?\%\]@!WBR2!Y6P%R6VXFL%)A(KDU#_5VW)+!,J1J[2CYC@W;9RZJIT*
M#CCE!W#/F=I*F+$,L_<$KHZP#3-X"_,J^)0QPO0,>OZ?$'A!T.'0].MPOP,>
M?1WN?1)-KTU:S_+U#_ EBJ?/P$MS<R00EL&."$&8DH"O*:VT9K 6O( LIY72
M$Z;K!^520HFBS@JDA*85)?;R916"XGM67.9FHRMSGWIFBM2E+$F*8T=7(8GB
M!9W)MS_\H?=WE^K')(N.1/8N(_TV(WW+WCN0D9"IW(JMBQ@DF%9""XCZ^WV7
MCBDORDK5FO,US(A@.=M(6.JL)"8K78+WCRGX,<FB(Y&]$WS0"C[X] HLN4*M
M.:'0RBY_R]Y]"_!-[Q/SE9\>N PG.6L*UVE7.FJWAM8MTU-?)GY_<!X,SX>#
MD?NRKW6'I:<M!Q?G'RRC+DO_XL+O??=;RUHE=Z_2%R@VMF-*2'G%5%T-V]6V
M*8>V%WU8O]+-NNZMOVGJ3G]/Q";7987B6E-Z9^?:.U%WSWJB>&G[R1-7NCO9
MX5;_<* P!GI_S75NFHDYH/V%F?P/4$L#!!0    ( %: <%:D*\:]6 (  .L$
M   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;'U4[V^;,!#]5TY,FC9I
M*X2DW=0E2.17A]20*"2=MFD?'#B"5<#4-DW[W\\VA&52FB_89]][?L_<>7A@
M_%%DB!)>BKP4(RN3LKJU;1%G6!!QQ2HLU4[*>$&D"OG>%A5'DAA0D=NNX]S8
M!:&EY0W-VHI[0U;+G):XXB#JHB#\=8PY.XRLGG5<6--])O6"[0TKLL<(Y;9:
M<179'4M""RP%925P3$>6W[L=#W2^27B@>! G<]!.=HP]ZB!(1I:C!6&.L=0,
M1 W/.,$\UT1*QE/+:75':N#I_,@^-]Z5EQT1.&'Y#YK(;&1]M2#!E-2Y7+/#
M=VS]7&N^F.7"?.'0YCH6Q+60K&C!2D%!RV8D+^T]G !Z-V\ W!;@&MW-04;E
ME$CB#3D[ -?9BDU/C%6#5N)HJ7]*)+G:I0HGO>7ZS@^#7_XF6(;@AU.(MHN%
MO_X)RSE$P5T8S(.)'V[ GTR6VW 3A'>P6MX'DV 6P6?81K/Y]A[N@P<5*H0?
M1;--!!^F* G-Q<>A+95&?9(=MWK&C1[W#3T]%Q:LE)F 69E@\C^!K<QU#MVC
MP[%[D7&*\17T>Y_ =5SW E^_N[&^X>N_R:>J/Z;$%-5O?R<D5Z7UYYS5AFAP
MGDBWVZVH2(PC2S$*Y,]H>>_?]6Z<;Q=D#CJ9@TOLWDQ(JHH6$Z@%IG4.N:I^
M 2P%(@1*<4[O9<8!O"+AXIPV^Z0 "^1[TV8"8E:7LJG%;K7K9+\IX'_IS3.P
M('Q/2P$YI@KJ7'VYMH WK=4$DE6FG'=,JN8PTTR]1LAU@MI/&9/'0!_0O6_>
M7U!+ P04    " !6@'!6I@W17-\'  " .@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S,RYX;6RUFVUOVS80Q[\*X15#"RRQ2)&4E24&4B?M C1#D(<.?:G8
M="Q4%CU)3II]^E&V:UKB0\2:?I-8]O&O.XKD_7B23E]X\;V<,5:!'_,L+\]Z
MLZI:G/3[Y7C&YDEYS!<L%[],>3%/*G%8//7+1<&2R:K1/.NC(*#]>9+FO>'I
MZKN;8GC*EU66YNRF .5R/D^*UX\LXR]G/=C[^<5M^C2KZB_ZP]-%\L3N6/6P
MN"G$47^K,DGG+"]3GH."3<]ZY_!D1..ZP<KB:\I>RIW/H [ED?/O]<'5Y*P7
MU!ZQC(VK6B(1_Y[9B&59K23\^'<CVMN>LVZX^_FG^J=5\"*8QZ1D(Y[]DTZJ
MV5EOT ,3-DV6677+7_YBFX!(K3?F6;GZ"U[6MA'I@?&RK/A\TUAX,$_S]?_D
MQZ8C=AI ;&B -@U0UP;AID&X"G3MV2JLBZ1*AJ<%?P%%;2W4Z@^KOEFU%M&D
M>7T9[ZI"_)J*=M7PT_G5+?AZ_N7A$EQ?GM\]W%Y>7_Y]?P>.P-WEZ.'VZOX;
MN/]V<PG>7[ J2;/R@_CEX>X"O'_W ;P#:0[N9WQ9)OFD/.U7PI]:M3_>G/OC
M^MS(<.X+-CX&(?P#H  A3?-1]^:PV;PO>F';%6C;%6BE%QKTKO)QMIRP21W5
M."EG0$2U_L#^7:;/2<;RJCS1A;G6Q7K=>B*>E(MDS,YZ8J:5K'AFO>'OOT$:
M_*D+VI-8HPO";1>$-O7A^9P75?J?Z(,1+RM=J.OV9-6^7B*>AV$<1:+[GW=C
MT%C!**!;JX9S>.L<MCIW65:IF+?"N4])6H"O2;9D.A?7*O0-%S569A?)UD5B
M'4*WK*R*=%S[6 \<[6 A/@>+)[%&L'0;+-USL%"UCREN70>[3<.Q:.M8Y&6@
M1!W<L]LTW!MLW1M8!\EU4GP7B^ECQD#)QLLBK5*F7U<&/H>*)[%&R/$VY'C/
MH1(K_0PAA1BU+H?&+(IH1/17! 8R"P96!S\7O"S!0RY(*%OY^5D0D#ZE!8H+
MM.6DQL0P9.!.FH9N#GX1QTSO(51.?X1PU'928R7ZTN"GS*'0FI\ZS[V-3/."
MDSAH+],ZNR@B 3(X*C,=M*>Z:YZS5T%2]5P$TZ4)8*PBKE/0EUHS9)D_(3X0
MX$!K9G;N!D]JS6Z0.1I:LV*'Q6@C\!9":,P01H%I#LF\"NV)M?,<TN1.G9NJ
MF<U-F65AM#?L0&NF=AXXGM2: <N\#:TYLLO &2A='8?MRV&U:;HF\RNT)]C.
M0T9-H*J#5IOFUDHF6&1/L",^G[-BG"896"0+5FBW458)YWV4)[5FP#)A(WBH
MW:25!)R[P9-:LQMV]M1V'GA[SM@%G,-5>2'"<6P8OI(6D)T6NLXONXQS,*%+
M,)(#D'TC/6+BDDS3L8@'\"F8L 4O4_VU\9KW?:DUPY9Y'^V_.4=>=^>^U)H!
M2XY ^V[0D08-%'YXPZCIG*0'Y&>3CM0=N,9%NU'319GOD3W?/QS?'8-[L>,J
ME\7KSEX=O)\L6;VN9TSLR:I9D@.QF0"O+"D^:$/PNH_WI=;L%$D:*/94O4!6
M9'$.VY-:LRXJ^26T\TN'RJBZZX<H'K3I2F=&R,!0P0@E;X3>"@2A9NM/VY46
MG1$<&+R4.!#Z*0^$FFT_BI%29]:8$4(-6YMPIPQN3_=OSOQZOE<<5"]\->U+
M[;RWG\1U OA2:W:)A(;07CSH/N]#K]#@2ZT9MH2&<-]B@5W .5RUI@ ),I0/
M0XD"H1T%7%8'JY)S/"H\'!DVDZ%DA] /.]AEG$-1(4-<&@-EA)(R0CME7"_S
M=)PNQ,;XUPG#?@KG0 ]!&*$DC- 7881>"<.76O/FIB0,O"]A8!4=PB (VC<V
M#U'WP))#L#<.P=H;%>UP#E&_P!)8L!]@P2J)H#AJWQFRG^Q7@Y%8@]^XYV%;
M:CHAC?T$KC/.EUJS.W:>)_"%--@KTOA2:X8MD0;OBS1V >=P-7=3=I>M9A@2
M:; WI+$K.<>C01IHV+]AR338#]/899QCT11.8M-F%$NFP7:F^<R?69'/65X=
ME0N>E[P0<8DC5BR*M&1[D([]Q,[A'X)TL"0=[(MTL%?2\:76?$9*D@[9EW2(
M2CKQ@+9)1V,%$3&M+$0B#/&&,$17)6DCC,[(4*(@$DR('S A*IC$ ]P&$XT5
M1-ATVX](XB!VXFC?]G.=[G9YYZ?E#L$;1/(&\<4;Q"MO^%)KAKWS3.2^O$%4
M0J 8[:2A31RJV0"'L:$H221)$$>2,#[\1=34K\PDS=T2@X.2#8B=#5P6)#6A
M'\7MVJ[.*#1UHTSZQ)[T.Z](Z@,0%,.=VYH;)U4S<;6IJ3-ETB7V1R5&O%CP
MHK[WF?/*'4#LZLY3\Q"9F,I,3 -/*Q+U^FR&+[5FV#+!4WN"[_#DLIJR$0V4
MS*XQ"RG&AG(ME<F=VI-[]Q7)+N1\7315#$,L$@&H'0$<%B^J/N]P1-I90&<$
M#3A%96ZF?EXNV,CLOMJ 2$S:BQ?5O%X@4IKAT0TJ<RFUYU+3XM6I>&/7=AXK
M!WGW8.?E ^IKZ?*Z^_>EU@Q;H@"UHT"'I<MK@8!J"@08F6Y(40D+](T*@<.J
MX'7+3U6L.(I,\U)"!?7S_*5=QCF66%V,,,3M\DU_Y_7 ^MU,,76>1#H1Q#,5
M[8+C^F7&8OVZX_J@XHO5&X./O*KX?/5QQI()*VH#\?N4B\5G<U"_A+A]Z73X
M/U!+ P04    " !6@'!6)WEC+V@'  #*.   &0   'AL+W=O<FMS:&5E=',O
M<VAE970S-"YX;6R]FVUOVS80@/\*X15#"ZRQ2)&RU24&TL1M R1M$<<ML&$?
M%)NIA4FB)]%)NU\_RE9-2Z)NH2WY2V+9Q]/=\>4>':G3)Y'^G2TXE^A['"79
M66\AY?)-OY_-%CP.LA.QY(GZY4&D<2#59?JMGRU3'LS7C>*H3QS'Z\=!F/1&
MI^OO/J>C4[&249CPSRG*5G$<I#_>\D@\G?5P[^<7M^&WA<R_Z(].E\$W/N%R
MNOR<JJO^5LL\C'F2A2)!*7\XZYWC-Q<>R1NL);Z$_"G;^8QR5^Z%^#N_N)J?
M]9S<(A[QF<Q5!.K?([_@491K4G;\4RCM;>^9-]S]_%/[N[7SRIG[(.,7(OH:
MSN7BK#?LH3E_"%:1O!5/'WCA$,OUS424K?^BIT+6Z:'9*I,B+AHK"^(PV?P/
MOA>!V&F :4,#4C0@SVW@%@W<M:,;R]9N708R&)VFX@FEN;32EG]8QV;=6GD3
M)GDW3F2J?@U5.SEZ=WYUB[Z<7T_'Z&9\/IG>CF_&'^\FZ#6:C"^FMU=W5^,)
M^GIU]P%-/]Z.SZ^O_AA?HNM/DXGZ^N4EET$89:^4]'1RB5Z^>(5>H#!!=PNQ
MRH)DGIWVI;(QOU-_5MCS=F,/:;#GDL].D(M_0\0AQ-#\XOG-<;EY7T5F&QZR
M#0]9ZW,;]$W4M)FO(HX^/:#S1^5L<*\NU !"DT!]F/#9*@UER#/TY[5JBJXD
MC[._3&YO[D/-]\DGZYML&<SX64_-QHRGC[PW^O47[#F_FX+0DK)22-QM2%Q(
M^^B:9YGJX2!!F* ;D<A%IOI_G,E032H^1^^",$5?@FC%36'8Z&9KW?D2\S@:
ML$'>58^[_M6E,!DR7XN5+*=;R^D>EK]/A?IZFJA%, K_50Y<JVMN'+H;]=Z.
M6:^QQRJVFX0&CMERMK6<@99K>]7(>Z\LE3RU"#JKF42&U*T:7I>BON^:#?>V
MAGO[&&X1<Z\>SB&I6&Z0&9CM'FSM'H!VWPD91!81'M0LP [%S*L8:A!S73:D
M9F.'6V.'SS+6(JK#>L0('52L-0CA04-@_:VM/FCK]&1R@NZ4A=DJ_8$RO7Z^
MG*]XGCNB?)+*?)(*M9[^X$'ZRN0 >!?;Y;0E9:6 8$=G8.=(.::X44M1:4M;
M.2P[8(([S#.%\M)4PY30RA WB3'F-0QRK+$!@RGX\%13Z"]-/E:=H"8A/&RP
M7>=W#"?X Y--H;T44NK73 =MV'=P:1+ , H<GI>P(<]7,RILQ+Y.:FC ,#78
M)C%<)P!,_!J<F<2 .:-1 <.LL$<:PX;,[U7IP"34.$LT(&"8$/XWD>7I2PHD
MG\0ZBV7&- ;?Q'K%;DE;.20:0_#P6(D,!![KL+2DK1P633P81IX#$UFKI%-H
M*\]=TO!<133"$) %#D]WL'[KQV.G/N,;'F2(YA$"\XCM:@JKLW;)!"J-';=3
MWH Y98\U%]9H[9<!89JZ2A,,@0GF9I6$LW"I/ ,?,(+FQPOX!M9.=@$[1,,.
MH<<J8K4$-$58NL CHO&(=%I4(8:JBC^H/O'#-NSKHV8JTG7]A1CHJ?88!5NQ
MKY>:Q4B[U1I2K\.8NJX+FB*:IDCK51UB+.M4W>J"AHBF(0+3$+@V/XN9X1M8
M+T)=%']<34[NL8H_;JL(U9:V<E@T;+E=%G]@Y=:AJ*,7\8?,#"FN1B^WXQ(1
MK-_:2U,MJ<G)G;TBF,1L5V98G;5/]5(4T'.:IURX>+3'R@QKM/;+M,?4Y);F
M(1?FH??BD:=)S!/Y.EN*)!.I<DE=\729AAD_H%@/W]C:^RZ0RM5(Y7K'6K%;
MHJ8B+%TPF*L9S(49[, 5NTYD_I!6ZZD&*<R<AKU55Y.6"Y/6X2NQ::>LREVP
M$?OVC^8N%^:N Y]V8.W68[5>AFK>:Z8:IBA<ACK\:0>^@:V;U%"':BB34XU&
MM-TZ%*WCBV%J&:0\VM@C&G)HZ_4E:@*1ZF0R"35%5L,*A6'E0L0Q3V>ALG@9
M+-70L4QSL'KKP=-%T8CNG)4Y5M&(MLH^;6DKAT5#$H4AZ; T1^LU(T8HJXWN
MNICG#0>D88!K=*%P->CP U"&8I!?W6\S";D-^VU4\P5MM\9#ZZQ@#'5=# JU
M9@K:>O6&&BBB'ER#4&-P-1Q0& XN1+H4J8HJ2H2TYWM8N_4,[Z(BPS1$L&-5
M9%BK,-&6MG)8-':P+BLRS+!]Y?O#RN V27F.T[#+Q32%L(Y++<R &]69:9+!
M#4S"-).P3@_C,$,%Q/5K1R1@(_8=6YHU6->G<9CI-(Y;];(+=& [9WC;/8[#
M#!M,S/><JE>&XSC I-&PP%H_CE-H9*5>J!TS-AW':9HG&@\8C =-&>Q9.PJP
M;NN%NHM](Z;)@QWK% YK]11.6]K*8=&(P[H\A0,KMPY%O?Q!**8-%5Q/HXO7
M\3$<6+^MFYZI_.$W.*E!Q&NW_@&KL_;)L!D$=)U&%*_U0@FLT=HQ4E^[:YW5
MWWG1+'_+[R9(OX5)IIX3'E0KYV2@FJ>;%^<V%U(LU^^>W0LI1;S^N.#!G*>Y
M@/K]0:C5NKC(7V?;OKXX^@]02P,$%     @ 5H!P5IP.U#,3!@  :BX  !D
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M'=:!M,/U7I13-$&(=B/$ Q<EJ#F!0FLVPK4YH?9>2G<KW#FH%6D(LXB2:M-
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M<FMS:&5E=',O<VAE970S."YX;6RU5EU/VS 4_2M6AB8F ?EHD[:LC01MT9"
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M=4\)\/I^JCN2%=41OV!271A5,U57.G =H,83QN2NHV^-YD]"] ]02P,$%
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M#0N\0\UDBC 73,*+2[2,"_-R&%K*[C#"M,ET46=*'LD4)S!5TA8&KF2&V8\
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MWE)SNYE@9S/!3LYK'^#=TBRC%-U2]7E%+LU"P1;Y(O#WK2J);B1-LG_J9KC
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MRQMH5'NDF?W"#K6[(&A#/%":#TH+H&A5KVS367QJ/%MX15#]7\?J>E?K%-"
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M>: T'Y060-&J7MG&M$ZSF/;4Z,V,;;RHP#Y0"_M$K7D .V7TUCO\V?!!&Q1
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M:H%\OJ14' ;J)*G^" 1_ 5!+ P04    " !6@'!6-0V9V=(.  #7A@  &0
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M"Z$TCJ+9M^TV?IWO=L^Z#.Z_-1O*J%>?JX]=U4Z(B;5)XKDCOKN178<"*"V
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M6D I*2^1@$7/Z7L726#P%O"%PE;NM9')9,[YRG2NLY[CF@4!@U09!:(_&Q@
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M]V93YD*G+("Q@SFA03V#,_GY)]KS?FU@;5>L[2;ODZE,EM@5DK2 EEOH5/$
M2 JJ6!?\0 *9)!CD&"_!$V$BQ'#'KI2)3]:@Z$XS%:PQ@LF&*<6$T76""Z1!
MCF13^GE"6UYWY#[7".E40CJ-0F9:9TP$AZ!<8%N(,D,WW*P/M'ZNW?N"M9BU
MM\?:;>=_G7K>;L7;;>1]CZ=AJF0 $&H2*9D<4+'(X.J'$&:(CNULFPZV$7(=
MR$R8?!^D6>/(RA!>\#S5&-&?R5F=I *LNR>I-QQB/'E>O:1>):G7*"E/K+F"
M\QN+&I+'(@3J$!H=?6/(]RO,_DG3L_\#6 <5ZZ!Q2<LEU,3(76KMA_<;W&U0
M <?N/&/K!!13]/?VVVMY'JW?[&%%-OQ>LO)<;<JNX4%VT8$W[/KM03T=]78U
MQSO9P88;=QX5,;L]MK[K?"O1^E\><)WA$4U[=93^?X(M<H[YEN.QB:/1W3>&
M+MV507K:.DA_1"&DNTI(FTOA27*-UM6VSI':1G?%C397M]-D&STL9NUNGW;\
M0>\K0'?OMF=OSG\PM>)"DQ@B-/5:?:P>JKB,%@TCT_P"N)0&KY/YZQHO\*#L
M /P>26FV#7NGK'X23/X#4$L#!!0    ( %: <%9-PV;]Q0,  /<0   9
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M??UA9DN5@*:QHRK8L@SFOA/,<=$MRV4B4)"O8-4DL%7F=?KN+OTKMY,QA&*
M\.@C<K&+VQ+JAOL0#=#0,7"W!>X?#W=:X,'Q<-PAQK#V<FCXAN_P+22Z)?Q9
M=9=K(38DCP"%) 6!%C$'4-4M!?KC1H'0M81,_-F2\5498=0>07>M2U&0".:6
M:DL"^ M8WC=?.1/\?9OX?9+Y?9(%/9$U;!K5-HVZV+W:'+9&$<LRU2Y5F4?/
MB.9JG.=5"]U2F2 B5;$;2]EZ#9SF\4>4FQ&B.YJ("2G:O.Q,XU0O^R3S2[*Q
M(=.WLA?/Q</S,<:J#%[V?7H[<82GC7D-"\:U!>-."W3!'=9&FX*=+*<JV">9
MWR=9T!-9PXI);<7D7V]:DSYMZI/,[Y,LZ(FL8=.TMFG:63&+6-D1$PEU(T(%
MIV^;6)L]TS=%[.#JTRSW96<.IVK?)UG0$UE#^_-:^_-.[6_)*\TVF=%9=7WS
MB*Z=.","$50 CU25M#V.796\%WO*XP$>'HC>&?Q4T?LD"WHB:XA^48M^\=_?
MI=&90HN$J'1;_>I,Z=1&5I)-]LUO.N^_G>'@\=09CR<'M^&>\FH8X> O6Q3\
M_WA@ZL[C5/U[9?,KMB.>F?J*6[IE[^TM,^"QV=0+I>$FE^4^K3Y;OSA8F.WR
MP?FE?J%@]JQ?:,JW$>K^']-<H!36BA(/IFJ1O-S@EP/)"K.#?6)2[8?-80)D
M!5Q/4-?7C,G=0 >H7[-X_P!02P,$%     @ 5H!P5N.-75^%#0  ";   !D
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MWLQO3\:Z.9;Z)KK* TISH30*I7E0F@^E!5 :@](XBJ9*IK'V!_H%[__XC&P
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M<"ZRLH#\_#Y-BZ<W90./:?:E.ISI_P!02P,$%     @ 5H!P5@O_0J7 !@
M62L  !D   !X;"]W;W)K<VAE971S+W-H965T-3(N>&ULO9IK4^,V%(;_BB;=
M:9>9!5OR+:&0F1!G@2D+E,#N]*.(E<2SCI7*"I?^^LH7XM@6PJ:B7\!V?%X=
M/9'E]T0Z>J3L9[(DA(.G510GQ[TEY^M#PTAF2[+"R0%=DUA\,J=LA;DX90LC
M63."@RQH%1G(-%UCA<.X-SS*KEVSX1'=\"B,R34#R6:UPNSYA$3T\;@'>R\7
M;L+%DJ<7C.'1&B_(E/"[]3439\96)0A7)$Y"&@-&YL>]$3ST+2L-R.[X'I+'
M9.<8I%VYI_1G>G(>'/?,-",2D1E/);#X]T#&)(I2)9''WX5H;]MF&KA[_*+^
M->N\Z,P]3LB81C_"@"^/>_T>",@<;R)^0Q_/2-$A)]6;T2C)_H+'XEZS!V:;
MA--5$2PR6(5Q_A\_%2!V I#S2@ J E M -JO!%A%@-4VP"X"[(Q,WI6,@X\Y
M'AXQ^@A8>K=02P\RF%FTZ'X8I]_[E#/Q:2CB^'!Z>S7^X^SJPI_<3'\#DS_O
MSF__ OLO!]<7H\NI.)V.SR;^W<4$7'T%H]/3F\GIZ'8"LEAP=7U[?G4)1I<^
M&/T8W8B_X]OS[VGT9Y]P'$;)GE"XF_K@\Z<]\ D8(%EB1A(0QN N#GGR15P4
MQ[=+NDEP'"1'!A<=2],S9D4G3O).H%<Z 1'X1F.^3, D#DA0%3 $D2T6](+E
M!"D5?3([ !;\ I")D"2A<?MP* GWVX>;BMY8VR_9RO2LU[[D'/CH07P;^#XB
M0#PRX)3AF,M8YUJV7"N=APZ3-9Z1XYZ8:!+"'DAO^.LOT#5_EW'2*>9K$JLP
MM+<,;97Z\ 1'.)X1@#G@2P+NR2*,XS!> #K/+JP)"VD /HN1G(_O/1G;O TW
M:R.=DA^&L.^YEC6PCHR'76[*9+IRTR16X>9LN3E*;J,@"-,9'D<OSSW>\"5E
MX3_D35I.DY;K.8YIFC5:RA2ZTM(D5J'E;FFY2EI33F<_ 5VGQ!*P2!_1MS&Y
M#4S[<.#9GN?6.2D;[\I)DUB%D[?EY*E'U2-F06M G@20,W!1C8ZRR:YT-(E5
MZ/2W=/H=1M$LG;>BB 2&L(ES$@I@!GE:A^QM</T&..2*')U^C9PRG:[D-(E5
MR VVY 9=9GD2!]WF]X%D?K<\TT.#&C'9C;(7@:_,]YTTH%FZ0U/I'"XWJWO"
M4@:%A]@'5\6PNMKPA N_)MZ!4L=FZK016M5\76I5J#N6&_X/5J)H9'<(V8.!
M@VRS/M;4Z72&ITFM"@^5\)#^-V2A67G<Y&](=>N=66E2J[(J;3]4.N(:*_)$
MV"Q,6M"R).]+V(<>A'5:6NV]+K4JK=+@0[7#U_;6A$V7OR]_;ZHSZLSO(WP^
M+(T^5#O]__KNA$V[[SH#4TQHC8>T>:=\ZO/5*;\72>GF81<[7SR 607^;DA-
MLV^Y9M^Q^HU97W*G:3L#:+EU2,T[D>,AZ)CE>*T"*&TZ5/OT*H#Y)HJ>P0-)
MTBE;6 =!9$UFZ0FGV>7W8VE:?-=VK(%K-[!H=?FZU*IX2Y\/^TI[]B/[65/P
M&ST0AA<$3(HY'ERS4#R*U\*[9<:M@V_3Z>7'6M5\76I5VF5M #L5!RK?%M H
MPBQ)+^7#5CYJ\_;ZNP_>@>G61ZRF$J!@^!$%!2H+"J3TU@K[U@Y9(0_AKI4[
ML+P:,W4679GI4JLR*^L%I*X75#:N)34HH^;4?P!1Y]&9VD<4"J@L%%"70N$M
M.]>2(Y)Q; P^K36$+K4JQK*&0.H:HI6K:TG/DM'K-_!9+69%7YWV>[&4Q0+J
M4BRT=G8M0=E-4.@ -D#9$E"64P<EN\NQY<X.E6X?J=V^5F?7$HO3Z(D8/O6:
M2IUWYZ?O(PH(5!80R&UA\+;V[H:D2_FIY1C3F#,\XQL<@8MP3C*,ST1 W&OO
M]9#.]8"Q5C5?EUH5?%FX('7A\M:T)\6IEG3S[P>X8)4O5B,( OPL6^\>JZ4Z
ML_R(*@6550KJLAS19JZ4TE4WXA1T84X7H-?9:JU)=*E5V98U"5+7)+JF82EQ
M==.-\>R]CEQK":-+K;J7HBQA+/6:R&BQ8&2!.0'G8@X.XR2<@>\XVG0HLBVM
MBR-:U7Q=:E6Z9;%C=5H<4?H%J4LH])T=E^"8R*S9HK$ZC<[0/J+6L<I:Q^I2
MZW1UHW*,S243A/I>W6VI$^N,\2-J'6MGFU27]1(]GE8.UVJ,4;L_<.K+*^IT
M.\/56C$9.WL.5X0MLKV;HLZFFYCG^^RV5[?[0T?9KLC:]1-X.,YW>98R^:;3
M;Y@MQ/0*(C(7DN:!)WBQ?!]G?L+I.MO9>$\YIZOL<$EP0%AZ@_A\3BE_.4D;
MV.ZF'?X+4$L#!!0    ( %: <%8Y?GP>V0(  )0(   9    >&PO=V]R:W-H
M965T<R]S:&5E=#4S+GAM;,5676_:,!3]*U8F;:VT-B% 6CJ(% )MT5C)@+::
MICVXR8583>+,-M#^^]E.B&"EJ)68]I+XXY[C>TZN[;17E#WR&$"@IS3)>,>(
MA<@O3).',:28G](<,CDSHRS%0G;9W.0Y QQI4)J8MF4Y9HI)9KAM/18PMTT7
M(B$9! SQ19IB]MR%A*XZ1LU8#XS)/!9JP'3;.9[#!,1M'C#9,RN6B*20<4(S
MQ&#6,;S:A>^H>!UP1V#%-]I(*7F@]%%U!E''L%1"D$ H% .6KR7XD"2*2*;Q
MN^0TJB45<+.]9K_4VJ66!\S!I\D]B43<,<X-%,$,+Q(QIJMK*/4T%5]($ZZ?
M:%7&6@8*%US0M 3+#%*2%6_\5/JP :@U7@'8)<!^*Z!> NI::)&9EM7# KMM
M1E>(J6C)IAK:&XV6:DBFON)$,#E+)$ZXD^G(_WH]&O;ZX\DGU/]^.YC^0"?K
M1C#T;B:R._&O^[W;81^-+I%W=37N7WG3/M)8- JF@]$-\FYZR+OWQO+I3P=W
M"GT48 :9B$&0$"?'Z*@' I.$'TM&'LLYWC:%U* R,<,RWVZ1K_U*OCT(3U&]
M]AG9EFWO@/MOA]>VX:9TKK+/KNRS-5_]-?N4#-25=10AGZ9R;W&LR]-C#&=S
MD/4N4/<9;<8%^%D/>RO,(O1S*"G10$#*?^VRHUB_L7M]M<<O>(Y#Z!AR$W-@
M2S#<CQ]JCO5EESD'(MNRJEY95=_'[DX$#1\1S94]',D#A0N<122;HR.2E?5P
MO,N!@M;1M.I06KI.LV79#<MJF\M-=2\#&ZU64P:VJL"MS!M5YHV]F0? ]'&9
MA7!2?,)"RZC0LBOGO83O_6H'(MO2WJRT-_]S@3</:=6!R+:L<BJKG']3X,Z+
MNCT_:]7.FG_7]][EWRO.W+@SU'W]#;,YD7DG,)/TUNF9M)(5=V#1$337U\@#
M%?)2TLU8_C8 4P%R?D:I6'?4S53]B+A_ %!+ P04    " !6@'!6&1D77'P$
M   Y$@  &0   'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6S%6/]OXC84_U>L
M3+K=I+OF"R6%#I" <FJU]LK*==-IV@]N8HC5Q,YL!UII?_R>G1#H$=QR0UN%
MFF]^'[_/Q^_9S^ZMN'B4"2$*/64IDWTG42H_=UT9)23#\H3GA,&7.1<95O H
M%J[,!<&Q,<I2-_"\T,TP9<Z@9]Y-Q:#'"Y521J8"R2++L'@>D92O^H[OK%_<
MT46B] MWT,OQ@LR(NL^G I[<&B6F&6&2<H8$F?>=H7\^]D-M8%K\1LE*;MTC
M3>6!\T?]<!7W'4][1%(2*0V!X;(D8Y*F&@G\^*L"=>H^M>'V_1K]DR$/9!ZP
M)&.>_DYCE?2=CH-B,L=%JN[XZI)4A-H:+^*I-/_1JFKK.2@JI.)990P>9)25
M5_Q4";%E$.PS""J#X%N#<(]!JS)H&:*E9X;6!59XT!-\A81N#6CZQFACK($-
M97H89TK 5PIV:C#[<CO^Y?+V^F)R-_L137Z]O_KR%7U$DYOI]>W7R029[VAZ
M?S>^',XF:'H]_(S>7Q"%:2I_ZKD*7-! ;E1U-RJ["_9TYZ,;SE0BT83%)&ZP
M'[]B'U@ 7.!>"Q"L!1@%5L0;_(Q:_@<4>$& 9((%D4UNV4$N2'2R0;E2)&N$
M>N%@JQZAEL%N[1LA#81&$*HQ&O,,\E=BDP%#(3!;$,@IA4;/:+O=%#^;U\,5
M%C'ZXQH@C5?RSZ8A*_L_;>Y?SR/G,L<1Z3LP44@BEL09O/O!#[V?FX0Z$M@+
MJ4YKJ4YMZ .0)P-A(&FBQP_5"*"JFQC!G(?FA2I )2IE@5E$T'O*JG:-P6SM
M[E!E2K#0@.G9=3GPNW[8[IZUVCUWV4"[7=-N6VE/LCSESX2@F2:.IH6($@@#
M-$TQ:V)E13N4U9' 7A /:^+A_YP:X3&E.A+8"ZG.:JG.K#$R7"P$66!%UFFA
M4P#D*& :%2C?$RE6S$/IG^W$?R?L!*VP.?@[-;'. 3E/603%#,1^G=?_*O\[
MNRGKF;_:YY*:U<7O'-EN+4#WOYWTNCND@T;25K>^D[3O;>H6STK[!C_1K,A0
M7(@RY_D<?G,B*%N@'"Z\J;P8V5$/#>E7?(1J)3/5BHWQ5J7F6]$^%]D#Y.HN
M3ZFC?970*$&8(;)>#2)XR+%0-**Y3GRL$$8*:G#TMYGQ&N6QNG"P//YN_C1G
MNQ]L5 C>J$+$F211H;<!*%^O>5N*8/:M4#;BUEX/)A[LYM >XILRT+>63H.+
MK4!7R0[E1E)'K>Q>\2]\0ZQO"CG?7LFMLQNX1;!:PX92T\:,%3A%$J>PXP01
M(*)UD#\0V#2I)"%ILPI'K>(JM.[6T'HG^Z)Z4\'Y]A)NNN&)\SRE,',K#A&^
MF=IATR<>85N_Q&EAEK<(IU&10DCH\*YC05"8X*M%O7ZY9W6W^W2P,.T&83I[
M2EM_4^+YUK)H)^P96;UIGC]JY?:*C]9YWMW:G&=$+,R9A82Q+9@J]^GUV_I<
M9&A. ]Q-\_)0Y0:+!642I60.IM[)&4@NRG.*\D'QW&SU'[A2/#.W"<$0#+H!
M?)]SKM8/NH/ZM&CP#U!+ P04    " !6@'!6TQ;1_>0"  #Z"   &0   'AL
M+W=O<FMS:&5E=',O<VAE970U-2YX;6S%5FEOVD 0_2LK5VH3J8D/P&Y28XDK
M"FH27$A:554_;.P!6[&][NX"X=]W#^-" JBMD,H'O,?,FWEOCUE_2>@32P X
M>LZS@K6-A//RTC19E$".V3DIH1 S4T)SS$67SDQ64L"Q<LHST[$LU\QQ6AB!
MK\9"&OADSK.T@) B-L]S3%==R,BR;=C&>F"<SA(N!\S +_$,)L ?RI"*GEFC
MQ&D.!4M)@2A,VT;'ONQYTEX9?$EAR3;:2#)Y).1)=H9QV[!D0I!!Q"4"%I\%
M]"#+))!(XV>%:=0AI>-F>XU^I;@++H^808]D7].8)VWC@X%BF.)YQL=D>0T5
MGY;$BTC&U#]::EOOPD#1G'&25\XB@SPM]!<_5SIL.-CN'@>G<G!>.C3W.#0J
MAX8BJC-3M/J8X\"G9(FHM!9HLJ&T4=Z"35K(59QP*F93X<>#R?VH]^EZ=-,?
MC"?OT.#SP_#^&SI#X6!\-1K?=NYZ ]3M3 9]I S1*+P?CNXFZ*0/'*<9.Q6V
M+,$4F&]RD8X$-:,J=%>'=O:$MAUT2PJ>,#0H8HBW 4S!HR;CK,ETG8.(?8C.
M4<-^CQS+<78DU/MS=_M .HU:VX;":^S35@J#NF*3Q:A'<G'P&%9[MT,I+F8@
M#@-'W17:M OQ2@UWEIC&Z/N-@$1##CG[L4M@';^Y.[Z\ "Y9B2-H&^*$,Z +
M,(*W;VS7^KA+G".!;4G5K*5J'D(/)IQ$3XB44AZ&9D(>+L0X28MJ=YWN8J\A
M704I;ZM%8%]X3<]S+=]<;#([&/L?F;5J9JV#S$*@ZJXM(CC32ZRYCC377;P.
M O[MJAX);(N[6W-W__,!<(\IU9' MJ3R:JF\XQ\ []4!<+RF[;5>[O_7=JV6
M)7ZUF4[9W"@C.="9JJX,161><'T)UZ-U >^HNO5BO"L*NZ[#OV'TJ^ 6TUDJ
M"&8P%9#6N2>V)]655G<X*56Q>B1<E#[53,3C!*@T$/-30OBZ(P/4SYW@%U!+
M P04    " !6@'!6*KKWIG0#  #U#0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970U-BYX;6R]5VMOVC 4_2M65FVMM#8O'J$#)"#I6JTMC-!M_>@FAD1-8F8;
MZ/[]KIV0 4M1)T7[ G[<>WS/R;U^=#>4/?.($(%>TB3C/2T28GFIZSR(2(KY
M!5V2#&;FE*580)<M=+YD!(?**4UTRS!:>HKC3.MWU=B$];MT)9(X(Q.&^"I-
M,?LU) G=]#13VPY,XT4DY(#>[R[Q@OA$/"PG#'IZB1+&*<EX3#/$R+RG#<Q+
MUS2D@[+X%I,-WVDC2>6)TF?9N0E[FB$C(@D)A(3 \+<F(Y(D$@GB^%F :N6:
MTG&WO46_4N2!S!/F9$23[W$HHI[F:"@D<[Q*Q)1NKDE!J"GQ IIP]8LVA:VA
MH6#%!4T+9X@@C;/\'[\40NPXF*U7'*S"P3IT:+SB8!<.]EL=&H5#0RF34U$Z
MN%C@?I?1#6+2&M!D0XFIO(%^G,GO[@L&LS'XB;X_&X^^7(]O76_J?T#>UX>;
MV2,Z1VKX?#CP/1>-QG<3[]X?S&[&]\C[(=L>NAI/D7<WN1T_>IZ/!O<N<F^F
MWF@VGOKHU"4"QPD_ Z 'WT6G)V?H!,49FD5TQ7$6\JXN('89@1X4<0[S.*U7
MXC0M=$<S$7'D92$)]P%T(%TRM[;,A]911)<$%\@V/R++L*R*@$9O=S<KW-VW
MNQM'V-CE=[05GOW:=Q0T>#X?0@6$:$13V!8X5H7EO<@VJ5(\1VQ4(\H-YY(O
M<4!Z&NPHG+ UT?KOWYDMXU.56G6"N36![2G9*)5L'$,OE'Q22@:[2I)<24CD
M(%E!#LJ,AOV7P6RVV,Y6IG:^8%,M*#?B==\Q#$B:]:Z 54:.L6_D_FW4<CK-
MTFB/<+,DW#Q*> H28A9$""H3MLPUG 5+V-E%%9.C2/^:,G6"N36![2G8*A5L
MU5Y\K3J5K!/,K0EL3\EVJ63[?Q=?OF!KIV3LMG505Z,*HV:G?5!\?QM9MMVN
M+CZG).P<)?R99$ B4;6'0SC@8RXDJ75ETAS%^M>DJ1/,K0EL3\-.J6&G]O+K
MU*EDG6!N36![2IK&G^N@\;\+L%AQ]]!J6,[A\5=EU7#L@Q*LLFHVG8,:U'?N
MPREA"_6NX,!GE8G\@EB.EF^7@;JQ'XP/Y9M&W;/_P.0/HCO,%G'&44+F &E<
MM"$DEK\Q\HZ@2W7K?J("[O"J&<&[C#!I /-S2L6V(Q<H7WK]WU!+ P04
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M$6OLD[..:B*"\"WI3'[Z 0Z=7W22V@3S+('5Y.X7<O=-Z!JYGZKY'L3JG"V
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MD&],2A:EARN" \*3 /7]@C&Y/TD&*+8=3?X#4$L#!!0    ( %: <%9?W-E
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MQ/7VB_JY9.<L#Y B'V?W:<R2H=)70(QFL,K8!"\O4,W3$WH1SJC\!<LZ5E-
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MO":1S817C8B( #X^PYB]=$1ATM2AWC]02P,$%     @ 5H!P5C6U1;?" P
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MS#C;K#-E>/TVX#JKOP?L!SWO"+#? /M'@1.));1E/!KVET?:;Z#ZKU>+_5<
M#QKPX+_78O!'+?J]H-MVM/9>S]37SPWFJH@$HK!2L<Y97XGPNJ77AF2E::,+
M)E53-L-,W8+ M8-:7S$F7PS=F9M[-?H%4$L#!!0    ( %: <%8;*IYC5 (
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MZA.&W2?8TG.E2YK"U,/:HD%MP(M^_ZT_ZOW9Q=Y'@L4?!'; [+!E=G@./7K
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M?YOD6[\B(ND.YFBZV&'?'_/<XGE>X93)[G2*]G0"^.Y?4$L#!!0    ( %:
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M^K=\-OXC;O$"4$L! A0#%     @ 5H!P5@=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !6@'!64 /0
MINX    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " !6@'!6F5R<(Q &  "<)P  $P              @ ', 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( %: <%9^)2]$;0@  $$T
M   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " !6@'!6A@5UQ#D&  "B&@  &               @(&P$
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 5H!P5A#\!AK\
M @  $0H  !@              ("!'Q<  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( %: <%:=<;?^L@0  -42   8              "
M@5$:  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !6@'!6
M%B[Z.AL#  !B"0  &               @($Y'P  >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ 5H!P5ED3^/(1"@  +58  !@
M     ("!BB(  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M %: <%9A.('<V (  /X(   8              " @=$L  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    " !6@'!6/=X5)"<)   Q+0  &
M            @('?+P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ 5H!P5M.F)'Q_(   -&4  !@              ("!/#D  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( %: <%;N0QV]J \  -\O
M   9              " @?%9  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ 5H!P5G*<F%?  @  Y@4  !D              ("!T&D
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !6@'!64Q^9
M@SP#  !M!P  &0              @('';   >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( %: <%9+A9?,P (  , %   9
M  " @3IP  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
M5H!P5C^4%UI\&0  =E8  !D              ("!,7,  'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    " !6@'!6<_C-=5H&  !O$0  &0
M            @('DC   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( %: <%8P"8B]'PX  #HI   9              " @763  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ 5H!P5G[&SUNB'0
MZV@  !D              ("!RZ$  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    " !6@'!6:8Z>XXT*  !Z&P  &0              @(&D
MOP  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( %: <%81
M9-XTW@(  $D&   9              " @6C*  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ 5H!P5H4M*_YH P  * @  !D
M     ("!?<T  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %: <%:8&V$NK0,  'D(   9              "
M@9W_  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 5H!P
M5E.]AO;U @  9P8  !D              ("!@0,! 'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    " !6@'!6R&SV-G\'  !4%   &0
M        @(&M!@$ >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( %: <%8M94,;N@0  %X,   9              " @6,. 0!X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ 5H!P5F5VT9[P @  /08
M !D              ("!5!,! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    " !6@'!63* %TG("   Z!0  &0              @(%[%@$
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( %: <%:+[%O4
M) ,  ,X(   9              " @209 0!X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ 5H!P5J0KQKU8 @  ZP0  !D
M ("!?QP! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !6
M@'!6I@W17-\'  " .@  &0              @($.'P$ >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( %: <%8G>6,O: <  ,HX   9
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M970S."YX;6Q02P$"% ,4    " !6@'!6SFVK1N@"   P"   &0
M    @('B/@$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M %: <%9$T;8<E@0  'P9   9              " @0%" 0!X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ 5H!P5I.''2PA P  M H  !D
M             ("!SD8! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    " !6@'!6*1'V?\T%  "2,@  &0              @($F2@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( %: <%952&?HO@(
M ! (   9              " @2I0 0!X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ 5H!P5E"@ H?Y @  % @  !D              ("!
M'U,! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !6@'!6
M-0V9V=(.  #7A@  &0              @(%/5@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( %: <%:J_J@+,@,  -0*   9
M      " @5AE 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ 5H!P5@*RBJET @  \08  !D              ("!P6@! 'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " !6@'!6T='HEJ$#   >#
M&0              @(%L:P$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( %: <%9-PV;]Q0,  /<0   9              " @41O 0!X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ 5H!P5@;-C"JX
M P  <A$  !D              ("!0',! 'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    " !6@'!6XXU=7X4-   )L   &0
M@($O=P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( %:
M<%8+_T*EP 8  %DK   9              " @>N$ 0!X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL4$L! A0#%     @ 5H!P5CE^?![9 @  E @  !D
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M=#4W+GAM;%!+ 0(4 Q0    ( %: <%9?W-E ! ,  &4*   9
M  " @;6@ 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @
M5H!P5GAW?*(+ P  DPH  !D              ("!\*,! 'AL+W=O<FMS:&5E
M=',O<VAE970U.2YX;6Q02P$"% ,4    " !6@'!6-;5%M\(#  !4#0  &0
M            @($RIP$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4
M Q0    ( %: <%;XQ7__\0,  &8.   9              " @2NK 0!X;"]W
M;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ 5H!P5JO7B;*/ @
M8P<  !D              ("!4Z\! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX
M;6Q02P$"% ,4    " !6@'!6&RJ>8U0"  "2!@  &0              @($9
ML@$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( %: <%8B
M9W10:@(  +<%   9              " @:2T 0!X;"]W;W)K<VAE971S+W-H
M965T-C0N>&UL4$L! A0#%     @ 5H!P5KLE=(:P @  F 8  !D
M     ("!1;<! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4
M" !6@'!6XN UV6D#  !4"@  &0              @($LN@$ >&PO=V]R:W-H
M965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( %: <%8)6F\SZ 0  '8A   9
M              " @<R] 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L!
M A0#%     @ 5H!P5O?IG%4O P  [A(   T              ( !Z\(! 'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    " !6@'!6EXJ[',     3 @  "P
M        @ %%Q@$ 7W)E;',O+G)E;'-02P$"% ,4    " !6@'!6@_/F\E(%
M  "%+   #P              @ $NQP$ >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ 5H!P5LA<P5(@ @  T"<  !H              ( !K<P! 'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 5H!P5N(A,D+Q 0
M&2<  !,              ( !!<\! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     $L 2P"$%   )]$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>219</ContextCount>
  <ElementCount>370</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>81</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - DOCUMENT AND ENTITY INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION</Role>
      <ShortName>DOCUMENT AND ENTITY INFORMATION</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100040 - Statement - STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100050 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100060 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100080 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100090 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100100 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100110 - Disclosure - LICENSE AGREEMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/DisclosureLicenseAgreement</Role>
      <ShortName>LICENSE AGREEMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100120 - Disclosure - ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIES</Role>
      <ShortName>ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100130 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100140 - Disclosure - OPERATING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASES</Role>
      <ShortName>OPERATING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100150 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100160 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100170 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100180 - Disclosure - CONSOLIDATED STATEMENTS OF CASH FLOWS DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsData1</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100190 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100200 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100210 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100220 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100230 - Disclosure - ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESTables</Role>
      <ShortName>ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIES</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100240 - Disclosure - OPERATING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESTables</Role>
      <ShortName>OPERATING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100250 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBT</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100260 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITY</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100270 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100280 - Disclosure - CONSOLIDATED STATEMENTS OF CASH FLOWS DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataTables</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsData1</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100290 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail</Role>
      <ShortName>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100300 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1</Role>
      <ShortName>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100310 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - USEFUL LIVES OF ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESUSEFULLIVESOFASSETSDetails</Role>
      <ShortName>ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - USEFUL LIVES OF ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100320 - Disclosure - FAIR VALUE MEASUREMENTS - SECURITY TYPE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - SECURITY TYPE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100330 - Disclosure - FAIR VALUE MEASUREMENTS - SECURITIES WITH UNREALIZED LOSSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - SECURITIES WITH UNREALIZED LOSSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100340 - Disclosure - FAIR VALUE MEASUREMENTS - RECURRING BASIS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - RECURRING BASIS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100350 - Disclosure - FAIR VALUE MEASUREMENTS - EQUITY INVESTMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - EQUITY INVESTMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100360 - Disclosure - FAIR VALUE MEASUREMENTS - CREDIT RISK (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSCREDITRISKDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - CREDIT RISK (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100370 - Disclosure - PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100390 - Disclosure - ACCRUED LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails</Role>
      <ShortName>ACCRUED LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100400 - Disclosure - COMMITMENTS AND CONTINGENCIES - Litigation Settlement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Litigation Settlement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100410 - Disclosure - COMMITMENTS AND CONTINGENCIES - Severance Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Severance Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100420 - Disclosure - OPERATING LEASES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails</Role>
      <ShortName>OPERATING LEASES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100430 - Disclosure - OPERATING LEASES - COMPONENTS OF LEASE COSTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails</Role>
      <ShortName>OPERATING LEASES - COMPONENTS OF LEASE COSTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100440 - Disclosure - OPERATING LEASES - UNDISCOUNTED FUTURE NON-CANCELLABLE LEASE PAYMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails</Role>
      <ShortName>OPERATING LEASES - UNDISCOUNTED FUTURE NON-CANCELLABLE LEASE PAYMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100460 - Disclosure - DEBT - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails</Role>
      <ShortName>DEBT - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100470 - Disclosure - DEBT - Schedule of Future Minimum Payments Under Term Loan Facility (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails</Role>
      <ShortName>DEBT - Schedule of Future Minimum Payments Under Term Loan Facility (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100480 - Disclosure - STOCKHOLDERS' EQUITY - AUTHORIZED COMMON STOCK (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYAUTHORIZEDCOMMONSTOCKDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - AUTHORIZED COMMON STOCK (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100490 - Disclosure - STOCKHOLDERS' EQUITY - PUBLIC OFFERING (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - PUBLIC OFFERING (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100500 - Disclosure - STOCKHOLDERS' EQUITY - WARRANT EXERCISES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - WARRANT EXERCISES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100510 - Disclosure - STOCKHOLDERS' EQUITY - SALES AGREEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - SALES AGREEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100520 - Disclosure - STOCKHOLDERS' EQUITY - EQUITY PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - EQUITY PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100530 - Disclosure - STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100540 - Disclosure - STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Parenthetical) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Parenthetical) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100550 - Disclosure - STOCKHOLDERS' EQUITY - EMPLOYEE STOCK PURCHASE PLAN (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - EMPLOYEE STOCK PURCHASE PLAN (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100560 - Disclosure - STOCKHOLDERS' EQUITY - PERFORMANCE BASED STOCK OPTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - PERFORMANCE BASED STOCK OPTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100570 - Disclosure - STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION EXPENSE FOR EMPLOYEES AND DIRECTORS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION EXPENSE FOR EMPLOYEES AND DIRECTORS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100580 - Disclosure - STOCKHOLDERS' EQUITY - PRICING MODEL ASSUMPTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - PRICING MODEL ASSUMPTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100590 - Disclosure - STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION TO SERVICE PROVIDERS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION TO SERVICE PROVIDERS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100600 - Disclosure - STOCKHOLDERS' EQUITY - COMMON STOCK RESERVED FOR FUTURE ISSUANCE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - COMMON STOCK RESERVED FOR FUTURE ISSUANCE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100610 - Disclosure - INCOME TAXES - EFFECTIVE INCOME TAX RATE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails</Role>
      <ShortName>INCOME TAXES - EFFECTIVE INCOME TAX RATE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100620 - Disclosure - INCOME TAXES - DEFERRED TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails</Role>
      <ShortName>INCOME TAXES - DEFERRED TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100630 - Disclosure - INCOME TAXES - OPERATING LOSS CARRYFORWARDS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails</Role>
      <ShortName>INCOME TAXES - OPERATING LOSS CARRYFORWARDS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100640 - Disclosure - INCOME TAXES - TAX CREDIT CARRYFORWARDS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails</Role>
      <ShortName>INCOME TAXES - TAX CREDIT CARRYFORWARDS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100650 - Disclosure - INCOME TAXES - CARES ACT IMPACT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESCARESACTIMPACTDetails</Role>
      <ShortName>INCOME TAXES - CARES ACT IMPACT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100660 - Disclosure - INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails</Role>
      <ShortName>INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100670 - Disclosure - CONSOLIDATED STATEMENTS OF CASH FLOWS DATA - Supplemental Investing Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS DATA - Supplemental Investing Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="gern-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>100680 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>SUBSEQUENT EVENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0540-EntityWellKnownSeasonedIssuer-Value] In submission type 10-K, EntityWellKnownSeasonedIssuer value "Yes", is not equivalent to header element wellKnownSeasonedIssuerFlag value "false" in the Required Context. gern-20221231.htm 66</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:CurrentFiscalYearEndDate, gern:LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan -  gern-20221231.htm 8</Log>
    <Log type="Warning">[dqc-0004-Element-Values-Are-Equal] CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect with a value of 21974000 is not equal to the total of NetCashProvidedByUsedInOperatingActivities, NetCashProvidedByUsedInInvestingActivities, NetCashProvidedByUsedInFinancingActivities with a value of -127379000 + 62067000 + 87264000. These values should be equal. The properties of this CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect fact are Context: C_e1b24643-c361-410f-bc44-b8aaa587644d, Unit: U_USD, Rule Element Id: 9286. gern-20221231.htm 5069, 5171, 5273, 5303</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="gern-20221231.htm">gern-20221231.htm</File>
    <File>gern-20221231.xsd</File>
    <File>gern-20221231_cal.xml</File>
    <File>gern-20221231_def.xml</File>
    <File>gern-20221231_lab.xml</File>
    <File>gern-20221231_pre.xml</File>
    <File>gern-ex21_1.htm</File>
    <File>gern-ex23_1.htm</File>
    <File>gern-ex31_1.htm</File>
    <File>gern-ex31_2.htm</File>
    <File>gern-ex32_1.htm</File>
    <File>gern-ex32_2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img42689296_0.jpg</File>
    <File>img42689296_1.jpg</File>
    <File>img42689296_2.jpg</File>
    <File>img42689296_3.jpg</File>
    <File>img42689296_4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="786">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>92
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "gern-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 786,
    "http://xbrl.sec.gov/dei/2022": 38
   },
   "contextCount": 219,
   "dts": {
    "calculationLink": {
     "local": [
      "gern-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "gern-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "gern-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "gern-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gern-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "gern-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 627,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 5,
    "http://www.geron.com/20221231": 1,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 10
   },
   "keyCustom": 68,
   "keyStandard": 302,
   "memberCustom": 48,
   "memberStandard": 29,
   "nsprefix": "gern",
   "nsuri": "http://www.geron.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - DOCUMENT AND ENTITY INFORMATION",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION",
     "shortName": "DOCUMENT AND ENTITY INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - FAIR VALUE MEASUREMENTS",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - PROPERTY AND EQUIPMENT",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - LICENSE AGREEMENT",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.geron.com/20221231/taxonomy/role/DisclosureLicenseAgreement",
     "shortName": "LICENSE AGREEMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - ACCRUED LIABILITIES",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIES",
     "shortName": "ACCRUED LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - OPERATING LEASES",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASES",
     "shortName": "OPERATING LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - DEBT",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - STOCKHOLDERS' EQUITY",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - CONSOLIDATED STATEMENTS OF CASH FLOWS DATA",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsData1",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - SUBSEQUENT EVENTS",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "21",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - ACCRUED LIABILITIES (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESTables",
     "shortName": "ACCRUED LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - OPERATING LEASES (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESTables",
     "shortName": "OPERATING LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - DEBT (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - CONSOLIDATED STATEMENTS OF CASH FLOWS DATA (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataTables",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_a3cf8441-940c-4769-a1c9-ba37e4bc2812",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
     "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_a3cf8441-940c-4769-a1c9-ba37e4bc2812",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_4183e218-4909-4bf2-b115-abdea99d97df",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail1)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1",
     "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER SHARE (Detail1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_4183e218-4909-4bf2-b115-abdea99d97df",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - USEFUL LIVES OF ASSETS (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESUSEFULLIVESOFASSETSDetails",
     "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - USEFUL LIVES OF ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock",
       "div",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - FAIR VALUE MEASUREMENTS - SECURITY TYPE (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - SECURITY TYPE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - FAIR VALUE MEASUREMENTS - SECURITIES WITH UNREALIZED LOSSES (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - SECURITIES WITH UNREALIZED LOSSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_6dfbe752-26a8-4b61-804f-713c8b76e3b2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - FAIR VALUE MEASUREMENTS - RECURRING BASIS (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - RECURRING BASIS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_6dfbe752-26a8-4b61-804f-713c8b76e3b2",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod",
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_0c264877-8e22-46f9-81fb-86523d23e816",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedBalanceShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - FAIR VALUE MEASUREMENTS - EQUITY INVESTMENT (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - EQUITY INVESTMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "us-gaap:BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod",
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_0c264877-8e22-46f9-81fb-86523d23e816",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentOwnedBalanceShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "gern:NumberOfFinancialInstitutions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Institution",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - FAIR VALUE MEASUREMENTS - CREDIT RISK (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSCREDITRISKDetails",
     "shortName": "FAIR VALUE MEASUREMENTS - CREDIT RISK (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "gern:NumberOfFinancialInstitutions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Institution",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - PROPERTY AND EQUIPMENT (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails",
     "shortName": "PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "gern:AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - ACCRUED LIABILITIES (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails",
     "shortName": "ACCRUED LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "gern:AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_5972d6c9-9d7e-481d-990f-61c5b5a57683",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencySettlementAgreementDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - COMMITMENTS AND CONTINGENCIES - Litigation Settlement (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Litigation Settlement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_5972d6c9-9d7e-481d-990f-61c5b5a57683",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencySettlementAgreementDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "gern:LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - COMMITMENTS AND CONTINGENCIES - Severance Plan (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Severance Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "gern:LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - OPERATING LEASES (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails",
     "shortName": "OPERATING LEASES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_7173b90d-0319-4205-a8c0-5d652abfb4d6",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - OPERATING LEASES - COMPONENTS OF LEASE COSTS (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails",
     "shortName": "OPERATING LEASES - COMPONENTS OF LEASE COSTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - OPERATING LEASES - UNDISCOUNTED FUTURE NON-CANCELLABLE LEASE PAYMENTS (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails",
     "shortName": "OPERATING LEASES - UNDISCOUNTED FUTURE NON-CANCELLABLE LEASE PAYMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_5989b6d5-f62b-49c2-8b91-aaa5680c6c8f",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_d1078eed-3e6a-4e01-b62d-1ba7e0711b75",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - DEBT - Additional Information (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails",
     "shortName": "DEBT - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_d1078eed-3e6a-4e01-b62d-1ba7e0711b75",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - DEBT - Schedule of Future Minimum Payments Under Term Loan Facility (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails",
     "shortName": "DEBT - Schedule of Future Minimum Payments Under Term Loan Facility (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - STOCKHOLDERS' EQUITY - AUTHORIZED COMMON STOCK (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYAUTHORIZEDCOMMONSTOCKDetails",
     "shortName": "STOCKHOLDERS' EQUITY - AUTHORIZED COMMON STOCK (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_de96a085-6c20-4cd2-b653-9124bc246e53",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_57eb8407-20bb-4fe8-b65e-a963754a7c2b",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - STOCKHOLDERS' EQUITY - PUBLIC OFFERING (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails",
     "shortName": "STOCKHOLDERS' EQUITY - PUBLIC OFFERING (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_57eb8407-20bb-4fe8-b65e-a963754a7c2b",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromWarrantExercises",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - STOCKHOLDERS' EQUITY - WARRANT EXERCISES (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails",
     "shortName": "STOCKHOLDERS' EQUITY - WARRANT EXERCISES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_4b658edd-fed5-40c3-886d-f2742643a130",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - STATEMENTS OF COMPREHENSIVE LOSS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS",
     "shortName": "STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ComprehensiveIncomeNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_05ddd28f-b8fe-4ce9-a237-31058693c7d7",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - STOCKHOLDERS' EQUITY - SALES AGREEMENTS (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails",
     "shortName": "STOCKHOLDERS' EQUITY - SALES AGREEMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_4cae8e78-c215-4912-8bd0-8a601c68ba56",
      "decimals": "INF",
      "lang": null,
      "name": "gern:CommonStockAggregateOfferingPrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "gern:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - STOCKHOLDERS' EQUITY - EQUITY PLANS (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
     "shortName": "STOCKHOLDERS' EQUITY - EQUITY PLANS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "2",
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1254ade3-fe72-434a-a6db-19a268f35273",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails",
     "shortName": "STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Parenthetical) (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails",
     "shortName": "STOCKHOLDERS' EQUITY - EQUITY PLANS - SCHEDULE OF AGGREGATE STOCK OPTION AND AWARD ACTIVITY (Parenthetical) (Details)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_6f3c409b-23a5-42d9-b49c-56b851f33720",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "gern:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - STOCKHOLDERS' EQUITY - EMPLOYEE STOCK PURCHASE PLAN (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails",
     "shortName": "STOCKHOLDERS' EQUITY - EMPLOYEE STOCK PURCHASE PLAN (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_a6f63570-90af-4655-9959-2d2b2d53203e",
      "decimals": "INF",
      "lang": null,
      "name": "gern:ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - STOCKHOLDERS' EQUITY - PERFORMANCE BASED STOCK OPTIONS (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails",
     "shortName": "STOCKHOLDERS' EQUITY - PERFORMANCE BASED STOCK OPTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_61a9529a-15e0-492a-891c-e7c1701d7744",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION EXPENSE FOR EMPLOYEES AND DIRECTORS (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails",
     "shortName": "STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION EXPENSE FOR EMPLOYEES AND DIRECTORS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - STOCKHOLDERS' EQUITY - PRICING MODEL ASSUMPTIONS (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails",
     "shortName": "STOCKHOLDERS' EQUITY - PRICING MODEL ASSUMPTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION TO SERVICE PROVIDERS (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails",
     "shortName": "STOCKHOLDERS' EQUITY - STOCK-BASED COMPENSATION TO SERVICE PROVIDERS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_6a7a9685-7310-4141-b7de-f1f3a5fe3099",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - STOCKHOLDERS' EQUITY - COMMON STOCK RESERVED FOR FUTURE ISSUANCE (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails",
     "shortName": "STOCKHOLDERS' EQUITY - COMMON STOCK RESERVED FOR FUTURE ISSUANCE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "gern:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_51546caa-efa4-41ff-89e0-38e80356cf4c",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_51546caa-efa4-41ff-89e0-38e80356cf4c",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - INCOME TAXES - EFFECTIVE INCOME TAX RATE (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails",
     "shortName": "INCOME TAXES - EFFECTIVE INCOME TAX RATE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - INCOME TAXES - DEFERRED TAXES (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails",
     "shortName": "INCOME TAXES - DEFERRED TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_a981f541-3690-49c7-8693-645d2e5d3905",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - INCOME TAXES - OPERATING LOSS CARRYFORWARDS (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails",
     "shortName": "INCOME TAXES - OPERATING LOSS CARRYFORWARDS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_a981f541-3690-49c7-8693-645d2e5d3905",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_a981f541-3690-49c7-8693-645d2e5d3905",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:TaxCreditCarryforwardAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - INCOME TAXES - TAX CREDIT CARRYFORWARDS (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails",
     "shortName": "INCOME TAXES - TAX CREDIT CARRYFORWARDS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_a981f541-3690-49c7-8693-645d2e5d3905",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:TaxCreditCarryforwardAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "gern:EmployerTaxReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - INCOME TAXES - CARES ACT IMPACT (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESCARESACTIMPACTDetails",
     "shortName": "INCOME TAXES - CARES ACT IMPACT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "gern:EmployerTaxReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100660 - Disclosure - INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails",
     "shortName": "INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_1ac565cd-3589-476a-8008-a137d294bc33",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100670 - Disclosure - CONSOLIDATED STATEMENTS OF CASH FLOWS DATA - Supplemental Investing Activities (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS DATA - Supplemental Investing Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "div",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromWarrantExercises",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100680 - Disclosure - SUBSEQUENT EVENTS - Additional Information (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "shortName": "SUBSEQUENT EVENTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e324494e-e119-4b64-9797-465da2721c25",
      "decimals": "INF",
      "lang": null,
      "name": "gern:ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_edb3e230-dfab-42f5-babc-05523982f83c",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_edb3e230-dfab-42f5-babc-05523982f83c",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "gern-20221231.htm",
      "contextRef": "C_e1b24643-c361-410f-bc44-b8aaa587644d",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 81,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r573"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r570",
      "r571",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DocumentDOCUMENTANDENTITYINFORMATION"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "gern_AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical related costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Clinical Research Organizations And Clinical Trial Costs Current",
        "terseLabel": "CRO and clinical trial costs"
       }
      }
     },
     "localname": "AccruedClinicalResearchOrganizationsAndClinicalTrialCostsCurrent",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_AccruedEndOfTermCharge": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued end of term charge.",
        "label": "Accrued End Of Term Charge",
        "terseLabel": "Accrued end of term charge"
       }
      }
     },
     "localname": "AccruedEndOfTermCharge",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_AccruedEndOfTermCharges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued end of term charges.",
        "label": "Accrued End Of Term Charges",
        "verboseLabel": "Accrued end of term charge"
       }
      }
     },
     "localname": "AccruedEndOfTermCharges",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_AccruedManufacturingActivitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet of obligations incurred through the date and payable for manufacturing related costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Manufacturing Activities Current",
        "terseLabel": "Manufacturing activities"
       }
      }
     },
     "localname": "AccruedManufacturingActivitiesCurrent",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_AtMarketIssuanceSalesAgreementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At Market Issuance Sales Agreements.",
        "label": "At Market Issuance Sales Agreements [Line Items]",
        "terseLabel": "At Market Issuance Sales Agreements [Line Items]"
       }
      }
     },
     "localname": "AtMarketIssuanceSalesAgreementsLineItems",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_AtMarketIssuanceSalesAgreementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At Market Issuance Sales Agreements.",
        "label": "At Market Issuance Sales Agreements [Table]",
        "terseLabel": "At Market Issuance Sales Agreements [Table]"
       }
      }
     },
     "localname": "AtMarketIssuanceSalesAgreementsTable",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At market issuance, 2018 sales agreement.",
        "label": "At Market Issuance Two Thousand And Eighteen Sales Agreement [Member]",
        "terseLabel": "2018 Sales Agreement"
       }
      }
     },
     "localname": "AtMarketIssuanceTwoThousandAndEighteenSalesAgreementMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At market issuance two thousand and twenty sales agreement.",
        "label": "At Market Issuance Two Thousand And Twenty Sales Agreement [Member]",
        "terseLabel": "2020 Sales Agreement"
       }
      }
     },
     "localname": "AtMarketIssuanceTwoThousandAndTwentySalesAgreementMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_AtTheMarketOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At The Market Offering Member.",
        "label": "At The Market Offering [Member]",
        "terseLabel": "At The Market Offering"
       }
      }
     },
     "localname": "AtTheMarketOfferingMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_BorrowingAvailableStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First date to available to drawdown any amount under a tranche.",
        "label": "Borrowing Available Start Date",
        "terseLabel": "Start date to borrow under a tranche for a debt instrument"
       }
      }
     },
     "localname": "BorrowingAvailableStartDate",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "gern_CARESActImpactAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES act impact.",
        "label": "C A R E S Act Impact [Abstract]"
       }
      }
     },
     "localname": "CARESActImpactAbstract",
     "nsuri": "http://www.geron.com/20221231",
     "xbrltype": "stringItemType"
    },
    "gern_CashAndCashEquivalentsUnrealizedGains": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_CashEquivalentsAtCarryingValue",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the gross unrealized gains for cash and cash equivalents.",
        "label": "Cash And Cash Equivalents Unrealized Gains",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "CashAndCashEquivalentsUnrealizedGains",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_CashAndCashEquivalentsUnrealizedLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the gross unrealized losses for cash and cash equivalents.",
        "label": "Cash And Cash Equivalents Unrealized Losses",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "CashAndCashEquivalentsUnrealizedLosses",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_ClassActionStipulationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class action stipulation.",
        "label": "Class Action Stipulation [Member]",
        "terseLabel": "Class Action Stipulation"
       }
      }
     },
     "localname": "ClassActionStipulationMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants exercised during the period",
        "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Exercised",
        "terseLabel": "Warrants to purchase common stock exercised, shares"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsExercised",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails",
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "gern_ClinicalSupplyAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Clinical supply agreement.",
        "label": "Clinical Supply Agreement [Member]",
        "terseLabel": "Clinical Supply Agreement"
       }
      }
     },
     "localname": "ClinicalSupplyAgreementMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of costs that the company must pay after the termination of the Collaboration Agreement.",
        "label": "Collaborative Arrangement After Termination Cost Sharing Percentage Of Entity",
        "terseLabel": "Percentage of costs to be paid by Geron after termination of Collaboration Agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementAfterTerminationCostSharingPercentageOfEntity",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_CollaborativeArrangementCostSharingPercentageOfCounterparty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of costs that Janssen must pay during certain phases of the agreement.",
        "label": "Collaborative Arrangement Cost Sharing Percentage Of Counterparty",
        "terseLabel": "Percentage of costs to be paid by Janssen"
       }
      }
     },
     "localname": "CollaborativeArrangementCostSharingPercentageOfCounterparty",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_CollaborativeArrangementCostSharingPercentageOfEntity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of costs that Geron must pay during certain phases of the agreement.",
        "label": "Collaborative Arrangement Cost Sharing Percentage Of Entity",
        "terseLabel": "Percentage of costs to be paid by Geron"
       }
      }
     },
     "localname": "CollaborativeArrangementCostSharingPercentageOfEntity",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_CollaborativeArrangementNumberOfStudies": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of agreed upon studies.",
        "label": "Collaborative Arrangement Number Of Studies",
        "terseLabel": "Number of agreed upon studies"
       }
      }
     },
     "localname": "CollaborativeArrangementNumberOfStudies",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "gern_CommercialPaperDueInLessThanOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to unsecured promissory note (generally negotiable) that provides institutions with short-term funds ), due in less than one year.",
        "label": "Commercial Paper Due In Less Than One Year [Member]",
        "terseLabel": "Commercial paper (due in less than one year)"
       }
      }
     },
     "localname": "CommercialPaperDueInLessThanOneYearMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_CommonStockAggregateOfferingPrice": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate offering price for which the entity may elect to issue and sell shares of its common stock under the sales agreement.",
        "label": "Common Stock Aggregate Offering Price",
        "terseLabel": "Aggregate offering price of common stock"
       }
      }
     },
     "localname": "CommonStockAggregateOfferingPrice",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_ConsultantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to consultants.",
        "label": "Consultants [Member]",
        "terseLabel": "Consultants"
       }
      }
     },
     "localname": "ConsultantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_CorporateNoteSecuritiesDueInLessThanOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest), due in less than one year.",
        "label": "Corporate Note Securities Due In Less Than One Year [Member]",
        "terseLabel": "Corporate notes (due in less than one year)"
       }
      }
     },
     "localname": "CorporateNoteSecuritiesDueInLessThanOneYearMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_CorporateNoteSecuritiesDueInOneToTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest), due in one to two years.",
        "label": "Corporate Note Securities Due In One To Two Years [Member]",
        "terseLabel": "Corporate notes (due in one to two years)"
       }
      }
     },
     "localname": "CorporateNoteSecuritiesDueInOneToTwoYearsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_CostMethodInvestmentOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost method investment ownership percentage.",
        "label": "Cost Method Investment Ownership Percentage",
        "terseLabel": "Cost method investments ownership percentage"
       }
      }
     },
     "localname": "CostMethodInvestmentOwnershipPercentage",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_CostMethodInvestmentsCostBasis": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost method investments cost basis.",
        "label": "Cost Method Investments Cost Basis",
        "terseLabel": "Cost method investments cost basis"
       }
      }
     },
     "localname": "CostMethodInvestmentsCostBasis",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DebtCovenantMinCashUponLicensingTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum cash covenant required upon certain licensing transactions being executed.",
        "label": "Debt Covenant Min Cash Upon Licensing Transaction",
        "terseLabel": "Debt covenant minimum cash balance upon licensing transaction"
       }
      }
     },
     "localname": "DebtCovenantMinCashUponLicensingTransaction",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DebtCovenantMinCashUponRegulatoryMilestone": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum cash covenant required upon achievement of certain regulatory milestones.",
        "label": "Debt Covenant Min Cash Upon Regulatory Milestone",
        "terseLabel": "Debt covenant minimum cash balance upon regulatory milestone achievement"
       }
      }
     },
     "localname": "DebtCovenantMinCashUponRegulatoryMilestone",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DebtCovenantMinimumCashBalance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Minimum Cash Balance",
        "label": "Debt Covenant Minimum Cash Balance",
        "terseLabel": "Debt covenant minimum cash balance"
       }
      }
     },
     "localname": "DebtCovenantMinimumCashBalance",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DebtCovenantMinimumCashBalancePercentageOfLoanAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of loan amount outstanding to be held as minimum cash balance under debt covenant.",
        "label": "Debt covenant minimum cash balance percentage of loan amount",
        "terseLabel": "Minimum cash balance as a percentage of loan amount outstanding"
       }
      }
     },
     "localname": "DebtCovenantMinimumCashBalancePercentageOfLoanAmount",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_DebtCovenantPercentageOfProductRevenueAgainstForecast": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of six-month product revenue forecast to satisfy minimum cash balance debt covenant.",
        "label": "Debt covenant percentage of product revenue against forecast",
        "verboseLabel": "Minimum cash balance requirement to be met as a percentage of six-month product revenue against forecast"
       }
      }
     },
     "localname": "DebtCovenantPercentageOfProductRevenueAgainstForecast",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_DebtInstrumentEndOfTermChargePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of outstanding loan amount payable upon maturity.",
        "label": "Debt Instrument End Of Term Charge Percentage",
        "terseLabel": "End of term charge for loan, percentage"
       }
      }
     },
     "localname": "DebtInstrumentEndOfTermChargePercentage",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_DebtInstrumentMinimumPrepaymentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount allowed to be prepaid under debt instrument.",
        "label": "Debt Instrument Minimum Prepayment Amount",
        "terseLabel": "Minimum amount of prepayment allowed under debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentMinimumPrepaymentAmount",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DebtInstrumentUnamortizedEndOfTermCharge": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument unamortized end of term charge.",
        "label": "Debt Instrument Unamortized End Of Term Charge",
        "negatedLabel": "Less: unamortized end of term charge"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedEndOfTermCharge",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DeferredTaxAssetsCapitalizedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to the treatment of research and development costs.",
        "label": "Deferred Tax Assets Capitalized Research And Development",
        "terseLabel": "Capitalized research and development"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopment",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DeferredTaxAssetsFederalAndStateCredits": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets federal and state credits.",
        "label": "Deferred Tax Assets Federal And State Credits",
        "terseLabel": "Federal and state tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsFederalAndStateCredits",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets operating lease liabilities.",
        "label": "Deferred Tax Assets Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities operating leases right of use assets.",
        "label": "Deferred Tax Liabilities Operating Leases Right Of Use Assets",
        "negatedLabel": "Operating leases, right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeasesRightOfUseAssets",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DepositsAndOtherAssetsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer; and amount of noncurrent assets classified as other.",
        "label": "Deposits And Other Assets Noncurrent",
        "terseLabel": "Deposits and other assets"
       }
      }
     },
     "localname": "DepositsAndOtherAssetsNoncurrent",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DerivativeStipulationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative stipulation.",
        "label": "Derivative Stipulation [Member]",
        "terseLabel": "Derivative Stipulation"
       }
      }
     },
     "localname": "DerivativeStipulationMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_DirectorsMarketValueStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Directors\u2019 market value stock purchase plan.",
        "label": "Directors Market Value Stock Purchase Plan [Member]",
        "terseLabel": "Directors Market Value Stock Purchase Plan"
       }
      }
     },
     "localname": "DirectorsMarketValueStockPurchasePlanMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_DirectorsPlan2006Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the 2006 Directors Plan.",
        "label": "Directors Plan2006 [Member]",
        "terseLabel": "2006 Directors Plan"
       }
      }
     },
     "localname": "DirectorsPlan2006Member",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_DollarPrepaymentCharge36MonthsAfterEffectiveDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment charge assessed upon debt prepayment occurring 36 months after June 30, 2022 under second amendment.",
        "label": "Dollar prepayment charge 36 months after effective date",
        "verboseLabel": "Charge for prepayment occurring 36 months after effective date"
       }
      }
     },
     "localname": "DollarPrepaymentCharge36MonthsAfterEffectiveDate",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_DueToCounterParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of obligations due to counterparty. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due To Counter Party",
        "terseLabel": "Amount due to Janssen Biotech, Inc."
       }
      }
     },
     "localname": "DueToCounterParty",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of unrealized losses and exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect Of Unrealized Losses And Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations",
        "terseLabel": "Net effect of unrealized gains and exchange rates on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfUnrealizedLossesAndExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax Rate reconciliation net operating loss not benefitted.",
        "label": "Effective Income Tax Rate Reconciliation Net Operating Loss Not Benefitted",
        "terseLabel": "Net operating loss not benefitted"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNetOperatingLossNotBenefitted",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_EmployerTaxReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of employer taxes paid to tax authorities representing refunds based on calculated eligible credits. Also called employer tax refund receivable.",
        "label": "Employer Tax Receivable",
        "terseLabel": "Employee retention credit, CARES Act"
       }
      }
     },
     "localname": "EmployerTaxReceivable",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESCARESACTIMPACTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_EquityInvestmentReverseStockSplit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse stock split ratio for equity investment.",
        "label": "Equity Investment Reverse Stock Split",
        "terseLabel": "Equity investment reverse stock split"
       }
      }
     },
     "localname": "EquityInvestmentReverseStockSplit",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_ExpiryDateOfTranche": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Last date to drawdown any amounts under a tranche.",
        "label": "Expiry Date Of Tranche",
        "terseLabel": "Expiration date to borrow under a tranche for a debt instrument"
       }
      }
     },
     "localname": "ExpiryDateOfTranche",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "gern_FirstDirectorOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the stock options to be granted by the entity to a person who first becomes a non-employee director.",
        "label": "First Director Option [Member]",
        "terseLabel": "First Director Option"
       }
      }
     },
     "localname": "FirstDirectorOptionMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_FormerCollaborativeArrangementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former collaborative arrangement.",
        "label": "Former Collaborative Arrangement [Member]",
        "terseLabel": "Former Collaboration Agreement"
       }
      }
     },
     "localname": "FormerCollaborativeArrangementMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_FosterCityOfficeSpaceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foster City office space lease.",
        "label": "Foster City Office Space Lease [Member]",
        "terseLabel": "Foster City Office Space Lease"
       }
      }
     },
     "localname": "FosterCityOfficeSpaceLeaseMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government sponsored enterprise securities due in less than one year.",
        "label": "Government Sponsored Enterprise Securities Due In Less Than One Year [Member]",
        "terseLabel": "Government-sponsored enterprise securities (due in less than one year)"
       }
      }
     },
     "localname": "GovernmentSponsoredEnterpriseSecuritiesDueInLessThanOneYearMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae) due in 1 to 2 years.",
        "label": "Government Sponsored Enterprise Securities Due In One To Two Years [Member]",
        "terseLabel": "Government-sponsored enterprise securities (due in one to two years)"
       }
      }
     },
     "localname": "GovernmentSponsoredEnterpriseSecuritiesDueInOneToTwoYearsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_HerculesAndSiliconValleyBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hercules and Silicon Valley Bank. member.",
        "label": "Hercules And Silicon Valley Bank [Member]",
        "terseLabel": "Hercules and Silicon Valley Bank [Member]"
       }
      }
     },
     "localname": "HerculesAndSiliconValleyBankMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_HerculesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hercules.",
        "label": "Hercules [Member]"
       }
      }
     },
     "localname": "HerculesMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_IncentiveAwardPlan2011Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the 2011 Incentive Award Plan.",
        "label": "Incentive Award Plan2011 [Member]",
        "terseLabel": "2011 Plan"
       }
      }
     },
     "localname": "IncentiveAwardPlan2011Member",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_IncreaseDecreaseDueToCounterparty": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period for amount due to counterparty.",
        "label": "Increase Decrease Due To Counterparty",
        "terseLabel": "Amount due to Janssen Biotech, Inc."
       }
      }
     },
     "localname": "IncreaseDecreaseDueToCounterparty",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due for interest payments related to marketable securities and in other amounts due to the reporting entity, which are not otherwise defined in the taxonomy.",
        "label": "Increase Decrease In Accrued Interest Receivable Net And Other Receivables",
        "negatedLabel": "Interest and other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedInterestReceivableNetAndOtherReceivables",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase decrease in operating lease liabilities.",
        "label": "Increase Decrease In Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_InterestOnlyPeriodPaymentTermDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest only period payment term description.",
        "label": "Interest Only Period Payment Term Description",
        "terseLabel": "Interest only period payment term description"
       }
      }
     },
     "localname": "InterestOnlyPeriodPaymentTermDescription",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new shares issued during the period in connection with exercise of warrants.",
        "label": "Issuance Of Common Stock In Connection With Warrant Exercise Shares",
        "terseLabel": "Issuance of common stock in connection exercise of warrants (in shares)"
       }
      }
     },
     "localname": "IssuanceOfCommonStockInConnectionWithWarrantExerciseShares",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "gern_IssuanceOfCommonStockInConnectionWithWarrantExerciseValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock issued in connection with exercise of warrants during the period.",
        "label": "Issuance Of Common Stock In Connection With Warrant Exercise Value",
        "terseLabel": "Issuance of common stock in connection exercise of warrants"
       }
      }
     },
     "localname": "IssuanceOfCommonStockInConnectionWithWarrantExerciseValue",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_JanssenBiotechIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the Janssen Biotech Inc.",
        "label": "Janssen Biotech Inc [Member]",
        "terseLabel": "Janssen Biotech"
       }
      }
     },
     "localname": "JanssenBiotechIncMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_LicenseAgreementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "No definition available.",
        "label": "License Agreement Disclosure [Abstract]"
       }
      }
     },
     "localname": "LicenseAgreementDisclosureAbstract",
     "nsuri": "http://www.geron.com/20221231",
     "xbrltype": "stringItemType"
    },
    "gern_LitigationSettlementAmountAccruedLiabilitiesRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation settlement amount, Accrued liabilities recognized",
        "label": "Litigation settlement amount, Accrued liabilities recognized",
        "terseLabel": "Settlement amount, Accrued liabilities recognized"
       }
      }
     },
     "localname": "LitigationSettlementAmountAccruedLiabilitiesRecognized",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation settlement amount, General and administrative expense recognized.",
        "label": "Litigation settlement amount, General and administrative expense recognized",
        "terseLabel": "Settlement amount, General and administrative expense recognized"
       }
      }
     },
     "localname": "LitigationSettlementAmountGeneralAndAdministrativeExpenseRecognized",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_LitigationSettlementAmountInterestAndOtherReceivableRecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement Amount, Interest and other receivable Recognized",
        "label": "Litigation Settlement Amount, Interest and other receivable Recognized",
        "terseLabel": "Settlement amount, Interest and other receivable recognized"
       }
      }
     },
     "localname": "LitigationSettlementAmountInterestAndOtherReceivableRecognized",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_LitigationSettlementAmountPaidInCashOrKind": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the settlement to be paid by the company in either cash or shares, at the company's election.",
        "label": "Litigation Settlement Amount Paid in Cash or Kind",
        "terseLabel": "Settlement to be paid in cash or shares as elected by company"
       }
      }
     },
     "localname": "LitigationSettlementAmountPaidInCashOrKind",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_LitigationSettlementAmountToBePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation settlement amount to be paid.",
        "label": "Litigation Settlement Amount to be Paid",
        "terseLabel": "Settlement amount to be paid"
       }
      }
     },
     "localname": "LitigationSettlementAmountToBePaid",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_LongTermDebtGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of term loan, including accrued interest payable and end of term charge.",
        "label": "Long Term Debt Gross",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "LongTermDebtGross",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss contingency period of current base salary to be paid under severance plan.",
        "label": "Loss Contingency Period Of Current Base Salary To Be Paid Under Severance Plan",
        "terseLabel": "Period of base salary to be considered for severance payments"
       }
      }
     },
     "localname": "LossContingencyPeriodOfCurrentBaseSalaryToBePaidUnderSeverancePlan",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of months following a change in control when an employee is terminated without cause to be classified as a triggering event for severance payments.",
        "label": "Loss Contingency Triggering Event Employee Termination Without Cause Following Change Of Control Period",
        "terseLabel": "Period within which employee is terminated by entity without cause following a change of control"
       }
      }
     },
     "localname": "LossContingencyTriggeringEventEmployeeTerminationWithoutCauseFollowingChangeOfControlPeriod",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the period following change of control within which an employee is not offered comparable employment (new or continuing) by the entity or its successor or acquired and to be considered as triggering event for severance payments.",
        "label": "Loss Contingency Triggering Event Period Following Change Of Control During Which No Comparable Employment Is Offered By Entity",
        "terseLabel": "Period within which no comparable employment is offered by the entity following a change of control"
       }
      }
     },
     "localname": "LossContingencyTriggeringEventPeriodFollowingChangeOfControlDuringWhichNoComparableEmploymentIsOfferedByEntity",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the period within which employee resigns following a change of control due to material change in terms of employment and to be considered as triggering event for severance payments.",
        "label": "Loss Contingency Triggering Event Period Following Change Of Control Within Which Employee Resigns Due To Material Change In Terms Of Employment",
        "terseLabel": "Period within which employee resigns following a change of control due to material change in terms of employment"
       }
      }
     },
     "localname": "LossContingencyTriggeringEventPeriodFollowingChangeOfControlWithinWhichEmployeeResignsDueToMaterialChangeInTermsOfEmployment",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_MarketCapMinimumToUseOptionTwo": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum market capitalization required for this option to be available to meet the minimum cash balance debt covenant.",
        "label": "Market cap minimum to use option two",
        "verboseLabel": "Minimum market capitalization requirement for option"
       }
      }
     },
     "localname": "MarketCapMinimumToUseOptionTwo",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_MaximumCommissionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the percentage of maximum commission rate, based on gross proceeds of sale price per share of common stock sold through sales agent under the sales agreement.",
        "label": "Maximum Commission Rate",
        "terseLabel": "Maximum commission rate (as a percent)"
       }
      }
     },
     "localname": "MaximumCommissionRate",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_MenloParkOfficeSpaceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Menlo park office space lease.",
        "label": "Menlo Park Office Space Lease [Member]",
        "terseLabel": "Menlo Park Office Space Lease"
       }
      }
     },
     "localname": "MenloParkOfficeSpaceLeaseMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_MinimumPercentageOfNetProductRevenuesMaintenancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of net product revenues maintenance period.",
        "label": "Minimum percentage of net product revenues maintenance period",
        "verboseLabel": "Minimum percentage of net product revenues maintenance period"
       }
      }
     },
     "localname": "MinimumPercentageOfNetProductRevenuesMaintenancePeriod",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_MunicipalSecuritiesDueInLessThanOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Municipal securities due in less than one year.",
        "label": "Municipal Securities Due In Less Than One Year [Member]",
        "terseLabel": "Municipal securities (due in less than a year)",
        "verboseLabel": "Municipal securities (due in less than one year)"
       }
      }
     },
     "localname": "MunicipalSecuritiesDueInLessThanOneYearMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_MunicipalSecuritiesDueInOneToTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Municipal securities due in one to two years member.",
        "label": "Municipal Securities Due In One To Two Years [Member]",
        "terseLabel": "Municipal securities (due in one to two years)"
       }
      }
     },
     "localname": "MunicipalSecuritiesDueInOneToTwoYearsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_NewJerseyLeaseAndFosterCityLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Jersey lease and Foster city lease member.",
        "label": "New Jersey Lease And Foster City Lease [Member]",
        "terseLabel": "New Jersey Lease And Foster City Lease"
       }
      }
     },
     "localname": "NewJerseyLeaseAndFosterCityLeaseMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_NewJerseyOfficeSpaceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New jersey office space lease.",
        "label": "New Jersey Office Space Lease [Member]",
        "terseLabel": "New Jersey Office Space Lease"
       }
      }
     },
     "localname": "NewJerseyOfficeSpaceLeaseMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_NumberOfFinancialInstitutions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of financial institutions.",
        "label": "Number Of Financial Institutions",
        "terseLabel": "Number of financial institutions"
       }
      }
     },
     "localname": "NumberOfFinancialInstitutions",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSCREDITRISKDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "gern_NumberOfSharesSoldFromEquityInvestment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares from equity investment that have been sold during the period.",
        "label": "Number Of Shares Sold From Equity Investment",
        "terseLabel": "Number Of Shares Sold From Equity Investment"
       }
      }
     },
     "localname": "NumberOfSharesSoldFromEquityInvestment",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "gern_OperatingLeaseRentAbatementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease rent abatement period.",
        "label": "Operating Lease Rent Abatement Period",
        "terseLabel": "Operating lease, rent abatement period"
       }
      }
     },
     "localname": "OperatingLeaseRentAbatementPeriod",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_OperatingLeaseTermAdditionalPeriodExtension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease term additional period extension.",
        "label": "Operating Lease Term Additional Period Extension",
        "terseLabel": "Operating lease term, additional period extension"
       }
      }
     },
     "localname": "OperatingLeaseTermAdditionalPeriodExtension",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_OperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards subject to expiration.",
        "label": "Operating Loss Carryforwards Subject To Expiration",
        "terseLabel": "Net operating loss carryforwards, expire beginning 2023 through 2037"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_OptionOneMinCashDebtCovenantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option one min cash debt covenant.",
        "label": "Option one min cash debt covenant [Member]"
       }
      }
     },
     "localname": "OptionOneMinCashDebtCovenantMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_OptionThreeMinCashDebtCovenantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option three min cash debt covenant.",
        "label": "Option three min cash debt covenant [Member]"
       }
      }
     },
     "localname": "OptionThreeMinCashDebtCovenantMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_OptionTwoMinCashDebtCovenantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Option two min cash debt covenant.",
        "label": "Option Two Min Cash Debt Covenant [Member]"
       }
      }
     },
     "localname": "OptionTwoMinCashDebtCovenantMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_PercentageOfInterestOnPastDueOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Added percentage to current interest rate under debt instrument to past due amounts.",
        "label": "Percentage Of Interest On Past Due Outstanding",
        "terseLabel": "Additional percentage of interest on past due amounts"
       }
      }
     },
     "localname": "PercentageOfInterestOnPastDueOutstanding",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_PercentageOfPrepaymentCharge": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of prepayment amount to be paid upon prepayment under debt instrument.",
        "label": "Percentage Of Prepayment Charge",
        "terseLabel": "Prepayment charge (as a percentage)"
       }
      }
     },
     "localname": "PercentageOfPrepaymentCharge",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining term commitments held under loan agreement.",
        "label": "Percentage of Remaining Term Commitments Held Under Loan Agreement",
        "terseLabel": "Percentage of remaining term commitments held under loan agreement"
       }
      }
     },
     "localname": "PercentageOfRemainingTermCommitmentsHeldUnderLoanAgreement",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_PerformanceBasedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance based stock options.",
        "label": "Performance Based Stock Options [Member]",
        "terseLabel": "Performance-Based Stock Options"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_PreFundedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded warrants purchase.",
        "label": "Pre Funded Warrants [Member]",
        "terseLabel": "Pre-Funded Warrants"
       }
      }
     },
     "localname": "PreFundedWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from public offering issuance of common stock and warrants.",
        "label": "Proceeds From Public Offering Issuance Of Common Stock And Warrants",
        "terseLabel": "Proceeds from issuance of common stock and warrants in public offering, net of paid issuance costs"
       }
      }
     },
     "localname": "ProceedsFromPublicOfferingIssuanceOfCommonStockAndWarrants",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_PublicOfferingLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public offering.",
        "label": "Public Offering [Line Items]",
        "terseLabel": "Public Offering [Line Items]"
       }
      }
     },
     "localname": "PublicOfferingLineItems",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_PublicOfferingOfCommonStockAndWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Offering of Common Stock and Warrants [Member]",
        "label": "Public Offering Of Common Stock And Warrants [Member]",
        "terseLabel": "Public Offering of Common Stock and Warrants"
       }
      }
     },
     "localname": "PublicOfferingOfCommonStockAndWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_PublicOfferingStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public offering stock issued during period shares new issues.",
        "label": "Public Offering Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "PublicOfferingStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "gern_PublicOfferingStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public offering stock issued during period value new issues.",
        "label": "Public Offering Stock Issued During Period Value New Issues",
        "terseLabel": "Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs"
       }
      }
     },
     "localname": "PublicOfferingStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_PublicOfferingTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public offering.",
        "label": "Public Offering [Table]",
        "terseLabel": "Public Offering [Table]"
       }
      }
     },
     "localname": "PublicOfferingTable",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_PurchaseWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase warrants.",
        "label": "Purchase Warrants [Member]",
        "terseLabel": "Purchase Warrants [Member]"
       }
      }
     },
     "localname": "PurchaseWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification between prepaid and other current assets and deposits and other assets.",
        "label": "Reclassification Between Prepaid And Other Current Assets And Deposits And Other Assets",
        "terseLabel": "Reclassification between prepaid and other current assets and deposits and other assets"
       }
      }
     },
     "localname": "ReclassificationBetweenPrepaidAndOtherCurrentAssetsAndDepositsAndOtherAssets",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_RestrictedCashAndCashEquivalentsGrossUnrealizedLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash and cash equivalents gross unrealized losses.",
        "label": "Restricted Cash And Cash Equivalents Gross Unrealized Losses",
        "terseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsGrossUnrealizedLosses",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_RestrictedCashAndCashEquivalentsUnrealizedGains": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash and cash equivalents unrealized gains.",
        "label": "Restricted Cash And Cash Equivalents Unrealized Gains",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsUnrealizedGains",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "gern_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of common stock reserved for future issuance, which may include but is not limited to outstanding options and outstanding warrants.",
        "label": "Schedule Of Common Stock Reserved For Future Issuance Table [Text Block]",
        "terseLabel": "Schedule of common stock reserved for future issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "gern_SecondAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second amendment.",
        "label": "Second Amendment [Member]",
        "verboseLabel": "Second Amendment [Member]"
       }
      }
     },
     "localname": "SecondAmendmentMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_SeverancePlanLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance plan.",
        "label": "Severance Plan [Line Items]",
        "terseLabel": "Severance Plan"
       }
      }
     },
     "localname": "SeverancePlanLineItems",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_SeverancePlanTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Severance plan.",
        "label": "Severance Plan [Table]",
        "terseLabel": "Severance Plan [Table]"
       }
      }
     },
     "localname": "SeverancePlanTable",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate number of share instruments issued under a share-based compensation plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Aggregate Shares Issued Under Plan",
        "terseLabel": "Aggregate shares issued under plan"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAggregateSharesIssuedUnderPlan",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the duration of new offering period in a case where the fair market value of common stock on the purchase date is less than the fair market value at the beginning of the offering period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Duration Of New Offering Period",
        "terseLabel": "Duration of the new offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfNewOfferingPeriod",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the duration of the purchase period under the employee stock purchase plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Duration Of Purchase Period",
        "terseLabel": "Duration of the purchase period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDurationOfPurchasePeriod",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum duration of the offering period under the employee stock purchase plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Duration Of Offering Period",
        "terseLabel": "Maximum duration of offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumDurationOfOfferingPeriod",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of offering periods in which an employee can participate at a time in the purchase plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Offering Periods In Which Employee May Participate At One Time",
        "terseLabel": "Number of offering periods in which an employee can participate at a time"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfOfferingPeriodsInWhichEmployeeMayParticipateAtOneTime",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum percentage of annual salary that an employee can choose to have withheld to purchase common stock under the purchase plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Percentage Of Annual Salary That Can Be Withheld",
        "terseLabel": "Maximum percentage of annual salary that can be withheld"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumPercentageOfAnnualSalaryThatCanBeWithheld",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award minimum exercise price of options granted to employees with more than 10 percentage of common stock.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Minimum Exercise Price Of Options Granted To Employees With More Than10 Percentage Of Common Stock",
        "terseLabel": "Minimum exercise price as a percentage of fair market value for employees having more than 10 % outstanding common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumExercisePriceOfOptionsGrantedToEmployeesWithMoreThan10PercentageOfCommonStock",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum percentage of ownership required for granting of options at a price not less than 110 percent of the fair market value of common stock.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Minimum Percentage Of Ownership Required For Granting Options At Minimum110 Percent Of Fair Market Value",
        "terseLabel": "Minimum percentage of ownership required for granting stock options at least 110% of fair market value of common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMinimumPercentageOfOwnershipRequiredForGrantingOptionsAtMinimum110PercentOfFairMarketValue",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of consecutive purchase periods in an offering period in the purchase plan.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Consecutive Purchase Periods In Each Offering Period",
        "terseLabel": "Number of consecutive purchase periods in an offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfConsecutivePurchasePeriodsInEachOfferingPeriod",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value - Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAbstract",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of options to be granted to purchase shares in each year during the optionee's service on the Board of Directors.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options To Be Granted To Purchase Shares",
        "terseLabel": "Stock options to be granted to purchase shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseShares",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of options to be granted to purchase shares upon appointment to Board of Directors.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options To Be Granted To Purchase Shares Upon Appointment",
        "terseLabel": "Stock options to be granted to purchase shares upon appointment (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsToBeGrantedToPurchaseSharesUponAppointment",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Life (In years)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Life [Abstract]",
        "terseLabel": "Weight Average Remaining Contractual Life (in years) - Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeAbstract",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Available For Grant",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant Roll Forward",
        "terseLabel": "Shares Available For Grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "gern_ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the maximum expiration term of options granted to employees having more than 10 % outstanding common stock.",
        "label": "Share Based Compensation By Share Based Payment Award Options Maximum Expiration Term For Options Granted To Optionees With Ownership Of More Than10 Percentage Of Common Stock",
        "terseLabel": "Maximum expiration term of stock options granted to employees having more than 10 % outstanding common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationByShareBasedPaymentAwardOptionsMaximumExpirationTermForOptionsGrantedToOptioneesWithOwnershipOfMoreThan10PercentageOfCommonStock",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "gern_ShareBasedCompensationForfeituresAndExpirationsInPeriodNet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled or that expired during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share Based Compensation Forfeitures And Expirations In Period Net",
        "terseLabel": "Stock options cancelled/forfeited/expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationForfeituresAndExpirationsInPeriodNet",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "gern_ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new shares of common stock issued during the period in connection with public offering.",
        "label": "Share Of Common Stock Issued During Period Shares New Issues Public Offering",
        "terseLabel": "Issuance of common stock in connection with public offering"
       }
      }
     },
     "localname": "ShareOfCommonStockIssuedDuringPeriodSharesNewIssuesPublicOffering",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "gern_SiliconValleyBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Silicon Valley Bank.",
        "label": "Silicon Valley Bank [Member]"
       }
      }
     },
     "localname": "SiliconValleyBankMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_StockPurchaseWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock purchase warrants.",
        "label": "Stock Purchase Warrants [Member]",
        "terseLabel": "Stock Purchase Warrants"
       }
      }
     },
     "localname": "StockPurchaseWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_SubsequentDirectorOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to the stock options to be granted by the entity subsequent to the grant upon first appointment to the Board of Directors.",
        "label": "Subsequent Director Option [Member]",
        "terseLabel": "Subsequent Director Option"
       }
      }
     },
     "localname": "SubsequentDirectorOptionMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TrancheAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche A [Member]",
        "label": "Tranche A [Member]",
        "terseLabel": "Tranche A [Member]"
       }
      }
     },
     "localname": "TrancheAMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TrancheBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche B [Member]",
        "label": "Tranche B [Member]",
        "terseLabel": "Tranche B [Member]"
       }
      }
     },
     "localname": "TrancheBMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TrancheCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche C [Member]",
        "label": "Tranche C [Member]",
        "terseLabel": "Tranche C [Member]"
       }
      }
     },
     "localname": "TrancheCMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TrancheFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche four.",
        "label": "Tranche Four [Member]"
       }
      }
     },
     "localname": "TrancheFourMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche one.",
        "label": "Tranche One [Member]"
       }
      }
     },
     "localname": "TrancheOneMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche three.",
        "label": "Tranche Three [Member]"
       }
      }
     },
     "localname": "TrancheThreeMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche two.",
        "label": "Tranche Two [Member]"
       }
      }
     },
     "localname": "TrancheTwoMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandAndEighteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 equity incentive plan.",
        "label": "Two Thousand And Eighteen Equity Incentive Plan [Member]",
        "terseLabel": "2018 Plan"
       }
      }
     },
     "localname": "TwoThousandAndEighteenEquityIncentivePlanMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandAndEighteenInducementAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and eighteen inducement award plan.",
        "label": "Two Thousand And Eighteen Inducement Award Plan [Member]",
        "terseLabel": "2018 Inducement Award Plan"
       }
      }
     },
     "localname": "TwoThousandAndEighteenInducementAwardPlanMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandTwentyPreFundedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Pre-funded warrants.",
        "label": "Two Thousand Twenty Pre Funded Warrants [Member]",
        "terseLabel": "2020 Pre-Funded Warrant"
       }
      }
     },
     "localname": "TwoThousandTwentyPreFundedWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Public Offering of Common Stock and Warrants.",
        "label": "Two Thousand Twenty Public Offering Of Common Stock And Warrants [Member]",
        "terseLabel": "2020 Public Offering of Common Stock and Warrants"
       }
      }
     },
     "localname": "TwoThousandTwentyPublicOfferingOfCommonStockAndWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandTwentyPurchaseWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty purchase warrants.",
        "label": "Two Thousand Twenty Purchase Warrants [Member]",
        "terseLabel": "2020 Purchase Warrants"
       }
      }
     },
     "localname": "TwoThousandTwentyPurchaseWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandTwentyStockPurchaseWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Twenty Stock Purchase Warrants [Member]",
        "label": "Two Thousand Twenty Stock Purchase Warrants [Member]",
        "terseLabel": "2020 Stock Purchase Warrant"
       }
      }
     },
     "localname": "TwoThousandTwentyStockPurchaseWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandTwentyThreeUnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2023 Underwritten Public Offering.",
        "label": "Two Thousand Twenty Three Underwritten Public Offering [Member]",
        "terseLabel": "2023 Underwritten Public Offering"
       }
      }
     },
     "localname": "TwoThousandTwentyThreeUnderwrittenPublicOfferingMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandTwentyTwoPreFundedWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 pre-funded warrant.",
        "label": "Two Thousand Twenty Two Pre Funded Warrant [Member]",
        "terseLabel": "2022 Pre-Funded Warrant"
       }
      }
     },
     "localname": "TwoThousandTwentyTwoPreFundedWarrantMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandTwentyTwoPurchaseWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty two purchase warrants.",
        "label": "Two Thousand Twenty Two Purchase Warrants [Member]",
        "terseLabel": "2022 Purchase Warrants"
       }
      }
     },
     "localname": "TwoThousandTwentyTwoPurchaseWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandTwentyTwoStockPurchaseWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Stock Purchase Warrants.",
        "label": "Two Thousand Twenty Two Stock Purchase Warrants [Member]",
        "terseLabel": "2022 Stock Purchase Warrants"
       }
      }
     },
     "localname": "TwoThousandTwentyTwoStockPurchaseWarrantsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_TwoThousandTwentyTwoUnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock. = 2022 Underwritten Public Offering [Member].",
        "label": "Two Thousand Twenty Two Underwritten Public Offering [Member]",
        "terseLabel": "2022 Underwritten Public Offering"
       }
      }
     },
     "localname": "TwoThousandTwentyTwoUnderwrittenPublicOfferingMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae, due in less than one year.",
        "label": "U S Government Sponsored Enterprises Debt Securities Due In Less Than One Year [Member]",
        "terseLabel": "Government-sponsored enterprise securities (due in less than one year)"
       }
      }
     },
     "localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesDueInLessThanOneYearMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae), due in one to two years.",
        "label": "U S Government Sponsored Enterprises Debt Securities Due In One To Two Years [Member]",
        "terseLabel": "Government-sponsored enterprise securities (due in one to two years)"
       }
      }
     },
     "localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesDueInOneToTwoYearsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_USTreasurySecuritiesDueInLessThanOneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Treasury Securities Due In less than one Year Member.",
        "label": "U S Treasury Securities Due In Less Than One Year [Member]",
        "terseLabel": "U.S. Treasury securities (due in less than one year)"
       }
      }
     },
     "localname": "USTreasurySecuritiesDueInLessThanOneYearMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_USTreasurySecuritiesDueInOneToTwoYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Treasury securities due in one to two years member.",
        "label": "U S Treasury Securities Due In One To Two Years [Member]",
        "terseLabel": "U.S. Treasury securities (due in one to two years)"
       }
      }
     },
     "localname": "USTreasurySecuritiesDueInOneToTwoYearsMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "gern_UnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwritten Public Offering [Member]",
        "label": "Underwritten Public Offering [Member]",
        "terseLabel": "Underwritten Public Offering"
       }
      }
     },
     "localname": "UnderwrittenPublicOfferingMember",
     "nsuri": "http://www.geron.com/20221231",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r193",
      "r194",
      "r291",
      "r319",
      "r533",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r278",
      "r342",
      "r486",
      "r497",
      "r530",
      "r531",
      "r548",
      "r552",
      "r562",
      "r610",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum",
        "verboseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r278",
      "r342",
      "r486",
      "r497",
      "r530",
      "r531",
      "r548",
      "r552",
      "r562",
      "r610",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]",
        "verboseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r278",
      "r334",
      "r342",
      "r372",
      "r373",
      "r374",
      "r462",
      "r486",
      "r497",
      "r530",
      "r531",
      "r548",
      "r552",
      "r562",
      "r604",
      "r610",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r278",
      "r334",
      "r342",
      "r372",
      "r373",
      "r374",
      "r462",
      "r486",
      "r497",
      "r530",
      "r531",
      "r548",
      "r552",
      "r562",
      "r604",
      "r610",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r193",
      "r194",
      "r291",
      "r319",
      "r534",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r343",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r209",
      "r343",
      "r576",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r209",
      "r343",
      "r576",
      "r577",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "ACCRUED LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r11",
      "r561"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Accretion and amortization on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional legal and accounting fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r66",
      "r161"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation and amortization",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r165",
      "r493",
      "r502",
      "r503"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r26",
      "r29",
      "r112",
      "r452",
      "r498",
      "r499",
      "r583",
      "r584",
      "r585",
      "r593",
      "r594",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Gain (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r378",
      "r379",
      "r380",
      "r593",
      "r594",
      "r595",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r99",
      "r100",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation for equity-based awards to employees and directors",
        "totalLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r79",
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "terseLabel": "Issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense included in operating expenses"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r310",
      "r438",
      "r546",
      "r547",
      "r590"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt issuance costs/debt discount",
        "totalLabel": "Amortization of Debt Issuance Costs and Discounts, Total"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potential dilutive securities excluded from diluted earnings (loss) per share calculation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r126",
      "r139",
      "r162",
      "r191",
      "r228",
      "r237",
      "r241",
      "r256",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r412",
      "r416",
      "r429",
      "r561",
      "r608",
      "r609",
      "r654"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r156",
      "r166",
      "r191",
      "r256",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r412",
      "r416",
      "r429",
      "r561",
      "r608",
      "r609",
      "r654"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which an asset could be incurred (settled) in a current transaction between willing parties.",
        "label": "Assets, Fair Value Adjustment",
        "terseLabel": "Change in fair value of equity investment, including foreign currency translation"
       }
      }
     },
     "localname": "AssetsFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total",
        "totalLabel": "Assets, Fair Value Disclosure, Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r247",
      "r263"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Abstract]",
        "terseLabel": "Marketable securities:"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r60",
      "r246",
      "r263",
      "r488"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Estimated Fair Value",
        "totalLabel": "Debt Securities, Available-for-Sale, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r59",
      "r263"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r59",
      "r159",
      "r263"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Noncurrent marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The method of determining the fair value of the equity interests of the acquirer, including the number of instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Fair Value Method",
        "terseLabel": "Business Combination Cost Of Acquired Entity Equity Interests Issued And Issuable Fair Value Method"
       }
      }
     },
     "localname": "BusinessCombinationCostOfAcquiredEntityEquityInterestsIssuedAndIssuableFairValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]",
        "terseLabel": "Included in cash and cash equivalents:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r46",
      "r158",
      "r532"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r47",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r40",
      "r46",
      "r48"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r40",
      "r120"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r578"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "CONSOLIDATED STATEMENTS OF CASH FLOWS DATA"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsData1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificate of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrants exercise price",
        "verboseLabel": "Warrants to purchase common stock, exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Warrants to purchase common stock, shares"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails",
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r85",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r408",
      "r409",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "LICENSE AGREEMENT"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureLicenseAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r22",
      "r131",
      "r144"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r69",
      "r272",
      "r273",
      "r526",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock, shares reserved for future issuance (in shares)",
        "verboseLabel": "Common stock reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r593",
      "r594",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYAUTHORIZEDCOMMONSTOCKDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balances (in shares)",
        "periodStartLabel": "Balances (in shares)",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r561"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value; 675,000,000 shares authorized; 390,262,524 and 323,731,591 shares issued and outstanding at December 31, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Significant components of deferred tax assets"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r30",
      "r172",
      "r174",
      "r180",
      "r489",
      "r494"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRisksTypesNoConcentrationPercentageAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risks, Types, No Concentration Percentage [Abstract]",
        "terseLabel": "Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRisksTypesNoConcentrationPercentageAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSCREDITRISKDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r111",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateNoteSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest).",
        "label": "Corporate Note Securities [Member]",
        "terseLabel": "Corporate notes"
       }
      }
     },
     "localname": "CorporateNoteSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r163"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Debt",
        "totalLabel": "Debt, Current, Total"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r77",
      "r190",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r304",
      "r311",
      "r312",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r127",
      "r128",
      "r137",
      "r195",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r439",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Percentage added to prime rate for debt instrument interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r128",
      "r137",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Principal amount outstanding under term loan"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateBasisForEffectiveRate": {
     "auth_ref": [
      "r18",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of any adjustments made to the stated rate to determine the effective rate.",
        "label": "Debt Instrument, Interest Rate, Basis for Effective Rate",
        "terseLabel": "Term loan interest rate description"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateBasisForEffectiveRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r18",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Minimum interest rate (as a percentage)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r167",
      "r543",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Term loan maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r21",
      "r195",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r439",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPaymentTerms": {
     "auth_ref": [
      "r19",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.",
        "label": "Debt Instrument, Payment Terms",
        "terseLabel": "Description of term loan payment terms"
       }
      }
     },
     "localname": "DebtInstrumentPaymentTerms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r21",
      "r80",
      "r81",
      "r82",
      "r83",
      "r121",
      "r122",
      "r124",
      "r136",
      "r195",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r294",
      "r300",
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r313",
      "r439",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r121",
      "r124",
      "r611"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Less: unamortized debt discount and issuance costs",
        "totalLabel": "Debt Instrument, Unamortized Discount, Total",
        "verboseLabel": "Debt discount under second amendment"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r123",
      "r300",
      "r316",
      "r544",
      "r545"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedLabel": "Less: unamortized debt discount and issuance costs",
        "totalLabel": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net, Total"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.",
        "label": "Debt Instrument, Unused Borrowing Capacity, Amount",
        "verboseLabel": "Available remaining loan principal under second amendment"
       }
      }
     },
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Debt Issuance Costs and Debt Discounts"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r253",
      "r267",
      "r542"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "12 Months or Greater - Estimated Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r253",
      "r267"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedLabel": "12 Months or Greater - Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r253",
      "r267",
      "r542"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less Than 12 Months - Estimated Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r253",
      "r267"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Less Than 12 Months - Gross Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities Available For Sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r251",
      "r264",
      "r542"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Total - Estimated Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r252",
      "r265"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Total - Gross Unrealized Losses",
        "totalLabel": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss, Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r250",
      "r542",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of cash equivalents and marketable securities with unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "verboseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r394"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r641"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Total net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r641"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r109",
      "r642"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r109",
      "r642"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r109",
      "r642"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r103",
      "r641"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "totalLabel": "Deferred Tax Liabilities, Net, Total"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r341"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Amortization related to 401(k) contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation [Abstract]",
        "terseLabel": "Depreciation [Abstract]"
       }
      }
     },
     "localname": "DepreciationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESUSEFULLIVESOFASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r44",
      "r64"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.",
        "label": "Depreciation, Depletion, and Amortization [Policy Text Block]",
        "terseLabel": "Depreciation and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortizationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r181",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r210",
      "r212",
      "r214",
      "r215",
      "r216",
      "r218",
      "r420",
      "r421",
      "r490",
      "r495",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net loss per share",
        "totalLabel": "Earnings Per Share, Basic, Total"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r181",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r212",
      "r214",
      "r215",
      "r216",
      "r218",
      "r420",
      "r421",
      "r490",
      "r495",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net loss per share",
        "totalLabel": "Earnings Per Share, Diluted, Total"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r51",
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r386"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Abstract]"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r192",
      "r386",
      "r403"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Tax at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r639",
      "r643"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r639",
      "r643"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r639",
      "r643"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r639",
      "r643"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income tax, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r639",
      "r643"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "terseLabel": "Federal and state tax credits",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESEFFECTIVEINCOMETAXRATEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits",
        "totalLabel": "Employee-related Liabilities, Current, Total"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Additional Disclosure [Abstract]",
        "terseLabel": "Additional disclosures"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAggregateDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation cost not yet recognized, net of estimated forfeitures (in dollars)",
        "totalLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount [Abstract]",
        "terseLabel": "Compensation cost related to unvested stock awards not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Period for recognition of compensation cost on weighted average basis"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "verboseLabel": "Employee stock purchase"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r79",
      "r154",
      "r176",
      "r177",
      "r178",
      "r196",
      "r197",
      "r198",
      "r200",
      "r206",
      "r208",
      "r219",
      "r257",
      "r322",
      "r378",
      "r379",
      "r380",
      "r400",
      "r401",
      "r419",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r452",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r496",
      "r601"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Change in fair value of equity investment",
        "totalLabel": "Equity Securities, FV-NI, Unrealized Gain (Loss), Total"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r63",
      "r138",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity investment"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r422",
      "r423",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r114",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r114",
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of cash equivalents, restricted cash and marketable securities by security type"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r302",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r423",
      "r459",
      "r460",
      "r461",
      "r544",
      "r545",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r422",
      "r423",
      "r424",
      "r425",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r302",
      "r335",
      "r340",
      "r423",
      "r459",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r302",
      "r335",
      "r340",
      "r423",
      "r460",
      "r544",
      "r545",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r302",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r423",
      "r461",
      "r544",
      "r545",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r302",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r459",
      "r460",
      "r461",
      "r544",
      "r545",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r426",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r117",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r248",
      "r249",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r266",
      "r268",
      "r269",
      "r313",
      "r320",
      "r418",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r542",
      "r598",
      "r599",
      "r600",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r45",
      "r648",
      "r649"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "terseLabel": "Gain (loss) related to foreign currency translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and computer equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedLabel": "Net gain on exchange and sales of equity investment"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainOnSaleOfInvestments": {
     "auth_ref": [
      "r586",
      "r587",
      "r590",
      "r662",
      "r664"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale.",
        "label": "Gain on Sale of Investments",
        "negatedLabel": "Gain on sales of available for sale securities"
       }
      }
     },
     "localname": "GainOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total",
        "verboseLabel": "General and administrative expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r270",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r192",
      "r387",
      "r392",
      "r398",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r175",
      "r384",
      "r385",
      "r392",
      "r393",
      "r397",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDepositOtherAssets": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.",
        "label": "Increase (Decrease) in Deposit Assets",
        "negatedLabel": "Deposit and other assets",
        "totalLabel": "Increase (Decrease) in Deposit Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInDepositOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits",
        "totalLabel": "Increase (Decrease) in Employee Related Liabilities, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "auth_ref": [
      "r185",
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "terseLabel": "Increase (decrease) in fair value of equity investment"
       }
      }
     },
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceClaimsMember": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A demand for payment of a policy benefit because of the occurrence of an insured event, such as the death or disability of the insured; the maturity of an endowment; the incurrence of hospital or medical bills; the destruction or damage of property and related deaths or injuries; defects in, liens on, or challenges to the title to real estate; or the occurrence of a surety loss; and the costs to process claims.",
        "label": "Insurance Claims [Member]",
        "terseLabel": "Insurance Claims"
       }
      }
     },
     "localname": "InsuranceClaimsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r123",
      "r133",
      "r179",
      "r227",
      "r437"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "totalLabel": "Interest Expense, Total"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r184",
      "r188",
      "r189"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Interest payable"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r130",
      "r145"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "negatedLabel": "Less: amount representing interest"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]",
        "terseLabel": "Investment Holdings [Line Items]",
        "verboseLabel": "Equity Investments [Line Item]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r151",
      "r153",
      "r516",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]",
        "terseLabel": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r34",
      "r226"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r149",
      "r511",
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Investment Owned, at Fair Value",
        "terseLabel": "Fair value of equity investment"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "auth_ref": [
      "r150",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance held at close of period in number of shares.",
        "label": "Investment Owned, Balance, Shares",
        "terseLabel": "Number of shares owned"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r514",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r504",
      "r505",
      "r506",
      "r508",
      "r509",
      "r510",
      "r512",
      "r513",
      "r514",
      "r517",
      "r518",
      "r520",
      "r521",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "terseLabel": "Stock-based compensation for services by non-employees",
        "verboseLabel": "Stock-based compensation for services by non-employees"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r449",
      "r560"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease Cost"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of lease costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee Lease Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee Lease Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Operating Lease, Percentage of Discount Rate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Undiscounted future non-cancellable lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToTerminate": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to terminate lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee, Operating Lease, Option to Terminate",
        "terseLabel": "Operating lease term, option to terminate lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToTerminate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease term, option to extend additional period"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, initial term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "OPERATING LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r15",
      "r191",
      "r256",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r413",
      "r416",
      "r417",
      "r429",
      "r540",
      "r608",
      "r654",
      "r655"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r129",
      "r142",
      "r561",
      "r592",
      "r602",
      "r647"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r157",
      "r191",
      "r256",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r413",
      "r416",
      "r417",
      "r429",
      "r561",
      "r608",
      "r654",
      "r655"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityBorrowingCapacityDescription": {
     "auth_ref": [
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the credit facility's borrowing capacity including discussion of how the borrowing capacity is determined (for example, borrowing capacity based on the amount of current assets).",
        "label": "Line of Credit Facility, Borrowing Capacity, Description",
        "terseLabel": "Expiration date to borrow under a tranche for a debt instrument, description"
       }
      }
     },
     "localname": "LineOfCreditFacilityBorrowingCapacityDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r13"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity under term loan"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation settlement, amount"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r128",
      "r140",
      "r301",
      "r317",
      "r544",
      "r545"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Carrying value of term loan, net",
        "totalLabel": "Long-Term Debt, Total"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "negatedLabel": "Less: current portion of debt",
        "terseLabel": "Less: current portion of debt",
        "totalLabel": "Long-Term Debt, Current Maturities, Total"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtDescription": {
     "auth_ref": [
      "r21",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of long-term debt arrangements, which are debt arrangements that originally require full repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer, and disclosures pertaining to the underlying arrangements, including repayment terms, conversion features, interest rates, restrictions on assets and activities, debt covenants, and other matters important to users of the financial statements. Types of long-term debt arrangements include borrowing under notes payable, bonds payable, debentures, term loans, and other contractual obligations for payment.",
        "label": "Long-Term Debt, Description",
        "terseLabel": "Description of maturity date terms for term loan"
       }
      }
     },
     "localname": "LongTermDebtDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r76",
      "r195",
      "r306"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails": {
       "order": 0.0,
       "parentTag": "gern_LongTermDebtGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r76",
      "r195",
      "r306"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails": {
       "order": 1.0,
       "parentTag": "gern_LongTermDebtGross",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Noncurrent debt",
        "totalLabel": "Noncurrent portion of debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTScheduleOfFutureMinimumPaymentsUnderTermLoanFacilityDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r73",
      "r74",
      "r274",
      "r275",
      "r276",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r73",
      "r74",
      "r274",
      "r275",
      "r276",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r73",
      "r74",
      "r274",
      "r275",
      "r276",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureCOMMITMENTSANDCONTINGENCIESSeverancePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencySettlementAgreementDate": {
     "auth_ref": [
      "r70",
      "r71",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective date of a duly executed litigation settlement agreement.",
        "label": "Loss Contingency, Settlement Agreement, Date",
        "terseLabel": "Settlement agreement date"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal securities"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r187"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r187"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r40",
      "r42",
      "r45"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r31",
      "r45",
      "r132",
      "r146",
      "r155",
      "r171",
      "r173",
      "r178",
      "r191",
      "r199",
      "r201",
      "r202",
      "r203",
      "r204",
      "r207",
      "r208",
      "r213",
      "r228",
      "r236",
      "r240",
      "r242",
      "r256",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r421",
      "r429",
      "r541",
      "r608"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NontradeReceivablesCurrent": {
     "auth_ref": [
      "r581"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Nontrade Receivables, Current",
        "terseLabel": "Interest and other receivables",
        "totalLabel": "Nontrade Receivables, Current, Total"
       }
      }
     },
     "localname": "NontradeReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r228",
      "r236",
      "r240",
      "r242",
      "r541"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r445",
      "r560"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Lease Liabilities, Payments Due"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r441"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating Lease, Liability",
        "totalLabel": "Operating Lease, Liability, Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESUNDISCOUNTEDFUTURENONCANCELLABLELEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r441"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r441"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Noncurrent operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r440"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating leases, right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r448",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating lease,remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards, expire beginning 2028 through 2041",
        "verboseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r0",
      "r50",
      "r56",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r168",
      "r169",
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "terseLabel": "Net unrealized loss on marketable securities",
        "totalLabel": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment",
        "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r168",
      "r170"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net unrealized loss on marketable securities",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_StatementSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income , net",
        "totalLabel": "Other Nonoperating Income (Expense), Total"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Settlement to be paid by insurers"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesLitigationSettlementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r4",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r4",
      "r561"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 3,000,000 shares authorized; no shares issued and outstanding at December 31, 2022 and 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuances of common stock from at market offerings, net of paid issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Proceeds from debt financing, net of paid debt issuance costs and debt discounts",
        "totalLabel": "Proceeds from Issuance of Long-Term Debt, Total"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r38",
      "r96"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuances of common stock from equity plans",
        "totalLabel": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised, Total"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
        "label": "Proceeds from Issuance or Sale of Equity",
        "terseLabel": "Net proceeds from public offering after deducting underwriting discount and other offering expenses",
        "totalLabel": "Proceeds from Issuance or Sale of Equity, Total"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOrSaleOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r58",
      "r182",
      "r183"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r36",
      "r58",
      "r182"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from sales of securities available for sale"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities": {
     "auth_ref": [
      "r588"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale of other assets recognized in investing activities.",
        "label": "Proceeds from Sale of Other Assets, Investing Activities",
        "terseLabel": "Proceeds from sales of equity investment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfOtherAssetsInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r38",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Cash received from exercise of stock options (in dollars)"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails",
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r155",
      "r171",
      "r173",
      "r186",
      "r191",
      "r199",
      "r207",
      "r208",
      "r228",
      "r236",
      "r240",
      "r242",
      "r256",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r411",
      "r414",
      "r415",
      "r421",
      "r429",
      "r491",
      "r541",
      "r557",
      "r558",
      "r585",
      "r608"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r68",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r65",
      "r160"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "terseLabel": "Property and equipment, gross",
        "totalLabel": "Property, Plant and Equipment, Gross, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r67",
      "r143",
      "r492",
      "r561"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment, stated at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives of assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESUSEFULLIVESOFASSETSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Realized investment gains (losses)",
        "totalLabel": "Realized Investment Gains (Losses), Total"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSEQUITYINVESTMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r46",
      "r48",
      "r158"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash and Investments [Abstract]",
        "terseLabel": "Restricted cash:"
       }
      }
     },
     "localname": "RestrictedCashAndInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedInvestmentsAtFairValue": {
     "auth_ref": [
      "r152",
      "r515",
      "r524",
      "r525"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate value of all restricted investments.",
        "label": "Restricted Investments, at Fair Value",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "RestrictedInvestmentsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r84",
      "r141",
      "r501",
      "r503",
      "r561"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r154",
      "r196",
      "r197",
      "r198",
      "r200",
      "r206",
      "r208",
      "r257",
      "r378",
      "r379",
      "r380",
      "r400",
      "r401",
      "r419",
      "r498",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r224",
      "r225",
      "r235",
      "r238",
      "r239",
      "r243",
      "r244",
      "r245",
      "r331",
      "r332",
      "r487"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "License fees and royalties"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r333",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r447",
      "r560"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails",
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Combined public offering price per share of pre-funded warrants and accompanying stock purchase warrants"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of accrued liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureACCRUEDLIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Schedule Of Available For Sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental schedule of non-cash operating and investing activities"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of significant components of the entity's deferred tax assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule reconciles the federal statutory tax rate to the effective income tax rate from continuing operations"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r94",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONEXPENSEFOREMPLOYEESANDDIRECTORSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of allocation of stock-based compensation expense related to share-based payment awards"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r422",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of financial instruments measured at fair value on recurring basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Future Minimum Payments Under Term Loan Facility"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r67"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosurePROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r88",
      "r89",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Schedule of aggregate stock option and award activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable": {
     "auth_ref": [
      "r95",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details pertaining to each transaction in which an entity acquires goods or services other than employee services in exchange for equity securities of the company, including the purpose of the transaction, identification and quantity of the securities issued, the accounting made, disclosure of amounts by which report lines were affected, and noncash effects on the statement of cash flows.",
        "label": "Schedule of Share-Based Goods and Nonemployee Services Transaction [Table]",
        "terseLabel": "Schedule Of Share Based Goods And Nonemployee Services Transaction [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedGoodsAndNonemployeeServicesTransactionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of assumptions used to estimate the fair value of employee stock purchases under the purchase plan"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of assumptions used to estimate the fair value of stock options granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r556",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the beginning and ending amounts of unrecognized tax benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation for employees and directors",
        "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "verboseLabel": "Vesting period of stock options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "negatedLabel": "Awards granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average estimated fair value of other than employee stock options granted (in dollars per share)",
        "verboseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r366"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of restricted stock that vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Assumptions used to estimate fair value of awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility range, maximum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility range, minimum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate range, maximum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate range, minimum (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]",
        "verboseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares of common stock authorized for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "periodEndLabel": "Balance at the end of the period (in shares)",
        "periodStartLabel": "Balance at the beginning of the period (in shares)",
        "terseLabel": "Stock options and awards available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Stock options exercisable at the end of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Stock options exercisable at the end of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r366"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total pretax intrinsic value of stock options exercised (in dollars)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Stock options cancelled/forfeited/expired (in shares)",
        "totalLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "negatedLabel": "Stock options granted (in shares)",
        "terseLabel": "Stock options granted (in shares)",
        "verboseLabel": "Stock options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average estimated fair value of employee stock options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The addition or reduction in the number of reserved shares that could potentially be issued under the option plan attributable to reasons other than grants, exercises, forfeitures, and expirations during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Other Increases (Decreases) in Period",
        "terseLabel": "Common stock, increase in option reserves (in shares)",
        "verboseLabel": "Common stock, increase in shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Balance at the end of the period (in dollars)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at the end of the period (in shares)",
        "periodStartLabel": "Balance at the beginning of the period (in shares)",
        "terseLabel": "Stock options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares - Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at the end of the period (in dollars per share)",
        "periodStartLabel": "Balance at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price Per Share - Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Stock options fully vested and expected to vest at the end of the period (in dollars)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Stock options fully vested and expected to vest at the end of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Stock options fully vested and expected to vest at the end of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYParentheticalDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPERFORMANCEBASEDSTOCKOPTIONSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Stock options exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Stock options cancelled/forfeited/expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Stock options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r350",
      "r369",
      "r370",
      "r371",
      "r372",
      "r375",
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by supplier.",
        "label": "Supplier [Axis]",
        "terseLabel": "Supplier"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Goods and Nonemployee Services Transaction [Line Items]",
        "verboseLabel": "Stock-Based Compensation to Service Providers"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.",
        "label": "Supplier [Domain]",
        "terseLabel": "Supplier"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSTOCKBASEDCOMPENSATIONTOSERVICEPROVIDERSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Closing stock price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration term of stock options from date of grant"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term range"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Stock options exercisable at the end of the period (in dollars)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Stock options exercisable at the end of the period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance at the end of the period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Stock options fully vested and expected to vest at the end of the period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "verboseLabel": "Percentage applied to common stock market value in calculating purchase price under purchase plan"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r86",
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Combined public offering price per share of common stock and accompanying stock purchase warrants"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESOPERATINGLOSSCARRYFORWARDSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r24",
      "r79",
      "r154",
      "r176",
      "r177",
      "r178",
      "r196",
      "r197",
      "r198",
      "r200",
      "r206",
      "r208",
      "r219",
      "r257",
      "r322",
      "r378",
      "r379",
      "r380",
      "r400",
      "r401",
      "r419",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r452",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r219",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Stock options and warrants excluded from diluted net loss per share calculation due to net loss position",
        "verboseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail1",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEMPLOYEESTOCKPURCHASEPLANDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPRICINGMODELASSUMPTIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Stock-based compensation related to issuance of common stock and options in exchange for services (in shares)",
        "verboseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r4",
      "r5",
      "r79",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock in connection with at market offering, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r4",
      "r5",
      "r79",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuances of common stock under equity plans (in shares)",
        "totalLabel": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture, Total"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r4",
      "r5",
      "r79",
      "r84",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Stock options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYEQUITYPLANSSCHEDULEOFAGGREGATESTOCKOPTIONANDAWARDACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "terseLabel": "Stock-based compensation related to issuance of common stock and options in exchange for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r4",
      "r5",
      "r79",
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with at market offering, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r4",
      "r5",
      "r84",
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuances of common stock under equity plans",
        "totalLabel": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture, Total"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r57",
      "r561",
      "r592",
      "r602",
      "r647"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balances",
        "periodStartLabel": "Balances",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Gain (Loss)"
       }
      }
     },
     "localname": "StockholdersEquityPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r436",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r436",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r436",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r436",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r453",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureStockholdersEquityWarrantExercisesDetails",
      "http://www.geron.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNETLOSSPERSHAREDetail",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYCOMMONSTOCKRESERVEDFORFUTUREISSUANCEDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYPUBLICOFFERINGDetails",
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental operating and investing activities:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/DisclosureConsolidatedStatementsOfCashFlowsDataSupplementalInvestingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r107"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Tax Credit Carryforward [Line Items]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Tax Credit Carryforward [Table]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESTAXCREDITCARRYFORWARDSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r248",
      "r249",
      "r313",
      "r320",
      "r418",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r598",
      "r599",
      "r600",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITIESWITHUNREALIZEDLOSSESDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSSECURITYTYPEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureLICENSEAGREEMENTSDetails",
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureSTOCKHOLDERSEQUITYSALESAGREEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember": {
     "auth_ref": [
      "r612",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae).",
        "label": "US Government-sponsored Enterprises Debt Securities [Member]",
        "terseLabel": "Government-sponsored enterprise securities"
       }
      }
     },
     "localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryNotesSecuritiesMember": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one to ten years, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "US Treasury Notes Securities [Member]",
        "terseLabel": "U.S. Treasury securities"
       }
      }
     },
     "localname": "USTreasuryNotesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureFAIRVALUEMEASUREMENTSRECURRINGBASISDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized debt discount and issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r383",
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at the end of the period",
        "periodStartLabel": "Balance at the beginning of the period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedLabel": "Decrease related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits, if recognized would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r53",
      "r54",
      "r55",
      "r220",
      "r221",
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureORGANIZATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Valuation Allowance [Abstract]",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase (decrease) in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureINCOMETAXESDEFERREDTAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r446",
      "r560"
     ],
     "calculation": {
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureOPERATINGLEASESCOMPONENTSOFLEASECOSTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/Role_DisclosureDEBTAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r211",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in computing diluted net loss per share",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r210",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in computing basic net loss per share",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.geron.com/20221231/taxonomy/role/StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB Topic 5.W)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12.6(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org/topic&trid=5833765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Footnote 11(c)))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r566": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r567": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r568": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r569": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r571": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r572": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r573": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r574": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r575": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21459-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5444-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>93
<FILENAME>0000950170-23-008437-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-008437-xbrl.zip
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M+MXZL_QCU(".DJ1,/9%&@(D+DA'':(HE]4R)P5*5-6Q(?I<?=X^/Y^+ :7+
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M2 [^58YLL%'O<\1AO@AM7SE*RYM<]I-Z] ?0+$E'SDN:P9!YQ8E,<&,+_(8
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MQG_P/Z(_B_4ZNV'R]!NWQ<Y(V5:R[K5D?:@FHR[;,KFP7X21:]MS168K"P]
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ME'?ST2]5H!2O8/1]B6(W ]L\Y"W^;[,2OBDKX>C^)R7\^S8GX8&1ASONESR
M93Q%'M3']&6_\M6D/:_)P<<V[-]O\O!R-OI3-:J+/@?%7MA/<3K:$H@M@=C:
M@ U?Z=X&;%L9G[(!Y?V&^%?PX(+1O@4F>_;W8F]Z !-UO 7T^PKH<MNJYCL
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ME,P5K1NEKJ)M^2X1LWTPGHTW".ZPW].M9HH_PXZ B<K(K?M=W?2/:5\2!6R
M(!LX!DYPW+GCU8&? AH@_^]C'-5HA 3[Y'UF.8%]UN_R&-+6J1Z@3&YQX.[R
M %&1T4$]49GB5(K::MGKB<;-W-JYSKFPCR7??;UK7QC>);0@J"R<W2YOHT]W
M&Q]O,S(&(PU;#1R:UWM^=?F*(O:UZ<>KIB^-VXZ3S^J;>B8]MZ;P[WC2;R^<
M*L?OO-Z4)ETI7(4)OR==0^8/6?"$S@J?E#=?F)^+SODBSC;NLL$PWPP1(4R;
M9E$2OR@OF^'$>5[^2MGZ?(L82/Z6S@]&H+<@<A<@\OY$^ZIQMY?4*6Y?C[;@
MSDMPTO11Z445:4Q]TG^8[3J>7(J6?Q8_[W<?X>,9<U_)3Y_5]*%?/T_7_.KC
MNY+ ?M.R<P] 9[ ;T:QJIUW.GMW2]>')W%;/[Z:?VGE=7O:QRU<7%4MQYK'W
M666=EBVE1"_E4<\#ZJ>:"F&2PM',=&/\K$M>/R>U'7Y"&H _=EUCILVL<!4;
MFM0-J-_I?D7]=[J-;RP^#E.@(MW&?A6+49K^!2-Q72A@]X_?^YM>FA)P8=G-
M/ERW5'>S7&_>E_&?-XN(AWW"VBQ<T4P/)RN\9C$WBS&OPN0210O[;M8FIR-?
MI_+QYHEZX[,%-]L0Y?#T;HMU=QN:.'%L9F'"Y89<RP6+F \[PI9(T[[H W0)
M0X8-N UAT:)IR>/I.S:=N$;N -.L.MX"5W50TO=*+-H -YOG;EWZF%G[@Y,W
M T3P3>WBXWEE2M=W 7L=].1IELUP)MRZJ&)N%YEBB]X?H>^$=MH9/(7S5XJ"
M+IR[4W4T*6Y!:"@*L06A.P*A96V=Z^F)EW*FRT#G(P$0['<M(Q=M9KHVHU/,
MM*R['NBXR]*W=&DG9)$UVC<L75;IKI](OZV)YVAT49D.3Y;\K8N3+XNC:LD9
M.[GO,Q@VJ'JGZ1?5SYTT75GDDJXPE6],7^S[PF^3*C9'^K>(<V='/6 ,I>U2
MLD&'3J*>71PFQ;9OP)"^H)*W?1QW%DO%0/)TTC420X_D_[+WI<UM&UF[?Z4K
M[W6*SI PP4U;Y:U2;"?1C&6K+&5ROTV!0)/$& 08+)*9#_>WWW-.=V/AHI44
M0>FD9A); AJ]/'WVY<:)L8?#HO74BYT;+[H)$UWG"*\[ZEHBB&#OM(%G3O+/
M)_S)Z3B6QM6*(92_PX>Q;:1XKRNRGH6N18^;WRA9Y!+&@96)?X/>)>?B%R?\
M1D]=_ON7PH6DK<CELF'E*/51II8"I,*D%0&YPF*6NI14+L3 [HQC9UJV'*43
M./SQQ*0UE5*85JBR.?E:TF25;ISKKZ4"8UJ--F'P1N5M5O3&-9;KW)M>Z)6%
M?1S-8^8=DAX7"L^2=P#]ZX)";E9%IRO2CI4D:-?R*J&>,>P7 N.J:KNX\<I*
MZ,288I!$46A*:F-)Z1"D0_$GU=*@6E^ZOI>*LX>O%L6,;R92G9LJO'N#_!!H
MB\DW6PE8X\\W(%?3<YUDTC35FT%&U_D)SK4#LG'!Z)96H6".+RWBN51T@QPO
M6 (PA@T?8PZ'KG>.N5YPM%&BF1K %UT>0X S3B _ZD15=QL'T1!K[9K$_B2(
MZ+;=FC_/Z6W;(:?=YTAO8VGCZ4=U#1="W>#CB>_!OM9(_G@-<H<JX&%88"'3
MC\C1FQ?Q*/$^31A7>F^U^92\4&3N=74^'!)-K-^&>6JD*@5247[DBWZJ:EOK
M<BGTK XP->5#2LTCUFHN)?-'["#K6JXAWZSXKDP?@.HP@0^"B:<$H44S[4-S
MM\0J:Y::'&EXIK0]L,J0N#'VL<I3]Z@L:>RJ3'"R4:. 0;XSV$&)F=,AVJ]P
MFL!-I!-CA9?0JVJ&"^9K8LF%WB6B>(5L IHIU6)_?)[;O8/IQ5='\<05%?]U
M65F,)]*O9^'(N8Z*#@W:7X'("S)34IT*;'[W534PJI\YB0(LM(O;A^&(^J2+
M631+<0WZ2S$29?A!,C$BC:[97[6^Y7IKF0[4\:)SP%5=SJ(^#.XU*=A_ZH H
MRH>.9<6N!@HPA3E0*I]I#H-*AQB!$*_U[A+-!'KE2NW]Q*8/)CBZ:&.3!V&1
M0E,N]Z'RL<L?5PF+^O-Z)B.M[&#EPD1*HG>*P["AK"Z8XGN\J^RC .4;$K5@
M]X>I]'(!#?^* US[>$'S1BO&X7:'Q3NOQ5<$6%(7 5\78L=.9F@J4"Y$)2>@
MI6%!FN K6A>X\!7=5=5N]$>9O'I5G3O"NX,A@,2&AUAL,G2PS9Z##K81Z(-D
M <02(5HW3(JF46[@X U7?O; N4DR7^M>R02T*R7?PS"Q?ZVXMWF&;'-)\??F
M@N):\J^;GFS%HXNE*\NV:L^9.F.T>'L8P)BJ1EX+?2;SW@A.2M_#4 02)2H%
M0?)PH3N5JS6=#U:ML#  Y[M%-EC2YZ3V2Y)FU<R-KNB4#.9*V<3SH!)>69R8
M<INDQ9I35<F<?FS*)C#1J\L%9**WPU8%QEP!ER@ 32+( S/108.!0V6AI-0%
M<H:4RU76K5)'-T,#YY9 P<>,$6.A U?ZE+EI+&6D,CAI'G^=IY1D,Q@HO_KH
M_F^J6- IQBR2YX:* R_+2T!;J]2*\[9J SF^YCNII%L)*?9'V@I07-@\!F@N
MDGF".*7:;4[JZ!L:Z4:_=UY1:K(9P]]U"RB0'- C2@9B=3U+-=R,P.":+F N
MIT?5!S=\5W=2.HQZS"I/5)@SRF21]Y59+_4Y*87TEEDBQ43<UCJC6;81TA=S
MRX*N2X3Q*QLN:7LW6FK2&G*K?4C?.X'JXJC"?$['XQCMN%*<JVB9?SM!1F3W
M<Q2:[KJGH) &5 WR$G7(9$.].O?G1+9\_7Y5ZN,L,K%JYHQTU)23'Y(.:;HV
MAT0Z?=[6J]*N<R(#2CP.BW-TS#EB@4^8$UGGX%[K)F%47$1@V,?].SXWB_QI
MZOELVEYCV\)2V)*>)S+J6^?5-,VAT6RH7S(O2 <E[Y%V6H*TKZL$*F,)FA=B
MJ?HCEFTJ_3?4Y!O+G%)APL+':0D=2N@Z2M!8_VBQ2HSD\C VRE.:0/DITR6T
MV.4L#)2'%R437#SF0NGYE;M.5]S'.@!->T:6OV(BOE00&2I,$6PV'ATUWS96
M#CH/'6%0ZF\ZE&;^*LD-^&.*J6:4YF$ZC.=GN(E]QH533ALNOEG>'MASFG*A
MD14[%>H&],@0$EP#EK75:1C% JK;;<:SQ*\Z$K(L;\)B8;)A#D><'OPEN3^F
M@/^%Z+4*JNOSJ15[!/<W)B65LOU'L! 4-_,NF&=Y'\S. QJJ;Z1'-(>[Y:2V
M]^APMQVUYS8[+WP/YQBG__'W702Y./VZ*A9D[]9Q)<XV<CT'FQ&#""%&PMYW
MC)Q=?3P7MB7PGU_^N#S[_/'R<C.T<&^$SNVJ :#6H?SPY1I=P/*&]_;A>ZO>
MQTD>8Q">[Z[=[4O5SWPCF[R5/5Z_85O WH__8P_:)QM2(O<&<L_C57$$.DI:
MJ@#[T(]FZ)B .64J']K5UYZ<E5J]Q*[V4M=^I]#FW.6+E;(P#445S9!A[.NV
MBUB*AN3FO$<%_(324W"0B02)FY([L6@$;K)#=7.49Z9('M()*'Z<X(&WE.<Z
ME4$TA3E5>TZ4,SYA1:$JMO,Y&LI 7,28K'WCATJT=WTC=SNE[A9YB2XG2'6F
M"^6\!',56XVU,G7Z.L7()AA]F^QAS&H-;Q,3EWTG+BJ4S/%*R7%+):N3#3:"
M)M/,/QU0CN.YZ+0[W:9R]J":++VBB0^<40M-\'F\1QXTLM!\NUIJ1Z6AJ:3%
MJ50]U4"W1Q8-5,Z;1;XJ<G$(VRN_P8-.F(PRLHP@=C#JAF@,-3>B@ _Q3<[1
M QV%WN(@G=X]1FF6^B4A0<("/<$<^VBD&)WO4CY'.12VX5O2:HJ+'X/T!(ZZ
M;=-Y  PG;Y591B\87IM*!RDC%BT=RE".?!4[5#H[M-1G"28MNG(8Y=83C.1K
MWC*']=_)NZ&;<R'77#3$>$/IF?+FIJ)2' '=IPW,ANE\)BNUS8HN2)-(#8.9
MGKJE7QP-$4TY( A*7R]+?Z<&)<LOF-AE\X+Y^\E"UR4\!QH#MFBN_F;\<Y4#
M'68Q9F0I*Y$9@1@:;):*W+KE:CBN&\4FB1=WYJS2VOTBCL9A1)?F$A[$YR[)
M84JS/[NXO&0^Q7R*^=0/__L+=<O6[HQE+D$^2V(1"^RAR.K#ZB.57W:(]6 ^
MMZH6-,0FG Y-[ /V63J=S0+-$NDZ?OYPVC37&'O8F58.%C UK!OI>RUD:)IM
ME$K JZ*P)N5]8=3STU,RH7_,L)J2&50Q'!"(@Q%Q&AS7Y$-DR4**'4G$'L9G
M5DG<$N=5-9P^X]P32DR<I3J[' WMNHS;+<7QEY/DAO-\._"3AOSG56]O) 5H
MN*IN=BDWI%2H)7"R4/E_JDNJ3K^RW2KT(W)=TCI4E@@J&^4-ZY&HH;9U\>NQ
M1,N(*6JE4_KU48S0!T?U;#RS/#4(X.0<$_UI8:=CX/"J3L3'\U,3)IMBI#QM
MV7?3-=#N"6#_Z83\#"KI7F_IXJ2,F^1Q>Z/Q4]X9/7N*8M5;4F>JQ$1ZWXGT
MGQC3'E 9_!S,#Z35BQ2ZE'2M*NLC&=>_7:S@^3+[;"*QP![7H$%$0*(E_D65
M@,%%ELJB ,1D6C&S4*H=?4.;1;1/&0N[P+"!/]*A.KAUQIZ3"A1 M5<T C*'
M,Q0N'$("I 3[G%#A#PHIH)(CPRBD\(48Q&#5"!!!)H9!%'GTGJD41BQ/^<.3
M;#R6)-[GA7F48:8UC3Q_1*8;G;4]IU(K!:[@?$HY]QA7J-X4]*;1875Q07]$
MWMJ4#J)<_A#A5Q0.RKE<?IBJ%+0NTKK>['5JY'N*A SS!&Z*?:[0Z*9).=")
MZ0M%;0QS+]"$,2!8J0PUV3OF45CX1G"XT0W5A@G'$1G JL7DC_?64KWL2]LT
M^=]03&B;8T(Y)K2^>_[#_Q8%P)PU9K1;*FL1J:%>54#8DRR^]J^QI@B0KR^7
MQ*ZUME4QN345MRH(KH^\!#E1V1!DB5S+(UZ/8CDQ@E*\$]))]69>\Q&[ZJ2B
MX0'AG+P5JIA+V0[5++20O(8MS _>=8(YLOL13;Y<Y9O\";EZ@9)SLRARXH>4
MTJ)?7GRR#ZN0JAZ'\CBH)W6(',VUY<548HNT+=*RBI2RO&"8RG)1JUFWZ,24
MD1MA2=Z\J<BJC6OJ@E[*:&>*WJKB88'$0F YKR3U+5'5SHH34QN(A<\XHKXF
M-YFIYXZH9U[_7Y-/&U7VH1]JT7.)E"I'*"D_52-Q\_Y*"9%8$%OA,N(X^/G[
MT-02V4+[B/ZQN,&$XRA1%OM3(-<!TBZ;S-Q\OVN"-;[?N[K?.B=]N1SJ&LL#
MB@Z;:MFA<]?OZ!*2:WPP#U5<U<PH@>W+39I8"6PF0RV;=#>;=_.:K("[V8P7
M$"!W5M@X2JVZ/DAT-ZLTL?IN?TVQR!;I^Q/S GW8*HHJKHRQS#+0QE\Q7. *
M5%NLREG L>S3(O-BJ9 DJI4W4;F0]+$0#?OM:O/=*I]<*;2@92)%4*-#ZFZ*
M?RX9#B<1"&N4XZ-KI'A2E_/N_R7<";"2*(G0YNH,U7Y2Y4XG2"+Q+8QN0E3+
M0_I@T.C_]59Q&!QUP9I-5FB0-;&^RRK3=BAD/,?"XJ#4XW, #']JTMF<L41%
M'QUBEZ<FBJ6Z)[-H9A(42=DN6__?JA"+1N<!FWD;ST53!>69&_/PQ$E6V//]
MI&K.?U'A%IP^=/\-[>];^M +H= 51UCIRM^+@"AKW5L5]8<$V]#V*)ZA^<K#
M.(X2<:_6K<4Q_IF!,MUIV_W55$>W$EC].^5X_R!=.1T"-<%1"C/AQ_.[9[/X
M]L+T;IL133V@$,KVVNE1!,07(&WJ QV;3*%CQT?5H"A,K>+2PDB7#?ODPZ5.
M3#C(J7KLPDDG-XX*>#C[='K1S.,Q0/^ T?X%SWN1BEO[P_H7G5S1@ +K9?LS
M1<?#_%L1)E F"65(+L2<&N:S&,/RNLCS:Q)J7P[!?.X,)$P(:?U&\4KG?B"3
M- IEZX-R,?RF&G*\+R**+@)'NU$*V;B^YU-3L+(&]I V<FLB"I?#V!"51=PD
M)=L7K814%*7JSUN*VUS;V)$2?X+KPAE(D8.FIFV"@?O+\8R8AAUBYC^Q5!G'
M*)5@A 66O, H'!TR2&.9<MI4VF 4%;$=R%W+47RX[SJ2KUIY4_]0K66B]D<[
M![46ZK@3C'LQ3#TOPU]LS-3<>=@7*BD!>@Z*0BJ^D[I%E2(\=44$8Q^DF-92
MC!5*+3K\48<%E9_^^ ?&2*I062HG07O@4&VNO!D4+K:Z=MA4I_#>FNW+9WLL
M9#C!0!8E<;Q#9R><X##PDXENCZ$RV_)6[%3S5!<6H]#=&<D0SLI>4WJ3L>_!
MR">WJ&I?3.56\I812V!LPJS&SEAU*BI'\U:[#"HIZETL_>D0 :?$5+UF/![=
M1J*RR[H>!47IP&?#<8M2<%2IU%(;:G.<@&.I-M>IM)7'2" T*"<F2"QNYKV^
MJ.T#1CT%N3BGFSM,<[\0#$4G1G4X0AF4-[-4'M:AKF9KMZ!<AA7DS8#Z79C0
MVJ7HOX68O[S!(A5T*TK$2RR$8QI[4/*,',]S_"S=H,7NL3E\J]*^"I)=B#/P
M54I&@*BCJ%V5_QC[!I$8U84N ?*4&P]:H8HDRKK>;2O!?+2&:AG"MRCA%_NZ
M3! IQV5-7.!-.2A.:@^D+%.7&:BL!N@1G6H68G.817J("3IYB+-Z/EF1!%:-
M:_X_7:LMAGX0J$#VD0[L6U@ 7 2\8@2XZNNVU3&OW[+,6P<X- /LCUK >@'K
M!<^D%_R:%][[*A.@<^[]JKLQ^%C.?U116.*:N3FK:S?1XM31]=6\)>I]T+5L
ME%T#;0A3_2VIX0R**<#^D>@7W:J L]$OB=/K0#<5;1Z:ORK615RZ*)MOB2]%
MPK'=;A9)QUI20F$]5"4#;N 56(Z892!\NE@L3,9::!X<-MOM@^9!S[ZM,I]*
M_<+MQY88,+)NZDG5K>$*JNB!/@S5QO_?,E3>ZI-2OY9'5";/4*9J5ZKM<2E(
M/I\]%8^H[G['[EI=L_M-[0WQ9+F?:[XA^ //3UQ 8UINGV:&SUOWS!R?,J8R
M77Y??L=,7Q+7YZ8UW.(\BRZG1F)<N]ZS(KJ^J5[/3U4=:FYQ/">)_JATU#J9
M0U<+_S_](Y =%K!WQ]16=6KE;"JFJ,^1\DJT0=,XK6RAUH9& ]/%6$7GYB7U
MQXY..B_U"E;7J]#=%TP1)7,!43%25E12U8+!8-%!?FMF8IY_>TL7Z+(^\L0D
MUP6U2)F!BD:(VV(RU<;;:^FRZE_BJG!-[*H,W[N5\?C56AGE'J6WT*J\D[1I
MP)93/KW39DP<[E<YC,O%.'0?E"3#0@^DZ98;/,&'_TMAX"4@5LP*9:^/3CPE
M$%*E][_@0^1WIVS4ODD&4WLGRWE=.LOWD3G":W*!G[VY_*JNV]S[G7N_O[3>
M[ZQ7LE'C>8P:7U0D!=7G*,>0TB73=>X_HMZ14.IP?<^BIL!D\7PCH:5K GZ2
MO)37<KC.[3D">5X \+=%\WW)KW%6_*I9HO[E6W/JTN?LH\-N<VU@DBI7#VN]
MEG/#<&5QK<P4S"MRJ7P<9JZ'8BX=K*^NK OX#5T((-<NT(J!Y@*?6L13#3!J
M.T[BZNI7EK2%QPF$*XNOE(8B1DQF@_(>K=^*?#KDLROM1@;?"%9.HFNS 8$I
MU#8I5%'^J* %N:/OCQ#A^:6$;BW1X8\;']^_%9\C2]@]^UT'S97WHQ5V1U]Z
M*BBR>%F:*B.9)%XL&0)B,C5'73,R15YFP0BOHFJ6 O*KMS>^/H[0WNR&#CA"
M>R?[3GWY9I1E$8-@4JGRK*R03Z8NCY0#=,VS^TH!RT7U-BH&E&:S7@A8FD-W
MP.HSJ\_/I#Y?.&D>_*7^+*YD/ 65.<48,4[&9'ETN^4!B93Z( 2"RI@KL#G3
MF&EX$A4V=>_4#U4+.VQ] $)CA'2SBW&+*#^6JBNORI1!!D#6V8*LJ[!53(_$
M1E]F/N;K]*4%NS-:T2F4T=3*2T',V)^PLSH#F>_UOM_KBM5)![(LWY:EBZP:
MD"1:."HEPG7ZA8L&KN D4F[$(@M0#13CVI1)S7B:X<K+[S.?_#TZ# 0IA07B
MJ)%0B:P0JS.^23*+78!H*S%/9B93/]<^RSSR*T;9ZW*9A1&M)QH.\-,I)G)[
M;W,GS>].ZDY:?SK?IPX]W53=K4MY<"N%VF;9*:F^C1G.:JL2Y;Q"UTTX;R[7
M\"IZNM Z2Z_#YZ2OHG;N.!U:P!W[/C+VR)+IBRDA4T*FA&6+VT/H(%(LRB*X
MQ(KLA@KV-D(%/\-G](@@,F$JB_HKQ?.IU*9157771.\]6O3"E+)\OH0R#P32
M4A*,1&U[*\/-[Q[,T"T)Y^XCV<*9KZ1UVJS@B,ML-@O(<8TA A=%9_+W( "J
MDK^JW<?EQ?LF2H53C*;1H37%5-[#%%W@-&1]^%I8(] 0T1L<H2'B*"?@^5LP
M9NGA>]-QG;K35+4;OSL8A-&\)V5EMP 3J2T2J2N*]2FZ)VM%2T>'8547?;UT
M;^FAZ9=0!)#18-_S+"_S M[P%".'5)=C]P0KL21P?0+R$8* 8BXO:%?8>0H+
MN 28VY:I9CBHT<W5R]X)^@+<V!^JSY:'%+]2M$^2/YFW8C:-F$_O;,3<VE '
MYM=TR=CN=K\+EE?@/Q:7%$.)3$I\U5V?9'VWFG&W#[B[O[U7(U&G3%^5&W""
MV$-M&CX4Y<WJ>Q0UQ24+'0^U$4TR-(@,(V_>-'U"8"$WZ4079L!<[-#1 =HI
M&68355Z=ZO)1-Q'/5P8<2_P>W6"'C*:81DFJ6Y1@ME,48D\/;1/!QSUJG^M/
MJ511F)'&0A^@^"H5  VR0O$;\XU$%8@C\5_W@])72@0R'*<32Y3N&%73,P8D
M4JRP5%_T?0Y23!1F;B"!#3BN[Y&:\>'S*>[:7QD%I >12Y_0;7/(,H;QYZ:Z
M'V:R@>0VQ[AI#,&>:4GJ&D.19XF*C-8!%5@]044%J_BP5(YC'2-,TELQI@G!
MQX-RC' '^Z@DJZ.31(QE*%/J-X)5\S%D2Q$.;'@BJ06,*EM0G(TG=;7Y--\9
MD"1C.%A+?$0M,%-OI[B:9!+[X3></8R R12Z&26^H+=8%\2%_=75 IKY-(U9
MRT,]=HA]7*)92BU\T D+]R]1,S*)_ DL)G$E9VXQL=NJAE5BM C;T$FSF'!-
MI$RE389_SZ<ZX,!<W*1T953_)=WF 4 ^5<DI^B914F9& U5H8JEF".I!BB2J
M;V0)ECO!3PE_.H51J&*.5Z[YH2GR1#I!B;+A,F!M6!=4T32\F%@[%4NA8D&6
M/,-C%H4XW6.\J:LHWE>D>#"O64 6&T5ZACZ2.N/ T^O7=QY(&TQS3O&PV1"K
M5RA7'NX+MO6F:JI -F8I3M(TC#(C.YZ'NY_,I$L".!#<@M[J#Q:TD$BN2JM%
M2U"E!?F(FH[-88>#:$QU4DTG0*JD[]PXL:>V\D,,8WS$))>AA(G^;HE? @#P
M,(OA;-X[<12(/RWQ6RQ]3Z>&_!,+T%[^#1S,^4;F(EB_^$W&U,0J")QA1)5D
MM"F)PFXQ&]=TWYI$-V6"3DQ(\P;%L%2X<05718LP)H1,")^/$"IQ1=,M.1W&
M\RB$>UFJL-PL6LQ1$I(S\[TJA5/43%.LI"I$6N*#&AO?#92U/<'R>$2WE.PY
MDBEFZI6*.NL8>DHNG421URRWT"/QCQ+@E!FJD#2;Y:MDQ$', /!(OH%/N#$6
M'D[,@E$"A:_#/JI ?2W=TGIT76=J0PV\(L3K;=+XHBRE-PO:KEKKX>?'65J9
MKHO2M::+OLI;S&:%_.J'RSW]T&T8DK!<= ?$<PU&2@BT3XS@7&T92 %ZU%A<
M#Q3@UIC40\WRU-FI,EIY_2Y+G)HV43B7N2JWM#"M*0X@%\\"LRN+Y90/(!<R
M%8=8X(J:D^(TUG=!9(,@&V9J8)AYC_IO7-_MKRD6F2T_DBTO,(@I9C&GV32*
MEXCR G<V]?H4(;Z]NRP^7W28+>DE5.Y2?Z]D"J*L=JF+3);F*[_/](^+K+L1
M;C[RHR&R%*H61PR]4O/FJ/V&FM7ZT2Q!:P&VZ@Z53N6(81PY'D@;X5@6DH)+
M]Q +"&&J>!2VBA8[:>;IJ@]:U2CI+CA+-)HHS4 YJ%4VNX_;XV6NWC"]%+7K
M6HY1&X/[H K3@$A"7)#D ]TT%Q4-ZJY<?,^+,(L^@F6GR+B%ZC_HE$=5^^.B
MHI.? \HA,)[C-75MD"15M<%S2)C3*QT R0J)/K%<A,AM3PL"D>E?K#$S+1H7
MN0[@'ZU2H-:\J/ ASNFY_X8><$[/3O:=1/H "_M7)6"QJH7[O>@",!)COU6&
MBIR#&'H-Y-!/<_I1,(-5&HGCJNHH^ ,L35&8K+11V[G&OFBYO9?,2TKFQS:P
M+,FS)+]MR>E,-2TQH<*_EWJSGY=ZLQ_#@\#SD?\IP5Z\1YA^0)C6]V!JBE*6
M\1^2;%,AY+K'#LEA!8A-$#E@.$UC;: CP1EC.TT7%E4ZC< [U+VM_93>)3YB
M;#F&CUR7A#L*>S64GGP21KJO*A;:8A_GLS8"O3]%0Q^^39J"2BV_75WX4Q9U
M*A.=O3F$W=(5T*Z=V(\RBF"]]D$B5^6G(VK$I@:>PE^,?K)RWXY%PWF;=],N
M2[TE_PRU,QN^A45A>;FDJB!5=:$%?8GL6J4E<G@]TS2F:3_\;YG'3DL\EJ0_
M91372GM3=:4('" )(U]UNXIBKY0J"//'J!(C-J9SK)]SFG?<G:SZU%RY<S4I
M5.4E56R*#IVHOHU=$M%UN4SMC"%_>2)$WF+TW*GEJ.?)81I(G;EKFH"8K]&Q
M5%\P'\""1%D0N?,4S>[G^H501EAF:)J8THMJJ"H)SQ]JYHD%I^>?+/%1!;,G
M>=&B-:_E8Z-W$MT\R\V,"^<QN@VF0YSG).]S_/$*TZ&"N?FAP'P)G>! ?MJD
MV/#BJWCNGH\%-"FB'NT[P7PZF^#8"[ QMIOY3$>=T&&:LU1O&?=3Z0RQC04H
MI\4FKSC!J^*CVL;[2_DGU5W,OU29G-D^U0E:/3/4Q:&*+32;6UYC\5OUTZFC
MIC %;N7#1]6N31UV_C*UWB*U/D=#\JWTM-+D!J][D;*M39YDWP69ZH;\C:HB
M)]WI>PB5BD!K*ZOILEZ2?4VXB&J%0P96$M[BDD_Q9B)#U8 H5A)I)41&!22J
MMC=*E-26X=7VVI+%E*R@*LBM^)C)C** %14&AYE0NG^.*H$$Y-*X9:MT5P+)
M<U6 SDJ1E2\[&T6>S;U9U$8\5JU9J?3=LO$$[821.#6%C2/QWKA8."R=>=2S
M%O%LFOKFLQBD=JI%7?;*&[@JD1%=>R8*3WOS2JW_4A6^UU2/44$[Q3ST,-61
ME]RB*GY%^5:C+%D(X5E!T=DJP'>8[[#I4@?Z&04-1N%_LS%=&;MK1"8,K06A
M::Q"DZ,4$T-,DX3R11V:NODFZ3Q55D*,55;WDR+UG!%VE$SG1CK[^ODT#V^N
MNL>:JDGH< YD [3%E*(!5AEDC5!JE=KS%NY]G?M!C3]2'Z7#,FU2872I1 46
M P #[=.[TFT *$QB0HD4%3HW\:-<IIQ$"?P_AD/Q<!$(AV$4YL':?I6@F1I-
M(+WZ2>J4XJJ5.*I:EFH7'NTY!D3B9F341& D8UUI2?>$+3)7?*HMF$R5QJ^#
M)2M-"/*7\%3(X%HZ#A^CY@'^$CLE1>99W0(BKYA?[2PPPU07[#19S!FK&\!6
MRKQ!I<$45?!?1%*4HP^OT*Q\AD5"S=G[/E53534 IPY&J 3%*<[Q*^C?CW7!
M =CRKLY^[IZ((Q&>4V0(;L(HEA)+JCIST$$N80L":0[2BP :WWS*W2'S5-XU
M!0&@-"I\)G]>SB11'K0[Z+A5+/'P?:;J_U<ZTS=UNP-S0KB2(EAT5$:+[EA
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M%CR$Y,@<3X"=Z /8<9TM@@(0U1T*TT5ZN<*\B%K@*O\SNIR2(L^Y%$RZ8A!
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MDU^._WE9 C8;>'>^&2_*P7 1Z:+?5]&L]0F;S'_5 ;OD1:^*EG56>6H*4=8
M[V]W"\4_G3!#[MYI=[I4!3,/C)I%>7'Z60MO1!Y8O@*GV%PEC5)5(\$^.%PP
MT^?F+>!2U1=UY&S!&G,C'UKM'#+\#1T,HJW4J!2-\&?;/GR+'%W; O%'@_;;
MIHZ!UZUBE2KITXKA[%NDZ<#:9J;/H>:;RAY/%KG2+TUU#@=DB3E. E:GDVJI
MC ;:KHR%T3XX*);1*)?3I*GF-DO\>__H;=YK"S,I]'LY$]<K<N(I61_-]JG
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M-/&RW>[?E5/9MP9W9V<>6-WN01T3+SOU47+O+;-UGBBSU4S%K2,AWEWBY78
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M_"&5"9"3-'92?^1+3XRB6,QB'_[]]9?W(BU9.H<9T*%0-)21LW<R$%GHIXF
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M\1\_FZMG)$*#1!B*OG(9$ADQNESU71EJ7=2$XI)X1L3(0Y=B \0\27W528-
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MKC/#V"K*TZ7,;. >&#BII @J9*A\L8O#<VKMZU7.GSNZ[_9D1 )N4>#I@\H
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M!()&% <>V3$I//GKGQ]0_0VT^T(;",\C.,$T%>]5#8CW1"J6BR&C(Z1(2:1
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M)\FU11;+K8[% U[()7F9K]_6_HX3-Q1Q]"DKA&+.U;*^RI2S$7#)6H 1MU4
M# S[S;X,)MCF_FM(4BYE33Z)F>%YM8%,I= *;UTFH&,T.CPC-\#5HM]@V1D9
M%^P[HFVS,DZH:1&E^2AD G^A0HVD,LU?A\7K$-/3OK:@T]99EN$G[=1$Z$+2
M^1<# :OUMYCU+JO:%HQ^Q,<E _P]OCQ*QB3[IL%AT9FJ)=?6:FF_7V4H&E[
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M#LW>7K)"\PH3F>!E-;+]SGJI+X/50>-:.QC=&>(.TQ9]/B4'/U_'&1\R;L6
MOP6<%&E=BI\K* [4LF45'.Q[%K)82;%,W[F45Y#TPM<LL.O?:!UUG>8=F/QM
M.RF'-=-$:99@9665"'X:&^!ZU06[E!50^$E[<#H'GR[G6^(U][D&&?>'+=KI
MJ /7@F\A,;50QP=+3F;!)F#!+/X=QIBZC.@!4LY<XJS]<Y.^1ZDD[: <);O>
M:4\%_5'L4G!);3;7E"LT5I*'$IKBO&N+U"]KZ[7/Q"D6F+%]XY*I1Z:G@2<T
MMY VX7Q<;COGY4WC:?:>7''6\Y%E6-?@ L4/8@RQ._T92_UEW[(N21'GASA?
M<;:5 ,XOF.:-ZE:DZ #E=AJ>%;ANLLKXRDR;U,T\=6PS)C8]0#*3H,&7,R,*
MK3]2/LV<%"&C&L70@CJ%)M[M'!G#]'F;9']!"I@-?W -E[2H :HMIVN%%RL\
MI&ZE*_0/+QK+)>6"RGPE^=*GI[O[)FW/EOV;Y"P:><*^$PW4\]J0"G3S@=F?
MVX)AG^_S40F<EOOW1V[#K[@\'3/1;O^6-*"X$_RPIQ\S!::]*MFDWR&;,G3!
M9(&B>("\($2Z!NLWMF*045'(O'="CC$T3<?** OQC_9+0<9YH.M>"1-IN(%=
M'#:(GJ9C]>OQL_AWSCQ'@&/'AE4"F1)'6"[W0__#:(K%=U';%KYH^[V0,)O#
M;M\E]2'W?O1Q)^#G1^GHS7A^__&CNZ.M]U?VH>[35'3)]NF(MAO*CD1'>XG[
MS_;AI@)>$.^3;"5].3>WJ6?]5U'U()K>]NVZNS]PNIOG=/[TD_F8O=]9TA\7
M9!A-L[2I )CHHG\;F7#AMJW:JFZUYH9E7EE.11[R9D>%:LF95\U>^HQQ/1$D
M-P^84Y'8/'M)QH2.F)<%T(7#P'\5G3.-F/OYR<&#+Y%5OBV!>XS=88HN^"['
MMMRBW<E30];+-WQ[7%+>Y2X>%Z=DL!G!U=&T\#HRCR.TG,"XY@0,8%T768R_
M( X!YKD"Q> JX5AW!,):-C/6=D';$]P"-M!H1+)U"JV+F)HQ8]0TME=*Z.[
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MIGT7Z#([:5V7DXQM83D3M<K,>[P)+]\<_;+_PSVA<C8W>;\A=BAI',ZL\WX
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M1)F4HUX,5LTY%<%X<!L4M398V#8[,#SI73*2LJ[42R;B:MR:9L5MB^F*,9Y
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M/GMUR(G#7DOEY#AS@9^8,"Y'-$QED()%?CN ./'7N<\EIDE1?/X+&Y'</XQ
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M6&*S:@3TZ_%(U_O33V?!TGC:E5D PXC>/,UIMB#@D?0VP<)^(NXC?8I.*\X
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ME$$1.S/T/S2553O.B86FGE+$17\Y/7F1G)+]"#EYD4W>\73&9I(NB8\1TZ[
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M*T.8I$<CCA[N:DSVMU^25]DRP_O;!B23%#_]0GQV2N9J&955/1ZI:UR&^]5
M#R?&/T6*_.^[6P<-'RR#^MK]ASS@W1O2^A[=S/%)LNG__A=18?G?^^E_5UG]
M[K\AQ\JJ_M+O[LNWSTZ2_:/=Q/_?FT_EX/JX"SO[)7E^=/SV]9NS@17]/=+*
M^YCFCRA;SB:7J+Z?S2FZ><%E$< 2&5>96Q%IR#O7U,>^NNT1_=Q(%OYT7:1
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M%_8*/!"??GU=@K[& ^ZGT'UDBE&I[1C)[WEEVY_'GH<*=1+'RHQ:O)I4NW7
M,2;-FE;TFGKMKN@'L;_;9*Y/B1LRV\VO/X&?J2#\JG[ZQ:]+!9$/^D<O/6C!
M KV*L((=['PNP:H+?TVNEGR%NO_[AYT+FW8NA)P[X8=)16G(EVYQ^"D# 0\+
M/XT?)AF],#(?Y?)!#" _GGQ!VBS2$)*1\7F/B1(8*G(1\7?HP101O8SG]9U*
M5/9EG1Y5RF!6S'#/W$L]4]@[>72+*'OKS)?R<?A2?DPD'H^(_Z$+$#K@=QLG
MM%M,,R)VQ<&6-:YGN$<TG1"27'$AZZ:\&RRNE]_16[#@WL+(W:[D@MI(WJ29
M)>XW]P%YKY5(;D5"L?XFZ/]6S!PE<CS^=Y4M%Q6W*EM=3LB?;5%?I1N=HWG>
M?"UH3% FBM4@U]SW/K8E9>3 $1R4-YK#HBF1DVIRSGKHPNH971('43T(;>"N
MNT-M(#I[\3GN6[7[OF.;77+.@TISTW1WJ=K&O1(;0E5*_XKLDG$!T1%\#]B"
M[WB@=]!P!]\_RL!.:,G\_;A-M 2[5DK?=;MN1L>&KPTNC4C$PBU;W93<$2L7
M:WII8+V_K:N1,THYD3D/E@IZ=/Y+*MI@-6,%$5 WPI,LEGU75DY(8L>6L\9M
M^<Y<C[SNZ-$?_[P-/!763[4'Z?'C[Y3RNON(R]L*%%QM">&9@&<T:>2KKER/
M]L5>>6^F27.YVM1.8JJP76B=8]"-AE>*JIB'-WE7&EOM)9KE(OO\[/.?K0@[
MP7D-&U"=,_$[,H4.CO5JW$%XH^ZJ*#9IRL'7+8.DDF\Y<F7LQ>>++?W2AA.(
M%R^C/[B6_09(XU43P5OG:MQ?=>NU%%>-Y9D.B"W<=$DYS@& L:,J)[F5!D6N
MFXW U92R?=<--?J9]*.[*_1^O+OC.TRO@:O^5]F.^*67G[S\M.#LS)1:<-^Z
M/!^X./!VQT2Q?@7HGW80EDOH^CB!CG[BQ<LK7LX3"R>52O<+G\6Q8-5D(>4D
MY,\-_IRD]56?R97/DU_66V/Q!CF 4.Y&M=M#4">:5NQZX_HF!<)VG.$C?=D.
M D''&>@80$)'9Y%0SPI+8$0I&!&+1Q%]VE!N$$](*?7-UV\_ &M2:%I,7]^:
M9H$2LB=HO3V7_3E($J+Q.$L_;M/9+I I=L >:^Q].N)[$+8S:?IA-N"BS\@"
MW/O$^;C+QUT^[H+8"H>I\+1,-]T=Y_GKKH^&",Q9C#T8SK0DIHD16S8,5 4*
M*CIS\,=^FUX8CD)P,*4:)SI<1LU62HMJS<A EA3DJPRK#;G71J']4I>C!(+=
MC;^TZ8N31]Z46F,=QA67$\C3U=@F]?H@-]F(F/8O]0KNA%:QM5O@&Y#8&4?F
M0$&!:_UQ5 BF?CWWLP.(XBN<#>2Q=QBQII/EKZ:^$DZ1UV^6Y*HXTEA2\N!N
M];G,ZR4+8W=WIU[_G6OB<],^NW5539ORN[=V2M3#W"W:X64W6%AU9Z[EB9=W
MO?CFEUIN2QJ 4#D:QIL;L//P7?/O6S+%MRRW*IHUX3[-W=/M1QDJ'YLB@-0N
M0E>/JT\2]O :E ,$.NY$G$DTZ"(4N!U 5?7@]I-]'1C(L9VK6B[1+7]6.T#$
MPRDLWETR_B%;-6Q(V@E?7'^VV-[\Z1U3>_4X4GM'B^#<.WK]WXV]O.0U!SQ
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ML;IVL@:6[._[T?E=.3=&_JUOVP<I=VW@W[?S;+:6#@R%X6GA64Y%^QB=YUH
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M\@X*&%[*\7WUW+PRJ\DYTJESD!O[VU??VY<\8P/\2E7VU6#G*,OWM3<%1 '
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MT[B-=1Y9I]6W=&$$]:!J"Q'Z#7YL'(+R"T?Y^'_I#C/!KV!CVL&+XM'W6^T
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M]/DA%+6B$:]7WW__PW?_^^J_^?5]-?>.7_MWG#.=7$?^.'5DC%]0?![J"\H
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MN@QX5!(QE$'W'I]2W_+-FU>+9=UY'NIMU]9DP(+Y"R@Y"1Y^'MLH>O@?N0(
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M@?.$PA1%0!K$[XG#8D.[G0?2'\6^Q1EP$:XG(^PA#89[K??X*X0B?A'JP22
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M?WZLDAH%1Q2__=ACPC0VF= $23%E\Q\?S*J/A$;7$H1)C>W;8B[#G&D/F!_
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M,A3R@-#Z3#(B<[\(IO#-JB_O3BV3"=J%DC<KS*'#V=2TP%'N.=D@;4?G""V
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M+,N>/HYAY%U?KYS20NE!R?C$KADB$ID3Z6RVODO9"=GZSF%]2J*]</17'8[
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M#VY':LJL_5/O.<=[(O].WO07L1R_P4W_DV/NC[(9NICKHQVWCAYD.,D5,)<
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M#%=1+-'3(OHKG8H,RU7?#8,6(6'W28V3,F4MGJ#L\HOD^DE5%!$6Q;:2^E-
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M@>[.S,((EC'*SPU4%L;OA)2 A#^[H>T&1\<U4X\3,[)#*/!*HB#UD3N;"B6
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MJ6_>N6TJ&=%D1/\,1G0LJJ0 6PT)7!0K@"6KJGS9M$3F%[(878_,B5=(Y(.
M\2N!?#%M8N>P^RV+S65('+BN#\D,:T-'U-^SZ8<I>M\B@E-D<BX++6WN4VUN
MU0$BQ;0-ZP@JJ!<[8P)T.+"Q42)0P-:20610J[9N"?Y9\)W<##(E##S F'"
MG<18H<ZS,%1[U0NG[[5NS+IR[?8HV-0U=>TJ_NUN!P\\=M#N:S]22?PLUW*R
M'V?@'$3;4MK=.+0"<Q"E.J*36[H\.]UT<YT=).@B)8OL+A[/0$:8=\2!V:O&
M>-JPY[)XTH8];4K$=.5$7:S+H:Q(29'ZY]C#'V\WV^DZIM -C:ZS.[_;4*-*
MZ7?]W&Z?,H2"E:#R)HTJ"P[\7%K%Z[V0NP_V!%N^N#.4! 5+TWB*+68^8FG:
ME#(]F[6:[,/) *ZT\W<M)D-CK@QNOZ[WZ10]ES>6=LG)NJU&' 8K%.5%HG)F
MO(3 %[N*;:F@=>5V.;0=1\]I9YWW6TX[ZU0[:ZRB<8NMC<PY0RW5%Q6<3'7G
M-?G:X4K<6;?:U/!05]J-;2_1#+W_84K@G-^[3_OM7/<;DE!@"*C4$+BY1("5
M>QFB;8<"'<3A=.L,!Q6Q&=9-I%^%&'DE]A%0JQ!'!1T&9 79[Q@E2\SU@H%-
M^_9<UE#:M^>T;]O .4,8#<1G-J;ZBIYH[5I4 4*MFE"L5=!G7E4EP\))7AC/
M2V9 -E5;H@QC8CSBX'*=0<HH&>(]8-RJ#26Z-ZQZG&!KY[/.TMX^@Z)*H#0[
M!+00WJ)U?@/_I-WOVFUGN/+2:7DN;S?MJ)-E-;DV.<WZLP"=$,Z2V'TX.*<G
M7=I*Y_):TU8ZQ5;R6A6FLDZ[I'-]7SGM$"3Z;&D1"I33V ^$/(/<M5#EM]U0
M6MG>IKYJ6)NR+6\806B^%!H' TEN .Q@4_,5[>:T1<]EN:0M>N+8D$KPR%>C
ME/A7#J(_@?+E!5RAI-@0=YKN;-OV<'"W3X!R9ONE^.U<UD+:?Z>*WRH$E@I7
MFUO"MO$$NV8GX2>^[:B!&(\W4/(QS^9EI@UT^KX]PU]!4$\OW['.5\KE7M:+
M%[#LUDU;E[F(PMXN_H$\V/MLT;O*83IRJ*/^]M'YA_7[#A\O<C611MRUX2"D
M]"8)KZ=S[FR63-JFI]BFR[;)4:9CEI<]^)!EO:Z4'['LE#."F*>P*M%E'"PJ
MW;STA&&NAI45J:OC,!7ZB(LMYRP/ EF1([UP.Y2*YFJ&Q*.V!ED,SG]7^-0S
M3@9A)DB%>,?M^'0+.KV5-KGQ%/O8EU8CZ\;:1<E8KM&0/,N8H/\H*3KQPS$/
M>BJ-G,_R3R;GY)Z!0P4/;<Z/6KQNF_8:MM&V0:U6:XNXMY^24@/2W:#UP=T6
M.L \F&%O8/%2T]Q2>[]KX9^D75:V,:0<T\-TD;1+SV3%I%UZ,G@L"5PS 15K
MU"G$-6/1:Y0SM'IU1C'R@&;=Y8%M=48"MDG!]&-?N[^!<UF)5)1D2WN'[5!!
M5C(L[=;=..1))/7%6.R/O4$GVAJPV*U7E\7B8RS\)"Q/I%/%.DGV.MY'A$N1
M1H?72LS1H5V6M0?9J" GBEYB&<71$4<H=9;H1,YR=%Z]QSJ! F66L$$10=DA
M/%#HP Q2:S.-6.$7UAO&YJPE\C^"OP_N\N7B^0A83WU?P;GN8$81GB2J;;6[
MHO"]0G$L9.1EX2,63#>R4AWK+F+G-S-A,E,[O3FE\@UPQZ;MR& __N89'OBH
M,BN3"WOE LWT^ HQ@7L!;@&L8U'Q@@A@AXWI>@UZHB+O<U5OP!"EQ%=O$@^B
M;12Q[@I0R@=<7=60;&=V9Y 5-&T/QEGAUA\TW$J*U,F>/Z ]?VZD1;T-4=,Y
MM91D%^'?8C&MA311!#)\Y0R]%/WW1XO7U#7GE4JY3/;=Y>*7LG+[Q6LCN_QC
MO;JD]@3]-)/NU*VD.1'HO-JP6S3L\"Y_>?KT\I&7?Y?6H\H=4^LE YNS3J]*
MPK!*%!TS6JA7#&806J1\BV_)A7NB/:R5Y0.,3+>6 K[].><N+,F.TA?;8\_6
M\+6SGZRUU3ID@]$[-T<6?XYK;'&?/9MHV>X_H5\^>F=:MC,*!C["B4?-[9;4
MFV%O_S<X/H.*Z**&\M_0/^H[A=(UK89T?_>H;S28U>(O3ZRY$G/VS"<X*U(.
MM>T<@2ALXNAEUDL,EJ]AWV/7VQQKD.A%H>N)KF^;HRZVF'89#/U(ODED!X4H
M '<-70M>9K.ZEFYH'*6RC=,M.57,VILBUP#&T"JC%^#DJ+$$3XVA]UYUCRZ^
M:2JDF[Q<_"KJU3N2%/4Z?G)*,6VS.:9(780?AOUN\L.0@[DA_6U_=BW +87G
M<]'(?/J9'6:ODPM7$[H'Q8JHNYE98H>@(@$G!PGHBF_W<6M5W.U)9\:%1BRI
M]:'%H_Z I0J&A/M7IO*P+GJWLK,DH B>P5"+"#QM$#JS,1#UL6EHVJK[MJE(
MX+??E!@@7.5MD8W?]>S;Y*N \X2BRTZY]Q8W#<XRQ7A, A9O(=AW8%9+"+G1
MSZJ:^NH"-YR90KRAQ$.!H4SV@;H_>E6NXH!7ATJ_==Y/2CIL&28R].HG6C<P
MC'82>K+*/=F%80<CC()\OD6_@;W)5[]<O&;EO8H=P,X=WBPTAZ1;##,(IPXZ
M5.,I-%,CJT'MK5H'4DOH)+G AHXNK('R.+R$_^W P* ^ ZH[BPX-6QR:!EP]
MO;]\X>#92TPA..LMC[1L_D0&H3N!02BY<KE%>7),@H0BQJ'09K%MQL++K"#"
M^[ '/X+8O.H:U2?;V4X3N@069C!UV^H5\>2[<;1RI#=M?!:;'6<JJ:;CI1)-
M2ES^$;/H@88TH5J(OZM-;Q/.A>,4@'=UL*G7$*N79SQHEC'/X>44$#P5/N-U
MMXSZ.2< 4C[D8_?P?PSDF)D>39USUW-;40R,G-C&5#>6T!=/">1+%V05IL0Q
M++A%-Z0BW0)U)4P.G<]7+SXM"D*!)#2@O'85A F7BY<\EC_LIOJ'IM-JB\:>
M?'BPFW T!FN)FQ<S%.!Q$X_+01\!OH-!#+D!.%G.L;_B6O98T-M>E3LZN2=/
M]>N4Y@R&=] VJC^B+$U4!9?</G*PU>"^]9A%5VAI2#J]7?8J6^SQO82 Q1]Y
M=)J;L$6M(%E[LGYR[K(?Q+XIWAHAXC#40BRIQGL,E"$70W$WZ$5P?$(@O1%8
MA@;6XE;I)H,A#S5:WK3NX"!HFUL=7.PJT_#I\VQNQKFR4W=]V0_R4<Q92\>O
MK4M@S09]#W-0C(\8? *Y/5B/VWYSZ/7@%^/$'OM @7W/?KL&2S ]%O%@=[2[
MT(>@.//?]K%E&6.<SIXKI10#,4/L.HW3C+QWY 7C H$X64YKL ,Y_3X\F__C
M AUQV@A, ,X_FRJ?].C&H&^%D8#JGX41P97!<I"3&5X=+GVT ?16]#T2?A.^
M G/."IYN59$J$LP/JCV0/_X3N"T8 65BO^Z("K0PEHW<C;=IG/?FB!8J6AE$
M:\ ^ >?G)J\&<I=DM4=R;PLQG99\ _]VU5+ Q$0WYK72BU(R1.._@4E-+D=R
M.1[2Y?@W%=-QW>5=AT8/3#BO1Z(??U,ROW^ /_K,7[ <-3H@6/M6- E;9CH+
M., BNW7;8N&@]H4=*7BCS?]'7@]XL,-Q]WFFYM<?:W"G9NO\W^.[F)!@ ELY
M#EF9#_N88%$Q+W"4-#6?8O:)0VGG'N4E>RKXX++-J3@LP!O-G&::J0GUIKD:
MTZ'*TN)OGT)E:?&0B>Z_9Y[_WGB\ZA>07S7V \>)-;C83ZB)L7C\*),5BS?]
MP17DZK[DS #\#/83P4->-.VN41EZ&.(/+W]\ 8.&_>:0S)=4B?%LH6 3SP\N
M@\(>Q.>]S;$UE[+&,&>4@PG=%"]1/[#7M_J#S[7]W,**6_F7\B/L\!L9@"R1
MW:[!#<;^((Y(P05P2H*O]FJ\#LE?MAF.P^7-Z)7AJP+O$+P&@CJ@+[CX\NE?
MZ;//X7]O88\O-JZBIX/GO5P\G^HKX_-3Y+'&K]"Y7#1T6E[7X"6I,O-XK2A,
M9&:QR#)82R9*T**._2,"HE L=><L-&W0A:X+YON!%R=! XR3;D.;XA8=EF7@
M $(;L$ C,+K'_?9Z9H,Y"FP8?^OCP,X1CR58(G&J1[8B1M!:'TW')0E5CKX4
M ^0#(7HP+?W((TF2#'-;(\\LMIKS!?%;R0@SO1EG8"3;9:Z&@S69)P,<:# @
M\<"N@[*XUI>$&U<4 Q=E00]#ZY-.$IOA,UWRO"MI&;&IPQA#6@'\]C-!22>4
M%;JU,&++8,[P2,/O-=6-A YAD6#"<!0*$4"*X,PN(,\X$>;?. =A;#Q<B'U(
M^V,T0$T+V]MF!WHI1HX J@OQ40OO"2RY1YGQ-6DIF/G2$)03< SG<!22%'$E
M@)SLW(>8&EQ*#8-J>S 0Y;G+_'^9#&_\C(S<:NI[>= )DIK@$.\&AWB<X!#S
M$[\$4_J'IYU_CX/\ECS-U=%(9D)IR=&*(-V1%-/#@K4XR_A>L<?P);@HFK!D
M-%+0_7"X1Z5AE3-^EW>]3XB*HU!HGLA$5;M\;WUO;'5R;?2]""D>)0J#RSS:
M)21<K(>N[(X+ =?CB>\)G=LC5]?]YJEG.<X3<;%YH3_^#6T_Q?(7-)H(N:_[
MEN+R:0XY)]_(9QKULORG**L/(02F!?!^^\7>Y6"F2_450X4/+,$5Q:6+Q]]\
M _&=>X.0'RZ&U(Z"$S F+^$=;9<P\,\?4PCX1'RGU6K8#I7P1V!PV5/X1I/Q
MADH<,.M_>7SYQ6+)[OTEN,(T+'GU&/0X@A+56)? +#+- O?5^:<BBL&ZE@B/
MT@V<;6&U1I&!-XGM%:&62@F-Z))'V&9$A&9$*Q-/5,I+)A/Y@";R=0R&JRI-
MR8EQH."PP.H?5Y$0(#(RCX>L%1_]/L&5+=IF#Q&E;@Y-8,EM?"ISOFQPN7@U
M&!,\HLQF' _^>O/K][_\:AM8:=CNS:X4- (] 5<]V7YP396^X0$.>%C0PU5[
M' A?%,N7M3*U^:@\M$>9;AM]*BHSJ<U68K<1ZZ)Y@)&0JX>>2668\F0C5F.F
M<>2\EXLOG5FBXU"0B6:/D@P!<:;CCAG,0WE\'E-"P:;<*B/ :!W7C4O,*N-@
MNPZ,'V8<]$#V^=JW%L2D+)*H;PT]%M^]/%>F*2)1,?>)$3Q=N&SF[70RK\F\
M/FS9)Z^ZQO0RXG^U)=;Z#1Y4492<\%E76)'6''N#WH:C=(_DJ"C-/TFD*Z./
M,2*^ZG#$1_&^#&R6JS;?=H1T+<$*B*'#: VSWZR#=6]D&"*YRX[M9# PA>-'
M)@N @T>6 E/X0C.!]2^P% K6M/!PWX_(@(_+Q0]L<'T%.8:ZNUWE:JPBS]P)
MT^ RGP'92O::3;MCD^S-NX7BVK-1"CZ, .IZQO5H_8R"7,KS><!!U.=Z]Z^^
M#\EG""LFX7.<O?33,$H7=T-'V5UJ[>07$-^'.@D6_QG B..91[G?NAX(V0'C
MX\-7X)5O\=!',<("4)*F@FD=<%[R6![D[=SCE#\X^61\ HFO5_%:1/0J+D^L
MRL?1+YB8MMV#M;S-VX*-F!9RI6TF?P-N$K>%A]0]P8%<D59T\D<>;%)?W6O!
MRM+4XP.7*R9R*&E3UE0\73IT3#R@A-(SC[\6@\_A%IS$0T>IID+.9=^XAL':
M>DV54RV[T<&&=ZK*7(F$+A>_^5+FK_#1BT%\@G\TRV[Q?$4%1[CO5RQT)M^"
MOQ,48ML4<&";<G[3-C"&LH7XXWE99(M?$)J[I@M^K[T8TJ.\YZO 55\\_^7[
MU_ROM2 /IA/HXIP1/ 8]YGC2J#HQ3FKAZ)%G8^GH-92<R\,W0;RIX)R4S. $
M;T3 ^IBH*\?D$,<']W9C>O((<1-JD?!U??WHKQ08RU7X?5TN?J2:M0<D<]%_
M4IZ_R=NR@5E'O]")3XAM)T0AU=@7I^_1S_KE)]7_G +)LYB.C]!PLR%\[:15
M^/.OGS"RY^O/-5_U8TU@C0K,&J?U7S0%.=:/O_GZ2S*(^1;!SX4WEO@%[>5K
M&?40".(Z!>;0ID4) H;T^&R3!\U<-11*+C@X6ST+@/G5!O-W&7]0/--4>+6G
MK'V-9P-BD*ZHIP_'!%=Y^HB__O@9<<[4?7[E_%\02K60W#^%RW2#Q=_ PB-0
MV/T=+1UB2;0AP ^%FCISA"T[=T%5"0S#&^G?-,\4L$PC7P\OBV]>[GDOM\_#
M^_57(\_O;PKB/EA1P!]PBV'W=W-LTF":KC?7-7:97G#^9NI:+E[0UWWTS8&6
MGR58A/3KM>F/U>2:C]"H#38+>&U?3"D9=2>-MD+5)/<;M;;BJEN,UPGUR.4\
M5EY>A%G#<'.WPP-PP$;/D&O(%3^F8RM@\%T/A_C,NZ%3R<_EZ%7QZ,(\X?1H
M/$NK9%P0BV[-7:;V>B2@PSZ0^$G,<10Y0-*1>]0!BH [H0M$HFAJH9C"<!;/
MV4^0C8N+B59YZU,D\E"+8J!J'M^$<MX=O>@[UW:)2+]N1^8DAE3)#,:0(P0X
M59Q&:6CC@=GCRJA/1_!@>=%BF\J91$'S\)DS/4Y/-1UW'*?T>R*Z0(?OVV&'
MAAW>^0F#_D-S_4O977<8%]B2TH]&O> \7L-'Y.*E;-,?R#8=%M XI)HQ.2JD
M83 ^*CR6-7!G4*\\]LW'??"8\A]"/]\[0!/2;D@!SSMAMPX!@*BOEHI$MMG(
M(WF4F?1@[PX"A?[R]%& _C/GD.>;T\+;H4:!R(D;#O=GL XQ7J^JFMONV\7?
M\K]+UTR+M!ECICM\W+\\-N-"+RO<C/ 14;KMR>=P;R1J]9/T^*DVRKROKJ3L
M:%O2M ?I&<1B_)0=MJ(7!Q[SR?''?.UV??Q$\J23#[[X4(\ZZL"*GQE_^+>5
MOMV:\'VSC_WTT&-K.^UXO<?/]Y!-79>+?Y<(^:#8X9-*NB64_5N@[)\DE/U)
M)GYDMO@ (AM3?*#FT5&KF8/9+6T''??]A]..CS%*J,W0MBKAD6"A!6P];[+4
MK+W+&.:-[:$S>93&.=1ABEV:J6TTM8VFMM&C;:,/TC/ZFC+B][CD04;4'JP
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M5YN+?^=OMM@B!T?O#EL'B:<X0+F<J:9[@($J[[A@P^+B/FW?'>&2\%MLT(1
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M[4J\"\M11R_7OG5I>C9>HM[Z7D]$LXL2N&.B._."^9S[?PJA@HLCDB \?,R
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M=ZF6M6W>C6;,$X%@G90+Q"AYX.I>V^,+#!-*H@)!Y&4NO/K/25  \^S[^?G
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M?>/<'@;IBK99"W\>.NIM@VUT X)AK\"1%X<W]IYD$N,9A-&1ZTJ<WN@ ,G*
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M&Y%O@\X!R>&2JQ#P&35,O32_2XLU=I""=0&CDE,#_J9<8OL4VY.)#61.=Q+
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M4N%Z"--2L"N'EU?_\]WC[[P&1U4UF"]R2^2*^OO$5,I004&47BMZ=1R[H/:
M?[OW9&_C'8+8?<TM_'4N'G__W%^D<P(89)*;]FU@9W:2NB[' A61,U&K!#_E
MEW!Z<?C+_K^>RBYG4Y.O#[\/> 2/#^9]]@<8&?H'9X&"N))O$:90G/5\V9XE
M[W9.7WT?/:*?=YY__^RQO+5"8%BGKW:^1Q=Y.<X=6&M4ILM8KR 9\R:Y+A?(
M];J](.TV1S/3O,S-&(.-.1>?Z-Z8:@E+3,:<HMAEU7*66#8D>G3^RP5;=W#5
M)&N%,<'Q*<'_F$)M:7Q^@()I0E=IZ0"J1/I7P(EU;^2[YP_C5G]Z_O09+EW
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M:_"^!N_KO_[/)=*?I@K:2.%),3T\IR"4S3CD!PFZ0F)INQR3SH#MM7.! L4
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ME3(_.S"\"GF:M'FG87I.WCKK(U9&?L#/S"1Y,QLG*GYMD37+<(H6?>6:A^Q
MT;'Z+66X1UL(183:,B!N5\B<'5?S]AZ"+96(P6.]]Z:>Z#"8#J> 0R1WA4!Y
MD:U'*)^R!IK'@6H+L&?+OBFK/+U!UR[]B3EJ*HR?:3O,XVIZ*6BKP=5'2\Z
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MSR-37&=560R][=MT&@8)?# )?-=HT\UM"!>1-IBVFFUB82<35O!NR4]U*-B
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M\F/8IZ8]*PSGR8 JR_/!L]J68SJHAH=0#7:R-&HSJS#-D!6'R937)7U&;</
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M=M+-M83 E9W%*K7)A$>W+DOUM_&MJB1]10[XX ULR2L<Q.:AO(%R+#-*Q!]
MW[U2\F;U6PE2D5RJ$)ARP1!3X-H:T%AZ4B,=^#.3<+C+>[<_/K@ 7<P+D<%=
M^67Z7N-*G@XSU(<9ZA^PJ9=^8KK"+"LYF==EWN)Z$P:3TR%?Q8N[@H*;%VXB
MNH=1$K\D*EJ>9,Y%=8PEZV1ZK,6A'1C/& LS,HSX=@364C<<M36/'3+*C&^'
M,]I6$>FK5^@W ]9<Y1[]]G0QR4'-$\S'*.@C=<U5_3*I4GGFNF1:4?DR+;V=
MUQZ+"M" D#@Y2N Y/0WWY5M<:C"1C!:&$>=E6_O")<[$0F+J:DH[)M0:]6YT
M6KBXP.)^F#C*[DUJZG&5C8RV768U@ B"4^='S!WZW^/P8^S#C:$_T7]7V@?*
M/M.XA>G']DJ2Z;80? _>[\Z'*VNC[X+?957.!1,UF5B(_#^J"0 ,#FV>(E5I
M*NF1P*65.!,_\<:$13J6.4LCUHDJ[:FJ3--6!<[L4K M#DZFE7"/2MG=9K4X
M6(DOW4H$>HK5BQN+ZUP;+4 '?@RP6:0Z43%K, S2OI(O9"OD^UCF#TC69.-;
M3ISX<+^+.E'7STIVB0'#R*C.DFM$5:1\BH0L#;8Q-1, T6"=4,304F. -1OG
M25U'DK?EX3 M)H:SR?+)6KI,E5V+H;*?V8VN9J;V/\>] J;%!+!%%8/K/RJJ
M3+0[%E:W([*C\L4TF9/QK#';F%1; ]> ?H92DFUX?E SG:BHOX;OAW(,# 2V
MPUIS61#O2>*T9CB5&=JR%#6WUN:O?T+OC;O=(KLJ+L:-X<"6G@9 W9A<%;*1
M(]!EU4TNW,+\/EC/MU7=ZD-4QCOT>LXSGKA%2MOT??4OY'1O.LOQ%_8<]Y?2
M+TW_;'J.&SF5/&3B4VF8CF,:]S6:F]!I[\M:3W^)?Y,'/2<)9 >;?&7$ /=8
M'(/>=8''7J.]LG(\R7)O9UZ7;("*Z#A#>RK$F3U*6A_/M3N:(5]?+2T4_Q)Q
M 'XX)FUWDZ"]S'I9]@KZ9<N1YW[=^9(.*J6%Y<O=Z!*^IE,T_(3EA-Z3/&=0
M9DNF"7[R$5/H3&,VP0T[U,%[X8MA9FJ5(=.08IYI5J827_B>VZSHN).L%-TN
M=@P&-*/[Q8C'.S=N7:U[ XY"<+,)@+[D);-2Y0_.>-M;F?]:C+,P<-#@:8T*
MY[_<8D>\^=!+T!W&QMVZOT8*/)-E?=N0ZG 2];^8=P!7H-_A51B! =$U[AP\
M*W,G-GQYE4*1K!G ZO?TT8<\SOUK7E^,?SXB3^TS&KLK'EZ62X*R([P^)<,>
M9,V)EP\*4^]UG!_F#6[I<1X"SGMOZB'K\3/NPWD>1X_W'C^)HV_WOH^_>_PX
M?OK],WMZ^P5Y..NHUL/F<O6JP<F'-12#3][3+&&C8:IK^M#^LV?QX[WOXF_W
MGP:77,G(3'C0'YL"AP7@$ $,GX"A(1DCC0P+9[ P<9---.KJ/&$H3XJZOZZ(
M'(L*/M"0PADDZA-*U LYOK *Z\^X^KV>SD%JP9Q/E6^)Q\/EK]A^_#9HS*35
M G+/Y0OXI .4: <%&L@6[D+ROQ==\B(.+9TUM^U%/^Y&%Q08<%]MN]!Y)MY_
M,^_@BM6R/ E1R,JM$S^;]F 6&UHB%P,H9DBSO'4B_6&&,O+FN.IL6#>'VTG<
M<S+]'<4@QGW6KSE4-4$Z:%4=.CTW">\L9<B/H;-HR7E=;O8AA*B<WTLG!V.G
M&;M14'UL%'V;0Q0=PRJ>C"XNW+$P$K MGG\[VQZVM-EH),B^#X[/X,=_)C_^
M#1U62"L(Q3E)2XN:&%)CJ1Y>2%Y6S+)1U@1:+^ <CT996A]([?"#77TG(]>E
M<%@R;!^?='#A#XP/!G]F*[;C"_1G(!I(3#+/ON3VR&J5U<+.O5 ^C5K*#IR+
MI,^D6644=P#W@8OW.F";2P </)#%PK^?Q'M[>_C_P+S>*HTL)B@CP.YE,@8X
MR1O%_-AF%_D6[#K_@(JWF2J8 -5F9!W9L$]A8P4*P3,107D %)&Z.4@8RKKP
M*.!!L&4Y$E.YMZ1U1TMO[%5@Q2<)?1'_B.MTC*2VN #.F,$HB:3U%(DWQ0<"
M.E+4>L_^DFY;"@5[B>;QXOOI(T6+])6920>E,RB=SU4'SR;=I'D,[U;T1U^$
M.)*:D5OO99\!/*LGF[625AD<%5"RG$O!!=ERTFE%6KMXAX?0963O4\6NI+2$
M4F,6)C<1E[U=<,Q&B]ZX2KYWU\3SPCD$,J$#L. 9=VLD,PXTW1W^@8T@[Q1V
M\>X_7-P'5WQH(_FP-I(G']Q&LD4'\2L(@\[ARM4AGSXY'^0+53$Y%"AJLN]D
MJ[0H<]XS,.*\2.OR"/B2=7!NTUR,9AF9PDPR#W^\F?%\- //),_H(M9+D8R4
M4E$E 7PPF PEKF/RUL JW"\5/*BUP8?YD$T-A,F>;1&F*"W'K6"E<1I5LG"(
MYW0PHZP)"XEDA.=EA?0H4""HP ODFTE&=] 4V1F]9$,$1%!R^5#6 A8;'26O
M6(!.3MBO&U[)#[UC,70@#1U(_X0.)"LS'=XUP=\G;YFI1K,'%&K?5!D@-)"^
M&M\>FO>VY#4.HO,P)#5"L#LSZ_*!64'VJC9DNI!.9%RDL5E"+F/!6C+DT3?)
MUDV%QJ=*DG0N-Y;G%G?H+Z\^(R34Y!R\PMPQ7KDPT=(DU=!?NTW'91#1AQ#1
M6F8*DLR1NS<V*7?9P;-$%UDA'%)>IKCRW8[F9.740Z0X*\GE&S!Z).YV"G;7
M8KJR+MB\Z;M!R/4QN#B&T&L(O>X,O5;R%8REN'?2(JS&M&I?3#%-IM*YZ#IM
MD+H89<6:EM-8X'#7*.*P;6S1&6306(H$=3 XGJT@0C/SSHQ;X=0.T?^)(MN7
M>&P37 /PD3@R&=> Z)F[R&V)#9/^LU8HF(%9A[8DFM&+,96%MY_(E3 NV\+P
MI:75KC]?QEH;"^+%CY37D7R.Y';PWMX_L=/MH0V!2I7Q>'$&[>IS5UK;].@4
M:3\*FD%M\RT]<[-<2 TO*,4-V:0!K_(Y\2H)R/45?XMR=B(\<YQ,<C,N5*;>
MHV''M>LQ(JS,I0W*O"-QJB%_W+8OAE_;E9PPV(A8QW2,C8$ :G%+D[190?*J
M2UTI47=Q9GE&#L?*9YQ'L<I.F423Y+JL&/3V)PD_]\?X]3KN3-:R?I:!\W-B
MIVRYA&?FB[Q<FGLV?0^"/?@J'XJON:\HQU%;Y' U;HS--=G:=<W!KK5JA<!A
M"FGM8Q%XW\:]>^N!(4'\T(=H"*$?AMU\&3("*/!*N$O4]+G^3\6/C,PLR2=#
M>GA;7N(@. \E."HMR/U6' (FR 1G<U@@P#W(">3H;$+!)KEQ9*?2%D/=;I1+
MN5C:P'*-]^;)T9T+!S,I'E_81:8NY2"0VW(X!H'<.H%,E*,K;!7#%US:QWJ0
M/RD%VE& #7^5W-S"#%'> 2V/;80FKO !_3A(ZI:<FD%2MTY2ITA]%F(@92PJ
MAX Y4+Q)!I;#<MQ4M!%##6;(:WSRH_K[+,N-MM=V<P:+%92IICK2,BK*)DH6
M"Z$)6Z'1H=^9@BZ"HHDZA #EVTP@AAHV_OR?O-/6F<-Q8T'PEY[YYU XA_:?
M/WG"'<&:A(EE1N)2A0J)0TE*<@."2=G&C9%&<>1!]O'^I$O7::;$H6NK(T59
M&/H#)W$DOYF$KFC R>.SFZ,JE'+.<_:RFYQ@I6M-,G0L^"3H;5E/QRY561ZI
M37G0GBL=@GC!2T@7 \UKW>%H"@B/[#2A>][0#T7W^=?HT&>S4'C*)EP)0RKK
MQLBT:#SZ7:<-AQ-LI&GOW&&/H2YQ\,@3&4D#>5OH6>-?,(9$=6]LATJ3MX+L
M7=!5#<HFJ&80W>(HVC:3,K_FAG(F31V[\9S\G.&QZ:7 5WC[?&\\^M02S]WG
MJI!VN]<P1 UY[*% ]9D*5+\;J\WAA4B[)NK,XZ2>A<U5:T;4VEZO$J0*(GS2
M]S4<W\%=^73NBCNPP-V/,TRZPXF%UOY;AS8Z1+#L.PM[%^,J2VI )>C[#-?H
M[G@3([LE\E"4A^\K$..B#.?*RJ0E'2T*PWI7QA:-UK=O]X LGFQ$O_&JI-?N
MN6+Z0!G=0?^\EB)169Y2,VI" ,R<B?WH#12M4:BGT/YMNF"OJ]GN!IER^F:6
MN Y2NF>\%HNR4N82]D-\%CZ,&W#8Q8&K.WF+D@KE81L/?#1T,7[D+L:GG[F+
M\1YIE:W9^X_B?FS:^8O3RU\NHXN35X=7)\?1U9OH]/6+-Q=GAU>G;UY'5R='
M+U^_>?7FIW]'E_^^O#HYNXRCX\.KP^CRY.C7B].K?T>'KX_E-^<7I[\='OW[
MXPC&%V-8/[-G>"HZ.$-L-9<LL9L=NXSJ98WD*K.\)DVB]&>E$(MQSQL/ D3\
MWF6[JC@P!&X! ;OA5K@YQ7[SK$9,?V.I=CW5KPND&$GQ5\M$(?U9&QRP^2L%
MN,*80JZ&'0:.X[DS(0Z'EPAR4&?KJN&3&.\@'&@-8Z^D).0$)#F>[0#IC:RN
MVD7'.-L0+Z!YLU,XV*QUR7,/:#$4^=OY(Q@I0S<NZUI@CF2FE7B=GHU>47T0
M> WKMF:@_!@<\$]+^<%#ORH2+ADETU:UZ9]]EN1'0I-UNS+X1GU)!C#'/$$F
MN^9)125J3PS2P/5:2#7#>"?H<^<6W&3,XV;(JXOMK.M8Z/ ,\WXL1"'I]TCZ
M^;=C$B[C,V8WF:3_<*GHD?B<^3)Z6Y0WR-[;/Y$J^2:<U1WS$!TXM\ KB]]>
MFT+1SZ(4@V9=$E,6;_PA>F35P<R0(IGMV)$3_$<6=6P7@AMN;&S3911^Y)N8
MHW7>,4#4L2I3\:0C'5C%U.D4,O #>6AX'*PP4.S?K*+@*P:2%YWV95 GHMM+
MD6XRS!4HN%&>4:PD3<Q9(1#/A6P5HK,-)H3)SO' RE^X#,:5U\(&(]616PT0
M ]$M]J[E)8G:-:)K*YV:Y)2R?C%\.70@VG0'=4)D'"=5XMK8Y*W:;]A$)_TC
MR?25RQ/0645N5;; -FO;+^Y&+\L;= #$2'J:16/;<>A-R0M,6Q8.UNNTF5,;
M,]IV!&NY@F2SXYAB]'N=3,B@N?E=%N ;S [C$Z>#XQW7/Q#R'?&4U'>C^<R4
M3$K_!;J7Y69^88Y"GJ 9X85P6\U9<&^XKG#C6!^,G7L#0C 9FH)XCV?2WWK(
M)K37_ 2T@'JRU"<&3U@RYL*"79(3HV /!4\2<RB+:G;J\<UUBUQVIMC,L:,?
M<A-=V$'Q@]@L1R=I*/ZLR#"NN1O]+I]CSC"9(<-:;+VX:?=(91L5@A? @BC"
M3^Y)%:\?"\;,2<S+FNJ1GY=I-EFN)I@W",\"!R\;FU[_!=#?9=U87>Y!.6&D
M?U-6X%&=DZA"H8@NQX+H2IAJ1VN2P8\*X+E#?JT,<6G'W['%/(?_F*@P#=^0
M5E 8FWF'G]?Z@YR::Y[6!T)6: '<E2PC_$"YOEZD\[3X!9=KT $S=^<5^2'8
MBJS1_8L6+9VF,3ED8]LQ=.CJ"-I<P]F4))=\"IO">3G"U>S*I#^6C95RW*X[
M%G8#:S_WSJ&L!K=N<.L^.;S]=E$-I2>S@ZB@!D0EF.(ZJ\J"#5_B4WT65K1F
MMJ$8(1<S]FW1IKC1]8B1AW+=Y@ SJ68VUUJ^:V:H,+N16/JC?-N*:MS1:E;V
M9%489"7:.>'AE:9A&*/.6W'!G!UT-J/7#6UD9U_I#8/9DN1_)&R6.<4KSF!A
M<N\(!O3.$UJ:J2H>CAF1$B.50@Y?72YF&296LH4KU!@W/(>1=1S_9H=_LU.W
M"^7&U FZO8V0%VDD-,:N],-C&0"Z8PHZ^<9(7;MIZ#%K>-ZD#WF>Y[B4.2]S
MI,E@\\E("G?H?]B3(B^J%HU-THCKE9,=:]_=Y?QFS%&D+M)64 "\!?1W:.-R
MSIT.[CMXOGRY,YZQJ^E^6TX:_MRHG096(J)S27M8LP3 <--R)VUAC8G]5HS(
M.[U1 \YNG:3=V &!IQ.[J)S_ZBKNF_S;NC:@-Z4WT_+(T:PFQY*M5L,/E]7S
M&,SA*@EH#*'@HT5NP/./PW>OV(.URUCQ$59W2 >6C]$C/K5GF_Z9+P-3)0'+
MM5$O=TSJ*S>).(NDV!CL5TA=L-(,AP!!@J)&9T/$8([9FJZD-&(_W,B"$4&'
MCZ=A!D:+#PCR/B(;]@7#>::S+%2V4J8A?S7CJ4T4X5QSJ $M8FG/7>&=!Y/V
M]TC./OP[O@1[>"@Q8,,85&"5"@>:O!1WUY1U1LQNO'F7D-,"O>%!"0Q68"^0
MDTR\<>3/<A^S0Q?8J^U&ES)[D,.S-0?;3@[D?]/#=]-']*Y8!7BF_""UQ2,%
M.<1TI+YNEI9WUU \J21[M/2G(K/Q)%)R20$-@0@##+RN7S%4U^INAL&3G<K*
M#Q7)0VF5)G3Y\;]%V#$8?D&A+9,-C]V=0[S^>6-Y8#P!SR$+$HZ2MK3]S%I8
M5/@)CF)>9@V_4HQFXV[FBK6+?*D_<"L)(/&"Z+&9P?OYPH]6!PJ[^,W/B/C&
M8J3"/;PS2N;)%6P5+-9'NM$J\5 UW$HE7I)BJ%KE!,4S'%6Z-CZ@-@3QCG_T
M4/-S]UMR,VESX5P><Y*$WAFT!?2R52>Q^L2QQ"^J]V MY S)1P I2NS'?>>_
M;#!R.3AJL,[KG&H__[AW?JP*[WQV0U8ER/KX\,KG:L+4CO!("[Q(6AD PZ:H
M>[YHI$[**0Z'N^+561??,[L&"KB310I<'ZDCR[R\32%@<* *<@[<%K"^[^Z'
MG]C]C8J]C=]%6T#)X1" ''<E!2 4X);T1Y[PGK$?CC;GT"9+E68[:,3Z=DAY
ML!1+"L/>TZ8J1JR=<8SHP+E(W$?LW3E^RD9.Z^M=WBJK.Y9,1I7GH?!:G%_)
MYIL^FY$2K2T1N.K4QOJM70\N*\0Q4(\S>!I9'T)[VA6 @N&#!%DR>J>\8QQT
M\_"9:N#Y'J+#3YOT9Q^MK.X,T4+_#<J_T@%*V;5HAY4QGM9F.JSF'84_&\IT
MBH&*\41,\X/"ZSD.56"HQ*2:$WW4\=JZQ;]8BGRQK_"1=)+^M-.4264O- NE
M.?BN9]P9[10J[M4BX?J93]">TRJ9]R_.SF0P"4'&.6A9HE=VB![=.@X4ZV0:
M!JZ-JCN6%2LL#9T:*:?SK\$DQ?ZAMT[YTCF2"ME1RV>SI+QR^C*%=>*>:P%C
M38#@BZVAX>H,Y&5HM>Q]:N:%\QFZ:7,7 4CNCCW9.0#=,. \A,O%(?+*%<0E
M_HFOKF)9?6"5N!/6T1,GB %= YYH6S$MGQI/].W BOX@&T_^4J  )%A1N60%
ME)MKJ9]2!.]FJ_"(:A\X2*I$)M[[$=AA8*$ 0DF^2*5HCNB4BSBL#3J(3J7$
MT43*@,\87+7/+!5G0<^]K3'7MK]EC4A8QZE3->7$ ^<AE+7&UI=O";2%]TX%
ML"L&8K;#9J/14@=I=H237+N*LTV(@XH2*=16>/,<019GJ765M!;?5&8'(?A'
MML%TV!X$G]26M5'?E0F>(0R$@T.+8K:79T\P+ SK$X7[)+5C\K]L:5I2:1JU
M!;O;\R@"U>+@$X;GN<@6V^;0,>UIP3?3VG^GOM]%4KB, D?ZRQ&4D L?HZEV
M@,M+LFE2=$AY)]"Y;'0&\Z6B"N@2V#CO,7&YP4/9Y8)U._I3-Y'UL/,BZW'5
MT@,LAP:1H;_I\_4W<>Y%CR1J&VBMGMH"".=J(%._[E[N\F^0[:0-X21^'*;P
MZ8<V-W7<0>YTXHY%B6C#A&T=*THUD-9U>F(W8IXQO7@5!,^W>2#A7;J:]V/A
M7'T ZX =:V"N'P/*ZBXK>FEPEP9WZ6'@K!THJ\6'=G&<_O3>@OP,B@=B(SUJ
MM%M-B+O0S8WE"+XU ^7YCV2U,5A2TO@!<+36492*FQ)UT<.>]V&K84E)RAF_
M.VK?RD UAJH4SI0.GH-#5[1S4P$7<"\OR%=F@+# U[1I/Q:O(F;(57Z73IYB
MT%^A4+:T)>V^C'@L-\"07#-6]XG3=_K#VK59[>T5?"<9%.I823$ZTF*?B<.T
MT,X)H6VQK?4AM9S-8H8791@TEP[BOLW"4"%!8? CD)PT@19WB$9F>,>$=#H3
M\Y(^W>E8CP1T.J&G;*1,-<W+D5VHQ][2+A=I/4X6&(L8D3AF*?*ZBJW11*@M
M!SD<BFRX8!:"K*M#&O(CY=E;(Y01%2"T*!M:<MI;.O5HK;00+$"&./)&,86$
M_[X/ *Q('=B!S@&5 @D,"4L%>^BJS?$JY-13UXJ\\F$H-U#:*M@8LJ:/LK+K
M;+(5WZZP=@]D1S7)3:SOGIZ#B&07)ZNQV ;42Q>-'5'+ Z?*0H0N/$K]6.@@
M2 .[B.G #M'% OK4"+3-;>V+F5R A]>1\;WMJ.#:K(HD/XR32APA,'?+J:F#
M$^#2QIT"W2;!"#?"3L>ZK:@N!4,+7!.7PYU$*3LZZ!D"YFY=@Z/-]2J_)\;]
MIMLU2[>T[A(.:7&PXT#-R]3D@Y\S^#F?%-\IX&B(&F(="$6 #(/Q'LE(@C5&
M5HQGW[IZ J!;PID78;6-V7Y:.#)T\U\+NK@GTK&T=,>XUKFW1A=N(=&CGX[/
M+[Z)'IW\^DU$WWKVKV??/8]MAO;DUPA_CE6EU9&4R[K961D7<)O%WJ5UI:9W
MR:"DZ (JK3J*_@2^@^Q*Q?T(J9DP>SKY4Z-$BG76Q.I=XQ"O)?$6!@'RD'7>
MD61\\'@OF@./)E"7I__+P7&* NZ@VFX-JFK[UZ(LK)YN[ P*!>D#U 45/&73
M60WZ9M WGVLR^+HV&NL!]>PKIUU%1P3.=]>ETJ0TIVP<"I>SHQ6LM\ SY7(<
M0]@Y(EU54'5SR>2_565=TWNI(/^RF+R\(2_HCN4(IJ%(. YB[*?'9O%EA+=*
MER*@0[ZU#2#<5JR$#W!QND^WMD/(Z=03>@$E.H0.2<B]:CPY]+4M4KM8YR]T
M\[2<\V=^_44ADMW"OD4<F/3N5097OO2@]/Z;N6&7RQH*WJJLL2-D)$2@*%SS
M\[O1FS6;S7.!TG+1T&(5-AND]/KAD6C%K%IS&-BW7WGC[B&Q..8SFUE<?B61
ML-*CH?E X]:Y@5.7U?/N! UNS[KCH.O;X<7\^DOG8&?%BL=-:_)1<_>KWHY:
M\]Q)4X[S1"#PXJ(&*^Y%FKF9XN,S0*H++G;HN:DX&ERMR0@ZV#7G,=S#MH[*
MK12O)SR!DQ;8Q0U;$C[^Z:1S5\63DOHI3&4'/MUO<T5$<,:=KMBH3O@SF9C2
MCK:08;Z\.\!G.Q/K[L])DK*TX5C 9#!)QAW)6EL4[@]""N$_XE-,JR1UI>X^
MTDAP[T93OMRK9EA+*!19)S!VT[95WRT)0*!>\W3W"C#BX%$ UBJ4;D'1Y/0K
MJ9QWL\^)Z[?P,Y/7I9IC??P@Q'9[[')NW'#$(F&QXW%$?E!J9^#)RCLQG75B
M_[2='ZX:*>V"WB&LW VKM2D="47AZ_5ZC>W.KJ46VF(3?O]J2O2%/=FFY[A$
M?Y<SFH%+SU90N;%,J@XTQ$$42G@N>FF!ED5-/86)B)R9&J3.KK/25HE!OTT1
MA=?6MUD@[YW<RU=_LOMD\-4'7_T#-O55]M;<,&O.C8!SX0LHX,(.& J;)0'.
MH#O(>%'U>5=S@&L2!B%<(DP7]#/0FA)D1Z"30'AY>GYX&+( (\'^\A3<44'@
M3P\  ]6UX'U(B]X_=KD*QYX!II#:-JF%DQ1MIT+&,8PV&DG28+4G_(B.".F!
M(DNB(]H2U$:B<WUFI30F'? ]>QQ'1^>'?OUA K'T<RO%* NV-Q/VY<SCH;OI
MWSO:.R73S=!ANU<A) Y=[[I28.QLSC293+A,-@V?C3[/NU*[]'>%(]NI=BMC
MPVJ?#)X;BI*B+-:9*/RT["Z(9S#Q@P0&6.T_#5;[;(#5/A"LM@@"ST>2E?SO
M[^)O]_8@P]:=8=H@3Q[/HJR=D[53-L)WPTJ).6]6>_!B]VWO%'W>ZN)I@QC3
ML\FF'FP8Z#FKNB]$NSD-_GA/-/CY!6EPMI1D0&VN!8^U)@6.#WOB)*R>[>F:
MNP5Y\,,I]^=R*ZAN3[@?[L)=8G)790LI1>AXKG;&*(!3K H;:*NOPP);@(O@
MO@Y3RVNZ5AL1<,%+]D8I"H10"/.<;:*L4S.0;$MGHW[+(&RT%PLTTNM^6D/:
M+Q(<HK2*^Q]!H)*T['Y+?Q>87[*-93/S$YBEPN[S!OR*<$'NHC<=0";>^A/;
MMZY_#U(H>)4K#Q=;+E_>CRA'RT^'@2SNO*'5UQ."9WNOUO8DNBQK?T5!=;<#
MP+#'U-=^O+?#^0'F;'(%T3%7C&0LK)\AZY>E75BRJ$<A68B[*(7I]$9U:QHC
MOH(?2:MPE$9O0!'9-T.9XOU#GX>*!+] 8Q>4*6XM9*H0^T)&D%U%!MH+V[HZ
M*?+5$JNXOV*?%B%^IR^T*\#.'DY"&YU9I])Z1MAVGM6L.?>U&-5[85!C-YO"
MP..7?KY;,:>W]V)S%UX]<_?R0"LZ8V\-!V5V<D8'<N71Y4$;?R\G;BV\GT]F
M43>UR2<[00:2;E^0A6<(+_TZD5#FEM*UI*!1L @6K,N,RG!Y['Y,^ U(>(P2
M,%/+Q71PQF^5,HECRP5]MD#<F1KVC:Z9-P>#GV(E_.G:59NW#3C;_"GLG+L
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M$MOW,%17K.B?;144A_\J'LQT:UZC(9W&DKM#4Y?F#+0P3+$HR,^J2\;Y@R9
MI5;!1ISN_1X;UVT..W4A0!(9,&2+^B[2LF$UL%151DE;S*0F2+@71=P@&L4*
MS%!:*:BYJX(BF'*USHHKB0!#(JLY;8*A=]&=FTF]CRK/0207JC>RM+_5]<^?
M8 F17;3&?9MW;\#V>6ZTTZ4IV>VER<[%*\/3J)HHV%ON=G/%UM>74MT6\)K'
M&;WPMB:C\*M>\RV+\3WV,</RS+YH+?]=FJ6UH-JQ?)G!]?5^EO6E! W@]\^E
M0,,!G_R 6RX.#++M2L&<5G%/&]K>Q[L4@SE5HA?;<82JQ,<4Q5=!/EU,DN'
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MO?O%#7[0/J8GV7V<G9TPJW35K)C>,>>4,E0MO%TODF>I3G?!_:(#:"T:@<E
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MT2PWNO(\6X0A;7Z1ZX7<<K7*7$KT))S]XEC,?<+'L,O#UN!;MXA%$H(BHU8
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MH(]]:#4'?.55=]2V.P._E;R@V>T=XD.K,;S$9::T0^]$7:,XP5=?;N[-GL\
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M_)-,X18V?ZL!J<D[VP6>K_.!E!2GD(<VXAN."W;'%@EFBY@.<Q1VV&QX>DE
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M.\.D [8=,SIM',T[L.<1DX/=T%%'4E/&>5D#,?VYE,N2>A%>>6H])O:G4R1
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M*Z]UB^@^W5([#;1HLIP'[['/(.ZY,N9^_#U/3<2J^LGC\I"?#"2 #0<0(0I
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M:#"4T70YC>)P&QSMV\I\#B)G%PM_&LZ=F.TCPW%)+=_C7&Y"P ;BG2S" >C
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M;+I,\6#^9KD(J6WW%^VJEQHH*R>2&DRICAR@4#$A+8_/ZY&6AT;+3(7"RHX
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MNN+BS,]2W6*\[C;1W]41=M]OW?H#=(!$B W[MS;L6^>YT!:\,&5?8HP$'U0
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M*@Y4'*@X<,^*>U:,)V20RDV 'E^%Q^.>%?>L6]BS1NMYBBR"%=:"B-R!X5X
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MN'BSZ2UO@9 T2$A"$D82'I?'8W%9I<5E&$^#C"=D$&20<7D\,@@R",83,L@
M38 >7X7'XT%@K0QT_4&@DB(:PP@(&AT(+CT8YS4H(B-A,:K '[T\^9$/ B4>
M!-8'23A"^-M&&1[&W#A"N)OK>UZE##>5,I^_ROWJEK%M5HLFG9S.%I]2:F]Z
M03=;.$Z7*:P62QP6/%BAUVM;B"_?G9:_+51YR*9=S*:Q^3).ZK+5+ICE&X+P
M>PV#1P^U'3T\97Q>_67%'!BH2&%(84AA2&%(84AA&*A(8=68 "FL2K-LG<+P
M^/YIC^\)HR%0#HXH"T+H",9S"MYZ(XSUDL:-9M;[U/'NQ7^>M:N3\E;:=XN]
M&*?=>W"S-VX:#^;[[G2Z<K/U,;[_^AC_;7?LUY:ENY@]<G[N_S:%Q?OY^J?T
M=V&@F1#26^L-:H9Q("-J!M0,&!FX[:V1\W';BX&*%%:3"9#"JC0+4AA2&%+8
M@ ,5*0PI#",#3V['<W)+K W::@<N! V"1 \FJ0A,,"I(9M[FC1%(]RF\QI-;
MU R#K.O>W1ZLX4'87]SL?"ZU6S4O4T@G/BT;3B<-(XQAC]U0I6.O#2U?(B5[
MSCJHC(LS/TLH'K?;C??]ID'Y6!WVWC!!DWFMF-+ #(L@9-+@G$\@B=2&995]
M#%_+1T.-"59'B(8Y$")Q\,1)2"HKS9*4-IBOY>/^^A:"=5_/^>3JP[-5NW+S
M.)V_?^"X:FZ+ARLVD:S.45W?C!H4?\CZR/K#9/U[\,#30?[O4#:@;'@4V9!4
M8"H2"<57% @=&)@4*8C@HI),&65C'[)A+1B.%[/B/^VK==_O]U\Y5G0!Z@'4
M Z@'*C4!Z@'4 Z@'=D,/V!Q4$L9#DC&"H*IXB#*I_%,ZXH(3SF_T#_B433(N
M@&)%"@B5*5C:31&7)"@J&$F$]:@';K_Q2E@^$<JB8$#!@(*A4A.@8$#!,'C!
M,#S&_\.E$Z#NV= ]+ ?J1(A@N:$@?!1@LS-0Y$O424<:#/U:]U!J(U%20)"D
MZ!Y-//C(#1B:74[E3^%4G[JG+;Y8/OJ6 *)\H@1# 30ZD/\O5%"HH%!!H8)"
M!84*ZLD5E$DR">HD4)EE-WFBJ*% -"2A@Y5$,1GRUPI****$IT5U^42*ZA(.
M/"OZ*RK-0Z BVY >0T']R"B>$(T/PU$@H4!"@80":2@""97%6EEP*[./.H&2
MHJ@$$0SX1!T0EZRV1 JF-SJCJ M2R1"!2V-!:.7 $&+ 4:XCL\('SI\H)Z7M
MQ%J#<F,G$E*7[4SE;U=6:?WA3>OQ^ULA0SUT/7X#K2??5)F-]_Z0.R)2:ESH
M;H=P\T_3^?MFOEBE]OF5U;__(E,VX%6FFR'S@&6FQ'RUI,>?&_).W?MT#B/@
M<GG<%V[VJ_O4_O%9\\,#%O_!$?]T:^\+ZC_:RO_\ZNWAZV;_\.V;P[=[[PX.
M7_?BVKWAQYIEVY5;I753\#^":X__D6>+7]NA+_S^X>NCPU\.7NZ]>_6R.7I7
M_OKO5Z_?'36'UQWC#.[I?FKV]X[^VOSTR^'?CWKQJ&WL,/M=D@W>[A9C3=27
M;^?B";IW^L*=K1:7$JA[@X5[7I _KK\=9N[3XFQ5?OS'5/34^E=1LE[!BQ<4
M?YBYTS:]:-.I6Y;@N5R<M9(__]G/OFY\_C!MIWXZ*\KRQ>7KK^E_/O]U0C\W
M2OV^6\_KY.'%>WJNB/[F]Y!O?8=XSJ5]^(]YKJAY^$_AS[FV5_^KYXU)2>_X
M8VYI?S=W:W_?QF0=4P-$]"HVJQCA@B:XQ01EP;NO_/D9)<^>T![WF*=SN9!;
MLN/6U'&OWO"_R2V;5V7-XA>#)"J(T#M/>JG=->H(<F3$0<$QFF#K)OC,B P)
M<?<)\0$3E)#]JF>_)[8B&@51%E'V>I2E%<0GHBRB[*B,@B@[,I0E%<0GHBR>
MY. Q II@ZR;84FZC=C@;&JW]X6#>K(X79ZV;Q_:^305C,G =(7@+7]F[\=4V
M&D+LDX#E$X2B[;7$R[7'S;I8K<G+Q4FS.$U+M^JJ2+LRZP_3U32U+P;4]O,T
M5OY&//9JH=XVA#TWBMR__:-_&UW;_5&1D= PHS8, EA5 (;FP(A $Z )J@(E
M).]*XP0-LYTS@B_/=ZXN\$7/2W_0=[6IA5Y9[9T[2=AHD>S5*UZG53-;M&T%
M!WI(;$]B@EN;X^NR0=^S/WHUVGUG?_1\)W+]$SV&!XK?&'EVK]\UO%6X?C!)
M)H8E3QQHSPD(%Q/8R"5(+:6EVM$H>1]7-K]9+LK;^:504\_#8@6=V$KO64;T
M??2Q9BA84+",-&10L*!@&:%@253IQ&EQ6F8M".(".)<Y<$E=T"%T]_M\+5B(
MC#$R4V2*R0E$2!8<XQHX)=(HRX..^LD$"U432GN;;8_HBX*E#G.A8-F^#:H.
M&10L*%A&*%A44IDK:T!%501+-P36*QO!\6A4#H(8M7$],5?:!\$L**<RB,P"
M>,L$!.(MB33GP#:NY7DLP:+E1%&->F78X'NM7GFL:F+,%-8/5GOQGV?M:CTN
MLUDMFF4J7PK366KF%RG$[K/=Q]TLS>:L3;&9SO_DE\T/%^H+RY0'IHJQH*;N
MN@TLJ$'#(( A@&&<H&$&:Q@$, 0PC!,TS/!*FIE\Q(.*BQ^^?30<WD'%RU1^
M:9BZ]9&JF\?&G2S*NO__ZT]@%J[*>!WW0? N+/?@DVB8?5IGGTCF,1AO0/DD
M0&2?P5.60 ?&DF/:"[F1?;I/?>]5E-Z;Q[TK&-W+#83,]';]("+/()$'N1:Y
M=EP>CUP[+*YE4=F@E08=K0%!"N&Z2 DD%92E)#*O21^EJ8_.M50BUXX:>9!K
MD6O'Y?'(M</B6B5)%J+PII!,@U#4@V<T J/*NFQ#MG:C#>0^596/S;54XKZV
M0N1YBLI(3#C4"3A[(2S3M=F&IH.?^8=T43<YZ>HC,=\^5*5V5Q,@7NY&YAS;
M>+"-YQZ)E"!EBLF $[J(1YHC6$L<4"Y]U(GR1$P?B93/['-5:A[FE],VE$5<
MM46$OEFFD^G927OP&Q7UHD6MZNW<9X>Q=7AM/BA'4(Z@'!F['$$>O^!Q0:W.
M JBQ H23%"P/A9BM(D8*[Z(,?21I'IO'OVO6R$0P@90^:GQ"1D9&'I?'(R,/
MBY&9U9K;+$%&PD#(PLU>>=W]LQ SI8EEW4<JIP9&-K2W= ^B4XWI'NPO&1HH
M[7V1X,DEJ/VJF;;MF9N'5&"G7;4_K#\7+X ":W.&*N@P0U[U<J.@&QIVWB#H
M@F?."@=4* ^": I>*@-44\],R%XHT4NJY L=]]-T7A![.G^_WT%V$7.?A5T_
MA3H3SG *VKB!"*D7J7=<'H_4.RSJM2Q8;12!Z P!D6VQ>R81E'=2"!J4]*R7
M[,934J^Q'(EWU#"$Q(O$.RZ/1^(=%O$*%0G5D9>M:]>4PF7HYBPH<$DXZ67T
M(FST?MXKB?&D>UYMD7CK@R%L3AEOMN)G-UVWH;0EF-LN7>$^N.G,^5GJ GG]
MZ?(3PMER/8\;:T^&*MLPNUOU<@]]K./P@.\__^,C(U1@/(TJGI!!D$'&Y?'(
M(,@@&$_(( ,T 7I\%1X_F*/CX5$(-LC?? ).%;/,1@V6T@R"9 J&, E12B^E
MD-:[7LKXNQ.PP_F1FZ7#W'<'/.WMO'N'L7-X#?!8WC_> _/7:=6\OS@T3Q_#
ML9N_3^O!3I]/T-._SZ:K3U<&.V&QPU 5*V89JUYN//,8V)D'QM,@XPD9!!ED
M7!Z/9QYXYK&5VY6T=\0F4%%($$$K,-PPH)JS+!+SSJ8^RNV[,X]?%FU[>>YQ
MN#I.R[VV3;TUMS&.-?:[>/2!J@-5!ZH.5!U#XUM4'3>K#DYSTCH4F>$I!6&E
M!<,< 1<=<TIGXD(O=U\\NNH0>/?%+FH.[$\8;[IE_SS!,ITWV4V7S0<W.TO7
M)EDFS9_\LOGA@LC/_YS.P^PL3N?O.]0H[W;>A+/E,LW#IV:U=/-V]I [O[&@
M:.NZ:X>3XKNPW)B>&5AZ!N-ID/&$#((,,BZ/1P9!!L%X0@89H G0XZOP>#QJ
MQZ/V+1RU.^X9MU8"L2Z"\#* S=J##EE%FYFB-O<RUF=]JOZ3FR[_ISLQVXO_
M/#L_)NOY0B#56Y9_AW%TS"?NV. P-. Z6BW"O\"[-L4"1">G:=Z>WV6PG@>4
MEA^FH?Q0_ZDI00_IY'2V^)3N/1D(:T6VKJAV.-6Y"\L]> &+RF^M_%+PA%N7
MP=.00&BOP7F?P1#J->/*,+_1SGJ?2PP.+FZ:.<QK(-^;Q[^[Y=+-BQI<+(\N
MX/MPN3]STY-^RBZ8ZNU.2,2B06(1LB^R[[@\'MEW6.SKG/#"&P^Z,"\(0@J)
M6AE ::-X9"JKZ/MHK'AZ]K44R7?44(3DB^0[+H]'\AT6^2I.3#:"@2=E+RN2
M,^4C*L!$3C*17&2I^DAZ/#WY&HGD6Q\48;\ 9B^NS5Y\SE:L!S;%Z3*%U6*)
MMQH,5L#M<-)X%Y8;!=S0X/-Z :>]5)3(HMB,3T6,"05.Y  F:\HM+>+,;PBX
M^^0NCH[=,OVEP^[]*]#=CU*;$-+;20G"SB!A!XD6B79<'H]$.RRBC8%%R6P
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MQQG2-D6*")XCD4F.XDP(5>2L()P<)C+5(8]+B7(]"/>3WYPQ EE01TA2@7P
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MZNN?<X A0P&[?G,WGM%R;C\_^)--/=)J(H8A6/Z%U[)'X^[$E*2]:ZBLE^;
MU)\==_48:H;C?.49O >\]6WIW/% -Q[#DO=]/8H!JL\\S7"&<-X><PBPW7(=
M,?%?L/NL<=O(5AE<7]EHKSDM^1,&5Y4M^^BVK*499]&Y.4YOY,7"><GZNA;W
MQ#9W_C,O[TR K>ZZ[IB2].3?MFXTZ\F_O7W2OK5A5_K0!W65?PU[*G4?MPO*
MG)AL?=_:YF"X YD[B_F5PZ.V,H:--_V^Z3((+.\Q]S37&7?6H"!W"NN_9];O
MJKXT1$"O/E1-O?(<:4AAZ(7HNW2Y/WKZ9CDA[VM]?#["CBUB][;4C;5TTRY3
M"R?BR+4,J[HJ@\9Z)NU9TY@W7BEK(ZVM7=E<.;OWI;:N$]=JH*_\670E'<['
MZ(Z)?1"^-OO)G:-K+QG7/VSR0MW:W+'IO!?"'Z^'J/WU\!+#X;I:+L=R/7MO
M]T;^ <XB![]CEZYVZE9Q*FW-HG3RLL?IJ4;OL@7@P=QGV,DYS*ULAUX4[8V>
M%3:&/S2D<^?^A'5-5KL%UUW +#)CI="P47S/LWZ)C[]PUFTKE<IN5.U]?'W3
MM.7UZ 1QK3STTJ\$Y]B9.I<^#\X])7 >4]\RUQX\5MZYT<<,H+/:5^6@QFF>
M2,Y1[L8RIB5&0A&%"I4F,H\5,P>F?9R3GFJQAO/1 <]'5L#1\];VD#$;YHF#
M';N5W>_=V*@-.)'V+_&JE[@'^M&4OC<<H-0NEV],+>U^L>J#-ULD82CEW-%$
MR(.HEIO^H&9-I8LK#>V>S[RJ5:_JR>EB0D(& F4/+6WWG1LOX1M ;UW+QWIL
MJVAKW_OCAS2G0'_N\1RMSQ*UW^UY[?40*QH=\%-/^>!AZKF"XRS=E?I KKOB
M&&/RU0@^WM5=IJM.?H@,0AA/-$DA3""%$%((CTNTLT@A)+;G42X%THD6AK<)
MCJC*.6(D(SPIJ>;E7F8!O?89\KXTSSL>_FD Z8DY^-KI!D#I#K@0.]E'K\?J
M!.!O>PT"CJ?/OA)D1[60]W_6'ZK6N6(,-1EG6=F:H)7BC6H-Y59CMLO;^LIL
MU3S.%U&O1<>:^CW4'6+[;>2+BH8O.9_0S2P9?F4>XJJIG%_1\RWGV[6]Y-]/
MZFN& HW!/],7:%1M]'Y3N3=SCJ8KW=AR))^1,K@R2]<:8ZVOVI^C'ZN?^CR>
MZRY5QS__C^U/_@W<D;U[BU_,YV]^P3SSI>OH]+ZVS4^<9Z#Y4,DQ%V9LGNEY
MYXYHP[7CC]WC.L6,OO)V5]K)\!W#8(V:Y*2GE3.(0TY(?V_WZ.;9^ZBP[W\S
M=.#WL=KM^B*?2V.]7I;Y^O(:%]?=ZD9L+_SA)YL76<O>8W?KPCTKO^,-1U>\
MJ]DUN]#Z/&SB2U>N9J3IQ_[\:&YU>TT[!^"/M@V-U9IM2[.N6J,?%\7>?<^S
MZ-]$8UG:<11$WQZ4"Q['[XT>WK%RK&^8]]O>F=/59(O;A6Y7?^E<_</NM,9A
M8AOZ_= ;%I^LU_:!1-\LR]M@>X>)W9P,'(S,D_$N0FF3N?I0Y31Y;+0V_E#\
M02]=CD59^M%8W2?[JD9?ENB/JC[:8;VA2]T?RN_;P^;.@Q?<&^2I8(S%+Z<U
M=6-57Z/?\Z8W;JL[+^\:8E5#1JAY)NT$NA'69G3MP(:_&/E8_ZNP(0^E74.E
MU:YB2/O4R@X(:]Q3KZNET=J.Q[07[*]V-B">U]AJ*U30G_+'F-\8*>K%6VZ]
MY7CL[U)?+3X96RHOT.9JU[D?MO;W$Z-MO*IMN&\G:MT#(=L!Y$D\4'<ZO!O,
MAKUT-WF8!-WOA;%GPWUOW,(&*<S9Q?F>NHENT]YA0TZS&QKGDXDM ;/WNJR5
ML1.3!.(;#.HO2S[&"MK%8'ZZNN%^;_]\:Z"=[7=IXV=C9;+-V9*\74_+ OKQ
M=GT-]6)PU/E@JQN+U]1B:V+/6LL+/W+/5_J^MV]9-R[,)V<;-H&]_MV!PW[5
M.MQ6YOS>5%=;@+9K"*$[S QMZGT0<#TPSK/HCVYG68>W7W#U-5^NKX=U;:YJ
M!&R3%48W==\KH,O0[U!RC&>Z8&6]L2%F?W5[^'#KVHYMO+;VJ,]J]TTC*GU,
MRQK<)M^:3-VOQO-A+8$?98\MQ=Q)T4^H^V!WG]G46ZD'K;:-<I<#W$ZVM/,A
M#(TI5M)M9(MG_/VJ-C@I?1,K/YAT7==+;TU$Y0>UVL3!V@TPK5?CGK>I2.;N
MXMK9)MO)RA9]=/DNX_16:SULHL,XQ74L'.R-BLO*>M<WN-AZ]H7[<J-M\VS?
M!^/*6$5CQ@:;9TCV9O+:EO :D3F*XC[S43>CM\!UM/GDJE,F[@.7566N;71D
M:(-E2F,RX&!5J_Y:?<F53S7;[9#H>\?^^\9<#,=]C]A5[<V[WJ4E3]9]>MK
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M H@$$(F@B<0,B< >@C$ C ", (P![A8 1@!& $8 QA#V_-'88P#&0!0!P C
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M),]*%&,L$*$D0TP9BFD^JU56I 4F8>2!I/DB#K5@YS-[:7HGLPS X $G $X
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MI J0XW,?9=(%44)1CG(F!2),,R0TR5'*1:9XP5FA'\(=\X"]65)2 &DZ13R
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M7OP<2&@M,,4&M"._$J] *8'@%2@"%'%JB@ S%:!20!&@"% $F*G E0** $6
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MT"77MR)!BFJ6,9HC1K#Y#HXE8CBF*"&%9$5)2"[#: &!\P4A!%)OP2X%*7.
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M,PAB>E7.W[)NGDX7WX#ECZT)D'O^]:=G^MGC:N4;YO/VTK,>(5O>JDV\R5G
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M/",\H_4/")X'"*]8;+AWUJ)*7H>0BPV.$TEE(I40D80R.&XCBR*HIZ(96%+
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MLIXJ\51$YT&J*OW=R6[HG&>@594'WZ(&2=;@)XBC(OJT/,+U0,D/>(Z4H5D
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M8Y7.SNRD78[_M?>=W'C(*9:DLUVD5/LZ/T3*"6><^&6:_Z$9 P7.1'0Z:S[
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M'>,>F6^(LMO18FUW5]1\_2$&+^%G/[^>^/$BQ%#4D\+;]K2PD[#\$/^]J#\
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M/MJV\]V3"8@SW)HB0;H)B?VR< V/,XVS+@T"> .>>3B=U6-X$TY'%P\TF8"
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MEE"CJJ(CL\,)UJ4#=&YR61>[V9#Q_44;QK%JTPG]Y6*6XTG' .H9(-B_@2A
M=,Y: "1C'54 6 9<'X_7S"#C'YS5I<#+B)91[0JBVV(2Y\6)K3LRTN'I)S#C
M>1R?%W_!.'4?3S?>2RLE"39H(BN=V7=0Q M9ECQYX\U&*:B,7E=6>2(ILWD]
M)LA5'40L[5(5*6/ BC;65GH7P8Q!59?QZE?05ONFR9SPRYGZ1AEHQ(484;JS
M26B19LU9YRXM9.!M+NKD<8'L0]G<V^7O("%XFO6XFC\OYC,[:<?+!B4;\@!+
MQVW7!9I3H(B08TU65UN.,C1PEUG^ICE;,NOX:=J5BKZ.+Q]VW_QF9W ?T24
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M'R\Z,[, 3K-)/&__\S\^@4E4/W:K&>9(5!SY>=-9"U^[XAUN.%D;_Q?YXVU
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ML::Z2:S'0*!UY;P3,W/-5SSQW*Z?;\_0'N9\XNK?PW9=3KK*!2<MSOIMBMX
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M%P]3D$M>,Z$$,)?3<7EC%L+#!"^*7YH"5Q0&_\1$MX\ ]@LD/#" KLQX!-?
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M=S&>DHU/R6R2VX%,_FH'[,IYC:F:H+Y<D9?+'40SNAV$V::.K^V ;X/D$MM
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MU8(V3H+WGL%NX[<%4S7KE<95VKKJ!0?4?"&H+_%;Z+@E(-A_H;;RKUUMG^\
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MN/:UG^] 28!L?(TJ9<C3>.0\C19,[#E3(Z=Y\%;4L^#OQ7A<:X!RP:_E?&P
M:0!T[YWPJ%?4W*5N]"G@EMR-M4N?6*%(GF8VC#3);*H(R_.<Y"QE\&,$$)H*
M&MHU]TH29R:.,T%LQL#4U2&HHT2F)%$VCA,CHRBQ>_+Y'DF749X=N0IINHP>
M9M*##$.5)*$E3-H,:-PR(B,)A&[#)(H3QG.]9B7NB\:'I(<C(_6AH<"^BW[6
M5>!2Y/5W48'E34-G:89-X-7U")A+K.B8^;QW5\O=5+1C;Q!GN,_Z(T#KU@KO
MPMKK4>\A;O4=O'BY,$I09DC"=$Y8QBGA4J5$YAATCBCGZ)%;EL],BDQG(B-<
M&1#L61Z3/#<)B1*=Y2$U(:?R^\:M6 C_5QD1BH'2$4E"<AY&1/ 0U%"JDEBL
M]79_^$OM(6X5CU@TQ*TVQJU6/4-=!&OPY3]<"M@\839EBH@,@VXL-(0+^"-#
M9WZ6RIAGX3X89J^^_.Q8>>+G75'9)\Y+DKG)5)XQ$@H!E&&%(+D!39&JF$8B
M9)G,]J(?!AOUF(%[8Z-^GXR"C.9&96!]&D6!'(4(B;!I2"R5(E0JS6FTYF81
MB<A3@7D$ HQ5!K1.!-4I2448&QWE41;R(:-@92S1CYM1T(^CKIE4CQ](G8FO
M3<_*NX90X87J0CMG+9P1Z2PR,+ <J,)[+=I -BUD]&(9H)35?-QUW-^#X>;J
M&8;@[@\;W/W>SGA!P1#6L2!)C@.P.9<@^TU,(L,R$3,JXG5#. I9DF4Q)8I;
M#9I%@ITI(DJ88A'@GS16?*TZ:XCN=E3!3I(C5Q;KT=W';^Q 4VJU4HJD5*0(
M710!T*U(DIA4V,SHT,;[:>P )/H:N/8+:JUM'1VZML#Z=';7U?U?NJT1Q.#>
MO9][MZ?1N]1?#P(\>/ *=J&4.^BQJ*^IRW&A'5YQ':DOVYOU6K%LR\\9;1'L
MOG31K\8A"N%DG/$=OKU;8A+\;B;C$@OU_UJ.\UZ[$:;M;-;ZY3YB @_N,KB)
M9K83P".<]O_Y7S0-7ZWUO0S^T\\A:9;4O 6N]J68S\I7TO4==XN$\W\9OG*7
MD[&X*><S>,17HU_YQZ4N!:6Y'@=VB&EM7K80M=T?!P+]K7]JEP!KZ)IOX@P/
M#_A>MO?H70A7ZF[WW%,I/\GP\&!K_V.F=UP8T9.49G>XD.)KW'Y5>I*';&^W
MBTZ2:']WH\E)EK!P\3^ZMUO')S1*]KG0F$7?>#OXH=I$0A=>>OI\I\VTLUE:
M1TDR:O]#^0RD[/O OO3=8/$7FZ7V2KTK2(Q7.UH5M4SMN)P?@JA9SPW;IZ39
M>K;#,7S?8X!-QT__GY]H^-,3G8G?K59-='N73&>! Q+!,D;:L)_?Z3B_6YO@
MO1+%?X.]$;R=(*[KNQ(.@%GO1AC]Q\$1/0,*.1R6/VQ]>5>)<%@"_;GQ_XOW
M;MCSO 83J_[E -C^#D>_SO.'10.'P^'+2CT:=/H/H=/[88!!@1^Q G_ZPQS.
M9A"]@^C=*7KIX7#K('H'T?NCGLT@>G\\T1L>#K<.HO=[N:V:*.E/WRH.PFP4
ML1!.)GJZ8,,3Q9>?84["V4KZG\M%> ";W_=T)^7QGNT3'N/_?L(CV\60&\7<
M]SI&E_JP>HY#A5&3E::,U%;&"8EU&&,Q>$*XB4*BK3:A3+,L3]0^LM*6TRLQ
M/6V]&J\I*8K[%44DWEF8ES.VM=IHD%O[H_=',]^.& =\WSRS@?0'E3VH[*-4
MV=KD2<PTT=R$A*G,$H&]6&28I)E->,*E65798:*UCC@H:FX-?,?D1$1Q1F(:
M)CS-8Y7I6_K=[5%EIX/*'E3V0>[YH+(/XA@&E3VH[*-2V9%-C4V%(1K'-+ D
M-42H7)"<YE+(G$K+UOIXQ&D&5G64DU2DEC ;*2+SB!$58J=N[%X;W3*P86\J
MFXXHBP>E?;!*^Y%]]=^C,.!P-<WWEC#_;/L1;'#5/_#5<)L).TEYWO]? FN_
M_TM_T["Y:5F[7I@O*X--#*[,+0SQ@CYE,NUV*;3O+.JCEE:'E>:\*5-@@%.'
M(NPVPZDLEVEDDIR('+T9*1:K6RT)95IE)N$QE6NSB+XE:-&*VOVBJ9AN:B-X
M^%+LVPL"!G%VM #J6STFI\!9XV[[Q:0F!W8&@[)_CMPQ*/OC4_8B852&DH@L
M,SC?/"%Y2A/"N<Q5QJVEV5J&PK>$.QY'V4=)-"C[09P-RGY0]@-W#,I^4/:[
ME7V2ARS*0DI"*ADH[C@F,A$)43S)318GU*;9/@(ECZ3L\[U&209E?]1AE>4@
M6'^7$W?C_4&'?GNY9+'?0^CEOJT;RUG7\_]P2B26F3LZB9"[=3G'&-%!@Y0A
MS>/^*&?7\0XXYP!EQF:<PTUJ<Y.GQ*0A)TS'0""QS(G2RD1I8D5BUW(X']0,
M>$]Y(%%RH/46MW+)@'$.09@=V)[_J/F> V08(,, &9X79+")Y6G((I+H-"/,
MYHSD5.<DE#96H;"4F;5Q2=\2!]E[ZFC.!\@P0(8!,CR'@Q@@PP 9!LAP+) A
M95Q&@N=$"T$),SPDTBA+8D%-&,9&:K:7:,J^(0.+#[1$=( ,#X^DP+\Q\K9A
MMI@NKK8$+7"M/Z\&+7Y^-14:IQ>V&T ?:4NW1L^6I^NDBT4>+'R +6^&1FXG
MR\>>X_5TC? >6>C2B*T-=OK/BRY,.!7GQ@L:(BR\\4LQOA8W]:N?@O_XULU_
ML$CX;DT(][OS?WO[Z>Q#\/KLT\>S3Z=?WI]]N'78V+"U=]S:#V=?WGX.OIS!
M[G[X?/;;^S>G7]Z^"=Z]_W#ZX?7[T]^"SU_@%[^__?#E\Y*P[PL6)\?A%\V(
M0=%#)'<>,]B;QW@'1:"+>CH6-R_MV'Q=/]1_S>M986_:EW17D7HFJMDK=W0$
M]ONR?HDC?,?%Q&P\Z,5VL1,:WRKFGYTT6]K2;C^+"6X(<=NZ\[FKO+)CR_L[
MF?#^_W*<-=8KZ>O1P/*"GOUN;Z[B#"H#2ZGA@HW#G^&6."Q:U-NF20?J BC7
M] :;.DYL_EQAR/;W R+8*R)(!D0P((+CVMK](()]&: _;9FNG"6I$+$@EC%!
MF%22<,TL,8E)$I5;EO"U,>'?EE!1U\8L]]GX#22YFYWZNYC-*_A[Y^3E883R
MP_/P+DP ZRUJ!<O&$<AV#AMOG-94J G'XYYNG8H;/QT9OF(V3T1VHX^W#$5V
M4Y6/9/!Y?_A@@ .,5J<V!R^*_J2REYO>^Q!?++A5W _3IO<Q;3I.OL>TZ92?
M\/@N<YJC$Y[F^YL.G9Y$>?HX8Y(W)X__L%'59RA+07S&!Q*\.[##_%%#Y =V
M#$/@>^BB>%3A[#!*XE#D@H0AVGA9Q@A/-"<TYH93L/O26*S:>$G.<YGJA-@T
MDH3E*B)<YI2@A9?R4*6*VWO9>!\;:^+-W'R QWRY-N,K\SL\\Z+>3WOD=*\-
M XY6NGW_0/:>4-T1]PMXAI('4!U[PI+=9W28SPO5[:]V^L".X6AV? !ESTPT
M;IE&D1E)HY@1K:4A+(PX$7D2$ZZSR(C8:JGU4X*R_S:B^G)=[@>+\>PP^SD,
M,FGPL/T06"PY$"_!@1WF\\)B@PUZZ#L^8+%G)AHW8[$\IYRG-"2QS2QAS!B2
MQRPFC,;4*)%(F49/CL4N*F/V5!<2T@/M/C'(I<$W]D/@L?1 ' 0'=IC/"X\-
M=NBA[_B QYZ9:-S2Y2MCAHHL(KFDV.4KRPE/N"988JL!C%&5Y$^-Q]Z5\VI?
M<(P=Z""302P-[K$? HYE!^(C.+##?%YP;#!##WW'!SCVS$3C9C@6IR;)M>8D
M8ABJE'E(9,9C8N)4F9#&F4SYD\.QXFH_WK&,[C56.0BE0P=C1^Q.>882Y\N%
M@6W'HMX#<1,<V)$^+T@VS \ZEI,9Y@?]4! OLU$2RS0E(I<189G."5>"$JKB
M2&0\3VSVI!'04]0(>\5Y=!0F!^IV&Z8,#5.&ABE#>YTRU/8N&"RY0V'7P;TT
M8(\MY8G84I<K32(C0\),Q$ANTHSDJ376QHE(0_:4V&,O<",99=E>X<8@CIX3
M>CABC\0SE#O(^2^#XG(ZQZ9'V/>O,O7L.6#_P<\Q^#GV@#6>(<^^V-1":\!,
M#682*<NXSB/">"H(BXT N$1CHB/ 18G(-9-K;?OVCIG^Z+62>_M5P:6GE_C3
MO@8@97O-6A_\-<^CP<TO0V+6#PK3G /G0/P'!W::SRL,.$S/.G 9>RA-Q(;I
M64>(31G5<:RCD,C$*L*T,D28)"<JIE'$ )G:C.X#FVY!I7M!GVR4Y,,LK:-R
M'MQCEM;&W\)7OU=#_,-#!+@9C]^</LZ%M;'!]CBY)DR&DD@I!#$R3VP"8B:5
M:W/XOJ4Y_1LC9V_ E!V7];RZ;P/Z6X^?'PB^^+[3$/A)\.;MKU_VT6\\?2X;
M^LCJ]VP2?#;36=.9/G2=Z>'/TO?J?PW4#,HQ>"-F9A1<PW]_-Y6:C^$YK\6T
M %-K%+R?J!/WA?:CD>OH_QD4*3PF^*<8C\U-\*N8_.6N^OS/7T>!0U_>C5X&
M(H ?+H-Q"1MIA7(*N%O!%_SH-_AH%,RG 5S]OP>?WLZIHS+3- M)PF(&TDXH
M(JA)2!QQE2A*PSA:PTVACA.M4T.L<7/!X%^Y,1G^$?*81S+)XC6?7C$Q9_8U
MG&$Q>]><V>_B:W$YO_RUK*KR&J@&* 0^V02F%A#J_8=WNS/K 7Z$(?ZW%4@]
M<P8$MKHHU$5P+>H MA@$&+)%<#H_G]<SY$;:\<(9V S%1(P=/P2GYY4Q&&\^
M"8")_S&?F)9_H^X;;ZTUL%M7IN/@5=:K#2Q%^R?CS9#%=CS+W7FQTI&[=G4Y
M?W2S/E;O[J\7YW#M.2PHF%;%1!53>(QP7M] 7(G"SP^!=<QK6*6J$)GKP%;E
MY<#\NY,@1"12P"U$I0!P6 B6$T]C3IA-0JKR1*A4#LQ_2.<X*+1;:5JGTDVI
MS*2VA*66$P[0G409$[D-LRQ5:T$J3<.,&Z-);#"P94)*9!II0J7(3)A1*K/D
M>]$TC8Z>J$'-%+,+/S!Q(>"E02"YD.^@XX2[D7%#GF:5F*@+XP8MRG^!TD+6
M4*::"1R*!""P=J@2U4F!FU6?!*='/1WJ2-YKA/#>)=7"60VB;F<'N5!HEE)&
M:(2B+H]3DO,8WBH.0Z;R6-#U;KZ*RC#D>4) \0/>3W5$1)):(FF8ISS2F;!K
M/D_T5+R?U+-JCI#LM:BJ&V#-;6'WNXNV)#QVR19< /25QDP"78GK26^HW0H$
MWH>'8I@XV.SZ;>;$(%5V214 \&E.I27:*@42(LJ(9 #UXR3F>9I%2<3LJE3)
M)%5<)QGA6DO,#%(D3[4@(>6AC7-KDX3NEBI_3.9@M*TAIX<+F1_ )@# 4QD<
M+8V R7G%>F:RPSSKHR057"5-(Y86(R5?!B_$+XY);%'5LQ9E#;KX-JX!0UJ)
M*,Y)&H4"#>B4<*DUD2&+=!)Q)=1:+6.>,B6 JT@:THPP$4L,&$1$Y3J/#/ :
MM^'W,CNBX]?-1=VS+M "<=-4S48#X9%B39F%4Y8F N&J." X [(V5I(DTN9<
MY(8G)EFE&J:B.(H$)3S--&%:@K&JP, 560:4IJ1.XOPN5+-&+F],K:IBBF?\
M_#& $=6X ($'@BL. RUNO-&(SD1U49@K![OP5ZW)J,8@/Q5*3  ,MIB W"O@
M)UB'J6?E!(W.JA?YH(D3I(NADJO1VZ/@D27C>L/F.9-]L46O@A?RES[P&M3'
M'=5'$HD0V%D0S%8!]9$I4 61(DDL0T/3-#3A6O-)Q= 3RU(<FYX#4!,&C#KX
MH@U#991.9:+$=_-:_6#JPP4;GE!Q@)RGG +@UA1.G''X@]/,D-0RS7D2):%8
M4QPRCC 7P1*A8U <4982&2%$B6A.C61IHCK/_;FI)B\[BCAMW_/S3%0SC PM
M'[Z&WUS"LRY SMZ Y#5'H$#^(29S4=T$]$>0\\#ILV+\E 1L=91(&H8D=V$D
M 1A(Y$R1B!EM$IDSG:ZYZ>]-P&^_3HOJ!NGUS'[QJNCX";>S]0:(LA7?5>9\
M/A:S$OA[@5Y\&DHM9D5M&^7<^WX)]Z[@B_^>%Y6[.:(=Y=$.F [5 ';NWO>'
M<A:&J26YX^.8:9(G!@SF*+.12;*$BC6PPS(M<QDF)-.Y(8Q%P/O&AD3G4AEM
M<Y9@6&^PE8\1[,0JT5)%EBA-E0>ZTN+@')YE@'&IY.MQCBPU84@IAC@L!4 =
M@;T<)9;(A&:243"WTW  .^WY_FAV[=/C'<9D8C#!)N-1CM,%-!$A$"7-10CP
MW5 :A0^FX1\2[ZS1+CMNVGTJP*-\OF[Q/\)]LHQ\\(LO=!LIP+2_ ?W<->,V
MLUK&S!*:Y" )PBPA/ ?[G8(F"W5DE;+K"4HF,Z$!\PAKG$ 22) > '\ _7 1
M&I/!K[\?^OD! FQ]]#.[@-6?7SQIF""+<VTT);E$DA&2$QYFD@!2UFG,PBA9
M;U9EPRS5&J@E%Y8#R(XR -DJ);%(J<+\3L!4@_)8#8S^2+I#3*=5>869=C<@
MSX-B<@5ZP6D155Y>%K.9,?BO:55@.C7(]:Z4PY5K_//7X$59!<6LQC  -N(H
MJU%06/CTYI>3X._E-2@E^ T(OM]%I2X"ZI/-8Y^$\<YH4\'#WYAI61>SX/VD
MGB/5F>!U64W+RFD=ESW^[LW[UW#CNI[#,D0 ^U;7H(Y\S\5ZYJHQX99BYM:$
M:?%84P77PGNYFA108D#'DT+@PP#3MYKR71?E^5B5,^.%-+[;^\D$-L8OP"?;
MPUZ5V,))^[7#BC!H7@'U%/"2)\&9CRTMPO"N0L7OHU.96U-_1LO;BMLIK 5I
M#=Q6!Q?E6#^*I'F&Q+LE787;7(9I2KA56+,7:I)'H%U#I:+4,!9QME; PK1F
M.F4YR4UL039:=#Y22@1+E(DB+5*V[$C\"$<$BQ#G(!L_M6>,E4:O%R?\=S/6
M+O,(S[<[WB7-.IU7IJL,)E%?RT8[=6R:'*MN_=E1_4#ANP;3)9%-$Q:3C$4)
M9J=+(HVR)$U-3%.3)S86:ZDE89Y)&PE0]P8!8QP2@ $ID9+&5//<R)P=%(7'
M1TSAUZ8RP05L'FHDT%$N$UV LJCGXUF;EM#4 >./KN+QV@2Z#";E+/AK4EZ#
M&C+. 8W< KK[&M4='#=J,KCRNISCW<$6;"JA,*\+OG\]65%+@VFV,XDKCCFG
M,B>)83B26VO".0==PEFBHR2A4;[FF.9<4B8-A8N4A.]027*%G>PE-VE,LS2Q
M:^DX#TI];)@K76HLD>Q.M$Y.CM<X@QN,\0BW RS H1,$IL HE\;,/+MU=2%P
M_QENWNPB:!+ EK\?3 R"6XP%6ZQEU/Y[@!H[)FL\*8!BP5($.%L7WE 4GCEA
M@8Z1>_PI'&!&J-R_H85W0"[=FB8>_(F%,OB!^:K,M'79K'EA&L].#^LO^XB<
MVV@Z'1?*+:B7Y(3?6P]U^0(=$%C3YGX&;KAXV&(C C + WCM<EX%@- =I0W)
M[4^9W XR8%Z!^ BT*^!M^\Z"&3:^:3O4N\]JK*IW=IVW52Y@^_"7\-)C^+C"
M4GWDG)G+G-/&"M!6(R "-, 0*CCN 44E*J"#66':@BOXCL!O>:V#G%87M==4
M+?7Z^JR&$+=6#GL:[V<G;Y)9AWA(KMO+@NA[34OZ<Q> ["/^\^K@A9]?Z:*>
MCL7-2SLV7]=;4/QK7L\*>],^S5U%:HQ5O7*$3N#5+^N7$JSC<3$Q&]EBL6YD
MO>SGH^.3I3WM-K28X(X0MZ\[G[LJ6G;L>7\KLR2B&0?#,HHSED7)SZZ+S5=,
MN._ZV/1H87E9SW[/?_JO7PU0FL.9KKM 6VN 8F%:%=ABH&SP:!>-Z)Q0J%OA
MF3,S1I=.UY!@6N*]T4?S:?&ET^9+K;O)H674/(W.<A 9A8\+9 C0;Q-T>P=*
MU!>!%&/G9L)/)FT; ?@>:D^_/)! * !!/KT<+-.=3==X:&V>Y83)1&* TA(A
M0P'PV28J-4:K;*U5DC!*"IO$A%/#",O2B'!#.9&IU=:$L3&97;),$2R_;I3*
M[_X@7\,Y_NJ/L6^W.K-T'35_LTVZ8W33,V?4GUO=6\YGP&X>=:[UUM@&0Y$W
M!T-R%V.H-%-1SC)B(JSLH5R!40B4SJ30L8K22/.U@,V>&>,A(;WXZ!.:3A;X
MS#??<W\..&W :3\"3G.##N\#KYQAV0=1/><  *T;=&WX/)+"A<A\A+R<F,X[
MX0PX'Z@#+1*4T\9Z!./.^0E\N&[>%*"VV,UU -D!V]"K,D9'RNP"?CFHI!TJ
MR9HTC&R6DD@:@7[*F.2<&Z)3F](T39,D62M0%0S3<6-);(;?2:PA(@]3DJ6)
MR7BF,ZJS \%J[&A5U<.PFB_)&_CI,2KVF-4F)8RKD+#06,*UX03[4#/!&8>_
MUBKV9)0)%D<D5/ '$_!%GF@![)4PED8Y-1D]$'Z*CC@>]Q!^<CH1O=L U_XR
M,\R21*<_6$3HK32Z'BRCW6RC9([-UD@L<.ZBH)C3;"V)M9#4<DK#;"W$%FN6
MF30'0THS^$YF-)$FM"0UB0([2^A>RT''-K^[LWDMI@W/?"G_J,V9@QQ?KLN'
M=1,Y>M/H%1(S5C;UE<83)CM&1E A%0C6E.)DSEB3W$I#\C3GVL9,:[Y6VAIF
M29[:)"&I2W<0:4:XC &R")WGJ>%&:;%,(9XP^A+T@YE]K$H]5W!3D+AS4_^.
M&X"RUXG:HM1+I$%JHU[J>85=].MCR(6LBZ^!R^\\[AS(8 )B>^I/&NP8?]2H
M$\3,S7&>#;AGEP"G>9@SDTL2IR&VNI<1$1S8TUBM-4UBP?+UAM'W9<\^[NGS
MZ#*#GIX#@]:S=V5E -+N"?CL&*#[S G? 9^-Q&^;'6R-<+C3A<LHPOR$G2Z"
ME; -^@%*B4K#Z)--'K8A_/_P]OOK?;I;1+N>$7"-4^D+/8#2W8,M8QY3'AF2
M*:7!EA/84T"G!)C"*DMSJ_.U.%8N,A9S:V!1>8Q&("<\2R3),J,L8['(9'1;
MWA?8&M4,7E*_:49:/JSERE'#4M=$OAOWT*2K=#E6(+_*\PENI;].PTX'[:!0
M%X!VB4E^OQ'0NLY%JJQ=-E.7)&.^3LVD!GZZ:HR_<6$[[G*=]>:U=V*:P'0L
MV'V]0EX$87A1ZI/@M)?7M;SJVN=>^3"UG<\P[;.70N7RQ4"0SEP86@=U 7LG
MJO'-2? G/DS-*PQQN\CY5SA[D+TW X/O#E1':1B*Q,VV4,#@&JS.S$8D#T.N
M$\LCS==Z6GX;@UN#A^,K2\QKH*_Z;U59U[L8.[Q#_\JCY>IBLYOQ&;[*V)PC
MJQN#0RB0EB9-15&7];9!/?M)'JOR"Z77LTEUZR>Z 9&:KVH\U^9;YU8]'.@M
M)C4^<X*B4;H\_ RS"B^Z"<13L(C\.#\B,)[W4HROQ4W]ZJ?@/[YU\Q\\,^[I
M]OY1QX;][>VGLP_!Z[-/'\\^G7YY?_;AU@SF86OON+4?SKZ\_1Q\.8/=_?#Y
M[+?W;TZ_O'T3O'O_X?3#Z_>GOP6?O\ O?G_[X<OGI9&*AR!8CL2"Q$):%_D[
M$KV+(+[^/A#_78/=T=CHMM6O9P>(?T)?NDB52I-4D2BQEC 12D# <4A,K&@:
M9Y1GZXT#DD0GH8PXR?(8<&^D(\)S)< 89I'DF4XS=<N$B(^^R@"K!^OGSR^[
M"BY\49&Z*,O:E?7 ^J;"5YTO(HJKM3/H5%NU^@+1I>2LCF##RYO1.*:MW^AU
MJ_9]VN/4N^[KK3?J*+)?%=2_9V-1=YG0@T&Y*YN&Z227(B%"Y)0PDP@B=9;B
MS.F(<R4DU_%#&&NM)O=C=U"OW3G=U=F]>^(T/3G^,/]::-_1?*$?1Q _PYW:
MDL(<F3##7)74X$!URQ*21_ACJ#)0*D8D9LUE<F\*?X.U9M4J;<?I[TZ6N33%
M3HKY3GQW]X^Z^"S0>Q>?_5 >*ZUO$..MM!=U;6HW#A-K5S&<L[BT5.A*1+ #
MH,GXG*_;%<G)/<+#![E90SGJ7M$1$-SDO)VWNK.>\RD[9L6Q8%EL219A,06C
M(+UX:@A-E<WS4"59NM8S(Y2*<QIS G^'A*78:#IU02')1,R%3#5?:[)6^BX9
M;IC[,<W/6!JE[8N*,4OB<9)"MQQBGH@\DUP0FN%83ASJF?.$X:2<6,.9PA&M
MIQI\PR$N6R^_-P74/T;GUS,U*UWOS!^C_5G9R^EL#[JSLW1;RN :J^!<;3]!
M'O.C%\$\&K4:<CXM)W?IP#E:*GC=,E[F/FKU&6[]4\H-:B.9AE(3'FJ!,RXE
M$0F-B8YB*40B8I6MS\74N3 Q3T@6A@!=$YH2F<<9">.(QRJ))5?9;KGQOG$1
M?0)J^E741?VN7(!7_.7S%Q9?EI2"!!%8+SQC8H;Q^7'I^_$Y/]G4-2P"#+ZM
MOCHPA>LU\J+X)<A/PI]=ZFD!/PRFV0[33&LEPE #I!&4$V8DS@)3DE"56YLQ
MFK+]@)ME^G8T_1EV0>BSR3]%56#K&*1K>E=?!%IH_Y4?;RNBGX/I>%ZW3H=+
MXYG ]8F<EA5Z@4$I( _]*< X^SRKL!G1/\IYA6KE17:2_+QM7.,OOBHG/HF2
MGX]=42P+&4PS+'1GO\(.%BX7L14[9*FOS=2E:2],D=?CTCGSG0/4]WS_4%XU
MW<+]UK9CP=?V_$GME9CGH8A 1R4QQ2Z6B2!YRB5A5"G->:1MPA_"TL[;TFJH
M,]@RG]#>\]0?G?6R0B&>,@PV.8;[_2ZZR4XGP1^WX+@[H#=?(KOQD:N8TA.R
M[['5I=S7FZDS/G9F?]>K"S;^=$2_J]FF'1UU3=46T9:%P(#S\F##[2M\J8D(
M^MLV@L)Q?,\QC,W;6ASC#V*SE=#0BIVW#^\W5.O6T+6C :U7!J4<%^<N!H@!
M(N%Z+:\WWMK2CF; 0;MP$&/",!D2&<8,6_^"T+0X>CI);*2LB<P>A.8R"'H[
MT6?6M45UI[:(T-P+ Z4GR?''71I27F4.$+(S(&Y@3.DZ7AI]$GS&\.8FGJA!
M<KJ:9:6JN>>@[8%\]\VUQ]T]FO^$ZEXJ9@18FB24%"S46',BF$U))D.:\#"7
M<CT?]>$(_KCB\J>^RZ3O)#'RSIBNA,OB,4L\>\3-./[7]?>@^:NF$]EUA0WN
M)UCQ7B@7NV_;L#OIC4J[">8C5F]C)ZA)X#&M >LB)ECZVXKK(0M[9Q9VGK$L
MT2E)#$ZNSBE0<)3GA&.B=9HQGM!]R^NVSK-3UMNZZMZ]SN+XQYULJ(]WB5'2
M&5J=. 6<5/7#ZVU'"9P*T7(*HEQ3VE]\?A9P4BO)\>?YQ-4FM=*XT0.] &51
MWY:M DL=6&XGRZ4T4=*2)-$90*04V$>IF$1&2BM9E*3)H>2I_"#)*!T%>WSD
M<LA6/@&ROQ2Z,0EN%@V>EQ.][)+IM.3I:&/]O:*BI?Z;JXEL)^AT 9V&$?_1
M:I8 K ;;PNQFQ-OLU"'6OG?W.PI'H^:5+]J%XT%AC;ZQ<8-9;/ W4Y63%OC4
M+A=D5G=]E1$]H>P=8_\M!##3J@0+>W;3UJ44WI?9GCR6R <3 [8L@JOIV&@X
M]Q5W'2X6B[)[OI.E=M%.[B\Z1H_<K!M4M7C+KG7T:/&813MIWURZZ]KN*O_0
MR%;S&@Y=5+"YB_ZOR %-RFWKKYF<UZZ #K_C"G0NI^/"*:RN0&?QL$7[EY[A
MLME/>#(DOOR(S/C>NPQ=A_1>@_3@1<,N(T=D#1=@FP(D-?03E@%F A>N4]XY
MZ#G3N+7J7T;+^8J]YNT./:$J<%Y#4 !FAO,(&M>2XP>T?L;C9APU&#9]].95
MS6:J]NY)X 83Z+GQO9K%C1L+4%Q>&EVX^M*>D]1GC1ED')0(D[4M&+GZ6[\;
MRY:VO[X72Q^PVZY!D3P7H<;)5G&BP%QBC$@F.8EMEK,$;*8-8[+O;2[UL=LB
M/O 1;.@W<W.VH*%[^;>.&,<UWOQ> ??V5F*-0>132Q;N!>'5JM#841,,5:_H
MX 00#>+]83?'WGT\7KISG]U[O+G&MP\007Z^D/C+^)(#+V_\&2)^6)^5T@F2
MK1*B78 4D[^J^72F;AI_>UV.07+ CW[*A)=^_7?<)*[\I",Q1Y4_P^2:\3;Q
M=?O8D=MKQOAS47:/6K/W%O".QM#5&[CLRI&KAV/H:PG:WA7U/N!%^EPV_ F@
M?@=V0928KR ^BMJQMW)R8=I,91ZWH:6-: 0@O)N_ HSDKT+9!2J[/5'=G>@"
M\_>'*,#ELK#S2KFG.!BBW&FW@4QLME'C5$UG=W:1T:+SP)T$#5)J1$S0V -&
M>X:_$N-Y5W^W:5V-_8E]+JJB"=8YMQ)V+0)+H6PC#1<"PP5FTBNFAX=OA"B-
MR*A]XCO8/;(9[>OM*B^^9B!:0!NZ#AM^L9.MBU3- #8GB+JE%I.VT*M]>6?^
MM,/:5IN6[-Q']&T[FP<69 :;XX>4"ELR58X$7'EY,'%-5:O*^9F7A$,/!(BA
MS>INV\&(C.=<YR3*$D-8%@J<_VE(*',IJ$A88M9"+8K*,.1Y A8#F!HLU1$1
M26J)I&&>\DAGPJX5_O;K'[Z]QTU"1S3)CCFFTKG4)JZ)0;ULZ?=BY0-9[R3K
M/,F3+!)$TS@!DQCL8LFM(%'.PBS/1:S61^%^"UDO!Q%?-^+H]MCA+60>'GWH
ML&D>[\7X?-'@KNO%YB'0IHX) _'?0OQ6YPE71A(F3$883S3A"8\)8SB-@1K)
MXK6DD6\A_GY?0N2#YIC>^GR;;R?_-.)'3?LN^;N-;V_(9AH(_!8"ITDJ9:XB
M@BT4@%A3020# N=A'M+<RMRRM6#U?0C<.3Q/_0&M)/(]H$$?'67\J'OT^1C?
M9DSN!'FO$Z47_E8457.=#YH=R4ZLQ_[<UBPU&]VNX-"EVZ0S=FKQ3IV)7/+-
M<@SG&_(;ASY]CT05-,J&/GU#G[[CVMH/WZU/WQ!SP=4WK>6:_-6@2=U>BK'T
M)A0^4IJZ2&,39J$EU$I*F+18:F$X@BMF94:%96L-& R5$4M93%2<XGP(^+94
M&+KF0HB$9P#3]*K%\5E=&#T?FS/;5-L4IL:15@O?TA?TSW^!I_PZ+M5?/P6F
M5F**I 58[J<AW+2/<%,OG] %0YHX3=V&,-KYCVT)U:AQ9N$WEA)5?'+PJODS
MVI%3=:SP,'CAHN3EO(9]J7]YN8]@R(,5U":2W;YSC[!-_^=_T31\M0:9@O_T
M=+=A "^&^U_)L@+Z<8L$DGL9OG*7D[&X*><S>,17HU_YQZ44E4QSO<(68]/:
MO&RC:^W^5(XDW*U_:I< :^APVU51%]*U[7_9WJ-W(5RIN]WS3TU.TBC"4;+_
M^1\SO>-"@,Y9>I?K\"UNORH_22G_QMO!#]6F=[_P_-*<^^:WWLR@49B-(A:.
MHB1R+ F'X,'O2P^!\1>;&16L'I?0T9 IT/JK;9*]1XY/R27/4"1A#?$20-M"
M(C_>87Y?D??8!S$IG\DQ? -//2'[_.\#X9V-]N7W.D:G.%?/<7!BMYT'&3<\
M,3DQ8<H(BT1.I#2:Q)%*1:AC8W6X:C-1H9(T47!1PG/"L-L=#T..O;HS'>5,
MJCC>%7E?6$V?VKJ<&DNQFO#R^\D'>-:7:S.^,KZSZKJWNTGFC?M^;[*[>7"4
MCCB+MWJ]!RFW/^[X-KWR".@N24;M?\<&")ZA!%KJV'A_=COBPWQ>Z.Z^![%=
M[C5&;[=5R706U.6XT,$RY1[8<1W-R>QBD;N>S0#V#E#4;@9[H0Q-&H6&Z%A)
MPDQJ"&<B)(FTG(4R$9R;)P=[_VU$M7',_3=@O)B-@(/VB?&>3-;UGP2D, B]
M!X!".$"\FYN=?1\(W]_EQ-UX?RBC[R!.%OL]@,C[QG[*F1@/1MNA\.?@61K
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MNKFZ"0J'?2D2[=;*)^'V/+GG+CVFH$X=QWN.VLD-%^+*H+EGOII*%;59L-G
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MQ^F42W$3R YD8/@%=<U-,(-[PT;/0(OM4DM%W?LJ*$T['X_!\G;F_MH@V%$
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M<0C[[ K[1'DLM;8DI=("FLU"(J.(DCA3D5&)CK5:\T4HE82&AH+D7''L)9\
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M"T>& +4 M<LU\4N<5@W<=D=! 6U[A+8@&\!?P-_=:^+'C^/J/-II_<?NZ"P
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MN8_/RH7U\7Q6S^PX#,=?6UO^0)/-S<#DM<ZQ 9,-P 4F&TSV/OU:3X?J?^B
MZH#-/RR;'ZET1&6#;43(]MMIAHSR#!$?&%.>"!MIQVS^LK+XHK#XLLI!4^3@
M$A/X+?\8P^>9G<7Z.+TYS=/C[;O):&2G=?.P5U6=5VX>)5ZG"_1:LD"/L 2:
M #0!:,(^3\4?S_S H697U 5DTUW9 )0= )3=D4GO7TY;B73'! 7"Z:9P'KOR
MP/ID+_:0^X/#Q=07G%K>_/D1\O"VH&]"&);]DAU5K9>VLO/9R62:'Q0Z$$('
M1O!)(Y!A)]OAH&_PVG4#,K=[[6Q4RELG$;>8(!Y*M(VD%(44O/,R<5U<89>]
M=I$XRB5GR#.9OT-P0LYSCIRVU@JM).=A[S$V%XB_B+99X?U#PVSD0)489HSW
MZ8P#"#M8" /C#<;[9:[\0]F+'I[Q_>__^DXQX:!7+U*OP** 17EA42!@DL D
M';)B]@4+P20=6AX^G&IW4%U -MV5#4#9 4!9-UE;QP0%PNFF<!Z[7@=$''1_
MN_1Y-O'_KB9M#'GUM>1W/RC4 .+M.@&J$#3?^2D_^%"#PP.['Y?BA8B)C8@)
MDD)@3DFDG-"(NT21YH$AKATW1#L1M'[6B(E%GE-3@J3^./XEO^,D_&TZJ>N'
M1DJ8@>)JH.1>(R5ZC,"=]NX_I-0@D)>#M*0'I#I]F?*#)R]@]1NK+TV(09.
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M X^N<--Z;3L&KH:;](EIG5Q02$:'$0]6(.<E0<%Y2["E5I.-YJA0![6G*C@
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MC7,93V2IFT00*0T'># .6:\=HBE:S(.76&_41GI"SL<'5)-]<KZGA+C-@![
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MX\TB6RA*BS!GF"<B F9Z'UT^GI"EZ@'&>SW)>EJ<!)[ZW'@'Q *(!1 +(!9
M+!Y +*0TB=FD$4TAE,,M@HQ)!!$M*1%$)J(V0F2P""%0G>F$3A%Q'PVRE"G$
M"!9:&N954,]++'1W4Y>!6'3&G@&QZ(@@@%@ L0!BT3-B84.*/ H4)6&(:]ZT
MIL;(1<V2B<$3:Z\2"R:5\YP:)*U,B"?JD3.4(X^=P8&DY*E\1F(A!]H((!8]
M(Q;K)VOYY]+U"WHTKDW5I:;#^?<P_/84?8T3-8Y;%I'61.:-28$.RA42RE,<
M-*.4T/WV-=[>];XYESMN^X;^TX[F;7?CNIZ?MI]]*0OF2]QW,^.N,)+G-BY-
M;U@[G%;?\MPW?<,O=W+].K7C67OZV9.VO!?=90<7[65/;%VY&,=K#>1+^]QE
M8_H\+<U$5/.Z[:T;JY]'^=6KO+HGHSR&=KJ6#73/LIJ5ZTXG(8ZJWX>SML?]
M10]>>[&^H77M-ECL34])KF_7)Y%R>IOK9*8=M^MMN/\;"G'+&TH)?17OKXQ=
MKWP,LNFX;%9%YP44G7\11>?OV%81L+A?^@ZR =D _D*K.VCZ 2K=51D>H$I#
M"S50:5#I7JGTSM9<D/W5\V..=\-OPSQEH3H?QE'H0&A&!\7ZW >A7:DT?">T
M?039;(?;BT>:SL:]W&MD=PM[,=P)2FA$F%N/.+,,&>$=(M@[K40BB:JKQ]::
M2D&D\DA:4IH->(HT90(%)K"CA.,@\,:Q]=9HES?3J1U_C>7P^N?S[>?9'^QP
M6LZQX]H9=@F2\;,8EBCTJYU=CI@YFT_C*F0&T?68&7IMR,SN.-PG!^R]"O^'
M#B##72#:= &A]RH! &@ Z/L M-<>F\A=!N@H$"<Z@RT.%%FJL0]8<Y[X1L)#
MI%I%G_'<A_R=B#5RF"1$+2;8Z)"$< #0G1(^ #0 - !TMW5T.T!CK+6()*),
M?@/BPIH,MDHA&GF*R1BGW0:#YC%23X5!RFJ#.*<4F1@)HB(I:A@QD@D Z$X)
M?R= 0\N,GONZEKI2?9N,LLZ5<,6J4;H.^, [*.'#<GMU))P#C/83N[T,)RKD
M;50VQ-D $Z.0MLF@Q#7+YE>IJ#:RO3KC]OKG"H>*V?['<#P\G9_NMMYXW7A?
MGS&&CY2B/37@+53,)EOS+D M&K6@,FKMB4719$++)2?(1D60EEPEYK6D?J-L
M4U?5PG[?HUIHLM?&=<]A_F''#L8?4*Z@G/**A;)%-\Z65&]3ZL&8O/M.BFME
M J5;:LATQ:7ZN,9_=[HX&/^^JX6DM#27C0B'I!"G0B)K0U[QW%I*#&?";AC_
MKJK%7HV_>MY^)6#\P?B#\=];CT7K(K.$H$AB1KG2)TD;09'$.E'LHB21==9=
M_ZC&_YH^C6#\^Z\6WGFG V(V:,0)]\@EE9"A./#R'RX/1BWV:_S-[8T_A#WW
M_"CHUV'];Y2F,5;#8F)C/:M*O8L''P?U6,J'=1P$,1POTOI%[*7@P2'-&<G;
M6*F0P9X@&13&*24B^$93K6?W>Q<P^I"QZ.,"BFY%"2^'<O!KC1\YDJ:GE/"'
M"NC@=0HA*/'4J(BDX5DAF,N[).7S?DE1%77I-Z_\82C$363P+@K!C\3N8Z #
M5X@.&$UP: %W >YRYU 6SPBW-N:]MXB(AXS2FBN3=^%."A:XE&(#JI_=;?_H
MW 4?B;ZZLX"[7*\0G&*1;/(H9+7(W(5J9(TQ63^,-9I:I[P[#(78)W<A1^S%
MA68#=P'N MRE$SJZ*_L\Q&1Q%K9)!O$4+=*16J0D]EIASDA*G3MU> +NPH"[
MO$R%T$P038E *BB..&8:F4 ,8H(23*2*DFYT$>BF0NR7N\B^1J5#6ME+/4M<
MI95EI3F%A+*^G"!"6-F=Y+"CFPZW(7!O&!*^"='V"1E-+&)14"N-%(;@O9T_
MN)OMH+M+.,J7K-#DDD%#=?2OPWQZ'NWT.9!KKR9+'(F5?EQMMM0'D]Q"P/FT
M[@ *@%L!P/C9P5@K%PS#,0.KDHCGO3HRCN5?N?2<.>.YW=B4W-NA"F ,8 Q@
M#& ,8+P=C WA+C#ND/0FLUP< K+>,>0\YI@(KSW9.-VZMX<(P/B.8$Q?.!I#
M<]KK$?.9FM-JSHG-P("P(R2#1DGM%,ZCD()(C&+BN7R*YK3O3\]&D_,8FR:U
MO\RG_B1?\<O(CJ%3;0<ZU<:%=*JV9>W90C[U"VQ6"WUIH2_M[?O2,G-D--]C
M&UE*CP3><QM9O=_;&6A*N_<=PTMNXP.R@::TT&X)FM)V97UT3-]!-B ;P%]H
M2@L=+$&ENRK# U1I:$H+*@TJW2N5AJ:T+_5$ YK2=MW=#VF!D!9XFRRH2"@.
MQ*-@*$;<.(R<XA)1RQ1G6 1?XE4N'U=;F203"B.#;4)<"H&,$0;10!T-@E',
M(K34ZI3P(6_[X&/Z *!?)$"[P)*A3<]#5:K%TH1<D [AE*S$3--D-])S?$A:
M"&F0R1<A[@)!AG*&I"$1N\@E3@0 NE/"!X &@ : [K:.[NCEX37#CGDDK&>(
M<Q50!F:!9(;M1#)-%F$#H+'S,1FFD<JK)@-T-$C+P! 54A(7G*&6 T!W2OA0
M/>"E^KJ@*6V/W5X=">< H_W$NRKKN7%$(B$USKLJPI 1QB-,A#$&Z_S/1B?Y
MSKB]'K,UC22\IP8<6M/<HD@<U9)$&U'2(I1:( SIY"P*2E+.$BN938>B%OMM
M2BMWMVL\$/,/.W8P_H!R35-:3H67I6HQ%B[OOK5&FDB/C#0VHYRVE&XTI>V,
M2_4QC;_ ?>VY ,;_%L8_<(N),RBRE-5"Q&S\530H6W#LE?%"XW@H:K'?OG37
MJ 48?S#^8/P/".6(51ZG4B-+IKS%440AF^T>$BI%S:*CUFX$O'3&7?^8QI\K
M#<;_Q:I%5(YIK!1*JC2ES>L:N4@$PD89Z8REFF^VMNFH6NQWYT]VJP6$/;^P
MHR!H2MOSXR"(X7B1UH]3;)WW$LD8(N(Q161,E,AGCHB#(]*K#8_0L_N]GZ Y
M"N]M- <T1[E6(5APR00?$27!(DZX0IK8@*)(+&#/"28;W8*ZJ1#[;(Y"CU1O
MNS1WP&B"0PNX"W"7.T.U%LJZ:!%SE"+NN4:&Z("TSWB;L)#*=<]M_P3<!?<6
MJH&[7*L05%HF13G""LYD[I)5PV*)48A:<>)ID&S#E=5-A=@G=\%'1/95(3I@
M-(&[ '<![G)7J+8Z&.,50Y0&CS@5!&E3NI ES;#@P1/?O<.X)^ N_85JX"[7
MDWGNA8DR,Q;I2%[<B2#G\N).GEIF1?(I;@3@=E,A]MN45O0U, W2RE[J62(T
MI>WE"2*$E=U)#CNZZ"B>#1HQ'.'$\GX\NHB,=!8E)RAET8;(V,8>7E&I16(H
MIA+6S1A#5NB E'6)44XCWW'^\'2MMT[S@$\.OO>6? &-M]!CL-0=B]U1;[7P
M'"F/:=[[)(XT<PX)+3A14J@0-YI^LF2%]32O;H>S@@2OD.-YL0?!5!(R4L:>
MNP-S/Q8[H2]@M9].H.GGP?O0@'GL XRQ\99:A9$V(8.Q8JJDP&*D6%*):&7(
MYG&:PE+92")*P1?F(1AR-I.79"WS4NI@K 8P!N;1.>9AJ/"1>(H<50EE_J#*
MPG7(,!H$9E9F,K*EPVW"*0J4:;A&F:<[Y PNWR&4<VE(XL_=;KP?BQV8!S /
M8!XOAWD0C0-)JD0>E!2<H'P&8YEWA1F;+=/&,[$!QCJ$:#S6R-A4V$I,R$B=
M4,Q_X)@0F90', ;FT3GFX6-*4HKBV[,$<6Z+_R(J%''6 I<")7'CY%=BCXDD
M*5-S(Q''/&32(37RD9.L!1$; 0X^8!X/9Q[K9V_YY](!&1I)KTW5U441AM^@
M2?Q^6ZI4P[IJ,*F:C*N383V;3 M1JKRM3ZJPO/2L!:RZ:;#^>ZQ.[+>8/QR&
M:CRY?&E= B^"G<6CJG2CC[MJ6NYZ[NJZ87ZS2:HF\W(B/?'_SJ\U'/M8S::V
M-$QMN[;7Y=OE$C\YS9#87EF%21[6+'\VG<;Z;)*'G,?4?J$Y!&U?H[1U+S<K
M3=WS4_,B:YZWN&\>WFAXFB45VA>9#NM_+WO$[TK,O/1.Y?:_'7T^JO[?.)U4
M;R?S/)#J2^:I]7QZ7GV>38=GU?\4"=0%WYO+XZ63VN&XRK8K?["\6YG5,L2O
M^6&SYDMY'=IB0Z[,=?/U?&$[&VMO%/+"^)8O2-/):67];)XG?&WNX_<X]<,Z
M-M-S-JEGRQ?^EM^S3).W60*C46/:RG!L<^4TYF5<-\NC#/,L/V02RO-G>7GF
MC^SLRDB:%\C#R.9P;="3RN77F\_J6;YI?MJ.EXJG9Z/)>8QU.SCS4W4VG_J3
M/.U5TP.^>='XG_)J^9;-@)9_;T=VM XQ]P430@%-&C3Y>7V]_SS*+U!]]B>3
M4='>1MS+-726UUA90Z>3$$>#YO)VA&4AY/V9S?I3EEEF.F6%9E94?2NT:',A
M+Y=/ID'EAN5.Y]%.L]0W6BE7I<5G\R]IENIZ+[$#G_CJ=UM7?[B>2-_OB0<X
M&3NB/B677A.&,*,,<1-MWO(ZCX+E1N?-+]5F@_MK*@61>4LL+<%YH^LITI0)
M%)C CA*.@]A^WGF?(+?C=D7_K2SH^N/XEP:?_K70BC>M4C1_?)>58K51N!3K
M]MNXV*C/LWQ!?9S>-$S)OIMDD)[6S4.W5Z.XH;;ZD:'=B8/;[U(9@-)<JS3>
M&H,CMRB0D)4&2X,LSPI@A'+!N)@WTYL%6B+5*GJ/N \B[[1+U2.<]\_48H*-
M#DF([:[Z/BD-.2(="A[=L[$IQA/TYMJ(ZFA,B!R7DL8\ZP UR+GD\_,P(]$&
MR]1&< V/D7HJ#%)6&\0YI<C$2! 525'#B)&E*5[/]08?Z0X5!-NSWN0M1U67
MF1E492^:MS)Y S8Z;_<VM^:_-^]YEEO(=2+<DSD$/@\0NZ@=9QAC1@1$(\T0
M&ZA"ABB%6 S*"4Z,5?)9BX6\_\]\.#O_.*YGTWGC+SO..CG]<F+'SPF^I;Y.
M;Q$6Z/P-=-YXD3?!O"QXB3B-&IG .'*9IF NE!!J(]'K29/4.ZLSHD.YD<#F
MGYK-!\5EB3LC4O+B.LJFQ@2#-(Y.&NFT#OI9\R,[JS:RMYZCW63^37-4U9/7
MW.#;/7FO036;S,K)YIJBY5_*"5X<V<41U'Q<SKKRSXV<EV<7[:'>XA"T/7*K
MFR/&\UB^[2=?QWF\85"-\^]EOW:QCYM,4QS.YGF]-*AK2Y!'.;483ZJSZ<19
MUYZ)YB]9?S*,WQJE;[9S:T=A9>4U.^BQCZ@=S*4CD0%L'FX^#"#,4ATM\C3O
M 3A+*J.SX\A+C9/1>6>@^%5$)S:3)^$#8J+X9Y2TV0!@C?*]5*"&.U^R R\C
M^OO%7OUSG'X;^K@=X#]-%NNLP?+Z2UF8ZW]_FY?EI\GL?V(>R7)U74;HS^_6
MD1=?[YE4 V7( .,.5=G<MV[G$?B3YNCW\H'RA796DVS[&B?).$OXAA"T^PUO
M5_1[WJ2Z3!N0#BZ6ZB,8:5<21HWB&#LM#=[HW!N)HUQFTNV9)(@3G)#S//-V
M;:T56DG.PY,MO99#?)A,%Q^5ZSH6E[;?]40[%X:Y9RK3R*F)GK$K-^32VBV]
MD=G0#.N;HR5N#$TC^E!B)=QD%!YMSC\7B[V<XS9L8EWO"EXM%+?Z93HIT533
M>A^A*O)09O^1U_R_XB)RZG(T29[V?$T]'\W*?JD-C6H#ER;M_Y8XK._^I GP
M*KRL;H54+TE9R_*J>7U4?1Q77^,X:\\BP.7RDPKL7ABA,K#I(@9K+62J_4L9
M3N%]]F(CV!X97!<7<U+"^=SYI=?)!K%8P&DY#[ E)"</KKES,9/CND3I+ >T
M#/):!EJ5SRZV.26DJA#5EOP>5?\:SDZ:2VQ81-;EK[SQ/B^)YBZ?"W5M>/)O
M9TW@6E[V&F$U.+1M4OO],LS7PVPJAW[G OMXFAE]2^";994M[?+@IFIL,6JU
M?K&-7YNM YN2W2PLZ\&;S[]=R'K8QH6EX30O_?_,[30OKK)0RB%6JR*G34!D
MN^M9!CAN#_>ZHJAEQY.&W\NZGC5W:I6["3U]OODD>[72/5D7_XH7(%2O6\%V
M*WMI0[[ I;(,8#][;2L))[CFQ*+ 2[R!XP(YR1*BF1!882B/Q&PDMEAEC=0"
M*5:"VP@GR*D042*I%'V+#!MS=5/QL:[GQ>]PG!H"\V8<_M58I5F=]P,+PE(?
M3]^.[/"TOO\>E3+1[PTJK.9K_>W.*V^ISUMD:Q%/BB'#3$0^KTEIHPTJ;$2=
M2<RL"IB@D()$W 2%K,EJP*7AG'%&+97/M)HE[?-BAO.C&]>S4"E1KR-2492S
M(%<J;9*(+"$R^.@B51OG1XD[*8S!B.C2,=+0B)SC$66LQI)23HBUS[2>A>SU
M>EY&3RU\_V>3Z7)',[O/GFO<%^)V$6TU6(5;73G[6O=0Y-61=\JC>;AW%N/#
MTVJV)](?X-P3QM;FMDT2_?/)JCSKF?T:V^('R*;\QJ_MZ'=[7O_TJOK3LZ60
M/MW</ZJC[F_O?SW^5+T]_O67XU_??/EX_.GA+E"8VG9J/QU_>?^Y^G*<9_?3
MY^._?WSWYLO[=]6'CY_>?'K[\<W?J\]?\@?_>/_IR^>K>< /!1;P09?1OVW3
M9!NN4/T:BRMSX;[\,"^'U-623ZQ/?QA^>^0#,B6<XDV1!AY+K^Q,F9PAH03?
MI"0\QDYMU$*[RP'9US@=O_[L3V*8CS)5:F>AF83E'&2VU,[ <@*^E&3\+_EQ
M/X_R9:^J6'M[5E;==!YWU8D!9_Q=%V)+IJ;K"S&U"W&XD$/CM>YO;$UQT!='
MYF0TFOQ>O^Z I>E>'8AE@8RF/L9R2(NW**-];>>SR4^N^!>GS2"'XZ^O\4_-
MY6ADSR?SV>O&4_Q3^SC93.+B>E^BVL[J^+J.9[:D\B_GITFL:&_]:EM]_&_#
M>M@&[[Q>WF-'E?SVJ8H=:2-_*%.[J^I5>R$YDHK?ZCI\BZLH/>+LGG>#-N,]
M1^'CM1"S2_O:[G18ZIB0G[LBSN/*8CPY'$GT9M)O7Z3P8A/X7()HC.*^)7&
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M:*"(8=^'GOJ)=V>;Y/>0Y'*=@CS^>>?^9;75(_4$6XF]KH+USCM=ULW[^U!
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M"@(PJ$M+'WC1P?"B2(-<!,:+B'ARKISU242)]S1JP8G'3W7@MV]>)(X4\"+
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M?!'XXE/PQ> D=HQ+A&4J@92R).,H@IC# 4?MHHU/EF'^Z'QQKXDWO85:X(M
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MQ)4E2)>6[DZ5''4?4N*;X=%[J?5;S,)^2L5T.@?]SJV2 -N %P O %[0)>$
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M@]Z,PQ .2\X?)*O9MPRC(X3==CMBPG[ER8QG<Z:I/::KNM%C5P+LSL4T%H7
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MBFE90N&NZBJ&:H6V;NBFH]Y:'K7,D/LZ#Q7-4VU<MO$5QW8<A6NA:PC-M_7
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MN)&G"?8!X7X0LPP+)U@L+D5<T>*S\ 4"<6:4JXSZHUPNZ>=3AIF!+./.HK+
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MO+9(X#PQ6S9_PO(C^Z5,%_:J7-C:#!A&'G\D0&@6"EX&(U5291T)*Z;+Z0L
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M/B6K?*I_NN5/5AW)<@Q@7KEGG\N.7SBN3@>!UYRF.3@5[0,;Q<NRK(6,+%)
ME1LIFW'Q\6XXW&:YC,XI[:UT*HT%:8*.+F(0W/Q!LD668*UF7LN8JL?V\72M
M##@?-2V#%&J#("P-9!9^!+3W276V-%&'!VE9K\]J>N^5]1PE,"RW*\&JN7G5
M] =?I0Q+#5:0X<URDG5]A-%U7"B+(.?EMD4W[XSE<S)CB"G 2Q[%LEBYJJ"X
M$EX.I%LIG]A/+D4NG>Y?^<7T(\#2(.(+!\KA3:ZN^N?XG'VX*]XRRA>7X4&0
M83I1>N6B[)HN82M'+,AEPK''4 !*W:\]-?8D? 07GRPF]2[*&F6URLH]\'UX
MF5=][-2=_7(^2#[S<"I&6791@\NR2%$V1E3)R9L$E&ATSJYXA.#R'"?-8G/W
MDDGX:X15J #XJ\-Z9>S!EYG.^KUN7AUN>D_-4._.H1;P5'MUV%/7LL15$9%<
M!JD2($+>-9'5EXNJTB6TALM4+U8/):KIC,$5+HO<(*SS-/M,5N0I-GH:+2MD
M;UL08"IH4C@#[YM/1%F?AH-K_ F01XJOS+4O#0L(_ 669'-6[YB)/AV+ $I3
M4FHGW@QK Y+5ZK:E;)T(/Q,%S^8]5I4ZE9X>"P!\&7/#UZ[FLA&'"_\"3YD'
M'"S,IW06BTLP73UV,D.!TBVU!S*$50QL+RK@>GO /C![2<1[S#5-U227OX5U
MUR4K?\;EL;*W]"MRG&+H1L30'-Q((8=ORV+)WLTO5@IPT.EGQ<W6>;AX&5KD
MJPO'V & +8H7:.R7\+ER..NG$\REA4&2KTY)$%73XVWX_$E>Y4!PO.,DFLHG
M6XK9 CSCU_4Y8SGTH!+ ]?!ZS7IVT_)WK1=5S7"H4O_5*_5?(X>@K60.$#F(
M).]. 9NF]>MT02<R!;^-V-[XZ]'H\(2JV%[-83]IE7F=GSR975S@<("]%75C
MIV7;,.8@< ,3B?M6IB&#H[[[M-Y:UWKMN+6KV"_E9S=OM?2SO,SBS\_2JZ0,
M-\ZJG/.9)Q(1=L-^Z7UV N;K>/_TWVS\^^'H^.27_2,V_L+V1L>GP_U#]FET
M./JR+_<2&/_>"1MW6.="OPX/AS_+G2'DG\>C@^'IZ#,[.1WO_>N7\<'GT3$<
M<GH*AY,=;*4=++?>OF[/CF*.P_46]UYKV:H*GCD;U[HOUT8JB/L)U3\JU\?D
M[_+<F^/\7@YE;-[Z&0M3EXFR^@AID)=_B>"LR+IA_8S^PLY)[<?"6+!_)ROV
MH!,F[S,[/1Y"3%>6_O:JG7'*@A>V?_AY!!'?Y]$C2T'(T#7.T#V^KN!:_%;9
ML].545/MMUWF636TBL=GRZZULU"('&*Z[#+JQE97FMEG1\?[AWO[1Q":R?V?
M.F&JY)Y6[,MH5!KAD]'Q;_M[C]L6APS3JQJFM7:ITL2Z>QBKFK^(JC#Z1&JC
M>'&;XVRAJ^*R[4:E0TT5OS75-5EGXOLD\J(B/ULD6<X6=?]GN3]INQ25KLG"
M1=%?]C_MGYXLMR/LA'#)=9"34\ %<MG@9.^7T>=O![1KVR9I_):_8V^U=RM5
M* L'0!GDC0^[KSIF%I63=>FDLRAY*@>$W!R6WJ"DW-U$W +%UB;;"KFVOF8(
M+9\5Z4</Y_9F\@$!B7Q0/\K#E9C/TUD!E_\N@H_EK3154K Z 0?YX4C!#WDY
MV7<Q;3:3HB&O_0;O#P^P2*9B_5<YI/]#?7YU$!P5+$@F;^<:?4<U<([JW]\7
MP1T'V7W-'5P[!CYD-V\[*<6U#*UNW^\!U;B"%RXSP!_*/#!^L5XY+@5.Q^)Q
M)0^EG*R3D+L$M!8%*1ON<P54>US&_@$1=;<JH6N9NVV.5#*\T&-K6L@VQ>"'
M>>6\$*]>P&'>1B#/B=SYN5C'[7O4M#*)+ZBGP*]',WJ+;H.S"0#8?[SY2UEG
M>K8R].AL.?3HK"QA?O:VZ+IE/<7)R^<-<,R[Q.0?9$V4G&"]+6?VW-E?_/7L
MRX]:D2T(5W>*M%2##,D3#8G'8ZP]/,LG0A3/VV*]\>9B#V=J@@N7:X&?RA=G
M)_+%Z\&6MW>MPY4^^* ]8L3D$PFPM14DLF]=M6\6V3>R;X^R;RTU5PN^+8?S
MGY4;:F-VM]OL6RX38D0[7KQU[9O^+7B6L]'ZW57EO[7:6ZGD KKJ FQR >0"
M=LT%8.-%)B8BR;$-(T[SCK/QNBO86WU[=@!O3RZ!7,+2)0S()9!+V#67L-J]
M>R9DI7RW^7C=)ZQ.O:RG8[*R88"< SF'I7-PR#F0<]@UY^#S?'(6QNE5Q]EW
M R? 6[,O^-;D L@%+%V 2R[@B2X@20MQIIUUVW@<PDO*"3?7\J+WEJV2:>B6
M:=#4^TP#_!<K/:E>]F:];!!=KJN6-?N6[OST\1:%<%/ZF,\_A+'X?ILZ_YGE
M113.ZWO*HQ2(9;+BHZ2!@LT7^0?<C52:@W446SX]5H\/?NI84?TUBB[(&25(
M#T52]=[[WI2Y>RB^2LB!I6L#QS9=W1B8 ]W"(N*W^KM:%E:$X/H3M9S8;_ZY
MQ@6P$W\B@EDLEKX WK_Z-[4R;)3HRYU4\IKH<NQJO=U+O85+,1%S^0/N7;)H
M@*PV.+FVKTB^F&^Z:$T,;]\N9S'63<I#RO'3UEO^#EM9N)=>-FY/J-9S7#/<
M&R2EF7*;6B#8IMNN&G#);[?);QL[X+='57?N4USTKH;P+6UY ].C:0]TO)E6
MW]'=!PYR^[9J/M@Z-] &#QP#QE WK(<.TF[=[4>:\$H:ET*Y[,=Z0$VKLTH&
MK)[WA!6)ZAI2/E8O\5*M8\]N\WMD$-7 -K]7XWEK>-N^%DY@&?[RCS?FF]WA
M,[5_WMG"7PWH0:CJS=EQ/:'GB5F+'^S=[H)_>+9LO2+(WJ9L50'QW[T,8//A
M#+.?S^PKWRF+TU&I^"QR/XODK"^2AIV7!K(1)!7K5N-C /XD""0(4A#89UZL
MC4=)&G9-&@0[3/LO5%#U@M@$*[ V+T=4?'.W+.E]K7D6Y7XQ>&FV7UL\AZ]L
M9V!%R7V5>Y.BF.8?WK_'?5=SX??/T\OWP\R?1)<B?R^"<YZ]#WC!WSN./3#-
M]ZJJ:KIJ#P:F9N!GU7E?C3C5%:T_*2Y>3LQ>OOYOF./.TW(WU,B;R>67X7DF
MRM(#;RX+@_E%"MY/[K2[V!HQPEUW/T4IWK3']A._+P\=YG(/VAQ_PDWK^%3
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M1Q*Q6Q)!!7LD4YL//>RVF98N@Z6!JAJZ85?))D,S7-7"9).Y$YA)9I>*E!&
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MQ)"[&%)2IOD\:6&<]O/H>'S(]L;'1^/CX>G^^/"ABL-FNB6["5YINVG4]MC
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MDU+J?KD\5'*@/F!DJ;F_\M^'%2I*'(E4)#S@J':ZK#,7)HL>QF2U2:$!2/E
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ME3O.H&?]%2X;-(+=+CQ.A]MP'PG#$WZRY=N/@*!TSTZ;J@7^D@\V-KBL$*:
MJ4)(22FD?3%ZKSKM0Q3BK=]'IA7X14%4\? #%O]OMX/_<OG,EN_,W<X&S/@H
M>N"Z7EAZ_@P?D>@H+?($3N#^'G;@EJ]N=Z;ERP_,I_#OA>2:6_+^HNRM#UF_
MOWA^H([]#IY!#5.A3< "74@,2/=M/\!\[Z@7[&)!&T0NI/#WCE#;6RZXFF5
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ME2)II#C#>.6V2NBO.*G!1@3^P?,)CZ83'E.CQ'3L?Y/E';2^B??6%#X?-D6
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MQ*\^EOE9-\.W=]$'4;*8JF4Z"BO\N #_TM!+B6\*A+H)#/IZC/Z8SMP$W:.
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MSZ_0<5Z2.M'XMMEDIS*;HBEJEE6RI$C4[#HO*9J";)ZE2(477_+K3P.D)%X
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MUX?'^-3I.KW5/=TM:LO0R9F=Q3G7D,*U/L[L/?[O$>#^^/]02P,$%     @
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MU$/F3*&I ?]@K=AWW,4 W'CF\!7#]_8W9N^CVID4Q<E;MK[<9EM$2/<=J,W
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M4XW,.;@FEYIY57DS9V3DTC<9ZJ YXR"7KDE10LV9?AD53.9B;<Z82*AK,I6
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M)%YQ?I!'OZU=>WW(>AY;NZD5QJ[M;J%8T&+#!W-H:C0!V743$H_K8?X]* "
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MW7<,>\'88<B#8,LN_- )7=\)V+T:=,8N0_<[-@\"=H>]$G;'$QX_<^\[03,
M#GX,%!NOB?]CXC[QM7,5N32]/WQC\//Z$ ??1?'C]Y\^?/CA>]VKM@7^Z[UJ
M]AY_]?[CI_<_?/SN-?&^8; ;84)C=QA$-7_=:?_R [7^^/O?__Y[^JMNFOA5
M#8'LQ^__X_KJGOA\#SN4PJKQ;_[M?S FEB.. G['5PS_^^7NLG9VO_\>6WP?
M\D?80N_*>> !C$TDGF*^JNX7Q'&A&R[+[W%9/OX.E^7OJJBEVPW_PS>)O]X$
M_)OO^TYT&:5.,.QL=TG633G 1OC9R'9(O&'[:6RYJ8*NGV('3:8X'G]->>AQ
MCS93#QFYA48!'NTHWF4^@2G0\ EWOWN,GK_WN _3^/0)?WB//Q#/\(\_GX<P
MD>W<\V*>)*?PXR)>1B^AHDG3^\,W32V_WWN*CSP.:18?/XE/Z._P-W^^?W)B
M?@*?B'<:K3<\3.B[G<>Q$SYRO)-.MGF36V>+OYJ_.+%WEL74=+&"6VZQ6O$8
M+L);^-_(*_%A;YS]5Z&P42LG>:##DB7O'QUG(W:+!VFB?I-OF_S%G_&[][*
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MG( (5*-/[--]L#GG=_O;I*:]^D]D#>RF[U>UG/ LW_& PKCSB+;31OVBO=^
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MLH44E ?A-J%*-_8Y"!QB68E-Q'Z06EW_(;1W'3#HN!37O%=ITCUZ3^X@-5T
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M MWZ'(S38=O\%K9TFA1&HY3K"6MMN$'J,C_WA'P>8HS#P7=ISJQI[#,%$SN
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M0KB*I$/.Q)MI32*KODBG.$:&Q%$(/[K<L)UT.\U[DYG6\]Z6&=^IRS2H"[&
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M[.D1!FKN!@-;U4H.PX&',VP-K9X,N;0H/"#D8N-;6=O<NE7^+')IS L_<9T
M2U)?P&_*3TM3RP-V#^(D06[JZ1545*;(.!&VNL:S4VPSA=Y:JB^-E>'=.C6U
MLNUQ7[9-F1=8F6#56-]@@HD<2HA0DPS1T&%Z!X<$T(=#C% L#IH2YF&8.<&]
M$SCQ=OGDP+3#$XZ&A2<>5,;7C3?X%#$ %+7;AI]2;'0(X)A&WNH-K_=(-/<:
MW#H C1HJ_52T.J;[M"K-1P6,_1RA?H[/\<AY1LT3&!@F3.S<_D!A+?U&"##>
MQ=M_:TQQ(Z5)3!)\X_B>#&E6%3/$Y]X,AMFEYU3?I_2/DT"@)+"FSZFR_52U
M"<S/&BT^S0C<#3T&^S"^W"]C B0Q_"YG6!46-0MXAQ'*#Y6'^@]Y3PI3P+:H
M=.U.I2SJ6A^24?%DVP(UWZ7G1":%YJNG'_[N,%=,L2!(Z.V\N4EK-/6^9(Y)
MVME5VMHKX%D:; J[3?Z\XY[N6W&F<W=[41(D<PU30;03I2ETMS#U/3_(R$>F
M7Z56$V9KM\G<EJBG9>E3%.,1J;_V:QH?@EJZAR[Z-@5TB-=VY:<-\2E&@P'E
MK\^@\L0A7GCW&T2=$9G@/-[$6!>@&"%/<A7(4\L(OD44JAJBFP:B/(6\!C/U
M'T,A!F <C /OA8OO@(H!RJ."ZH2X?4A,9ER2@DXG&U.Y[023/@V<)%FL9&#<
M(B:0BH*%5O\QD7]-ZN)_WT9KL,\.SL>:QZ<@2C@/D4C]-821II+4'?H-&'GO
MXC+Y*U_$G9SP](7#*RO4<Z67JY,A3)$(W+/!!)FDJ+=7A^4/2'^*KZ@6.+=X
MN=U$H=M<='%_0I/&/.P\F5B^+Y<L]\SXW(_:T>6B*3N$2A<S@(<;'GN[8TX)
M7FL T";ZES_Y/$;@KVVC@+P?C8,[*=5[I>??Z;,9<H1)8$4W&V&T=@(TNE\$
MT<MYT D?L5/7*>1V9XO+BK<6F>"=H(V3IAX'\F5J:.B]O\=RSX. Y]41*C+3
MN66#]B P!<ZM5"$6X0[(4PT_33VF!--K,U;MM+,>RX4.P+AF6KM_'PX?WT#N
M*AJQ5"(^9EJLUU@M&6YNN#B4<E(E5_>@-GF<WY<P2[AW$L6Q2#-Q-HZ+=J0F
M*)Q]*$R"3FBFIR]6-1G3YZ]ND!'0.<T4X[L0J!!^@7BNSAHQ"ZG@79K%8=)N
M\[8^[(%'+5Z <CQ V"*1&0YGID9UQUL./1 BJUA')9E%QZN^]#[D#B &3 2#
ME,PN9LX3 AZI?+($H[&NHYB38O.AR)>^S(:-$[,Q04OX$R7@B'STZA2>;EVG
M=7!ULT\V=!@)SUB&$];"&!?_/@5L/=G1X.S'_ F.O\9/R=5%6<+,$!1S'3/V
M$PR.SF(->7##4S@PSFO-CE@;;E*CUS#HE=W-8D./-YRP6A I#= H<\]$\-,-
M?Z$_58NI;Z$S&!<"2DB(16;=1 +;$R#7&+"XH-C $E[,#IY,\1=&2SCX0KHZ
M\Y--E#C!YSC*-JH*!QGQN%<+'GO $YW@4X1K "<-VLVS[X&$O_V2("1Y=WSD
M/0A,888!^=I/$: E]"[\5_RI&72AH<.D%V5U&(/0,[B'2BG>8)FJ9E+.9^F6
M%CG((%/%8=9=<V:!.R5TUH8T[4]H"E.<-CB430UHL18O6[*(3P/'KT41V(^&
M+7@.L;P@R@L9$U]BF2T2G7"$4:1 I'N.B4,PV3J8K@&H3FDBO@SAFTJNL#;+
M#\V74T./X31/77GLS(_AD<2B%,W8!2T]ID#;VRM.IG'-WT1J"I83%&_AR5V#
MW%*+*UAL-+EA$M,LDWM0:1QO$?[LQ#Z^("AXU868=.X^12A-4?B;BQ1!N).:
M2CRV=+(8,?H2]876:B%Q:(* ^+WQO+U%"-@E,J 9,]Z@U9'?1"E_6WS@OB2F
MV"+^B)_N'=\@.*NL4;\5_]NJQW?J.]B&@(+\1QXG?$NV;%0(0/GG\:F?BM_4
M[T/'GI-F"'R.(@_UW9LHY$6K2&*$5E* @,_C1I=U3Z*'E(4#+^0J"Z[\5=V%
MW:7G-+'9Z%0BY#C_(5.I96BNJLU]W*_O@6)>ZX3\_8H$U1*97"92 L >WME2
MEREDG]P7(^MYBV2%^D/7U&,X>Z0LO(:V*/%R/..U+$:%*Z@2LK&]D_6(";@K
MT6QXOUT_1$%%Q$3Q[P> "=JH0M4TGB12KEA5NSGALJ[U(:3>D#NH:_*-:#R%
MCZP0#5 J@&F6U&XN)[XWF6ENP+)KKL6CU]1C.!F6D- DXEUR'P5DQBU?<94R
M;+>>4Z0(N*+6N@SY;$X^KFE\ )D-I:CC/)J<L&B+GJD3OL(8B-JS- SM*01Q
M$#0Q&;,I[]UL,F!T(,?RE]QK-WS4-3TDO04?IT8=K4O/2>+XE.\TOU.2>:HM
MW;5Q>"W=II6!;YUX$1/$L$?3:0$UZ=+3NLQY3J4%?^%!\.]A]!+>PU,;A:)H
M5651I.;VPV7U^7'2V1-1WW@*D$1ID&XK<[[;;CB3(J8"SH7-I0L*=6/[8\*S
M4&**TI"%"$S(-57H[ZUV+<O#'])+DA>U:3/'[D5BFK>%8^X:Y;<^\R"BR4D=
M(0_1EJ7:83,PQ!\]R;6?:A^*A_CYU,)<5Q[3)AS/MWY! \Y@^MAK.>=+M*."
M5N<*^+[J2%N;(QWB4:OC1*F9>?G,C@9$FR-.;@2^:BG-5=?Z8'!Y.@>--9JY
MAZ$]42S ;DE$K9[D#V1#6$"W_H<"FMQV8ELZ%=G KNQU'<!/X>,?ON'A^R_W
MWQ0X@^\URN*==R=73.#KCO'IA1\7\1(4E#\'#]J4'D<!%PL!Z_#R\O(=K04N
MPZ</'W[X'O_\?8I&_RLD^\V_"9),TIPQI,JBF"'=?_T^G\#!,1%,,?]^3]M9
M%LO/^8:_J$!V\?SWV4)%ED4K!L(X"_D+_"BHLPV1_XI70IX#&H?10,R<##-F
MPTZVS&PG9\1H2DPOXV+%8%9,38O=?NU+Z,DZ$T3OFW^[XQN8,=[*=)P\XWA5
M'"WFA\QA+DR/O8 FR*G/"JYSMG;B7WG*GO%:Q\XNV8)8@L8@!C]@PXT,L&*>
MDW+F)RR KQC^XH0U=)R4_O# '_T07T1UZ$NS^F[X[=+269YRT\G_;F)H]/G,
MU;@LE@-PL3\K4;X:UE76KV:I\\HP5(JE$;7@:IZP5SC1O,$*Y PF\S5H,77&
MQM>Q?D%IZ>"PZ$&9&)7!L S'9<6!V9]H:(9C,QK\_[-T!>PX-25H!,KKU6IY
MGV-D$&>QI,Z<T&->3O]H&97[K0:BO15#,9-O-1B#T=C95\!WZ087V@%<DNC^
M8HY.^L/SC]>H^ ?^_@73!!+\O:?6#"\'!Z<)=ZV(FJ+O0-XE:<P=\DE@G[KS
M U=*DB86[^ *=4%CXKSQS"!)1C29093]29&U\/7O<&,D/WP4IND^7SK181^/
M8MX[FS!C@NB,23;8GP1EB_M@I(OM%$>P\([#!^2(<5B0#W2,[%4\LW((9HPQ
MRHNJF*W"[)!%/"+$+O!#>/+[;*,F#2(K"K#PM_4,!"BZ6O&R5(.(OQ\9IX&Z
M0I#VC.7,$GG\A>)3#V&/PS,0TY+4=PF/)-[VOQDOA,A\X#-6PHRD)809A90]
MQG58G2U"U[/.L.^S#2I3<T<Y!)421/&0D[N6O?CI$^I]4@]4FMX,M%&20GQ%
MAJ2.(UL/=742WX(X$]2EW6&FWD.T28@Q[+'8Z 44V2A]-OS.E!>- 9@<X;@X
M"[HQ-6."//N3_.\H[U\->($L%V."%[Q5;BXJE<D36X$ZD0B3PDH-PQP]SH_'
MS*S<:QB($:]J*/:P9=_B:'!GO6-Z0):/.(H&T0O+0]PS91!+[?,W44.$\63O
MDQ*!LGN5KZ OAV+?>G*P=W3EP[1F]+^,Y[.CSRK6<Z>__U87,LB_MIDXA\;H
M,Y9/C(DFN'2E7Q9[B!FS2[TA:M+O9DS/FZF)"S.9F+K%9]9&6<$S'S]7V+N>
M4K^BP[8^#SSVK0/G$TW.B(#V[C>T)J;7Y7V+U^5!>EW>5WA=9LRPNQASG#$U
M2Z:7_,ZJDE&E1A&8$4CP?4_-COJ48^:A *N&.3(.VW1$RVQI9$)5A=-$4(3W
MV<M<2G +X? _.GZ8I%AF!9Z/O:_=9QX_1'HS)<JC>*@>G(!4#T2Q]@6B-2K%
M#YRMT8!JW YRKQ/_]?T:0?;91DP1NM(<F2,FR59REL>\8MH._X"V8#%8:2&^
M9O9+YGAU8KJ>!+4$>)+P/DU66[:N.G6>N;X6S.W"0ZW-AD8P/RH]\3/!15QD
M""6F='D[=M*"=2"68^,ZL16-KFT 7\$:E(VIBQ43@S)A)%##,AB7B8&9MJ0(
M"^N?[#LMQUR1TN<$Q++ B9FGW31['9$9>WGR05U?.UO41##>CCUD*08?A%'*
M G_MH]@!WUZ4EW&4AEVAC9B_?Y&)4Q:^/@R6F@/?'M5)")S'/E^3)L20T@%.
M-AAGGO83('X&A8LBY$FW6J+NJZ7P/CM(E$1$C ZI,?1B<?#3)R=ESS2#W_K:
M#:>BB&DS8]Z,)B[BE!9*8Q&31TN&LMSFNHVE6[B(B4NW;)\C)LCED6_"86?K
M"1E@\L&1SKOTHLGY*\^&S>"UOJD%Y82"7A(>T=IYO!U-G)YO>Z+=P2S*<%>5
MF!$NJ5S<?%(6UV\7342D7?<Z')HH(ZH,R1X!#T'#]-F?!$V+GH#<O(/(L49"
M0M+[=3 ,/$";%8C;NW(M,19,R1,](XW@JR6$0U6@<1%2D9G^$1#YX.\3-3KC
M>GB6Z/'9MUZ&@<-&9'84<K:%:5@P>$^S,D%Y49@>F.4CLWQH!F.#/,AP=+8D
M*1#6!"=@,2YCFK4IB2K&&K4=G-IS8T&^P;HI5S#L(TWS%)[&WC=X3@X=9S;O
M;MK8>7I-\2W*9()8-\G\,>8BF?A*Y9/U,@*D3 R2&XQH&):/P_Z$(S$:ZMA8
M#7X37)9CO=NYM:A/-.*7]?.SE (L0<&.D?S[:/4^@\^10M0M!@P-REFC,_!.
ML0741;;"D7"U*T.-SU Q7;RWC$L>JYR>?;%V@/F7'0:@_%U%X>-[C,QE)89&
M$-3-<J*B?FQSO?I>!BLYEH@Z2^C>0]=:+H0X:FRR)6"+X^4\J&(:R5(0 6YT
M3G_&]-CO@?/W]U8YSV6E>YZFHLJV2$(BNP26/22+Z2V6DNR5TY(+98D>:<8<
M&NM(^=N5-^\-UF0NEQP'W5+"]DQ#61)=KGD81## KXO5"FO);1R7&^CN?3:0
M2./D?V6"."/JXNDX#G:"#IS85@,'9JD<L$"L;9"U2+"6$&LDB%F4)AL+[7X)
M/1E0Q+&2'305GT9G7G\O> WY(V(0J@L%Z/S(?(1:(=\-G%5N(_AD'!8[1F;I
M 6?,')*),>658V\-RF VI3(7?:X7#"\F2Q[0%B;PHV%#;IJBFG,P30+!&:)
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MC#E0 :2D.J:R_%\:T;B)<;!M^Z0(*N@TGQG6'NR/_BNPCPRRMFL:#L9%T,2
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MW;-\ DS/@!E38"4Y?+HRT%,M5GVZHQ^N$ 9,>(4+3F.X+J$%.M=G[ &NOL2
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MRRE+D0II'R=O<M\*=58H=4H.5,WKB-56;##=5'(%_Y\KYOV<>4H=L9619.9
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M<S+#J#%M8HM=^ &/3V')'Z.XEVM,0HL1/:8('NS,@U$G71L>+["$\1CD9V/
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MJM<"\=,48U_4F\A%PHR_=K)86L(DNR@-H6(O;DE0> 3,WQXT6S9'(C"#P,!
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M1\#PXQ^#07D%M =6U]AN:25J:T]28UM#=(*)/*;)6Q22\'+_C6W,NUAECBX
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M97]K!!NU-G2:\=@(F3"GC46F%,?^?>?WVAYXXK[ZWP$-N_0F@ C$='/=G(@
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M5>@TRR),. 5%EX3(4O:2\.CN2H;M0Y+_G6#\R3J&]Z7KDK8^Z%Q>K+K91Z]
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M81B4B]D9$,11,W#]^A\.L$6AD0F1J[;2>\>1F$D"  #?X5<AL7QF-<":PWD
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M\@G@Y^-1^O*("_P =KDBF LHSO)BX$9H$_MV1IHO$MH-B@XD'@$+K8O4C/"
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MFD?#M[U#.T3?*!-0)!B\A\#=@$U\)SVCV?&L0B,'W=#W_"* B/8 $A]?H@^
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M#(@!&J[7^4$9&(.U77%Y21DP [1CKW.@,C &:+I6YUYE@ S6>*7D>Z7X_&6
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M\0!C=IJ8MA\G25].;G N'[9]WQ3:;::J%!*ZP_[L:HQC@,;"PN,(K+T1,H>
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M_IJ@ZH*=&:9M>X\K+85?:*IFKO2=M#R)L?ZPOER>G;I;SS_$'^E9$L0J>@G
M[Q&D+:[&=_UD:"G$B&\O(3I:(H;XFDEU6PE$C\%+.'6A*$5(L$A'UE4MI1-,
M.*FM:-C20QDK"[@FU"_/;G $EKVUP::2B\EM6R9VXOG ,H-JMB4TE/'""E3-
M=C@QK5BK$Q5$95-AZ5%K5)!P#PR7D AUU48Z8 29J6@H(SD;!&CS)M"9;R&/
M0"+G%=NT)<QA>K\G$U;,VVC5[:1K\[EY(._WV.:22&=^T G36)@F^@1\*W(
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M\7#.J,0YORJ*26W.(=WQO&-6Y_)H=M0QC!-5O*?+?G<U0VP8IT-XQ)COSV:
M"0UM]QXP["7>#*YAQ"WQ<)'O$F<H#2,*Q:'NBY>6,YA4#1?PR![_'>H,/56=
M9#'H77!2U?MCQ8EVDSS#2:BOT^%#7C:.XKC9G@$HU,CO)8!UK]1G:0;JYN;>
MD*!1<4<_PTNHM=]?O+!E #*<AI*_0E!MW(4),NR$6OS]Q(ZG+$(&VX!= .ZZ
M#!EF0_<'V"M#9(@-V >H+CN1 3-@HY^UV$4&E:IG'*Q2AZN[D>$SX-@]N1I(
MELHX:*O]YB(E&8J-1NZEODZWLO9@$SD0FTD4PM]E7F+ZH%\,"@(+ 7,^DNS7
MXW5R'H016K(I/?^V0;#,G(0 A3YLU[*/Z&'!.<1W_0:<5Y X#9C9W39FUT$X
M/U!^^]RSH8252LI_O:H.'J:1!,@SXQ:J '16/HI\I(DU=S/W7"OY!P9AEIY=
MK*L(/>^#'1T@H7E;+(Y5S$'MJHN441NJ])LCA*%8&7-?R:(_(O)=54O)!%-E
M!=.X"T856QF0&[>G 5S+;P#'\PXW@/O&9/APFVH3ER([]+(Y.U\Q;>-"+[QU
M\<7RNF6-:E@)0B\Y]1-+3GM$Z,64?B)&-':$7KA0!Y\*!28VHEQ2]]+B,ZNU
M,?K[)V,VUI<K_;^>I^NOVO/ZD[&<_E,?CXRG)V,>M^A9.&85>M9O>\^!"Q?H
MOT=PR>9>2 O+4#I)L/91]-!S8[I64)^!0(O"/>1 J.@P<R#UD"V);(M2J"A%
MFG\;UGV'Q'+Q_#";CHS)1%].YX_MRB.N-'?TXMB6L84 HW!W_DYR/@!0U4S2
MD\[VQC;]T\I$L>B8K2B/.E>W%U?;O(#,U?$"'L1+4QE QJ*(C%.P@7YCG,45
M_PX')+:]#.(O:XDJ""4%!-+D#>+S\PP=A?%%?"+R!E4:%-CBPN,?OJ/VD0&V
M&MOPN6!)0@[<E8Z>B^(F).U!["-A$B4ZB+Q>W5;<*XYOWGKO18'I;M9O</P3
M_ 7T?"<1VIV^F+Y/?,:5H[>X9[J1NC*V.7LD46?C" E8DL6:J+DY>(O_%!1E
ML&HBMP_:Z(K444*UQFET%C&NB\BW]F8 4NX(^"9 &D*"("]\SP)@$TR@<9U%
MB P_V9X2P<5(-4-'<99-22 )D..:RO"W'#,(C&U*B.$O[=T^U-^!;]D!B$V7
M\Q^#]*\![AW7>F-U9=+S"*T!M'> E9X6C% UQ<W#J4PSS_0Y1I5K&C*9M;CF
MLOQLFD]6KF>(<884/35C<;@*".&]'$41XG>1SO%XNJV@.F:TX$*!M1@ 5ATO
MYE@@7JLI#Q&#UYEG*XR'ISA,1+_V4LJ&P^54%# N\X#,>XIFAK":"*)" HK"
M>(,=42\.H3B.]34<,?BA*&HL:HXLZ(VD=W42&*(#Q!)G4A0J/LG#QKH418>7
MD6I&U9HHE-^)RV5"\.,)T"E:&IT[HH.-[[51O;J]5))<%LF5EYTR1R9]0=_R
MNOIP>G]EB15YM. S:"[#"<EM W;E2*$J/XBAP\ RA9K!_DHOLN _NR')"",:
M-VYEF=HJ9S^*'?N>*'-/E.EHH@S'L3ISWWO6&B'!HFPO,:167'5ICAUN36X1
MF]F"37)EI:\[.38]R(GH:4"7SQ96]"B&W4Z6F+/A=!>B2C=?L(&I..OU(F&A
M&RQ8X]X20:Y5QJF["0O=0*CF21[M@$%9'=5@(IIJQYXU38KV\SRZ(8GL9@6;
M5Z@X5]547$/,/[A!>5&04NT<N9[*HDEN$V#U56>).CENE/,Z=,=^I<WTE?:X
MU/4G?;Y>=>*2O18F[[=D*3A(KP3G\K$![F2'KZ^X YY<.&<'/[2+'VE/++#X
MT+WRY(;:24((< W'-K8:DHA=#!?A#*.ZK02B<R0$21DN\_*;W 94'82M.\I@
M#\SJB2RV4 93O\:HS%EO<-%UM , X!9IP,?N;QA-V(R>S/?X$3!4<SL(((,F
MCT!?$UO=L"5D4]-8"*Z$L60))34+GB2<],[=F=9GTXE S5F5^DK-H.,U,"ZQ
M=OI>KWB BF@CY UQ[GU9<> XK_^Q;:B*8L9M4N09#\.ABD)UHQF,Y3<>TTA1
M:&_;*C"6F:(AP%H2RPFPHM"U(\$D$UQ18&O++Z]QKVBPNBG\REY$$[>>.AQQ
M36N;SK1YR]'6V[-$'=-%!SO$_.!2(V$1AJF+GANS7X'V9OH;])6??OSX$1]%
M(+87Y5('?I@##O[K AK\Q[<E4M\50=3BW]HDIA*O\E];(F@%%\B$$O_L!D=@
MV5L;JHDJSB*W;9G8[ ET+)"8ABV1F5J=6.J*?Q]L%/OV:9S?]XNM@0<S !N4
M*P"@E99LS1=C[N%T:9,^ !CK)-+M,''CMR4?65I-QO\8M5?=3E9)YUJX)N!"
MTJ!9S;0E-O(I81OKQ/:#<&Q#;05[&+&]A=]5\8UE'/V=T<&?4Q;;=)'/<&M_
M95KS<A5]8%EPO-"I?BE3K;\?;3]NG'@1)%2$C"_C&E8JX@1^+C3I$SLGRB+(
M/>G^!<11Q8WV"GQS!PKE,: 7Y6P]'W44S?[U">DAW.E<D"5 FF5#&+-^O8?
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M_TXG=1838RMP :13*E\"TKFLO0=PGD\FJLD&_'R$ QV/GNV&J%<3[C#'U_N
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MH$T;2=38P_+T#^@_+U##_OO_!U!+ P04    " !6@'!6#]NA,\X!  "F#
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M_X<"KX?E[95V5T&>?P#VTZDQY@M;$C3"VI!C=*.A4&+NHFB"IB+_F+.E9Y^
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MCQX\W$].#9-H&)8<PH&*T"PK*"<2S*1%D&POT 'BMBKN_E61>LD[$@MIOR^
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MK-6._?]RIOX-APEK@6.#<_4A4(<Q4U5;/B@Z#%7KT73GS*Y_I=FH!4&W<5?
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M+O;=[HA3?ZZ48\*Q:P:T6R!P.QE+/[S9A5,D*C-TL9'P)2YO$/A@G>)]T5\
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M&XOS-Z)"K?#RF I)1'8SY%7[R>]>)![!AMR]+3^=-]TXN=Q6 S>GJ@V4,''
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MJDYEKN(DY)/WK=+$X(,(#I9$$KY@V_^&DL=TC4?:&Y[& !9ZI;HR\55#0II
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M/'2I:U51L.G^LO1QWQFOZ)0<B80[/!=LOZD#NAAH/D)GR+_KWTL9QBY8<D/
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MA$7N(%*/YL?=21SY;FD.@!?07A&*OZ.$&.4D,UER(\0%29J3(AN2YZ#\"U3
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ME^'C_4U-&7HT2(!-YV6_J8\**^P];EJJ_*$4PTB6^L8]I_'LJLK#HLPP1X.
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M7[P$RDB'#<Q:O>@H#:)4P.>25_-D]BJ*+H2V 5=L:/_H.#NV_2<J_/H&PO:
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MQV$SZ=K#B?[V*G++4U,>2H[#9EX^&DDVUBH&_6@ L;\1*^?_4I)]T5[9PJ/
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M)>;=UV'Q >]K1H=TF5S-#^12:(= %LE;(,@S1(\!40066JNR)  :E.:W6*+
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MRV^)WEVMZ[YC\EKX4/0ZR T[U8\'KJ.(A[5X.JPU\I>BY$JU>[^1_2P"7:L
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M>?]S[4#K#V%"Q*7(Y^A(;9&J1B)?LKL?;_/DI6R*V/,;"4>-'UN[,0$G%=J
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MQAB,WSYRXG3[EJMKW$W@Q<%#6Z_TSTN.H'##3,!95(TFDGRW49D>AP*R8->
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M_V9I6;<J$Y36C 55@!JY)HF'KJ;BUKSOB!F\\O9"?-29_RYS.>6+, 37K\*
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M'>UO2#9M)6/A\^]?23YC\Y",X58\^.KE#*":!-V':)X@59$]X,9HB@:^MG4
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MOM0.#H$5X3<0G0]_P10+N4T&<CA0A:: !<#S$B &4"E,]J!%V%&%47<JR>5
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MR+V%IG#"?7A(O#,O/X])#[:<Q#"1*CYZNG.M-ULMV:][_24]X -"E61G\[F
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MR\Y_,R0:5,*Z*!$SII'<W!:WLC&KF&D?SKYPJ!5V<*U)WO0(=L#B-$$VIB"
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M(Q9^SP,:RIFC86D4*4:8RN$\/HW>2CJ?-E=96TR)D"*=I<B![I*62 <"7.@
M06X24LP5F#$;_AJ<U7;$4@$[%'+@S<U-R[8F9Z4F_1F++0LALJX_]@#5$4J,
M1[@TWY0X)2#0\#7Y9,8'.6T10L-VS9$&HQ0[39F7\-%Y.A"? H'=)K'2+D:#
M8*M?'?N](ZN?_T\JA#L.1EX6H3"MJ>=$0D=FMS$M(R"CW[Y$>?Y[;\#\:7QK
M,7:PP>ZS5-3=$'TSV!*68[AY6B.C6;(QZ("+<%Y@,9OBU3/./@?@HW!"#C&V
M#^VG15AKWC1>+2[2RC,WS1]'W,3%O(WT7K]H0#+NQ8\:Z\HTRL'&PJHKMWP@
M4@T\\9<KF9,A85?Z%GTCRR@<9>/'[(_I1K-ZV9OQ-[STPI5K#<T>^>3L3TRA
M& ^@BE:6>'#M@^SU119V]H,>>;9G:[ILG+O.H2IJ _@ZQG !_*?/HIN3MEF)
MK(0]Q$BRKI=';V?_N>QZ=SMW7A3F\,,IGFU56RR>E_QJ(<09=BW;F/6 ]CF%
M3#/[;G69D^T%*+,@L;7IB$'3]9I$K?D13GS(T@OR98HV29L01V:MJSEA#M5U
M4&9"%?D_&G2(:JSWZ]+\\K7#9Q,-OHW!LZ0A.G AE@Z,O6NC Q%]37>\C/G"
MWS!K*#5U&1L[TH%M[8W^E!.U.+C.XPGQQJ&+F,_4>V\Q)^@ KD)=G@YT3&)(
M8B JF9"[6T]<)77;>![I(KT=W995DM_D-<_2(AX7,FKN")OSXWMN-A$R"C(%
M=A3U_D<Z($&;^MYB..>9,0O^POA=O]LD8]P*]ZGWQ?Z:>V7,LC\UBZEH"3)T
M^\C+#'$.]S7<R%26.ZYC__54YGQT0::AW!O>IYYZYCX@_A47.OL'\#5_RA]/
M_AG^/SW/3-L[%3O4("/Q7IMWITOL]8?&MMG/KL>%SU^_ASM^O(/B!7H^&\H#
MT/-=B:,#@9>R?OB<LT0'!E5HC*QCT0';W]I#W,BB59;CX:ZEXUU=5L&C Y@/
MP@T*[;1/.99O!N$S_@HTQL;Q:BV+XC(Z\)A5,ZK+NTL- W_6POF<M3K"!J6S
M[<-)(#U.OR+6OKWL%RS$FG#'[(9UM]D&)68*@E^D U&P]?U=2+P=)R* 5@_=
M0]''0\9R:;P$A^KJTJS!XLT[IV9,$MO<GH@.JTSI<V(ISM37JCQD-9*]FDWC
M=N!07NV]XJ+2)VTN;O-GC.3FAA\TG&QIY<F#!$*YBI%1$)9U)(_M^4N+[KOO
MWGXI<(]-G-,+>^3>::A!X&C5=OEGS6,1'Q(K2Y;6J*Q7HG8Q!:.YN5?FNS!Z
MF&NEX(O\2>WU;WW*?XRUX>_".0XM+AO!K_1.@%#,N,SX":T+ZUF/,8NFIL-0
MA$U*G!>:[$H'KES<1H#W$5,"(?O2 6V;D+Y^]5W@9Z'Z[ZT=P&?:"8=!C'_6
M)9",:>10.K"3TEXXH;_IHXY>5;!]&T:+A9[XO1-Y?Q+*%K4,>8_J1:JC ^,,
MCV4'2AQ4#-0]TBUM>+SS,IC6=#CN%<HKL"D?F0F$O>XQSDNPOE%801N-JN;U
M-YB:5O*7^!12D)-YG2R#?X?5JZRJ,3MYRCIE ]5FYC5QZJC3<M N)2*ZPZG?
MC&C2JPZ!?9G 'C8I37ZGN\ML;O#>_,4.<4N_0E;<W;T=F4^9;'@XB;:1NQ(9
MWT0;-4-G'EY!IWU1?%=Z)\3+QVV+HZQW*7](7&"O>;WL>[EO/G$S< >):D^;
M5N01S!TS;"2&70[&->)%=2-X3J7)PP;V&NRV?7@^>*U/;;_(K@2Y6F1]/I86
M9@CZSG Z4 %?X15O36\P269T2;^2E\IIM=QLM:JF_.& N>F#;,/D(4^?-O1G
MD@J-WX,.K!N"6&XWC-H-8[Q4R9^8?T!\\P%FOPT=,!<A-V_US:J>2KJ[)N6P
MD;WV8'7H8MET3:N'.G?HF6%)V"(B[X"%(WQ^M'<9Z[J!)'+2@3ASO">Y#[-M
MHN8[XB6R*$X'3E2.K6RBD>N%/K,U9Q ] CM(?&*#7H&&"1/&]]@DXS(U3WP8
M= T6?)K%ZO!99A"CT(R;'W=57I]M_'3E0:=/T?H13I^;?A61.ET&MV*^;0OU
MVJ*35%E YK"3=&="SP.KDZ &/Y>$ZSUIW9-WL&%Y>,_G*Y-L7I,[6J:K5YI2
M%#L0_"3$Q"W"B>R],>GG C:Y=T^(O,WBD6@N#-!>S^<E,1MQI=D99?2D%Y;2
MDK]^4ER4/W8@72RTT7&E#&WY(&Q+9X;&J(&O8;DXU)SAE3 ^?!I6TFRS[SRT
M:M=E/HA!2I4QQD^&5("#A8.("1,D9UNB<N/HB:N,NKMBD@N%@.NTD"/LIG?/
M#%NS,:;[7!&OU/3RJ]\?EGB<-TR_Y&M-V$GTZ?7SOX0S5ITB4"4, 8B]GTI3
M!'O2R[\-[ Y/F^L,S?=XA7LB++9KR)69B%;'>U(XQ'&PL!+;1<>O:!SF=$"9
M:4GAOC.^7%%:XNT/@$VT4<*-J#S=H6NI(@)$2B4E6C[#*C#U6G_/NV>5L.V"
M]6^<_-4-Q@D$_=W9LFQ97I.1@>+9/+L/]1P:34.?7'_TG]&5K8EQK:4!/ ;W
MM4@RGIA#!PZ-UDTK-84R:A^YO'\W#W_GS0CD?NC7$MI!6C_V@/H9^Q@[9?>E
MWNB\RQ[UF0N')/2E9QY;66NJNHW$S5GD%N:ZV9*]#1*E?-U69KUC/N,-<Q9O
MW/@R.%-NH,$Y)?#\#[! _J?\RP4D]KA ^?SNN.!!DT@'(E6U;:%=Z]7'YN<A
M=ESR8DA58X>;"$5\.CJJBB_?Z\%FN)[I)[CH%9F@&,8XDHT<.\G$N4L;%84J
M0((XQ9)\U>\>IH"@F>I1896<EI1'OG!"4K*_Y1VW-P/?B]4O?<#$[LG;M$Z!
M'9WJW(B>06Q0E9)]KZGDRVQ3+8==GU;C]RH^GWH>^^"SODBUP&&"5C3F+FNT
M<?JIU$"S;I[%Y3S'IR]]%ZP%B8+/G#F_/1Q[.*OA"CU<(U76B(Y4+FM@Z I.
M& SJ41#1-XN6/1HI=,O[I;'2 *JRR7>\AAC^K$!VOI:VD$BH*$T)F7X>='AL
MOB.)NJGP=3A/S1]!Y=D&6?H>Q2[9!1!E/EI>7KJVE*"<GE9Z&>O[V>;D1W\#
MU&H^ VV_^#A33GMPC5)GFC5<E]^0[[GK0/J3X%TT2C8%/H$=#"0V$6R6U-3B
MTZG)-4&X-A[FWD&-U.(73R.\8UO.CGYDV[LS8/^$<!(5= &/?"B'>M19*/NB
MS!T'<C?:#]U*ON+KS7W_Z44#H\/]'BKG[K(*MIR;- [+:F,*R.8=5)*SH@,!
MH.M0#^J+DCF3KLS;M']DDX39$O97T^ P;D==^<WPYW>L&O>35&D1$\@U_-O#
MR"4QXCP!,FBV3/)< !]*<<X:3?W[;8)CYHB<:T'IUT-7Y5/I@!-R3@*_36;X
MB%P5]D+2:HD@\3T%GYC_4;.*!4DSU@4Z!GM!O&5'6]'Z1M-<XC" =6E-UOX!
MH@3_K< >%]&!_#CJ!&5ATQX#K1%!UBKX:?B/+VENUB81HV3AV4FV>>[&":*G
MZMG\WALJ,.]U9F7@SUDIUY>NOVUCJOAB=<VT;Q6SA3K4L(40XN,UK&]^F;"Y
M-42)ODF-H=SQ',/VY_LCO(22U ZP&"[W'C=D#N73EN1+T?:?$#IBV1&W538N
M==!>0+Q/JB32=%YW1&?;.L4WU$QBN5F8#FQ4,E(-2$QXIEMX_45RGI\\(>AK
M\ND:[H0Y]42)V*Q'XZI'5BX>#91)4?N _LSZ!,:Z@0X6D.Q154(/JJ6DVAPU
M/.Q7*(5O":EX/\F['260%YP=U:3S\HIA?-\K1^+6RJJZJUKZD\S .DV[K"9Y
MA&$WLF-CI=^XMG?T-/7MNGQ5A-[>..9!5$*]8-7M?>UCRY$;!N80T.F/:Z:.
M.T7&D4S28]5$ZM^?CQF:?.R='FKE?6G9>?[#.@SAA>EO'M^#KL<,,M7W&:]*
M</&&O,C0DWFU>TWS8%R_]\,S^L"]ODQD[84:YGE32(,E86?7H/:ZFKUB:D4R
MM[C3@R="C*,/8PX&#@=#+-[E2X\?5B8K>X3D;6P-SLC)B=Z[=MWSVF;UJ<Q/
M1/5S:!MJC/H)&$6>M(1++'W16V]4&:Y;$^@R(.RJ>/:S#(7Y$VAPBY8UO!K]
M]Y Y*#P]-2?\[G66((LNU4#P2ST^02,X6-SGB)4P0=\BQ5O1RX\0-30[,>E:
M(W>:@#'5!^LDT]!F:73SDTY(HSO5QU.]C/H>8\]Z&-&N+HA?*GV8:5O6JYR>
M6RAC?_7R<J%0P%E1,>8[B1$^:S!U9'V;^G$ZT+&K#D5B @E.*^<*K)1[L7(B
M>I"U<9!_^J'_FX$Y'ZNX\WM37<_H=%7&SNQG9RG?'^7ZJB\ 65]2(P(>"P>/
MY0&/;=G \^BT(-+U%UZE=.=MCM!"AJ:=E+=']-^M/7 KR]R*I0,_76W#J8XU
M>G S FJ=;#/N]$1"0JBZJ Q3$=:G'W8Q-';$# CV$$[0;&V!7+:N 2U4"/S[
MOH?7?4%0_)D9T!LN+$ ",$!)^VY:>T5?O=/A6W/=3#AOQ[BY!ZUB3R2%:K^N
MGS\LHS0QE#3S%5F@]MB"-8'RB8A-S*ZY1BU82BOPZYWRJ.F;11A[A3?PAH1M
MM"U9&E7$;AK6O,A,&3=J4REHA5(=ZXIR4DE!H%,T)=T97[I0GT1-'9B7?\!Y
M-*3M&!U@?N*;<^!<_@.,4>9)G4-N-#X[AUR$C<$5&?O,QE[R,)47-.^.E,L8
M@D( Y1Q.[;Q-.8SU"W."DQ";$4\@;=%U\T:JL(]3<W?;]VR9/6RD%S@4!YQ7
MQ=:"TZ-[Y42Q1&^B(.K4)QN:NEK.(&8,10?VEN@'8UDV8 ?A7(4F\PCA6-&[
M)<\Y[Y5&FGV2@#XNB/DJW>V$P_G0 0I[V7CF$[D1K>NHF_BD=G_7XY_#RLH4
MF1=OTH$V3#;ZLVC;R11X>()X8NQ\WPHQ;PVJF?3%,@%G&3P]W4M<(CJMBOW\
MP#A^GC#<%!6S<21U;Y4H'7B8"/TE_^?7"@L,Q1(Z3-&7HIV16J'MQN!7VT.1
MZP ^D[9SF ZL:O@+D:W\#'LIK&29P>'S=.!>+^5L[Z#;VF#P.=87[-K25[2O
M7KP?&'O6J:G&[B_,@7G8H/%81C5!EVA3V$$I=_0S?]OHX/-^X(/MLN2Q)\UB
MFI\YGGY:=6B97!JON@QO38VH:V-J:_NR8C8%W[JU@0]72.!F/Z*OH"!5B4Q>
MFD9<[TG89!ML/]+1@O_"QZ M=#<W]\"YW6Z"G2Z[2XM:F3NK9#0;!90X<L1W
M/=JGMD_.Z7Q'"2L[G,OG2IR-_)MLBTM''PWN&5Y5F@70WUYJFR\B;.,<VUPW
M+GR$\I<X7"">+R4][27,*_>B,EJ/?Y:1-E 9:NEL:8@*ZCTSL&B6:;\!"\(<
M7%07]X-VJIID"#7:9-=./TE3LNV7UCKO&^]NU>YG_ 7&L[1$!ZS;^WWZ:HUE
MFK:_;!3.U9W&(KS3S@S'S+_C/<NJ7SF_Q^<',DF!\ >F;B@_']1I_6:O[E*$
MS$#)$',%Q,IZYW!B*B7:2LBP.00F9L7-0,.O8/TWAV;^E/_3\H_?/,-A/--.
MX90:QT90>+*\I.JW]Q9EV9IJ+%5M>K+-K56QN!RKR-)T%WSZ>L;1)6'W.N<W
M.E"KI"[AU=9,!W;[.3"$RJF,F,AJ5U5##:OBTY[O#7J1NK:_[?[12ZTMK%$!
M._HV[/P-;U;.HC-3RZ:=J8X0\RC&P4^#Z]]@JQ3]5'4%Q!?:#NKKXO(\OSNI
MI[Y\9C0:,BQU91FI058*SJLLW6Y+<8&)S&/QE["L7[*XN]6%[#T2E,;YJN65
MIA:H&VX0TI*?"AU@T2"$T,)"PI%X5Y=_W^#W:TU?F>ZNT#?IR@GJB%*KP :X
M43QV8A.5A=H-<JH4#!."98%K</C]J%?9K3*K6*9DNYBWC\YU3@1=EW1]Q+0L
M&'!N;TTRNG:%9"\5 5V_KFI&!P)?1M,D,?K0L5<(10)K ^L <>(Z0;XL"[[]
MI'?Y#K=/?%O[R7-'A"6GA<?8O#;EVB+JC*^ZVW\E*N,5%U7?B7'8K6(I^?ZZ
MOS2 ^*UYCSNFL?A.U &0#]R%D!C G]>TP-H,$ZC:G^LETB#/Y3.;M+QPI?S1
M85JK\K)':+RFSNU[,;W5T?9TP UQXPOEL@$=8,0V^K%N[1X!\7>&E*FDV:+N
MAVD((T+12Z0>>6!=3<:@M[%DHYCO>/ABD7QW^2NKJX%]!?E%-%X9');*?($.
M ,M0TH@%B3>5QJD0[ 4A+,S1NHU=2Y 54#']!/+.ZB>R7W2P-[L=I!8GU_(D
MWVKCXNS,6S[Q7-G7TB*49_(V[-&C/YG(WUMN(1OT'ZNSD KN)=1(X#=2"F,B
MM(3?&=HV.\=F'TA-"0A;/)DGVI/,(]H=I^=N*J/\#&<DR<EFM^Z3<FYL94 $
M)_50SG9#3;RV%.,8$1QE-I!1N4_K?(YX82!6T+K:V+!;8B-G_Z([TR6IW$SS
MV*%;385:Q[;/O!>,SC-]6Y(7BGX2FVSW0>Y;*1V04;[I(WL,I\,HNJXM5)^/
MO(M\U&<:6HW<<[%0AD&ZV=\MQH;:^.RDP,>[U9[U".Y."E]J;;JMJ55^7.9Y
M:?Z\5[J\K'X[6M5:)S?S=,1R+*45GV3U9HL>'RG;BM-E"JDO$Y/M,5N,I8!3
M*/]"UO? ] 3MF-]1O%-CN' )P28D=^-9Q%VEXX9QFBJ/XR^Y'UG?;7ST?_Z!
MB+#%8!GV*ZC"().31+VA9261Q_4]J))DQ0^>=K 5D#R7?WW_'Q&PS^I'$9]!
MC%DC:J]E0( \SI,LV:OD6^DM7)IP87Z)7=1U>2 '-$&T':1=.+ZJ&@[\EXP7
M;A-P\P+O9>EA[T*NVP=\=H6M,XH73$B?25\T-WG@45DV4M#R_KG[M2$QE^D5
M*V05!4[:('0W0 2J; >;2@H'!X=EY97])"X;%<PH\LPW1W[![GH-L':B^HUI
M>IZUV!4+.C!W;V/KG NM1G\S>@T-6NE??[6=R660&?(IVS MC_.X%?AZM%#Z
M@L6^UE@9YAE[*U9B7NG[O@T3)ZQM7/T#Q!C_E'^>_!/BN8IT(!2USX^/$*<1
MK4U A2RY+QQ.6[MK%OF)H/!.^>DG_0O%$5$E\%K:#GQ9/>L^R4#<DD#[13RU
M0H;O)OO^1^H>#Q[<C/GV/-8W"5M=H<NDM'R/V3)8/N;1QD<>14K.Q"D8C3$>
M'TS6KBZ-UB7<CK45D#MU9^^9ZP]16')O0:3]^V>B)Y;R,%(M3:YO-)V3K5/]
MV2F@E>JH@KRE?4(=E)N5U6>9Q1R0RS.ULH[ZVJY?XGU8+.$N<.4C.\GX#<BU
MI+[WHG@+PT$H;$-T@,"YQ4 ^1KG=J;Z;XM99=6?\L)--5^[8AZB+W1,F)TY<
M,N'>\>+[9B3,60QN'L6 F>4<QU* ,CHP&;9!N*G<DQ;/-9E'&J$#'U4E!.Z<
M+[ZWD-68F9F>@/&G3?2KPO#Z1"0)^;8UURNQ5F!7AUMYOY#Y/*]#KO2R&@>7
M0:SOCM:\]@"$*,E\W(D11@?J,FB?]%D'8:H*AV:)FKV'7 J8^-.YA;/UG^]D
M17/BC9?BR?Y>*A/H.A,_3IP:N[%6U8=@^,LOIB??WDR0/[!S=TSKW;,\BH!-
M/KP+.A:#'T$_5!?\1*ZI&XPO;)R;WO?R<W,-,S+]WOL21)YAGG6WF>0V>@WI
M4M9GIVHN)LMF;URYE(9I]9_!7O_>%:/BS_7-?SE4\=?R%)S<I_CR9X<>'7G$
MVEN=BN->>DC@'EM.3)^M,-_(FPE>Y'_A]C+GTJ>GJS+E:YP77TA\=BV?4)-N
M](>0+R ^;G,8U9PF]#X<5RKV]87KYEGH">A*G^&^Z&TBY#QOH'V8AR5B<PZV
MHV_]!!]G0/M[$+\FF664>JPM3$?7%1SV<]2&(8R(=LOHJ>Y65#F-E7 <$U$E
M\G:!&-8*?S=PP9\-,WH]5LZ9M9S%=&,&G$$KE*?($!A1<@Y\.E?B9SE)7,<8
MD^WJ5$[TC2-&SCNFG]1;[D(&&&AP/BS_ T28_I1_COPSMA:5B$.76)3G^Y")
M,PV=3DT>R[MM()$(:U(.;;_4N(/D5^]UV!->HXR[Y\E2N<+%(U$N\79*C8CD
MKD,QC\Z(V]^8QVTE<UO3 =VA-:4%W.SX,TM3!=VI:G396^B.FH.4HWTT>:_M
M[MI1?K+8 K>H>.;0<>GF)QV55@%JSXCH-U!<'Y(76HUKIQP&W1$?ND;598)U
MH)MXI^]UCYP9A(&DU6!E\I;6UOF6UL$X]LAEMZ:&$0]?U(Y)Z_*V:))H<^U)
MZWNZ7QZX\PM'7[Z=.9? L([VN+FH ==E97#2G?=;/#-\ZH#MN+TX5L\A$S7N
M5X2#D8Y#&JIUM@^AO:+K*XX_A%;'CFKG9QK0/B-,12FWC&>QM5*!Z@(D)CRQ
MOD[]2)1^P5"<<)_,0:L/+VHH^6?GG1E> SL^HO?2@9 4"@<=2-G>I#%!R<J;
MR$<8/C\YPEIM.^@%2[KM0MV(]T8O3$&?/]3>>N!5'P4/9S?F,>1ZEQ2='GUA
MO]8NG<SE>Z]0R;2)&A#CMOZ9$/4OD1#UMX)19!1J]2+B*+*_,@LY)QM/*H(5
M8_FADT\HY^E @>=5.M!E)TZPQIB-H3=]1G-6H5+C=&"B:QWY@JQ&!F% *P/)
MG0[<74;1@;0YBX<6R+^@A"6"QXR*(4-I-K/]L$T?1/@J>.D/!W[SQ/M3_L_*
M/R-/=HHFZM6*X*?($[3">':C^K<=&F<O="8IMNT@/17/RA>:" FR(K37MO-Y
M(88=RWN*?7-LGWEZA#Z*;N=D[SI5B,N-A1YT@S"35HA/22]<#R3:>8ZCN>:[
MM#V5)'>H3B6/M%PW>'KFTJX %4;$!SRTT8*/5,U:KZ<Y.#K4:#@R-"!QRCE#
M2OYVL/3T@=.>:+EUR/=^+4U<ZIS45,GBO(NY[ L^EWOEOX@P?#76]G#MB ?'
MX^">^W2@5J]*'#D&&90Y1VA"5; NZ2I*'BTWV'3,>RXZTW/R<=_0I[*"1L/Z
M=%MM9,JHD=9,03WY_O%;UU^ZAM.!4[3[6]@)V.(7 A,1Z7N"$/7$X924UZ/M
MP1LI(\\?7*W YSU,SMP=I0G?4*'MIP-C_@JUD")$'#5N_*2?KDW.K=;L\.<.
MG]5UE=^J2J2'#D?R[":T.\Z UG0PD$C!8YO!1[,,V6=&<KI:0% ;[EW%:CL+
MR9=.RS,W<3.;E!UZ&']KKU-S/W0LMB(CW07?W<S%GN@@V7<C6->\X:FP5W02
MPU@!JJE\H6+CM#N_E0WW9@[Z&TW QH/G3K;EG"_#YS04M6*1#FB04%X@OER=
MZ0_Z/[C/]1=!'Z*FUZR$(,H@9)WJBO]*GD!R'8V9?-F('$)M/Q#IQK=3(K/H
MP!!V6U=5O:86#Z&$"H"$^KT_AA9N2MJN7JB'"JA"4TF>NN]3^@SL\ASN/AQ4
M3!4SN;HK G,YC&)9G]N])WZ<P-[T[:IAF [579T<]MXKPHK7H+ZV-8.XKA8;
MMHHEV:)9D.TIV70 80E:ZV?(>@TO.,UO0Y^\!OG>11CTT;V4$-JCB4W42SIP
MQQJY-JZ5;6!A1@=8.''HK;5OT)7/R%\:!O]PGKPM5NJ>YA7618EVFM^E#3'Q
M-B3N;94<'5#WR:1N1=.!*(,?S[&!.4H'7I=3<=2@%W2@/50@7</;B2)K'(R9
M:;].!S#2=(#P"?KC66AED]!U;D@5]'T1=(L@U).5[UNGKMI)<6!&9USY(@Q;
M$(SW:*DA+:LUNLFM]]^_P6QULJ]>[PJK=7+GI%'J-5:%*[FW[E5\W[F1U?![
M;Q3ZFYIF(13.;T+V4) <]A9:>-KK=SD]<0Z".S&<"YL/+G79#BIQFA_FM+KS
M]-S\/G0B19L.[%X@F:#M-[E[^WB)P7%*R(*Y30/O??I6;!<7&4J=58Q'\+WN
MP9\F#%-.T-;T9//]8 ?OD2(^79^_LY3>K7]A;>8*"4O@UNI>RKWOYSUN)BYN
MVWOX5-Z&[^.HDSUW;EQ7!\!_<V$%?ZE4).Q_*!7I;S:N&E-93@<F0SY+!"J:
MBGXOZHCY:VIH?OOM-319R0R*-"?*<Q"X\>X:1U(YOJ]2C,V#-#<\]2<-N@+S
M8P61GTJ*0'LEHK>@JV=IM5^AX+MR0AT\.CB !"(;#;Y&)$GY QT8G_U9M;",
M)GF@ZO6W64G@S]F9A]D2B/Y)L1$N1-.G/(6^=XV>!@U4=!#RQQ*YT)]JYN;\
M6"'WIY*YJ=2[+70@C@X(LRX>F=C"K%J"S..O*/XU#_(*.XHL^++2@>^/5VP(
M1,.S_XWR9B%T$KSE77\.]Q]DN-%FU.<8>Z<GRK#&%>8YY>;0$JE#MA6-%&7W
MQM(<Y[[C?GW[\B,F"^.M&0(?[=A; 1W$$L_A0SY"@TL%CG7(Z3D2B1,WPAI3
M>S*")O9UZDP&Q(A^M;0@31)@:A0F\+T:PI-I3?Q0.J!CB3:%#FQE[$PWE>V.
M3"(9#@A8;A/-(H/$BOSZS,U&4,4]!AJ(O8C!W[M8V)_ROY=_?,$U#8[6#%VO
M%!-SRTB.(I4C>W;%:J^GWE9WP^LO"N&Q=9##<DY/8B^X9,_'S>MEVQ$?U+0Y
M*)_WM.+4_UK;=O#FV+T[#V3,9Y;8R6HD7^)3/',*7Y^IKG9JW!*7\C-&YM*X
M'9$?(55I1\YL\M?60EAH73#\M>A#(UYAY LD0X?U/(%>S7 RPHO+-_SM ::&
M*,9C B[QUD(,4W.PTZ.(/ABO%+IQ$L6N>JDP,/D]5M5EHWV[I(X6OV18>S>G
MB>U9;GR>_[=26MFR%V<1LP"OZV-+CZ'J/!M_.I!7"=$Q!8&],,5Z<#/>=2)O
M[RENA'H?9U6[2UE?JZ"D?U5[$^:L^EX*.W[S(R2DU((-/WC)X8YUDF]VRYF1
MR_TCXC%-5X"/8P"#/:6#)$,']IPAO1CS-]SG9R-LH=@1OB?>.E2P*M3?,IYC
MKQH>5]0MWHLQ1/!1-#L0$E[BN@3C8/0>8DR6UK3&"?G"I\XM"Q2)W'U"/3<L
M:SX</GYC5!V&WKC[8.9ALI;8H>)*]5$0][WH!O$W#G7^-R_ _*%"%D[$I]T9
M+R]W.AGPO"Z+O3EY6WW.N;R=BH</B/&U*<HQF3CDO]$-]S:&-Q\+-A)XS(N7
M6<RS,7&XSZ @I6SDGV2';K3W\7:4(4.Y]=GAJ^L;1L@7!#7.#574'@J?1-#7
MJ!UJ">-7H8+K6)(A KS_UR $^9B-(570_!#<-FIB7>0I.M "R:0#^8JLDZAA
MS);0U#OQ>=@/?PW%:9,4: \90+^4\6_N[(EY,K)]$$;BP&SM  ]60J[J+\,H
M,:O?.#>D**)0D+UT"(*&_CKV.TQ*HX!C>3:0#CR\AB2X(1LDOV)FEJ0HC#!*
M /(?=:@?;KSML!N&8X'+HW5J:&A4C\,NUN/=!^#>JA?G:M6Y.L7E(^F,Y1]J
MLRLEC;"HFZD#;3*?Y>%*YQ_?>W5C0W?]_ES-ON%6)X+0Y8OW)=ID'=6,VZR;
MIU-7T5DY4]&/Z,#J-5FG7"Q(W^9]J$5U6PIQ-_3339!SIZ%J$QP)ZI QV"N0
MGZ'[68-^[]6R?[2H7Z4#C^*^+Z"!,'?Q#@AMNWR32$)C,$H"-@1+//T]1'.-
MWQ]DMGM$OJ/=5#K07^]$!](VY?!:'S%;IS"LF,4[W2#2R%"FO@S^7A(02O9=
MA1YO!__K B&[43.^IS7$;;S^3^Y:A2)&4%\7HP96:N'O+,X[;<";;-U&E,R<
M4() D0R24?*<R/".7@RT9&6H;>)$P3M==_BXN#_O7B5=E5/*(ZGG7HWQ&/33
M).!S#T8A3=//J'GB)S?]_25>K T$>S]NLUE\-])6.+?@$?TM27R"=<"&.%=!
M"AS7A3*0B'RV[KJ]!_OM>[.GTE;C&AYD:EC/\CCO__CQ*WQQ>TUZ"R%T*F_1
MA;$=#V]9=[XYSQ,D!3\W@A#_W@]J3?_L[\W0_I3?)O_H_N4[J]:(3\(-46/0
MAI/KSLV&#GO7S[*O.*Z:9=;(6(3<*%%)+^IV7!: RAT-G;2E U4[X\)"*9)3
MW1CE A*&?(#6[@-9XB3X^$,:$J]II-J5LF2U.SB<:'4L."88H7#C5HWVD;';
MEDJ0# _D^_:/.>+7RZ)QO:]F4W=D)'E#"-9/"R@+JWH(N2]CF,A$"RC)QD;A
M4>*2GEKIJ\V=4Y;&9()T_YM42]2SJ!V[A /@L_HD7X;&]FUN/VXZ$*" I,3#
M8.&IH0T/=%Z6)N4LTH%K.+P<_KF%UXU;7[=5'&M\^3V7)L@'O41PT/I2PN9#
M-@<V<=TGKZN[K,J]<>XQI3E-76SSM4]:),[Q2T?Y?]_VE35_C2)-J'Y&_AKG
ME'.1F%Y4K$- K+/6WH7BI7Q([<3'U"+UHX@N4[W@N'&9C+DDC;04)!$1N3M&
M0[9<4/7EI,?='8+, 3+=JGWZ>$\BE8#^B-K13]*M2^'$1YBZ?[ 33EKNG==>
M/N%4+1$AR<&EN"L  '9\Y$@-:: :NMFKM%;+#=AN;D&K'C3@N.23?703I$WG
M*K\YK,%<R*(:?C R*VU00)Z:7B,('X2$KE?OK.NJOTR^KY\VU'XDB-)S63K6
MYG"]0,"1B23R^9H'U?MQ4ZUJ[>_JQ^W&W\[HWUL$D8=K\KG?E WXARC)\]^)
M^,2* +)E99R5O.\6<K8)_1[^@Z*^ZCH=>%"/#*5IS;[BH1',*.)K\C4@,6N]
MW%E3A)Q-1&<O_.A)5_"5M(O?D L@XNH2='5))%.@'S'KV7LX#& %D'V_-[7X
M1XM? >@C!=ZGK(VQ/'O?U,Z?7^DD^YEA7[#H4_:E#SV(8Y@S/@_$-Z%F'>MT
M@,U.P=0BQVIO:J;YT2A?L^?US<=2&@1*QKL1]:C=,R\FU9D&;TX^[EGA1 (G
M/J(["@6$ZJ>>&X>@]ZN9Z9FA<[3J;$SV^-6S;X2QZ>JJ_%OW]F21S:&UU*]Q
MY*6MO@76?V_G9_9#.[^R?VOGYR^R/94(SD4:B 17M1[2LBTQ*1!?T&'KMZXH
MZZ^4S6C]<C9T+^37QT'^O=F?WG\T^X/V26"V1#:UOB.##5U^"IZ,I0/'$/K>
M74A_C/(&=H#_[@=JFNK>Q/N784ZCNQXHY#JVTH'H/>@._5^?&88'T0<<'U)7
ML8S*G;/@BNTV[%YFFQ]T_R:U/^KB[4_.5H*K#+MO;^;?,N8:$^_(UCF=]$#O
M?D4.4KHS!.?GP-N1(ZJ15;SI#R'IQV#&TLL4H@DOZWM7N<G,/AQ.C#&K*_#0
MP)B5H,O4/7[AL%QL2>;B-\C2'AR?=?=T6%NC\I7-@B2#)]-&3;/W%%L8@,#^
MZ//PM7 +ZDN$J)?K]82ZA8\"@@FV7Q4&[%;-+PY/3,4*?L(^7!;OPE6U,UW;
MP7C _DQPI(+3BQG"7EAH9F2R%=?$J6NFE&AHMZ-D[@:?R>*++J+HC3';IIN7
M]HEIU;C 7F/QAI,7\$.UUS[OM&?*5@ZH?E:G&^!_)ON6UB**?,@KP*M,CX!L
M8-J59C?HEN-JE]9>W.XJ]BH[QKL_(,"C3 2PY 21VI[S+64D9T]Y)GL>\V:G
MG4.OW-I%DJ8:+=^3%M?V:SY&MW[Q*/WF0$*(&$$88 QQX_:]D1^V[J/BL 0*
MJP3U(4($OBW5?$JD;BYK6/<-W."6AEQ$+%>HR5%O(PU#Y[SGA)B!2 3*>!*]
M>($.B&B,16_F@S ORH=JCXZ?X'4.OL/-"6]4 (%6.D[[DQ>/J,J@GM2'[R\[
MH_^?&_'_[\@_8P/].7_;1*(G5Q?7H2]\FHT^ 9H'U+:R9].Z8HMX'25G264T
M?B@^CA8LQ8L<<P?)[+'O2^XHDC8=N, ="<4K@_0B!KXD)EZY4!X]8Y-,1071
M 93M7WO8R>UEH:U^I T..3.HRD3TIH93V,FRI)>&?:K2[^";FYY$Y-UX.?@3
MX8@3&WY941Q*GZ+2(FS"-@=/YOO$V]Q8TQM)OI[5_?J#78[@][I<MW]+D.Z/
MD[CR%]=2")O1T$E/ @/UL21TW=*X7^X'!6Y4#/GA#J:!#@BM7P%OQRN/QKGU
M$K8'=!49ME@3S+IN7\_&:G,M<DLT2:'7B<JVL:'F23(''X4]9F.##LP=5"IO
MH]) /KU]_1="'?WX]R:\OXN0KM$8P3DK0 =8,-@>9'R)?Q^,$5E[%3.!Q961
MMZ-72]%9.-06GP$=*,.L)_C-'$*VY*/;Z(".5@"B ;KJ9K&/#OB ,^C2#+KW
M'26>^@0Y.5MUB+:!I<6TP_)N++B@_AUL"<#V(\O;*4ZK3PPT./$B0T&<8W2@
M&+UD]QK1_KX^,Z^,N!+F:+EVK-LR\6Y=B*"VS.TQ]LZSK;6S2NAG2Z#GQ!QB
M-V"[Y>5;;]B_+#S4S%*GCCT[?2UPI7ASO"::H7XK6#FQ+)W5?<D3OBVP5TKU
MX]@\F;=H,X%H7):]K:WA#5TDDS6]7(F/\8M]2::ER3FF!Z6*7PS+/K59?G][
M[[JBXFV&RP?%>\7KT>?SN5)3354+S5+[4TU3CB7EZ!B'SW,8JTW0 8@MBME/
M!#D./3AZ*B'1^F5RN\2BU_5SE,O- >)C*X?I0.UE51/7'/ ]WU<6+!O.(JV]
MGYI[O#RY^:Z.LMCV!,.\[[8W0C_B\S*>T.GN(]3>;%U^N>)358D_5RZ5[6V-
M.C6%#HR]YH(>4CUG@VOGFRNM@?2L'-%RR#95\8_5/K S53RV,]9K=Q'STP/B
MB[Q3S5:D5Q69A0U-[7A$Q&SMQ'O2-J*;51S=]LNZP%?\'R#7Y4_Y6?X)^3]0
M5<Q8SNCIWBHH$M_$(KF]H+?/R;%WO,LHM-=@ZN31Q-T'>2H$IJN11#7J6U6U
M/-H797UB>P,3?(7'Q&S$_X/[%P/3S<]LEZZ^CR\[LR0:V++4PSL'=6@?2)@@
MQI)L'!Q2M9G513LSX'DJ[0[9I^^$'K6F\7\49<BX;A.11$DBB"RN$53J%-9,
MYD<! G]N 1L3RQD3H?ONXL>RC03F+Z'A3+PW7_'5Z]PJU*O<6*!Y; G-$.+0
M04W-G/O6--+RNK>[Z("\?R)9F#8*.T@[X>?<N<[*#Q]4*PM>%OS@/>EKFW?6
M*N@%U.M2\V>&WAH0' 1ECZ&WC\A"*#RU=*#1>$PR^LV\^C&,+K^X?D7/RBVV
MTE[GXL+3NX2#KFI_G*Z D*Z-JM&!-T(-2))H.1T8%^]JF%JWUY;MD:5:8/HL
M/]5.N\\UZ1BX5F)+P_5JD#*;-C2NS$>86><.)-Z&@0YPFOFH5V>0PCI&[$R#
M\C/M#[])^NH>K\!\S]%0T_N(;]\8C"*Z MK4CIAQ*(5C&$G@W$X'^4D'GIB#
M0PUT3;??[):2S<$L#66KM_L[XEN+FP_PP0&7VIG!JBK-O1QVRF'I2U1/-3]Y
M*\-JV^YX<9&^*41S+^@8O6:J?JLK]493!.G (<QL!IJV[Q0=(+VK)_0%5OG"
MQU 'OW@36)P<A+KS!>"PQ4M":T\O-L8Y*]V*B(AZ@;;^$2&8QGU0S5I="5(_
M1&C<K/]R8$*/L#KG<>;<\]ROD<RC5X>]1J^8$?*+: >13[#KUXS!W\M%!R@W
M;/U^"&\<26YXFWNC6_!#2;?#T:H*LL.P\UL]]ZDGE!G&7>J==9.38VY?3-^&
M/:K[>S=4J5$GS%"B:.!HO ]JID78D_?^J*&H-.IO2BB04).(T%K4"B>F#B,#
M'\-0GGWA6U"@A?ILI]3<)$G1@>,RFMM?Z,!;BYI,D'DP82;UC&DU&.HQ!@4>
M)*;^>Y18YRGHY<B'\ __ #LP_ND" P>@]NH;CP*2ZTE#2Q.Y/:?ZV4ZU0-Y0
M<I;#)M3%_83P[4W13*6!X^$G*HK9]K^-%1&58 /.NCDV[XYZ<,![;W5$*@\S
MAE^?W<!<<[,L";ZAFMNW7]7C0(; @2^#V!.H683TK"GMO[99QGK&>UO)7)#U
M-LR$9^^^QZ:HMC^__M\3 V#_)>OB)6U_)KZC0,B"<)5GS/_=4#0E,>V7/ .Y
M7^<9+&R($N3U;HR^K5R+;/^"J_]0(F>K(B4*8?J/1J[A_]G(=:./PE[9/"I*
MP(95W1T5)E@4Y>>E/]O)Y*][-0G'417YH:[R(&O+7I^U93CZ+UZJ2WTOHK6&
MFXJB:/GG>OF:]#E.5I7(%YG-RYPG< [G\NUG2_Z(9E [W!?^TL;DBO@>PRA^
M4R<GCQ'C:[UM9R+:6<(SC2JKC&@;VY"7D.*$:M]Q:'0*M (3GYZD9C__S9-]
MM9DYD@/>_O98=%W58$W_7U\K\K#97)EG8IO5GMSNT:(MN-,1J[13U([7-NK?
M-I6NG D6WW/ENFFAMMQ@F[6?M4T0.KCQJUQ"7BG*M[IS!?8>^42JV&G0K+ZT
M-*J.Y0I?CFY6#Y74P'JRO7,")'4!?>\1WU)4"1:!9!-;7J[$"35/[<X2UD6L
M^M>VZRF'K_G5F%'"/C*_>^2L,I/GCGI?MEB4ZZ>.>=E<<[K(0>5ZPMZR[N+6
MGM#71DU;]R!U#2QO] 6YOIX1[U$_B6A29R<5$-B0//,U1PG',_*.AK29\3UA
M.ZE:<O7EKO,-#RH_B,3"<2X#&;O(=V]8KW >,$OW_40',I%"2Z>]'17()V3'
M\T34X0IP32S:2:89.I:9M+%4$SW&SZMD(DO^L"*9$<$>$GL\Z&K*\'X8;1L=
ML+#13$23_A][WQW05+;M?1@+-HB*B-2H@"A5*=*)C28"HA2E104$I"F*((0<
M!0&I41!0BI$N($9$>@F]"DB7#J'WT -IWV'NO/N]8>;=[\YWR\R=YQ^+D)V<
MLW?VV7NMWV_OM=<"('2HQ/$!:R9\S\7_4LB,X8,6+N' ;!@+SV.9*D4_G&W'
MB+9_ 0N.Q&@0HC%_$/,H#EEY]V;!LQBE2>T]<H[BS#:]@PHFNU[M&"102=E.
M'?H0!SM?24")6)E9F&KTA+Y?MTHS8[T6M_V*WI-JWG>XYCG,&_EY-LHI,6_*
M=9NT20ZQ9[<SFC^\6:B<5.,/';X 6SRRU;O/:.NZ,^M\__0B6824.H1Y]C[J
MF_'$FP,&,.?WVOO4OIAMC;] 7>5]$K3=T68IE=!1[,Y(@!Z.L (G^.B=U3I_
M5+HZE^NE%W&LOKOXS/,0M0R,AQIT[QMS*;^ZR1M0=LY.2=W4Q/9SR]BWZ>J[
M,LDW[['X92O8\82[TTP::['_Y>>#^H7GSU]+BB9^;4:,_^HT2?JK<]')OWI$
M'?RK^Q/;+SVBV/ZO1Q1VPP$*N=DC"ODW/:+P/SE *6_VB/IK 3EIPP&J8[-'
M5,??]HAR^.?VRZ]X1!G]0O'%_8HJ!#?\S<#-#FC@WW) ^][=W[O[>W?_.;I[
M:G2NFW?%@M@X/0=[BBW+\TY#.3W,8Z$#UG4L,PM/Y1].!Y["GLJ(6F+M]*Q?
M"'!R&1POZPOKFQR'>-:K]SC)DJ90UXQ5@]7\?.[LZ?/D2RY#!J3")))TN>O,
MV+//:;=.A)UN39#0<!"^)QD3IE)WXZG@69EAGK9U7F0P-AU.B6;S0/3GTX%F
MV:GE#T4P_X]+'TDD\O%W?2?RG?.1,2L%8J8)M@<*WT=^CC"8,:<#EV/]A C:
M'W_W];(_H<C\W/O@PQ:"-"50:0\=P/53WPC.C?_#2QZ)FKMZSLW+U,J%WIQ6
M.;&,O(S/;IX6=; ?N29B%V>=$)IW]#B_[SIPQ\)&R<X;YRZM9$TR(C-33E&C
M%.[#RXW$]DU]K$]2EK5LGYOQBK(^*G[*\<@Y8,]=9QBJ YF"[D9N^>Q^YGKC
M/%P]^%:WLZ&O/6\C]4$@^ZE&8P(>XKMWQ+KNE].!SV/E.^.";.*)Y=+'1.#G
M/1\V2V3RF</1^HVFG<6KQ2UTP!P;T!6=8GR6V%+N(3#\J!W& O:+>:X;-*LR
M"J8'7K+0L(Z=1KU/GX^[\H H.9?6/;M2&)XX-N/SA";@HD&P\.]SN5H>@7QF
M-U3UJLNI^=(M@;=.5T.5OC!\B,#_( (GP*87A_R%YNW27.#E[4GU3WN-:NQ.
M&"^&WI6.J=QQ.)69V6;%:.4*:95MAI7HK#DO7\6=A6/)#$NV._A0U?'Q02'L
MH(7%7=EB6W-"[JEK<#.8C99QD_S'1^'M@FX<Z2/AHVY,&]GQ9OYC3PW]FN P
M!8_H "_^&6+ZR#TZ$,=15/*+(CSS_%5J'1--8 T>>]>27.% Q'WIVD32<6%*
M/W<0P)?.K;'H04,<4MEJ3^HKD7-$2'=#ZBC^@(XRNAQU^ ^P_?6[RM4+5EPY
M>GM<LV3I@,(NIY\*326?WVR[YGJR7NZ?X.@QB"0)LE%<*=)T -2AZ;>MZJ&$
M-K:.Z0 &Z4T'YB81M5U%<=[@L)TJK0]Z--<7HY3IP-$\O!CU!!R!+@?_LOF
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MJ%S-1WXLUU&"_=11Z<!-\E]Y3#2-3'.9*G=>MZ@8$L[*-GR_4"$VVY/R*6/
MH\2U VKN-I'< C"@CR?[.?Z;V=<X%UU,N)OQ)2X,2M!R7"C8ARE%-D&8YQBJ
MR>9UMR;K$BV/6R_G25O=G5O$^1'KA=2IPDQ:7I1^(?D1RKQ=2MT^#:7L$'>F
MZH2E19+19RN)J"V"\O"*0'=6LC"M5QJY%Z5N.4 '>,KLF)-=2SF9#-L4/K^Y
MXA*D._Z^=XLH@\PA]GJTBU[T:<)DHT[FFYIHL5NAIML#+)X^]HAW&V-=/R9V
MN&Y>DOMX<P!2)30"Q'TA*8@Z!Y6UZUGHU#AI]B(6UN!YGPUJH/Z[#.-Q\2\&
M805'W-].=?GX+*L['0T&;_<JG%->N/;1+MZ>(8OH*/NA?T6,5/$>9462DX+O
M5<OFJ(QT/Q:I^/5RXH"@RM01X ;W)^!>ZP>WCJ']M9-5#%PEDH3>M#9X6I5X
M@O"#CR)*YKAAMWH(R)^:^H==F_Z7"]>F WH=/P<G2_\4F&S FX(Z3.3)?<=)
MU2A1XFX5\ZW)S6N^$79I3+:G6M.I]:IFTH-C+T-?;PL,S'IMPYT67: ?UA28
MO&?'O@.N@ RKXH$KOS7$[U^JE9J7IJGC_1'3+,X;#"?/<+3H&&1\I.<MJ1[V
M=&!)HR5H7-M,Z.?.6@:[B=!58M[@5 <=N'UG]IV;QS?(VIW_YSL5D:NP"_(D
M3UHI&WS]5.HTQZ8"XAPKHN=C/P%\L2ZP'2S0AV (I1[W<VNY9O:S?==\BB@$
M):60Z^O0KWO&U6-!HP.P#6!_5OF P;1JZ>\]VOY4<@_+6K2/9#FDZA5Y9EXY
MQ.3ZFH=5O&^MQM;'>[DYTTMXHSQ@ASLLE:VUXL?K=1-G^#-4G$Z4ON<2%$IJ
MPO)+4UBT!V-NJ102WDH4D_6RX6MBZC_&*;#Y>9R"CO96@VQJX48@C)5'\&^O
MG2EKJC6(C8 )^$T!%/[;>W<[97AW)Y9"!VY2?</!QI>HD%^[=]/_4*'.3_7]
M5%U=$=M&+A_2[A(:?W-FKW2YJ6 0'=#,"YK=;A-Y2SINN_$31E[>%Q,F!C/6
M9"E5\ED7E<[/:[&?YK5""J=OO[PE&YJ>Q\XLSE!\>(7W:\2JGQ!L!G4?M^=2
MBK2,;?_(N!TUW%-7P"=0,DYD&BUETY_A4"'&?"?XFXG+EO+]]>R59!$EC7>1
M4:A/%]B-B(H; 0\%:.6FAWE$6E#(^1^*)S@>1@OV=%E+S$CTU"8)FIL^/'R8
M.ZVF^% %VE,'>=Z?,'W[F&?<H7?9<7=6UQY2M'?O+B5=4K30O^*H83Y#6D6<
M1#C@ FKF.0F?2(Y5=YLI@A89MV^HOGYP;6<WCY_.93"O*@87 W5.!&)!6>$\
M'3#;@U_7=$ RH;_V+Y@6'=TX3@?2@008TI$.E$B"PWXN/K1*=G IHJ\H7"YF
MCS2L-%0J=H3B!/HN=BI;$R1J6I/S1RF2R"?+%1"D?8Y-]OJ]Q_%_N/S++9B>
M^_G+V<WO?UJ*C;5._'$I]A498+J&DZ'&"\\MPQ[#]]E]+JY<U_QA^=;N5BQ_
M#MS[COG,P5J_@F#+4<:9;60;E#KU+<5!R6<@O]Y C=@3$NDNK_J54I%7R'Y8
MTAL1W9FW9C;"M6>_.!IEPF9(Q)<+:2),/A4U9Z:Z?4,WV8&<%?<X][^73KWY
MY+!G8YK["3JPM7Q>VD=!GGQ!FR=7I#!S-B9!PSJAT?$,W$I<Y>$)1?;G)[D;
M>8M@1\CFD,6;(N%II5G@^K%=Y"AQ;SBK-I.6G.'JY'0S0J8RE_!1[YZ30$JX
M2)Y0!?XK=0<5KR2*.D,Z1?3H-B)*KF1I2 UDX(N"]_&MU$X^E#0JT@G>%:P[
MQ'MH2A^\@0CL\JG$/\YJL0D/1I)\+N2ZBZ],/NSE&P#FJZN2^;E." 1??K,\
MAB7JPOPC#OH3S6A[3SW:0^-M_S 0/JV3(WYVJ\,HNS&X0S@E3M'QWM=V1LI^
M#?6\;)+S4*^69FG#E*['CHP6U+W]P^C]22-(Q7,O+1ZGRHI<U0<=J=>7K_DU
M!UFH1/$$B4)D\0<P5FGYQ^B$'W_K^NE_FI/W@FIYH9R==%7$\/VX(\&3ZBV\
M[ :WBC'%'00EP7/:#-X1AB?P%? 8HGEX^YTJG-BD*G&U7+^/9=X;F]+']\FH
M>RVR?>_NZ*9/ 3^<F2PK=-/>'%MIK<&/XLQ/Z&D\4E;'Y'%/QR%2S]U08TFU
M[S;[,9AX2NHMECS]IFY-Y*0[^_\C_E/H8C0KU*7E:HWX"#AIYRB8\LC2VGVL
M"4ML,N6 6)GB51JEB@Y4':<#WG[$#LK:)'9U%$&31<HVJ5(N!)#7(,W[V&<]
M*>QA>-_?4]D!\*>J=OR'U&0!D3+?+K; 1"OA8\'R"2;]ECF:0:J.LH=IV_-J
MUQ@'J5_"BF2^\OEFI1=Y[5RQW*4ZK.GNCLPB:N\CR/AONY(H>$)K?V9[O913
MTOW%AL.UR18NSRK][<4-.M[J*+.N'UDH^0.L=_X9A'&(;8:)#O!/$<2H =)T
M8/WR\JH8A465II;T#)R^&4X'U-.F!G%=G#2-CG(D^9 #A+]CIF:1I&,8R@OM
MO1LH08P68M0QW0-!B*,R8+?/<"Z,$F1!!QS@QM"C(M6L?_V;=LAX-;#HB(O#
M8-%S)P3+E+ZK2-C=3R9J!W*7E"?'.L]*C>;!9B*)#N6N\?H'BTYG^SW2:K7I
M-O*_5M,@&WRM396@_/!*"<'F;&O"Q2M^DR%6(\G^94W!7A?]1);LCKF9'*B^
M'40X$"9P_=:+\[PQVZ[M>WZ66UDII^'MCQHRAPX\P[(5<!+?U(@67"=P*K+S
ML0?)7BMH9AXY>MG$A_N,5+6+_$H626.HT%!1XN)\**X[_HB9WPI[VI:0KT(7
M_>)7BF4_5-^8ESI!OG8E!/,@NF@QV*5 499\HM4O_'8;;:AC/-9O2.[O<V0=
M*[";WUT&,BUY)I.PAAE-MAE>P9-G$AICQ0R4:G?BI+Z"MOV>:-ZVHQ\SYS,+
MKM8^C#/MZC&LU+KW);@R!;%?Z%,8C,60.4'PRDL#W4A5D4NF/ $O!75U'.*L
M);K&$\]+.N^-3Y>K.^#'SKU#L#C 8\?DB>5*IU^''C6)07UL80;78@,UY',9
M=!F"U16WN105DF]3.(FCR2)>'8%I(V]X,[MJVPF3)^\'\?F=ODIB,9$\F3DO
MDG*@)ZU3>HUK.?W W0FY%AW\P_!1-Q/61A<! ILWC<]ZRU5B9:9EVG5+)O[W
M3_S@JJ;OW%]M,6$RD[D8%77L?8>*'7MEO.[;V5<ZRA:DD H.A.>#1\LFSE<S
MFR7'5<SS"D+-SLZ$M+XI=G2[$F <$:#7S14?BQ,POZ-CRFU'MD4=S&M5#G9I
MYW_QZFVP!F>\/V+N\]DSJP*LT^OVR99IU\ZZ)_66N%O(S?F-=BD'R[*U75??
MZBX4F\6RSSL[.W$(/8'[,A;G%_,,G_XNP;X>49T)<<L3S;_W:N8_(O_ZJ$6:
MP9(1IX.4F0-V??I8?7AY>[2>DU%6RU)^7?SEQCUBA_7'+R;+4 7-F_T=;L5&
MQ0?W4&*I'_ W$ <H,O.GXPC:P(2TTA&B76N@S.>/ 77WD_8[FIW"?6D*^O)V
MX.ZW2NUJ.>\8T/F=8OUR?7G'P.,68WG)M^]V,0B\ ;9T_X"_A+>$DX[3TN;O
M$])\?!2T8\=Y#C7Q9^>\&=*UR0XXQ^L;91%O]W8_,-9>E$^D X$T3M3%UM</
M%,'2(L'6HR9?),EU-C4ZJO?37SU!:G#I"VP/E?M:&!:TWMV(KJK18'SZA5_P
MU:.%WLY4:W<>?ZTQPFI)?V<'07J&G<!GPJA>D)_]!KF4YDJ1ZU)N_-(H 7N=
M/V.</BVTXC#@4-(+'T"4B<!+NDZ)EYA[)>4Y,<Q:FKWF=W!T92YFZ,I#'G+!
M:1!A3Y>1>R<7W</5F]-,)PEG)+(DC:.8QP(8IOPHG1WX@30E<9!%(4+,8^DX
M2N$3*FMU3C+<_O6DN8'N%54R$\9U+/K.&F8V6:7)D Z\:-.&^=3BW0T-0IK0
M>>BD"2KK$)@!GU$<;.QR*%F\$W%)._'.BG#ZI*'" F-PYZO][P\Q%)TN*;MA
M:;WU!Z%.H9IDK0?F@U*W,8ZAU_0]DC5[-P)&\OZFE"]_<+3I3Q#;/MXGK,OQ
M <O=&7"3:\1$]>V-LU5#1KKZK,2E>[J]@L2K_KV2$> Q&ZVTB^)7DP0.YJ6Q
MEX&E(40'Z@\PVC;-OZRI[](NP2_M0)!8(6O)9E+/2J #J;EB5(8K$$V^M^&:
M0#8X20?>^D+46IO2P$D[@/4$Q_>"1$&'#>^LG\<_FK6*HYK4@..[PFF[,6N,
M*Q]NTH&S+-"'V+4HZ;\=L\BIITEU/3\8^@*K&(4-O@";,2ZC>0A 'R(691S^
M=IREJ=Q8S+(S/_0%021)%#$,[\KUH6[5WN :HW?[-\=&^ED'=-Q7AD_.:D"?
MZ^*)QF U(O,^;'T'EK:5#GP9Q/\BG).7P$#_^E8X95<D'?#_,.J':.L)ISU.
M!@<@V_L<O#,*7]J'H.RD Z\W]7.'!^KRU^D"V:% 5>V6P07AP84LU=Q(]L!K
M"^J*ZK@TH1%<(';AJA0F'K'.+[2 W_<I"K_E94OJT[+2J.@+N$,5\HZ-&@E9
M/IW$1&E6WRHMUI1:C1?CW>YF/25$!"4H J(<(A"0N=7QS6E^[ D=&'[P%3%]
M!,(V<0>+RE*)J=1&5AK_&DLEMBH.^A$;4V&5=_'M'^#LV)]!MLS[KWA#>F%Y
MGHU6"8TTZG'79>W.R)5*9&=_B1S&I[M4$Q=9J#Q'^RH%S[#K/6"=X?!RC0X8
M1(WAM83RJ8G@+3C<!LDJU;_?1;R4VTVCW=YP.89-YZQ4P0=GM?=\%EOM^3QV
M#BS(C-4@!GUHIZ$9\KR?)/$)HC=MY/?WKFO=?)*DRJ(O>MI 2]]9HTUBWO=F
MQB7FTTYWET;<"G7MW],T><AT '8>0_--!0>(/ZY"+LE ZBLBFP9CW%A(? *6
MP2AV="#F")YH"2'=JG<0(X*3NNG N?/@0$,='< 8,*Y80BI-$D&$:-5P4/\,
M\U':=6@B9]*!ZC?_^.UUJ*_+$/4PRB$ZL':8]I4@-H*E[492?.?P/[]7T\]K
M<F&C0*JILG]]/]3MVQ\B?XR_ 1E&_!*?-&W/-)ZT#.^,DJ!\A3099B-RQO=6
M_S%:[;Z3+$%K"B0K6\GUO=](:[ECIBCR;EB9TVH7JOU$+F;]<Q<@-!6U4H7
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M=;ZH]+C"U83=_OY.0@Z@_:C0*P;9(\9.\.F/O-U20Q$P"DOXH#TF1=G)R9G
M=/M0 [K*[1%'.65LSRU?SH6;?46)L847V1.EF;0[=5*/5V72 =%^WOJTL(%Y
M5L4T0_6Z0KP2'1#W]HFQIK$WS4BF':OEEM?\'*"\+2UOJUKK0T!O_3CN5+:
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M =>OWM/%#T2""Z:9VF2V6<22>Z')WV/ER)+@\&LZD(VXNG =K%&F PXTGXG
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MQ.8](GC![FVL][1:3M2+=4Q#T75BH_]R_[9)&#A(O4T'SA>Y?!&YGV1<L/\
MW_Z$YYX>NEQNNZAU#-XN/=Z'7/)E53K6L(%F]W8S1C<4A+9:@,74JEC\(<3@
MVZ+C8)/RO,%?4UG^[/V:]K+0/CJ B%N5F* #[>OPQ0GJ.!7[=UR):'VO2J%A
M>LJH#M!O4,+V83K7A>8]:1R["3X;Z3W!O^;[W%1 O5@.-HY3OR#^T=I24^[H
MYXE&.K]#:H6UZS\O6*P_4EK%D7S;;!H0(.(J<20K,3_XD@Y*[[]R:XZ10G&3
M>1#JR'1"S.RNU]#):Q;6;!LI#Q1N=LA]IIGKRT>\MM_-X'7 8$0.>U/@1=^4
M8)TF.W12C!>!PZ5:+U3.3D:YSC1+ 3DD33D@7[$^FGO?FD@I&^QE%A!BFFZO
MD>HMI0,NOEL$MW2>&[8,F? G]M-VL<[SELE]T22\GJ$8Q>=CY$Z(Q&9'L_$>
MD_;5M<3MV3%3Y1 VCFLU>V&1'C?M'F X9X>F-C;P1]_>GSI3F(&WF5BU10^Z
MP"LCM,NU=TZ@^;[.*K4EW#GI^_9Y )>YQWOYDX>3N9])Y2)Y:,5Y7N/45Q1]
M>\NPW1HF*D0CK?A4%?QMWU<Q,]["9[EKEG#/\)MZE5**V=/(YE=^.4Z'7[,;
M*=]-V[DN8G_$FXWI7.:UTY-"$R,V$'E"6([C*F&;>Q.SN: 0_M>AY/.[C8GO
MM?UI:L.94L/!.P[/Y,!*V)[Q]4;?3/@^JZYZBMR#E:Z$,F-6\9P+#YSY7Z:>
M5.#:]]P]=YX+[A=W4<],1TG/S>9KGP_K8*I>H+1F:C[R_/)VO^.XQTH]_R^-
M_:]?'YL+0(N'#_:7@H=<(ACRW 4NYA8\V_>BD/=6+N7,A\H-_UE36#;IR8#V
M7M+MZ9GLMFF!](=5O?N/&$/H:5 'X14.\X4'P3^I%L-)-K" ""_,,Z?(?)OC
M=L-MF?(Y%R,C/<SU2C-^V"*A'ES.PT#XB%9$R30K[:.U&.*?2HI]YA;0:+6[
M];A7C>^E)Y>6QLDM L)NNS*)'02V0,0M$,/6K)YTI$VR/42K]7-=K+Y\SLZM
MC\N>,^]K*D:4WE4Y.X:60IGZ$#JJ1)"$K8;F$;9R7JULR)N/G@;R5 ]=R2=*
MU/+<E5O"%<8.STM.GJ5-A2=VY&4/IJ\E'CVU'FVHQS:7FS=G(S\UE;N.W'#;
M)JY$I]"^9,L%-HMU/RC4:C>21KC=QX=-*J640SI'->$>G*B.83'NIXC-)WH)
M971/Y+TWV#L[7O3@PDEX@"S%9AC75;;2.L\X(Y<E=ZUYB-CO]3YA<:@E+JJ>
MKWG@7?#UDV\'6+QV 3VNR[@BQ$ 4N'T9Y@4R*-,R;%=<<;[V0?%V(R8X+LX?
M2@\]Y/N!M'3/E,^J;O?C5(XN62D'2C@E4LFW(TA"/$&0XUV2,P0VP0C5-ET=
M91?&EG^47D30@:=D HS*PD@'2F;P)'UX4('=4"1N*\E[-]Y'V\SZ6/3=$!/0
M[JQ L/>Q/>0S=3?,!YPJ#/US%:JGE#:1$!?M4BR[2XLVZ5%,]T0_K%OW4] >
M91<IEZ.+*D,-E>SP0"<L$8LZ2P=B;T"86Q'BZ;NX3,KCW[OJL1I<RLG):[$3
MR,\D,_4\CZNW&=VI$"ZX^]A@V8UA<ZB^=\*_)W@2(DB3ZY=QV3^]CLT=/%U,
M!WJTJ1^I\A[@*"^MEPYT8RY3H\%AEP(Z\!&%71>76Q<ONO^+$GP9N+:WBN)(
MA<'\$</F=* 4XFFX5DS@[^V,^UW^.*+0/Z0]30<&81A#DX0DWQG+Q?>=$>WK
MM6>YRSG3<X3VGF7<<N0)UZYY..EA^(_9XU-_RAY?E!5;:*MD%U1Z=457,*<J
M?=2@[J1+,OEB:TCX_6'LYF]C?N7R/# [ [%&:P"G+^734'%_WT68F>E&&OB1
M5EZ''ZM54M_(&8_Z*6<\_B\IX\=_I6QJZLYQ6M\7.C!&AOUS:YOJ07$2I<\2
MP5)V)<Y(_QG+LD_G%=-IS0\>77 ,NWVYUD]&6$VF>NBK06R3<4Y !Z>?7^"=
M#^KR.-,QY3T9C-XAH1S6I]]3Y>$O07;\+>PS<,]R'78ZD&.QH@@NJIFY$KXS
MPB3ZZ8MCUZ]9A@06EBQ5D!S(ARF728'O*ZSIP(Y"J$73V4^48M*Z"]_?$U51
M,V"(PB@S$H<[IC)9E_<-"=M:+4#(?0UO9 >65:_5W'W#U#9VY8XB?H .F"9%
MDAP&3/T'00\[8G/I[&S+I;!*#=FYF2S^+]Z749WBNH_K<_.Y?@#&A<K!P2XD
M$SB.(. HN[(V8M6L=_FM^<E^D&<>$=0S='1&VZ[+Y=YFSO-+UI1BM1C&!/_B
M L2OW&'BIT<B2P?2Q>?6%O[.RQ _#ILR,HLH'< >7Q.@<2<0.VB>-$'(>J8Z
MT%3C-A?@TM[%D=TDH&]/([Y7])]243VN:VKE/!%3#/=>=WCV@.FJ86%!;EO<
M1Y?E$S$NY79[&M1V[H_N]'4;VCIONHT(HVG@RK!D=LE^JF!0T1P=\ @#:W9]
MQ4^;>](!=?O40=AC<,$$S44'OM4DTH$)7:=U;PV_-/]: ?V"W(2Y.U18_2)*
M45C49M<#LSJX\_D5/\A6EL.^E?X_D"WS)J>CJ<>D0#K J^V)F%JE Y9^^>O_
M!%20B_ WE40PHP^YX"H8%*J:)>O\6\_)W%;K? FW?:*>+Q0D]#K^'A*.L$#X
MT('/%E&6Y>L/GM\A"H0[I%DW',WW?22OL??\!_4UX[WB]SSN(_D@&%IRI,Q4
M]A,I;J2+92&MTBNWU76_*& V]V3I/8QT#%<QY_M&E%3VWHK%INH*L?RKL0U'
MO%R8A7EH%!.1:X0]_OE^I0G.( E/9.+RE.YZI0F_ED0O<AW_FM"R_L&:[<KE
MSNX,B@+F!7H#Z$G1N%%";6E.T>C9L2K#B@S&9\AS'SMYMSPO!8SNP6?R8;8=
M'?OR:C@^B7\Z66TAN]7-H 9+O!))!]C'00:5U$%PG[%5EZV!M<-[HZY!GE%V
MK;;RQ_:7X<"[PR?OOWGU'D_B[R_/[V='[6Y54'RGU;&?=!M"B"O3,V%&U@:N
M)U:81I], S,Z_ 9LYUQ\&R@?VLGX>C;VRR6WCG@E[;Z?VM],!Z0SE&IB_83J
M%6_\UG7H/W8N@=\BK/.<U-'UCN[0O[PNKOISW@!G!6C?T-$EB,5]=,">#LQ4
MO4,WX!<43,%O2MI4=FYW=J0L;5,!<A!/>69&DT7[^%1@%\3!P;/*!PPF52O_
MK0Y5W^5_C<"/@24:B&$O*^2*.,3VXK/UB#[%B#51/#,X;=X"+J7(D?&T7=?I
M )_0.0AF!,.H_'FXITH,$)MT(MVG V;'($V3H-,QW0.AD*,0PNL>&\Y=I03Q
M0B,>^UGW[SN:_J\_3FZ,JW" &'!I&<F2@-MCOZ.KZ/4]\_>]6Q1L4[0)RDZZ
M[1:!&J=VI8A?BV*X>'$B-G;-T'(0/STWGV]$#:&)UZ6J)W+&,48F3*[KIHWD
M5Q4X7+[[,"_O!V:$#_?4TGUER%I&H/:U29;<=WXWN:Y<V1,I7RBN&J+TVM\5
M'&J+)$/=5X)X@,'(Q=-$B-%4O(_"3?'18:WXSO[G)]E7/'3F,=%G&V2-%Y$L
M=Y!$+23FH72S4<G@;G<5?ADV_:["5X&%Q<%ZMNZZ!LWD2Z)*IYRPPAUUB\W]
MO@M*C>QA#1HP'BOI)&2=$8W1FFR#[FT'X11Y-D\%>&+O-Q=SK6PVYXC'NA$S
MSZ/]WL5[G;G;$Q7,N#L([0<U6I?$O%A&![93SA,T<B*.4\XF,]CD(Q1.GM <
MZG930PQ(#2.V@@.A-+Y6)QN3\X2'J3;QUL?/U\1;WW_4<=4L1?*Q;8!;\OV.
M)$/J<>*<S^?^G>/Z'*(8RX/8A&_GLE;:/P;PZ;PKUB'IR_CEH)2X!S_.4KII
M\"#_80>O.-]R@IE?A9!C&EL_S>&^"@06MJ[_IC0TW\W'=_/Q77YO^=]B/L2J
MM'=/*ITFG1IRWZ(NT[HLPC/9]<V2_47LC532&P3';,J'U(==Z/!'#_S8![V&
M=_7NU!. )USHC>T6C;"WYIWO7]D^OSSG 5KC=X]W5>:^FY"[M-!S72.IQHE/
M?^9NDYQ*<-7S^+57P+[5=.0G/9+\?/?02RRW@FD?'[;4%>8M96#78CSN*^EH
M_*9>=()= S8GF*Q8,\2-]B$_HCPBSH;8)'92SN:ZV9COJW00%A%-**8M?2IM
MJ.I]%;'>H\^<>.K<0YU@?9ND/I06C%MCRXF6_)><>>[H471G$](?)!+[NQAI
M$/.AQ%E#?S#(6.Q'1$7C0=0=$B?BF8)E*F@[.97:8^B/R3C/.-MV5##_EK+I
M;FF91JGA]KK)KXF3ZJEBR 7% B5KU7UZ5SR<T=&XGO5SD$877OG-^QS_J=ZE
MF\6@W&$U<@II_]-K8Y^PW1,ZD(,EWUQWWLBAI4K-IP/9/#%D.3I0/?\(^KEK
MB"5SIR4+U-@OBMQ!;SJP< 1#&EGG@1\$JVOH@!<T]Y#)<([?^U#4=_ES"NHU
M'=@F#"$IUACP6PTC+;C7H!0.T('A/,K&8F,(!+*:WTW-T@'2"4O*\[3=M$HU
MQ%+89-%>$B,=X.\8;*0&1#C00E61&7?'*+X"=, !&SS6OR"#H>:AF_Z>=+'*
M!QB*42ITX$52"7:93 <R*DRHF]7\/V[ E.\[<(\4?+R43PC=)3<<D'R(%W,G
M+'62PZLH].9]-V?!$AL[%DW)M*9]9X6KO@'6%]M1W:R<O8ZSJ%4ZP+Q Q>+'
MS]"!VH88R)H= ,L*\)9SZWL1"QGOP 5EU&[R6717_W[0"L'9&$,27=1K5I#F
M&^W7:EI"G++'J:@Q'<&,/;0ONK:FNF5K !;+IMQ>(#:_JT6[PQ;W.>U.WPK\
MLQ&R<MY8I3R5:?+;#;7#BU-(39\20JIC2JBQT<3#_E',\XHAH@O:4LLC F/$
M5Z3UA>K^H^-G8_^/CI^7-QP_EQN]\#LH D2#,I%!".=;([YUG3=6;,HF7VJA
MS7MXVS7G2Q\Q"!CRFT=T+Q+&RF&>\/_#WGN'1;DL^\*O(J(@HI($A%$!R6(@
M21H1 1$!40&)HR 21D 0)/,J2 ZC(*!$)><1R7'(44"R@#!D),\0AH%)=UA[
MW^_;:^VSSU[GG+O/>;[O\D<]^@PSW5WUJZZNZNJN/B)6C*+1AC\I-&60(RR<
M.Z7]+#_#7*5REN-L%K_6E<OAQ98X&OQ8IB<<SV K5>[&3P$"G31B^L3M,FQ[
MM0"F,Z'N$3KU$6[\1]=,M0DJ-J>RYW[>+]0'A^RK<!1@.-/LL<K]VYI2"3%)
M.U<79 63RYC^5)&]WR7X_K][4>V/M*?A;C7%N-F__H=(FFK^ 2$$48 22,9S
M;6(C.(HB."Q""I%$!'L2CBF2 JBJP53UN\ _?C*$MZ?Z3Z?W+I9\GL1:$D.3
M\'?W7M!^A_W\WWEM>Y_^KR&ZO5WF[IUSANRDT+?@@MB Y[G_1!*!('T<;(T
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M]>K*7^8W%,?EXPP4W E92QNEG_.P?63Z^YG(D'Q/#H(\GGYI^CC*FK[#(]O
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M@Y\4X/,FP&SRH76LZ\JV+1B%ZL NOI@T*;> N%,MVQ:>$\2HH1$52.H,\ZE
M^VR-MHDC/;D<CNF]N.-( 1Y_-&H/C1PR5SN/4!&6TV^#ENC7&Z'"49@'E=1(
M>L2X.(X:N%I4E8H,GCZ<Q'!GPN6\Y(MP?)-7-P4XM(;7P=#5.KBVZ.(YIL<L
MF[&PO%S9)%QAOFT)QYWK@B5^[TOF";7S-!E@+-$(.8RW)S,X9(S!;G]I$!T<
M#%Y]+M]6Y,!BCG71P0_V%M^QO6A101B+(5/7@RO6Y#7&P%EW_HR8*A3O&@4X
M2&X%#Y-Y\!?%&190QSWE'-*/O+E?DI+>X"PY#@VVYKO7>WFI;;KD,*VWA?<
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M^&\FI$<LH5,'Q YI 8T$[(V&ASY3Z2+>V]X+RH)3ZP@55^R5 R%])@O%-(
M$$B-RCL"(BN9PS:W]Z2P?\):<U=+U_YK+?=?0B?_\X6$<."G<,E),]4$ Y3:
M< D"(S/^?H<LE@E*1E>?V?>(8)_SVD5G%W;!S]$ 180]:BQDBLQOZ-1SUSGH
M!_J?!IO\VK7;_ZI/YK^7D$EM,"!I/L</-+/Q+OO74L#NW$_IUMP*C.:KZOMK
M-W5CIF49N>_^5C3"'K3/.P8D#_]&YR;#(C_-I_X*V_]UA81-$0)QN4DXQHB
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M): 3S5A?:U4YK9==:&[6ZDK_V/C@F-B;%^[&.<*-'9QUX_I8_(44<\FL]8+
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M)*'CZ4;$*)) KEI7<RW@%I7\>1!A(C-O=X!S%!C$4ODS&I_6N+,65>E,D5C
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MGW<5:>X-.T$&^(VW3#$<2O_^='ODKMS &L9 NM99JR727,CDH>UW?L-[[N2
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MJ480.V6%B1%8BC2*7P3*3B8W7'ED55.I,"D2K=H/^!9>LVSX2KM/;N=@P[2
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MP?;;Y]_UY_,4M#-&SO(1@',96NUJ(DW6O*)=TJ +RUY']K&(R'$LS<$*6OH
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MW.,FX5GVB[&,IVZC+>9ID\#J/O?R\2>?V]9 ?'6EHL,%MTR^7MKK.#D<F:$
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MTW,GFZ;)NNR>13*AYPI5@5R8_"XN?6ZMF\4=/XO%&-XR&FJ(U(18;P3X_:0
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M3*VSW-W=P?*]00UUB]75;[@LG5);!%_DB/_I? TXGP!=X9]<7*QMA3##>U#
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MC]C6TL"L;9_%RS2=F J1MJ ^JNK=(UR9N\[9.(,_3'?0IDFK/W\F$T7\0XI
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M:QN]K0A(57H)"HATD2HM(M)$0$"Z$!40 0'I/4&0WJ0("D)$1)H0Z5(C741
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M61VZ+?5=IW=2%'@T(H",/Y/KLB2.#+.O#7CE!;ZKRY)>OI6>K_6PSR*-&JE
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MC0K,4 &"F:KDISU;3LH:)9T*_"2;DE-ARY,47MAO3M"R^QX"1UNJC%I\/!6
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M)6EKD93TC3,W=*--\GJ![K,2Q>YM-;I$KWE3[?/EC9(#S<96#.!3)963C88
M3V="6<D2I1ARM$4#HKWQ1.4-\4KT>UFEZC75*T]W35U8M7W)MAO0]5Q>ED2*
ME(2D3BRK9>&$-&35@]UU.SH@(JCI#.A!\D=L7=\1-T%<1X2_VM)5=)*>6TU
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MF"](R%(^].9!]>[X_"_[=M#H(5/CW)#4XD(#$H^0AC0?R;2J+QGE9D*6 $=
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M]]L*[_=%H8KZ2TRYV/?M+'CJ_OVS&ZOR)]3& 02]#D3;;:WGL/@0-L<'I@6
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M@J26 @===&;;.C@*7"!4)PH)G!1&?@J9#9)?Q%)87/G.L;E]]I,)O)A'J*/
MR5M6].DE8^)[SP-?#B_A  U3@1(4J,&D;ZL29(-X;; ==XDPO84#&,6<+_16
MYRI557&TNT=(/]RB/=B/;8*77LF8=5,:LD69SUFQ?70Z_6H9PO(YK)PP2HY
M5$:4E?64-!<9D[A()(> J;P(N'+0=0I4O=QJK9:NE#W$%U6ZMI'8"4??VX8%
MPPW@;R?Y$6Z3OM1O;"TN:;Q-KTU-'Y6!V!#.+4#Y)+F]O'Q8&7?P,Q7Q& >@
M,=M%..[-=.=8[U$XVB^_+%9G?5<FYG>'QYEG7IUP\,,>S KE?6CHRH$ >6[L
MC(-IE@YVOKXM^12;/LFZ=UE6ILU'X$;HY<!H ,D6$,5&W,@-4?CJJH6D:[JR
MI?T-53JCWW=/-4>,LWM=D!Q1U=Z:^7C[>G9(\:Y 3<G^JS*L^3)$ OMH:%>I
MAMS TKP&'C4V.2'JM.86^]N.@&M_;+LZSFJZSA4P!)^WQG^3'X9_'(;T$^P!
M&G&NKJB%9&P/#D">7ZV89QF_YW1%G2].?*)>1?VVRX5SW".$P\D"EFV*:?F[
M]W" L8C=T#Z@,1C0!;T5IHL*WZ$59U,TB+B5./5\C+^-%0.8'_9WKX<"[$PV
M8+7\CIM?*I# =P\[,P(2=\*:KW5V-Q;)"BN/ B?K]C-F($U@0O0S5)<+DFMN
M,?#:&SHYM5Q; F.;U^&AUGZEPM]NG<-\6QB'T4SL,6/@$J<R 8ZK %NFD3T<
M /VB)N/!IRL1;Z]_FR\Q?57%JP\?K*9ZEQJ0G:%B^M2K5S "LI^8 5HYF"HM
MC1F#K54A3U&>?E\HA]H.-OF&#= =1E]N?:+3,PINM.)0L;"$7'ME#S1Q6)RZ
MP#4:B >_$XA: T,;3/(,_))IGPQ#ZWOD?FB'MX/%ZZOTC-.TJ,1=$50!Y) '
MU=D,)Y:X.=$ZLZ S9Y>Q(N3;6<JCRF780Q)^/36'GI?LW&G_[XW-'9&OQ&O6
M;UB6:0,K&!S],@>3];$;6;4QZ9#J ]_=EMH0$.8#]EHGRQGU?EJ*JL/N%0_W
M5UP^>$AKO5RHB>T\>)1_EMIA+^*3M/ />2B_P$)B&7GK.M?L;D2JZW64L1MQ
MP$Z0]<'-R@BY4-!9M7NR3?[VX3IDLL)J#\/O@L%H!I0+>4.(-Y86\?["#5JU
M\/NL.7URSFUS*PLA<X]>+#]G74R-5=_6<T>\CWSUTDG@24#5#Q?>JJ<%>"/8
M+2[YAQ'D;81N\>M!QT$8DJ/Z_F/DKED$OZRN59#[,UVI9D,8-_::)_ -0@NV
M*WBN#/)(=-W:CXS\P#,2%IM2)MQ*V6<Q>JXX O+RB GBC"X>IX%G-C'N>CC
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M\IG!MHO1T7@RO\!C&88B_03!2"5MZP5[98U^R-.6SM6GWW,8#1WNZ>AA+JS
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M?<.;^WI\H^I5M/\C5.:?D*#6Z7K_ZQI_#<^D@H[FM/T'CI<,TOW-SF>LX)3
M>5)\Q ,FQ.--,TDMQ)2/;54>48MI[HMPC7=7C.@CM,%_-)F.2$0'.#M@K*CR
M_F>[Q&,2=-F";:OT1/6+?,9.^[ %*7 &G_LFY1SI!&^"[-/< JZ&'WG OPGD
MPN-/B6CS3//AT&]U$8_""M2>UXG6P51@0B@['("%&P? 6$,QYTT)1OXN#L[
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MFRYZA^-+LJV3Y]P]PY.=^!+#4G65-]GDNL-E#Q2R]0,8T<VC@\Z-V\LX%2J
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MC-FW6AE>,2[.K_ -67JFZQ=F.\S#CZ4KK2T7+'<RV10&JYP[JZ=IZNKB.;Q
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M1VX\(;0OBJ6UX3?'9YZZAEVM*[FET%D\+'Q1]. #<0.^X-0@+?%]KE;?U?@
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M2C7;2V7O;>+X!;ME=A3.VZ^%Z([83V1%G='-:A:'<]WT"0/ D7\W/ %5I'0
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M0[3@_9 P[^VCH1=/KLNNI"]BQM$AJ$+'T$HH&EGWA) >A,&>.JS:OG&D BK
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M:6KHTSRH7*$3OK .[-N:86'^_7H^TU2H@<BT<2#6D,)$&3#I6XS#GJWF\7Z
M!P595G:XF\ZY]U[4&!\_KM?=6BXFNF;,DB#V)#0T4=*/?Q\!A7/=T3$AP0BE
M@4O*\F.)S'>_%2U,G4Z_&/4-=Y1^BNEZF/ %T\/27U5,X*XZ[-E5MNIET!1S
MSMQ%>,]%IO<LV D2^*6]/0I,RG5>-C_3Z%(E_+E%=:J(\="VZ!.RZ# [).*<
M@MSHK>%0PWOO=LL(;][X57TE:=!,HZAZ2IGD7^N,:6HA9O+^;AZ"#A607"S,
MD/KS'?\]$&NC\"$_M=)4&#,4%7#59%<3#H2N2.T6)-(.\UOOBUU=^!\'IG*8
M::_)]EG3)Q^#(?;T;#B,^C$\EP?!8D@AR(T!3)JKX3^HIO^K8V\&\SM!N3RV
M\?1MG#QY !3?YVY%!? _0O;)4@Q]D_Y8?-*1"A"Z3-LA3:/L>+!;M#?ZUVK_
M-BK@7=NON4@,"<W_\> MVA\6:#)E8E?$(!=H:FN'ZQS[;S(&_E7@!&+'3/):
M_64LLI\Y,  Y:=&%7!@&K;&8S31*;M$/(/LL:3>P3Q-+TZ.*1K<W]<D';L[3
M)_Z4F_HWPY_RA!E2^ G@DN8NI>Q6VNYQ^_W]D]Y3B+@&W3H' :X/.D[NDN"V
M).EE=@3M7%;L?D_@_A[\FBPJ>R]['KC"3&.^>;JD,,"C/4X6-(@(V2P&I2)W
M9#T/"OZA4.F/+39W)TO_T'!S'^K' NPR5"!R1;R>AFS@5I_NWP])_R?\D(>X
M#'M*S*2@KV^W4 $%G7?<3'ZPJWMT12AJ8.AZ(^WDP'-_H('$_[E=^C=I_)^H
M;/XM_,M*E7\?'F-8D9-FP/4!9&1VTD$:/P/7SU(!V[Q&H-^U&S)=Z3S_X,(9
M$KUI:XMH9=Z>'OT"2;Y*>0_:U%Q!J_R>*GV-H>,/<,I_MMKW;]R<?ZJ$]W?@
MQZY=Q0L"C:,K$O/ ]4_?Z'_3GVNBFI.&2:892C4SY6EQ_[<_1$<_)>%4B$X@
MSB(_G>BC5#-0GG:_XDUBV_VZ'NWK9XJS17Y-T/G'-_^OKH>@T16IV\@^(=K+
M!W?5U!_23U)K_EB:"$W516]QTUCZ0C05, O[2V+7C_DGG72=?X1/<_R88>+8
MRQ".F32JWA:A!!3MN_6KS#+Z3)+?W3%E2'XM+^L?[W#7M[_Y>[+*J,[;<-?;
M3P54B*R:+"UB)K[2:!7S^07;'R%&L38<C8-E +<71[?%=Q-LAJB EAN@]0',
MFG'JKY)_%?[7I^:1:^8T-N^6#\L>@I?,4SJ;L*^MA!5.T%LI6ZHHC.^V\E<?
M7]Y:H:D @';B31K"T+1=/@MI'%V= E'VH? I%%9)3F3[2RJ 2(^L"WDRQPY)
MV/N?#*@ 1LX0S,QG)(D.A%6GG9T839IBS]!T[:W=$EEKTMD];WPWYJF^2_3X
M2'@%Q3N="JB1IK C][SQ$8U-K2*)UW:G?*K2)/ 8S=0^#-KSRH\TCNB!(0E:
MT"X!ZASM;4>I '_@GG>:,5][5SFZ9_T1/[WS/ UC%HY[-J#YTSLY_\3)OSM.
MCDD&0U>.[8I:FM:GEA=1#UJ1M,6L+Z&V#Z$5>X4)_!5'G8;[S0HTAN+LLYF<
MUK+!GLW!.?;W2H.;QC19G]VPYWK#7.>KHOCG^?SWG _=GKY*DXHO$:=Z'-]5
M?.Q:BH?7' 8/^(Y%*7G&]^Y9W=L_$?G?15R #N1DFAF29II%0U(A+X::T8/S
M;9F:Z<-'WC^XUS20'_L5WEP%V[.!&W^B^I\DOQ\K[/I0>W=_RZJOTE3&D==8
MO_C)+4J0)Y"&(]B/\>K)>$F2H"+CJX&Y3;'I";<%L(IT^,ATT4\8^A/Q_Q0Q
M<GSUODQ3"$T6R#1E\YN_,_3'=7! #+N5];.-JW+;PNJO3+*>Z'@R-M/IJ]C^
MH\5I89PV"D=I%IK"8$?\GVN=DLUF:\>"_SR=?\GIU.YJV9#W/O>I@ &[])_>
M\&!!=UP"?D529B=VI;"4)M0_MCO>O<R/VE-)Z)'*,Q,B@0T7+'ASYJP1%?"+
M"J Y#;3G0[[_EV'E?P^E6#B.2VZ=[86N]S)/[_U$3D(&2<TCJSE#)WV8]]6
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M8SZ;-J2N'?SN"U($=+_+KY2<T&>&C]>B*Q7RYI).%8#[^Q3-)]TO!JR)AVK
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M$=:R!<I914<AY[)KMDALQZY<D*'\5_DXD 8\2I\_D\R3[[[#4C/Q"MFJP/\
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M,FX^G&0D!CHD\9IS3=V!O'V]-7Z8?VQC:2#Z-Z2G2HP8_RCB.J6V[;H0>WZ
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MK[DI[H+Y9&<<R=1'6#SMP8YN7'&N;FZ6+[4&7;Z*3D=Z^V!EK2@7B!/=TQT
M<0%*XN(?#]2/&Z\ NKUWL@3?+UFSQ ZRLU]]F6R,EQ:PNZ$)184>!5Z/U8;9
M]@5YRD' _JAF=%GAB!6X_8B#QJ/-P>_^T2N;J^4RY1L3@#_]ZXE'V5;9PV\U
MGV(V?T4.R8QVZRO[MO(BR6 *:@$=CA&KCI\Z/NY9I6SD4A1?W>^ DO<JBN7O
M=D_R/;%+SOW;>DWZG.IBC(M/R1W'X4*=7IDM[^G__4>8G@W+>,5BRZ68-# F
MK*P!LE*V,JT.[H14$]X&@*8(^.6W5 .*ZG#>&SF+_BX;SABES@OO=CFH'>=
MSVRG)XH1P\Y:H&D>//]KO0L4GH>:8@+'$,<%B[>JN<%EG\PA)&YXXC46&;O
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MB,+$_VTM1G/"HKNRKI+,CX4C? *,<BU8U;9ZK3L"\,&?UI2OX$M(_J!XJU6
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M.%$FF6!2Q-TK<2YJ2@?X(7WCP6K[11=[OUIU[V0,ZCBZ_[LWD6E2EJSE/#B
MZP5BG#"BH&\*"SX4^6Q:>ESJL4+SUC(BZ]"RE* Y(/]Q0ACI6N-5^& ]G4>%
M$0C^/\X:!9G?ULKX?SU2O7CF7]5-.:ZZ2J]?:2TAH9"I( MZ1@N776$$+;AD
M \BQ77WO"9)CXWE%<_-@KYWTA^0[KU_-A5NOJS76WKU**K1)*](Q(076I@7Z
M8/;]4@KDK3VL_7-@]B8'.YYK@71M\7S&&28@0;:#"2!SU#(!PUX.R1%S/H?<
M<" 3\(B*I/-5.^#=:$E(7B;@CPR!";C;[/LDO]\BK_%ZB);MKF6AV)JH$N]A
M-%4(SDJ*W[I$=%:2=20-YAS30XC34E=3B/D;O$[)X9\/4JKUITY!KKTX^RCX
M\/9A+(<0C*<'\P.WQ?(5YC(/_* <H" N>$MI\_E^X07^;$D!H[3<YZX)4Z*.
M5S;>G/WI??@H5Z@L M@\[!"FXJ/2N;/PV<3*1G:*FNE$GL J-QR)%ZF#VY#<
MP+G,VK34UP$0 2\@CZX1&FY959U(@PRH1NO+GV0X>H)_&2RX/YIC/_M SYX,
M^L."7ZXD(<E!/YI)I\<:WJ/S9\WR^T-UO!/G'TA*UF]/2UE+[00N[ICY-7"1
M7V;(!@E#S.F6&Q31AYU#6$/>2WWYH5[3-FEKA45[X;R'QZ8%Y=6-K 5ML>*1
M '=GV29B:OL0:_E;BVS0DPJ(UI-WU\_^=4IN?W]X)^<Y3ULT'KWI@D+T97$W
M4:*)ECV(R[7-P_Q;(>_3OP^(? @XN;-R-K+LXM-/ 8]N:4F\3A7B?!A=H@=6
MLDD=WL3Y#'MS=PY:).:"OAA,;4!MUH)H&MB5527>!=P9I'NL&AZ\2? BZ>W;
M="N$LA:.7XK/4VT5'K0>>F*5/*3EBOZHQTN3_7<95]]B AY$XN_2+HL@,A1Z
M:D:JE.1O?4UFS+WX>?W-UY_67Z9?+%S,?9^J.Z_I>@$WAYI=2%'6&^0IJ,\@
M0Z(Q7@$Z!(H"/RT!<QQ!?]HQ1R"-L%I7)D#L!7)2@V%]Z$#U00RDH3<WB-0.
M<@@XKAK""3NY867]]NY$5*]2\N^H.V*:YR[*.<V%LPZJ"G^G"U*Z2.9#<^BV
M&9_NH/*P'/7&2U(VU)K#T>M\6KO3?A4Q9$&-:O=N+=N7.F4>(5NB2G_;8PH5
M7<@)2_ 2U 3!(>NU 9R-2"#?G$1Z@<[;'=OTT87FX/Q)3HA'@UB\O,&%V,9=
ML5-1ZSFII^2_:TFD2&7X0U@72,#-9.I]=R"K"NUA&!X3T:)<F>C$NV^DHI>M
M_C@^A>,6^U_.KW*SA8"WGV%6>6M^U/4CAQH4I(7.9ENO5=R4W1@X<;2^F=GH
M5%:[H\8$>!,.M3FF"AD='DQ ?DKR@0%<A1J$[/V-& "2A4%TQ2IT@YPIO2^^
ME G8^U^DO7DTU&\<]SVE$HJ$;#$5$D*)[*8-,2'[%E,A,9B0?9BR[T+X14RV
M9)UDRSK9ET(,AA'#B+(,,Y8QS'9/][G/?<Y][C^>YSG/.3-_S!\SW^WS>;]?
M[_E>U_<J*F0R(.-(9H:@N9TD"*NL<V,!PK\N%H":#3@-,OW:TM38J>>5(*!2
M)EERA(I%ROF5R?[<+1:^7-22MVN[$K2!IZD]1S<VQ>P!)>@&U#R4Y[P"=)"_
MGJ&U+1.N>_M O22>9MTL?T;^];<_&C2>!=0&#077HB((J!/!>81SE4NZXA8[
MBO6K2E97*3=1_'<*9WT5=R1+/N%*K@P*X2%\8ER]W_%.5XG;"!*?-E]"]L5R
M \FE]0!$+@L0Z6<+$6NS9P%.;[F3YA4=85'H14GUC%7TLZ25K]-$] ^Y%430
MJ^FE,H=#/_05*48R7,B7YO4+?C'<L8>S.^EC>"L1Z1%%_&AVP2B2:?J#G6+\
M-;8@OL\1=2Q '-H=.-/4SQ0A3:Z4A3_1C2V$CWM^Z9<N,FC W;K>%^5S)G#4
MV;/6O-@T6M[ %MXT&^[, N0,C')J[?D*1"^5J36UMT__S6K8P@2&$84.\F@7
MZ9QD0R*(I&XRQO;-8<-N!,]+QZ0D:+CRO72+)<NO'F+VTEG_J43?O?"PU.XL
MUS<=9*T;E:>:KL?()U#]2<6]_L%AYO7:W@'5YF=#[L$T0X*$'IS ;1RQ%OG6
MIQ43W]W/)\NI/<1HT4,UA4'W_SJ+"UU]8*W/8S!W2 &C*AL[' IF]>% MOS+
M(E[5,\1,7/J!H@V_R2Z%3U!0AY2VFRM>+WK=CI,+YGW"US^SSVT@W0D;(0/7
M(P=%PTTJF^*5X<JA5Q<GZ2R QB_'^^>5MTR#%OJH+N\KE4L??":_+-6R6/'%
M@P,:TR9\>T;4GIC6:UHU3C&4*]@_-9)#P/:AA*@PRBC5DD0#3W8,+U8_[8.F
M&/=OC($*?/6Z5U2$'XG$S3W!Y!Z"[#&V#F-;]?O9]\]N<EWP>.)=\_IMS;)N
M_*C0@3U9BJ)!@L6Q %[HXW#%*!OR,1Q?_%4F-B#(UY_'62%=LTLC^@JPQ?E3
M*+)["_$:40>,03^#<%%S3$GMS%K$B4\18S<\=_2E%*YZ?5#.$7O\>/\$2L T
M^5IZ1M9<*081LGGH"$O7"/V:X"(C+*[07S._-N-8LS7Q@Y') KB)(V9@#\@R
M57I76L@*4/7K/QY,$>8N6IT2/,8[X_)UTRMY,5@$A63OF\0I^#-&0X<@_#JV
M9M,PNK2.]J@Q<%MP_O?(2'C25?F\EE>F"D%,+M/6CC/4:4GF)5\6X,TE%(#Z
MCB9!5;_+J&L3)75)V$+R;I.%"MM:6W)7SK4:7EI8/']'D&].V5K73"^?'&7'
M LP/$17*O!FC8^%_3N&8HQ%]YTQF*ED Q![B':4I'O04"$!T?2 'O6H3E>B/
M]&Z[3P+[!L!4FUQUKHJJR+RIDWWT<4%35^$G"^#. D2-P4]0S8JHER6<EQXY
M:=PWV>L*<9OY[:YM*?LT\I>2J:Y)<% _)!(G^PTX;=COS$?:FRH,^>CXS=T^
M0/.L49*1O_@U&?X3-S#+-6P'UYRX,(YPA0#P3O<O-32.BWFXZ@H)_;Z* )P.
MV7F?+Y;QQT=G:']]<VO;N-];H]>FE._9VV8WZ,M)CS^!FV$-0@>T!22 6L;D
MEBF'%EPCPQ+W8*?@"DWM81)2W2WW7HLM7.9*_WZT^;?;.[L,N].%(4%)>A*>
M+ #)#'0N6+MG_BPYL+8:?F,R0&.WVOW.E-O9$.?'LL,FB>6MGK7'Y-\\Y/AZ
M_4@_=W.6YA F$#.\D;=U&%V;EFW]A =CVXK6;P570*1VCR8>H"BKC*( LU=L
MS-\H)'6R (FM/4&7^TW?7/#G?G4JHP+9UNU7L;?<^4<$)4>"T04>!$<9-I)E
M>_CBY^4S"6I=U3TYC<*>^B4E1P7;$L?O6[$ 9P)6^[2FK/Z6WYXL5S"@;,YN
M[]ZL=#;/+376&6_8_P+V9@%NL[4,L2P'X0=M<+( ]=4*FZ'TOXQLN#K!C/VY
M\XZ.4U%P70]GK\-D:B1)[_-@PZ8+C_?RC=16BO>Q#*,+OYLL#Y4=GV8D7Y'>
M;#Z'OND>G?EV75-!+ZAL$'B:_?T'Z-\R)%MF-Y$%*+P+\;/M I*L4(TAB)/H
MND;$<X37, 5Q8_, V3R#]"(T-?!19:W0@E4C=61;0EH"&X'%'ZB_VY!.N>I]
M/JWYO)FH]A'F:AIHSN&BR'<NWA![.;/AW>DAR_>^_K]39I/AV=MS3(<;1#&%
MQ:WI?H)LBMYYNC\9\8U/ FH9G$2[?+EY7(TGYUEX(G_CT9[&OE3]%R7Y>7;<
M48MO.2D>##0<O'@.Z$9"]3CZ(\I0]WO['&X5_[KV]1;G/@97MM;! ES*PJ2I
M0B(:]QJ82V8U$5OY?</@;/!!*&38"=7Q9T[0=AA">@A+,".QZQ$V=;7Z/ O@
M2<VP&O,V]V^.?J>RP'?XK$:O2@&#=C>+E2,%+2"CX;*U%BM]O:?G\81FQ/P#
MQ%8CK%MHI'P^LP+OJ*RKQ"3J[91/-KCI*^5$.,R$'S+ZB\><=6E/$(.?X6 6
MX/-5%F# =A!89[:!)J!P+@N(6)\V!%G YC,5<;P.]YPI3J(G<;FF&EA*;PP-
MF2X_/F*CT<>]6RUG;GU1;LC&"-7' J3F(=*SO.Z66:@NB3?+4AU)6$2WY>[3
M1/HO,F=LFR$+<.P/=7AA<!<BN.;PIPM]UBD\=\MTXCQ0X:T]EW770:*(5DM%
M9GWYDN8^FBKW9'2CM"I]@/GS"QNGB][_E=E8YG*^$8AV?UE08'N0>0KL6>4N
M;LQ-:=^LPM7M-+2E52C\OQ]TZ:RYD#;- M@RRMLX%[>$Z4[DFF:O' <X7W$P
MXFZN!G%#L>VSE+N*5%PZ%GJ=C6)&?R\RFKR>CK, 'L"9R)$CC3SA#E=<.+]4
MSWT ?JC)M=(M4,K7L-K?G)JU!Z$;T +9C5*SC]>LRTU)RZ;8>6+X' 8_" PV
M=U:D.<%#83/XA;YB OC^$M+Q:[K7RX&/HF;U&M+:O(O6]K7XYQ+K*__LFV1&
M&TW5$_A,1O5!@,%%^[T.;0IA$NVE/9Y7T_M^&^SP'W1R>A[CR2_^",W($M)H
MR0Q,##S8<FWGQ4W.:58\3%/-;6_$0)O6PG?8MDD*ZNO09+Q%>#BI+S2EM!GZ
M$D:/!\<<^:FF37"P$_TB]= NXXC;]?^V;\G8O^#B-&1RAU<Y!2/ 5'"%78]L
M>RV9OSGRT@O)>U9NCRB# !ND3;NQ;S)*%#?ZQ[NUI@_BV*"5\=;[BD^'K0,%
M6DYA"&V#8M!/*M.$@ROO4I/(D'ZQE=:E[V$# 3?<W*_ZKDZ52CQRO*1R0]#B
MYK+]C5&)4:Q0S'T#+AF%CO8.LW*,<<G:S5]>+4$1E84D$+&T(GC)B5&C)T[E
M[ :=:;N]$*889A(K)ST.*TM532]['Q)[Y?<M8@S')PV. H6('8H,%5_Z#>N@
M3KQ-"&,8@'(5PN_-E?!V?WCJ4[K$!$1D]4?,%%P;UP,RY_ GV=%FCA%E@'E)
M55*J@9=E?K_MZYO9<,1E%Y!+(?HSN75)0*/Q/RUU9.NI!E^QC&R;4!,<6&[W
MA-T8)Z&KG=NG_D7]G,@\'?NO+ YN?*_X!!:UMLVJ*H2%XMT@%2J(IRP 3J&O
M0)ULFQPA##>U<R.C8^PRP[GEPS_*A*=]O<)M7/M Y77S(U?7LW 4)3NO?UZ/
MT?(2%%MPGII' !WUP'W,$M\:WZHY=EVK6Z>T[6WV-7#(8W>IFI ^A2^,.#@?
M 2D"MZ,FD&=[<#KSDHWDA]<\;-0!56D\6LWP,[P_:_L*T4DK4LGNW]$>^/-K
M>+:"+A05G"=+QBTZXL76LAUTGDGPF"G)-L\=[Y)HE4KOL'[:SQULB?F$NPYQ
MB/QBL1P$=E.RW9[O$WC;46;>^"ND'3O9_\[QQVZ*&46->K 89J2F?"IBO. "
M5BWX2+!70)3?&V-#4L:^@#*(>%&R817$SJ7"*'HH2:D)2J!*I?46B+6=4\=T
MBZ3X<' T#*5E0:XL1I*W(P$CG"GT>XSV#E5[J@T%#)Q9AY"B.]A8G-!1>_H7
MR3%UTVKVGL;Z=Y<)R:R_>)(I@IOJ>)MJ7NGIH)Y\M<V%</H9C1@ZU_O?RVV9
MSAE^(R%I":<FE93>O/-'S#4F7WH:MS@X3#5@T/NA#K0]U3)Y!7Y3C6>36V'S
MP^Q-J#O.^N0T5](>,2>UFKK"+>]2$22:B4D0 1:?6%W:6K-;;_"T8J-9]-D%
MXK&8(V!U#L[77QAO6(#G,$&'CW4$$$[;;@Q^^\*.N,GXO94Q\4^6R\-GPWU%
M@0X]5!X ^0]=,(_0T5!Q1.?P>!5I.N[/$.[G;&0'\B*;F#C4]AO\_<.=L]2/
M;QGYJT.WOMANTT9*@=53%17JW[G\2O(<JF<;#XDSDA=I-U!]U3>QSF-Z2BDW
MS,6\!L^]0\T,',N-Y,_XD?CAL9L!0:CNS>V^-<JA?$UY67^E1T[VC1LEM@_;
M>,?>B"C(61B$[3RR]M1*RQUB.B!L=;E5)U4+@V"ZB$K@S>#^)??$719@MKL3
M=+JJX0E?-.JED=+6RZVZ>_"9P$=?FOY[^)4%L'FO<*3?U"1<&Y*)8P$VW!=:
M@;,N=ZGW6IKBI4DKA1_S9E#2S='S"3KO2KXA9)_=$-N[\\),;3^M&SC3WPVI
M,^L"B?QU%NF8A!&5B[ZV9^UY/,VXQ33X(9>J*M*5^F%_I=7W83&8CZO/8;NI
MD;F#;_)IE1KMG$ Y"FF8WK0%A\W..2I PP\]9S8%;9?W-]Q(CKV(^J;.XL5V
MQ]X@IC#5OGA-0#H[]T9TRZ12"?=&S8^3=C]5SG!_EDD3_1U>7LH</<SI0LQL
M;BUN=:4)F!5[CKV3KIT*B#&:LU^>IU'ZFS8S/D0O125/$*Z-=0]VCFQCRB)0
M34MEOYR%A:Y:L3.(/MZ1Z<0F&WB#;F,BU;*778-L+S,LZ:@C2RTIQU\FW[@H
MZS2I=O)BT]E [6>G:+>)*VF?:J*87*/D(&>R 7()"0B.^K=28BE=*K1V&NJ,
MP!WOK:N//SJ8V7XDR2_#;&CA)0?GY.(58ZL_01+.!8%C_X:9K=](N=]7I6E5
M[U#VAYU"XO2^%Z&U$<_UR;U;=$%MT_$(2<]LG&R"&HRWW[4E97S3\;FQ\?@
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M^F^3:;Z:=!,L\+!A"KL1<JWG3D/%1 5A=DPQHR-AM[UU7Z^TB)TZF=S#;*I
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MWZ%A//15:'J&"9A43 $B3E+7C<AIJ7I7@BL)!NCB 5=, 7/%[LFK]*@L#]?
MI492B>L9_5"+OI8TG$%E6A8*E6/"X)/7A'N@W.3EH>W$,B3$\1$%E3 O1!+N
M6==HXUNR4VVWI!E)AH4K;3_.X97ZYO&DDY=[$ZCR.&4N!)7:H18QTK*_X;[
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MKD)2*XN3!D_399\56[9$K=S'*6L9VDC]'$AG =JFB8X@DC7L@*VC?*"-QRP
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MY45 V/$F#G(D/18.)*W91+2_"PE9  K:1V[O;8B]VK3>%#"/[PBY+CMSK!'
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M_-8ZQP).*' *)A@HW2%8R\0G_D<W-??3K\$+1= [Z]:Z5M[41R=&XI(\(9'
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MHUY<M4I/6V\F_IURN/ORTE!NN#GG:[)^/6=\0ASW@R"^OK"9=)VTZ". D[R
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MDI>#-#"QKHNSNS/:U0-V/EGJ-Q)(X:;CYF5QDNPI+G+Y4N/Y'Q8PY4> =TQ
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MDDI9LNA_F4_2W[VV:&A<K&U=T)V5MAY=:.<)J01C ZKJHU8N#T+G/WQ]KVK
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M,BF#JW+>4#N6X1'8M?+"E$[A']+'='5]^D+BG\1^E'TJK:KQ;6M_C?(,]KI
MW<;N91%(-0^](;\S0X$PV):/ ))8\OLCP(]5Q(KQAC^3UIHG'B@U#E Y;(\
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MRY,*>K;\AP?+BF9A2U7:@5%X#01%=J08]'8*RN'\I&X.Y\1Z@FA^8#UV!!
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M>*?QB!(?5'S5_9I2_!][EC.LJ:*V%]T08&7MARTH]>+(1Y<C-ZX4@@(:T4<
M[8("TRGS3K7M.=[%\>J4K/'>KPM(HB'L0"*,*6O+XX\ N_<LK0DJM+SE!7EZ
M.()LU+./G#0E>QP!HIR(";5?__4>_P^)2<WQXP:O@UVV=P2E_N6I;2ZKB01;
M:-^D?\(L7*,7:$J2$ Q>2 7BL5UH&E5H78C&D!)JVKH./0(X##^AHFG!Y]K-
M G'/D(TP>@7N<Y<@'S_;8&TS@L[\R/<#TQD,8ST\D![$?%<NH<1T<N!V'<ET
M_=*7OV-QW7[? Y^N#DF9AXNT%]6!S4"C_\L.[Z;A""[$@@D-1,1%@*L03/PI
MWT /D+?$?^Z@GT[7>$.;@[VU0+],Y+G,DH/KI;<K]0*NILIF65090D)\O+;_
M_U^4MO9?16F=_[,H;2>1(I/)&^AE1Y''KXAY5,4+6?G5M?2?=G>V!%N^.P+(
M4M-TQZXVZ>39>J9#1ZP;0O_(^,!\.4X9.#UFK_@P<E;G,=R,XK" B\MFPQ!1
M,5?1TWESQ^I T"05X9*WN+:>(-:=GQ+6/<$JM'/15L2#4'$3R@:!"]PRI $C
MTK,I ;FABU<K@YRSE[N7A^H\>OBNR"I)]N"G34-PH0TXHI;L^T)=3'6^J(M$
MLKV2U^3:T"\L!5QJXX4CFF^]K;6#_KE QDQLZRS;_Q11R;'++=,3X,P#WCF-
M:@8MR[]!E$.BM4_3GFFK$,MRGNU^R#D".)=%C77,U%^Q\Z]3X/W5H:#;.AX.
MZ @5,G^;*2GX\-MF[GGTTA%@H1=[)\_!P,+J10IU,XUV@XBAG=]F>D)DA/6Y
MGS]:^1LEDO27V8LX)9)" *!-(:,U+^H5F%S9Y;JJ]/^'MO<,:W+KUD:S1$5!
MQ4)O40&1KO0>&R"P .D"0I8B74! >DB4+H)(7](BO1.IH2;2F_0.0@B]!1)*
M"*1PXGJ_LZ]OOWN?ZWS[NL[Y,9Y?29Z99\YQC_L>SQQSW!?WO:;H.'>AV^YE
MRUFO.!L)L@ZMCPBJSE@+!M7(Q7YW0@''+J_T?ZR6IJ+NB*#X%I_<7[[%$[[;
M/!I%P 72+G9YEGCD^NDN@3ZIWE]P"9YW#[=8K@MQX:V\I,>-6P-*WS^\D\ZG
MA%W2\:S2-W I<Z6!UVR5.FM4GQ2WJO84EFT?>,[NG@($DDD/BQX3(FA,YDM
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M,L)P9#?+4=+5C<-3E^<2VVV4^O_QL<#/1]*%M(<+<66CQX*CY.3\\2PCMJ0
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MR)X!H@_<=&*E/7H0&Z'.7%6A?6OTG<25CEO7_\0*A%_(81#O>G\&<0?E3_I
M9J+(D;X62L6HWBBV(=UH5P!O^)Q@PMPJSI:VW7[V?HFQ_-7K :^$U!/A_]=7
M_\M.Z(4,972$?>8H]JC+@--/N"WAOL^(@).@C8' .^/6"[C>A$T]!TW?] *1
MNC[T6B LKLS9IX!3,S71W*!W\OA0#FT+BK91;B!E$!CHDQ4K]W>352 6F#K;
M?FUO+[ON4;P" ?A5WVKUK*+0]_N'_/ E Y;-^9NHH=*:.>G]%]^?'06X-B^[
M>[D5<$H_X?&\HO5,.6H?-CU(!.,+MJ>S,2U9?;[%SB=II:GA%87WG':8UI@
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MX<RV*#)W0\GP.]% ^5WD8KFM9G8)_^N&FB-Y](/L* )\QIP8#9Y>;&OU97Q
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MGN";X>[D$>G*]*N/>*\&.=M)TKU,\MI:?*PGE6T/2+DAU<4O0-AM 5X%D]+
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MJLI_+/JOF;#1 +<&H4;URNPBQQ)(JEKP9NREU+^1T=9J=;?E4QSG38#8N?1
MTYF5^"K'K4^KVK]9M,8YUI@C@Q&4\N_.MZ3==I1B)2E[7H!PI011DUGW?9;/
MB&B5<.8ES62^RW'AK>)B#9V5&[MLY]*.;+F33)4>24#T,2&P+*+<_TP"&N?I
MC:>(;F-^I5'/V51F7?%!%(,#=0_5>^F<Y<;;_TA)_,L8&+N@%T>@@GX@<WQG
MHSNQ3-@$Z>(2V=(RHV6J]C?OU<"KET$MZM<J\"RA[V"7-V(][L#S9O+R&JU_
MVJ7T/0S[U85@H"B6-8CLRZ8'2/L;.YN-0]'X[G_^/-L^ D==S'!I05>Q1-:
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MQL.A2/3F<_$C,]70@@7T(;\O^F@__AAPEY<4\']]N>P8X /"P=(NPU!HHN)
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MGW=E-1)(_E%:5W)VU.OI=C\:%YS\+DS*AE(PSXC'?W:P&-S63[;\G/7MU(4
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M--8.\G=GP1'I$39[?;?%LJ)_#4P8H>[KA-/+T>Y-XE/P5B6/^P-^7A<]WN9
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M!1F#6<XV'P/4H!_^&[72DOZ0F-4)._E[*:L=)=M8]\[NQ_T>0*BZP66:26@
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MYOL2LS/[#89]1MJ.>>G@LO7I"9_@=BQYDC20&W:]?APJO< >]-&,/ZKR2_+
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M4OJ3 H>PV!#Q36LREO+"09'0= S =SS94=_?:5XC,T2]"?;;-.ZB^XS!QC;
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MQ$O1DQ16>TVM<?J)U0N-H[Y3=.4[0>_/8'_I: B?/^)<"B?<) GU((04=2_
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MSQ%>K3MO$&>MS:>V#Y)#FR8:7 ULS'[;6$$B_I9P9@D%;7Q+N^.RUIOV M*
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MG6[9IZ1<M(=MZ;&<1*-IG6(*_ZB9865K8!BE?@4L2.4D-593$!'2B_JER:N
MDOF8$V[3FF+#MC*P/*N(OXIY'YG%?#M]+UKPN"5)QKPHWYV%;(OA/0%9=KU[
M>',X4 Y^OG\040_N9/R5-JVX0RVBLD=0B0Q_N2B'S3-MI=APQ7PTZTGEZ'DZ
MM/L%<DW$!_I&]"RMJ$V<I&5#*NL:X?X-H PF3K,0X:V-&O.XUEO)DO8BQ@](
MM2-:M;G'A4F80+G>Z>C*G)75.]V]Y968R.9 7_69H8$_@*$5<)FB1Y_LD"=B
MJ8K)KFR=NNR_=GA)^]52^AFFI2)A6]EN1H/;WJ#[/7'22?M*P%7.;R<@ 5@
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MM7)W_]S>.37X$!N!62A\^X([1?6LDAK4MK34;)KC:$]9C+;@@J$2IC 'G?7
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M+\7V]2W0!I.CTQ:EEAU*+9.BW_N8("KV>C%[\3'LL29N6%QCQ#\X[00MZOL
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MM?_$5P%^3%# AM(+2=2@R,U<Y#\XG)#[7'%[)$LGI70/Q.B2M\AZ,!99C".
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M?U>[&EMKE)TM'P5K,AK1\^\)I)^C6)$@ZTT*A"3?NB?.\LUSNB 51B 05&D
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M;OA]W<*NYZLU[ 2V_@\VZE7AQDZ@7G\!"_,*Q@T'_GY ]%Y4#H>*(S:_M?M
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MS"QI-'BY/E+_:_+S2$6Y [UV\R>74O0W !6:(*QPA+_WI3ZLNC"GZW&N4%(
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M3:IG$%* [J<(&PW+4-Z2Q7%JI"6V\/RVI/:LC*[R\AB$M<"4I_-$BNM:0-*
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MKAMR,\]//WTUY77$'56QG,'X7!-K. &!/RKN\9XVZ%VL0BZ_!I^!JH]Z6I#
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M+:_G;;4YVMT^WM=35+D.I;\O)OF80Q]@/84[K#VR$IO*?F],0V%A^X\:]43
MY4V ,/\U&N ,#>""9@T;5..)OE4G:/BD<=3;:YKXH&0VTVSP+%N*XH8:AXU
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M'A>6E[%Z'=3736_3D^=:2O<DP:R25X)W_G1K9WIL;YL&8#O.Z$'$6/-TPLY
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MH<]AC6H#),0!D(R(1"\6+!P\0KOLD]CZZ$U5RIA0N3-V6VB ?UZWPXA\/#3
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MAL4/HGZ.\;?7KQ[.&>F-Q=D/69X\;;Y3+D:I" X+I+#C>GN\3_2'.\"D<S3
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M>UUOF2?U\3W)O*9BZZ1_)NA1@9<QLC/A83NL-FG7?TF3:<DDH0+Z />G5X^
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M+(OBE4VV7/;^/CQ5\( 87+*]<%$#MK1_.6A;^_T6O\=T8#PWUB;&0>#]:_L
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MWR0,SQAG6^MJS,,@)IW:D\++RIW$H_T=93PF,L-Z817FW(#PD@ND 0('%EJ
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MW :F4S8B.]")&<XA=G'G8,&LQ(G*@9G@L,S9,Z%OC;"H,$E0#)BA11+CHY$
MX7)M/4DT4.<4,!,A,&LMVLAX&C#DY-QI^G/H// \/,<O*)+5\)GY_WF._O^_
M_C]P7>@*<2'X\W?!WI.%L1$_8A$0&C%,2I/@C]]OPI)8R6S[CML7<,<@K&F$
M/Q;4,RE)L.O*XT-F<=_S%6*B?1](*ZT[T.;K]X:.U-??("]SK!%PW$W)7KE%
M^,Z%VW,!Q4]$RF\'.I=M['.(AR>]K?KEH41MVN.R\=7T@5&QH>W#AE+(:Y30
MLM>K>WWYD;IN(XG'4\5-T.+/4R&Z!,0B\+TJ)\P&9]L *?BK&?E![^:!T$U[
M09WCW.077R;OX*A[N$"=\"F[+N2]/T7.A[G&[0V3LGNW65V+I@TX0>H,:L=L
M*V&4*A;N0.+$^B%NY/O>:,# [D<4%C4&<C_BX DWNK<T"YQZI;9+'WH? Z;>
M( MA#4H6G4W*ZRK4VVUD,GZ)OKYG*\7)A#71-NZY3,<@+**96K2D7X].S]QT
MCLYU=RDT%9:T]8=^/0#^MRV.S9FM)ZC:'_4?JI*<IF5%QBX^\-P;\ !?#*->
M!]>BWZ:UV_(VC[G[C#6FKNN5ZO"DN878.S!=D5^*.]0=Y31BV](UI !T2M*5
M'.S8+1HWU&]" YD7B$TC1TEP01=\B\\!MX?/ 0PP@LXYX#%[(A"K.$JY';(C
M+$QNCB'[:>'#V,FA^?\78_#9YX"%(C"C.PE"5(0Z;?Q1Z43RC=F-%24]T-F7
M57;[2P&  +OU"S)'%5K*3'./!:4T:SIN?PQ8?M;7IWGUYM%E,[DZ6)V)^Y[M
M.4!I=@O_#.^66,%MM0+A Q$?DGRP:Y1(B%3D*RYTD1UQ\<-[:I1L8#18+ U*
MV3KN>K%^T&U0E[1)BE^BT&22>@ON2N0W")ZK:S7K,E>"K%0L?6.*U868)66Y
M/^&,,@?H).#"9_25$(>*WA(KM8H \,"K?4LG_YB,E=C>=CV>;*V:#]0O1*;(
MU\A#JE1GL$/G<F7N?+&T65<YLU&%C,WEI.QEY07O2(YG.C?ILC;@1T$MH_K$
M.3'T(#%,2)Q_ZWFC<Z^(U@XX.- *FIN<0H'SL =5!/ZEO1@T%<G&ER&^HJ<L
M\!0Z_5>SP9X^X;M5B;UYKJ976RROR#34'9;(QT?PQS)V-M&/DR0P_$R6LKD.
M1?D14C2J9A_@S^(*<GL2%GQE9D)\SM+">,A_ND6263<>:I6UYSVW1&9+I/B4
M3.F]*'LW>*G,3HACP!-,0UF5/-C5,&9".+T;-Z]6YW1Z;:QK 8ZJ_>D'^?5^
M'J<8[4U:D1=O-1EERDL-.V6,:ETL;>ZTUHTB3LE7#(O!#(6ZX09BS;([_?ZA
M)H@&=?1V!_;X&<&!R+D1)%O!,K,)*K %@RY'T#/!?J<_2^H4^2Y0/>#!C]6%
MG\CI6Y$IKW?&Y Y^L=GD$]2=&?A2ZF&'+^W/'<X+X37I@O:^;7"5,Q@E,,X!
MC&&#JK0_L#U1<!FE+9H]VY."<8<DG2<),067>)QD%ZG?'*T6;UV#FG\\SJW8
M=TW>K.0W39!Y?@(_T ES_'T.P!I+G-"$L)T#JHC0]6>3?Z#U[*1LZDX4\>(0
M*=**L$:4#X#@WV:W[Q.BB":U[HRVW#/@[=YO"4JIQ<SNB?NJ:J/4<)F_)&WL
M#1A.ZV?0VOLCBTK7PYU7XQ5"&0/IKY^[%=** ,*^3$IE!008;^; T) PK:?.
MO:^$S/(-P=[IYP#I@'/ ]H5SP-V4!8G3-=]S0*&W61+I?PR;5X0QDD1&PJZ1
ME$:4.;_.VMHX![WZ537P75%Y!ZGY8?=>:7&F"JMGW&H=<*JY0Y&Z9P""66G%
MEY,%QRM4>U3*:Y^\&9?M;C1ABJ9FDC!3 ?'E)C,Q5DQ4C.@Z0V=F>#YTC"4Q
M)++C--K/ 6)#&>< 5[%')/ZSZC#&$,,QS >"LX"54G:D>KM8JK;@NF+,VBRU
M<1T&.=5(B%^$ *]"VTWD8NI^D616 I=,Y73PKS[]NG4003"!QH)I29*XX/8&
M/AZ<6QI#=<'OQQP%?34/UM<W'PO0'5WF@ZR!Z:%MDF%T =!.G5*#+'SC-=6C
M41F19=DO:S>9>)RVJ?,EJ9$0CL%<7<E"P[JE8"7;C>89'U=YTV);$^<[=T1L
MY"#2%:%Y&<I;9)HI##?_C9!  K%B(_7SX8[FJ5*9LVZZ!/>L=4T]H\#-)$:9
M;O(?&*,R]2)XYA<ZQ&9D -UQ#N"8RF\+O/-[ F<U>W5$91NGF".B%=7[DSE*
MX)(,?J@=/374#J,F^2XQLA)\YM4\,:]C9O]*QKJ*O0^N+[^:4J)QDGRYP66=
M?"_D#C:SVYT.&;'$>X/>T>#U?/Q=4VUP;3?EGP:7\'@$R%<@$5=-(W6=IS0T
MCA'E1[MU_ON2I^6;AKF*B3:]O7ZM>PV.I8>.4;-A':A:WLIPW]X6R9<WX@0.
M4'6P3O]OZ-=2S;^)!K-V2,@8F9M _1/&J,IH;4&20S348RMV6J8CFRWG>KUY
MNK7/ 1,T@GZOKM*B><RBG5%8/?<(6<41L+XGQE5]"NPYZN;+T4D';-)]4F.W
M?G(,_WX(I')"LF,3^#B&W]P:D=8+]JN/FAA6+]=6&U0Y$1(23-49\,84[]S7
M92JY#\Z?.7A-4 P;K'-4-$QLJB!;2D@M@PB"YP#2!WYFZ-]^.7+JC D_0=B,
M]#:,DE)_0U&'5/!"H"-J:JT#5@N.V&M16,R>,SKMWC^!+Z>99BC<899V>O\O
M3S$R.SEI QJX [P[=G*'S7&1"&4&NTSH?)OGGO$N'&!UR'G[@+@4DJ1DMV7C
M*RF]DI3HBRUF/[:D($X7SQV33#TZLA"G!!)/&J+\;G@>"3BF;$,$3F^>^DAX
MS/..C9PN7F=^0I?(C:1V$'U_"@"YX"GT8&FI.%I5,41Z1*:5WZ@AX\C5SD:S
M4_L;1*'][>;&N.:"AV?X XT@A_%RN?J1F=DG:3._HQ1NIS\6*>$05EL(5S+K
M"Y/^+UC'^37<S7>]T;B8(L >K'+CZ,9LJI='3<\MP^V""W^OK10:,:3EFVD$
M%[?6U9J>\")*QA)-;./TIP=4)"I&4= _I[1ZN)Y(5:$>C VM.HXJJMKS%7W&
MMPRIV+#!D5L_7Q5S=@?QE6H]@QQ$X+4((MA7Q&Z^!P0'7)IZI')HD8LK;T)F
M4^Y UIPZ "P.%']N^D(3UVUA?]G^4O(?> 00$,*(I7V<^13KEI 5\$-XTBRU
M.F-UY>U"KX#7H[5K#_*% /83U#V@*8E%U ZMH+_M_1'!>/-8Y>]'B;+@V^M"
M#F+AE=0O-O_V=DN9:=8].$B-"*G1 3OZCH?L%;]VM'R/DUY8S92V<E8QR=O8
MV*AHT,HE1.#OGV6&",F\5QR*.CP3=U7W0=3&[76:5;=V5K:9"!A[9PBF_(07
MU\VIHK5'=]Z\P5RWM.RL>LR<JG[[;:G"(<!L@)\.NI"#HD9R;OW9XK<?5S8,
M=-L2^S&YFVK^U<.+0XO'LPSZL^/::?BW5@/[;Z4*0>> CMJG,JJFRQN:?##L
MKY-H\C4-2D7-Q$!/3ZO/ 2.?ML:@KU$G<HQ1,+SHQCG@]&EZ(:YV83<>M[8X
M=PZ("%'SA3H6SNNPINH7_8I](/F+U\.&-^C[4/](0POC A$(( @]QB)AH@?.
MIRH)BB',UC5U%3S:3'KI@!L_.7]>4HE\M8PL5@0Z]YT#Q*W"'/IR\L1EFNY9
MK?U&+X=0*OKE,DJ84F,DSA+XB=J&YP"J5^> 5+D%-)'#[#^^A7PH!<>F>CK
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M1"="<^;CQ?4ESJW]2:T%]ZM3)"#6-G(Q45%GM6IX^V550^I&>J$3YE&<]7=
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M/1I ,B"4*P=BXB&YKPZ(HAMBA;-UKJ^&*>Q?=2Z[,R*P@YKC)M,ON"B"0KS
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M@'G\6E*[/FZ">:HH;2CJ)#EQ7(B)B8F)B8F)_0]0^.$_4$L#!!0    ( %:
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MRS]0^E&%J<)48:HP59@J3!6F"E.%J<)48:KP?U4XWNF+IFBU8]>[7SHXTUI
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M)KV!_U G Q@!>'PO,>\Y&<BD)'=CRK];0A'N\!"TPPXF'(4L@,9]00>4:H3
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M?EJ$\< [+V RB<'%\!T3E*FMF1AN<!?^=K<&BH]AQ^C\NDI)$=65O[O#_\"
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M:Q[W$K +F.H(7+>8@>'R&8"<K[MN3!CZ&F3T5Z\ _"_;3@&IBP$PP0&WBQB
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M!; DNE&;/4^RZ01&<^9V0+!<%-C.505!@RJ=3U6J2"TCEVTB#8#/001KN6?
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M(O.C/T"4?@^V@J954K&QL%D@?8(!&-5D0LC^A*[&W^90_[YPSN[W]#.5GQD
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M')R+MUZJ(/Q#"GOD-!J8%FC//Y9<Z_]0KA6I:33YK"/U>2$;O?4::#-EL8;
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MWD@1?"V<9$6+H M VXEH?UR!=89U,])HQT+DQ,#P_:JS_6U\9FQ'N8=U;A[
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MU;[Q%RG/$1BR.;)56;2KW#F98@@\")'UG=^GZV*W'R<=)4@NL6;Q.0K*C/W
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M[WP355<YHRD!>)HT0RD^DITXZ" D&@!/<0XSEI]B0[W[1R;"_TI#+!0H&\,
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M6C;9E95TGDF),IE=;#]U!V*H>P^*&[!_)#5L=4/-WGX[GU#QF^H3#CMUI 1
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MI4$=C9=]+"(GE>L7@Z-A=5 <E@KZO]?V())$G* !$_G(2CBQD?JH&$(A)M"
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M;9O_J ,>#"^<*AGFH>26F+F^'TAX&KJ1/5\KK/YFU?RH[YD#5#:2!IQKAZY
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MXO@VXI9\@#;7K3M'ZJ0+]OW?10 /8Y<WP!_S"D=H@"24,$,=1#C40-= SNJ
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M*-FZ'ZWR/+3C//1A_=*3[=HQD7P1GPOF2=Q)-;[,G+$\.N_J(B^^3]ZEFRX
M'""RE,-QFC2 Q2/AZP=;P\"G2R[7#>=W*7!?BPT]L>=@1N.)L=S2B_JU<Z8:
M./0X,@AS#Q(4I2J<>,!PB.>ZA9HE97 V.X!S[M/!&.0T/=U2WFF9TZO::7XY
MK]+1 ?V^-,"_NT-ICV@UK,X\<^+,2FQFC_N7E:()RWM4U3G(DL@,LN()?B7B
M2Q.U#K6\43.,O(9]!@XX.1\T4;=,<*"HE3I@1_WB\]1M9N "QG [UBI+P6!L
M)K1BR#H^,5W[@OK!9Q0]C"'Q\L!7)#?&@@9PV5I\]6)-.H-K>5?9V'=7:/S#
MWL6SJBSTS,I[0RB=290R';$IM!_ZH=/-5_$VV\*6&1M*C=+3R4&5]XX$1Q]K
M2BRP5K=:&OAL1'BK#R*]05Q<'W1BLC4%Y/Y061IPS@)?(SJ(L7<(9O& C@WR
M'^[@0E7QBR _IMQ8.SXP2?>5K_?Y$ZSC.EJ>2(>3JP&97ZXS/GR\BS$E^#+V
M0_^P1)R 6J:?!>16\C.5B_=Y,S8FNY#[+!SZ=0BQ6*K(?*6#'UG<;:Y1[@<N
MY\D-ZNR0R+IYP6)7*$^['G?T@[:2^+[Z)58*DB%)1CZ&!B"UHXTM@^)#6-K[
MQ"P=A-#>O=M&!'>B!E-YN+^\:B!!@O ,7F!S5N+"LO%N\B;#PR=]^[ST?"1R
MJ%T03L0YCP7=CK(#<U3-B'=KA(A]7]1/W7FXJEB[W.E(9Q/">X@\\842C[0)
M/^*14.L.9:0*]:F:C==II);6/;W<4??$6?DX4[1LVZVS8VI\\BSCYA^S[)05
M]/1?4454J*M:F28<D]ZWK@WLN51)IZY^24E9U#N4, V.6ZGY_IV$B^WGOXZW
M_[]8=BFZ-C%11&:UK1G91U4B9E9HC(6RZ+9)9_H%L;VXSM@I\HPSZJA32:R@
M3^(/Z#8O\@#H^E]Z,(W%; ;O+RR3S,?1@"JKQ0DY>6E"$;/XFQ_VJ@R,ASY6
M?Y3//OIPEV@(UI0I:B!56TYS@<HT1GQU;L7JPVJ,B%.]P<@Z5A/C7XQR*1^#
M,OC<P84';J#9/>2N=-\K_?!X97$[\95<Q1Y!FRFV%,V+PEQ?6^3UT?X(3N*%
MKQ]+RKAQL8%C<[QV[AWYO7;!3)<M;L:35RDO0&">NHVL1 5Z(?VHQZSB<](H
M40<&;LU[G0M2%_17.2*DS@><>@V4AUWDXJI7JJ0!3+>)ZC3@\DHH%+=_)[*7
MF5-XH$3X9&?P5%GLHJ/9VD&9JXZ)!N*VMK[+OJG*/@,X.<(Z$4FZZ'.Q"!<8
MF(]D-IC7N216T9C>/U#[PRVL('/4YQ9Y1[@Z+%$[>C8_0U2J*]DTT67J*DSC
M(@A/!'Z5982N71GHI&I'X"JI7XA(&J#!B/B*G=A< EF B!K1C :8D*&@RP\(
M0JYX(/'H>C\:\,B(#,V WK;:J9?- #_%L(_:5AF/QWXN57*);9SC3%+;5^3Z
MV](]!! L/7Y-;4VBP]$]IO(UTP!ZN4"[?!/Q$2T[(YV."5GT<16VP2WFN@GG
MY?O1*RVB ]23H,F#*C#B21.QV7B6<9_-)($BVUO2%(F+A9\B>X;[?\ *U@O>
M45OND Y=_?B0A].^ .2#?-#1Y_ ?2DS&>#!$?0+6=!]>05+*4!*3M-SB*5EQ
M+2_O@TZGTQF!\Y46=/).,=Q.T[!I=]_M =RBM;9DIK9"3H\^_((<D0;H*\VT
MN5+DJN7%8M')\ &;>+U%#<6"I5>9IZ54*H]%1#^_Q%<-1]<CB8):-6@6#X%Q
M;!!BCT>\NG]\=G-U8F+ELBQ'STKAN. ZC.?%HYK9U?/F6@O*+IJ25\\^*;F3
M$^91/WPSLD>\210?/(X(IP&,H.G:9QA589BG[CR6+:HC?S]VZYS1!<Z^F?!>
M]>-7S]& I +2!7@X,C<_^!W8+P9E1XV&(@ZNV9@>"Y.Q9Y"+7WE$ W9I(P^T
M!)6=8ERX*[RF;K2])I.Q]2#/-C,$<?T+#4#541#Y^4^T"@)Z^CF70"H2=M+\
MQON@_;L?G@-VA<"F:\GLR%'-Q'0?1=QFM3?#N?&>_,:JC@*NB1L'"1\#)#G.
M3:8\/$F()L'F['S<P:>]6_QXA"""O^;T\9DPIG/"C_?.AV(5\$$?9L)D!<:T
M%UR)^1AA"QMN.;8"U*0[$J>%>H9%LB/OP /[6]Z(MKX?Z)>-<SX=8I!B:\U]
M>#(I-88U:OZZ+PN<$WP]@>S))P3)=I.VC.9,>#%D12*A"!H?083U=<^9R[R?
M&FY=@5GNAQ#=EEPW99^#,+;I3SNZLVD;B/>HT#-_M'RL10-,$V9,:4 K*YD&
M;*_OR(W^XM03BUFKAD*II3\)CO[/";_K"AFOU4H#T#\)COY\IIKH30,4=-9H
MP$+;CI[IGT_;_UV:V*F$:U]#(V>"$$B*%UG\[UT*_ITGV-@1Q/A?/C@VRA:>
MS]LOFX=,2Z07E"UBO@A?^M&^O]HY-)!/M++9N00CZ&=SC^T\:V)LI!?X<.E)
M80P2U?>8'U1>>9F]H;%F1; 1K82.I0K1@#>^4-QI&H!G159>U0 MY#9RU( &
MC(M.8[#+/#3@-9H<"9+"XUXC\RT@Q%="KEK1@)?++K" O_Q[T*($1,=1_7?*
ML/) /W&3BGDP0MF'G(R!;AT&Y[RSPQ;XX%&JY%;GMR525&YM^#8':(=W@^]Y
M1)4LG8)9ETBC[D-1CX=OD )HP*PH#1!,IP%U@=MY"<A6%#D>.NV=R#:&PG5$
M@NZY#$5D1Q*#OGT#]* <#;@$WQ+2HOX([7XU0/4!*3#HPJ6:E;ZM*AQ#LGN,
MD"PF[O"?L-42Z2&T(#\&#D+=!#B'PDB^YYJ]T;]\IK*)I\2\$U_-/K!)RFSI
M&=Z,]NU;8(\M5EV#"H[>#S]39;'VHB/-_>"/G9O)R24E?^L-RR 4Q!AF^P (
MJT\A5X47D/_)/3LXFV7"<:NDQ\66\:)ABOG\\/D*^Y:A!AZN"46;E5\,V.'.
M=.ZV4+4+[W)*N=:T@_U>W2W>D4M;&-D:1Z% @Q(NOTGU2)L!(58V_>_\XB>9
MMI_/DEM*0<LMLD4#-F9W=-I^<?KS7-T1:OOY1.'G6S[\WL ?T<!OR.)T#?]L
MS. [F$-=\)/#HV+.6!EE&N 7=D@5W9=3NO"KM=O/?]?:+?C >P>L81.QG\QO
M+-& 'R;)$*W\?NP<Y!>C\=N:VKC?,;O8&HCAO\Z+<4&8,9.)'IG4<AA\6RBS
M FH!V2@3IP%NX/2VA17ZJ,3BR(KXBU:Z$@23'DWD7+ W-H!:ZW"V<;Q5: ^Y
M\',KI1"=6H&L2V-9@#1#XBPAJ[ IY!@X]U/JM@-^^U%\VG\2AO]O=N??F_BG
M-[%U_=MZ\4["B*5#?V!-@#+H!F<-]E!+7J,9T+.+F51E(A*G2@/454?/HT@;
M2/R?)+TR/-_\U>6[;], 5N]A8$AS>O$X@BGN5IC0'1IPO1RZ08*6_DY^K=*C
MWWS;G7VG_DW[]'L3_T9-_"H(WK[U/[>V(%8JE^ M_3:R#\<4<,=$]R 00U3X
M"W\YNT&ID!DNMIMND?>9FL*_C80+D+DH 3F(PV2-=A_C,@EJM[SMU1$+^=N!
M32,LM9MD0HW<S)LYN-[/S?AJ'9GX0"1?.V66VA1MEV<XM*E&7.9LQ)]'<*<J
MZ'H:Q6QJO5WL6RU:TB/I^EPB,N /C%SM6 \],/-C2;Y&@E$PR7I8Y7Y,A+IZ
M](.+2^W^WI85\-!^CJIPOQ[3,Y^Z[MOM=7M3<'=M=^JK!DRI_M[(S.=7)U=3
M^)UOD.\315/)KKCW[1N-S@?;<F-;J(/ALOV7)2.B'C.Y*D#,=T%XYY$X30B_
MLL]"VL(V8W<2PL ^R>J.P!"[W![J=EI &"RTO";4^I2>10]V&HX=US]KD$/'
M<VK]^()V)-'!'D;Q=,T=?:"B<!/_!E9I4U<<@$D\;V',!OM$Z:&[OQL3@R@@
MJQ'#WY!%<#$C3\E7G'KZ7<M8MZQ+)]W.Z2HO5X'8!"=:@;1$]O94CI;E<CPM
MT(C!TST3T#[JFR"V=/;,57&GYL<J$V%,!YADYD>XE5@K\7E?W1&<W0=C(ZXN
M2,-DB1(',S>-]HZ&J0E\$DXS')!O.O-B?OUD>9$FMUQWFNW 9-D:;[A8S6UK
M<TDV;3T;F^1V&3>T_=+ZK*4/"^6= @]^WI;DP%2P].[-O;([L?+1&KSO%!Y-
MB_?<%8W<-2,@</0.;"9MR7%LH/4 M5WI-.F:LO)0&Z;HWBR^;L]NQ;Q/OKK8
M 51>^&*R'4EI/CXLJS@EGIKKR=3G7UDA-A'$5Q[D=ZA/,&,RJO?V(><V,H*2
MF(\*[__QR/S-Q NW\O<:S,>.2M4P"7&I;[4E.48LJDK?QA-/HZ5<SS077S>D
MZ+<LY"RL';P'#V_^B+8(OBH35:QA:9NIV)..J6RR?(RT=0A ".#X"K]XCB?*
MJ7X*VV>;+;OZ($Y2C6-:.83<X=SV^CRZ&1-D>@(9 N7<:(:K?WQ>6/1^O*7K
M8!WIJ5H-'?XP1[B.Z8(K",DFB _CL@K[5P*G\EN9&T^WUZGFE/,PD;W*'E)0
M2 L3X=&R='[,^Z8R0;R@Q2:+.J>:&#WOBT[!V'FYJ/7=I?>5!$[63^FP!;Z?
M$1$]294=Z'2NKC);RYI.5& _$>EGWNFT<M=V99K0V;9-5\$MY>%<X24>N3*M
MZ!_-GK4E[*C6K5Z_K5_Z9Z2+?F\3.><FQQ%G?E+,;L+Z;DP+VQ$5=85U #8C
M%?7J5=(BY6RBC*9D&E]L8,M(D5:U43@CD;WQZ[:(I\^5\?1]F*@?FAZ//#@(
M;+@=H\LQ+)!A"H3@WM  "_@1J]AK+#K!RDFV T^W2YN>D7I:'TCE>Y_"1I/W
MY)514C!62^[CA6_NWVUS.;^76U<[/%IMUQ& R57[CE+(O.T"#6"ULAL?89R/
M%]HH+DA*MA/*J@Q9<CWEV&IJ.R?I9.![ZI:H3?PKBFG[ED0UZOP3>/^Y^!<+
MI Q<VFR9B,]PJ[<H1 K$V;*+H^%C\&<YW1<_QQE*7G _]>%'7<2^D37T:<J;
M%[,C1>X!R_<Y[!I'K,^>"1G]PJ%\E**[RZ#L('XS#&,&9?9X<JE'X8QK-LN-
M:/6]K0)76+,^,YS6]C=KB/C\0]W7N3 O]$/XH1(+_,)$'ODVWO3YMGW4W@5W
M:][W=7EU&>RL3^5./_,7VF;^M.RXOAJ86ZO??%=PMD&\9<$H=7G >=)"&":>
M&E4C!@N)Z4YZIEYFN^2PIK3^V^[W)23CGV#R(<(>WZ0W\7O(I$(*[I;K[?])
M53[N3ZKR?V8["W]%5OXW6-/_R,K_NS&V[PW\%S6@EO+%FE7A:GJ2&I3B5?0/
M5KP5)MU!5""4*&_*SLH%*YS/)#HU:LK[L"?IISL[\@ZT%6HRTW%N!7J1/I;$
M$9Z"7@]"DO6X)Z91%:7A[.O^^;Y+@@)/\#L^M;T/WY\]6_LHZ>R#0UTVFHEJ
M#:CJMIDJG33#Z#>PL7F$+PVH3*.*(]NJ1S'D0R"MGS2$CH%DEP,Z:XZ#4^E,
M:,"JF*U'%/5 ^P0I\5)")941-YQH09:T41E?AE=WJ 52+\#O(1IH0+[^&WSP
M*&-ME01GN5FJ8LJFAC,E;F^9]I4?]GZZW#(Y(?S8RP7ME7W?E=L^6T,P/"$Y
ML#&738\;9K>=Q$0ZBBA''H9:TH!0?5,)_*'<L2_-LCP:P6[!USY_BC3O.+%K
MU^BED(WILG5T$F(W=8#_ -@M0K9ES+B-[*6B7COE[M0I'#UABK'P<N[&C<^7
MSSI=X?4?@%^!106GFZ:,+V1>0' G#>]/XH\6_- RO[W1TT@%;BJS57C]*G,2
M'CY2E$9.%1@+I+CC:  UEIOR"!U>IH@L5T*.N5.[DCB)M32 ?H4@01",]_Y)
M/=O"D^K>=V_-<<9SH<A=ZY,C-BGZRE#5S83^L]>W#?P*DK5%W;+*UGV?&$-K
MPD.2N(ETN!D]?%'PO<]/?NQ\O)5M?7^MKJF)[?"I, 9)AMACEP0$#]E^RJ(!
MASV0U_&F@<AD6]DS-EYZ9 D[5TM73H]WH0%<7%I[#]L(-S=LN9]2*&E,L)A9
MZ;,@K!%M23I]K?OCO,IX\0I2:FF5Q?FS1=H_<B[&*G7L_G2:18C^*#[ X2IQ
MC'39@XG@B0OMP4S #QM:1]3R2+.KZ,FYA]$=J61WO\ 2]F3/>4'@.L+7QXD&
M/#Z5DYQM,@^E)]^U?6?0,C711E:+9"VJ%\PPKN$*"GLH??<A;QZ_;2S1&K3-
M:GB3&C0+^1+Q4?(M:ZOY.X&5DHVNTHU)N@KUS#6.[85EBHPZE/%\7^P,!?D"
M$T!9\43"L5I=C6 SQAY(0V(WR<IC9.)@K)AERH!O&<'-U,(HH8_G#C 1>20%
MBCN2]!:CCK$9Z;>]1(FBLK1.7'>JF=!W_Z0ARBC;5Z'871EP]_+DX:#=4NSE
M7WEW/V""X6Q',7Y*NXB'&BOX#W1$76U?^CAIZ9)7YUAL8+RZW,LEW+;K(< ;
MMV1"DIR%%@16O"SARH$;6TOP-<!OV>B_Y\NV/V*@%\2\)QUV&R9P%'>I_%!A
M](1F6+NZA,8")O/#^[ZNF*L#]844N[M;HJ]&%LU(EE:00KDG!78:6NW3N.&B
MY);G\_(_8G>/J@@>-(\0.O"E^_&'*=W'69(A+%LK).?9[9%%9Q+2"L+MDG B
M0:7'WJ)[ C 3C+AQQ=LNJ:E.PY*:P'250D<)!L<8'QWA',X-_6YNNVE8L*?@
M98?=%5C\H-&SO69^-U,N)9CGS"CD,=]ZM;ZG':'HLQ<7N'0,M[Q97B:5:YLM
M[R04,,Y.[VAY9N_IMK)#6"[%2WN9?SCZW,3H<I;HC6'9K=F<,AK0^"&=U#5S
MM; #0Z:CN-QM]4/Q*'#A*\MEDT[AW$JM,ZUU:OC(GX'(OMPHWOI7-1/%A5!Q
MV]45ZH$"DO8<AM='?2S\"?Q0#K:JW<"&09'<;[86.4UY%,1C]=+#Z<W(N;K!
M45<=/1_;G^3\_6W1:F5'\)L!KF*LA=HFUO:GEW4MWZA-Q-QZ-/*@]34Z"VD!
M)YY0]:,!]TQL(!P>P3IP'H_Q8]3@!SU4O:17:E-O+JM;RX=+/AW%93A=G?2W
M%M%0R[;#=FZ3MF73Y"5MY.OG$"CLAOW(16HCE*[U*[QOLYQ__W/A 9=21>4%
M%:=W\Y?OO'HRZ!E&)%1[9;/JQYR8O]Z\7.>G=^Y]SB-E5OV[_Z>"C3\@21)6
M6R9/ R(&JJ"$(R#1;<^&F_WZ4J!'.G7*GP:PD,/;/20HXT5OR4WR)]]B$K1Z
M_B(;4$H7_+]2Z$(6O-XV+^<OSM!#Y*O@*9P)V7L:NOX"U3K,@:P;> 9=%$^C
MQAQ]&R2*>[*]]Y?I#"2&KYA50:(WM;P'Q'DBMDX?R PTX+A6(&:1SX$&O(TM
M$B6UBM, IV0J)U6->K\:6:*[@7P!VMI9WK\:3OH_98[_*@%S(_$W(N&ESVE
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MC*S[.N_W_%Y@V*:6=>^A4*=1-&6+"3 =@=Y&>PIT$TMH?>JT#-,E'(RNTA.
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M2Z6=@KJO]"A%)&V:NO 7S]F"#_YAY[#B.6F#T&,MYE8R;H_/Q0 2&<*5?*<
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M;C8"D+@D=,&O>]S ?\\AF%GF[Z%%=TPUFB1L>@RT$71ZZ/[6V)#/=33[0,Q
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M\F5%IA!@/*8&Z$.1C=5MB" 7"C95 @26O/5K%Q.=>Y@->11@NZE69$PSN;^
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M46W$JI3M(MD3+[BI1%2._N1!N0KX;GHI@7W9!W7#Z-K$:Z@<51J0ON]8JU;
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MY-B0V$L:B#*]$X76*/V\$6;L6@ =1\!SXG9R3C$@U?K@E*#4MPQ(+S^&',:
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M( =6+I$X0&R"S@9)X"!2OA:Q! *)G_Y:/ZW2X^"?>)B]B22UP8VM;.R;A/J
M\FW$LD052(APLBI\4S,#,I3.@ 0CHL$9E6FU_%TV_L:/+4QZ8T+]<M:G((TA
MV'%HFI!RW]U(RBH# NZW;!P.I.LQX;GU0T_FCZA<!#6X&T%@4Z?QB+G>=D,M
M<(%J.B^2YAW&@%QL,C5 U)3> 'NH""+F9^#L+<2RZ)MU]U</A\5?W1]^<Z*6
MFHFH@SYHG65 *&+(DA$9:L1+* 445<G)2.DQ+NJS+[XT<,(=N2T#OSDQTU)A
M0)[IH&@.ZN/'!I"NZ_S7 :)BA# ( Z568WSI2K+JY#5VVA'P;:9'%W^%I)Y<
M%#F@/@P4?3? 0;=IZ'T,_^;4*Y5H#XZ>R( \4:YSL* &0M/.7 499DX =_S/
MDB_K4%VB!KXL"LX:/R5#?V@S94B&;>B@B 82'?&*6J?I@F=^6J_'H'C_[XKZ
MK\"1^#?@*8-ZVDW*$%$=DJ88 $+KY:K5W_/H9?K>D=8S#W#!A*T<P)4#5X_V
MDS697!Y]AGX$BE7&P\6'V=>,[6D :F+7>NYL]7]Z[NS_N+:>3<(-_,#S;P.5
M*VJ]4)4=7&8,2O(%E2Z& )HQ,+S RMT_(HHU-W"CUU-&_+*C8T-\0/W"*)2R
MK1^8[D:_3]_0456JS8#<JV1 _.G*TZ5<=)Q1&]*<;Z\&HB5E[H\N@7Z4#O_C
MTN%Z[+ATNDI<#@-R!UB][]2_X>\5ZKH=>,>>YK9>3D>JLQ$4QZ""& NAOPB)
ML 0!$R\\_E=&>'*M\1PWL]?.O5IJ*?=W"KUKQ'PYA5B9 D4-,I(J0F\ =0Q*
M'J"L8D9T4]$(BL5Z0MPH%)$7TXP#LB0QY"TI#,A#9:K?FYR"O)LWO&3]AU^<
M+:*F&8J@Y?+<"OV+PY,GA+ORAP9;KS[A#S[ $KY-I.:^RI&U=:<>IK^2W8_C
M@1_' __KCP>&@1'%3OA44 %M>8BJX]PU%HZCG@M$^Q!,:^UDRA@0IH'&::V,
MU@4!=R.\'(*HGL=.&@,AH0<H)#F5J<*]OE1</@-2#@J,@$SK !+[PAUG*LVB
M#"\JLRR0Q( \IEQC0.).#:TU 3AMH-(S%6CEL:=,8(AIDZD)%",^!@2N[WEY
M)]5OYJMQ0+$H:^A*;1^=9$\_5I0F0N^N UJ[H9I5P.$_'@0\+VMH!>_;^7ZH
M/H0#6UZ.I;=I(<22,+UL"2Y]Y1ZWWA7)#BPA+C$@OQT.R:(*6#8U!TTVGQZZ
M]Q%/)L0;AV1Y#M_J&YS'@DR?\N!+0^H4I*K:,[SKBFKD;UI+5#)?9D"V$]XP
M( JVF*4(!F0T]>OIZK1H(.(8$!LSS-0<W(P<P4/:W?[U.^&_G;*CM@8M(Q@4
M>^\4DY[0?[Z/^>T2A'P]9^.NO< OO\O^]@;F.9_$UTN00.=8N$!WZ0.&0(JH
MT9-6@O9^7B*1JV;U[<>5LT##DTS"/OJSG"?^*<TCDF(!5/RLP$<1NA*U>=_.
MT26^ECW-)RV%=]78\'CV%$;:V-:/']SB5_O ZT#YP3;,<#YJ[^N>/29&'^)V
ME;6MW<X0K>DJJT"<DU([[+TT0><\$1K]Z:U2C36RH<U4C")*[^9GH;TK91<J
M&S&XG5N><SM0J\W^N/B=1 $!V9'G[Q\4#@^O'DPE1+5KW'WP/.968J97 *R>
M ;$">MTK$-F8AR'^'@A' 87%&QVK)6</3)*O2V4?OP39U'3BH(A $63JJ BL
MOOW$O0?*F1J(H/7X):]>ZM6B'GX3Y@_(/1VYGD-',A,(Z24/RY<3L\2!A5C/
M5Y3]0,6ETB,4'6L$-M#:S0KK'++95M3P?ABI>ZTQ0?3ZLX?.$)G]GV^QG;N^
M/TB 2_I-3&(\7K$Z/N"8ZC\L?:B'T .SX$>GBP#])K#02BND#CT%)J%T4 ;V
MG?\E0*"E\H\<60=F01$2R3[S%\42XN$$BIX"/V!>  3$"8;EE=]T8=AP6K0F
M5KHP"1J/15!J[)5(+^^#P.44ZMT?:L4?E;C_J!*W,;P631)R:Z5E@0JYK<=A
MP]^M."ZJ?Q8&/YM"?]:J!2(< #0A@^%D344#$#80[]+]_XAJ?AP/_#@>^'$\
M (HZ7K09V!Z/AI <?RD'E])^"X2+*Q/D=1N)Q?.W-+YI90V$DN.E+>#RL:)I
M6U7)6\N1V"%JY"O,_"%0.KYN0)SMF3%VHJ]X@URSBSJ.E!AQID2 Q'!#&BX"
M;@!HF^7^5A#RUX&$M9CRA[7G_FW-&%V#X.^EBA$M1E'[38.ZB_>]<DB5 X"F
MH)<2G<^8QTQT/"88D"U[BB)Z"&+$9-P)75MI 4' *<5?'_ESC^+AJWLM1);,
M[<\?<[K!E6-)Q?T?]MX[KJEF71N.%:6(2 <E*DU 0 4$I<0&" A1JM*B(M($
M!*2'1$5!J0("2HM*KY$20%JD" )BI'="D4X@H81 DI5WN<_YWK-]]OG.<W[?
M[_WVV><]^X_)'\G*FGONF?N^KFO6FADP<A\"A!A@ 'VXQH'B/ADA-ZFI:EA-
MOY90$5['P;QTUUHN=^)#I ZRM*5#Z-SUBTQW2G\#9A]2GVQ(>(;4FR#!3,E+
MY"W8G:0]@R)3D)8G]'+;;Y6R%XZ&T;J!?8U.G+"2[Q5GCMZZ3]%NC:DNER=]
M9LJM!*Q@C4Y%.&8N9Y1MZ %X[ZCS2J\S93OH'?CZ 88.S= =5+?U6NCQ](]^
M,%)W^T0XG5:6*Y'\Q#O;)GY5 GE;(/+M_J-!<R,'*K'#2;^._WY:JY.$)D6.
MB[;?%:]R96_6\6[V!:LRV=J!*#E5[/@J3>^ZH;WAISNWI_.-;FQ)X<?Q;S-O
MYMR]E]"AS1CJ7Z>']D^V?!DVU 78]X/.DTBLYPY41O%TNDMV[[KD5U%<)DU2
MJ UN/7I;](BM!EF.^K;2."B?L@GLEPW/00UB^!27+;Y5BYBM[1?-40PZ,+6A
MPG<W._QI0*:PP4P"!CMFIC,5DFQI\P69##-'"I*Q#= ##&&V9XQS$QWJ>N2?
MI_W%C9Z.(K.M;R?N1BX%EMXKEHC5PW[EILFP+2U"E]"4[@8$GY;P>S(0GV\C
MVNX2J#TLD)ISH6VI^$E#\WC(_NZ7D*V';"1#Y"[0]@S<4\1@<*-7I8F&K6P%
M3US$X[Y^]>(M]K:"Z?TZ):A5%XH/"Q*\X*+#DV*OC?7.IDD12NL.,*Z4TW#D
M[ 9;I;(;A\\O)[JCIZ.W[G?I",<!.YNB&ZK9MS# ?IR')&$)3J[/]%PJ3]RW
M'U@8O09A0/C7O_C>/?[>TL-*B@51"N>6EKWA'OAK#B!EY"^)H(!CA0=A.=K.
M&:#RI>'8YQC?.[4 Z2)(Z\W369 +'%@&F/I>O#N0%#:#GI#M0<_M ,,V&OWK
M="(SD.S_V+G(@HC].C=G5]:'3QB:/@ZZ#;%!3Q%_G4$4[PQ;AU2Q("UX6AAD
M/J?( 3A4J L\%D30-D&*H,N0M(QF0A3PE!7@^./SSG)O0>V0?P-,"GOZ <U_
M.3OIOZD1V :17PC\VXTL&J#D91M=(&08RS@("A@HMG;"NGM_ MV]$)Z8G#"D
M6J%"A7^B:!@DWBWEMMMP]/)<0YA6X"I<BBDX?BJ<H9X(WNQ].5C);C!/M\RQ
M(*&>"[#ULZ/H\>=X&C-H99OP&DU8820@&"\IL(5E)Q9$"[_JR(*\_4_]'[JH
M!?X.PZ_>0J\> XIF,&O@E5+16QC1&P@PO3=^\H9NB[KAR9>(#%0TS5<!=,EE
MUWY@'RBVHCN!TFGH&IT%D4P$<1'ZS[K_:^O>EM/V@OTV[F%_/5[Y:3+T.]TW
MK E_/?2C_SIH((]Z_[ +2#?FM_M12+X39],+70)"W@/QW$/+$I6K0'-'::!
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M,-Y_J&O](][\@8 ,L"!]R/1_S6L_X>#EO2/=0!#Z9R?(%*><Y98P?P0=%N3
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M%J_$?HU^IG4LE J.\:?O_>(,*7*1ZHU57YAC:?V>C.+,S,4":E>LWY!H*V<
MIVIFT 38HA'F&X8979'!6=NEX7#RQN)0<]9V2I5K3?N96[L.>Q38]\0['-<H
M-M8]NM,C"8REIT]1]>4L""[AB4,1S3/01GI2*H8G;&AR48Z+6:='URC8(7M1
M(GU\/&'WG1+9S(\;4^9BJ_J$+CW$\D 2NBY=UJNSUF3-<'A[O2Y1JX%3:.>!
MBW,NJZ$ AS8ECV#;6\-/CM-]8[L@8)**, G9]2D]OKN]_,43AK:MSG _9VBM
MOU9<$4#$[UG_6@>=K_*-UL$\P-\/7=J6L"SSD#HEH$Z4M<ECV_7@\8G#=OPK
M^(]$!B_B2Y)ODZ.6 L,G)JO_W2=5JN61WJ\UE;&+$N')G\Y\?H6RO]ZT7'_W
M+$EN4*>LVWW$:*6Z KXXF]E".G*B5G/S PF+6%PKWD0L-9+'W)_!2HF-*VRC
M"NVC<KH58?.Z3FTKK]'$![WSZS<L37^=Q]([\CU%,X5/4/OVAS YI0O_!U_9
M_&?Y9_EG^6?Y9_EG^?^K["( IY%^9-W/00?D39H#>@+N><664Q>RK,)#CESQ
MR)&8$I=^][65?VTFC@798TA3S5EXZ>+A,)FJL/>!Z&*MEM1SW5R>;RO1'^(0
M7,#(F'QOW5&@-TVVI":UIO8\23E<Z)[:5;OK;&*/2Y6@F_E#,,<5FK1",-EE
M7'(VXA&&SUEU>SGZ\)D%GK%]7PH_.YBB)<TNZUR\K3.#?!*UA;T?)<K-SK=X
M5W23NC7,Z"5@"B.:>II,WS\/8XYM@D(GKGC;8'Q%> Y]4..</9;F95K1IQS8
M1-PSFK^L<V3?QFXQ]I2#%W?OLC+;*@993QPE*I-9.X5G+RO1RQ"]Z2T1D9)A
MPK8Z\&2@))Z 3="46T^KI+SQ#LG_FMHWMWY*+3O\0YZ*0RG[B0^5T1?^-Z/.
MJBYP_+[$SW>O]#!$TR4"1QLE+]!OBFCCHVL4/?(25[]$6':4&EG1ZVX&#5*_
M&(<GO.25.;$H;8?[RTHSN; >K;,,]2[OD"[WFL")<,T;5G>**_M<TU-4LQKH
MI:2PI:F8^Y$VPC9";N8FKR[.7<QNZZJ^LB8U!#=%$NC6J"$HN6V[/_01"T*[
MC)^0!OHK$M!*=).E-/-FLV:-MZH.OM91\0LL"$CLOV!IMIA]Z]RB+(@]^B[:
MN:"0"BT+2F\;E&L!2N^Z??_&[.RKXP;9W2?TUT7R"E"_B=@^+;>P,K +,!3_
MC-CX#FHG_1DL?* ;()B15KPL 8O$+?%6OS#\D&<C<63::,PG?&.!\-[Q0]@J
MX?9LW3&_L98)[),-(K^SAS4\>X[J:3NBZYC757(\X=BN,T\?JK7N&JLS8D%"
M/R(E6)#WOLT8VJY?1V:8;:A^B=X!*K8?-(=)]#YF-5V)[@)/:B&EP9-_;H59
MH#K:JX7G8S:P'=!H(MD03[N!W[?!@H#-:F@"AH'6J\E+L &,PYIO6PP+4D"_
M[-K,8'9W59/#N:3ZC@V[N/=OZR9')BC(PLPLQNC^5NBWZ[H,S> ):29'G3(+
M\ED4#NAC;9FIZ ?0O4"W95;IG8D@)9N/R?HAYV9=;<>$>N,'<CBFOVV=8RN2
M6\VGFC!36)");*WC8S0+X!"4IE/7D=6:P\0N(9Q'2Z[&W2></HU1.D=P2^F?
M1R]%TP71C7*+J.,]L(G3H 3%T&W'3FC@E_ E_E;"R>?6,D931T^=M\@,:[QS
MBN+AFFNYZ-56?[=X(%?FEIHMX2X6[,(3B8W1P6@>%<S>14OI,#><H:QVE'^!
MO'R:@+Q(Y9#EQ$WR5%Z4%T)_[OPWK>,_RDB6@_<, A<=ES_<NG" O^<4YPYQ
M-8WQ),9-9C7^)TGK.+J_![IMR(5J0<K_Y1 )*'W7( LR][I(I-+O\G[]$EI&
M/. \&\1IIO]F8< ?>=JSHG5@ 1SW:]RW_[Z:54L!Z((>0.VV<2H'SE&$?LSV
MW/B)@Q>/6 OS[^-$>XE.[0FU=JC07Z^B;5(GF='+J//6UGXS<!$6Q&[8S^MR
M<EL7NH3!@IQJF=%OZ5A+=%L67$YQ7;$TH2(7AZIU\[=@/6U8'-5]()]@H)BT
M/H_*SJ-Q4[MH*A2E+U6^(4B5*2A)WNOZ?0,7Q%+U0$T#7[%HQG/3AQFKNOK4
M(88^\]=.N4N & O2W\.";!O*HX;ZTZ,;&MDGWXWEY\[85[:]^=IF=LA\B7^:
M*(!W(H0@=GD;R*LVC\F$Z^!K7A"X2H8(GC.G/"I?V 6]2WE2+5S?_- %,>7^
M910Z[MYHX] LTJGH;@==+NR96)9R$W\9-%A,N!,WA!==UY1N@99C2;O;5I-3
MW:TJU]S<A.Z+<IA]EH_J;'X#\54[8EE2?P>%4_U&$EIF0;"U6P%)4Q2,Z=,;
M%BGEB/Z1:OQEJN($M"5Z%^-1,;Z6K%6L@'.P.][H\?"!@FNG=<1S+F5'H:E8
M0;6OW\_(X8LN3\ :2-SCA,?*F'VT &)K=QFM?,4=KQR:&$_PN=\*L^:$[/'>
M:+487,/I,^H<7*&.\]F6(Z,/^&YHWWOP;^LSK;%AJ)-^XI_[G5PFX4(T=..F
MT9F/"TD9 M\;>^0JI9(,JX^=_5!$/9\GFQ!=Z 0<[7[?HUR]Z*K?<*=*+O]<
MPLT,L;RVJ[#G-NFN0E)I.2>*++[ !#1XQEW*<!3I""1L@IXM?-/;T)C#X<X"
M_PBO5946+IL6;!1ZO6NE$">W/V2NJ&#FUMU7 ?DR1P$^SVHOJXM><JM$DQC:
M+.4RP(=OB.;QZP>3CAW].#^82QQ7-4:JLE1)KOA V*-UK @S%NV*H3DC>%VJ
M=!G',.0(M/U@(3&5F4O%JWH]'XZ6TO#^[NF2^^L,P1[4,7!$O$9O:YVG#0/[
MI5D02=46!)4MG 7195]_^/J.>:13ATV+>^5J<678:Y?.9T=>I^&?;/_:UB$I
M8 (AP_BU(5@T4IEF,D5R;SA?'CI9'6EPM?)L=[N]TX,?I9 #IKB&V'/+>X)N
M(;B0]\%K[X%)<(26.8D01C>T JW 8+4+MAA]QW_,Z(*H+S/3]]%BF861L+&W
MJ\W0630J@6FD8564B^#$RF&KOM.W!KK_G6Q</$Z@R50TK!RF-5XF3X<$3\ZY
MXP+G3AZ-G?S>>_>69,P-@QC/J]=O.D!2?%2V;DW"V4 38!1!4S)V".BD'C&W
M42*AS$?I4J=7!N,BIM1:USM0X4AUT%8+\,)=4RP(EU\R(( >QA?CU%UUE_#D
MZ"V4;[QL:ZGO4-0(J?FA1UI([?S$0^4IX8ZRS'( ,8.<UKAO9^F5;2A]8J4\
M>6M+:8Y[2)K:0D8L=13.BR#"E#L"@"F3"I<W5E<K0JZ8F0]=%I:Z="!H1]':
M.*997G2JI;&=6]A1H((:8/,SMN7P^=>.<;M$7S]XYFN;Y['V"$L@TN1\&:]_
M(=" E#OS".(ZNEX5C.YN#3!C(RR(VR:2_AZ-]>-:Q=2B_LG^N4!%WAOW%;FH
M#S" /F8A2!WLNS<!]7^W)8+\:](,/J5):CHYD1I8+:+2/NA<M='E=,.Z2;_F
M:AM!3H8MN)A]MGRI.\(Z(_W(L,'*C[=ZEQ0\!Z4 D@%>@ 5Q7WD&W>?]<CV\
MT'RMR;*P^LVRO 9LYXC_2379+B4)_]VW'S<%][ '3\ 9?-+C((D(<B/JAAKC
MR7W97D?#QJ 'K0HXE,0>7XVB/ V ?#OS<*\A<@?](- J ,7MK9X4QC&-Z=?(
M0/CA2R;9#W@[E*O+\TKS91_SO-R"WUFY22SW7<*S+35.D52-NE7T-EPYS,M=
MDL\I[@Q_02WOUQV"/+"_>GNO[Z/)NM %OYNF-YU:U_"K^&GL K*%&G(F4S4L
MFR\7NU8QFXV]3"T/VUJA<M)>YB'UF6^1IX,*"))]Z7>[G;!>,I*9-U,*'N@M
M^#S8O2FK-U..=R8,F>@QDP!10MXWNRH*_VJ-B%827,DPNJX1\,^Z:+=^Y"I6
M "=LG#=7:+-40X=>O%3C<L-L[&4^7H$%\8BG7T -HP^P( ZP0Y:.8D>CS7N]
M_2?H5Q*J3O+H]WU%S2=^BX?(MT+NC=^;$M?$?X9%B["1^,<=*!8A2QMR\N<4
M)4I.+Q3K'J[N-'O9H!YQIP6Y,8GG1TDZBBGWE(VJ3NJ&C]U*;A945;(:M3F]
MYH;\\.3G<!2O C]Z1 VR ].M2)/$,I(U"<S09?RZM<I"[^?N].=>;JM6U-JE
M_G:[IO0WO841D<J%;!6!M\J 0,SM&]K\$]"K_Y9\KR7=JW@Y'=^G]D/ P>OQ
M.V\)*A]D6RZ\&W46J=&G\KSKI ;(0TEFF'8K4=>[8WKMZ$<ZA\N#BFTR3<*C
MYN(EY=_\.W?@;W'"BVJ)N8@TS N(:9*_4/,(TX61Y<7N$M/X*O$#5EH#&1^F
M2_;KZ4[ZJ.MON5/+F!4@:TK4L$EW1).?@XG D)E^UUVKDYE/A2MN1B3[;)UQ
M6)X]=R3 HB=^RQ44&HX@.ZD>)])WJ@+1 7,-#2JG^>8)]XD_!]LC<V75+../
M+G69@^0MEO%V6Y(,G[1@*"@^1XE2,%1?JB[U2\605N/L%@#_9N'&S*_.MDDO
M]-F8A!7K,I(J&J/I>UD0DB[6+9UW7S=63??>$$,W.%>VTME;:GG$!*W,W\Z
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ME7\H^IX6%C4V*9<CGB1\R/'>]7F)!\*WKGX]&O4N+/950YC<<9B@HXE? N)
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ML8[<^S?7J]BJ_@P?5'2>97M7RXBHW\D9^6-H/&GQK-GD0Z\7+4C 7__(O!Z
MTG/1)F*V'0T@6@)/\;/OU%$5TAN!^%0>HBK<)BY<GCN*;?K.$6R<A;F'3;)
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M%9$9O"J'X\\ B2FEZE)QLLT(Y!G@1L "O2F'+2:P72&]DZB*7*^OY,/$A7U
M-(X%#PL>+"O>(=GHBYX!RO4N.?[:FLP3$+"+8T\QGE-D%<Q_W_X/JQ1)QZ5B
M9#M UR "GN=>9ALZH\#77.BQX$^K&^Y#46#W<L!#<U-P88:\F7])]4M^Z59
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MLAW-C]=Z%!O_/9$W\AZ2&G(@5Y+"FLN_A_WY9=PPHC9 !&2E<C@F"(O1(#!
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M-OVW.JY_%6X@FVTJ;51_ OEJ8J=ND/$KIHE",+_P4W[TJR11@YKFRVHLHCT
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M<E;Z?P>-IHLT*$VI9#:@2Q>>N#O4VS 6N!;<\NU;Y[.STJ_^)N(!NIDJ?]F
M_S]BZA#M!?$]97X$>3#5N]*_1*:Q ?;D#;AJ2.9A6\LZ(^7<?G+.O1,ZG9JC
M]VTJ;F&[])MR5=;&]!BY\X$VV<ZA\$<Z+]WTAVZW(OU ):$,&/G^L)>S4Q!,
M@'&<$MR&_S(7#:9\ !POY^^UYDXYE58$F4PZ,"$@^J6!1.XN!PHN9CV(;\C]
MPM.TKM6Y3X5+*5)=E\0NJU[;L.A62'EK!&W!"V+=^]WK'6("TX\RW&EV%9T?
MO;^J9:.3VJ]5&33TH%4]^WF^I9G.5[\<]-+<7>[B&+,0#8Z?M8CH=*"VQL7K
M79MNLE)_\F&HZA.@^&_]#<!VT7Y-P-5/8B!/:5U3/28KREF<H&)IXS8=M>>(
MA+35M.\:<DH@;HW&433C"J(5?6.3#7BK@F2^0S^K,:?F4YYVE("Z6QAJ/L6S
M8;FBFQ7Y;QM$>;]>>2^+[8$8P%Y1.-3AEYZ6AXH'ES+D:%$U813)/O=_8S5M
MA/6:?.5Q(<.5AV*' Y"WFLE)N^B9";Q;!MV H3X!52GCRELQ@7_!'>UVG;LD
MN6CXQ^_^C"UO2/&ZM(DE9EP7G8_SI-7[)3@FC-NY--6/07-FT9WAQ7G,SR!P
M.@]K-$1$PJBW=#.QW?7+JV<,4,D7G]]"-QO@>&MC[J/IGMK:VT!^6.?-U/2$
M1I+>0GH70HBA4C]9>A*[VIKW@TI/#[ERZY3=KK*DM.6Q._M#G!&"G D-H1;3
MVHA@P1A=3*]?$%)<]7R^Y7:SSZ7J>N.*F.9<GR>IML!W"]>D%C$1%"(UA99/
MP1#<6O!#FS/@OFL>]U*.0]Q46H:K*SLS[\$?/WAKLA?/E3+=2!Z\%/U\J=6"
M/N#,%/V\V;9UN2+E1<75RA=;3;FM<Z2IMJ!(D:&?!T1J=<93Y@=#^=9+@1!!
MU_KZ@C?\)EP2!#8 7XC;\H[B&$P4G0TP]ZKN< KZ@<87[)%IF8.;5M,DQFFU
MCF'DCI_4/VNA5[I?N:Y-<;W1&/:%=>JA%W\Q3K&8>ZR<42?M"%U-?"%)$<%4
MQ6%UD<]W)9!$A;TO140B&R#D%@KJU%UJ*?=N-CR/FB#)M42;-O _;0NROFV*
M=-SPC^:-RMY/Q8]B/?I%@$U6J?IA?F2(^U2[461)LA(#R&=!'1+[WG38I+<.
M&D72[0--GPCWVGV*$J6I<-S7D(;F! 9CEKVP-K>P-70,W:(^OK9D_[A\?>7;
MX#S# 1<,'\0M19J2O1;BJBB2A.HH)8I5#,10VG7SO56I[\;"'=D4^/SE3.T?
MUL<V;/E#-+?W$D#XSRJ5:WO3(#[#,[3\A>SLF#B]0BM+4X]XPR]"XHZ(-J[1
MB?_N/'"$4!E-1J\WUY;&9-[&EDZA"J]F4!-G7[Z).,;3R 9T)%$@T4"D>SI+
ME'&1C(MCZ-!5:/5$LX;Z%/F_%:T\H;TWP&FJ=R[<-%]6V S2M%7LJR_TE#Y=
M[]!LWARR)7LJ(9OG9G1AOL,+Y#S5;"!\9SU2AZ[+FG*38'Z**R^?=<2%0GK#
MK1@Q^J#*+TX+XIV>K*VX?=.S)P.RQ<4'.='RF<41O$Q+>:@;YM8DU(OH9R3B
MXL=G!KPV+:<4?"A!]49799WVOV,JR[!X0T5:/ 5$G2=#TFL->6GYA.%W.:=7
M\GKV<IH%N-86!ZU-Y2-"LRVAR&6=W\4&*F,@;\%HM) ^#]WX-R.8YO?9B39M
M5"\2GAN_(29'./SL:4S6@%)Z6PXWS5%(:216>ZI\=*,LWW>OP:$>?7L=N?(\
M[GSUOTEJU':R?3!R CG7V.80'E171^ZGDB"G0K?OD&'I*)'_%I;K:LS.3D3-
M<37TZQ6]VHC3DL(_D3U4D,FM^=>=;*.>4G1>1G22!03&'U2[28.3=3BA^@KD
MDM,=&FX1L=&4,V)R\)-1GD2%Q(*:1=\8RH6BNKO<U'X%@>*C=+;/W"@+3</Y
M[J_SQB19'SIQ0UFK\G3;$;F%%@XHJ3/RK\!^^V/8@!N9G^_;KHV_*/=S<"FO
M;' K:O*PSKZKZ2G1/IW\+\M9KZR=>=H(/I-++:!LIB*MN&D@.YKD HC?V\O*
M$4U0; >G-_@EX139 ,W*BW+*@'TV(.%A$1O@[*!.;F:9YL; U@4Y#/G9NC5I
M2%1QL+'% ZRUC7D)Y?>2.+64O9'=-&'T:5NA7W V_B[-@W*(<90 X@8#A:!@
MWKAO$X&O.A\-QF&=K(V?\MXX=^]UD65H%>@P1S#Y($E%>E:':?G?W<[3PH@Z
MCR(2 DEF\Z:RF9KB"F&IXMI<?W^IB\UE'MH&B3%T::7TRU&_YM5I"#SDN!%%
MI5M&T?H@+=]_5I//^LY31[)XPI\KO%6+SVU/2G2$X"&D9#*=F)O8%]/47"1*
MF6K5A_W&[GY+6B1+V";N"Z1^S-9SC!WYPY_ZR?)$TKM'/TDAM14'P6[Y09>R
MG9/:BW6V5+#*6-/PO4A$\3_H!XXY<]$("Y&POB(I\ARNV\_#9*+=8.%"7K==
MRS:7\^PYP'&-XU*+D=.P=FU$-1O@A<;>Z@>*M;M$EM#R\<T)AI(S+C.:/\-S
MJB?>+[W554P(RQD3Z+D,:;<:#-VAC-*4<ADQ*%XVX'<D>D<1O&&F@__ZO/WB
MIGS;G&(5@_Y,WK*X;](WV#YYQB_,9VL353YX$$^B$^ "-,2"6_R"-._"((P'
MUU_N:.3YXF)M4$5AR;V,WKI@X%M@>S<WXGH$XA6P4331\*(S+6>SUYT_*#TN
M..]FOYPU6$T)W/CP[P<[? KCT[& MDW>_0FJ*[DINR8*AY-$FJ\I;B :/Y1G
M#IH>@\:'O=% %/O]&/UDB-R+*_WBO"(1-+6[0\'.N-R>L-+_*2R;>D/UI]5U
MP(6ZJO65L>C[>Z7'VW8LL4PV(+A53>!?*[)J6">BKB"[ILITCP4/AB;7P#IO
MBSZ8O/B)9D>&]\+/J-:X#^5;US?GB&E@_L[RUZ3 (N_1'3ZSAD%-QZ+IMWTE
M:J,O)$<2@&(K9D_:?NV*_)D]XO?4N"NK,9M?W/9-=_1T^R>8?PNRK:)=ARR(
MWZ@@JAGV_CS/$A,HC;EK>C;FMI[M5E1P"MWA+4.5 NSA&Z4I[L6IH\[2'G=W
MLN2GGEUP207=?6Y])ZK_6O\+N2Q5:%U!QI[)X;8*0K'VMV\O_F']Z%@5TM;Z
M\\E>RX)W1)M\V[S[>\_FBEI)J\,(FA*\#W9J5<*BOWL?!5S%AL23@EQ\%BB!
M\UXSZHXWA_^:O+^9E6L@I[#GE?9M;W1F]K^)V(,6]HD2YP0J6GJGA-7O#^CF
M79%OESQ/^@$-JL';5,XDU"6@\56PK9OZ',GPX'<_..]+/]T-V[JX MM=$V6]
M4CD^6/#<EXQNG]Z,LD,P!!IUO2Q+ZIIMZO]:>39K3+!.'!2!2ED3,*P[TJV&
M[,$ZA59?%SE,IT-(^[CWQ5E>&7\IK ;Q^?# )93-?X<)H-88I%XH5%#KM::Y
MVA'+R9H-/.49BM,#.7#PA3,_;X0(K)^04UC4#P\Q%&$#WE6%-K"^\_VW^S<%
M8_%RT$E.MAM.O=3+$8H+Y<:78N^JUE 4FU?_HH>:NJN4)DL3TS5;(!#+VZ1M
MS*:!!]6-MLM)F<F?]ZPH"EU^$,)<;;[G$1=WW[+'N26,D@OTT'C D4Y_)(3J
MQ2P'$3XC&"_]V(#C. 8GAY)3W&O2-IN9Y22=*P*_MR:\#E!P+;=VAZ\T",MH
M3IW5\9@-^'44ZL3!^E$.R.WUJ],%.<WZ]&=RP*9">?Q^L_(V+D^9#7AY_DJ%
MT2/B<)27U^?93$M<N,DO8*,)R8H G!GLZ]6,;9W:99HD"PA:W-O3V$[M5^!M
M(2IDAA^)=M,J80,Z;_LWNEK_@-ZEZ2P@XB4$%JOX=:<6S%6O%\5&=XJ*+:ZK
M/M<^UG[>/67^_"^8/R01I=) <ZJ&VD\U?@":?T5^W0[Q"9 ]WO-13HCXW!Z
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MJ$ S>>Z/+BSA:8%)V=P?P..XQ;F;YT..NB@#?4 JSW5EWGT%;C9&NK,R^S_
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M8^DL/TYY]VCP\ENBG,,$$ #S&8V'-VJX6Q!\%ALQ^-2HN=+5>ZJB8WW5-W,
M;__QR=B]5_)_;JF\; :O[]#>5H$Z3($T)S;V,R20!AV55KD.WLABA_'1*O#H
M(E244DQ]38E#T)^$BO8V0,]C&IE>-V-F'6G^,.T'JU\0AO+)UPA?0YKG3.CQ
M<*NFT]0"#$=!9A#NM/(%];C6]-A=-:7W0'[?7*%;5Y/D;@LNZ?/:2N\#VPQ4
M^F#>5ONFW)U .K<Z*S[$;8[^$C;PA7&+#4 HL@$[T$"[ L,J(\4-'&P)L\D&
MQ"EGZR:+.[6L;.RX/J[9\UN>W$!Q,6S8@-@9<FXWZAKK)ZN/A4G\^]^5%C9
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MX1P;$%.T96[!!D#H6C--C;>"]<MQ<*WRH;U(VEX238_%"V$#9!V^X^C\5FQ
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M*V8#2F4QE07/ITZ'0#/9@'&G7>YNL6FK6):0R;U_6(./RMUG6025!1"6K^M
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M;".ZMM?61Z4,MQY7O]*G-P U;-'L97&5QCXN7HW&7S,6+*:Q!@N0N#L[I]P
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M O$"!B;N]"!X]9UA57+Y!47',_O4/E\.[-6>#S_^NW2!UR&@@&O)JVLGD0D
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M^U1OQM!YGH64VZ 4]7<>CW]XNA\Z.QGC%(DXS>C%U.^DQXC3SH_0KGZ"<9.
MJ?4OHM7A73>0#5^?L]#!T-Q1Y/<P".0_<=#7"T\M$*)P+;;0+)8&)QOK['8_
M-<6%#8=<.IZP=#>EIG/C.N!QA@Y*@*5BO%DJIFP-1S[3P02,E+9KD6=)?XJ
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M&CY$J6]VK9.+R:^MD',94?SCP'M*_DF]E1V5)2H'NI?Z9GJO;L6$AG/T@@5
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M&(H(R!!]-;PSYAC+BQEKH,3#D^]BWG8?3>8)I79,5-YX$99R*\/A>6BSQ.M
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M]\:;6%A?[_]-<2-KE1M6L\;\#(?/]'F+2P_(#SZ@8GQTHNE\0U8S*/+4" -
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MNO^OE"#^NL3(AVOJUC #XG :R(]O%L2*GR#M/KX"=9JF12QS#(88W# ;#-W
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M,T9R$7VXA-GC!0(OMZH@A6L'G \>ENA_"?W"+>2A^O?*B?>[)Y5*Z'6@)TR
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MND)T\("F'H/+HUJFTJV@1VLI"IA"N'KMV' [OHL<:7>=!D A790/[L>\%/H
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M/N.&EOF\XURA$EJH=4F):0P0TMJ=C4-ZJ;V;^GI%',R@R7K[55:8J='K;U<
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ME]!Q53' %L$K9/U7"Y'\X8A%21VAM\#K[-@%RY%8;)W TQ<N#!XQ5,#;7&*
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MOO3DH\P%+4*/<5N>[@$(OIFY=\^+5CN6\%,1A75VXQ)S!3&5JS$) ;NC4U2
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MQEC6M6!M-:O; Y+QAI?!4:9,,6]E<QP%0@IOT[!-47[58J6Y@1SIFA7U\-_
M20PI?9JCH>KVYRFEK4T/.XXF/0OT^"(]79XC*[%LS?X%+_BSSWQ.$V#'N<[F
MU$=6)8"="C;9+6B6&=D)GQ)<M(CRU1OB)BN.R M&3%4WS'046C\R7I2727Z?
MZ!$!_HP5E/=H&0@QM)[,EI!=24(N[Y[*,2@LV:D-&\RYH_?M[FNRF]/=,]*T
M&)=*[3*LJWOB6.?ZW.V\S)7&T+/^R+I.<<6LTLX$K^YR3>@129@R?D0K]'X-
M8##FH@WDL6N*S,_2_2_QQJ1];A$VUELM/WR.(G1/6&L*='V=>A1<*$&?1XL8
M1M;R=E#=-*3I_A?<?)'O.6]X.YI5WKB_Z]NY>#<ESR=>&E%$:\/3JF9%LBM>
ML4FTQ3"<QZYI@5]@J3M^WSRQN'+OI5DT7LS9*#V*[[56$'JZ7@V=PJ,>71\M
M,^W.?-[3YXI^G5!BOE1A\&MO.5L%,8-$DXR4#?1JK#ODO5E"M!1V<LJM*=-X
MA=W(9NW1?T_0]<YDTQ"'V,_OACGA13\<&F['7!,WYJS;$_G*M,:@V%G<)3IL
MU%#!YJ_?'&&A>=\AF"G7 1SP@N+4U.YQ&_Q6"0BXW[+\,GC\8.J5_]-4]W4Q
M9)J\_=3#]OHX;$DI]'I\EXX]XY.-MP35W'#[&LX[;;>XR0.?^V-&Z  ^]MH3
MO5^CGXE6):&_LQ1PUVF&I+@<B9Z$_3M^3#[CJ929*I35P=I$M%(!'YI9B4/?
M9CSL&"=0-;Y]P8B*9'AEW\7?B>).[?DY\[)[%Y6W]$6!534S*32BV/&7-S*:
ML=%TNSR@5G!%3$DM_H[9'UWV*$L7V'=@/^6S (^$"=V?UQ?L5%1!18E:N&)]
M#^,7Y<HM?P6NYUV_9]XMG:'N,2ZQPJTUTXN^*1?]U2B@9D'31P-$_+)@'Y;*
M/4&V1CY9YX'Y%Z/CPV05Y:HY=U4=B*9L6!O1-M34/@T].SP#Y0VO$!=[C\P^
M8J,F%[E+!)PIVS#O6_O;=?)+!C[Z'4K/G<S3%1.7$V N92/_D$[_Q[''WE0
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MMH<U[SV5QW3[(N]->)I?GDXX&KZH) @+]KP>_?MMM"G?)0W]E>)[GQQO-OI
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M5&U>%SG[GKAQM]%U 2Z[2=(=1H1Q^.]12YVH4Q_0:M%(#_G.D3PN:O;9O/C
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M((+;,OI;^D\PP.9ZQG8Q6AG3Q!=RAE<W73ZSYBX!P;1CN&VS>PQ9SG\8X7W
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M#/7H+A770_$BBYQ;GKC"]AV<>!N(I2_CWO"!,BE=+U4H;>I)OM-KB&/P1XO
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M6UL_%)SCV[, IP@LNODDX5DBIA6(VHE5>?F++(9G: &S$..T,!Z07U-]R32
ML];'\VSU]PJ5 _&_SP>^4=FS86O1'+).UI%'2$,-UBD6KJE=AIQJCHV!;Z;T
MWU6@-K>&^ST#XNJXMDS4^_G%=^L61;9$%PU9 T<QS"KZGCC_5A[S4BQQU@5V
M[]T;3LNT<FV5SCTWKC/]C^#5 ?CC'/#EP '$;@)])Q&8P13F[1KWRW=,[R(;
MZBO@F1U>+[GUF-0L7!L#3YK/'0$?!/:A><D6^,P.&T0;B.D@[M,[I]U'GS4*
M4W7JF+G*15+/6M\=8)8Y#-/=Y:=; ;GOZ[:L(]O_<*'DQCLV;UR!>KB21'>H
MF^<9'B'?&CK$['E!+O)9]!8,"*0!/!N3<(;DJTS-4Z9I'6UQK*I?H$5MA4RW
MMR?L%S^F>#W>/Q<DPN\5IVLZ*E92-./R,[$LT,ESAP:XI*]E&9FC;[#[):U.
MKR*S!U6QX^J7N8?=F8*T*H#+#Z/5A(F)V-B<>1*&Y:@-IEI@7>]A7>08@_;X
M$WKJKJ87L-9OW)<$(EN>> M<G#H>3; @B! *NC$O25I3*L4)]? -^5N;F_VS
M_! &0C,-D/B"F$*G5<]I@,\E4,(I^H VCI/B47NBF9*O.)S!DV3JZG"M:CT'
MW@D;%1W/TS5I&$D?A#CP!HPK(<,15>U)V3Y5)KBJEOY3/HD+R>A<[4';MNQI
M'3ZI^Z7F)LT*[S1.R_S;VK]50F:@5._O1**OQ 7!S.9[+;#HZ"5S?U=ETU<;
M\IQOGU2\+6L<>';ZZW5#I3\J.]%H-QL6#7PN$@L,P3#+L40(".JE)!JE/ [I
M0LE<12TYQ"HX71 \_>_A-_?E1A=BUR(R\GAE2P&GUPIB4V%Z.0]!C6XM#B=W
M&PW/--_].5>&N-??@SXCA@ZH5JV3JG8<6\J[;95>Z#<WRVFV.YW?$=5F$*>J
M;4!&VO-+^#_OR3K:R8G[!9_/ ^Y"O!$$CG(:8""M(0^[$RZ(0VRN8#/>K2N]
MJ1R&B4)\[[C?7>.VJ["XKO5.?:'>ZK_7O&#4&'\ESJ.#1H/LH2P3IR]T"FT.
MCE^"'HA.']$ A!&O;LR4%)I,H@&F)U> 9= M>WO2TS6U&S4A+2D"?-6#)4(1
M"PE+UL(1@J^B^6Y@&S6[%V.5E!8QXL 6M<L#*NP.$GEA%:H*#U!I3U4^.R7'
M3PMU^M68 C@4^3)]BB.[*_*[O7-X[TYGR-J92*&>>ZAZHFK7B$ UZA"B%!U,
M SC.6@ZW"MP<.=C@[;W;5OPC3K?ZD^*DALR_CY]K1$1*^2RBZ!9*1(@5)H-?
M8'ZX$9FE-E <@"Z$=XH=4JO1U&#(@B3Q)@LY$0ZD 28\X?NZXV]XLC-Y&I17
MO[@TV.=W1.2=B_AA)NE;8W.LH;$=*?Z7"B*;XEF:6<Y9;=CRX)CS\!Q4O9%*
M5Q%=Z8LF\EIVHKL+7[;.J9.JC\+4&E5QPX0_Q)3%.(%5/^9BDI(/LGG*[<>[
MWX9%<W+]B8YY17&UO><9ZEB*WSW]<;^KFU]EB-Q74!WYWC)Z#MF%[N)'-X.F
M0J@<(ATL_##),159%9D2(E3Z88L121?3S'=&4,#$Y<CV5D=O"\ECE0;@5!.:
M)-\@.BV N#!MA*@ @=[MP/YE%QE%K-#ED."_9AXAXSFP')+M1-4?^)0>-JY#
M3\ZQHF;;XA'^C*#B[@0[\UQ>M\/&G' QE'C[397'HH0,=KQ9E<T=2G8M:EO^
M2G6QTNS9 Q*\[U=1RN7*?A:*J?4;0#V/BS&S.UP!+P>3X!"D9'T#SV# 84S_
M=S4&LB5BH:.)(M215AF9R19F]$GOAY/$3N:-#\^#.X>NJ9\1VU[[(Y2&8[D"
M;WID83:^4Q3( 1/%*[2)BU^\Y'T_\UM"!W. D;!T*=CK(B)/KI@48(MNQDQL
M;VC@B/[*(O*6-XXTMJTNG<XFG+.;@L\=(D6(]TAF1!H "V_>N4R$MB#*T%%W
M90N5;S?;6J9_3XDVY:A>: U^+=SX+O#PJ=50%F-?CJ,FWJ3,HBJS^,@*KU3X
M2LR8\%Y,=^AMG1<Z*4&OX=C5;JW__S1K^A=3P;EEC 5.8DCW^Y]5C:#@5YR#
M,D":0\71B=:P)H]JK'K7F9)MG_.-UD2/A;AP^%4:P'7G//%X<1X9T<@WJ?-2
M+;7(T!?B/F#0^"1'.,&B*L)TI<?6(R-29J@QEI(-=^H'!/;79L8>]Z6*A->[
MRKK5FJ?G36>G1"9<*?)&'&AO?G^;T.9CWM1J_CW+),V86!7I[3W^Z& 3D=/K
MN,"7;^H&9AYR[IYRJQAUKH5 -3JS3ZY0.3>RCQ1E$T-PRFV!#+A_(S]OCI9$
M?]P;^)@P)SCS[F&-(@-@?-+2H-P>Z4CP*\EXR[^,\#UM/3WSZ%U">S?W,^##
M"W)'6)(6S)VX@?>?3XD8-B+R<H;"+HTM6/4TO#-7,%\O*2K3+.-*=Q>T8ZVR
M/(83.$=R1T&O$0 ]&9EZ+P]U)KZ,_+=BM\GLZN3;;<9&S=T%D=$_M[(:UW8:
M:[FQ>+;DZR;OWD7IS[9/Y59.D3*A6 Q1]'QHB0^SS2,?&:,:_,>IHF/;="S_
MC?FYF3G?M^W+KYIOWD:HJ2WRY?]QX?/'_ %&!@H2&^8C//M9B5>-B+Z!*0E6
MET6>>CM%BN6SP?":?]A:[:"X ^27$_3%,12;A.=M?=,M/X9&/0Z>D^K)/N6]
M^72"0TEQ([3_ 1CVM*TYB;O6/;;2$@/)WJ>O(#3,LX"Z:S*H)&[E+X^B 3[L
M,1(A5,8D&D 0& HG *&44Y!MR_]MB(^3-"J)U]I[D JOL3B)ZM\*Z 'SPO];
MH49 XO\^]E*+6$$#M %[^3WI3[,@2].=W/,#EO^:_>PD+N+S'A'/X*@;[0+7
M42.2LCV^/S\L# MI?:V(06DSK][+1,M!R!)T &J/!9+.3-(!Z)>BN%@0SWO#
M(!#+=OW+!5Z;AWM/JM)N"TA(R_I&:4^;!FV'<&_LF2>A6N4H.VB;1G]N(Z_F
MMKFQN-E<&D"B/_VD)]A%T/]J">9\$H\(P)6WS8D,R8JKGFEGM5GW_CSY<&]R
M*GQTR3WR652">L^E>6 .'8/__Q;[W$_F!1]ZTQ<"_D<%60P?>0+' 8DBXZ,+
MP(J\+54'D@+&A]^3G]OS,JC5,J*\NA[2+_A,D]'M*S)Y&L>740.N&T\C'!-/
M)NK _$.AJ<<J? SB>]!U(T%^M;O]RH/C$-LW/(RY-S*47&;CK-B-AUI&\OF'
MH-M:C^E>XW9,VU**!9J9RDPL[Z!RH;QTZA]<,YF>AC7H)@7;WJ/LAHTP$N(F
MT83ON)2M>]CI0AJ Y8AP/^F#&7H(^G;%*KEO["S??3YY+C^^(!^DV5!%N@2+
M?N5PQ;3VG3L2=L^^HRJCM:[]3Y5.+##,#P9DI@'F?\V)#LEJCV'TQRJZ;M56
M!;UDS9Q3_B3,G!KO00.<.2Q)<PYU<S:.28MRPASY[X_WV"47E5Y3<NYVRA-.
MJ\S<JXP+  :0X[X'2@6.\1@VP6,$V'$&=;D=S/%%3GOKG&J"R8<]5C=C[!7O
M^3H$PNK=_Y!G3OLH B^B720<%H&MO0I:@XUL/@G#33QA:2_PF3_+--RZX\O/
M3R]]:6'_(^ 6^'(?":24ULOE$EL(BT3>K V.B(!<F\<\_:Z2HF)1$;P0YOG%
M^!F+N<C"L]>-'_Z\RV[Z G ?( Z:?=KRL&C1ZPA]_H!<7['Q[I_8Z#TY44WS
M:%_;V85T,")@'Q6'H/M[Z+1R,^(4J@=Z22,7X]/17O7@B25S@O1&W?9%7@8G
MM^Z"WH'%LSQ[_<PG D+?A\@Z=CDP,R)XP3#4&%PY#=EZ_#I!TLL=U]JDJ26&
MC-[[T/L6@3-HD&<)1W"H29'UQT;=R-J>UUW/],G<+-,=D@D"A5TW9BAC'9;;
M1VX%S*N*+#!LKBVFVYC/B>K'IJIE061#OHI\DH_G-[3;79RYQ[^^_ OK^])<
MI:^KP:NV,3.JD?JH:;Q-2?=+C8GKX_^ETNE TN6615=-Z_"/UFFLM D;,&K7
M>9_F<G_ 3]E81%^"-STARRT +T2D-*6A,#';DCGEY;C8J.N-F?:/S=E252JF
M\NY(L:?_4V']YHGXS1 E238C75\3,HK/3=172'MOHM1U3X@M9+6@2:LL<@],
MO"D9MM]/5(=!BRG!,QL,EA!0%5=3>A>KYMPSMQ_>;&\'$#F.OW%Y]_'Y!6$2
MM6Z8E9R_U'(3E(K*FN/R[/$F6M^U*G7$1YG**/&F4;$,U]]* WPZ7FG.WTDU
MGUHQ=?!I7PP:BK@>$2_3/L_%3.26.Z",+G'(>]C,]/)Q_/Z1K)/]XE?X>3TV
M'P"S!UB<_K_HD27R(/!RYIS\60W6QL&=8H?RC+"_T;M%!M])A9FJ83GNX K.
M5E=G$/$6,G3GX[ $ 96[EA8P0@.T#I;%+"$(K3YJ=90-T8?LOPJ^9'4??5$N
M=G6@OBG-?\KR?+CPKGWGBK_P?L,X]L?@QHE4:S@*R@IV0C"I<=#A?5)#"'L-
M>GA,>X'P^N*E(M.]X":/R/VXR17"7UQ*1_&KE1;HRP LD&?JDXPC3^V"YO0A
MN?+/;%7MYR(E9?>+)8D$?9Q $NZ0X(N3^)1XR;BX+P7ZR[J7BSO3-^NYL)=J
MG]495<"9[T@Z(9G_8?D>>%E-#L9/3/UQ8Y(8<W#U7$_++JJ[%<\^&XL6KP6:
MO;C_JLIT5>_*[TCERAID,6D:PM=7>4,16E(C;I6>/&7EA6S8HA.J !G2T\"!
M#9(L3*4,K^<(PL5+M.=P9+H^7IFL#-/A#=R1V(N3S#WO,58_WH:H<DGPJ77E
MQ2);6*[ C"K*JCG2/I7G7F3KGC-1%RL3ECY_1B6QXFV34!J=' ?GTP!=U6MP
MPCTK^&I4Y+'=_$YH!?(<60)7$O=S4NMEGM7:P 5L^(O7W^]TC$8()_@*)T R
MHYTTXRJ_N8T4NR)_PC_5>6,T2NH+=6NS#*SSVP]1!\L0PY8 V6DK1"8-4 7M
MB&/W"5D A^Q;]7^R[(MQPB+8=.YF^+ZSGT3*OA,4T'S!QW>7D;Y8SQ37$$B0
M V)*IAW#K:*?[Y0I0I1!DN4K4.6D)Y:?BH:_K@2L-YH<)0]>PD:YZS1G*H^?
M('LM]-*/P'X, 9A( VA96LR@D"IJ.?K5SC.U#:-)U(#*>Z;K*J^G\G-^$JQL
M+>%-F*<M@6S483"NHE&)_)!(-Y@7, 0'\HTG/90< @V@L/4LT>$8+>'E1UDN
M02QV;#%@62:GFR$E/B7K#U;NQ?8;HHP.%=Z=2OB5_2'H7K+PJ?A^06 J^C7R
M2 TZQ4FM!5&_1'838_(>X/VIC*Y8S&5BQ+FQ,&RODIO$IMMYNZ2Q,^X7GK:\
MT30)>.2CPMAW3<C$U*[,W22ERR;ISI.U]OHJ9[=[1UTWX?5S8#K,*<]MX:A"
MDB_@O>+G4R^(+USNZ[:SV_W-<EK3(Y[N<OT/D$6-/+ GN)6V'88)(J*Y-M+9
M[_&$\FLCL_BP.:VGW;]5'U ?\6!&]GOT(?JUPSM;/^M+:V-^9,Z]OI0@=$F:
M_O;YQA-!8+^*3 ;B&KX'VQM=+!+VOO=!;D5TJ7UXATK\V^VG+T30R:)M)DCN
M7UI);380_QP(9H<OQXKEME)_FK27GV5O'L0J-PVSH_JT'5R%"%7C(;_"HX/K
M;7(;DQRP/8K;+T9^U.S]&['W# \7JIJ0FOBR5Q]]7>1,?-,&"&>BK]?L/9:2
M>9/(N]#/XO-PW>CSAL5?O$JDYH-G<^R:+AX5>L0QEA"R0@XQBLJ8NOBTP(EP
M'#8AV]: XF0-8S7X;1GZ^0S=Y,P31(32CA4((T/%GO!)Z,(=;_>B'HZOXQ>K
MSU1J3]IP^0>?4]AT',X2?;AMK+]Q2*8!3L$KS/,MI1!BT6F6(H.!P+C4#0%.
M_-V,14GFM;3MN'=5:;8Y4/Y15/-[GUD-T0XW%HTAE/C*SL2-92ODI.2?R^*I
MW"^JHSDV"SUOG\$!&/?C8@-OU^$,FQ!\D*G G2JG*;G9WAKCA+([3TRI# RX
M$FLSN8?%NF_'DU"'_%_OQ[%J9N@X+J4L^,2U]4\O:N# L24J5^>A%]9I@&NP
MY\Y_4^3][CXR+J,L,><+R4@&_%)7<1 ,0ER$0V.8V@44*W$6<2I"1; [>)MI
M,<LIR(-HDW*^&YRO8Y*^XA0$GT:[=0$6Z$=#BLR:NP8"Y.)-?NJ7^(085T/J
MVH]R)J]^T>[Q_',]7:!$GV[0O><#))]1$%J1-S]<M1J ;DWUX35O,MT)5HA6
ML.;[U%%PQF;H1*4S[#]5.NM<*LN@^2N:N3=0W*]^B NG&U<F6_@U; ^M'0K$
MD>Q@)N.-/&3QABB-DX+ ET66LY,V.KE'Z>]7_PIS_YN\2OY^==QQL1B&I"/>
M0^+A(LLEHF%+X[G?1+T22"9_XUB& SZT-'TS^:>FT;]2MZY=3Z7/@>P'N7$+
M41C>P/;2C:E$;KG+&DT2;]\*>?KR_-V&MBY1Y5: N">@([EI..F2+5PV[[%F
M]-MK*[S5NY@ 3P@.LVP@E%F/&[VN9FLO[E@Q".J QA_DP*;Q5H09W'@3//8J
MD;/-#_)L36KMS-/[Z]:IW-]"*L]5L2XE3P=Y'RZ=Z@VX"3Y+UL914Q>@1#&M
MCW=0$*8 W;^./0J3VUEL6@T2V_Q<^?-)]F?]/UC[.+_-?YKL;PG^:*6,3Q+1
M3%%1J(=S"[N=;/3+%IK:!S6-YWP:64YK=W<MB#?CPF+"6T*EOO9Y_-G['0!9
M1X:"V%64\5E_CN&19$D?M_W"/^I[G"Z?JQ4=E\!83U4M@X]L%T2R1RL*]3WT
MZH:16XMUI741WS/GS&82A$YS:V]?D,-AR%?/.[T/T%N4#+T>GSTDF_%&R+7/
MXF9>3+A:SLNX7?:R&+&1E9[_E.>L-: !_*2^%!H5&F;"N@WZ]9Y/HJ"U4YE5
M^#C"_$ @O\_83I, %RX7C>=L'T/@\=FK8R4<5X/<^TN_?I,"W9!:21 _@X5N
M'3%$J D[S3'0*>2.)=&J>#VV= +N7%>FN^D>27UM+.VF:*:L+3P?;QYX-W#*
MEIWHA >:XE*"R"P!>,X%OJ+"7U:K[B[G'QG5V2>QSFD^_O/'G&G@\X,S2]!I
MK06M=D-NI\;+XXV",+E2W*U4^WS.H9($F_'<AS^B79Z$!C6?7Y;[IS54*_75
M9^Q_R7/^0^?W1[<:I*CD]VV#[#4W#!+\IOO-W#JFT)55[5!6\EVBIW_>:B9@
M%&8%*7;R'K!9KQ1P2,Q&)G/VIKL8W N3V&,'7E^I/DHDR%#R5/SG@1\;N7')
M<3B%UL"[@X\WZ2C^XLTH:R87'65.D$0ALJLZ9(\^M 9V#1QBXX8[ ,-C_:K"
MH!?)+YSW@,1;-  YS>$3:&.=1 /HOB["#7V4.O#%^BMB+$K**F=C[MW+-T=Q
M&L#R\ZT>Y\8W4OKR""&4/#CVD<\B=CP,CN4YR81^;"1M@IU(\$EJ%VDBT0LC
M>D@#%/>=]!E0\=<L+7KN ]>M'SD0_U7TGJ28YA^5.B'VF">Z_)XJX'3CB;!L
M"+SK+24#OJE$=\?RJ"&Z93!6L8%C=R:GAO7+G82B+,>N5]0Z[LJP9?54(!X.
MYOU[)B;V_G8U^>D7.F7=6DJ9)688E(<ZSV NW<AHU$<WMMEH41G%/9#K*2%8
M1!.:G:PYL+ETK[=P2KA4*W[63/#+(E_,/\-?)U6(Y?U;<ECHE(P6.D4K<D-G
MK***U=GR5O:/NZ[/EAP Y&YM(;7OP:<6&IUQ+%N>>$XL?;;[4.954)E#M,1^
MQOU1P:IG^A/F1FHT  =?LM(K_P1#OV(2:,-6#=^Q54M5:2 ^6)#\-*56^K/'
MOH")I-/*IAW);>]D>R'%XUK,VVC\R')=3FA8@X"5< 9"NC%MO9Y<J=)I]V9&
M>,5KRD"EI/O8<6NX=]T_CVZ$Q=6)(OB>)SC)B/V#TL&2BI316_BKLXB9>5WS
MZX#HE#NO&*4F;W:P_VL4HL\QWME2OW9C#'ZFW@H4-/DE+P(:-=6^:G#FUZZ
M3":F867J-\@1RKR628>ZP0DPL6&Y] MRJO=M[LHGC*V=:?^G-K)18WCVO)FB
MRENP(UE_R%4.^:E1=!@IJ%.T+5OX-3OB"[O8JY?1%M<:8ABO%-_VD$=8N6 6
MARLS#!^('>#E;C?#\A6G]1I>H9DV,+9AJO15BSF&QE(O=.&!35,!F/"MJ69(
MG>NMFS?6G>PNI[L6<$4HB-J>\1@6C*9ZKX(J.F(%*>5DK<5.M<LG@B>M,FNG
MVPW/M[\AV1>]O"X 69AH5#/RC887\>WW#X%PNJ34-Y3T@PNS/<)J@C7/Z!#\
MPCWU5I;61.(X"#=.-4G"7Z7^@9-TA^KRA_/"VLWR(#D7Y=;L\_H(Z!G?W<*G
M["$Y%FF]72(K)33 K9* B_/@*0Z]_F#+E%9P>.#5$36NICP5M-.PW .AOM(?
MIYXQ1,K?[ %D045JD!?#J(Q*Q<Z#C:@?9 9\('+^_1N)A0M_TQ\YN_]]^&<P
M6,IGS__=XP!6TA,8+SP.?([\8+Y3TL*@ON'94F7UYZL\O;Q%X4"^K9ON;SL9
M%!7;8*/SAE.)[9@R=.A[Z'F8'=&LX)GCE%R]%P?U-FZWB)"@&21L'W8Q 2#"
M=EZ)%(2W_F*GBU0V/BPIYIW6@P:64.YZ6?R'+">LTCNI9"<@#950905\#A,@
MHG[ H+CS&72?RQS5.BSI?4YOP^/2KVZOLOB!^6#IG!3!^6^F0+[&FS9D(-%L
M@87[^2H"][DQ[D)- &@+_ ;#]8)O9X(XE5TUN^+J2+Z'7PD-%";*]]CB["DE
M/[[/N.UFH_0_\"K9OQ:\]L)03%V%-(:,4E&&+.PPK1_SKX=5C!3?+$_5[N^Y
MP0[Z4<(SMY3C.#4+TACX>83E[3Y<1ZOER> 4%E#(]IU0-0$\*B=O0FCTN[0<
M(F/YB$V\[#YTJNYWMZ:[S)JMSCP-,&VGAW?8TLHG"X!9*)G*3FX2K@<[53N<
M5YO3YT B/;Q^VC+UE,$.%5_X)@/^"EF1?F@L6BSW?]P-%%A7\&8K_.8:9<>F
MEOE:F@; F"T:^;PA89%_0"$8?K<;T"TP43]OW%/GVLN8AI$/AB/2TT@*!?G\
MY5K F[?P,V6VY<0 %Y_=-O/CHIN$<9F4'%#<CA>%I0'NA(@SQY2'-4_'<1GF
MP%V[JZ2F'N11\C:I'G7O,:7X_[Q\4(RW6QS%-$,G5Z@<-G1VJD(:J2BO3G](
M\NJ76'$<S=JK+S\1YER!/K"]3'+7IG-]&1@3T<*E>;G?= 2-VDF6R1A;5Y_=
MWQV;I[*O8G!&_YA(PL364T$\?P&@C64Q;(QB@>E,<ED&>FMDQ/5$F'-61[=B
MD3/[)3Q=/^_0:D=9'!T[580HSTS!*S_&J=( X0<2#YO'"*!+:PGUPPC%7V(E
M\6S3&FS:!I$^[#B%31+I"7&EB0;@5;M+3-$FRB&)+2;X<^L] 5D3LG->GQ^5
MQ?/E2'Q+W&,_2E+2Z,A;Y=S,HA^@85P_]0\'XOB.12\-\#N,_*U_"T@#O(12
M:FM*CITSQ";"W\UUVQ"6(ZLV OIXYL90EU2.-J?C'M=%G03)2F>IHX%W1^I]
M26>)B:T\Z+"2>I%\\.14CUH4[%FO(\8EW,6U,TP1L)M5[(MI!DYK&.)8_O0#
M?#2:;"^-JXD2&SL>?4#N;YT6<=RL7KL3P?=10?4TWWMA ?%I.+3_2#:./I5Q
M<3!%_%-Q8$LCZV"]!$F:>,-5Q""XW=6D21)I'Q'H'S%=6.<I\ET@"" EGAG]
MX\"Y[.UPAA,-X+85B(E :8\0]K'<D![Q.M\.*U?XGRY*&LA5 DCX@+^;C]77
M:/&>NXA/SHP17U,8.DH?U&9FCQ2"FFB:?>;CBYY?'*/>A=GB.II8SLWZ9+71
M*>6KX9<W9$UM=F>T/2H5AXE?YTF B\( ?5C4HIYV!9PHUA'\NMSXC/-]&1W/
MWZ>6%2;OIHB,AP_O%M  E0&U9 -*62 C67&,"7CI=^RNOR^ST+?Z_H: W=]G
MZ2L)M'0[4>3\L9U?[#?59U$U^SWY1@ZCYZRA[S"JUI: HD+!0H[P)FVYFBTK
M6Q3Q\L(DF3&[!L]Q.'&#'WSZ#% @TTUU8VTG&,VG(H(_;"HEQC5;]'I ZKJK
M*S.\K"U[@IZ\RS5@9C'25GT@-Z/E=%:^$,)W+Z?L>\Q+LU.G/P1]?]].-VCL
M)/G)-AR"RLB.U_I3>[JXZA-T<VIC\QZ?UM4/E[H^3$,S;GR8D!=[R:,8Z_-0
MI5A$>">@"DT^G;V!K1%1VA.YR5$, ;]!SR,>_!\5"OFEM/9STP#-M43?!<-K
M 7$D#1+0D$[Q-S.A22N^CE9OR/PU[3(A<;K$\?]:TGL@N76/OG7W\$+4-A*&
MPC;:;\L:*O8N=DN>!L")2G;Q/W/JSO'[G3BH<Y,&"&JCNORC7J4.C2,X0 [*
M-$ DCW?PMNWQ[-V_ KSEM9#\$ELV]4>>X6S]L0"-\0:8S'S_E%T'![#2,$;%
MUQ4'!8_6/P[(CA(E YGT"3U<?RI/:[65P@*W[K>#QIC]'#: _U74'])/9:0!
MN@T;)6F "59T4JC?Y]#[BK6_C0<?VI#$D1DT0.>NF$&Q"S]CK)?;6\/'HW6@
M)/3?X[QY[U97Z$)>"PEZQ2>L*2TL"*7T)OG6H*?TLN.H%>,*S/B;U!(,G>%I
M*XI72Y]'7UZW))1[$%3%]:O\"PMCHJG6SM*]J <B *^S8\4OB8NM]SE#84*%
MZW,BU54H'*6XO&$_!5(K*<[UHB>D3JE]AF^%2PG)EIWHVO9<@*)8G<.M7+Y$
MH:,PH5\;98:>N,7YN&@5W^\/_\84:5W[_6C:+_Y?DP)PAUWMNT49M1>$$OF$
M=@I@,*H>*G:K<(7H><89#^Z$2ZM;*=J_/!SXW*+((/:.@1NW 9Y.;\M483 @
M\N*TS/#,,1!JS/E"G]RI7GG<E1MWVP!V@.X\_E#?_DV'(I]R*F_/ ANQY5$Y
M;CP<Q7_#R5-"Q. EP<<>XS(?K1RLK1SWU]=C.,=OXS*WYEOW?\X2A0WOM]'S
MX@*\;08R'Y,,7B_]W )ZV]+1:/!._@&P0W)J7(O(A+=KFKLVOK^Z.'@P[53B
MYKD&54&5FLZ.2=Y)E5;GDU+!75RH3VD]">EM;"@_]\1<)E_#OZF;?];5'[']
M,3EY\_M\;?S9B*IACY#U<R^HT_<Y$ O0::%YYJ2"R;9?3E4)'9?;BC9JE8QF
M+Q4RSQ_R;VS;:.A4U _>?=\EL4@Z6[GE,H8%&-[)-ZGS.Y'C1'MJ,3'NQLG
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MX6Z29V':^("PC_56W]?AS&2/Y=LA3_#\C:-[$^P7KV6?Y@LVA9J*>)W7:?-
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MO(G._G]&=CS\%2FV<@+D,6AW3U[2)&9+Y"!%W[7G??WV\5$F*POYFH?E:%8
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MIDVDT#3;0\%(=<F4P,+5C#7?0SEM>M:Q3RW3I;\<LKVC_W1UT\)JL<[,<(E
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M?F)TT;$M\IB:=#YHO$T@R0_P[=!9]F$F&#ZFG4D^/A\_^HFEA:M5/:3OL>S
M2+8AG/F:_5SJP:WV,S-]:@MG%RZV[B'+TDD6&V_U?DWL05JQ<\A<J2+)VQIZ
MW2-]=#*"(0:28:,Q)T,H;41)71W:#BDI4[:U9&6X0J(^[=!3HTOZ%MD=JC]6
MA[\8$%*_VO"4\L=S>%\40>G2)E1<IZ"H9ZY>2I#*ZR7I?VI<TF>COK4!]YX<
MIZ,;Y$NCW9D:]RI>I!(<0/0M%O>J\.'Q I"M$L2DV$MUS:4#<SU$M6L?( 5^
MTNIB@!VV-: EE19V/]\SRZH^5K7@FMDG</QLM==17>]EC#,[!^S-P)R":8R
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MO#8%LV?(":21LK5J6Q$=OU5@.G3K#5:!Q"MZ8.^,C34@],H=? WX*1%OZ<C
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M0M'_9*[XDR81<R42#[7OCZ#AXHQ/JG&/8 5Y%?(7U!8D@T4W;\HUO+V[,A
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MR^V;O=MWA)_F:4O]-M&8AOR#^ VJ=DJF&=$UP#PVD]GJIK7I&PUIF0--DP\
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M/-UX'GN*NHWDI49:DCDHN.7D4YGE&W4/>0-O$\TEQ?-T(ODIJG"M(\"ITB-
M(BM!B1$+I-VWGK*<^"@M=L^X&KF;HL]99SA[4' $*+B>&RW?KW4W6O;SR?\S
M_L_X_V-@_JW:6XGL%B7!&+'R1X#\G6-;W'$E+I-8VR'5K*VB"EJMB1T^%>Y!
M29 V5Y52[A^.\;%?_H9S[BR\O.@UUO!JV(+,MZR0DKX4#__'T8A?4GP*LM S
M2WH4%G($X @C0+YM3C9T$45]4/(#"?[X[!H"]C0"B!@[Q+9"SCH%J!.P81YP
M!<6,$\.>SVK>-W%OG'#V8>3,WMR%9=2S)H]AJD@2801P-/#$_!_,]0#$\,.Q
M/2W#LAI/M?Y_ FH%7/2M##Z<N5KYPSEBMU-^Z9CX11E%()>KBM6@<.\5+*\V
MQXYVK1VBZK*!=.%\\H?MCNKE8D.VY#1<?B8Q3_JAQ><I6-_KF9)5S^-#C0%6
MK-$$3UA7E^4]3XOS;:X+R=S61X6#7+9P0%OJSIR2!-V8/!ON2X6K:O%03KL5
M;=MPKWQ-2Y1W!;4'=%>,4S(9Q7 ('A;5(-,*#A?AQ]3,,ZQXO*0[]J_;=M[C
M]OK [FGE_=NOF"5"AN4+E=V9]L^ZKG)R.Y)_JPGT>07R+$"25)C,G?@N/U3Z
MYAG/?&=FD.X=2?:Q'Q <E!)(10&[%$3G#5HFRM#:ANYNUS:K8U9Y3O6P*%K4
M6\C]FKQ_+=_SE-ANNFQ/N8:5UZ+U)+011]FI\MM:<\N3'2PQ"TU7KNMH3D5#
M]VJ&L+![OW6U$<><6\TQ>P;N2("]QXKJ#L*>%'5[Z;[-;>WU?/W&M<<[E+]E
M*^7)'MJ?\7;#DWZ/)D0U!H\\L6^4+ZYAM_WBM=WTT/]6JFX[K_QONCL)14$Q
M"K0OE/ZEWVX8A)_.[W!5[L!CSS=4X\I;OUSONA;ASN^L%+OD$(2^JV-/\:4J
MS2NQ,[O\0%R^QMUT3@*E#A-&]!O2\Y).-O:1SRLQD#,99UWTB-T[Y>5;B"F]
MY>W5/)];.Y9^O$ZB[E/1*D< 7,EH:&K9YF+P[N8N76E;>Q,TX3,/VICU#0;]
M1(GBUF8$DOP:CD%0O?T76R@R5)/K%.K1("^@^ZFR$XJFP!P9!XHI-=W#0_@"
M?.G'1-#V3+&@\*7"A;C)!XG+'U@>\TO->W_HR]'.'8--6N/C?I 8.:EX2)1:
M(N<'Z'AR9Y7'2F,=F$7Y1/>U6)_1S&86BA$C2]N:-- ^HTB-(@.M:T?A(83<
MT^U^#AV>$L0._\<GV\.%3&ON L[U7;5[E%PNK:""?,$ <6[R+,42BN^:CELP
M17WKC&=?FO=I*QP!KEJ171EO!/\-G"G=M*-V4:(9.1CY%62U97HG-LS+_;"S
M4OK[),1M?SO_R:^$7E#(H*WPR068U>D[X@&'+!3D*$(.*L'3V$"MRW,7$7PO
M08QKSDFX0AV:??I83>K#RVEL7L[958<]WI+(_)'T1GZ!AFGUX27?(>^B]R7G
M]&C]J[MU<NO;.I>W^SGO#@7;%TO6UV2+7'V2P9+_7I_M>\[9BQ_NE('9X#JD
MKK>OU0:;=/ ,=;VACTEC?E8E8B_!9C^Y/J*"EIBZ<#DLM9LTL]^6Z1JMRG5V
MC?.:O]IA6DZ'K4M<V$4X=X<Z &%V_K;F/.O2+!$Y"6OQ@WYNPV^=#1C1Q]A1
MHPJCGDE^?BH2X'U[+^:33V9K*L@MT\R0$N081)R]%S0:DORPI68:ZKJ*_;WP
MLNEJ 1WX;Q^X +NNEE<&!7_7<3Y]Q:NU[M_Y9SD6.SOFKE[/_[C"I;K?7UEF
M0T4:-8[L:?WP4*'=SX3&E$:>$[N?)_TQYPW;00(%PDC1-IA# U^@^!%RZY4!
MZ03=_#B1L^=7/!+?<$;\/$UY\_$1O_5%5TTQ)>+HL?0.HPX3-)INS&UQ,*KP
M'=\[E ]$"LKK1Z[@/QI)94!>Y)R<XXB;^N1<D6OI*">VMFK;6TBD$X,5E\6O
M&L5"G^ID5?F;VC?S8I-AUG\+A$:0<U^00IZ;'.H"D!/T2_[-'.\?K:<;3^:T
MOPK^*O&;'C+!<17&IL=[S>MRN,6=-Y]? <3#X<IX$"_B+X*%M!@92=<BJ?_$
M6<44M5^JJ8[>O':9RYR1MW-AI'(AR7!A?!A8-?M>5XX:T[(_#A345BV@VK=?
MA0].VKG?E&^GS-CQ>UL%8CR7[NQ'LFEL.EW.?+18)-TMGCK\DE:W= 0XO6(B
MD)<R]55OI]>_9\AJ0GX7$C->,D2W@XY2K><O%"%_W78;CY@5/@+8+NC.Y%#1
M'T%SJ7D/C@ 1 :.<GR%$('&".3GL!R^N=9V$@4-&*<:RB4;?.,JNWUG1@RN5
M,7N!0DA7KJC,\1BLZWJ?EOD?W\@=Q2:9DE_%GQ<^H+3DOI?(0%D- ,2%9Y^N
M#\5]-4NNNV45HIB]MU<_&!-;7V(5C97T=_24AJ*-/4=H7S'LD:YT'6\8L:\1
M^QU),,46(MIOQ.YWH88QT"$,OSNR!AC/E'([5F[M]GWL/R6$AJ9SD%RKEUP]
M[\E90SV33*X;=J<O7N1^MZV*A0(GP(^H?24K3FHD_>H<(6HBGL"9NONNS">W
M=M'@\3FS,D/.4-WGI[B]%=,51;[[)+F7R'AZ^D*/ (YGRQ:C<P\N#YLH0(PG
MBF!41-&0+\F:?@$+HRLEX%AH\B!2_#&6<\FX'C8Q"I=[NV"-C1)_RSG_O4TG
MG(E1"MMZ#6&GVN&6E#V]"#'!'].>W[W>MPV^9-:FG2^G'S#YG]OTJL)DFBI<
M$\QE,Y5M;%:?3K1+R^_^-O7[MAA'=O'GQQR'.?FCG3?:6O-2DKVM#*&C6EAC
M][&%'K,.D\Q8$5-_SU*/S.];P>M#7?W8_QXCNT49C7O&2&5*G7GTT_W=ME84
M=YA3" D[AXQKTJ+YTPVH4<5N6%>2'[H@"ZI@3'RDGG5%01>BX/ +NY:_F,*5
M/N4ZCG7?.@,%\>B>")AL0P"KF'_&:D19.,O1F8F!"?4FZIIL&JPE_/&7C2R*
MI2COK//&R6IM^J8E[SUA9@\#*YB1/#2!E3$G*48L_4+!"ZMU_Z)9]SJK<6[#
M_6=QRQFVX,I3T3ORR(GD>?^-4>EA.B>Y/ >+OR?OD,!*S6#M 6M))A?)E'">
M#^@'JZY!SB XJ5A#1OQN0J1_9ES76[B3R@31CC(ZGV,L$[CP^)XDOZ:56.DS
MU]"S\]U$-,@S(=(JKXV"4P_7O63?KOVCZ9ZO-E1QYDWMZMRUG[X*HA>FZA E
MW;W\=A9+-;"0_ JF$^IMF[[VCVO:+UJM3>UA@BX[X^C"HA)F'[)&>KPK!L@?
M@+0AT7/XJ%'XFALO1.R3!M,/4FZY?F"I8/LT+]_KJDJ&;+CB(3C!]AD)LA?5
M=G[V/-5.UM>/.5HU=M&@/C@T;/]=37Z7>PO+-4VK^1*0,^(7MLHU"G-A;4:)
MW-4N_G36AKP5(VVKR.SZ;;4B5.GX%U#Y]"8 ]P4@O.Z@U)XP 2&XMJ)B[.K:
M!]Z(-'\RAUYS&84K%*?>5Q2K79IH/&M1J1!JFI*&^^O!%FYD\;7_1ETS_S*_
M=.D!J.7=ZEBI/F\J8P)T5:-98-IZT2>9FDI38HX= 02;9+SP*$&X"<D*G>MP
MRU"Z)*:[5_*,.49'Q^;QVS\C2))9N8P%:6MCE80V'%'4'19/W1# Q9)</9*E
MOSBV77SE=4EXCW]%0O@'HQ)Q&8I[=HM1] XAY$:INS'@Z^51XJLP\N)G]1.!
MP._GK^NO4 ?Z(+?A/E35/'@0%?HU .2@P"?X6%O0E*.Y>KW'* _#93K%JS5B
M4EW<P[E=G5_@-EG0Z%ZW6!Y3%!GG8IZ>H2XHVL. S3H"TQT5?1&"(D%45T.1
M^['N=X> W\\BEI._>4P2ZX3*C:CJ+3D7&-^PKB'2VJ+X;.4V"(^V.I36K'MX
MB#]1&R/#IC[ _@;4X!^^<AZ SL,^/P*<H]N2F.GE:T"!)G/7\C5<3:O#G<*_
M_VAGJ]Z=ZZP G *FRYTY8>9_XRF4;<0YT")VV%$+FX[8OW5]K\!M*%4M<W U
M=Q@SMJO[^O@8<[N:T'D$$!^,&'=\SFVQ!VQN*$=2Y7:XJ(^88L(+U%!M+MH3
MU:=09-56%W)B=KXNFNY*,C89@IM^#LBURIDW&I&)5XW+Z$WU#7S:/^Z*^W70
M]CBZBWI DZ7[4??FSC69SLN7ZMAW\3SD"P*'51N__UPY/.=,H[BFME9'LE G
MW^YGO6F66#1**?7)3Y>F%9;5'L!J:C2MJPM,FD^?F5RN>U[@CQWPW"I(J/]7
MR4J-&Q\!OOT#.92R[@:2C& '4@C5(T!EW+^M0RPIZA&O)Z[1I0O<]Q,WTN2%
M/F=JAT7PA#])['+81;^C"Y) E&1&"MR>$*>,-XG[3.UM.1R=Q3U)MO@1ISLP
M(G]3A7S]5?[5SCVM.R7O\N0^OG=4#+:O3<(<:^<:/5GSMH%4S$,BIK)VIC$;
M1N>',>\;1((VGL0< ?YY"+&"!%CU=H$XI$F4 J&T-HLA1->M;P,]9$^9-654
M*\:;48/@I!M1EVDZ5.7[PRI:(=:=CYPF'==J:]-?M;%IU/FFY!FML&V]/.,3
M!K%T2]NV7:GE?M H'3VCXOM+X_%GG@Z?@?2UBJR@'5"W?/8-[X "2P5-P=G?
MT\WPA%C0$TC40Q(6K]X!/!U0"%%<QV<31[;EL[$K[5KB]<0E@ZM'@-H8>RS)
M1.GLC&, 5P>2SS=?QH$\AE:=2*Q"71+_V1DL+ +[J?!JM@:UT4BVMZ&V$$*@
M>*=$\<V8^3@)!9"3<_ I"?.R8AMBDIZ,/!^\6%M0?)V(C,QAKZ+ZS#FRM!X&
M=.0D.G.FN I-5YY,TUT(!==79*8ZRYF5(Q&YAA5C5%1?/KU?SL)%I"<<):U^
M!15,ESL"3)L8/ZP&:3X>1"@%A%$VJ5@H::##3CU<VSPR4&8LU_J";=CYD03?
MIJFY]@"6MV/-, >J#,TM(%D/.^2K%.-TKF$835RHJ7];[GSR_K11PX+[S]A0
M U;5:>8PY'OD>[CK/%&=@&XM1X#8Z8;#B<X^FI.GUV0OOM2R.8,S^M!CF0Z8
M%Z[0YPRF3)(MG.]FM3EQDD)_:=>2+Z5=%==QD)MZ.,"HI)^VD)-+<>_4KHLV
MA8^MXAC"GU9O6:X9.5!2/B7'A 1I^8+1YM-' !?0NX;EGUMO&UC#M/6"79 E
MJUNO[!QUIO%L.TW1_-F6\2S^IOT&=YS"Y\$<]@'C+8>SD5L6.H4E+JJ?OD0@
M;+E+F+XR[\I\'95:#Q_FU!<;E$(%*)4=@4@^7;,I([XS'ZZ83'WZY-H,M<YZ
MGURN6:\U<Y@WWM9A6G2VQ6YZH _[Y@@@I(@18+8#A>'J2,U(!U+<7G_RR7W]
M!EV[Q\'&R\#66H0<' 2;Z,6#-KKFW^=>!^-%_UX:K3T">&^<JS@!V@HL/0*P
ME""N(;IF>?:V<!![9OM@7CH>$KW7IVXU!CN]V.#)PSN4<#7_/,(UA12I%2&_
MMH7+PCMV=8+?(!1(%2B/NEL%'<7IX/#L1ZKM'E)Q_C=.>%N_-&3)W)-Y'^MP
M0[1>HUYQJM(0C5(9N"SD;HSBA.K+&2G1S1J0BC8YY^9=@$+8N3S,^2%KS_[D
MN8=\:\DG>J(^P<SWIJ4KCP!OQH]M^/0U"+<AV7[.VVU_[- A+D2V$H-Q'!O;
MCX"&)-UG^X;#7M6TFI/@,MJ%_87-0=JY3E##NG1O4O,*%+,(<4^N;3P&ND=X
M>^)CKWH.:KW]4?8XU">E7WX<Z8Z>&#=@%.B*82-]12.&8<1%FE5VB7X6#O?J
M;#>$</>\L+?NY[>V#1]:QW*3E^)TB#/6+V?2Z=?<17QOO);O,4ZS5,/$#WZ'
MA&"6 @SH<K.3_LP8KM C .F\$M-JW)HFP^P_7D8^N@EY-I8I28VY.PZC/SQU
MUWJP-TSJ5_O6Z^W+E@<!!P::JJTK_L!:;)NH$%S5\S/5NHN2]OG>^>807^$/
MGX4<TGZ\_?MV^D/EYL,0( WD!N*KAG"L\=*MR>>S*J!U=<^7A%[_4--S%GZD
M_>&G[*L;J,86F26/I6S;'YTFB@(O<-)^*$+C^M],E7G-#D.3U5DKW,/ #9K[
M%)W.R&A2)Z^WSW+K*LJTSHJZ2?"-7![+J"GV?<^SF'GO&LW6W^ZW7ZB4N'7R
MG_'O 3L4+\8WW2M4\"/20!3F:H",^9^]TQ;U-=>O!?]\W+;T4,?F28K$V57'
MR,Z$"7#7C!"UT9_L,V=2YUE C:=?*'6S;E=H)FM,64NZS]R6A@#5?PN)E!?-
M('! GHK/PZH*ZJU #@\K/?>]]]J-&8XGA"WO:!](^;4BFVIRB[]V\B;(?3?<
MD7X]5-?G:T6+S1;4]XD]V/.LL-H8]C_0\=@JLL]&=AUK/UT XXTOBF-M_/K,
MBR"#\,^5/W*F*N-F;HCP%KR1\FJY>&&*C0HVJ*:6DFD4:.7P+J<\K&TK8JQ<
MIZ,Q[0@0U3S^:0@#H#$=7IK\"0#LI ,0F8AA"?9QW4N( 8PR:2SR14-.<_'J
MC%X3V^K9M(<]K]B_68I)E%-'E2:4\#-H4A?%EQ09WF10>"6C;*+EYHQME&2*
MO,JVNH*PBT<I2XL.5"0@WL;BZ\9BGT!S"-%SD>JHV[GWJFG/W<SZD6D2(F<I
M?64:XZ[BSNP[)AX58!R$=9>+QXV[S1FVH%!VZ $X79FIRD8"W#H]#_N:JK/>
MKZN-Z!:)C$-<:B.KX[&Q,B2N=K<G/(:O+_RNP5@*6:8&O^+CO5?"=C-2N,(5
M#_XY*X'HAU13&N"7OAP!7L!%R::"@H;B"SQ'@&?]_MQ6,HFVH;4&O\Z;_ESX
MS \E1(:"W)$ NM&XMBVIMST3&?^:T^K.55)%D]6-%W?#SPG8\LFR?/WU[@C
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MCCVSY5(S\!1<\?(TA05=A/-;1B<J_CX"S,\6A"#G[A2B0[6U51Z'W6<.U-&
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MCY_OSTT8&.DR1YE8F)A8^$ZPG>#[G[YHGP'NX\R1K#<9&:2 (]P,C-P,M Y
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M$)F<.)68+X^4PD'6'^+\NS'<$TM8KAW;AJ2G!DSS7=\-[OD=*6UED_Q+$</
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ML=O\\5[%,EI,5V+RUZ6?)_$<")GXI;R%"W!C"@&Y>"MFAY1W/'EJ0;#U*']
M(.CMR5A2FC&]RDABNSD1?NP-*'*'M,G7Z7N*.I6*?V;V^2_#T=;+OL]FK[#T
M P^=R]VB<Z2X MZ,H^<@6]JP$GYSMLM=U55!9!6J1SB=*MXF3C*A7N;!5(;*
M&2=_?6E\7UP,'^EHX.J:6AN#P2M0M3C$9V34'EPX0IGHTDKXV.%E^R*-1YX&
M6/NB5?MI ,.5[JUR_\ZILZ,1)Z'YMS"[J\NUIAX6;_L>^JLHK85' PR/@6D
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MDN^A3Z%]$;'.(L0!DB5TJ$N7:UCT-HY0,/I^=#TWF8>D?"\>9<1O=_=-],F
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MW!9R8 )\>!A2/ZNC,-J)8#J; W:59?7K._[=AW_WX=]]^'<?_G_4A\&>J8H
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MS@=FU"7IK37Q?CO"[K7@2 =V/N*HP",Z26"#$ZK-!/QG'[88K#31,N)OEL*
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MN1%>.<K-8?B(;:?VQ]G7^L?85J%HPRUAT:*2H/UR\4J/ J^*.;WCN\L%V,<
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M&OVH,PA<R\ZEH^V<]5@R.TORFN1^]T9^%7&<"9@*I/VGI?G!!#R"LLP".Q.
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MA(!_SHS;;JGUIR#FYBHV4) #LL$ R+*^G:VCP4+! ;SY*[?FOW="N:7"WE<
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MI^,_/U-*$M4DV6Z<44:+S&8UU#_.'GOG<]J[A4 V8^)M@O=>0-CDL(3F5[;
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M=*W@H-TC32?2R2ZG:3KX$/,V+=2/8DN2KB#EG/^69%+JQ"?A-G4)<GM"O#5
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MY  *R5["L.,N6&,7&=M2:L0!5G@YFAW;=,?\OQ3AV$SC@"2 US4PB)Y3TC$
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MJSN;6P,;C#7'7'E'%S855^'*7XU&3./:8(!G +:0RI2+-G4G*W\=$ZH577\
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MB-E?AXY?5>H%H;4+/UBN7>B35Q/3FK:295B8.2J<N(\5S6S]IALB@7NZL#9
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MEQ1K\Z\D:U&47FO+A@IHY@6 UA347UUXF/]U9Z.AC/8C](EJ,!L/%L4YMW7
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M<W1V^;;VUJ9LG,@)R0_+,3P=YFVBC:D4U-,-=F[L;>A*F1:N:L[:+NW[Q1Q
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MP@$38"XPIZ/9"4J(3K,K<X^E-V^.@8BC2QDM'^P6S&/-XQ$SKH8X_CON&8]
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M'BEW*'%XZI* MFK<.N)/GT*0UO;:>!T;PAVLD@RGFZ/Q#H/Z#M>>KWP3]&$
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M1V?S9/V,+CN_8U4ZMCN-6XN44+T(%=<BJB9R-G'Q9N['GUT=,'QDH-5XZ!F
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M?A-1_U+UX@LTDH/*/G4Q26M324"<8I%V,B >;VP=+BW0D?E8,'EL$*.&L10
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MQ#?1*@C4K'2"+;&X-?WUC7GF="\%?PO#1IC+JR>U+#J=6/A>LOC -(\OZ%'
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M+K58DB<HM=?[3>2G^=?D \16(_+QZ24''["DLX7(^7ZW%?+=7-<VTF^:1\+
M 1"O:3WQ>,-N5% Y]EBW;Q:DR3*)2X)52>9CRM5KYR)O 89F(:U.?C=:OS$
M9U63$0=7LI^L)NC5QLO4P6YN*K-]=#G EO9+'=[\;FYS(USIFY7[QT+4*&0.
M,X6,G3<VN_>YJ@4G%['KFT 'T_?-;RO&?$\%?V@9L?$RD($:OCQ\SOM=/@,
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M8(?D-\19'E8/.ID=5G+@ #2.E$)TR%+?4OG)KI\:TZ%&M_IJKF?>UKXK<&5
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M]LWXWN@<*F$ @N!/, V0MX(7R0/XKV7 D\:^Z:X;W:XBAL<?;W2V302A#:"
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MA'QL0JGAI98CY# IB]NHU*<D@RT!F\E"^BQFWQ@6,PXL;[@NZ5^+@IU!_J7
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M86.KX*DP^R<&$>T5BUN28C%0340SIE"59EH;U"PL7?J8)N0DX;QJ==C][#%
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M#T$[/MO+M\G"V+304G3B<9FR:Y/W0W*#6-11/M"W%]^<GSP\*G61E$!'UPK
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MBJ8!Z)%2/8F!%9M+3-!A5I_V])5WUHD.?JLR\*I$ ]V.N^F)U!@D$G:Q7D,
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MWU\]\"1AN$LEX.U>D^""ME:^GP]5;Q_JUY9:D3N(F(06S8=)#_UHF<8&KL[
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M^E_SI?].Z$%_)/0.C?/(5CR@PACU8*JA )DA [P3=0C1B D:R%=?B:0S-&(
M#A;S23IF +WG=>H_$0G*^DOHPJ_1#2U/XVDAM@P5#,7#OBH),%TQOR<B#_X]
M.=VK/T=&_-6!;&-.#&!HKP/03CK"!(V^Q0*/LP-O7.ID@IH LM:_OEV 6^,#
M[]I'3\[\I<I[R@MY^'_D.*[D$D2V)J*1V-<MC%#'><8!X,TK]".*D OSZ$C
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M*O\%K[U+VX??WBUQOKV$/R R&=PJ"OML*+54>1;M>1_LZR;5(,S=I\:=,K;
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M%]P(ES*E:"$M>:H/I Q[P68\"M(=/ I&'(8LK.Y8CM6?+V@N&'MM0&8GW=Q
M<0$*K,$KGE'-S01=*4.;H'_<%G0Q)CJOKRXC%Y_0?RK=O/ IGD8%%D+:)W1"
M[24O.<:1'F[D8\N6TA8#"<WBI]%,D #C\@09=9-B4K$N[&4"YO=ZL*[_Y,![
M[[>7&0=8)\"]5&XSHL?UHI6\Y_<PWB(^PMD9].KBK:(%AZ@?$)EF[314^69\
M!C)NO@?*5FW'!+$%A4S_Q 'V0K#LQ3[O'2@!_%EQ2Q&NYPH33V_,OQ5X.>5!
M1/AWLQ.'D0(4^RE,.!A_AE Y9J5;=6> R/%!K1+)@KC&.NZ+_:'!/Y]W-%DO
MV&_NX#;5@(XDB*Y<JI(Q-.@\*W<6$;E)C=1,"9&B<-"J_Q&GI4^BI0V*JO9J
M\3^R?0%:<^)E<*,!6ZBW+ATY]01*N_L$PF[5('9!=F'6,*RB69/O=#F&;%C+
MP01]4F;HZP.D@@U]KZ<0&DEZ[E""36KSL8R3(ZISG*LK9A3/5CU+8U"+79#U
M[G@,A4\!3>,$^#@D.P$6K%#S2$<?;%A4^YS?KC1)[)SZ[7Y7FXN$=?QZT!:.
MQZN]FPKYN5I,K>,I].Z7BZN:XVN]!V&O<>NO@38@6'JK114&')3 #Z/MV%;G
M;^R YD4N"A">W>JXW"7*H6_Q/%6W0M(!DCCAHB)KZ5*U.O]Y\1'?K?V<[>\D
ME15B3 U*,S6V1TCC.&!.U[B2_DMQPQM=K+N9V9"_9V9CW\U9_,=_DQFG&;)0
M@*EF@,5X:[L0$\ #0!J.$<L]N/ +7_W[UU5_M2HZP/;('>X2+BH;AA$:L9L:
M.0"@B&NOF""NI1Y/ /*C8F%W?@\^8/M3'CG,460;DH"A>X$WDFL,J]&-J TH
M30[X3%RT#+0Q.A*_/O,(O,6 4K0N3G:!@UX#LM.)";KY]M>K8K\V VO+W+F<
MWLNGQ+6UI;![;4,,*_73OWY'9\KPS*$(W<F[\2$3I@Q&TVYRK% "N#Y<M'%2
MG'@;Y>[J>T+E;D_,P:L+_/'P@!_M)SZ>7&#U(;/OD-R"T#I<1GN$'7._,JA9
MH3&8-:KH8N9<.7OQTMT(\='CL&V_"4QBE4902@777II\/XW5W>U_L?<>4$UO
MV[YPW!:L("HB-2H("@)*$5 @VP(("(B4T*/2N_26HJB@M&RI2HM2!80@O4>*
M($VDA@ZA=Y(0(*1^P7WVN;N<<_;Y[CGOOOO>NV.0,58R2/YSK37+;ZXUBPK*
MW5]FY+0:MV0X@$W)1<\"!HMCSQ0IX5*RD-.!/<SH( _"U9^\>"[FS6_?F:"\
MXE:_S%J;5<6_7E-6[UP$1 +_>!'P*S=CBES&N+4!VD'G.I^V"D%;9 IK>/O5
MHM<?CN=/U4KBD[,B9'UZW*P3SO/TM9D5''G5\UZ(A)8C<'^"<"RH 'O7WE7W
M)CB9F=BI1AFWQAE<W-4(DQ8?%/\>I\S:@$V.[Q4<(*+)TR:N*LEWC,2"8E6Y
M;;>ZKB#=I-K=_1SJ(W@C5%L<EJR^U K03G4I6> ."1@1E^Y&3GJ*S 3=VG_E
M2^NE@\>_L6\LU7*RB DB>?<XIR<8<PTVF%^2B,:^W4WZP!&$(-XA(;_'0%?D
MLW.U%-(D(<^;OJ6F&1G@_+U]0]W6['2\7S_,?9C[8-' ]:!'(<EUYY1A%'7E
M?\*^?Q/=Q9+$"=I-)N#^S%_#NW[W4>2DU*3-WXOO^OBG=U\_7 M[D><RG>)_
M[)35O37A<"[#'UN$4QZS;[#XLYY&MF("5/GJ(62EDIT<O2''DY<<X^2O^&K,
M#INK?6M](^1QZ71XI/H>$IK%X<$\9!:/W]!E&*(Q9'K *<,@![I+B\^,!GW+
M'M=8;>JTV"J%D7%:+;1#PC\!CU<+3(P_MSQ;3& +DU4^N&H!=TA[>J_W79EO
M>!V G6O@6,4>NZQ]M67XYD:W ^2A23^E:Y,P/DC"7HZ+ 9;ON-K4TB=.[F_>
MK=SAKTN[U%D'I!Q#$/-@3$#S4@G9B@KR8YL8W5B9>TH"+H<E#O3SC*_$'U_[
MT6/?N5>/Y[IKS'LXXZW$#!J[/>?B2AVO4+<3E=HK@T$'=%($4T.$ [+$&4;*
M[*SU2U!Y]E\31_X/XHY8GK>]U), ]14!?!,+8R4PT!_L*7*TCQJ>(B&R>KIB
M3;A&F_3(Z\4%]]2D?2(#YKK/9\<8Q+[1BPZK!%W$3"1C#LNB@Y@ _%W="$NV
M+DDIR>)D#HVX[B&7ZUUS7MPGFR7U##7F"D/IVNBO4H/BC'LHJBH3@$UB B@J
M0QAUQX66S@/!,66/((DR,0;N7).E]^@[L#OTYU27I/CF *CTU5/Y!^X9X,!E
MM(-OF( ##)9KII2/6'N^TU#BY]X?NJ2U[1E/)@#*,A!<ZC11BB^-R!*:6FZ6
MZ?Y+[PY0#V8NMI..Q] ,@7C4POAZZQR##&&(_=+^@Z4=F8 4,&BKG@D@&"#J
M$5F(3G$4%8<@Y_S<0.0X_1K#WYP)&#_$ A!Z_T/'OTS'D0ZM>V5=)&K8<,6M
M*]_.^ M4[:([33,!0+_NN6;!TW$4BZYA=(O;+B6U9,SQ7JPA(6S2EW;.]T"&
MP\Q4C\NP5[C.X6XXVVKD&(T"9L/1>;5]#8+[?"]:/[T8*O-1IH4)4%[:CH\@
M!^7#(B*UXJC?[I6B7!$SP,JM0!,4^M$F^' 9^_IARRA'"OTU$Y#(!#P966$<
MH2FJ7.P#%;NEBFH4NX8K)%S_ GF[B-@U5ANS\"E?YA9!,@2W(CFL^[&D/'1H
M[U!NB0=,8[M"F*A;8^'VPM3:L;UK1.Q]R\,<@" F ..$@PMF-)1SA426G/LP
M[CO<Y5Q+']S>=$_0E6VL1-_..ULEM0[3Q'"KG'< L4%WY_AE&3L/#XF<+3/:
MM2JB)*RUVDSD4=Z%;M9]H:+4QQ#Q:S,@2%8\<O66N*$OA,*ISK]/*\QY_#9@
ME^5GJA6\*X+0UJQEE:'94']51M9'*T726DEI69DBE1K.!'#FZV^ZD*^H7()>
M+RWK/6:#[PN[2$G_AO\L0VS,*E(\M<F'=&3$?2%2_ 4/&H^PUF2MQ<L2O5XX
M#^=(FLJQ._5E E_Y^9J4?!]%JLTRJX<E[KJHP7;38>1+QNF2?28W55/-VD/.
MUPC.L57,@(?=5S-K9_-UFIM,KR3:N3DX.,C5Y%4[G;C;S)N3>K[^/5\Y "#F
M]EO>@,39FCR_TW;\HJI.E61;*J,2E3Y#YO6'"\I>((UNP4R:R0B&#E\C9F,"
M1=E;$U#B%Q<V&6@,EU^BA F/W2IU#'VGMKS\% U:3B A?O?+R?A._$?(SYW?
MT1V,JZ"-510C*O(?"D'M)SQ2B$R?P"R/FDH$#"F9C0G$\ZD?.L\/)!\%OE8I
M^0Q5) 22I3Y?P3:6#9[:!HM=:PI("HC<3P'7DM,LNZKUWXXYQ%\:V?8]\'CX
M1(QK3L/L(OL1:(._T[F(WM)UR4&KAQ^4/R,NN3>9@$.*$OQK#XV&CTL3$_K0
MZICDH7EX0T/Y%]O7!^Z[\Y;G!GQ>V7+9 CHVG]7FU>!CB_AD8Z.X1_"9_E)3
M+3M-YSE423;Y1ZUSG^,YI0&>W ]:!*["+ELP ;\5-?2\,THV(^F^@]7[%;DR
MNS[HFVU7$)O2/A&_@,3/]*6T[;0_E5:T]<3_<PKJOXJ.\L':BWX!8VJ19BA)
M504;WW#.#;YL%+ZL6HX) +'\* 0+]TPN!1G3A,W"<U7EZ#,,.\T&L.-B(O7-
M4)>Y,^BDDK+[V6:NSC="_&)I31J4(WV>OWTH6%6,E)OOJ'_/4AOTI=5K3GO(
MW:GWSVG+]93Y[[-(_SWHB")KL2!\9R-H)XJ-(NVX<96@&PP_7]P#?3#E/Z,1
M:F$9\F/.@=WM,>N=Y6C5WS_0D#!RC@DX^P(1B68DOUF=0ZQU_^Q/_*6GZZ^H
M ?UZ*K"7.(%__!^_]*W]#;5_F._/O6]_LVYIOYWQ7SK'_FKED+]=]A__AY#_
MWX3T_>[:N-L1<J+81:0O7U*UT1U-%8^" 49;T.>^U8H[%- ,>JO5/=W<C\3.
ME)<9WN7I^>'2*98![U$9JUE:S[_0<<G87.>'B( <:<,TD<0AI2(P+'9HG&37
M9SV@I.JHD! S,?3(P;_J\Z!O /!6EWD)IM%%;)$KCBO%>,#&Q/ VB+P!^IUJ
MF'>/L>,Z7Y4)+=*1['#\9Q;-\,;_94+]+].A*#4XSKBU<I-1S_IRZA3+CSY!
MYIL,T^:NQQ9\C9:16R\G]G)&O+B&<B1!?H=.!.J8 .*9>D3(AEU5RDZ^;EGV
MG[(D>""%\[^ ;SU4A)F *"8 AZ#@$3/* 1E^F36381H,.;_ NP:O;QY)%+J@
M5Z60F 5:.?B':0$;QIO:$4LT#"G4KB8!P<&BR!++B!7Z<YQ1H'3\_QJ^^'?1
M@;Y(UF:9G?%&J;^8G:7?/-0?VP Y8>HP=IE034S_+(G>_=:09S<T*P7V&>KC
MQOJ><Q'-&T3J1?KN9DRQ=,EA!*DXT.*_C\'Y'E*@SO$?(05FO\<A7VO/^Z7V
MW".H!]F^%#$LK1VCQOR@1D;R4_]&R 3EYY")/YO@DXD_L;G_Q@D:?P^OEH$P
M 06PG<B&K-_/3_QSK4)!)3Z_Z*#J(T&M"S^Y&C;=<59V>GJ)"?#,8_# [RRP
M'B:(RJ$U0W<"L^W283\'9G?X@^LAW"8.\%T]$K:1/J\.5YQ_&VGCN;1F@?B=
M5,F'(*:U@I@ ],[18XSW+(9XJ1$1"4G\<PZE'&_[=['Q!^ I<H\V7B<.ZTN$
MSKUPZ:41R]X*IF2]S;?[C."51;,/EH?R9&%LZ+V' 3P;#SEV;V._,DX3N%@3
MD%-TV^ 9"GP)6HL1B%6_+T[\*CGEJ,AO>?R PR1PE$-^;@@D/[=I N0P:#=%
M0T8SR&T];9VKQ$59CK"K(<$;HY[WB@M+/7,ZYS3XAQ/MVML!IY%KJ-9*>R;
MX8@VHM]^,X*Q'(Z9LG1X1_98:SQRJ>0R4OB',2M.K,+*LI-&K<#B4M<#MW34
M%"1BQN_K)<H'1YNQKFY7;=,+N17RXO:,OLZ:I@=$*6=<Z(R^4<VPKHUKS8<
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M9^U'\D!^VAEV'X@VB.Y9RI+)=[M,XH'%ZL&37R*Q>J^IMQ[#T73QEMS/)ES
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M%<<QO)]!+R>"=!_8#K=86E%P:C0]]=5<TLW1^ZKN,@8R@PAY-V%+$]?G"!@
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M$;.=**\:02; O/PD!9:$C49XG+BH7M%\W6($L=L[%\:2&8/>V1!=+3,'R3V
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M[U#JO%A4$65DM340Y0$CZL[I-?/'RXB=+2[\,F!X5TOF^+> A T@:[/9O9@
M3L>$$=Z-8J1D4E?S)N+2^\-:P4?*HH.2D7D(R<F/%6@!VY]246+1CA?*6@3X
MQCJ-HJM*QC/#-L44H-SL]V>NY/<E!G@JWZ/F;\[[6[@XJ!S"EK3S"9Q=Q7%H
M[+DE2B?YT9T6:T3K*D^&/+5*'S(K7SC;>(@)&%=']9<ZK>$MN9P)_Q]S[QG6
MU-JMC<9E045!1$1J1$#$4!0$E1:5!0@($5!0$*(BO2.=D"Q!0;J @( 0$9!.
MI'="KP)2(YV$WA,@D)!V@FOM=Z^UWO?=>Y]SOG.^[\>\+I*9ZYF3.9]GC'$_
M8XS[KD"]YUYF@A;.>1=^FP%VC06Q/>DM%<?^??G<TU,.=N6E S$5T3H;9"F-
M%=.4&,J-)6<'!XT'5=6.*[](:&\ON- ?K@P:34S7@-NO>#C&9%$ZRDD@Z7IR
MG@;GO/NVP9R9-M$3$=RQ!#Y.!:6M75D<WJR@*[ZS!$.3A#<+/I\3+@_3.&-W
MQJY/[]9!/)<HU^ZY)VS<AP6?2%YJ0+B+DH&*)IPFIS:,'2'=^V*HGOS8?Z(@
MVM^1_ZLN+(%JPL0]/LA].=7,I[XC0 K5CQF'I-\E*C02-/S=$.=,R#[)B9W+
M5V)079?]^/;<\D=!RU?/^=RHTHVX<%S/]TM!)&^L\?N+.?HQ8?$/8-@9R"N%
MLH#Y)TNBI;Y"/2WGDEFJ& !N*@O2=NNB8<B=O.,*'T^I'[U0-UY@T H\L0WF
M%5:>*(_RCHS;G&(5FQD)&D9S]-;(9A@2-[U=T;-Q4V)5VYY$C45O)V[=LYF1
MX9@M2;H=JG,RC  \ K,?KI&=&YLL',KC#H^YOG$*4<0 ?%_ H]SPD<V2G*WO
M C(G#KP,*TV?DL@E>0K.7*AA;46RN/<>(\>T '=24FIHGR=TYX!KF7JD%[Z8
MDR?Z33JCF]?.O'4M>.W/GB5'(+&!>DFZ10V6SB_]*;*34Q-QY5"?-?.)YME*
M1W?(RCG-2QW$B"DY!N!$;]DB*D6)F["EWP^K=G"5'Y+4$/29UDTC7Y\)V###
M8GO/VIA)E%#4X[T%.E]MB6E + W:49,R*N)=LHL9@=DVQ-<E\53@PY=;]FT7
M6RU0NWTUB 1;]#2LVZ=EGQ6=B3)I 3];0(;^V@(R]0T\OH((A,8H?9,F+.VA
MOM7_)8BL3L36_2GME2\M +LU4',LDXS163!M9X^R#EIXMT>11F^A6,1:OM?C
MZ=R<P8EAPEK<3E30GG;VDGG6@^;YV&R]\-D%D'32-24=7+YBHX+)E*W!V\_\
M%]C,U.G+$?-U+PA,2Z:CVI882 XN_QI&Q_5!.NL6AFH9@,L]!*O04B"/+<HO
M2[MB.X(+>P&ZGL6\P>&VIJE GZ"(]:;?AJN>. 0[_G!G "R43;8%:.S3(PP
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M503?&UBF9,C*C)$V)[=VPXD'UR/KC9X#[@/.<6TG0-\,B=HF9/@B/'C15&8
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MLB?+U/<=.2KAW<*YGJ/=8O'SQR@7:7-C)3.;%$RBQO+CN"-!'$]G0AK1?I+
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MKR-5QVU,XAU\,FY?.2SZ1%->1IB%Q#DVN$L#D:=87G77W/J6(LPA9>PR0?N
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MGG'E5VDCSZ-4A=F?'Y5+@]Y@ !H4B*S=VCN2I,>2!,M8MR6A.Q.PDI0'D0P
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M5&F#GA;N<)(I*E:3<'C7>=?BJ0^%=\\.*]V<1;7Y$JK8QIHW)K9Q8*9'KY5
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M>"W1_R6,0D00UPVSMR8"&T3 E@C XO"/CZXPJ.W9DO0R? ^RAT=.*6'[X40
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MW\9/7W==PVU9G-]]93.RL+LD22Y%4A5D$(,NA<>CRR'=18[E.TBT#$&7"9-
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M?T7@M+Y@FIZ"IT;#@^VF>@;]&ZHK0ZM6-IPWRL/$913UK]V0+34:D=4FZ<5
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MTP6A&O- H_SK3'&AWS[$C%0^_YH7T#1TE30%LLQYUO=-<\7]LL8-U1UMLXT
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MPU?2CN])E7@P++@[=^4_NFWS@F1#JOZ1G@-<?4.%*^V;)D0;J"/VH#_O2_)
MVWZ.9\T/>R].ZX0!BV(Z^JLOV-!K%U1>1-/0L>B1D\\ 3F> JU[+"C[I5/!
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MQ9[Q)BX^=JG(YICA?9'A9J;Y;=>^,%?>2IXISIN=^P0!JM+F(.CBINRPX/C
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MY#U/7?;I?K9[^89X>2;%FYF-:!GX^?%:6E+TV<>._V6M._[W LM&*8E!%GU
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M/0U2O.B#I(<YP\.S!9.GVNR51@F:7N]?!%W/E[7+/4?E&W*OBK://[E7/N]
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ML#8MQHCDPDKBT@CA':T2^.SD\C7K5];O*D=WRBRL//I>GHNJT/_9GI0[B=H
M;XT2VON)<21Q3,)'7@N/0C;KLWM;4W6!7-TXH2+!4Z_9X\+?)8:#LX#XAW)'
M(+EX\$&/&8,L,\R[91TRDNJ:3&I&B."T>U*&U$35EOPSJ\@#GZV=&5V0$$6+
MFK(3HH'7:#\<V=@5L];)1T9^HZYDNE0?)7#*77YO%U/WR?;B2+,H49J!@!<4
MK0J206Y &A;]?A45XE6BZ[DZ>A E$:6X],*O_=D9'XE9WKT35Z).75I=@\WX
M$.M_4#_1>/00U'=*\(L;R9FRHH\2^W1W/UP?T=?3MC[/R2166:Z+ZUB$G6#
M-90V+B(<V64-B]E'1+9>&O]DN[ZNWO$"P1HZ$=,?8?/VO??Y2+$+=RZ'6YEY
M].4E-8W@]D<AV70 +'W4)+AZU,]ZRG_OZ-5+6)LN';  AS/3@)03$S11$NL]
M;<Z)-VK/DH*#;:+LI[>E).(Y"U2<S_79WI2J^W9:*$S[KZGT"BA?7+3<,L#,
M@/DNEN>(KX2_J<O]S:?\"R?0(P'%[Z8_7BWB(<!P=F06BC&>;VL3"_X(XFG5
M?#FOVC+<U=3VS4!I8+PXP_ C]E=J8/#UV-L7.8H0I<B%1-"N<X8E-4*.P9#/
MRJZ5=%<+-@[/U/;O0G842G%;SBE9T\@^.@ .WM76(!WAP3^S&68X+#^ ]><Q
MY'UUIAS3O*V;H5?.G9<E[M<^"6-R3S'YPZRIGB1_?%T[D%G1;1]^AN1CA.].
M5UQ9,7PD/_<\;EGZNVT1[2J/+FR*YRB&;$ ']+W0%F0@=#".$@>M&'L^<YP#
M0Q<AN1^!#XOEMCMVG^MPF_W7U7$)'-,V-*<A<B C(YEC>7!T0'4=I1_^UY)7
MEW3*D X3D$MY7; 9^+&GY/8L0Y!=S0 1#VF?VQF*;BBA\+\^6=O69KC5WH?#
M2%P=+2JI/N@__FZ-C(0M^831 8AJ1G]4!Z87DB-$*0RS-_+T0(DAY6;U]HHL
ML?ZXO45#(..JX,U"5;HROEARK4_SK'PHGNUR_3ZJ^;I4_N;MWU\K6%XSG]+J
M@DZB%OEPW_*L2.$TE@9,G)Q95?CC48@OC'UF=MI.5RS:]<O/\OC""%/FTR+G
ME!2/LN78OR&5X5X%V>UURK/([]H,!$6.4R[0 =]LL$PTUE+8D7P]. :.M]YA
MK?L D:4)D&1L0Z$!TZIRFOJ7PU@M1*,TZ_,^_[I#$RK2;BG!#9$<.=[!]_5"
M6!E>[Z"0#A L0S+3!ND %@ISL40N9BABGO-/S27:\DI6CLT=>:KPXYN4]?IB
M&:V/C[KF@,P,L2 !<@+SD&S,"4S=<!$&O1_'UWD2&\U;O\:FR?>(A1F49UDY
MW4MYW+ 4U_/--(3\KUX?6H=:BJ3P.M ,>]J!9"8D+86E1ORZ/8_.4ZF\M)1\
M*NRG9,IWGF5)/^P,>?@XE&!I3V#Z0.,FI9GC"Q(E6K#N=O)/%0>4+S-GKS[?
M19V.C9L<^J%TU$6^R*B:EB.I)1"+C )59[\K!Y/"-DT#</NAOH75@?^<<6E,
M.V/7=IT'H'$SKNU2SYI+#S!V6G*+C(?9$W8^GDYR.]:I["4&Z'/:/N@4,[D1
M7%59'NRB5;*7C*$#>B S#L39;+(]R=TGCZ*%OSM(')Z]]#5^]F;;S$J_4-6O
MA8L-N8\;AE@"2C$4M_J2)AN*.@T":?H%6O[-G95"HRH?00Z/X#JT80;A(=[-
M2Y&>8Z4H:AC59F&LH9:VVY:O[ VLN7GBA<;21+YK&YW/*$T_ JXVPVGG,@F"
MYBAM(<H=O"]N+$W +SS8W=]!*-;J]@T+\"T^R0^R[%OL6STMS@'A-.9%PE[7
M/!=*"1@+JH[(]2FPL7[DZY7G5N?OGUHE?>5%WH-AW2SU(X_]4@CI"N)X*!;^
MB)$E(3*O0%U/58AF==06Y- ^CX=;N\6T#;4/G8"5HW#W8Q-BM-6@P[0+U(P0
M8)%6UH?.VICB/,^[QKYJY[/]U&YU\$XI[_=SQ7Y?W !&(O&&R*G#-BAGI,%8
MLU"KS)C 1>%YQ/<YX]7!R>7/HM^[QA:?G?;J%54BK-1=70/A;60"?8UGN[R^
MMU]Q"P(J/'@2PW_@#3A$H(+ZHL'FL<<#M70 FS9X>;)Q@/J\(\^T;A$QB ))
MY5,_T\2A7<C:G4A?1!@42.#X2!/:Z%9!UKX3L'I6$\AB:_U(2L/@#OG7U.!.
MTUBQY!B#8,M@U40D'ME&$R&Y+&PV;"FA^9A%B-OC?4/"&3_N<%[L2[?]I$_C
M?DXQ/QCJ0DQ;8N _LVQT1D."L3/&;':;,J)696.F*9]UGZC=*#('W$ &Q*[&
M+J"6_^Y%KJ<>B0/CB8;]*Z.*<??N5+_SE<WO:J16/A?]\*OW,:8B<<Q;6L"7
M1X!C/B;9OJG5YLAFKW4EL5K<HG5 !]1KC];.2JG5_D'-9-0R!<2L#21Q&*9A
MV=\!XYK=-&5D*8=UG#'N@?RZ+Z+%G$Q+1GW".L,"3E_##\VL$OG^P)SAK-,A
MKTE7E';"$!2-0-9YJQD[@ZNZ(K>CO%@U%*38-TK??Y:>/1$F6&A,$@/%YNGX
M4@N5)BSXSRL&_M"CG9?AZ&;0ED$FCJ]#Q=_^)K5X^WJ(9C[O2JB/H2ONK.UI
M]I&-$VK>7UT:+JU4ET@]L"6$E&EG-\' Z2D\W V.#<GHH6-:M?8R-8&F <(!
MR9HDPQZ56SWLQ8&G[A1U76B7'3-R^%S4VUYA]]/OO QAE.A&_5)C/)U +"<@
MPR(J@G,##'&'_O-74P?ZJFLKYBB))PX-%3\H;Y^^P?H,UP6M_SL;Z<3^T!1J
MX0V49Y@"<2.<,DXVR3[6<NX^$RVQ=_+DV^N5X7$M_OYK,M@=DE@-M116C>K9
M5''BJU(PY(0WF\@Y<22\:H2^^/Z LZ<KOU!LKAG'=RA)XI=479@.WM,)*4>A
M(9W'R?:,' :F#6;TA,/OA/]$3IE^3+\R7KJSK3W%E9B@$*S!='FOID.N)B2<
MS!30U(FNY, 58T%30YW6N6B2OVE#DN"CSH\32SJK-K-7DW<#*YY;L9>:E4]3
MW1&]'+$C>M@$TG74>]Q^/N> 0Y&;NT]%U%%.#><OXP*NNAII>9CU^R"C]6/_
M(ZC?EMV3UC)3BPF6S?$W##]J9VS.J%<C="3[*MXS#9/P7H2MJ;YR/,2<OWXL
MO\H[6:L8)JWA*_I)_#7YA^Y=C[5.RV"R!JQ-&GJ!HH'7_A(2^%5O,>'2 $LO
MS#=4,V>:GU]W[5L4O^7+;)6;U_4E+POGKH!)4D]B,&C2M;1V87=S;?O83ZZC
M_&++)_6*^APU"3^74)L_U/B%HI^8/A$VJOR<0LG- :..YC=5<"G:B=%^>ZEE
M=$ :Y=;1'3(4VA8$VIK!S!C'P4\[M^+?MP*;/NQ4DX,;P%OD+]*V/[>[QB*=
M+.X^^#3[["3''+H"C#NA@I,E:Y#<N]-ZN:U'F2K'1=\_/S/VJ&:2O:T;=>K'
M:QD@C86_Y*DK'5"1T*4&(1Z9KK^8OMG#GVI@(MK3NF)&LHQE4+[ FYD2N2D]
MLWHX+#D0Z][@<7B>+4SPC>J!8")2:+2C3MPZ>5K*(%!Y"[5Y^$8_HU?.R<1U
MQ@OJ)D-E* R+4(P.M^FE_^R9WO^._Y0X0;JG$\K0).P,\_D]G0[X#*2MY]*$
M_>D <X96O :BCH);8*5'>A0:0Q$ZT0&_X%%T0$E#(>68\3N7YM+.;3G'(,]-
MY'$Q_.@.';"= <*@8 =FH-UP.F!.\3\<&GG<E $;0E R0"LA5_Y?2M4['OH,
M&]JAI((I'V'_<WD\QP/D\XSOI21)&AJYWXAM%OV/U7U*82/9,:0<&.,9M8#&
M@7 )6V@0566+II>^8BR&]/%Q$''6)@PJH'EV-1]]>>9S7LCM^7<? P.MC)$!
M7\.& TV-SXLW51O,.^^EJ-8T!LWY02KF_SY'2S_F7P%7'U(R7;H@9!XE,%4L
MM96'04TBC);%$2QI[<J@8VEKJDI.%LC;+&U/K'7U=3'YUVC";B_2I@28#,=;
M<1RI_EUJY& +M%_A?A ?+>U&VX[.IZZ#*,QH/'>:DJ5E8S0=\!-R-$MA?(:%
MP?J,H1Q410ZJ:C^XO-K$G,,O*7^JEY$AP4MJP>-"E"1RPB]D-' W8X"/UA[D
M0LMT0+0@/>!3GBAB)4G&'_.F/M*8P/:EG0[0;?TBG&C[/;&",-ACX:3*Q,\6
M]H3E<$-&6V=+],Z^/W+NR*I.!3?G-"43) -5 5UI98=.(07H@&?"9^48DOX2
ME'<CHR=BOV=7<>Y.GJOUN;VL1%N/ $]1_J/;SRP3FP#2'80J8CNIAPXXPS;,
MD WMH B![$1,UEU?.R/R;X7 M3SY4I0@KTQ I?R=%U9%_$LE4.2PI=P\3!#<
M3LN38R"(U;A[/C*"UHVLTH)O%>+O/<1[V^K!2@U%P1N'PR<Y@^L RK-[%>;F
M?*IB$OJG,RC[U!:/$'>R @UM#>XI ;,.E07XMO;XLW7(L%JZXCY4U^Y(AR^K
MF8LYPBY<5CZ'0$U+#9JF6$T8#<H=@]-FN<>>&STI\Q5W.9P] A-]2;BO#!;5
M1;I !-K* IZ0(,:-V:$G#Q_QT0&OGI6QJ/^N##19H.V)+B\4^(#9 X21KD"2
M.#CN@*R"]^WIE/O@O\<_CQUV)(O57S+H+$(0GU9\<$K4]Z@7?&N)F&R4TI(<
M,C;,@]O0 <9@N:0SI6J2Y75VLE19CCZD$*-<&TUW0G+'H3TW20X/MTSH"GI_
M]B*T?/K]1&:]<_2YG*-_3G54 (0X"UHZ:,RYY N;P"K/J!(2JL>U>''G0N</
M:JR^N'IH^<*R<-OE7UL\F:??5>CZ9)"3HHN4C':CQ]=A<E<=O^!X]ZUGAGY3
M8OX7MX30X%K4UB3H)>1M$/*]K',$RC[B_IAB3$S8?3??2ZH6HCF-5=]45=%?
MA"Q;3)YZ2^I-MN+0XVA\19T&<7[*SW#;@F+\"Q8&K'/I D]:MBLCST-O4B3'
MM_=;KF2CC<;$_&I353NXEDMCXW@ZGWV1$04P\3^/U2.@B.4D! ,O@OAFT/E6
M'LK5L5)-E>! [K3CLH[T84HM>YA!<TWTW"E S_6NVK<<CV'@:R5I.\(;FZ17
M+L"Y.=-1PNPN?,I](01<E?83QDPZX?GAH#O-LWM[W:?6)DHX[W-YX$S+),<S
MF=T7**Q_''+A"[ 6T@F[N D]!;<>]>V/(7E,8)VKHW>GW1,US>Z]%O45 S0(
M&LG_7(@'05P+I1Z8MS0&32$^UW$[\!A.*?GF'N7N^1#'2/Y8(.D:QU8D?@B+
M?%MM(#91RAE\B)]5.-JMEL=(QDM,M[[ZB+]Q]H^5Y\_!$TM_C72;-1PC]^X-
M[$3(0Q(8H8.-.SLH>\NZ\[KQ:]''42MWKNE&X;\*\?;V EQ.'3R(YFM<^9;G
MN..)OD4QB=2NC*ZA X1;C'OEIL.[0=66N'X\'#Q^F>3KA>_  ",\Q"=6ZL:7
M$CT/_#ZPEO\QL;[-=_W;8]US:GY7;A^?HIU;Q);(.A#-FH8QZ6S$!(1M?N=E
M2E_E=_U8O6_] -B4=LJA!_=ZC7&6CILX:?Z0PKDKD>.K)I1= ?N048>=.A)G
M7!_)84UWO![Q#]Z_QT.EPV=31+@RNAOC6:M@PXR;C0RS?!R2TU\=-N<OY.)V
M"C<TF4#\%4[\A7?YZ)N/1U*N6EHK'4_U.E!SB7,;PY%/58Y,%B4#NCGF-L'Z
MPV:&AV_F5+XWN??6^6].?L^FC.OD5AH/B#NMS_Z/QTS_<G/C0*43&0''5X"J
M8%@G*IP(4J!9!38=;M$!K@Z",&LL"),!VW!@) <@;0H\,&O7SC_OEH7J?G[-
MQRQ-%J[(^R<Z2$VR,91CPEMS3ZYM>7_-LMA-9L[:.%!E6.2*3C",HF!,?0@[
M$J4#9J[1 1%N=$!Q AT@!B,[A?@?AW?"]UGI@.11.F IP9_JW =;/:09RNUJ
MWHTFT@$D9_CQ/W3 KAX=4&M"!YQG_,L,2-.G XA]H#$1,3K@*YB2#6><#+BI
M;$8'@)"[3V&)6)[9$$8*24K/A<U J%SB?HQ,.@ ZN/6W! ;UE V="6'_NP51
MYT00DHB:I@TA#T&.4TW>\@?S7H=5HS7!_"JG5TD/AU@_ED567S'EA&0+B(O-
MC%C.5+0E8(4J:]EKI'TA4KH&P95SA9Z1Q<,Z/-0GT)L\I!FR+1W09]O,&/_/
MT6RPM=>66RG<]V811G6[&C/U,RUJHS0G2!?H#^,2G.8YNL)  :-I201\)*UM
MAP[(OXNT6<L'^M5((WMECM=0&\H[1J__'B#"2G8/81Y#NNY,97;.LPZ+Q\MZ
M.T9LMSD_*Q;[T_BKHD*3#?-@"<]Z,LAR-6VKB1Q 2B-RX?TITI 8,*OO+]DW
MY/3EROK[9*4^)N_?'\1/.)DN?TRT/2^B<EZ &IGS&<)LT+4NB]H\"IVOLWYP
M,;8NGN&[:D"*(1[D!Q1_:DNS1O#"WU4961$4YH6Y%\IU8\U.6#7^BSBKY\.7
M+IO/RI>*RC>P=0\GV[I0+D(>&S,SQF/70M:C5)3=K@=XJ_+UZM;($/=/#J*U
MX] $TLJU3*K&Z%%^7@K<?\:^_T=AT*=EB',&%0I!)N+Y*-P)Q.L$2-<C_SND
M-GS>+0(=$&EZ2RNNZ73V^E68//]7R?#KKXS[ IU^"A59[(5RT%BYL&# NLQ7
MRF.24G';8HQ5I^EUGYJW#<G"ULPO9)DU'=FH1H %RPU9GB]F8:^-YSR)6_/$
M UJC]=+8=+)UF;:]RS)3^TX8C!>T\ U<79M,",;V1!3B73KB+F+=V:2W)1-P
M%[IICGZ$ZV\5HW_[&]QZ7,K,.BDWCL0_WIF< $_W8^)B D)QN&8?#"HI5+9<
MT-'_5KV(1Y4*?GOZ@Q6>_[;J>?WCOFB?6*='IM&5UN6'.[#-O<;8?('XTJR9
MT;XY)&(7)-'*RV S?6T9:&^V< 4)1AC"6%2%2B3!':O&5_RJ&P)R!<VM&A7]
M :]/%RU>/K4'_&</>$E;X>_NQF'?[-U$6/' CGXD"T4K?MFEH:D^<7Y:C^FD
M369.=.9CX7;N,U7)>Y^:8 [7OL.:DU+,_9'N2- F01R*\QX9)8S^VH-/K2YD
M)Y,U*,)X]-LW@6Q=K<F06IL"NS(?C5N!3J*2@EG_+&J>9Q\G-9'5W&!\BL8)
M2"Z:>(A(I1W$!N^9KYAV#+#P'RLMK$]WC'.P=^Q)91_><SGC_82%NI938#M2
M7L$W+M%*A@IXC+M]%>?1&:Y- W]@<*__3O'1.P2L[05%K\0*&4&1Q>L]B<$J
M?BN;Z-Y8WC[33#UQ04SF>AYPX8BCQ0^&-T)/]G3/"Q*(%83%Q6LI(?YES'F5
MHXA;Q$P?M=]U7"<ZO>632BZ1HW^?8V)!?OMLWE:DHMBR:4U-GI]'HNX8J(FS
MDIN.9]SI '#Q+I#"[4"4:Z"6T(37#UOY7:\25B//)[EMOL9P$OE._:YUT902
M-T]).!'!?HI3&TQB=/,995(6^98KK_T9$@Y?\K1IK+J3+-M:(5.3U4DH[/LV
MOBAU:U'DI>IY@*I#*JCDLX67$9])D);UWBZ.&IAA4#S5^[(6"D8=5)#(!$,L
M7\\.25KW6P[)IAW&L=W,AN_C[_I]6(>X4IW8]C/5/?4^)XY)YOP#(P-)OQ/@
M,=!;Y-E]V%O@.8K*@BQ;AHVLR$R?>Z2M4F>IH:$,>]=<>L6,*LZ.RI/S\L+K
ML)HY="8-65:6:61JFCRCLTR%V=W]GS?Q^G?\._X=_YM$.9<EZ0 _U'&<-9CY
M/40'GYU9--T0'6PXX#TA]<)KW(Z_S53K7#E2;Z+Z[YK&?M.I*:$>Q>LH?;&P
MW4&G5/['^XZ^8C</SY:D6JS4OM_3:7UR<(/AI\7_'Q=WYADB56'Y/C0S"9D&
M9'8V@B(=TJ@V+U$$Z\AC_DO."2R4NWA$_&(B10GK >R4 J(]I&DR7Y%F@D+F
MWK4-27^R'>$R05EG_M=;(KP(0';/ TFP7.TRK-W+CCNC%\,$R^YBGB=XK7VM
MX)?\(90!F,EI&#I%T</7=98I&](!+ &1CQ@FVGBY]T:6=_*Y&?[I&>,^KT%V
MF=P"+'9K^%924K-=>_2UO/^?]E_X=_S?$I;9M#_9TN.:''B5'OO+PS=:NTK6
M&[4&QO-[4I,"O:]REM6TF85/ALG\*>FE ]PYCI1A46BBW#QL+==@2ZGAR-?A
M[WY=)+)[*$21IFSXRR'1#I<W<MW<Z?&=:P]^7CJI^NOR7AO/\3(>@55.(T P
MV^%8'/^AU<O:?O7R.ZZ9N=V3-/%G?:%CJ(6A<$V^T,7,@;M#1AWSUNN' F$=
M80]+6/C%S'M>1^-VZH0WMX$D\<(>]%:6ORG)LL06BS*1+7)=T<6XF%/W1:E+
M@C\/=+?'#^JWQ-5&H(-2#]37&F&&>)=.I\F-'Z4MI9FQ\!OEQ"!8!AGET,"0
M@I'04327]MD07?Q@VD(")QWPPFK>37<EH+7-PZO56 GEYQ3U:X']1%?0(86+
M#ECDBZ$I4_C&?'<$7C)\F76I^N^)*"^BZ[-.0^[K?*_T2\9GOKAD'(%H+,-T
M@+A_&Y)X&D(5.=A!XQ\@CE0>V="Z91*H%R'VONJO QV*L WE!YN$R0/I\:(J
MIT<&NU-NH=JLN,UBHAT/'HY+)/L%D(F!I%_S7/B51$S_G*H;WNZH,;^F,QGB
M/<5O\,=A6;@$#7) Q OLX)CQSG*\I.A1H\JQ;%JP&6^:4&)'C?("9FXP<#5C
MK[7,;)(,JZ(#SO:4'/39HS?0[K0S0Z]S6J]0:Y >.\+002#/=4TE3)ED!VJ"
M3\#6OTRBQ$,S*=)-S/1$O..E=O:IS8$@.F#+G'P[()(83S()Q<(XI]935? O
M*R=+@YZ8ZEV,<XAZ=]5 :+L_F[3>I111M/;?ROM)>),JNC&$I0/>P7X='LLL
MH&=.$?<8!F6+2LC9;!<1'J:H!!9TN4!>5V[XH3@?-8PE,3-:-AJ]W"H):S-%
MR-*$2-[H=H'0SZW*+3_B/>R)^N M/Z[$/;WSKSJ;7+Y4\0 2FGVB(]AK]'7S
M>$;]*'3 KZC%-;-B:9^4+^9T@-P>2'<-T8,^S? *AJV*)/_."W:;&35IT?L_
M%P='RZM)LAT2@<QBUV++XM]OGZI7VM?#G6! &32R#V=W2T6REN6.^0[<'='(
MS)R[*_]\-*9(0O9M@KSY((?&'6#7'P^S&YUF;N+!1.I#*>?ZE]\?-=D@UQL.
MQWE(APMHDI1_-Y)C<]C>7;TE(?H-;G%@%*&X=MFT84FF_6/?Y)K!,XUP< F(
MA2;*, C:(FO:<L-_YQ!L3/2KBUZPEE@CU)$?M'TF%Y<2+DG7NQ8/041M;SS7
MXY,\9P=2(%@2ZQGN/YV4PC#-30E4%B3#0SN@CY3H@ @X\4SDD0 EEEH.6EJ!
MBL,F/1?I@+L(2S#I6F0<!8A'MD//X<^4(2(]]CWD60UJ#(LL5E;<S'6).B'=
M44VJ9ZP2PQ-'6A(<-'7M=+^H5,/V4P-,.LTZG .B4T32TFB?H4@3\&?0V;\K
M2S)2;(@*EM65=ED0S+?&^>O,[XII'8] EFP5W1<L<?%-3P.[5>2LJ0_QZ(_[
MZ$L!,".48G!UZTC-.<Z5Z150DYCG"3-<VUH@#Q9[T_?UA,_4@1[R0X])UYS9
MW!OG%)Y=2]P[<N ZLFIN+\"FP\*"=IE0'*O9_[IGJ_9$A.7 ]!U_4:9GHN%)
M>@"*A@J%.WAQ;/I;$YC7NN,L%?W\T=4_[6>AVP^=&%@[.=1B#SQE<U$D8*WY
M5^>*XLW*I<RFK82I()DEN<DA(CZ<&#Z6\+[9W,$CAS3PPLUCJ5K,YB5+[O6+
M5DE))WIM/]U^<:Z;J1 Z"1,\0$\=+@STQ#1KN!7.;YB@;6;.U>@O)0F7ZTN>
M6_/I$9K@>7UP;>Q)08U?W<"4,+?7DY(1WZ_[!G6[EBYUPV X[ QLH: QH@P#
M$MZ$77PSP#M7[>[N/[)5K;\<83BUY *^EBZ>/&QT^^CV"Y^?",&_$R68%N%=
M'#$TX,A^BV?/W<KQ \/@:_M-C^297Y@GF1O9/W%C[O#V9\\J*>?W"!Q[LV^Q
M^0=;G($I'C6_,7?L"[*^EE.RH?ZA-KEP%FT_)%R65>VA.-K79JKXV%"!ZP^
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M]?O8/I?W@/TF054U8-;/Z=D3JNJO-L1GF/L.Z1I[ Q[8C8*RX _#^<C6EY+
M.#NOWKI$(4=%$]V?C0>",>4LGRRC%^($DDJV3 ^;1#Y7<.?JS=1M'QYH3^<@
M^2'(A5PP\,:.=4"S \3IHAKO'U>B\ZTMULZ!!!)/J E9!-9V7XXF%=#=_Y/!
M8!ZORFKL;A]9^U6\B!#+MO7B+C(XD?E%?L'EE.N@>VN@\]5;*\-'OIK3@:T"
M/DOC@2T)S25[P8M#%.Y<K&0'.!9Z U\>GD.RV#08WEFJ"G.?L4E+KWVFC*UC
MR=N>&]8)O4*&0$?FKU+3FWDP.'!'AE]:T>R&)<[MZD:4:$Y17.9ET6^#>F50
M#5)'%U^V"L&Y"BM\7[?NN&P)555Z^3V':-JSKTFW3Q.2C#0R2NM8<04;C^RE
M-U<+UUPR';3>\TA[CGJ 4I%E"6NB'4&QC3V1;YJ.4BS<2ZP*?6,O?$L_=4$^
MR!'5#<.;&;^;UR"5?27I6>#CL_P1TZZXUW49YM'IDK\SE1]4Q(,%^8W^Z,^J
M=GLMP1D)<"$7S=EL3N#XF<W<](<B)9(2"G/)-U!43KOJQ:7>;<7UVM)/(T54
MJV0=,I-+S"%8;O7FD(SVVH^A"; ;95Z:9G'V_([FYXITT3>>M!W%^V1$_Q/T
MSZN'XMPUR<NT%OXR37,A9][7R7XFA\B%T)X81FZ6IP$H]TC^V!VN@-PN@1O?
M,'$"F\:\MYZ^]%+DLAU8D8G<M3E_\LSSAK=#Z=V!/6OF(3#R>>BDMCRUH%D'
M6\+![9;!\U[=O%3AY[1.\W"50I,4V\K#HTNG"F2FZ0!7Y+1,![@*\BX>B8 T
M-6;%JD/33IRT:?#Z<A*Z\:[_UIJ6 6!0:SS+\;NLM85^:8U)8:3G9X1@[8R6
M130%2JBC</<L6D8IN<!UQO;I &:K;6V[_'@X6T__C,]@N<&AH-X/A DU"[90
M>'P<$-^O0RICRZ<E^U[MHB)= &'N%I*"RSI'PDS\T]SODO?>E-#Z.[WWGH+K
MP+N4AW1 [<UF2IW?C@=H" ]Z>.V[>NHW8BCOQO%<[F?QID>"+M[*W)\"-CAJ
MH&X49<8H+0Z8,2.L?'!;%)9I;X1\6&G4/Q#LEY'YIG@SFQ^EPO%K\]!XI+[H
M^<8+H5R.*G?*#DWO6U27:7NW?-%^"FZW[@A>^,1RV;\'2)+FB]>\@["UIBCI
M:\I^;2<_;VFLB<<2%SBPSR^[_@%N?Q"#!?^8I/X#6LAK58!CSZ9@=J)0RAD3
M,=]M91'$RND>#ZTO\7=S;WZ45@R\#/Q\@=VGF\-6?O8^9@B29A816,O+HR8'
MTXY<'X!Z0_\@\:9R'V&L4$527;OUV1B,38ND?C/YN@+8>K9YX(/=3/H-'H.Y
MIISHXWO$:6J>YAVR @7TYP#-OC[MF>L/*Z9&C3XQ$% "2Z$OBQ8//O8_0/1
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M+C5'Z6>F)\5#(V@?BU2%.7(PS9'0Q%12L(-K;#?:(O)QRF=',8LMB1>A9[F
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M#17/7B"#NNA^$OO7>"G!3;,[-*FD.@21RBZSU//7TN_@529K"'C.&20@XI6
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M&X<_YWRC S/"79BGOSBM\F-VRLA;PG$Z[TV$]BTRR#NFFD#;""7FHFS?R,O
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M+PJ*2%.D28N(= 'IG8@(" B1'B D(@)*%1#X256J2(ETJ:$7D=YK"+TGH80
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M)_6!12UJ7QE(IH_.W:B$\@W)*OVS9.?-:/>\,I7ZS_TJ3Z>G1[/[1:>A]N>
MLX<AQ3:D3.6+]2O.:^ZQ--,B>LGS:S<^4/WBKWOJHN(#RDY-&U^/4I5W321/
M2!-2=:K"RPLM&94U"I;?2*2H9TLIJ7..3_^:6V8_3<KO=_$JL-8K5)9VQ=#+
M5LY>??'J=VS^Y67/^S$4%RE6GT*;B2 >-$T4NUL!.[/,Z*-98I)?U@4Z]KGD
M!BWL^N[$R:,-6U"7H*R5R%ILQ$>F%*E"U[U;O8$@X63]]<SHC+N' L8Z!^#9
MOM89PRBX<S;;O-N]+D_?]WK;8A%&]:)/HGX9!WE>,3U=:PY'O$<N?D5Q2D)=
MBEZAJ!NYF0K+W"S>U.3SU<VI7[LBMSZ4])%'Y4(9Y':=J&;!S:J;F:M^"'>_
M$WB+4K%N"O_[U5NOIC<72*IPK*$S*519+61)8#J@K12&$9MNZOQL_%#XG]PO
M[YAS8N[@C4#JDZQ8"W1^;>LY(!S&@PVO% ][6FVYFARD]^#:_B^\BS,PUG_<
MLJXK/W" 1^X<@":_7-S\G<6?(5*O1^99^3^1G+SY(E66*?&[ 6(E"GTGN'?X
MBWYWY1C>2;F^&#9N96CFI" 8]]Z8P-RB2-LNQ6 %"6BW?JUHG_0JW3&"I8]_
MK[OX_I;EOKXO6TRK:>(;6N&T,N><Y1"ZU>C$).M<M #AKF&$[QD?;0OY7K59
M%8Y-,<Q*8@PHCKC>?G,ESJ#K:;S^^D3S$ %>8DN(;('QC(,Y/.;QZ1X^TLN<
M 1^M(M?TH52X8KMT_#SIAZ\ %<1;\Q?6(E(87 -Z[,,CZ'3V=#'NWIOR;WMO
M@F1AL38VG2Y@MJM?XS@_W;QY:$8-8&YKV!(QI#-@G:\9V4$N[@5^+C7A,<Z3
MT]$X01(8U-%2T^,T3>> 2VR$VN\)=:]W,4(7?2)8U3@*O\H>QT*%<F#=0&X)
MF!Q4?=(7R3L-X='%71K;\PNFPA?7?4LTN9LC.C/\R>L7QN33/4MS4*<A@#PL
M4)&5N" [#!/; EVM$I,S'[LQWMC[5.>3]%"_,/(V1#R.TT7Y2D(>VJ#J5?>,
M\-B+>LQZ083ONOG[;;WIFHR54X_5TNG32QJ!J3OKN)H^_%N"10&A;(;*Q7=G
M8G+";?8]!UWL%O.Q]HV(P/8K!_;I]GZZWOGR=*5&6\9%W$-F@GM?_MN!<,D)
M1;^A!@00>C"&G[D!.QDE?HF<^D;=XXK9LM>Q':=WB4I(SX9V*8@>8JB%E8_<
MJ5*A-J@=J4J786EU?YUNI'4DO*^SDJC36^KV\J#;_4J2_LW.*VYV*]X7?H0F
MZJ@ V&W[-;I./0WO>AO7-,!;@$#D8D&]!B*,",*BNJW5;)A9 T=$LZZRK^QS
MRW_LY4W,2\A^3.MV-GIF)P$%DHH@RA^6J\^>MB+?7IQ#I<J>H,M ?6>^Y*DT
MCZRT4F#[(-U/:5O'8^]'<=Q:@R4#%Z3.!/F[FF=).>"\$?(%Z.-?D6\256@.
MP"D/!>H<NM?MIL+O0A1-49T8X!,\N9X?QMY5)E>J353= <^7DG<18X1CO#1V
MDY0/?,7,0W3$V=XD2RBNFNC5_GHVW"GFTM>B#-NZ91O\RS-7]I0JT(7FF[ML
MZ=C].9NG$0\=DM6%BCCOJBV^4[)8@^\XXFRZ3L%M9X-4Q-O8JJ#N&+#L0_ 1
M(\A825QFUE\[-_:?%4_'\AY;O )C#W_J,H8+-I%=V9P&!2UY6+1G*6'G&ZB#
M/9Q>IWL,93C5J%]YZQ/;\I.7M=/?\1YQG)WB(XE&^B?P[)"!*TRW-)-*EE9%
MY59&9D'#OA;E>')\[A0!KE<U*M.G_5KF3'N")]C&EXY7.Y?*3 M 92'VCL"'
M"],E;&(G]7#^"3PVG;[<#W>%GP_^/9+W\KAUA7\Q+#3#(MA>0WN U2MKVV<N
M7\'T7:9*5O=_R3VSXLYPZ02'D=D)D^B$KX3:IW::K;?U/F#7'M[T4S'J%DM(
M5MBB8Q_9".+/1&?>'-4=>?UUU'=6N^.9]4S7-84Q7_K<4(L?-?E%UANG(?U'
M1QW^*>;#5:.&#RYI#VM:_9/UELKBSU@@N&!E7T32W;TV^]O)T5GP5"MV'?^9
M8+-LR-PEX7=6=\TFOC*V](&ZC -7^5A%G?H6&SV)"3$ NJ03<.8!F^Y;RHLP
M)#R""N)Z&;0OF\>)2-!GX_-3);6.U?B*#YD[%\1&E1G0L88=W/V_IS>#7C/Z
M>#V TW\?I*[[CW<?J ]-RK+<)H1D5 Y8X]A7^8\4QLML6QT-+0KJM$*F;T'@
MN_EGZO*MP$@A@V%A5V7W);Z)(-M[L2-/F*@':&W+'H','3;<T223Q08H(V$=
M2ZV)G%L0'I.L(EE8^#_LV$>]%1H,B0HU++H2/#F$JF0.\S.< 2]K%N$.NLQ+
MTF0SUF;;N5^WWVV@HU_TO:D:R/?26=FC+ #_YQR0M$(0(Y-3SP&%'&4[W*?5
M0::PL<S5U;T&K=6& X7[R%W+H&IRA['1P7%N(!1O;U^XP4=I%JD.(_\7!MV_
M\^N,J2,(I5@32G'AD9E7[>X\?>SVR7*N=(S62TOSHJ==>V8)#5=P_)O+.[Z[
MBI/:/VO+RVLB!GXOR$;Q!%-<[17-A1]Q .J?Q>S92P)771?8AC#5L=9[8HS2
M7=>SEM:<9\IS8A+U+1X8K3:G)_VNJRLMZVZ!5QV]%[B"!!M&6!]'LGO(\KUP
M%Y5RJ*5Z6G+,>/%]Z(+VP.AV& @&"6L_#8BJTML5L*B,?C8J]>V5I(2S7>_-
M>ZT7+=8Q+3PJ6O@F$N)(*FIRHD(=+<"H7=#KQ.OY2*,*A+GPM'\#0KX!RC';
M>)&S.9RK";^FCQ2>'SD1ZF_3,458-ZI>'['W$)-K IEPM#8S#)'Y"?Z#:MBU
M+^ \5[GH"AX;O[9X8T-SQ[%RX:3>V\W7*4UKD6N0?BX4."%HN8A[T.O%G,[1
M)]82RJ4CE)T\&Z_?U1Q-RFNTPLVVU]9#X73*M_+=3WU3!B9K+4JR?*7WVMZ;
M9RD3&TD3Z_N(6%7.K5.#ZC/UF2U@%>GX@SC1[DKY.<#9:EM.S"._@.?8J4?Y
M]MZCRT(]M_Y9B1J]9&!2S*N>,H!'-AYOKI]P.6ZU97(Y? [0L9^(FBV;@;EL
MNH2M-?W"IGR4S.'RHRT/+5._PB(:J[>.>E@:]*CUK> *?T1*XW1?FH%Y]:!U
M1J!@;O#4TJ' "4\9<B'U9-+5]M^G=LI8M1"?$3@6LV-2N847)(=OC.<-[ZD.
MNPUHGW81SH;+ 9^5>>GW2G>7JFKC+M_4=HA]+.SUW8Q2:P&* "73Y,AE,+>K
M +.R:!$AWJY!3T+,(+PPRT4E4H.Z@?4MK?>C'][0QMJAY$O]?U)*"/)+EV($
M&."+^5EL2>U&T1J3W-.8TMVNL=N+RB9.6M\OJ._Y8$#?QD]P9S=>*2)W;YT]
M)20M1S2\QKXZ]1WDS^0AH10*4]G<MU<[O V/OQ@&D6@16M<S%8SSI:+$0&);
MJ3T']_1-BZRK5+GT#)5>H?JS+\#&4#\+WS:R4.H1D$7<#\[25_K$FN2Q)^DQ
M,_LGT>$7^U6:V8,,Z/1F?] QD365K!^L=0Y G V2N-W+2#7 E0DB_!SP]U14
M;FZ9%IFN[QQPNRF7$E>D=7*LK._60,&U'TGU!J*PBP:QBI 9[W>5T$G5S)PH
ML=\J8?^G>:<MN.,P\>:;!#$;;'.^1,=U[J:\%)]>M]\5/Q23;^E=H&K=8QY!
M2@,]X-,"E%"MA$= 92E@S7A2JG ,(5S[Q<\5G4 QPX5F6YVP;&/W(^MF3HK3
MEL![PA8-S^@&SP$YX0'/MP8R7W5)]E;#&P_*#UW'OHGJV^7M'@LX0*7/ 8E@
M-/#LX@Q\X_-_O.PN:)9IQJ):FH#:E0DY^CZF>L$I)C$='T;83Z^;$B^%W,?V
MD760[\\!.ZR4U<@Q;G3$[Q&DBHC.! %Q1?;*A>TTB9$M\XGR_8/OYE8L6OXS
M':%SW_FV7B[SFJU7I&Z9"HD^KW-HB,@FT&T"*X_;=Q^@XUM1]*^L;5G:$J;4
M9?9O+O8K?745!AO_,42'#M&?*)'I+Z$KL=%+(F]592!NLN7CR\CKQ_V79R3Y
M: ZEXAH^:<=N_6(?)@\BL<^8(T_A[?HBCPEA(0%HQ+57-;T."BE=@8G+OWFH
M16,YBZ_FOGG^Z_41@IU4359R!U;1OGU]9$?]N'X4QN$ZDZ;.5%RDM:I7M""M
M3?T$>=#/#D*:<[4N!M%GOG)LRJ]:0^7JD^4W&K)\2B.S[#=%$))]OB-GXVGC
M>*">K\H+5 ?W[>P?UG+;-MN0O1=@4[\KA?LWRVKG@;KHYHN>%/PNA#T'P +@
MSRU= D"$8]T]F[WL_$"SG*+QS]=[JX(Y ^L_.SST'(&'=A'^;\[ELC+M.4 @
M +3'O&Z7^3PN+)F0BUW7)U0O\CFV*38>F\]X%EV-<GUM9^Q$%0;-3W[[T&B,
MFX@D59\#G%#TY/Y4U:N@*UO<G=CQYB$7\D2:J-R)LTH#]%>2 '3]X2ZHU.QD
MEX*!K<\!\8,12#W,^J6@.B>==BY=EB!=ZY.-P0?2N08%U_-6RI:J]L<%OOJ#
M<.NT)!_0JCW=6:"=FS^R8C(F_:ET\<_:.!\.T(U"M=LA-8G,Y;*8_[R1THAV
M]-NT<XN\]9M%<C550.P\[/R8:R0W9F[>,T68BR@ O'4 /O;NT$KCG=&S+-2#
MFL2UO-QYFY%M>,(*\F=X7*3+V3V"QJ$:G>N$%7CA'G7UY#]M^@3RC7"C;#3#
M+#L:A7T6(L?'L"S5BF!Y=?]#HY/*.>!S >!BTN6U]^W9M@\JXIUO-J8NDM-Q
M\2W']C=PJ!8)5JL&@M.M99X0,>O]%?>I,>\V #K;E2>@(R"+QH"'+W('A7N@
M3<"=F>LL@:*M0T<:G0H]JK&8R-NUKSQN) 1<^%HGK)N7R/)33TY-^)* ^DY:
M5XBK4GZ@+#YYLAV</0=%U42WAACH]I_] #EMXT"KL-U9GT//_V(H<?.;T]PO
M_[GK6S^STO@O.\,UB=0QA%9LL0YAG.(ZQMB(.J]@]P+4/W\J-O<^WIO:6G;U
M<QC7>@9!_$',3.+=L-T[\SCJ%G]5KN9Q1,XX79KS>$&4IKG.,T"SK6OHNZ U
MI+7803N9'GP.N&6(!I&\*7!"J]N^V<+8JW.DD",WB#1(3$"OFWY3ON26:'_H
MF+O[XQSPX%"UHM$*W0#F@MA8#DG9ORHYTGM84A#L?3$J\8;F76U!WOM=:OSC
MQ1J!S'9<>P6C]4 )N(?4%*8UNS+U;94*N-TZJR$D(*0H^B&KV:^()W2K2JM/
MWGP;,/430;*?"F YR-KP=LP9QP[P,%-L#42X&TE,0-'!IR#P3>7JP\D6T,F-
M<P S<@?T\QPPXHNPS[>::/71GS\@1X;KQBIR14K(.O6> VKYYO];#NN^X9O_
MDL2Z").'<@RKJD"N&])#WFT_JQS-^Q6WTE?0\U%N13@T58MS?02IT"P#&US@
M)V4"W<#A,[01&%FE6:6^3%6\UKA3G YU^L@_EX348@1WLQHGM^9A$/)<]GX@
MZC)\;A1^N'BTM9HLPFNFZ!4D_^,$N*^5D&94J"RA6V%_:%RYBY$Z<-GP\T&R
M*#,ZX!ZTG$Z&^^EX"HX>N3M79^EIFB6;U2>+EU"=AMFQLZ_RUYUHG;TF]S:S
MD-)]P0QV!!>C"43>N*1(E$.QX970QW<3:OL^WH,Y3LJ>AO_;UBB(]1S0:@%<
ML?B[ P)*A9]>],-WOX.OZ _!M]M0YP"-TJ#JNP,U3-+?]TZ^+ _G&D3(&164
MU%FL>9B#/YP#5F@#R>M'[/E6S4*4LL6W?I8]9O$YF 8>BEQAE2<% $_I)S5L
M,?]Z]>@29'+WX[(>"D#N)\N-^VYR\ZQ5VVCGJT?$#R2\$&=^09VH@K/OLP\\
M4X/*)BT=MV:S0PQH3!O&)"Y7NS*Q&;Q7#E2).'H6$LMMY^/A!S= OG7'!VQN
M!0*)K(-H\A>TP'2?UH1'Z3)WX0?AE/W]%:D!M!-D^>DYP,\,PB?])WB"F<@6
MC+9#?%"]VKU<K- \N"1UQ;;SYL)CN=\>\VW2>[S$DI[E45H^_4#$3M*9S0:(
M"BH$;,-$X4 $"Z,A3R=+R=N5B<]8YNIBQ]DS[CF_N&R<K[T>]YH\!JIF.P?P
M-W,0<M4(-OGS((+!;]0N]SD@2JHTC<'OHY5NZV6OS)W9H+=>0X[B*B4:BH-<
MN^CJ4<-"*41!=N@!P;KJ.L/6D:J8S/($R1<38N%9. &J3.UP516'LF CHR0Y
M559W$TM'F0ZZGGIG=P['+]LG@.3AK<K'\'8QB*/_3DC.L6>(ZJB(8;?L8>R;
M9<&BI;N:2G99*33>6=P9^4V?_EMVL%=FARHCQ8)W*:!%LW2F#0LFAEJ0ZV4]
MAZA *K"%Y@?-6-#.X)+.7W/%JJ%'G_YX8_X0=,UQ*S25? GT>#(!-HZBVR/+
M0!EP A%5BSSF+_6*;PD##IZTCDL'>0+*X#.%US_GK%:/DZ00BT\_9PA_:\IL
M\BA<<H!U )D/!ZG( ZJLB;\O3QQ8U=@9X]$6S#*)Q+Y?QS/AIO &C+T>I0[=
M)OCP(=[[,D=9WR,/XB1#X5>,08_D>H8?.$MK;QD_^C6HW_43[@2<M6G+9B#S
MVT!5"#F3"^P3C0KVP[=_E:=I0-JO?>_CKLPMTUTLNT<U^.PA9N88G]A$^@IC
MVZ[) @SOI:/7DL6EM\C"8X+W\L>RW"Y_#;5T4?IBN<X8.L3<M&M::.785.*_
M9D 21X74C*"$VO(MF+!,[VM7W5,1L@W@YMJ3;&^B$.XW\2G! 0UF^_%#KK2P
MW>^FU).$SV"C0X]V;%E](Q O_/> >.7?8K]#2@0U;>(_>IV^:&IKW#%E5SRZ
MP9?DCE-1YM.R8-3-J_4RQ*A9VE,@V"<Q^*0&Q2BX5&*H#;E>PCOS_0(E;#]=
MJB4R_-5*0%CQ_]OEHTL.$/S9F51+\\W& 53EYN2U%?PLJ\"F374_41=+PD3#
M^ C9ZJ-.48SJQJ.2XHLISDY/ H5>&G>J"5X(IH^*PKIRFT KHT,&*8W@8@JW
M2P(6WAFP^L93MOVZUY@P2[8A?G ;Y&;1"J0Y![R(CYT1>;LRY D3U\&B#,]>
MINHXH E_1I7?7Y(2'F[4?\?RIF'*\>=#]LBEP0\@/K@#BNO5[A**51\GTF+]
MON'B<=F(\C]=JTPKO6S?O!^)]X1@O3 O7-LY/GAF:@2X2P3=FG1<PR:[/<>6
MFXDJB<UOCC>GUIW>TG"!!( J<!:1A_/N^O_8NL[$5@7X[\<OQXY)9_=$#2.N
M&WEYJ QC-'5U_H[9#>@&[M-%DAOB29>*<_[UZH>5EM7B.>#DNN\YX.^DK-<3
M\O]&Y?Y/V0!F42R(&+YW#I@#GEXM&_@U>.D<T&./(;7_/5FQ\S\D2>1 1^!#
MF2U-N]]J>_>-9%9I/DVLKQ<2KZ'(6H91H+]$Q8W>XB'*DA8)[*M#@>< AXUS
MP.&3\1TD%= )3D<>F"E AJ";U*V:TJU9HL/'1:(T[&+^R+W^>+\OJV[7!LC?
M#" $XS]B2[,CB3J!1=-6,_.E6SKY?;S>')?[WMG+<[9G+61,EG[H>%QPF]VQ
M8I4HX?.G\+'7-_/T!=N)DX6NR/^U8$;]Q?/G@'U3,CLE[$7AAU"_X\'W4%GW
M123]QNFESTEZ+OG3[4Y74B]R<0D]BK)\2Z5 K0 (MD@E^I*2H2)G:NZG-(@E
M"77KBKIALY1YWSIT+(]D24#DQ]Y5K<>B1HC+CLL?X/1)\"#XFM.'MK&B%#T&
M@8^=4FGNQ'AGQ"#P0_;^9T-&./+O&/Q8T+?DY:#)'01:Q6=Y/+ZS[HC125G+
MV?'^3+?RXS\[,5W2!3=)S,>G$YRZ";EVIED3+N;2GXN-WD2<PEP>G 5#[S<1
MOIPI;145V%1/Y.8:\A>SW7]G-W&O3Q#@I\07I[2;1PHGR[B"V%1I7ED;VW6?
M ^AH(SV2])LKG?F?:W=-Y7<;EX3"P!@:ON*-YD;N$]"2!9$24NW\PKB7S7>Q
M\A]E#2-@@LE_XB434M[>/_OSH23F_?JG,HZ93.Y/>.]O)D_F1W=VP?4=2Z*F
M^/(.X_%\YX9B%.;I:03^=%:_]L'\G(;[Y1M/DQ0T>@6IDN82:9=-)GO20$16
M7'6_YL3RDD4GXCI4O;;ZDQYCWD$O/0U__FIR)!%0=(PH$PSW0,<)SQG+TLN7
M.[=PKB0EA@S*)FN;1-DFKL&RU\"Z?LXHY8<6I11@> !4ACN(LNJ0?L+$-X]C
M)# O]0ZU7Z+_*=U/H9ZDSLZ'A4+"M*([K)GR\PW).:<S>J[ >;^[<'60//$U
M*;PJ^R/\:GQ<H]32KA[Z.&K52_@X#>JL$<!0^^<9@D<HH?4&-D1:1S7A#$AD
MFU"]LAE4I8B*/XH76-B2SAL,*$[YXV1:QNK3 %#CZN,/R_=]<4N/15/B=[^&
M&#SIX9NAXO!2F5S(;P.=>5?8QHDZG@J71F0C?%F&AV5))?LV&;L/WXJ?N?PD
MQ?<2%UM6P9/]:95'"BLQY#"+C^0A@0JMT'/ *T?&O7*^KN0E!E^6]I+-DF*Y
MX1X=JHN*8:-"0N5<LBMOR"W-DDWO7>M1NY>62";M+P/!^8)?V',W:]?K?+N
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M Q'2T89AU2&F+$6H#7RJQ</M->4[?^#2[J4%:E?\?W9?N5.NP?W^B=K;'S0
MZI^=JHTSB289><E)+J6ZDID*;0:[PMXPE7. A=,1G)12KR]/5L,CCWKAG\K
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M-8(]BD$))WUGAN0^^%557BC[)%2M#!J $XF5F35_JY>SQ?#F1K9O3Z[_6:&
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MH="*E'0;DRD2D HXNXPBSJ&)G -6)M"]WQP4W*@ $QITNFF$$3E^'7H$46<
MGKF.%2(_GZ?ABQNUZ839%)+R0/4)T5KV92(B2%X3GS4Z;NV0VS3S;&2 @<-#
M"(;%+X%FQ(/114",-*Y*ZV,1#MD(9+0QZ)<LZ<>1.I^ZGA:2,#PO[SE7];$P
M0C;[O.#C\IU+'7^+@&84$L"/Y SH89"!T'5-DA 5<#]>BWPBNGO@2^(!@M:N
M(<%)%[MWN;]Q[=#WR=Q#MM.?B@/'F$ISV)@Y"S\R"M(!5AE'79 ?%&4(XHU)
MQVHYEX@LSTGJXR?["UY=\ P^*W!D/=YWU#>(:^#U^]#NQGJ13,E(:TV,MX(S
MJ<#@A*/S&T&&][KCPXL]T/8FLM>DN&^U?C85\&39YP@67YCE0(E%I%^7KW;>
M&3M$WA-2PN-Y\L:Y<"F"T@<^Q5QO>#E#/T#B(&ST\^'P9ZNO=@_D5_$8X[NQ
M-7X$N+M;/47@N/B;1/[$J9-G>>B=Y#WX^U):UZ),8U?F=P67*"RX/G3C6K#L
MBL\%PDN7JK8GK4\NE#.G98M([OKH!.AKJP*V"H*UPPXUIZMEGEZ*]*J-<UYM
M-^H3>I$I<G?QTU>CR_UM!37.PRW=O,"N2>RJ?\:B <EX<$3)!KB;Y:NR(++K
MW;.9OE?F.GKNZQW-UM4.(PGMX%!7%:X),&&WD@JP1\BN+(?^4/GZX =D!XP@
M,D#R@4L3H8@KH.6DB''@;W4A%SM)0CBQV,DP*['ML5'KPMRT5T\?%%[W,W-C
M SL[R^.1D8H@GV9H26SS=@\- "I@74N&[:B HO?5O&;D*E2?H9A3J>=\NJ?[
M@=,/SP^\C]3Q<AFA')J;3C^ODW#Z>KE@Y0@"RK_)T$:1GZ I1AM2[A1M(@;E
M")L)&/TB2.#UDX'A]TC/+_8<J4J#F0-K%<1\5RJ Q8>'TE<)#2TY3]+'7:JO
MC T\4QE6R@0R?M)8;.PGD_+Z89  H@2E8]:&&YE(#,)M3V+F TIK.H/X;#0&
M!R2-[M Q\8635?D_"7CU:\2R&+$9ZZJ-M[41._D[7C2T1X!"9DO1<>4:I/:J
M>D^S^!1WJ&K/YI.4(+6RDF"0ZD1SW;%K)^UD0\WC"+&4P[X3W]G5.^&"TR'"
M/5JXATLW>C"T&0H4*_-;'G@Q\^:1B8SMX&8NA16;A*&)B<5"FMQR3>0AO)Y<
MUID=;$/8^^9/ 5V4=Y+M)4@"G\R>3=P=AJYDXO3P_H2 ='?D]'CN ]M4J_Q*
M=/VP<:#9A[?MW?IL+[CBO:KH0L,/+F;>D<(=1I6:9(^3?3"K[=;1@GI'L)2F
M#6D;8RUCC$7%5GF#Z</M1NA1N&C.DEJQ3FUWOIT=Y'1CQ(EBAY%(&]==BGP!
M>#D>P:_;PMG$F2)\B\9^IP%'ZU/^R. P\$Y77<]1O36Q1OB37NBCU6ZC]W]9
M&[PT3NHPB0;H_>*I@%8] H0F8-)IL@0W,  L80GR$26$J':;$S2FPH3JB<^=
MJJ :N;<*BAHAL_K?3CJR*##VUVH2$O9<JV .:4V0+BXH LZ3.[YX/_]]A;O\
MAWL24R!!QE>R_MTUMU&1B7P)'JV"[.6F23N)BE8=QDP0YCO,%:) S9Z!U16?
MYUU0";@$E@6CD4[84*["E3<F';'A90NV'0X(BRZQD>K"R)\_I7J]G66<!S18
M*VW%JS@@S^ADA1TP_HC=#HY[$BHS',D88,Z\X7=$-_3UYQVM21.7\\)2;Z)0
M=HF5O &R[6D60@SYX\-$:W@;36=J4P&1<I/BNRPL9*&8VKA?2CJN,S9I#8GC
M$PE#J<-69E*$H G,X_IN1.G-HYS,1;:@*HE[V?(2IX6X!\PGD/[@TO+G'SI+
M2@A)DVQ82MR9\E.O1U(OED58KQSIYWHY*!$YM+UF%IS)DKL+M.+:@.:7E9NW
MNHAXVRSS?C68+?NZ7;.;]*A/P9)RG?WO(7X0D40:8#\3@B9._59_BWL[%$Q'
M!;3D#^Q.[T!T3%![]5GZE\DX4F[6AWTH>82=UH[\VG/PJA6*:.])S,4_QZ*:
MDXXKOO Y3JA2QA8U"E*Z.$M$* YR\)JJ_+GFBSN[-2IF:%'"//XB.<U'@-"C
M@K-\0?*:P*@T<EX+-32SF%JOKCCR<ETP,O=!*_BB8E#P)O8PZ[(>\FI:E*?+
M4.K7;X)7NQ)YC]F6E!K;)2'$6A:4V#;<ZJ@ >I\>6?%&9MFU*:%&,//R^(E0
M-7P5L^+8":M#87ZV>[=\HH7FN8^20=VU\D\0)ZJO3PR*UK(1@C2Q R_Z<;P:
MWW6EW>-&08'7CDBNWTO>K8E0K*9MHIK*.SG\XG+F-TRF86]HVD1?I9PI30G$
M9J]GDMB<*$J((-36#DTU?E"!/G47HMP:8Z14B]((:3103P6P40'FZ&'H=$!!
MDNTT] 7OT?[DGK&9,F@BB^A;0(N$H9@C8#EN<XT.+D[.<P8><W>13GHY?K(*
MVY3PO7+<T'@D\YU@BN1:F-;@W57A@XSV5U=E!Y)7)K<L5(:5MV'('5[+LJ1^
M4Y@%R''$ MU+["Z&TT#&&;F.;7!6OL@?1=RK_4<ND9AI3]ZAEBNH@$Z#2I%Y
M^,^? <(IQ?):F>@E"D]O7DF-9HFM\M385'GOJ;/GRUYE,YVYV7!_PW]1+<Q.
M&Z?5@#CD/CN%..$.5<+1-TIP6<?!9009/XQGLFU8DEA/-AG)- "'"JOYTT:,
M%B-MRB4,C:SP.A=4"_E?/A()!C"MYV!E/Q6X*?4@GH+]7=<^6,74 @GQ&?S'
M;;.7(.H688>N[&^5$M-2X/*1I7\&TIML64F:1KU GUSQ$8![]MNZ:(S)Y\7!
M E=4;=Q/\WP%TM_7E\>8CKPX\';"?_%&*+_P5Y>3?FX];K:V,/"EUFPSI]#4
M.U'ZG&6Y2C[5X\8+7K$K#1,<E-,D>BPDJ"#UXOC(X(4!B8]U:NGFH.SM(S,^
M;$M2.B8NUK)]@CJK(P@/M')DJKI4:HDNU/X_S2#QZ.E?%IC?2_3#S&* D_';
M"@/=Z(]OB*L9*U:RS1'@,RAS5,3J*B/D0V><U$*#FH!,)*YIF[0*'/OS$E&?
M*8G2<WU2@W:F*A_$TH)WH)3#UZ?"P#2N.K#)$E0IG7=QW"86)UH;;W%:^^,-
MMP?F.I\E3W\&>/;9'D<\30KP]'2WZU##HAN90 ZS(\N0 =7NG*,,AO,!@Q$0
M \6Y2J _M @:XA(1+ &_2Q@K,";X-YUJ@M[IMKVS["59G2Q_8.>0H X#/;SI
M[4#VG3?GVR\EW)ID]^8M&,Z7M1E=%S%(N*>>(&M[1WW 1LF;=P]==$(/D$Z@
MF2DG""H-)\P[>J2^B,Z-='X]QL%"QAM5J0L7'(YR.3<O.E*QJ)>1?4-JNLA@
MU^_/B]Y_Z_Q/J]YGJ$G>2$YSN79/^()#ZQ7Z);5]269:N^KP0[!A^L_G/S1-
M@=#,8R,FZ9C2[^42[_3D;KTX>('!\>+U_?0CK#3J;MZ(WMF[+/6P]@9-\R18
MQ]DB/W,Q@5*"M"O['URV]L$.AIL&?=3SIV#S,(I:(Z#)L+@G_43+ (K 2/UE
MI1S3T3.Q3R;L'L>-O9VN8A"JD$Z8I *&3D[!6B)>>")"?< VEU/J&P/+L>V)
M2\O/AM;#.UX?>R5SK/T;PR%NSLWSG<]%E!VS*O2T.E2\R^4K/P5'GU=_?UXC
M3BW?("X75A;4A2BJC?=(H[0CCF*0#:)?%SJO0DZ+Y%6].KZ2KC)IEJT9+A4H
M'2Y]-^R:_I[F?7;8Q=$@&V.MGNF*'G?3SERQNI&P]C5R]Q5$;CII9S_-,#-M
MH?CU=?W\T5]&MF.O'D9QYM]^GGE<6$T#_'SM2;_=&LG.C[O/JJ,$V&L>6GXT
MZ"_N1IG<BSUR=6EV%Z?<V$:L LD'(99J !TEUL_"*<& _YWV<UU;DY^ND0H#
M4H+_M-%'X=:(5>*Y-$Q1VFV%6F>A ?\"#5* TY_>O4OO9:(MYN)AX91GO[?\
M;,27RVN4"C#%S_J[02]JAFO/OJ%1X+H473N!A:P_O]M&MLDMT/NC^*0 G1*K
MWC_,ID"\!;A^8F]\Q*Y$0?>GO;34ZK^EI5YICJ(O20D^_XQ&)L"/#2(XO;;C
M0 -!2;NB+J6M[KL4$P0FD]*FYMMSCZ9JHU%D)^B,B*=?"T4^GT:8.)HQIM?S
MZ\#[,FC/SN3^74_G ?>4= UZMXT4!K-&KQ_^/<%3'0VX>XWMU3OYTLFHI\2J
M3?=#.\#\9]'7_7\>JOWA:,S?$X+\V [^<T&W:8RF?T)%^I !\(P]C8@^XG.@
MDH*?0BF?_;1O?V__;*2<=;!PQH\+9V ,0\T<!2_GT+C-H)I&J#-<6JDT^9)#
M&*%<FZ94(M>E;6BB=IVNA"A#>6[E0F_P2P>,TM/('<:]^H/0!1OCZU3 *]$D
MLA-;U)_]E[72U^?7KX.F.[8N(]9DUMDZK:#K3#2:%=!6\R%XGN1!R>@@SU%N
M5#*#*-==$5M-X,WCJDQW?V'@*U0 +R*OB C>+"@:H2A,[9EI(C.T+Q>U+5 !
MW95M,,)V"+F.E$TGR*IS^\<-.[K'L,=_8]C>/>,^'#S#_[?[8ME_0NPK*%;$
MES8KR@J">'R/NW_\](\OUT I*G((XB+[YEX([ \?7AWX=19_Z2K_DU?_V@^:
M]NN9I _I1,S8T:Q63^B\:;J#)PLI; "ZID%:+DE[1A,WOTNVO?9+MLD"<1J*
M7.>MVBLX1@4DY[N^^7DJKVL7B;K=,F-@=< T_(?<@PY[16DCJI#;C!L%[9&
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M/:*LE3%__Y(NY%VI:LMAS8<$2 LO-ZXO?HP :^2$OK#5*2LAZJ^X"6=V%DD
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MQ:7>!*=;BAQ-1B*^L.C0;%,K\.9)$V1]!V$3105X(UX7Y)I1 :]X4_]N7%1
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M=::D%<9F$YW,ZJ!>JJ8[8Y6_9E?E\KB)1H<@J_K_A[3W#FMJZ[:'@XB(@HB
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M</ 5HFS@)<Q.M-26?=M1RO?,<1Y3SXT"S[>!=>$\EM_F7@*%:)=C94]-!DF
M*\BY-"05$>BDA^[- 6/SUUGH&7;I!E*D>,<$!GE?;:ZW-#A[*2B4,"MFSVZO
MB;<<*UA0/7GBCCG2,W>8)HB\1F/.(N+^\'?0"TYR*WG.1]$+Y"\JIM1OW$R9
MO,JC\7[@KAOOR/,#GGI4!WHO2?P*K(:>^%$1&J;*KL*NSB[RZNNE'UD4#U8!
M!XA^$H #UF-:+TM< IT^.- KW&4]-BJPDL07RE5[!3?E"\[V026UX4&^*.6:
M7?4/A]$\J*>U@V([+K;ON#2[C_J<-[-%P@*894#!@<US8.SMJE;SB[;UNX=C
M1;L<;29@Q5'BMR"IVGOI/6%I(,+1IN_64&,T-F?WK@H6-*<(;F_D2?\Z5#Y1
MWSDAN2=QT^ >U^3G8*"5N_ B/5W@*T(N"&)<35Z"N8X@.CP3G\/\Z"'S,W8+
M3N;9U664E4T80.VRK0DWFW%@?T+IT [D[.BAWJZM=CGNA2)N^Z*DXYWO:&FB
M_1?H$)!V^(@&NS47RX67K:XOPQQE;_UQ?&UQMYC7=K^H5X(OR]-=;?.CLNR<
MS4&9Y6[(EWD4-=@WX_35]3A[VZD/9=R#0F[\>X@>\'3J'+(-'&(&_' H'@9D
M<E,(\LBST(F;["J]''#_Z<,^[C^=LI0?K!*/P5L/7%F.;NQ*3U;YP3$QT]O3
M!-0,>1EU>EB:PF$T-++[&O<1&QL3BRT!G[O;59)$^5T4Q8HJ4)^(5['\;3",
M/BK"[$\D/B@?;!HH.RBF4*#(W6\965-CROB.@N;]K<^_?018NZ8/^*-!<RE@
M&JE(K?N8<O_<MX?FS[(2O>B4B(Z3E3_Y>>R=.>UI<]S=_3IHP1BMPS+P9,A=
MEUB%#>F7&[FGOVZ#=OO2(1O^OK7#K6-'3\$B-A#SH=/CDX1WWW09U:?'-0W2
M=V#FS[RKXE;0;$I\CB1 &:K9TKRM2E1TTU\TOMTY.:$\?D:[[95P5UO9]1=U
MG^/]4TXN'SD3$G6W#&WX.\1C6,:)/*EF<?VI645M29B<VA**\(=LAC<V'PD!
M.,)=?ON+XYF%MT"8OONS:CO"..]QU/2P?;+873)#F":[.]WYG:U7!8&\F"#T
M^T9A7Y NIKS6@N[[) K"%G_Q/J"D!D=I]\D=^G*)6]<L301<DO=,0]#C]<R!
M<5U5*CZB0R/ WY/3XFM6G]WH;,]I$7/CD0I.']J7A"SEJORR&SG7WK<3"M2J
MBZ!3UX34\+][;/D&&)AD)UKQC"WLYEM6GL8UK,\B!!P.I*\'+:3R34(*357\
MXQ+B4P<D#+=I>#&(2.(-8A^L@DPX+Z)];=I!3(&,^:L^TTJ#3M8,;E/SXW]B
M=8U9[:C?R9F03609NK5!:UZ\&73)5\4T8^R/X9 S$:50J8.Z?']%UJ G.XIA
MY!+JVDZP4_9(=D8Z6-ALE@C[XNLY=OM@K5JYT_*:B:[6LR/8VY,"'#"08Y>^
M@P0(0U\+5+1?P"$O^:KFFHR/:\N+[63MOV1HB8Y-U$75*7CV5+D5*_B1 .?[
ML,I%OF(KK:W^+NA0K\,/A%1CEGW4EP<G@1-+KX,U-LH%_[P3[H;-)8/W#*%W
M8>-:, +7*W"F4:-DA>;K*,>>V4WO [Q&B_7:TZ/X/&XW?_.-\5RW.$P5GM%M
M$1Q&?H@A)K3]V&#&"<KZ^TC4';<4P[JT]_U-R5*^K';CV[!5  <)@-%SFU)I
M ](['P!#B.<S3!7 "U'4-17.NN=IB68B]E@K]9Z0]7-ISS^J?R3VT";#,?HD
M0/CP6NM]S=-669U4Z-![13DW'CA.C3Q=#&&AL"GYQMX_CDHZFS8$&Y>-Z5^H
M#7,Y][87/W0@BQ$)5MZP981'\A3J\OLVM53LK46624M81GJC>EF@!-D5..#%
M!O&\YWP7^C?:&P6J=26/"(<T<X^7K9,81%QK ,=!;8>+,MS PLHZ<N?-$+YZ
M:EG*FS:.0AE\O^"[1=PX8)_JWO6XR^S;]/RTH_3_^!VIM3&'P K[3)( \Q;8
MR][H"IA37QEN6@&>RCTY>6HB2FND^3DL/V8WH<Q2!.==,A[6/)03DO"]2* @
MSZMV^Q3]"]?#%K_ NAP^]CA;KV?]-2O#1U6E:N2[D"4\!^9F0W<=L;EDO\I>
MOK'_2W_ 2IWF7 &]O8'>YI2BD)1BD< (Q!,^2W:$MLY^R##04M8S$F#<%/3Y
MKS13:OPG".AT@WJ?^5_,F *%?[ KB15O@O*.HRD\&^06CN&G]AR@ T0X:"X)
M"@RNO[O+LF!<)A2$U!N!=O,=-E^NT'\T+&$S<%>3#)BKA==)@"DGFF*8?6RX
M1-/C3UCH\7DQ_X=MNP>(MS!KQ.2X(2%3B>VWF2^B33H)=MFSP5A=FUKK\Z/3
MZ#73R2EOSDTCAC=R2^DY?OQ#S>T!0MM'0T*$Q!DB(9:?ZW:!]9#)F,[,E";:
MFZB^VAGZ5YH1^[=A3R [UL=\1,W#/M?IIX5V)SB.$SY46Q">-#O[S'R[(P<U
M0#O>2@*4Y^(94?/;L1BDZ2Y_:R0'\K)OPL/*(#6@$-%O:.Z1="E<:J+@.5=A
M]O.W8PT<1US8]@*\#R%E.>CU&J*"(*9Q$!!9<\6VNLUIL&NVJ%3U_+&0QE+*
M2I'FE0_K PG'/MJ08A3"\'NB4US;PQ@>04'GX=IAK]))R 2&!,#>5E#O@#,W
M2F#W<,<IT6TE7^-J>+<8M432"#:Z/8TGNR_?4T<HB!<ZC#\N-7>Z[F'6%2-Y
MJ9;Y!O%"XV7R?-3H/C('1?@'P(I"5MJJ$%K!:X>&X*_#,C$LWO)&3^-UK2.F
M[VM*<;*T9,8?+*NQ/<U>DXLW3OB4>K@"P]"_A<TEU!ZVR8FW(2[I+'U/A[EY
M<3J_"HFSC=&A)[S2Q!TAY4F N<22BN-HI3OK#A)NMRJ_08OX6F$W3\=7@R%?
M(%8[WEFPF@L6GQRJU>T$^8Y_9D8(]RJJO,/F$1':IV0H7CIN0X9*73R=Q&HR
MRA6.^1]^$*1X'2'PG<I%Q:!L2/16;6/MNYZQ.\]6JC^J15 ;F*91@%-@E>KA
MFS!GW:G+37!Z*'M/(X^ER./DE(J/^Z)9^UP*G=>NT+[*/V?JKO7\&F0=,25^
MQ(UQV^);J%;0*(:8;2?G-]M62D0K/0Z,CNAO^N0;R9BLR.K)O$\W E4@=Z(M
M-DO++D%[%][*Y3_7J3"X-CAMM<V9Z$C=MT)UZX>][0WIR].C34*O"M@CP/7F
M_)F-!3!=7<.N7WQ&PXE*X)DZ*RT3%^[(\>):B,U!"BO^L\&=U\P/_ZP*'JHH
MCXO4:W];F^I(OU,]?'C9=[MHA8M;6J\''<93#9N2[D1AD'/@Z'KMRV';A9[=
MVF6,44\6;<%8G*B?X4KTL!DQMT W25,!H3MP<JX]="L/YV'!$7>$# 5?\5AN
M47M1_05(J1C[12AA^^,"4KE@,1;+AWJ;H(RE#%K08)1NY!GE^_0+NJ]"O_W1
M?K*MDT@%MAG_%J7Y*2LD9L#XI,'\L.;/<_,"MA=V]>C?27%@OI/@_RT]!J5X
M-PYK0LS2/PO=))CX6/"W( _98W'=^)2ZVG_E EL%X![ZYNI@[)M( ,[UJ8(;
MI:&/:QX6J]VRC\KD5YS\8K*+4.Z75;B$GR<4-@I!@!7'':+"<_:MSU1GPQV]
M5IQ2TD1K:6ZI['>UO5I^2+.S+]OTQ]4K1WG!?C/9$I]L;&-^]>?/(Y17Z?8I
M[R!R[I,_\S8<(]UF%MU2:N;$OICZO.E-\\WH9YV5FXA1NE=6%"DRH+D"J*"E
M.5')-L2S1)($"-A\E3A-YNJMQ(ICZ59@J+]N"PRP"KTVR+MW,",T^3SJ)T>V
MHID:">#XN0SH+;5_=LC%C0T2X!K>)0NO@[4O;/\6^'#HD8USOTW,JII&]/NY
M8'<:BSM"O6_<J97@8]\4G->1(1H=A.)X70Q>EW\]\>;;8+["S)&BV;Y*)+#I
M= @I1[RR?KV1BCSIOF*'50=??ECSGZN-\=V:8'I&*_QZ,4::1C^T\C%">7B%
M4-YX8PH1<@BAOX17*H][Y,,M$)R5M&&O9FOZYY,;KTP+O^*E0VY1#/V\5V@K
M'"O(!&4;=-VND'>Y-&1?UUC_8@]UUQ1Z:BP[5UYZL)6F_R$S;R2O[Q:A>PNA
MBDC6E7Q5,6/V].3Y:"Z=665517+ QK)=S:F?*I-)3$#S/PHWSC9R_E'8H?%V
M[2_JE%< ZQ(Z)E8CB>^<9IZ.(I>8 \@7@$D 9:E$\'SO8(HA=G$=2@81S;=(
M@"7!7<A&+FS5Q.A4')P.Q&B 3BX%FIVNH4^91Z&1XU4IL'KD8Q)@36!7$CD'
MV@7]$IYWF][OF,IMIP_+H"; %23DU3V*+54\"KJ!\KRBN JW(R.C9>O5/+ G
MX]N$(:0"TD:6O@,];;-0U5;W4^SF\/F?$R6R#.&W]JQYB1,/%XGG(:G43!L!
M&J(WTAHA=L=$=34Y@Z=!:=QE3DKAV\0-PI]9)2J,52+F3_,4*,13ZQ4DQ]&[
M&W+>IG@4Z'M:(GOK^%;*3&;$TJ>TI65^[_Z)CGL+WYAMWU731R#WR7:X$HGC
M\SEL"C0B 3Z#SX[YF11B4X?\HV#%:(C<"QQD(&QA2.XB9J?/5($S)  5/0F0
MH+6;C#N"G1HQ!_&"I6'-*N0+A_!V1 *<F*AJ1+^@@B>ON:&XNUC^53([!6)T
M=D[N@<[#D&1NFU,VGH_WW<U&7B%>QDZW?>2JDG-->*5 MR;6PD@"< M;D5_H
M_#;Y$2H8==PQ^M1<T1-9F2W9AQ/&JYOJC+%;VW1 ]=;-#R[4[C/W1>3#?4[2
M9"'++4.0DGD01@MU>8W(C 4NN'$Y):@XWB_*J]6"^=Q0-?=E CR;P$C7U]P:
M'^=FP9;,Q7):-<!#%6SF28"KEE]%QDZM\JA^D4VW$6<<&(XL<=OL]L$]"N0=
M<E6 %<]*MT;?7O<]0- ZEIT(>DE\+"_[+;G?*F'43-=)I3Z["8, )^2;0?2-
MK$Y*BE@P\\Z'"C0=_]';&(Z390V;AY<ERV/ZXP5.WAI3OI/HXD5RL$NV]4[U
M%25%/BHB]_><LQ^6S23FNM@GL0K_NOL[0?=@ ;]QVQ$8U$35XO5ONW5'00-2
MA!?ZKXJFRU."\!. 7A%UBG[Y4B:;;>V =#^I/,UH#<.DU2,'XQB>-*?.EWK_
M4_'0N-'_E.E3J-V_<I;SW@_$"L#PZ;'-R&,7T$$M4KU@/_2O#09^&XP;85J7
M((887#_@)RZJC,%.]5>&20!8FS]Y;@SI)I/;D0FFJ4!$H,M^MSZHBL?I#>S8
MC&JG\8K?TXR)I^+J,IEYVSWUH+L 69*\I3Q' D0!:?'2\]A#CB#Y#G:C#_=-
MS$0V>>-U!<_Y_7P?O?IP^\2C2D9F[@O9]*&G7AS/B0=[I@NW7N_^X;O?-DQ(
MT*BRG>59?MIC@HUY9O04\ZRFZ[Q)5!7^VE%G.S>=I:'E[O=OD%VE(S5DXTC1
M8G1A<&MZ^WDAIGD=J)W=4D*4M:K>\FE]HLN-Y:P-S\*#]60PJ$6"DP0PB_H!
MD>*0&DZL*_*_?[2W-08,?ZV.(T_N9I5ZQEQ?Z_:9T#<V,8LF(]8G6=$+B3FV
MO^72.V1(@%G15<A.!'Z4D![X:L%MPF21%6NR"WQ,[I^?>&W/>.4%^4<<7R8V
M-0)_4]XRK[9S9[M\368>J9GW(FMS;>@#U[R]_4R5GS]D^.OS/UM"HVFCWZ=J
M-^/+@UPKD(;"[: ]L77083,R\7F@. GP41O]5TA7U0V;2U2=42=62^\5T@>3
M 'LT9^4E) !. "%SJ#-T5L: E('-Y:#WW.'49YKWL#6S\=5#J#NY-5K(I7DE
M\C(>OT<>NPJ$BA@) ,TB8]V#)#^_*GQDP:DX08A_]3"PBKS:!1KOPTIC&EA?
M?%\Y[>&^B]I)+"$!8DQ&$ML"7V#EYQ$Q&=0U&$1$T9_4)U_&["".40;M/'\@
M>9RVMAAESCTZ]^:]?LD@=IC'DP,G?B&/B)GOC0>#^_ FT-3T'*H9_09VI5Y^
M@9[KF;G3Q]6!>T=C/W5]K;TY)FWO9'UX;I[XXN(!\P&R%1G)38^MR*[,(<\;
MAC7BC8HG?B']SU$,BN?#H+;\U"& <9:OQ"[P!07%K^K9RICIUJK[ZZFTQT=D
M?CR;W7=#TIY(U>ELTD("L-6SPW_"MASGT%>Q/ &1XI<@P5:6LCDBF<![?'TU
M_$E/F.UFXFF ,Q<:K,Q8?ZM$B>7<WZI %%3%+=8LW&'UDLV>/Y]0L9T40?AR
M&J=Z0Y:-,\)LC][Y;R<?0,+_7KSC\C_\,$2)/-O"-<D@#D IZK$Y&-T.*/-P
MNJ'>Z+W)FY6S[M\M7%7Y?XH 4 W^S'[)6VR[2%T"7(EI?5:\\8-EWY4)D<)C
M%YQV[Q*/_<^Y$L5$[=NI@ZXM:TY'ZKU(C"YL"MC:> 7CAY5>E$UH@8H-(K9Y
MWG%I72WJ/[G,>LQ)(50GN<5_RV4ZXX$/GNF] 3C"[+@U]CV4\_(/WRJ]4:K-
MCYTAN'MV;,S9G3/G[]8<F'8K&,/>D  O I!3B)8RO"ZV&0%^ABUK&\CIAU^)
M8])3MW&):FVXQ'5B<(6FR\(NTC96/+3E3$W\'01O7KFKE&=GLQA[ <+AN3(Z
MQE5U[F9_FXB6LH!1_\RO&";:M'-(U5[-[X*:.J/7-[+B5^':/GCZ+RM%NA?G
M66<3IBR?@HUKUZIF!T_?9ZTM/AX2<3;Z%0DY[T[M6E3Q<(EH]+JL7G;A,OUU
M7YCVV$%!,)FC<#AL;^5:Q7+\L /%,6=9T9[4P)4(NIFYO5TU]RLSWJHR/67G
M=EMP.Q'P!AV.T9]MJYJD8E.)FERQ!*_W),##?S-'@,D?>CRC#5%'?I&>X$&V
M;EITT-C__IT/>4(N[V#!JWZ^.R<>1*E3>-;HR21.X"<VCKQT:+$E"P&#*]TY
M1:?3KFP3CW:G;RO%A0"CH>'C?\";YZXDX,!XUZ$5UE3IT SZ;E@,'".A2Y6=
M+X6\A7SP2XE=8VN+]Q2>::!6IM:USL7*;&?]47D+G '$Z+*E-J'+CSMB 6W>
MIAW[W9RR-^C++#^/4Q(FD<K@3*F3<1P;"= V3KQ$N5N@'_J9V>N!'VIVA,Q<
MWCDT.ZVW;\Z+MXQQ@QX/QJ.GU'<;4(.: IGU^\.R9#Z])_S[+'W\]&HVE@R-
M>-J .TABL-8N-5$U 'Z<0.X?)C@];,GT/>&8!!C(\Z+,(<_CMR?U\+WDBV0;
M4T"&0SD%!R%(Z02BP3R0X 4CW*N ?AS/"B=>X,!?WK?_$D*&XFTD0!A^&TN
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M]79$(!V^)Y1I1XB\BB+J)[MBZ6+P@K6QE*(/R U1M^?/,F'Y/V^, 8.)U[#
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MR*;I4J XQNW-2CR8SE?K(6:SE%:>_/_W"UL'/H^\K/7OJ2K]Y.?XO7Y:*KN
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M*E,M*Y[Q?K33E/PBR7I5F3IM/'O\#03^$]R$8-@P.:W,FG,K=V(YOF9IT4=
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M+<?UJ,J;:-.YHK9(6_<QA(VK^4(]/Y%K&0>"#;PE 1+35<B@2]A?J5M#,^?
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M]YP]"2^G_)9:DN3U.4M:WNE0/]#V4\?+]QY!28!OE"2 L%PH"7#+1!6#.XO
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M7E/@6]2-@5_:P2LN1+-8E92ILDB;O?Q&UZ8'RQ$.W(QZN(M2+#B@7/C3!*+
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M<4>*1SX<MRID]6C_>U2< CU%^>##3V:J')C#RP4BBV8&8J6K'<I'1Y^_9.8
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MI/$L&KF?^5RT"WI'0K#QXQQ9/&U:-:>31[MMHT^>=0X*JM&R'\R,:*!^!K-
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MKJEDLA=="5:0JQQ#UK#5O3O<NN-@REYC$8(.58FN#UN8[4.+TN#M/38[E=I
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M[[GPU1.5_IOUQW>C/^&O*I4V48Z9]&(,@;[RN:5BWW\R0,%CZ%*$9:C'@1<
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MCN]4#;3IK+<XH08+"ZAG\#BMPTZ,OQMR6J6BO+3LRA:7LZQ;.V\DPZ6]JU<
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M$)>^.=&%=#'XXA9MBR IWQ?QXV<JP35!YV'(\YZ)NWYQI^-F+*GG"/+E%/)
MMP"*'D5<OV U0;,BC;@.A)P9=%9\?RGL9>%)[N'CRT3>!ZRZW301*-&)DM8S
MD8 $GR$W1=T12ZT/B<[6\ZIYMHS(_;K_Z@Q4W+Q'N?4T)GXM V8"IE]2Z%DG
MOXF($T.')U6+3EU@7I/=1/EL;9K,Y;K7\5[9APY>^F1L]_L5(0L]>[ TMH29
MFV]9-#KK;+=?SJ,],C/3A%2WT@[<)7?_W43Y(_8-X'-#[ X.8A8+=Q73LO][
M"KA@@RD#8LK@*._@P6O#I21&\%QG2I^ASP%RD4T&.E/AV&JV-9@6PI&.;?C?
M@6+V*<=#@#3\51%-BV,,'V?NO?*W[;OEHFL.__4'FIA1:BMBPS]FH@+[&)M2
MZ0[W6<4XNNA/7)3/\0[I\%40)4UU)M'L69]1^+)NB45Z]?^>5C)A3U0,/Z)9
MM["J(_I3]LA;:-'MJYRH,A9=_A;TRVT&M#X+9@$P@T"*5<Q\@3;-DAJ[F$ON
M0,X$E[XVC71QLDC[?HI8?H$AMBO;+23<';A KE6LHD<_B5@)M?Z5A;J&8?HQ
MG"Q09YH%CC(Y >\3U;3_P(G+5C@G_8'3W#FFH)O9J81E9NL:-X=;'/% TI5"
M/>H8[AG,!6]@A%])(Y'8L^U:G]1=C<,%(I&M-X1O7%_FIX_/#HW OR#Z!1*E
M+M"-X.%X@1=]0_5KN<T#8^0WX@/9$>K6H)%3&C:5(4W1A9&">I@2^LN;]'FJ
M#RV>;DY4,5W>8TI'+(ETI:LA.&GW4@-J6\4+V\!78=_JQ@3,X7Y$[LB]?JU;
MI=Y<6].618:08A&EM3&0L+%4=7N_=DKW@6E6TPQC/@82@SUPVD4E 9MY*,']
M,<$)AJ<IG />#P9:!M*&GW9<KR!)-R<T6H5(*[UZ(7 GM$WFR7A";U&J^V4J
M/+F4@DCN/@=9.C;C,(,07JU[C$+G7KDQA"WN)<LEC!QA*H]W7V,>I>?@4:G7
MF-[TZ_ RMW5,MK)'%3W29?]Q9\K19S*P9SQGAWH\>UPW?R4NT*\RP$!1YFT@
M'Q.^O,X!=-"9.]YFEX,6K *CJTK?)KKR?W)Z_J)$L2]S(!1=+FISE\?"(1)C
MMSL7;GDW;7S(=<U"J*@I,SFH]G/C?*2/3TPM)FOB\Q]OLX)T_:%3%F4AK311
M$CAO29Y>2C7<IM$I2U4X;AJT?>A6QA*N-Z$_NV2"QWPB/ZAE'])W=2Z9V4H&
MEV11Y;L. 8HVE!56DO4AH&1[\J6??:3CGA?G\^CV'%OX\7?5O]778WYP2)FX
M']2YU_YC!Y?J_I_'HSS@;[7_/Y>?VGSW_]K\C9.8[<='HE92BX560(W (9(_
MFA9.<4Q@2S#UI[OE('I6+X8JFQSK_5JT4A_DC6A?>[)%DGY_X^=QS]2L37B+
M"#./JQ_%.#K!?.WS?[WNMH._Q#B5$;(NJ1>H5D3</D]4JT$G9G<V8BS) EEL
M\$7X')&67T]?C2)(\N_=Z*1$)C,-U+(J_XIL\8A)FQ^9NB$2_>LAY>K08YYF
MJ@=QLWP9)#P/M>X#\W/T#'5VP86WR>7"U%*OSJB05""ZH"*TO)YE# 7U*IX&
M4FS3DNX-O4H%"U2W5PR:";NRR[HB"2ND!R(OV/\84\@]<8+3AC*PF]!76WX.
M@K6=PNGY9]#C7]_0I7>^?AL6%;4IR:^T.$LGE ;GQ"W";? .]U.<IG-ZY!%[
M+G</YJU;!RF' !*\ZN]_**MV'&9/]X%3)NYA%HQ+W25M)"VF"+=N<$\-5IW/
ML(<NOAC-/Y9+@"^7NFM0@W(H/DX_:CM%:$4\8%YP$[UD+5T:F4<Z\@KD-?3O
M_D_4%1WQKNIOAX! EB-1JO03S'"&+>UK*$09+Q!Y\XEQHCL]4G/\T^D!R\?F
M IN)>'A"_FL2^ :\QQ+^:WH7P>!^ /^+=VX/22JVS7(;'U,(+TYI)R-B_.:-
M"ASRLR_F7-M[]#W/W,"N,[N0#%G'V<;0'M$3J->=*>27&K$Q>"!3)DXHS0CI
M!+,\!/"HU&)R*X]RYVU\^X3Y#I XM[62NU=T!KRPZLQ?&N/EK<D["O&3C_\Q
M_'M_L\JB;$.R3?KT,M& +PQ^_!#P*YG.R_XJ##RPEHS(&DN&S91]KMD\!&C7
MH2A##NYM3W86"G; &6AKNMKWK>"Y-"(+29*A#.@_X,]XJORJ,W=DQ0I2U'3!
M\Q;W/DT^M"9ES^1:ZER=40^P1:J(",)"7.EFW4"(4P!?OQ9V;SZR=K'_5,KE
M6VJ7 Y5$]Y?BEHE_B",@'^ 9%_8$6!3D2SX)!BI8HB/I#2-:>.,V&W(:_?0[
M!/-DYV!?'[*(M_LTDV.W$?$&5LQ'6O4U8^-QHQ7=LPH_A\3@N/"Y4QKECA_4
M0BVT#@'G,1U[&INA=[M\[_]&H40M#H(O!/^N"D$B*FG@(3+V#%-H5O]$\8._
MQ_IS)Y*:O= JM8;S-+"B^;VIS-_=-U3S'X:O#_C"PEF?.J]3@%9H>-/'SMEF
MDG-PHY\[<*IX.UBMY-L%XXV/[WACGAV1/44%"4K3ZSDX?9ZR5-1_ .9D58'N
M8NFUSW^"1*BLC<N@!80A/9T0+,*QKQ-BG6T_F+R' %Y>FQ^=!A>F=CZ$OWF*
M%]3W=P^/NFES,]<8>_+NQB& S\,BV5\I))MD83WI/MK2@FM$&?FWONV9>1_A
M6N]>AXGV9ZNTSW^GN2"PVP-2@-8O'70$)<:>'HN'K&8L:OX-]]74^>@#4FPU
M>Z]AM)XY?[)+AI9$)P*_6K\\2$@E3#GVAS@/!U7[YL!]!-]ZVIV6_<GDFV.4
M:Q* 8OKFU'6B2"].$*I.I(4(\]0X:[8O%HFO;D<)O+.QRG.,F 409<KO.Z&:
M55\CH& V3T_YWZ5+"1L'["*?$JS[+:\'%GI6@LOM&34WCKTS^VQ'V!<W-_2M
M5H@I8[EP%/JF&-IU56OJ5<%"H'=V@6!<H5M0^!1[,84 %O%K!_45Q>?N]2L+
M%R[-VV TMM8]/&3S0O4'XF_T:(>Z/%Q>)N;NI*44-0UF4G+ZQ:Q?[2R*W*,B
MT\*?. _U19OH+^:SMQSU;^<#_WWY];^+_ D<H607X(N>&QZIGZHAU#>Q^YOR
M1EX_.9UQJVXS]L&'#V_U,ZQ@/A3<8*%A/:O14'>]4(+.$6I>H"NRS4V'1Y,1
MJUFC8I1EU1U:@)^]Q"8OSD\LU1ID*6*R+E5?"C/8:S17>>J,ZIBPE7.N>4)%
M*+I-9,D%UN4%6[DT, Y<C/X&"M 0LQIJHG\+Q>GU'-VA/]+JNM(RM2L\C9_>
M\/Z7>%9_$B#SV.RK-&,Y#&SLV(=K*@$!X;YI\:'0>^R)0P E;8'WFUK@[C]$
M \/E'MG _%?[NDI./D\&X:<8ML8BD.*?O)03>^E [)6;4MZ3'>7=D,)FG2K_
M:(6(FH*=J8G(/X5=_+E"LFLZ;JUSUYL#@S9;'/_.%MP5(((&T^AV#@>W(]AG
MJ2+)S6[N/B]&^FXT;9N'WS-/'SZJV;,6QME!+BDC@L"\\@".5[5I%)6(.A%N
M?8SN?!#>(O:[#AE<67,9]W14PD+KM&=^"U3G-!1A3-]GW/$M.OIG<J=HH]9H
MP/T*YD)9%GY13MOZR<W!/Z"O;40=A;HC/4-CH.:]-X9Z]'E:&-48E\CDP8-.
M0BVN!JL,% R6R]$J6EN3_TGY+'7O>N)*Y..8R81$?]40*VT(,J@%;8_ 53R6
M1X>\PF:XR,$M_VX4C5JE?40%" A#7UJQBF#F:J\[U?7MO2K](N\O+0Y5#OBW
M"-<>.Q=Z[.4*0&#AKA5T8N,8<>+-+.HH[%HQ%G:9$?E:^N7][/G^OGZM25;9
M(XW-^MA_ZW86U3:1YY[OM3N66FGD "G6M[,=U&1@UV]]C\ZD'>&([G&.2&8:
M44P9>[@#%X.GK54:$'0S29:#5L^KF>W1ZV$?1NRK'E4M8:SFK3=;6M8;M[ 3
MMG\FN)@.]&(UTB+1RG\"SS7?Z:ZOWQ)I>)X3IG)G00V]?/7;W=..H_#E?3N?
MO:*-7 ;"BIX>\IFI''P!9CSUF Y7J1%T]=>#8:A+M9^KSQ2/)P>^^W+JQOW\
M+^[-6^1>^+[Y(6# FB%BNE5?C:/8N=FP<<OD5SNC4"R$S[+_WD"4X,A%P:K!
MC?1L_4N7KV5^5>(3NE@UQ&=QU3+W*L9-%5=4P-A_K?57W_B!>3.7BL;LI+N[
M ^E7>"Z<%$Z<$/%3(<"Y8<>I)[N6W=T-W&,=EJ;6H D/+C9ZJ4G+E$V%N6,H
M<")70IP.5!@]X"Y::'[9VSO13/6<)PVMADLT'NX[G?KJ!;?TNYL(:73<%1AT
MJHGAH@R:>ZVR0?KL]"@>).77<_\\H.KD^#. 4OF&#V5EB'T"8WC97^HJI8CY
M3R[\S>[KF2:2,L-B:>?VQ!_19U"G5%"$^JV58ZG*8M/+E=-^<E[A9/FER@?5
MW:D'<O6E>C.Z^(C%I>YU<]]%=,-:;75DVW<_3E/=7U1SH"P.T2*?[1I AKCL
MV] U3+EB5\V%;5/N6T&2L]+W^0D [B&EZ.7TG?*>0X"$/T[04')52@:CKQ*Y
M/'9WQ\QK4JT@%Q+8H Z83^<WN_=32><16!G><Y4)*C?]Q+R+.9$/QFY!4UVT
M.N<_Z&?9AUPPB%_Q>#Y--#@1VV8BKU$9MWEU=GB)-4.B'P+,,/QKTT%AV3D9
MS1U:6;C=O?RB?O)K=V'Z,)ZS!<D:*%*LZ!]S[#Q)L"?G#NGZ9Z^@:^M@2?9P
MW/$?;%'V(HH3T?#5P(U% >LI&4L(6,\<UJSB_RLH_4/:]_XM:V=&;[<*78!#
MI&+TU4/ PPIX5NEEB9)2&Y[5885@4*2M?N_9)Z5:S;1WCNO!4?-3*]C+/789
M3[AD<YG;='RM%>,A-&\(FRR(8BJ!XIWM=]+O?-C:M7)RZ1Z\P!@I/PYO *V6
MQNR1,(0)J;]%7(> ^C@I>J3S;+-5G'=]>_ODY=+V[)'Y(,_ ^DKI+_LW==:B
MQI7[Z[HO^^+XX%X&,?C9! J8,)OEKZ%<'17N9MO;??NDW\5'<M_)?PJJG#*L
MK]\8NJ'D:YLC6VT:_GFWI6'_Z3;F4VUT/>U+L<K%W9Q2-K (K*)72&8 X,,E
M4%YVVR)\U75F1P7VFM.AJ_125BW%IT^*8[>O3 <<X'.T2$<@Y=WB:K=[>AC[
M/4Y66[P[DK5B5;P)*HU5H9K:=7)VE(Z\C]Z+[4:;=Q3B@L%7'WF[QDG;?D=8
MGW6P"@^F>GHY5+XN/7\@"T6^104H[JJ]R2UZ87B>?NP>O;)VE2NHW*"+Z2"L
M5<-S@J__^?LOTLD/C][LT='9WR-R&I,C&V_ 33D;NQYU=&U'"NC-3E>L(:9L
MS<7K;=8*$DMQ_6=.'5:C??K,S>.G=CDQ5?YNFH</0\.H\NNQ-;&RZDB#G:$<
M/Z&62QZX4U7P9=/9+ZC M'U=Z[DB=M_*(<!"I;KE_3]&DA:)CG[DE1&V [LN
MQ*'@CLG1VCB(?,O4+ H'+^A,*XM3@]DAZ4;XJ[4+OLZX-UC+-Z1_T#N\U\+"
M9!'O/JJ:G#1UW9,T/]H)&@ WK_2#$Z+-J&K)(!\6Q)ABH[=_4*)':A[[?K8>
M<!U;]:++]/37HT^LHG%#:6EL,5:1ODIP]?IZ>%1(C$XS>J?+$*3^9^NQ(4%1
M.M9<WS-<]M@R7+@SC'H((/CTP$6MM/N ?%!@+]H7:>-F3'"SL<Q;:=EZ\&_)
MDXHY^06\YS&^9$R!N;-JD&+UYF).V3H8%9MVMPFAR3U6-COLMCOS=X?1LD 3
M2 8WO0(+=!^=9]I3!N.[-2=E+6->BBWEW5+Y+<T3]ANE]/UCY3%1?6KB#OD$
MO6YHR/WL),RT#/7A4=7<0,PQ'Y#LFPO'-J^]W$'DPQ\7G<;"C%BOFP3XU]9I
M27QW,3;U62Y%B\W3ZT-HY%0;XN<VH03%:WB":4;)2?P]6$XI^T.2<P#%S:]D
M7#1(JGD6$UB[/OE:P3UWB7^=>1W4-D_6_>M8:7\OOR6W\1 @O$YV9*3Y4$1(
M%U!G#'6AAX"OV='<22:4 $7:Q-DNFOU*@+>:PBCQ0HX*BOV@4)<8CP8%J G!
MS%JG-]GGF!+33#@^UA!?ZXE1F*W=^?8G/6XO(T-9]"2W_IDHT:,?62_8$J,B
M7PU,^Z.WKD& 9]14PR&K OR/WS687/OK&)9VL.JJ_0IVECI/4VQ$33$5/OYD
MNM ?YPBZ]?B<1OG,!-IS8H'DD,&MF@\RTJIF532[RNDL19=<117W5+ _N3R[
M\AS)?[I<[ OJ<LE2DCVPT6N6T25N6$&_256%)Q:>TQN8>!V.XEH8"I&KP09U
M 1(?77QXU17X0?V)^#$=?4?_K<N^XQM"YST;)0 &D.\@'QQ6O _<Y/AJ4S/E
MA&I-4(TW0[6X%"?MDJ1;7U##=5SJ25\=_Y.;1Q-(L37^8@(;8U3AO3L^E@-3
MGC>H^>K*[U*_,I2OUBE-9NFVML[1V.V2.PIB[VQL_K@= NK*S^!:Y*N)77 '
M-)N?J3;-5IA;O28>,^;#N,NG^O6;7HWZB$!N[)?K9]_=-(#W@+!P4WHSP<"Q
M5R\[I0*J,(2U('=1_B#2K@6+0CTE+/)3GPA($X^+3;#BG[J!;K.R8(#VZ++Y
M/*WV#].AV_JIX]:57+\/ <\2J1-8E*$8JP7ETP4QD[I;#W\2$+2D*F89IBXO
M+FDR7 ID5Y%I&NS&W=L=U;OMUNZS: AL0GM^Q@E<ARS-_#TU&Z@<V=VQM&0J
MPLD)1ZF1R?-$GUZ( T79M'PUFI)YNX/]\U5*J!OMN^U#463?(VWSHJ["%]T+
M='M"F@@=V9?I#D7W "G/UJJ?3)9]8-7REW9+5]WN#KAQ:?BRUJYXV%*WTR'@
MQ2OXL ,K_Q"PX0DZ,)SJQM8LY$S[J;HWDB=K(]<QY9ZI;P98H:%_8DRM0%UE
M&'09<G-N&TZ:(5H+TWV6X6]K=JQ/' *"_T;'9X:=K*R%^P\$:#0_/*.=T0?K
MW]17N!/F&KQA314@A- =*<2;(&[J,JIA'TS)@?=:0MC5847:&WFPB:XMTG@,
MIIJ-!6]!@(*@#6'<@1@:]#AM7S,X 4CC.P1@TRS>OW^"[K3=*\8U=6@BF0;?
M:D4M17G-$1%N'7W_NS_P$&;':H;I4H*)4M7+J'.K*9#R.5](=5FET.Q^D)?/
MJ9;Z^0W1B.$>W,]?1S(TXGC8:*E_Z*40PIBI._T^0>V8+U;E\Y*+JS^/LE7%
MH%&^\;E;'P(K\Y5!2\?T.84\#X5;40680N*WW"S&E:>;*(2E&XVJO\W392_1
M=VU"#;BY*H1H:LF=CTJ8($I=)<$@@A3P-$7K9&M;Z\.[TU+/0LW_ GYEG# V
MOEMPH2-FRMI]:=L1&6O YV=1:['MNK3AF=7!J(_8P4Q3CC!L8594X5PL[A7(
M!W[6OUN"YX_*;'WU_&J.S:654.>&CE:9=*0NR3V'8<C^(05D?=87DN_ZU!=>
M/@&Y_@"WFC,B'&,^?=3^2]1QB7CRPE%N*5L\#FM)( ^.@DG UT6G5&HZKUV]
MB.Z/TYB.FY#\*A'DXCOTKR.K]#*_WDKB-L=E%$JB!W(&K;%2HZXNW,U.NV_$
MMB25X7/"RZ.1?Z)<V($?5COR/311]4FOC2]5M%;7AB^JV#,9,GGSPQ;YQ=IR
M"CZEV1,^P:HDIQT4/7!,#Y08ITLY0HFKK("FW>I*';5$[T1J.XIU7'E,;OHL
MRR-UOO'ZNV,^^H_S@AF/(87GZ"EX,B_,GNX82R$ SXS1 J_9LS$)-L@H<\#E
M>+DCNEZ2YN+/I4_G$D%>K=/L>5232]:)6:<; :%'PM(/!$:JX3TVOSB)GR\.
MZ&JZ-2;REGB)-;3I"?HN,%*@]#3_[\TAXOUNUM/V_?5:S,=J^UHQ:&)Z#F5A
MHZ8ES73?SV<M5H8Z3T0FP'W()^"]1H03;>W;Y2Z6*H8#QQ;<QK]FI1R1?GH\
MPQH0J</U'<\J-U3PW7K@1J^F0:E2.1\7AR7,(TO\9P\*1D2D%3/FA!YPR5Q_
M,_ 4WNRXL1?.,()R639/-:=_@N89=UG96G2F6]Y2N'?C >#XL["]9[)G^ 6D
M]^W@S<C^B6<YPL) H*'4OMB=C-HOU/+XDG/.5Y=/9OQ34+)EK02][D%R^O%*
M3OR!+MB;5)876'<(^!7\IE)G^'IK[WQI;#@=V=",DKR#H"MQO6%:"?1,%O?@
MM7)Z&Q><)\((UJ1+.=_RKY.0#&T<[!D_)2*9X=@4-\X&<1($9>L< 1>/HR3X
M8;U3_ _"5V@;(CBLQ3_K#9K?04J5^XU[5&PGCGWJ?H6+/Z[!!??@>XY6CEY*
M\H\QT9%O*1DU D]NGNQ^1DECIO.)L =^PG<^^,NI^3ROW%PK89!'FG%Q!9V(
MROL)3=\K&5@=U?DPS<"6F#V4BV\8L %#XL@(GPIE'"P"?PCOU6V\ESVT 0]@
M.$0H:;'8SN$XM&3[#/!\W!2*DA(W+76>;G (X%[!PI$!4GL,"&D>EE)YG;0%
M:^Q@F5SKC-W,YQ@]Q1*\KQ53Q!!8A/]MA9PCI#%+>?'6K&>EAX!)D9DYO?/$
MY"S9KGE0+Q_;1U+"ZH$7AYUCK."D'93,8IQ.W%0+F$??_"/=U)S"8:^4SAC$
MR5A0W\'3I+.7KGV0RVI-,718X=JLUP'DEBX#T[IU9_3#R^C@(>")9O*)!?^;
M8RW%?O"3U8\[SC=&H8>:C+\NAYI+/VY#88UH453$F^Y+4 @!T[OH/3@T)";4
M^*"EJ%I1"_E%<M]UF21KMF8J>IK;2T8>T5<T+^[00D\H85ZG]RU;(A+B+D^/
M##R*DO@<J\>V>7)49WRA_M25<?4;EWF$)BSR?:Q"Y10AX3&&+0WKI46.W4/V
M_AGE]MO#@V(/L.NE^P5-LZL!+3,%N/XTK#);B#R$2.!@-Q[(@#/EWLH< OQ8
MR%&&ZB)N:W3T^C:2,3K;CDLN$F6J411ZM*44J&[S+G,FO9<^OHZ<"%,\7G-?
MU>2/CH$9X*@YP+L[@%4"^L4"^4P<$$.8OZK@__V'>J\IPX,]$2<Q<Q=F0,N$
M_O/NCZZ/X(LCDH> F4$4!12M>#_%Z8>+;IO;OOPAP/AA[9LLD3?9:Z>TW /5
M9A8+FE=((51>XQ\329II<WO]#H;'[;9_3:,=D!D'.GK[:1Y->LNAH5^/#.L@
M8/00JG@?AZ?TQ<NAQ7TBZQ5_]X;;=>V$O*3QZ=-;-25G;N[4I?K:$!02[1[(
MA"M]Z_OG^?(+ V4"@B[/G/)KQPURCA[VZG]S;2RIBHSC#W^?4U.71-DGJGVS
M*SWU(^]^8V([SOYI,ZH*N_3R?=6]2BL+UY&[BQH1P99/)\EPVWH*F#0CDDJ&
MF7_RQ0GLNGD,M@=5AY2[^.K9?_W7ZO1M@6;K)ZL2$9/9(\S^[63O%I@ P]7_
M&LP-S19G6M##8RCH?N<:;RO%DNG/TRIUU**<L11[(XDS5UL]'[XSFRC\[PEF
M&3!I(C6M*=A0.5PE-:3=_1I])G@^UPC",(L;.S?T.H<M>,**OG)R;?KL0>[?
MUWHV_;:?1JER=>W:O*O;9'CVD'ZUPT'SG5LY7W][>7F_)R%&F[M]4,P8UN>=
MM.<A?R-42L'0O %WZ?QYWX.3>6EZ:S=N#'OT2E\NCA!P3\@/<Q=E?3:\J);4
M%"C"V:JCS8< WI[J\999;.J'RODURNVA_'&/4__<4S>7W=&WAV/S:!%4A0$5
M2*^4#H6_(_@S=*]7O3,;&.PVB^'N%S99)NF']QP7Y-=+M>V#MS@FZA\CL("]
M($GF$87GY&9%XZ[R-TVKMP_<^E\M^V1O#<D4MXD_?UB<._A:9[KLO<W[S4V$
MS^_1YIW='>U^NP*]E)&[5QH:+=984<B6[MQPPP;$!7HUPP3>VT"?HQ#Q>TP9
M'!9,^==LE55,PREOY#F=WH]S"5YG_4;X())!_^<=R?K>7LVK9UZU1!X"IERT
M!NVR+FM:O(OPG^6 >0;S PG<-$22#&1H_>V^,!/\-*1J;NV@/]IS2Q,W-U 2
M4#.F?8#$-2GN0R=J0Z4NLJH[?>230@C!QYEG,9T/EO^5\4.U;.Y>>(HIE!-5
M[_%?0YN+2E1BU:\['N' W>U[AP#^.,EJP C,GEMZ!]26W3V>JZFU^=JNK+<C
M9/ J^KQE1K:H0TA'9\>\L0@:,[HRI5MN>TY)R<'B:K3S09N*VNH<,Q6X#!],
M.49<Z>L0$*$_'<F./#UI&?@$D(WU8E"[>41%N61><!NL1PZUSW;@R3QK8@GQ
MG3HPE]K>JL"FD!C)(BS/0^[MDGU;0/8*HY4,EN.<N\OE893,0=H^:]I=X=_/
M!][<8<S7L96.2:5BFODR+6ED\_D=C=[Q<$4%@UUP&&0'I(7R/ 0DXLX'L)5@
MP3/ZFI1G4.2]Z>;F'+MZ*?F6!C'7SY9IB\'I9GD9Q-!E6"&A2YE]ZE%L>#C#
MD,Z_;=L@9K61NUN"=/#V>N]B%OA;#?BO3F"YS)-EH@:.KH!@9B&PU]B#-SF5
M(BL= IA"BD;,"Y2,+Z?+^W\<Y5YF__'?# 4[?[HPH(;?(TEJSU.W]2M,P';]
M(S;!]"Y45]T\6\HT%L&>D;I<9)P#IL=0PIRIN)<D#Y_8""L3%=V@LZ;?:3_T
MFAK+N4Z?]Y'PJ8T._IJ6@N4BG:!LH@>ZI;8_(].QO$F6SXZWH%6U37XN4^Q>
MZ,5S83LZG#Q>]%XJ3O%X>_%4?<41^QM? 1%"5#7FN?@#HC7=BPIUEO9NHI[X
MWD*I^(K[E<RI-ZRB3F!Q),MQE")+GEGWB2L*-2T&^HF]=]0>) 7EN;D@[M9N
MQ@#30/Y#C?2W4<O >#;WM.$E:(>UVT&REF/(W!P'W!M5II]5H5KTJ/F_'!)Z
MB[ 0]CD@T(IR"!B,.S-M*$'?#QQ;T+/:[74SBN(>=^9]=<1SD-^$RR@97[^5
ML*%(Y2(D)'2+KF/37K%/IP&[:VNM0RH@)$*UE:&Y A;5X5MJ<PA0)83>Y7F7
MNX.ZX L79U^!A=)-"7F'@)=@RHL^O-N]KC^?]6T]8KNG'&XJO;]5^ZQJ@8^#
M_(X>O8/Y,Z+S@5[?,^]BL RPI3-M=N74H$6)I"\X5F8$ZV=8-]\\-V=P.;;<
M_29UB)8Q&7=Z3<SP)7].!10YV#XI<X>RE/JI3OX8Z'IFOU_/_AL#GIY39KL'
MS)U)V"-B'FB>2%A"X,D)8$K];I?>['7QF ?A\[$:/YU);[B,U-_-?S$D6ZV
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M9=LFA3U[P)&I7=+%"0*YM]847YA3XZI26MC2WB16FOL=%^X#?;;52/Z?9+;
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M(UR"/3?):/=L=%U961LQ1ED@(3HA:>=/DA-Z&2T[HX+EN6'Y[ZS,1=(3_F,
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MCP/%I4"ZR8B[PQ=ZU0]VK:/F+JV6NW0$QJ@6Q+3$A;._'@+$Q'N O$Q;/$(
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M%Q@R1B/K#AO+AY40#)U7(DCFMQMZ.DG3S>,37>#:F79&9I^0(7$Q"B<Q63M
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MRA&8WDY0HD=&$UL,!\<\<6-GH"XF$(Z! RK8-4TX=Z%[&%>4%],YZOG>S?>
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MS[YZ8&;M=D7P^-]@ZS)3<XD!TSCNZMA&;*AF'V;^A<5M6MR\:?V?9&.6&?Y
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ME*S]"G1$HSKH>HM[3*F5I[2L/C3$#[M=77W]#G?R^X)Y.&:$RK3_O2F^:G^
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M,P&$[[D6/K44R?[&DER0^64RBX]#G?T+@=33$A)928JE577S>:PR?N8O W+
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M!3O1OI6Y*ES@MX;(W]H'>GUQ][KNP68,&KM3FG^<Z4BT*1+I0SI@SV^!65L
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M\Y^X3F  G(?>9=_YXX.L7;?C&Q,*,=O"W^LAO99M;]WV9Z&*A+0&F8\<^?W
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MRR<VIT$S+FYK<8[O7]_OY8\MD> 1CE^()F?2+U6PAJ+A'H342O9\9_JMKM)
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M7#J^D=#3\8P<4!ZUF)JV:U&M."E%*K)<%:O]K"@NJ?0H+S[UB+L#\N[453S
MA9@\)$AGBH=O^W*[%-R;&U"-TF7:YRKT%WY[0=5SI-BS\$?*<HM,<.[D_.;N
M*&I=4_EY0,//))N2])+1.6N0[]SQD?K9Z&-K"UH4_9K%>@6$:D*\4;;8_/R=
M;$!"E]VM-.98!F!4[>GW8C;A>V^",M:0+\"1YFM=0,X67KU%1V)\&"YX/(3-
M OK-MV7X\]B=CQR\_Y@*GWNK=Z:'ZWX>;[<!1V-TRS0\9ZA84[=IX[=D_IM\
M?$NS/T0Z+L=A6!,1##]#=@HD>I-B:=\.K#%<KM.*']RH6J.;*@8),E/Y8UFK
M=:;F60C?V/,AO_/=9V6U0)*FM)*DYE(TN>"4X-9E)<])DM*3C;7SF30P1/R$
M4Q/.3OD7SEE!BSW($E_L:>N+80"NQ@@^XI%WNXI>S1ZD<XO"%[4<E95,DJF6
M/"+RV\AJ%/Z^/P%#@H_ =7!&<<BN'*?:X;DQQ23'A/[]>P%B)H4!L^;RJ!]K
ML0Z:^[9[)/^1.;LCV9,>T8++6VG#J_-;Z=;-:1/X#>\-7= *Y-2WMH&;V(L#
M[.9W>_RG=Z-:;AI>3-OJXMCBON)YM8U7XRE;E61.8[TU2B.5;3N,:-BE NM$
M"U&O$0?1,I'5"9=J<PJW%)D^EY=&/6.*#70\^S127'Q-.+G*A'0_7<[E]XXD
MQ7ED?JAOX&;(*Z.5U*?3LGY6FYG36P74S+%=.!OE7LYY^O \B%S& %Q**T#(
M_^(#;NMPLG<EH5@H@X>VF%MXV_I-Z.S6(O8M ["7B([/(5V..+8RD^D9D+$A
MLE&OJ[:I2+];E*""?(L"7I:MCDN]LA2/9SM(_ZC=&.95]!;;_E1MB0OU,]70
MGED*Y[N<Y(X-IWR6)*+PJWF$L<I)OQ4>;%](S;[&]G<9]_-97_:S$[4& WL>
M9I!C2*6T).I-0@Z.%4T4:3.WFH];F@-T!-(PMW]ZJP],[7,!!Z277X>+2W(G
M;G0%<^U&G/I28\3O%H$)->_"JY:KPR(3+)ZS>NXE 5(STFJ%-G%=+2:)>)MQ
MB8Z_NJ6OM[.R,\ID?,N;@P5]B@V>I_)JFY578ZTM-PJWH+MC991+5!NB87=.
M*'>+,-&OB(8NDJ[UA@KV3"U&7"ON-O+D*/[BKK:D=HC.W=HOH5_:I4A3[Y/+
M")YPZ\4<%@; -2!\U"9#"::!]64=CWOEPR^2^@P7I1;O/>"+K7:*NBL_--W1
MKG&>_*U\/L ?=[X[G93(9Z,#=?ENF]3Q9J^(Y]DCEB0%XN^=@2">XFMIH"F3
MT95IQ='&D-)JM:;;DJAQ]>;GOEOS9I/Z' V;!Y2$^G7T9;(A!40^A\N)D6,
M;L!5QWWC0%K!_G-Y%ENRLR[^!=TWS,R=I+5T@ H/0F=R?-$*^?;<.XTG)8C2
MPZ+?7N89>L/8 ^T!!H";?C\@KP-8/=3& )QSL?I>32#5PWREBQR6']$18][
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M%;=P.(-_EJV]UQ"'2P7O7IUC -X4I!4Y^E[:N8F)2LUJ&I+_^^7#"RW/?2?
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M=7DDY;G>Q)=,\XH0VZ0-1/2<;FR6JA'J?+!MR93HS)9[.8VM:!T=A^# 0AD
M(,:1 8C!7E:#!)T,13?)>/I_90"<_WT@-=BJ7XK>I"R)B"=7<>B(3NI0.*@V
MX;"_TZ-F8RO'U)NP0(? IH7BF??K*/7[G%K@RQDI(5]<=8]65A#%.J<.04KM
M-RJ2E(QBM?;VEM'1S)]<.P*:&$&RD#^:)] +P'@%3FC%#^"-)K!BY'7%<W@=
MWP=A0%)G);)U:ZS)'$B5.LTX/>%R37=/G#KPEPXETK];?T;LA+0E76  WIJ-
MM-<]-YUM4,"Z6V,GG]OS+%W?T,VWKXS6PRA*Y:0EU9.XN(B8>'E!Z*F>0/EB
MPHR@5N&AA,FVF@WIA@:;[DO5>A'=PDX"D7M/>RBL0:F@5.+^0G<JA9?LV+.(
M:N<>4U/*T*<U0%6X9];J*\?PKSUB12UM?TR)L+#QBKYX"U4RBGFVEOH%#\NL
MP$"I![,C 5'BBA?G'AU-5C36!@?.V+*? H (H5XOZ912;!T"0!OL!&<ZS?QK
M&ALX7J2.JM% Q61ORHVAD*6R<XNHSB$^J-U-<H2;1T.HU4Q_5.%TC:S4\.4'
M;QYY*%2$QJ<L/?3R'DN7;+2&^B33?/'[UXD<:R2?O/YIX_G? ]4G+O-T[?'G
M^_[MD%C$'2(,_X[HW:8XC9I6D\%1]!Q__-R[";FM95&;<_^9ZNM*CWY/N^-%
M])6-;'G"?,'7+87579VQK\'0[TP)O$D*/ ZS'V27_9GXJ*MD-HH4_!XQ!P\E
MQK0%#85K3.'0;&]]9H"U<^*)E"Y@B /K+.?1I^$/L6+*^P<Q&XCIW8:-S4-;
M,P7?FY<10Z6+M;4A"E.'!U-8PV\,P$(!9L\U:)+VX2[FP .-)%LS *)][6 2
M<R4#,"P!>4#'9K./P,]1N(9P<Q=&M_D4,GU?PJ!NJVK9-J^,WM7WVA^*9DP1
M_+>#<=AH!H"%JAY"-#<>:W(IM7%)VW6K. G6TY=]P+$=/WUQSGS%QF'V_JM+
M&N\7OAVZ;*' ;@BN$08 W3^8ES-YTV$W6.,$;EB&,4P\5.<B,@!4SK6NZ5DO
MN!'9K63SB&^N]KUO3H7+I+F[G9'[D"R3*.F"P+L9SW-OSP>!.]FF%-MS.-1>
MEI!C%MFBU!XO"K*^*H/A9LJL]-QDNQY]%S-3,$EZ++ ##&96&K W3G$96TFI
MJO#?<Y%'G8J=]SZC99)5LWG 0(6RU4Q#2#KUW+PS>@C+O"DD0/N"?)-S,< 0
MAXQ>'$<  QK$:UH(AS5E)'(5!?WIK(;?G9E45NO5-L\O/AL8&!@?3B92U+N^
MND+SH(I\^2120^BCVS=V1=,V5M^H*9SC#)VHMG!W3<GCSM]U'"^#[K38GGQJ
M@DBI5&1,9)4GMY"V]O%_*%[1Q_Q+YMN/%Y()/9T($?HP\?QNI[JB8>:SB*[)
MDZ[.=#>UIZ^9RG>E3%.[V2\P&Z2N8WXJ=@Z8+_9LS^%LO6T;H/B73!/FBH9]
MOU^E)MHF^-WA%J_O+6U.L54VX,!(H5'!4V@IM;CFJO&G[9X5J7@TU!:L'ER]
M&APRQ@ X5&>\DA71@@<M.&+ R->0T!9^&OHNW(4(6DR"D#,AI\QYKZ<'?O L
MFV?[U9-X38LTQ6?,NYZA'\_&JZSA83&0JW!EHGUK0T0$]3E*T.3IQTO3LX9W
ME7V.4W;B4NM$"CV")SLP!'W#MQIGB:C07;AWZ3KX#=$@;-%)7X4!P*=?6KZX
M^.Y/(%18JT,5^-G >\#GQ;$]W[CTJ*X"M "K;X9V6IG\-A"_FK(^:J2OL),Y
M7)5]HGZ#WJR2DRN9*__<*,SH+;.K+_QYN:L*!O^.\BP A5O.F/^62Y4BJ+P9
MEY(K"7^O;[5>,RH0W[0]*V _\N#/#Q!DZ6C[B&W[V\(D.8_P:/\9H6PP[*[7
M9@8_Q-#7_OO,@S#8?3$_T;C6PXVD>__(?W#N_N,KYJ1J;9#@2(&L%:[NE8$&
M3,+&Y()FGC?HE=5LE$=2_**/34BEQ!54%]M?3ANB6S1/676<;#OQE7TR+_33
ME9OJO[\DM#>'DIP8@&1?LOVIX)[(8@#R>XW7Z]J]TN)E5VI_KW0W.2G=V<S/
MQ,S1G0J&(9ST7YB]0 :@RI\6@J8G!"UKW'.FR__W#W%N"\+0N\,NPL!J+2[R
MS>[AQ_P^)Z<]'5#G&>9^52XM5@0B;_>J2,2JASDY;V C#UG( +Q+(=HD?JE'
M\'J=4";HZ8N(T&$[$$45\1O!2\MTEZ>4<9I/5)?@/1[!I.4_+Z7&:-FL^-U:
M\O0R\!=BELNI2:=F]'0F4,[7TL.KAXP>2?_QAWB.&IBDP)2F3F9)#: E\-0:
MR?I/BQS\ L'@)_&QQ82:&\N)?L/&R>/Y/@?[PM:H&OFG7WWG<?_TQ^O =+\1
M'/>?TSXCWUP@BPM5(TO)5SJM/,?D]$)T[>4R@HM5M[74N8^,RR\\V!.J%R^W
M<"Y.SBW8U:+)^6'M2!B]P"^>7;VC82Z/AE,;-M&5U36-MK#ED%K-0/%NMJGY
MGB7S2)^M+&070J2:,%?6J.F):Y:EE;W9M:CQ[S=AF?6,C0]E\LY) #O'L;4"
M?^Y&P6\N@=_316M'Y'E\G]1,4$%0M/R?IAKAG[*/]E275B2]6^_FGY)&\KJ]
ME1%JP$5G!I:$H5[)? 4R^. @S]^MLEL^Z6=&G?Y+ 9**B*0R H840LR).@"U
MH;84;D1/I&O))?<EYC]AAKY'[?H(_U>[&,OAJG&?++.@'VQ>1[$K*5KW\T_W
MY^=2ZWT=QCOC^C9/-/DMX(!K'T.]'HJ#A<$U"2)FQ)75-$>B1C)7U0UNK$LJ
M_-,\[AS;726M7WXK*=G0;[3$TX6,#=?@)LAT)$0V.(4C!I9X#T#0>GF9VCF-
M#<>:LV9[TR; @>:ZF7?9]ZU,PA3#OJP>KM;,Z\^$Y$!Z_W87Z&*L/KQ(CHD)
MKAZ'5HY#W6G#$P'FI)<:O+1"M<=$;SJGE,&VZT0WEG+Y2:?G\IVV9,_9F%K)
M3*W1V<7FP189\F,&0.(N&<, O+B(2<UR@;\FBD>"G0VG7<'O&A1J0W"8B\XU
MYTR)ZCOI$M&;Z_>,:S89@'9,4RS0MO^IZC_Y&P:Y>?R[3#21DN.97?LX9Q/?
M@KXJ_):XPUXS[<;:Y)AY%T0(XTCC)MF1@WV)X(6QC(0/U;NLO5P#*[F;G+-6
MFVFKFI8< 2M^S.%SW<S,L0LQD-JCF)O$VFVC G+:\+\>KI-\#E1= ]W2F"86
MBOMWTSQI\TO.R[D'XW;3TR?'T.%M%WP!JX.Q@JNT[N#&3,%V]0SJ>3W)EFO_
M=@Z%GVR_./GAC2\R.J.F<@G#B9W.7SS1.RY[\4/Z[8?JVJ@/SB4]\RPZ3-EU
MY>8D)J)"T:+A%>HSLL.BK<%2YPW$]?&"D;(=Z0)[D%5]V@,AZD[K_?L"R[#6
MUG.LIARQ>-!O?M+\--BL@5- ;Q4UQ*\5#"T?V&SFW/1K0';+7+>ESV6D=Z#Q
MS^ B4%P8ACZX=W-QN<H)^;FR?YT!\/=3+]FX3/U#Z-FN)?08TUJ:K FK:QT:
ML- W/II-M:/(*NGPWEBS?NL!CN.(S\#WG=[;H'D,M(\?,X4F::LHM@<'8ZYN
M/(.(58U:#-RMM)CNWU,KKU!]\/[UB\9:SU4/;9Z),A7WZZ9"%7H^Z5WB)?X;
MM;8J!P_RS(I374RMM':UYH<->BT1&9C/AV5<Q,F.G"G0@F(GFGD*BF&%&Y8\
M1DMJ[054/B8R,0#3CVS._OMKT$S1W:O@^OYT2VMU[8VT'ZU".D^>?A=-C5%]
M87_7T&03FEVF- HO:BS?Q**/!>5<?Q>ONECBG9##B/PJ<W9B,*YZJ MR*>XR
MMBL(^X&K7"0-BC^+O+7Z--S_"1!XYT40A35/F)I)T:3W(2\@KE.5)ZJ'6,EA
M3?Q$\7]K@K>NFBUU[A4<SJXKO@&)-E4N 6^%)MW?,#*XE]Z-7T?OSR%S$GW%
MC,$=T8ARK%3.,;3^2)]K_Z@M)ZHAHIOM[R#;]<V!5==:J_,'BL9+0F]^1+UT
MN;_9K=XCV(M.0;X^#:DM[;O&>9<;] ?$<%0>7&E$K*YZY$#_\I-XO?I_!T23
M!P<%#01_?Y<TX(YKMD9MUF19&)B1W""KTS2P4)JRG2RA0,434V6 %<W&(%JR
M#$=.0$LY\2HUM=_(,3CS[3["FF73'TS5W6NN*GLZ],\7LBY?\ZL[QR';=5/4
M_B.@U=ZL10S1F<U!]B;LFA/-._3*O#O UWRLE>4ORO^J=EG)(#U-:13=[#<*
MQ0N__?KZH/MA[RB*9W_0+*:Y:CVK?/P $CR<45PM!G:Z:*<[.?EDNCFY!KUC
M56:(OH.6IV72)?2(>0L)'YI>>L0([N2YT%-^QLKD\,MY?50]N][)VAJ]AR%+
M<%,S(%$,P-9F#P.@:_\]5>)1[<\TZF]P7)R(E?P=%>),:M^.N49V;LMS@LQV
M FXH-H>%JEH.-Q_W10INJ:2EP[S9/B/ELPHS$CA2XN<OVCYS8SK;S_/S=&F5
MPOYR=YX,IB[*Q$ N'^J_6K/Z03 KESJHWQ5H*CF3Y/S;'=RN5B#L<SY>J6PE
M(MKW5D'@8]L&6REUF;]K\9+&IJM+SH,3D]95TPW[M4C3A!_KZ$C\VAC2+6$:
MU$WG&_,MT]8GZRT$GD\Y,?CL-;%FUG#W%WS5^-*_/>*"[\OO662@*?_ N8$_
M41%2+1)P[D;,G[L')=]-+ G]DZ,V?R$SC1_Z[I9V*JR>4UY0,'<1Z'?NF35)
M_5+FIHI'3([FS1:]$MMM\&P(VT6[X>?GB_'.(7JGDK=KDGZ&++*4P.YB#GP]
M=C!P:W5U(J1X1LRB]W'U.Y-]^_<7Y3]3I,FCEN28__YY)TJ\ND8*K_[^]WC2
MW,Y8<U6#Q#L=?=V#^1]0#_@-^-)_5]HN 7?.9$F5[VX?<(U568>?)IPWXGM_
M5]C;E;N9^UGO>9IB7B&G_''15!#9DR@:X$0'&5;0T!1#_!%DRU_%?:\)*[-#
MC*LKLS=@SP.[^(J)UC2WR,AC( :%'&7&%M&(WX/24COC]*M^P3Y[,+>$']]S
M,6H' 4V\Q!E2 3D3ATTXZ2?V%4*N&+($0)^-%?ZHN.?^0D@V_EV^P]ZGJU-N
MRSA,1$8<V$U<Z#<]Y$9,^9I#T'RWI-E<P93MW.:)E 9%Y$"VY0$M#;-,PCAC
M3_#,]' H5N,*?>A$IK6^^A-5O71KDD_J.';&>3KMZY%" V)VY]J%9?=?O:(Y
M*=X04:H4&5D"?TJK:E%W,:/?;B:LOB-]QYK92C25]/WM$/PHVO'IXY<TA^-(
MP%E9?9^7>4"H/#=*M';T.,3@C6G!=E&]5$B^WV1^,]L?5]#^&BF#;/X-T46_
M30XD<N.\L0$>LULZ+TM<L+#L1?[U3]QN=.A/Y><>7I[[9^]I0>?!;KOQT]@V
M;/C)\X@/3PVYR<7'/F4*7F?V%.WA;X4468IC#Z397 ?^K#[SR3K.D7'SV0]R
M_9S;N??;L[3L5WW5I#X\K4&=+>\[.JT*2Q;'O)5N4KX^+S(F3X/V[%X+;'I]
MTO6KR3KV=9,]HO6<#TNIYUCR@#DM04,R(-EZHD68RD\.0_@R -<"-/S>JQN[
MV]%[H_YYK6X9\=LK\-;#+Q]U#&*MTBM29Y]3; ,1_/GR=D8>OO:_\_'-VT<Z
M:%7US+&3FFCR)/T2:81\KA/"@^"8NV]&F&B9-(OL26:J_T>[YE8<9L%WF9W<
M0 ).[V"70FUT&("+*SWQ^009\&;GV:F7;#GZG;6%FE !&76($Z_S8H;?/*GB
MN-9>XM6QA$I2?+&!%,3=>@X_K(FI#\PID#/OP=:&[T;:R9+O$S(X!EMN$<_.
M8[4P^UNLYSCQU<M@PN5V6A.G&20>6SF B?"]/BSO4JV,=Y/I/^M0XQ0<T''L
M%-[J'E'FI,V&MY4/]JYI6<%@???DRR))&L/3U"C%_>"0">0#_"9H&18'^<GV
MWK #R$Y.H&AW<F.N'<QIN#T"<D.VN#ELJX@W/W(T-E4;F_,\X1%4,<^E=V(Y
MY2$QP$K_,-\!OPUT]0=.2YLYL(Q$M)FFG_K?KS;9:[=14YJC*3C0WO2)?W/&
MWN@OM)N\\;TO;PJ"H=.3AD-V^,#L#<WKYO?'KAMI OZW_<]N7(35QJ6KS*T,
M ,$$-*?7&32?]=4%2X@N1;X9EUZJB0A\WK[K=<& C1</\9Q,@.O3$A&<<'NB
M:;8H$?F! :@^++KUU&J+HK7#DLMR9^9Z<1.;ZWK'6)S*E]'I@9 -]-A*YVB6
M+OS'_,;6\BB-]?%2!'Z*T(A#?H"YR\&NNV3+$#D[^UZBG--!/F@)'A/1Q*3(
MKQ\-##Q8S\CW(SH8 !:X#B%B028:#EF\(L$<0]47/5FR',S7J;9W#+,-"G>4
M_KO)]-;#"S0./T,1A@N0[8M[BLC!K4&^+=_XF:-7B2O- 9\$PA^KMG0+E83:
M=9FKI"SI^JS/[\VUS$S)V#Y%&91NMI<%6ZGD-S9+S^R-KL+9**)4"8(__B%.
ME0&(AMPX-">N1='G9'50FXJ#-1E/7!&FUT" ,T %_I4V'EZFC)SS[DW,IYGG
M/'<SD%5X!$?HU^!/8Z)WUUJX63W_*_IZ^BRF_W[3:PZ5C!.('2T&<3D@L\LX
M(,&(C$0-%/?)9(EHWQU^++(FEG'=DY\C4-DN>+71%KR >B^7(&@9T-W1,4$2
M$OXYBJR0*I>R78P'_:/#?E>R_=X9\:QZH>KQP^_>RJ "Q_H@4!<Z9[9QT^NN
MH,%S;L?CY-5-O"@=$HQ'&:8Q *Z6WPB[^&'"%9NQU?@^W8#E&HKI0,W]VT<\
M=P,$?N=DA4A0'I&WC,E(@G:/D CA.-[627?4(9M5\1@6+X"F".^T'1R4)43E
M7%(#$A,>\BG&'O#;!AN:[XO$A_PF*MRO%WSZ6FE)4IOK,0[6FG,6SOWG\"JP
M;1Z8H#/JR[PO738=6,[4XX[]]'O'D)GGH%Q<J8^-SS  .SR'78%]QO(8*'U^
M;K:2BIZSM%Y#IO<?)Y"@9&8"JAM[26XH!L+ARP,/611\=*%I[#"!8_.V=?#M
MWKE+6B^B.7E4VY8%7KPP,]P6#\&5Z9&^D==\%];=7A":2MRG??S,& "GB-[Y
M&5WM=V'JVN>4AX).S@Z11,F"]HLP_'J+H$L.;%^M32#AP<P%!@#MZ,VJ7O.J
MF;D#>4E-# ?DA\Y+#Q_X_"1>:!0P<N4V&KC)>5?WQOV5M#MU +94;0-HA<5W
M[T&=1KD16RX\S>? 7\G^0\:'6R--KS.#YLT,(;9^D^,66ULXY-^C[@RV" 8
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M,='#T/1<B70(&XD!('\K"/!>L"M;(#OJ,0!<Y)*^41_\K=G=NG1X3'T[6R:
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MS4,B$;>"S;O,)NFXK@R^Q.9+$Z7+W\L_7%,5K/]U*ONQ8>]D_.?-8++=?]U
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M]TS(ZD]T80F1CWX%4>"7RWQPD*U(]K@\ODZ&W]G2=_2ZT^.[JOK5>BS[V$W
M:6I_$)B_.@=O@VMMS$F\!D=^6;*JO34(A_.YY.K[<::]:HA!.\G,F'QY8V%A
MM/RZ7Y6K64'C5EI5$Z(QY!"0_C[,Z-K=W)100_TM;#H);?QG/R-VTWMRD)0/
M/H_A6&*!QBY%W4_ZFLXP4'7\IR=]K4_J:,BIP'71@6..LJ)H20JD Q4/K2E8
M*"MG@J@ZZ6V#4;>"(&Y%[N9+U!6K_4S9TPL:]_0AA5S:\ [Q%Y2M!"/SM,]-
MF#@6L,AWXC)_T:DD7*;S^"&@/0 3O;\2N]<]M]$%%J,C228;K8.Q?F[[A8T>
MX!H5Z-GEH? L5:V7]YR#&Z]%G$;8\26U' $;6@9<;0R<6%[)V=D5,_]6##56
MS;-O9)G<0&=CO="QF*MT-0K_8@>";QQ<J?IAS/.+;4Y5)^ALS]2MWM)FTJAJ
M'_PV?8_*24SO]M2;![8V5!^(+"7M95^@!G[UNF[97__;Y^ZL_ U9+Q'Q6L->
M@9K@7?+D_$:\ P_]F$Y4O+9]/OPN9;PKSZ._Y/K'1ON#_)_)Q<\3XGT-0D1%
MGMXCVYKG3GWO-;GN(B8[;@^OV9I:*(N^+^C(,2N7BE_:@PZLEJ&]FH#AP98T
M3^.V?9WIOKUT8:&7?5)S/+]_G507YX6XCZ/5<)C+KFPP9G'H$0\")OW)BO?J
M4I.UO5/CW?E5!ZG*9_)6'>3GK+%N?(G9PG74#@?0"$AH>3\YO.0^94KSM,WK
M,+_?GCXJ1;YI(F!%Q\]7]_2^&V<4&%3'!F(A,D5+4:>FJI=+U"[7KHYLV"JV
MY#QYY"#&4&+Z36!DD6U/YB'GK6W<LL&4\*6*<:F*YY[K@J\WUZ4XWXO!?-;X
MQ'YH0^=ENV83<X1!,DQ+BD-$6'Y9>1S:^&APBE5=0KI1#?^]F-.65#G1OUI*
MYPTN>&BA+N6M;/GZC.KW_W/Q1 H< N:6K":>YHEJK>S!1W$&&!/DSS&&>RR]
MCRC;"8EG6P!@M+9.*1M-.FO! B!Q]_0XQ[ 0R02AK)"BIJ-!<OJ;2:_N3=D&
MCH#,=-'^!WE@5P7%.;[V$]2[[Y&PF9E[:8VF.=Q/9^S494X84N:$I /%??6O
M/DI^]!+>TR0?1"ZK&1<\3_6Z#TOM_%^'L &>HJLJ5GV!&)Z#[S6*O.A8&7KJ
M_(&B?3!F!,,%Y>N@W29=XFR2[>?YD_2>ST J8QOX"BF)ZE9\LPNZPC@SO+-Z
MSL?QN_6Q>IN9.PU/E<?.6+S2Z%H3)Q86*+J<-%W>W/#*6=QLE&/;6?7V5+9>
MXG8<$@<1W17#4#Y6'U8( T:P[?NIX;*  \7V.%B BG#V+<SH?&-#?<K%-/DP
ME;,=1^6O+R*:(H]<P#VA=).$.P8C#P'5V\ 3&%E8&D(ERN8'[$"LXQ;M[)_>
MP)(*J]@;PB*QNHGW+L [)#5EWGZ^O%S;D-S2E(_>\P_]/-355J ^_@B.-J8U
MU3;NKI0W#Y;)\W5KI@Z@YG+.0"=[_D[CEW?/M5\>(M@_?V'^ADO]0@"QV996
M>)"OBGPGS!*A6+VN_J:Z$<V2R^P=+?.*V?0D35?W7^!P<E'_RY<:HVXGZ=B9
M??(@#RY%V;4?1[.DER1!TX6#M$, K]V2SQ^#I(^$WPR=,>OG<R[>'[^(^]DE
MY__3'VLTFI;?@3&;FJ0J5?/.]V;$I5AZ39_;6)VTWY,(6M/Z7Q91!.Q"5N[
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MCC-QP$,-L8]CWWFY,33TBV"KGI;38IJHR:"NC,$.Z"O)DU39:&]PM6J90?=
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M'R*>^0YW_U4'QLGS]>NVZNF.D&72X '@DCR(Y3L$WWZA%DJT75</HJ:V9-[
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M1:JZY3Q_:OJ L/YI3)GIOH<XJ"6B1"VVU )_LR,$M1Q 1S;M97;EG:!W,\Y
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MCVZ;Q+PS4H#/':^-N9HH:@A=M!&1JD::T2<82G_!PDS=(GK9@,U(D^A\\Y7
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M=\O)CB?U$;&W(XL/3[P(ZU;7$'\?8!?"$&2-G:>Y4P1QA9XEV XA?>?<#7=
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M8E1R"1Y+U>;C)^"!TGU9K@/]_;5\?SIGAYORX,\0"9;C!??&V  W-N"D'2U
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M>4CZ4D21 <>JGL[VRK;3C,SNJ2TSUO:[X1E[.X1O(S'Q+5AE@C7P;Q*)");
M$IJ;A6--T<^F]U WJIDY\ ]2NMK-&XD^75.+PHD_I.(J38S6+>J9&HW[G,SR
M;+JIU.+=A%=!?R2RLA&"VBO"MG!\!ANPJ<=P80.<7 99Z801705X[WU=#G+^
M.?C/"D];UL+Z_OE))4C43AX79Z'1[G'D-<@]"%P;F;"*=J#-@A5\W^]U9>7.
M!2UUR"3\BT@CC'O*$:C=OS>]BB$G+VU:<;Z>F0#'JU6L8 :VCDR$,56!C=A\
MS46'G [Z(R9!A0UXAV=L*P:Z[A@.UU=.LP%7K\!L<I&,4R"6B4(G9 /'!BP]
M>KP,J=E@O(7'0:CRG!RV#Y9XS/RL>X*3Q>@TXPJ:%!U"YZ7?;85-4GUKPV!V
MY3(34Q\&)B*)XPV(N*E_[="$?L+.DJ?QZ$EF2K'MG\CRODW&]%45$[I_\**/
M7WKBCDJ7:(=CD<GZ/#Q+#J/T^4%Z>^MGF\MU6PL_YH$H-49V2CMH?S.%$^Q=
M5H@:T$]PK,WN*IV\93;*.DL#FXW*UQI;NS8V_EYSR72]$64]67 Q7J<':4E;
M)&-8(@;_KF>1I8/I0+J#<-S:M.L6HT(3'>QC/QT"# WZ=SW+88ZH.OZ[GD60
M(ZI95+E7JB"O32A2ZVG,=$V ]X"F,].M^&':*U)>3AI<]GJI<7ZM\]@P>,,'
M-#<8CYDI /(PA&?XCS,T&LA=T=M OHE!DG"R=6V2(J]EJJI07;;*H<2M:(@!
MC( 'QNP,XA"=QTB$I=I)S:E3WV.7IT"*=W]82MY[U#WYH]O.^7E7ZJ@5LP3#
M$3-W$V";*I"<RGG+&LR$4CZ#7W1^?-/J%?OW6T*^#DU,62[J#N5T@A-9<+$-
M7Y^/+YI^X_MD:+O[T-0]XR_>0[T#M_ GOZSGSDIL*B\&N0]_R?%?W%OI\0Q$
M)T]%_'44\TCR&+,Q.L$[8AHQA<?W0QK^$!DBLT!\U KQ1 +Q-5K4#8.W%'ND
M2J:UKD!B'-^HOCZ<9FOVX?BG>P/#^NO!J1T16:M#9%U^W 91,HMXJDDLB:0U
M"7&XNF9=):WA7U#U^V#)H+I9]A:8CS6 D81J$)E:QK7,PKFHJ>$I=?,KVN*N
M@0^NOD3UI^Y^ESC@X_>(=8#QC);D1+\76CS3U<X' 5/>-3ADJ\C"!:QP<H7O
M=<UPU]PWC\<;W'IK\#!?TP-?47957G.RT6%-P5X9W;WP.>_R2%"!W+6,/:^<
MZK\;55A7+3;@$"=ZW_IVL %T\2]LP&\/)$/X-$G.DMCU4EO6[?-LNR;F=0&=
MKP$QI2H5*,UO,MP)$K"W?(EQ3,#$(@C9R!C8Y15=("6VJ!0<QJQT>A8[]NEM
M5/T6KG?C;,N)3>!5_X6&E#AX]<UAV,5;%'Z20E(=?SQ+L<:^(;)_I\S&QBIE
M0\\K)L/*>2;ZA6GP>DO)XRL1'D$3:$E[E6929L*7E0 'H][$OR4K\MZ!U>:^
MEEC7:DSW[LKE?%YUJ514=VI9C5\/5WH'U/-_@,1_E.+UCU+\H$8T5](T[1Z\
M&D3D'=6=I(*^A7'2#',._/_.=W9_/-Z<R0Z2^0R&_,A3+S,--7KGOHROI@_-
M ?]'"2'RY?_M.S@'J3-8Y= XWPWR\D@K)V' 6]6HD49R=];@3^D6:_$75G$+
MEY067#76AIMCSS#>.Z5HX#\%K+Q\. @L+PE:\)T;M?S;]SQK/++8]!$:.@PO
MI5C^CT:&7I;Q')JH\64H-88.88@7_NN;*&@"IANPM&']5'CS)OR_%(^4T+2L
M-WN=ZZH\BY==?P.FR/":/EJJNXA41DQ?PLX,QG,,^J@;&^#)C[>W-T)1OZL[
M1D<'/+_%2.)\V/*0#9B;#$RAGUG#;-_?F:"-4 W'Q$GKI11Q(K(]82,6SZHY
MF? X*;"[3CRBPFE!X%ZO,/J!?TA =Z=ID*X.[%=X2M=@5#;_RSJX>%-X/B+D
M\&0GYM+[:A5"U]G7AC'.>N93ST+5SRSU!W86:I!WSJ(E[XYC7,HQ)CK0Q!\R
M7GJZD(2\XF*\:5_SSO:6SD ?2WN&#:CR9)23D+1+RTWQE&]2D<G0>RVV5<>V
M-#HB:X[#[M_HREU[\&/G)_(T,QO^;)KF&DPI@+?J_>\Z9S:"FL((9>9P*"AB
MC@VPHK-V'30#J]QZM3.<9"BR\+DA>)J+4>[&K2)R(X9QQ'C+;4^**D6#4[1L
MAIHB/M,@LV=HD27NDN<^J)B(,FZXEW1OOA495#1J>>$D+C\5W:=;MR&VNQI'
MD>V:ND2&%<_"D^/:Q]%B8Q_'*BM%6E7'O1S4+,X9GOJ8&--Y[UQ02T<0&R"(
M<29 !!BWLDC\+YML2QE*E%'*7HA-<I8@V#=<G0V ^-"L^7NU7CP_=NB%Q^X+
MV&':KB$E&4%2$(=Z8)N<Y!&-W2,5V_3(JYTFO8_VR)UGC%MFYDX^OU6U^&;1
MKUST<FTFQ612/GFP/LMC6BIKN:EI=%Y$FH WD56+?(R-],ICN:(L%S___^K.
MS>1%7J MT95I(;,QG>GE)I$EH9X=>"6?$6V# N-Y>]NMO,)MET'U9<7G^J:A
MSW>$Q9H&GV73]PE5I>[XQ>"K"4CC5)_LM"64<66MKP-5NZL+48WH!,=/"8UJ
M*Y%\\=(>X9(?R[)4_S7(V.!IB?N55GY<,?JM@=$<?.;CE(CN,6:BM@IQ)!B[
M:-@TXJ4[VO.U?_[VTO\MTFP3(+@VTI=RE5K)J\S/VK=*W<CWJGF]A?3JAJO.
MEAZ^,W$^V/%G][G%YB!,'?<J"^[.'WN%R(5$\&<TQVZM?1E<N[MZ7'5U*B\D
MZ%_#T;4P5]--DRMZC;)>XXWR61JS^I224;'TQ+0F9$.XS_Z? 6;A-HB7%DU]
M2!%&)2I<'-E6'KZ0MSZ3\BOMR@.IN[V8=NC/:!_]@,3D.@Z9<#."Z,8XA@ 9
M'5/,4!C:N7)Q^(F)4D>(S?;UCL,_$L,4=)#R Z4H+;"VWWBS G68(ADS \$E
M6(ZHK(BJO*^[1QR2\_[\]J;S=]\=WZ:HDU=2X'=V;]@M1H&>32>S!,BPI )K
MV%"EHZ^+^UE9-^AY]_#S^(]>UD61Z^6_3Z]R<Q5I0JN+'V9/5&?9$O2J\%/]
MD*(*5S-3E2N7B_O/-.*Q-1[3IS,;L@86BSCX=("#:_EHX3;B2L[.6%!Y8ZF*
MG#GU^FWC@',/"(I*M8<?'YK)=>52EQ3AY(I=-B MGGZ7PU^C\.V@L4 (-^PZ
MPYB,60/!R9"N_07$[#M-"#6O'N/ZI/ZAP<_S+LF@MP<5;R3.(674D0;,?#;
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M4ES&8A*P7+!2G2<YI8Y!.]"./_N3DYR<YF[EW^(7%FZ:+T<(4D?]\U*$X@.
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M]U\BHM6F#;7$'FJRDW'TGGH%K!<A5BPJ<N">FRCK25W^=#3%VKH.!4)LP$=
M3.> 5N YP$6?DV@]60NC)VI.:!;_F#,OA.599YI+#*3MB+=+AS#Q*?IP:_J[
M3YPH='E$75 [*C(+/J]S2L!MM,P^1T[Q;*V+7Q_/G,H;QY;!W#;8%HB2VD'F
MY+4MWXX)S9(](3>Z;OJFF/7R_F3XVW3\EAL12MD19[T=&)_@Z<AUOS;KUOHE
M 2\944;-KZI2"T/W;:<)3\'&YX!P*8Q^9XY$_)-X7-]@6O\ (,QK58"?$C;4
MY[E))W;L$%F\NP#3;1IU/:*5O\-6 IE4EO [= /V'"/$5Q=_PU>@'0PL_J6=
M9 I\Z84J6AY4GNPWJTG>_3F;[*HJ,I#Y^@GE*_]#SZP&]B6S"<MP(H=MKG>0
M#U_TS(Q0A@7G]^^AVD2 ;.FH?X"E?L%^'0]/C>?]]=#@LE/^!/.?Z<:9SW5F
M_<:_?7J3-.A@)*W9$>[[?%64[\/3UM;2U"/>71M'A0Y>_'.RO,M(Y3C1^4?O
MK>SUD[K1O=_=M*Y;::;"W+[%90FS#"M2W<.1RAY1DF#*I48:!BKGSP)C_EW+
MN)F NE3#+A6S=\:E3"AI=<_/8@4:7=_SY[-KD6G!9OT>35^F# NW"WS\7%U]
M@D!Z!!C_CK+X(.K-(NLV61W/L 1E=)V">DSZ2$B+QY3F2O ?"? GUP(,C@'4
MQQG1-?-B24428Z[[<@4&ID4<B=/Y9,SW!H;HF0LZ"99;:BP]N.)O"63#?[)A
MHI.TPN].A"@Z2C]]A-92[!&>1()(J605HCT6OJ>V KP*-I#/T,>Y?W;OCMQ]
M!;]O^=0^S-GB<R.\]_8./T-FW3VQ5'930T_7)PND1HES@+Z,\N^H7YZ&^@O.
M3C43LV;P?BC_KJZ1:>6OW9D#@V;XSUK#F\,^8ET?DC\HW*<0^"PV_P[*A62U
M^%O:=AE(9?L]%S[S$YX:>6].9/YFV*_2<&"V%V_E0:?*</0YX/*QZZ#-)^RM
MI$.GF9_>1Z1"BI_5T)K^RH1&CB_M&4Q)\U;[P1 2R2"_Q&L\UG84M8  3Y:.
MY+06N4PJ=WBKA>\U;S\6?RANU5=U)1%R*,] JQ+64^ISV-U>QTL!?0MEQC/Q
M21"EL)<'\,DZ']Y]7BS4Z.,[![B99)T#$+4G:LR18K%IHV8DWKFQA]19HUFV
M6%^2V4+&J[_JXMM_V4>XZJ:O6S<I.UM*T_-Q,MU EEE3^])(B"E78*@KY]_:
M,TJ8QC8<D@=3D>CQ?1,W?;A7WKJ:4S:@[6@W_R4I*&/S1V&F=L&XKM"8J\?X
M!<C*+$GMMD$HB0^P&Y^&8VN!C PWK0,N6&ZC;JG'4;5#IG= O((;77C+"HN!
M@=^Z[]A!<%16 :=7Z0XLZ> < #A5_C_;$O]FL"QU(?!KK'H8P1$LBH<6N7Q?
M;+<<RO3S*38/N '/Z;^Y+M-4[-,:%3P)6-D!:4W&T]^+_7,A;\)<CS1=OJ=J
M&^UP0D2!%\\8/?"??R#^ 3^+T6D'\8(9%,*)!C>[)O(MEA"U[Y)G!OX)3Y+G
M^_! P.LZWV>- +_=3FQ"QSF 6?T>T7ODI-P8M$GFG$SJU_[PD)K&_W2H3.%.
M!/C,M9_)'Y8OKJUI/ >R$D(ZRQV1GG]3G# T'5'2(&;JKYX#^-<S>:=1*_+)
M]ADFZ7O"I9*?.,Z<N:<BRB6EKD BMA8#WD)9+8]Y0_Z>CPDG7Q4J\BD<A);C
M$\R@,D98^EI@;I#O]! [!F"=\\&[2YM?;KO&I*]96PB&_",(M7)WY%)3K-FK
MFW*;'5%P.+Q(L#^5_ZOP^[\9O? *:^LY@![LA>$^^$@TN)*T!1>TMY!8M/_U
MM*DLL8Z>+2B4_BE?6#1V7@KGC&]'][,=Q['B/D^4'U\WZXM8(+2;IJ=KLRU)
MS=B<,E$"5J+_O(Z>9!'452S/U4P&>=\OUF3A2(';&#F3MH>ZD\",I(PF.8P>
MP732[4!.B@G?:/ZOACERO41"?\AG7XH/+-*76E:7[+/S>. :+#)9)2J]J=2>
MA>577WZ/%J/[_YO(_].0UYHQ$3 L)9GZ/I:_'0&-/I&BVCI5IBN;R9K1'$<T
MP)^64R8EY;P6S-;VV:#6 D\MRF&ZPE?4:%I1&*,#;F1CJ:4SXS8/;VC?C$[O
M$V>!/>[,NZ\2+D5I=ND+O/1Z4#' BEUSP G_X5+L#Q(,;LB[D)9WIO;X"8)X
MZ%)">[;^LD>;5;-5*_(>9KO\>.K&=CIS#+Z=X=YS0=]A=D5"T94;#U=&P9[8
MVT@I2,O";>S'Q+O,VPN,#1G^*T,37S3[1:QQ"^4)+D /_1A+8"CDT@Z9EV#L
MIRZ 54/AWF07M*&+,@=O6[31^X8+9[U,HC2R4%BD/X#<O$BHRCY06A?M-1=3
M"&.CZX]SP$;6J'C?UHFI%RK<N$#LB\6S/%13.53K?5/=62);5X[T_?RR+"O?
M$^OR,U308(X408W<^P>^IXT!M@7".G+9MW'JMZIK;@521AZS&PH\_?Y&7_WU
M]O:HS#4RUP=*?A4M'VR,;J0&"05TW%/_?0]>,[(6RM<M[-+]+@_X 6;[;_T,
M AR[$\Z>1K; "-?FH)L*<HO*20%A12//H'^>UYXXYFIF0:M9/&I%VD&$0(Y
MR4@M@@/8 ON<1PSSUVDONQ@ZV=[&E@_-9K_F/:DS#0FMUGQXY?[9T,,K5_AN
MZ#W)Z"8R;[28(KG35MIF(E#?B _C[^#(]S@Z^VW56M@91!9_1JCYEF2]O]/
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M/+AO+<-Z@Q'%:L&^1(8H"#5894)=D#S%6T.?EB.$Q)P#(KI^P$H?%RA%[)/
MO>#Z)ROKT=)^K.(1_ #&)!>/&7XT)))PB_@([[ "BY &^7M-&4R:Z4W*5@?+
M=; F<MV26F]D3EU0$KY2S,8O-POI 1[Z@6I@I(_?S@$CU1.\>#$%XJ=%VG/
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MF^HZ"9G!NR\9"2T_? F)/=MJC62J'9CSU&(5-.Q;*([J3750IE74Y$.$J.Y
M+&/D:Y.4D+E[)Q64G<##%-C?CGBEPN08!,PR/Q\[<;-6)Z=WS]T"PG"H^LPS
MUFO;*[0ZO;K1BN@)"B0.H=I!%$1A AU>>)FR(],&9(-5_S'C^-5/J-J3\^RP
M6/#1G@8_./:?M+O!.\EX?L(]<\@HS]4J?"H6N6& ]6U8EE.8M'0>%ZZK'MW[
MDLS4SJ57+_AN+NF>%GNO^AG!@*C2C"\G /&S[1QO(>X% :\M)^^N#*3)6Q@
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M:E*Y-+0M\L=]K#IKH=U6VW6*SD8^/X^_9_AZC6SG)\.'9JRT&K:AU]5O/<1
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M60W%QJ'1-I;)[L^&H3XV"\-F!5\/*7>Y,8YD5L>V"V)DY5_489F?<ZT2>W5
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M>QFU:T Q]5L3"V60HU$<L2[.AV@?1KT-QGT@&&">A_6-'![:,#D5@ ?&D]6
M.TV,.2P>Q'$T(6"9O@/XT;O,'*T_#JJM27HZ.BDZ#RPJ(0V_JW$D+HVMD&#+
MPY_. )QO)U*H3"UF4CBS9:Z:Q*[@A(US24&5H]0!0GX/:!:"W>W>PVYI5Z;"
MQ;__?OC++OI!TI\3[@)5[ER7H926;8+XM@#"=$9C=RWX6%)[<;DXQ&:/4.RO
MMX/P$:$>V%&GF7) -77;?5PN3,P&7D8OWP.RT.=+_YU=+%8F$G23)+,VJLHR
MKR)8%\]^^9<)D[;A\O0'(]3_O4[AI@U)2(,25W[Y## ]2-..'P[Y89-R.F<
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MM\BJI^WKH\9=&=;R2UST_5),QK+*>>UJ]>C?)O3Q915-9%X9CTQ*,'YI8[\
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M0?9"Z!K8FA?Y\0/DR;R7@WZKB428ZO?N_MN[ ^J=@*BI&Y35UB(NPOK6QA<
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M-F7[#F*'56F@"$/"?,N)YI[3R'7WPKS,G L ?^&IVS /O07$G_BMU63MPP4
MBH+%SKAU9SL3S>PTC[SMZ,/C?\02U^5/U2TF Q.XN)53NX:6>@72RU*\"A]W
M#RR'_@+(]#>I93<:!&PD.C;$-^Z0L/,B3']<E-5_'YY+-O'%LV.C2L%%>LT3
M]4D:\Y:3$FG#^:-'_!G"H/'TUV2@A,<178A_ A=]G_\DJ'[Q_$AZFAR6$U=]
M? &PY=;B5F]8FVM;C?]@D:?^=']+>3+:4+A7-43($$64"&>H\Y";UYU@YZGE
M4O]H?B6!]8C0ZC6?+)WHV.K(\\MSQ4+C-OL0065R9 4J.^RQZ?GBTM2;TH;Z
M&WZ$@5I,C>4%R==O33Y3\2U_[\8T<?"VVNO9UX;XI3G6_7V4)J=OSR=3)IIK
M %\ 5[3O9>K3(,-QK-7D/'NVEG<M:-B3RCK,!?]P9I\CI>[=N$HJY9ZQ$G?Z
MTOBCXLD-$[-<<]MJ=[/QP#!)NBVLBE6.=T-V>"*5EY</=W _NY"E:7X'0'2$
M)!0Q#*0FR7I*[RQ)H8-*JRKO1N.= XR\1%]WT/UL9@$$+N:"*L<MRO@E D\/
MIXQS.979)QNU?HSM3:,' Y=I?FFAKG.HFM#N4%5N^SV1RUCE*.GC]Q'/_.&3
M'K#A/4H>8 -D^ L#JS^R.?-%)X#U#@]:6,Y#\0]__I%-?'8!"-YM^8CZIEY5
M6UA0ES?5E#>)&$/4O,&+>"B55\E[-0>?3(DFH'DZ$10$F1F"817.4X\T,@71
M#<".F/G4C4C.\2_LM]Q4)=O01=WC/%D!>6C?3TO:.Q/O-4#:/ \%]=+/NJ$<
M^KQ<U6WZN.GJIH,>/$*\2/:H+O%5NC+'<G^%+J<V_AO4%1YC6(IS[>*A?#P[
M!_9Y9 0RC!\L;KRQ*"$M&OJBW0E252 ;["N;?3(DJC==P53$)I>9=;/(V,S_
MO;F/4;+LJF+G,B7D29I66N]+76S55J;C!<#D,FGS"/@E @\60P(Y%73K@Y *
MF"6;8;+A=N%'135Z0RF12M@*]\_SWFIPIP?O748;#_P*J/\^J)7,6(&?$)9B
MJ..VN:W\_#RQU.-85*3":Z)%\8&];+(H[VK!WC)Z<LT"8PL>ZU)0Z?W]G,%'
M!GO&H:LMTS.TKF,R9*Q\28G54SF9JM[$\W<5G5JSY37V,Y,':H<HG[UC].8*
MXL,2#3H])L'O[ONP>EKY0?/IAQ.WTGRN)OVJ:!>&D..@F-(E(8('RI,KZ)-=
MBJT>N^I;I/)<K8[EE-N7%Z!P[9L5RH9Y#<N^24HZ:BGQAHU:0Q%LI&$>:@WZ
M'<-RG$FG2D1>A;" ZG:V8=7;;U+!^K*J IJ\Z[S5+^N9S/+TIT)R$.7W<X6K
M[@M+\@Z1!"*&H=3M4@X<A[? @B930>3*8;\,YQ;TD\G_/'-VO0"\9K1>IB9=
M!5]=R:M#XT2[L"\9OG.XYJM/C-W=O&/]Y+HJ#58\_K"\M-)(-T5_OE%3Q6*!
M6!2_<>AE++D*ZRRX!O$8+YP@>*)V[5Z.LBS3YS[ABX.9I=X!/5QQ\V#KE\]"
M\<PNHPY?D7AV-:A^0E2:H3'RT2D^>U8'(<=G'W4%=-Y]Y[_'1D/_3QMWO(&_
MJ:^)[N0GVY0 2_:S3/LRU4LV1)%>HQN[%+A9T;VQ6-?8IZPV<W\F#+_(UC:.
M\<IRUC(.JC^G?[M\G2"*\>F&?P(CM.J1@0T^4EK^E$(K#$U<>LXO;BH*4Z39
M&3%=!G7;D<7+QN$TR.SRZPA*%C$$I=;@W#H?S;JTF3D/['GOYPS%B=!)0[4O
M>BWV0.7%8DO>;U_V7L8?0"A6[.A1!6_J#FEPS_OQBEJ3XZESR)%4!W'#6[P!
MM=)_/N3K[]J<6!H4;T9X*$(G?4:(OW72E6Q2A:V)JG,7@/!T(L/O@IL(Y^4W
M!2Q!,=.MEBLY'$334>?6QE0;?1>E/F=WN^NY )G9;3O=;H>H""J<>FD;+ HB
M_^RCUNU_0 TPF9'D?.?/ANTR?DW)LG9Y3&'Z1T<!JL%;W$,%P+IUV\5]^%*H
M8L_AK"%*MT\\- AQ"Z> -)^.C/8<V,R>TP>P<C^+GHP@!RSFDXLV9J(.8P[4
MZ/+IOH_O>[=*9<0YR@VG'SL>60 J8D;O 9[FZUP+M# +2(N/>BF11_TH/J<\
MLVWY<GR*;O@L#XJE"\8@T8:"D<W^>KZEGWS@4=KLKG_(DWO JY:2WMG9&PRD
MBV "@U 2!16S8!-#TE##%+QXJJ8(_Z V-)..275#UU&&&<S*&5C3'%]A62$9
M;T083&+WQ3EFVB5+=D OZ1L];(.1@*.J>?&*IABNL7EY_?9).81[9D##GMX>
M8Q9/-"!@\K7=^Y3B\3I_D=87U-^^#-P^)3,O__Q[H5W<,-$B@MD;H0 V;L'3
M$*@QM[Z=EVQV#Y,UNRY8C:ZNSOP]H"I4_/@"@)D[]:$A -'(*#4%"/"3NTI$
M2B&SB^=UU:!DP06IWO?T'U*F<M.6FJE%_K.Q6#RW]\##_$W3&E-!V',_Z'42
M#4YRI3TSK PLJ1FE6=?V71%$=;TU1I^RSU!5NH.+18GK5<U$_-\5Y"7CO>]]
M4K9?K32UF2S>,YEJ _[5O_K_CQQD(WXZU#=\78&^S4#0D-APZH00#!WXP;%-
M+7/CM_LRI0^=U&X8/_DGQLPFU[+K9@4_956#FUFQ1^^H]R#/PW$'EGG2]#*/
M!M.2]2+$&2?-J<'Q/>N.EV$7;%.]9NW5DUL>W<[O &)9@H"T5^'#V$)<=Q6$
M!4=?C5OKQC9DJJ07S/Z0>OYEP.FNOBG=B94.&;F:\]/3DVJW^X_6I^46ZT*0
MYZX6F!L580+9H%HCC^,3]9?QN)#N"P G\,4AL[M*<'T)@1]M-Y-3/M\?X@F<
M,U4;R-/B]?)ZP/!.LQ. ;".-1@CA9E<?UT]B8%WLDM%\T9](/]C5A@7SZ2X
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M7N;U_F6<OIR[ 'U0\>7_.5P\L<4'^<^5G<?*-]I&6V4[$90D>?=VH4F?^@L
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M;<K?ANHRELZ)^7+<XQMC')Q9/?>C94/]'DJ.,/!9,K1OLC4I5I/+--SWZS]
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MM8=K^&CF5.'UK!>!L5I>""WKWOG!+\1F?7&N\K!?&)B\Y;AEBU(%3^7'%[)
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MFITD[CO#3=(QN#3L#MXSBW0.MU:$L3)']&TM=CR\DW:^-\E0LQM;^*YA&>I
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M/@O."V#M]_2MWC-B(:*-%PWKRDVLL'G'S):G*FP./?R0T_LT3LI ?BB0CO]
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MNK1I5#6WL$!<Y1+3;.BXUFEZ[F(E(]H1<%O/&[L.F?/W$DKH9X$RVO(I+-!
M01!PO7P/QMJ.F=''P_X=Q#EM\D1..)L%>A:HVKZ;!9K_,!%U1)LF#F9N88$V
M80Y56\C74U\+A#%J3F57CWB;$QAZH=ZBM,B/0(IWE*+'WJ74  HQF'I9E%$<
MFTM0842S%QI[23Q$?Y] \1QU9RX\>HTF9\4!+S+?T@6)SBR0V]58H.(#KKFG
M^P \@3WT F#_/LGI1IR2DVI0#F >#H"7E9O>TO<2@S">-Z[A\,6!U OL:]GX
M&N,YIPG@I)D/>]KSX=ZP78[7Z%JO&?=PUY(BC1 OFLRX2<"$%Y%S;A);1!U4
M4-,@F[!EMW>+L=^:305;2 9+@.+-DJO<BSKP!,X]%(^C[6&KX3BE$"L'/2N1
MU*@&5-JS:IJ$$JR;\BBF5P3$OK2%?:E=>Q3#%HMDB\!)T16)V15XPIZM(WV>
M=^ ?M8'8$'T'/FN16=0^1 )I K.4L5QCT//L0?Y+@M"UXO,91K'BF<7OQW99
MC%&=^HJS/*M*<+[FI +9[5E[[ _WG,8K\8+?]Y30OP["]JXM@]N7B=6$727L
MY@TX?(V\%7?I_=)6#NDFO5/!RNI)$8I#,CK/#>QR595)%MUWI6+V/:PMD3B9
MME.Y8?; 4 4VA^CBF^*2,I!5&]=<F(=5.>'X!K;/)&($T[?9H'U-,:.:+PM$
M /8UPO:>!_91>A*1,<,:?@4M[?J0*3)'.:Z%S_L3"W0%TE"FMJ1=$P_&"UPB
MZ!28>#7!7N8L8#Q)+5XM-P(#*-=MLW<W5)>!Q5'VP!N;"0]B<Z[1PAGN=JUY
M$7 C8JS5AJU<L+N1,?<<A@)E4UF@*,]FI=X5C@7,^QZS6B\5 9O]N3+A+E)G
MJK\%7Y_V$B/RUT /]$7*^,2PD6*4%5N+\,F#Y&&[X!UFT-/JE]*BVW#D!&HM
M,]B#3UW2)Y%!Y]8(Q[4 4<W4O@ 2>!>S[8CWT.>"4LFW80GQ^(O*JQ"RWTCT
MZFY^DXX"VAUHG.?N,>.^0QQ\-2X<LXA<,W>F?JP2Y4RC1B$;T[PWQHR8#N>\
M-!<#S?NGMB^6T+J?S@A;8E_)Y9Q.27S(%6!P>M-OGTAA@O D-0E,,H(J#3%]
MCR#Q4P!FV?$?4T?8T&\LVAIV#?<E=P3W0^H(\O)&N$4%%$S2UF';R!_J!?8"
M'Q)AJR0$]89:'_O!;^5._,F#?W&2K5S79Q=DEYT54RU3$!_W3<)^D<9O]/,J
M#P>7>D-:Y50RO*XO520E]1I3?!M57%3*_ UX^,]D11Q^4'4>ZM A/SLF!N4/
MT16F/1"$;\LO?HZ&E#\OF(B?%RF2'^#3(0;(10PG+R;94H%^;&+%Y+LV$S.K
M5W0MU=<&A)IHP_?';@3D9%^?_![F,&T29U*'>*'*ESSN%P<!9*XS(\-#=ND=
ME#)_GGD8OV[HNEIRA0TU/":W_1VH^G]WLBEPHTM"P4]=$O"_ZI(0]\\N"?&_
M[)( ^ZE+0MKQKRO:M; IP&>^_X87^'+"!_^RUV7]TUX7:? 04YW3A 5ZZ\@"
M39WOV2B\V[I$!%:91<QPSV)<O0*SO)K-A-ERL5$C\;JPY:MO$R,#0'_EI(Z(
M^9<7 .SZW>G*_Y]/FOVO.K@+1"[UZ'?8KM ^<TTTS@@]1MX[K,]O=J;1VU\
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MH.2KI]E+=7_5>;KB<-S^VFM*:6D*<B_>O]B=RYFT!TAQ5WZ&L]#?[U5R\)7
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M.T\#PWG O_63>><Y<4\5B5O\A9WZ8G(7>#.*7HVQ0&(&;#MN?7U/G%1E0ZE
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MGWY3F&QK%RJO0=1FT[JW\@-H!A4:QM9& AYQ7PJ4_574_6,'0#9B#ET>Y60
MG/_H  BL@Z%L>MFS]"]M ?BEM=W\3ZWMR#]O;>?W!P3)RUOCI]9V'_A68&.:
M,+9U89Q2=OE;>SZ;/B#[M8C!P5VY% N5O,[;]TZ9%]OO*$1NOBAJEV7?5U^#
M]H_>,H2Q 1*L;FH 0A$/BD7*<[=>/"4U[F?D@K5D*ZQ:ML*R> C[485]I&"V
M/ZL:R9@X<"'B[N*6QEAWN'C2(;,F[S@R?@&:*91UO>#6G?N??/0BLV2G8A9M
MXPHY*=>@$!;H4UX*@&?3%L+J='<6I*^JX[5*HW H_-4#1PZ"5AM"-VH\[[VT
M]-W[NKCE=Z4>!A?DC/3.284_3^$Q7->&KY;>8;]UOOO(7_Z^ECB2O0>9X1/%
MAFM?F+LB"Q3FTX.;X\51=TEL!(.)T>40#""+3;'Y%NR(;+N&M6=+$YM78G/^
M)L7]3UW7?\V!<F"!*J]4;,%LIU1Q^LOH\+07U).P70=&C[X7*Z-N/V#!&#.E
M7\$I0R(I"4N+-RA9P_(6526Y+%#B_?,\-0F7+>_Q)@=B1O4V^;67-\=<B-0/
M"K;+RR\'K]LBUPLWF4OI:](,L0B*+#@,EV=1YXE^A.,6;P&<"L.$:>?2OAE;
MC_RH1 B92^;@FPV9P-TY:Y>U"H%X-JD\'^T>E8@43I*&*X$R-P_LO8RMT>!%
MRFI1O$?G#:NC:Z#J*:D#$F5-G[]'WO;,W'5>OI*;3*;O;R6DT05-]F%&%K(<
M2G7:]K=T]+9>[ UKY-0^R@N4S,!\*\B!%S^/GJZ_D) 563A[*.]+NZ00GOHR
M>:O;$"OO,HSN,KWGY9H@6[N%@=/")7[JRY#S&WT9.'ZG+P-)G[S+C'Y9_?.+
M/FLK[#,@F@1 Y#7L1#Y>T#=:5!R2O[L&C-';B *.*G9G&HZ*.YYHS(WEYG\G
M'^P)_MTRM+_7F&&N&I/EM3R*V'$_?A_N4G1<YG<,36JR3Y=A.0"]ZTAG@1XZ
M(&XE0-KM1@VJ3+2,P:L'40G*W)$.(F S30/K)$I4M#>0F31+.SKK_26>EO!#
M/*U-8_6LB=6HQKHHDTV L!QL76*!/;3DAG8!OAU<C]P_L54ZLEO=-&QISKM>
M8DK&#GVVS(SH62V3D9YS+4L@P.6E;Z=]&+A\P*LZ'K((Z[D!WGNSJNWYFDO$
M?9':N?;H4HVBL"[W!2_\VA:O[*S[SY:UG2<M>D8\Q#V[N!MG, ?*(,GWU+(,
MKU53;!I>,*#?;7 RRRPN_,FZ*M*JGUL_%Z9>@!E!=15[EOM@-Z/BS/;L9X.,
MME(Z)SHAW)0(JTX2+6E:=%5^HXF0NX_)URMVBLC-R<O5IFN4P,$AWS$@H5W0
MT\A,^ >,0;$BK-KV*O\T:1-B?Q!1[%2"BU_0#$S0C)+/ FV>LK0/@:86&-U9
M+J6+TS4R15T@:I=@%Q=FCMYB0WWQ1QP3:HXE:76<VZW<=V<*-J%'"I3"8/X\
M#.OQ9]F"Q=\WB*//^F7*<FF,6N74M;^[JK6 W)$DT%-[EZY=U]G!X1L$U S@
MSFE/G;:WY9/IR< GJBX7+WJDS9](4PA-LY*4%,HSNI;#F;UU9LQ%HV]G3=3+
M@Z'ZT[.?D\WZE^\J3QNE1BT1:JAUT)9$XPA;]!GWZ\"A]]FEJHQX+P4WW[+B
MO+<FP\6A]<-;808DMAEYAY=A?O,ZD06*E MD@;YAK^#V$'RZ_1J"KGR0CA>C
M%=!#)'4HCT;53$\N&I2YR&L*G$YC?O..^V&S_K.[*G+/K?$KN-[ZZSY;62"=
MDE+^C*I,+DRK \,ZNYW)A=10J40K^[J!:YUO%--Y0JEZX73HZ-E&DXYCFFP;
M@++56)J@?X@Z8'9+L<G7!Q@)4"46C7EA;:SDQQ[+(N_%*[3Q7ZDG<7=, SN\
MX)FW:Y,TN#"CQ36PI+W6,YF&1SVWT4NMD5D$YMBU Z@K:=@WE13XT^!XL?W"
M[HJGF:(Q)+GK= L#@YN)49EVI)SEB2B:].PA'DEJ1$IT?-O6"+\1$KJ[9%YT
MS>V3C7U/4514RZ#"MD],D,4J5C>QHI_C_<NM>UKNK./=+[% ._N7H!XX+G.7
ME;6RS 9!RB(EMBYJJ;6*"MU=\>S^+6>KJ!:[;(1$NR+799YK;::*4QGG.48T
M$BM:=_M4WR8T^:;PB"XDX_C?9_IG&0^]&<#$V"VS85;IKJ^W.BFJ;/O>\W7?
M2AQ)WNM7?2NK_]FW$A7U<R_-?]F^WK]_,=&M0OY>AQ(I&1=+XC&[JPG?/+ )
M105)8X6)DG-3317&'#<'!PQ-[%&/WC--B5B'Q I#B9'8-!FUT:ELNPD#U45#
M^@+:8DNLJ2/CM([KW"K";1W,2_&IDFE].M&;/KUL$#1\K>E%_U2USWJW2P3C
M8XQ]T<$HKKZ/.-=K1IF<-?"^,(5C-6H'<M[DO*WF?WT<;6_=6J:V)%D=O3 M
M8FIS<FRYI(>!&/5#-W%3AJQ&0B"<HC;AW1.%C29S%5H&DFQUC?'T(>R0@)^Z
M%%?6_<5WU5,- Q>T"-TSB'686=HC*;DPOIDQ_"7J[@W2@L#A6Z::*U%&V](!
M-.UL5G*:Z^T#Y&CP(&3,L)__RFZ2855)0>YR18?@C^W<FO97;G D1^%JR!?G
MU4$_;@?8+AT=,9Z-9FXLT/8%YCI_1:IJN,4^%_LLH2'8&V"8?_Y5Y</C8WR^
MD16*2_@:>:#JJ5[US>^_PY'F15L/,4@>*![LK:76^?UF3H4BCK5O\ GO"IKJ
M5\^@[OS@OE)L%/N'^XJM-X=55Z]1!MQV$-X618"'?G1?<7/')2'];A"Y<9A4
MO(([&!#^@5492%!=SN3/7M9)$3Q='NV&<"<N/TEOJ+O?XO;_P5>E]96O*OW?
MP5?UI3D<^Y6\*&QVB*C^J3L<AJG<Z@];I?\+N\-I?L<S]$=^HH2-'J]]/X5X
M+?X\Q L!UF9>-T"LC@)41XYRSO4#&LP*-D=5"1W\>XWL-_J X,8>+''\S&7^
ML]]$NO'/"MYX]H)I='DVU4N^MBKSMQU5_W$\_5L>4/8$/ Z@[V1VM-N@!*<O
MK9?D[K3*?&,:]216\0)X+BP?HV32A."B7Z \3:=#B$/HT;@3.>YIZ@*DIKUY
M0LK!.?2SR>G4GGFEXL1>9)AR17L!Y%Y9Q^(=3\] ]ZUZUSYSF\%NJJ&DO) 4
M5?<EC5%7[(AG%NGRSO5"^)X+D_T73DE2"3[,]K?SB&S[[#N\YD?T7;R-]*)F
M#Y5L, IZT;.W%ZM&^=$)B78(X7,X6#/CX9)D4#[>WX2SW4LE6772JB^B9.#J
M8)U'^HJ9M);L7FM7')2M&N. 8WLBWAC3);JR0?D5YJ7M!@IDH<T7:\-ZPVTW
M=QF6PJ<$4>XQ9J2F"XZOU@:AT_-,C69:,_88;_W.([/>F+!9)NH16[4$>53J
M_#9U@4^]F=%^:BGC<C+6)%A>>U6Q[DNW)7&OZ3^@-.,%:_/(UB YL909,*^S
MK/3<76O#)J7(48FC5T.^K7>HDUZ'D["3'\\.GY78WE$SGCNF*\3C6!X6DVNU
M$$$V6'>%:31(169=:XP4<7*L;9SU5#1I;6U=7$ JVEBAMO>LOCDJST<RDQ<@
M7=.@31&I/5U4Q-,5[T/@V^WS(CS @9L919-!T9W90>"GFFV$"XC3]:MV+)#-
M16P=^OX!E TSD-X:G8]["#U=4?GN8(D'>3EU /]\,WTVNYT%,I^]6MGI\C)U
M5?76$R#S(%-W;@7>?YLN_^%\H5/R#&Q1A7F]:0F*PATP=RF,#B A)EWM^Q"5
MP':K%[#>U/EZHO'U5NH]T6EC6TS2+2OAPKJZH1:'H,M<:21NQP":T2GXP_=
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M7_%#$@MK."''YF,9UJ^J9#!//^PW\C;[U.S7&\H"6<Z'>-4D?+0ZG&I@R7=
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M@WUG1QDB"P&\ :,+\ :[&?)ES2XFZ'+?VTEPR"D^,9RBJ,>EV4(MB96.=U?
M,6.<6XZXE])O?8FRC?V>%RS8!\.)M]%?7TFW$/A.]=&@4CH+\JZ-*6UJH6J!
ML_R<A[S)O$JV[6W.2:*I 2Z2YSL'1L5'TZT^1IEM7ER(T\6PQDU%9669\W@6
M#YKV:&ML^*+2BL9"S$[T7>;O-_='$8<#0B A(*C1_"*9U>XZ5*)_AOL-L-&L
M@9 WF."WMPKVW@\_($41$RQ^K7X8<_A%RLU&-9J*KQA'HZ:)5.-$BCBQ%-+Y
M9M7VJ=5!V^N%9IG0EN:A>["O1@X-3!"[C=Q16W?-%(JU^>5MGW$<+(W1Q47/
M.[7:W4'V3LSE1C?P(&(V/+1/.'GUZTW(.W1)4Q08+'[&+Z^LD]//M\Y:4^8I
M:!4=LQO _PW>^\ZQK=>7N6SN&@WNM,G#:%%J)T1U=[EZ+ T#H*5%RH"FUDR
M6[_$YT1Q.UB$^%-E6QCSADG[GL1= 2CT\=":6TQ03$='<+9%EN&"XTIAY?,E
M:/7>X,EUZ<<U29)A:FO71O@4D_%+@CNMMPU_[5+X_T[ ^8[+[@&PU,*?T:.?
M/VDFN?^9'JU8(E>(/Z%'?U<$@>(OP[K_$M2'3Z G\$P0@>Y /[_IC P/I'L'
M,B)_$83"CLKQJ/_QFR3]0Y;18!F!6TV6"1KC1W>7V5ELO"22P_6;6'/5J1+I
MT8$D>R1ID.@XL $#L#KI6(BIN/NF"/;S.G'+7I:#=D@K;Z-GQ8LO1<6'D(/X
M-DB>T:_KQ]V^W?Y"!-4 4/IP $U[#)GA5L7)MMDO[0O>'DJGKUZ&WJ*M\>+=
M= ,KZG1C8$S0,TPU@0F*1.L$CM/LM&S5K_FN$'M(RA_[%3TGEEB>UO0M/7 E
M<-5L0HCL7^DB ?W01V&G>ISF^V6-7H2'4H+ >"?DK:V9$BGD 5LO!K1PO3([
M%;K:=4X!NI("B#O+*Q*W8IOPXJ?MBVQ+EK/BS=JTZ&TC$Y$X<XO.X(2X[&GX
M+"4QKX#Z@T?4G>$2&]LT80L>A 7#+F(;!LZF9!O@@*/^Z+$[#&"\>R,C4^:J
M6:9-9U!498\ JBU<RS8MW=5ZC0?!VLQ0,FU"417G9+R-&,L$'<>^:\?.TEB@
M%+(3\'9(<4=M0YQTD)UB>L!Z'7:J;3)!-I97X<23QO"6/":(*$X1[NBK3J&
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MMHS3],-.)[[^CEPIC*6]RH.I$/NS\1=\JF6URZJNUEXY>Q&K/P<]818!R,/
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M'%F^V-HAGM[JH &)(?'M]E#4=%R7TAKKUL!T(HW1^36LI)(@$FN]F]=*(/F
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M)%90O)R"NO4,P&VM5J3%%\)KC8" ,4 4I,;@]HOV;$WY(' <A+Y:Q;#$I>O
MLZS>L41,ET2E+EE6=,+KU1@L319R<5<:1RZLBG7UD,9(%VTJM&)1]F<*B@(Z
MCM&.WCR*B+$/%ED_<%T*_V&?907_C. %]37U$?^3.OIJ?ZTXS127..W=PVH
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ME;Z>!?%0?K8J:M7MW(RN9 4Q>Y778#RS%=NUK5.<=L3Y:%^Z;DA+S28A=Y]
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M1F&/'AE^%C,!B!AD<G[W'$]1UXG3G^E-Q>,F NV6]%["XLV7L$&58V@C$DH
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MR$RU8G)*4/\T?0W]O5/PLWA8N4$OC&;_*.($:OOW.L"?/$^-=LO=^J4NX_?
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M]<:Z6<R<5KW/J,:(1#2\S_3!G1JT;VF\B["&Y]]&G6(#PO0(IK03R:A)!39
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M@&_0X]1;R_4LJ:ZT[J*VD%6#P_62?C[76S]B]YY#53Z!@4[FG'^#4Y6^+.@
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MG[N?[7,7B>FM<#TY=JXK[HU8<C^R^8VDN?P!D&FZMB(S!^TL$0;;I[V5FMT
M%2.64OP*;Y9,C4S3S\\YO,Z_H;_A:&V1<$LTAMP%$67&0/?[YXXI/"(C+>J
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MT">.[5%GG;5>WA2FP/M?4^IPK)W#>AES-=#J4<Q9-P%(VYU4U!8M+2.)%VS
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MLLT)/Q4$@[-?+*,]G]B,\D9Z7LH5L3K2YY/* 4C3Q, *3REK\N?.O079?^(
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M I,I#_]6L@W6A"[Q9<:[#W2Q&[2XOJV2Z8^\KSVJZ1XK&;+5!F1B9\/69G,
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MS!K7N)G=>_0;8#= 6+Z)LX?^ '8#OP*[9"ZP2UKW_@.P,XP+W!3\<V!7^Q_
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ML]V<IU"BJ&HP\HP?['O"U0@HU?33\@&TAWB2&+6Y%&TG:T-8#]%,FK&,T^<
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MN0GN#&MH3@ :-FTB,7<]21=>(R3\LUMT^YBE]B5;49G_7.4KU1?/U8,'NA;
M)WH$KT9&?AJ^R(O:^$5IDKD-T]86ABLEU&%$_>/IETK8?%U)48D.! ]=ALGY
M1O#T8:Q7]YK!B!/=<D1GF<1>-BDWB,BRT!>AQ]_1QY17>[@ZQ<=?1&07]+ 8
M\G6T[_9'C8+)P:$*BZOP!QS BPT.H Y#.V,3FI$6S]Y%66C >+;#G?"-#T%&
M0B\7P>DRX]S%BP7K,!%B+A9]86XGN]+(#&4NMW1*\>]-)_",B6P>(J$:(H*
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M_S>241G;V7V&JX8[VT@.D@OQZVZ_(K@CW90.FN7YOV2W6MDISH&WYO93E.@
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MJM=9C[!<FDO[(!28)5#V-;NVY%"Q)J<>O['9O;-,$KLO8@&QC]C8@&+?&IN
MU=-%^ZF7'?Q\)&C-=6E A$H:J9(<PW;MW)]%NOU5$>]&%6<,_+'*.ZB,C<67
M=MO:*HLUR9I[V'/_SNZDQ-T]--&86P#!0LN@FD]C1U4:(W%HSHE;#XCTXHQ1
M7:6:Y\LZEN*."]K"NH["<1O9P"6CGBLM)/A+*FRF4V(+R[MH[11>TGK93=ZZ
M2_6S[K;TF;@]L^6LK+KUE7Q9;4'!'70: RCM)BPQZ=>H_H]RV $Z8+6,/JIF
MA">6>=G6YW9X<-56WGMP_+WQMVOU]I_XK=Z5\Y,]5HN)CC G[I&5!G6VBLH8
MFVC)SBQLI05MI")NU"I<"KQ1#1C=DRTGPAMAAQ#*I2EC#>I\O6KR'N<GY)BN
MD"OE\O9]H<]2*[9<S366MW4Y>[-Z?F:+7N:[\"WNY:&K&OS^UWEO3]J4SP5
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M&("X['4&4!S/39.HPA2NS':#TD[4-T4<]!8=V%;2<NUJ&%WK&:S)]_T4-;+
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M:4&Y;2@R-^SG)IES=5.Y;'R/ --[KWM=P62$_WBE$G^U:KYL/=8!-II %UK
M:0Y'HW G&, KTY\#<_UUC60&4/;X=UP9C6X6B/CEX/&X9KAFZ%O41P(4VFIZ
MJ4W7%F7QI]U>OOP?2I_R%W_Q/PEUMYC#/0G5QMZ#77T0S !T'Q>L7/GO^+>
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M4(=9>MBIFR2I1E_4?3@H'<M4<_M=5>*<A4KGTSO<U;)''JU+GC-X1&A]][&
M?Z+[D*'>VN7^N<0[O0%M(^K)=.R7T.]5N3*1J\O#<7M2E&?(7@AWW5'$"9)1
MJ)HMGGLUS:L9>7)0_ID;O/BN 3D/V>4P5G5IQ'0^\>#=S[NU^S"A_R5B1VER
M ^;%U!$U QQ6Q#>7PFT]N#V;TCY,N;(VTVD1>JE^@M.P8'._NCU,AK)#[@)U
MI[O#(?L1WD6^"8U"#\L+G.U.#$KUK4.+AG0?S5(NUBV^H_57'IWU,5Z"\Z+J
M3R-9$6I@-C&S1:@ULN9$IF^L^5?2?FTWO\^C<M]^9!P:/V!_X2#>:"B3FZKW
M82*1=KFD'#WM$HXMSNV@]I5C9&JIV&/;%DQ^]R;CGS[I7C#ZC[JRUH@<R;0U
MHQWT^C8&D.F(D</@)\\Q2^A0*CP#]O$"=%?@]I]YNKI+.]?_=])X9&8:0WW;
M*4P?0RV^EUUVW77ZC\?T#&(U_>8@:F45NQ4.B2$E4ZBP']BMO -,<O@5?0BI
M@JH_=S_&8XR"/_,S\@PMV/+2_3@& .D97C4B!V*HE!L, -D*6D[OK!90]$$'
MLAD-4Q,P Q&XXSH:\UZ%G/ZAV/EKLUR#=K4%ZVOQZ.=X9;K<QB5,%1:WC6*%
M+5J 0<R^N *AWRHD;ABQA>EG"<YWY*<T67@4HA?]H50^&[(C4;N9>Z2[!2F.
MUBPN)L'#%)=*W41<)UEC9G9D'CC;_CB0Z3VN7'R*]_A3V7;L="3LJ!+T*)6=
MY!.R_C ^P(C;=7G(INNF\=W3SZ,#RS/+AV[8':-8H^IO*S  E]@#XU0YIO>M
M?3@$X^$OJ:RL,4^BSU]XZHXK?U5Q@+C/_9=>TCXM+[@'JOXR]J&(/MD>9!%%
MX\\.007<AK7-!Z8MN,CVQA:7#I_DC< J7QK_M4_L8%EC<[-Y0I^\>,U$/RIL
M.[_.?#0AF[_ H'SI8?(,S<,C"@%A -)EM0S@:_8"/44<,VQ-C2"BJ#FC._2&
M9/2><WS=+V:=Q+JB^"W)"/1-4/_CBE#+]Z+Q2/W=+9T4_4@;^<(',LQJ>I.7
M>*)1R?$7[D5C"68-T\D ;@T9S[>8&8SM.;F09,ES(#<QP339@*325"LZ91SR
MR]3ZCE_Y1L/T=.'K1_%\]_Q#@5YB*WD6/$8*OA.F2RQO2I-9-WO?]&1D,FN(
M]]?LM)S;D[ADA\5*I6G8-SB5ERG@G4*1O&" *9B($\/#3[I:O/9!B1;(_4R2
M/Q-*N=)0F,^^GT7@0/G!6<Y]> 9 -#7Z#<6%-<""4<1O2-$E>9S-BLCUX]!'
MIRJ3;-S>S;M_2GSP<&/$YK'RT0KYEB>: ZZOBDQM3?JKGU-_AJTGXG)MD9O;
MC[]2'6?01ZBJ/4Y#5-,O2W21OM.G= /SQK-K9(PT*G^>N!IF:J=$8:%J#JI+
M(W]BCR TBB9T _*5WB8E3-QJ3G?P4'S#9F^HSW-4/#U7$JOZ6''"C<X>0O%:
M\1?-*YJ\0[U(_'[W>$8I\LRW"(VCY_>SOW9Z>KR2->1JP]F"/$/CID [U15,
M_$3"82GM,2/-C/+4Q<!M-R8C/$M+65>*RVXE:;4]UM]%/J@*7'WB=!4Q_TH[
M-I#I9#,0,+P(M-G_:@XFP]4BI27Q^4N;@)430\X/;_3&#;QI'!?:S31GMK(]
MO<LZ^=6#GOO$_2ZS+197#4?I"X2XRZR'6:-/CVM<'OV!H5S"UR&99_I1I<%>
MRCEZK]TET+W V7J0:7#]Q-$_AZ7*G5=KMAIO>/$XQ$YJ;U3<HHX]1>K=GGN;
MIE*;BC6 0:%@P+$:^YRR*HL5S#9F&]7;Z7#G*Y&>[)WGFCPT^CC-[4120$>;
MQ=G[&H-IOU]\]$^ 7W&#$TV,1LHUAB"W*L'L^_+MRGUD"Y7DVTZCSI^<?^YP
M18#5Y"Y2>23,W6A,7Y_V :%2T)8%PO2JC\(5'[R;2[E$'4M]S0=!M]\VYB-5
M&AF,!P;A8D%)Z.H"KIOS2ZS*"U/KYU'B>TG9@4^&3<\=A];:WGS  /K/!8]^
MS^V\)(-U)$Q\H<?F4J]8&R5=) =:T.WLL,.8'AAWG92O/K[N9=5P,$([!TS5
MD_\ZX9(L?2%S6B2ZA%KT4MVB_L22G2/%BP&TH:DV3$'LO\  -#!=J.C)PP.H
MZ42FR@Q1LR4R --:-&[X=8=PFM#R=<JGZ(&[UI7=W:4/+%]W_SI<WW78HY=[
MS&Z/RY1\'LP.<#^5-#K3:-K)%YPI>^H4_:;%G70KG)2)L+7NC@%T>>K"XN8-
M'J&G&VZ=J!\K-+%Y""CAT0PYC#A#B_2.1K4@S_13E;*D(A02"-:O\.?69Z]=
M/Z56_>8(OX846\2>Y8\IXFW8R I>N:S*,))T0T^PJ]Y8Z>QCQ>VXUS_, ][-
M6(AO ?%NFP'TPWD4WM_(_E';]==U9R;@=E15(FTU:105-E,9?_;+N@A/SE.S
MEY\%V[L:3L3TW&&MIPB2F8;ZI255C+30F':+"B/.VG&2THJJ=7/O6MW5NU?A
M;6)Q(O.AH\R$RHOC)T^^.1?@>7$.V>>F+R] UD4&[/E]J/#-4]"Y^G@[P'6*
M>GX'./WBU*RY@8-U/U4U>\+5OVB[['W.:(MC14W->_M0OI-)/O;[@Y8-D,S.
M6G\*Y5SDU#JYGR38R'ULHM,G#[S6*HF6Z!=(7C74.ZXK)7YS)6CQ2T&OIN\P
MX?T,5! YR@#*AE(I:KX^ELEZQ-"$Y_*/RWCM_3)C.ZLJXS2$?[F>X-%ML7RI
MDM*5!2^)EO'?=*V]4KXTW+VN&'PW(<W@\C-D;5W 7F#K6,H4E2^5_(A(QTBF
M>I/T6FQ>N6>O/H(J3'>7]%[OC5L3YB=@C]!E?%7Q\V&TXFGL,1>D5'_P([^M
MCJQW6K^[AH$Y84C##X@KD9N=^1[G84Y&7*"5H@OU8-5JZ*F$9?^T[4;;6S_N
MU<UZ\R0P#6Y#K"NH2GX-PK^@ZN51SNL<OA1<>J:?2M#V,&(IV52 ,[S=J?@=
M Q#B?]);N1MFI_=8^I+T9X/U[#UX=\?>E!;ALF8[A[O[\!Z]IGLD7Q;:0#_S
MG80*?9;F8YC0V;^MKX-QGZ+T_@P:H-^2-?F0@1]WK)*\8*)G/!+"9VQR^_\#
M^?;^XG]16+:AB2;=NZ>M!6E1;U!+\H.!3G!)5+T^;#;$&4Z^H,$ LLK-UQ_
M-BY^HHLU=3& 65N;'NI 1H3L'A_U/X3IHTTR"W>?T-^P4V.8!FL2U78--&8
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M9OO5Q+EL-..UP7@1R.W[WK5B&XN"@@1$XC($:XP^$ @"RX3R0= DX2A1,(K
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MHW?&$$=$Y/RMOW1_Z?[2_4_1^9"1Q3ZA9)B6^7B4I:H)FQ]#VS"14$OVUZ4
MB&2B/?60/>KJ'^(R]B_=_U1=@<-A;:3X+X^:QD^I0X]#TM\1M0%_&I;%49PK
M$8\D4P!!0C_R @7H=:  6]N(., O[B_EGU(."KYIO]_*GV2A4Y&=9KN3'DRK
M> ;PRV-9\'/)F5-4EG8R_QQEI'/QM1KD=;'OWR_KHRWHM[+\XXW9_E+^2:5N
MH/><O[Q7VMSJG$PXU4/)PR/.?AO?.:=QS[2IU3GU*)YKKQ&%/8!?^W_<2?X/
M4@YK:^GAN)'L4L.3;9J=0)0:_$L?;9F>%<Q5.KJ,)UY]4]!^]+;Q3GHB(2/H
MC[A M7H#EOYW<%#]2_?OZ1)6Y6HC;QR<OXIRX;5E [2&@DZ@EOZ7Q?O_+752
MRL[F;><=Z1WW:^F?J5,I3$GZ>;?_!9/__RKG\2 SN=SD;[_EPCZK=4)7.EC-
M*I\%H21& ;(&*<#T @5@!_;81;HKYZ8/-J DLBXNYR_EGU?&^%3?ONR+HP"6
MR43'^#=%A.?W[<Q!-JX96_.8,\@V6#$H>GO]#PSR#^0Q6%'U+]V_H7.4CTE@
M'A_O$JUE*G&4[%D2I\:"J;L*EN0P%A$E=?+UALNF@,H31ELN!)/QWVWUCD$O
MN^'S/QCL^E_*/Z?,.-QI&[GYR_Q-<>3<5XX7K8?LGJF8J"VQ)'/_-U&\3V9C
MNWME-MUO<:/^UP6?_UUT4KKZ0PTJ^44<Q=V1SYEJ&>,1?+>X/ZOX/I+T*;/7
M&YCS4KW_+6!QX7RGG]=_FC+]GZ!+F':<XJGXI%XF[L*7&BR<;94CL^X&V_G/
MA]S_L4IM#N,1@_8+:;6PY+0=0PT.C=1F[DRY^[2%>BK,7_YA,[ _B$@*(9D"
M\"Y3@+(U8IRGY[< #0J0Z(' >))5DX^EAZ$7J!UV74DG1TH?^YB3;]U$JE*
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MF,._??O?CY"U$];(T-+?ABL;^(3F0G3NU9+<R=5C^L"?ZBAK(>+K!@/)(^&
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MJY]QK7V2FE.AF8HOW3W 4^.<7#CP\NQ%N^,DIU:R#'ELZ@3A>BGR[!V6I9@
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M01F0(8CJW,SW-<5011 ME1'6;A*@JT%+:V(6)I<2G.=_1]" ES<58R8.6<X
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MX&87L=8R3OR/U'CVSP!NE)K#7!@;WOU0E+CPW9]9[^+Z<F<F$_4OM=K>R0+
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M1$Y7: <>01'[M<C'$A.=QNG6PCQ#"XN(5.6O\J(&W6:A\HZO$!L*JA+4L,N
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M!7>P3VJXEDA@?[.??3[S9ETS5 7N7EJZ%NB$(Q!XL1CT-K8T.,S+'5&J*Y#
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MI\I>43=)UN7(B<VW6+ACGO=5[%>4;A[-?8KP202F4X'W@)>*D^\B+R7^F$S
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MTB?G/6/.1S1"OPOD&G^QXN<#+G*< &UCA!6-"\93NC@0NHVY>\J#@B:N9J7
M$/V!X?XA\F FO3]8$Z\0OEVM0JM?-UZ=)L?:YNJ69J!Y(+2GO1*OW5?^ ;&4
MUZ!>_IX,P:-[+-6L6-@"QL4RKG"L[/$J?.J[%I\3E_F(SN64)L,?]R+>.<<\
M*UJW*89*X66U1;Z=0]X_&#A&O,Z<8].KFC#))P9@[EW4C8+O:+%V:!T??&FE
M\FX'VE_CK7]TN7A+-_CZP?TC?P1>]#$*%0H3+&5L ZUVT)1KIUP3.P*[X-J,
M)S)-%1*5 D5:YR,J'F+?M7YO.BIN4!'-^YY 1=AQ:O^O?UB7QX(F9\\ 3>A>
M,Y-_O#!\[LT+(;^7 FU%('[?+#6Q^8?$JO!?6;\\0:)5$=$E?6Y+E6WJ94/=
M1(VYZHARK5NQ;)E:?[(I@##/N_'J&TO?R)SKH0D^<WO6'7,9=K? U6RHN,^S
MBEJCP(SO8!6L-AG6VK$M7E\/RZ>DF:E^BLRE OX2R G@[V/)EXK1!"Q^@M((
M.0.(2NR,_.L_F)9:3+=.)&GZ#0GV9FND7W/(UK/P+!]*E2> <5D$05-B!;:4
M[3 8+]1UP&_X"FW;\#'^AWK'I?E8C,DIEG2!O[<<?IK7HF1.&4$SR+-<>6H(
MM71#;?BZ(6:L?RAY@AJ:JH(8?6XVH:FDG ZQ!&)&PQX2/L:O+]-%>OEX"8^>
MXJJ9YSJ=5'B&^</=DSSV9E1Y9:()'%R-_"D!WK:1?GN*,D:)I6%Y.+'7),WB
M RJ9L&]#.D N;[30GC:2G3%#-RR\<2+Z#97A@Z1!P5?L%4="5^$U)W<AF<BJ
M<G*.US*"E!I+B0E#/BQ^ZI![_UEB^MP'A)$DHZ"^"8;#H4@;3K6FV=? =_^(
M>;I_G;),ZB(.4!Y3[3>$V!>TR?TO,J. W1[I$%XN',U2' 9Q96&3,]"_(69W
M<$(HYH'?M^<7;:[9KZD4_\E?-FN%TAX&G%:H<OI[=:2D)N&B3L)2 L==XGN$
MWJ&.G '?KW=?\3U80YI*_.DXI$9FPCY1DUK8Y&)/I5T.*OL38FZQ3XS5(1HI
M--BU:N<1)L5*VSV=$<HB9&UD](3H1Z%WQ2J1HN^VHIF]^W@<9G;UNCI=/-;.
M.VI]/@G9 4]=".Z"9*)K)_ABYY26<JF%5"K_2WYZS[L_+N<55!1IK']Q%RYO
M:%A!]O0HKS8&A46?;_;?'D:G:5,827Z8D;?[R#!5NK$FZ>S6S^;.M7WG+G O
MML*&%TN&DD7J;[4($(::_M[Q9+_;$1CS.:3G,>'SI]<X[+'=+<R@[!NERR;"
M)S._I>#P,T";^E]S9#^B@L?EKO:?UV/ 7 9)V$T]UW>)1?9V.12E_+54*$6#
MYX.@+HT"!]ZS9F5"&^[TFX.*2IVW_E5-9H#H>Q).:2BGO)4H+=.1/A;]3/5H
M$ZK%+EQ7>?1?E.?_N*SS.S./N31/_2 KKL5E1LM@<F0VI;%\3^XO]G].K[I*
M_&.N]7]I:O>_7#!J6KAPA6I14X+T:; %8N.ISWZZ!Y"GA?7W&>!:"Q#M_]BV
MOJ5ZPETH0EMX(N?)7]SSBDL-=S:SE;V+WZ\67E:-!M7GJ3]9U?>P^MD7O)$]
MC'A^!CB6!]$B9I0R3\536P*(V#. F!0QB((+ITR5UZA>)<N,4YC(H/$FX/=Y
M6QOGU%=Q+Y)/Q]:@>W+A'B;/ KS&-+G+%+H@E>NA, BA1X-8&%#@RNH?KG/E
M(_1;ZHU7B[:XQL1.ZU/LU_OEZG9BI[XFE 'HZ9%R2FCAP24,9=R +!G$! ^@
MC)P!]N(A'R&[+I 37K/?CO[H]V< 1\1EH@C6MXJ@T_-LVI%PL<CIKI4UF+4&
M(A<R9_R$VYZ6QXLX<X\SQUG?,\5<&[90XFNWH5-]@]O[J^.>6?V693DY9!>T
M%7D&^'VKY3P59QE3\Y71<OX,F&K<,M?]B\L</^OB;PE)1CS#EEWJ"F#9/@.0
MI(A&AV]^SJSBI[-*(/=J5DZS2::O<AA6O]!O[RT_192XK:M<4%8QG\BWE%W4
M$8.E=[#IF#BI]VS7HN=A Z2@5R>Q[2.Q$":*["RJSR/?<L#]PFS4&Z$P0\QE
M7,N]YZ %^2.N]S#';-A#?'?F,M,Y"K^N=LM'7:9.22JO,?K=NL*A''))10QF
MO[3 M4P7MEO-<F5C=+-!?=,M8]HCZ<7D%<WK[T,NM9T_QP3+$B&SM>^VHY(F
M,YDH,L3LUL#@ ??X8:8]KXT6L:Q>_HM+8'X]:W&C0G6#HNWEA8P3U=C]NX7Z
MN;Q[Y=I>8L(^M<5/9C:#0V8.^X+XTZR?U'D*ZB2OML;%:3&V!7YF$!6IU2SU
M7\=EN4JAMY&$"S<>"TJ]_1Q*V>R-ZL$#,MLK5"]3ND\4VA&\TM$^8$[_]]T9
MLJQR$)1ETH0X],7[O8N2\P(QVXI7:  SS2XHD[SFW$7GAM &FU^+C_#@\^\E
MA-SH*S/M+G/T&=Z)M!TV(\LK;NAX@5&:*>M>:Q#BK;4L=S^2[*P:XX#0=$/Z
MO-?-#'L[3"L(SVE$G-$C>9'O-A.S2$JNM:D.3#Z%SO&:16KTM]<0$DKM,>L#
M3JT[_N4R$**(WDPHM9A3@.07!)%W^Y'3@PW!10\\FS!/*T8$EF0?SN>04D\:
M6VTY$>>)TAJCPI,[-2D34,,9W%$.3S[]'9[>30^;GPV)F\8G76*NWCAH*?%U
MS#5^Q>J-8,MJN2HSL#?)9S:#E72>[#1.$8(QC7FS^G$36,*6>(,7$N[\4<ZY
M'_:L68<=54_9B]N :"ZBK9QK1SP"/#A*&^R]J^X_X;G/(Q)3\X>K"_B+I7U1
MBN#0(H%W^B@/"EL42AHL]\CQ8OYSE&[/&!45M/U&I6%:/IS,M@.Y8CO71Y!>
MWHU4O3X[]S->0FPMGKWW0%97IH>4"VY6S.A@53!+2SZI<3V9.WF4??!5CD-
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M_S!G;&/J8? 8?0G9K7YZ'?P2BS</J?D*]G-Y[Q<>\(A#$IHLPO8BA@X8\.I
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M9/8A+'WM6!&/3Y?2>&$]8'8-M@3X?I*F8:^'M1Y_LT72],?%6J^@S%;4LOG
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M%$5]EU]&R$6Z5__,O@B:>Z_#2>TSE.P(=,4A=<=1*NI%HJ-I_B/1NDB-'@)
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M<,K&H740'WYA_<+ZA?4+ZQ?6+ZP_8>T37WSB@-0+P_)O:CONS9Q](_K5L9@
M""MP(@ 4:8FG/6WZPWO^<!4D:;\[.QYM9@P[@(O@4(+%O[_ WUW'2QGPWT[D
M^P7W"^[_/EPCF )-]'38(QTNX5L)M\/TR63(6I7_50+Q%]9_/ZRR$NS]!NC8
MBXK4@7OB]T;";TKW<4I._Z/"08G-%<Y^507>[/]ZI<$W)HZ1_K%H,+%$1=16
M0']T@##;)G]X@QJ6\Q2$(WE. .QU@,, ;K\YE7CF18U9?  W =#6[<F.B-\
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M1H&Y 8)HQR6:J+W'W2^<)3YNT)!?2QJ,,K;I XH:D;-8NUO =G!+LP0 .7X
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M-YL6+XZ? )['/@LB09=]%MN0*K,I=I!B2!/+GZS^:'Q@[6@7(L"IV<\5\*/
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M@P, !'@O)LDXE4_F^LRF8>OH592Y*9^&AP_7[SVM,5:$M-GNAV$'>N(/N_K
MC7VQV@*T%R3@:YI5R0G S3-4++$92<;,'Z:\)*QX-YF$O_FK[<;$$1K +!4N
M#F;V6N ;:[5E1(&E70-$9@=?-U;8%G,]9H7;T(O=Q]"O-'6;B6"'+Q#*>.7>
M)(>82ZJQOFJ,4%)IM<5*H:T6M 'T\8AKE/DEC7GU [SX.TU>_'(M9%8K^,GM
M*_-):U^_QO Z=&OO9!K@S>U[*>-4/P\$!\Q;,4KS,MX!O A-DC@!I"3=N6\S
MP\Q1-ERV]=3%Y<9-T?,L\0?0./M_=%Y*\&*>UZ3)O"?&87+.N%"JU?>.HNCA
M*;02VAF!8>L%GF]E^SI'@>/$W]&O@"'JT5DJ"]>_0:(4! +>U=H_T+:T6PJV
M=7Z=O59H)A!G;)'TP7*,VKA .(+LU@R^J[!B$^CU;\D)G75)0R5,FQ[-'<WB
M1@@=)30=TCSR-0V":X/@X0D[!B\J QN@"JO5O YC=]E?OF0%^$;ZOW;8(>A3
M=>!==VEWP/RB+/1+<EA]5S*P,3QK)T:CZ1 Z#GT8O GFIH]B^;5E(WYGYO-2
M@5O8)46VS7SQ2>>)%_N^D$"_-?[*$.J59WSG9N93WONN;Y\ B(_/NAU_=')S
MJ RLN&?[>ROM:Y5 SUAZTH^B=%M45DK>OAGVBL?B59FI^"P5.9#9U-2(:;-2
M_GRX(26'SLKK#7_E"R4VX5/B4#?ZW%^'A9?HR05]JQ%L#XBQ45U-^\IQ^[S(
M=#A5B?YG@>^XL!KYSZ.>BF8/:3'7NSH56W;Q5_W=*0\L\TM+'8FOWZ1+U) &
ME,OXXSN=)X!S,'&G(CO0>B.D&&2T;-_+%5QO/-S-43ED)+7+R,,^K&@ 19.A
M)V>N42PJ/4:KVJ;0[-?A(LQG[Q'D6S28-L743@#.6E\+6;DKB0/J&^GHQSG3
MQ?57K&_QK,D]+0VHQ#09C(U7[?_3;J.,D.HZ&?+!#XQK?1(Z->6U\/@NL?IP
MNU@B5<0H-5-5ZP& /8U%>8_!AAT&#14A,3_*8&=)28C7G#M _!6F&5CA*/&9
MW0E@]Z[6YC!#X)!B7K?H&''.?TNXP9%W08[BXYGTZ<ZIG -'L[\V"J?Z+C]#
M/7T1<>_<NS>]IJ&B(X0NDLWN% B2,@/LM0(-Q*A=>3]?VYP:523,H<M3AC\!
M^'WU\U<#&VREF2TTSX[R@GFIAY:K*Q:-HRW>%>1:DQWW*02G]F4/,*^F<$E(
M89?M8)G'472$RQV9#A%\1JRUJT04Y[T+,!*)FTP9JT_AVW#DH[S"*5Z"64[_
MZQ>2_5.?XRD9PV)S8\#.8/O!,P-8&RIZRIW&_4:/9!L#8U[RUNAVY)ZDB3['
M["UX-D<@(7(71/RNK' /Z<M5-!C@;IJ%KZ-N'_\(T.+LS49'1W#"5">TI4)>
M*SB:WG/@X[PV,60VG9JO.E\D$<F6P>K;E1WW*-&7(]=YJ"H,/+I!0[HWEB1P
M77>R-C+)6)BNV[.7WR8$-/Q>0S'3YT*#>\#O#-NU;Q#=*HC87C]9K<:\K[<"
M<]B^E]BKSH ]Y)@>7BS-Q8G9TEFODK(83TD)K@ZYW=<N5%U1L"EDKXQ-N+QW
M)C_?/ASU]&-<EB^FS0$^Q?F"MDY*[P/S[H]@H+BL=Q%2(7Q=[=.0BMF^4OD/
M!:4_HAWTVURUG1%9$6>M(Z@OP\(1U AX?U'(?\=+VS.0_ZFR=?D]1$W%0)6T
M6WKSPBR-O%UI(%9E7%TEYAZ"^56A94T^ ;S^&JQI1=8[+H6%B;^-$*3P1IP-
M2:)IK,RN,]+MX]GO5.DTLPLCM-"M/TPC1T.^!Q7K4 P;.9,(W\+CJ9 3P"43
MK<GC39YO8W(\6K_&V5TB'S 9&-CE^K].TU&&.V,/E4\ ,0CRF=A#(4K38G!/
MGK\)@\G>A.38-U&\RVE6+<2>;'O/;/G83\U#YQ:!GIUZU]L]P2P>?_753K-B
M&E07;]659%0N+[3,'*Y5T^T_6I9K*ISE?8H,Y*FNMW6T;Y$]7G"OQ< [] /E
M.386]OK0IV$.."3KW(.R[*U^N7<JXAGQK5RG-&C5?;^%J"QZTW*:)E]FO##6
M<[9'WENROMZ!;#Y&SL]8OVE'"U'@?<"&U6ZL>(B*/7&AF"I-Z06)6HZ9&-F8
M-WQGFDCZ0V5Y]$!RCA5-1%J2D(RTIUP[B ,V!LR;=#734UW+0)BN<E!;6[>%
M9JPSX:6 \R_O5OBY'F?'J,?%VOI\561DV/%1E?8)0!*F?7F@WG/OAW08M;&A
M:KD^E/$?3$G"=%;^8D]M]68&:\!/;0)Y&W+NNOZ@_W2ST[6*V1TPE$6-=VB<
M.N(&*T?\0=3_19!F#8E\J8'X*N<.1\71_8ZK]#>5[0-KR9]E"S.>)B;"!DKS
MH_W!5O\-ED6(KXOQ'&<K>?L,+P )X(N#6O/[4V</9N[T";E73S[&A=:)[:\"
MB8^KM*>I0+S#P<P7*I0\KD=.>C.T2XQUVV[Q'U9W:R[K36)W51=I\C)R//9I
M]H;01<U$'E8LWC[ZG@RY?L_4 &,_4GW0M/2;VO@#F""F>0)X"R:.=-,5J)QD
M!%D!H7SPA[8C.[P[T?B+"O+QG699=W!]!20XG0"NC9 TZ#W4D6,>2$>8^,,F
M3;/_!CF+*&\Z0T7RN8AG?RR!A;&8ALF1&"6M V;S1RN^<IM<:A)GA9TUN?):
MW58[=R@RJU&MIM+OY%K#"N=IMZ8"/!P705K&>C??7P?T(JX <]* P772C:]Z
MFVC<P5W-;NE468J_1=VWJ(43P./\;=#LQ]_G%0057)/8FJP:>  :$==:(>1(
MHMB;17/*=7!7@JCMPR9TS<0_BH^BO)N.<]X2*.EM'PG^-46">"\R9+&MSY!S
MOQS_ YX#(D#:^+WEJTM'>AME-VIZ_$O^C6&T+"</@E'9"GVV5? .$P4E<!W$
MDL9'<M$&?$^]KWVU11Z086Z@?TO@3W[7\.H4JIT(3%)"O,OG&H.9%CP]1CZ8
ME)_ZBWGQ+,/I=W*W2)3&1?V7Z ;M+$AYQ"\T%\'GLI&$ ^N&_KVSO&FW?QH6
ML'].*7X%IW%3K;/[R+=_;__TQ(Q0]9?,2MDT*WDB@,/?2[>*8_,>] Y?"&P;
M1R\5K.G-=G&Q^F7=SCNR_P4B3B,77M!"CAMH&L38GG)<&YO.!/URR/J'6Z-*
MUM(#/W\^$9&]V.W?8/%.U#<UU_PMNBD<$:<96!JBL2@>J8Q]*T0NZU#:GWIS
MR,]NQAO<ZGL[4Y5Y62+_]GG!0T6&R!3 G'$"FDZ+WI*X"#1)[RGI;,DN-B3=
M],[[3TR_4)93C\ZY*T0XY0VFME<CR;F4?I(A.85XH3$*6V>>2 .6S6#UP]TK
M$B MG^1G_+_?.$[B'.+0/GCVJB>X4JA49CP7VH"];8,B.SJ&_=D3TYJPK#B/
MF:Y=\2%CMN=AC>C4(TZ2QJ)[+.IBB,()H,=1IA4B*C0(S9%[V5KUX^.-,NO3
M:7:OUT>D; ="4V@\MMW\?,BJ$'\<?Z(RXMR-3\ FZ3V)E$%1\')3*J#O6 GY
MI36<)-RES4R1Y7^'NE9TTQ/AW 29E1WTO96)SP#U<W'M:9/:^TZ[X$X9#G^+
MP&#Y4++=(\1TG$$!O+"_IQ&)_.G<]"DT0%CROY%5'D^(%/Z7NS=!'(T>\8DM
M=&Q\7W_H@X0XFJ\@5]!6:SN1<+%69>K]$ X@-\6S)%XYHVJ[LCJ2&S,$N"IR
M2O>G1!3'.<F"GV)/2%UD_#B#<'7@3"'F'9B^;H109T&UTKS$33N_@L;,QZF?
MHMX_>"SAGIXOVW,"P'U4P>0"+VK?]<PN_J#NBEGHD.]%>!FF0E0S5UR2 ')W
MW^PFWL(;2E<%H&Y1 DDFY.?'!:U@$KA]X6+"HFV,YJ/B?=&[\XU>?$7OAVIP
M=[B^N_#:_L2522A#U7G*%W^(=RX%5F=Y*B%GPV&9)1>[;<O?_DWI+G8O:6QI
M:0JOWQ_7&]<^0\?P87DU@_+/D%0B6_6)>[U^G0<7US$9K6F&4EZWS?:$;K\\
M/_C9\5:+%',#"4IFV.*W(-(F@S6ZP!0#>/T) "_KD46U(M#-9X*'G$\ UBMW
M:<[ 5^$WFMJQL_SX@SY%[J3SWE!-Q:6* $9IK&G8].7MQRF5<^\*"^O>"*IA
MR_LN*"9.!<'[C^@C)X#]L>D3@#&F1*E0SOJ&?^R-X&94BL$VHC^0UW@WAK7*
M[O%?WX:\C*D:&P@*67!@4/SJ&%'JX/!B3_-=ML.G7L+G7/<F8Q)\Y@XYFU'X
MOA =D<@30*<*@Q%'R!$%9/&ZXQ9"A/OVZ,'V[E(?MO=F:" 23)*F)327'H<.
MG@ ^"U%:Z.?OG "DP#U8LCCPR)S7_W>IX!CRNOSS0FB.9][W^+2W]EP)8V;!
MAU*CZ]IRQ\V:RL2#Q8,4F/!BTO5_@^)L?_J"Q8HO3.<I%$@>:CQ+QC['C^3U
M#1L.&+7WB_)O'5 -0PJ7H''*$"T0_FX;3O3*U,13C%=V?ZH^SIW)VJ) -]<5
M9?/LU@Y8BV+2>60;A\:5+]P*MQS0&"_Q'(1[U;%7^E>UU59^7'O \6=$[\T$
M*Y5S"1&O0.,FNO<)D1$M!$Q04K"_SR.7R@1N7N#K#MJ-C:\!'E99\BLRTFCP
M'DWS73&APK9<+,S@3N.\TO@X:4_3=G&5@"^DJ/3Q.[(2I=\T(.(C9.NN^A"4
M=!8>LW,(JGQY,#002KC'M*3V4PC(#/?VEEV,3<IJI]\@9M80QWMW"]*P1E,3
M;[\#N!M$4X6#F%1=!#LZM&27T7^HY&A22@?V;15G#-P=>2ED95_VAX\/S:*T
MH0.TROY88:7^O=--6^$1C933V=,4+,EJ$=DWP@O3F*@Z ;B#^2DF3XA3#1>V
MU"OLY\T>ADW4W\]Y0*ZVMDM[>3/D;QOOZT2WLN_8PHRQ0PQ5>G33>>!5=#&+
M@_'\XU>@\09"BX--UEIX*=4@8ER,[SB;INQ9MKGN#X>7:>B7KMM("%;;.?OV
MJUH+"CIOW#R_V I\R."B./!:\]L<FC[E^N(.4TC$KGZ\Z'./E4\JMW 9(5=^
M[NSR:4=.6U#=(D86;E+BJD/X%SF[_M5.:%KC!A'U^H4;4N>0/.H/ '(Z<X(L
MIZOU1&Y*N,MVP9MZ8SEJO/'@Q(4SDW2!37X.[J%)[R$,[.V#KIT; @I;%V>?
M&)Y&J57+::G[E2 4-:NWD6Y9)L'-^QHDY1OW*LQ@[VOK&L;#H9B1L>.1*N]5
M4$7(7]-9J4>;;<:Y7*GO=22H8I NM.<.)A#MED4,_S4= VRL=_"CS#S%)IP
MZG(NW<V;U2S!9BC\F4._3#Y$^D:%;!<D>[@\*4C5*TK]YNHJ*1&E'B6["J;(
M\'=A*7;B=2QQ0Q8[K:.P-D>.VX8?X*]2J&YCMKPJYR83RMIF*Y"RFP>B^SPK
MQL8Y!Y6$36\@]X*FQ:*)^7F*K?7TC@B;J/HP: :D*LS%EA\1U6I%?G!<Y0WW
M\K[3;9G"@6 'KXW?0[I!49-_#:_4&*F\\EWZX)0H]B8?TA<A#_-"],")9B<
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MH3WAL0Q_O3*< 'RG=##="KZ-)IOE./ND.9[QX_VH ?]J(*&@.^@,N,NAYF6
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MD)N;XB[QA^\%G:-WW/2A^-.19NHX]\]58,H-<@XS38P84_R-;=8AQ)"G'3:
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MJQW.I4!CP2&8(6#N5A #$L0;0Q^X/C@'R)A+_3DTF)I[[:QO[C*G.B,?'IT
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M2U @BX<^\CZ$@./GY]F#;Q4-MCC7^WZ3<*']/,MR.E]V^P0P<T!_P  U*G\
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MG-_C9SY] -"Z1?[;G2VH03=J,Z=R/Z 5( LPWGEO->"UH-8PH[9ZR*:-=NF
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M)OS^VV[OO?5:MC+(9N^B(9XKC0EHR6'->845RG,,TU[0/(>,VF0"EN6%X&0
M$S!U%_E+MJ30:O+!G_%!9).=O"5YT*()%4_-@N<[6 U7[">J;[5M75>L&#$_
M496;D,#Y@Q:+'("S!3=T 8EF.:%.Q*Y8F$Q)<,V\'F%C=@TWF]& FPIDEZ;E
MQY5&)?;Z(CY^"*&?+2A-!#^;S;0<K*0W>UA_+^U5(G]T'";@EX[R9&G:],:T
M1??$V@=B\]M8H* 7[LF!J61).5CZX5UGCHV+<EO1$B__?)M[P]%2"B0^ A^J
M/V/I@1DDX]WEL%#P1?C_T@_UR=]T>U@*NDD23;WWYV&)J&#8M\.F27_T)'QL
M]>H\F"(KD,<.X\CW@ NP)'V:T9CSCP@=^41UV:6:$:FSR,Q+NDD_NSMO?[[F
MMW<V_(\^&ZF+($(U!G4-2'J<"P8;#'_=@8$0,Z=XF0 IN3/"Q[OS9_H^L.DD
M-K(E5X6?9P)Z5(C)]+>LZ.Z9V%HX!EP_6VSC<Z8698L)VVQ@ DRZ),15UP>+
MBG7:>G S*./FLB/W;B:@#MZJ+/J$TM<&%&D6MD\TZ-0_=ZBD.NHX$.+#\530
MD.N#Y%U9W@7DS@Z@$OY??Y>"8.>+R?='F\4I;<.=H'6\(1H==W>W_@7WG^H
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M#R\L*H07:H?I35.IAPH%;#C9=_#XZ=B:6_K17YU)=1%O7'(/ L]5/"5]48K
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M W^+C8UEQ]LS2NSY3VZ;YTB9QQOIVHS-5J#@(*2]F_=FXMPTU8KTP4XZQRD
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M%<D&?^L*]]C\*8 "IQ8[Z:LC^<S\VIX>L!ZRGK$:07T?&>*H*4]V[:, ,$;
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MZ"JV>C9FN,H41/?(\VDI:<%8PARG6'8/E64"A#TZ N%>D&J4X#.QRWO:#!I
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MX"9"PTGC1XLN0PYQ:PN/(;%M3P\;C^/CUE;73L$[?S>(A5CTYEV?A(IQ=5(
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MAH**+;O_B_!OM!8?%ML8EI!$=EFEQ,@LYO=%>(^57-"*28J+8*9@IK,GPO*
ME<;:RS13\&%HUZ#:!H)8T.QF'2<YD+H*:0I&5U6="?B6&A;K3_TMU/" %Q^<
MY>=23\@4OTKUNO175T")41>GM#G<\P12S%I#1_[]?*0U;'Y=C_;%^X^A7C9E
MNXZF1'8^LE'BWB[52X^0FAO@S5M5J[$-[LH!L,AB! 70"M.,(Y<1LNJ;D=%5
MQ&/DXN2Y)\<9&FMDC,W8LR>8@U"<2N!K"Y#\953,(Y72='>#)M>;:XSW[W'K
MMT[^ZW$S9DU0;\N88U"WHE#+!UYH[&_J_;6=PXD_?G9(B:!<I\6,CR6XN"/K
M^[I,62' 9:&NJL!U>:6SU4GE]D")I?J:IL/^U @# =N!-0D9ID!I'_A?+_2N
MMRZD7Y!7[\G6M.K 0->-,&]QCF,21WU%UXQ)ZDT7:5_$- 6@C0_Z5X_98O9A
ME<%"+TFFH8F:_B^!A/*RE#<3M)=RD2P:9HQY; @LK*/=;P_U(*"XS$T)-WQE
M_W8E%YT5+G*V^.FSF!-FNK][)<B2Y2 I!J-D/J@<%APU"_I>."'G61A#5_E9
M1O6GK:#.3X?5H!O#=]% QU'3W>M9)O5WBUH6IQNG#_ ,.Y,W4#5E@US^(''0
M@2<J^HB9R!Y+-I;OI@!.3IRIY*(P74;^10$<>B(987MVX\CC3.FQK4IGF_2P
M_P>4P5(:?Z*F$:/K3<.G6KP3R'5I.QO2>SX*0'^]^@@W3ZHDVA 41I:%\'I$
M1=<*6_=$:<?%'6G)Z(<<I %V%_J]JW=?0(1\CH"6T\.H!O'(-A@V&03\2.8=
MM3?!(&KX+787;W]/@I;*ICO47__J-=;8T?=%X(*,<KB.N8^S:)6 P&*BK6:0
M'05P+^#/9BZ7(<<FS[U^E$[YF$+M05" '4G6>Q[*M_):PVU9@*V;LW1TSKWQ
M">IQXFG:RWB'2_N7;#Z24:AKT$=8/=R[29\#QEGCTAT5_[? ;+ZW=D91J^*!
MY8EM/U26VDWFF=X![[\.U(1'^CAJ&]8D#M36-"5,T1WEUA2$F^$!4B?>_<46
M67G]"]#<T4FZ <MFJ?W)_"';?%JH+#4BPK=5M&A&H2R?H1)8G=.$^D'N/9'?
M/H27!-5,7AI"1UQ4,\_=V+B<S:H7(;VW(8WR<RDK/HOJ-8WC4"O_@H9U=&[A
ME1C.='NWBQ>O$LI_")K>. R<WG+AF#LIE1Q^%U%KK!F$(R-<:2>^+M-[E?E>
MR1IO@NVN094)#V$#^EK4&/ES%W9\KX5@VIU_*+>3?[(K3WX/,HQ9*9-W>Z@4
MY W:V0^T+-S#LL)1&::8(B2?$#NL0_P,?V&%&LT6_RG^=0*[ED,JR%=1V,%>
MU28$UX3&(TQ^#QNI&.QS,C)#]GMYEC@@:JKPNS!M_O:#%:3>5O7,ZMW=@:;_
M]]-%P#%&BALRNC$EMWVV.[[I? 3')9#*E0]F@Y; ,4H40"2,^206>+G#75X9
MS@H)5?K *I'[\G"9;J]R/2U006UD0 MS/OB_S2S6ID&"Q'6OUWIH'M2"B(A5
M.TA >7F#P4+1U)1=/05@JOU#HB!F]5YHC,3GB__'OZHR=Y5SW5Q?F+]XBAN(
MS53I7W%W"9F^2RGOF0V)2UA:M"UFF( [QQQT<V"UJ";#[9SACT%9K'0RIP7_
MZNO$@2/F(>&X<!$$J""<QR8E+O 6!7!E>G$RJ3^Z6^_:94E?-[^%(E3_/>1O
MDD3!=^9(H* & ]:YHZ4DIDVZ&N:^Q?LR6<??'V>P?#BK-J7')ZKC_-%%X]+T
MI:Q>V&S%\F/@-30T2#ZNZ@:F86($# [04-0]TO\8^3C\DV'W=<C5\;R<*<^<
M\7?O_*V)?H1S/JGZM=34M%PTW(.\7U)IYM#7E1_MQ(]O6)8&LD$LS,B3O_<S
MI_B0POK^["^J#G^6=]&P_$0[O5N!S]DO982>;(XVF$;Q!NZP-!MPCO'LCW+S
M<[C=C$_2UWR@X5^R5W[W4*(5U_AYU^()+L$HH_V8,.)94-LFO]+.USLKT%BW
M3#(?MQVKUMT"R[RR?1'R]NU 8%B'P -NY20LVTI?&)EM&U2*[^H.A$6B@5JV
M;?]*#^B)"C-GCM2&NO/;0:O<[9)!F9I,M3'8D<C\1MJ.@YB\&[&/,-,),@?*
M;@E_/#QOY(U^!>_W;>I^F)OQHAX*B:WH0%UJN\=9LRK[W"=(.M.XH2UBT:VM
MWT^1YJ+2"S6+?NZ57$-?R:V5@U%[KYO6N8_7>6YE9"Z, K-AWVS0SS%=2P==
M\FQN"%7L@]$3JH&\/E*J=_5;RW<46Q=]Y +[/U=L^4*]^PP)%7T4 !^1#=/Z
M:%09Q@YR-AKW+5MM_)9;]?63D4C92QIA!8=2<1F P)"O3>=$H9:1:I#/0D/3
MEO=HKWD5K=;+JJ#=6E/_&=][Y=(_R6(A4\"K6BP@V!^R%+8A+:*\S<"5QL)Q
MD&4WFI/=FZ>#]EK,]EZ($I[-#$-+%+\.J3,$7_V0/IFU;LZAJ:*@)G5VX\T-
M%1.%K'6<]_IF8^ZY@-88/WDDT]MOQZ_>)I&H2:I&7"=:8J4@L"XMU3KDE*BH
M#DB);4ZIVR]N((8? S$W#KI\=SQ7\U;6"9UEN [$0/M^05OA"AAMA2E<VB\C
M9:Z@>)]NMWSJ)4@XI^^\/KRC6B2QE\E/_&%CA4']'47YUU7E^'O=*G:DY.NU
MRA5$K,*:3-3;G_I[/W@U<\X"]M"HST'ZW@0MEZ$Y^+QOO0W/RD&<$S-&*$Y#
M<=G#_RDG[T&TZ&N?"NNF-/+84JE(X!?+]51HMZMR-V0:-XR7Q9P"4W2FB,'.
MG,5L;]+Y]%W;6&ZK2:$9/<M_G-"$WAOE]<YM?D&U4<;D9<,J=?_-9.N&DUE"
M,(G9O:"FGIGG=8@4YI>@\&B#D:/%XSP1)9NIY*LB/CS]-('/0M5#Z7:!>4 6
MJBT_B,C:1(]BYOJL$>)L$/F'8U\;6R?2!S99!K +C'2_[$?NZ-XIU].$J$TE
M"/J6J[MY!)W9JB!PE2Y -GKV]@J0O;WCB<'<Z+W\H@D;6DS&:D:HEKJ;S6S&
MAQ,DNE5:,KR]&_DR#_4R_-&%:+.K2PGWA5L'>I^DJ0XJOP)?[2T*^+S?%AIS
MF!@-; !V@C\&IK@M2F$1^<]+OW2GOY7)\.X.)&([J_LI@(L7F\B<1 ^,:F^5
M2M#!94CRB%/$_(<[CYIO1=[MQ>=(?U93DRE44RO9VU@=&4"COFA-9>77;3@L
MP.'S_NPV?%B15=J/6BQ?X\BRD[V?6GI6_M@JV@]*I/MM(5MUYT[>, =N$)\3
M+*#2&*'XJK:;E?C.*696AW_2=TOFNI0'*Q/N6WJSWHZ/%HD4*2U0VKPGT=-*
M 0!+UZW9]S=%J\[W ALX>MQA/&U\A5"C;WA84)5L4RRXBO<<90H1Z^K\,JB=
M73?(S=+<\2S$*:W#7;OQ],>"='?DP^_XZ)+@-GUA>4:+P3?<.=YOD_Y]?W(/
M\Y^A3?T[M,M(!<,&-6"6@;TQ&99>TFSF(-\MGQ!R 6_UV0[D)(FUSBUVFXX2
M;?C4O]$P\(EI*_GVT(T.6BEF,RLR&_FW$'.(FHX/F0ZK6?T=US9RL>C3"&_*
M^UY)*Z G9"$NZ'?94(D8UTNF*F4Q+C'_QM:\<!T.X),)69]LG@/YZN=U=1\8
MD^<=]%G5)KQL_\4 3I0SRU[$8!P?X?;P+,6[M/]DKXC%SD?.(!:G-EXK4@".
MR2*"FJ<OVIMTIHXI %8WE9:O*<'@,K>F=]$>^V@Q6^$T9EUKBU"MM**R84E#
M,S=%B<F2NVJ]!@T;C@5M(RLE:$G,X%+5A#5"$>N;GA@D'&FO;" GIY(7]R+:
ML3/?'% E'TX!\+?18@L&[.&7(7E]3D_O*SYBN&-Z71S0)L<Q(=A=2LLNY?UN
MT\SOX+=G)3LI.WD#/;%?6H"\B_1@GK7X(2B&1V'\!!2[A7=0'8A;BKN_&IL
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M%!S;I2.G?P:%,+!-FS_AWQJ'?).<.ZIO-6[<@/.3/I*?0P5(8!SC/=!5TMK
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M'A;I(^5GV4"^E5*(;IV<[.F!28N8_$*;77\ P)]36+=![%CB\S1)L'S_N3-
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M'OXHKGQNK[-I]QM\[G9[MD%+_-K=8&;AJS1GZ0-6I[6/1(-KX)^@QC@8PQG
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M1+Y#)(N@FSU$M<3")IR>HOA5+X<(0;(885<T&:*\#61VI+2G<+=O&@2]N7'
M^^J9(""1L9/?)2NB9/R[$VZJ!+RZ]%L_7Z0Q>=PS:RDKTD<K(*$3/&>+A?>P
M77,3%,3[1=^<]H%<L@GZ_*,^\ZDV]VWGQ"_"L55 2<$Z+USVS@7\'B:W\PS
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M"U&1[\JGJ^*B^\(F(+FQ:?JV*^BVE]YLX8G- DH*.I)69J+PECJG6FUI*$H
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MV4"(V8M8R@R#,'V6!%;)J%+"&S=1(:"\2--@B?3WVZ.='>5?\X)/;(:7<C9
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MH^M7%X63]+&(VHNB 7<W&Q-IWRMO0UVBD>P<7Z&<+?+*6B3\/Z)&C7+J!D]
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M]R1/L+Z*DM89 %V_!CM6A7&DGS:C5C9 K[+)K$745!O+YI!9=4;\WF>4RQE
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M^\MDGWA"$T0W<]ZE9@3--9$+EO1[/#NM3P[OY!/G6?[5GP+OGST5WL6!FR4
M/^P(R561&OD>+J<%%;ZZJ)\6$0D6?"+&?@PK:(<)]TP:7>Y;\+08W$)*9F!
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MI!T!?@9:W@\AOD@K@@J+GJT#.SA=>FO8>O_Y?(_TX\Z9M3-B>:)"F=]R#?^
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M;<94B"Y90<9'55:2/7/%]WA]DJU;HZ*TI,WT>W+DDR124R,<7IH"A!-W-[N
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M-G$NFW>HMPMOXMOZ>9=-KU:SL9/:/ *Y*E%7[D?^/*7?Q7_<3.DM8 WDBHS
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M@H_Q<M6^_[^]$M\L@4*/ .6P-E"8IDO:95)U>A%TM%QB.//RB(?9 L/FJZX
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M1B5"W^G.V=;ZQGZ_5VY>>FM\.BXW4$HOO5@+ !K\)U;M'\^"(B#E8^MG9XX
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MC4*/ "; ^[TSJ&-!_<WGR7R1VFHSAWRW/-0,T]QRAXJRWX&S(]C3189/(Y*
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M8<4YT=LMRS8\+=*U-0)RROZO$A+,HNJ?ZG&;?^)^J ?X_X__]8.GE6Y.!<Y
M8M("FU)B&M6@:+T7X. Y!>$R5X&)JR]*OLXXG6[YV>=K_L@XS[LVS<SX9NKB
M$8 CZ!B5A0 )]0:=AUNVE2X+ZG\OJOG8I5PR]"[79%FD%_4I?J^VGR>+5$,
MOF>P4IT;03-]4C2A>]#P>M4C@%L:<OKZ@[YZ2Y<Y6?*75W:A/)XY<[C7_IN+
M'N@EE_Q'D9$/[=?7OX]-3Z&'#<D*_(P.T,E&OV*C0G?FJ=<$&18*XLF/^EU*
MVN<JQ+FN))B:Z9OZ4U9D'65N;^M-)*GK?YM/J]_6P!RCJY%J6@]YO.+.+JEJ
MGLX\?U_U^OOI\<Y%SY)QAJ0X;4R!;$-Y074CUZ^PH07AAD-/&D/O2(PGV/A1
MH@GWRQ1O/$S<2C!06?[T:#%%[>;NYK#]'^'&9(OUOUN%R E7PF-4VY3N3\HT
M6UD5:?2KHUKRZ*:XV22WPY)3AI5A^X4;*8=R PC0UW&XY>VA2KMK'.7+]=Z-
M/LFE,-<MHAYK5%V$%.!8 KB85:8G9S[(96IW_[U;*^]\I,70''PL%NF("4%Q
M:3]4^-!X>P:JU??,=5NR-LQOO;WO<)E+AL<V<SY8JLD+= 'CB@\_ O!HBV7#
M(>W3(K%'@-L#$Z*MG7*IQ0G'XS^/G99Z]/9]-)>>OP3WB'6$>,X.SJ[IU%I^
M]1RQ9&\(^;#L:PP/]U-S!U8"G86DVP)AIQL332]0H7J,OE%M/354@6U@@5_0
M7]K$=K6!,R1UG/[U?%#2U,,'N=+3_:\GGPT:OW@%XFEFIVK-!H5X9,/'#!C8
M(8^-4\,/ @N>J_;P?%)=R@ 3TM^]ZO-1'25/X#I.RI5+?[QR#=P:_%:#DO\\
M.Q67?, BBU&ITD83?=>J2(6SO+F'V43\J?$5ZXC.U?$THR=S/W_BQ:]&4X'3
MDE7-?/335"3)?OI>(Q_!YMRY7"&GVAAKHP@^#>S0/6M]@34;'OQ#\P)C@W@P
MKN:.B*QGT$#'&]_J/+;9_F#F,$PEQIV#1[77*U"2*PAU'7^2WE#RB33MX($V
M#X/'R#1E]9<&0.N-']_R4K=^X/4.-B!7_;X4%TX=>.P)J[6!WNFP4K5>E?01
MSO'1KMB]GK%S/T?)7]S..?4!-JWE05MOG7EC1G] 59O!Q AJ6T-BM&]"T4]:
M.PC;->+Q-U;,[LHN9RI51A,;#*5?)[H;KV",FPG2^C(=\B)' !$&(^\4"35C
M&:QS>GQZ@@IL^[OT8%JQJAN<FSHOE]&0J>^B/CF^6%>RC6:)-]+C^E2@X]90
M^E[,^'7+$S]18'%0.^:D]FVBZ]AFD.CR^H]NJ33&_:&V$ZJOP<'BG,*9=?8!
M8XY^)+Z?:LW2)/0'FS:+O^Z9O#%9 YF#8'EBA>Z7@C:AJTZOX<XWH9AO:.SP
MT+2_1\GT^P!!7U@2M#E]=VSA)9ZG^2Q<8=8'E6=%'=-C8*N&-G1&/(#8O)#>
M%/ZISQG@F1T-GDG9T <L@)<RSW\L^,PWAWTI6UA@QKX8<8%D^4%'R@UX8?<<
MW[KH]<&G6U>K%*I,FLV>=FJ7$IF"8'4$\ ,OCEL^)IYC[>H0Y,W.=G\9F&<\
M+#]761<>()5Z,=_2KN>VP,GH=^>>/P1W=TLW?1Q\F)@P]07=!@IE\%-!A'L(
M%8*($DU,+\P@23YHX.JXJX9CO;[+'&V$XP*=DV09V2S^/$AG1!E2!:_0B^LN
M'=89T?239?OBYTX02@5NRJRNR=4Q;]TT/7/C\"!^C="]MF^IX!ELE7F#9!%"
M9FO;TP1&**?;0<&U)_HJ&Z,UN318,M^+WA:.':G1<WD.WVS;G&"9V6R=>J6"
M.@_G[1PSCPGI\/:^.A;#=N+CP/X&36CJ);2$&DB",>F7346!$T*%&#!Z&\CG
M\+@J#9TA9<SS]&N^SPP<&AM(7\_[>Y4,1HX^=C<B)B*5^ =RV5YWR$%K[-![
MJGZF[?T3$()!YSDCFD%')FOIL#>O1L"X-7.:K*EULXF!F+.D1H>/?IX$; F0
M*6[D(42)G'(!&"O+]FM_%7Z[5>?JH/'SZJNTC1^YZY+9OW+6<5\/D]1 SXEU
M#3A(HUP&>;.M_QS] 6D.RQ&Y [5[ _X<!H7F_&+75(SO*>UNDSGI6NQE;N&2
M]YDN=9@6)(@X/WQML_$BX;F7#>Y'8VI)T-#-]AC1V[AZRV>GS84Y;EMGGJ!>
MGD&'!4F2I3X@5+X= 5Q61:^D]X]<TQG1QCP/7-O'B96C?Z\%/6 !&6[\*+:S
M3O"HTVI26Q[O47;KD.Z4D<-[-AV:6!(A_ZH3$0ZDG&E!LD_J(?I;WQ4C"316
M(OQJ^.N,@?(:ENGJQO\)J9750"G([^ 7F!.[;KUD;&O-#]*^.0$E6';*_XMG
M,UO9<-7%F+$RY>2*[N#@YGM/!$B@1F,H0H%ZCL2TCTV-\7"%UFI!(4/5[E>"
ME2E<U]Y4??]8&:TT7BW7_"W?/"WN2F*-YWM-\\G#[,B%38\[M1!1! ?)LKV?
M&PYMMY<80%96H<[]N>95B*HRY9N8.Q\KY*Y92!_(:GNG?C#FK7??B2 AW:!L
MFRW0T6FXO*.Q":2>N$W-(HCHMHE*E3*&_FZV%O>A,\1M6NOKZ>3RTC;9S#/+
M%MI @HC43QV^(6VMK]C $/VAIS8!-K ;<UNS(J<7)>*&$Z ND1II49'^L.WS
MCX.@[B_K4WX> 4ZYXWF4\1%\_@KIL\::'!76*TCW#$0MI7Y]*V3?-<+6*1^D
M5EJ"MOOKA>=VX[.V*'OJ4>"6<L\Q\\^61+*,.<79X39/4*2)"5ARY]:W;Y,)
M(YG KTP9.D%7(DJ,KC%EB'@(_ VI[+O9+COQYZ[BO8%HT<_V6I9( NJ]#B<)
M&:NMQ_S"/1J0F=\J:"8D6T-&4'_#EM(G6V3YMP9!.0/KG)K$=8Q)YZML0Q"[
MV2C->W/%%1[25F\9I1R0(64]Y.'MH3CO8^P:P-K+'3*0%'RZT;J7PD7ES%LU
M*M C;724/*:W"(]9*K:@X**/!$1QK];M=_6DS3-N.F!W9+T(9CVO3*9ZJJMY
ML?89(AE)E:K)'PWF.V#'3\:JG#CVV # <1N"0I),@:$Z%ZAUI&RB9-(L!X?5
M*L6(R.5H\V.+?)'UW4!MV^4N[TMC2VY"P2Q9)4""90OH%/WBT*Z0PJDE_/@H
M-K0+6Y)-,]_>3Y@5JI K$_;AYRD6+/CBGM>84%/@JUAHE&F.Q<H?3A8'?3=H
MQ4_$$9 MT&6%1I$9FKS4@Y>6ZR5;MI.RF:Q%B4KE(9,R@+$?#_4<97JR&Z<F
MBF1:T^;?@?U$C<AR%%.J$?F-A<>C#ITS99CAR06C7Z(VX%R=<NUKH?TGDB7K
M%<) )Q%G22Z=1I#3\&=MMY_H2Z2=5-#._L$AE[#!XO#[E5T']V'.OI]&1H,7
M7WE>_[J&I5H =.^+0DS0&:H<42I:6XV(NK"$P0KNA3M==/-%NF<J5)2^G%DS
M8,4KAFR?&&S(;#0;># W:6[?FU<RO]4![I.WWQR"U1*8Z?HB"=+R>=>+Y!-S
M&%M?U85%&V#S4'TIJ/2]$IQ_)M]Q%%EKIB:8H>169D4=:K.PWKGAVN,W7#3@
M6M+](/S^'K9-O00;Z6D&2VVZF\7#QUV)+&&FBKEIML-/01<1VH/>@5IM#-;R
MTA"+JN2>K4=7RR?!)R,?SUYLJ(S,$8UL;4 RX8ACAR.TF;.4U!5V%52AK 5H
MG1[[DV 7G)'1["?P>?YS)GC5CH?'+%\#GV:,W\%M(_UNY)K\X["M30S>>4_X
M7R5#</-Q:A^46U29U!3;-!>MI]QC!@_6N"QQI^3KP6G *$>;Z80I0:WUW -W
M>VZ2<1@J7Z;'WF1KJH^O$:;4($4_&;D;*1T#[M0N2[PG8?AE+D_Z^YB-,*I]
M,]2>E]I-<"4M1BMCU@,%%L!8W#I72\K]=:UOSIY*JS8'DC&NA"G>-O!0%DT'
M]10F4MRHE5JM'\G#=Q6L#F!/,+9CL@H3H6#;"LG:DY0QZ+Z/.A3"!)5R:K$O
M65*$SS7&LYC1JYI'R?^S1)'UV(K:=YS7$V#+E,LBPT)V3$7A09NZY/,IT"(W
M/F@U5*NVK9.JP<*2=?+XF;D+9XHC9314$V >C<%Z>M7)BXF(&X=).CP((3+;
M:C,'*5K0I.37P&'1E*W)2O'>N_URU;^!9?85>CR/\C5CMWUW);D)QM:<8#]A
M='M_:#,?M8WPI%&->"CC'</[A,NBVBWGPZ9ND@-3Q2X=< ['AJ%(LP1T&(,+
M;C+6IL,UQ'=O0/[)M-SC9/#+/QV?4^)3/S,Q/U#SF-U-[D\YWV8RXVS.M5XS
M]'"OQ-CPVZN2%,(98E2?V3MDG7AH\3(?OZ+UM+[(:\WK&T5:UUM$8OPVV] 3
M? 26U@P/[SAVJF!GO[ENO5Q#JDM# B]CQ\47>956<L[_D'O6[*6Q'I:8I&[N
M]D>FJJP3H475(G"\WUZM@#^ZQ^A)M&U0PP;3[@_Y#7&!7]Q;K]D4Y3N1F70Z
MB@1JL1>A9A4A[@[M0"JH798A:V/U*=@\F"IHBMYLHQ&#'#'H^0%2J.OWUA/>
M;MHL+MY:7YX3_<,[/V_1Q @\]/:/3I/(E(KIG/.6;1L6/?<*R1K$2E6:B8T/
MR*7*Z3,ZRIKJU-YT4/+S\#(/&OYIB?2,\"N[)NY/7QZ!-S&I)K+&JM7CV\!(
M3 6H#1B3\G>:VM^JFM:T(\L)XP5[Y,EJRH'9LA6COQR_)_ #1$@.XE%H:^@_
MWC'3( 1CMV]\;6=MW5C:_7*@U,E-TH"K[J3WM4!-RX*!?R2=!,:]%I%]G:(5
MV3Q68](%\IV19Z7]C)N96/.E>NP< =:JR[=S!*JWZ!@%^+\_E,;@*C;39E3B
M)H"$\YB9)K'6^O#@-<]*#TG5R [K)\T#Q_E<96N.T==X7=058J%C2[GK4@'X
M_D4\&0D__'(U1;;< O<]S?]Y\]Q+)%O0*3C;3/&7408KJ2/YO11_VO,0L/;7
MUR=^SV>\76.[(%=(Y@OWZN=[;HE5K7 ^GYL+N?O7%CMY;2Z)WR&?)UM/IN>Q
MR,(&O>N,?EHE3TI\&T+J7_/2X/J;"TDS,7PTKM:MV7_]N//SSDG^_>^@\I\\
M+YO2H3"!(V ZDV--!:B&7=9U,3X2$_AS/Q\.()8F(#"IF/&%)L'(/#-F2#P/
M#R(>O7^Z-LQ$Q?!4Q#4F$O'3^>H"T"QPS39PDX,!SJJIXQ=+05%Y17W(TAF>
M8?@V 1W:++V4!R:[!#NBE_<G2_%W@+TO'%^KF;] <GT,7,W]]BE/H]E-JS14
M_9%M::31+S+D)*,3>*I9%%H&U91Z6_1L.,N!;.RGO?=.DN5RO&O\B)7H;0 G
MMJD@4N9/S@KB-6SX0:Y)\L=(^P]ROQ$"-&6Z*C6 S&9&[@JG*Z;Y1JIPJ$_B
MY:?:PK9MM3_'S$G7/:7+WOCK8)GW\)& H=J\3S/J2B[_G\D>RMCBY%R0-$**
ME-<)8T.=I_:"[5P-E"2Z)K!^3Z_H_1GE$)([GY>U:<$0I=\D[;5BSHQ3'5NQ
MKY>M_WG0"FP1^EK?GS]XI8H;O4JB3(45X7X#UFNYJ5:#>ODR*B'=NEAA="J6
MKPMU@LY#5NH0%23S17A!UN5=V]Y$9<@NKC_JH/B=R [#QA8< 92?OYR)U:F:
MW)W9DF$ZQMH?-=\.?8&R"V^JT;[+-9/PL"S:13KGB/:#Z<NUU,"\(X!;9?,;
MOS>FPJ>VO^RS78I"TU2PB%M4X PJTGHQ7 7)_1R#]8\+=Z69I*IA\\+7MCSU
M_XQ/Z;X1%+XN%E?LZ_689IVYV7@X584;*A/M1#5MH ,"U78W>%KI:E2Q&?1[
M_Y0/"G0I)LLZVZWN'5\U2UQ_U+?X2V!<5=R'[7<<TP6NR=5_RP)W+M_L_>0H
MIXIV0-^@%M*4Z#>H$X'G-J/I8FZ%^#M9O&2G9.SK[&^5'^N5I+M_B@>G[:Q(
M1W^!*-M]-I1U8^)?YF,F\E:0\H-$IN&\"J?&<?!GN[,)*X,C\V%&83$A8F!%
M]:1?8OEOE@>;Q.X.%-&UOHV[:7J!7(?6/&:K:L+?J/X:N/-M_K_)M[#R41*X
M9\5D;VSAOENKO'J'G!RBIB:WGW,,\PSUSEZ2?#?STK .<'G+_;71XKVG:?"G
MOG_ S\UN"SGM]FQ/-XC8S!B\K4)SPHUL:TGS]>XZ%T]YZ5<E&,'74N*2GL4D
MG9EQ4/RH91F@9UF5_VWAO[PC3= TM?9?X%;1K_]U@"G^UP%&*\KO8Y>XV0\G
M;[%3][0O&+B3,]@H"E1Y HK?AHJZ3Q+)^%[AH3G9(CMIR_\MR4JQ_([3UO"[
M8_SV-SH"['BN?UEN:,']S1\*O?MIT&?#$=[04L\7YZ6Q ^-<YO6?3@(=]!HM
M65AUBYP_,Q/;_EK+,A'N2KE"%2&(O%()U"*L!S?%U.3AI#(W)%[,<7(/:A[G
M,$V)W).5:<U9QL=7!;5FR'K+]W.O3YWY*@U@/_;S>"WR+(+I'(,1WD0@_Y*_
MPCC"@'C<)#> DC^WO86+^[7QT&]Q_J%='P^KR;7E?3[I3K",' Z">LE\W%DT
M):9GZ(/79%XG><<6!WU5P)EWPU[^?'G"Z*)8J4BP..O_Z6$;)1LN;6-",17X
M-M2[5MV9_K-6SRM^L39AP]+F/QT!SJ;=&?2@3$7NPRC#9$KB*YH>78O$USY1
MHMP?4H[+,"03SW-1EOPBH\2^3G/RZY^QSW0Q?::S5 +M0IU#R)-U]1C=_RTV
MA)HBM;_A6SC^R? "5:W\TS6A+@6=Q:;^^/G]XK$TC94'9MFRRDTXBCW45+\R
MZ/Z^T .J&NW\D^4M2.\/^/V.RCH;)-]DMP*:4Z+[!>T472[I"/#.;\GG"$#"
M,*3_O9FS-(^:V8NGV"C]X&53Z:3^AD\-%T24H3Y?C6I(1F<Q<\7X_VCOO**:
M3+L]'@<1I(B4B'1&>D>*E "149H(2!,!(2-%A!A")](B*-)[&U! 5 Q50$I
MNJ%+D1H22@B]$XHQ0( 3Y_N^<WO.N3AW<_%?Z[U[U]/V_OWW?M9ZA.;$LXK$
M%L%LL#P76+NGPHY$DLYN4Z<A602X;2?XXB,"8H0>.0C5Q-X9A66YW BX5Z;8
MU>Q5]!:@$]'H*'T]/MU5RL'>(2O?(?BIERQ_H62#_O6EP)_W/\THN*)"!RW;
MD.>U@*2ACEG17;97-9#-&><.RV='A=UX5-866W,^R"7 ^C WJ0^PLN8PSF7S
MU^(2M!IK;MZ<N9)!-3W); &&.(VUUH38SS4*&)NKSP1S&D&U_KK*MQB9DD]W
MW#&!IGG0YP2V4^:I7NX(JLRC@IKW3[/82XV\KZV [-R9#3':<4Z-Z](91D5[
M4J" U5N%)D-X]4^>Y+'Y,/$0($FM"W1U2\N-&,<:>NV\GEB'Z^-HP0(Q"P%E
M I0%JT8:(IM33$@O;'@K(K6 SJCUN--/>\_$&G/D%>_"E1MN11CT&=C]**%1
M9+MZEXDX1Z&ICT6Z);1G)<27M(,1XE2Y/Z)E7?!@X\@;])+[NVPXW]7I#WOE
MIR.TE#*@Q7<,I('XE<8K5>\IOW6J,C[0LG T^_4@Y*+2ASW-4KH>89> "MB[
M:*M<4)%1*?GB",H<I8[R7&W?Q8;7F,4X<HZ%J,Z#%+8$.._I"@Q4Y.P^B[VJ
MR)>2$27L=RUW+I_F=BXUR7RDP#$32-R1?"YW&A2ZW-1BY_+&,T#VF42Q:H.>
M@;)QAC;SDLUR'>K<KN\<.%P'],"='*;QW>8A>G3)O3P*_QC]!/>*CY6S0/BY
MN@0_VYV-$#7B@%K[J="HG[;@^%._<LU9D+V]BV@TS="7IM+HU\=(HMG=W"SG
M85/6:&6#R, 0+*#5GNL'3+ ;,NKIMV7:1S ?W;[7K5T^9BQK4;!>5L8H,HF-
M1F(8J0R:0V045:91H69G7ZNU=OJ09]![\;#%4;MN =^\'>M5K.E)"CC@6OOZ
MKF8^O]C,<'A3"_QQ:@WOD-'R&C4EG,AG;)@I^<Y\V)H+P% )](F5MH?-9*;>
MZ2&&\?TJ-7W5-N[@/N4<1G[^].,XW+_8B%R\O+_(LLG' :)?-B!Z:9"Y6J_H
M7*0H+&0FN!8B"/JG4Y75]<=6ET]*@D-3MV0:KVNF8=@CO <"5:R#C?:E(-;0
MD+KC+YR;Q+X%F,#./F%G_88*^[MW\=+QYQZ",7]7-BT_(=(>D.KB3K***(G>
MOB4FM'\>WP[/Q<!2)B4&9-Y(TBV3@3/F1G?ND(-?O'3X5#?9M1OXPD]!<-5W
M=59D1/9'LS3R1V;6][*J5$U^]G:!Z,6 "G'2T*8>"?15<][C*! S11?,!S>K
M,].>OH/KN2;UP>^\8+X"<-O*^H]_A<^.P0S-S)78@.V7][@ %P!SYQY&=2J\
M#..@C!)3B&< GM6-<G<9S>DR5I7*C!3=<R^Z^C"O1%X,0BO?O=L"O==/,]'.
M'D(PM/$RT$[9Q0<(YZ]'OUCBN2NZUE;0Y/5?C2&#QARV,;VB^P_. /^'V3LV
M/IXBE!^G%K??PA5N;WEF;KI!\X1&J4;$XQ,V<_2Q?A82)I;;P8<+[%@WS_))
MQD@;]@@?3ZC]CW5%K+6>F'B:T4[]H?/'U["E5:\6+1IB5,3D29*PT4W&[WX]
M0JC#]^;AF@WXEU_N$>"_,>9O<_C^5M1Y[Q\5N;\N(Q N5X0HT.;F-TK D7TS
MJ$WGVGC8T#Q,OU?-F&SM(L=$\K(U1O/G*_#OL4U:9\W#F9^<J@Q[JB0$&U=/
M^#6&QSS=*;!U0MXM_4T))#CNMZY^YY)=ESQY[<2?VK]N:1D_YI>>48&%*C32
M!H(GS.UL@HK=>XOD"XBJ,<F*MEH.OBSUW8B$GC]#ZY:;&LF!I)67VV#/;Z"D
MYZUX&=)/D\ID:"#+OFKQ#']<E9U9=DI^'YX_U=8VBCGGJ/P,\*?"<Q\(7S6)
M?$Y^:\K&HIE]Y;0AIFYAZFK%8U)@> B(]-/ 00;#*_ J_&/Q#!FF,_/HCYG)
M2#K94#/Q9J'R+F[O]$*_\=>CUO#\N6=(B_3-0D;] 5#AI\2C *H)?F\G-K^:
M[>M.0E"Z75)\T^_NI1[7BW01J=]@(,G5<E'Y^+8 %E.9L2<5\DK>(<,!;E62
M7?\B)K7-6E()),I&D![R"Y@<YQ\LYPT.+X8OIRJG/Q/7Y]!@:+Q^L.:85;B6
MB9?/<D/A#!9Q^#\R2=WU=1UZ3.]%4[T BV_&2_[NR+@%;^R+JQ#Y:+#DOC?;
MG878(3M37'>5N^\+*NTJ1+X?HQHY+T8K\&[/*VJA"(*K(S>3(I QI@8,(K$_
M>"4_+$D KQS<NA>;EFK73!T,[A9B"U'=5;X5*M1)(^3FCU4SY.#5V^'V?X?I
MWL/T"&UHOY;$,0?U,NE^K6!I(56G4JTJMP<[.A04&\S.OZ?Y&^BR^I8C4<]*
MVC1W3'3\F%/3:MUV4&KJBQ)M+Y>K=9X*C/D)V$UMV9D6>)*S;A#Q8"4)B[+&
M]%<\Y_<85;-)!"+JU2D[Y0[-77..(C_[@>X'QF*',F&%D]4"(\K7>T7WH*AW
MJ.P/(T%*TY;NM26*3; Y"!O5@+35%3D?>@UK/R*OZ%+;%*^YZ/=HYD' HP@0
M[SXA"O)9X2M;I"9^0Y"'I)J05Q3E9Q.H-! H*G>RVK]]:OOS(>^/(ZFN#W,Y
M<;6]_W'5G=1_NVKH*,+2X%^N^HCFJD<.]U.-_FZE=$>VK1324N;/AQ2]W:D%
MAHZ8,\"3J6_!9E?LU^50:SEA5<'RN>YNKIR*C*DTZN'3F,5IL;^I#4O'_A5B
M>I*MPQWBW'(<&$?E0ZVC*4QPJ^9F#$"1AEXRE0*?366"5!O$ET#KY6&EL)8[
MLU$ZUUX4F^CGU@16XW:"J3,G_CI*E&/2#EF)Y(8)]8!=VC&MW^6<,E09)Q&B
MY55Y6H9K-GOV/R38J/=Z75">;<D\"3\ <U*0Y$>D6G1L9'_@W<>9(\S]AY5X
MY32.Y&=T0HH"&>G!-K?F(),;<T.8!"-55N8VWJ>!596(E19WN!W-Q24/[M2\
MF/X3^WGBA[?4J-_\DDSMKA_:Q7?X:_UX@JW^]<]!>O"P';/4JH7\RTCG,\"+
M5B[_8E4D.^5*UXI%1IRQ/U1V BXC6+;,8+(R\QE:0X&3HMKS&?T^CC8)$!M9
M?\/M+O/]ZK#(:_*(:@2*C,=\:HF=)Z<M+2X';'W?(5L=GJ"DEW=@8:2*_#,
M;"@RD, 1=M'!<?5)=Z<@=T.2XTC.]:S]WY<R0OL\VWXP0VY:^,_M28M(_7''
M*\!])JC<.-U9O=[$0=5M]< M:DU3 4.8<J;9)-4A3G<1NU%QZZ9CWMDA +J1
MR<(*+C666MX<]G1W*(@\%8S8^C/QJKG3*U7&Z/?GK%@ VE7WW(-,$J.<@9FO
M7>$H7&>^_.R$6*Q*;^_7(H#O_0V[- N8@>'L6H RRJ1+)M]6#/KS>HC[W S?
M/'=DK<(EQ*M.?P%N\^AV?X_!'M%;@VI2+)=N+E[6E\D9/:5#\!E3S-4P]J'
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MW7N_\XUSSMYG#.;(+V-DYEEKSF>MS&?^GY6Y$G 4G :.&>D;Z@.'Z,7HD!$
M@.. +L!P^/"?#WHY0G\P'F5D/'*$D969F>DH.RL[.QLK&QL')\\Q#DYN3C:V
M8P+'N'GY^/GYV;D$A03XA'CX^/G^W,DA!OHV1QA9&!E9^#C8./C^APOX%> ^
MRHS@\F<X= HXS'V(@?L0V I  . 0XZ%_*\!_*X<.T_O(Q'R4A96-;E!Y##A\
MB('A\!&&/WM-?S>8_CYPA)N1Y^3YRTR\9L[,IQ[R*3U[\?ZHQ)72)G[S?KRD
M\BV?$!96 4$AX>-2I\](R\BJJ%Y04[^HH7M53]_@FJ&1A:65-<S&UL[E]IV[
MKF[N'KZ/'C_Q0_@'A#X/"X^(C(I.2GZ9DIKVZG5Z=DYNWH?\CP6?RLHK*JNJ
M:[[4-K>TMK5W?.OL&AC\.30\,OIK; 8W.S>_L+BTO$+8W-K>(>Z2]O;_].L0
MP'#H;^4_](N;[M?A(T<8CC#_Z=>APWY_&G ?83QYGHGGLAFS\T/>4TK/CO)=
M>?&^M(E%0MD<SW_+IY]50%)E1HKPIVO_YME_SK&0_Y)G?W?LO_LU!K S'**?
M/ 9N  I0+;*CI8$##CC@GTC]UFQ$!P?;--?S=2U=G(B)_F;7PLY9'FTE]:G+
M$@82(;JU'#51=8N2#YT@(,!UEN0" I<4!4!@6@P- I(CA1%=I36UR.&P,]*[
M!J\COW]&V)(UAOCNC.[W1N\IT\1M\1VTIT[R(/!5$TXSS/EK10EZ3;2/%G1M
MD3;>C5G<U"G/;OP#!")2@\Z#P#O!&!2><P0$DMS^@RI:TW<06&P-)7LK@$#6
MM_]<<SED9F6Z-0_7>GT=#26QJB$WUT?R=VV![!]"5(, L([:.]U8CH;R/VV[
MZ8\L-VDGP[MIHK];7!Z0NJE.'M934\YZ?+!#8WQF>L !!QSP?S9!KT& \2P]
MG/"_1XUV,M.2)F$+><@4$&@RALZ%N<&)2I=!(+?::J\ 7O,@C1(C2'I-6N1#
M?6O;/Y$=+;?6E\0JG?WTWZ!.H9N/TY^Z$5B:,V8=!*@55(E0S(($;1($QD.B
MI='="0.'HQ=V-J*0Q_ E7^YDKSK)]JL$W]KU_O6(3-474C@S,0Z[?;_IS5G6
M6(:D\XY2FIH.,%CUC>QH&7;I[&C@'ZF/(&93WT%GWN@(HV,PGU$SIWJVK5$N
M9-=?2))+'2J5>F&[ UDQL. A]V2 O,V7'NN0V:FV:5<^\K'$8L8@'C/C2E'%
M]\4@6ZAOJ)7.'+NC%*Q:Y]3[*N^QNM+,&HC1RDH^BT7R\VH[7I;V7,O9\I_T
M9D.:HZ7?'3[@@ /^)>%*AD[G96U>J5 D"Y\ @0'[3Y2?Z $,2<:5DEC,1FN_
M!MU.7<&HRNUR\H# BUL@P L5Q27L"6&NTN-A\.O-RWI\-P[]";QNB*1+?]KS
M%@&![VI4# A49>4^\*.THL8QY =F>OQ[#_<O[V'(_JC.WY3C(.!+%VZ#L2G[
ME^%O0* ZC9*YT83>5>FCJG?"LVNK*2%HU&H,""R=KBOL3CND[_@6!)1#HA>^
MRZ%E4?N&;F]]$/R=[B @I,5<B @ELW:T3XG5CZB] H%RKQU/OR\3&NB7D"?!
MI?#7\,\;S^K="74F!.^6<?D ;XX@3;(/EA2^81I<76W_,MNNO>-W8>1H:?NY
MFHO?+-8PE2-K(OC%KZ@CC[T%$6S7:W^H8KBR'<O9EO/M7[4 Y.>QXS8,-7SC
MWY;M?C8/M/R<*]1>+]L86LW?\W Q%81QF_3&7FC<J-;[@ E9GB OK*RPB;C?
M5[@;/S4EI2A9]ME23\SPS%.Y-WA,F_<1$F[?6)$3T7)I9.,48V[UP(ZZPNU+
M&DD?6Z-)OD3__J"'9 0">@T$PA**',;HP;<K+W;XB;**+R)\!Y!:1-99&;G^
M?!O+<VT!<U_Q%ZP%5>X4,X..@K,Q+H;]OK<CO3X?KMEYE_N;5>;%%W-W'UR^
M<K236>)9+VS(?;!PS?-Z3YV<W#Y\I!H[EZJ49Z<S]5R1K^3W>M6R^Z CW$L+
M!/[PN+@8/RR8[BX@G6/>)QG+;\F9F_P#)H%W;=\,,B*9SG#Q??^4=KPQS=M/
M*7^21^5FC?AX.9R;M&%%%]S>\#%[*Y)7_BK,3JTY@559S,B8-Q3Q;48X'G'7
MM>O#M)65\70FE]:#K117O>7NP,8H>6JP1H9%VQ45%UNY+;ON0N\[\PO[D/M+
M6<+UAW!>-]TU#.*#U#ZM%!G%B(@Y3;EWBNFW^6#SGJANPN(PT^G0HZK>S!.V
M"&^3>OQB),_9L97ECWW*_N^"/EQ]\8LU.7;=2N>Y!6HZ"P2$53>BQ(\0#)X%
MN?K)+T91((^I6:H_^QK=;WJMU+VB+NC'ZTT$//VRF&R>=_W1O(9\M=C@H$E)
M]>HN]_$A9_-C:+Z75>Y8Q[5M1RXE$ CYZ $G0$G:^:$)V]T%W_K@F9,&D*Q%
M^+L4$IE\#]G=*$C-H@1/-RA?^KG3H"\6?#MIQ<0.)W/;7.JJ".O55S,)-P)A
MXU@6U'0&AE.'@Z+;7T^?YY$RM4,J!<>OG<3452%LRI3$FKR&$M@#SBWRC\L^
M0N8;8P>VAL?KT-KRI4VLE32,K;3'2P&RHG]^577=DZ5@0P=D R'YJSC_4'Q:
M,6FV)4#GPU&F+A" 58?<#PB*GZ:E;!FLSQ-66\<4\F82GD.X%)S&VW44'AF6
M%(_?J\)?H]G)?IYGJUJKMK)47WV1-XTBG8YH%A-L+K5#I+?OMME1HFH78:DT
M!%>ZP7>7>#4KMLPWH1!SS_ ,(3+4R^J79I[79/6V08YY/;7PO9Z3X>GQ?KGU
MA7&=TNJ:Z,VIB],I9\+UV)/TFU)>;I^(SV[4IQ_#;!#H+#]##5]';0O+/24)
M7T"3(;01B>FB_;;A0CP(M/X(+M071'\ISKVY]OPFP.(V%Q?R5"CE'NL&/:O\
MB-F\UPD"SG5P*I.13V[!4(YT7?MU>=2TL<%"%+$W[S@AO2)'^#1F?7C0R42\
MARQ-;ZR"0D_J/C/FTV+XEW0D"4\BIB>UL*10N\%MN6,/[E?*?5S']7U8/ '+
M0G9!-[V@[""P=H@>:K+;@K3Q?DU5D*K==5O"X54<,L\W,)\4G"<@+AX__][B
MV-OVCW77[EQE9;O7='8Z>42;7YI\S_'V9)*/]]QW]V&BD)&\7%5V6J&C:3^<
MA7(-GY9 ;U4_R"*;%-,EG$P^<R-\U76DVR5ZZ72B+GM\A\>GU#.#AQLMAS'3
M] #)GD,X'5&"4-JPQ_/_SG@LVD=-^=AS)OWI?(J3@9+^W ,Q^]BLER,HLBGR
M.U*(FJT%O1FD5[!JS7 Y>L'^\4")1*R1H^6+,Z]%?D/JG%ZM>(:4Y70C#/.*
M?U?:>3?F>PE&)C]\R[]ONX3ULH[H 0&\T?AL@0=66)'+/H9L:'J1W.,30%/=
MI2(O(YLQ9?#G4/=QE% G+L/ _K.&YE@QAJB%[ZCKX?F-7;BZ!P+6YV,?:WMN
M[TXG-)GP3D-:QE',B("-&W6#)U)M4[V,+/UWKXV_6;AZ.78;U_!'5X:ZU9.
M/#'YN=I]<6N8=9Z1W_RN?7(#N7J@PP)G*NCFQ%%*OHLI=A\3RWQ(C#-:T42
MP$;^"6O4<YHT0JVCW%@P/,C^/2+>1G]98N"Q]/W7S 7<I1VS<#5W*/YZ LMJ
MIMQ/BAY!K>WX;FO,:DP41SUL)$E7](; :96[UEO"3W^7%"Y5SF"J.M8RWB%[
MQC@C"+HSNE,DNUF3GZ?" Q%HJ;3NNWUI*MX2RJ$U7B=*CYR;]LTT>H3??/C\
MPX;<HWZUK<9%+[N:5S+7SSF4UF&MTQR+J_*7K9#((*-&,IS";_^5X J]6Q8M
M_J7=ZSX$3][9$0R;*Z,60N]JRU=&W;\G3X'EM"O>'G0TM\F=-IQ/M6;@C(L-
M;4-ZK<++T&%G4?>-34/="SQ-9UY/G=M-T-+?72C?ZNN;OT>>".[-I(Q<9TT*
ME[5<6)<N0%JC'M-<%33*"\)BEPO;'= HE9$I9'._$R-9B]9&8Z&F!YD4>&8*
M#:F2R75D:*E1>F4KCSYO0*.E :OHO(&YOG);X+I_I<31NBLPIU1M(_,"J8 7
M\\AJ$/@S=9&XF?W/OO!TP $'_ G#7-\_Z/-M-(W5%@0DY:Z 0&D2%U6J%MUC
M1&UYCIFSP;3V=:CGT/05^QGYS.!W@Q+-]/B /X']WD$>&Z$_V;>#P!8'7;2!
MP'K^LJ@8")R'$#=H$W2)CW1 )B*]:5/PS4 ,$V9B$+H]*X6,7L%NLC: 0(DB
M"+Q+IZQ0ZS%SNT@.U)</J.5V(RK_$&:./Q $'. @<%GU5S0]<7BL2([:>VN#
MVA,:!H$:NH"G3Q,@<"2%C.%'K>(Z0."^W IZG(UF$HJ#4Y^YTJXT6M&5@1$5
M&XW9(;C0\P/^'=AZ& B<;B(HTKZ6@\!)1^%\<O=V BTIWJ&0BJ5-I=%>]M$3
MF!"[/]7$! B,(E=!0*_%]"\"0R8+;PS?NQ"81>::1"W5T*=UO"7]]6VZ()A$
MTT*EM%S)^R# !U5_?1,Z9ZN(_PD"XPE6U"1*'^D.-"+3=!^[)DU$-53@,)H@
M<*N/@_* <+IR=HG&0^J[BL_8-O\Z5NMY(Z=3Q\XKS,_>9-?T=59=-V?EOCQ9
MG-X)-$6%WLY9Z+>1;QANBAHN:U2-^/)GHXQ;@&K[%WQ+JP^4^/)"#DW[.?K+
MK,LW?5L=M]'I8T]NWQZY>C<GKO7RV%8M;&S%)&]+J8#Y+*>X!S%![LE4CRTF
M;2\S!018JXF3=)'2,HVA,- 3IY3*'S3Z:2W#MG(]0^H0L%&4QT5+&@W8*"NQ
MW/ZYQ&2U],UKWXO9/=ZE+6$2B]51T[GP0W/]UGOUIH'\G2:+)L&G%_N8(7XG
MV?U!X-GL5 .4&$PB.)-U$0JSK;5W(PK=4HV?$/$EA4PM6C</E^6P%S*\%<N=
M#E%VV$P]Q9VR_+'0MM'>>^&11;B ;X(\[$Q@7D]P?4(,:KH@:]-:AQ<U(H/:
M#K+:UX73)3G>RO2PQ^;E:46(S5BG7_[20+>G?Z7AL;1'B->E_8;6#OLI8JN3
MC2+(*>Q1I!26Y&E0.J)P@G[8)9^LYO:Y:%0HGR/'R9B>W?IZ,MY'QL>HBNFE
M>V%-EU^U<1WZZ\59@_/%&B5=9F'HD13ZT>>=RQI+[VNWBZ#P65RKQ"/1KN](
MV9Z!U[:#=2WT/!&OOK8DNB2*9DP'12Q XP+]*++8<3]:#%<(O9><BC3KGYAJ
M[-H&#L4/1_CB^EJ^2=40(L*ZA+V\+!YMZ8EFWO;1Q[3W5VVD%3*I]YY[I",$
M DU_Z/"30EL2J^-*2NKY<=*P[KKR]'8<3N+$3*P7S\7QS%Z^^+>S9^Q\7N(_
M6V;GSCX:A 4NT>Y:.;,BOI#=:PIL/[PQ7+Z;E:X^>8:H2WT79$:@YZ;'D%*(
MD6:GDR#PW&>3^6XYEAWK:OA'&+]+>9S-7)6:.-6S[*_"NI&D278E:<Y6MXZC
M61&Z?PQO%!6OV_F-Y);=KI@ZV@S!_1$RJL38Z0#XR,71MWWCKA:0M8;QDR_B
M4K+UJ*I68V1Z8I!JTC'NBUYT&#H#&S.+N[:9)UU1[#57*V:YW$^T6M1WZ&DW
MK,.ZU7EN:7L2S4 @V9WD"@(WV4RI G+-(.#&-<JZV":N4T.*P6>U*4[#A;K6
M'YZ5W=0]4@YI.&4,Z>.^E_&5B=UP^O;B#_K82HC1$2=@UF9F5AT/XQQ-S?'M
M:8SA>2ZB?R1U:.@U*U#D[H\W,8MN&JAO;1Q!-1D&*;L7>]@QMR5P>F X'M<9
M3EY*'[:=W=P5>S8$^PYKUY"QB U1CA[+]>P0MK9$2H[OJ8U_0LV1A:_8^-\L
MD%WWJ4CK4: >WWOLV'>Q'W4/%0<OA\0\VF"G!.$7B1]B'I E1HIG]5ZU'V6Z
MFJ0X^0??S9<GX2^2,[FFTL,+/(M)LHMFI1D*1?>WB34AB%[K:V-*72VC(1Q(
M?]HO$*B A8. IST76]!YDHEKX"R'DY>9(@?.UI#U _>@1Q2_#=?;\O.'+!4,
MM\G8F=UG64T@P!*D/;WW^\C <JW*<8<TMO[7)VVZN5IY;69EMIS]%SEMZPJ]
M'GNM#SIJ]7Q6O7@^*#%+6R6YD>@W1GWTDQ1(8^$& 7$H+V;U0Q:E1&Y;Q'K(
M2T5>8<O\IP+/<'NO8$VF/Z> ^I"Q,N3F(=4]%%F$ N^'ND"BX=SUW 3==0U6
M!T,>J=U?MU];S;@?3OI8U"9IRR G+9$00/:U)E2%DFUHO8U:"3-3N8^%-HK0
M*I&G4\^$JHG#&#R??A5;[60H]DJ7L?Q(. :+,<1^Z!3=TXV3]>0P&_,P40WV
MN[<W2SN^. M;U\;U&%\E,<]TFXBT5)G[^Y"R;/3N.F2*;C#R2KP0,H2([C];
MA%1V?/6.I0F1)% X=!14Z -!Y>&D?<>9B**DR[?7-IWMBSPW%R5VX2D>R&9L
M)>P9QA5^9!7+U2CY!LOB*3!6,6*B,LS3)52F'ZYF,Y3A^(?KI]DCOM8@<,]T
MC#Y+$I-(VC@VQ0@=@<9ZDG].-\<P&M=S12#DHO#M&R_&"V^63G392SP0L^3T
MS+:<OU(AH<^6HD[NLR]6+!S\O2?ZN4!4CZ6;6ZWW9]HI+]N5I'D[C";V^WXR
MD7[HDXU)?B#@E(Q:_J-RLR\*,R]OYTU]% H")H]WU-8DZ+-8&GZ#UG :! 9>
M>\XKTF<,]*\-(AZ/;LN F7ZIQ5=NO)!PN/*:X=[IJ=M.XT/G9@R%OU'XCMOF
M&>\LPB_0DUX^S)R9(3$6,H=,[G?2QN<0JTB.A+HVDQDL$RELQ\OLWMC.K*?,
M>G-V68%PBJ!\FB@[GB.0 S&8KW%_T'I'>__Q22NGM\E.E_7XK.\^^]L%O ,.
M.."?"G-G%MZ\;^^DG2 U-A&U+#^$]("M<%'X1)HU-N)TV)>&=<3['XL](6HC
MA3.Q?U0DX?1B[1U"YF_P\ F89;YV7H5GP?'O:&=0_1<)WK2COS&D2>1@<^6R
M1;>EJTK&U#KDQ4/5XY7*3#,"0VFZH=EU?:0;*%[,TEL2/<D_X@>GW$_X:T5C
MRRI=LY,:MX/00X4@T%>]J_R?VBZAV!D$%G'D'\%V& H9Y:NN(5</ F',!$U:
M5%\,"F_P& 3:E_ZQ9G\80D,J-C#_O3'TY K%\1_L5HG1&*59HXH5*OQ7IZ;O
MO0U*_M);":,\J'>?0*/8""DD6AK]O>]'\__SNX[79PVUO$4CR_1G/2780[AN
MZ.E$ S/.)"[\ -;\>"R<DR(C\ [RG6SGEMKLB)W"EE_<[?&3?6\I&WOHZ^'4
MZ/PS\K]DS\<7<#N,Z_I[GQ7DEL0;Y4E&Z[&7Y-X,X3IR?&X;$HH$\"4?5>4%
MOTZ)].\<\U$\JQ*#.-U7LGT)9;?FEIL[6\[,+_\#=A)G&MIXB)#ZSIMR>1K%
MZ5G=ZK)NEYKL_5"1NKUD\GC[QIN86A$CH[Y;\3'OEQM%!W&?!QZ1'17:%20J
MR\*<HW2BWQVR5CR[OB-B6'Q_.GYE[/;Y;O9O8F+7FJPMFIA__/QI'O!;]?>:
M+STA"9R! QV^D' MY1S20X576JNYHWH>4LYO!;D_3NB;PBVN$V!/ZY5G"Q^%
MMF:*#@3IL@?E!A3'PF0QEU8>VO^TNGCA]U3NQW:Y%'EV+A8*%%_]="95D9WD
M>0V_9B':*9[LS/_IRR[WQ[Y9^VTSP^HS3U3Y^6_'>[=E<6B=G%T(JS>=,>%M
M]3K::E+H_F-2J"-[+_HAR3HS=&;R3/-8@(U;K6/FBUM9/L/-DR>BD'2?[%3,
MOJ]W!S-VH7N\KENT05@HW+.>VXT$P= @*'JJ_7!>;T%>D^^I9S^8'DG"#.^X
M>'\8T_-T]^8OKI#E47>^%!FM >0\U4G1YO/5M'^W9[57_-$:63>S+M=V_%[M
MD_(/MBO[09A5><7B 4362NQ1:(J;V357U1G3<"077C0)&EXO\Y[T>$[HR<"C
M)2]C+I2\OF=>=O3]Z]?7DX4^%NK92&='Z]&3YTL'''# OP#\*3A%/O=,WE+C
M'NO%M:J-$U'P;M?N8]>$;ICJ05-\L_"U]<(@<#F+DO(&!"+19WC?S(]J9';S
M1CV7&K.(1OFZ/A;E5.06#U#)DYK4JR1)U&37H$B.3NP@\*Z/9M0# JWT_)6M
ML"EKF[Z;3EL,*7H>!&S*O/<Y\D @]"3M+O87 @3VF;-H#(J;FM%R$?0Y:FBZ
M;Y^^@[DB+$4/\N\[D$.]U8E9NI!&8X_8BR Z06G/%D'@:3<E'A<] P(SCQ'*
MM%#HGIP:"' ;4!303*@?],19ZBX(X*3_7;/.U+0$>A?]Z3F $@C\![V&/70*
MYSW?Y++76&"G>M%O/BD%7;DVB;[K,]*,.S=,W)[PKAR$D>D3(_K2_-_7(AUP
MP '_QZ)53HP!@1>GNVG-,B"0G8?.D%O"C"G2KKY1)!_-IT6G-CY"SV%YH',H
M17S')O3>#'1/0-'ZWZ[M!T?^_;N \2$"1W #_(<3+PA\]Z.V@,!XWW?$.(TN
MY-<WJ!5T!41[!CWW?[?Y26,!S16Q;:)K66,K/M4^9?Q:X 1;BM[92T>>O>6<
M,_>2>J+R-N-%0/2F]R\L,07?L7Y^A@J#X1OBBYV]/DRR&<)@X=*3;]_=^QAO
M<.3F[JF&NY4%URWS.E7OWKF>*Z=WG7,YC,_,-OW?!_Q%B'BCIAND'//,()IB
MX%[@M-R^HFDJ9QQ]46IJ)E+=[W+"R]V2-S,;<45(21+D"L'Z-7_K<62IJ]@:
M]^2GHD_Q[Y\^*/HJ*MY*]?@I.;V0&C6^B)DST+*DO@D8 P$Y.OX_^O7X&</^
MV3/; 0<<\/^)N"U9#P2^)=\! 6<^$.@W'^E-V8:O"X+ *9,TZG,+$- SAFO
M-KVC()O0-)++'J3J018E1K"0'KTP"CJM?UL2+;>^0@IOG$(O*;* P((FC2[%
MUA<7M+Q X!P($'=I?]ZV@;J4]0KR"H,W1W. 0/,=LB5%_8?.(!&Z[GAAH&-=
M1&W/R6NM '-??^U^KY)R?'8M,PB$Z/:PIE63/K-W=]W'$RYG?:Q5IWR"C'?3
M3/VF1\CIKK2WM]$#K$2)R(*()K-'&26+I&N$,V$Y41W6Q-*&EYH@H/ABSUDM
M1D<5!)JTD5)NUD[2(PL$UZ<[S#B!+TF![C/F#)'/LU1X/MY\<(Y3WX^5>HHP
M]9ZI&)_5JC9<QE)\_Y%Q5';BH]MN0@64R_P$+@J_<5LZ*DH2S]Q"E2S)QWUH
M]$PMKVKI%GK,W?J<4U=3C:$1FQ?\(OA=YPS\U^;LU=?5/1](CD63Y6\KGKQA
MH0Q_*4TBCDK9>4[MIA!KX?.E_<\2/G?4\DW.N-4Y44K(0</Y75EX0],]*:0Z
M"'S^B=H_Z?E[A61 8Z%/1I+H#@CQ.%VR7I4/W%U7Q(_@T*U+VV**,XL)%E_W
M+1-.>5ID<S^<3V15N9Z#-/A^(?R/N: )Z[VDA7;UJ9%J6E*LSQ>?:1<YIY%!
MVI1KC1G\F"<$;PQE\PBP'/$FL+7Y(<^[[2H4^Y\U97DCJFQ0_KT=M5P2O(*F
M\&)G(V)/$_)CD1PDLEG-4*4WUUZ9[:1CUYV4(TJ1'YY_PRI+GXW],L?1\@%H
M<IY1[QS(F+!:]W0?GHK0;;/,E_[T<\\R([EA9QD%?[UKPC^-K5);E\XJAS5O
MK!NK9]<1%/)E*@:*/W2:D+J-IA];BLY^D57O]5R$A&65,D>AW$W9QQ"KLVD)
M08:J4VBANO*!LPMZGFY9+UT:''D?G(CL9_JA?]V00=92.U?,MM&F6''QEX3=
M:(*KJA'WPAM8]9W)QH@E;?XMQ;4M\FE2%C&0%.-W.HN@;#G4*%I9< P10&+V
M5L_"?9-^;]!3>RXL"HCE2L]?QY!-5J',*@U<38W,L0Y!EPD6>Q>N2C^IC/U\
M^53!=-W%L=>S)Z-ZS]T9,"\X_@BNG#JI P)]/_)LV]]^@B7(QN]C?U-J/8*-
M]8)4L^F?.Z7U>GA>1U&0"2D.%^?:H?PNR;-.,]?M76+L&H>L9HW%!%^O^N%<
MZEND!&EQ&KHN]A#/AH-$GB98O_'W)B9P>:K%_E$SUEOX)<JKZ.-J17)E(N/T
M, A8/T<?]ZU/NC\\-?YKAQH@%.R1ZR7[<EU@H&$'-K::/WL_WQ $&.EC._FN
M*9F#/B<O*<'*_[H(#]%'X1>DF;R&KJEYTA.?3J= O#+1DQ1*-@@2P4>1HF;C
M=%L@7#<'9JH'@E1GTFQR:Y_=8,S$Z7XQO*E<F5*[?3U\2<^8464R30,$!F X
M5Z?[0DOJ[1N__M0YOPVPV[ %TPZN9T@EZM/[C[(B(6Q!+I^F$#<FBP3'[N?.
MO#S?VZ]QPC)5K<EAW=HB5C318,FTV3MR&"I $T'XM1_WV7M2VY#N$!G5&=7'
M):S=57.'(L?ZDL_]T\_Y'I'QRJS7#6>-4V!7BOSO>&X\&AXQ_;GJANY+B$8)
M::'(3L@?::BC.D*D$!0K"6KH+F@]O/8K98'[L^WML[GG33INZ1_EO&XS36E@
MJ@.!(YV5^ \)"J7X<9QBM$J6V/C[5)'NPMQK^8GLZY,\$ATUA#I?%ZU0DQNQ
MSL+#:8H7"HWK_((QYXUY+UZ_\9[SOJ-(0PI9@1ZKMG06LQL-J&$HCSA?W,IJ
MYB$"GF46RWF?/D ,ZNA)=?"*.H\^R;KCR#GU7I/@A[;6.;*\\VG8_I(E+)>3
M>J1OQ_4X[<$U>D)9Q/GT7V!IS $''/#O8>B&NF'V>.YAUDYE[<O:[0TTQE#I
M,7[.L(P^7T>CE@H\%XUH)@0)FL$F"+"C)(B]O'_>ZK'CK,<'F^\8#?N;\J)G
MA\=&QH>HC#-02@=J DJMIW3$818@M"EZKG@E6AJ]Q+O%L*5(8[V8.[$* I75
M+6)*?3?2KM4UE)951=P(U;E3WK#]J:R$]6W!R?"CRS]AGPW)S$%6-19B'>LF
MLQ>G[XM?,*X_M[U  @'9+>A?]=(.M6)I^F/-8]^E++AR^R.9X0[KQ:7W0^CR
MN:!EO"!1D(3"JSF)2VTIUMOB?AB7H(MJ?-G>_G;+86#M@/I7GUMD5_+\U7@:
MU:E&@%-#[H/ MO&(L<-&JXUD+2D8A[BEGV2K4I=[U2SI^ZV; %J"U_JQ\QFU
M8"X7-OT,X7:5H4J#=M1?1,X29,R%6(9/6^O.&=<I2?88V]DLMUFJNG<DZ5G[
MKDOKP\6X4<FWTZ*B0?WT:/V&\"3&<P8JA/ )MAX0"Y@U-_ZH\NNT5:;;\Q/*
MV;RI0$&O<KQR;/0BU'.\#AJ!J5Y\JN4\:^_JS119-&\<$=E]O.B/F?@?%S?G
M9.?UKQ^=7N3?P'W\]"LZ7SX#<W2;G)#1#'NDU.?.88?IVES=S4SX$&1'12-5
MKU0C!?"G(_!;5VI%BC=4WY-W+'Z\D!-PGN &F.H#B>?+":??D%&(DI&VW>']
MM&B)ZI\P\[KR&Y][=)9VRYY&GC,E2RS#/1 CQ!\DM6D,>V/9E.: :GGYN>5]
M^0''R>^M#T(D)0NTE<B7?NL%W2&+KZ:G18' ]+M,F>%*+Y[%EK3]C(R=K66_
MIU%>PW"9?OL3HNMWM)GMWLHEIQA;F"5(-CP9VX##4SJBS8Q25KX89XIG/"[K
M]P]:_SGTYP(DZ6$=:-#I_@WL_61)5M'$:X>-WY5!4"G6F&O9<2?C).*NZ#^5
M_10+,%^&BZ":C!J!%2QO$$,NHKOE2=F4IY.@^_' P =_E-GIL"D]ZY3^)L+P
M5F"[))_H1:W3$0_Z \^4KF6%RU!L;I2O>';KI]=.S,N*>%N^F]U\\5?.W7-U
MN^B0:'#%G\_Q'I\$AX-H":;U]^O1N8^SB[+ILB_BLDA6Z3NK2\$&\%>02GWT
MK!#=Z6P[E4RN@;.5(, [.C[& ;G^<U2JONBDWUS%BW@V3:X,?X9EN#O"E]A&
M@L\JQ@Q#.2G:)7&^UG7AMCS$-JUN^24U_RM.L6U^Y^12]AZ^391;Q)*D#9JS
M>!#P#G$>TM;TN'5='7[VBJITCGF;@ Q;F[+T7/[9A"568B<;4X:HR44KZ^OD
MO4GXQH\B3YM8^6L#03WV>G.#U1/T3WKS +4:M92 4 0!AE,@,)_RX 5%CIK;
M*(<<Q' TGB"19Q92WMDOJ3TA.#BX[8?57+Y75EZN)/+%-G(*Z_=QEG\[O[EO
MW'M&L+6/;=S#!]%MB&\C7"9F*#LUQ/?:2';(LC]G8<XY>2)!-U&#BY$V!&%'
M2@1=\V8@N;82]X>KJOI\:X>,[3]?49,UCBL9U?R<&ROGVW;ODU6.A9&,D=H2
MV7.DM'?9K-6\O&3BSOW"QABOWPCL7Q3>/]RV,0O]]ZLVU8AZU.)&B"WE#'XD
MI-ZV4&\:RNNF\4B@;(P4UY;KVWY,:"'>]D(!77@=.K'U58+]80Z+*:.9GN,6
M%@2D#/0\7N0GA+ZI7!X'@3.N#^D2]%#XF/<OQ0ZX^]>QU&((&;<B7[/P17&4
M<Y^()<I4O&;SK\*.W1U'"R7IT\_]L[OTL;1$S=T&@83S2R# A.3K 0&68%H^
M2F1J8AE3'WXE_WR+R+9SW:(K1/:Y*'4MN!!_9L8!PHSD1+@T7<ZIT?!*C%[0
M@TB67U149B<J]!J4YL[((EA?I,;[]/M+8994S565CZI[O*M$>E&@!017"H_.
ML,@S M0\<2\]5#OVSNB=JBSM!)W%/58J+_I['\.*!:I)"P0\>IZTM [OLN!'
MVIS#JO+8]?HEINS.?"6WG_H>G_/VPC070 V;18^;3F^$:)W4J=5ZG+,:6_H[
MU*1_0^)+W>O2S?S4W)>2N\'O_$Y5=3C5ST9^0 M+><O)V0]3V96(G_&9XD4-
M2]6!RX\F![>K+>:\&4I_T ="T?&VJO0+]I..CFQAL;''B$RP/FK%XBH\SPK/
MO,: [VB%<NN<1903GQ+N)/\J*9;Z.F!NU?%J +,A^<>SS5-<\O;ONU%/&D&@
MJ#1S)4>/<B/$].?@H8VNRL?X7A_/P1HS/?Y%\<]_NVKY/T[0.&&0V-I/$Z$\
M(7GA(_3.K3@I$"Z@/06RE5,&[V6T&Z,&#9E9&YZ=144\:%AN9_-72?MNONLL
MTY#]!AFY;Q0M%T/J)_ H/D>QT .T88JD(YM1#<9FCERFH6]T<BYX84QC]^/;
M(?4OW7<*<F\M2O'7:1K)$>QI$!@!0POSC@ !D@+=N;FN=1U65),C[7S0-5+;
MM#?+"E($KW7\25V)K7N:TIB-T]E.T<'<>S<JQX&OYYM.Q!)5&]0UDF_$KX]V
MF9O%)"\A:_OU^%]?UGL %]6Y@+"GIXC>GTCC;2/A(T:E#F?-IGL>RY 36W/C
M>CO>?6-(N@:\V+N,@Y)D7-?U"+NM:2" SP]2]<]SO^#UXLX,A@MU;R+7]?>;
M*'$9?836IQ-$]1X#U?FNRNIIN)S90@"D_"5LKGIMBSXLW G8T"!_KE 0<.,0
M%8%K>Y54/LQ_(Z9[W0=);:LY9,ND?R7[G#!4[3#&9FWCQ,^ST[65Z9HQ[OUW
MHMU>*6F<^W;3X,9E9M7RF'D+NP^W\C9\&H15^<QNV/S7S^8!!QQ Y]!\5@6<
M$G4!3N0VI?++!RW#]6C]J$W)7ZA1/>BV9>56'NHTZ04(2.RAPJ$OR*XL(/"M
M-.!S=K3<YNS:E;^MD6J<0D=ZKJ_00O!9-!?,;[JR1[JT8[>X0, ;M?Z>G@YL
ML^P]ZUG%<@2=Q!7[=-L-U\ME>QYO2\66K0CN/U*>N%Q9K= I9JP@E"JDQ9N^
M+)V=,5DD)X?]2.]@N#\L''4''=;(08H/\G]/,N*0:Q/)15793?2^"#V5$G1%
M<C-<5SQJJA8;"6</DB&X7-%0BZD0T0Z\WCL?_5OKU;C01.RY;Z,TJ1,C9GKV
M;_,\&ZHV3ZG,B&P6PE%0BV\Z8LAOV*,Z?*MLA0C7K\,"Z6_O'9>K*Y"J3Q*
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MQ)\=!(/0"BY1]ZQ?C1(_MK''W,=;,;>'Y"6^Q"!Z15Q"E)3\.P+F&B61O2#
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M#VP/; ]L#VP/; ]L#VP/;/^)MF(%[A<T6MDXJ!D-V[+CK7[GST:+''$](O[
M=-$6BP\A>=/"UN5  ,@& 9P'"/Q]PX1J$Q#02=@'@3 ?RZ:90N/,8O7.77=E
M!*S0Q*?92_%T%^0O6[N!P'/!%M2VHCN<Q"@( KPPVE\[*:>XMB9(V4N@'<9\
MPQ3?@B[.DG_ITH[!.4#@1T,>:IH/3C'YZV[_7SH%^36JN+<%H3"B$H,]N4$
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M'Y5J? ,KR-/+F#(,A8]9?W"]2(6,%1T='6O]W.3I1> \BHM6%;+4LY_FOP0
MZ@#L.0D$9C#KW+FT_BD1?$>,8KVN8KOFLWLJ4264:VF"!5_>?..>8ADUV/*6
MV UUER2DTZ+E<%FQV%+3>)U3R,DI)M+(AY5&2&ASK?!GLDG&4.MJ$$VW3J?5
MQD@T7*@[(<BZU&LXOZ<\%5TV8B&SK!]4:%GAB'490=U>A0M39*BI%8<(U5:9
M?6W''?R25S4B(E4?U;GED/\H29 ?>;5R*3)?LQ=@B+U5T<A,&X6P8MP2N#WW
M(<\H)@)Y!6Z;ZX@[NFR.!L]>3UNW&!Z[95FE+O%!V#A@H3CWE^>8X\*; CO=
MX/RI*S\<["9.(.;CGEGK6S0=X3FJ4[EG0+Z$:CH9Y#+C+6R,0S\=V[[;?T?M
MPICVY*H=?%3'1V!J]G<-L[K"MZ\W>3KDKZY\L?))[R?21V'W_IK#S11-O55D
M P:]G%6X'Y[CF6OC (<[M+C>\18Q5FUK>1XO:99ZU^4KP)[D2? U(?!7KYN!
M */;8+W>=(IG#X]8P/":DWYNSKA-R_%Z6M<"Y&5FW<B7MHNHFUGCIK.G>Y@[
MTG\7,D5\L4V(T7(EDLU"FS:STWVNK6_23F'T,"[04;]F>!E7Q/WTKIEZW5D.
M0WY5,23B^>UW%X\UO]9Q\)^+36H];,HJL-215.'92=%4A*[NK_-+SAM9WFJ4
M%]FD80H==J$0TI8N"3[=X-*&E,(X*E\9\!I;^;W\LZH5K@>D2DXS,D@F,ML1
ML+\BB#B2.]G6:54#%9KW<ZW22R;HUZ-UC\F3Z=<,V18-2B=MU8YQ:3Z3.'';
MM8::T\@V3ON!.4*!X?<7J-N5P\6IZAMF:GM*N3&2]V 2/A%ZW_XLZ%34=!8*
M?SW#EWB#,(R9511"Q!@/[<2\N3!XUJO"0NY*8GE.?9)*9(3_^8^L3,Q:;PD9
M\AZ&EOWVIG!2H*))L,*'E[@9 AQN IVF8E%]67CKOB.K$!;,G_^[@Q)1<3,,
M=[[?^&2P5'%M?DN"W<!DN5J\T2( MES]%03BQ$5)5'R?'GW8;DA\^?SSI'42
M_X/;E6\8OH=<TEE]KRZQ9'#DN(YZ$#^^8YT1/V*--XWQXNA-06:=+4T\7?72
M)_EJJUA)?N+#T&\G0BY3WA$$*;RFQ!P2 \YX@V0Q=;I^Z%%AU=<&_$@DM/2^
MT_E=O5;OLRY:F?P3@5O1T>;$!X]N5]2Y[V^@5JM?6TGT25DKVMNB38JI?ILZ
MQ2 04HD<. YK27BZB^*\A\Y);FM48.&UTY_N]+Y5<MS6 74TN-%NL62Q8U+U
M!P@TG6GDG J2IZ:<K=2^SESU,\@V\'3E_+=SW?>M7$+QMQ.^BP_ >C'E* J/
M=[OX:<*<DQKU?658 USU_IT?M*F1D;1-SA&8\ E%AI/"W9Q*#2!@);^.JPQ1
M/QGG'*YZ]$4[8'7C',#P[G!5/K^^LM>4!85G>9?6\#W_C+F9H=UYBCT(/-M_
M(ID=+<OZS[X!^8 ##OA/,-LH2W' HYO@+'TXJ*!'Z7+ /==;MP62_(]*&ASG
MM(WG8OB1_)2EI!TCAO).B$KO:S<=\R"W"#C=F<R,\*D]_=I%4'-1ZNISK@V5
M".]^2]AU@= V:\NTPFU:NCKA5<KS=ZNJR)@AN@13V]3N:$?A88>KM_1FH!'-
MQJKJT:LVC>,2"19\'E>H:ND8/ C06(><_3XV><V:'N[.M[O L')<>S'SQOZ>
M0F$'4C3+Q6$D!#6=%-";DWW9%Y<%L7>K?1DMO*9"59\LNDI4>FTA^4C=P?6]
MMJ<<+I_"D].:R8OO62B>412R)WU:&+[P>KO[#:_KV>AW21+.$H5JV1D8.Z)7
MJNZD]R)ZL7H)(6M;3]UN=-J8QZP@DQ&0#COF5C3;*"FF12/W>'M<P)N9VFHM
MB-6)S2(NQFM'N$,8O6'SBA2>#=P./5^@G9]$,/E/+-%.5:?:K(\2Q":D'=3%
MRH_79CDHYB&+8:_C6H*MT;)^)H[B[0R".UT./;;Y=_]<FR*>^$]8F'?  0?\
M+P*& X'UQSF>$ 80N.?E[1 NEHSR;,.97##4-W?LE6*>8&&0@:RE4]^AA:D?
MH'<P;,A!)\'H#AOY#ZO6@?$9Q?;OW+TZ5XIRXPAOV0LD/EQF3E]KPND4.EHM
ME^^-4^)%GXBL(OP,M?V</H% CFLB@IG&&H7/:K5SK$.DRMLW!Z2V;>&2ADK>
M<6&[$67?&]>B@PLE<",4?LC,[X29\24M#O<"1(QCZFEC]_RJ"\,OSD\KIYWL
MU5AGZSW_8KC1CI!/X56>A87O,,<8#%9@!>SN:RJ<53WZ3C-0P'9,"W+3].?0
M1D06_@](3*/TSU-PGI+7TSU:ZCS=OGYB$^.!+^.9[KBL]6+L=C)%% LV?)?V
MX?NNX:6V;Z%^:[_)X_M1S!1>@Z_5M'/4#_*4JQ)WR_#4O+;YGO9SC;=+*Z0Q
M%@OG.[*/4P/0JB1F/',SMKPZA+>E43AL_+NWQM:-FJ;,30>7P$2-0U_-OHK/
M)2];+<X2SK<.71>1NK-'RR],<W8-RZ7F[.;^!@'TZHWL:+D>[1O_ K<Z'G#
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MW/4O.(R^=9<'<E1Z;ILU-.]]5N)B3O_7HB )LLSD;.RBAW2Y3^4#(WD>7>:
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M"KT/#M3BSY,16V+V"R)94WV/TQH<=JU1Y!;@?+&F!NA"A<08ZMJ3W*C VXA
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MA@H6X$T5+"&L6RX7VJI"D7P*X4&6*C&^RK:<>F;1ERRV_V%WQ4KAQC4.3SV
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M?F[L]/'%DT-[;2]WX4_@!91"5,T+IGI0'ZPY1L?N&GZQ'XS0KLY;GIL,&2O
M))9+?[#0=F9-3"S;'B3N]&UM(-IN'?,L;&?2Y ^5.?DV[8@1$R"V74)A&$@C
M],T*8INA@8@C./)^B ?L4X',6">,]=N;,R>M?!Y-6QL\_;SPXH2:?Q6.?T8
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MA5'W=(6:JHW>('NLW;*6?M6PW'CXU&4WYD8V\-S<?C17SGK/I!5U5)7+>]]
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M6O_O:/[YK-,I?2#&W:@+C@CVJ+9J"_1;Z;'VPLJ^W5.(3J$OX0_>*_]*U=/
M74#K'E,,N/9=8PJ&1^^AR0FJ(L-P6WSWV^Y7'F%U+ :#5S>=T*5$9%F;E<_#
MV.'6&MM;(.2)6M0T3:IOAB!/VFC62L[R6M\-/0%>.OIBK[%F8?)>&V0 -IH1
MWWY672I+Q<S$TM^?!96? #EMZ;[2MV_H !9;7DTA<N+%]M0(&GBKC,^6.+TO
MDNF""51 S]#NN2D5.*^LYH7:WV<XN#-C0CIG-J@6C02\1S6Y08+!;U.8TZG
MD/?+B\@QJ=T"]FD,B<VMG8LC%-N&X.PEZ1]]F;G2,=HV=UCR'%^T=S)V%]*,
M) @O-D:!.)+K!C9(E_PO,5P:R@]5A[@MJEM>J]_HW,E8<QV&!NQM#?AC<?2[
MX37<)!UHM\8^C5XHP_;.DS]0!"C=V%*^(I^9];.7>@5_%4@\'I"X:@#S>2HU
M5DA'_R*:[2USKK?,X>F']2#\U?<S/V55-.X,/"M+5(54>66-"^#E>GZ]0RKV
M%O"H7\Z\K-5OEF'=US2=,YT\J[4T03,_!7<*_\,Y?:99",(F;?YZ$B^ZIQ<^
MN0D6)$G$;1IL#><D?DE\7T19HO-4BN.+W??W\8H"VX*#4.?A6K)U,]#35,#!
ML>^R^C[(I2I,-(U!MOTRFFZT#IYW-KCIR2ST/+MP>UE2G1R,PK,E]4R5G_UU
M(I/X!QN)JQNEJ\5^:W (#KG'.D@1@TN7XZT)T6-JT0>6.MR<$ES0ZT=$N328
M99TOSC*,/]YO]0$W=W-Z!^]Y$1IYO]>,3BZ;Y-OEF.7QQK2ARTT_]_/P\+4<
M53B*,:C507O;3;$TC5R=8(?\DA93"QKM5[!U2GOF*O)$Y[H\3[1/QR8T'L-"
M4LI%_,+R.:5XCV0-ELG5UWO,W3GE)I"/NEE%IZ)'[TNF%_F19VO0TD]S$35Y
M&W%A%4F?-W^1QN2_9]NX%_YJ1M:6E[N88#LGQ]2&B@[IB%;P9W4$,"[YD7VQ
MC^)DD>3P^M7K,8#HPSF^:6^^-19'PITIEK6#&991G9;1^/@<1D;N1SK9COO:
M=DX;>K_8+]84,?E8-0@DO233+,EQ5IS30A&NXL[@UQF'BSWHJ-$'ZIX:E]^P
M[##E@J<>S(,*P>V23'"EF!8^+KQLRHG0A ]%$V98"WE-QMS8IU[*0AP7OS"?
M[')%*0F_:)X;<.60G\PG6ZYNF25ENJ>%=#TG/'+/UQY:^SRT[2!YYSL5L'<9
MB;<D)[J4KGZ2$=Z-N(S_/N;HB?_XT,;24]%9R9PG_'H72X9_)Y&39%5/J,%%
MR@U>D5.<C%(HK*ITBTN\'12I3KM'3J/*]YC)6L:]/<+N-(3'WE<NL%8F9VRU
MN-%K;S6O4^18H4:@C9$)/9/>C-Z-$RJKY32KZ;14<0'#3'J0JYGAM"DC$"0>
M6?_H<=$A L?2T!,9^\Q68QU?1)[Q57I8YU210%Q_\?Q^RJN9X\$-.OLOHFK1
M[J4NR.B=&HUA5OU["9"K[' I)P//[ ZP-FFB1@R5!8JB JS\5817Q)O>T:._
MT*-ED#,_84=B+GDISY]7T5/T'2I!-E<B:,[_EUL3BL#N]COI1YOD6AD^SW2P
M *Z52;ASO_A3P>@>9\(&H_E;K(^'C?'[1]?D^>D4\L$ 91##AF DU"[7B]7V
MR]3H/*RM(0M9"&ZP9WI^HP**Y8I/8Q668'L^_2W:@2(VL8_G3ZX4?.Z1K%E
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MA]>O%>%YT^5^?=?X;G%&[?+K%081*O JE!BV1T<X2(,;$D IWOZ;TQ!6@O.
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MJ ]EY=*DUC-6?'%_E5O[9&D\-)T":!PB%1&9A8>*9O!1MLXLZ[9PX][YN!$
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M'#*CG]LFK+$<=5(]9E7"99T"$$@?Q)3_@7XO(Q66/?BI L*45-SHFR<H*@?
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MT5-":#KXS?^NW^RPC+#@ZK Q;>MAEY-"ZZY_6/#V-AZ]E;1X_BU=QYE8NQ#
MN5GW2K;*1S/,D"2.)K\7;)'Y@SJ)ES_?B02=N.]N9*V1$M@W=GVY1B2S_MZ>
MWI\@C?L@Q?N _M/Y20<IWG]LBK<"5>RN(XKNDXI4S&)_ZO >68$:/68@^K>
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M"%3A:KA8+^YH)AR>4S40*.IV S["9B4_E)0[=K@YRFF5_.%J^CMQVDK_A-/
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MDA9OGHA6# PEK9A$D4?!/%XQ(_,XI[)/H9;IA-;D,O=%5J>5_%-?&V15VX\
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M?N91U])N!;^9^UF3&YX9NKJGTN8M!^[YW3V9^?8VP&/J%MPC[I2\/Y^"U9A
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M)]M(N4,M.-:)7Z/PPJI%.+OH@%^&I<VM.-L+!YL+9=[C-1K(-K#P>LSUCRP
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MH4U,W_K+93NT4&,SBI.VP1.0(KL^C5S[\@93D$<'/FS$@?]R!6+GN!!MQG0
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M:5GL ;)>NZ&AY*BIZHW EGVUS_E62E9A).%,^&?$3G_Y86&5\^ZG&N4]O$I
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MG E- AO\ASF$R+/0=$L2@@$YH\K)=^6]<0U79%**[0J^./4EG9\\$BN(6!B
M5&1?%;_0!QVLG,O?H D@%:=NNN5F6P[I8#N=:9@G'QD( LV-\XX?-6D+2ROQ
M:*<HP0[+5(&D!R\%*9SSBQ"\V- YOL*[@;%JJ$$$H85(NB."LFPDR*5PG0Z9
M;7UL/L=FX4OE(N;AGA(*G=CP9W4!CBBY/FG1P18"TBBU><UYEH$[EMHN_=DH
M3/K7L< _):SXPT]&_TTH,/0(I.='!?9XV0+UZ1V& FN2Y\V_1GDJO2$RI,T
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M%W^X-4U6*EOW0-Q10=U'[Z -]7 4>(G</F:Y=BUXGVX7G!4[$[(A5Z"J_'K
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MIDKLV%//6>-I]<0/8]&K'^8*C6Y$7 M+[#/@V7_3]AXPK8V*A1]&5%U$LU'
MW>.=U]'=JB:JQPTA!&JV[KZWTSLB51D#9GSL[&3F90^[EIV>O%+JH3[99T2G
M=:0G. ,1A"N@ATA>C].G&CURD.S37NSO!:%[S\E0ZF=W9+?N%2-L<]6>BMM0
M2]0Q.7K&..Q)ND6BG:_[9K*!QM[_D*P,RZC?B1%BH*,CR%\8KPI0$[EDFJ8'
M':B%ST0B&LO"7S.6Y7#2IK_BMN!1U/H^_PMTX.I,.)6GFS@7$/CK&H22=Q:-
MS)C^K)2V'F]9ZE!)-F731%NCW_Y=YF]&86_;SE@;<R,+Y-V; 1?=J+<YH[C?
M5&WH5F/6CNF38L?@^O7(!9X T#>&S(7CX7?_5>*>EX"B\+"N=G2C>7&<P? =
MY?MM#L;LC#?J3JV*;!6RNQY.?B]'J2M[(RJ4$%Z60Y0?[;" (8H;GKPF^K<Z
MI>GAJUP0\HJXXVV?C0>3/JIO:_7E#SB /WDR\VPN+K^%(0;;N%05>;N"YM*G
M_,II^]>_$J,X*D>=#*<)&:FH:3F0(GYTGU4S0S/E+A&CZNEE3-N(DUQ0 [C>
MKXY)_#U7U_&E@6E%B?)?N1X^W, N3#RBG$GQ-JI9M; /OGUL>5#@P,>2DK=A
MAGM+A\,JA%;:X$4/B>'5:IS$V)I*Y[:&_3$0$1%=<_$D6+>5Y;VT]>R&>;D5
MMMV'*_EO3B?.Z0]J10N%=15XG)T8QVY,^Z^1=])ZE1"%^\/\1L)Y*Z"$N%N$
M7)QCF#J[.N[0I7*M;5W1;,S,K@<YSFU\PPB AQ/7^!0Q11.!MIU]_?UF"ZDO
MZ8 OJ$"G!DP0O[!2!V_!'K?7Y'',W&DGCJA#?9EKAGTN.JJ96OZTB+8PTU'%
M 'W/_;Y7K_Z'R^8)>KK@L<!;T%6Y\W0@K<1D)?%W]H0JGS,FZN=@4CCWF4UE
MW.7"DB%C]D\:$;[;$(C*_2DSAK4'CKQ_@@&A<RS6Y7YO5^AC&V;,'/IE=5%_
M_4#["EAG,N7'_9]_=3#DOT^PY*_W>K ,/>;[]GHV>:O9QO=&.?[I8<A@:P(M
M%A^FJ'?&O//V2H":.FL_]%S4#[5"#PSN,^]@ZBR"6]/ZX<(=_M+$)9/.9>OC
M;5IO=2UO6EJRWGT@?N2$]NY[@/8JJEN'4D&M0(R->H1O+!?1@79U=$.@O>P<
MA^Y4\S(Y/!3?J#'^/MYB$+:DMDZ-HP-C][V9:1\WG20 E Y*X;=5"0UTH)(Q
M>CP8Q0 1:]JX%N4D)8(83N%A&ED+K) GU%SJ*D2PW]JXG.J6^R9NL;Y:\N:+
M V/7^;O/*ZLF)!7%TH$=K70 0F2>L:4#13.;4_P9HDFX'3PK#Z(]B2EE"">7
M#<QCL"6(BH+:J;LC.4S=O; ,9/6$>+I14T@OR,!T#:&-=&,(J/7UC1.0>C#A
M"F?PT'Y"6PV[O&$[12%U2B6L_GT*K$5P=W+<%=N(Q_8F.\86W7VQ?=V+P12>
M.[2+\PSI>XW!;I8O%<W=Z'SAMFQLC1+S[JL5/88NCZQ,E6U*L*=P*U&AM:"\
M<!H659HS@ONO1+E![/?]-0-.:LL(=)VG<R66]J*M#7? B0"E\.A4DXVON<!\
M$"YBAB6LQ9;7]B5LN(P24)Y4M +,DK-OPJ HR4[WZ<R V>O0B%B[Y\H?5XV/
ME- !!_V^<%WJZU,MVCU+9%!M#(LI]DI?I?F>IF<:C<T3S[4.3N1?5.-.@_\_
M]MXSKJEM6Q^.%4$!11!!)2H@TL1&+[$! AL0D"(M(AV$T&M(;(!TZ4J5)IU(
MEQKI34!Z;Z&70$()@;0WN.__W+/=^[S'W[UGWW/N/7Y8'YA9K+G6+&,\H\QG
MU)!!6+,R(ZJZY431+<6<"ZVWUQL?'6LOY+R6'I>5OY]&K8+#IXI.+)"#3TQW
M*VM=\85"MK2[05^51]Q;_].C7%BG#+7Y8,YWZ4XY<S&1:\/;X+X*H:'.QFM0
M)E+ 0(-N 5K3.CM;Y\S+&T5I%V^3-_;ASW:3:Y$,0F8]SIW^U1?'9*I0[JFG
MUN_+&!TF5H0HKS.V"C<=_K0VS -DK;[J)C0)>N4[2 2EN)L1]4C-=]XW4P E
M]@PW^A+/6<&'2U&7RJ4,IN#/P0QI-APB_L/]QC877L=/"CQ8.YMC]=9LB^;K
MV=7%3I8OF83"^E(>>*&"#1S<=/>=RFD5L/6:1FUJ$4'3, H\A6PI\2J6A=E#
M[^,9IQ&#<P.*V$Y?J,7 T@ O_>2+4\_OOM$1>&WP*C\^%3HX?]85Z KEQ/O:
M8/6FJE^BLG6(D;TV=2T,CK.*J3E^"9,2'SOM^.>OO7.RVS3V2])\^&$,899#
MN-F96F.F4:\5Q7I2H2<C6C@O?KJXQ] SWHM9S9!W]6\9+1S.A-MNX$;8=;P\
M8A'(N-6)EZ_4M&</T$//7;\Z64X+^&(:P<(@?G ^N!C35(^&HVQ]"0+X],_P
M(B%?YVM<%F%XSX;616B!?HIM\!F_B^9U(G0Y(2_N'A]=A\V1D@2(7AG0"UAZ
M9!TOJA0;%WJYT)WM^+3;^(G$66W>3[RV^SA#^ZN/XT,QU-5[!&X&/(D?F/9!
M>$T+<5AEE1L&?5C:#9AH2)5*?7DQRN7NU5OH,@=6"SKW2Q68/*D"]>*RE/3A
MZJA9-,+K5+GKACUT%&NO:FE BG6>6TMOWT;WNX4_P+=C'?>JFQ/9"#*+[$T^
MY'.+(EJXO7KQRG8W,X69,E*^!!8*5*LX*-Q2"O,\!BR' 1?+YT(F;?8WU9>_
M\BA];9-C%/"@^K413_P#VK-V8H+A7\V_.B&\MRB Y_#CE4J8B1H@%0:;2]M2
M '7J5OVGMME#7MU$RZ]HR7F]EPJ]]^4C"5,3^I'ANC@7L%P&6(<Z"M^_<,*M
MP.U*I4K4U;QTX8_[1<N.2-6^!US5DP9P/-/"EY3I*H/?3>P@<B=B-@M&5$;Q
MS#LIE^++-!.'2J*4"K<J)@Q)AZ![?M.+%$"X$A9$\M*A !9_<=[<^J/6.0VR
M( @K3]7&\MEZ>&%XG1")._$=J&#M\S7"?:B:*DW))Z@4?=R #T;7*WW59L<%
MHE)1/A_HE)>-RR,%4C]SR+FH8F@K 'X"[ZG^IH8AA?GP6/=C47?(";/&ATQ'
MC.,XXM<I &-XL"[CR@8V%/H():DLMZW"#L4E:$6?=5"NPDU.C1V6T1BO0(Y8
MX[H+21^2NIQ C!8#NMH^FRU!0^'J@U?,XS)O1\J9:FH*$N^%C>6#30UUO%]_
MR(2>&EB#2^= +W&(:5,-2ZB7:'7KN-[H+B>9%HPMU,&*!*"$?,NKIL=KDNO.
MK4;UB,S[GWI2<(]QF\7_N*0MYX=#GB%-G2.QG^&%B&!.#,+O9N()PR5&\W,+
MX8HE+^Z72$H\CXYG</ MD7 T9*3*^33\[4R+&"%_F0M66ITVD&P!#Y>W)OIL
M3^0$!5Y*/RQIH"F3VT2XX7<(QZ@FI3^V'L:'O92+XA>\+3!=<&)1^ZK\J7KS
MQW88\0[][285_H9& C"/0' N]837@><\=^#],DD$9,#*!%6K3:'7I2;('#68
M<++W!#M\DGXO;89J/S$^QE--G#MK02#,X3V2S+T:!ZK$/;JF@,9$_#DJMFHN
M@M>EDYG@7QNF58D,151MIPO&),Z!\ _)"_"Z01GJ+Q747_;M_9*U>V;Z<"'C
M:Z39!-M2?]M%O0DW]?4E[@C E&'7X&% :!R'G3)T@P)@2-SK]2XKM5<):J^A
MU@N00'8IF7.D6*AYZLC-$(CQE%*;3HSZT4@E^0<ZSP[;B7]FJ0O<113 :K<W
MI 5H!J3+=]MS9\?G)\=@:11 C1C(JF=Z@K$)T]3 ZDV43:V+YYLSVT$(,L.S
M.ET#8=R@L4M(21D:MRMM*-%&QB-N>NJ63$TZO4D%[U!BSMJ/4T/LX\@LV=BC
M-1Q"I$BRL$*Z='T4.\[;J52+/9!/T^R6(W-+0M9G!W&@N^I=L,'K((GEI8VQ
MI6H#F#8AQ*>V-]LWNM\R.V,()$]V(:S OL!Z@.L0$!-H!5Q%Q1."X##D1S@Q
M/K%N8G=WCYLB#?&U#3S,JD1*03X)X7#S&6@K[3^/(<V6Y*9GS@W/W!KZ#/H\
MX:Z:U/3 >J,31UTGX85X3PH K$'=73>+9V:+9N4T%]NMHA<Y)[XLU5;:]9W?
MM*$ T.E[5K(&,H ]\1F,SG+X<+A45+A; CK7UBS(OW0H5/3^LY UIF>[0755
M4$L"([EY&((&Y;B%08Y;E98;>B<W,7WL412L[U%"6AQ;:F4^^ 2FKG+K7+M7
M[AZ8QPMG$57P_.:Y%E'=AA/X)XL([F)O)<D1"71$QJHVW82L%7%Q#PE9(D^2
MOU0+?.IS$GO?>Y,P<[^8GF\A]%PK+_=]HU:)V8^CT_;-G/YQQ8Y&68VQ16MD
M+:+01IEXX6Q#=Z2IAPN):H0K[>@U[Z:H4N6GAI4(_/3*^W(LLX=OG5&L'X+U
M!/AXZI/!=.7VQ*V7@8?%:.C@\D7Q5WKN=J]LCAPY-=S8P5SZ@J6#2?A!5HK,
MLWU@,>@^$K+Z+-2A5_"F0@S\"#YA,DLVW2KP ^\,J.;8]*QQ'. T)Y.;!EA9
M.]8_TZ_($B4!DX'!!]XM/\Z<.AFI+PJN:VM#$H]2=9:A^]*_2PC^;YPY>/='
M++K$K41X<P<2'S+FH+K#JK9)-1 J3X[LF3-7B<[4UU%]#5\Y9T\!),=42R,^
M5OZN:6Z-!31AAYR"O]OM/$0!5/1O@=]082O><O=' _G[RB;!.^<JI:EX]0R<
MQ%Z,8X%Z?M\"5W#3)L]21XN)&-*"[R&A0E*(M52;:52UXX?S#__1%U(4-)D*
M*C K=$=9DOG=E%3"U0O+_.3*+*V\T[R[[@0\2PGSOD4?4E'*\^(^B3.Y.$7K
M(1_?FS&XUE6$W&E_E0@<O*^S!G(0UC7!+'-6I\YXJO/<<HSI*\X3CP2GI2N-
MNYY ,XB''F*;FE1?3S G$8!^1-/<Y9*\SR0?%/K+H<(WT/<N\])BB*'$,["6
M1!KR1;""9QX4U#5?&5K:8F]]1E>!DR-MF,D[I*S=  \G7"<*X/7<6>9]I.A3
M+0>ZSG49%LEXU9OWF;XI1$Q:CY.[WY-V-+:KP>\V$H?$(@F?^K9A\*@)OPU&
MXDDX3K5?AKW)$WNF483)LKPC"8(SN*%2IEYXV[;^1MO%!,U$NOT)=UXF5H%=
MU&3=!N/NY0N+SW@.ZM^\&D&*DX'M6;6SDG_Z=/Q!6M W_J#O>1$\+^R1!S%B
M.2ZY[F6KC?O.I3&K@;^F3]W^88?)'R0&K9MZF?_']EK>VUZE('*D[L!SZMXJ
M0":A9Q+7KZ4LP2*[9%F(.-C2/SU\]W>N_TEN[^]/@;\"_98J#':TG@)8%\W]
M-8?Q&NCIU,0.2_<WK_$'ZKM"\S>?_PL$DG]=%]&)I2'$.-M\"L P"KE[67OI
MG+MK",A,U2?Q)%1>I H%IJ>J5ZN>BW+;0$A9 %\*G4C31<2!X:K1Z'-*5QH(
M'IG%9D43>JX6&,?*0_IMAS&;NLI%6R.J]UHH #/DSGG#?13 1VDD^1E_=_:-
M.L,S/97 ]SH6,;+(H9MM1[3&A^E7""?D */U^;MARI8#T7X9V=J96I(*I=N%
MO;7=D<>D)=3'>87*=';NDNG$J7O"E3K#'[_ =R_I3H,FWR&7R.=)3^&X*B\;
M+' *[$T67,!8&@I01[KXZ86W^O*,P]R^3("'9QM;/:Y-B\UE0F_@>2:1+U,>
M<!SO0A8<3IHEI9/XW(GML2440(Y+HZCH+\X(EV!SN00-#4#/?'C59LGB-E*E
MJ1/ED+55Z"_^2G?F1:'NA*5-6OFV9 P>7#^!4:.WOH=/=$^OFPI@DQ(R]\ 5
M</G<ABX%:\;)H/W=FM73>Z275_TWK->&ZJ;RTJ:-4,L(VD?*B)UD1SM=Y:#S
MXN-=MNM#A1V*X0D> X?UP#1W4A-$8F.LE5R),F3?M'=?&U&\<F+L64SE%5[5
M\]2]NFEA<O)>V.4+C^X>"^2PG@7A+\\30\=.DNNH6GCAG?72[@R9D\B/0394
M<=#S-\2 <;FO;AQ]/46X]Q%UB^[EVR%5.2GSLP,RAROM/F4YSQ4%J-Y-/W/'
M+8Y;\01L,WD@<CA_7?6W'A8?O#E&M09.(_=>ZD(*W(3^;AM!=??AQDZL*!7[
MZ: #;6W?+ANT.\T-MKH13;#,X0HC7IL*[CBQ GWZ7TH/'!/6BHO$C6A-/'SQ
M*3%PXJ2@S FB2'^EJI-F3#^38))QB(0+ZB91)Y!PP* 86D-0(W)CMYL@0+QJ
MG8N'L2Y1IO"=>:\PN+A65/*L^(FU<<4/FC##/$]'_4_L-Y=1G'3=:C[H4IM3
M%(!HP89D?O&2$68C4XY!0X\+D=T%C5IK3B?0$F]4E&#(".R-^GT?!H@:_$77
M6V7L(96%HJ5O=T#W[HY7INB/[4%Y><%4)*G7T>K!CC+/'8ZO?,9+]?O6P%!+
M#YN\@ _#EK@'N<7Q.0H'C[^O3;Z\5TQG?[4+*1MD.K(6$!WC&B#%Z<X1.RTH
MK"FW<^S.K&;II;->+<SSUD[S!P,/&)(9;Z1K7,O4*ISUOO]):#7=VJN?I)K0
M,*MI.?LF17X\DU8.0NC6GB.LDF?\0)"VC,>D! AG:*1)[(/B^Q%; J?SFR;I
MP23OIZLV<#/2H;Q]M,(-O1]?@%YV&!'K@(V5?*I#3;AG^(V<12TP\Y91.AZN
MZC5N$CY<P;+0*(9>9[\C-G;I6GBG\3:K#U3<:(J1T7+X4B2@I*<(SS1\Q!>3
M''@L8;YW6_ATF7J-:=L^]M"X-!FSZ2S%_@DDD>FC?PGH!OEK)*_&*Z/FB,A8
M5UO<"F*'W8DJPS*W_F:BC#ZR/L1'YC2^8LJ2*(Y"7Y(VEWO7+U<:.GZ=344S
MLBLR(N2!O(:!++.[S]*7+Y@!GTTDC1M<]>NFWN4B-(^JMPTZU^BTSK3:,QI\
M@JJ&KI.:<BF/ZZ<4%N84%I,7U494C1D*;TG#)Y*K<^";'R1V/7[?E@5O2"=3
MY?SB_8Y2C!4%X />50*)[AGOS\L9T?14XYT')5DEUZ8B =V&V49SV;=7B4R:
M=C7*& \CY: ']LZYX@4GO>0D1X)$U;$/\]]T?4"Z</G=7S4.XM3FZ#CMJ=T
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MJ-Y8@_N"2LQK&5\GL!3U:S=)\/C.1#PQ$#7LO5!0]AQ#JQYV=?0P;'U6U=@
M1+P97:NZRV=XE *H]>GY1F@[0;P!:>C<Y:ZF(IQ:#RHN#.JB (Z-8!W)?I @
M$":!NGNGG9?:KM25C%H]@H:<$B_AE>75J-A)+*UFQI=-@CFL5-/QYHT)'%@6
MHCU;PH!"W^/R2..#^V>-'>Z\:+T1:!*BNVR]P4.F3<&$-!D>P&_D6'%<PH!?
M0R6->'SGO:\4V_!YZL3<M;>]<S@4(' GO]'QF1?_YG!EH.D1H[D46L,E"B!
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MXK=@=;)2=<\K,D$%ON$G<1U[X3:#;^$V12-99NTVX/UOJ@I+[U4%/CZPL1T
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M.?+XD97IU<N-2"-]A.8"22",)]CT$V/$\K9U'IF/;#]# :S ".;SH%*FIP&
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MOD,!/+'IV*AY97SM-7G8:\Y5YG'XINS VS19[J2SJG,4 &!V=C;L'A):"VT
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M=Y@.FX]IBP(Y7+.YB"FK]LP7?K:2GL2YRGA\:.J8I?@55=.!MMG]N0>U<Y;
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M<59H:^6023@;.1#4B4 A'M>=PFA$RBIYE@?3T:9:/*>O21N\2+=U*K8>(CM
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M;E.R17,B_?4L3S>A'NDC+]YI781DP9J-H:')=6<"]$M[4H5*(D1B'W3T/A.
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M9T1*\1J>:S>Y#J% :U>1J>X22X/\=Z,5!X%4V*]%A?V/"T";!B9MI5B.[_Y
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M1"CU;2K\F]&@(N?(7E)>(K4E/X#0(KM1#CL;Q%PS555QD#5?_/UV:V(+P!2
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MT(\<\CS=S%$KK3IG4SO(Z_3P<\2/>>=OT$HN6X'( 6>A:Y]V%<YP%92(,Z<
M)N*I&J5:':!/;J'"S;E&))D(Q^F1PJ@FKOLIG(0'H_-*]F3W9/=D]V3W9/=D
M]V3W9/=D]V3W9/=D]V3W9/=D]V3W9/=D]V3W9/=D]V3W9/=D_V5EC;*GKM@8
M1K"?M]Z?70]\JOH_G^KOO_?D.HV6)CS._.+$'?]%CEUN_D[2[-3%Z-:T'#OE
M?9HOV.?A2<1K%  M &>"(JFMN+PV0PY>/]KZRJ[.6O-=_+3PXD&Q(IP!P31
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M>Z_>KMKB4E<CW,KQETP<T%$H4IG=JD6K$<=L8"+:WVQ4]K"!>>#^--^=9@I
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MAV^N:*RHHN,QSM.1<''X$(15BW>JGL<L&_H9T^K@48=9N'=[IQT[(]GRO$(
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M?Z,EU+NL>VI[<_,$B0M&)/SXYI1MQ4QX*4HW9&*H=L>[1M_+2?!IWF4;+7]
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M)V4 62?^F@IPRP)9CS;+0<K<)F?LY>;TSU=>E%.HK.:8%TJ37+D%X%_FFZR
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MP+2G0);MA+')/G$M/P(T6F9;._UYX'&@?,3W#@(W?S+35#*1%<9BLZ3H +P
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M$19DI7GT5[!-A?$!6-L-*F#%CI!&!8 #@*?TX]MP["/4&T=%PCK-^8: WBB
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M=TF('*Q+!>0M(P:H (+87FPS<!$\P[QN@A/[44B @3RNK%T/_#;?[<'F*_)
MYOC:LU=!@T[@?*&:J'<D(YPOW@DG]J' 55Y[*0X,BGH9ISAV9CDM[,4P3^#)
MLPKNERQOXUF@3V#MS4A7H=/+P/WJOZ?A:1O;W;RO6#*69#7J/S,3**E@(:JJ
MZ':O=V:'E-V2,%'.M]S=#F)S3YUYGHQC_95>6."WI"RU<]3D5IB2H/W 2C3A
M.\>\U:K2SBB1C2:G,-QVFZ#P)(D+S\)G-);7T/B#,EZ5W/?7)6.:R3H%&$'+
M)CDEXB3NXLW6?FP\QG%4\B_,P*5;8&8X<?PNS<+6$&@4"7X$VU10))[#@BAZ
M@Z^0.V>>4 'YN,EU,,:%R$ER)GPA:A$&.Q9XL8'XU*AB^P?X29J7,PF.OA;'
M-"O2V[YFJD)7 /U(DAE&J*MA!W^I&N>Q3A]=8+DQ,+$DT#LKHF?BX)/_;VO<
MK!S</P:'<XM5?/+;QF9RAU@(IUL5+YW8I635$-+,BG*C)3LUW_W3HO(O_ O_
MPK_P+_P+_\+_?_%LI(Q-/3X@]]9SY0T&L>9V- BC@>U>#O@1FD>0[93;YLW*
MU R;*'?S?KFDT6;(>E=A[LPU@1]=.B&3>5NH?>86*J!"E@KXFDXR(,AY+X'>
M5<Z27F"WU7%!OAT7BMP#HF\7,IE=DZ/LO/VCM1$@V%!!$F!\RC\V7Y;28N<&
M7G<:Z'XJ'A$K>BZT'O:@ K,.@3=PK#MJDG/4SV"17;9"$6%&""K@.61F^E[1
M3'C\$E@M+-N6A.OJ_0'5? J4V%)G63:27!)_>PB[ZIIV=MU@7#II:\&8:.U"
M'_#8AW'G'@<6A,%1 >(Q6""ET9H*V S7$8RJZ=1B-3.L@X=?I0*$'QH+3Z/%
MWQ>5)T'JRF5[X+E^)O91'9XQV1<)NH6B5$!LF'X1 ;KP\ 0,2;MB&)^KW&7S
M^_ 1)"'P68 &Q_3DL*/<(FA6?+&[(^NYAO@]W"Y<)D>2/OK"5&&5?*4R<Z3?
M7SN@OWZ(M6379*F,$I8F2RZ7,D=CDZ"12M'-;NB]LVXEQ4%I#J/J&H_W&2VW
M+9KC)X2OT[]C%3[3\,KX3C:+N^V\5CB$I;]F>,[N3XR(V8.VQ+'82%/E:V\_
M:H<Q40'G] @Y:-CE,.DA=6!>4)KN>*VU(N8XX*[2L)'ZF>LIQH>6HE[=GG]4
M<6 029R P4YLMT%9AM&$*+2^OYL"4>W!]P2[.K<9)]Z;[W6$O,/G/+I\.U]^
MW_<+_V:[@))T7%>H-(D7GJHK[X-E89RF7'.;G;IA=;IM"9$S?]*-6Y;G-07N
MW[TEQ>EM%/+T29O5;>%W3S:F%/NY>SU3)7:V,I>-U4<#'%VJA^WKVU'1CE<(
ME;E4@#M!JX-3\UJE*<=*]:<[#SJ>2;V'/GL1\)C%7\% 1F;$TBDV3[&?RX_=
M1%M?5QRGMH2(:&4AV)!TEUG,B,(Z^DGG?Q#5J]$H-9VIE(S,$*L$6M!MA[GL
M_?L*GV+8OH8O&&N6<*+8-$B\8$,%;!C9I^TT$:^2N @Q6+HV31$<ZUM@C6*Y
M3O= 8R-EK"7F3_C.G5HQ9F6ZKQRHJ (=<U';VL,TF=0=./C+VE.(5?P-Y1#.
M"?49U$GZYK[&\4]8[7';X ?;3R'0U\L8><BFM8CE\1O#6Z)/O3@X_>]WG%Y,
MQ_,2KN*_40%O_$G (2CG-BVITUME"XX=&NK+IK=5Y/^H;X@[OPY>2/7W^+H8
MV<T?[Z/A0F$:Q-E9$PJ(:K\4^[[((@XE3Q02 ^^\3+).$4Z2[RZY_NQ"\MC-
M(E4%%P,+5Z7=F<V3G4/FH.C#;9WX&Y(++>DM-?/NX=K:/L#+4)D@6;11]#RA
MJ6/&,VK)ZR$DU*M4I&&[4O. "OAY#W$7>XP9QDIV\G:$.*=UJ+$W)M:5M-;^
MJ(D!'DVX#C,LC7<S^__;;D'"C?XEHP&924<N31.LT<WAZ(2S,5I+(+9-3<'_
MP=Q[MC75?MNC45! >N]%NE2E=Q2E!!Y .M*B(C5 I(<:1>E-0$"I2N^($&H@
MTD$$I$NH"4UZ0HD! OSQV;]]]HMSKGW.R_,!UK6NM>:\QYQCS'*S)CDV7DQU
MQ,V-/DNH@#QK/E#B*6@DKAX@%K;7=A>0:HXUOIN@;$VLZ6A<. LN,U:#&?6;
M1WCL>&!'RLNYS5/A5/PU)/,5[=U"NI9;>B,J'#/4NMO,:-W"X!/(A0[;#]VI
MEQ.UQ(KMX?QB>?120^!NV#)R-F-?NQXG65)=MK@5=] +*7[(^56GZ/J._4]_
M)0 #5'[!59.K@PM::=DTW@"*X6&9.C9(M:04IW9'!17S,6@5M#@O,W[[3>VS
MU"#R.IP2VL'-8!R_T8V51"2?YRK *ZC5XU_:FQ![I#0V[Z2JO##74H/S5XA
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M?FW+B*\?G>,>Y#@] 9+E)'<UN-NXS69DI;8JT\9?2",(,&QM;X?01$$$^%S
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M07?>Y]]-&:!,#;%BQ)[A.PFJ.-T>>M=P3MQP^F*UK$?4]#K%+H?S3MW)V*<
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MR,B)04:$DF#3>A7"17!)K]%#+?!Z"<O3QO(;54EYCQ[Z5"50L).^".8X.WR
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MS4M.>E)O9);,Z,W]^-K'$2O#UJ@'V+J'5%"8B389NO#-F-!4GW\BS8([SEB
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MYGV8SCO;WYS*_9%NC0VY.HD1:8\2O-ZK:J>][3<Z<8[UX[+T0B; &\'%^,$
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M@N%DG [7P</CMH(M3JRP8*7)8W# U91]NO3KG)SM[9F24+>=PB2V%&UP!Q-
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MG,,/R+T*G)PT3$@6.$ZA/EAR6/QRF)=DW6RO[N"^5XL%MR0R0=GPU+_1<]E
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MJ(>,0\TT,!#/:F//(E4X/^]^N ,N4'N?]N&9:V=@W*/%\E%=,1*8!$\Z'&9
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M_KK40+;>16DM;A@*SW8_6_7A\ZSUZPT^4X0Z+*J&^ X8!7>"1[W2R:3$LM6
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MT#8T65F*V-]]O5FKT&Y6^*U3-6NW)O,%<F:U6G5GMZT&4P%DD,\VY8#PVHE
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M?OL,JC2F]=GR?9L,>*-)RO65Q(3'NZ)=H#*DF7)MA$'1VO4).TAR]C\,534
M3C"$7>*]"K('D2:@T-]+R*]\'9WLYDMX\1[]@'TRW_8<P#'-%3KW_@'Z/?E?
M#W&$*X9)7<!%@%G- G_<#<-_7O--=O6T<JV/WGXK]#QY1X=/6%,0\,C\KS.2
M=DV1/8=G@&U9U[/%!N7N#NF;JN<WD]2LN^_5+^7N/;G;@##9'R2TXD&]F*2I
M7/Z]^JI%>A*?U$B0NU1'IEU!0P/!4R[2=>?)+4G;TOB[7+,)99,HHZV)B@)
M_/78JT#=S%B?>_QCGUS%IS7JD;[G "G,+],?"\-EY7_G,FM01_M5)\%YFS,C
MY!LDPO>]7 06PK 1" ^%/ADOYXF(?[2;L'S@X#(=_63#*S[BTP'\V=DH28TR
M&@C<YOOFUM03DP=654S(Z6CGGA*TG%G2#6]5JI'@[EM*O+=K7Z-Q'YV@ZQF?
MORN<MCL:X,>NIE9B]NF;K*]^?<4D(3@I'/A:()(BC1_9+MQ[9SOUSX*LI?<W
M!!PG$+4GW^I_S@?SRF8(B9L/_+,@;D1+U@Z\4)H]P2VQUH&3\"K_F-<HKWC
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M5;.N3)/#*J5HVSV^U]13X-%Q^*#WZ:F)!EBS.9];$VU<1]%4Q&_4?E-WRH:
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MEP<T"[8OA68[)-MC2&KK&9FR;9"HP)!\UX<19XBHK5L_ZYH2\M.Y.>9IA,H
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MX8?Y"Q7X=U37'B0>Z)(4/I,>OA0,MADOM[_A%U#D>F#[%!)7Z["B*G%M/RQ
M*!&\2R=>OFPV$"\^J]T()%^;FU$P!0_7'67(4G3+V4]PU$7W'OFCSHE#Y!0[
M[#<@?F^0]__74Y%G 8B$KZC64WDU9U(%"%_3"IKMM24*%6GD0]V)S@C7P(FK
M0G'FOQT2P7Q:-#$L.:,60MQT0_&'H":U3. UXCF 0B>R5Z:QQX%:&ARY2A89
M-7AA\V/ .?J'D^6?T!4=F=_TXC.QM,*AS8>Q@Q2UQ7- )9A<&CBF\GD,7AO/
MJ3I]:.^[2PRX64:O.I%V?P*:(%7F1D;,+L/D(XC]^&VD$)1OSR+\C?T#"<6'
M,C923CVL2A(?:$>] *<6;; :X+:5\I;#TO;3I8QN@8O^D6-8WA,9=]$?H3Q:
MU*#R)C%V,ZW/^Q733O9K2I:1I1%BZR1?\5<AF-PR7$J$N2V)JUMI$C91R2?C
M)'TPG"IZP(81@3D[X?@#8SRZ<UM)V^/%.$0ZT\[!.L/?['6H:74>K71;>_N#
MK+PS=]*MM<",2)@3"N :B(3[%+J9SX3T;^U^<W&*:>E5>?V"+INEG7V+S23]
MEJI!O(-C$(7CY!R@]^IEI%MUEX'^P%" ]?KZ'_+*67F+(C9I>I70-AKR8'U!
MH D-O2>6)H*;+7&,^""Z8#G_7MW*97C9H5UL!OGY+/<<\ ;#$#*F+M'T;[ T
MAL5USWJZ;B+CM*+6]<*+#>1SE_F>W<^YVGTFW<$T&D (MU&"9')S;+7?^O@.
M<]F XK)Y]E8AN P$&3CS4V<F?L'CNAO. 7CCI*O^N>B.T\F1R*]Z+V5JF.#R
M5KW1PK3>[;X,K+1BK<&I>_)+.QE[-FVJJQ_J"IS&Z\!.#<D9N[?4RA DW;:[
MQQ>; J6X)]\5T;E#E<EV0^MCIAL&>3!VU&6' ]@2O$LV!HXW?#"DUTY1P2=^
MPXY$)GBA.:P7/A6F\_6F:P+%Y^,_VY8PZ-#2KAQ.4>TS22#:1N$<\ %.!S7#
M;GMHTIF?7HKE>DP1O=N2#6MY[B>*',]K<HR)T!JRYLP(FJ&4D<N]M*ZI2J5$
M&%@2ZK;7S@'#RS:\,0B%V8#5NI0!K&7:W[KDM%P.J90/)9+::J]951;1G2"\
M 3"*7QH/[#*,4U87PB/KEDA!T[>4:MPRH5/]ZJ+9.1$35]H$]W+SD+MYC>M3
M!"@!Q-KPO4&UU(B0G0&C1U5& N-?I&QVJ/Z]VS.N+Q*_EMQ3^.5S3QN UE@?
M&G0.N-1*#,;"HRCT>[_XQ?%354N-.XKT?I$/[3MLS-/^>W/-Z';\^Z!8DENL
MQ*3WDO$UJ*MLXYR92VF=A"EDT?UTWO)$BT*GB->R(W;B7_6L=IJ;N&4V1.TB
M9PGT/M)W\-5L'V\G6D4-_+GYD>D^]J=L* IOE, (?; D0+-I3[\G[S\P+5U;
MEE95I_7!?9;[4P+V\7Y"-[0F43,(/>]M7EO6PS8OF;QB@21,39'BRUXNJU)O
M[#4P-;.!1BU >TFZ9 ^J^X%Z9^S+ED:BRG#,D?W@>M+6@X(FN=24WA?2UY]?
MN6;^-#4U1>EDN.(?4N )#04CW_T?M/'?F6AQ5>6JJ"7%N;14W>/BWO\;P$7S
M1U","XO$YM7$KWMYF450?&' S5>K!@W AZKI*,U4D.SZ!C3YWQ[*64Z+!MZF
M[932BMWT':\[![#ILQ7IIYXYUMZ+DEAA7O*5:Y2:8/RZ^)>Y8BTO7L/UE:1J
M"J7BFW\@/;.^B0$%4A98DT1L7[1$BD'O[%E$. *H3NTZ;G,+V'GK:17JR@R,
MCKQVED!A(NM.A2A![]?NH<(5MYD[U2^%$3;&@DV>Y2YPI/UU?LXW(0%1TGAQ
M8>W+-JCXT&QIC[7SP,K^'!!>8V$?^.75VZINKW</K,XVUJ?/^O9!,\U++7!V
ME#.*AQ@X,XE0O/;&&CO 9CQ\S,)RQ^VKC\A'YAZDW%DTA9W\WY[R-N,W?RJ'
M?O 9NCC2P<]K!S3,LAQWKK>B$TMF+4G6U-81]E!]A=)9RXN\;2JD4A@":9\N
M._MUC\L2*W:MP0/4;?<@>$UJ$?,'N(2*HR8+33)HXFB7'FPMF@4=/TLY,!I?
M:8C$*<=W#OH]YY4:N;0W%+RLX:Q;5CCDV 3>5:C0,/_;3+2&>2[#ZC@[-E'Q
MJ LM=DL/'[A.[$K_E^XV5*LPVM07:^C>??'O*;H+4\.Y70$AW8,^!$6< ZZW
ML&!=ZEI%5UXZ,Z;E!216/] V_B_M=QA?%D-S]=7#U</ZV";%-!7=[#2<E/I,
M98%%9U-UA+9>NA$J-^G;$K!6L?L<T V:INE"6\O$E>@7@P/9WLVNT[_9]>4F
M**<M7_CYL__2A3]3G.0;F(Y 3-@YP"E'3&^/*:'813439-=LY>:+@,B5Z>JF
M)%X )&9;C'D;FS4ZJ&BX2D'+3?*'5$Q3IY1/YD[0! J^O@XG.QW596T1=1AW
M]LXT?64HOWK</1?K3/\V(OJ_RXD X;TV=A2)DP@SQ3=L=2_J2UF/0Q02C&=F
M'','*+1A+C$_/[WO:Y/+OA[ =Q4!SONN:.NB&U'KM4*^P_JU,"91]+3XY^SD
MPA)(FFQ]5JDN1'Y(C"DG^FF<Y4)-<'PR/1K:BH-7&J_/T_!4.<XZ;;:_:KFW
M;#B&+,C+R\[GMC=JVCX',(#-Y;(#7LI88&#I1=TH_#R,$[@VJ>9Z#@BF\N7^
M93=_"\($L0A!A&N/RP*=#+E<.3(:/L[J%QN@[>VJ'T2XVBA)WOV:?E^HR @$
M,K*SGTDBGX*H84<^=8.8=$*FK/T;=JB\_9@JMY. 3%#P5_^BI84HVC@HB[-'
M?\D:Q^@7F2)?R)=H&AC=E4Y^WYS93^&Q!R>HQ9(%QA^U8+US0!1%MF9/M7*\
M4.WN!]9SP-O&C^KRF(&1NN :#4>#0L7+=!];F[:HLB-SHM!H:#A'#Y1O 9*N
M.(;#@5?4&<C_G97 7,H,$X!LM=QJTDM#TKA4G='*Y!0=M6KK2Z8O>%]5'7#_
M8?Q+SJ==)AGBQ#KY@-2+P'7B V.(#,:LWB7]1>/=/G67OS23MA)DJ9J\-+?A
MZGCCY7A?O2(XXC/^D)U30GE(P@,#(O)KK7*VPV:TNC _D!D^^'$<;7A=<P)/
M#U9K]"A84C&9SZJ![<E6]%Z*WD5>KQU!Q$MP)X5OSV_[A/3$15UEBJP<L(3Z
M@.21)'BZ280'U75N<7/Y)H?M2J69V36*<9_=R&M"-NZ2/ P7_ YF"#M>P1K[
M04RP>9ALVBZ80(9V- )C42RUJ \P9D4,)YB)HU>WWG5@]8K%6C*"]*S;-"AS
M4QQQ;_/;IC1S)NH5*$JU,./#45(LOXS^@A(QU/.LY*TM=(H0);K LJ:4\^=0
MDGF^!.4Q$MJ$[DGZX#M&M.(!L?M['?G87'W^_L#]DIH;K#7^[I$X;>"I>NQZ
MCJMN:0FC-#C QG&_:I!!S4Q,-^18<8?4T'R"^1L"\P^GT$F4^:.6MGM##V%1
M]D))V+.CJO'"&I+XW4YYF=XT4P%E(9$P.0;^\D?]IX:$^T0A'SSSHD'"TKR1
MD<_T@OY38\L_=W7^]O8GM\_$QFHOI@E[VL]KN*KNO?WDVIF1B3YYD^%8DJ"F
M,(%3K5E9;JW=;0Z>3T,]*H?P^)OW]MJS3$$?E&B*_)B\LUR3HSTRL&$*+QZ&
MT4WG_<Q<,7]X:6LGJ0]Q@0P@-F!A-_P?+*)CU&XA9HDWM/;TN[=[*I2^J%HK
M:+E\+._V=9=BBV *D#_N0Z#%<=H.VKCGT>\E2^,!M(\-\YJKN*BR@5VD 7N(
MQJN1E9BX7'6Z=QM2)F?W@ ^ KKM,Q :"Y]F/\A U2W^OU2X*6X[I?/#GFX_T
M&QN2^=X_4+>5J^(2QK9*H@F'4R&*T^> UU!6HB.6#]2E+-"DFM[(\'9])D#H
M['5BBHI@X+UGI%SF:05C,^QZ3XXV*$.CHI;J 07,C"J3:;HFRRN396*5:!#>
M(R0XI!-V)420+'=6IGYKSG]$>\)2OVA.BAA:+A+;<[JT\S(YD]N*W<9S[A%?
MZ.*K9A!1XO@]U)#*ZY%(YCI\+U6\L]JVE[6D=!98#GKO%:5TOKOCILV-$T7^
MSHO!%MX?+YZJ:E@J+EG$&>3HZC3K-QR7W5S]O]GS?@NOZXDJ)J82W/<H7PI<
MCZTK"WV*V,*&!S@R76T"R:6QUQRV+@<>L0\9VX\9&)9,&_ /LX2ME4.G_TUJ
MQN<V+**FBW3&R$_SW7B8OF>@/::L<\IF?Y6.I13DOW\D5,1^@.AU5^Z&52=M
M?_'<*X$J^F%!ES>^UG5-E7I>36%A2ZX!/%$1E-MI>]D3B#OTC=T\G4#^V)SU
M<6K)W<2K4(HX(Q/YJ;):7WWHS4C"M[.?+7I[V$$2[Z)S9[#OIF7CV43F;O2W
M1$:@_H@5=_*\96B?<5OVVXIC0V[JXYT2'^+@$2A^=7%F3I?,G"8%QHM@3@[6
M3C!,L'%034XNXNW<C]D_:,RGYU4LWPM*.@9T9^?/S@'HSX41.5K<9CESUD%6
MP1AT,O[X_VDQ76T+D+?SZWI57\+-&'>>ZA_MEP3[A*80HY9!%EMFO"Y9L(#)
M+8MZ'T1%.9272D<,1 @6PT-V(.H$+?U+U4<Y<0)UMJZ94/2]6:K]_ ?S[RN0
M!>1ZMBD>I[$925::OM2<T>BGQE:#OSVQ"8%IN^6?+"@7RT- +DV$&NH+4\Y*
M6IS+B%F=JKE%BZ#KM9M7OCE<?X +@/Z947IUO2D[_Y:CVNHXT#MD!%AKGT32
M<K&NK,ISR1Q.<'!^^T/3)YI#Z:?QUUW]\@%-+Q6'^"!T^:CU<(N;2;RC0( P
M(B1NL#'M_UJH$(:ZCW*I8.Z&U]!N?X+?W&Y1]L'"KH(8T;)N3(+S'M)_M5XP
M=;[GUF.XB7OH>2JOX?BD[)M)#CC?<.CA:/WM#YYL9]FUDPHDQ1IUI8:SIJ-S
M0*(2Z,\Y@(;"LWF:V.Q)*IH\(CI$&8Y7WT^>YYNLFM:Q/56>5P-NL>,AO2CZ
M<X K) :"8^0U-@N2R*/,IW18OME=43:J\G_]VNP%1I[!=TOJ\$KL@LKG\173
M;X["4\<P].&PU4LQF^3)$C^.S.KJ\<'3_0VH/G4EC/'J-5C(!W7>R=IF;D2%
MM[O.7^3^]<9(Y?C06S1Y80"Q^B7[$](=LMLH114J,';4RC.UTW\G;#WCNKUD
MI%5>C++[3!?[@TCF2\<TA8';[)_ UG%Y:)LB(N] ^&D'@MM&3Q&#Z"/WX4?B
M44OIU 7\QJ\TH>90X"9D0(UJW74)W;6/RJ0G?QEKB=\QE6-P=R_X^*Y=B)T
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MHW\[#N> E.X]V%G?.> PS_J,KS+;NZ#4)'->'#712V,@DV;M-7E?)P0><'*
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M2WUXG=E\M0' JEU-VF<)(U>B<5;HL\F+ZK;%=LM8F50B!VL.TS(6MX*_@;X
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MKG*PEZ'>P'7I3I&C8&&2#(6[8RLZ6P_-LR-\H<"AF?F[W?18A4;7D9:SP8J
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M&C<)K4;;6:HF0I1O;V0P&AKST;<GWLKHJ.15S/5'(,]A1T+D(N<0(@U^44#
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MYJ@-/2!^(K6/M[-3 PF)732P3K1K\^]O"T;+@@<73P5*CEQS++B3U!$</'Q
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MZ1->-Y#^J1[6!J&P-JZFFT@Q6C;:5>X\?8Q^QL-/)\9 BS[9+920KAZ9,O5
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MLP]W9C-7Z&7$M:[CUN/I=P%>I]R:-?MK6B*IP%N_>RWMI?D.;W8Z.@@'R=U
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MY3YLO01>C) [Q<5'1B\-IQ:1A2S-WNS-;A>84\K$2Q6"WX0XXNP,[^1*;3(
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MNUG%0]_9&3, ISK('J]PB%DJN?25SB14+U3AA\^[QH<<=7JB82>EXP^\BD+
M^-$E2J(P;%!+K;;N8W%3?7WBLQ>_N!^'FZ4WBL">NRW!E_ZCJU43);;F/+YT
MR<-=("''RXO+G%3<]>3B^/Y]]9F3&U%C;=(@2DZ0R(XP Q#% & TRG4I^/,>
M%5+P6"3.'@-W_6O?2,N!B8M7EY?2WD'F;.\+7KS#2K@"_-X>R$13IKW[P4*4
MH,75PM=E4&&L%-,-\VSPUAI1R'KP/X_78><W^((_7W&&9!G?U]1[#1#Y@42
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MNA+9H%K6182&B'WP.8[\XB678^C=W,!Y//;WUX6XS\[%!O[/UY;+) ]L'Y/
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M 8WACQN6/B39^ZZQ1 E29H[WEK#X=P3D2NI]=R;U<FN[E_\$",F6:PT%-3(
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ME^\H7G?UG;/-#IDE39?.DH.Z,;JQ^]%*'AQFM5/^@^_^0TI+6.;#"VY=F>Y
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MMEFPU181Y.SI6$]MT[) _\15X-NKHRPL?H?BAZ;7W(,]G6'30%1#!SR. 0!
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MGC5KGN?_7VMFWL^+K,6"P\X^>U_E\]U[G^O<OR\M3SLWL8B/@%S2.I<C;TN
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MXLEM[3]TD)6ABON#'JE:LU]QF"UX.Z/4S7A=WM'X@@%Q5Q?2AG>PAS,C"0-
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M'M$7>$"K,9K7E88G,0@B#D""NQUH3CN#98;)/=$MUBA?\9\0@X=!>K03U#^
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M\Z(C^7Q6MNY(AYT7P10)^B_,!8G!* )LX95=&\CW'/"R%C]N4/6Y-B_R83?
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M:#^+$%0:]$S,]JF(%HLK%';TT_Q>.XS%,-IA/\.<-LVW@.XQ[C29S@[&LSS
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M%Y&*5IO>_(U2HDP&9H1F[P:V^8_Q,/GFF</.YQBE6S=(_!6$M'@]T5]HH6.
MVX-CP,QTZU\%].@TYN_Z9[NJN=*!P@7D^=5.(HA+:"G?2*I0HV!Z=FKGWX>#
M *M89=5W#FGR__PB&3R3V"(**Q\9/ 3"888DSB.A,:34/$ZFU'C]ON9@_E)2
MA$>TXX;R-C>O^I@2V%_HZ!- !UP./_\3Z'EJ^<\T0N;$?U7TMO%G*%-#C1(X
ML]O.U \HKD3'B!SQ J\$;]K6ZK3S&4Z8:QQ"0$ZZ:O;Y$O9IS4'%>9ZE]/I,
M3#FZ0U=5+Z$8;4%>2P1Z@1+T5+%!$("'EF)?&I=GCJ(/?S=*,]>,6)$@>59#
M1/"2X;4K+S4RSHGFO 9Z<*4 69@Z,.C2V)!VBFR_<&BBR+?)%H:Z5)KWCYY+
MI],'V7=D:NL$GW5;!/0$D28J<^2R%JH@X+)C@$)>8KV"JL.?I,807YR\S]'!
MS+^:98W^&*H^J:V_0!G*1;Q7@E,;FZ'O2(]>>26 F)[-"%]DW#H&L*&O(GMG
M_C?[31!Y0LNN2!^[ZVLS73O:W^;IVI3ZG?KQ?=1_QX#%DES0 )CJ5^>5RQ6_
M7Z,8Z[_^<ZAVG??!A=4?(R\O"\[TSD!R%3(4YW7"]_"-$E% 3T,2JD_W,?#D
M-"$Q:*>NH0?JZQ3,I[7_VB+3M,GIA1I,5GO+OL%R<6O1#/@W:*1J.'P?^O5[
MZXV@!O;<)*^1=1^$6,MZ-<*;(I&,\R.R!=#NPF20@ 6[/M(4O) 8E%[W1:);
M#YE;KS/X \:QNJ^7#YU >H 2!(#G$.S4S@'*H])#G%.2B9]HR:T_&=P<%Q=5
M3ANUP(:&TE(6U$CNQ->DI!XM]18*D!/ZM<*R@2;'M?8';+77*.!\.7):3%:1
MR:Y4##?OIEI70V"!_<).<7TT*!>UT#-'*3HX9-#U]RHOQU/.>O_UB8;5P#(3
M;:E9;/V_>>:Y69Q,<'5+R/)PA;G-AQJRNR3M-OT*=9)L!2*=N.I+\$#LU59,
MI\.ZCII0>EU%BYW_U[M9S\V7'%:Y+YT27:OX1->9Q'C<Q'CN7':$%>^.,[D;
M1QCYPGDOV5?"3O$AP^O/A@HLTN<1CF%Q6P)+H-00IA#I!JH:-J;?3C7$P<OQ
M]Q(O"\27:B;STV[KF'QCK"]CRX+Q; @-&'8 THH?D !LY&)Q7=>+?ZM."R-_
M/P5=CW9(/DH\X1DCVH]P&OM^357D\Z"E[Q/)S:W?UQW\$H*VPC0]C3::-\;>
MWS$]WTDWK\$C8PY^=WI'.AC I(GFM(<@DA[VP4\=E9(3DP0B\_9G' GKI4=9
M54+4'UXR77EUF;L@#,#KK!WJ2?.!N8!R!MJ$\6^"*XOT Z7?/(]2N?%3V87U
MV>/^B\-WI!O4_E@5KXF'F1CJXIU/X,@YKL'J4M78[T&%QUO96!RSFW]MMAG\
M'V+T&""FBD\[!K ''0,$[>\Q\F4%VC"-Z4T4A_ACP/2-"-35U\Q-SL45\ _[
M'.(=<@DEEYI5!W-?/&/O&[=4QP]26![0^F!R[>O+N]X=6C'/+T[9_HX726"Y
MHA97N6&:.3Z$&%X["OU[ZWF5X3NOBF#YSC8<OM"WXH2S6&^1*^+AYTE<YK]T
MU.HW$.*8R/ %_HX)E%3+N\%G']XIBK TO[VHDLH:J;3X>[6#%!NG.J$Z:>+"
MTI6AY.:F5"65^2L3\KZPM;Z*O'./:N"^Y)<T;6\4K_I;S=BWENY0?"EA3<:4
M4_GC R&9_K1TO?753D0.583YH)#K1 KU\,< @[H@TYRFWFZKPT/(DI&.;(2C
M_7B-OCM3^E^PX:SZE/1/-\P=A, 0.8^R2 Y-@9L\(X<^H?HLC8C3<;:VZS<>
M550]>9%JNQ?#;M;^W$R4TU_O%_6@F&Z,[3H[C>%0(ZKT%4C3[BMU3[EP";QE
M\7O$^9C>3QP:GJU#A"%Z$;Q4<MWZOX.A/J3P7X0$B8%N$YSV"1:T7&E_RZK@
M<F/ZX>D/_L-C:]:OHS)JM$LG;#!FW11$TNB*&Y^HDQ:\T;.S,WA\O>-@'PBB
MRY8M>!0(3*@2C1YEVOR2E[\616 ^BVM/?W3V+:WA#%.M!J+&G(:TN!X#>E+T
M[Y' 44$>='.R=+\4AZS0*8]%0Y_J[8]1 WE7P5?@M2: IT>^=2?LUG!2@0UR
M!@4ZL#%T2ZB/4/MG4G=WL[GR1R'7HRO)#98%/&[2HK[UL/$L:^*+7U9^D8H+
M"X4!DS+DDNN&W"\]Y?E;B4A(=V&@I;,^[39S/!Q$E"4MZ1BX^ ;-&^(@C1OV
M4+T]G]L DK^&Y&GV#Q>7*]7VXA(P4+\$ICBC&BT%U_KIG9;L:W>UA308.TT:
MX&OI2;TE;N?VJ-[%6EEICADM<^?\L^J.QB*_L!O,361AQ7^K267"2OW.9!]%
M]#%@A4Y/Z_1 <3 *X&KD-2.L6@TFB2GW\Z!;BW!&*S(VA5WQ=ZF<V?:S,]YW
M!5GD&.'8=F/3P?[@TY_J^ S_553HAUM1$NEUX:G%&"T]%L1483-H,$7"AM06
M$S2LB^P/\%)^3X?4]%SFMW>MLN8>?"QE[:G!IA/K+=$Q(^5-[5P.):K0I#:%
M;9K(SLL&U->+29LQK9_;)XI257PM+'Z]B.4'?Y'R,[2*4N:2;%DL+_NZDAD!
M[3X&U+=J+FB=OW.S-6O'M053LW[B(YG%GQ7CQ>_(DA3[$4JDJ;]S.MH!U>MM
MU8E]3-U<VU+<EVBZ]!GN#=GEL6A(LR*1FV8"5YEHQ@#4\SSK9A+ $/)@N]_E
M1V&#8*5[G":\5Y]Q)S=P:UCF=_&O5<3E6_C^_]?%X?_]9[42L><\/4UI6T..
M4O3R&#5R3'D(7,F6>6%,5$^:]L+-N^N6I,-2VSF<WUNQV?/?V "+V$A2K^)E
M?=).7P-UVD.:_'RF7^V.?%0\;MECP?"G ,JI1&A4<P"^3#."ZU-;2+P4X.1!
MTC& S_X;^0;'S%/TM%SM(NP%ERRIDO1F<"1:^Q0!'4/B2L1M+G'%Z9BAG#^&
MJ<KZ&#)W[U:VJV]*-5[Z"- C+P)DR@38><-5RZ 'LR5,R*_X7U;]]]4S,F.(
M$W/SX#T(2/]3,9I[$ND!/)&UEISXEECJ5?&L113+>MO9>36&%U]HN[]*-/I.
MV)587'K^QY21KW5<7(A?$OS' />TA%SI:*"'K)/&X_&6"FX[&,;,((6%Y^P?
M7&79Y2Q.=<F;VNAGB>-/-[0-UTT8!=V4G=7VO*''X SS 3_9B.XV(J)3PL_2
M^0[-&7X7BQ9@CJ(5R4:QBL> IN#A<XM0*.;&G5;^SPDBJ^EV%M;Q*^(M>VO1
M"'G$1&'SV.M][9W80 _FI0FB]]/$PW[<OE+<%"K[M@+\/_I[/A<>7R'NUV_]
M^[($)TIDQ@,MOFEK_X/\VUP)LNXW?/?.WJ>9Z-O:=C#[@Y:+#F!\/O&=/,P1
M(->^6& ?OY8U8Y59*5=F;B_T(EDZ2W+UP<NKHX^"I5QTP%U4"[QU$PF==K8S
M5(S2)O;A5F0P3XR)[^E3DI4  ,>+5X#-G^!!(,D&="2I=_$8T/ *N:[SZV^/
M&3>[G_6/'(+,E'#?:/'X;MN?9OD^<C1E.F-"NX6JN_C;9_Y,]'#[_1^E+YXB
M/=8J6D*036W$LF"R).'$ZEY 7(49(D_!F%)NB;C["^;CUG/?JQ>5U><^"3W]
M?O["3XE25:&2-M)@GEQ]@V%K.G_H%8#Z11,U4F$*7;\,[G,,B$J#Z_JQC/"C
M!&)]3DVUF/'O73VM(OM)H>N21FW8J(8>WHL8'>-5GU2>@;6.E"M .:5I%5?%
ME0AOU/B9B[5TVLMK_** 9B,HN>30K:5RJA;HW'J'7EEPW?R(SS4OTO<-]6J?
MV49;DHGO2W/_7;H3HZ76Q7-;[P+,T%92)%]^V[)4<D;A8W_A1[6Q$U&UKI=L
MFF1>GGLX>RW)^G.H-V_,Z6L@\:DM<"')$O1*O;713""EK"M8Z%)?"9X-^0S-
MY\@PKBP1./ 8O7R4]Q*=0H3Z[,DT3PZ8YIMVI5LFV9>%S*$PQ3<8.1CO<WJZ
MT-RQ-\$G(9NC*@[E*@LI-.?%RC5>^P1VG:O^_OV'<K*RQFF.P+3GU"(RL _#
MUB50":L8$.CM,VF"O&]H7PGL'4RB6PR] KX]@_T*;$3DU<)?,FIT7,G;NNQK
M?0N<'4WJ6NZSDK^O;_HDZBXW]/:;73+F[+FGJ69$F<&?5+Y/)YXWA& G<,_-
MW)#))W4^M'.;_N#19[;6/8MR<379B=(<V0P+,P38#;^(ICCI/*Q:VIC.7+/T
MRR+^:#8C1]3'8R>!T$*<R+*67ATI;;$[#^82>,ZORTCOPO?HE*_VL,O[*U?]
M+QJ:AT.^2. *!\35J#&*?<@$")<:%RMU0=:FTT1^.<S;]YJCK__<EM"5LW,;
M()'HIQ(E00R]69.&ML;&*&T';=BTX-.8^Z4>)>S5;'<!+'R*[PH\,I\?O?+A
M2@W "NT3/F5YV0^J3J%#=T,9<G["?%D5,JB\^J2<$7OLT5PD#$ODHQDH?A'J
MXN;^"6R#].-Z/?49*B<HZ<[Y1 @XA:;[2BA*V%/LZ3V,KB#%Y&DDOXX0 T/H
M%MXS^J6CKP*[OX#CXZI(EW.V^\#(-[FB8_?M+;P"%=9KE>+]X-:P&_,8H&CC
MK%Q;N;3V6*3LT.-@WVC]@&\1TC06C?$ 7J#F/2XD'*8V<_%Y9-AM-;=./#5>
M25T.S]^RF197CY6 [1J);?80D5!04B \@EI'PO=EFRV+P;P@KJ2ILH&NV[AU
M_Q*3-9!./-_[RX+4$*D/3RDO/NV^F]=4Q8$GIQ2G&76_0'R"D]8R!@.0'*<#
M\WT,-!2COV,OVX\ 4)'+:;$^.N;  0S/7Z;\YW3)R!M8PY1KME\OOC!\=L8Q
M<_5U_DS/GRZ$N0.EGSK\QRN7%1/+Y/+4'OM=&_RJ:?XK&M4AU#X:7HJTV.].
M0Q-*FUO;)B$#]'2(;?/EN>NAD?+UA5%'S9'Y!O $FC)S',\-&O1Q61P:-(M0
M)P?7M7<T3'DOVTZ3[W+>.W?ZT\U061G4N2_)4X6S.91$,GCKB* 8HV%_8:MA
M7>!?,GY6&*[^:>3Z/G?SF?YR@^NV-9]933]\^I/7-XSKS?#<V_IWDB72/RT'
M[C^IL!EYZ;Q9W8J9KIA^ AZP'UDC9I%E33,'G,61%^%W)M]S3A<(M!NO_I)*
M$[*\FGW^\AW1I\TP76OH./(Y$ >V813!N6H'"$G&WG2GI=D&]\ISEP8S8ME>
MY)T_<KBY\24@Z^N@OTB?R7VKCL-0\%30/OZ'Y4"O5;(<5GT4IZNXV184>=4
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M=V^&J ^XWVZ8S\^+?R>.N4EK>=3W/6C*9B()S;3 3Z%#KL$J>VLK2^>R6O?
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MX%)DC^&R$O,K6M)0.W'.]G0D<L*EWHR"9+0CSL,$%OU>[U^ #L9.VDZJ1D1
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M=E\-I'BSXBS#R\P^'M7V-H.>9=T9=@TGF5[_[:C.K!OV!_A7#FVZ$_FL:5>
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M:A$^+@Q<8MG9_6E&1?#:$>L<TH?J_J+OT:HI63USR'8-M BM;L9K"5./A.=
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M+G2.6--91X/UG>Y?Q7(_R&;V<V\SQ\OT#F=!:4F'R:E=%BGVTDJ#,M]LVMB
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M,6O1^],AG/].2Z3_9@/:*YGU/)(+/!%' HPVP!XX@!_"A\''E,'X.\1*0E1
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M)X)X\:S&.;D'EU-NBSV2/@[1.RV+S,:]<3X!I:LS0IAI#,.R?K+BO@DE*")
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MEKPA\I,>7WQ/%('O84=K0&IRT@]J#W#?$\T*VN&G >J$ZF">HV>]8)S(?[V
MO+HRP2BUQ2^>*7,V)Z77_OMIYJBL+IG$L*4-^4,7"IADK"U).?22]CB$.U!6
MT"/-1E<T3VAJ53M'M]%E0?HQ-="S_\?C\R["^P\25IN9[WXQR4DU'%"$Z5+
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M0X%+,'H8*D=1XBW' ^,C;%M@<J+[JV8,6?Z<)8R-HI;Y4RJE$HZ2>NK%Z/5
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M@;F.7H&(3[:"5Y+?J_6T5ZV@N?6K[2G)_Y7_EG-LJ61P['9FJ'L D)]J!'\
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MIJ&G0I$.+L^:Y5)S8(3M:8M3[SG;SR%=<(E_9:I"JM2%SE9[>O"H;AT9)D1
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M@PAQR\PHM:>1IJ/9H<N:H5"U7ULHNYFFCZ2>>#DST#M!":FUKLF+]Q:SFJD
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M;'?;+%[SLMY$Q[IM96OR 5G*6;ZZ.'"Z)4V3@(-2AZ9=0*PN\.1VB\H9 J:
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MKJ!(S9_\[;J)+5-O]]_]O_ I%G1CMY]<KF+7@9<W)/9[HK:.2E/2Y-'.VI]
M.G7CB2-=<8YNYX7'NPP,PJ;06D[#8H_NEN+?#VFV++G).:HL(OPD0ZR9 "6/
M!TRY;\#5#[E<GY/+1=+OR3:PW N&"?@9]9CX^L)X<*K1&!X+M<CPPY+'8E\_
MKRB^T[CI1WNPH9M+>H(MK5^N;U++]TO5G)"]I$OO8V%!R*E^C/23+>S2D)9)
MZ&(2M]YZ:1A5XE _,F4:3C+.]A-3JY_R(1N.:XR5?)"QACPM?_)=D=M>L4\0
MH)P0,83-Z-RC\SMUQ&"'(V5!UP8 OPMR-I\MR-I.?G[K09A6)JKYT;7!65K8
MG$Z%.AD-O,%7[L=H']UICAFQD*Z;H;S-N)4V [S'O\Z5G=B5*RY_X;9P+2_\
M]PX)A!&7[$J1*T5D;<HWU"1[IRXU52;:11@/21?G?.H5V!0;IHC"QC,8*/2;
M]S8H,CB?TKA?3X/4*\URZ[^)_!V\(;S]<VFI#( IAMX9@5[ &BVUQ-HM[WB.
M^ '!'P:8JGU_/<'V5MRW%=._I%8_OW_O?FN/#@&R%)*+3>Z!5Q]WPUF@3Z=4
MA H=(WUN_1TG1.!GBUVO_C8P!\G5Z(:- @04Z01^R<WJ?Q8U^6%\\BKU8-QN
M=;;#XIK2\YM"KHZRM>,66W\2D;S#30+DGRT\M9^]P6S:*WI\PX^FTK+']Q"E
MZA7STN4FEP51GI?X5SW0['\OMTU(?^GOX(]YA$B%@2C#\/--_LL0VA>$RA?C
M),Y,QS$07FC&1]E%E7[,JG14LXG=SBVQ1=]_*6IZ-$G^GF.2//[=Z(G)%*[8
M0(->V?@A /:X[(?CKT6%YD5R@S,:>12XT9^=?+>D8@Z9[XJ>S,^J1W) =;"A
M'U)NXQ0BJL!,5?/=<BX:/(94 %@JQ-E"?5IVC\6QS$E)/].YT/$@>M1J]FFE
M.O^1J>$C$J.M@ZOS&[??B(% W8FS&DM%+YL U@]4LYQ\Z^U,J^A<\GB-/RSP
M12][VK)D.!\+[CB#"KC4$^$-N7;"=0"O\+GDVM1TN+!6WK/R.-*QZF/?G83W
M:;SL:E;3A\,,&PK7\RI_H1ROVU7LIN-/?4*X0AX.*%\ME'ZX>ER\ \8 @[TA
M3'-^GPQP\K$V/Q=N]5TL\(&SO:LHNE(D6-QF=O41+9\ZAYO-@L#/K/(FR140
M,V$%K$"Y,>V-OFI6]%9!R6K55RKD</YSU/0@!/LL-OJ9'^=23$$NX7UW^=]T
M>>?&ATD-]H7B1X)A=?8O?V$>YFH*7GEY>OU7NV%*OHN%[MYKG1Q;?6/)+#UR
M[VE#Q/[>)RJ 1^7:"C.3GX5.)6[W8PDAR46>YG;4]4Y.SGBMLI $X1OU-B'B
M<>E,SA-.A4:)(HJ]*7*VYI<]-MD,U%^__6]OD_S'_F/_S0:-I@(N2! "%<(H
MM"@" GRE ?&YF@LQ9M;SNZS^$N%4*AJYQ+[- ;]1G$?^;DOXM9T')&@BJZTT
M2?AK=MFG)Q\04XU(/C^-\9Y%^NDF!5AF\9&S2''N\,N_IJ 0+X+IF@^RBU%_
M#J_31*#[P[HBL"+U\_:WMPJS*,@]K']/>C$2>]-JPK%)C]MFBM2'T'Z/V'WG
MD!96<$/<#V-7&0F>4H@GDE<#O:@ VDFLX*ED*W&/RTGM'6*%5]_EL?8WFQ3!
M5^$91?06%#K+,VX=[0Z3AHU!Z&!7'D*WKKV36WAU>V-- G-&NVL\!JF P(C3
MN=86M@J"[Y(5<T>-G6&/1EG((!=NO_NC+[!4&E9]@L;V+.G'$@.A[H3RE0PV
M)Z6NV) =R?@!W4#1-Z,YER___!U7UQI]+0S@Q?^G(=-0SB,>466#6-CM =>3
M8G2^KNO27.<9"@"9[H&Q#2?I_Y0=.<9<FUB%.B2CKC]QP>_1.TMUJ0XI/-R^
M(8*?#X;O%"#*#GF=QCM3^#**S'3NE"-K8S;I.;,U-KG!F$N(,!6/L_LN)+RW
M65KPW.I(.8Y8G_Y9D6+!A9#82>>^\_PV>_M< ?\7.EH?A!85$.1.TG<#PH;>
M*>G-!U>#&.95$T5K%_=#A^D%1@3>GDV!?<57QX$K*_J6\S%$"^U LBG&F7XR
M1%RG^/[SR=KF>9C.XE9M[XD,WH6P@4$'(3E:9!2"6]BW(*SZV<77W&6][A$Y
MDQ\,+5 L6<CDG:@=8BC"K03&0IFB JY1;I+41IL>E,"&546P[Y(#!01/UXB6
MWUP>:KP<;!CDC,_TMQE@SO6/);'"*3I[.PQ4@(T?_# +W[)?(L4NTM6EPPDM
MG]H[,5UU",XUT?>,UI5P=+2;%UM'H&CP-[&2.\ 5,3<60K()CC&:W)SRXFZ
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MBMDZ$9_? 9JM75YOU>4-<*/Y*Z25:E!US:KW.&&>^XE-/Q50\FYNX,9.JTJ
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MEA>8H>=$5JK:6[()WW$6[1ET*M*+_+B82H[PG.*B2^E/_!FT9ML+;U5*+?T
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MJJJO.!MFN4+0+JVC[-?P>4WII\ J*JLI>VTW6)I%%;^I:15&.XZI].-/Y /
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MT$4,Q;D;2JWC>\^M+^-A$1H,>H&^1I:EW":?E/HWS0[H((]'DRQ4H;'@@Y"
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MGRR01I\QNB6^P L0CB"SI=YH)R(A<C>N%B;)U_\E.G\M945:L.KFUHMS>AN
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M]1__^,<__O&/?_SC'__X;^B/I_\+4$L! A0#%     @ 5H!P5@)(YWA-" 4
MU,-& !$              ( !     &=E<FXM,C R,C$R,S$N:'1M4$L! A0#
M%     @ 5H!P5OMJ6]X?&@  C"T! !$              ( !? @% &=E<FXM
M,C R,C$R,S$N>'-D4$L! A0#%     @ 5H!P5LF8MZW;$P  4A0! !4
M         ( !RB(% &=E<FXM,C R,C$R,S%?8V%L+GAM;%!+ 0(4 Q0    (
M %: <%:84'Y] 38  +CJ P 5              "  =@V!0!G97)N+3(P,C(Q
M,C,Q7V1E9BYX;6Q02P$"% ,4    " !6@'!68GWO20#E  "@K D %0
M        @ $,;04 9V5R;BTR,#(R,3(S,5]L86(N>&UL4$L! A0#%     @
M5H!P5A3L4_QF6@  _-P& !4              ( !/U(& &=E<FXM,C R,C$R
M,S%?<')E+GAM;%!+ 0(4 Q0    ( %: <%8/VZ$SS@$  *8,   /
M      "  =BL!@!G97)N+65X,C%?,2YH=&U02P$"% ,4    " !6@'!6V;LN
M=P,%  !!.@  #P              @ '3K@8 9V5R;BUE>#(S7S$N:'1M4$L!
M A0#%     @ 5H!P5JC%3JB3"   @D(   \              ( ! [0& &=E
M<FXM97@S,5\Q+FAT;5!+ 0(4 Q0    ( %: <%:@S=*RI @   1$   /
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M-E\Q+FIP9U!+ 0(4 Q0    ( %: <%;+3Z95;VH& &I4"  1
M  "  4)Q$ !I;6<T,C8X.3(Y-E\R+FIP9U!+ 0(4 Q0    ( %: <%9J-XZ%
MOCH$ (",!@ 1              "  >#;%@!I;6<T,C8X.3(Y-E\S+FIP9U!+
M 0(4 Q0    ( %> <%9P5:Z&&'X% #(U"  1              "  <T6&P!I
F;6<T,C8X.3(Y-E\T+FIP9U!+!08     $0 1 #,$   4E2     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
